>FECAFAII_00001 hypothetical protein
MIPHHSIAILASKRADLKDPEVKKLAEEIIQAQEEEIDKMKKMIKEME
>FECAFAII_00002 Na(+)/H(+) antiporter NhaC
MTSIGVNIFIGEQFLSVILPGNAFKETYEKAGFDPTVLGRTLEDGGTVINYLVPWGIAGS
FVASTFGIPTLTYLPFVFFSLLSPVFSMVSAFTGWESQKNL
>FECAFAII_00003 Na(+)/H(+) antiporter NhaC
MVIVLGIAIGVVGLKVSPNITILAAIGMVMLYAVIKRYPTDWLHEGIINGIKPGIIPIFI
FILVGSLIAVWIQAGIIPTLMVIGFKLISVQWFVPSVFVVCAIVGSAVGSAFTVMSTIGI
AFFGIGTTLGLNPALVVGAIVSGAVFGDKMSPLSESTNLAAAIVDADLFKHIKHMMWSTV
PAFVVSFFLFMILGHTSKAASLSSIREVTDVLEANFTISIWSLIPLFLMLLCAWKKVPAI
LTILLNIAVAVGMIFIQNPQTSLTKLAGVIESGFVSNTGNQQIDSLLSRGGIESMMPTVS
LIILTLSLGGLLIEFGLISTVMERVSKKDDEHTKFDFYNIDDKYRSKYFYW
>FECAFAII_00004 p-aminobenzoyl-glutamate hydrolase subunit B
MTTTISTNQLKDLIQYRLPEYQALALDIHEHPEVSNYEFYSSAALIKQLEKERFWVEKEV
AGHRTAFDARYISNKPGPTIAFLAEFDALPGIGHACGHNLFGTYSVLAASIVKQFIDETG
GEIRVYGTPGEEGGENGSAKGSFVREGFFEDVDVALCVHPAFRYGKTTESLANDPVDIKF
YGVASHAAAAPEKGVNALEALIQVFNGINALRLQLPKDVNIHGIITDGGVAANVIPDYAA
GRFYLRAGNRQTLDKVYEKVENIVRGAAISTGTTFEFGLFQNAVDDVIVTPSFDDLFFQH
AKEAGVPDEEIETEQRTSLGSSDVGNVSQVIPTIQPTVAISETYIAGHTEEFKAAAKSDK
GLASIAIAAELLANTALDLLKEPKLLERIKQEHQEIVARKKQEGATF
>FECAFAII_00005 D-methionine-binding lipoprotein MetQ
MKKIIRFVVITFVAIIWLAGCSQGKADTTDKKETIVKLGIIGEDTDVWDNVKDRLKKENI
NLEYVKFTDYNQPNVALADGSIDLNSFQHQFFLDNYNKEHGTDLVSIGNTVNAPLGIYSN
TLKDVADIKDGAKVAIPNDVTNGGRALLLLQTAGLIKVDKAKGQAPTVSDITENRKNLDI
SELDASQTARALSDVDISVINSGVAVDAGFNPASDAIFLEPVDDHARPYVNIIVARKEDE
NNKTYQKIVDAYQTEDTVKVIEKTSKGSSVPAWETFGRK
>FECAFAII_00006 Methionine import system permease protein MetP
MTDFFKTYLPNVYLIPDEFVEATKQTLYMSFWTAFIGGMIGIILGVTLVVTRPNGLLANR
LLFEILDKLINIIRSIPFIILLSLLALTTRFLVGTTIGAKAALVPLIFGVVPFFARQIEN
ALLEVDPGVIEAAEAMGTSPIGIILRVYLLEGLPGIIRVSALTIINVIGLTTMAGAVGAG
GLGNLAISRGYNRFQTDVTIVATLLILILVFLSQFISNQLIKKITH
>FECAFAII_00007 Methionine import ATP-binding protein MetN
MIELRDVSVCFKQKEKEIQAVDSVDLTIEKGDVYGIVGYSGAGKSTLVRVMNLLQKPTAG
EVIVNQTNLSQLSPKELRKERKAIGMIFQHFNLMESRTIFDNVDFSLKYSGKSKQERRQK
VNELLELVGLEEKASAYPKQLSGGQKQRVAIARALANEPKVLLCDEATSALDPKTTLQIL
ALLKKLNRQLGLTIVLITHEMQVVKEICNKVAVMEDGRIVEKGSSIQIFSNPEEELTKDF
IRTATHLDQALETIIAHSAFADQIANKWLVELSYIGNQTNEPLIAHLYSKYQVTANILYG
NVELLQETPLGSLIVTLAGETKQRKKALDYLIKSGVKINILQKNDLDSRIKVIEGGR
>FECAFAII_00008 hypothetical protein
MRVTTSCSSCVHTQLLFKYDHTLARYRSQPSSPYIYARDELLDGHFPIVVPCFFSATEAL
CQRFFYRTYHFNANNIQKKSPFTNINYVSKRTTYRGTTFFRKFPSLKPNISKREIGVRFN
GRTVPNLPTYRQIILQGHFQLFLLDSSHQPEPLCKVSKLTFLFNEIDILLLGLIYMRKTE
KSSTKFKLFFLYLFFCFFI
>FECAFAII_00009 Phosphorylated carbohydrates phosphatase
MKGAIFDLDGLLVDTEKTYRDGWLWGFQQFDIHIPKEIVDAWGGKNWKQSFDILVKAAGS
PEKVQEVRAKREEYFYQQLTSGAIHLKPYAKEILADLKERHMKLGIATTTVTKRATDILD
HFKLADYLDTFTFGDEVSENKPSPIPYLTALERTGLEASSAFAVEDSLVGATAASRAGLG
VVLIPDSSFVRNYTVEEKEKLKLLAEGKDLRTVIEMLNKKTEK
>FECAFAII_00010 Magnesium-transporting ATPase, P-type 1
MEKKKDTQKIYAAFAGKTKQELFELFHASANGLTEEQIERSRENYGENAISYGKKTPFIV
EILKAYITPFTLVLIALGIISFITEYVLAAPGDKDLFGVAIIFTMVIVSGTMTLIQSVRS
NQAAEKLKSLVKVTAAVKRNGKYTEIPMEEIVCGDLVRLSAGDMIPADMRLLSAKDLFIS
QAALTGESYPVEKHAKVCEDDQQSETSYENLVFMGSNVISGSAEGIIVSVGNETLFGHVA
ETLSEKPIQSSFELGIHKTSMLLIKFMSLMAPAVIVINGLTKGDWLEAFLFGLSVAVGLT
PEMLPMIVTTNLVKGASVMAKKGTVIKNLNAIQNFGAIDVLCTDKTGTLTQDKIILEYHM
DCEGNEDDRVLRHAYLNSYYQTGLKNLLDVAIIDEATETLDTDKINYQKVDEIPFDFERR
RMSVVVADPAGKTQMITKGAIEEMLNISKFIDLGGTVTPLTKERKEAVLAKVQSLNEDGL
RVIGVAQKTNPSVVGEFSVKDESDMVLIGYLAFLDPPKETTKQALKALKEHGVAVKVLTG
DNELVTRSVCRQVGLEINELVTGEKISEMSDHELAQVAEDHEVFVKLNPQQKARLTTALR
KNGHTVGFLGDGINDAPAMKVADIGISVDTAVDIAKESADVILLEKDLTILERGLLSGRE
TFGNIMKYIKATASSNFGNMFSVLIASTFLPFLPMLPLQLLFLNLIYDVSCISLPWDRMD
KEYLDEPKKWNASSIGEFMVYFGPTSSIFDITTYLLMYFVICPAVVGGSFHTLDSSQRVI
FIALFHAGWFVESLWTQTLVLHALRTPKVPFIQSNATFAMFVITTLGIIVGSVLPFTSFG
AELGLMPLPGNYWLWLFATVIAYLALVTAVKKIYIRRFQELL
>FECAFAII_00011 Nucleoside diphosphate kinase
MERTLVIIKPDGVRRHLVGSIIQRFEAKGLAIAEMKFETMTPELAKEHYQHLTERSFFDE
LIDYMTSGPVVYLVLVGEEVIDIVRKMVGATKAADAVPGTIRGDYALPGTENIIHASDSR
DAAVKEIARFFPPFDINKPSEKAAK
>FECAFAII_00012 hypothetical protein
MYDGELIKKLRVNKKLTQSQLAEGICFKTSLVGIETNSVKKMSFVTLRSFLERMNMTLAE
YEWMRNQLDEPIKLKKKRRMLDRVQEDSFDPYKEISNNRRHFKKTEDLYYLVLNLHMVEK
TEVSETEFEFLRYECRIIEEYLMQIPDYGQFELSILADFPWIFSDRFIENNYLKIKKRMR
RLAQLNNHEQYLFTFLMNLTSFYIENGRLKKARSVNEDMKRSLAHKERSTVIYETLMADY
YQRLISAALGEEKTKDYQEFFTVLEYMLGKNQRRSLEKKLLAIAEPSN
>FECAFAII_00013 Lipoteichoic acid synthase 1
MTQLKKLCQNRLAIVLTAVFFFWLKTIIAYYADFSLGVEGTIQYFILWINPIATTLLFFG
LSLYIKKPKPALAILLIIDILNTLLLYLNIIFYREFTDFITVKSVLGFSKVSQGLSGSSF
SLMKPHDVIYWLDIAVFIGLLVWLKVKKIPIKSNPVGKPMAIAVTCLSGLIFSGNLALSE
ANRPQLLQRTFDRSYIVKYLGIDAYTIYDGIKTGMTSSVRAHASSNGIDEVLDYTKKHYA
EPNPETFGIAKGKNVIVLHLESFQQFLINMKVDGQEVTPFLNSIFQNQATISFDNFFHEV
GQGKTSDAENMLETGTFGLPQGSLFTELGSDNVFQAAPAILGQKQGYTSAVFHGNVASFW
NRDHVYKNLGYDNFFDRSYFDESDETLGYGILDKDLFRESAQYLEHLQQPFYTKFLSVTN
HTPYYTDDKNFDFPSLNTGNSTVDNYVRTAHYLDQSLEQFFTYLKKSGIYQNSIFVIYGD
HFGISNTDNKDLASALGKDPDTWDEFDNAQMQRVPLMIHMPGYTKGTVNHEYGGEIDVLP
TLLHLLGIDDKDYLHFGTDLLSSQHDQVVAFRNGNFVTPKYTVLGGKAYNNQTGEIIDTK
AAGIDEEISKDQEKVKTALSLSDKLNQENLLRFYVPNGFETIDPKKYDYKNEAERNEAIE
KQKGEHSTSVFSKNGNKTTTNLYPVTRTDVEQQKNNQ
>FECAFAII_00014 hypothetical protein
MRKKRPFLLFWLFGFFLLLILSAAFSGKMTADLAQKETEKIVASKESVDNFKKEFSTYWW
AEYKITANYEKGELDIYLPKGKEENQFINIDDVLSAISLRQYQFKDKHLTVLLLTHDGDK
VARLKNGKVITAYSEKVDKKVVADRLAEWKKTNEQVKKTTVSSQKNESTGTSPSDSGSGQ
TITGSEENQASIITNESSQGQYQSYGQ
>FECAFAII_00015 6-phospho-beta-glucosidase GmuD
MKKYQFPANFWWGSAASGPQTEGRISGDGKGENIFDYWYKKEPQKFFDQVGPEKTSQVYT
KYQEDVQLMKQTGHNSFRTSIQWSRLIPDESGTINEEAVRFYHRYFDELIENGIEPFVNL
YHFDMPMYLQEKGGWLNRETVEAYEKYAKSCFELFGSKVKKWFTHNEPIVPVEAGYLYRW
HYPEESDMKKAIQVGYHEALASALAIKSYHEMEQGGVIGIILNLTPSYPRDESNPEDVKA
AQIADAFFNRSFLDPAVKGEFPSELIEIVKELDLMPVIHAEDLTVIKENTVDLLGINYYQ
PRRVKAKETPIDTKNGPMPEDYFDNYEMPGRKMNPYRGWEIYEQGIYDILINVRDHYGNI
DCFISENGMGVENEARFIKEDGMIHDDYRIEFVQSHLKYVHQAIQEGANCLGYHMWTCMD
NWSWTNAYKNRYGFISVDLAQDGKRTIKKSGHWFKDVSDKNGFEA
>FECAFAII_00016 Ribose operon repressor
MASIRDVAKMAGVSVGTVSRYLNGQQLKEKNMKKIAEAISALDYKENIIAKGLKNNRSFS
IGLLINGISSRFGSEVVSGIERVAEENGYSLLLSGFADQPEKIEQKIEYLMKHVIDGLIV
FLSEEEWSGFEMLTKMSIPVIALNCPEGPAGIDTILVNDRESVAKVIAHHGEQGHKKIGF
IAATQTDYVARERLAGAKEAVQNDPSIQLEVFTGDYSRKSGYYGAKALLEKGATAIFVSN
YNMSIGAIECFNQEGVRIGKDIAFSHYDYLDKNDLSILPKITITPPTDKIGERAAEQLLK
RIKKEEEENEKVIVMENIIHGIN
>FECAFAII_00017 hypothetical protein
MKKLIVLFILSAGLLTLTGCDLFGGSDQSSDETTDSSVLKAEKADTTNSVYTLKVRKDMD
LSAGQLTFTDKKMEWTRTYQTQGTDSSESSEEKTVLTDIKITTKDDEYIISGKENKKETT
VIFTKIGNYRLKDEDGNIYSL
>FECAFAII_00018 hypothetical protein
MIDSPDYCTCNNNKNIHTEFNDQGSLSICDNCHKLVKDSFKTFESYPVQNYVKSRRR
>FECAFAII_00019 Deoxyguanosine kinase
MSVILISGTIGAGKSSLTDMLAKEIDSKPFYENVEDNEVLPLFYSNPEQYAFLLQIFFLN
KRFLAMKNALVNDDNVLDRSIYEDSLLFHLNADLGRVTDIEVQQYDSLLDTMLNELDDVA
PKKRPDLMVHIKVSLDTMLERIKKRGRDYEQLESDETLYTYYETLNTRYNQWYEDFDVCP
KIQVDGDKFDFVENPEDAKKVIRQIQEKLAELEGKPAGKYFTDNQHAKGQELG
>FECAFAII_00020 2'-deoxynucleoside 5'-phosphate N-hydrolase 1
MSQIYLAGPFFSEEQIDRVSRIEKALEENKTVTSFYSPRHHQESNYELFSAGWAQEVYEK
DMEELTNAEFVVAILDFEHQTIDPGTAYELGVATMLKKPMIIVQEETVPTNLMITQSLHT
YLKSDQAVREYDFETLPVETYVGEYL
>FECAFAII_00021 LOG family protein YvdD
MKLTVFCGSRFGNKESYKFIAQTLGKYMAQEEIELVYGGSYSGIMGVISKTVLENNGKVT
GIYPNGLFETELPGKDVTTFIPTETIDERKVLLFEKGDAVLVFPGGLGTLEEFSQLLSWI
AIGLTPDKPIGILNIGGYYSGLQQLLETFAKEDFMDKKWLDQVIFSNNPLELVNELRAVS
IKNQLLLKEAK
>FECAFAII_00022 hypothetical protein
MKESELERIEYTDFGLGAIETVQSIGTLLEMTMKEK
>FECAFAII_00023 PTS system fructose-specific EIIB'BC component
MARFSEGIYEPITVLILASMVTPFGLTIAYFLGKIIRKNILNRQEIDTLKTAFPMGICQI
TEGCFPIVLNDLARNVIATGVGGTVGGGLSMFWGADSRIPASGMFAVATMTRPWAFIGAL
LAGSFVTGITILLLKKPVDPNAEIIQEEKEEEDISWDDLTIS
>FECAFAII_00024 Mannosyl-D-glycerate transport/metabolism system repressor MngR
MKRTRVLYLEVADKIKEDIFSGKYPVGSMLPTESELEELFQVSKITVRKAIELLASDEYV
AKKSGRGTTVLSNRPYNRLSKAASFTQILENSRYEVRKETLDLQLVHIKKEDPLFSFFGE
QAVCFKRLYYLNNQPYIYFVHYLPQEMMQFSREEFGKESLYRLLTKKGYTIDSFSDDFSA
VFLTEEEQGILKTDAQIGIKRIRKSSTQIGEMIEYSEAVYHTELHPYHIDYET
>FECAFAII_00025 Aryl-phospho-beta-D-glucosidase BglH
MIETEKDYPLQMLCLEVSSALRLSAEEFDWTIDQEKYIYPNHRGIDHYDRFKEDLALFAE
MGFKCYRFSIAWTRIFPNGDEGTPNEAGLEFYDQLIDECLKYDIEPVITISHYEMPLHLA
KEYGGWKNRKLIDFYERFAQTVLERYSSKVKYWMTFNEINSAFHFPALSQGLVKSNGAGE
YQNIFQAWHNQFVASSKAVKIGHELRSDIQIGCMIIYATTYSIDANPVNQAATMIQNQEF
NFFCTDVQVRGEYPAYTARTHKKYGVDPEKLEQTEKDFQLLKEYPVDYIGFSYYMSTAIN
ETDPQAATSEGNLLGGVKNPFLEASEWGWQIDPEGLRIALNELYNRYQKPLFIVENGLGA
IDHMEEDGTIIDDYRIDYLRRHIEAMANAVADGVDLMGYTPWGCIDLVSASTGEMSKRYG
FIYVDLDDEGNGTLNRSKKKSFDWYKEVIASNGVNL
>FECAFAII_00026 PTS system beta-glucoside-specific EIIBCA component
MDNQAVGRRVWEAVGGQKNVKSLVHCATRLRFRLKDESLADTQKLKEDPDVIQVVQSGGQ
YQVVIGSNVADVYQSIVDEEGLAVSEDGKEESKNILNRLIDIISSIFTPFLGAMAAAGVL
KGFLSLATVMGWLTADSGTYQILFAAADGVFTFLPVMLAFTAAKKFKANQFLAVAIAMAL
VYPAITAVAGAGEAISFFGIPVILSPSGYTSSVIPIILAVWVQSKLEPFVKKVIPQFLQM
ILVPLVVLVVMVPLTFLALGPIGTVAGNALGGLFNSIYGFSPIVAGLIMGSLWQVFVMFG
MHWGFVPIMFLNIEQYGFDVLMPMLLPAILAQGGAALAVALRTKDTKLRALGISSTVTSL
FGITEPTVYGVTLPLKKPFIAACISGGIGGAIIGFSGVKAFSSSLVSLLTIPTFINTVDG
VESNVTVAVIATGIAFVLAFVGTLILGFDEQTQDNQLENKHANAGEPITSARHTLKSPLT
GKVLPLSEVPDQVFSSGVMGKGIAIDPEVGELVAPADGEITTIFPTGHAVGITTTDGAEI
LIHIGMDTVELNGNGFEILVKQGDLVKAGDLLIRFDIEAIRAAGYSVITPVVITNTDAFA
DILELDQKEIIANEDVLAIVK
>FECAFAII_00027 hypothetical protein
MAGKTWIEKIGSRMFVTVFFNLGFYFLNKKERRKKQWIIKQLVVVYGKR
>FECAFAII_00028 Transcription antiterminator LicT
MKIDKILNNNVVISKNGFGEEVVCMGKGLAFQKKIGDEISPEAVQKEFVLRDSFAKNQFQ
QLMADIPAEEIEWVKQVVELAEDKLKVEFSPNIYLTLTDHLHYAITRAKENIQLPNPLLF
ETKKFYPKEYQAAKEALLFVKQKTGVELSEDEAGFIAFHFVNSQQGNEDMQVTMTATTMV
RDILSIISKFFGIVFDEESLNYQRIITHLQFFAQRYLKGEGSDEQDEFLYALVQGKYPKA
FHCVERINEYLRQTQKQEMGIAEQIYLTIHIQRVVSEKKSIQS
>FECAFAII_00029 hypothetical protein
MKKKGKAKRWLVNILLFLLLLVGLALIFNEQIKDYFVRETGDKYAIANVTKEDLKKNNDK
DVSFDFDAVEPMTTEGVMRSQMRGTDLPVIASIAVPSVSINLPVFKGLDNTSLLYGAGTL
SPDQEMGKGNYALASHRATNPELLFTPLENLEMGAKIYLTDLENVYTYKTFFKEKVAPTD
TQLLNEVEGKEIVTLITCGDMDAVTRLVVQGELESVTSIKDATDDMRSAFNLETKTF
>FECAFAII_00030 hypothetical protein
MNSMEKVNQFRDERNWRQFHNEKDLAISISLEASELLELFQWKTPEEVKETQLERIKEEL
ADVLIYSYMMADNLHLDLDEIIEEKLIKNNLKYPVEKSAGVRKKYTEL
>FECAFAII_00031 putative HTH-type transcriptional regulator YtcD
MLTQQLRELEQDESIHRKAYNQVPPKVEYSLTEEGKSLREILVALSVWEEERIEKQKASR
EEDTLLHTHGGYLNY
>FECAFAII_00032 hypothetical protein
MVATVTLYLTFTLILDLGIYLFFSKQLLVKNSFGCIALMVVTLLLPIPKVSFPYLVGLLL
MFLFYFTTKNLFISCLISNLFFAITGLSFFLVFDLMDYLGKRHLGTASFFALLIAFIFYL
LVKSIDKQTRFLNLLFTYPTEHYFGGICILLSWGVIYLVLGSVHFRSSNYLLLSLLSIVI
SFFSLFFSIMLISFQVKERQHQESLQLYQINEEYYHHLEEFKHDYKSLLFSLKITLQENK
KETLEFLEILEDHSAAIFEKPQIQQLTNIVSPAVRGVFLKFLEKAESEKIPIQVVIPVEV
KTIPIDLVVFIRCLSIFISNAFDHRVADQSPITINLLEEKEGSRFSIANKANPTNLTLSE
MVKRGKTSKKNGGLGLYSAKKMLDVYENAELKIEFSKQNHYFFVEMYLASRKSKSAY
>FECAFAII_00033 hypothetical protein
MKKYFIIEDNQFHSEWIIRELVNHHIENIVQLTSISQINQLIQLGTIDNHDVFFIDIDLK
QSLTGIDVAEQIRKKNAHSNIVFFTAYTNFAVEIINRKILPIGYIRKDRNLSEQIRQVLE
QINWKEQQIVNVDKIFIDQKGGSLVLYPREILYIESIKGLKNQVMVKTTTEDKLVNTSLK
QLKTELEKYAYFLLLKSYCINLSQLQKIDSAHYVLEFFNGDSLLVGRKIFEKTKERFHDF
QKTASS
>FECAFAII_00034 hypothetical protein
MKKTIALSTVLAGSLLLCTQSVFAENKSSATTEGTISVTKPDAANPEDVVPVPPVDPNDP
DTPFTPDEPNQGTSGLLTIDQAPDLDFGTIKLGTAKTVYAALQSGTDSTGAQTQVQNFVQ
VTDKSGNYAGWKLSVKRTEFIGTTSDTNKLTGSKVKFKNAVIRNSATNSSGMPSTVSGTG
AEGIEIPADQAVDLVTAGANEGIGTWIYSLGENVEQGRQSVELFVPVSNYAVDNYVSTFT
WSLTDAPTEEEA
>FECAFAII_00035 hypothetical protein
MKLKKAYADQSDGRNVIKANLQNPNASYMFGLTTSVEIYKKETKEPYLSIKKEKIDVAPN
TNFDLLVPLEGKKLAPGHYQAVVKGAWKEKRWNLHTDFEITDDAADQLNEKDIDLKNQPE
TFDWRWLILVGVILIGLFAGLFILKERRKKK
>FECAFAII_00036 hypothetical protein
MNRIWNKSHRNNCSLLMILLLGFILWQTPVHASEFNFAVDFELPANQIDKNKTYINVRME
PGKTQEIPYTVFNRTDKSVTVETLIHSATTNSNGVIEYGESKSKFDETLSYDMKNLAKTV
GEITVPPQSAVTETLSLKAPEKELAGVVAGGITFQEKKENVSNKSTVGVVNQFSQVKAIL
I
>FECAFAII_00037 hypothetical protein
MNQCVKKLIASILFVFPLLMVTSVFADVEKTNESTQSENQSFDKTTFSEESITSETTESQ
SEASTNKRQEENKTSETSEVAEQTSDSSEAALARAVSADGYSEAATTEELAQLLADESVT
KIRLIQPLTLDRELEIKRDIVIDFGGFAHNFGTHHIYINEIPQSIEFQNFKGTAAHPGGL
TPNIDGNAIIIAYMTDFWGSRYHFTGEIKFTGTLDLYDGSKLGLIYAPRATVTLDGVSGV
LDVQPVKEGLNAAPGKAYFCRSYQLNVINGSQLYGPYLGKFYGFLDSGDETGSGKTAPGI
HILSGSKVSLDYDRADGVSDEGEAVDTLPGNVMFEVSGSGSEFSVNTKINITNDNNRGII
QMRGSGSKVTVSNGGKITINTATTGGFRLQGDSSQIHVSSGGQISVKMAGDDDQPGNNGM
RFVGKGLSLIVEGAGSVIDIDKQSGRSSAVRFENGTQKLTVTNGGSLRVRNTGDGKSYVN
RLNQGNQAIQFYDASGFLESPGSADFTVTGEKSNIDIRADSGATVDTTGDIDLNFTAGEK
TYLVMVGKTGEDKTGIISGDVLNVDLESPTYFDFQNKRIGSETNGIGGWVFQGNGDSSLK
IAHSEIALWRKTGATFDNFEKDPDYFSDMTDLSINGTDLGNFVSSPSAGLTNEFAQTGAG
MKNYNRISANNQLPMIESLRVPTNADKKIYGHVVVPEGVEAKPRDAWTGEVEVTLRITYA
DTTKSSVEITALTQGQTDENEGAGYNPWGEGEQGGLFEVQVPNDERLKTEDQVQVVAAKK
VRGGQEVTELDSAKTTVDVIPPEPANLSTTLINAASRTITGTGEAGALVSLKKNQAVLSE
TTIDDTGEFVLSIPENQLFAGDVLEIVLNDQAGEATAKGVQNKPSTNDEIGNHNPSDTPV
VYHDAPPFAPATKIVVEGGLSFLAPSKLDFGQIKATGLTQEAFGQMDIQEKLWIYDQRET
KNPWILTIKLSQPFTNDAGFSMQDVLYFKKGEEYQLVNEEELEIVRGQNSTNVQADYSEY
LNNGRAFKLVLTKENQIAGNYSAEITWTLADAPTE
>FECAFAII_00038 Putative lipid kinase
MKKVLLVVNPSSGGEQAKEFEQLAIAKLESVFDEVVVLHTKKAGDAKNFTREAATEGYHS
VFVMGGDGTVNEGISGIAEQEHRPNFGFFPLGTVNDLARALGIPLEPEEAINHFSIESVK
PLDIGKINDDYFMNVVAIGSIPESINDVDAEKKTKFGKLAYFMSGIKQLASTQSYSFHVE
VDGKKEEIESSTLLIGLTNSVGGFETLLPNAKVDDGKLHLVYLKDSSLIDTLKTLPDLLK
GVDESTKNLAYLTCEQLVVSLADEEELTTNVDGDEGDKLPVTIKVLPSHLQVYC
>FECAFAII_00039 hypothetical protein
MEWFCKFLLFLEVIHVYGFVFLTNKKAGSTMDHLYIKYIHQFSVLVLGTLIIAGIVAFII
QGRDILTVHQEFFSYAFGIPLIAIRSDNKKWKKRYYILLLFLCFYLPPKIFTLLGIQCLS
FSFISYIIVLIFLSFIVWMFYLVKK
>FECAFAII_00040 Foldase protein PrsA
MKKRFLALAIVLGTGLLSGCTNAGEKTAVSYKGGTISEQEVMDSLKKMQGADSAVQQLIV
YQVFEDKYGDDVSTKEIDSQYDQTKKQLGDSFDSQLKSAGYTEQTFKDSIKQSLAFQEGL
KKHIKLTDEDLKTAWESFHPEVEAQIIQVASEDDAKDVKKAADKGDDFSKLAKDKSTDTT
TKEDGGKVKFDSTTTTVPAEVKEAAFKLKDGQVSDVITSTNASTYTTEYYVVKMVKNQNK
GNDMDKYKKELKEIATDTKLSDSTFQNKVIGEVLKDANVKIKDKDFENVLSTFTSDSSTA
SSK
>FECAFAII_00041 hypothetical protein
MKKAVIICALGIGFVGGNAMSSEVEANSVHGEIYYKSLKPGEIHFDAKGNIIKSNLPVDR
EISRTAINHSSGRWVYYSDTTCTRKTGHSNHYSRVYNRHGAKAKVGNSIRSANATKGVWA
YASATGNRTDTFSCWYNPTGWY
>FECAFAII_00042 putative ABC transporter ATP-binding protein YknY
MEPLIVIKGAKKIIRNKTILHLDRFTADAGDLVTVVGESGAGKSTLLNILGLNDQFSSGQ
FYLFDQETKQLTGREKRLIKRNTISFLFQDFGLIEYETIDFNLDIGLKFSNLNVSDKRTA
KYEALKKVNINKKLSTPIYTLSGGEKQRIACARVLLKNSKIILADEPTGSLDKRNKDKVV
EILSQQASQGTLVIVVTHDPYLTKIGNKKIML
>FECAFAII_00043 hypothetical protein
MIIKKKFTVLLTIIVTGIMSGFALVSINKQVLYRTNEFFHQTDTYTPIRLPQHFIGQEEY
EQLIMVFENVSSETELSYMKKTVNESNEVDTSWNFKIQPKLEMTLYYQGDVKSSHEKVPY
SNTSFRVTSIEESIKIKDFEGEFFLMTREKEAYERFISLFTDRFNQAFHTDYATNIFEDF
ENSYSYSVISNTDVYNYRVYLTIGLILLFLLLSSFFLLMNKEISLLLNNDFSLHQVLWCL
LGKKKIIITFIIAGIIGGFIFMYYKEQFLYLFQMYVFLFSGIYGISLISLLLVEKIASLR
EAFNYIQYILFTFGLLFSLLLTVANVELATIVFSSSQLAVSHEPPKEIAGEDYHVFYPVT
IGKNHVDFIYSNRFASAADQELYETLNKNGSILVNVSDYLNEENEQFGRGIKINLNYLKK
FPLIDVSGRLIQITEKETHPVILIPERYRHTDLKNDLAQITEYYQEISEKEPKFLFIKNN
QPIYTFIPSIPWIEHYPVVEILTLKNSMYLERNILSGEIYPPLKIKIGSLSKERLFELIE
ESQLRDNLQLSFPYTQTEEIAVKVLSRSFHYLIQIFLLTFFSFFLLSYVMLCIYFVYNCR
KIAIFRSSGYSLFETYKDFFMMNLIKWGTTSVIFLFLIEREPKYLFNIFFFSFIDFILSV
VFILSTEKKSQLLLMNGG
>FECAFAII_00044 hypothetical protein
MNTGEKIRTYRRNCKLTQKELGEKIGVSDKTISSWENSRTMPDLEMLSLLHHTLGLPIDF
PSIESATESIEPTLPDEPLVNKKSYSSKQPFSLKKTLSFFLLVFCLVYLFLINYQYKNET
IDRFNPFLKPQIGYTTLPVGYVDNSIERWVCNDIFGHGTWLSFHAGEVEKEKNHAVIKHK
GKHVMNVRLLTWEAIPSDYQEILSQDYDDALKRSPQEPDRH
>FECAFAII_00045 hypothetical protein
MMSKNNTNGRNQFAMLTIDDLVPQDHLVRKIDAALDFEFIYPIVEATYSDLGRPSIDPVI
LIKLVFIQYLFGIRSMRQTIKEVDTNVAYRWFLGYSFEEKIPHFSTFGKNYVRRFRETTV
FEDIFAYILEQAVKAGFVTEDNLYLDSTHIKANANKHKFTKEMTHDEAKAYQDELEDEIN
RQRIEAGKRPFTLDLEKEVKLKERKISKADPESGYYVKGEREKQFAYSAHTSCDDNGFIL
STIITPGNIYDSQVAFQLVKQSKRLFLKSIVLSLMLGIRHLSLFTF
>FECAFAII_00046 hypothetical protein
MDEVEHLRLTDLNKSIYKKRKQTIERIFADAKEKHGMRWTKYRGLEKVATHTMLVFAAMN
LKKLATWLWKGKEPLFFCSKIRNEVDKKLFQARVTSLEQLLSTV
>FECAFAII_00047 Type-1 restriction enzyme R protein
MKISHREEAEVEEQLIRVLGEGHNQWTYRPDLKSEEDLWVNLRQKIISNNQAELNDFPLT
DKEFETIKTELLLRTKTPFDAAKWLKGENGMARITIEREDPQLGSVSLILYSNQDIGGGI
STYEVVHQIAKRGSNIEARDRRFDVTLLINGLPIVQIELKQVTAKDSFYQAFNQIKKYAE
EGMFRNNIFSTLQLFVVSNEQTTRYFANALPKDLHPKFLFSWRTKDNKKVENLYEFCKQV
LNIPDAHRLIADYTIVSEDQDNKILMVLHPYQVHAIQALFIAANKHQSGYVWHATGSGKT
LTSFVSTKLLARKSGIDRTIMLVDRKDLDNQTTTEFTKFASEFNTGISSGNAKANSLIVG
TGSAKELSETLLADANANVVIITTRQKLDAALKYAKKQEEKKGTNRFQKLMGQHIVFVVD
ECHRALSAENMEEIKKMFPKSTWFGFTGTPIFPENRKQAKGQLARTTHDQYGEVLHTYTI
KNALEDGSVLGFQVEHENTVEPTSLENKIYRKLKEVETYAEYSPEQINRMIDQMEPVKKE
SYLDPTVFEADEHIQKVIHKMFRPDNAYTKFDFRNGRPTKSAILTTSSIDMAKKYYRAIK
EMTKEPDWLTKEFPNQPIREGRTMEDPDFPRIAITYSLEENSRDSSVQQEEMQKIIEEYN
QYYDTSWSLADIERYNGDINNRLARKRAEFKQFGKQIDLVIVVDRLLTGFDAPTIQTLFV
DRNLEYAGLIQAFSRTNRTYPEKTKGLIVTFRKPATMEKNVEDATKLYSEAKEESGLIYP
SYQESKKRFKQAYGKLKEVSSMESIDEHTPLEIRIEYVKAFQELNRAYESLVTYDDYNDD
MVKSSTLNNQIQLLEEQIGVYETVKGSLIEEEPEKEGEDFSTIEFYSENTTKLYDIDSTY
IDQLLGTYAANSSDAREEIEKALAKLNKTEGVKEVYRQILNAFDVGTLDSNEDIFVIKRR
YFTQASDDLIHVFSNEWFVSEKELHASNLQYMPGEDPIPNMKAIINSKDYEGYKANHPEA
KPFKYPQEMKRAWRKMLDDELIPLENELR
>FECAFAII_00048 hypothetical protein
MSNDIQPEIRFPGFTEAWEQRKFECLLDKKDGVRRGPFGSALKKEFFVSNSNFVVYEQQN
AIYDNYETRYKITEKKYNELIKFKLEPGDFIMSGAGTIGRISRVPKQIKPGVFNQALIRL
RINKEITDSEYFIQFIRADFMQRKLTGANPGSAITNLVPMSEVKKWIVQFPILEEQKKIG
NFFKQLDDTIALQQRKLDLLKETKKGFLQKMFPKNGAKVPEIRFPGFTEDWEQRKFKEFS
KKTGKKNTKDLDFPAYSVSNKAGLISQTEQFDGSRLDDLEKTNYKFVEPNEFAYNPARVN
VGSIAFNNLGMTVIVSSLYVVVKMSEDLDNEFILQFIKSPTFIKEVKRNTEGSVREYLFY
ENFANIKFPFTRNKEEQQKIGAFFKQLDDTIALHQRKLDLLKETKKGFLQKMFV
>FECAFAII_00049 putative type I restriction enzymeP M protein
MGAELNQKLFSAADNLRSKMDASEYKNYLLGLIFYKYLSDRLLEQVVLLADESLEEYDTV
SKQTMLYRELLSDEESKEDLIATIVDILGYAISPEYLFNVLADQAKQATFQLNDLNKAFV
QLASTYNQFNGLFDDVDLQSKKLGTDEQQRNVTITEVIKKLNDVEVLGHDGDVIGDAYEF
LISQFASEAGKKAGEFYTPHMVSDMMAQIVTLDQKERRFFSVFDPTMGSGSLMLNVRNYL
THPDNVKYHGQELNTTTYNLAKMNLILHGVDAEEMNLRNGDTLNKDWPTDEPYTFDAVVM
NPPYSANWSADTTFLDDSRFNRYGKLAPKSKADFAFLLHGFYHLKETGTMAIVLPHGVLF
RGAAEGVIRQKLLEDGSIYAVIGMPANLFFGTSIPTTVIVLKKNRQTRDVLFIDASREFV
KGKNQNKLSEENIQKILETYAERKDVEKYAHLANFDEIKENDYNLNIPRYVDTFEEEEPI
DMVHVGNDIKKIRQEQQVLEKELLEAISSLQTTPENEAWLQGALEVFKHE
>FECAFAII_00050 hypothetical protein
MKKKKLLWICLAILLIIGGIEIFTTYRLKTNQPKQYVSDMLNIIEEIDSEMKAFSKTSMD
LGERYDFKGFMEDKMDEVSSREIPEGTPKAVRDTKDTLLEAIDNVNTALLTNDVKLLEQG
QLCFSIAQAIYTEFLDGNIKEKSLNEKLNSFVETYTAIPPTWKLVNEDKGITINTDTEIS
TDAQSLSDLLANLTGISNAVTEKVGKDIPLRLLENGKKDYSVVFKNGQVTDYNEVFKKVI
E
>FECAFAII_00051 hypothetical protein
MNKVNMNKKFVIIGIVVLAIIGIIFSRMTGSSGLEKSSVPLVTQILQEQYNLNRTCDDVT
ITHDNGDNTYRAKATLDNGSAININVEYYPKKDRVYVEIPYTEVLMLN
>FECAFAII_00052 hypothetical protein
MYCRKCGKEITNESKYCQFCGALQETDETTGTDTVKKSTEQTINEMKEQIVHGQETGKLY
LIIGWISMVVSLAFIPVVFGAVAVIMGYLYREKDEQMGTILMIAGVAGAIFGVLLGMSMS
Y
>FECAFAII_00053 hypothetical protein
MKKVSNLSRYRKEKGLSQTELAKKMNVTQQCVSSWQTGRTIPKPYQMKMLSEILSVPINE
LFSDVFNKVNS
>FECAFAII_00054 hypothetical protein
MKQKQYAKVIREKRKALGWTQKELAKKIFSTQQAVARWENSVTEPNLDSLTALSRALGTP
VSHFLDNVDIDYEEEFLALYRSLSTEDAIRTIDYMKLLKRQENERNQLLKD
>FECAFAII_00055 hypothetical protein
METSMINIPIYVDKEKLLEKPVTKKEKTDVRDRCLDNYREVTRDEFVEILNSSQSFIPSK
TKNKGNDKESFVETRVIILDVDNTVKDEKGKVVDLSKDDSRYLSIEKVLSINLVHNSAFA
IQKSIRYSENLEKYKIVFLLKEAITDYGKMVAVYEYLKKNIPGCDDNVNASNRMFFGGYK
SDAVIIINEDNMLDITELPIDFTMTCSKNCQSDSGREYELVNETDFVKLIKNDDKEEMKQ
WFKDCLFDSSDMSFNEIYERLLTIDMNKLLKSSKNLRCLFHNDHNPSASIFTSKTGHSIF
YCHSSNCDISENFIGVVMLILKKDSRVETFNWLLENLDLYPTHFRKLKEESKVLFDTLES
MKDKLFRTIRNYLEEMRRVYDVLLSDVNFFDDSKESVTCILSGEQLAKKMSSYYGKTYDI
DKCNKLLSLMTFIGLIKKLDDEDVPLKMLEYLNRLKEEKALGNFKHKRSNVYRLDVFNAT
SVIQKLNEDILPLLEKFHFTYQYFSYEWVKICFNEKEAKRVFPQNSRSELSKEKQLILDE
AHEVLQGLSWQGTYLMTEKELINTVCERLRNVRDNSVKNALIENRGYFVKQGFTLERASK
DIKKLYNVKASSSFLVYLAKGAGIDEVIKELILSGVELVPIYQFTSVTRDDGRRVRNRRD
PIILN
>FECAFAII_00056 hypothetical protein
MSLQIIDSIVSIQVEQQVKEIITVLKPMLEDIISGVTLEYMDYQQASEYLGVSVGTIRKY
VSQYGLPVIKIDTVIRFKKSDIDSFMERYKG
>FECAFAII_00057 hypothetical protein
MIKRPPINYLERKKILGTKIKAIRKSKKLTQPAFGLMINNGQLIDKKTIYEWEKGTYLPI
PERLSRIADLGNMSIEELVCGNVEEYILGIILYRDSIVLDGITFPDKNLFQHLRQQFPPV
HSNLDTWLDRYSKLEPEMQEFIANKTCNKVKNEKISLFNILKIEELFINAIVEEFDNNIL
FLTSSIEELLERMVDEWLPIQLKDMSYPEEAVREITDNINKLEQTISSIGKKYTKKKMKG
GDTI
>FECAFAII_00058 Transposase from transposon Tn916
MAKISKYKKKNGQVAWMYKGHIATDPRTGEKINTTRRGFSSKQEAQKDYDEYRHQILYGV
KKKAPDMTFEDLYNEWITHQRTSVKASTIAISVRYANNQILPAFGKLKLSNISVPYCQKV
VDEWHSKYESYDYMRKQTAQILRYGVAMQYIDNNPMEKTLLPRKKEYEKNRKFYSKEELN
NLLDAFKDFGNMKQYAFFRLLAYTGMRKSEVLALQWKDIDTFNKELHVNKTLAVDEFGKV
IIQSPKTRASRRVISLDTETLSILNNWKLQQKEEYLKLGYNTSSKEQHVFTTVKNTLYIP
NTVNDWLRYILKKYNLPRITPHGFRHTHASLLLEAGESVKVVQQRLGHENSKVTLDIYAH
ITNNAPKKTGQDFADMMAHQ
>FECAFAII_00059 FeS cluster assembly protein SufB
MGVPELEEYKFGFHDDVEPVFSTGEGLTEEVIREMSRIKGEPEWMLEFRLKSLETFNKMP
MQTWGPDLSDIDFDAIKYYQKPSDKPARDWEDVPEKIKDTFEKIGIPEAERAYLAGASAQ
YESEVVYHNMKDEFEKLGIVFTDTDSALKEYPELFKEYFSKLVPPTDNKLAALNSAVWSG
GTFIYVPKGVKVDVPLQTYFRINAENTGQFERTLIIVDEGASIHYVEGCTAPTYSSNSLH
AAIVEIFTRKDAYCRYTTIQNWSDNVYNLVTKRAKAYEGATVEWIDGNLGAKTTMKYPSV
YLDGKGARGTMLSIAFAGANQIQDTGAKMIHNAPNTSSSIVSKSISKDGGEVNYRGQVTF
AKNSAGSISHIECDTIIMDEWSKSDTIPFNEIHNSQVSLEHEAKVSKISEEQLYYLMSRG
LTESEATEMIVMGFVEPFTKELPMEYAVELNRLISYEMEGSVG
>FECAFAII_00060 Iron-sulfur cluster assembly scaffold protein IscU
MGLSKLDNLYRQVILDHSSHPHHRGSLTDSTSKIELNNPTCGDVIELQVDVKDGIIKNIA
FDGSGCSISTASASMMTDAVIGKSIEEAEHLTVDFLQLVQGKEVKDPDQLGDAAMLGGVA
KFPARIKCATLAWKALGKAMENDGTAAFHHYHKEEE
>FECAFAII_00061 Cysteine desulfurase SufS
MIDAKKLRNDFPILFQDVNDEPLVYLDNAATTQKPKQVLQALAYYYEHDNANVHRGVHTL
AERATHDYEQAREKVRAFIHAKETAEVLFTRGTTTSLNWVARTFGDRYIKAGDEIVLSYM
EHHSNVIPWQQLAKRTGAVLKYIELTEEGFLDMEDAAKKITDKTKIVSIAHVSNVLGVFN
PVQELAELVHENGGVIVVDGAQSAPHMAIDVQALDCDFFAFSGHKMCGPTGIGVLYGKRK
WLEEMEPVEFGGEMIDFVELYDSTWKELPWKFEAGTPNIAGAIALGHAIDYLQKLGMDNI
HRYEEELAAYVLPKLQAIDGLTVYGPQDPNFRTGVVAFNLDGLHPHDVATALDMEGVAVR
AGHHCAQPLLKYLEVSATARASFYFYNTTQDADRLVEAIMATKEFFQHGTI
>FECAFAII_00062 FeS cluster assembly protein SufB
MKEKNWLDYLDAVNDFSLSKGEPDWMRTFRQDALAKADELPLPHIDRVKFHRWSLFDVKE
TQTISETGTIPAFDAMKDNPVLVQQGSWTIFEQLPVELAEKGVIFTDLFTAMIEYPELVQ
EYYMKKAVNMNEDQLTALHVAFMNSGIFLYVPKNVVIDEPLESLFIQDGASDEHFFKHVL
IVADEHSEFSYLERFQTTKEQVAKSSGNIIVEVIAKAGSKIKYSAVDQLGENITSYMNRR
GHILRDASVDWAIGVMNDGHVIADFDSDLAGEGAHAEVKIVAISSGRQIQGIDTRVTNKA
PHTIGHILQHGVIREKGTLTFNGIGHILKGAKGADAQQESRVLMLSDKARGDANPILLID
ENEVTAGHAASVGRVDPEEMYYLMSRGLHKEEAERLVIRGFLGSVLTAIPVEQVRKELVE
VIEGKLNG
>FECAFAII_00063 putative ABC transporter ATP-binding protein
MSVLEIKNLHVSIEEKEILKGVNLTMKTGEIHAIMGPNGTGKSTLSAAIMGNPNYEVTEG
EILFDGKNVLDLEVDERARLGLFLAMQYPSEIPGITNAEFMRAAINAKRDENDKISVMAF
LKKLDEKMALLNMPEEMAERYLNEGFSGGEKKRNEILQLLMLEPTFAILDEIDSGLDIDA
LKVVAKGVNEMRGDNFGALIITHYQRLLNYITPDVVHIMMEGRVVMTGNADLAKRLEAEG
YAGISKELGIDYKEEEA
>FECAFAII_00064 Methionine-binding lipoprotein MetQ
MKKKIFGFAAALLLTVGLAACGNNSDSKDSANKADDTTLKVGASPTPHAEILEHVKPLLK
DEGIDLEIVKFDDYVLPNQSLEEGDIDANYFQHIPYLNKEIKEKGYDFVNAGAVHIEPMG
LYSKKVKDVSELKDGATIITSNSESDWGRIITILQDAGLVKVKDGVDLETATFDDIEENP
KNLKFNHTIDPSLLASTYQNDEGDLVAINANFAYGAGLNPLEDAVLLEKDNSPYVNIIAT
RKGDEDSDKIKKLIEVLHRKEVQEWITDKWGGSVKPVKADAK
>FECAFAII_00065 Methionine import system permease protein MetP
MDKSFSETYLDFKQINPETMNQAILDTLYMTLISMVLVTIIGLVLGLILYSIGRKNKPYA
RIIYGIVSIISNIFRSTPFMILMVLIIPFTKAIVGTMLGAQAAIPALVLSAAPFYARLVE
IAFREVSPGVLEAADAMGASYWEIIWKVLIPESIPALISGLTVTTISMIGFTAMAGAIGA
GGLGGLAWQEGYQRGNLTVTFVATLIILLIVFIVQGIGDFLTKKTDKR
>FECAFAII_00066 Methionine import ATP-binding protein MetN 2
MNGMSLIQLTNVKKTFNGKNGNIQAVNDVSLNVEKGDIYGIVGYSGAGKSTLVRLLNGLE
LPTSGEVIVNDQDITKLKNKELRTFRKKIGMIFQHFNLLWSRTVLENIQLPLELAGVPKS
KRKERAEELLRLVGLEGRGQAYPSQLSGGQKQRVGIARALANDPEILLCDEATSALDPQT
TEEVLDLLLAINKKLNLTIVLITHEMNVIRKICNKVAVMELGKVVEEGDVLTVFRQPKKE
VTKRFVQQDIEPEADSTELLAELIKENPSGRLATLTFSERNANEPVISQAIRRYNIDVNV
VYGKIKQVKEGSFGSLTVLMTGETKELDQAEVFIKEQGVGIEVIHRG
>FECAFAII_00067 Glycine cleavage system H protein
MAGKHLKKKDNLWILFNGKEYCVGLTNEAQEELGDITFANLPKAGQSLKKDEPLIEVEAE
KAVNEFASPLTGTVSSVNDKIGEDINILNDSDEMNAWILSFKDVDPKEFDEL
>FECAFAII_00068 Regulatory protein MgsR
MYTFYWYPKCSTCKKAKAWLDQHGVSYQTVDMIKEVPKASTIETWLETSQVPIRRLFNTS
GMKYRELGLKDQVGEFTASKASQVLSTDGMLIKRPLILREDQLVAIGFNEKIYEGELI
>FECAFAII_00069 Peptidoglycan glycosyltransferase RodA
MEKKLKASNDNRIDYGVILPVFLLCLIGLLSLYVALSHDPNNPAVLKGVGMQVVWYLVGA
AAIVVIMHLNSKWIWKLTPYLYGLGLVVMGLLLKFYDQNLAASTGSKNWFRFGAFTFQPA
ELMKIAYILMMALIVTKHNTQVKERTMKSDFWLIGKLLIVTIPVLALIMAQDDFGTMLVF
LAIFGGIFLMSGISWRIIAPVVILAVVVGAGTIFLVTTEGGRDLLYKVGFKSYQFARIDS
WLDPFHDTSGMSYQPAQGLLAIGTGGLFGKGFNVSNIYVPVRESDMIFTVIGENFGFIGG
AFVIFLYFILIYRMIRVCFDTNNEFYAYIASGLIMMLLFHVFENIGANIGLLPLTGIPLP
FISQGGSSILGNMIGIGLILSMRYQNEAPARSSRR
>FECAFAII_00070 HTH-type transcriptional regulator CysL
MFKLLTTFRAVYETRNFSRAAEVLFLSQPAVSNQIKQLERELNIDLFQRNGRKEMLPTKQ
ADLLYERTLVLLEEWEETQQKLLNEQNEEEVCRIVASHTFAVYLLPQLMKHLIKRFPKVH
FEIEITNSHESLEQVAKHESDFGFIEKPLETSGVQRYSLMEDQLVIAGDPKSKLWLVREA
NSGVFHYTQRYFEEMNIQDKKMIVKSNDVIVALLKEGIGRSILSKRSVPENVPMTPLNFH
RYFYFIQRTNLVSDQLLEIAEEILRYNESTETSHSEENLSW
>FECAFAII_00071 hypothetical protein
MKNFLKIIPIPICGLILGLASLGNLFKDYHHVALGNLTGGISMILMIFIFVKLFILFEHT
KQTLHDPIIASVSPTFTMSLMVICTYFVSYESIAPIVKFIWLCAVIFQVILVFYFNYHHV
IKADLSIEAIYPSWFIIYVGFGVITVTAGNFFPLIGKIFFWISLICYAFLLPIIIKRVFF
VRNMAHPTRPLITIVAAPGSLCLTGYLKNFAEPNFYLVVALFALSQVLYFVVLSMLPRLF
KLRFYPSYAAFTFPLVISATAIFTTVHYFNSLGIYSSVLDFLKVAECLFASVVVFYVLAH
YVRFLIKEHSKHGKFVSKKIA
>FECAFAII_00072 hypothetical protein
MKSLSHPIKSVKDSAVREILPGLLLSFAIAAFSRLLAIYLPQLGGATIAILLGILLGNTF
FKQPVLAIGTKFAESKLLEFSVFLLGATVTAQTIAQIGVKGIVFVLLQMSVTIIGAYLIG
KKLQFSDTSSLMMAGGNAVCGSSAIASIAPSIHAKEEEKGQIITLVNLLGTVMMLTLPFL
GLQLFGGNLIEKSALLGGTLQSVGQVVAGASLLDNSVVEFAMLFKILRIMMLVVVVYLFE
KFMHKKQPALFETPTDTQKKRKLPLPWYVLGFVIFCLVNSLFSLPVVIDQSAHFISSWFE
ITALAAIGLRLDFAKFMKEGTRFLSYGLAVGLLQTVMALLFIWLIKV
>FECAFAII_00073 Methylated-DNA--protein-cysteine methyltransferase, constitutive
MKIHTPIGFLWLDADESGLTAVSFQPISESESANQRILTRTQEQFEEYFAGKRKEFDVPL
SIKRGTPFQQNVWKALSTIPYGEIRTYKEVAVAVDSPKAVRAIGQANRTNPLPIVIPCHR
VIGQNGKLTGYMGNAIDGVEIKRQLLLLEGYLQN
>FECAFAII_00074 Prophage bactoprenol glucosyl transferase 
MKVSIVVPCFNEEKTVPLFFDEVEKFKGAHEFEYLFIDDGSKDGTLAAIKKLASAYPYVR
FVSFSRNFGKEAALYAGLQASTGDLVTVMDVDLQDPPELLPEMINRITTSDIDCVGTRRS
TREGEPAIRSFFAKKFYQLINKISDTEMVDGARDFRLMTRQMVDAVLELTEYNRFSKGLF
SWVGFKTEYISYENRERVAGETSWSFWKLFNYSIDGIVNFSDAPLTIASFIGALSCVGSG
IAILFIILRALLFGDPTSGWPSMVSIFLFIGGIQLLCLGIIGKYIGKIFLETKQRPVYII
RETEKVKPNELKPHQ
>FECAFAII_00075 DNA topoisomerase 3
MIVTWALGHLLGLKMPEDLNKEWQSWQMDTLPMIPKKLGIKPLPKTGHQLKAIKQLAQRK
DVSEAVIATDAGREGELVARWILEYVHFNKPVKRLWISSQTDKAIKTGFKQLRPAKEYDA
LYESALARAKADWLVGLNVTRALTVKYADNLSAGRVQTPTLALVRDQEKKIEQFRPQTYF
TITLQAGKEQAKMLQKNQFALKTQEEAQKLVQLISTSKGTVTEVQEKLKTESAPLPYDLT
EIQREANQRYGYSAKKTLSLVQSLYETHKIVTYPRTDSKYLTNDMKSTMKERLQAVSDFA
PEVKQYLKNGAIVQQTKVFQDSKVTDHHALLPTENRARYEKLSNEERKIYQMIVSRFLGL
FAQPHKVSQTKVTVEFGKERFIFRQNRVVQAGWKGETETETETVKWEKGMRINPDFAIKK
ELSAPPKPLSEASLLGQMEKYSLGTPATRAEIIEKLIKSELMERTPQGLQVSPKGKQLLV
LVNPSLVTPDLTESWEKDLEAIAAGKKQAGTFLNGIEKETKRLVNEIKSSKQEYQDFSIT
QKKCPECGANLREKNTRDGKIYVCTNSDCNYRRRKDPKVSNHRCPQCHRKMEIIEGKNGA
YFRCKYDGTTEKLLDKKEQKKKMTKHEERRLLKKYAQAEEPEESPLAAALKAAMKK
>FECAFAII_00076 hypothetical protein
MYQVITMFGDNEPWWFFEDWEEDIEEEETFESFEEARQAYEKQWNEIHQNYEYINAKSNF
LSAFWNDGDERWCEECDDDLQQYKGLALLKNHQPITVESRKEFYETTNSSGKTKRCERPK
QGAWC
>FECAFAII_00077 hypothetical protein
MKKRNLSQEKIIDCFRELAEEMDVQQITFQHLAKRLDIKAPSLYNHFKNIRDVKTALTAK
LLQELNDQLRRALVGKSGQEALQIYAETYRSFAFSNQAVYELLISVPHTNEAVLLDGIHE
TNQIILQIFEAFQLTKEEKVHRSRELRSMIHGYLSLRFLGYFTKEPTIDPEDSYFWMINN
FIATLP
>FECAFAII_00078 Putative metabolite transport protein YjhB
MAARIKEKLFRKRETWEQNLFVLWFGTFMAGIGFSLVMPFMSLYIDTLGNYSTSQLNFWS
GLTFSSTFLVTTLISPWWGKLADQKGRKLMLLRASLGMAIVISLMGCVTSVYQLVALRLL
QGIFSGYISNATALVATGTPKEKSGQVLGTLATGSVTGTLLGPLLGGISASAFGYRPTFF
ITGIILFFVFLLSLFFVHEKFVPVKKENMVSAKQIFKDLKYPHVVIGMFVTTMIIQASNN
SISPIISLYIRQLLHGHGNVTLISGIIASIPGIATLIAAPRFGRLGDKIGSERILAIGLG
FAILVYIPMAFVTNVWQLAALRFLIGISDACLLPAVQALITKYSPHQAAGRIFSYNQSFQ
ATGNVVGPMIGSSVSSAFGYRGVFLSTSLLVLVNFLLVRHNTQEIHQQETAEEKASGVSI
ASGHSPSHRQ
>FECAFAII_00079 Capreomycidine synthase
MKIANFGVEEWLNKWEKKAVYDIAQSSIEALTLDELVGLDGTSVSKFFEKRKNEPLDYGW
IEGSDVFKQEVASLYQTVDPENILQTNGATGANLLALYALVEAGDHVVSMLPTYQQLYDI
PKSLGAAVDFVHLKEEEDWQFDLEQLEALVKPETKIICLNSANNPTGTLLDRKTLEKIAE
IARTVDAYVLIDEVYAPLTDKGEFLSIVDVYEKGIATNSLSKTYSIPGIRIGWTATGPEL
AEVFRKYRDYTMICGGVLSDDLAVHALKNKEKILARNKKIITENLVILKQWVANEPKVEL
VAPNYVSTSFIKLAIEEDDQTFCINLLEETGVLLVPGSAFDLPKHARLGYCCKKETLEKG
LFLLSEFLKKQA
>FECAFAII_00080 Arginine/ornithine antiporter ArcD1
MEKKSTGISKWGLVALVVSSSIGSGVFGITSDLASSAAPGPAILSWIIVGIGILALVLSL
NHLGEKRPDLDGGIFGYAEASFGKLGGFISGWGYWLSAWLGNVAFATMLMSAMGEFFPIF
KGGQNVPSILFASIFIWGLTLLVNNGVEGASVINTIVTICKLVPLFLFLIFVFIAFKVNI
FTADFWGNVSDNLVNGTGQQGTIWLQIKGCLMVMMWVFVGIEGASVLANRAKKRSEAQQA
SIIGLLCLLFIYILASILPYGVLSQEELATISQPAMANILKGIVGNWGAALINIGLIISI
IGSWLSWTMLPAETTMLMARDGLLPKGWGKTNKKNAPTYSLVVTAILTNLFLLTFLVTDY
AYQFAYSLCTAAILICYLLVGIYQVQFSLKEGIKKQVVIGGIAVVFELMGIILAGFSYVL
LCSIAYLPGFCFYWIACRETKHQITGKEKVMIGLICVAALLSIGLLAVGWIKI
>FECAFAII_00081 tRNA-specific 2-thiouridylase MnmA
MTDNSKTRVVVGMSGGVDSSVTALLLKEQGYDVIGIFMKNWDDTDENGVCTATEDYKDVA
KVAAQIGIPYYSVNFEKEYWDRVFEYFLAEYRAGRTPNPDVMCNKEIKFKAFLDYAMDLG
ADYVATGHYAQVTRDENGVVHMLRGVDNNKDQTYFLSQLSQEQLSKTMFPLGGMEKSEVR
AIAERAGLATAKKKDSTGICFIGEKNFKQFLSNYLPAKKGNMVTLDGEVKGQHAGLMYYT
IGQRQGLGIGGGGDSQEPWFVVGKDLATNTLYVGQGFHHPALYATSLDASEIHFTTNEPM
PKEFKCTAKFRYRQQDVPVTVRLLDDNRAEVVFDEPVRAITPGQAVVFYDGMECLGGGLI
DHAYQETKVLQYV
>FECAFAII_00082 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MNYFISDMHFFHERLLGKNDFAPRLFANVDEMNQQLITSWNAVIKETDHVYHLGDLAMHP
QYEKANAEILELVTQLQGTIHLIKGNHDSRAFFRYLEKNDPRLTDGSPKFYFYDVGAIVK
FDHQQYYLTHYPMLLGPNDTIRNLHGHIHHYSVPIENDVNVGVDAPERELLKEKLPFGTP
LSEQQIKEIYEAKRKYDRS
>FECAFAII_00083 hypothetical protein
MENEQSVVLTNWKRNYLFFLSGQFLSGITSMVVQYAIIWYLTRETGSATILSFATLLGMI
PMVLLSPFVGPLVDRWDKKALLIVTDIIVAIFALILAVVGTISESFPIWLVFVSLFMRSV
AQTFQMPTIQSIMPTIVPSSHITRTNGQLGMVQSANFIIAPALGAALFSVVPVNYLILLD
VLGAVFGVGLLIFVKIPKVSPEILEVPLTIFKDAKFGLQQLMDNKGLWYITINGAFVMLL
FMPAISLYPLMTLDYFGGSVGQAGAVEVVYAVGMLLGGALISFIGTWKDRMKPIIIAYII
MGLTIGASGLVPNDSQGFLYFLILNAGAGCATPYFNTLLMAMIQQSYESNVLGRVLGNFN
SLMNLAGPIGLLFAGPLADRLGVEKMFLFSGIGILLCGIVLFLTSAARNYDKELQKKLVK
EHHEQKDE
>FECAFAII_00084 hypothetical protein
MAFETTATVLGAPISYRLHPDAKRYTLRDNGFTETNGGNYQLIRPLDATPQSKEGFKLKI
TVSKDIQTLKMSITTANGLKAVNIFKDPKQKMSQDKFYFLMDGMISRGLFEKVE
>FECAFAII_00085 Cysteine desulfurase IscS
MKTIYLDHAATTPMHPQVIEAMTAIMQDTFGNPSSIHGFGRHAHEKLETARQIIADSLQA
KPHEIIFNSGGTEGDNTAILETAFSRQKEGRHLITTAIEHPAVLNTMKYLETKGFDVTYL
PVDEKGNLSIEEVKKALREDTILVSVMYGNNEIGNLMPIKEIGELLADHPAYFHTDAVQA
YGNQTIHPEELGIDLLSISAHKINGPKGVGFLYKRDGVNIPALLLGGEQEEKRRAGTENL
AGIWGMAKAVELLSPEEREARNNKYKGFQQLILDTLEANEIPYQVNGDLTNKLPHVLNLR
LIGEANDLLLMKLDLNGVAISTGSACTAGNIEPSHVLEAMYGEDTPILKESIRISFGLGN
TEDDIQYFLDQLVRAVKK
>FECAFAII_00086 Ribose-phosphate pyrophosphokinase 2
MSNKYQDDTLKIFSLNGNRPLAEKIAKVFGTELGKSVVKQFSDGEISINIEESIRGDHVY
IVQSTNAPVNDYYMELLIMIDAMKRASAKTINVVLPYYGYARQDRTAKPHEPITAKLIAN
LIEEAGATRVLTLDLHTVQVQGFFDIPVDNLFTMPLFAHYYRQLGLTGDDIVVVSPKNSG
VQRARSLSEYLNSTLAIVDHADDASTEGGYVIGDVQGKTCIMVDDILNTGATLARAANVL
KENGAKEVYACASHGLLSDHAKSILDNAPIKDICITDSVFTEENRHPENLTIVTCSELMG
EAVKRIHENTPMSPLFRLEEKEFE
>FECAFAII_00087 hypothetical protein
MKKRRRSQLNQVVDKPLYFKVDKKIKKLASTQQLQSRKSKLLFLALVFEDQSYVIIDQSG
HPVEYSPAKYTYQEGLSCKKWKLINEEPIELSRWINRKEDIPVLIEEKRSGKELANCWVG
LPEERFLRYKKWATPSGYLCGTYAAAVLLAYYQDYRKGWMLPNEIRKKNTADSLVLTKAL
RSQIQPLGLPTIPFQVSTGISSFLKKNGNHERARATLLGSWQRATKRIREGKPVMIGILK
VLGSTYGNHWVTAYAYFETETGERYYKVHDNWGDYHKVIPASWSNGTVSLP
>FECAFAII_00088 Neutral endopeptidase
MNKERLKQDFYEAVNEEWQKTAKIPADKPATGGFQDLVDGIDQLLMGETDDLLAHPEKVS
SEKMKHFLAYYQLANDYDRRNELHAQPLQPIIEKVESLQSFDELNKQFPEWLLDTLPLPF
NLDVDADMKNAQTNAFFAYPPSLFLPDKTYYASDHPNGAQLIGVFFDMAVQLLELAGKEK
SQAEAITEQAVQFDKLIAPHVKSAEENADYSKMYNPQSFDTFIKYTDKLDLKKLVTGLIG
TTPDKVIVTDPVYFDHLNDILTEAHFPLFKSWMIIKTVRSLSGYLSEEFRQVSGIYSRVL
SGTDEAMPQKKAAYYLASGQFDQVVGDYYGKKYFGEAAKKDVEQMVKKMIAVYKKRLEEN
DWLGDATKEKAVIKLNNLGIQVGYPDKIPALFDQFKTVPADQGGTLLSNTLVFSKLTLKD
RFSKWNKPVDRSEWEMSADTVNAYYHPFRNVIVFPAAILQAPFYSLEQSSSANYGGIGAV
IAHEISHAFDNNGALFDEYGNLNNWWTEEDLTQFQNKAQAMIEEFDGLPFADGKVNGKLT
VSENIADAGGLSCALEAAKTESDLSIEEFFVNWATIWRTKAKKEYQQLLLQIDVHAPAKL
RANVQPKNLDEFYETFGITEQDAMYLAPEKRVRIW
>FECAFAII_00089 Pectate disaccharide-lyase
MLKKRIKYSALMMNLLMLSTPVLISVVEVAANEQQSVNEENAHVNIEGMSTMEEIPRTSE
DMDTEEGNDPMMKESENEKTKKQSEEANEEWKGVVFGESTSASRYAIEPLEDGVRLSSTN
NGGKFQSSGSDGMTYYYQAIPKDINFRMRATIEIESWTYTNAQEGFALMVRDAVPKNHLF
GQAFYSNSFAILGSRIEYVWDSDRQEVVNTSGSKYTMRLGLGTRAITGISSEDPQAAPAP
GSVSVETTPLETSAGFLEKETGSYNIFGNGHGNLFPATNSITKLDVEMKKTNTGLEAYYY
DPETGEEMASDIMYDWEKLYASDESVIYAGFAAARNMTIKVEGIEVAYSDPATDPPGQER
PTRLIDPIYTVTSSNHSGNQDHTMSFRANADGLLTIKNKATGEVLKNAKNLAITANREFD
YQTKLMEGTNEFTFSFTPDKNYPPEEYVEMTSYETKEILHTVDYRKPKYSTVYVTPEGSD
AGNGSRQNPLSLTQALRYAYAGQTIVMAPGTYSFERGLTIPKGVNGTRENPIQLIAEKNP
ENKRPVLDFKGTGNGMTLFSHYWGLRGFDITNSAAMQKGLQISGNHNLIEEIHAYRNGNT
GIQISGSSNDPFEAWPAHNLVKNCTSFENADPGFEDADGFAAKLTIGEGNVFDGCIAYHN
ADDGWDLFAKNETGSIGKVIIKNSVAYRNGWVPGIEGEGNGNGFKMGGSSLTGPHELINS
LSFENLAKGIDSNSGTDIIVNSSTSFNNGSYNVALYTSSAGNTDYHASGILSFRTENLEM
REQIRPLNQNEDQIYHSLNYYWNEREKQSENTLGHTISKDWIESLNTCSKEGQQPVTRYE
NGSIHVHGLMQIKPGNRQTEKERVDGLPLSVGAIFDGETSPSSEYPEYAIVQEPNQTKPN
EQNNPIIIQEANGVAENAEGNIIELKPFTVFVSTFTPNQGTPVFEDMRYFPEKIQIVETQ
SSAQFSNHTAIFSAPSKGEYTLEVTYRSEIFDGEKWSAHTESVTQQKAITVRETADVPPG
NDKPERENPGNESPNGKPNGKPSHPDRTAKESEKNGTQGLPKTGEFNNPLLALAGGILLI
GVVVYVMKQRKK
>FECAFAII_00090 Isochorismatase family protein YecD
MNALISIDYTYDFVAEDGKLTTGTAGQVIEKKLTAHTKKFIDQKDFVVFAIDAHDPKDSF
HPENRLFPPHNVIGTGGRELYGSLKSLYQDYEQEENVYWIDKRHYSAFSGTDLDIRLRER
QITDIYLTGVCTDICVLHTAVDAYNLGYKLHIFKDSVASFDPVGHEWALRHFESTLGAEI
L
>FECAFAII_00091 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase
MKIGIIGAMEEEVKILRENLSEPLSWERAGALFISGSLGNHEVIVVRSGIGKVLASITTS
LLIQQYGVNMVINTGSAGGIGEGLQVGDIVISDKVAYFDADATGFGYNPGQLPGMPLYYE
ASTYLRSEMVKAAKATNLNAKEGLIVTGDTFVDSPDKIKEILTNFPEALACEMEGAAVGQ
TARQFNIPFLIVRAMSDTADHSATQSFDEFIEDAGKRSAEMVIEFVKHLV
>FECAFAII_00092 hypothetical protein
MAKGPLITRSELRKRQQAQASESLKKQRKAETAYQQEEKKIASFYRKESKKNKPITKTRI
SEREKTTKWNSFLMKSLIIVILMLCVVFLAIAFI
>FECAFAII_00093 Methanol dehydrogenase activator
MLNNEQFEEKTISRKEIYSGKIIDVAVDEVRLPDGGTSKRELVFHPGGVGIIAFDEQDRL
LLVKQFRKPLEKVILEIPAGKIDPGEGQNPEMTAARELEEETGYRAKSLSHLTSMYLSPG
FANEVLHIYHAQGVEKVENPLAQDEDEVLELYHLTLEEAQQAMKDQLICDAKTIYAIQYW
ELLTKGK
>FECAFAII_00094 hypothetical protein
MIKRNWPWLLALVLLFLFVRNNSFSFVLGLLLIGVVLVLWGLFGSRRKKGKQEEIPALTD
ELETHYEKSGMTANEISFFRQTMNQTKNEINQLQMNMQQTAKLKAIDLRHDPVKAAKALF
KELVKEPNRLHEASQFLYTHLPNLVDLTNKYNEINDHEIKNKQTYEKLEESAQIIDQLSA
LIAQDYQKFVAEDLDDIDVEISVAKQSLKRDNKYEPEQKD
>FECAFAII_00095 TelA-like protein
MDHKPTETKDVTPVNDTLEDLLNNPFSTPTDTLTTSQQAEIDQLQEQQTAARLIDKLPAE
RQEQAKQLAAKIDANDAQSVISYGSAAQAKLSEFSQSMLNHVQAQDIGPVGDSLTELMYR
LQEANPDELRAGEGNIFQRVFGKVKQSIYEVTAKYQKIGAQIDKISVKLDKEKDGLLKDN
LMLEQLYQKNKDYFDALNIYIAAGELKMEELQTTIIPEAMKRAEETGDQMDVQIANDYTQ
FLDRLDKRTHDLRLARQITIQQAPQIRLIQNTNQALAEKIQASIATAIPLWKNQVVIALT
LLRQKDAVTAQRQVSETTNDLLKKNSEMLKISAIETAKENERGIVDIETLQTTQNDLIET
IQETLRIQKEGKEKRRHAEVELGHMEEDLKQKLLDLTQ
>FECAFAII_00096 putative amino acid permease YhdG
MDLFRKKEINLNHTSEMKKELKTSDLIMLGIGAIIGTGIFVVTGVAANQNAGPALSLSFV
LAAIVVILSGLSFAEFASRVPVIGGPYAYLYVVFGEFAAWLTGWLLIGEFLLAVSSVASG
WSGYMQGFLKSLGAELPQALTGGYNPENGTYIDLIAVLVVIFVTYIVSLEAKKALRLNNA
MVYVKFGIIALFIIVGIFFVKPDNWQPFMPFGFSGVLDGAALVFFAFLGFDAVAMAAEEV
KNPQKDVPRGIIGSILIATVLYIIVTLILTGIVPYTELGVNDPVAFAMRYVGHGTVGAVI
AVGAILTLLTVTISMMYSLARLLFAVSKDGLFPKFMTEIDQKHRTPKKATYAAGVAAVFF
AGFFPLNVLAELTNIMALAYLMLVSLGLLKLRKMFGKPKAGEFKVPFVPLLPIVSILTCI
VLMLRLQTVTWIVFGIVMVIGLIIYFGYGYGHSKMNEK
>FECAFAII_00097 putative glucose uptake protein GlcU
MEILIALVPMLAWGSIGLVSGKIGGDANQQTLGMTIGAFLFSLVVFFVVSPVITPWIFLI
GFLSGLAWSVGQNGQFHGMKYMGVSVGLPLSTGFQLILNTIAGAVFFHEWTQTKDYVYGI
IALALLVSGAYLTARQDDEGKIDTDNKMLDFGKGFRALIFSTIGYGVYTIIVNWANLDAM
SIILPQSIGMILGASFFAFRKVKVDQFVWKNMICGLLWGLGNICMLLTVKSLGLAVGFSL
SQMGIIISTLGGIFILGERKTKKELIYVIVGCLLVILGGILLGYMKTV
>FECAFAII_00098 Sensor histidine kinase GraS
MNFFKYLKDQWTLILGWLFFIALTIFVMWLAPNIKVDLSTIAYLALIEGVFLIFYLLGGY
LSKRRWWGKLADIQKTSPLQNYLSGGRTEEEKLVEEYINQLIREHQEVMQSAISNQQDQK
DYIDSWVHEIKVPLSASKLLVRSIEFDIDDQKYTLLENELSKIDEYVEQVLYYARLDSFS
RDYLIQEYGLKGIIQPVIRSQANYFIQKNIRYEIVGEDHTVLTDAKWIAFIFNQLLSNAI
KYTPDHGNIIVSIEKEAQGVSLSVKDSGIGIPAEDLKRIFDKGFTGRNGRLSKTHSTGLG
LYLAKNLAEKLGIHLTAESTEGKGTTMTLFFPILNFYNEKR
>FECAFAII_00099 Response regulator protein GraR
MAKIMVVEDEEIIRQLIMEELEKWQFETFGTTDFNQVFSDFEREEPQLVLLDINLPVLDG
YYWCQKIREVSKVPIIFISSRNTNMDMIMAMNMGADDFVTKHFQIDVLIAKINALLRRSY
NYTELSSEMMSHNGITLNVDNGSMEINGEIIDLSKNEYRLLFILMKHNGKILSREKLLRA
LWDDERFVDDNTLTVNINRLRRKIEQAGIQGYIETKVGQGYIVP
>FECAFAII_00100 hypothetical protein
MKKKIGNRPQTQISLLLQLFMAVMFLAGAAVFTYPFLADALSNYLDQRRIENYQKQLERD
KEEKHEQQLAVHEKKNQTLAHTSVIPGMGQVKDPFEQAVRNVQNPGKEYYEQHMIGAIYI
PKINVSLPLFDETNDLLLDRGATVLQGTSFPTGGESTHSVITAHSGIAEKKLFTDLEEME
QDDRFYLEVYGRMLAYEVVEKIVVLPTKTNTLAIREKQDLVTLITCTPYTVNTHRLLVTG
RRVPFTEEVSSKIEQTKKYHLYRLLILLLGILLVLTLFGYWCYRKFKRQKQRKKNNR
>FECAFAII_00101 hypothetical protein
MNKKMIVTGMSVLLLVTAGIGIFGNGKLVKAEEVAQKPSEVTITLHKKGFSSVPEERPNS
GLVSTDFGEENIPGVDFDLFDVTEVYYDLIRDNPLTPEREDGLNSAEAIEWIQKRHTESW
FLKYRLTSIDKQTTNEAGEAVFSTVQVTEEAPSSRDKVYLFLETYSPAHISRIASPMVVM
MPVMMPDMVDGVWDGSTWKDTYNTDVHLYPKNEIREADKQMNVEESDLRQVTIINEAGEQ
ETISYIDLERGKTASYTITAPIPYFIDSVLENGSAVIKNYKITDTPTVGLTYYDQEIEVR
AGETILTKGQDYIVEVVSNGFVVTILTEENGVAKVDTLGRLADARGGDLTITYNLKVSTE
LEADDFHNNTAVIEIGRNDEFDYEEGVEPPEKVTTGGRKFEKYDASSSELLKDARFELWN
EDRSEYAIFYKGESPLAVYESGADRIEWATSGQATEFVADGNGYFEVQGLDYGTYQMKET
MAPEGYVLPTGEAAFTEFIISYGSYNEEIQIVGVENPGPERVPNMKRGSLPATGGNGLLA
FLLIGISLMIGAYSWYRKSKMKSEV
>FECAFAII_00102 hypothetical protein
MKKLLCLMLQLLVLLPLAAVLLPHAMSAEESGEDVVEFVLHKRMIRDIDYNDQFEYHEND
GLAISEEAGETADIISQTVPLNGATFAIYDMTDYYHEKKAAENMTPKEFVQQIAETNRNN
IRQLITEERLVQIGTSVTTGKDTVGGLGDGIARIKAPKKNQDRDAVYLIFEESIDPEVGL
DVDIDQTAIPIAAILPIYHPTESTEELQEIHIYPKNVGYLRDPYFFKYGRQRGTTEKGKP
LEGAVFALYQMIEGGKYYLDMAPANDLKNQWIKPADNDPLNDKNVSKFISDKEGLVTTGQ
RFLPSGTYYFEELKGVEGYEMDEASKRIEVIIPEFWVDAKGQPQYVVVNGQEMAELESGK
VPVSAYESATPRVYNETVKETTDKPKEPSGPSNPGQSGKWSVFPQTNEARTLISLLGILL
LLGAVLLIKKERGEKNE
>FECAFAII_00103 hypothetical protein
MVVDERIDNQELQENETDTEDSAEIQRSEENEMEKLDEPIVPSGQALQRIQRQLFNGILE
RLGPTATQDPYEYIYPSGEVENEQHRYPKFTTNDYTKVLGNWTQSNERYQGDKGSPYDGE
NLIDDSDYTNGGANWRNYDYATNNGSTAGEEDRNVPAQTVQLWGNERNFENSYLDYNGAY
IKKWVEPVLPSSTASDLHPEDATTLYNVYLDVIGGEKKEISPIDIVFVLDKSASMSELTA
GTNSQTKNAALIEAVNEMSKDLLSDPSLDIRIGMVNFYHNSTAINNHEQISSDIFPLTND
INRLTGSENTALNRTPIGGTPLTLGLKNGYETLYKDNGGENRNPEKILIVVGDGTPTFSY
APIQSSYRTSTNGAWSNWTVMEDKIAEDNDVLFRNFEEFSGNTSNAGFTHPVTYASDFNR
PEDEVNVHYRYGEVKEGDNKATHWVGDGSSNNNTNGSPTSQEKSSAINTVAYHHWLKNKY
QENPPSIFSIGLGIDGNVSGRQRLDAIGRNVLKNIADLEEDGVTPRYYNANNKNDIVTAL
EDISSTFKRTIQQATLYDETGFNVSPFGAGRSADIQFYHLDPGENGMKYQEPEIWDEERH
GQAPPEVVATPTTYVGRENQAYKFSPISLGEGEMVRIKYQVKLDAGAQDGNFCTVNNMAY
IQNLEDYENDITTGRMYFPSSSIRYEHKGRNFQVSKKGQNGEPLAGVEFALYDQNPESGE
AEPIETSKTTTDGIAIFETKMPILGDETGAVSDIFWIREIAGPPRYQLVDETYQFQIKKY
AANEDEMLGHYELVDEYTSGSRVGGPEGKDPNSYYEGEYHKLSVVQEPNIEGTEYDELYV
KLEMRNEFKPIHMNINKLIEGSNMPINGAEFELYETDGNGLEIGYPVAKGLSGVNEVEEE
KGRLTFYSVDEDGKYVIVDGEKVIHPIGEPDSFVYKDSEETTNYAEYKIIESQNPEGFKE
PDENDTWILRLYDNAIGTIQLKQTGEENWQYLTYTTDEEDRLWVAFTAYNTFDYREIRVR
KLDHEGHTLDGAGFDIRKVGDSSFPLYRAYTGNPLEPEESKRLPGIGYFYSRAVGVEKYV
DLNYDQPLHLSIGEYEVSESVAPNGYRLSDQVFQFALNEEGKFIIEDTVIEDETAPLPEG
YEIIDGVLQVTLEDELAPIDLELLKIDSMNSRRLEGAEFSIEKQNSAGEYEIIEGGLAPD
PNDSSLFNASDLLEGVYRIKEVKSPDSYRKLPGYFILEISYREEPDIENDRVVPGKEAGT
LKVEISYYPNEEAETPDLQQELEYELLETNRIRLQLSVGNDPENPLPATGGSGRLFYILL
AAFFMALAGAAYGLFVRQSKKEGAR
>FECAFAII_00104 hypothetical protein
MKGLKLKLLQLVTVSLLFGPYFQSVYHMTTLDVAAESTETKEDEVFLDEDYAKIEGKYIE
KEETLEWHLAFEKKESANEGRIRLAIDAAAAGIGTVKNVRGTGLSSYDEDGEDLKVETID
GQEWYVGKVYSKEAETGTLIFETEKIPDVNEG
>FECAFAII_00105 Putative undecaprenyl-diphosphatase YbjG
MLRLIAKIDDSIINKFAKQRKTDSRKINFLKFISNISNGGFIWLLLAAVLVLIPDTREYG
LAILIGSLIYFFVGLLFIKKTTRRKRPYEKNRRLVLYTSKPKTSSFPSGHTALAFLSVAA
LFELSPVAGILAFLFACLIAYSRIFLLLHYPTDILGGAILGSVIGILCAAVI
>FECAFAII_00106 hypothetical protein
MMNRSIGKKANDYFLEIIEWIPRLIHLQLLWFLCVLPVFTLGTASRTVLYMIYHYKKNEE
KKFGSLFWKKFRENFSLYGKQDSLASVYFLLLLIDYQIFRYWGGGIGYTLMYTTLFLLLL
SALLFSYKILLQLEQKEASWITAFFLFFNDFKSALFYLAGTLILLVAFWFAGPIYFALLG
FSFLFYFQVLLFIHRTQEKVLKKEE
>FECAFAII_00107 L-arabinose transport system permease protein AraQ
MMDYFKKTSVNRQTKKILSYVLMTVIGIILIIPLLWMVFTSLKPMEEIVRYPPTFFPEKI
VWENYLDTIAAFPFWRYARNTLFITVLVVIGNVLSNSFIAYGFAKLDFPGKKLMFALVLS
TMMIPGFVTMIPQYVLFSKIGWVGTYLPLIVPSFFGNAFNIFLMRQFYLSINNELIEAAE
IDGANHLYIWSHLMLPLTKPALITIAINSFNAAWNDFLGPLLYIQDQEKYTLQIGLQVFQ
NQATTQWNYLMAGATLVLIPTILLFFFAQRYFIEGMDLTGGSKG
>FECAFAII_00108 Lactose transport system permease protein LacF
MKRLSIRKKKEARWAYLFISPFIIGFLVFMLGPMLFSVIGSFTDYNLTSKMNFIGLANFK
RMFVHDDLFWKSLYNTVYFVIFNVPLTTIFSVFLATVLNQKIKGISVFRTAFYLPAVLSG
VAVYILWMQLLSPSAGLINTFLGWFHIPGPAWLFDPQWTKPALILMKIWSSGGAMLLYLA
TLQNVPRSLYESAEIDGAGVWGKFKSITLPLITPIIFYDVITSTIGSFQIFQEAYVMTKN
GTGGPANSLLFYNLHMWNKAFVAFDMGYAMAMSMILFLIVLVLTFVNLKLAPKWVYYSGG
DGK
>FECAFAII_00109 putative arabinose-binding protein
MKKLLFTGLLASSALFLLGGCGSSNASDASSSAANSSEKTSDGRKNIDFWSFWGSGARKE
AIEEIIEDFNQSQNEIHVNYKYQPWGDIWTKSLSAITAGNAPDVIVQDINSVAQRAEAQQ
ATNLSKYVEKDTSKDFYPQLWDTVEYEGDPYAIPFNTDTQVIFYNKKLFKEAGISEQDLP
TTWDELEETARKLDKKEGKEFTRIGFYPLWNLGADVWALNADNGTSWFDKDEKVKIDTKN
KVEALEWIQDWQDYYGKNTINKLEAEFGSGVSDPFISGLVAMRAQNINYYSSLMENAPDD
FDFGVMQLPEKEEGSGHWSWGGGFVLEVPYGAKDPEASYEFIKYLSSPEVQEKFGEKSFD
IMASKTANENLVNNDNLTDKGKMIYQMADENFKNTVITPVPLDAPDYTTLVNEQIDQILL
GTKSPKEGLADAQKAVENLVKQNQ
>FECAFAII_00110 putative manganese catalase
MFRHQKELQFEAKPDRPNPLIAKYLQELIGGQYGEMSVAMQYLFQGWSCRGEEKYKDMLM
DIATEEIGHVEMLATMVARLLEGAPVEDQEAAMQKDPTIGAIISGMNPQHAIVAGLGPRP
ADSVGNPWSGAYIIASGNLLADFRANLNAESQGRLQVARIYEMIDDRGVKDMLSVLLARD
SYHQNLWECAVKELEEKEGSILVPSTFPRDKERKDIAYDFYNFSEGDQSSEGSWASGKAL
DGEGEYQWLKEPKIEGAAPKLEPVTPKMYGTPPFKK
>FECAFAII_00111 hypothetical protein
MKTTLVLFYKKHPYFTLLINILLASVIGISVEYLINKDFIGSCFYTALFLGLLEAFSIYK
KSKK
>FECAFAII_00112 hypothetical protein
MSKNSKGFLTILLAFIGYMLVGLLKSYSNELLNFSTFINDTLVPSLFFIVFFAVGYFIIK
I
>FECAFAII_00113 Endoribonuclease MazF
MSEERIYIPKKGDIVWIDFDPSVGKEIQKRRPGLVVSRYEFNRKTMFSVICPITSTIKNL
PTRYSLPEELDIKGQVIITQLKSLDFKERKLKKIENLPLQDMAKIDQIIQYMF
>FECAFAII_00114 hypothetical protein
MLVTKSRLQGSSVVVTLPSDNGKKPSENQEYIVVYSDDGTITLVPKIEDPFSGGEEAEYY
EKDEWEDLTPEGREIL
>FECAFAII_00115 hypothetical protein
MPDYKQKAGYSFCSDKFQLGKFTKLAGEEVSTVRIKECPLQIETLVQRISTRQDFAIVER
EIVAIFVEEGILHDPTHINVDKWQPLIYKFREYTTANQSLTLNFRFQEFKES
>FECAFAII_00116 hypothetical protein
MYIGGFYRSHQDEKMAESIIMTTEPNRTVAPIHDRMPLVLTEEQIEPWVTDISFARKIIT
QQMPELVMEKV
>FECAFAII_00117 hypothetical protein
MCGRYFFDLESELLQNYYREAQTKQPKQAAELAAGEVFPSNLVVTLRKEEENILTPEIMK
WGFTGFKKGQLMINARAETVEEKKTFHQPFLQNRCVFPMSGMKKKTNLCFQIRKK
>FECAFAII_00118 Transcriptional regulator AcuR
MKTKEKILEATKDLIYKKGYHETSIRDILAASDTGKGQFYYYFSSKKEVCLAVIHAHMDV
WQTELFEDILNAGKQPEEALEEMLDWIFADHETQITYHGCPVGNLIIELSTVDEEYRLLL
LELVNQWVKYTKQNILALSEEKLSDEEADRQAKALIAEIQGSILLLKVTQDLSLLRQNFQ
LIKERLLTSQKVL
>FECAFAII_00119 Isochorismatase family protein YecD
MFNNKNTAVVLTDPQVEFLKPAGGGFGLTKDILEKYNTIENMIEMVKQAKEKGYKLFISP
HYFYPHDHKWQFGGAGEHMMLEQQMFARKSQYESVEEGSGADFIEELKPYLDENTIISSP
HKIFGPESNDLALQLRKNGIDTVILGGMNGNLCSDSHMRELVESGFNVVVATDAIGAPGQ
EAMDAALTNFGFIADQVMTTEEVLEQLS
>FECAFAII_00120 putative pyridine nucleotide-disulfide oxidoreductase RclA
MMEKYQNIVIGFGKGGKTLAKALASKGESVLVVEKSTRMYGGTCINIGCIPSKSLIFNGE
RGIDFTEAVARKEKLTGMLRAKNYHMISDEATGTVMDGTARFLSNHQIEVTNNGEKVIVE
GERIFINTGSEPIILPIKGLNTSRYLIDSTQAMDQEQLPEKLVIIGAGYIGLEFASMFNE
YGSKVVVLDAHSEFLPREDEDIAQMILEDMTNAGIEFHLGVSVDQVADQESTAAVTFTED
GQEVTIQASKVLAATGRKPSTASLGLENTDVKLTDRGAIAVDEYLRTDADNIWAIGDVKG
GLQFTYISLDDYRIIMDQLKGENKRTTNNRKAVPYSVFITPTLSNVGLTEKQAKAQGVNY
KLFKYMTSGVPKAQVLEDPKGVFKVLVDPETDLILGASIYAEDSHEVINLISLAMNGKLP
YTLLRDQIYSHPTMSEALNDVLK
>FECAFAII_00121 Organic hydroperoxide resistance protein OhrB
MKKAYETAMINHGGRNGEVEAPNGSMHMKITPPGIHAEGTNPEQLFAAGYASCFNGAVQH
MIKEAGMTAESTVKARVSLYNLDDGGYQIGVVLEVHIDGISEEEAQKIAEDAHEFCPYSK
ATRGNIDVEVTIV
>FECAFAII_00122 hypothetical protein
MVTNMVIFLTVLVYGVNFLVYMYLKINHIKDYVEKIAIYFGTNMTLLFTSSIFLFFGKIV
EDGILVFE
>FECAFAII_00123 Phosphomannomutase/phosphoglucomutase
MKDMKALQNGSDIRGIALPVEGYEVNLTTDMVKKIGWGLANWIKKKKKSTDPNKKWTIGI
GHDSRISGPALKEALIQSLKEQGIHVIDFELATTPAMFMSTQFEQFSCDAAVMLTASHLP
YYYNGIKFFTSEGGAEKEDIAFILSQQQKIKSEQTGSVEKADLLTPYAQDLVTKIKKGIG
TLESKPLNGWKIIVDAGNGAGGFFAEKVLNSLGADSTGSQFLEPDGRFPNHIPNPDNKEA
MESIKQAVLANEADLGIIFDTDVDRSAVVSASGTVINRNNLIAVLSTIVLKEHPGTRIVT
NSPTSSHLQRFIEEKGGIQVRYISGYRNVINKALELNRLGKDTQLAIETSGHAAFKENYF
LDDGAYVIAKILMLLPELKRKGITLDEQIKELKQPVEVQEIRLKLFSDEPREQGNKILEE
MKRLLEEEKGMNFDPENEEGIRYDLEEPYGNGWFLIRLSLHEPLLVLQIENDEFGKNKLA
LVKLAKLFGHFSDLESLTAE
>FECAFAII_00124 Arginine repressor
MKKKQRQALIRQIITEQPIGTQEELLARLHEAGADVTQATISRDIREMKLVKSQNENKIV
RYTLFNQPSVSLNEERLRTAIRREVLRIQSVQFMVIVLTERNGADVVTNWLDEVAYPEVV
GTMAGVDTFIIICRSEEEAQRFAEKLEKMRE
>FECAFAII_00125 hypothetical protein
MEKIEWRKDKSYSMKKSPQILEVPKKSFFSIRGIGDPNQEDFKRRVACLYAVSYAIRMSP
KKNWLIPDYQMYTVYPLEGQWGLQEKYLHEPVMKKEHFSYQLMIRQPDFVTEAIAQEAIQ
RSSKLPEDLKEQVVFKKMEEGLCAQILHVGPYAEEPATFEKLEAFIAKEGYERASKEHKE
IYISDPRKSAPEKMKTILRVKIEKG
>FECAFAII_00126 Riboflavin transporter RibZ
MTKQKQLLLVPAVIATGMMSFAGVLIETAMNVTFPTLIRQFDLTTAQVQWVTTIYLLMIS
IIVPLSTYLNRNFSLKKLFLASNLLFLAGIMIDFFSPTFMVLLFGRLLQGAATGIALPLM
FHIILTFAPLNRRGAMMGVGTLTTAIAPAIGPTYGGIMTSHFTWNHIFLFLVPVLFLSLI
IGWFAIPEMAVQKSGYLDWISVLGICLLFSGSLTFLSTLGTVSSWIALIIGGIGWFLFYY
RSKKVEHPLIRLSILSNKTFRLFLIGFLVYQFLLLGVSFVLPNFLQIVQGSSPFVAGLAM
LPGAAVGALLSPFSGKMLDQYGPKKPIFAGLILSLIGWLALFLLIGHASVGVLIACHVFY
MIGIGLSYSNMMTTGMNALNEELQGDGNAMFNTLQQFSGAVATSLVAVIINYVQHHTSHN
YEVSTTLGSKAALGVLLLLLLVSFARFAYYLFFAKKA
>FECAFAII_00127 Glycine oxidase
MEKIAIIGGGIIGMTLASYLDTSKFNVALFDEGTGQATKASAGIISPWLSKRRNKQWYRL
AKDGAAFFPKLIKDFQLDQTIYAQSGTLLLRPEKDLAELAVLAEKRKEEAPEIGNIEWLS
PEQTSQALPLLKPAVSLRISGGGRLDGKAYLEHLGQRLAQKQMEQIQAKVTLHKKSDSWL
IKGPFGEYTADRVILTPGPALKPLLQELGYAADIRPQKGQLLAFQTSYKMSQDWPVAMLD
GEADFIPFMDGKILLGATHENDQGWDLAPTSEAYKGLTKSTEQFLTDPDQIKNWPYEFRV
GTRAYTSDFSPFFGVLPDDPSLLAASGLGSSGLTTGPYIGYLLANFLNTGHWPTEDYQKD
ISTYITKNPS
>FECAFAII_00128 hypothetical protein
MSTKESLELNEITSGNPLLSSIRSIVETTFYGNNVHEVFDRKTAYQLAKGSPGTIITDLT
ISHAEELDLPADVRTLVFNDGSIVGRTASARRIFEDLDKEQSKYEKILREAVYQSRKRQF
YHTKVIVGLSEEFSVQSHLLIPEGFENNLYSYLLNFQPANSKILETYQKSVSFDEGDLYI
FCDPEWTHETFPNGLILFDALHNTAAVLGLRYFGELKKATLTLAWALGNRNGFIACHGGM
KQYASNDQTYTMAVFGLSGSGKSTITLAKHTEGHSVSILHDDAFVISRKNGFATALEPSY
FDKTQDYPSDDPAISSFLTCQNVGVTCTSKGEKVLVTGDIRNGNGRTVKSRYATPDRVDH
LSEKIDAVFWIMKDDSLPPIIKINDPVLAASFGATLATKRSDAENITTKRQLDELVIEPF
ANPFRVYPLREDYQAFRELFLKQQTACYVLNTGYFDDKKIKPETTLSIVERIVQQTAEFK
SFGPFEDIHYLPIPDFPVSFEDTSYKNLVKQRLDIRLRFIEAQIGKDLLPDEAKESLENL
IQKLN
>FECAFAII_00129 hypothetical protein
MNSFKKIVLGTTFAAGATAMFVGTTNAHADEVYTVKSGDSLSKISQKFAGDNSMIDAIAE
KNSIANINRIYVGEQLTIPTSNDSSATTENKTTENTASTTETATQEHTYVAPVETVEVAP
AAPAAATAPTSSSAKEWIAQKESGGSYTATNGRYIGRYQLDASYLNGDYSAANQERVAEQ
YVTSRYGSWDAAKTFWLANGWY
>FECAFAII_00130 Epoxyqueuosine reductase
MTLKEEIIQESKRLGIDKIGFTTAEPFDSLKESLEEQKAAGHTSGFEHPNIDERLYPEMT
FDQPKSIISIALAYPTRIHEEVPRDEKRGQFARASWGIDYHDILRDRLNRLIEFIQTRAE
KWQKEEEWRLAPQVDTGELIDVAVAQRAGLGFIGRNGLLITEEFGSFVYLGEIVTNIVFE
PDKPGEFGCGDCMRCVTACPTKALLGDGRMNAQRCLSYQTQTKGMMPEEYRKKMRNVIYG
CDICQLVCPYNQGKDFHFHEEMEPKVDEIYPKLKPMLSMSNKDFKQQFGHLAGSWRGKKP
LQRNALIALANLGDRTALPEISECLTDVRPVIRGTAAWAIGRLGTKEPEKWLDVLDEILA
KETEEVVINELEHAQKLLRRKLK
>FECAFAII_00131 hypothetical protein
MNFTRKDKYTIKEEVFRLISQQENTDKDQDLQFLEAELAKLFIANQNETTEPDEELYIGK
WLFDEFQPLDENTGIGYFVFLSPVGFTPGVLVKQNDEITVKAWPALFSVIKAEGVIKKIQ
SAYYKSQFIANSKLMNMFYNRLVEIARPGKIPQTFTYTQQKNLYEEVLYSRDLSEFSPWE
EVRLHELLSTKPVSLNFFNALDNKRKLISTNYWEVFAARKKWMEEKKIADQQIQFVQLKK
EKLYYGLYSR
>FECAFAII_00132 Manganese ABC transporter substrate-binding lipoprotein
MKTKKSLFLILAVSFLVLAGCGKQASDQADEGSKEKLSVVATNSILADMAKEVGTDQIDI
HSIVPVGTDPHEYEVLPEDIKKASDADVILYNGLNLETGNSWFDNLMETAKKEEGKDYFA
VSKNVEPLYLTSGEEHTKADPHAWLDLSNGIKYVEEIARIFSEKDAENATLYKKNAEAYV
EKLKELDTQAKESFASIEENKKLLVTSEGAFKYFSRAYDLPAAYIWEINTESQGTPDQMK
AIIDQIRAKEVPVLFVETSVDSRSMERVAKETGLKIYDKLFTDSIAKEGEQGDSYYQMMK
WNIETIHEGLSQTKES
>FECAFAII_00133 Manganese transport system membrane protein MntB
MIQSFIDGLMNYQFLQYALVTSMLVGLASGVIGSFIILRGMSLMGDAISHAVLPGVAISY
MFGFSYIFGATAFGMLTAAVIGFVTQRSRLKNDTAIGIVFSSFFALGIILISYAQSATDL
YHILFGNVLAVRESDLLLTALVSGIVLIFVFFFYKELKITSFDPTMAKAYGLNTSLIHYL
LMFFLTLVAVVSLQTVGTILVIAMLITPAATAYLLTNHLLKMIITAAGIGMLSAVVGVFF
SYSYNWPSGATIVLACTAFFILAFLFSPTKGILFQKGSR
>FECAFAII_00134 High-affinity zinc uptake system ATP-binding protein ZnuC
MERTAIVIQDLSAAYQGKTVLKTINLTINPQKITGIIGPNGAGKSTFMKSLLELIPATTG
KVTFSGQSVNSVRKKIAYVEQRSELDLSFPIDVLGVVLLGTYPSLRIGQRPGKKEKERAR
QALKKVGMEEYAKRQISELSGGQLQRVFIARALAQGAEWIFLDEPFVGIDALSERKIFDI
LQELKNSGKTILIVHHDLHKVEEYFDEVILLNKQLIASGPVQEVFTSKNLQLAYGEIIRH
LVKGGEKK
>FECAFAII_00135 putative transport protein YifK
MEEEKLTRSLSARHIQMIALGGTIGVGLFMGASSTIRWTGPSVMGAYAIAGFFLYLIMRA
LGEMLYVDPSTGSFANYASEYIHPVAGYLTAWSNIFQYIVVGISEVIAVGSYMNYWWPDL
PAIIPGIIVVLFLMLANLISVKAFGELEFWFSIIKVITIILMIIAGLGVILFGFGNHGQA
VGISNLWKNGGFFTGGVKGFFFALSIVVASYQGIELIGMTAGEAENPKKTIIEAVQSTIG
RILIFYIGAIFIIVSIYPWNQLSEIGSPFVQTFSKVGITFAAGLINFVVITAALSGCNSG
IFSASRMVYTLAINGKMSKKFLKLSRHGAPFYPVVAISGGILIGLILNYLLPMFINQSEN
IFVFVYSSSILPGMVPWVVILISEIRFKKKHADKMHDHPFKMPLSPYTNYVTLAFLAIVL
IFMFINPETRISLIIGLVFLLYMTIHYFVREKRTGK
>FECAFAII_00136 hypothetical protein
MYDENEWGENVRMTRRRQQKQAARKRMIMIGAAVAVFLIIAGGVAGLYFHGKNSSEAKST
TITETTTKKTETKQTSESSTKTKETQTSEEKTANGLPEQLQAIVNDYSKKIEEKTPALIE
EYQTEIQGNQEGIAGLSAVANQKARELQAISDEGIRKLRAAYQAAENKDGVDLDTLINQL
SANYTNHVAKISDIYLQTSASLQAESTSTQDTTSSDSETAESVEASEMQARTTQDTTDSS
ETNTNSATSQAATTVVLEGEGPNQIAERTGVPVETILSLNGMSMENYFLTPGETLKLN
>FECAFAII_00137 hypothetical protein
MTNDWLIQQLDELSEKSEYQDRALLYEIKKLMAEIDERTMQLQGEIDGQSWNHLNW
>FECAFAII_00138 General stress protein 14
MRTLIIISHPTIEESLNQQFFKEASAGLPATWHHLESSYPDGKIDIETELQLLAQHDRII
FQFPFYWYSSPAHLKIWQDNVLERAAHVLKGKELGIVLTTGVAEKEYQAGGKEEYTISEF
LRPYQRIANKFHMTYLPPFVLAQFMYLSQEKRWEKLIAYQQYLSLEGKPSLTQRIDWFIQ
RVQENQKMQEEESEKQAYIVEALTEAKEQIEDLTFTLQEMKGTSL
>FECAFAII_00139 Arabinose operon regulatory protein
MEQSIFLKKEHQQVEKELYFDFCGFSKTMPFHSFGPAIRNDYILHVVMEGKGSYHVKNQQ
FQLKKGDLFLIRPGDSTFYLSDGEDPWMYCWLSFGGSAAEEIIRQSLFREDQYTMVSSDI
QKYIDIILECMKDTEETLENELQLTALTYRFLSVLLKDGGKVSGGVQKVHSSLAVETVKY
IEAHYAEKLSVEEIAQHLAVNRSHLSRVFKNHMGTSIKEYLIGVRINRGAFLLSLTDESV
ESIAYQVGFNSLVVFSRMFKKSTGETATNYRKRMKNENFKNIALDTLKKQLEKQTAVSWT
T
>FECAFAII_00140 Lactose permease
MKSKMIQRVSYALGAFGHDTFYVTLSTYFMVFVTSQMFAGTDKATNAKMIATVTSLVVGI
RLVEIIFDPLIGGIIDNTRTKYGKFKPWLVIGGVVSSVLLVAIFTNFFGLATHNTTLFII
LFAIVFILLDSFYSFKDIAFWSMIPALSTETKEREKFATFARFGSSLGANGTTLVVVPIV
TFFTYLVTHKHIEGASGWFWFGVIAAVISGGTAIITALGTKEVDTAIRQQNEKAGIKDVF
KAVAQNDQLMWLALAYIAYAIANVATTAVLFYFFKYVLGQPTEFWIVGLVAALLGLVAVP
LFPMLTRVISRRYVYLGGIAMMISSYFFFTIAGSSLPIVIIGLVLFYFPQQLIFLSALMT
ITDSVEYGQWKNGIRNEAVTLSIRPLLDKIAGALSNGIVGFVAIASGMTGNATAADITAH
GVTTFKAYAFYAPAALMIFSAIIFAWKITLTEKKHAQIVEKLENKLAPADTMEDELHDAV
VPPIKKGS
>FECAFAII_00141 Aldose 1-epimerase
MKITEKDFGQGYHLITLENKNKLALSISDLGARIVSLKSNDRELVLGFDTAEEYIEKDPY
IGASIGRTAGRIENGRFSLNGKTYQLATDPKTGHNLHGGAPGFELKKWSYVILNGENEAS
VIFTTTSPDGEHGFPGTMDVEIRYTLTKDNIWRVTSRGTSDQDTLFNPTNHVYFNLTGDA
SQSIDQHELWLNSEAYAPLRTDSIPIGVKENAAGSAFDFQIPKKLASVFASDLDQKNLVD
GIDHPFFLKETGLGKEAARLTSPDKRIQVDIATDASSVVIFTANFGTETPEMRNRKLAHH
GGITFETQTAPGAERFSAFGSIHLKAGSVFETVTEFKIKTRKE
>FECAFAII_00142 Galactokinase
MEIKRSLNTKFAETFGPKKTTQYFSPGRINLIGEHTDYNGGHVFPASITYGTQGVAAPRD
DNKILVYSTNFDDIGVISFTLDELEYDKKANWANYVKGMVLKLKEAGHSIDHGFELLVEG
TIPNGAGLSSSASLELLVGVVLEDLFDLKTDRLELVQTGKKVENEFIGVNSGIMDQFAIG
FGELDHAILLDTNTLKYEMVPVKLDGYAIVIMNTNKRRELADSKYNERRSECEEALARLQ
KTLPISSLGDLDEEEFESTIDQIGDDTLIRRARHAVSENQRTLKAKAELEAGNLEAFGQL
LNDSHHSLRYDYEVTGIELDTLVDAAQKQEGVLGARMTGAGFGGCAIALVKEENIPAFKN
NVYDEYMKVVGYAPEFYVAHIGNGTTKIDPEAVHV
>FECAFAII_00143 DNA polymerase IV
MWANQNPVFVYEKEPSRDILCIDCKSFYASVECVEKDLDPLTTKLVVMSYPSDSTETRGS
GLILASSPAAKKAYGITNISRARDLPFPYPSDLYIVAPRMAYYMEKNREINSIYKKYADE
ANHHVYSVDESFLDVTNSMALFGKTNAYDMAKLIHKDVFEQTGIYTTIGIGDNPLLAKLA
LDNGSKDGKQMFAEWRYEDVPEKLWKISDITDFWGIGKRTAKRLKQMGIHSVYDLAHADY
YHLKSKLGVIGTQLYAHAWGIDRSFLGQEYTPKSKSIGNSQILDRDYTRREEIEIVIKEM
ADQVGTRLRRSAAKTQVVSLWVGYSLGYLDPNGKTGFHQQMKIEATNASRDLADALLTIF
HQHYHYQDIRRVGVNCSDLVYATGLQLNLFEDPEKQINEAKVDFVVDTIRKKYGFQSIIH
AHSLLQGGRAIARSSLVGGHAGGMSGLEGGKDETDSKKIH
>FECAFAII_00144 hypothetical protein
MGDCFCDGRTSQRYQKNEEEARKQPLPKQQMTLQEIDSILTEAFLSRKAVIIQLNLKDEF
GRLLDEVEGHFIGEAYEDYFMIDHQPILWEDVRYIELKETKKWFVT
>FECAFAII_00145 hypothetical protein
MIFSITMKLVFGLIGLLLVVRLLGKKSMSEITPFDLVYTLVLGGILEESTYDDNVHVGHV
LFAIALWAVMIYGIERIVQKNEKVNRWVKGEPSVLIKDGVINMTELTNNHIEMEQLRAIL
RQQECFFLENAKHVILENAGQMSVLKKSDEDKALSILLVDEGQIQHKVLQSNQLTEAWLM
ENLKKEGYADVKQLIYVEWSEEKGLYILNKEDVMHESYRIDG
>FECAFAII_00146 hypothetical protein
MTNELRNRGFSINKKKVQRLIKKLGIKVTAYTRKSRRYNSYRGKVGAVAKNRIHRRFYTS
ICHQKITTDTTEFKYHEVDAKGIIRQKKLYLDPFMDMFNSEILSYRISEKPNALAVMEGL
EEAIQTTNDCPYRRTFHSDQGWAYQMKAYRNKLKEYKIFQSMSRKGNCLDNSLMENFFGL
LKQEIFHGKVYNCFEELKSAIDSYIYYYNNERIKQKLNWQSLVQFRKTTVTVV
>FECAFAII_00147 hypothetical protein
MVKYTFELKLKIVHDYLDGKGDWTVKIQIKRLKRKCLKFGRSTRIMAVYG
>FECAFAII_00148 NADH peroxidase
MEKIKVVIVGASHGGHQSILELLTRYGENVDITLFEAGDYISFMSCGMELYLEDKVTDVN
DVRNFRPENFPQSNVHILNNHEVKTIDADKKTVTVTSASDNETKEYPYDKLILSSGVKPN
NLPVPGADLENVYLMRGYNWATKIKEKLNDPAIKKIAVVGAGYIGIEAAEASRKAGKEVV
LLDVIDRPLGTYLDAEMTDILEQHLNENGIEVLTNAKIEAFTGNGKVEAIKTSEKEIPAD
LVIQAAGVKANTEWLKGIVDLDERGWIQTNEYLQTNLPDVYAVGDATLAYSIPARKKMPI
ALATVARREARYVVKHLFEEVPNKPFGGVVGSSALSVFDYHFAASGLNSFTAAKAGVDVR
VSYYEDTLRPKYVPEEQGNPKVSIQLFSDPMTHQLLGGAVLSTYDVTGQGNVLALAIQNK
LTLEELAEADFFFQPGFDRQWSMLNLAAQQALGEEPFVE
>FECAFAII_00149 Putative N-acetyl-LL-diaminopimelate aminotransferase
MMNLSNRFSPRLSRIEVSKIRQFDQQISSIPDVIKLTLGEPDFPTPEHVKQAGIAAIEED
FSHYTGMRGLEELREAACIFQQQRYGLTYDPQTEVLTTVGATEAIASALLSVLEEGDKVL
IPAPAYSGYQPLVELAGAELIPIDTSDTGFVCQPEQFERAFEQYGSAVKAVILNYPNNPT
GTTLSAKQLKAIAEVLKKYPVFVISDEVYAELTYSGTHMSIATYLPEQTIVISGLSKSHA
MTGWRVGFIFAQKALIDELIKVHQYLVTAATTMSQKAAAEALINGVKDSENMKEQYQTRR
DYLVQQLAPLGFEVTQPNGAFYLFCKLPAAIQTDSWQFCVELAEQAKVACIPGIAFGPEG
EGYIRISYASSMEKLHEACKRIKDFLTEQ
>FECAFAII_00150 putative hydrolase YxeP
MLKEYRMALHQIPEIGFHEFKTKKYLYEQVKNSEAVIHEIGETGLLLYFDNQQEETIAFR
TDIDALPVKEETNLSFASKHEGYMHACGHDGHMAMLLGLTDFITKHIEDLIYNVVLIYQP
SEEISGGAQSVIQSGLLDKYEVQAIFGFHLWPGLAKGEVFSRPGPLMAQSSETDIIIKGQ
SAHIASSEKGIDSLEAAVRFLKNVYDFDRQLPAEWNHLMKFGQIQGGTIRNVLAGEVIVS
GSIRSYSSDMQNYLKRGLDHLAEQFHSTATISFRYNDGYPAVINHRGLYAALLDSNKLHE
LDAPVLQAEDFGIYTQQYPCVFFFLGVGDTPALHDPTFDFDMDVLENGVEWYKTILFTEN
LLVKIDSSSKEERVNNDEFIQSI
>FECAFAII_00151 Aspartokinase 3
MSNTLKVAKFGGTSMSHEEQFKKVRTIVLSDPNRQVIVVSALGKRTSDDDKVTDLLYLIY
AYLQHHVDWTPLWKRICDRFIQVRDVLALQLPIEDELARIQKQLEDEKITEDYLVSRGEY
LTAQLMAEYLGYQFIDAKDLIFFDYDGKIDQEKTAQEITKAFKRYPKMVVPGFYGANPAG
KEKLLGRGGSDITGAILAKMLQAESYENWTDVSGIMMADPRIIDHPKIIEEISFRELREM
AYMGANVLHEAAVFPVQEADIPIQIKNTNDPFAQGTKISNHEIEKENGLTGIAGRKDFLS
ITLFKRHMSDEIGFIWKAMSIFAKHEISIEHIPSGIDNIGVIVSAEAIADKLFLITKELK
ETLGVEEIVVIEDLALISVVGGPHKELIGLSGKVLSILNKLEIRTSILSQGAQELNLIIG
VPNNQYETVVKGIYEGMVNTDAERISNGTPSNS
>FECAFAII_00152 Aspartate-semialdehyde dehydrogenase
MREIDTCIVGATGLVGQTMLKVLEEYDFPVGRLKLLASKRSAGKVCVFKKKKHTVQELTE
TSFEGYDLALFSAGASVSKEFAPIARSQGLFVIDNSSAWREDSDIPLIVPEVNLEDYTLN
RLIANPNCSTIQAVLPLKALQEAFGIQRVNYSTYQAVSGSGQKGIEDLHRTQNDEEPVLY
PYNISQTVIPEIDQPLENGYTKEEQKMINETRKILHQPALPVSATCVRVPIENGHGVSVA
VQLQKEFTTEEIRECLSQFPGIQLEDDLAAHKYPTSILARGTDMVYVGRIRKDTSLENGL
LFYTTADNIRKGAAANAVQIAAALMQKIAEVAR
>FECAFAII_00153 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase
MEAQEIIRYIQTASKKTPVKVYLNVTEPIEFKESKVFGEGSSFVVFGDYETIAPVLEAES
EKIIEIEIETAARYSAVPLLDIKKINARIEPGAIIRDQVSIGNNAVIMMGAIINIGAVIG
ENTMIDMGAVLGGRATVGKNCHIGAGAVLAGVIEPASAKPVIVEDGVLVGANAVIVEGVH
IGKDAVVAAGAVVLEDVAAETVVGGIPARVLKISDDQTKENTALIAALREL
>FECAFAII_00154 4-hydroxy-tetrahydrodipicolinate reductase
MKIGLIGSGQMGNRVEEVAQERGDTVLLLRTAPKEATTLAFTELPELLIDFSHPDNLEKI
LSYSLSYQLPLVIGTTGYTQSQFQEIKEHAKHVPVMYSANFSFGIMVMNQLIKQAAAMLQ
GWQIELIEKHHSRKKDAPSGTANMLLQTIQEVQKLQPVYNWQGKKREENQIGVHSIRAGS
LPGEHDVLFAATDEIFTIKHESFSNRIFAAGAVEAADWLKDQSPGYYKLEDLLMDKGV
>FECAFAII_00155 4-hydroxy-tetrahydrodipicolinate synthase
MIKGSIVALITPMNEEGSVDYAGLEKLIQFHLDEQTDGLLVLGTTGESSTLTQSEEEQIL
QLTVKKVAGRVPVIAGAGTNNTKETIEKAKHFASLGADALLVITPYYNKTSDAGLAAHFT
AIAEASPIPLILYNVPSRTGMSIPIHVLVNLAEHPNIIGLKEASGDMAYVMDAARLIGEE
FFLYSGNDDLILPVMSVGGSGVISVWANIQPKIVHELVKDTQDGRWQQAKEKQLNALELI
HALFSETNPIPVKAAMSLLDLPSGPLRLPLVSLSKEKKKQLAQLLLKERTVEK
>FECAFAII_00156 Diaminopimelate epimerase
MILHKYNGCGNDFILLDYAEDTDYSQLAASLCTKEKYDIDGLIAVKIDPLEMIYYNKDGS
RAPMCGNGIRCFARYVNDQNMMNEQEFNVETLAGTRKITVLDPSPFYCSVDMGVPDDSPE
KIKANQTYPIKNQEIEINGEKVTITSLFLGTIHTVVFVENAREEVWRKRGELICHHPLFK
EKTNVNFVEVVNEQELIVRTYERGVGWTLACGTGCCASYVVAKETGKISADQVVVHLEQG
DLMISGEDAIQMAGPAVHEWTRILEE
>FECAFAII_00157 Diaminopimelate decarboxylase
MTELIIGGVTASTLAEKYKTPLYVYDEEKMRQTMLSFKRGFVSKRFDTKVLYASKAFQTI
EMLHLVREYGFGLDVVSGGEIYTALQADFPRDTIYFHGNNKTPEELIYALENDLLHIVAD
NLMEVELLAELSQRYLKKICIMLRLNVGVEAHTHEYIVTAHIDSKFGMSYESKECQQALQ
LIKESSYLELEGFHAHIGSQIFDVTAWLAEIDKLTNYLTDFDQPLSLNLGGGFGIRYTQN
DQPIPVEEALKKLIEYTEEALEKRKLTIRQLLIEPGRSIVGEAGTTLYTIGFIKKTPHKK
YYFVDGGMTDNIRPALYQAEYDCDLAAKLSEEKTEKVTIAGKMCESGDVVIKEAYLPKAE
SGDLLAVYSTGAYGYSMSSNYNRATRPAVVFVNNGQSRLIVRRQAFSDLLRGEVSYDPS
>FECAFAII_00158 Elongation factor P
MISASDLRAGMTFVQDGKLIKVLDASHHKPGKGNTVMRMKLKDVRSGATYDTTFRPEEKF
EKAHIDTKPVQYLYTMDDTAFFMDLETYEQYEIPVETVEEEMKYILENMEVKIQFFGSEV
IGVQLPTTVVLRVVETQPSIKGATVTGSGKPATMETGLVVNVPDFIETDELLEINTAEGS
YVKRASK
>FECAFAII_00159 Cysteine synthase
MIISTITEAIGSTPLYRFDNQHYSMPKGSAIYAKLEYLNPGGSIKDRLGSYLIKEGFAQG
KINEKTTIIEPTAGNTGIGIALAALTYKLRTVFVVPEKFSLEKQQLMKALGAKIIHSPSE
QGIIGAISKSKKLAEEISNSYLPLQFENKDNPAAYYHTLGPEIFHEIKENIHSFVAGIGS
GGTFAGTSTFLKEKYPDIRIIGVEPEGSVLNGGDPAPHEIEGIGVEFIPPFLSPLSINQI
ETISDVEGFNYTRQLAREQGLLVGSSSGAAFAAALREIRRLPPGHRVVTIFPDAADRYLS
KNIYL
>FECAFAII_00160 Cystathionine gamma-synthase
MHIQTKLIHGGISEDPTTGAVSVPIYQTSTYRQDGVGQPKQYEYSRSGNPTRFALEELIA
DLEGGVRGFAFSSGLSGIHAVFSLFQAGDHILLGDDVYGGTFRLFDKVLTKNGLEYTIID
TSNLDKIEQSIKPNTKALYLETPSNPLLKITDLEKSATLAHQHGLIVIADNTFATPYFQR
PLDLGSDIVVHSGTKYLGGHSDVVAGLVTSNHKDLADQIGFYQNAIGAVLGPQDSWLLQR
GIKTLSVRMEEHQKNAFVVADFLFSHPAVEKVYYPGLPDHELHGVAKQQMSGFSGMISFT
LKNEESAIPFVESLQLFTLAESLGGVESLVEIPSVMTHASIPKEKREEAGIKDGLIRLSV
GIEYGQDLINDLAQAFDRIKN
>FECAFAII_00161 S-ribosylhomocysteine lyase
MRMNVESFNLDHTKVKAPYVRVADRKTGAHGDVIIKYDVRFKQPNKEHMDMPSLHSLEHL
TAELIRNHADYIVDWSPMGCQTGFYLTVLNHESYEDILDVLEATMKDVLEATEVPASNET
QCGWAASHTLEGAQALAREFLAKRDEWSEVEA
>FECAFAII_00162 Glutathione peroxidase BsaA
MSIYNFETTLEDGTVYSLKKYAGKPIIIVNTATKCGLAPQFKQLEELYQAYQTQGLVILG
FPSNQFKQELDSATEAAEACKTTYGVTFPMHQLIDVNGENTDPLFTYLKNEAPGTVTKAI
KWNFTKFLIDRNGKVIERFAPQTSPLKMTAAIESVL
>FECAFAII_00166 Regulatory protein Spx
MEVKVYGSAHCVTSLKAKQWLEHHQLPYQFVDLEERDLSTEEAEELCSFEEVQAEQLFAT
WSEAFHNIAIDLSCVGKKQLIFLCTQHTNLLRRPLIIIDEVLFIGYNEQLMEQLILNK
>FECAFAII_00167 Regulatory protein Spx
MIKVYTSPSCTSCRKARAWLQANQLEFEEKNIFAEPLTESEIKKILAATEGGVQDIISTR
SKIYEKLGIDFNELTLKQMIVLFKEYPSLLRRPILIDEKRILIGFNEDEIRSFVPREIRC
VARNLIYLQNNNILNS
>FECAFAII_00168 Putative ATP-dependent DNA helicase YjcD
MNEKEILRLQKELKRWENKYKKLQQVFRLQEEIIATYEAAYGEAPGLIEEEVQVKESEGN
SSFFKMMEKRSYNRFNQEQKAAITYDMKKHLRIIAGAGSGKTQTICAKAVYLMTQKQVDE
ERILMITFTRNAANELKKRVDNFSQRKTAVHIGTFHSIFFRIYNEICRKFPEVAMQGIQG
DFSKDTAQKVNAVLQQLIRKYNLYIFDQYGEKTIASRLDYWQNMNLSVEEMVQLVKEKYD
SIDKNARQPISERLYGLLTELQEQKRSQQLLEFNDVLQNLKSALENEEIQHYIGQKYDYL
FIDEFQDTNPLQWEIVKRMTKENRIKLIVVGDDDQSIYGFRGSEPAYIKNFEKEYPTKTL
FLLTNYRSRAAIVQGANRLISYNKNDRIPKAMIPAQKEAGVMEAYLFSDTKAESQWLIKQ
IQTFIQKNGKYKESIILYRSASQTQQLVQSLLKTNIPFVLEADSPYEGIFGIKSFQHFYQ
KIVHWQTALNLQKKNQAYQQLLRQLMADCYLKKSECDQYFSPKYQNIAVADYILSISPNL
KSKSAEIREFEEALRKTDQHQEIYSLVQSYLHLPRIAKEIDQSDQEWIREEVKQHATFRR
LQALSQETQATAKELKTRLIAYRQGKLDALCIQSIHKSKGLSYRNVFLIGCNEGSLPYNG
ATEKKVIDFNEIKAEPVTTIEEERRLFYVAMTRARNRLYLCVPQMKNSRKLKVSRFIKET
GSRVKKGK
>FECAFAII_00169 hypothetical protein
MQTSFHEGRTIGLLLTFIGGAMDSYTYIQYGAFASAQTGNIILSIIQAFDGEWLSVGKKV
LSTLFFFLGILLTKYLIDYFRKKEKHFWRLFVLYYEAVIFFFVSLTPVHEHPALVTILIA
FTASIQWVAFDKINGRAYTNLFTTGNLKGVATNLYDYCISKEKADFDRFFHYLSVVLAFI
AGAIVLVFCHHLFGAHSILIVSILFLIMALTQTFHLWQFYHTNRFTI
>FECAFAII_00170 Deoxyguanosine kinase
MIIVAGTIGAGKSTLTEMLAQDLETKPFYENVEDNEVLPLFYSNPEKYTFLLQIFFLNKR
FLAIKDAFSHDDNVLDRSIYEDSMLFHLNADLGRVSEVEVKQYEGLLETMLKELEEISPQ
KKPDLLVYIRVSFETMLARIKKRGREYEQLEQDPELYSYYKELNRRYEEWYEQFDICPKI
VIDGDKYDFVADPACGEQIVQEIKMRAKKMTEEADAQSIRYTTNNPKAKGIFTTK
>FECAFAII_00171 hypothetical protein
MENEQLFEVGETYAFKSDLFESPIKGKIEKIYENSVMIRVMKCAVEDNDTAHNLHWQLVV
RKSSTIEE
>FECAFAII_00172 Accessory gene regulator protein B
MKDKVVNKLLEALFSGDKSEEDMVYVQVKFVLEVLLNNLGKLAVVLVFSLVTGSWAETGI
TFLSYICIRRYAYGLHSDSEFVCLLWTLLYLWGVPLVMKHLQLTISFPMMVFLLISCFLL
LLRYGSRGTAINPIEPEKRPPLLKKAISMFLIFSLITLFFSASYFSTYLLLGIVLEIATL
LPITNYLMNFGGIFHEKNNH
>FECAFAII_00173 hypothetical protein
MKKTIIKQLTNLSDFFVSGCCFGMSSEFKIPEKLKK
>FECAFAII_00174 hypothetical protein
MFLWSIALQYLIYTICILLIDHHIRYKYLFAGVILISCILIGWVYSILGIFTALIAIGML
MLTFFFFSTSRQQLVYALPFGLLTSLLGDHLTSIGDFFVLKSSVIEPGDSLQYFHIVLSA
FLSALLAFCLKKSLETWFHTVDRRMIGTIGTLILFTYYIIIFYTRFSGETPDVLALNTSF
FILYLCVGLIILVYYWKISNKKLADQLLEQQVRMQQDYIKDLEKNYQDLREFKHDYQNLL
FSLHSYISEGDLEGLRSYYDQTILPTRQMMNLFPANLSMLDNMKVPEIRSLLSLKLMMAQ
EKGLIVQLHFPEPIELDTKHTVNLVRMLGIILDNAIEGASAAKKKKIELTILKKNHSVMI
RVINTTTNTLPLNQLKQKGFSTKTNPKNEGLGLFILDELTKTNPYLFLETSIENQRFSQT
IYIQIK
>FECAFAII_00175 Accessory gene regulator A
MIPIYICEDDPKQLEVLSTVIKNRIMIENLDSYVHISTSDPEELLNAAKIRTSSFGIYFL
DIELEDSEMDGVAIGKLIRELDPLGKIIYVTSHTEMSMKILKSNIEPTDYIVKEDLYDLK
ENVEHILSKIFEDFQMSQIQKDIFKIEFNDEIKFLPIKDIQYFSTSLGAPHKLEVHLTHA
QLQFYEKIKEIEKMHRNFIRCHKSYVINTQNVRSINKKTREVTLANGETIPASIRGLKKL
IS
>FECAFAII_00176 High-affinity zinc uptake system binding-protein ZnuA
MKRLIGILAMLVLAGMLTACGASGKAEDSKEKLSVMTTFYPMYDFTKAIVGDEGEVELLI
PAGTDSHDYEPSAKDMAKIQDTDIFVYNDENMETWVPAIQKTLQEGNVHTIKATEGMLLL
PGSEEGHDHDHEHEHGEEGHTHELDPHVWLAPSLAIKQVANIRDQLIEAYPEKQEVWTKN
AAAYTEKLQALHQLYQETFKQAKQRSFVTQHAAFNYLALEYGLNQVSIAGLSSSEEPSAA
RIAELKHFVKEHGINYIYFEENAKDSIARTLANEAGVSLEVLNPLEGLTNEQIENGENYL
SIMEANLEALKKTTETENPLEDTLTPKKEKSVYNGYFEDEDVQDRSLSDWAGTWQTVDTY
VEDGTFDPVFEYKEKLNQDKTAQEYKEYYTKGYQTDIASIKISEKEMAFTFKNGTTKRSN
YRYVGKEILTYEAGNRGVRYLFEAEDKESGAFRYIQFSDHTIAPADSEHFHLYAGNESQE
VLLKEMENWPTFYPDTMDGREIAQEMLLH
>FECAFAII_00177 AI-2 transport protein TqsA
MKKETDTTNRLIRFLGGKTSYYVLGIVILLALIIYFFHQISFIFKPVGIIIATILPPLLF
ALILYYLLEPVIKRLSKHLSRNLSVIIVYVIILFLLGLGSIWLIPFLEEQAKTLISSLPD
LFQDFQESLRQFLEKTPFADSFNQFFASIDDVTSDIAGFIGNYWESGAQRISNIFSTVTA
IFITLFTGPIVAFFLLRDPQKFYQSVLAIVPPAFRTDFKNLTKIANQQLGSFLKGQIIAS
FILGAVYWVCFLLIGLEFASVLAISAGLLCIIPYIGPFIAFFPGLIIAFQDSTFMAVKFV
IVWFAVQLLHGDLVIPRVMGDRLQIHPITILIVLLVMGDLMGIVGVIFGIPIYTLVKLLV
TFIFRKFKQRYNKFYGDKGEYENSSFSEEDYFK
>FECAFAII_00178 Trehalose-6-phosphate hydrolase
MTFKDKVIYQIYPKSYKDSNGDGIGDLKGIKEKLPYLNDLGIDMIWLNPIYPSPQKDNGY
DISDYTAIDPIFGTMEEFEQLIAEAKKYRIEIMLDMVLNHVSTEHEWFKKALAGDQHYQD
FFILREEPTDWVSKFGGSAWSPFGDTGKYYLHLYDRTQADLNWRNQAVREELFKVVRFWM
EKGVKGFRFDVINVIGKDEQLKNNKENDGKPEYTDKPITHTYLKELNQATFGTDSTIITV
GEMSSTTIENCILYTEPSREELSMVFNFHHLKVDYENGNKWSTPPFDFAELKRLFHTWGE
KMSEGNGWNALFFNNHDQPRALNRFVAIDQYRKQGAEMLATMIHLNRGTPYIYMGEEIGM
IDPDYSSISDYIDVESLNAYKLLLEQGFTEKEAFRRIKAKSRDNSRTPMQWSDTEQAGFT
TGKPWLKVGGKLEEINVEKELSSEDSILSYYKKLIRLRKTYPIVAQGDYHAYEANHPEVY
GFLRQFEGQQLLVLTNFYDKDTRIAIPEGFTEANILIDNYSDTVLHQSLELKPYQAIALL
KN
>FECAFAII_00179 hypothetical protein
MKTRTYLKAGFREIRQSKGRFIAIILIVMLGTLLFVGVKTAGPVMQKTMDHYVGTAGLSD
LQIVSTGGLTQKDIAQAEKIPDAKVETGKQIYYSNTGKNEVIQIFSYNKNNKQNKLQLTD
GKLPEKPNQLVLDEKAEDEGYKIGDIYQIDSDELKEKEYTITGFVRSPLFINNLERGYAN
VGNGSVDYFVYLPESVFKTDIYSVLYLDFTNVKNLNTYSKAYKDKMEQNQEKAEKYLQDR
PEERLEELKKSANEELEPAQQKIADGKAQTTQARTRLEDAKKQLAQQSATIQQLPEAQRT
IAVQTLSQQEAQLAEQERQLVEKERELASAEEELNRNAEKIENLTKPSYLYNERSENVGF
QEFGDLSDRIAAIANVFPVFFFFIAALITFTTMTRMVEENRREIGTLKALGYTKVEIAKK
YAIYASLASGIGIVLGTILGTNLLPRIIFELSNERYDIGSALIFYDWPPILQAAAAFFIA
AFGAAMIVLFKDLRERPAALLQPKAPKPGKRIFLEYITPLWSRLSFNQKISYRNLFRYKS
RMLMAIIGIAGCAGLMVAGVGLKDSLSSVSAKQFGPIIDYQAIVTLDSSTEDSRQKAADM
LQKQEKVNEILAIHTQTVELRKKGHASQSLTVIVPSKTADLDRFIHLTDLEENPRSLPKT
GIAITQKVAELFDLSTGDHISLYDEDQKEWKVEVKEIVKNYLGSFIYMSPEYYASVTDQS
MMDNAFLLRTDKMTTKEEEMLSEKLLATDAVTNTSFMSKQIETQEESMANLDSVVLIFVV
LSGLLAFIVLYNLTNINISERVRELSTIKVLGFFDKEVTMYIVRENIIFTLLGIIGGFGV
GYILTDFILQQASMENVIFPLVITWWAYVLSAGLTIVFTVIVMIVTHFKLKHIDMIDALK
SNE
>FECAFAII_00180 putative ABC transporter ATP-binding protein
MKYVEVKNEYKRYKMGETTITANDDISFSIEKGELVIILGPSGAGKSTILNILGGMDTPD
EGQIIIDDTDIAQFSDKQLTAYRRTDVGFVFQFYNLVPNLTAKENVELATEVSPDALDPV
EVLRQVGLAHRLNNFPSQLSGGEQQRVSIARALAKNPKLLLCDEPTGALDFETGKQVLKL
LQNASRQHGNTVLIITHNSALAPIADRVIHINDAKVRSVELNDHPSSIDEIVW
>FECAFAII_00181 Isochorismatase family protein YecD
MNDLKENMIFDLSKTAFVAIDMQKEIVNNGTLSPHTAASILTNNDLLVRTLKRTAALKVL
VNVDISTFPYLSQQTDMGGMTASVPPEFTDLLLKDSLKDTDNMLTITKYNPSAFFGTSLD
LQLRRRGIETIILSGVATTNGVYATALDAFQHGYHIVLAEDACSDRDKESHQLFIKKIFP
KTARVRSTKQIIEAIQQSK
>FECAFAII_00182 HTH-type transcriptional regulator DegA
MVKKKITIKEVAKLSGVSITTVSLILNGNTEKFSPKTVQKVLAAKEELGYQPDYFARQMI
TKETKTIGVLVPDITNPFFSTLMRGIEDILYKQNFVTILCNADSDHQKEIEYLAELTRRG
VDGFIIATSAVSTDAINENLKKQGRPFIVLDQKKSEGFSDAVRTDDFRGGYLAGMHLLSL
GHQTIALVYPENPPENVHARIEGFKSALDVYQIPHDQLILLPTQFSKQGGYQITAELLDS
AATGVFALNDELAFGLYRGLEEAGKSIPEDYSIIGYDNIDMCEYIKPKLTTIAQPIFELG
QTSAKLLLDRIQFPEKEWEEKRLPVRLEKRFSTAPLK
>FECAFAII_00183 Bifunctional ribokinase/ribose-5-phosphate isomerase A
MNTVTVIGSINMDTTLRLTNMPKPGETMHAHEIFHAGGGKGANQAVAAKRSGARTSFIGG
VGADSEGQQLLDLLTKENIDTSGIAEIQGATTGQAMIMVDAAGENSILIHAGANNAFHEQ
EVLKNKQLITNSDFIIAQFESSLDATILAFSIAKDAGKTTILNPAPARETIPTELLEKTD
IIIPNETETEIITGIRVTDHNSLVAAAEKLHELGIGTVIITLGSAGAFYHTEKEHGIVPA
FKVDAVDTTAAGDTFIGALSSTLQPDLSNLKEAILYGNLASSVAVQSYGAQPSIPYREAL
EQSAV
>FECAFAII_00184 D-ribose pyranase
MKKGKVINSDISRVIAQMGHFDKLSIGDAGMPVPFGTEKIDLAVSNGLPSFLSVLENVLE
ELEVQSIELAEEIKTMNPEILEKIKLLLPDTPISFIPHEEMKKELNNCHAFIRTGEMTPY
ANIILVSGVVF
>FECAFAII_00185 PTS system beta-glucoside-specific EIIBCA component
METTMNPEQMVLSEQIHMLIEQLGGKDNIDSVLPCATRLRIKLKKQPVANAEKLKQQIPS
IKYFILLDRYAEIIMDQGLAPAYKELTRQIDHSAPKEKLNPIEKLFGLISEIFTPIIPLF
AGSGILKGLVVLATTIGWLSETSGTYHILSAASNAVFYFLPIFLAFSAAKTFKVNGYIAA
VIAAALIEPNLTSLLSDSGKAATDFLGIPVVLMQYTSTVMPAILGIFFYSFVEKFLKKYI
RENMQLVFVPLLSLVITVPLTLMVFGPAGVYLGEGLAAAITWMMDINGPISGAIIAGGWN
ILVIFGIQWAVNPVMISNISAYGFDRIVPLTGAANFGMAGAALGVFLRSKRSKTRSISGS
AFASILLAGVTEPTVYGIAIPLKKPFVAACIGAAAGGAVMGFAQVKAIAFVFGSLTTLPA
FISGTFFWYLAGLAVSLVVAMITTLVSGFDEDLMSYE
>FECAFAII_00186 N-acetylmuramoyl-L-alanine amidase domain-containing protein
MKNKKTIRLLAATWLIAPSVLSTNTVFAVDNQIADQTVTTDTTTSSSATSETTDSFTEDP
TGTTNSTTGSTEPTEIDPADPSENEKPAETYSLTIAPSLIGKIQLTASTADSPEQQPLDI
TESGTVEGLLAETKVTYTITPAEGEQIASVAVNGAKEVNYDAKTFTVGTNNLSITAEFKA
GPDTSTEKPTDPSEEVPSTPDPETPNKPDVGNNNNNNGSNNSNNNNNNSNSGNSSNQTNP
SGSNNNGNTQREPNHPNNGSSNGGTNNASSRPNTANQSGIENPSSASSDFVVKSPIDAVL
PTNTTNVQQAIVREAFKHLGKPYVWGAKGPNTFDCSGLTYYVYMKATGHYIGGWTGEQQY
AGTQIPVSQAQPGDLVFWGPSSGVTHHVGIYIGNGQFIHAPQPGDKVRVTSISDFTPDFA
VRVNLAGLPAASGSLTGGSSILDGLDGSFHFSQNQTTDQFLKKIADDAQEIGQKEGIYAS
VMMAQAILESGSGNSLLSSEPNHNLFGIKGSYKGSSVTFNTLEQDSSGQSYQIRAQFRKY
PSYKESLEDYADLIKNGLTGNPDFYKPTWKSETKDYKEATKYLEGRYATDRQYSQKLNAI
IEAYDLTKYDEPKKEAATTEEANAEILNMSKRFDVPIKWTTDGVPITGLEFSTIKRVNNA
SSIFRVASIWDLWNNFTARQIPETTTRTVKAATVPVLTLLSLDKSFWLDLPLKK
>FECAFAII_00187 Aldose 1-epimerase
MEINEQNFGENYHLITITNQNGTSLSVSDLGARVVHFQTIIDNEKRELILGFDEAKEYLE
KDPYIGASIGRMAGRITNGTFKLDDETFEVKTDPDTGHCLHGGAPSFEAKQWHYTVINGE
NEASVIFYQTSPDMENGFPGTLDVEVRYTLTNDDTWRVTVQGISDRKTVFNPTNHVYFNL
TGDPAQSIDEHILWLNSRLFATLNKDTTPTGEVVSVSGTAFDFQRPKKLGEVFASDFRQS
MIVGGIDHPFLLKKQSGLLNAAELTSPDEKVSIQVKTDASGIVIFTANFGEDGPEMRGNK
LVNHGGITFETQELPGAERLESFGDVTLEPNQVREFVTEYKINIKK
>FECAFAII_00188 Bacitracin export permease protein BceB
MLWKLSLTGIKSRLRDYLVLFSGLVMASAIFYMFESMASNEAFLKSNTIVAATVIIFRFG
SVLLGIITFVYILYANSFLMTMRQKDYAMFMMLGAKGRKIAQMIFSETFLVGIAATLVGS
AVGVGLTSIVHRLLVDQLDLNISHFTPFSIHGLLITVLFFAVLFLLAAVVNAFSIVKKPI
LALIRADQTPTRIKQHKFLFFLEVVLGIAFLGCGYYMMKHVGTYQVFGIGVALVTIVLGT
YFIFHSVIIFFLSLLKKSEQISLKKLNNFTLSQLNFRIREYTQMLSMVAMLFALALGALT
VGLGFKNEIADLTENNSGYDLVMNNPRAEDQQKIKELSPTLSASYTQKEDAGTIYYNASE
FAAQPLIMIKHEDGTPPKITKEKVPAKKMNELTVQEELRSYELPEQQEKEIKVVSQSEFD
QLNLPQSTLQLVQVKDFQANLKPIETLVAQNKMNNPSLQKVEYSNQKYEMYEVYNGLFSG
FEFMGFFLGLAFLTMLASCLMFKILSGSKSDIARYEMLEKIGTRRGLLKQSIRREVGVLF
LAPGILGVVHVLFGLQMFGLFMQNPYKDIWVPFTIFFVLYFIYYVLTTWLYTGIVLKKRL
>FECAFAII_00189 Bacitracin export ATP-binding protein BceA
MNKIVEVQNVTKVYGKNNEKKTQALSGISFDVEKGEFIGIMGASGSGKSTLLNILSTLDK
PTDGHIRINQKDVTTLKGNQLADFRANEIGFIFQDFNLLESLTAQENIAVPLSLQGVRPK
EIKQRVQKIAERLSISHILESYPSEISGGQKQRVAAARALITQPTILLGDEPTGALDSKS
ARDLLDTMDELNTKDHVSILLVTHDPFSASYCQRILFIKDGGIHQEVKRGDQSRDSFYRE
ILSILGNLEQ
>FECAFAII_00190 hypothetical protein
MKKLLIGLLVFIVVVLAGVKIADYVVMGGEEYYVQITTDGTKTVSKSDSGQETVNYRYIL
PGYTKEGKEKELDFKGQLTRPLRKGAYLKITWNKNKGVTSYEEVEKKDVPKTALEKLIKG
>FECAFAII_00191 hypothetical protein
MREKRAFYINGYAGIVGLVVLALVGLFFFYLGMWQAKVWALFLSIFLWLITLLLLSSATV
VSPNQAKVILFFGQYLGTIRENGFFLTIPLAQKMTVSLKVRNFNSSVLKVNDLDGNPIEI
SAVVVFKVVDTAKALFDVAYYQDFVEIQSETAIRHIASQYPYDTFNENDLTLRGNTTAVS
DELQKELQERLAVAGVEVIETRLNHLAYATEIASAMLQRQQAKAILSARQTIVEGAVTIT
QMALEQIEDGQEINFTDDRKVQLINNLLVSIITDKGTQPVINTGDMKDRK
>FECAFAII_00192 hypothetical protein
MKVEEGQREKLKTEMERLHTYITQLSQTFYDPDKEKVMVNYPNNSEGRQLEQVYHEVFKH
LLTVKKELDYYSLPIIDTGILKYDGKKERFIFKSVREDLPLSAGMDLEVLVEDYFTEEKH
WVRTKLDYLPQAAGGTQASGWYITEDKELELEGVMARIRKKN
>FECAFAII_00193 hypothetical protein
MRLKHFLITGIGLMLTGGLLAGATYTLGAQKSLTWDNGPRLIDMVTETKKIKDANKIVIH
AENQTVSVIRGLDFEIKTTYDKTEKPEIKEKNGVLTVNAVKKSTGAIISLEDTSAQITIV
VPADHELSELTIEGNNSAIDINEVSIKKVNTKTHDGWVSFNEFTGGTITAKDELGSLRLD
EANVDNLIVTGENSNFHLEDSLISKEGKVILNGGNLSLHEMENSGYTIQTSGESYIEKDY
QPITNTLLEQGQKKLKITAKDTSINITTDQEDNETD
>FECAFAII_00194 hypothetical protein
MNEYLNEVVDHLQEIPEDDRFDLIQYYEEYFLDSGKTLDQIIDEYGTPKQFALKLKISYF
SEEEQAENELVKNPKRQIRLIWLIIIGLFASPVLIPLALGFILVIGGLLVALLALIFSIY
VLCISILGVGLFMIISGISVFGQSILSGLFFIGVGLFATGSAVFISPLLLKGTKGLFYVM
MNFVKWMGRRFITKRDLHSAGV
>FECAFAII_00195 hypothetical protein
MHIQIPTVLLDGTVLAALSKEDMYGYALTKIVQESLSVSESTLYPVLRRLKKEGYLETYD
EPFEGRNRRYYSLTPMGSRHLEEIIDEWIVFRDSLDRLLEESTNE
>FECAFAII_00196 putative membrane protein YdfK
MPTGVLINVGSVLFGGLIGGLVGNKLSEHFKAQLTMVFGVCSMGMGIYSIAPMKNMPAVI
FALVIGTAIGLIVHLGNGINKGAALMQVPISKIFPSEKLGMTHDEFISTLVTVIVLFCAS
GTGIYGSLDSGMTGDSTILISKSVLDFFTAAIFACNLGYVVSVIAIPQFIIFYILFLLAK
FIYPLTTPDMILDFKACGGFLMVATGFRMINVKMFPVADMIPAMIVIMPLSWMWTNWIMP
LL
>FECAFAII_00197 HTH-type transcriptional regulator GltC
MDIHKFEVFLDLAETMNFTKTADRQFTTQGNISKQILSLETELDVKLFERAHRKIELTEA
GSLLLPYVKNVVEQYHAMQEVLETYTKDNNLSLNILTIPTMINYKGFSKITEFLKRHPEF
TVQLKEVESVELTYNDANEHSDTIHFARSFQAPPSSIEWLPTETDDFVAVLPKNHPLASK
KKLDLSELKKENFLLLGPTTNLYQPVLDLCREAGFEPKISYKGARIDLIINMIANDMGIA
IVMEKTVKNLLKENTVILPISPTTESYLAFTRKVGEHSLASDTFWEYLNQEEN
>FECAFAII_00198 Alkaline phosphatase synthesis sensor protein PhoR
MKKKLFSQLWIYFASIVFISILVTLLCFLGFIFLLSRHSISPAESAGKPTLYPLFVFAGF
SMVVGTGISIFVGRRILHPISALGTNMSLVATGDFSIRMDEQQKVAEVQQLYKDFNVMVQ
ELNSIETLRNDFVSSVSHEFKTPLATIQGYVQLLQAPNLSDEERQIFLYRIIESITQLSQ
LTENILKLNKLENQRIQLEKKEYRLDEQIREVIVFFQPKWEKEQLELDIELAAVNYTGNE
EFLYQVWLNIMDNAIKYNQINGQIHIKLFETATEIVLEVTDSGVGMNEETRDRMFEKFYQ
GDTSRQISGNGLGLSLVKKILELHDGRIDYSSIEGVGTTAMIRLSKQ
>FECAFAII_00199 Heme response regulator HssR
MNRILVVEDDPQLQLLYRSVLERAGFSVITALNGEDALKKLEATRIELIITDIMMPKMDG
YDLLDSLRSTRFDTPVLMITAKADFEDKKRGFKLGADDYMTKPIDVNEMILRVEALLRRS
KINYSSSLIIGQTKLELDAYTVLQDQHSLILPQKEFLLLYKLLSYPNKIFTRQQLMDDIW
GLDTNTEERTIDVHIKRLRTRFEKTEDFQIITVRGLGYKAVI
>FECAFAII_00200 putative ABC transporter ATP-binding protein YknY
MLQLKDIKKYYKVGETTTKALDGVSVAFRQKEFVAILGPSGSGKTTMLNVIGGLDNYDSG
DMVINGKSTKDFKDSDWDAYRNNSIGFIFQSYNLIGHLGIIENVELGMTLSGVSKDEKRK
RAEDALHRVGLTNHMHKKPNQLSGGQMQRVAIARALANDPDILLCDEPTGALDTETSIQI
MELIQELSKEKLVIMVTHNPELAHQYADRIIEFSDGKILTDSHPHIERPKDDQFNLRRTK
MSFWTALKLSFNNIRTKKGRTFLTSFASSIGIIGIAIVLSLSSGFQKQIDNTQAETMAKF
PITISKVTTNQTRDDAGLGASKADYPDSKTITAKVSEEDKAQHTNKIDQTYVDYVTDIDP
NLSNNIGFTRTTGINLLRDVNGKVQPVSFSNQNPDTESLSLSSTMSAMTGVGVSSFPTQL
DTSKENFLKDNYSLLAGSYPASATDVVLIVDGNNNTNINALKNLGFDVKEDEKLDFDDIV
GTTFKLVNNNTYYTKLPTGNFIPNTDYDAMYQNASDELKISGILRVKSSSTMNLLSPGIA
YSDQLTTQIVNENKESEIVKAQRDSGVNVLTTEKVDENAKQTLLSYLGGDSLPSSIMIYP
NNFEDKEKILDYLDDYNKGKSDEDKIIYTDLAGTMTELTGGLMDAITYVLIAFAGISLVT
SMIMISIITYTSVIERTKEIGVLKALGARKKDITRVFDAETCILGISSGILGVFIAWLAT
FPINSILYNMTDLKNVAQLNPVHAIILVIVSTILTMLGGHLPARMAAKKDAAIALRAE
>FECAFAII_00201 hypothetical protein
MKKMEESFPKAVKVENIANILKVTFENGEVKYVKSHWTEEITDALQFGKKGRGKRKNLLA
LSRNMWIGTEVTIEADGTVFINGKDRYTPEELWYKGKKSIPEL
>FECAFAII_00202 Phenolic acid decarboxylase subunit C
MTDQPYDLRKVIEELKTLPGQYHETDIEIDPEAELSGVYRYIGAGGTVKRPTQEGPAMTF
NNIKGFPGTRVNIGTMASRKRVGEILHHDYRTLGRFLKDAVENPIKPVKVDKADAPAQEV
VHLATDADFDIRNILPAPTNTPEDAGPYITMGVVLGSDPEKTMSDVTIHRMVLEDKDTIG
MYIMPGGRHIGHFQKQFEALNKPMPITINIGLDPAIAIGTTFEPPTTPLGYNELWCAGAL
RNEPIQIVDGIAVDEVGIARAEFIIEAEIMPNETMQEDINTNSGKAMPEFPGYTGDANPA
VQVVKVKAVTHRKDNPIMQTTIGPSEEHVSMAGIPTEASILALVDKAIPGKVVNVYNPPA
GGGKLMTIMQIRKENEADEGIQRQAAILALSAFKELKTVILVDEDVDIFDMNDVVWTFNT
RFQGDKDIIVIPGMRNHPLDPSELPEYNPGSIRFRGISAKTIFDGTVPFDMKEHFVRAKF
QEVEDWEKYLK
>FECAFAII_00203 putative UbiX-like flavin prenyltransferase
MEQLAQRKKKIVIGVSGASGTIYAINLVKKLKEYPMIETHGIISPWAKQNLKLESDLSLT
EFESLFDYHYSNKDLGAAVASGSFLTDGMIIVPASMKTVAGISVGLGDNLIARAADVTMK
EQRKLVIVPRETPLNAIHLENLTKLARLGVQIIPPIPAFYNQPQTIQDLVNHHTMKLLDQ
FEIVNEHSKRWQGD
>FECAFAII_00204 hypothetical protein
MEKETIVEVTKLGFTIQAAVKVIGKDLLITLTGGDTPHIGTVTTFSRDTEMQTVRFPSHD
GRFHKDDVLAEKIAVIIKTAVPGSCTITSGIHVDHISNAQINASFPMSEELGYKILDWLE
KIDFHIKEPVYYKDGEKPL
>FECAFAII_00205 hypothetical protein
MREIYSFESKIYASEVGKGGAYIIFPYDIRKEFGAGRVKVQATFDNVPYEGSIVNMGVKN
PDGSVCYILGLRKDIRKNIGKEIGDIVAVTVKQK
>FECAFAII_00206 hypothetical protein
MIIGVLIVSLLAFALTNVFAKKTWQTFLSLIFGLIFVASLSLIVANLSNHFGMEKVTETK
TEKIVSSADSQGADMLLYKALGNGKEKVYLYRTNEKQEKPKATGTDNETNKVEKTDGDAE
KVTKTTYWEYKNDMYKFWFNIADNNHEYDSRVNTFKIPETWVELSTDQAAKLAELVKKQQ
STMESEAKAYVQDGMVKAMTENPKMSKAEQEQRTKALAAEF
>FECAFAII_00207 Multidrug export protein EmrB
MSNNQPVDIYGKPYNRTLLVVVLLIGTFCTVLNQTLLTTAFPTLMKAFDISASDVQWLTT
GFLLVNGIMIPITAWLINKFSSRNLYLSAMTIFLIGTITCFTAPNFSTLLIGRLIQACGV
GISMPLLQNIMLSIFPPEKRGSAMGMSGIVIGLAPALGPTLSGYIIDNYHWRDLFGMVLP
IVVLVLVLAFFLMKSVIPLSNPSIDILSAILSTIGFGSLLYGFSSVGDDGWGSLKVIGFL
VVGVIFIALFSWRQLHLEHPFLELRVFKSSTFTIAAVLAGVTNMAMVGAEMVVPLYIQNI
RGESAFHSGLMLLPGALIMGAMMPVTGAIFDKYGAKRLAITGMFILTAATAPFAFLTKTT
PVLYIVILYAIRMFGISMVMMPVTTSGMNALPNNLISHGTAVNNTFRQIASSIGTAILIS
VLTNVTKANIPSKSVLDNTPLAYKDQAINATLSGYHAAFIVAIIFGILGFIIAFLLKKKE
PVLMKAGDNA
>FECAFAII_00208 hypothetical protein
MVGASLKRLLENDQLVVGISELSDIVGVSPRQLRYWEQKGFIRSIEADANCPRKYRLPTV
IKVELIKKYLDDGFTLSKAAEKAEIRQKKMHHVRKVFSKAIKDIELIDERYTILQIGNFK
EENAKMYIIHDNETDELTYKLLPVDEKADYEQLLKEL
>FECAFAII_00209 hypothetical protein
MARKNTLRYILLGLLSKKKMTGYELNQSFKNEIGEFWQAKHSQIYPELAKMEEQGIIQHQ
VEITGEKLEKKVYELTEEGKEQLAEWIHTPTNELPVNRDEFVLKLYFVKDVNDPALVEII
QQQRDLHEEKRLHLLERKKTIFPTEKEKHENYGHYLILAHAINRETEYANWLTDVLEESN
RKK
>FECAFAII_00210 Phenolic acid decarboxylase PadC
MKEFKELEDFIGTHFIYTYDNGWEYEWYAKNDHTVDYRIHGGMVKGRWVKDQEADIVKLT
DGVFKITWTEPTGTDVALDFMPNEKKLHGMIFFPKWVEEHPEITVTFQNEHIAEMEAARE
KYETYPKLLVPEFATITYMGDAGIDNEDVISEEPYDGMPDDIRSGKYFDENYKRVK
>FECAFAII_00211 putative N-acetyltransferase YjaB
MIRTTTKLSAKELESVLSIWLHANLDSHEFIPSTYWENQVESVRKALPDAVIYLAEIDQE
IIGFAGVIDQFIAGIFVKREYRQQRIGTQLMKKIKETNKTLTLTVYQKNQSAIHFYLSQG
FTIQTQQKDEAVNEEELVMKWNQNADF
>FECAFAII_00212 hypothetical protein
MEEKNQRLTDQGFNPGTDPFNEKNRNESTTSSQLEEWLIGSINIPKIQLNISLYDRLNGR
ILENGAGVLQGTSFPLGGNSTHSVISAHSGLPNRRLFTELDRLENGDTFILTVLGEKSAY
QVKNIQVVLPDDTSVLTISEGEDLVTLLTCTPYMINTHRLLVTGHRIPYNESVKKEEGKG
NQERTMRQWFILAGTIIAVVILLVFIGRLIYQYRLSKKVLDFSFIISDSSGKPVNGSSFI
LKHKKKTLTRNGVPFSVQSDHHGKVKLDQLPGGTYRIVSADDPKAAVSFGIRKVKQEKIY
FFEGRKLVKELQKNGFYFKINE
>FECAFAII_00213 hypothetical protein
MTSLHKNQVKFNSNITISHTGGQLSSDSGLVLVKELMNIFGFSELAKQHIHIEDERAYFT
HDNLSILEQFIMQLIAGYSADSAANLLRQDPVFKAVLDRKELASQSSLSRFLDRLSEENI
HELQALNQELIDKARLIRNDTELIIDLDSTHSDTFGHQEQTNYNTHYQTYGYHPLVAFDG
LTGDFLKAELRSGNQYTSKGVKEFLTPLLEHYNHSLPNTDILVRGDSGFATPGVYDSCES
KKSHYVIRLKNNRRLGQIAEKSVLYGDNQKWEEREVQYFSTTYQAQSWSQSRRVCIRSTR
EAGELLFRHEFIVTNLSENVSPDTIFSIYAKRGTMENFIKEAKAGFYFDKTDSPRFLENH
VRMMLSLIAYNLVNFLRTIGFEEVQKGMTIHSIRLKFLKVAGKLVQTGRRVYLKLSSYHV
YQNEFYRVFARLRRASQWI
>FECAFAII_00214 hypothetical protein
MKKYGPFLAIFFIALAFLMPHLFTHKLILGADAPFHYNRFYDAAQQIKYGDFHYFPSLYG
FQQSGRIVNAVYGPFFAYLQGLIVLLAGSWFHYQILSNFILYLISGFSMLILLRYVNVRN
WVSVPVAVLFMSTYSIQYWSINQGFTSWGTCFYPLCMIPIADFVLHKKFPVIKVAVSVGL
MTQIHLLSSIMLALMYIPFYLYYFFNQTEKGKALLQLIKSVLLYFVLTANIWAGLAIVYS
GNKILPPFVNREMSQKAIDLDGSYWLHYPKAFPILILSGFLLFIFFQQKNTLFQKIVLYT
SLVFFFLSTSLIPWTTLIEKNVPFISLIQFPFRFFVPFTLLLLLYLALSLNQWSEQKWFR
LLSIFGILIFSAQTIQNLYQHLEKWENETFVSRHTYLFDTPEEARKTFFSKDMSTSLFVF
QKTTPDYLPIYKETKDNKYDRYNEEILENETTFIKTHPGGLLTIKWKNTGDKTVHIPVIV
YDRTVLQQNGKTLTDYEVTDIGTPIVKQQKGINELTLHYQTPIYFYFILSLTLIGWFTLL
CLFIYHRYKHLRA
>FECAFAII_00215 Maltose 6'-phosphate phosphatase
MKFMTLNTHSWLEPEPEKKLQELADKILLEDYEVIALQEINQLLESEEVEPAKLMKFCPV
KNQVPIRKDNFAYRLVQLLKEHGKEYFWSWEMSHIGYDKYEEGNALLTKKTLESQVLTVS
QSQKKEDYQTRKILIGKTKIDDQDIFVSSCHFSWWTDKKSGFYFEWKNLENYFLETRVPL
FFLGDFNNPVDSQGYYTVRESCLLLQDSYVVANEKGKAATVEKKIDGWEQNTEKLRIDFI
FVPEGMQVKKYQRIFDGIDSPIISDHYGVEIELDVNE
>FECAFAII_00216 PTS system glucose-specific EIICBA component
MKKIFSFEFWQKFGKALMVVVAVMPAAGLMISIGKSIPLINPDWTPLVTTGGVIENIGWA
IIGNLHILFALAIGGSWAKERAGGAFAAGISFILINRITGAIFGVTSDMLANEDAFTHTL
FGTKIMVKGFFTSVLEAPALNMGVFVGIIAGFVGAMAYNKYYNYRKLPDALSFFNGKRFV
PFVVILWSTIVALILAVVWPNVQAGINNFGLWIAESQESAPILAPFLFGTLERLLLPFGL
HHMLTIPINYTQLGGSYEILSGAQAGTQVFGQDPLWLAWATDLVNLKGAGDMSQYEFVLH
NWTPARFKVGQMIGSSGILMGMAFAMYRNVDPDKKARYKSMYFSAALAVFLTGVTEPLEF
MFMFAAVPLYVIYSVIQGAAFAMADILPLRVHSFGNIELLTRTPLAIKAGLGGDLINFVL
CVIAFGVVTYFLANFLIKKFNFATPGRNGNYDNDSEETVVSNSGTGTADQQVVQIIHLLG
GKENIKDVDACMTRLRVSVNDREKVGTEEAWKRAGAMGLIVKDNGVQAVYGPKADVLKSD
IEDLLQSGAEIPEPEMVSTGNGQAGSKQYLGIEQELVSAASGEVIPLSEVKDPVFSQKMM
GDGFAVIPTSREVVAPIAGKVTSIFPSKHAIGLETKDGIEVLIHMGIDTVQMNQPAFEIA
VKEGQEVGTGTKLAEMDLDVIQNEEKDPTIMIVFTNDKVEEVVIKQLGTVTAGKVIGSIK
M
>FECAFAII_00217 Maltose phosphorylase
MKQIKRLFAIDPWKISTTQLDKKNLRLQESLTSIGNGYMGMRGNFEETYSGDHHQGTYLA
GVWYPDKTRVGWWKNGYPEYFGKVINALNFIAIDISINDQLIDLASLEPEDFYWELDMKN
GVLSRTFTITTSTNKVRISFERFLSIVKKESAYIYLTIEMLEGSGTVKLVSKLDGNVQNE
DSNYDEHFWNEIDRGTIEEIGYLTTKTIPNNFGIEQFTVTAAMRHFVNGKSVIPDYHEDT
LALHGCLSAELSQGETWSVEKEIIVLTSRDIPEAQQAEKAVSELTNQTNNYIQAKEEQTA
AWAERWKLADVVIEGDKEAQQGIRFNLFQLFSTYYGEDERLNIGPKGFTGEKYGGATYWD
TEAYAVPLYLALAKPEVTKNLLKYRHNQLPQAIHNAQQQGLKGALYPMVTFTGVECHNEW
EITFEEIHRNGAIAYAIYNYTNYTGDTEYLKNEGLEVLAEIARFWADRVHFSKRANKYMI
HGVTGPNEYENNINNNWYTNTIAAWVLRYTRENYLTYQKEAAITISEEELAKWKDIAENM
YFPVDEELGIFVQHDTFLDKDLMPVSDIPTSDLPLNQHWSWDKILRSCFIKQADVLQGIY
FFNDTFTKEEKQKNFDFYEPMTVHESSLSPSIHSILAAELGMESKAVEMYQRTARLDLDN
YNNDTEDGLHITSMTGSWLSIVQGFAQMKTAHDQLRFAPFLPKTWKAYSFHINYRGRLLF
ISVTDEQVTFELLEGSPLEIYVYEQSYSLADRLEITLRKEEANV
>FECAFAII_00218 Beta-phosphoglucomutase
MFKGVLFDLDGVITDTAEFHYRAWRKLGQEIGITIDHTFNEQLKGVSREDSLSLLLAYGG
KEHSFSKEEFAELAKRKNDYYLEMIQTIEPKDVFPGVVPLLDSLKEEKIKIALASASKNG
PFLLEKMGLTPYFDAIADPAEATNGKPAPDIFLLAAKAVGLKAEECIGIEDAQAGIQAIL
SSGAQPIGVGRAEDLGEEIPLVPDTTFLTIDYLKEKWHDHG
>FECAFAII_00219 Aldose 1-epimerase
MDNPEISVVPVPETEIKKITLKNDYLEVVLLNYGARLHQIFAPDKEGKSENVLLSYDRFE
DVLTDKSFFGATVGPVAGRIRDASWGEHRLEKNCGSHHIHGGTKGWSFQFWEVEVFKTPS
SIGVVFYLKDEFSTYPGPITATITYRLTKNELEMTTSASSLVETICNPTNHAYFNLSGNG
TRDIYEHQLTVFLDGVLELDQEKLPTGNWTKKEKLPIDFRKSPTLQEILACYPDGLDDVF
LLHHPRLSKTSLQLFEKHSGRQMTIATSNKSMVLFSTTGFEADFSVNGKQMHSNYGLAIE
PQEIPDIVHFPKFGSINLHPGQERISQTIYRFSAQ
>FECAFAII_00220 Catabolite control protein A
MAITVKDVAKKAGVATSTVSRVINDHPSISETTKKKVRKIMDELGYVPNMTARNLGKRIS
SAIGVILPPLDSKERIGNPFYLEIMEAINEEARNYDMTTAIATAKNFELLLENVQRMHLQ
KQVDGFILVYSDSQDPVIDYLYQNHIPFTLIGQPYHHENEIVYVDNDNQLLGKQATEFLI
QNGHKNILFVTNTTHESLYFERYFGYQKAMMMAGLPALSSVVLEHPEDYLSFEKTLKENE
ATALVVIDDIFALRTMQLAQMYGYVIPETLSVISFNNSIFSTLTHPYLTSIDIDISELGR
VAMQKLRELIHEELSSGVRLVIPHRLIKRETVVPLENPY
>FECAFAII_00221 Na(+)/H(+) antiporter NhaC
MNGYVANTPDPKLDELLSRGGIMSMLGSASLILLALALGGLLIKYLIVDTIVQELKEKMD
RPSRLVGFTALSCIGINLIVGEQYLSIILPGETFKRSFDDVGLSKTYLTRTLADSGATVN
SLVPWGVSGTFIMGTMKVSALHYLPFAFFSILAPVFTILGGFLLNRRRVKN
>FECAFAII_00222 Na(+)/H(+) antiporter NhaC
MNKNISLKESIAVLIVLLALLGVLIIGFQLSPHIPILAAFMCLLFYGRFKKFTWDEIHDG
IIKGITPGIIPILIFLLIGVLVASWILSGTIPTIMVYGFKLVSVRFFLPTAFLVCAIVGV
TVGSSFTTISTIGIAFLGIGHLLGFNDAMTTGAVVSGAFLGNNCSPLSDTTNLAAGIGGV
NLFEHIAGMRYTDFPAFVLSLIFYTILGHNSHSADLASINEMIQNMKASFWISPWTLIPL
VILFGGGNQKNSSYPYITSGIDSCSRSFFYP
>FECAFAII_00223 putative glutamate/gamma-aminobutyrate antiporter
MSKSEVSKMGLGTFIGLTMALCATVRSIPTLAAVGWTLIFYSIFAVLFFAGPISMVSGEL
STMLPQEGGPQLWVKTALGSKWGFVVAWLLWVQMFPGMVMVASTLGPLLGNTFGNVELGN
NHWFVLGCILVIYWIITILNLKFDMAKVGGNIGVWLGVYIPVVIMFVLGVLAAFKVGLVS
NGYLGDFSWSKAFPDLEHIDSLKYLAGITFIFVGIEMSSVYMPRLKDATKNYTKGVFIAL
IGLVLLNVINAMLVANVVPDGKMELANITQPILIDCQILGLPEVIGNIFSFMVFIGVLLQ
LSAWVTGPSKTIIQVAREGFLPPKFGFHKENKYGVSRNVVLTQSIVISLFALLYGVMDDV
SAVFLTLTNATTVIYCIVYILIAVSLLKMRKKHPEFERPYRIGKNGNGLAWVVSCMLIFS
IIVVVFATLGTATLSDALLVAAITVVMFVIPLIINHFKKDSWGIEVEKSLEEK
>FECAFAII_00224 L-2,4-diaminobutyrate decarboxylase
MSESLSKDLNLNALFIGDKAENGQIYKALLNELVDEHLGWRQNYMPQDMPIITPEEKSSA
SFEHTVNKTKDVLSEISARMRTHSVPWHNAGRYWGHMNSETLMPSLLAYNFAMLWNGNNV
AYESSPATSQMEEEVGMEFAKLMSYKDGWGHIVADGSLANLEGLWYARNIKSLPLAMKEV
TPELVAGKSDWELMNLSTEEIMNLLDSVPEKIDEIKAHSARSGKHLEKLGKWLVPQTKHY
SWLKAADIIGIGLDQVIPVPVDHNYRMDINELEKIVRGLAAEKTPILGVVGVVGSTEEGA
IDGIDKIVALRRVLEKDGIYFYLHVDAAYGGYGRAIFLDEDNNFIPFEDLKDVHYKYNVF
TENKDYILEEVHSAYKAIEEAESVTIDPHKMGYVPYSAGGIVIKDIRMRDVISYFATYVF
EKGADIPALLGAYILEGSKAGATAASVWAAHHVLPLNVTGYGKLMGASIEGAHRFYNFLN
DLSFKVGDKEIEVHPLTYPDFNMVDYVFKEKGNDDLVAMNKLNHDVYDYSSYVKGSIYGN
EFLTSHTDFAIPDYGNSPLQFVNQLGFSDEEWNRAGKVTVLRASVMTPYMNKEEHFEEYA
EKIKAALQEKLEKIYADQLLASEAK
>FECAFAII_00225 Tyrosine--tRNA ligase 1
MNIIDELTWRDAINQQTNEERLRELVEEKSISLYCGVDPTGDSMHIGHLIPFMMMKRFQL
AGHHPYILIGGGTGTIGDPSGRKTERVLQTMEQVQHNVDALSNQMRKLFGKDANITFVNN
YDWLSKISLLEFLRDYGKNFNINTMLAKDIVASRLEVGISFTEFTYQILQSIDFLHLYKT
YDVQLQIGGADQWGNITAGLDLIRKLEGPEAEAFGLTIPLMLKADGTKFGKTAGGAVWLD
PKKTSPFEFYQFWLNQDDRDVVKYLKFFTFLSQEEIEDLAKKVETEPEKREAQRRLAEEV
TRFVHSEEDLKEAQKITQALFSGNIKELNAEEIAQGFGKMPNVEISSTPENIVELLVSTK
IEPSKRQAREDVSNGAISINGDRVTDLNFVINPSDEFDGKFVVIRKGKKNYFLAKVID
>FECAFAII_00226 hypothetical protein
MEKKQKIILGATSALTIVILILSLFFVIRSSTKKEPIIPEKKITEKAKEPTDDKQQLVTQ
AKNLAQSYDYDQAIALLEKDSKNGSTETQQLLQTLKKEKEQLIDWSDPTQISHVFFHSLI
VDPQKAFHSQQAQGYKDYMVTVEEFNRSIEQLYQNDFVLVNLNDLIQKDEQGNLSFNGLA
LPEGKKPLVLSQDDVSYYEYMDNSGFPSRLVVSNNNEIKNVYKEKDKEEIGDFDMVPLID
AFVKKHPDFSYRGAKGTLALTGYNGVLGYRTSKSQYGDNEKTKKEIKEAKKVAEQLKKDG
WSFASHTWGHLNMTQASLEDVKKDNELWQQEVAPILGKTNILIYPFGADISDWQPYSAEN
QKFAYLKSQGFDIFCNVDASTPAWGQLGTDFYRNARINIDGIRFQSDLDGKNPILDPFIN
VHDVYDKEARESA
>FECAFAII_00227 HTH-type transcriptional regulator BetI
MNGFEKRAQEKKKEILQAAFDLMNTDIGTAGVTMDKVAENAQVSKATIFKYFVSKEGLIY
EVFFAFMNDLGQEAKALIAENLPFEETLIAMSENKIRYLNRVNKQFYIDLMTYYTKKEKK
EFSDAMDAYTQESFSIMLDLFHRGRKEGKVDLKYSDEFLILYFQAMVEGISKPEIYAKLL
PYTAEWTEVLIKGIAPKKK
>FECAFAII_00228 Arginine transport ATP-binding protein ArtM
MAEIVKVTHLKKSFGRFEALKDVSFTVHSGEVVGFIGPNGSGKSTTIRTLLGIIICQIKR
DKTFHLRNSKKLLMVFGNLVIF
>FECAFAII_00229 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIAAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYIAKRSTEGWTPDVIIGRAERTFSCSVSTLYRRFKTGEFNVL
HLPMQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEGDTIVGIHHKSAVITL
VERLSKAIIALKPEGRKAVDIENSINEWLQSVPKNLFKSITFDCGKEFSNWKSISNTNDI
DIYFADPGTPSQRGLNEHSNGLLRKDGLPKEMDFNQVNQGFISSVASKRNHIPRKSLNYQ
TPLEVFLSYVNGKFCLA
>FECAFAII_00230 ABC transporter ATP-binding protein NatA
MWGNLTGGAIIDLFMKLHGKGSAQKKDELIQRFSLDPKKKAKNYSKGNRQKVGLIAALAV
DSDLYLFDEPTSGLDPLMETIFQEEVEKLKEQGKSILLSSHILSEVERLADKVVIIREGT
VVEEGTLDELRHLTRSTITIETEAENSHLAQLNGVHDFVQKGHLAQFAADNEAFDVILAE
ASKLGAKKFESITPTLEDLFMRHYEG
>FECAFAII_00231 hypothetical protein
MTDKFSRWSTLFSQNLSRDWKKILIWLVGVTAFSGGFVPAFEELTSGQGLAGLYETLQNP
AMIAMVGPTPASNAAEYTLGAMYANEMLLFCSLFAAVISVLHVVSQTRKKEELGLIELIR
SFRVGRQANSLAVIAESILINLLLAISISCTMIFFQADSITAEGAWLFGLSVGSMGILGS
AVALFAAQLMPSSASSNGLSLAFLGGLYLLRAITDVADSSLSMWNPLGWSYLTYPFTTNN
WIPLLYLFLFSLILIISSFVLEEHRDLNTGYIPEREGKPYAKRSLLSLRGLLFYLNKGMT
ISWLITFGLMGAAYGSIYGNMQQFLESNDLMKQMFIQSGVSIEKNFTSMIMVVLICLAAI
LPIASINRLFTEETHGRMNQLFATKISRNQLYWTNMLLAILFAILAILISSGALGLSALA
SMKDAKDMDLLMFLKAGFNFLPAVLVFIGISGFLFGWLPRMGKLAYIYLAYSFALNYFGG
ILDLPEWFSKTAVPSWVPRMPNDSFDLSVFLTLSCISLALFVLGSIGYRRRDLLEV
>FECAFAII_00232 Transcriptional activator protein Anr
MSHDHLCVSFVPLFNHLVQQDQEKVHALVKHHYVEKGEQILAPNGEPQLVIVASGSMKVY
QLSASGKEQLLRVIEPGGYEGESQLLGVPNESLFGEALEKTEICILRQKDFSELLLHYPA
LSLKLLAINVEKLTKVQQQTTFLMMEKVEERVAVYLLDLAKATGKDHFFLPMKMKELAAF
IGTTPETLSRKFKLLEENGYVKRKNREVWIIDKEQLEDL
>FECAFAII_00233 hypothetical protein
MELGKSDYQLFDRPIYAFKQLKESHPTDKIEQIKKEYKEHWQKWKEIQLQTAALLPDMYG
MSKPKIESWTNGWNLRSHFWSAYRSESRQDENACLAVLLNQKQYQIYLMYQHYKSEERYG
SIAAYNQLLAILKEWSKTVDIKDYYIWPQPEHELDDHLALSDYLSDTKKQEELKKAMRDR
TFQMGKLFFYPQEIEHVEQITAETLQELAPLYQKLGAEKFQ
>FECAFAII_00234 PTS-dependent dihydroxyacetone kinase, ADP-binding subunit DhaL
MKLSVQEIQEWLTQFAEAINQNKQYLSDLDTPIGDGDHGNNMGRGVSAYEEAFQADHPET
ISDTFKVFSMAMISKVGGASGPLYGSAFMNMMKATKEVDSIDSQEKLGEVIEQGTAGIQS
RGKAEVDDKTMLDVWLPVTEALKAGNLTKEIIDQAKEHTKDLVAKKGRASYLGERAIGHI
DPGAASSAILFSTLLDVINQP
>FECAFAII_00235 PTS-dependent dihydroxyacetone kinase, dihydroxyacetone-binding subunit DhaK
MPERKDGNKLKKIMNDPSNIVEEMLEGLVKSYPELVHRVESSRVVAKNQKAEQVGLVSGG
GSGHEPSHAGFVGEGMLSAAVLGDVFTSPTPDQIQTAIKEADSGKGVLLIVKNYTGDALN
FDMAKELAAMDDIEVESVIVDDDIAVENSTYTAGKRGVAGTVLVHKIVGDAARNGASLAE
LKELGEKVVQATKTIGLALRAATVPEVGKPGFELGEDEIEYGVGIHGEPGYRREKMQPSK
VLAKELVTKILDDYSNLPKEAGVLVNGMGGTPLMEQFVFMNDVLALLEERGVNVVFRKVG
NFMTSLDMQGLSLTLIDLTGTQWKDSLESNVQTISW
>FECAFAII_00236 Protein-lysine deacetylase
MKKSILLISHSQKVTDGIKEMIEQMQKSEEVQIFSLGGINGEIGSDPMKIVEAVNESSDA
ASYFVFADIGSAVLNSELAKDMLEEEQQQRYHLVDAPLVEGAFAAAITAGITDDTQQILT
EAQNAGKKGWE
>FECAFAII_00237 hypothetical protein
MITTTTNSVEGKTVVAYKGIVFGEVITGINVLKDFGAGLRNVFGGRSKSYENELMGAREE
ALAEMAERAKALGADAIIGVKMDYEVLGSDNGMLMVTCSGTAVSTR
>FECAFAII_00238 hypothetical protein
MKKRMKPLIWPIAVSSIFLLGQTAFAETSEPAQTEPSTTISSSDAEKGASETETTSNVPI
DNSGETISSSEDTSINSSTSSDQIDHLQDLENKRKELEEALEAAKNKLKEDQAAIDQDLA
DLKNKVGNDRAQLEKKLAEAKAKAEAVQTDLDGKIQQAKEFNQQLNQVAQTASGKLSQTQ
ADIIAASQAIHGKISEAQTVANDFEAKKADIAASIQRIKDILHSAGEKSVTSGSTTETVQ
QTTEPSKSTSQTLPKTNEKTASVSYSLAGAGVLVAAAYGIIRKKK
>FECAFAII_00239 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MISITHTGNLFLDTCLSIMYFFLVSYPILGGFVWFIGVWCYVFLYKHKQKEWVDVPLSVE
PFITIMVPAHNEEIVIEDTIEYLMTKLNYHNYEVLVTDDGSTDQTPEILARLMKKYANLR
VVRIEKNKGKAHAFNIGLAFAKGKLILSNDADTVPEPDALIRYVNYFIRPGARHIAAVTA
NMDVQNRTKLIAKSQTVEFSSIVGIIKRTQSAVFGGLYAYSGTNTMYRKEALIDVGGFRQ
DRATEDISIAWDHQLNDWVSVFAPGIIFFMEVPVTLKMLYRQRKRWAKGGTEVWLTNFKK
VMLHPFKHIGRTIIFIDQTLSIVWSIFFCISVVLFAGLIGHYVYQGNYEQIYITFTFSFV
FICFEMVAGFFQLLASLIVDDRRRKLKYLLFAPLYMLLFWIVNAITIVTTFIPAVKTILG
YGSGTWKSPERTKK
>FECAFAII_00240 hypothetical protein
MKKVTREEVASILVKDKYFSKGNYWLKIWQTLVALLGWMIVVLPFIWVFFPLTRPERAKD
FSLYAFLSEKKMLYFLNGFFVLIFFSFLITSFVLTRWNNRNLYKKVNKSFEYEDE
>FECAFAII_00241 hypothetical protein
MKILAEILVSLKGEKAAVITQTEEETQTLQESIKKNSYGLENCQIIPLSLAKGLEFDHVI
LYPFENDGDEQRRRRQMYTAISRGMKSIVVLERAT
>FECAFAII_00242 DNA helicase IV
MVNTQKQLEEAYLKNVYQKLIDKRNELRESMDTAKIEGNQSLKEMAGDLRLNFDSYLDNL
DTFSMIEMKNREIDQMNIKQKNAENQLAKIERLLKSPYFGKVIVDFLDNEPQESFYIGTA
NFTDDADENLVYDWRSPIAELFYNNMIGPSSYTVRQNKIDTVIKERRQFLLERDRLVKFF
DTSVAIQDDVLLEVLGQDETNEMKAITATIQSEQNTIIRDVKSQNILVNGVAGSGKTSAI
MQRIAYLLYLYRDTMTSDDLLILSPNHRFIDYISNVLPSLGERNPLNLTIMQLVSQLSAE
EIEGEEAYFKHITGENVSEQTERLRSKKFIDNLKQSDPLFLDHPNFIRGLTKNGKTVLSK
KTIEKIYEKVPAHPKLIDRLQATKKALMSEWKNHLLKQEKSPAVQNQVLSLTEDRQLELF
GKLISDDSEQSIAAYARKLLQKKYRKITRQIEEMAWVAEHQLFERIYEKRYGSAYAWQPT
RTVDEAVIILAIRHLLVEKVNVPAFRYLLIDEVQDYTLAQLGLLIELFPKTHFTLVGDEN
QAIFNSSTTFADIMRCFDDYHLPIHRHDLRNSYRSSGAITELFKTYAVDQEKSTSYRSDR
KEKNPNTALFDPLKNC
>FECAFAII_00243 Coenzyme A disulfide reductase
MKIVIVGGVAGGMSAATRLRRLMEDAEIVVFEKGPYVSFANCGLPYYLSGEISERENLLV
QTPESLSARFCLDVRPNHEVTAIFPENKTVEVVHEGQKHIEQYDALVLSPGAKPVVPSIP
GITEADNVFSIRNVPDIDKVMHALEKQPKRAVIVGAGFIGLEMAENLKRRGLEVMVIEQA
PHILPTLDEEMAAFIEKELSHQGVEVITSHAVAGFEDHGKRLRLDDGRTIPADLVILSIG
VRPDNQLAVTAGIELGIRGGILVDERYQTNIPDIYAVGDAIVVKQQITGKDALISLASPA
NRQGRQVADTISGISRRNQGGIGTAIIRMFGMTAASTGLSERTAKENELSFEVVHVSGKD
HASYYPEATDILLKLIFHPETGEIYGAQGVGAKGVDKRIDILATAIKGHLTIFDLPELEL
TYAPPFGSAKDPVNMLGYAAMNIAEGLSETVQWHKLPTELAKGKILLDVRTAEELEKGKF
KEAKHIPLNELRDRLDELDSQQEYIVICHSGLRSYLAERILKQSGYHVKNLDGAFSLYQT
VRPEELIYPNK
>FECAFAII_00244 putative adenylyltransferase/sulfurtransferase MoeZ
MNLLFQSIKSITVPELKEKLLENPALLDVRTPAEYRGGHIKGAKNVPLQSINRYDGDKEK
TVYVICQSGMRSKQAAKELKKSGYDVVNVRGGMNQWFDRTVGGK
>FECAFAII_00245 Copper-sensing transcriptional repressor RicR
MEIDNKNILNRLKRTEGQIRGIQKMIEDEKECMDVITQLSAVRSSIDRVMGMIVADNLKN
CFEKPDSNPEEQAAKLEQAIKMIIKK
>FECAFAII_00246 hypothetical protein
MKVVFHIDELEKWSETGKNVKNLIKASPETTIVVSVNGIAITGYLDSANAEFLDLQGVVF
HACANAMRANHISESSLPEQVIVVPAGVLDLVELQSQGYAYIKP
>FECAFAII_00247 Putative CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyl-transferase 1
MKLSTDWRKEIQTIPNLLSIFRIFLLPIYLYFVLRQSFYIAGAVIVVSGLSDYLDGVIAR
RYNQVTDLGKVLDPFADKLTQLFLILSMAWYRPWLWLLFGLFLIKEGFMFVAGLIGLSKN
IKLSGAKWYGKVATAVIYVGMILLLLFPELPTLWVRVIFAVITYGLLQSFVLYAVEYRKM
FQRK
>FECAFAII_00248 Endonuclease MutS2
MNNEMISQLQFDRIKKEIQARAIGNYSKKRISDMTVSTNLQTVLDRQEETREARLILESS
QHVPFMGLPRIDALTEQVKKGLILQPTDLIEYADFLRSSRMITKFFDKNQYQTPLLFAYS
KHLPDLINVEELIDQKIKNNKVSDDASRNLRKVRKQLQLIEKEIQSKLLKFLRHPKNKEM
IQEAMIVQKGEYYMIPIKASYKNKIDGTIIDESNKRTTVFIEPTVISKLNERYQLLKAEE
ISEEYQVLAALTGAIAENEEVIDLLIETNTVLDIIFARAKVSREINGITPRINKSEHIII
KQGRHPFLPEHAVPLDVEIGKDYRGLIITGANAGGKTVVLKTVGLLTLMAMFGMQVPAKE
GTELAVFDEIFVDVGDHQNLENALSTFSGHMQNIAAILKKIKRNTLVLLDEIGSGTEPNE
GAALAIAIMESIYEQGALIIATTHYGEIKKFAGDHEDFVPAAMAFDREALRPKYQLRVGE
TGESQALWIAHKMDMSMKLIHQAERYLAEKAYRTQKKEFLPKTAVTNRKDNKKERQLFAK
GDRIFVNEYQKEALVYEDIGEDTIDVYLGKKIIHVPRQRVRLVRSAEDLYPTGYDLDSLF
IDYKTRKRQRDLERGSKKAHKVLVKEMRKRQEERRVNDENSK
>FECAFAII_00249 Glycerol uptake facilitator protein
MNSDMTQIMGEFIGTLILVLLGDGVCAAVNLNKSKAQASGWIVIAFGWGLAVTMAVYISG
FMGPAHLNPAVSLAMAMTGAISWNLVVPFIIAQVLGAFAGAILVWLSYLPHWNATKDESA
ILGTFATGPAIRNYPANVITELIGTFVLVLGLLAFGQNEFAPGTNVFAVGGLILAIGLSL
GGPTGYAINPARDFGPRLAHAVLPIANKGTSDWAYSWVPIAGPMIGAIIAVGVYSLMV
>FECAFAII_00250 Alpha-glycerophosphate oxidase
MFSNKTRQDSIQKMQQEELDLLIIGGGITGAGVAVQSAASGIKTGLIEMQDFAEGTSSRS
TKLVHGGIRYLKTFDVEVVADTVGERAVVQSIAPHIPKPDPMLLPIYEGEGATTFNMFSV
KVAMDLYDKLANVTGTKYENYTLTPEEVLEREPFLKKEGLKGAGVYLDFRNNDARLVIDN
IKKAAEDGAYLVSKMKAVGFLYDGDQIVGVKARDLLTDEVIEIKAKLVINTSGPWVDKVR
NLNFTRPVSPKMRPTKGIHLVVDAKKLPVPQPTYFDTGKQDGRMVFAIPRENKTYFGTTD
TDYQGDFTDPKVTQEDVDYLLDVINHRYPEANITLKDIEASWAGLRPLLIGNSGSDYNGG
DNGSISDKSFNKVVDTVSEYKENKVSRAEVEDVLNHLENSRDEKAPSTISRGSSLEREPD
GLLTLSGGKITDYRKMAEGALRLIRQLLKEEYGIETKEIDSKKYQISGGNFDPTKLEETV
TELAKEGVAAGLEEEDATYIADFYGTNARRIFELAKEMAPYPGLSRAESARLRYGLEEEM
VLAPGDYLIRRTNHLLFERDQLDEIKQPVIDAIAGYFGWTEEEKAQQTKRLEALIAESDL
RELKGEK
>FECAFAII_00251 Glycerol kinase
MTESTYIMAIDQGTTSSRAIIFDKKGRHIGSSQKEFTQYFPQESWVEHDANEIWNSVQSV
IAGAFIESGIKPNQIAGIGITNQRETTVIWEKDTGRPIYHAVVWQSRQSAGIADNLKNEG
YQEFFHEKTGLVIDAYFSATKIRWILDHVEGAQERAEKGELMFGTIDSWLVWKLTDGQAH
VTDYSNASRTMLFNIHQLDWDQEILDLLNIPRVMLPKVTSNSEVYGYTQGYHFYGSEAPI
SGMAGDQQAALFGQMAFEPGMVKNTYGTGSFIVMNTGEKPQLSKNNLLTTIGYGINGKVY
YALEGSIFVAGSSIQWLRDGLQMLQKASDSEDAAKRSTSEDEVYVVPAFVGLGAPYWDQA
ARGAMFGLTRGTTKEDIIKATLQSIAYQVRDIIDTMQDDTGIKIPVLKVDGGAANNEYLM
QFQTDILNVPIQRAENLETTALGAAFLAGLAVGYWKDTDEIREFYEAGKLFEVQMEEERR
EKLYNGWKKAVKATQAFE
>FECAFAII_00252 hypothetical protein
MKIEALLERKEQLQILILRNLVLQGGTASINGLREHVQLSKASFDQYLEDIELIGRMMEK
KVEVQRNEYQALLVLDEDVSLEKILLFLLQESLKFKMLVYLLEHQQVSIVRLATAFNISE
SSVFRKIKELNQLLEEFGLQIKNGQLYGEELQIRYFYYELFQYIPEDQRPLFLQNTPEKR
PFILGLDRVLETTFTASAEAQIACWLGITKKRLLNEKSTYATLKEKKLLYQSDRLYQAID
PIIVMHLSRTAAELNVYETMMFYSFFVSFSIVDEEIFYQYDLTRSKKLPTAVLDTYIRET
MLWHYRPRRLKIKEEKAVGYQISQINNEWFFFVGKIEVYERDRLLEQQQKMLGHSLTQLL
AKLQETAVQQLPRKRAEDSELSYLMIQYANVLLMIDFYIAKPVVIGIDLESLPIYRIAFQ
QYLIRELRGIGGIEIGSYEEGKEYDLVITFCQRNKKQCEYYLSEFASPYDIIRLKRRIET
LKKEKN
>FECAFAII_00253 NADH peroxidase
MNIVIVGGSFAGIHAAIYLRQLMPTSEIYLIEKQSKLGWIPSGFNLILKGKVTSEKQLSW
ITKEELTDRYRIHVYTEKTVIGLKEKKVVLAEGEKLDFDRLILATGSNQKFRNISAEATL
IHPVKKIQNVTALQQKIMNAKKIAIIGAGQAGIEIAEGLASRKKQIHLYESRKSILFRYL
DPEMTEPLVKEMKNQGLLLFLEEQVVSLTENETAIVETEKRKENYDLVLLANHSRPDNQM
WEEQLTLNDDGTIWVDDYLQTSQKDVYAIGDAIQVTFRPTNEKMYVSLVNNAVRTARNVS
KTISGSQTKDQGTYRPVGNQWFGYFLGSVGLTEEESIFYPQKIETGYVEYKLTAINQSKV
KLKFLFDSEKKILGAQLQSKKEMFHLLDQLTIAVEEGWTFEQLEEHELFFQPEYRVPDMV
WSKVANTAYED
>FECAFAII_00254 Molecular chaperone Hsp31 and glyoxalase 3
MKVLIVLTNVEKYEKIERPTGLWLSELTHFYDVLVKNGIEADFVSPKGGYVPLEPQSVLN
MDEIDWTYYKDEDFRNRALGSTLRPDDVDANDYAAVYYAGGHGTMWDFPEAIDLGKVASQ
IYRNEGLVSAVCHGVVGLLPVTDESGKSILAGRTVTGFSNEEEEANGTTNEVPFLAEDAL
KEKGANYQSGGAFSEVVQIDGRLLTGQNPQSAHQLGEAVVEALKN
>FECAFAII_00255 putative oxidoreductase
MSQFDQSITLPSGVQLKNRLMLSPMTTQLSFFNGVITEDEITYYKQRSKGLGAVITGAAN
VQDIGKGWPGELSIAHDEMIPRLSELAKAIQGEGAKAIIQIFHGGRMTSRATLSGEQPVS
ASAVAAKRPDAETPRAMSEEEIVETIQAFGKATRRAIESGFDGIELHGANTYLIQQFFSP
HSNRREDQWGGSLENRYRFIEELLTTVFSAVEKYAKKPFIVGYRFSPEEYETPSIRFEDT
IWLLERLRESKLDYLHVSLNMYDRIARSDKYNDKSILEVVHNTIQGKIPLVGVGGIRNRE
DVEQVLKYAELAAVGQQMIVDPDWAEKLFENREDEFVTKPFEEAYKELYLPSPLYNFLKA
RYQ
>FECAFAII_00256 hypothetical protein
MFFDKKQKSYYDMYANGGDEMEKPIEKALDECLFFSVKKLDRMLNKLADEAFRRTGLAPT
YGFILLILKEKDGIPQKDIAQMLYSAPSTIARFVEKLEYKGYVKTVSEGRLSLVYLTEQG
RQFAKEVDGSWEELHQSYKAVLGNEASKELAQTMNDATDKLQKK
>FECAFAII_00257 Oligo-1,6-glucosidase
MEQKWWHHSVVYQIYPRSFQDSNQDGIGDLRGIISRLDYLAYLGIDAIWLSPVYESPNDD
NGYDISNYQAIMAEFGTMEEMEELIEEAKKRNIRIIMDLVVNHTSDEHPWFIEARKNKEN
PYRDYYIWRDPVNGKEPNRLRSIFSGSAWQLDEKTGQYFLHLYSKRQPDLNWKNKQVRQE
IYQMMNFWIDKGIGGFRMDVIDMIGKEPDKEITSNGPKLHEYLQEMNQATFGDKNLMTVG
ETWGATTEIAKLYSNPKRNELSMVFQFEHIGLDQQEGKDKWDLKPLSISELKKVLSKWQT
SLGDEGWNSLFWNNHDLPRIVSRWGNDDVYRKESAKMFAILLHMMKGTPYIYQGEELGMT
NCPIDDIAEAKDIETINMYNERISSGFTKEEILESINAKGRDNARTPMQWNAREHAGFTT
GIPWLRVNPNYKEINAEEALADQDSVFYMYKKLIDLRRKYDIIVWGDYELVEKTPEHVFA
YSRIYEDQQWLVVCNMSSEKQVFTVPREALRIIVSNYPLKQLPDGKVELRPYEAFVVEVN
KEKLI
>FECAFAII_00258 Guanine/hypoxanthine permease PbuG
MKEKILSYFEIEKLNTTVKREVLAGFTTFISMAYILFVNPTVLGASGMDEGAVFTATALA
SAIGCILMGVLARYPIGTAPALGINAFFAYSVCLGMGIPWETALAGVFVASLIFILITIF
KLREMIIDAIPADLKYAISGGIGLFIAFLGLSEGGIIVSNESTLVGLGSLNVGSTWLTIF
GLVVTAILLVRRVPGGIFIGMAATTILGLVTGLIPMPSEIVAAAPSLKPTFLVALKHVGD
INSLQMWVVVLTFLLVTFFDTAGTLVGLANQAGFMKDNKMPRVGKALASDSTAMLAGSLL
GTSPVGAFVESSAGIAVGGRSGITAITTGIFFLLGLFFSPLLSVVTSQVTAPALIMVGVL
MAQSLRQIEWGKLEIAIPSFLILIGMPLTYSISDGIALGFIFYPITMLAAKRGKEVSPIM
YGLFFVFVGFMWILNVK
>FECAFAII_00259 hypothetical protein
MEKGIKGIYRLFAVLVIFFMIWAMASTIFSPRIGAIFSLFRDSYSPKVTIVINIFCLFFA
FLLFFILKNLLKKIRIDWDLSDKLLFYIFGLELVIYAVSLFLFIRFIGFHQPVDDTAITL
KFLEQLKAGENWGYNYMYSNPQNLLLMYIFRGIQFFFGTNYYPIIAVFCGIHLITIIFLF
LSLRNLKVSNFTTLITIQIMLFAVQITLHVPVAYTDILSLFFGSATFFFITKYVNKKKQY
VNRNIIYVLIATATSTIGFISKGTGLILILAMILFFAFYHTGKWRLLAFLPLVFLVLGNF
GWKQFIDAQKLYPNSHYGQPNTHYLMMGLNNTPIPDNLSGDDKYRWVVGAYSSADQRFTW
DMFLDKKMPKKEVEEKHLSIIKERLNAMDFKQFLAAINNKVAVTWSSGDLKSSFEIFLGT
GKNEKNMWVFRSKTSGLILYAVMMVIQYLVYLGIIFTSIKFFKNINPLVFLSNIYISGYF
AFLLIWESSPRYAMGIFVPAIIMIGLLIEKEKTKRIS
>FECAFAII_00260 hypothetical protein
MDLMGRLEGYLKYRRAKHSEKLRAKNLKSGKKKTKGWGKMVDTGFGGLNNLNPVDTKEFI
KEEQKRMNKGYTKK
>FECAFAII_00261 hypothetical protein
MIQKTRVMLYVNDVEMICRFFVEKIGAEISETIELPEEFKSIVLSISKELELGVFPKVFV
QKFSPEVLGPPPSLVFFTDEFETIYENMEEPGEITDNNGILTFNFSDPEGNYFVIGKAES
SD
>FECAFAII_00262 hypothetical protein
MKKVIVDTNFWEVFPEATIEILSVNGIDNHVTKESEETYHQLLNEAAKEARNYLTEETFS
QNEVIAQWRQAFTTFKTKKGARSSIEALLKRANQEREFFPINPLVDIYNSISLSFGVPCG
GEDIEKIAGNLHLGKAQGGESFLPLGADSDAPALPEEIIYYDEQGAVCRCLNWREAQRTM
LTEETQAAVLVIESINAEQAARGAQAIEALKEKIDQTFGVTSVRHTLTKDESEAEL
>FECAFAII_00263 Spermidine/spermine N(1)-acetyltransferase
MNKYEIRKMTPSDVDLLQQISIETFTDTFGKDNSPKHLADYLTQAYAPEKLTEELKDKET
DFFLVSIDQEPAGYLKLNTGTSQSEEMADHFLEIERIYVRKKFKHQGIGTFLLDTAIEKA
KEKQKTAIWLGVWEHNDVALAFYRKKGFIKYSEHVFYMGDDPQTDYLFIKQLF
>FECAFAII_00264 Transcriptional regulator HosA
MAEILRDIGMIARALDSISNIEFKEVDLTRGQYLYLVRICENPGIIQEKLAEMIKVDRTT
TARAIKKLESNGMIERLEDKENKKIKKLYPTKKGAEIYPFIIRENNYSNAVALNGLSDEE
AKQLEYLLKKVCKNVSEDWNFVKKGNKRIY
>FECAFAII_00265 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIAAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYIAKRSTEGWTPDVIIGRAERTFSCSVSTLYRRFKTGEFNVL
HLPMQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEGDTIVGIHHKSAVITL
VERLSKAIIALKPEGRKAVDIENSINEWLQSVPKNLFKSITFDCGKEFSNWKSISNTNDI
DIYFADPGTPSQRGLSEHSNGLLRKDGLPKEMDFNQVNQGFISSVASKRNHIPRKSLNYQ
TPLEVFLSYVNGKFCLA
>FECAFAII_00266 Ascorbate-specific PTS system EIIB component
MKILAVCGFGVGSSMVLKMSLDKVIKELGLKATVENTDLSTAKATMADVYFTSIICQIKR
DKTFHLRNSKKLLMVFGNLVIF
>FECAFAII_00267 Mannitol-specific cryptic phosphotransferase enzyme IIA component
MSSINKLLPKNQIQVIETAENWIKAVEIASNPLLKNKMITHTYLENMIRSVEENGPYMVL
ADYFALMHAKPGLGVNEQSMSLLVVKDAVDMKGKPIHIFLVLAAKNHESHLERLKDIMEI
FMDNEKYQTILSGNKETIIQLFA
>FECAFAII_00268 Transcriptional regulator ManR
MSVIQYQESKLRRVAILNRLSNFEHVSYQQLSEEYYVSRSSIANDISYIKYVFAKEGLNL
SFDRFGTYFEGNEIQVQKVLKRMILNHFDELEIVREIVDRKLLAIVERSFRESIADKQIE
IPESYFSSIIVSILLMIQRSREGKKISLKGKNQYGKYFLEFNKYPLVCELLHQLEEQRIY
QFSQEEVQYLTYVIVGSSLRFFMKNETIPLVFREKIRQLIQKVSRGIQIDLTQDSRLEED
LLVHLYQLLLRIEAQTTIVNPLIDEIKQNYPSLYGVVWFALNDFRWPYQVSLSEDEVGFV
AIHFQAAIERVKRLNRLLFVCPNGMGTSSFVSAKIRRILPDIDSIETVSVDKLNRLDLFD
VDFSTVDIPKQIRPVVRISPMVTTRDMKRIMNHYIDLVIDNEQINIEGSISEKVKNLISS
NVYFDHFGSKEAAIRFLVDQQQFENEDSKQRFLHSIFEREEIQSTYLENGFAIPHGNPNV
VKQTSVAVLIADKPFSWGYQKADIVVLLMIREEDVKEVEPVMKMVMQGIEDKNWFISKML
EVRE
>FECAFAII_00269 hypothetical protein
MDFLRKFGFFFLLLGVLSDFLTPYVLGLYYPELDQMKSVISVFGEVSSPVRKAFLIWSVV
SGIFFILSLPALYAAFVSTSRVLATLVTAAIAFYGIGDCIFTGLFSIDTHESSWNVSTWV
HNIGSGLGYSGFLLFPVLLLLIYRKNGQMDVSHIYLGLSVISLLFAAIYGLARIPSINSW
PLLNKIGFCQRISFFFNYVPIAWLSILHLKQ
>FECAFAII_00270 Serine/threonine transporter SstT
MLEKFLDMSLVQRIVVGILVGILFGIFFPTWTFISILGTLFVSCLKAIAPLLVFFLTMAS
IAKHKIGNKTFVKPILILYLVGTLLSALVAVIVSSIFTVPITLQETVSEKAPQSLESVLS
TMLTNVTQNPVQSLIDANYLGVLFWAVLLGLAFRARSESTKELVDQISIALSQVVQVIIA
FAPIGILGLVYQSIATTGIAGLAEYLQLLLVLIGTMLFVALVVYPFLTFLFIKENPYPLI
FFCLKESALPAFFTRSSAANIPINMMLAERLKLTKESYSISIPLGATINMGGAAITISLM
TLTAVHSLGIEAPFVLKVLLCILSALAACGASGVAGGSLLLIPLACSLFGISNDVAMQIV
GIGFIIGVIQDSMETALNSSSDLLFTAIGELGARKRSGEKIKLKDCLDGLSER
>FECAFAII_00271 hypothetical protein
MKKIKKESYGFLTIFVACIMMILQRILISAVTIPTYATNPGRFYIYTFLQTSVVIGTNLI
PLYMGYQYQKITRLKVLHYLSRFAFIFLTATLACNIFFYVQAGSLNIRDYWLILTPISQN
YFTYAVSCTLLFCSIPYTVGFLNKLSKTTIKYLLLFLTIGLVGCSTLFNKDPFALQNGQS
ILWIFYLFLMGYGLKEWNWKEKVRYKLPQVFISLIVLFGLIILMTQISLIIRGNTDTALR
FSKPYSLFAMYYTFSSFLFLEMLSDKLGIKGRGNFLAVFLIVTQVICNFPLVSYRVSTFM
KREFPNSGKAWLINIGQFFIYYLLAVSLLYRLN
>FECAFAII_00272 hypothetical protein
MIRDYQAIGCTWFLRGHQRKIPTYGQHKGVKLIGTLDYETGRIICTEEGAYDAAAFLRFL
ERTLREYPTGKIVMVLDNALIHHAKLIQSFLEENARRLALIFLPPYSPQLNLMEGVWKWL
KESVINNVFF
>FECAFAII_00273 hypothetical protein
METERQIRELEKAMNTTDNRRLYERFLAVKLVLEGHTRKEAGHTIGRDEHTVSHYVKNYC
HNGIQGLVSKKKSGRPSRLTDEQEAELVQIVAYHTPEEVGFKSRANWTLAIVCDLILREW
SYGYTQKGVADLLHRLGLSWTRPTYTLKKADSKKQQVFLEETFPSLKKNC
>FECAFAII_00274 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIVAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYIAKRSTEGWTSDVIIGRAERTFSCSVSTLYRRFKTGEFNVL
HLPMQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEGDTIIGIHHKSAVITL
VERLSKAIIALKPEGREAVDIENSINEWLQSVPKNLFKSITFDCGKEFSNWKSISNTNDI
DIYFADPGTPSQRGLNEHSNGLLRKDGLPKEMDFNQVNQGFISSVASKRNHIPRKSLNYQ
TPLEVFLSYVNGKFCLA
>FECAFAII_00275 hypothetical protein
MIDEKKCLKNLLEDMDDIEEKLSKWTGKTNIFQILKLSKNEIRHSNFLASPFV
>FECAFAII_00276 Putative fructokinase
MYGSIEAGGTKFVCAIGNDDLKVLERVSFPTTTPNETMSLVIDFFNHYKEQLESIGVGSF
GPIDIHRESKTYGHITSTPKTAWKNFDFVGTLNKHFEIPIAWTTDVNAACYGEYVSGHGK
GLSSVVYYTVGTGIGGGAIQDGIFVEGFSHPEMGHTLVKRHSGDTFSGTCPFHHDCLEGL
ASGPAIEMRTGTKGQDLSIEDPFWEIEADYIAQCACNTTLMLSPDIIIFGGGVMQQEHLK
KKVQRRFLELINGYVDTPNIEEYIVTPKLADNAGTIGCLTLAKDVRINS
>FECAFAII_00277 hypothetical protein
MNCLNNIWLHKGEESRTISPENKNGEKGKAAMTASHLGIGRKGSPSVPINAGETITLAEM
EGPGILRHFWMTVTDKTIAGSFVLRDLILRIYWDDESTPSVESPLGDFFCNGFGTRCEVN
SLPIVVNPTSGMNCYFEMPFRKKAKITLTNEHPEFIKHIFYTFNYALTEVPDDAMYFHAK
WNREPITTKGKDYTLIDGIKGTGYYVGTYFALCALERYWWGEGEFKFYIDGDEDFPTITS
TGAEDYFGGAWAFHKKNFGERAYAQNFNTLFMGYPFQSKRDHTRDYFSAGKPNPNPVHGF
GDDALPMHGLYRWHLPDPISFKENLRVTFQTLGNDDIKLYERQDDISSVAYWYQKEPHEF
FEKLLDREERIPR
>FECAFAII_00278 hypothetical protein
MRRLIIASHSILAEGFKETLEFLTGMHNQISSLCAYVEEIDDIDEQIKELVDTTDEIIVL
TDMAGGSVNQKFFTYISDRVHVIAGMNLPLAMSIALQLGNDNLDIGAIIAEAQQQIIYMN
NQKSEERIEDE
>FECAFAII_00279 PTS system mannose-specific EIID component
MSEKYQVTKKDLRKANYRWLMSVCTFNYQTQQGASVTYALSPILRKLYKDDDEYIEALNN
HFQYYNTQPWLAAIILGACVAMEEKQGLEAKDAINDFKVGTMGPIAGIGDSLLMTMIPTI
MGSIAAYMALENNPVGIFLWFILIMVIFFFRMRGFEFGYKQGMKIVTEYGEKINYLTEAA
SVLGLTVVGSLIASVISVSTPLKFTFGEVSMKIQPMLDKILPTLIPVIITAAAYYLLSKK
KISMTILILLVIVFAMVMAAFGILA
>FECAFAII_00280 N-acetylgalactosamine permease IIC component 1
MHFTIFQIIMLTILAFIKHVDYYGIPMIFVNYAVFWGLFTGILMGDIKTGLIVGGTVQLM
SLGVAGFGGSSVPDYGTCAIIATAFGSQLGVEAGLAIGLPVGMLGVQLDVIVKILNGFVV
RKSQEYANKREFKKMNSVLWLGPIFFGLSAAIPVFIAVTLGQSAVNYVLDVLPNWFMDGL
TLAGKMLPAVGIAMLLRFMPTGRYISYLLVGFFLAAFLKVPIIGAAIIGFALAFNVYHRA
EKDAQITASAGASDVGFIGEDE
>FECAFAII_00281 PTS system sorbose-specific EIIB component
MSIVMSRVDNRLLHGIIVTQWAPMSKANRVMVIDDSVANNDIQKSSMRLARPAGMAVSII
TEETAIANFKKGKYDQEKVFVIVKEPETILHLVDNGIRIDRLIVGGTVVKDNALQLSSRA
YASDENISTYKKLLDSGVEIVTQFVPADKAQEIQSKLG
>FECAFAII_00282 Transcriptional regulatory protein DagR
MEELKERIVNYVIENSEIKNKWGNNTAQKISEKLNVSRNIVSQYLNEFVKDGEFGKINTR
PVIFFSLPEKVPNQQIFSSSEEAEKWYDSSFRVGIERVIGSQGSLRNVIAQIKAAIYYPP
NGLPILLHGETGTGKSYLANYVYKDLLANNYIEEKASFISVNCSEYANNPELFLSNFFGH
VKGAYTGAEDGRKGLAELANNGVLFLDEIHALSNECQEKLFQFMDTRKFHRMGDNENWYT
SSCWIIFATSEPPEDKLLSTLLRRIPVKLTLPTLDSRSLYERKQLIKIFFKSEEERLAKK
ILISQQLLDFLLNYRFSENVGNLKNIIQLTCANAFYFLDDLEELYIQMYHLPQWVNFNGM
KVMKRQNELKYIQMDDLEKVDEVFNINELIEYLYQTWKKDTDKQQLFEKYDRYFRQKNVD
IQNNSALTYPTYQEIRFRQYVKEIERDFQIEFDYYYLQITSIFLNSWIYQIQLTSDDKLY
SFINDINSWCSREVQLVNRFIQIGDIYLTKIQKNVLVILFKLMCSKEFQQKRLALILAHG
DLTATCIASTANRIVERYIYDAIDMPLMTSSSEIADKINRYLQECTGYEEIILLVDMGSL
EKIYLNLELDAQKKFGLLNNVSTRMAIDVANQILLDLPLKQILEQVKENQNVDYIYESSN
IKKDMIVCSCASGLGTSFKLKKILEDSFPRDTDLVIETCDYYSLVNENYLSELRKENNIL
FIVGTLNPHLEDVEFFSIEDMILGMNISKFSNQLNRHFNDNELKVLNNNILKNFSLTNLM
EQLTILNPTKLLERVSDAIYILQNDLGISFDNNTCFGLYVHISCLIERLVKQNTLEDEIY
FNETSEEFQKFQTHFKQSFSVVEHYYSVDIPIHEVKYVYDYVKRA
>FECAFAII_00283 hypothetical protein
MGAELNQKLFSAADNLRSKMDASEYKNYLLGLIFYKYLSDRLLEQVVLLADESLEEYDTV
SKQTMLYRELLSDEESKEDLIATIVDILGYAISPEYLFNVLADQAKQATFQLNDLNKAFL
ASHIYGKILSAKFE
>FECAFAII_00284 hypothetical protein
MEDSPELFPMLKDRLNELTEKRRQLQIRENEILGIFQQQGEPIQVKDVQQILTSLDCFLI
QSEKKQVKALYHTFIEKITFDPNQK
>FECAFAII_00285 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIVAKQLKRGRQTIYNVYTFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYIAKRSTEGWTPDVIIGRAERTFSCSVSTLYRRFKTGEFNVL
HLPMQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEGDTIVGIHHKSAVITL
VERLSKAIIALKPEGRKAVDIENSINEWLQSVPKNLFKSITFDCGKEFSNWKSISNTNDI
DIYFADPGTPSQRGLNEHSNGLLRKDGLPKEMDFNQVNQGFISSVASKRNHILRKSLNYQ
TPLEVFLSYVNGKFCLA
>FECAFAII_00286 hypothetical protein
MYSKNWKKKLVMGVMVGSIFVFAGCSASTDKSKTATSETKTAEVVKSKMKQIEKNVEKIL
AEKDKDTKLSEYKKFVTESSAYSKSDKTEKKITNTYTESIKKIKTNFKEQDDKDLKENTL
DNLEEATENDLSQKVNTLDELKKWVQKESTDVYSQAEVDSLIKKIDDTITTYKNQLEKIK
IDNQEATSTETTTESSEVATLQENVSEEPQVVYTNLLNSIEEAAQYLGQKLPQSGGSDAF
ENGQQNSDGSFTFHYQLHGGPEGITWNIITVNNNGEIIQDDYFKTVPNEATNNNVSTLSQ
AAISELEAAQLAIAKHNELGRPNATDAGRETTADGYYFYYMADGTDQMYKYFVSNSGQVQ
AE
>FECAFAII_00287 Serine recombinase PinR
MEMIQTKRVALYIRVSTQEQALEGHSIQAQEQNGRQFAERMGYEVVEVYADEGISGKSTK
NRFAYQRMMKDARNHRFDLLVIWKLTRLGRNMLDVLQTVEELLRYDVGLHSISEQFDVTT
STGKLMLQLLGSFGEFERNQIAENVQMSMQSLVKDKKRYAGGRRLGYVSGIDTNGQKQLV
IEPEEAKIVRLIYAKYLGGAGYRAIANFLNRQGYQTVKKNAFSTTAVKDILRNKIYAGYL
EYARYINWETKRRKGKNPKPILVKGTHEPIISEEDYQKVQERFALEGKQPKWNHTGENVL
TGLLRCPECGAPMAASNVTNTLKDGTKKRIRYYSCSVFRNKGASVCHANSIRAEQAETFV
ADRLKEIIQLPEVLPRLVAALNEEIVRQSQPLEQELVVLLERKEELKTKIEKWEAALEDS
PELFPMLKDRLDELTEKRRQLHIRENEILGIFQQQGEPIQVKDVQRILTSLDRFLAQSEK
KQIKALYRTFIEKITFDPNHKEMLEITMKFTPAVVQQLNEQYQIAVSKTKDTAIFVLKTP
FTLTI
>FECAFAII_00288 hypothetical protein
MRVACYDRTSVYEEAKISNDAQYDAVKEYVLEKYEQIPQRFSDKGESGGKADRPAFRQLR
AWVCASEEEGVIYVWRYDRLARQAKIALEFIELCQQHKVQVYSISEPLPASFSHASTNKL
FVQLLFTFAEQQRNVIIENVRAGLAYKKQQRQYLSSAVPYGYRLVNGKIQQEAHEAKVVC
RIFQLYLTKKYGYKKLCQRLTQQKIFFRERPFQPYHIYSILKNPLYYGEIKGGSLGKYLG
SFEPILSKATFLQVQEIRQSRCTAKKDTYPYLLRQKIKCPFCGRHLSSKYQWNTKKTKTL
HYYHCTDRSCQGIFLRAERVESEVLEKIQAFFQYEGVYQALITQLTQQLAEKRKDEKRKV
IQQKKQEAQWIKAFEEGNCSLEELKQQLQALQKPRSTSSFLSLQQCEAKVKEWLQLKDLS
SRQLLCDYVCRIEVTKEKTVCGIYFRQLTQNILERNE
>FECAFAII_00289 hypothetical protein
MTTNKMTLKAEVLLYIQEHFSNQAFFTKPIYLAFEIRGVSAGPIGGTLQALKNEGYLENH
FVQRSFNGRVAKEWYLVHS
>FECAFAII_00290 hypothetical protein
MRRIQTSSRGTPQTYSSIKEALINGKGFLYDCYYLSKEGVKVEDRVIAKQPIWIDQELCD
LETGLIKVEVKFCRRERYHSITLPYEEIMNHSPKKLMAMGLPILPKYWSDLQDYLARQIE
ESSLGIISKTIGWQRVGEKWHYLLQSERQLYCIENPLFHLKQKGSYEAWYADYCQYIRGN
LDLELLVLFGLCPVVIGYTPVAEQLDLEPFVLHLYGDSSSGKTTTLMLLISMYSSPTITE
PKGLFRSHSSTINALTKLGNLQGVLVGLDDSAASQNLDYTNFIYRIANSVDKFRLNSASE
LQETDTFKVVIFSTGEAPLGKGNQSGSFVRLLQLTDLTLTQSVTHSQAIKRMASTNYGFL
AKKLAQHLQQMDISQIVERIQFYSQYLLKEIPIENSKVQRIILRFSVVLFIGEILNELDF
NISIDQITLKLTELLKREALKLDILMVAYPLIRGYIESMQTQFKINGCLRNGHQVVLGKI
DKMENKYYRVRMTEQQFKTMLTSLNLPSERSILKEMKKRGLLVGCEKDRLYLRSNGGKYA
SFRIKLDL
>FECAFAII_00291 hypothetical protein
MEKRIKENAIKNQFYVSKSTVDPTLYDGKKNFYVTTYNFEGKDVNEDAQLQNHLNEMWDW
LYIDKGKKLDNLISRKKLGENKEDVKEKILTFCLYILLLHSRIIDIYNAQSKKNPEDKGA
FEFFKNHELRYRVTGVFFEKEEYHSQMAREIQKEVIYHEICLDTTCAFANYYLNSAGNFK
ELIDDIFHQASKKIRMIKEKLENEKKYGFDLYALEKLEESIAEICKLPSKKYYILAMEYF
TRLFDIKVESWTKGIIMEVEQKYWQKFKLTSPPRKVGKNDPIYSYYKEQLKRWKKETRNI
IELDRPLSWETPIIKQSIEDYYMKRDFLASIGLMDSIYQENLKKKRNSL
>FECAFAII_00292 hypothetical protein
MKKWLLLLIGMGILFTGCTSENTRTKATVETDTTIETNKSKTQSTEQTTTEMKQSVEAST
SESLTTESSSEEVKNTLWDSEKSTQLATFVPQWGKTLGQEYKSYNPQNNVSLYGTPLPSA
VIDGNWKMAINEAPVTVQWSEDGTGHADFNLVAVYSDVETGEYLGQHVYFFGFQNGQPKV
YLTQQNQGNENNYLYFNETQNQQLKQGFIDIVNGQTPQNPVVEESTQQATTDSATPSSHE
RAQAIREILKQNQGFNEEVLNSIPDEEILDSFVGNATNAQLAQSAMNLLEKYPNLK
>FECAFAII_00293 hypothetical protein
MAKLIVLGGLIYGGYWLYKYMLAHPNIDKGKVIKTVGVIIVGLIALTKKNNTNSPKIMRT
YRCRGCGREISTSFNPSESPQGRDRCHTGYRHYWERID
>FECAFAII_00294 hypothetical protein
MEIDKTCLSNSYKTMNNFFEEMELDSELLYQFYLAFRGQQISFPMKMYDRELVRKRIENM
IEQEKTVDIRQLTEVYGFSARWIQKVIKQKERRRVHG
>FECAFAII_00295 hypothetical protein
MTSLHKNQVKFNSNITISHTGGQLSSDSGLVLVKELMNIFGFSELAKQHIHIEDERAYFT
HDNLSILEQFIMQLIAGYSADSAANLLRQDPVFKAVLDRKELASQSSLSRFLDRLSEENI
RELQALNQELIDKARLIRNDTELIIDLDSTHSDTFGHQEQTNYNTHYQTYGYHPLVAFDG
LTGDFLKAELRSGNQYTSKGVKEFLTPLLEHYNHSLPNTDILVRGDSGFATPGVYDSCES
KKSHYVIRLKNNRRLGQIAEKSVLYGDNQKWEEREVQYFSTTYQAQSWSQSRRVCIRSTR
EAGELLFRHEFIVTNLSENVSPDTIFSIYAKRGTMENFIKEAKAGFYFDKTDSPRFLENH
VRMMLSLIAYNLVNFLRTIGFEEVQKGMTIHSIRLKFLKVAGKLVQTGRRVYLKLSSYHV
YQNEFYRVFARLRRASQWI
>FECAFAII_00296 hypothetical protein
MIEKELVTTQTEVWRDPHHTHRYVFKRQWAIKGKEAEDKLAVVITIRPTDTEPFTNDLSM
LLIEKNIRQLGFTGFIAVNLFSYTKAKSPRVFLRGNDEQSLEILTTVFTEKKINTIIFAC
GSITATSQVAYEQAKTIYDQLSAKQKKMTKVLINAEGKLSHPLSIHVRNEWQLADSQLLF
QEK
>FECAFAII_00297 hypothetical protein
MLETAIEVLEKRAQLVTIPEEWGYESVTMEKEEIEMGMLPKDVHLPRLVMTHLYIYCAPE
DGKDYVVYFITDITSQREFVRGLLVEGRLVWSQIGGTNE
>FECAFAII_00298 hypothetical protein
MFQNKGQRYVTKGVMDSLPVELQALCWNLIDQNVQKQLPLDYLQIFEFSTEKGNQKLVHR
QEEPEERKEYLISPKLRLKSVSQKIWVIDSGEYQTMLLPEEY
>FECAFAII_00299 hypothetical protein
MSEIADLIEKMYGHHYTPQTMSNMTKVLTEEVNAFKSRALNDKYVAIFMDATYIPLKRQT
VSKEAIYIAIGIREDGTKEVLSYAIAPTESTYVWNELLQDINSRGVQEVLLFITDGLKGM
KDTIHQIYPKAKYQHCCIHVSRNIAHKVRVKDRKEICDDFKAVYQANSKEEANTFLSGMI
EKWKKNYPKVTQSLIENQDLLTFYDFPPSIRRTIYSTNLIESFNKQIKRYSRRKEQFQNE
ESLERFLVSIFDTYNQKFLNRSHKGFQQVTDTLVSMFTE
>FECAFAII_00300 hypothetical protein
MNDFTTEIVQTLVTKGDLNELFRSHLEKAINTLLRTELTAFLDYGKYDRTGFNSGNSRNG
SYFRSIKTEYGELTLEIPRDRNGEFKQQTLPAYKRTNDTLETTIIHLSKKVLRCLKLLI
>FECAFAII_00301 hypothetical protein
MTSLHKNQVKFNSNITISHTGGQLSSDSGLVLVKELMNIFAFSELAKQHIHIEDERAYFT
HDNLSILEQFIMQLIAGYSADSAANLLRQDPVFKAVLDRKELASQSSLSRFLDRLSEENI
RELQALNQELIDKARLIRNDTELIIDLDSTHSDTFGHQEQTNYNTHYQTYGYHPLVAFDG
LTGDFLKAELRSGNQYTSKGVKEFLTPLLEHYNHSLPNTDILVRGDSGFATPGVYDSCES
KKSHYVIRLKNNRRLGQIAEKSVLYGDNQKWEEREVQYFSTTYQAQSWSQSRRVCIRSTR
EAGELLFRHEFIVTNLSENVSPDTIFSIYAKRGTMENFIKEAKAGFYFDKTDSPRFLENH
VRMMLSLIAYNLVNFLRTIGFEEVQKGMTIHSIRLKFLKVAGKLVQTGRRVYLKLSSYHV
YQNEFYRVFARLRRASQWI
>FECAFAII_00302 Bacillibactin exporter
MNNQKSLLQKGAILSISLMLTSSQAINGVIPQMKQSLGISQSQSELLGTAPSITVIVFIL
LSSYFAKRIGMKNTIILGLLLAGIGGIIPVFTATFQTVLISRVILGAGLGLYNSLAVTYI
SSLYSGNTRATLLGIRNSMEALGQTILIFLAGVLVNINWTASFLVYAIAFPVALLFALKV
PEIRDENSDIPENHVKEKMNPMVFALVLFAILLVMNSIAISVRFASIATEIKGVNFNASN
YLALMPILGILAGFMFGPINKWIGKGTLYLGIIFFIISNLLIATSNGNMAFLLTGLFLSS
ITGSWCFPFIFSNLDKVTTKNTINFATSLIFIGCNIGNFIAPISMQLAQFLTRSTSLTAP
FFVFAGIFMVVLFVTFFATKKKTTRVMTNL
>FECAFAII_00303 Bifunctional alpha-galactosidase/sucrose kinase AgaSK
MYKNNEMNIIYRSENQQFHLFNQEISYIFKISDDGKLLHLYYGENLPDNDYTHLIEMHHR
PMTTYRKENDLLYSLEHLKQEFPEYGTTDFRHPAISLLQKNGSRLTDFIYQGYEVEEGKP
KLEGLPATYVDNNDESKTLKVYVLDSVTNVQVELLYTIYRDYPVITRSARVMNKGKDIQI
IENISSLSLDLPDANYEWQQLSGAWGRERTIKSRTLQQGIQSIESTRGISSHQHNPFVTL
KRKNTDENQGEAIGAALVYSGNFLIQAEVDTWDVTRLQVGINPFGFNWKLNPGETFTAPE
AILVYSSKGLNAMSQTFHQLFRKRLARGKWREKDRPVLINNWEATYFDFDEEKLVNIAKK
AFDVGIELFVLDDGWFGERENDCAGLGDWHVNPKRLPRGIGSLSEKIRSFGMKFGLWFEP
EMVNKDSELYRTHPNWIISTPNRKPNHGRNQYVLNFGLDEVVENIFDQMCKIIDESNLDY
IKWDMNRPLTDVFDSHLSADQQGEVFHRYVLGVYCLYEKLITKYPNILFESCSSGGGRFD
PGMLHYAPQAWASDDSDAIERLKIQYGTSMLYPLSSIGAHVSIVPNHQTNRITPIKTRGN
VAFFGAFGYELDLNELSEGDLRIVKEQIAFYKKYRTIIHNGTFYRLLSPFDDDNQTAWMV
VSHDKKTAIVAHYKTLNEVNAPYRRLKLKGLDNDGFYKIGQNSLRSGIELMRAGLVCSDA
SSGQINDQNRRPETFDFDSKIWVITQEEK
>FECAFAII_00304 Melibiose operon regulatory protein
MENSLYLVKEPNTHLRDCYFNFCGYSKTEPRHSFGPAIREQYLIHIVLEGEGYYSINEQK
YYLKKGQGFVIPPGVSTFYQADEKNPWSYVWLGLSGELVEYYLKEIGVGKEHLTFKVENL
NSFKGIIFETLSYDQDNLISELSRQTQVYKFLELLLSSASYLKEGIITKKMNPFVRQTIE
IIRENAYQKLSVKDIAIKLSIHENYLSRLFKSDMGISIKEYISEIKLSIANDLLSSTEYS
IQQISDKIGFSTVQSFSKAFKKANGVSPGAYRKRRLGLGIINVE
>FECAFAII_00305 hypothetical protein
MRSSKYTEHYTDTFITFKEIMRTVSNIYHNCVPDKIKNRRNTDQLKQRDTVIIACVIWGI
INGYTSQRATYRAVCSVLFPNGDFPSRSRFTRLSSNLAYTIKIIRYFFIKKLTKGELVGI
IDSFPSPLCKPVRNRQAKLLNQIAKVGYNSTKKSYFYGLKIHMIVTKTGFPITYSITNPG
VHDVKVLETLSEEANLPNILGDKGYISHKIHEKLALKGITISVPPRKNMDKSEKLDHSLL
GKQRKTVETVFSSLEKLGCQNFNSRSVKGLESRFESILLAYSVLLSRTQRRFEGTLRYSL
GY
>FECAFAII_00306 hypothetical protein
MTEIKLEPQSMQLLEINGEGREQLIQKLSQNYLNTGRYTKKQMSISPTVMSSLITTSGLG
LTAISKNLSSKLFMATANPDLLMKLSSGGVGSAVMEGGRIVGQSGFIPVAASLPIVAPLI
AMQAMSTIAIMEQFKVVNKKLDIIQKEMNQILLRQEITSIAELSSAIGIVDELYTQHSII
GHFSQDMIIRLALVERDAGKLKARYEILDSINESTASEYKNSDAYFTLLSSLLLLRIKYL
RLCLDTQENPEFIKYSKDNFQKILDHTISIYGNFRNRSKAIKKLIDLEENSDNKKTLGKL
PKFMVHDTKKENIKEEYISMLEIENKINEDFGSAVQEMKKLQKVDNINNPATNLLYWEDI
TGTHCIVTDEDVLSLN
>FECAFAII_00307 hypothetical protein
MSKRTRRTFSQEFKQQIVNLYLAGKPRVEIIREYELTASAFDKWVKQSKTSGSFKEKDNL
TPEQKELLELRKRNQQLEMENDILKQAALIFGRRDK
>FECAFAII_00308 hypothetical protein
MCRILGLSRQSYYYQSKPKKDESELEEVVAEEFIRSRKAYGSRKIKKALSKRGIQISRRK
ISRIMKNRGLKSSYTVAYFKVHHSTCNEAKTTNVLNRKFLRDNPLEAIVTDLSYVRVGKK
WNYVCFILDLFNREILGYSCGEHKDAVLVKKAFSRIKQPLTEVEIFHTDRGKEFDNQAID
ELLTTFDINRSLSHKGCPFDNAVAESTYKSLKVEFVYQYTFETLQQLDLELFDYVNWWNH
LRLHGTLGYETPVGYRNQRLAQRILDNELGCANASEAV
>FECAFAII_00309 Ribosomal RNA large subunit methyltransferase H
MNIKIISVGKLKEKYLIQGINEYVKRLQAYAKIERIEVPDEKAPENLSEAQMRQVKEKEG
ERILSKIKEQEYVYALAIEGKNPTSEAFAKEIDQLGIQGKSQITFVIGGSLGLSEAVMKR
SNAQISFGKMTYPHQLMRLILVEQIYRAFRINAGAPYHK
>FECAFAII_00310 Serine protease Do-like HtrA
MERKDVTPKMKKNNGIWRKLGLGLVGGIIGGLVTAGIFYAVMGSGNAASNSGGHQNSAGE
TVVENVKVNVDSDITNAVDKVQDAVVSVINLQSQNQGTNGFGQLFGQQQESSDDSNLEAS
SEGSGVIYKKSGNSAYIVTNNHVVEGQQGLEVLLKDGTKVKAELVGTDAYSDLAVLKISA
DKVNKVASFGDSNSLKVGEPAIAIGSPLGSEYANSVTSGIISSLNRQVTSTNESNQTVNI
NAIQTDAAINPGNSGGPLVNIEGQVIGINSSKIASTSASSSGVSVEGMGFAIPSNDVVNI
INQLEKDGKVTRPALGITMVDLSAVSTQQQEQILKIPESVTNGVIVTSVQPATPAEKAGL
KQYDVITKIDDTDVSSGVELQSVLYQKKVGDSVKVTYYRGKEKKTTTIQLTIDQSALKQS
QSENSGN
>FECAFAII_00311 Phenylalanine--tRNA ligase beta subunit
MIFAYNKAHVGDTLMVIVSNDNGTENTVIRKWNVAQIKDETGQIVGWNFFHISDHLKIEG
NGQVKLTEEQIAQLNRLIKEAGFEETLTEENEPKIVVGYVKTCIPHPDSDHLSITETQVG
KEEVLQIVCGAPNIEAGQKVVVAKPGAMMPDGMMIWPGTLRGVESHGMICSAKELQLPDA
PKEKGILVLPEDAVIGEAFPK
>FECAFAII_00312 Putative universal stress protein
MEQEYKNILVGIDGSEQALSAFKKAVEVARRNDGTVYVANVIDQQFYNFMGYVPIDQTLV
DQQTEAAKQMIEDCKAYGKTVDYQKIEGIVAYGSVRESMAVNLPKKYAIDLIMVGQSGLN
AVERFMTGSVSSYVIRRAPCDVLIVSDEVENNTDN
>FECAFAII_00313 Thioredoxin-like protein YtpP
MIIPENLEELAGYVEKGNSVFFFTADWCGDCRFIKPQMPEIENDFAAWRFIEVDRDKYID
VAAEWNIFGIPSFVVIKDGKELGRLVNKDRKTKQEIEDFLNRVTNG
>FECAFAII_00314 Glutamyl aminopeptidase
MDEKTFQRIKELTELQGTSGFEQDIRAYMKAHMEPLVDELQLDGLGGIFGLRQHEEADAP
RVMVAAHMDEVGFMLTQIQDNGLFKVVPLGGWNPYVVSAQRYTLKTSSGKNYPCISSSVP
PHLLRGTSGQKSVEVTDILFDAGFESREEAMSFGVLPGDTIVPFAETIKTANGKNIISKS
WDNRYGCTMVLEALEALQNEKLGHTLIAGANVQEEVGLRGSKASVNKFKPDLFFAVDCSA
ADDTVTKKGTFGHLGEGTLMRIQDPGLIMLPRLREYLLDVAETNNIPYQYFVSKGGTDAG
AAHTQNEGIPSTVIGVVGRYIHTHQTMFSIRDFEAAREMLIQTLKGLDKSTVNTIVYGK
>FECAFAII_00315 hypothetical protein
MYSEECESNNFKNGLAIGIGLGLISGITSMVLYQRKKTLSADQVLEQVKESFLKEGSIEG
SWISFEKEPTRKFAIHSKAYRGGISRLEDGEIICYEFLADAYTGTVLEISRKKNELI
>FECAFAII_00316 Polyprenol monophosphomannose synthase
MEQQEKIAVLIPCYNEEATISTVIADFRRELPEAEIYVYDNNSTDTTYELAVACGAIVKK
EPRQGKGNVIRQMFFDIDADYYLMVDGDDTYPAEAVHGLLDKLRSGEADMVIGDRLSNGT
YFDENKRPFHDFGNNLVKNTITRLYKTKIRDVMTGYRGFNRIFVKSFPIMSSGFQIETEL
TIHALDKKFKLVELPIDYRDRPEGSESKLNTFSDGFKVIMMIVKMWKDYKPLMFFGIWTF
FFFVFGLFAGVPVIREYMLTHFITRVPSAILSTGLMILALLSLVTGLILDTVVTNAKKEY
ELNLYHVYHECRKQEQQK
>FECAFAII_00317 3-sulfolactaldehyde dehydrogenase
MDIFYQETFGPVIPLIAFKEEEEVIKDANDTIFGLASYFFATNIHTIANVSQKLQYGMVG
VNDTAISNSATPFGGVKHSGFGGENGTYGVEEYVVAKFVTIRTAK
>FECAFAII_00318 hypothetical protein
MMIIKMFKDYKPLLFFGIWTIFFFLFGLVTGIPVIREYMLTSFITRIPSAILSTGLMTLA
LLSLVTGLILDTVVTNAKKEYELNLYHVYHEYHSRK
>FECAFAII_00319 Beta-Ala-Xaa dipeptidase
MTIDWQKEVEARKEDLLEDLKNLLRVNSERDDSKVTPDAPFGPGPRDALKHMLAYGERDG
FKVKNVDNYAGHIDLGEGDETLGIFGHMDVVPAGDGWDTDPYEPVIKDGKIFARGSSDDK
GPSMAAYYAMKIIKELDLKLSKKVRFVVGSDEESGWGDMAYYFEHEEEPDFGFSPDAEFP
IINGEKGNVSLALRFKGDNAGDYVLKSFVSGLRENMVPGTATAALQVPSADAAIAMEEAF
YQFIEANPVSGTIEADNTYVKIELVGKGAHGASPQSGINAGSFLALFLDNYEFLGSAKQF
IHVAAAYVHEDFYGEKLGVAYEDEKMGKLTMNAGLFAFEENGTEEANFINMNFRFPKGVT
VDGLQSDIEQTVGQEGATVTRGARVMEPHYVPMDDPLVATLLQVYEDHTGEKGYEQIIGG
GTYGRLLKRGVAYGAMFPGYTDTMHQANEFMSLDDLFRATAIYADAIYRLAK
>FECAFAII_00320 ADP-dependent (S)-NAD(P)H-hydrate dehydratase
MLINEQLVKRVITPRPKISHKGTFGRIVLIGGNEQYGGAIIMSALAAAHTGAGLTTVVTD
EKNRSALHSHLPEAMIVDWTDTDQFLFVIKQADVLLIGPGLGTSSKSLERFKQVLENQSK
EQWLVIDGSALSLLAANHLLLPYPEQTVLTPHQMEWQRLSSLPIQEQRDKENKKKQQEIG
AVLVLKSHETKIYGHQHFYTNPLGSAAMATGGMGDTLAGMITGFLAQFPQNDQTIAAAVY
LHSFIGDQLAKEQYIVLPTQISEALPKWMNYFCKKSMENEA
>FECAFAII_00321 Putative esterase
MEKFTGYVREPFYYETDQMGIIHHSNYIRWFEEARVALLVHLGFPYKKIEESGIIIPVLE
VNCSYKEMIHYGEKVSIHPTIQKYTGTRLDFSYEIVGTEDKKLKTTGSSKHCFLLSDSQR
LVKLSKVNPELDQLFQAYASLDDVNS
>FECAFAII_00322 hypothetical protein
MYVVKVMHGYIDKTGCRTREKNLDNLLIFKDKKESEAFAKRIGGRVKSIQEVRPD
>FECAFAII_00323 HTH-type transcriptional repressor RspR
MVINNLQQQAYESIRKQIIYSELAPGSKISDKVLEEQLAIGRTPIREALIQLRNQELVKT
IPQSGTYVSKIDIRSASLARYTREKLEKPILQECSAKMTKQDQAKLEKILEQTDQAVIAQ
NKKAFFDLDTDFHRTCYEIAGKREIWDWLESYSTHLNRFRWLRLTISELDWGRVLDEHQT
MLQSMIDHNFDEVGFLCTMHLHMIIEEQEYVIHNYPDYFEDIQDRPIK
>FECAFAII_00324 hypothetical protein
MPEISNKHKLEELLNELQQIPEEIWGFYQFRRDLFWKKIPLSKQKILIQKSIDCGIETAC
SIKKKYPFADVGEICEQMAVPIVSCESEQINERITFATYAEDEGIRLMTEPLEKLKCSGL
ASISKETAQALIIGHELFHHIEASVKGIYTQSEKIVLWRLPFYTHQSNIRALSEIAAISF
SKEMNQSDFSPYVLEAVLLWPYNEIRSQGILEEIKEIEKRCTEYDLDYK
>FECAFAII_00325 Acetophenone carboxylase alpha subunit
MKRFVRMGIDVGGTHTKAVAIDNATHEIIGKSSVKTTHDDVRGVAAGVVQSFQNCLRENN
ISPEDVVFVAHSTTQATNALIEGDVAKVGVIGMAKGGLEGFLAKRQTRLNDIDLGNKKKI
EIVNAFLPVKHLNVDRVSETISSLERERAEVLVSSMAFGVDNGEPERVVYEAASVKAIPT
TMASDITKLYGLTRRTRTAAINASILPKMLDTATSTEDSVREAGVNVSLMIMRGDGGVME
INEMKKRPVLTMLSGPAASVMGSLMYLRASNSVYFEVGGTTTNIGVIKNGRPAIDYSIVG
GHPTYISSLDVRVLGVAGGSMVRANQSGIIDVGPRSAHIAGLDYAVFTETEKIKGPKVEF
FSPKEGDPADYVKVVMEDGEEVTITNTCAANVLGLVQEEHFSYGNVPSARKAIQALADYC
HTTVEDIAEQIMEKSYAKIEPVILELADKYHLEKDQISLVGVGGGAASLITYFSNKMGVK
YSIPENAEVISSIGVALAMVRDVVERIIPSPSKEDIRSLKNEAMNKAIESGATPESIEVH
VEIDPQTSKVTAIATGSTEVKATDLTKEITTEEALELAAEDMRLNKNEVCLLENTPFFYV
CGEQNRSKNAGSLRIIDQKGFIKVQRGHASCMKTTAANYMTAVEQLWEDMAVYQTELIAR
PEFYLCLGARVSDFTATDLEQLQLLMDLEVSTMEPEEEVIVVAGNIKQT
>FECAFAII_00326 hypothetical protein
MSDIIIGILLVISFFFMVWYCVKGYNLMVGFAIMATVWMGLALVGNTFSPNPAMEGQGVI
DVLTHIYTTGPAEYAKSILVNVFFGAFFGRVLVDSGIAATLIRKVVELGGDKPRITMSLL
CIVTAVIFMSMTGIGPVISIAVIVLPILMSLGISVPVALFSFMGSIMAGIFANIVNFKQY
QTIYAGFNPAAESYTYNDYFQIGMIGMIVSLVVVLTVANISMNKKKRYAMAANVPAEGGD
APMISWLAVLLPVLGVVLLDLPIILGFILAGIWALLFTGKLRGGYKEICRQFAKLFTDGA
VDVALMVGFLMTLAMFNNSAAYASPYFSAIFGDWIPQSPLVLAIVFAILTPLGFFRGPMN
LVGSGSAILAVVLAVNPTMSPAFLFPLFAITTIAPQHLDITQSWVAWGLGYTKVTSREYM
KKSIPTGWIIGAILCLITFLLYGNA
>FECAFAII_00327 50S ribosomal protein L20
MARVKGGTVTRKRRKRVLKLAKGYYGSKHTLFKTAKEQVMNSYNYAYRDRRQKKRDFRKL
WIARINAAARMNGLSYSKLMHGLKVAEIDINRKMLADLAVNDAAAFTALADQAKEALAK
>FECAFAII_00328 50S ribosomal protein L35
MPKQKTHRGSAKRFKRTGKGGLKRFRAFTSHRFHGKTKKQRRQLRKASMVSSGDFKRIRQ
QLAKMK
>FECAFAII_00329 Translation initiation factor IF-3
MTIAKDMMVNDGIRARELRLIGSDGEQLGVKTKAEALNIAEQANLDLVLVAPGAKPPVAR
IMDYGKYRFEQQKKDREARKKQKVINVKEVRLSPTIDLNDFNTKLRNARKFLEKGDKVKA
SIRFKGRAITHKEIGQKVLNRLAEETADIATVEQKAKMDGRSMFLTLAPKNDSK
>FECAFAII_00330 Pentapeptide repeat protein MfpA
MKKIEPIPPSLPLLTKGEFYLEDEEIFSGLLINGGDQSYLDAKNMVLRESHIQKLTMQKT
VLRHFECSNVIFEKCDFSNLEWIGGSFHQVVFHQCKLTGTNFAESYLRDCTFTDCIASMA
SFSSTNLKAVSFDHCQLEDSEFYEVTWKNLFLSDNQLTGSNWFRTSLKGLDFTTNFFTAI
ALSQDSLAGLIVNQEQALVIAQALGLQIKD
>FECAFAII_00331 Cobalt/magnesium transport protein CorA
MREKHYFNQDRNFWINVQQNDVLAVKNLKEEYGISDEMLTYSLDKNERARVEYDSFDEAL
LLVSNVPHQQKVDNHYETSPIAFILKEDGLFTFTTPNTEYVIRLIRSLLERMPDMSVYSL
LFRTLFLISDSFFPLIEEVNSERQRLNLKLREKTTNKNLLQLSDLEIGLVYLVTGTKQNV
VLLEQIKALAIYRKLSEKEKEELDDALIEARQAVEMTNLASQILDQLSGTYNNLLNNNLN
DTMKFLTVWSLILTVPTIVTGFFGMNLQLPFTHSVFGWGIALIISLVLSIWMLIALWRRI
R
>FECAFAII_00332 Deoxyguanosine kinase
MIVLAGTIGAGKSSLTEMMAEHFDSQAFYESIDDNEVLPLFYANPEQYAFLLQIYFLNKR
FASIKQAMKDDNNVLDRSIYEDSLLFHLNADLGRATETEVRVYDELLKNMMEELPYAAHK
KHPDLLVHIRVSFDTMLERIEKRGRSYEQLSFDPSLYDYYKELNRRYDQWYEEYKESPKI
QIDGDRYNFVEDPQAKEEVLKMIEEKLAEIRQTKVAI
>FECAFAII_00333 Galactokinase
MANYGQGESSGKIILMGEHAVVYGEPAIAFPFYATKVTAFLEELDAMDDQLVSSYYSGNL
AEAPHALKNIKKLFIHLKKQHDIQKNLQLTIESTIPAERGMGSSAAVATAVTRAFYDYLA
FPLSREILLENVQLSEKIAHGNPSGIDAAATSSLQPIYFTKGHPFDYFSLNIDAFLIVAD
TGIKGQTREAVKDVAHLFETQPHETGQMIQKLGYLTKQAKQAIIENSPETLAQTMDESQS
LLEKLTISNDFLNLLIQTAKDTGALGAKLTGGGRGGCMIALAQTKTKAQEISQALEDAGA
AETWIQGLGVHTYV
>FECAFAII_00334 Homoserine kinase
MFKGKARAYTNIALIKYWGKKNEELILPMNNSLSLTLDAFYTETEVIFSDSYMVDEFYLD
GTLQDEKATKKVSQFLDLFRKEAGLSLKASVISQNFVPTAAGLASSASGLAALAGACNTA
LKLGLDDLSLSRFARRGSGSACRSIFGGFVEWEKGHDDLSSYAKPVPSDSFEDDLAMVFV
LINDQKKEVSSRNGMRRTVETSNFYQGWLDSVEGDLYQLKQAIKTKDFQLLGETMERNGL
KMHGTTLAAQPPFTYWSPDSLKAMDAVRQLRKQGIPCYFTMDAGPNVKVLVENSHLSEVQ
ETFTKLFSKEQVITAHAGPGIAIIE
>FECAFAII_00335 Phosphomevalonate kinase
MIEVSAPGKLYIAGEYAVVETGHPAVIAAVDQFVTVTVESARKVGSIQSAQYSGMPVRWT
RRNGELVLDIRENPFHYILAAIRLTEKYAQEKNILLSFYDLKVTSELDSSNGRKYGLGSS
GAVTVATVKALNVFYALNLSQLEIFKIAALANLAVQDNGSCGDIAASCYGGWIAFSTFDH
PWLQEQETQHSISELLALDWPGLSIEPLIAPEDLRLLIGWTGSPASTSDLVDQVHRSRED
KMVAYQLFLKNSTECVNEMIKGFKENNVTLIQQMIRKNRQLLHDLSAITGVVIETPALNK
LCNLAEQYEGAAKSSGAGGGDCGIVIVDQKSGILPLMSAWEKAEITPLPLHVYSDQRKEN
R
>FECAFAII_00336 Isopentenyl-diphosphate delta-isomerase
MNRKDEHVSLAKAFHDKQKNEFDFVRIIHNPLPQIAVSDVDLSTQAVGFTLSSPFYINAM
TGGSEKTKKINQDLAIVAREADLMIATGSVSAALKDPSLADTYTIMRQEYPHGKIIANIG
AGTSVERAQEAIRLFHADALQIHLNAPQELVMPEGDRDFTNWKVLIQETQTAIDVPLIVK
EVGFGMTRETLNDLASLGVHTVDISGRSGTSFTQIENARRSKRELSYLADWGQSTVSSLL
EANEADTSMEILASGGIRNAYDIFKALCLGANAVGTSGTVLTHLMKHGVEETIILMKQWQ
EELRLLYTMVGATNTAALHQHSLIFSGPVKDWCEARGIDLVKYGRRTEKSVGQK
>FECAFAII_00337 Gluconate 5-dehydrogenase
MNQESVDEGIAHHKEAGIDAKGYVCDVTDEEAVQAMVQQIKEDVGLVDILVNNTGIIKRT
PMIEMDAADFRQVIDVDLNAPFIVSKAVIPDMIEKGGGKIINICSMMSELGRETVSAYAA
AKGGLKMLTKNIASEYGQYNIQCNGIGPGYIATPQTAPLRETQENGERHPFDQFIVGRTP
AARWGEPIDLAGPSVFLASSASDFVNGHVLYVDGGILAYIGKQP
>FECAFAII_00338 7-alpha-hydroxysteroid dehydrogenase
MMEFSMDMFRLDGKVALVTGAVYGIGFEIARSLATAGAKSYLIT
>FECAFAII_00339 4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase 1
MQEMETRYTHSPEDIRHYSTEQLRKEFLVEKVFEPGKISLTYTHNDRMIFGGVTPTEKEL
EITLDKELGVDYFLERRELGVINIGGPGFIEIDGQKEEMKKQDGYYIGKETRHVVFSSQD
AENPAKFYISSVPAHHKYPNVKISIDQVKPMETGEGLTLNERKIYQYIHPNVCESCQLQM
GYTILEPGSAWNTMPCHTHERRMEAYVYFDYANEDTCVFHMMGKPDETKHLVVDNEQAII
SPSWSIHSGVGTSNYSFIWAMCGENITYTDMDMVQMDQLK
>FECAFAII_00340 2-dehydro-3-deoxygluconokinase
MGKVVTLGEIMLRLSTEQGTRIDSSKRFAAHYGGGEANVAISLANYGHEAIFATKVPDNA
LGKAVKKHLQCYGVDTKQVLSGGPRLGTYYMETGSGERAASVIYDRAGSSFAEMDHLEWS
LEELFQGIDIFHVSGITPALSKKWQKMTKQVIEAAKRAGCLISFDINYRGKLWTQQEASE
VIHQLLPLVDICSAGKMDALYLLGIEKAPEAEEQPLIYYYQKMQEKFPNIQVFYSTKRTV
HSASENELKGTLWMNHEYVESQVHRITPIVDRVGGGDAFAGGVLHGILSNMSPQEIIDFA
TAASALKHTIHGDCNQFSQEEVAQFLACGSGKIIR
>FECAFAII_00341 KHG/KDPG aldolase
MKKIDILSRLKNAGVIAVVRGKSKEEALNACHAIIKGGLTGIELTFTVPQADQVIKELLS
FYKDQPEIVIGAGTVLDAVTARLAILAGAEYIVSPSFDQETAEMCNLYQIPYLPGCMTIT
EIKTALKSGVDIVKLFPGSAYGPSIISAFKAPMPQVNIMPTGGVSLDNMKEWFDAGVVTV
GVGGNLLAPAATGDFDKVTEVAQQYAAKMKEIKR
>FECAFAII_00342 Transcriptional repressor IclR
MENKKPYGTVLIKASKILDYLAENQDVSLQTIAKGVGMTSSTVLKILDTLLMIGYVNKNS
EKNYRLGAKLIRYANKNIEQIDLVELTLPFLEQLQQKIDETIHLGVLDNNEILYVNKLDP
KHQTIRMSSKIGITRPLYNSAMGKAVLAEFSEEQYTDYLEKHPLIPYTEYTITNALRLKK
EIQTVKETHIAFDDEEIERDIFCIGASIVKNEQIIGAFSVSMPKYRLTDETKEQIISALK
QTKSEIEQRIQK
>FECAFAII_00343 Lactaldehyde reductase
MSNQMILNETSYFGKGAIESIVPEFQQRGFSKAAVITDKGLIEHGIATKVTELLDKAAID
YALYDGIVPNPTIQNVKDGVAFVKEAEADCLIAIGGGSPIDTAKAIGIILTNPEFSDVIS
LEGVADTKNPCLPILAIPTTSGTAAEVTINYVITDEVNHRKFVCVDPHDIPIVAFIDSDM
MMGMPKKLAASTGMDAMTHAIEGFITKGAWEMTDMLHLKAIEIIGHSLEASVDGDQNGRE
KMALGQYIAGMGFSNVGLGLVYGMAHPLSAWYNIPHGLACAALLPTVMKYNKEYTGEKYR
EIALVLGIKGAAEMSLEDVREAACGEIDRLSKAVGIPETISELGVKEADIPAIAEDALRD
VCTPGNPRETTVEEIIALYQSLM
>FECAFAII_00344 L-rhamnose mutarotase
MVKKAFCMKVYPEKQEEYKKRHDELWPEMRTALREHGVIDYSIYLDPSISLLFGYLVIED
EKLCEKMANTSINQKWWKYMEDIMETNPDASPVSWELMPVFEL
>FECAFAII_00345 Rhamnulose-1-phosphate aldolase
MKKIDILQAPYVKEMIETTSNLYRLGWDERNGGNISYLLKEEEITPFLDPEKVIRRISMI
FDASRLAGCYFIVTGSGRYFKNVASEPAENLGIVRVAEDGKTLELLWGLENECLPTSELP
SHFMSHIARLEVDPDNRIVMHCHASHLLAMSFTHELDERSFSRTLWQMCTECLVVFPEGI
SIIPWMVPGTNEIGEATAEKMKETRLVLWPQHGIYGSGKDMDEVFGLIETAEKAAEVYTY
VKAQGPILQTITDENLWHLADAFGVTPKAGYLEEVHTKAGV
>FECAFAII_00346 L-rhamnose isomerase
MNTIEKNYEQAKEKYATIGVDTDAVLEKIQDIKISMHCWQGDDVKGFLTPDGELTGGIMA
TGNFPGAARTPEELRQDLEKAYSLIPGKHKLNLHAIYLDTEESVDLNEIEPKHFEKWVEW
AKKEEIGLDFNPTFFSHPMMKDGFTLAHPDKEVREYWIEHGKRSRKIAEYFGKETGQTSI
NNFWVPDGMKDNPIDRFTPRERLMESLDEISTEELDERYVQDAVESKLFGLGAEAYTVGS
HEFYMGYGLTRDKLVCLDAGHFHPTEVISNKLSSLALFSEGIMLHVSRPVRWDSDHVVLM
DDELQEIAKELVRNELLEKTNIGLDFFDATINRIAAWVIGTRNTQKALLKAMLEPVERLK
EMELAFDFTSRMAYTEELKDFPYADVWNYFCYKNQVPVGLDWLEEVQEYQKDVLELRK
>FECAFAII_00347 Rhamnulokinase
MNPTFVAIDIGASSGRLMKSTRDAKGALILEEVHRFKNGFRNKDGHDRWKIDYLIKEILI
GFEKLKQTGIDRLFAGIDTWAVDYCLIDEQGDRINDPIAYRDKRINGAVEQFSEIYSLDK
LCEQTGIQIQPFNTLFQLFAEEKENLAKAHKLLLIPDYLGYVFTGNMVTEKTNASTMQLL
NAGIKEWEIELLEKIGVSKELFPPLTEPGTILGDLQKEQFSKYDLPDVTFITVASHDTAS
AVLGTPGQGERWGYISSGTWSLLGIETKIANVSRNAFSENYTNEWGAHNTVRFLKNIMGM
WLIQEVARMQEYEYSYAELAELAAKEKPLQQVMEINDPRFLNPPNMIEEIQQYCFETEQP
VPVSSGAIARCVYDNLALCYAQELIKVEHLTGTKLEKLHIVGGGSNNRLLNQLTADYAGI
IVEAGPSEATAIGNVAMQMLSTGQFSNIEQARNVIKQSFPCETFYPDENKQNMMEWYVNK
IKGVIV
>FECAFAII_00348 hypothetical protein
MDYWEKANHSWFEDSKRVILTPTQRSRNLFFYIIICQIKRDKTFHLRNSKKLLMVFGNLV
IF
>FECAFAII_00349 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIVAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYIAKRSTEGWTPDVIIGRAERTFSCSVSTLYRRFKTGEFNVL
HLPMQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEGDTIIGIHHKSAVITL
VERLSKAIIALKPEGRKAVDIENSINEWLQSVPKNLFKSITFDCGKEFSNWKSISNTNDI
DIYFADPGTPSQRGLNEHSNGLLRKDGLPKEMDFNQVNQGFISSVASKRNHIPRKSLNYQ
TPLEVFLSYVNGKFCLA
>FECAFAII_00350 Aldehyde-alcohol dehydrogenase
MAKVMEKEKTKTIDVQAMIDDLAEKANAALKEMESFDQEKVDHIVHEMAMAALDQHMPLA
KMAVEETGRGVYEDKAIKNMYASEYIWHNIKHDKTVGVINEDVQKGLIEIAEPVGVVCGV
TPTTNPTSTTIFKSMIALKTRNPIVFAFHPSAQKSSAEAARVVRDAAIAAGAPENCIQWI
EHPSIEATSMLMNHPGIAIVLATGGAGMVKSAYSTGKPALGVGPGNVPAYIEKTAKIKRA
VNDLIVSKTFDNGMICASEQAVIVDKEIYAAVKAEFQAHQVYIVKPDELQKLEDAVMNEG
KYAVNPSIVGHSAMEIAKLAGISVPKGTKMLIAELEGVGPDYPLSREKLSPVLAMIKANN
TDHAFDLCEGMLNLGGLGHTAVIHSENEELHVKFGLRMKACRILVNTPSAEGGIGDIYNE
MIPSLTLGCGSYGKNSVSRNVSAVNLINVKTVAKRRNNMQWFKLPPKIFFEKNSLLYLEK
MENVERVMIVCDPGMVQFGYCDTVREVLARRKNDVKIEVFSDVEPNPSTNTVYAGTKLMA
DFKPDTVIALGGGSAMDAAKGMWMFYEHPDTSFFGAKQKFLDIRKRTYKIDKPEKTQFVC
IPTTSGTGSEVTPFAVITDSETHVKYPLADYALTPDVAIVDPQFVMSVPASVTADTGMDV
LTHAIESYVSVMASDYTRGLSLQAIKLVFDYLEKSVKTPDMESREKMHNASTMAGMAFAN
AFLGICHSVAHKIGGEYGIPHGRTNAILLPHIIRYNAKDPQKHAMFPKYDYFRADTDYAD
IAKFLGLKGETTEELVEALATAVYELGKSVGINMSLKAQGVTQETLDTTVDRMAELAYED
QCTTANPKEPLISELKQIIIDAYNG
>FECAFAII_00351 hypothetical protein
MTSLHKNQVKFNSNITISHTGGQLSSDSGLVLVKELMNIFGFSELAKQHIHIEDERAYFT
HDNLSILEQFIMQLIAGYSADSAANLLRQDPVFKAVLDRKELASQSSLSRFLDRLSEENI
HELQALNQELIDKARLIRNDTELIIDLDSTHSDTFGHQEQTNYNTHYQTYGYHPLVAFDG
LTGDFLKAELRSGNQYTSKGVKEFLTPLLEHYNHSLPNTDILVRGDSGFATPGVYDSCES
KKSHYVIRLKNNRRLGQIAEKSVLYGDNQKWEEREVQYFSTTYQAQSWSQSRRVCIRSTR
EAGELLFRHEFIVTNLSENVSPDTIFSIYAKRGTMENFIKEAKAGFYFDKTDSPRFLENH
VRMMLSLIAYNLVNFLRTIGFEEVQKGMTIHSIRLKFLKVAGKLVQTGRRVYLKLSSYHV
YQNEFYRVFARLRRASQWI
>FECAFAII_00352 hypothetical protein
MGTLPMLVMFIALLAMWFFMSRSQKKQQQERQNLLDSMKPGDSVVTIGGLHGVVSEIDND
KRTVVLDCEGIFLEYDRAAIKTVKPGTVVTNDATTTVETTEEPAETVEVKTETTETLEET
EEKKEK
>FECAFAII_00353 Queuine tRNA-ribosyltransferase
MTQPAIRYRLIKKEKHTGARLGELITPHGTFPTPMFMPVGTLATVKTMSPEELKEMGAGV
ILSNTYHLWLRPGEDLVEEAGGLHKFMNWDQPILTDSGGFQVFSLSDMRNIEEEGVHFKN
HLNGSRMFLSPEKAINIQNKLGSDIMMSFDECPPFDESYDYVKKSVERTSRWAERGLKAH
ANPDRQGLFGIIQGAGFEDLRRQSAKDLVGMDFPGYSIGGLSVGEPKSEMNRVLEFTTPL
IPENKPRYLMGVGAADSLIDGVIRGVDMFDCVLPTRIARNGTCMTSQGRLVVKNAKYAHD
FRPIDEKCDCYTCKNYTRAYIRHLIKCDETFGIRLTSYHNLYFLLNLMKQVRQAIMDDNL
LEFREAFFEEYGFNKENAKSF
>FECAFAII_00354 hypothetical protein
MQSSAELKRQAKESLKGRWGQAVLLNLIPTLIGIAAILLIMIPIILFATTIYDGSASVSD
ATTSGGGSSGGGGGIISSIISALFMSGISWTYLDILRGQKDQIEPFKDAFRGFKGLFIGG
VIGLAVLISIFTTLWGLLLVIPGIIKSYSYSQSYFIYYDIVQETGQTPKVLDTITASRKL
MDGYKGQLFWLDLSFIGWHILALATAGIGYLWLSPYISATKAAFYEQLPKDI
>FECAFAII_00355 Calcium-transporting ATPase 1
MNKQTATVIRDGKVTTVESEQLVVGDILVLESGDAISADARLIEASQLRVEESALTGESE
AVEKDAAFIAEEDESLGDQLNMVFKGCTVAAGRGKAIVTAIGMATEMGKIADLLNENTMQ
KTPLQVRLNQLGKRISMIALAAAALVFVIGELQGEPLLEMFMTSISLAVAAVPETLTVIV
TLTLAYGVQKMARKHAIIRQLPAVETLGTANVICSDKTGTLTQNEMRVRRVWSKEDEVTN
IEDSMTNSAMEILKMAALCTDVTVEQEDDDLVIKGNPTEVAIVRAVEENYHTKAELEEKY
PRVNELPFDSERKMMTTVHQMGEKYISITKGAFDVLAPRFSSGDVEQAAIVNDRFGKRAL
RVIAVGYATYDEEPQDISSEALEKDLRLIGLIGMIDPPRPESKGAIKRAKKAGIKTVMIT
GDHVVTASAIAKELGILNDPSEALSGSELHQLSDEELDARVKALSVYARVTPEDKIRIVK
SWQRTGAVVAMTGDGVNDAPALKASNVGCAMGITGTDVAQSAADMILTDDNFATIVDAVS
QGRSVYQNIRKAINFLLSCNISEIFIILIAMLLGWGAPFTAVQLLFVNVVADGLPGFALG
GEPAEHGIMDQPPIPKNEGIFARGLLQKIAINAGVFTIVTLFGYYLGSYVDTISPWVDAS
QHVGQTVAFLILAYSSILHVFNVRSSQSIFKVNLATNKALVEMALLALAITTAVALLPFT
QELFGLVHISLNHWFLVGILSIVPIAVNELIKFHRLPEAEEEE
>FECAFAII_00356 Calcium-transporting ATPase 1
MEEYKQTIEEVKKVTEADPDTGLSSQEVDERRKKQGLNKFDEAPKESMIKKFFRSLSDFT
TIILLVAAVISFYTAFATEHGDLFEGLLIIAIVVINSVLAIV
>FECAFAII_00357 S-adenosylmethionine:tRNA ribosyltransferase-isomerase
MLTTEDFDFDLPEELIAQTPLKDRDHSRLLVLDRKTGEMEDKHFHEIIEELQPGDALVMN
NTRVLPARLYGEKPDTGAHLEVLLLTNTQGDTWETLIKPAKRAKVGTRISFGDGRLQAVV
KEELEHGGRIIDFEYEGIFLEILESLGEMPLPPYIKERLEDPDRYQTVYAKENGSAAAPT
AGLHFTKELLDEIEAKGVELVYLTLHVGLGTFRPVSVDKIEEHHMHSEFYRLTEEAAERL
NQVRKNGGKIVAVGTTSIRTLETIGTKFNGEIKADSGWTDIFITPGYEFKVVEAFSTNFH
LPKSTLVMLVSAFAGRELTLSAYQHAIEERYRFFSFGDAMFVK
>FECAFAII_00358 Carnitine transport ATP-binding protein OpuCA
MIEFQNVSKIYKGGKVAVEDVNLSFEKGEFICFIGTSGSGKTTTMRMINRMTDPTQGKIL
IDGKSIQEIDPVELRRQIGYVIQSIGLMPHMTIRENITLVQKLLKVSQEERNKTAEKMID
LVELPREMLDRYPHELSGGQQQRIGVVRALAANQDIILMDEPFGALDPITRDSLQDLVKD
LQERLGKTIVFVTHDMDEAIKLASRIAIMSEGRVIQFDTPENILRHPANVFVEELIGEDR
LLQAKPNATRVGEVMLNTAITITPEKSLQEAIKLMREKRVDTLLVTDNSNVLKGFIDVET
LNKKRGKVSSVGDILNKHVFYVKESAYLRDTLQRILKRGLKYVPVVDEQNKVVGILTRAS
LVDIVYDVIWGEDPATTDVAESATPEESKEV
>FECAFAII_00359 Carnitine transport permease protein OpuCB
MQQFFHQHGSEILSKGFEHLYISGLALIIGIIIAVPLGVLLTRFPKAATIVIGLTSALQT
IPSLALLALMIPLFGVGKLPAIIALFIYSLLPILRNTYIGMKNVDWNYRDVAKGMGMTEF
QSIFSVELPIAMPTIMAGIRLAAVYVIAWATLASYIGAGGLGDLIFSGLNNYQPDLILAG
TIPVTILALLADWLLGLLEHRLTPIALREENEE
>FECAFAII_00360 Glycine betaine/carnitine/choline-binding protein OpuCC
MKRILKMTMVLFSLLILASCSFPGLASNTDEDTISITGGITSEAQILASLVAGMVEHYTD
KNTAIINNLATTTINHQAMMNGDASISAARYTGTDLTTTLNLPPEKDPKKAFATVKDEFE
KRYDQTWFPSYGFENTYVFLVRKDTAQKYHLSKVSDLKNVADELVAGVDTSWINRKGDGY
DGFQETYGFSFNSILPMQIGLVYDAVEAGKMDIVLGYSTDGRIASYDLVMLEDDRQFFPP
YDAAPVVNNKILADTPHLKEALNKLGHTISTEKMQELNYEADNNLVEPSVVAQRFLQENH
YFEGK
>FECAFAII_00361 Glycine betaine/carnitine/choline transport system permease protein OpuCD
MKQLDKMNVFQQFFYYFQENGSYIFAQFIRHFLISIYGVLFAAVVGIPVGIMISRRRKLA
NWVIRLANIIQTIPSLAMISILIIGLGLGVNVVIVTVFLYSLLPIIKNTYTGMIQVDKNI
LDVGKGMGMTARQRLFMVELPLSVSVIMAGIRNALVVAIGITAIGAFVGAGGLGDIIIRG
TNATDGTSIILAGALPTALMAIITDWLLGILERRLDPASRTSR
>FECAFAII_00362 hypothetical protein
MKATPKDVRIDAQFKEQADEYLEIMWYEFHDE
>FECAFAII_00363 hypothetical protein
MTRKISKIGASLLVLAVATTIDYRQSEAKTIGNVVYRETAKSMLKKAMDNQPESSYWFPE
DSLAWSFGKDTDTKYNTSVVSLAERVSKATLPNMNVTQTEEVKVVALSAMNSSINGNASR
GIDIFYANVFSYWQYIDQLVYGGALLVKDHRTAKSSCDGCSP
>FECAFAII_00364 hypothetical protein
MSNYTVAIKNSAKVDLRKIKQSNLKKQFEEVIQTLKEDPYMPTQSFEKLRPTHEGRYSRR
LNRQHRVVYKVDEENKVVEIYSAWTHYE
>FECAFAII_00365 hypothetical protein
MANTTMNPSTARKNFYQLLKEVNENHTEIEIISDRSGNNAVLIGLEDWRAIQETLFLEQT
GTLDKVRDREKDDSGFTNIDNIDWEAL
>FECAFAII_00366 hypothetical protein
MDYLKRLLVGKPLKSAENDEHKLTRFAALALLSSDALSSIAYGTEQIVVVLVALSAAAIW
YSLPIAAFVIILLISLTLSYRQIIHAYPHGGGAYVVSSENLGKNAGLISGGSLLIDYMLT
VAVSVSAGAEAITSAVPALYGHQVAISVTIVLLLMMLNLRGLRESASFLLFPVYTFILVI
SLLIVVGLYNIVTGAVPLQATALPGAAVPGVSIALILRAFSSGSSSLTGVEAISNAVPFF
KKPRAKNAAATLTMMALILGFFFVGITFINYWYGIVPEKEVTVLSQIGKAVFGHGILYYV
LQFATALILAVAANTGFSAFPVLAYNLAKDKFMPHMYQDRGDRLGYSNGIITLALGSIVL
LFIFHGSTERLIPLYSIGVFIPFALSQTGMVVKWKKEGKRWLSKSIANITGAFISYAIIA
ILFVYRLGDIWPFFIIMPIVMFIFYKIHDHYKKVAEQLRLENDAKLHDYDGNTVLVLVGN
VTRVNIGALNYARSIGDYVVAMHVSLDEDVEKEKEIEAEFKKHFPDVRFSIVHSSYRSIE
NPIIRYVDIVSKNAAKQNYTTTVLIPQFVPNRRWQNILHNQTSLRLRLRLSWRENIVVST
YSYHLKK
>FECAFAII_00367 Chromosome partition protein Smc
MQSIKNTLRLYLLDWKRIFKNPIATLLIIAIMIIPSLYAWFNIKALWDPYGNTGELPIAV
YSADKPAEFQGKEVAIGEQVIESLHKNKQLGWQFVDSKEQLEDGVRSGKYYAGIYLPKDF
SENLLSFTSGDIKKPKIEYTVNEKINAIAPKITDKGASSIQSQITNEFIKTASSTLLKVF
NEIGYDIDTNLVSINKVKDMILSTDENLDTIDGYTKQVLELQSQLPEIKEKLNKANEFVD
YIPKVDEMGEKVVALNDKMPELKDQAKIILDLQEKIPEIQNAGKQLAEIDGDFASIQETM
NQGIDEAKQGLTIIQQVQDILPDVKNLENQASDLANQTKSGASQLKDAIPSITNSVDVTL
KSIGQVATTTGSLIDTVRTAIEDGKLTDDEKKNISNVLNGFIDGISQQQNAIDKLVEFLT
KLQTSAGNTKLQPIIDQLNQLKPLLSNLQNRLSALNTAVQNEDTKAIDELLDQIEAVVNN
INGIIAGINTGQISSTVTSLLDQVIDTIGTAQGVLSKADQIDFESLLSSTKATVTNAVAI
LEKYQKEMPAIGQEIHDANTMLNGNMDTIVNGINEGADLYNNELPILQQKLGLAADFIQN
DWPTLKNEITGTLTTVNEKMPEVETAVNAAADLINNDWPNIKAGIQKAADAIRKGEQEVD
LGEVIKLLKLDATKESDFFTQPVELQTNALYPIANNGSASTPFYTALCLWVGAVLLSSVA
TTEYYLGKKDRNNFTKREQFVARMLTFLTMAIAQSLIVTLGNIFLLGVDVQNPVYSVSFA
VLIALAFMMIVYVLAALFDNVGKGIAIIILVLSISGGGGNYPIQVSGKFFQMINPFLPFT
HAVNLLRESAGGIYWPNATKAIWIMIGLFVVFGIVGTAIYPFIEEKMTKFKEAAHESHIF
H
>FECAFAII_00368 Zinc-type alcohol dehydrogenase-like protein
MRRFAIKGYGEAQDVFEEIDAHPREVGSGHVRVEIKAFSVNPYDVALRLGEMKEIRTLKF
PYVPGNDGAGIVTEIGSDVTTVHVGDRVAVHAVGGTYGEEVVLPSAKVAKIPDKMSWEEA
AGMVTPGITAYNLINHLTEIQPTDTVMILGASGAVGSSLIQLLHEKGIRILTSASSKNEE
KVKKLGASAFAAYDKTNPGLQFADQADLVIDATKGSIKGETGIQIMKPGGRYVALNDLPD
LDLRQKKEGFYESFVPRKEYLDAEAFAGIIKAYQKGAFHVFISMNLSASLKHVIQAHQLV
EGHPPAGKIILSFEK
>FECAFAII_00369 Alternate 30S ribosomal protein S14
MAKKSKIAKAKKQQETIERYAALRQELKAQKDYEGLRKLPLDARPERLKNRDLIDGRPRG
YMRKFGMSRIKFRELAHKGLIPGVKKASW
>FECAFAII_00370 Endoribonuclease EndoA
MVKRGDIYFADLSPVVGSEQGGTRPVLVIQNNLGNHFSPTIIVAAITAKMAKPKLPTHIG
IKATGTGIERDSVILLEQIRTIDKSRLKEKVCHLDRPIMAEVDRALKISVGIEALTPVTK
>FECAFAII_00371 Alanine racemase
MVVAWHRPTKAVIHKKAITENVANEVARLPQGKELFAVVKANGYGHGAIETAEAAVAGGA
SGFCVSNLDEGVELREAGFTQPILILNMVPYDALTVAVAHDLSVTAGTREWLQAAAAVLE
KSKLETPLSIHLKADTGMGRIGFCTPEEVKEAAAFIKESRVLEWEGLFTHFSTADQADDT
YWNLQKERFIEVLKKLPELPRYVHVSNSATALWHDETIGNMIRYGVAMYGLNPSGHALPE
VYPLQPALELVSELIQIKKLPAGEGIGYGETYITSEAEWIGTIPIGYADGWPRKMQGFSL
LVEGNYCETIGRVCMDQLMIRLPQEFPVGTKVTLIGKNADKEITMQDIADQLGTIHYEVA
CGLGQRIPREYQE
>FECAFAII_00372 Holo-[acyl-carrier-protein] synthase
MIKGIGIDAVELPRITRLIEEKPKFIARILTSDEMKLFQSLPFHRQVEFLGGRYACKEAF
SKAWGTGIGKVTFQDVEILKNENGQPVVTRSPHEGNVWVSITHTNETAFAQIILED
>FECAFAII_00373 ATP-dependent RNA helicase CshA
MKFKELELSPELLKSVERAGFEEATPIQSETIPLALAGKDVIGQAQTGTGKTAAFGLPML
EKIDPDRHELQGLVIAPTRELAIQTQEELYRLGRDKKVRVQAVYGGADIGRQIRGLKDRP
HIVVGTPGRMLDHINRHTLKLGTVQTLVLDEADEMLNMGFLEDIEKIISQVPDQRQTLLF
SATMPPAIKNIGVKFMKNPHHVKIKAKEMTADLIDQYYVRAKEYEKFDIMTRLFDVQTPE
LTIVFGRTKRRVDELARGLEARGYRAEGIHGDLSQQKRMSVLRSFKSGHLDILVATDVAA
RGLDISGVTHVYNYDIPQDPESYVHRIGRTGRAGKGGMSVTFVTPNEMDYLHVIENLTKK
RMTTLRPPTEKEAFKGQLGAAVEQIETKLAENGLDKYLQTADKLLEEYSAQDLVALLLKT
TAKDPADAVPVKITPERPLPMQKKGYNKNGKRGGGNNRNRRDGGNYRGNKSKGGYSKNNN
SQKDGGKRHNDKKRGFVIRSNND
>FECAFAII_00374 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MRTRRLGQTLFSQPFLGEISMNLTIQEIAQAVGSECSALTKITNVEFDSRKITEGSLFVP
LAGTRDGHEFIQQAITNGASASFWSLPVEQAPKDFPVIPVADPLKAMQQLATYYLEKVGA
EVVAITGSNGKTTTKDLTASVLSEKYKTYKTQGNYNNNIGLPYTILHMPQDTEKIVLEMG
MDHANEITELSLMAQPKAAAITMIGEAHIENLGSREGIAKAKMEITDGLVPDGLLVVPAD
EPLLTPLTATLVQTVTTFGIGNGDVHAEVTAKGKAQTDFVVEGETFTIPLPGSYNVTNAL
IAYTIGRFFGLSIPEIRQGLAHVSITQNRTEWLTAGNGAAILSDVYNANPTAMGLVLDTF
KNLPTKGRRIAVLADMLELGKESLNMHAQMSEHIDPEKFAMIFLYGEQMHALKEELNQKY
PQLPVFYFEKEKNKLIDAVKQNLEATDSIMLKGSNSMGLFEVVEQLQQMK
>FECAFAII_00375 D-alanine--D-alanine ligase
MKITLLYGGRSAEHEVSILSAFSVLNAIYYNYYQVQLIFITKEGQWVKGPLLTEKPASKD
VLHLSWDPSGQTEEGFTGKVINPGEIKEEGAIVFPVLHGPNGEDGTIQGFLETLNMPYVG
AGVLTSACAMDKIMTKYILQAAGVPQVPYVPVLKNQWKENPKKVFDQCEGSLLYPMFVKP
ANMGSSVGITKAENREELQNALATAYQYDSRAIVEQGIEAREIEVAVLGNEDVRTTLPGE
VVKDVAFYDYEAKYINNKIEMQIPAEVPEEVYQKAQEYAKLAYTMLGGSGLSRCDFFLTN
KNELFLNELNSMPGFTEFSMYPLLWENMGLKYGDLIEELIQLGMNRYHQRQSFFEKNE
>FECAFAII_00376 putative protein kinase UbiB
MAQTNPRSRLAEIIRVFINYNVVPNFVQQKNPEQVKKAFEELGPTFIKIGQMLSVREDLL
SSAFTQTFKTLQDSVPSDTFSTVKKTIETELSLSLSDIFDDFSKSPFASASMGQAHRAKL
KNGDSVVVKIQHPNIAEEIRLDLQLFERAIPLIKYIPETSVVDLKGVLQEVKRSLINEMD
FLKESQNGEQFYQKNNGWKEIRIPKIYDAFCSKKVIVMEEMSGKNLNHLMNAKNGTETFI
TGIQNKQLKQEVAKLLVENFMKQVFDDGFFHADPHPGNLLFHVLTKEEQTRASQKTETVH
EKEFGSFTFRASTSTEDPVAPYTVNYIDFGMMGHLSAGLRQKLTQAVLALYTKDAYRIEK
AVLRLCQQEGVFDESRFHQELTSFLEQYYDSPIDEINLQEVFTHVVTICHQNNLQFDRDI
TLLLKAFGTLEGVIRVLDPEVSLMEVASPFAQHYFLTHLDVEDTLKQSGLDLLEGMKAAP
KIPQQLHHLLEMWSSGQGKVNLELKKQDKLLSRIESMINRLVFGMILAALIVGSSLLVQA
APVENAEVVSLLGIFTYAIAAFVIIFLAIDALIQMYKKRKK
>FECAFAII_00377 hypothetical protein
MRLFIDGDGSPVKEDVIKLGESYGLDVIIVTSVDHYTTKEYANHVQIVYVDRGADSADYK
IVGMVKKNDFLITQDYGLASLVLPKGLRVFHHSGKEFDEANIGTLLEQRYHSGKLRKAGI
RTKGPKPFTEKDHMSFRQALKKAIDQGLPSTEDSR
>FECAFAII_00378 hypothetical protein
MFEKLKRFGRNFTQTTPFILSNTVIFIPYLLFLGLTDSHNWLTILPFTLFYAFRMTGLFL
VNSLRFGLDSYTLLMIALLIGGAGSLLGILGVFYFPLFYFSSVLLGLSAAWLVPANTTVN
FHEKTQGFINMDGKKYLFAAIWLFLLYQAIELPAPTQIAASFTIYTLFYVMAYHTVSHYP
RYELDFKDIKRNLVATRELVLFLIFFGLLFLLRNARLLFDERLFDLAIYGFLLLFILFVF
VLGHQKKEWKLPSWLNLFTFLNGMLGNFLFLFSSFYVGILYGLEKLSIFMYLPYAAGLIA
AKIVGPWILKRLSWSPLAMQLLGLSSSLLVLLIPNGFAIGVFLLSFWHVVTGSWLNKEYY
QTDAAIPMDRRIVVKYTTQNKGSVIHQFLLMTLLFILAKEMGEPIHLLLITLNRESVPIE
SVQLLILAKWINVGLLLSGLVTVYHLWKKAKKNEAIH
>FECAFAII_00379 putative N-acetyltransferase
MEKIKVTENELDELMAVIQEVWPEAFVPIIGQKQVDYMLKTYQSKKQIQKELTEGVSYFL
LKSEEKTVGYTAYEEINGKIYLSKLYLLNKVRGQGLTSSVFRWYEELAAQTKEREIFLRV
NQGNHQAIEVYKHEGFEITEELISDIGQGFQMVDYKMKKALA
>FECAFAII_00380 TVP38/TMEM64 family inner membrane protein YdjZ
MSKKGSVLQKCLQIMPIIGLLFFFVLILYAYHHGIFRSSTSLQVFIQQFGKYAVMIFVLL
QVIQVIIPILPGGISSVAGMLMFGNGFGLLYSCIGLVIGEAIGFLLVRYYGVAFVQLILS
PKKYQKFDELLTRKTKDIKKVLVVTLLLPFAPDDLICLVAGLTKLSFREFMQIVIFLKPW
SVGVYSMIMLFLFHQAQGHL
>FECAFAII_00381 hypothetical protein
MNLLLSIAQLAKSTYYYWVKKLDKPDKYSKIKQEITAIVKESRNSYGYRRVTLALKMKGY
TINHKTVRKLMSQMGLTCQIRIKRYKSYKGTVGKIAKNVLKRNFSVDTPNKKWVTDVTEF
KIKGRKIYLSPILDLFNGEIISYSISTSPTYKLIEEMLQQAIKKKGTEGSLILHSDQGWQ
YQMPQYQKKLKENNIIQSMSRKGNCLDNSVIENFFGVLKSEFFYREKFRSIEIFQSKLNE
YIRWYNNKRIKLKLNGLSPVEYRKQSIK
>FECAFAII_00382 hypothetical protein
MRKYTFVFKKKVVSDYLNNEGGYKYLAHKYQINRTLVRHWVRIYNYHGWEGLVGGGKSYT
TKFKLDVIEYMETNGLSIQETAKKFNIGSNRTLSKWIEQYEEGGASSLESQKRGRKISMN
SKLNIPKKLKDESLEEEVIRLRAENAYLKKLETLIQEQDLSKKKSRLKQSFSSKKNLN
>FECAFAII_00383 Uridine kinase
MTKSKPIIIGVTGGSGSGKTSVSRAIFNNFPDHSIMMLEQDSYYKDQSHLSFEERLNTNY
DHPFAFDNDLLIQHVGDLLNYKAIEKPVYDYVAHTRSQATIIQEPKEVIILEGILILEDE
RLRDLMDIKVYVDTDDDIRIIRRIKRDMEERGRTLDSVIEQYLTVVKPMYHQFIEPTKRY
ADIIVPEGGENHVAIDLITTKVASFLNHK
>FECAFAII_00384 Putative HAD-hydrolase YfnB
MKYKTLLFDVDDTLLDFQLTEANALSALFAEQGITLTPEIETSYKALNHHLWQEFEKGRL
SREEIIGSRFGLLFQQFGKTVDSDQMEKRYRHYLNQGHDLVPGSLEILKKVHPHAELYIV
TNGVSHTQHRRLTDAGMLDYFKDIFVSEAVGAQKPMKEFFDHVFSHIPNFDKKQTVIIGD
SLTSDIKGGNMAGIDTIWFNRNKLPEIEEIQPTYRIDSLEELYSLLEIEKD
>FECAFAII_00385 Ribosomal small subunit pseudouridine synthase A
MRLDKLIEEKLETTRKEMKRLFALKQVMIDGTVEFRQNRNVDSLLHQIEVAGEHLETNES
YYLLNKPEKAVTAVSDPEKTTVIDLIASADRFQPLYPVGRLDRDTTGLLLITSNGQLGYE
MLLPEKKVSKTYQVVVNERVTPADVTAFENGIVFADGYQCKPADLKILKADKHQSTVLLT
IQEGKFHQVKKMFLAQGKKVTALKRLSMGPLELDEQLGVGEYRSLTLAEMKKLSIYFK
>FECAFAII_00386 General stress protein CTC
MSVSLEVSKREVRPRSLRNKLRHEGKVPAVVYGYKVESTPISFDGLTLSKLLREHGANTV
ITMDIDGQKVNTLVHKIQTNTFTNHFEHAEFLSVNMSEETEVETEVVLVGESVGAKSGGV
LAQNLYTVVVSATPDKLPERIEVDVTNLELGDSITVADLPKNDDYKFVTDSEEQIAAVVA
QSEEEESTGEGGEPEVIGSTEE
>FECAFAII_00387 hypothetical protein
MFESFDSSRNRYASVGVVSSLPDELIDSIWFIIDLDLKGVIPLENILTFDLIENRGKVTM
HFSQAGSNVEMDIDLPFAYSNQFPAQVYAYDDGTRETILLPSEIRQY
>FECAFAII_00388 DNA damage-inducible protein F
MRDLTKGSPAKLILMFTVPLLIGNVFQQFYNMIDMIIVGQTLGKNALAAVGATGSLTFLI
IGFAQGLTAGLAIITAQRYGAKDYRGLKKSFAASVVISLVVTVILTVLSLLFIRPMLQLM
QTPPEILDQAQTFISIILLGIFASVSFNLLSNVIRALGDSRTPLFFLIIAVIINVVLDLI
FIIYFGMGVEGAAIATVIAQVSSSVLCLVYIKKKMPLLQLRKKDFKFEKEEFAVHLNAAL
PMAFQSSIIAVGAIVLQAALNSLGTDVVAAQAAAGRIDQFANQPMMSFGIAMATFTAQNY
GAKEYGRILQGVRQTLLMSVGFSLLAGAIVIFFGHFFVQLFVSPSETRVFELAQTYFNIN
GSLYWILAVLFILRYTLQGLGQSKIPTIAGMMELLMRSFAAIVLTGMWGYPGAAAASPLA
WIGSVAVLLYSYMRSMKQLKHMGEEEHFTLEHAEAR
>FECAFAII_00389 Magnesium and cobalt efflux protein CorC
MVINFIILFLMIAITSFFVASEFALVKIRRSRLEQLEKENVKNAKLALHVTHHLDNYLSA
SQLGITLTGLIIGWVGEGSVAALLEPVIGKLPFSSAISSTISVALGFILVTYIDVVIGEL
LPKSYSIVNTEKVVLFVVKPLHYFYKVMFPFIWVLNHSAAGLGKLLGVRLVSEGEETLSQ
EELTLVALNSYEKGELTKEEYHYLENVFEFDDTLAKDIQVDRTSMQVFEASETVKEAIKA
SIEQGHTRYPVILESKDNVLGYVTLPDLIKQSYKDDQLTVEQLIEEPIVTTETIPIKKLL
TIMRKKGKHIAILKDEYGGTSGLVTIEDILEEIVGEIRDETDLDEALIAEQSDGSYIISG
KLTLDDFQRYFHVEIPEFEETNFTTLAGFASSRYKEIKAGTIIEIASFRFTVLEYQHAHI
DYFKVESTERKTE
>FECAFAII_00390 Low affinity potassium transport system protein kup
MATTHNTKKISMAGLLVAMGVVYGDIGTSPLYVMKSIVEDNGGLSGINPDFVIGSVSLIF
WTLTLLTTIKYVVIALNADNHGEGGIFSLYTLVRKGGKYLIIPAMIGGAALLADGVLTPA
VTVTTAIEGLRGIPQFFDRFGNNQNVIVIITLVIIFVLFMVQRFGTDIVGKAFGPIMFAW
FTFLGVMGLMNFSQDWTVIRALNPYYAIQLLFSADNKLGLFILGNIFLATTGAEALYSDL
GHVGKRNIRLSWPYVKICLVINYFGQAAWLLNVYQNPEAQQIKNLNPFFQMMPQSWIVIG
VAFATVAAVIASQALITGSFTLVSEAIKLKLLPRLKIMYPGNSIGQMYIPAVNLILWIAC
SLVVVTFRTSHHMEAAYGLSITVTMLMTTALLYFYLIQNGHSRWLAYLVTFFFGAIEVVF
FISSVVKFFRGGFVAVLIGLIILVVMFIWEQGNIIRESSTEDVSLRDYIPQLRELRDDTS
LPIYQTNVVFLVPDMAEDKVGRQFIYSILDKRPKRARVYWFVHVEVTDEPYTKEYQVDMM
DTDFIVQVNLFLGFRVQQEINVYVRQVIHDLMKQGRLPKQPQRYSLTPGREVGDFQFVLI
DEVVSNVTTLGKWQRQIMQAKLAIKKIATSPETWFGLEYSEVKHETVPLIIGNTRKTWLK
ERL
>FECAFAII_00391 hypothetical protein
MLNFLWSLFIGGILGLIAGAILGKEVPGGVSGNIIIGFLGSWLGEFLLGPLGPELGGFYL
IPALLGAIFCLALYSFVARRIRERPKKE
>FECAFAII_00392 Polyribonucleotide nucleotidyltransferase
MSEKQVFKTTWGGRPLQIEVGQLAKQANGAVLVRYGDTVVLSAAVASKEAKDTDFFPLTI
NYEEKMYAAGKIPGGFIKREGRPSTEATLTARLIDRPIRPMFAEGFRNEVQVTNIVMSVE
TDCSPAMAAMLGSSLALSISDIPFDGPIAGVEVGRVNGEYVLNPTVEQAEQTDIELTVAG
TKQAINMVESGAKEVSEEDMLGALLFGFDAIKELVAFQEEIVQAVGKEKMEVTLLQVDEV
LKKEIFDASYATMKAAVMTEEKLAREDNIEQVKIDIREAYAEKFAGHEDEDHLLKEVKQI
TEDLEKDVVRELITIDKIRPDGRKLDEIRPLSSEVSLLPRVHGSGLFTRGQTQALSACTL
APLGEHQIIDGLGVEVSKRFIHHYNFPQFSVGSTGRAGSPGRREIGHGALGERALAQVIP
SEEEFPYTIRLVAEVLESNGSSSQASICAGTLALMDAGVPIKAPVAGIAMGLVSDGENYT
ILTDIQGLEDHLGDMDFKVAGTKDGITALQMDIKIQGITEQILTEALTQAKQARMEILEE
LTSTIAAPREELSQYAPKIEMIQIEPAKIKDVIGKGGDTINGIIDETGVKIDIDQDGKVS
IASADAEMIKKAIKIIEDLTKEVKVGEVYLGKVVRIEKFGAFVNLFKGKDGLVHISQLAN
DRVNKVEDVVKLGDEILVKVTEIDKQGRVNLSRKAMLNEDGSTKNEEK
>FECAFAII_00393 30S ribosomal protein S15
MAISKERKNEIINEYARHEGDTGSPEVQIAVLTEEINHLNEHARVHKKDHHSYRGLMKKV
GHRRNLLAYLRKTDVQRYRELIKRLGLRR
>FECAFAII_00394 Peptide deformylase
MITMDDIIREGNPTLREVAKEVSLPLSEEDISLGKEMLEFLKNSQDPIKAEELHLRGGVG
LAAPQLDISKRIIAVHVPSPDPEADGPSLSTVMYNPKILSHSVQDACLGEGEGCLSVDRE
VPGYVVRHAKITVSYYDMNGEKHKIRLKNYESIVVQHEIDHINGVMFYDHINDQNPFALK
EGVLVIE
>FECAFAII_00395 Transcription repressor NadR
MIEGETRRKQIMQTLANTEKPVSASKFAKTFGVSRQIIVGDIALLRAAGKSIVATARGYI
LETEETNTGHISKIAVQHGKDQTEEELRLIVENGGEIIDVIVEHPLYGELAGTLHIKTPQ
DIDSFMRRYQKSNATLLSELTGGIHLHTIRYPEKHMLKNIKQKLAEAGILYEG
>FECAFAII_00396 Maltose O-acetyltransferase
MTEFKTEKEKMIAGELYFANDPELVADRMFARSQSQIINQAESAELRSQLLKETFGRTGK
KIYMEPVINFDYGYNIFVGENFYANFNCTFLDVSTIEIGDNCMFAPNVQLYTATHPLHPV
KRNSGLEYAKPIKIGNNVWLGGGVIVTPGVTLGDNVVVGAGSVVTKSFPDNVVIAGNPAR
IIKTVEEELTEESLETLRHKIDMIDRELVALLEKRMDTVTKIGQVKKEENQAVYDAKREQ
QVLDKVVSLLKNKGYKETITDTYVDLMKHSREYQNKMKEE
>FECAFAII_00397 NAD-dependent protein deacetylase
MKQLTVDEAAKEILAYQQITFLTGAGVSTPSGVPDYRSLSGIYHGMEQPEYLLSHQAMVN
EPDKFYQFVKKIYHPEAKPNIIHLEIAHLAKEKNVWVVSQNIDGLHAKAKSPQLVNFHGS
LYQCHCRKCQQTVDWKEYLHSDKHQACGGQIRPDIVLYGEGFQDGVMEQAAYAVSQAELI
VIVGTSFQVHPFCDLVQFRQPSAKILVINQTPVYLAEPYTFIQEDGAVVFKKIQELGADY
D
>FECAFAII_00398 hypothetical protein
MLPFFIYWGVILACIAWLALSVYFSVFYLVRKENGNLWAFALFNVIAAIVLAITLAVYRT
WGWGITQYSSLIYLILAIYGVVVLLQAILGREPKKAAA
>FECAFAII_00399 hypothetical protein
MCTFLLGVYVGTQVKSLRTVLAVMLSCAMFCERFITLWNFSGLFISINRSLFIFSDKALP
HFI
>FECAFAII_00400 Glutamine transport system permease protein GlnP
MKKNMVSVAVLFAFVFSLFSVGSLANADEKTPSDEFRVGMEAGYAPFNWSQQTDENNALP
IQGQNSYAGGYDVQIAKKVADGLGKKLVIVQTKWDGLAPALQSGKIDAIIAGMSPTAERR
KEIDFTDPYYESQLVVVVQKDSKYAKAKSLADLSGAKITAQLNTFHYTVIDQIPDVQKQQ
AMDNFSAMRTALASGMIDGYVSERPEGVTATSVNKDLEMLEFSGADGFQTNPEDVQISVG
MRKGDPDIQKVNQILSGISNDERTKIMDQAVKDQPAATDSEEKPGIISDFTTIWKQYGNM
FLRGAGLTLFIALIGTVVGTTLGLLIGVFRSVPESGNALTRFFQKIGNALLSIYVEVFRG
TPMMVQAMVIFYGLALAFGISLNRTIAALFIVSLNTGAYMTEIVRGGIFAVDEGQFEAAQ
AIGMTHGQTMRKVVIPQVLRNILPATGNEFVINIKDTAVLSVIGVADLFFQGNSASGANF
QFFQTFTIVGIIYLVMTFTITRILRAVEKKIDGPSAYTKLEEIDNSNLQE
>FECAFAII_00401 Arginine transport ATP-binding protein ArtM
MNEKIIEINHLRKSFGENEVLKDISVTVNKGEVVTIIGSSGSGKSTFLRCINLLEKPTGG
EIIYNGENVLAPKYNLPKYRTNLGMVFQSFNLFNNMNVLENCMSGQTTVLKRDKETAKKV
AIENLEKVGMDRYIEAKPAQLSGGQKQRVAIARALSMNPDVLLFDEPTSALDPEMVGEVL
NTIKDLAHTGLTMLIVTHEMEFAKDVSDRVIFMDKGVIAEEGTPEDIFVHPKEERTKEFL
SRILNA
>FECAFAII_00402 D-serine/D-alanine/glycine transporter
MNEDQELQRGLKNRHVQLISIGGAIGTGLFLGSGKSIQLAGPSILLAYLITGCICFFIMR
ALGELLLSNTNNHSFLDFVAEYLGKKAAFITGWTYWFCWVSIAMADLTAIGMYVRYWAPG
VPQWLPELIALGLLLCLNMVAVSLFGELEFWFALIKVVAIIAFILVGAYMILTHYTTDIG
TASITNLWSHGGFFPTGAKGFILAFQMVTFAFAGIELVGLVAGETENPEKVLPEAINNIP
IRIILFYLGSLFVIMAIYPWNSLNPDNSPFVEVFSEIGITIAASLINLVVLSAAASACNS
AIYSTGRMLRSLAQEGSAPKKFKKLTTHHVPGNALTFSTIVIFISVILNYVMPSEVFTLV
SSIATTCFLFIWSMLVYTHMKYRKSILGKKAHSFKMPLYPFSNYLVFLYMAFVCVVLFLG
KDTRIALLLTPVWFLLLLLIYHMKYERKK
>FECAFAII_00403 hypothetical protein
MTKSRLEAFTDGVVAIVLTVLVLEIKIPNTSSFHSLWVIRNTLLAYTISFIFVAVIWVNH
HRIFQMAERINYRVVWSNIFWLFWLTLCPSVTSWVGRNPEAFWPEMAYVLVYTMWSFSFG
ILMRQIMKANKPDSHVVRVLSKDRRSLISMMINLCLIAGVFFVPLIGLFGRFFVSGIWIF
SYKKADAYYQRLFPGK
>FECAFAII_00404 Branched-chain amino acid transport system 2 carrier protein
MTKKLSFKDYLFIGSMLFGLFFGAGNLIFPVHLGQEAGAATFWANLGFLVTGIGLPFLGV
IAIGVSKSSGVYELAKRINQTYAMVFTILLYLVIGPFFALPRLATTSFEIGLAPFIDPSR
QTLYLAIFSIVFFVLAWWFSRKPTKILDYVGKFLNPAFLVLLGALLLLAFLNPLGSVNQA
PIQPNYQEHAFFTGFTQGYNTLDALAALAFGIIIVTTIQNMGVTKPAEIAKDTIKSGAIS
IILMGIIYTLLAYLGAMSLGSFALSENGGITLAQIADHYLGTYGSILLAFIVILACLKTG
IGLITAFAETFTDLFPQRNYAFFVALASILPCLAANVGLTNIIQFSLPVLMFIYPLAMTL
ILLVLVGPLFKQRTAVYRMTTYFTLIASIFDGLNACPETIKQTPIVQNLLHVAESYLPFF
KLGMGWIVPAVIGFVIGLIWSFAKKEEVAD
>FECAFAII_00405 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIVAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYIAKRSTEGWTPDVIIGRAERTFSCSVSTLYRRFKTGEFNVL
HLPMQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEDDTIVGIHHKSAVITL
VERLSKAIIVLKPEGRKAVDIENSINEWLQSVPKNLFKSITFDCGKEFSNWKSISNTNDI
DIYFADPGTPSQRGLNEHSNGLLRKDGLPKEMDFNQVNQGFISSVASKRNHIPRKSLNYQ
TPLEVFLSYVNGKFCLA
>FECAFAII_00406 hypothetical protein
MNEETVSPMKKLTKLVTHTSYQLFDSFVNDTEEHAKNVRLQGKFILELKKAATEHSLVIL
QVRANRLSSKYETISGWVATKTVEKDRVMIRLQNEEQQIRMVPVEQIEKITILSPAGEQE
RLSK
>FECAFAII_00407 Low molecular weight protein-tyrosine-phosphatase YfkJ
MTKILFVCLGNICRSPMAEGLLRKRIALEGREAEFFVDSAATSTYEVGKTPHPGTKKILN
QEKVDMTNMVARQITPHDFETFDWIIGMDQENVEELKRRAPRSAQGKIHLFLSSIPGKEK
ENVPDPYYTNNFDETYHLITEGLNHWWNIWIDENKITNNL
>FECAFAII_00408 HTH-type dhaKLM operon transcriptional activator DhaS
MSDTTRTKQLIKNVLIDLCQTQSFRKISVQKIANEAKINRQTFYYHFTDKYDLLRWVYCE
DALHYLDPQCLSLDNWEEQALKMLKAIAEKKEFYANTVLSDPEILQKEFSQLIQKSFIKI
FEQMDEERQLSARDKLFYARFFSYGCSGVLVNWITNEYEETPMEIAMQLFRLAKDTELYS
YRLYAKEELEEQ
>FECAFAII_00409 Holliday junction ATP-dependent DNA helicase RuvB
MTDEYLLSPESGENELSLEKSLRPQLLSQYIGQRKVKQELQIYIEAARNREEPLDHVLLY
GPPGLGKTTMAMVIANEMTVNIRTTSGPAIERPGDLVAILNELEAGDVLFIDEIHRLPRV
VEEMLYSAMEDFYVDIMVGQGPTAHPVHFPLPPFTLIGATTRAGMLSAPLRDRFGIISHM
EYYDEQDLQEIVLRSSDIFQTEIIEEGALEIARRSRGTPRIANRLLKRVRDFAQVQGDGK
IDRPIADQALTLLQVDQAGLDYVDQKLLRTMIELYGGGPVGLSTLSVNIGEERETVEDMY
EPYLIQKGFLKRTPRGRIATAYAYEHFGYDYHI
>FECAFAII_00410 Holliday junction ATP-dependent DNA helicase RuvA
MYEYLTGVVTFINPYYIVVETNSIGYQIALGNPYRYSSKLNQKIKIYVHQVIREDAHLLY
GFDSLEEKQLFLRLVSVSGIGPKSALAIMASEDHSGLIQAVESSDVTYLTKFPGVGKKTA
QQMILDLKGKFGELSIDTPFSLFDEANTKDATALSEAMEALSALGYSDREIKRVEKQLKE
VDNQTTDEYLRQALKLMMKK
>FECAFAII_00411 Peptide methionine sulfoxide reductase MsrB
MDKPIRPEKEELKEKLSPMAYAVTQENATERPFSGKYDDFYEKGIYVDIVSGEPLFSSAE
KYDAGCGWPSFSKPITKRQVREKADFSHGMHRIEVRSKEADSHLGHVFTDGPVGQGGLRY
CINSASLKFIPYEKMDELGYGEFKSLVE
>FECAFAII_00412 HTH-type transcriptional regulator TreR
MNKFNEIFLDLEQKILAKEYPPHSLLPSENQLIKIYGVSRETIRKALNLLTTEGYIQKKQ
GKGSIVLDRNRFDFPISGLTSYKELQETQRIPSETIIHTLEETEVTKALNEITGWEIGAP
VWHLIRERKINGEVVILDTDYLLKEIVPILTPAQAQGSIYEYFENELSLTIAYAQKEITV
EEVTEIMKTAMDLHDDTYAVVVRSLVHLEDTRCFEYSESVHRLDKFRFVEFARRRKV
>FECAFAII_00413 PTS system trehalose-specific EIIBC component
MAKYQADAEKLLHDIGGKENIAAVSHCATRMRFVLNDPGKADEKAIEDIPSVKGMFTNAG
QFQVIIGNDVSTFYNDFVAVSGVEGVSKEQGKAAAKQNLHPVQRAIAVLAEIFTPLIPAI
IVGGLILGFRNVLEGIQFESLGGTIVEHSKFWNGVNAFLWLPGEAIFHFLPVGITWSIAK
KMGTTQILGIVLGITLVSPQLLNAYSVASTAAADIPFWDFGFAQVQMIGYQAQVIPAMLA
GFMLAYLEIFFRKYIPQSISMIFVPLFSLLPTVLAAHVILGPIGWTVGSWISNIVNTGLT
SSISWLFSAVFGFLYAPLVITGLHHMTNAIDMQLIADFGSTNLWPMIALSNIAQGSAVLA
IIFLHRGNKKEEQISIPAMISCYLGVTEPAMFGINLKYVYPFVAAMVGSGLAGMFANLMG
VRANAIGVGGLPGILAIQAETWVPFIIAMIIAVIIPFGLTIIFRRQGILNKIDPAVPENA
ADVQLQTANGATATPQSFEPVSATGTAVATKEPLFAVAAGTIKEITEVNDPVFSQKMMGD
GYAVEPSNGKVYAPVNGKVTSVFETKHAIGILSNEGLEVLVHMGLDTVELKGVPFNVFVK
EGDLVTPETLIAEMDLPEIEQAGKKTDIIVALTNNEKVAGLSLDQSGLVRPGEAVGKAEV
KS
>FECAFAII_00414 Septum formation protein Maf
MKIVLASQSPRRKELLAHIVSEFEIEPADIDETPFPDEQPVDYVRRMAEEKARTVWEQDE
KEDHLVIASDTTVVLNQEIMGKPEDLAEAEFMLKKLSGETHTVYTAVVLKTKEREERILA
EAHVTFYPLTDEEIKRYLETGDYADKAGAYGIQNAASVFVKEISGDYYSIVGFPIGAVNQ
ALKTFI
>FECAFAII_00415 DNA mismatch repair protein MutL
MAKIQELSERLANQIAAGEVVERPASVVKELVENAIDAGSTQIDILVEEAGLRTIQVIDN
GEGILADDVENAFKRHATSKIHNRDDLFRIRTLGFRGEALPSIASVSEMTLETANQEEKQ
GTYLSLKGGEVIEHRPAPLRQGTKITVSNLFFNTPARLKYVKTLHTELANIGDIVNRLAL
SHPSIAFRLVHDGNKMLATAGNGDLKQTIAGIYGLSTAKKMLKIEGKDLDFELFGYVSLP
EVTRASRNYLSTIINGRFIKNFSLNKAIVAGYGSKLMVGRFPIAVLEIKMDPLLVDVNVH
PTKQEVRLSKEKELTELISNAIQKALSQENLIPSAADNLRFKKKVPDQPKTEQIEIDLSY
AFEEEKPKKPSSLNFDRETGTFFVEEPKNTFVDRIVDKSVENVENFSGFSEENTSYPEKT
AKTVDKLGENVDNFVEKTVEKSEKKEFPIVDNMEKTNEEQADKSVEEDEKIYEEELTLHP
EFDFTQGNDKTLEQAIKKLETEKPVQRFPQLEYFGQMHGTYLFAQSSDGLYIIDQHAAQE
RIKYEYFREKIGEVSDDLQELLVPIVLDYPNSDALKLKEQKHLLEDAGIYLEEFGQNSFI
VRAHPTWYPNGEEESIIREMIDMLLTTGSVSVKKFREATAIMMSCKRSIKANHYLNEAQA
RVLLKDLARCENPFNCPHGRPVLIHFTNSDMERMFKRIQDPH
>FECAFAII_00416 DNA mismatch repair protein MutS
MPQKTKNTPMMEQYLSIKAQYQDAFLFYRLGDFYELFYEDAIKASQLLELTLTSRNRNAE
EPIPMCGVPHHAAQGYIDALIEKGYKVAICEQVEDPKTTKGMVKREVIQLVTPGTVMDSK
GLSAKDNNFLTAVVSQGNEFGFAYADLSTGELKTARLHDEEAVLNEASALQTKELVLGSE
ITDTLREQLSGRLGLVFSQQNEMEENAEFSFLTSELVDPLEKEATGKLLTYLSVTQKRSL
AHIQKAVEYQPDHFLKMDYYSKFNLELSQSIRTGKKHGTLLWLLDETKTAMGGRLLKQWL
DRPLIQAKQIKARQEMVASLLDSYFERIDLQSALTKVYDLERLAGRVAFGNINGRDLIQL
KTSLEQVPMIRGLIEGIDQGQWQSLLSEMQPMDHLVQLIDQAIQDDPPLQITEGNIIKDG
FNEQLDMYRSAMRNGKKWLAELEAKERQETGIKNLKIGFNRVFGYYIEITKANLGNAELE
KYERKQTLANAERFITPELKELETQILEAEEKSVDLEYQLFLAVREEVKKAIQPLQVLAK
AISAVDVLQSFATISERYQYVRPELVSDKHQLLIKDGRHPVVEKVLGHQEYIPNSVEMAE
DEMILLITGPNMSGKSTYMRQLALTVLLAQMGCFVPAKQAVLPIFDRIFTRIGASDDLIA
GQSTFMVEMMEANQALRYATPNSLILFDELGRGTATYDGMALAQAIIEYIHRHVQAKTLF
STHYHELTVLEKELPQLKNVHVGAVEKDGEVVFLHKMMDGPADKSYGIHVAKIAGLPSNL
LERAADILHTLENGDNGHHTVPAEVEEKTKTAKQEQIKPPAEKVNQDHIQDRVKEENQQL
SLFSELSENETEVIESLKQINLLEMTPMDALNTLYELQKQL
>FECAFAII_00417 hypothetical protein
MQQEPEIQKEVRKLTKLLRENETIIRYKELEEKIQQNQYLAELREKIKQAQKDAVHFAYY
DKPAAEQEAIKQADQFMQEFDQHPLVVAYRKQLLEADDLLHHLTTMIQEEINGQIEEEKH
ASKN
>FECAFAII_00418 hypothetical protein
MRVLFIGDVVGSMGREMITEYLPRLKKKYRPQVTIVNGENAASGRGITEKIYKKFLQDGV
DVVTMGNHTWDNRGIFEFVNEAKKMVRPANFPEGTPGQGMVFVKVNQVELAVINMQARSF
MVDLDDPFRKMNELVEEARKRTPIIFVDFHGETTSEKQAMGWFLDGKVSAVVGTHTHVQT
NDARILPRGTAYLTDVGMTGPYDGILGMRREPVIEKFLTALPKRFEVVEQGRSILSGCIL
ELDDTTGHAKEIQLIQINDDRPFME
>FECAFAII_00419 Putative bifunctional phosphatase/peptidyl-prolyl cis-trans isomerase
MRRKLFAFDIDGTLLDSNKQPLDSTREALEKLRKAGHLVTIATGRSRFHAQEIIRDLDFT
NYILCNGAAGFLDHEQVYKNLLDRDQLDAFVQEAHHEQIDTAFVSLDNIKRSSSNDVTVM
EEAMHSFGAVLPELDQFFAEEQEIYQALAFFDQTYDGKFSSYDKIRFVRWHENSVDVVPK
NGSKAATILHLAEQVGIPHEDIISFGDGQNDREMLRMSGIGIAMGNAVPEVQAEAKMVTD
TNDQDGIWKALKELSVI
>FECAFAII_00420 hypothetical protein
MEVLVFPKNEEKALQMEKYMKNLFSFAGVPKPERALLQQPLLDESKNLSISEVLAFVHYY
YEQIEREYQYVAIDLVQKNIKRLTFEDLVVLLPLVQKKEWWDSIDSWRKVYSTWCKAYPE
QREEVFQLFEKKEDFWLRRIAITLQLGYKQQTDTGLLIRAIDEDRQTKEFFIQKAIGWAL
RDYSKTDADWVKRQLTTDLSKLAVREASKYL
>FECAFAII_00421 Nitrite transporter NirC
MEKSEGSLRRKSMNPVSPLFEKIDASIEKKANLFENSFSRYAVRAVLACLFLTLGTAVAF
AIAMKGEDIAHGLGKILYAFMFSWGLVMILYMNAELGTSNMLYMTVGVFRQRLALSKAAK
ILFACIFFNMIGGILCGFLISMTTPFQDLTLDNFMLESIAVKLAKPAATILVEGMFANIV
VNTAVLISMRMKEDAGKVITVVFIIFIFAFLGYEHVIANFPAFTLAYFASQGQMDGMTVS
NVLHNLFFALAGNYIGGGLVMGLGYAWLNQSKSSYVD
>FECAFAII_00422 30S ribosomal protein S4
MSRYTGPSWKISRRLGISLSGTGKELARRPYAPGQHGPNSRGKQSEYGMQLTEKQKLRHM
YGMNERQFRNLFVKASKIKEGKHGVNFMILLEQRLDNVVYRLGLATTRRQARQLVNHGHI
LVDGKRVDIPSYHVEVGQVISVREKSQNIVTVKEAVEATVGRPAFVSFDAEKLEGSLTRL
PERDELYPEIDEALVVEYYNQSL
>FECAFAII_00423 Biotin transporter BioY2
MNRTLKELILAAEFAAIISVLSQMTIPFGLVPLTGQTFAIGLTATFLGRKLGLISVGVYL
LLGLIGLPVFSGMTGGIAVLFGPTGGYLIGFLLQTWITGWMIERTDAHYLYAIFANLMGS
LAALICGTIWLKISGDLTFTTAFASGLLPFLLPEAIKATGAAYIGILMKKRLNRFLHTN
>FECAFAII_00424 Queuosine precursor transporter QueT
MEKNNTRSAKRWTTTDVTRMALVTGLYVAVTLVLSVFSFGVIQIRLSEMFNYLSLYNKRY
IVAVTAGVALANIASPLGLIDVVVGSVSTLLVLLINYKITSRIKNMKIKMAVTACVFAFS
MFTVAGQLTILYQLPFFLNWWVIALGELASMIVGGIIIYWIGKKVDLSK
>FECAFAII_00425 Dihydroanticapsin 7-dehydrogenase
MKNQYPDLAKQVVFITGAASGIGAAQARAFLEQDAFVFGLDQKFGKMEELSLRFPETFAY
ALGDVRQMKELQQAISKCQDRFGEVTILLNTAGILDAYKPLMETDESLWDLIYETNVKSM
YQLTKIILPDMIRRKSGTIINMASIAGLVAGGGGIAYTSAKHAIVGFTKQLALDYAGQGI
RVKGIAPGAIQTPMNAADFEGKGEMAEWVANETPVKRWAQPEEVAELTLFLASPQASYIQ
GTIIPIDGGWLLK
>FECAFAII_00426 hypothetical protein
MTFEEILPELKKGAKIIRKGWSGFELYVVLVSDDEFDGCPVTPYLLIKTSDEGFSSFAPT
VCDILADDWAIVE
>FECAFAII_00427 hypothetical protein
MRKPLFYATITKTFEHKKGGKDVYLSSEYLKQFDKDLYYKILLLESFEDQAWHTAAQLAQ
VVQLDARSVSKYLNELSKNYQQFSGKTHPLFTKNHRSGYNFYDTLDSIEHERFLIYLVQS
TLKFQLLHDIFFEEFHTMYQFAQKHYISESTAHRKINEWKQQLQTYGIRLQRGTYIAQGE
EEIIRLYLHMTFWQLFRGKIWPFETISQMDVKNMAEHIMAFFNVRLNEIKKRRLEYMLGA
FFLRKSQKHYVVLNEKKRRLISDNLLFQRFCQVMEPVFPNYFQVEDELGALFLVLMTREE
YYSDPKIRKKIFDFHQQAKTPPFTALSEAKAALSLYQEEQGLPAENLTFEAENYLFSSHF
FAYLFPNAKETIDGNSSDFINHLVIENKELKQWLVHFFESRHKHPNHLAFKNHAFLMGRY
LTVFKTLGAFTPQLPKITILLMTDFPLFEEQLLEEGLRTFFRNEYQLIFLPTDYRGREVD
LLISTSKVHRKPWADLDYFIVTEELKLIDYIQLSQKFEMIKKKLLKQ
>FECAFAII_00428 Inner membrane protein YohK
MTEFFVNPLFGLSLTLGVYVLSDKFLRKYKLPVLNPLVLSIVVIILFLHFSGISYKDYNI
GGNFLTMLITPATVALAIPLYKNFRLLKENFYPVMAAILAGIVANCLVSVGFGYFFSLHK
EMVISLLPKSVTTAISVDLSHTMGGVNAVTLAIVVSTGIFGSLIATHIFRLFKIESPVAR
GVALGSTSHAIGTAKAIEIGEIEGIISGLAICVNGILTVLLLPLFFQPFAGLF
>FECAFAII_00429 Antiholin-like protein LrgA
MKFFQEFFIIIFFSVLGEGIRIFAHLSIPGSILGILFLFLAFEMHLVDPEKIGATGDFLL
NNLAILFVPAGVGLLEYFDDIASIWPVLLGAVVVCSIVTMVAAGKTAEGVEALLGYVRKK
KAGRVSVNEMEENQID
>FECAFAII_00430 Glycerol facilitator-aquaporin gla
MDYSLMTRLAAEMIGTALLIVLGNGAVANVDLKGTKGYGSDWMLIAVGYGFGVMMPAMIF
GGISGNHINPAFTIALASNGLFPWAEVVPYIIAQLIGAAIGQLIVVACYKPYYDQTEDVN
HVLGTFSTINSVGSKFNGFVNEFFGSFVLFFGALGITKAPFFQDNLGTAHLALGFLVWTL
VASLGGPTGPGLNPARDFAPRLVHALLPLKHKGSSQWGYAWVPVVAPICAGVVAVFLYKL
LFMA
>FECAFAII_00431 hypothetical protein
MTHKHLTIDELTMIESYYLQHNKPVEIANRMGRAIQTIYNVVNKFKQGKTALDYWHQYKE
NKKKCGRKVIQLPAHEVDYIKEKVTLGWTPDVIIGRKERPVSCGMRTLYRLFSKGIFDID
TLPMKGKRKPNGHQEKRGKQQYQRSIHDRPDNYPDFNSEFGHLEGDTIVGIHHKSAVITL
VERLSKVIITIKPNGRKALDIETALNQWFSRFPKNFFKSITFDCGKEFSNWKAISNQHDI
DIYFADPGTPSQRPLNENSNGILRRNGLPKSMDFRKVNQTFISSVSNQRNHIPRKSLNYR
TPIEIFLSYVQEAFYSSLI
>FECAFAII_00432 Pesticidal crystal protein Cry22Aa
MKKRRIVLILSSLLVTNIFPIIGYSLELNQLEHGNRRDEESKLTSTFDSLIESNQTQESS
EDLSISSSGETTDNVEAEGSDKQGLEDAPISAVELPDDPNIISIDKIFQTPIGTSTSILE
NGKLLQLNPAERSQRGAIWSNKKISLLSDFTFKSYLYLGNQRDRAGDGMTFTLTGDPRMA
SNPSQVIGSPGMGIGSYSTRSGQPYIANALSIEFDTYKNSGSSDRMDREITADNRGHGHV
AFVTPKPNNNNYSGEHTGVTVAPTFLSNGTWRLLIIRWDAEQRSLTYDLEGVGRSSRIIP
DLIRQFGSTEVNWEFTSSTGTFFQENAVAVTRLPSNVTSTADVKVNDSDYGAIAEAGGND
KITIRNTLKVEGDFLEYKKMQTSVDLPQELTIPEHILINGNQIDTKDILITGNRVTLNLT
DYFIAGDTLIIELETTLQEVIPEKVLTMHFEYLENENLIEQSNEINLKIAKLKEIDIHVY
YKDKDSQIDIAEMKTITGKIGEKYKETPIDIEGYVFDSDSANTEGIFSENTEDIYFYYRK
GKLYLSTAPQYVNFGKREL
>FECAFAII_00433 hypothetical protein
MKKEIVLTATTMLFSMVASTTFVSATEVYPKEYNTEGTITFEAGDEGVTPPVDPENPDPN
KPVDPSDPPSPGTGGALSIDYGSKFKFGTQKISTADKTYYAAADVMNDGSRKPTYVQVTD
RRGTLSGWKLSVSQPEQFKTASGDELVGAQLKFTKGQAVSLVDPTYTPQTVNSELTLTPG
GNNTLAINAKSGTGVGTWVYRFGANENENQDAVQLSVPGKSVKLAQQYSTKLVWTLEDTP
NN
>FECAFAII_00434 hypothetical protein
MRSSKYTEHYTDTFITFKEIMRTVSNIYHNCVPDKIKNRRNTDKLKQRDTVIIACVIWGI
INGYTSQRATYRAVCSVLFPNGDFPSRSRFTRLSSNLAYTIKIIRYFFIKKLTKGELDSF
PSPLCKPVRNRQAKLLNHIAKVGYNSTKKSYFYGLKIHMIVTKTGFPITYSITNPGVHDV
KVLETLSEEANLPNILGDKGYISHKIHEKLALKGITISVPPRKNMDKSEKLDHSLLGKQR
KTVETVFSSLEKLGCQNFNSRSVKGLESRFESILLAYSVLLSRAQRRFEGTLRYSLGY
>FECAFAII_00435 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MGKLAIISDLHVDINKFGESELMQLWQVLQKHKITRLHLAGDTANKVDRCLAVVEFFVNK
GLSTTFHFGNHELADVPNEQMMDHFPDPHFLNERYIALNEQTVLLGMNGWYDYQFSELKD
YEAIVRMKRLYWYDRFIQRGKTDLEVNAEMLAAAKNLLDQLEAKKLEVILSTHFVPKRAF
IMYQSAPYERWNKLNAFLGSESFGELLDRYSNIKQVVFGHTHRRFEDKSIGHTIYSCRPF
GYYYEWQLTRDFVLKEQLLDSYEPMKLRVLLRAHHPAFQAYQTQHLQEEFEQAMTIVPY
>FECAFAII_00436 hypothetical protein
MKLEVTKEAQEVLKNKLEADDQLLLDIENGDGPFAESQVSCQLDTAFRLIIVKKDTQTDL
SLYSVVADTPVGPIKIKDSAILYMDDPSTLALEPTYNSLQLKGPSGLRKGNLQVVRKD
>FECAFAII_00437 hypothetical protein
MTQVHFTLKSEEIQSIIEYSVKDDVSKNILTTVFNQLMENQRTEYIQAKEYERTENRQSQ
RNGYYERSFTTRVGTLELKVPRTRDGHFSPTVFERYQRNEKALMASMLEMYVSGVSTRKV
SKIVEELCGKSVSKSFVSSLTEQLEPMVNEWQNRLLSEKNYPYLMTDVLYIKVREENRVL
SKSCHIAIGITKDGDREIIGFMIQSGESEETWTTFFEYLKERGLQGTELVISDAHKGLVS
AIRKSFTNVSWQRCQVHFLRNIFTTIPKKNSRSFREAVKGIFKFTDINLAREAKNRLIHD
YIDQPKYSKACASLDDGFEDAFQYTVQGNSHNRLKSTNLIERLNQEVRRREKIIRIFPNQ
TSANRLIGAVLMDLHDEWIYSSRKYINFDK
>FECAFAII_00438 hypothetical protein
MKEYIKNIYFIEETQNIEGSYIEVKTLFVNEDKTKALDIYKKLASKKTNSFGLILSERRL
YN
>FECAFAII_00439 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIVAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYIAKRSTEGWTPDVIIGRAERTFSCSVSTLYRRFKTGEFNVL
HLPMQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEDDTIVGIHHKSAVITL
VERLSKAIIALKPEGRKAVDIENSINEWLQSVPKNLFKSITFDCGKEFSNWKSISNTNDI
DIYFADPGTPSQRGLNEHSNGLLRKDGLPKEMDFNQVNQGFISSVASKRNHIPRKSLNYQ
TPLEVFLSYVNGKFCLA
>FECAFAII_00440 hypothetical protein
MLKKWITLFFATPHSRINPYDVENEFTLKKDFPNK
>FECAFAII_00441 putative ABC transporter solute-binding protein YclQ
MKKLVVGILILASFGLAACGNSNNTSQADTKKSSTQAETALTIKDSNGDQIEVPKNPEKV
VVFDNGSLDTMDALGVGDKVVGAATSSLPEYLSSYKKVESAGGIKEPDLEKINQLQPDLI
IISGRQRDFQKDLSQIAPTIFLSLDAKKPWESFQQNVTTLGEIFGKQEEAKTQLEELSNA
VDQTKKKAEATDKKALVTLVNEGQLSAYGSGSRFGFIHDLFGFEQADDQIEASTHGQSVS
YEYVLEKNPDILFVVDRTKAIGGDDSKDDISANELVAQTNAGKNQQIISLEPDVWYLSGG
GLESMKLMIEDVNQAFK
>FECAFAII_00442 Iron(3+)-hydroxamate import ATP-binding protein FhuC
MIDLQKVNKLYHGKSVVKDVQLTIPEKKLTAFIGPNGAGKSTVLSMISRLIPKDTGEIYL
DHNEVKAWKSNELAKKLSILRQSNEINVQITVKELVEFGRFPYTKGKLTTKDEEIVQESL
EHLGLEEIADQSIDTLSGGQLQRAYIAMVLAQDTDYILLDEPLNNLDMNFAVQIMQILKK
LVQEIGKTIVIVLHDINFAASYADEIVAMKDGQLFTQGTTQEMIKKDVLDELYEMDIRIC
EIEGRRFCLYF
>FECAFAII_00443 Hemin transport system permease protein HmuU
MLKKKPSIFIGMLVLVLFVTGMYLTIHTYGNWHFAWALRSKKIFAFILVSLAVSSATISF
QTITHNQFLTPSVLGLESLYVLVQTVLFFFIGGVTMLQQTGTGFFLLNVGLMVGLSLLLF
FFLLKKMRANLFLLLMSGMILGTLFGSVSTFLQVIMDPNEYDLLQGRLFASFGNIQSQYL
LPASLIIIGCWYLLFRYRHVLDVFHLGNEQAVNLGIDTDRFEFLILCCVSLLTGTSMALV
GPVTFLGFIVANISYRVFSTYRHGQLFIGSFLVAMLFLAGGQLSVEQIFGWNTTVSVVVE
FVGGIYFVTKLIRERKSIL
>FECAFAII_00444 Iron-uptake system permease protein FeuB
MRYGRLVALLVILSSISLFIGVSNVQLSELLQLDGQSLQILLATRLPRTICLILVGATSS
ICGLIMQHLTQNKFVSPTTAGTMDSARLGILVAMIFLPGASLIVRSLTAFCFAFAGTLLF
LSLTRLFPQKNQLMLPLIGVMLGNIIGSVATFFAYQFQLVQNMTSWLQGNFATVIRGNYE
LLYAVVPLLLLVWLFAYRFTIIGLGESFAVNLGIDYQKMQFLGIGLVSLASAVMLIMVGS
IPFIGVIIPNLVSRIYGDQVHKTIGVTALAGSLFLVFCDLVARVLIFPYEIPVSVIVGII
GGAIFLYLLIRGRRYA
>FECAFAII_00445 hypothetical protein
MAQDDVKSHLDKGLYGTPLVNPEEQHKYLGTFRERCYLSMTVAEMIQPKNKENFLKELKK
HPDASILLNGALPLSVQNQYIQLATKNNSRFTVVNDYVTANPEEFGLLLTAKEAVNEPVI
DIEKKYPEENSSPAEKEKPKKKKSFWDRLF
>FECAFAII_00446 Glutathione biosynthesis bifunctional protein GshAB
MMNFKQLLLHVNARPFIDQARFGIEREGQRVDLAGNLAKTDHPAIFGDRSYHPYIQTDFS
ETQTEMITPVTDSIPELFQYLAAVYDVTARSIPKEEMIWPLSMPPALPEKDEEIIIAKLK
NFEDVLYRRYLAKEYGKRKQMVSGIHFNFEFGDELLRTLFSHQEEFQDFSEFKTELYLKT
ARNFMRYRWMITYLFGASPMSEKNYFLDESHPQEPVRSIRNSALGYTNHPNVKVSYASMK
QYLADIERMIEEGKLSEEKEFYTPLRFRGGKKVADLATTGVRYIELRNIDLNPYARLGIN
PEQVRFLQLFLMYMLWTEEKEDCDQWVAEGTTRNNKVALEQPSDQTEFHQEGREILEGMK
QMLVELDWLDSLYLVEEALTQMDHPEQTLAAKLYQEAQLSSQQEVAVALGHQYYKESHER
PYQLAGFREMELSTQIFMFDAIQKGVQVKVLDESDQFLRLQFQDHVEYVKNANMTSKDSY
IVPLIMENKTVTKKVLKEAGFRVPGGAEFSSMEEAVKAYPRFAEQAFVIKPKSTNYGLGI
TIFKEGASLEDYQAGLAIAFREDSSVLVEEFMPGTEYRFFVIDGEVQAIMLRVPANVIGD
GIRTVKELVEEKNSDPLRGTNHRAPLELIQLGELEQLMLKEQGLTIESVPQANQIVYLRE
NSNISTGGDSIDMTDEFSEAYKKIAVSAVEALGAKISGIDLIIPDKEIDPTTDKKAYGII
EANFNPAMHMHVYPFAGKGRRLTMNVLKLLYPEVF
>FECAFAII_00447 Signal recognition particle receptor FtsY
MGFFDKIKRAFTGEEKTEEVEVQEKYDKGLEKTRKTFGERMNELFANFRTVDEDFFEELE
ETLIGADVGFETAIRITEALRQEVKLRNAKKSAEVQNAIIEKLVDLYEAEGINEVNELNI
QEDGLTVILFVGVNGVGKTTSIGKLAHQFKKEGKKVLMAAADTFRAGAIDQLVVWGERAG
VEVVRGNAGGDPAAVVFDALERAKTEQADVLLVDTAGRLQNKVNLMNELEKIKRVIQREL
PEAPQETLLVLDATTGQNAMVQAKQFKETTDVTGLVLTKLDGTAKGGIVLAIRNELHLPV
KLVGLGEGIDDLEPFDPNDFVVGLFKGLLKEE
>FECAFAII_00448 Sugar phosphatase YidA
MIKLVAIDLDGTLLNEQKLISDENKQALAQAKQQGVKIVLCTGRPLAAMAHYLQELGLVD
EGDYNITFNGGLVQKNDTGEIMEKKVMEVSDIQRLYKLAQQLDLPLDVLSDNVVLQLPSA
PRKQSLYNVLNKLLQFQPADISDITDEFVLNKAVIAYDQEELDPKIKEIPAEFHEMYEII
KTRSMLLEFMPKGVTKAYGISLLAKDLGLKQEEIMAIGDEENDLPMIQYAGLGVAMENAV
PFVKEAADFVTASNEENGVAKVIQKFVLE
>FECAFAII_00449 Chromosome partition protein Smc
MYLKRIEIAGFKSFADKTVIDFENSVTAVVGPNGSGKSNITEAIRWVLGEQSAKSLRGGK
MPDIIFAGSDTRKQLNIAEVTVILDNSDHYLPLEYNEISVTRRYRRTGESEFFINKQSCR
LKDIQELFLDSGLGKESFSIISQGKVEAIFSSKPEDRRGIFEEAAGVLKYKQRKKKAEQK
LFETEDNLSRVQDIIHELEEQLTPLAAQSEAAKEFLRLKETLTQTDVSLMVAEIKTAKKD
WDNKQAQLAKFNLELGKLSESIQEQESILAKQRKENAQADRLIEKNQQVLLDLSEKLKQT
EGQKDVLQERTRHTQKSSQEYQTSLAEAQKKVKHFEKLQESLMKEAAEKETEIQKAEANL
IKTQQELEKYQKSTKELLAELRDQYVDLMQEQAAVGNELKYLERQYIQETAKSKQTLAKQ
SEVEASVDRLILQKEELTQKQAQLKSSLTETKEKLEMIQQNGKKFQEALAKEQPKMYQLM
NQVQQLRARQKSLQEIQENYFGFYQGVRLVLQHKQQLSGIVGAVAELIDVPADFTLAIET
ALGGAAQHVIVENEKDARQAITYLKQQRGGRATFLPLTTIKSRQLPAHILTQAAAVEGFI
GIASEQVSYPDQIQTVVQNLLGTILLAKDLTSANAIAQTIRYQYRVVSLEGDVMNAGGSM
TGGANKRGNQGSLFVQNQELKQLTSEFEEADKQLQAQEKKVQELQQETARLAEEQEVLRT
RGEQLRFEEQEATNQLQNIINELERFEKEKQISTFETRELQQFIEDYEKQTNELKDKQTD
LESQRQKIDEEIKSLSQESDQMEARRAQVQSQKAQEQADLAVLKEQFNHLQIQLRGARVQ
KAEATERQEAIEKQLATLTADFSDNEVTEESLEKQINELSAQRETLKVELAKAKEQRDRR
QKEIDKLEAVLAERNREQKARLSEQSKLEVQKDRAEMILDNHLTYLQSEYQLTFEKASQD
YQETTDIEDSRTKVSSLKEQIEKLGPVNLNSIEQYEQVSERHTFLATQRDDLLAAKNQLF
ETMDEMDDEVRTRFKEVFEAIRQEFKIVFPNMFGGGKAELVLTEPTDLLKTGIEIEVQPP
GKKLQSLSLLSGGERALTAIALLFSIIRVCPVPFCILDEVEAALDEANVKRFGRYLSDFQ
DDTQFIVVTHRKGTMVAADVLYGVTMQESGVSKIVSVRMEDINEEAKINETKV
>FECAFAII_00450 Ribonuclease 3
MDNQLTKELKENYNIVFHDLNLLEQAFTHSSYVNEHRNLQLSDNERLEFLGDAVLELMVS
QYLFRLYPHLPEGKLTKTRAAIVREDSLSKFAKECHFDQYVLLGKGEENSGGRTRPALLC
DLFEAFLGALYLDQGFDTTHAFIEKVIFPKVKAGAFSHEMDHKTKLQEVLQKSGDVSIEY
RLINEEGPAHERVFWIEVYVDDQLIGTGQGKSKKLAEQAAAENALAAL
>FECAFAII_00451 Oligopeptide-binding protein AppA
MKKTIFGFAALMSAVVLAACGGGGTDTSGNNSGGNGNNKEELTFPIATKNNDDAIEDGEL
EAAVATDSQFKGLFQWEFYQDSYDAAFMAPSHEPLFANDDDFRITDDGAATLDLDEDTKK
ATIKVKDNVKWSDGEDVTADDVIFPYEIIGNKDYTGIRYDDTFRNIVGMEEYHDGSADTI
SGIKKIDDKTVEIEYKEVNPSMLQSGGGIWSYAAPKHTLEGVAIKDMESSDQVRKNPVTF
GPYYMSNIVAGESVEYLPNEHYWNGTPKLKKITMKSVPMASATEALNSKLYDMIFQMPTD
TYDTYKEIAGYTNLGREQTSYTYLGFKLGKWNADTKSVEYNPDSKMADKSLRQAMGYALD
NDAVGERFYAGLRSNATSLIPPVFQSYHDDEMKGFTQDLDKAKKLLDDAGYKDVDDDGLR
EDKDGNKLTINFASMSGGETAQPLADYYIQQWKEIGLDVQYTTGRLIEFNSFYDKLENDD
PEIDVYQAAWNTGTDPNPSGLWGPNAAFNYTRYESEENTKLINDISSSKAFDEEYQKEAY
QKWQQYAFEEAFAIPTLFRNEVLPVNDRVKDWDWSYDVPNPWANVSVTADSRS
>FECAFAII_00452 Putative peptide transport permease protein
MSEKNNTAVQESIPPMGIRMIAREFKKDKIAIFSLGLLVVLLLVIFIGAMLTDQDKVMYV
SIFDKYAAPGTVSTQGQKFILGADEGGRDVLGQLIIGARNSVTIGFAITILTSIIGVGLG
IISGYYGGIIDNILMRIVDFIMILPIMLIIIVFVSIISRYNVWSFIFIMSAFYWVAKARL
FRSKTLSEARRDYVSASKTMGTNDFKIMFREIMPNLSSLIITNLTMNFAANIGIETTLTF
LGFGLPANVPSLGTLIGYASNGEVLVNRQWIWLPASILILVLMLSINYVGQAFKRSADAR
QRLG
>FECAFAII_00453 Glutathione transport system permease protein GsiC
MWKTILRRVLLMIPQVIILSVLIFLLAQAMPGDPFTGLINPNQDPAVIEQMRQAAGLNDP
WYVQYFRWIGNALQGDFGQSFLYKRSVADLIGERIINTLYLSILTVVLTYLIAVPLGMLA
GRYQNSILDKIVVIYNFFSFAVPLFIFGLIMLFVFGYRLGWFPTSGSQTLGLQGGFITQW
IDRLKYILLPSITQAFLATAVTIQYLRSEVIDSKSLDFVRTARSKGVPTNKVFSRHIFRN
AALPMASQMGYEITSLIAGSVVIEKIFGYPGVGKLFIDSIGQRDYTVITSLVLILGIATL
VGTLLSDIIMSIVDPRIRIQ
>FECAFAII_00454 Oligopeptide transport ATP-binding protein OppF
MTELITIRDLKVHYPIRSGFFNRVTDHVYAVDGVDFIIEKGKTYGLVGESGSGKSTTGKA
VVGLEKVTAGQIMYEGKDVTKRSNRKKMGYNKDVQMIFQDSMSSLNPKKRVLDIIAEPIR
NFERLSDQEEKKKVKGLLDIVGMPEDALYKYPHEFSGGQRQRLGVARAVATNPKLIVADE
PVSALDLSVQAQVLNFMKRIQQEYGLSYLFISHDLGVVKHMCDNIAIMYKGRFVEIGTRE
DIYNDPRHIYTKRLLSAIPQIDVENRESHKENRRRVEQEYIQNQKEYYDATGRVYDLRTI
TTTHKVALKDGGAS
>FECAFAII_00455 Oligopeptide transport ATP-binding protein OppD
MSDNQLLEVQNLHTGFRLKDDYYDAVDDVSFTLDKNEILAIVGESGCGKSTLATTIMGLL
DPNNTKITGEILYNDLNLIDLNETLYNKIRGNDIGMIFQDPLSALNPLMRIEDQIKEGLS
YHTKMNAEQRQARALELLEQVGIPNPARVGRQYPHELSGGMRQRVIIAIAIACKPPIVIA
DEPTTALDVTIQAQILDLLKDLQEETKTGIILITHDLGVVAEMADRVAVMYGGQFVEVAG
VKELFDHPKHPYTRSLLNSIPQEGNHDAELHVIEGVVPSLKNMPRKGCRFAPRIPWIPAS
DHEEEPILHEVAPNHLVRCSCYKHFHFRDEKGEV
>FECAFAII_00456 hypothetical protein
MYFLGIDIGKRTHVASIMNEEGKVLLKGFSFPNTTEGAESLIERMVDYSGAPSDFVIGME
ATGHYWLSIFSYLHESDYLIHVVNPLQTDGWRKGTEIRKRKNDIIDSVLIADLMRYGSFV
ETVLSDENVFSLKQLSRYRTYLVGTASDFKRKIIAVLDQVFPEYATIFTKQGVFGKASKE
LLLAFSAPIDLENISSETLAQYLAELSRNRIKAEKADQLKQAASNSFGVKFAQEAFTFQL
RSMIEQLKFIESQIKETEREIKHIMDTLNSVILTIPGIGPINGATILGEIGDIQKFSNPK
KLVAYAGIDASVTQSGQYEATHNVMSKRGSPYLRKALFSAALVASQCDPVFSAFYQKKVS
EGKHHLTALGAVSRKLCYVIHAILTKNEPYIIVSD
>FECAFAII_00457 Acyl carrier protein
MTREEVFNKVAKIISNHFEIDTDKVTDELNIKDDLKADSISIMEFVLELEDEFGTEISDE
DAEQIETVGGAVDYISSHLK
>FECAFAII_00458 Phosphate acyltransferase
MKIAVDAMGGDHAPQAIVEGVALAQQDFPEVEFLLYGKEAEIKKYLTNEKNITIIHTDEK
INSDDEPVKAIRRKKTASMVLAAQAVKNGEADAVFSAGNTGALLAAGLFIVGRIKNIERP
GLMSTLPVVGKEGAGFDMLDLGANAENKPEHLLQYGILGSFYARKVRGIGRPRVALLNNG
TEATKGSEVTKKAYELLQNETSLNFIGNVEARELLNGVADVVVTDGFTGNAVLKSIEGTA
MNMMNLLKSAILNEGIKGKMGAMLLKDGLRSLKAEMDYSKHGGAVLFGLKAPVIKTHGAT
GPDAVRYTIRQIHTMLETDVVGQLVEQFEKSEE
>FECAFAII_00459 ATP-dependent DNA helicase RecG
MRSLDDPITMLAGVGEKRAASLASLGIQTIEDLLTYYPFRYEDIQERNLNEIQDQEKVTL
KGIVVSPPVMNRFGYKKSRLQFRMMQEHDVFNVSFFNQPYLKEKVILSEEIAVYGKWDAK
RKALNGMKILGSQTMDDFSPIYHVNKSIRQTTLVDLIKKGFQEYGTLIEENLPNNLVEKY
RLLDRASAVRSMHFPKDHEENHQAKRRVVFEEFFLFQMRLQGLKKAEKAETNGLEILYDV
QKLKEFTQKLPFELTNAQKRVTNEICRDLRSPQHMQRLLQGDVGSGKTVVAAIALYATVT
AGFQGALMVPTEILAQQHMESLQQLFDPNEVTIALLTGSTKAKERRELLEKLGQGEINVV
IGTHALIQDGVEFQNLGLVITDEQHRFGVNQRKVLREKGWRPDVLFMTATPIPRTLAITA
YGEMDVSIIDELPAGRIPIETRWVRTPQLDSVLDWTKKELARGHQMYVICPLIEESEALD
VKNAVEIYEKLRELFAPKYEVGLLHGKMKNQEKEVIMEAFKDNQMQILVSTTVIEVGVNV
PNATVMLIMDADRFGLAQLHQLRGRVGRGSDASYCILVANPKNELGVERMKIMTETTNGF
VLSEKDLELRGPGEVFGFRQSGLPQFAIADLVTDGNVLEVAREEAAALWQIKDWQMLPEY
QPLAQSLQIENQDNRYFD
>FECAFAII_00460 hypothetical protein
MSVTEISASQFQEMVQAGANRLQVNAEYVNSLNVFPVPDGDTGTNMNLSMTSGAKAVVDS
TSEKVGELAAMLSKGLLMGARGNSGVILSQLFRGFSKQIPDVVSLDASDLAAAFTHGVET
AYKAVMKPVEGTILTVAREAAKAGEKKAKSTDDVVEVMTAVVKGAKRALAKTPDLLPVLK
EVGVVDSGGQGLLFVYEGFLSALNGEFQADETYEPSPAEMDDMVNAEHHRSVQGQMATED
IHFGYCTEIMVKIGEGPTVDSTFDYEEFRNYLDGIGDSLLVVNDDEIIKVHVHTENPGEV
LNYGQKFGSLVKIKVDNMRLQHETILEHDEEVNEFAKKEIPRIPYGIVAIAAGKGVQELF
ESLGANYVISGGQTMNPSTEDIVKAIQEVNADKVIVLPNNKNIFMAADQAAEVADIPVAV
VPSRTISQGLTAMLSFNDQASLEENKETMTEMLSSVVSGQVTHAIRDTSIDGVEIKEGDF
LGMIDGKILISNPDITATALSTLEQMINEDTEIVTILAGDEGTVEQANEFAEKLTEKHPD
LEIEIHQGDQPVYPYLFSAE
>FECAFAII_00461 hypothetical protein
MAVKIQTSAGTIEITNDVIATVVGGAATDVFGVVGMASKNQIKDNITEILRKENYSRGVV
VRQEDNGIAVDVYTIISYGTKISEVSRNVQEKVKYNLEALLGVTANSVNVFVQGVRVLPD
>FECAFAII_00462 50S ribosomal protein L28
MAKVCYFTGRKTKSGNNRSHAMNSTKRTVKPNLQKVRVMVDGKPKKVWVSTRALKSGKVE
RV
>FECAFAII_00463 hypothetical protein
MKKNLKSFFRENGRYAAASFLIPFLILALVYLSIGIYPGSSRSILASDAFSQFSNFHASF
RNVLLGKQSIFYTWNASLGLNYLSLISYYLGGIFTPLVFFFPNQMMPDALYVLTLLKVGC
AGLAFWFLARTFKIPRWGHVALSVSYALISFITAHSEIIMWLDAFIYLPLVILGIHRVMD
LKRPKLLFISYLLLFLSSFYMGFMIGVFSFLYFIARLLTNWSEYKKTIVPYGITSLLAGG
ASMIIVLPAVLDLRSNGEALSQITTLKTEATSYLDLIMKNMIGVYDTTKYGSIPFVYAGL
LPLVLCLFYFASRKVPLKNKFLYGSLFAILIASFYLVPLNLFWHGMHAPNMFLFRYAYLF
SFLVLLLAGKGWEKIEQDDRGLLLGIILVVAALFAVAWGIKPEGSYTYVTMTSFVLTVVF
LGIYAFAVGFYQHKKLSFNHLSILLLLIMSAEALVNTNSMIHGILDDWNYASRSLYTDPY
PDLKALVNETKKDSDSFYRLENLDPVSANDSINYGYSGISLFSSIRNRNSSSYLDKLGFR
SRGTNLNIRYNNNTLLMDGFTGIKYNISKNESTFSKYGFRQAGQSGDYTLYQNVNALPLA
FTAPLSVNDVEQPVTDNLTSQTNLINTLSGLNEQYFTFYTPTLKNQLNTTITKTTTGVTY
SETADNQPKELTWEVHVPANTQAYLSLFPTNFAQLESSSATITVNGTSRKTQINISGQYY
DLGYYPQETTVTFTASFYGTKEVSFMEPKVVGLDVVAYQAAMNQIKEKGVEMEATGRKAS
GTVNTAEDSMLVTTIPYDKGWKAKIDGKPVKVSNFKDAFLMIKVPAGKHTVTFSYLPEGF
MIGAILFVLCIALFILYVWYLDRNRPFHGTIDPAIEEQPRNTHRRRRRK
>FECAFAII_00464 hypothetical protein
MRSSKYTEHYTDTFITFKEIMRTVSNIYHNCVPDKIKNRRNTDQLKQRDTVIIACVIWGI
INGYTSQRATYRAVCSVLFPNGDFPSRSRFTRLSSNLAYTIKIIRYFFIKKLTKGELVGI
IDSFPSPLCKPVRNRQAKLLNQIAKVGYNSTKKSYFYGLKIHMIVTKTGFPITYSITNPG
VHDVKVLETLSEEANLPNILGDKGYISHKIHEKLALKGITISVPPRKNMDKSEKLDHSLL
GKQRKTVETVFSSLEKLGCQNFNSRSVKGLESRFESILLAYSVLLSRAQRRFGGTLRYSL
GY
>FECAFAII_00465 hypothetical protein
MFLINATDEILSVNKVFYTVPAEKMSRVSSDINTITSRIGLTKAMHMVLKYNQEDPPVPK
TYEAIDLIIVDEIDRLKLQHLEQLRDIYDRNDLAMVLIGMPGIEKRLSRYPQLYSRIGFA
HEFDNLSKDETHHILEYKWADLGIDIKLEDFSDYEAITTIIKITKGNFRLIHRLFAQIDR
ILRINQMDKITVEVVEAARDSLVIGIPVVLVNFFLEENV
>FECAFAII_00466 hypothetical protein
MITIKKLFSALFILLFGFIGIGTSGNIVKASTMVEQTSEMAKTFSQLTPEEQSYFKSKGF
SDKDTFYTQKIEPQDPKTRFSANVLRLTASTKKITNTQGRTEYIITSPNSAMYRISTRLS
LGSAKSYTQTVNLANSYGYGGGMYFTFTGKRQYYSVKLAMQVYNTFGVGSVSCTAGGLTI
GK
>FECAFAII_00467 hypothetical protein
MIISYYVLNRSDDEGLFVFQSLHEDTMLKEFYNRIKNKQIETNLYFLSDSILPFISNPKI
LNLLQTKDLKSLPIIVIDEEIVKYGAYLSVEELEKLTNIGMSIQEDNGVHGT
>FECAFAII_00468 hypothetical protein
MNDFTTEIVQTLVTKGDLNELFRSHLEKAINTLLRTELTAFLDYEKYDRTGFNSGNSRNG
SYFRSIKTEYGELTLEIPRDRNGEFKQQTLPAYKRTNDTLETTIIHLFEKGVTMSEIADL
IEKMYGHHYTPQTMSNMTKVLTEEVNAFKSRALNDKYVAIFMDATYIPLKRQTVSKEAIY
IAIGIREDGTKEVLSYAIAPTESTYVWNELLQDINSRGVQEVLLFITDGLKGMKDTIHQI
YPKAKYQHCCIHVSRNIAHKVRVKDRKEICDDFKAVYQANSKEEANTFLSGMIEKWKKNY
PKVTQSLIENQDLLTFYDFPPSIRRTIYSTNLIESFNKQIKRYSRRKEQFQNEESLERFL
VSIFDTYNQKFLNRSHKGFQQVTDTLVSMFTE
>FECAFAII_00469 hypothetical protein
MTQVHFTLKSEEIQSIIEYSVKDDVSKNILTTVFNQLMENQRTEYIQAKEYERTENRQSQ
RNGYYERSFTTRVGTLELKVPRTRDGHFSHTVFERYQRNEKALMASMLEMYVSGVSTRKV
SKIVEELCGKSVSKSFVSSLTEQLEPMVNEWQNRLLSEKNYPYLMTDVLYIKVREENRVL
SKSCHIAIGITKDGDREIIGFMIQSGESEETWTTFFEYLKERGLQGTELVISDAHKGLVS
AIRKSFTNVSWQRCQVHFLRNIFTTIPKKNSKSFREAVKGIFKFTDINLAREAKNRLIHD
YIDQPKYSKACASLDDGFEDAFQYTVQGNSHNRLKSTNLIERLNQEVRRREKIIRIFPNQ
TSANRLIGAVLMDLHDEWIYSSRKYINFDK
>FECAFAII_00470 HTH-type transcriptional regulator LrpC
MLDQTDINIIEELSKNSRITMKELGEKVHLTGPAVSARVTKLEESGVIENYTVKLNMEKL
GFSIHAFLIIITQNLNHKPYLSFIKNHEKFLIRNYKISGGGCYLLECRFTSKKSMNSFLE
QR
>FECAFAII_00471 hypothetical protein
MNIHHIRNATAILDYGGKKFLIDPMLAEKGTLPPFISKGPFPSPRKDQMNPLVDLPMPVE
DIINGIDAVIVTHLHLDHWDDIAKEVLPKEIKLFVQDENDANEIRLYGFKNVEVLREDTV
FESIQLVKTKGKHGRGEILNYVGNVCGIVFKHSTEKTLYFTGDTVWYEAVKQTIDQYKPE
IIVANAGDNHFLVGESLIMGKDDLYELHKAIPDSTIIAVHMEAVNHWGLSREELKSFNKE
KGISEKVLVPEDGDNIFIKKNKRLLIKG
>FECAFAII_00472 tRNA pseudouridine synthase A
MVRYKAIIAYDGTNFNGFQKQPNGRTVQEEVEKTLQKMANGKEITVFGSGRTDAGVHAIG
QVIHFDYPEERPLERMRFALDTQSPEDIAVRQVEIVSEDFHARYLVKEKTYQFRVDIGKP
RSPFRRHYASYFPYPLDLEKIQRALPDLLGTHDFTSFCASGSSIEDKVRTIYEAKMEVNE
TKDELLFTFRGNGFLYKMIRILVGTLLKIGNGRLPEDSIPDIIAKKDRNAAGPTAHPEGL
YLYEVKYE
>FECAFAII_00473 Energy-coupling factor transporter transmembrane protein EcfT
MMNKLIFGRYMPGDSLIHRLDPRAKLLASFYFIGIIFLANNWETYLLLAFFTLLSVFLSK
VDLKFFIRGIRPLIWLILFTVALQVLFTSGGETYWSWGVFHITEFGVMNGLFIFCRFVLI
IFMSTLLTLTTPPLELSDAIEYLLRPLKAVRFPVHEISLMLSIALRFVPTLMDETEKIMN
AQRARGVDFGEGNLVQKMKAVIPLLIPLFVSSFNRAEDLATAMEARGYKGGEGRTKYRVL
HWHNRDTMVIIAFVLLTVLLIFLRG
>FECAFAII_00474 Energy-coupling factor transporter ATP-binding protein EcfA2
MDIRFEQVDFTYQPNTPFEQRALFDINMTIKENSYTALVGHTGSGKSTLLQHLNALVKPT
SGTVHIGERDIQPDTDNKNLKPIRKKVGIVFQFPEAQLFEETVAKDIAFGPKNFGVSEEE
ALVLAKDTLEQVGLDESYLERSPFELSGGQMRRVAIAGVLAMRPEVLVLDEPTAGLDPQG
RKEMMEMFWRLHKEQQITIVLVTHLMDDVANFADYVYVLEKGRIVNSGEPQEVFQNIEWL
KEKQLGVPTATEFAEELMAKGMNFATLPLTAEELADAIVHYAGGNAHDE
>FECAFAII_00475 Energy-coupling factor transporter ATP-binding protein EcfA1
MEPIIELEKINYKYQPDDLRPALKDVSFTIDKGEWIAIIGHNGSGKSTLAKTINGLLLPE
SGIVKVGNQILDEENIWTIRQMVGMVFQNPDNQFVGSTVEDDVAFGLENQGIPREEMLVR
VKDALEKVRMAEFASREPARLSGGQKQRVAIAGVVALRPDIIILDEATSMLDPEGREEVI
STIKKIKEESQLTVISITHDIDEAANANRILVMRQGELVREGTPKEIFSAGPELIDLGLD
LPFPEKLKSALKEREVDVPSEYMTEERMVDWLWTSVLNK
>FECAFAII_00476 50S ribosomal protein L17
MSYRKLGRTSSQRKAMLRDLTTDLLINERIVTTEARAKEVRSTAEKMITLGKRGDLHARR
QAAAFVRNEVASVREENEDIVIESALQKLFNDIAPRYAERQGGYTRILKTEPRRGDGAPM
VVLELV
>FECAFAII_00477 DNA-directed RNA polymerase subunit alpha
MIEFEKPRIAKIDEEKDYGKFIVEPLERGYGTTLGNSLRRILLSSLPGAAITNIQIDGVL
HEFSTIKGVREDVTQIILNIKGLALKMYGQEEKTLEIDITGPATVTAGDIIVDSDVEILN
KDMYICSVSEGATFHARLTVKPGRGYVQADENKKEDMPIGVLPVDSIYTPVRRVNYQVEN
TRVGHREDFDKLTMEIWTDGSIEPLEAMSLSAKIMTEHLDIFVNLTDEAKNAEIMVEKEE
TQKEKMLEMTIEELDLSVRSYNCLKRAGINTVQELTNKSEPEMIKVRNLGRKSLEEVKAK
LHDLGLGLRKED
>FECAFAII_00478 30S ribosomal protein S11
MAAKKVNRKRRVKKNIEAGIAHIHSTFNNTIIMITDTHGNALAWSSAGSLGFKGSKKSTP
FAAQMAAETATKAAMEHGLKTVEVTVKGPGSGREAAIRSLQATGLEVTAIRDVTPVPHNG
ARPPKRRRV
>FECAFAII_00479 30S ribosomal protein S13
MARIAGVDIPRDKRVVVSLTYIYGIGNTTAKKILADAGVSEDVRVRELTNEQTDAIRAEV
DKLKVEGDLRREVNLNIKRLMEIGSYRGIRHRRGLPVRGQNTKNNARTRKGPARAIAGKK
K
>FECAFAII_00480 50S ribosomal protein L36
MKVRPSVKPMCEHCKVIRRKGRVMVICPANPKHKQRQG
>FECAFAII_00481 Translation initiation factor IF-1
MAKEDMIEVEGTVVETLPNAMFKVELENGHQVLATVSGKIRMHYIRILPGDKVTVELSPY
DLNRGRITYRFK
>FECAFAII_00482 Adenylate kinase
MNLILMGLPGAGKGTQAEKIIDAYGIPHISTGDMFRAAMQNETALGLEAKSYMDKGALVP
DEVTNGIVKERLAEPDTEKGFLLDGFPRTLDQAKALDAMLKDLNKKIDAVIDIHVGEEIL
VERLAGRFICSNCGATYHKIFNPTKVEDTCDRCGGHEFYQREDDKPETVKNRLAINIKNS
EPILAYYKEQGLLNTIDGAREIDAVFADVQKIIEK
>FECAFAII_00483 Protein translocase subunit SecY
MFRLLKDAFKVKDIRSKILFTVFVLFVFRLGAHITVPGVNAASLQNLSSLPFFNMLNLVS
GSAMQNFSIFSMGVSPYITASIVIQLLQMDIVPRFVEWSKQGEVGRKKLNQATRYLTLVL
AFIQSVGITAGFNQYAQLGFVNNPNVATYVTIGLILTAGTMFVTWLGEQITEKGIGNGVS
MIIFAGIISRLPESIREIYEDYFINIDPSDIWKSAIFVAILLVAVLLIVTFVTFFQQAER
KIPIQYTKRVAGAPTSSYLPLKVNAAGVIPVIFASSFIATPNAVLQALSGRFGSENWYKV
MMEIFNYNTAPGATIYTILIVAFTFFYAFVQVNPEKLAENLQKQGSYIPSVRPGKGTEEY
VSRLLMRLSTVGAVFLGLVALLPIIAQMVWDLPQSIGLGGTSLLIVIGVALETAKQLEGL
MLKRKYVGFIE
>FECAFAII_00484 50S ribosomal protein L15
MKLHELKPAEGSRQVRNRVGRGTSSGNGKTAGRGQKGQKARSGGGVRLGFEGGQTPLFRR
LPKRGFTNVNRKDYAVINLDVLNRFEDGAEVTPVALVEAGIVKNEKAGIKVLANGELNKK
LTVKAAKFSKAAQEAIEAAGGSIEVI
>FECAFAII_00485 50S ribosomal protein L30
MAELKVTLKRSIIGRPQNQRDTVKALGLTKINSSVVKPSNEAIKGMINTVSHLVDVEEI
>FECAFAII_00486 30S ribosomal protein S5
MVYIDPKHLELEDRVVAINRVTKVVKGGRRLRFAALVVVGDKNGHVGFGTGKAQEVPEAI
RKAIEDAKKNLVEVPMVGSTIPHEVIGAFSGGRILMKPAVEGSGVAAGGPVRAVLELAGV
ADITSKSLGSNTPINVVRATVEGLKQLKRAEEVAELRGKSVEELIG
>FECAFAII_00487 50S ribosomal protein L18
MITKPDKNKTRQKRHRRVRNNISGTAERPRLNVFRSNKNIYAQIIDDVAGVTLASASTLD
KEISGGTKTEAAQAVGKLVAERAAEKGIKVVVFDRGGYLYHGRVQALAEAARENGLEF
>FECAFAII_00488 50S ribosomal protein L6
MSRIGNKVVVIPEGVTVTQDGNNVTVKGPKGELTRTFSADIKMNIEGNEVTFTRPNDSKE
MKTIHGTTRANFNNMVVGVSEGFQKALELIGVGYRAQLQGSKLVLNVGYSHPVEITPPAG
VTVEVPANTQVIVKGANKEEVGELAANIRGTRPPEPYKGKGIRYVGEYVRRKEGKTGK
>FECAFAII_00489 30S ribosomal protein S8
MVMTDPIADFLTRIRNANMVKHESLEVPASKIKRDIAEILKREGFVRDVEYIEDDKQGVI
RVFLKFGKNGERVITNLKRISKPGLRAYVKADEVPKVLNGLGIAIISTSEGVVTDKEARE
KNIGGEVIAYVW
>FECAFAII_00490 30S ribosomal protein S14
MAKKSMIAKNKRPAKFSTQAYTRCERCGRPHSVYRKFHLCRICFRELAYKGQIPGVKKAS
W
>FECAFAII_00491 50S ribosomal protein L5
MNRLKEKYLKEVTPSLMEKFNYSSVMQTPKVEKIVINMGVGDAVSNAKNLDKAVEELTLI
TGQKPMITKAKKSIAGFRLREGMPIGAKVTLRGERMYEFLDKLVSVSLPRVRDFHGVSKK
AFDGRGNYTLGIKEQLIFPEVDYDLVDKVRGMDIVIVTTANSDEESRELLTQLGMPFQK
>FECAFAII_00492 50S ribosomal protein L24
MFVKKGDKVKVITGKDKNKEGVVLAAFPKKDKVIVEGVNVVKKHQKPSQAAPQGGIVEME
APIHVSNVMVVDSTGVAGRVGYKEVDGKKVRVSKKTGEVLDK
>FECAFAII_00493 50S ribosomal protein L14
MIQAESRLKVADNSGAREILTIKVLGGSGRKTANIGDVIVATVKQATPGGVVKKGDVVKA
VIVRTKSGARRTDGSYIKFDENAAVIIRDDKSPRGTRIFGPVARELRENNFMKIVSLAPE
VL
>FECAFAII_00494 30S ribosomal protein S17
MTEGRNQRKVYQGRVVSDKMDKTITVAVETKKNHPIYGKRMNYSKKYKVHDENNTAKVGD
IVRIMETRPLSATKRFRLLEVVEEAVII
>FECAFAII_00495 50S ribosomal protein L29
MKVKEIRELTTAEMLDQEKQLKEELFNLRFQLATGQLENTARIKEVRKSIARIKTVLREQ
AK
>FECAFAII_00496 50S ribosomal protein L16
MLVPKRVKHRREFRGKMRGEAKGGKEVAFGEYGLQAVDSHWITNRQIEAARIAMTRYMKR
GGKVWIKIFPHKSYTAKAIGVRMGSGKGAPEGWVAPVKRGKIMFEIAGVPEEVAREALRL
ASHKLPMKTKIVKREEMGGESNEG
>FECAFAII_00497 30S ribosomal protein S3
MGQKVHPIGMRVGIIRDWDAKWYAEKEYAEFLHEDLRIRKFISTKLADAAVSTVEIERAT
GRVNISIHTAKPGMVIGKGGSEVESLRKELNKLTGKRIHINIVEIKKPDLDAKLVGEGIA
RQLENRVAFRRAQKQAIQRSMRAGAQGIKTQVSGRLNGADIARSEGYSEGTVPLHTLRAD
IDYAWEEADTTYGKLGVKVWIYRGEILPTKKNTEKGGK
>FECAFAII_00498 50S ribosomal protein L22
MAEQITSAKATAKTVRTSPRKARLVIDLIRGKSVADAISILKFTPNKSAGIIEKVLMSAV
ANAENNFDLDVENLVVSEAFVNEGPTMKRFRPRAKGSASPINKRTSHITVVVSEK
>FECAFAII_00499 30S ribosomal protein S19
MGRSLKKGPFVDEHLMKKVEAQAGVEKKKVIKTWSRRSTVFPSFVGYTIAVYDGRKHVPV
YIQEDMVGHKLGEFAPTRTYRGHAADDKKTKR
>FECAFAII_00500 50S ribosomal protein L2
MAIKKYKPTSNGRRNMTGSDFAEITTSTPEKSLLQPLKNHAGRNNNGRITVRHQGGGHKR
QYRVIDFKRNKDNVVATVQTIEYDPNRSANIALVHYEDGVKAYILAPKGLEVGMKLVSGP
EADIKVGNALPLENIPVGTVIHNIEMKPGKGGQLIRSAGTSAQVLGKEGKYVLIRLNSGE
VRMILAACRATIGSVGNEQHELINIGKAGRSRWMRKRPTVRGSVMNPNDHPHGGGEGKAP
IGRKAPVSPWGQPALGYKTRNKKAKSDKLIVRRRKNK
>FECAFAII_00501 50S ribosomal protein L23
MNLLDVIKRPVITEKSMLAMDDKKYTFEVDTRANKTLVKQAVEAAFDVKVKNVNIVNVRA
KFKRMGKYAGYTKKRRKAIVTLTEDSKEIQLFEAAE
>FECAFAII_00502 50S ribosomal protein L4
MPNVALFKQDGSQNGEITLNEEIFGIEPNESVVYDAIVMQRASLRQGTHAVKNRSAVRGG
GRKPWRQKGTGRARQGSIRSPQWRGGGVVFGPTPRSYSYKLPKKVRRLAMKSVLSEKVAE
NNLVAIEGLKFDAPKTKEFKQVLANLSIDSKVLVVLEKGNDFAALSARNLPNVSVVTSDN
VSVLDVVSNTKVLATQTALTQIEEVLA
>FECAFAII_00503 50S ribosomal protein L3
MTKGILGKKVGMTQIFTESGELIPVTVVEATPNVVLQVKTMETDGYEAIQVGYQDMREVL
SNKPAKGHVAKANTAPKRFIREFKNVELGEYEVGKEITVDVFQAGDIIDVTGTTKGKGFQ
GVIKRHGQSRGPMAHGSRYHRRPGSMGPVAPNRVFKNKRLAGRMGGNRVTIQNLEVVRVD
AERNVILIKGNVPGAKKSLITIKSAVKAK
>FECAFAII_00504 30S ribosomal protein S10
MAKQKIRIRLKAYEHRILDQSADKIVETAKRTGASVSGPIPLPTERSLYTIIRATHKYKD
SREQFEMRTHKRLIDIVNPTPKTVDALMKLDLPSGVNIEIKL
>FECAFAII_00505 Elongation factor Tu
MAKEKFDRSKPHVNIGTIGHVDHGKTTLTAAITTVLSKKNGGQAMAYDQIDGAPEERERG
ITISTAHVEYETDTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVSAADGPMPQTREHI
LLSRQVGVPYIVVFLNKVDMVDDEELLELVEMEVRDLLTEYEFPGDDVPVVAGSALKALE
GDASYEEKILELMAAVDEYIPTPERDNDKPFMMPVEDVFSITGRGTVATGRVERGQVRVG
DEVEVVGIAEETSKTTVTGVEMFRKLLDYAEAGDNIGALLRGVAREDIQRGQVLAKPGTI
TPHTKFSAEVYVLTKEEGGRHTPFFTNYRPQFYFRTTDVTGVVELPEGTEMVMPGDNVTM
EVELIHPIAIENGTKFSIREGGRTVGAGVVTEIKA
>FECAFAII_00506 Elongation factor G
MTREFSLQNTRNIGIMAHIDAGKTTATERILYYTGKIHKIGETHEGASQMDWMEQEQERG
ITITSAATTAQWKGHRINIIDTPGHVDFTVEVERSLRVLDGAVTVLDAQSGVEPQTETVW
RQATTYGVPRIVFANKMDKIGADFLYSVSTLHDRLQANAHPIQLPIGAEDDFTGIIDLVT
MKAEMYTNDLGTEIEETEIPEEYRELAEEWREKLVEAVAETDEELTLKYLEGEEITEAEL
KEGIRRATVNVEFYPVLCGSAFKNKGVQLLLDAVLDYLPSPLDIPAIKGIDPKTDEEVER
PADDSAPFSALAFKVMTDPFVGRLTFFRVYSGVLQSGSYVQNATKGKRERVGRILQMHAN
SRSEISEVYAGDIAAAVGLKDTTTGDTLCDEKSLVILESMEFPEPVIQVAIEPKSKADQD
KMGVALQKLSEEDPTFRAETNVETGETIIAGMGELHLDIKVDRMRREFKVEANVGAPQVS
YRETFRAGTQAEGKFVRQSGGKGQYGHVWIEFTPNEEGAGFEFENAIVGGVVPREYIPAV
ETGLKDAMENGVLAGYPLVDIKAKLYDGSYHDVDSNETAFRVAASMALRAAAKKANPVIL
EPIMAVEVVIPEDYLGDVMGHVTARRGRVEGMEARAGGQQVVRAMVPLAEMFGYATTLRS
ATQGRGTFTMTFDHYEDVPKSVQEEIIKKNGGKAE
>FECAFAII_00507 30S ribosomal protein S7
MPRKGPVAKRDVLPDPIYNSKLVTRLINRVMVDGKRGIAANIIYNAFDLIKESTGNDPLE
VFEQAMKNVQPVLEVKARRVGGSNYQVPVEVRPERRVTLGLRWVVNYARLRGEHTMEERL
AKEIMDAANNTGASVKKREDTHKMADANRAFAHYRW
>FECAFAII_00508 30S ribosomal protein S12
MPTINQLVRKPRKSKVEKSNSPALNKGYNSFKKTQTNVNSPQKRGVATRVGTMTPKKPNS
ALRKYARVRLSNLIEVTAYIPGIGHNLQEHSVVLLRGGRVKDLPGVRYHIVRGALDTAGV
NDRKQSRSKYGTKKPKA
>FECAFAII_00509 Ribose-5-phosphate isomerase A
MNLKQLAGIEAAKFVKDGMIVGLGTGSTAYYMVEEIGRRMREEGLRITGVTTSNATKEQA
EKLGIPLKSIDEVPVVDLTIDGADEISADFQGIKGGGAALLFEKIVATYSKKTIWIVDSS
KLVDKLGKFPLPVEVIPYGSQQLLHIFEEKGFQPVLRTDENGEVLTTDGGHYIIDLHLEV
IEQPESLATYLDELVGVVEHGLFLNMVSKVVVGSEKGVEILDAIRRK
>FECAFAII_00510 DNA-invertase hin
MKIIGYARTTINDVDLTTQVDQLSDFGCQEIFHETYEVEQNDSTAVHLESVIADMQQGDA
LVICQLHRLGKSTRQLTELTQLFKDRGLHLISLDEGIDTREMGKIYFQLMENLANMECAL
IKERTLVGLDEARKKGKIGGRPKIDAKTIKKIRRLYYEKKETIQFISSKCGVSVGTCYKY
INLPEKEIEQLCI
>FECAFAII_00511 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase
MPKLVFSRHGLSEWNALNQFTGWADVNLAPEGIEEAKEGGRKIKEAGIEFDVAYTSVLTR
AIKTCNLILEYSDQLWVPQIKSWRLNERHYGKLQGLNKKETAEKYGDEQVHIWRRSYDTL
PPLMEETDEGSAANDRRYAMLDKRDIPGGENLKVTLERALPFWQDEIAPALLDNKTVLVA
AHGNSLRALAKHIEGISDEDIMDLEIPTGQPLVYELNDDLTVAKKYYL
>FECAFAII_00512 Purine nucleoside phosphorylase DeoD-type
MSVHIEAKEGEIADKILLPGDPLRAKYIAETFLEDPVCYNQVRGMLGFTGKYKGERISVQ
GTGMGMPSATIYAHELVQSYGVKKLIRVGTCGALSKDVHVRDLVLAQGAATSSSMIEKNF
QAFHFPPISDFNLLLKAYEIAKEKGYTVHVGNVLSEDSFYKDDLTETFQLAELGVLGVEM
EAAALYYLGAKYHVQTLSLMTVSDHLITGEETTAAERQSTFNEMIEVGLETAIAE
>FECAFAII_00513 Purine nucleoside phosphorylase 1
MTKLSEMLQETTQFILDKGVKEIDFGLILGSGLGELADEIEDAVMISYDEIPFFPVSTVV
GHAGKLVYGSLAGKKVLAMQGRFHYYEGHSMQTVTYPVRVMAGLGAHSVIVTNACGGVNE
SFVPGDLMLITDHINFTGENPLIGPNEDAMGPRFPDMSQAYTPDYQATAKAAAEKLGLDL
KEGVYMGYSGPTYETPAEIRMSRTIGADAVGMSTVPEVIVAAHSGLKVLGISCITNLAAG
MQANLSHEEVVETTQRVKQSFKALVKETLTLL
>FECAFAII_00514 Phosphopentomutase
MFKRVHLIVMDSVGIGEAPDADKFGDVGSDTLGHIAKEAGLNVPHLEQLGLGTIRPLEGV
ESVKDHQGYATKLEEVSVGKDTMTGHWEIMGLNIKTPFRVFPNGFPDDLIKQIEEFSGRK
VVCNKPYSGTAVIDDYGEHQMKTGDLIVYTSADPVLQIAAHEEIIPLEELYRICQFVRDI
TKDDPYMIGRIIARPYVGEPGDFTRTSNRHDYALNPFGHTVLDSLKEAGKDVIAVGKIND
IFNGQGITESVRTKSNMDGVDQLLKVMKNDFSGISFTNLVDFDALYGHRRDVVGYAHAIE
EFDLRIPELLEAMEEDDLLMITADHGNDPTFTGTDHTREYVPLLVYSKKMKEQGALPQGY
YSDISATIAENFSVSSTENGESFLKLLK
>FECAFAII_00515 hypothetical protein
MSTIELIALILTSTLVYSTPLILTSLGGTFSERSGIVNVGLEGIMVMGAFSSIVFNLTMS
PSLGSMTPWIAILVGGVVGILFSLIHAVATVSLRADHIISGTVINLMAPALGVFLIKAWY
GKGQTDNITQNLGYFSFPGLADIPVIGPIFFKNTFLPAYCAILIAVLAWVIIFKTKFGLR
LRSVGENPQAADTLGINVYAMRYSGVLISGLLGGMGGAVFAQSISGNFSAGTIVGQGFIS
MAAMIFGKWNPLGAMGASLFFGFAQSLSIIGAQLPVISSIPPVLLQIAPYLLTIIVLVVF
LGKASGPKANGKNYIKSK
>FECAFAII_00516 hypothetical protein
MNDRSEKFRNLLVPVLSVVLGLILGAILMAAFGFQPIQGYSSMLDAALGSQRGIGETLRQ
ATPLIFTALGFSVANSAGFFNIGLSGQALCGWIVSVWVALAFPDLPKVVLLPLCVILGAL
AGAMAAAVPGLLRAFFGTSEVIVTIMMNYILLYVSTFALHEVMPESYRSSLDSSNMISQN
ASLRLPWLTQAFGGSRVNSGLFLAIIALIFVWLLMKKTTLGFEIRSVGLNPFASEYAGMS
SKRTIVLSMVISGALAGLGGVVEGLGTYQNFFVQTTSLSIGFDGMAVSLLGSGSAIGILL
SAILFSILKIGGLGMQTGAGVPFEIVNVSIALIIFFVGINFLIRFVMAKVFQGKKQEEIV
ATIESKPTNQNHEGGEL
>FECAFAII_00517 Galactose/methyl galactoside import ATP-binding protein MglA
MVQENIVIEMQNITKEFGTFKANDNINLQVKAGEIHALLGENGAGKSTLMNVLSGLLEPT
SGKILMRGKEVKITSPTKANQLGIGMVHQHFMLVDAFTVTENIVLGSEPSRAGMLDHKKA
RKEIQKVSEQYGLSVNPDAYVRDISVGMEQRVEILKTLYRGADVLIFDEPTAVLTPQEID
ELIVIMKELVKEGKSIILITHKLDEIKAVADRCTVIRRGKGIGTVNVKDVTSQQLADMMV
GRTVSFKTMKKEAKPQEVVLSIENLVVKENRGLEAVKNLNLEVRAGEVLGIAGIDGNGQS
ELIQALTGLRKAESGHIKLKGEDITNKKPRKITEHGVGHVPEDRHKYGLVLDMTLSENIA
LQTYHQKPYSKNGMLNYSVMNEHARELIEEYDVRTTNELVPAKALSGGNQQKAIIAREVD
RDPDLLIVANPTRGLDVGAIEFIHKRLIEQRDKYKAVLLISFELEEILNVSDRIAVIHEG
EIVGIVDPKETSENELGLLMAGYTLEEARKELEKGAGAHE
>FECAFAII_00518 Membrane lipoprotein TmpC
MKKAKLFGLGAVALAAGLFLGACGNNGSTDSSGGKSSSDTTTAALITDTGGVDDRSFNQS
AWEGLEKWGKDQGLSRGNDGFQYFQSSNESDYIPNIDQALNAGFKTIFGIGYKLKPAIQE
QATNNTGTNFVIIDDVIDGLDNVVSATFKDNEASYLAGVAAAYTTETNVVGFIGGVKGEV
IDRFDAGFKAGVDAGAKELGKEIKVLNQYAGDFSAPDKGRSIAQGMYAQNADIIFHASGG
TGNGVFQEAKSLNESGDKKVWVIGVDRDQSDEGEYTLNGEKKNFTLTSTLKAVGTVVEDL
AQKSADGKFPGGEHTVYGLKEDGVGLTEGQLSDEAKKAVDEAKEKIISGDVKVPETPEEN
>FECAFAII_00519 Cytidine deaminase
MAELKQEWINTAIEALDKAYVPYSHFPVGACLVTESGKIYQGINIENASFGLTNCAERTA
FFKAVSEGEKTFTHLVVAGHTPDPISPCGACRQVMAEFCSPDMPVTLVGDNGVTKATTVR
ALLPYAFTEKDL
>FECAFAII_00520 Deoxyribose-phosphate aldolase
MELNRMIDHTILKADASKEAVMQIIEEAKKYHFYSVCINPAWVALAKEQLQGEPVAVCTV
IGFPLGANTPETKAFETTDAINNGADEVDMVINIGALKSKDDQQVQKDIEAVVEAAKDRA
LVKVIIETSLLDREEIIRACEIAKAAGADFVKTSTGFSTGGAKVEDVRLMRETVGPEMGV
KASGGIHNEEEAMAMIEAGATRIGTSAGVAIVSGSTGEGY
>FECAFAII_00521 Pyrimidine-nucleoside phosphorylase
MRMVDLIEKKRDGNELLKEEIEYIVTNYTNGKIPDYQVSALLMAIFYQDMTNEEITNLTL
AIANSGDVIDLSSLEGIKVDKHSTGGVGDTTTLILAPLVASVGVTVAKMSGRGLGYTGGT
LDKLEAIPGFQIELSDEEFVRIVNESKVAVIGQSGNLAPADKKLYALRDVTATVDSLPLI
ASSIMSKKIAAGADAIVLDVTTGDGAFMKNIEDARRLAKTMTSIGKLANRETVAVISDMS
EPLGEAIGNSLEVVEAIETLQGNGPEDLVEMCYALGSQMVVLAGKAKTTDEARTLLQEAL
ESGKALAKFKEMIQNQGGDPAIVEHPERILTARYTMELPAKQSGVVSKIVANELGIAAMM
LGAGRKTKEEDIDHAVGLKLHKKIGDTVTKGESLLTIYSNDEEITSVIELLYKNIEIGES
AMKPTLIHDIITE
>FECAFAII_00522 HTH-type transcriptional regulator DegA
MKLTIRDIAEMAGVSVTTVSQILNNKGSRFSDKTRKKVLSIVNEHHYKPDYFASNVINRH
SKTIGMIVPDVTDFFFSKLIEGVESYLNPLGYVIMLCNSRHSQENEIKYLQELSHRSVDG
ILLATPNILPEKYALDSGFYQKMPIILIDRGLNRRDNGRLIVKEYEGAYQAVSLFIENGH
TKIGMLKETTGYYQLEERFNGYRHALKDHGLPFNGKFVEHGELTVQGGYTASKKLLKHKD
ITAIFCGNDAMAIGCYQAIDELGKKIPEDISVIGFDGLKLSEYMIPQLTTVQQPSFDIGF
YAARFLIDTIEFPQRKVPNKVFETKLIIRESVKVLTKG
>FECAFAII_00523 Ribosomal RNA small subunit methyltransferase C
MTNHYYSERPDTAHDFEQWAFELKGRTFQFVTDSGVFSRETVDYGSRVLIDAFDWEELPD
EGKILDVGCGYGPIGLALAFATQRFVEMVDINERAVSLAQGNAKRNQIEHVDIHQSNIYE
AVHEETYAAIVSNPPIRAGKKVVHEILTGAYPRLKKGGTLTIVIQKKQGAPSAQKKMEET
FGNAEIVTKDKGYYIIKSVKE
>FECAFAII_00524 Pantothenate kinase
MNDPMNYYRVAREEWREFYRNGQAPLTQDELDNIKSLNDRISMQDVRDIYVPLAHLIYLY
MKEFESLFLSKGLFLHKYVEVPPFIIGIAGSVAVGKSTTARLLQTILSRTFKRRNVQLIT
TDGFLYPNRILKERGIMDRKGFPESYDMEMLIDFLNRVKSGQEEIKVPVYSHDVYDIIPD
KYELIQQPDILIVEGINTLQLPANQQIYVSDFFDFSVYVDADPVLIEKWYLDRFGALLDT
AFQNPENYYYRFAIGDREEAFKMAKDVWKNVNLKNLQEYILPTRGRADIILHKTENHIID
SIFMRKY
>FECAFAII_00525 GMP synthase [glutamine-hydrolyzing]
MTNVADMTNVEKIIVLDYGSQYNQLITRRIRDLGVFSELLSHRITAEEVKAMNPKGIILS
GGPNSVYDENAFGIDPEIFNLGIPVLGICYGMQLITYKLGGSVEPAKNREYGKALLEVTS
DQAVLFKETPKQQTVWMSHGDLVTKVPEGFETVGTSKDCPIASIQDTTRNFYGIQFHAEV
RHSEYGIELLRHFAFDVCHCEGNWTMDNFIDMQVEKIREQVGDKKVLLGLSGGVDSSVVG
VLLQKAIGDQLTSIFVDHGLLRKGEAEQVMESLGGKFGLNIIKVNARDRFLDKLKGVSDP
EQKRKIIGNEFVYVFDDEATKLAGEEGVSFLAQGTLYTDVIESGTETAQTIKSHHNVGGL
PEDMQFELIEPLNTLFKDEVRELGTQLGMPDSIVWRQPFPGPGLGIRVLGEITEDKLEIV
RESDAILREEIAAAGLDRDIWQYFTVLPGIRSVGVMGDGRTYDYTVGIRAVTSIDGMTAD
FARIPWEVLQKISVRIVNEVAHVNRIVYDITSKPPATVEWE
>FECAFAII_00526 Arabinogalactan endo-beta-1,4-galactanase
MKMGIWLRKAVLFAAVLGALGAVSKTVEASASEFIRGADISILSDMEKSGAKYYEDDISK
DALEILKNNGVNYVRLRLWQDPYNSNGESYGAGTNDLETTIDLAKRAKNLGLKVLLDFHY
SDFWVDPGKQNLPKAWQGLTFEEMNTALYDYTKNVLSEMKQLDVYPDMVQIGNELNSGML
WPYGKSWGEGGGEFDRLAAFLKSGIQAVRDTQPKTTPVMLHLADGGDTGAFTWWFDEITS
RGVSFDLIGVSYYPYWHGSMNELQTNMNAISQRYGKEVIVVETAYGHTTANADTMPNAFG
EAEAAAGGYEPTPTGQAEYLLDLADRIQAVPNNRGAGFFYWEPLWYNGNVSWATQAGMNY
LSVQSTMGNEWDNQAMFDFAGNALPSLRAFKQAGAQINLVKNASFESDGPTTSPSNWQTW
FQQGTAKGTIKTEAGTFFGDYKLTFWQDQAYEASAYQNVSGISKGTYTLSAYVMSGGEFD
TNQLYIKNYGGAELNTAVVKTSEWTKITIKDIPITTGVCEIGVYSKASGNAWTNVDFVSL
VKQ
>FECAFAII_00527 PTS system lactose-specific EIICB component
MDGIIKQIEKGKPFFEKISRNSYLGAVRDGFLTAMPAILFSSIFILIAAVPEIFGYQWPE
SVSTWLWKVYNYSMGVVGLLVSATTARCLADSMNRRLPKNKVINTTSVMLASVVSFLLLS
VSPIEGGFSTEYMGTKGLLASFVAAFLTVNLYKFCVLKDITIKMPKEVPGTISQTFRDIF
PFSFSVFAAVLIDLGIRQIFQISFAEAIITVLQPLFTAADGYLGIAIIWGAMALFWFVGV
HGPSIVEPAIAAIIYANVETNLQLFNSGEQASKVLTVGLGNFVGTMGGTGATLVVPFIFL
LFAKSKQLKAVGKASFIPVSFAVNEPLLFAAPMILNPYFFIPFLLTPVVNVCLFKFFVDV
LGMNSFMYVLPWATPAPIGLVLGTGMGILAFVLAAVLIVVDFLIYLPFCKAYDAVLVEKE
AQKAEVIATEEGASADVREEVPVAASQVISDANKEINVLVLCAGAGTSAMLANALKKGAS
ESKAPISAMAGAYGSHYEMLQDFDMVVLAPQVNSYYDDIKEDTDRLGIKLVATKGAEYIG
LTRDPEKAVQFILNQFQ
>FECAFAII_00528 PTS system lactose-specific EIIA component
MNKEELQMLGFEIVAYSGDARSTLLKLLKEVRQGNFEHVDSALKEADENLTLAHNSQTKI
LAEEASGKEMEMGFIFIHGQDHLMTTLLLRDLIQDFIVLYRQNQG
>FECAFAII_00529 6-phospho-beta-galactosidase
MLKLPEDFIFGGATAAYQVEGATKEGGKGAVAWDDFLEEQGRFSPDPASDFYHQYAKDIE
LCERFGVNGLRLSIAWSRIFPDGAGKPNPEGIAFYHRVFEECKKRNVTPFVTLHHFDTPK
RLFDHGDFLNRETIEAFVSYAIFCFHEFKEVKVWSTFNEIYPVATNQYLLGVFPPGIKYD
FTKIVACLHNMMVAHARVVNYFKENELPGEIGVVHSLETKYAATDAPEDKHAAFLDDALS
IRFLLDATYLGYYSTETLTALDEICEANQASYHFPEEDFVELKKASTRNDYLGINHYQCH
FVKAYDGENAIHHNGTGEKGTSVYKVKGIGERIYKEGIPRTDWDWLIYPEGLYDLLLRIK
SDYPHYNKIYITENGMGYKDQFEDGIIMDQPRIDYLRVYLESLSKAITAGVNVKGYFLWS
LMDLFSWTNGYNKRYGLFYVDFETQKRYPKESAYWYKLVSETKTII
>FECAFAII_00530 Lactose phosphotransferase system repressor
MLKKERLLTIVEMVNKKGILTVNEIINQLDVSDMTVRRDLDELEKSGKLLRVHGGAQSLS
YTLDQELSHTEKATLQIQEKKEIAATAASLIHEGETIFLGPGTTIELLATHLLNKKIRII
TNNYPVFDILAQADGPEILLIGGDFRKNTGAFVGPITNDNLRRLKFTKAFISSNGVHNEA
ISTYSTEEGEAQQIALNNSRKKYLLVDNKKFNRDDFYVFYNLHDFDLLITDRQISREVQE
HYAQYVDLQIADSTENTTIGA
>FECAFAII_00531 Beta-phosphoglucomutase
MKGIIFDFNGTMFLDSHLHEAAWLHMIHDHTKDGLSDEDILKNIHGRTNTEILKHFISEH
LTASEIAVLSEEKESYYRMLCLQNENELQLTKGLEATLDQLTDQQIPLTIATATVKENVA
FYFDIFDLARWFDWDKIVYDDGSFPGKPQPDIFLKAADKLSLAPADCLVIEDAYSGLLAA
KRAGIGTIIAIDPFGKNKTVFEQAQLNKDGTIKDFTGFWTEHLSATSVNS
>FECAFAII_00532 hypothetical protein
MRDYVTDKTQEVINQSQSLNELSDKAKEEAVAIISSGISDYIDMSGEINYGDKDKIVRMI
KAFIKTFDVKADLKFNDTYLVGKLINILGTEKDTETFISSLSMLFTDKHFSTQLGGEELV
EIF
>FECAFAII_00533 hypothetical protein
MKNFDTYYVIVFSISLLLILLTLMQYKEYPEYFILTFVYLVSSYTLLYKFRSSSRVSKVC
FLISLLIL
>FECAFAII_00534 hypothetical protein
MLVEKGKENIYYVNVTKVREDENEWKEFKSRYSINSTPTFTVYREGSIEKTVFWTKESGM
SLAEVEEFLDYVSMQQ
>FECAFAII_00535 hypothetical protein
MFIFPLFSQVTFSMTQPVSSEEHDNLFRATEEFKKYQENIVPETPLASEPITDIDGNQIG
WYIQYEVMVVNNDSIVKNTVGLELTPIEKVSSLLTYIYTDESDETEIILTDYSKIATDKK
YILWM
>FECAFAII_00536 hypothetical protein
MKRGNLMKKISNEIQILAETLTLPKVVIEQMIVQAKNILDEVFEQYSHELMDPNKAKATA
KKIDKVYEEEPFAALAIYLYAASQSWKKIYQPLKIPRTIYLATMNAFTRFIHEHFQVTGS
YRFDRGFWIWHYTSGLIFRIGELEYEMTYFPKGYTDLRLEGKQCLSLHIPSDADLSQNKI
RDSYESAIRFFELYFPDYHYQVMYTDTWLLSPNLTKWLKKESKICLFAADYRLLSVDEQD
DSGVPWIFGRVDAQIHDYPESTSLQRQAKEQLLAGEHIGSGLGILTS
>FECAFAII_00537 hypothetical protein
MFKTYFRFNKIQDNPFRIMNLMLLIFIVLWLGYINHDFLISSFSSLGIFTFFYYQNIPMK
YLLKRMFLIGCGLLVAFVLGILSTYVLWLEPFAVALVAFSSRFVLRLFHISKPGGLFFAM
LSAMGTSMQLPIAQLPIVSLYFFMGVVFALIAAVITKLLDSRPEQTIEKATLKERFHEEP
LVIIDSVFYSAALFLSVYVSHGLNLHNPYWLTLSCASILLAENLDAMKHRQVQYLIGSMG
GLCVSAFLSFVPFTQLQTIFLITFLYGIAQFLVARNYAVANIFLNPMALMLSTLIRGAYL
ISLIEYRFLGIVIGSFIGLGVAWVMTVGLQHYLTVVRQKLE
>FECAFAII_00538 hypothetical protein
MRYVSKFLLGIYLFFLLWLILFKLSFNLPQFLTYSYSNVNLVPFSTFSFENTTVLRETTY
NLIVFFPFGVLLNVNFKRLSFSKKLGIIFLVSFLAELIQFLFGIGVADITDLITNTTGGL
IGLWAYQLLNKHLSTNKLDRLAIILGYILFLFLIVAFLFLTRTVRLQ
>FECAFAII_00539 hypothetical protein
MDQKRIHVGLITSFVTMLIYLDQGHLTWTVVGVVGFLTLFTAIKK
>FECAFAII_00540 hypothetical protein
MPKNRLEAFTDAVIAIIMTILVLELHEPNGDTWEALAALGYRFFIYIVSFIILAIYWNNH
HHLFQVVHKINGRVLWANSFFVFALSLFPFATSWISEYINSLAPEMTYGFVTLTANIAYY
ILAKELVKANKGHEKALKAMLNNYKKSYLSIGLNVLGIVLGYLVAPVAVLIANIVILAAW
IIPSRTIESQYR
>FECAFAII_00541 hypothetical protein
MRQKNMFLNIFMVLLVLIAASFVISLFVSVLSGLLWFAVKVLIPIALIIWLVRWIKGNTH
RKNYY
>FECAFAII_00542 Zinc transporter ZupT
MVEWLLRLEPWQQALAGTAFTYFMTALGAGLVFFFKEIKKEVLNLMLGFASGVMIAASFW
SLLDPAITKAEENGDIAWLVVSIGFGLGGVFLYMADKTLPHMHFGPQHEAEGLPTHLKRT
ILLVFSITLHNIPEGLAVGVAFGAAATADNPTAAILAAVSVALGIGIQNFPEGAAVSIPL
RQEGLSRKKAFVYGQASGIVEPIAGVIGALLVTKVELLLPYALAFAAGAMIYVVVEELIP
EAQQTLSSKRHFAVFGVMSGFIIMMILDVALG
>FECAFAII_00543 Pyruvate oxidase
MSKINAGIAMVKVLESWGIDHIYGIPGGSFNSIMDALYQEKTEINYIQVRHEEVGALAAA
ADAKLTGKVGAVFGSAGPGATHLINGLYDAQMDHVPLVAFLGQVASTSMNYNSFQELNEN
PIFADVSVYNRTVMTPQSLPHVVDEAIKAAYEHKGVAIVTIPVDLGFEEIDEQPFSTAHT
HKTSVILPEEKDLLAALPYLEKAKKPVLYVGQGTRNGFPQIKEFSEHFSVPVVASVLAKG
IIPDDYENFLGFAGRVATKPGNEALAEADLILFVGSDFPFGRAFFNPTAEFIQIDIDASK
FGRRHETSLSILGDANTALQRLVELGDARPADSWYLANQENKEKWVNWLKSFEDREEEPI
RPEAVYKEINRIAEDDAIFVTDVGNTTIHSIRLLNMNGKQKHTTSGWFATMGNGVPGGIA
AQLSYPEKQVFTLSGDGGFAMVMQDIITQVKYQLPIINVVFSNDSFGFIEAEQEDTEQKK
FGVFLEDADFGKVGEALGANSFTVTEYSQLRFAFDAAAKSDRPVVIDVKINNKRPLPVED
LHLDPRKYSEEEIQAFKEKYEVHDLPVLNELYEKRL
>FECAFAII_00544 hypothetical protein
MDEKRTIDWGSLILGILFVLVSLLSFQDPVGNLVAIVVVFAIFAFIKGIFELFVRNRLKE
LTGYKGKMPLIIGIIDILVGVFFLFNIGAGVAALPFVFAVWFIADSVLALFTADLARGVS
EGYYWFTIIVNILGILLGIFLLFNPISSALTLSFLVGFYFMLFGITHIVYAFR
>FECAFAII_00545 putative ABC transporter ATP-binding protein YbiT
MITVNDVSLHFSDRKLFDDVNIKFTPGNCYGLIGANGAGKSTFLKVLSGDLQPSTGSVTM
GPDERMAVLKQNHYDYEDYTVLETVIMGHKRLYEVLKEKDAIYMKEDFTDEDGIRAAELE
GEFAELNGWEAEPEAAVLLQGLNIPEELHHQQMSELTGGQKVKVLLAQTLFGKPDVLLLD
EPTNGLDIQSINWLEEFLINFENTVIVVSHDRHFLNKVCTHMADLDFGKIKLYVGNYDFW
LESSQLAAKLQANANAKKEEQIKELQEFIARFSANASKSKQATSRKKMLEKITLDDIQPS
SRRYPFVGFKPEREIGNDLLQVENVSVTIDGKKILDDISFNLSKEDKVAFVAENDITTTT
LFKVIMGEITPDTGTVRWGVTTSNSYLPKDTTKEFDTDLTILDWLRQYASKEEDDNTFLR
SFLGRMLFSGEEVLKPVNVLSGGEKVRCMLSKMMLSKANVLVLDDPTNHLDLESITALND
GLMAFTGSILFASHDHQFIQTLANRIIAVSDKGVIDRADTTYDEFLENADIQKQLNELWA
>FECAFAII_00546 DegV domain-containing protein
MYQIVTDSCCDLPYHVLAKEKVDFLSMNLQLNDQELVDDLGKTFNYDRYMNQLKNGAMPT
TSQINVGRYLEFFRSYAEKQIPVLYVAFSSGLSGSYSSALQAVELLKEEYEDPEIYVFDT
KAASIGEGLLVLEAVRLKKEGKSIEETLEWLESNYLKVHSWVTVDDLKYLERGGRISKAS
ATLGSLLSVKPIITVDKEGRLTNVDKVRGRNKSIQTIVNETVKTIVAPLDQIVYVAYAGD
LESAEKAKRLLEEQIKMKDVKLYPLGPTIASHTGYGCIAIFSMGISR
>FECAFAII_00547 Adenylosuccinate synthetase
MSSVVVVGTQWGDEGKGKITDFLSENAEVIARYQGGDNAGHTIKFNGVTYKLHLIPSGIF
YKDKISVIGNGVVVNPKSLVKELAYLHEKGVETSNLRISDRAHVILPYHIKLDQLQEDAK
GENKIGTTIKGIGPAYMDKAARVGIRIADLLDKEIFEERLRLNLDDKNRQFVKMFDSEPL
DFDDIFEEYYEYGQQIKQYVTDTSVILNDALDAGKRVLFEGAQGVMLDIDQGTYPFVTSS
NPVAGGVTIGSGVGPSKINKVVGVCKAYTSRVGDGPFPTELFDETGEQIREVGREYGTTT
GRPRRVGWFDSVVMRHSKRVSGITNLSLNSIDVLSGLETVKICTAYELDGELIYHYPASL
KELNRCKPIYEELPGWSEDITGCKTLAELPENARNYVRRISELVGVRISTFSVGPDRTQT
NILESVWAQI
>FECAFAII_00548 Replicative DNA helicase
MNEVWQDRIPPQNIEAEQAVLGSVFLDAETIIDAMEYIEPKDFYRRGHQIIFETMIELND
RNEAIDVVTVKDRLEQANLLEDAGGLSYLSDLALAVPTAANIVYYAKIVEEKSLLRTLIQ
TATGIVTKGFEQGEEVQTILDDAERSILEVSEKRNRSGFLSIAEVLNSTIENIDRLAQNN
EEITGLPTGYQGLDKMTAGFQPEELIILAARPAVGKTAFALNIAQNVGTKTDRSVAIFSL
EMGAESLVNRMLCAEGSIEASHLRTGQLSEEEWSNLIVAMGSLSRANIFIDDTPGIKISE
IRAKCRKLAQEKGNLGLILIDYLQLIEGNGKENRQQEVSDISRQLKKLAKELKVPVIALS
QLSRGVEQRQDKRPVLSDIRESGSIEQDADIVAFLYRDDYYEREGGDDDDGNEPKNDNVI
EVIIEKNRSGARGTVELLFIKEYNKFSSLSPREEF
>FECAFAII_00549 50S ribosomal protein L9
MKVIFLQDVKGKGKKGDIKEVPAGYAQNYLIKNNLAKEATKSSISQLAGQKKAQEKHEAE
ILEEAKKLKEFLEKEDTVVELKAKAGEDSRLFGSIPSKQIAEGLNKQYKIKLDKRKIELE
NPIRSLGYTNVPVKLHHEVTATIKVHVVQE
>FECAFAII_00550 Cyclic-di-AMP phosphodiesterase GdpP
MENKNNHLSPKPLFLILFILIEVLVVLILPFRFVSASVILLMNLWGVRYWLKMKRWLILN
KREKIQQASTVAETNLAYVSEVMPVGVIAYQPSSQKIEWLNPLALKIKDQSGLTEEELLD
TFFTAKEKKKNQVYLADKTFQFDMDTVKGVVYFNDITQNQLLKLHQTNSQPVIGILSIDN
YADAIDKLDDKEISYLNSFVTTLVSDWMNEYHVFFKRINAERFFFVAQMIDLKKMMDKKF
DLLDRFRAEAEKQSSPITLSMGIAYGSRTLDEIGGEAQNNLDVALVRGGDQVVVKEVKEG
AKPVYYGGKSAKNVKRTRVRSRAMSTALRRIFDETGDVFIMGHKFPDMDALGSAFGVSCL
ARFNQKKAYIVINENEIIPDVERCLEEIHKHPELEMQLISPERAIELKKEEDLLVMVDYH
KPSLSISQGLYEQFDKIVIIDHHRRGEEFPSKPLLTYIESSASSASELVSELIQYQSSKT
NRLDRFEATLLLAGMVVDTNSFNVRTTARTFDVASYLRSCGADASLVQYLLSSDLATYLE
ISNLIAGSDYVTSDIVVAAGTDEKEYNSVIAAKTADTLLSMININAAFVITKRTDGLIGI
SARSTGTINVQIIMESLGGGGHFTNAATQLENTTVEETKQKLFAAIKENMNQIYDKE
>FECAFAII_00551 30S ribosomal protein S18
MAQQRRGGRKRRKVDYIAANHIEYIDYKDIELLKRFISERGKILPRRVTGTGAKNQRKIT
VAIKRARIMGLLPFVSED
>FECAFAII_00552 Single-stranded DNA-binding protein
MINNVVLVGRLTKDPDLRYTASGTAVATFTLAVNRNFTNQSGNREADFINCVIWRKSAET
LANYARKGTLLGVTGRIQTRSYDNQQGQRVYVTEVVADNFQLLESRSASENRQQSGGFQS
SGQSAGGFGGNNNSNQTSQSSNGMPDFDRDTSDPFGSSSTIDISDDDLPF
>FECAFAII_00553 30S ribosomal protein S6
MENTKYEIMYIIRPNIDEEAKTALIERFDAILKDNGAEVIESKDWEKRRFAYEMNGYREG
IYHIVKVSSPSSANAVNEFDRLAKINDDIIRHMIVKEEA
>FECAFAII_00554 DNA gyrase subunit A
MSEEIRENIHDVNLTSEMKDSFIDYAMSVIVARALPDVRDGLKPVHRRILYGMNELGVTP
DKAHKKSARIVGDVMGKYHPHGDSAIYGSMVRMAQPFSYRYMLVDGHGNFGSVDGDGAAA
MRYTEARMSKIATEMLRDINKNTVDFQSNYDDTEKEPVVLPARFPNLLVNGTTGIAVGMA
TNIPPHNLSEVVAAIDLLMDNPDVTTNELMEVLPGPDFPTGGLVMGKSGIRRAYETGKGS
ITVRAKVEITEMPNGKERIIVTELPYMVNKAKLIERISELHRDKRIEGITDLRDESSREG
MRIVIDIRRDASASVILNNLYKLTSLQNSFGFNMLAIEKGVPKVLSLKQILENYIEHQRE
VITRRTVFEKEKAEARAHILEGLRIALDHIDEIIAIIRGSKSDDEAKATMIERFDLSDRQ
SQAILDMRLRRLTGLEREKIENEYQELLKLIEDLTDILARPERVTEIIKNELADLNQRFG
DKRRTELLVGEVLSLEDEDLIEEEEIVITLTNNGYIKRLANNEFRAQRRGGRGVQGMGIH
NDDFVKNLVSCSTHDTLLFFTNNGKVYRAKGYEIPEYGRTAKGIPIINLLGIDSSESIQA
IIAVTGEAEEGHYLFFTTRQGTVKRTSVTAFANIRSNGLIAIGLKEDDELVNVLLTDGQS
NIIIGTHNGYSVTFKEEAVRDMGRTASGVRGIRLREEDYVVGAALMKENQEVLVITEKGY
GKRTKVSEYPVKGRGGKGIKTANITEKNGPLAGLTTVSGDEDIMLITDKGVIIRFNVSTV
SQTGRSTLGVRLMKMEADTKVVTMAAVEPEAAEQTVEEQGSEE
>FECAFAII_00555 DNA gyrase subunit B
MTEERSLVERAKEYDASQIQVLEGLEAVRKRPGMYIGSTSSEGLHHLVWEIVDNSIDEVL
AGFATKIHVIIEKDNSITVIDDGRGIPVDIQAKTGRPAVETVFTVLHAGGKFGGGGYKVS
GGLHGVGSSVVNALSTQLDVKVYKEGNVYYQEYRRGAVVDDLKIIEQTDRHGTTVHFTPD
PEIFTETTEFDFSKLATRIRELAFLNRGMRISIEDKREEEPVINEYHYDGGIKSYVEYLN
ANKTVIFPEPVYLEGEQQDIAVEVSMQYTDGYHSNIMSFANNIHTYEGGTHESGFKTALT
RVINDYARKQKLMKENDDNLTGEDVREGLTAVISIKHPDPQFEGQTKTKLGNSEVRTVTD
RLFSEHFMKFLLENPSVGRQIVEKGLLASRARLAAKRAREVTRRKGALEISNLPGKLADC
SSNDPEKCELFIVEGDSAGGSAKQGRNREFQAILPIRGKILNVEKASMDKILANEEIRSL
FTAMGTGFGEDFDVSKARYHKLVIMTDADVDGAHIRTLLLTLFYRYMRPIVEAGYVYIAQ
PPLYGVKQGKNITYVQPGKNAEEELKQVVASLPASPKPSVQRYKGLGEMDDHQLWETTMD
PSNRMMARVSVDDAIAADQIFEMLMGDRVEPRRAFIEENAHYVKNLDI
>FECAFAII_00556 DNA replication and repair protein RecF
MRLNKLYLKNYRNYEELNIEFSKNLVIFLGENAQGKTNLLESIYVLAMTRSHRTSSEQEL
IGWTDDQAMIQGEITKGSSTLPLEILLSKKGRKTKINHIEQKKLSTYVGQMNVILFAPED
LSLVKGSPQIRRKFLDMELGQINPIYLYDLVQYQAILKQRNQYLKQLNEKKQTDLLYLDI
LSEQLAAFGSKVLKARAQFVKRLEFWANSLHQQITHQKEQLEIEYLTAVDSLETHTQEQI
QEQFLALLNQNKKKDLFRGTTTVGPHRDDLSFFINQKNVQTYGSQGQQRTTALSVKLAEI
DLIKEETGEYPILLLDDVMSELDDNRQLHLLETIEGKVQTFLTTTTLDHVKNKMTVEPEI
FYVQQGKLKGEETE
>FECAFAII_00557 hypothetical protein
MFYCEKKGIIEYTFNNENEGWALKQQVILNTEFMTLGQMLKEVTVIGSGGQAKWYLAENT
VLVDGEPENRRGRKLYPGMMVEVPEVGTFFMVKKGNDDNEAE
>FECAFAII_00558 DNA polymerase III subunit beta
MKVTLNRASFMQELQTVQRAISSKTTIPILTGVKITLTQEGLTLTGSNADISIETFLSVE
NEKANMQIESTGSIVLQARFFSEIIRRLPEETFTLEVLENKQVAITSGKANFIVNGLDAD
NYPHLPVVESHNQMKLPVHVLTKLINETVFAVSQHESRPILTGVHFILSDNSLLAVATDS
HRLSQRVIPVEQAADHFDIVIPGKSLIELSRSLTNEEEIVEISIMENQVLFKTETMYFYS
RLLEGNYPDTNRLIPSSFNTEVEFSVPSFLAAIERASLLSHEGRNNIVRLSIRPDAVVLY
GNSPEIGKVEESLSYTASSGDPLDISFNPDYMKAALRAFGDMSIKVKFISAIRPFTLEPT
EDGVQFIQLITPVRTN
>FECAFAII_00559 Chromosomal replication initiator protein DnaA
MVSLDALWNELKATYQKDLSPASYNTWIETANPRTLDQNQLVVEVPSKIHKEYWEKNLAT
KIVEVGYMLSGNEIIPRFITGEEAEQEEVIEEKNPKVVAPSPLKKAMLNPKYTFDTFVIG
KGNQMAHAAALVVAEDPGSIYNPLFFYGGVGLGKTHLMHAIGHQMLQSQPNAKVKYVSSE
TFANDFINSIQNKTAEEFRQEYRNVDLLLVDDIQFFAEKEATQEEFFHTFNALYNEGKQI
VLTSDRLPNEIPKLQERLVSRFAWGLSVDITPPDLETRTAILRKKAAAERLEIPDDTLSY
IAGQIDSNIRELEGALVRVQAFAAMNSEDISTSLAADALKTLKSGKGHPQLSILQIQEEV
AKYYHIQLKDLKGKKRVKSIVVPRQIAMYLARELTDNSLPKIGAEFGGKDHTTVIHAHEK
IQQLMDSSVSMQNEVSEIKNFLLN
>FECAFAII_00560 50S ribosomal protein L34
MKRTYQPNKRKRQKVHGFRKRMSTKNGRRVLASRRRKGRKVLSA
>FECAFAII_00561 Ribonuclease P protein component
MRKAYRVKKEREFQAVFHTGDSFANRKFVVYRLEKPGQPHFRVGLSVGKKVGNAVNRNEV
KRKIRAAVYSIKEEIDPELDFIVIARPSVKGLTYDEVRSNLVHVLKLAKIIDREEKSK
>FECAFAII_00562 Membrane protein insertase MisCA
MKKYKRLLLMAGIVSLVIVLSGCGTGEVSAQSTGIWDRYIVYYFAEAIKALSFGNAGIGI
ILFTLIIRVILLPLMHFQTKSMRKTQELQPKLKALQQQYSSRDPETQSKLREEQQRLYAE
NGVNPYAGCLPLLVQMPILMALWQSISRVPELKQGHFLWLNLGNADPTFILPILAAIFTF
ASTYLSSMSQIESNASMKIMNFVMPVMILVMGVNLASGLSLYWVVSNAFQVVQTLLINNP
FKIRKEREEEARRIRERERALKKAMNPKKKRK
>FECAFAII_00563 hypothetical protein
MPIYEAATIDEAVQLGLADLGLAKDQVEIEILEEGKKGFLGMGRKNARLSIQPSISEKVS
ETVEQTVEEILEEEPTAEIEVVNETILEEKTEEVSELGDEAALTELAVYLTEISKQLDAP
ALVKMERESNNMVVFHLETQKQGILIGKHGKTLNALQYLAQVFIHRLARNKLSVVVNVGN
YREKRQEIIQRLADRTAEKVKRTGQPVFLEPMPAFERKQIHAALSKDEHVKTHSEGEEPY
RYLVVEPAKKYY
>FECAFAII_00564 hypothetical protein
MSPFRSAALEEESDPRINDVVLSTGNINQKYIVRDIVFVVECLEADLFDPSFPKDDLFLT
TKRKLKTKVLEYGANAVINCHFEYQQKKRDGKYFLELFAYGTVIQFIQTTIG
>FECAFAII_00565 tRNA modification GTPase MnmE
MAEITLEFDTIAAISTPPGEGAISIVRLSGDQAVQLADKVYQSGNKRLSEVPSHTIHYGH
IVDPKSNQLVDEVMVSVMRAPKTFTREDVVEINCHGGIVVVNQILQLLLREGARLAEPGE
FTKRAFLNGRVDLSQAEAVMDLIRAKTDKAMGLALNQLDGNLSALIRSLRQEILETLAQV
EVNIDYPEYDDVEELTTKLLLEKAQMIQQRIQALLATSKQGKVLREGLSTAIIGRPNVGK
SSLLNHLLREEKAIVTDIAGTTRDVIEEYVNVRGVPLKLIDTAGIRETEDVVERIGVERS
RKALAEADLILLVLNQSEPLTAEDEQLLEATSGLKRIILLNKTDLPAQLEQEKLKKLIEN
EPVFSISVAKNDGLDRLESAISDLFFSGETGERDATYVSNTRHIALLEKASLSLEEVIAG
IDSGMPVDLVQIDMTRCWDYLGEVVGDSVQDELITQLFSQFCLGK
>FECAFAII_00566 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MEHYEADAYDVIVVGAGHAGSEAALAAARMGSKTLLLTINLDMVAFMPCNPSVGGPAKGV
VVREIDALGGEMGKNIDKTYIQMRMLNTGKGPAVRALRAQADKHAYSTEMKHTIEKEPNL
TLRQGIVEELIVEDGVCHGVVTSTGASYRAKAVVITAGTALRGEIIIGELKYSSGPNNSQ
PSIGLANHLKELGFAIERFKTGTPPRVKSSTIDYSVTEEQPGDKEPNHFSFSTPDSAYKL
DQESCWLTYTGETTHQIIRDNLHRAPMFTGIVEGVGARYCPSIEDKIVRFADKPRHQLFL
EPEGLNTEEVYVQGLSTSLPEDVQVNMLHSIAGLEKVEMMRTGYAIEYDVVEPHQLRPTL
ETKVVENLYTAGQTNGTSGYEEAAGQGLIAGINAALKVQGKEPLVIKRSDGYIGVMIDDL
VTKGTNEPYRLLTSRAEYRLLLRHDNADLRLTEMGHRVGLVKEDQYKNYLKKKEAVEQEI
KRLMNVRIKPTEEVQDFLATINAAPLKDGVLASDFLRRPEITYAELLRFIPENEELTRKE
IEQVEVQIKYEGYIKKAMEKVEKLKRMEAKKIPENIDYAAINGLATEAKQKLQKIQPETI
AQASRISGVNPADLSILMVYIEQGKIAKVSEPA
>FECAFAII_00567 Ribosomal RNA small subunit methyltransferase G
MIPEEFRQSLAEKGIELTDHQMNQFAIYYRTLVEWNEKMNLTAITDEKDVYLKHFYDSLT
LAFEVDFTQPLSLCDVGSGAGFPSIPLKIAFPELQITIVDSLNKRITFLSELTRLLGIDA
SLYHDRAETFGQNPHFRASFDLVTARAVARLNVLAELCLPLAKQEGYFYALKAAKSEEEL
TEAKQAIALLGGKFLKEEAVTLPNVSDQRHIIVIQKKKPTPKKYPRKPGLPNKQPIK
>FECAFAII_00568 Sporulation initiation inhibitor protein Soj
MAQIISVANQKGGVGKTTTTVNLGACLASLGKKVLLVDMDAQGNATSGVGIRKPDVTRDI
YDVLVNELPIDEATLITEHENLSIVPATLQLAGAEIELTSMMARESRLKGSLAEVSSQYD
YILIDCPPSLGHLTINSFTASDSILIPVQCEYYALEGLSQLLNTVRLVQKHFNPELEIEG
VLLTMYDARTNLGNEVVEEVRKYFREKVYETIIPRNIRLSEAPSHGKPIIDYDPRSRGAE
VYQALAKEVVSREEK
>FECAFAII_00569 putative chromosome-partitioning protein ParB
MKKSKGLGRGIDALFQDLENLETVDVKDDTVVQLPLNELRPNPYQPRKTFEEVSLQELAN
SIEQSGVFQPIIVRRSAVKGYEIIAGERRFRASKLAEKETIPAIVRDFDEEAMMQVAVLE
NLQREDLNPLEEAEAYEMLMKNLKLTQAEVASRLGKSRPYIANYLRLLSLPDLVKEMVQD
QRLSMGQARTLLGLKNKTLILKLANRAVTENLTVRQLEQLVSELNQNDGKEKKKIPRLAK
EKPYYIRESEDRLMDKFGTSVAIQEKNGKGKIEIEYLSQKDLTRILDILNIQFDEE
>FECAFAII_00570 hypothetical protein
MYDLHDIVEMKKPHACQTNRWEVIRMGADIKIRCMNCGHIVMMTRRDFEKKLKKVIEKNA
EKE
>FECAFAII_00571 Ribosome-binding ATPase YchF
MALTAGIVGLPNVGKSTLFNAITKAGAEAANYPFATIDPNVGMVEVPDWRLQRLTELVHP
KKTVPTTFEFTDIAGIVKGASKGEGLGNQFLSHIRQVDAICHVVRCFDDDNITHVEGRVD
PLEDIDTINLELVLADLESINKRYTRVAKVAKTKDKDAVAELAVLDKIKPVLEEGKSART
IEFTEEEQKIVKSLFLLTTKPILYVANVSEDDVADADANHYVQEVRNFAAEENAEVIVVS
ARAEEEIAELDEEDKAEFLEALGIEESGLDQLIRAAYDLLGLATYFTAGEQEVRAWTFKK
GIKAPQAAGIIHSDFERGFIRAETVSFEDLDHYGNMHAAKEAGRVRLEGKDYVVQDGDVM
LFRFNV
>FECAFAII_00572 hypothetical protein
MEPEQLRAIVKENNSLETKLTKRNQQYIFDLKKSLEAANLSEEEKVKALHDILPTLVAEQ
KGGRTARQLFGTVSERTEAIINKPAEVKNSSTPLLMWLDNTLLLLGLLSIMIAITGLFSR
GTTPAYGFSTLVLGSAIGGWVFYMMYKYIYQYEYPGADRSKKPGMGKTLLILGGTTLLWV
VLFSATTLLTPVINPVLDPVVVIIIGATALAIRYYLKKKYGIIGSLSVPRR
>FECAFAII_00573 Inosine-5'-monophosphate dehydrogenase
MSNWETKFTKKGFTFDDVLLIPAESHVLPNEVDMSVQLAKNIKLNIPIISASMDTVTDSK
MAIAMARQGGLGVIHKNMTISQQADEVRKVKRSESGVIIDPFFLTPQHLVADAEELMSKY
RISGVPIVETLENRKLVGIITNRDMRFVTDYHMPIADVMTKDNLVTAPVGTSLKDAEKIL
QKHKIEKLPIVDNEGRLSGLITIKDIEKVIEFPNAAKDEHGRLLVAAAVGVTSDTFERAN
ALLEAGADAIIIDTAHGHSAGVIRKIQEIRSTFADATLIAGNVATAEATKALYDAGVDVV
KVGIGPGSICTTRVVAGVGVPQLTAIYDAASVARQYGKAIIADGGIKYSGDIVKALAAGG
HAVMLGSMLAGTDESPGEFEIFQGRRFKTYRGMGSLGAMEKGSKDRYFQGSVNEANKLVP
EGIEGRVAYKGSVADIIFQMIGGLRSGMGYVGAANLQQLRDEAQFIQMSGSGLKESHPHD
VQITKEAPNYSVES
>FECAFAII_00574 Serine--tRNA ligase
MLDVKMMRQNIEEVQEKLMTRGVKKETLAEFMELDENRRKLLVKSEELKKYRNDVSAEIA
QLKRAKEDASAKIAEMKEVGGNIKALDTEIAEVDEKLKQIATTLPNLPHDSVPVGTDEED
NVEIRRWSEPRTFAFEPKPHWEIAENLDILDFERGAKVAGSRFVYYKGLGARLERAVYNF
MLDQHIYEHGYTEMITPYIVNSKAMFGTGQFPKFKEDVFQLENTDLTLIPTAEVPLTNYY
NDEILDGADLPIYFTALSPAFRSEAGSAGRDTRGLIRLHQFNKVEMVKFSDVEHSYEELE
KMTADAEDILKKLHLPYRVMALSTGDMGFSAAKTYDLEVWIPAQDTYREISSCSNCEDFQ
ARRAMIRYRDNDGKIHYTHTLNGSGLAVGRTVAAILENYQNEDGSVTVPEALVPYMGNLK
VIK
>FECAFAII_00575 Sensor protein kinase WalK
MTQDSKRATEKRRRINLTSKEISELLAEGIITIILLLLLNVSILVVISSVINSSPSLTNA
IWDSKNIFAERLNTDLFWNGRNFIIPFFFLLDIGVLYWRLIRRYRQMQLRHIISELHYIA
NGNYDHRIPFELSGDLSRVVTSINGLVDSTVAAIEDERKIEKSKDELITNVSHDIRTPLT
SIIGYLGLIEDGQYHSEEDLLKYTHTAYIKAKQMKSLVDDLFEYTKVRQPAVPVNFSAFD
MIQLIEQLAADFELEASKKNIQILVQSKVDSLIMDGDTEKLVRVFNNLLTNALKYGKGAT
KIVIEVERIGSEVVATVKNNGAMIPQQAIDNLFDRFYRVEESRSQATGGTGLGLAIAQSI
VALHGGYIYAKSDKQWTSFIMHLPIKKNEKLPIDTQEVIDES
>FECAFAII_00576 Transcriptional regulatory protein SrrA
MKILIADDDKEIVELLSIYVHNEGYEAVKAYDGKEALSKIRTIPDIELLILDIMMPEMDG
MQVVKELRKESQIPIIMLTAKTTDMDKIKGLVAGADDYVTKPFNPLEVMARVKSLLRRTK
MQIAPDQPDVLEVNALIINKDSHEVKTIDGKEIQLTALEFGILYLLASHPNRVFSADEIF
ERVWKQESIVSAKTVMVHVSHLRDKIEEATGGEKVIQTVWGVGYKIDAR
>FECAFAII_00589 Transcriptional regulator CtsR
MAHQNTSDLIESYIKKILENSEMIEIRRIEMADLFNCVPSQINYVINTRFTIQRGYLVES
KRGGGGYIRIAKVRISDKKQLLEQINQLFDDTISEKNAFAIIQKLYEDQIITKKEGNLML
SAIAKNTLNFNEYEDHTRARILRAFLERLSYEDGK
>FECAFAII_00590 Negative regulator of genetic competence ClpC/MecB
MEELFTERAQAVLEIAQEEAKRLKHQSVSSEHVLLALVVEQNGIAGKVLREMDLNETEIY
EEIEHLIGYGGIRSYPKGVFLPYSPRMKQVFALASSEVKKTGSQKVGTEHILMSLLKDES
IMATRIMINLGISLSKARQVLKQKMGLAGDSAGKGMNRRRNVNVQDKRQTPQGTPTLDSL
ARDLTKLAKENKLDPVVGRSREVKRLIQILSRRTKNNPVLVGEPGVGKTAIAEGLAQKII
LGEVPEDMQEKRLMMLDMGSLVAGTKYRGEFEDRMKKVIDEIYNDGQVILFIDELHTLIG
AGGAEGAIDASNILKPALARGELQTIGATTLDEYQKYIEKDSALERRFARIQVDEPTPEE
AEVILQGLRTRYEEHHGVEITDEAVRAAVNLSVRYITSRQLPDKAIDLIDESAAKVRLDQ
TDHLTKSTVIKLEIDELVQEKEAAIQKQDFENAAQLRRQEKALRKKLQKVSAIEAKQEQG
YSDRVTEEDVATVVSEWTGVPLQQLEKKESERLLELEGLLHERVVGQDEAVKAVSRAIRR
ARSGLKDPDRPIGSFMFLGPTGVGKTELAKALSEVMFGSEDALIRVDMSEFMEKYSTSRL
IGSPPGYVGYDEGGQLTEKIRQKPYSVILLDEVEKAHPDVFNLLLQVLDDGHLTDSKGRK
VDFRNTIMIMTSNIGATQIREEKNVGFNVQDVTKDHKAMQKRILEELKKAFRPEFLNRID
ETVVFHSLSKDEIHTIVQIMSKAIIKRLKEQDIQVKITPSAIDVIGKAGFDPEYGARPIR
RALQKEIEDRLSEALLGGEIRLGDHVTVGASKGKITLNVRGPKKETVGSL
>FECAFAII_00591 putative protease YdcP
MIELITTVETIEQAEQLLAAGADTLYFGEEQFGLRLPASFTREEQRQLVELAHKYGKKAN
IAVNGIIHPEKMKNVPEYLAFLKEINVDVITVGDTGIIYTMKKNPELRIPYIYDAETLVT
SARQINFWAKKGAVGAVLAREVPFEEMKAMEEKLDIPVETLVYGATCIHQSKRPLLQNYY
NYTKQDEQKDRERGLFISEPKKEETHYSIYEDSHGTHIFASNDLNLSNELNELYQHHYCT
WKLDGLFTPGEKFVNITRLFAEAKKQILEGSWDQEKAEKMTSEISKLHPENRELDTGFFY
IDPSAIK
>FECAFAII_00592 putative protease YdcP
MKEMTVKRKLKRPEILAPAGTLEKLKTAIHYGADAVYIGGNAYGLRSRAGNFTYEEMAEG
VAFAKEHDAKVYVAANMVTHEGNEDGAGEFFRSLRDVGISAVIVSDPALIEICATEAPGL
PIHLSTQASATNFETLEFWKEEGLERVVLAREVSMEEVAEIRKNTDTEIEAFIHGAMCIS
YSGRCTLSNHMSMRDANRGGCSQSCRWKYGLFDMPFGQERNSLTDTGEVEEEFSMSAVDM
SMIEHIPELIENGVDSFKIEGRMKSIHYVSTVSNVYKAAVDSYMEDPENYVCKQEWIDEL
WKVAQRELATGFYYNTPTENEQLFGERRKIPVYKFVGEVLSYDEATQIATIRQRNLFSVG
DEIEFYGPGFSHFSQTVEVMHNEEGESIDRAPNPMMILTMPVAQPVKPGDMIRKRK
>FECAFAII_00593 Glutathione reductase
MQIYDYIVIGGGSGGIASANRAGMHGAKVLLIEANELGGTCVNVGCVPKKVMWQASTILE
TIERDASSYGIQADLKNVDFAGLVERREKYIDFLHGAYQRGLDSNHVEAIKGYATFIDSQ
TIEVNGETYRAPKILIATGGRASKMTIPGGEYAIDSNGFFELTELPKRAIVLGAGYIAAE
LSGVFRGLGSEVMWAYRKERPLRTFDKMLSDNLIQMYQEAGIKTYAHHIAKEITKNNDEY
TVLFENGETLTGDCVLFAGGRVPNTEKLGLENTNVELDKKGFIKVDKYQNTTDEHIFAVG
DVIGKLDLTPVAIAAGRRLSERLFNGKKDSYLDYKLVPTVVFTHPPIATIGLTEEEALEK
YGENELKVYRSRFTPMYFALNDYRQKCEMKLICVGKEERIVGLHAIGVGVDEMLQGFAVA
IKMGATKEDFDNTVAIHPTGAEEFVTMR
>FECAFAII_00594 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MTLKIFLEVVEIRTKVASVFPFAVGVLFSIAFFHEIHWLNTFLFFIGMLVFDLATTAINN
YMDYEKAHSEVYKYEENVIGRRNLSPVLIRNMILAMIAFVFVIGVILTINTGWLLLLMGF
ICCFIGVFYTFGPIPLSRMPLGEIFSGVTMGLGIFAMVVYVNTFGSDVYDLTVNFSSGQF
ALVGNLWAIAAIVLASLPLVFTIANIMLANNLRDLDRDIENHRYTLVFYIGRPAGTVLFQ
LLMYACYFVILMGLLSGIYEWPILVTFLTLPIVKKHLDQFKQTLPQPISFSYSIKNMVLF
NASYVLGLLLTIIMQAI
>FECAFAII_00595 FAD:protein FMN transferase
MRKKLLFSLITLGISFMVLTGCSNSANKTTTESSAATKILKDPYSDEQFLLGTYVRIRVY
DEGKESTLKPAFDRVKELGDKITINQKGSEIDEVNEQAGIKPVKVSDDVYTLVKRAYEYS
QDSQGGFDMAIGAITQLWRIGFDDARKPSQEEIDQALKLVDYHKIELNDKEKTVYLKEKG
MIIDLGAIAKGYITDEVVKVLKKQGVTTAIVDLGGNVYVLGHSPRGENQDWTVGIQDPNM
ARGSVLGSIKERNKTLVTSGIYERYLEVDGKKYHHLFDPKTGYPFDNDIASVTIITDKSI
DGDGLSTAVFSMGVKKGLEYVESELNNGTEAIFVTKDDKVYVTDPIKDTFKLSEDSHYTM
GDRSELK
>FECAFAII_00596 hypothetical protein
MEWWGIKMKKKRFVTGFAVLAFSALVLGACGADDNGSSNSSSESSTAQSSTAKSTTESSA
KVVAGGDLQDGTYKLEEKNYSNGYRAVFEMVVKDGKITESKYDNVNENGESKTKDAEYNK
NMEAKSGTNPEKYIPELNDQFLKAQSASGVEVVTGATHSSESFQNYAQQLIQAAQAGNTD
TIEIDNGADLKDGTYKLEEKNYSNGYRVQFEMTVAGGKVTESNFDYIDKDGKSKQDDTEY
NENMKAKSGTEPKTYIPTLNDEFVKAMGEEDGSPANVEVVTGATHSSHSFIMYAQQLVNA
AEKGDTQTIEVDNIVTEK
>FECAFAII_00597 NADH dehydrogenase-like protein YjlD
MAKQNIVVVGAGYAGVSATKYLAKKLKKEDVAITLIDRHSYHTMMTELHEVAGGRVEPEA
IQYDLQHLFARQKNVQLVTDTVIGIDKERKIVKTKLGSYPFDQLILGMGGEPNDFGTPGV
KAHGFTLWSFEDSVRIREHIEKTVAKAALEPDDELRKAMLTFVVCGSGFTGIEMIGELID
WKNRLAKDYKLDPNEITLMVVEAMPTILNMLDRNDAAKAERYLRKHNVELLLNAPIVEVA
ADHIKLKDGRNIPTHTLIWTAGVKGTSDAADFGLESARGQRLIANEYMQAKGYEDKNIYI
IGDLVFYEEFPGTPTPQIVQAAEQTGHTAAANIVASIKGGEKHKFKGNYQGFMVSIGAKW
GVANLFDKIHLSGFLAIVMKHIVNLKYFFDIRSGYYMFQYLMHEFFHIKDDRNVTRGHSS
RYGNVLWSVPLRIFYGLVWFVEASKKIIGNGEVFKPSTWFGEGSWFTGNSVFPWTWEYNV
TDVASGASAAGDATTAASGAGASAGEAATQAAHFGLSYAYGEEPMAVIEKSPDWFTKIMQ
VIMPNNDVAMFFQKFMVFFEIALALALIAGLFTWLCSATTIVLVITFCLSGMFYWVNIWF
IFVAFALMNGSGRAIGLDRWVIPWLQRTLGNWWYGRPSSQYGKK
>FECAFAII_00598 hypothetical protein
MSLKEFAEKSLLKPWDVFIILLLTVLSFLPVMIFGLQQNTATAEKEAVLRVDGTEIKTFP
LMAGEESNTYTYKDEHGDYNLIEIDGDRVRIKEADCDDQICVRRGWATKNGETIVCLPHK
LVIEVRSTDGGDEDSLIY
>FECAFAII_00599 hypothetical protein
MSKLQKMIYISLLVAQGVIIGLLENMIPYPFSFAPGAKLGLANLITIVAIFTMKKRDSFL
LLWLRLFLTTLLGGTISTFLYSMSGALLSYFGMLLVKQLGPKRVSIIGISAAGGFMHNVG
QLLMASFIAQSWTVMLYLPVLSVLGILSGIAIGIAANYLLRHVQTLQRFQKDYEQGTKQK
WSPMFTKK
>FECAFAII_00600 Heptaprenyl diphosphate synthase component 2
MKLHPMWENYPALSKELTETLKRMEETVRLKNKPVEQAIKETIHAGGKLLRPAYQLLFSQ
FGPEQDRDKAIALAASIEMLHTATLIHDDIVDEADLRRGQPNIRSQFGNVVSVYAGDYLF
VCCFKLLSDYSTSLKSLQLNSRSMEKVLNGELGQMDDRYNYELSVKEYLENISGKTAELF
QLSCSVGAFESGTSERFAKKAGDIGLSIGMAFQIIDDILDYTKESQEIGKPVLEDMRQGV
YSLPLIYSLQKNKPKLLPYLEKKAAMTEEDVDAVRKIVEHTGGVEEARKLAASYTEKALK
EIKKLPATSLRTKENLFSLTQLILDRKD
>FECAFAII_00601 hypothetical protein
MKKRASLLVLVALLFNIFSYGVAVSAETYIPKDPGNIYNDLTGNYGLLGIASQFHVFAKN
KTTVNAHTDGNIATHELDAKNNFGTELHEGLLNQEINYIQKTDSFANSSGIPTGSTRMNK
FVVGSNVDVALQDGHPTVNGSRLDHLTPDDFYKDRAGHEYIDFEQEFAKLNVAANDLATI
TPAKTYTAADFPDMNNRTIDLTDLSDTGFLLVNIDAEVLTMNTPLQIINPNDQVVVFNVI
NSSSALNVQSPIKYNDRSNHETEDFSDANISWNFGNEMTDLTISAPFQGTILAPNATIRI
TQNQDGTIIGTNVILDAATNRWDPNEIFISDNGTDTTDTSDSTDTSTTSDSSDSSTSSDS
TDTTSTTSDSTDTSASSDSTDTTSTTSDSTDTSASSDSTDTTSTTSDSTDTSASSDSTDT
TSTTSDSTDTSASSDSTDTTSTTSDSTDTSASSDSTDTTSTTSDSTDTSASSDSTDTTST
TSDSTDTSASSDSTDTTSTTSDSTDTSASSDSTDTSTTTSDSTDTSASSDSTDTTSTTSD
SSDSSTTTSDSTDTSASSDSTDTSSTTSDSSDSSTSSDSTDTSSTTSDTRHASVSFSKTS
SDNRTNFNLTNKTSNDNGNKSKRALPKTGSQSNNWITLAGVILLVIGLRITFMSYKKSKR
>FECAFAII_00602 hypothetical protein
MDYLDMLCESVDRAYDRFERLFEGVSIEEANRFPVEDRAPQIKSMTWLAWHTARELDFQI
ADLAGTSPIWHSQDWESRFPMTIADNEQDWKHSLEQAKQIQANQIEDLLGYLRGAADFAI
SYLRRLEPSELDEVIDENWTPPVTRGMRLVSIIDDAAMHSGQVIYARRLLGLRD
>FECAFAII_00603 Bifunctional ligase/repressor BirA
MTTKDKVLQLLKKTPDFLSGEKLAQQLEVSRTSIWKAIKELEKAGYRFEHGPTGYRYLPS
DVLDAKEIQQELRSFIPDLKVQTMLTSESTMKDAKLAAAQGDSVSKLFVADTQEQARGRF
GRPFFAEPGRGIYMSLLLHPDKRFDELPQYTIIAASACVKAIESVTGRSASIKWVNDIYM
DGKKVCGILSEAVSDMESGRISHIIIGIGLNFSVPQNHFPADLQEKAISVFPDGQASVTR
NQLISKIWQELFTYLSHPEKALDFYKEKSFVLGKTVSFNQKGTTYVGLAKEIGDHGELIV
QTNEQKMSLSSGEISLTSIRTQ
>FECAFAII_00604 ABC transporter ATP-binding protein YxdL
MNDVLTLENLHHTFEKGTINENHVLKGINLSLDPGDFVTIIGGNGAGKSTLLNSIAGTFS
VDQGQILLNGKNITKKSVVERSKSISRVFQDPKLGTAVRLTVEENLALAMKRGKKRGFFR
GVKPQDRTFFKDQLVRLNLGLENRLSSEIGLLSGGQRQAITLLMATLQRPELILLDEHTA
ALDPATSKTVMELTEKLITEQNLTAFMVTHDMEDAIRYGSRLIMLHQGRIVVDIQQEEKQ
QLTVPQLLALFKQNSGTALKDDQVLLSS
>FECAFAII_00605 Autoinducer 2 import system permease protein LsrC
MTNLLSLFLSSASQGVLWALLAIGVYVTFRILDIADLTAEGSFPLGAGIAAVSITNGYHP
LTACLLGFLGGAAAGLVSGLLHTKLKIPALLAGIITMTGLYSVTSRVMGAPNISLLGQPT
IFHWVESFGITKDNAVLIVGLLFALIVVCLLVLFLRTETGLAIRATGDNLAMSEANGINT
DNMKIIGYMISNGCIALSGSLLAQNNGFADLNSGIGTIVIGLASIIIAEVLLRNQPLFLR
LLTVVLGAVIYRFILALVFELNVEPSDSKLASAFVLVICLSFPQIQQKFHLPQKKKGGSV
K
>FECAFAII_00606 hypothetical protein
MKKNIIIGLGAALLLALGGCAQKDNSAEASDGQKTIGVLQLVQHNSLDAAYKGFKEGLAE
EGYKEGDNLTIDYQNAQNNQDNLKSMSEKLVKEDPDLLLGIATPAAQSLLNETTTIPMTV
TAVTDLEQAHLVTSNEKPGGNVTGTTDMVPIEKQIGLLLNIVPDAKTIGIMYNNGEANSK
IQADLAEKELKKAGVKVKVLTANSTNDVQQVTKSLAKDVDGIYIPTDNTFASAASVVGEV
AKETKTPVVAGAVDQVKDGGLATVGIDYESLGKQTGIMAAKILDGKNPSELPVETANDLE
LYVNKDMAKALGINPDSIKEAE
>FECAFAII_00607 DNA-directed RNA polymerase subunit beta
MAGHVVKYGKHRERRSFARISEVLELPNLIEIQTDSYQWFLDEGLREMFEDILPIDDFNG
NLSLEFVDYELKEPKYTVAEARAHDANYSAPLHVTLRLTNRETGEIKAQEVFFGDFPLMT
EQGTFIINGAERVIVSQLVRSPGVYFHGKVDKNGKEGFGSTVIPNRGAWLEMETDAKDIS
YVRIDRTRKIPLTVLVRALGFGSDDTIFEIFGDSETLRNTVEKDLHKNASDSRTEEGLKD
VYERLRPGEPKTADSSRNLLNARFFDPKRYDLANVGRYKVNKKLDLKTRLLNLTLAETLV
DPETGEIIVEKGTVLTHQVMETLAPFIDNGLNSVTYYPSEDGVVTDPMTVQVIKVFSPRD
PEREVNVIGNGYPEAAVKTVRPADIIASMSYFLNLMEGIGNVDDIDHLGNRRIRSVGELL
QNQFRIGLARMERVVRERMSIQDTETLTPQQLINIRPVVASIKEFFGSSQLSQFMDQTNP
LGELTHKRRLSALGPGGLTRDRAGYEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYAK
VNKFGFIETPYRRVDRETGRVTDQIDYLTADIEDHYIVAQANSPLNEDGTFAQDVVMARA
QSENLEVSIDKVDYMDVSPKQVVAVATACIPFLENDDSNRALMGANMQRQAVPLINPQAP
WVGTGMEYKSAHDSGAALLCKHDGVVEYVDASEIRVRRDNGALDKYDVTKFRRSNSGTSY
NQRPIVHLGEKVEKGDTLADGPSMEQGEMALGQNVLVGFMTWEGYNYEDAIIMSRRLVKD
DVYTSIHIEEYESEARDTKLGPEEITREIPNVGEDALKDLDEMGIIRIGAEVQDGDLLVG
KVTPKGVTELSAEERLLHAIFGEKAREVRDTSLRVPHGGGGIVHDVKIFTREAGDELSPG
VNMLVRVYIVQKRKIHEGDKMAGRHGNKGVVSRIMPEEDMPFLPDGTPIDIMLNPLGVPS
RMNIGQVLELHLGMAARQLGIHVATPVFDGASDEDVWETVREAGMASDAKTVLYDGRTGE
PFDGRVSVGVMYMIKLAHMVDDKLHARSIGPYSLVTQQPLGGKAQFGGQRFGEMEVWALE
AYGAAYTLQEILTYKSDDVVGRVKTYEAIVKGEPIPKPGVPESFRVLVKELQSLGLDMRV
LDIEETEIELRDMDDEDDDLITVDALTKFAEQQTAKELEKKAAEQVEDEKDDVIQNFETA
EDNLD
>FECAFAII_00608 DNA-directed RNA polymerase subunit beta'
MIDVNKFESMQIGLASPEKIRSWSYGEVKKPETINYRTLKPEREGLFCERIFGPTKDWEC
ACGKYKRIRYKGIVCDRCGVEVTRSKVRRERMGHIELAAPVSHIWYFKGIPSRMGLVLDM
SPRALEEIIYFASYVVIEPGNTNLEKKQLLTEREYREKREQYGQEFQAAMGAEAIKQLLD
NVDLDAEAAELKEELKSAQGQKRTRAIRRLDILEAFRASGNQPSWMVMDVIPVIPPDLRP
MVQLEGGRFATSDLNDLYRRVINRNNRLKRLLDLNAPGIIVQNEKRMLQEAVDALIDNGR
RGRPVTGPGNRPLKSLSHMLKGKQGRFRQNLLGKRVDYSGRSVIVVGPFLKMYQCGLPKE
MAIELFKPFVMRELVQRELASNIKNAKRKIERQEDEVWDVLEDVIKEHPVLLNRAPTLHR
LGIQAFEPVLVQGRAIRLHPLVCEAYNADFDGDQMAVHVPLNEEAQAEARMLMLAAQNIL
NPKDGKPVVTPSQDMVLGNYYLTMEEEGREGEGMVFRDQNEAVIAWRNGYVHLHSRIGVN
PNSLGEKPFTEWQKERTMITTVGKIIFNEIMPPEFPYLNEPTDFNLTVQTPDKYFVEAGT
DIPAHIKEQELVLPFKKKNLGNIIAEVFKRFKVTETSKMLDRMKDLGYKHSTHAGITVGI
ADISVLNEKQEIIENAHKQVETITKQFRRGLITDDERYERVIAVWNAAKDSIQQKLMEGL
EAKNPIFMMSDSGARGNISNFTQLAGMRGLMAAPNGRIMELPIISNFREGLSVLEMFIST
HGARKGMTDTALKTADSGYLTRRLVDVAQDVIIREEDCGTDRGLEIQAIREGNEIIESLE
DRLVGRYTRKEVRHPETNELIIAGNQLISEDIAKQIVDAGVETVTIRSVFTCNTKHGVCK
HCYGRNLATGSDVEVGEAVGTIAAQSIGEPGTQLTMRTFHTGGVAGDDITQGLPRVQEIF
EARNPKGQAVITEVTGDVIDISEDPATRTKEVTIKGKTDTRTYTVPYTARMKVAEGDMIH
RGAPLTEGSIDPKQLLQVRDVLSVENYLLREVQRVYRMQGVEIGDKHIEVMVRQMLRKVR
VMDPGDTDILPGTLLDIADFKDQNYNTLVSGGVPATSRPVLLGITKASLETNSFLSAASF
QETTRVLTDAAIRGKKDPLLGLKENVIIGKIIPAGTGMQRYRDMEPKEVGVASENVYSIS
DIEAQMAAEDAMNNQTK
>FECAFAII_00609 HTH-type transcriptional repressor PurR
MKPTIYDIAKKANVSKSTVSRVLNNQPNISDKAKASVLQAIKELNYEPSKIARGLSGNGF
DAILALSHRTSHTTYGNPFFSDVIQSISAVSEQNNFDLILQTAKTPEEELEKCAKKIQEK
MIRGIIILSSTMDETLLFELDQYNIPIVVIGKVGNDYTNIYSVDTDNFQDSYDLVETLIK
NGHRHIGCLHAPTEVYVSNDRLNGYRQCLFDHHLDIRNEWIIDGGFRLEDSMAAMNDLMK
LRERPTAIFSTDALKSLSIYKVAEQSGKQIPDDLSIAGFSDPLLSSLFSPQLTRIDIPTN
QLGIKATELLFQLIHHQYPEEKRIILSTEITLTDSIQQQEM
>FECAFAII_00610 Sucrose 6(F)-phosphate phosphorylase
MYTKLLQAIYRDSDLSEKTASMIEQKVSVYQQKKGQAGKLHWDEEDIFLITYGDQFFEEQ
QPTLRTFKKFYQKYLADTFRVVHFLPFFPYTSDDGFSVVNYQAINDRLGTWEDIEEMRSE
TRLMFDFVCNHMSAESTWFQEYLNLNDTYKDFFIDLPLDTDTSSVTRPRTSPLLTTFIDK
NGKEKHVWTTFSEDQVDLNFKNPEVLLKMIDILLFYLEKGASFIRLDAVGFLWKELGTSC
IHLPETHKIIQLFRAIADEAAPGTVLITETNVPHKDNISYFGNGENEAQMVYQFSLPPLT
LQAIRSGNTSKLKEWLKTIDFASKKTTFFNFLASHDGIGLNPVRGILPEKTILELVEQLK
KEGARVNYKKNPDGTTSPYEINATYLDALSSPTDTTEWRSKRFLAAHSFLVTLPGVPAIY
IQSVLGSRNDYKGVEKTGENRKINRQKFLLADIEKELQTDPLRTAVYGELTQMLSIRKKE
KAFHPNSLIYLLDSADSFISFIREAKEEKVLVIHNFSNQSAGYLLPKGDYLDLFSGQIIH
CSQERKLIFQPYEYMWLKIIK
>FECAFAII_00611 Multiple sugar-binding protein
MKKIIVTTCLLATGFLLTACGESQSSNESQQTTIQFMHSSVEQERLSVINELVADFEKEN
PDIKIKQVPVEESAFNTKIVTLARSGKLPEVMEVSQDFAKVMDKDELIDQTAVQNVIEEA
GEDNYYDGAKNLVRSEDGKSYIAAPISGWVQGIWYDKEKLSEAGFSEPENWDDILKIAQH
FTDKENKQYGIAMPTAEGTMSEQAFSQFALSNGANVLDDEGEVTIDTEKMREALSFYQNL
SQYTMPGSNDVTEIKDAFMNGTAPMAIYSTYILPSVYEAGNSENIGFAIPTQKDQAVYGT
VSGLTISSGLDEKQKEAAEAFTAFLSQPKNMEKWVLMSPGGAQPVNKQVVELDGYKENEV
IKSFGELPSEIASAFDEVQVFGLVGEKNFTKMGDITSSGVIGKAVNQVTVGNEDVDQALA
DAQKNTK
>FECAFAII_00612 Inner membrane ABC transporter permease protein YcjO
MNRPRKHSDLKLAMGLLAPSMLLLAVLVLIPMLSNIQISFFDMPLNPNSDAVFIGLSNYL
EILSDSEFYRSLGLTVAYTFLVVAGSTALGLAVAILLNRKFRFRKTVRSLILLSYVTPSI
SLIFAWKYMFNNSYGIVNDLLVDRLQLFNEAPLWFDQPVASFFMVVLFAIWRYYPYAFIS
FLAILQTVDKTLYEAAEMDGANAWQKFKIVTLPAIKPVLATVIVLRSIWMFYMFTDVYLL
TNKVNILGVYLYQTAFAFNDLGKAAAISILLFIIIAAVVLLSRKKVDLK
>FECAFAII_00613 Inner membrane ABC transporter permease protein YcjP
MKNKKSRKILFYATILLLLAVNLFPFLIMLMTSFKDSQEAIATTQTIFPKEWTFEHYQDI
FNAEIFPFIMYFKNSLVISLIASVTAVVIGISGAYALSKLRFKARSKINASFYTVYMFSG
ILIVVPLFKIISGLGLYDTNTALIITMVVQTLPTAIFMLKSYFDTIPTDIEEAAMIDGLS
RIQIIIRIIIPLAISGIISVFVYCFMVSWNDYLFASIFLSTSEKFTLPIGLNTLFSTPDY
IWGRMMAASLVTALPVIIMYALSERFIKGDLVEGGVKG
>FECAFAII_00614 Alcohol dehydrogenase
MKKLVALEPRIAGFKDYEDREIEKNEVRIRVIFATPKPGTEIVDFRGLSPFIDEEFSEEW
RLFLPREEGSQRGVVFGEFQLGNMIVGTIEETGSLVTEYQKGELVCTYGPIRETLITNGV
DNYKLRKLDRLDQWKNAVCYDPAQFALGGIREAHVRAGDAVAIFGLGAIGQIAIQLAKKA
GATTIVGIDPIAQRRELAEKYGADYTLDPMKADVGFRLKELTDKRGVDSVIETSGSAAAL
QASLRGIGYGGIISYVAFAKPFPAGFNLGREAHFNNAKIVFARASSEPNPDYPRWNRKRI
EDTCWELLMNGYLDCEEIIDPVVPFAESAEAYMRYVDQHPEESIKMGVQVRGGEQ
>FECAFAII_00615 D-psicose 3-epimerase
MKFGTQDQAFFPRDILEKFRFIKDCGFEEYEIDGKLLIENIDTVKQAIKETGIPVVTACN
GYDGWIGDFIEERRLNGVRQIAEILRALSEVGGKGIVIPAAWGMFTYRLPPMVSPRSKEG
DYKAVSESLRYLDKVAEETGTVIYLEPLNRYQDHMINLLADARHYIDSNQLKHVQIIADF
YHMNIEEDDISKALTTQKEYVGHIHLADNHRYQPGSGAIDFTRHFQTLLQNEYEGYMVYE
CRLRGENEVKIYQESLQYLKNCLETARHLNDLEKE
>FECAFAII_00616 Putative UDP-kanosamine synthase oxidoreductase subunit
MKKVAIIGAGQVAEKVHAAYYQKRSDVLELAAVVDPVSQRAEDFCRRTGFSHAYTSVTQM
LNEISPDIVSVCTPNRFHFEHVLAALEANASVMCEKPPAMTADQARKMAETADKNGQILA
YGFQHRFSDEATMIKNHLDVLGDIYYVEANALRRSGVPGWGTFIDKELQGGGPLIDYGIH
MLDTAMYITGFPKVKSVRAYSFQKIGTKKNSGKFGKWDPSKFTVEDAIFGTLELENGKII
QLNTSFALNIREDKLNVAFCGDQAGANLYPGELFEDVDGKLVSLQKTTPVNDPHELSMAH
FVNRALGDQTQMIADGWQGYVIQNLVENLYRSAETGEVITL
>FECAFAII_00617 Kojibiose phosphorylase
MKVEEKQFDLEYINKYASQMTIGNGFFGIRGSQEEDYRNQVRGMFAAGVYNRPLGAESAE
LVNLPDVIRWEIKIDGEHFSLETMKVLAYERALDLEMGELKRYALIETAQGKKVEVITCR
VADQNNLHQAALKVVIKPLTEDCQVDVKTGIDGQQTNFGTQQLVEKELRVFGDDLISASY
QTTESKIDIGIAAKFNKAGVFQAKNRRITASFSEKIRKNTSFTLEKIIVLSTSLQQTDPF
KKSIAQAQKSVSYTEILEQSMSYWTDFWHQHRITIQGDSSFDQLAMDFAAYHLQIMTPRN
DPSVSVGAKGLTGEGYKGHVFWDTEIFILPFFLYQFPEVAKNLLLYRYDRLEGARQKARD
YHYQGALFPWESAHTGQEETPKFAALNIKTGTRQEVASAAAEHHISADLAYAVQEYVQAT
EDQSFLETKGKTLIHETAAFWLSRAVKVDDHLEIHRVIGPDEYTEYIDNNAYTNYLAHYN
VALAVKYQAGDPLFLKECQNFLDKLYLPVPNKEQLIPQDDTYLSKPVIDLTTYKERPGSQ
SILLDYARSEVNELQVSKQADLVMLLYLLPEYFSQPIVSKNLHYYENKTIHDSSLSKAIH
AIEACRIQEMEWAYHLFQEACLIDLGPDPHSSDDGIHAASLGALWLAVIFGFSGITVTNG
TLSISPRLPSAWEKISFPFIWKNHRLLFVLTKKQIVIKKETKETLPIFVNGDQYQLEKEL
ILERRGK
>FECAFAII_00618 Glycerate kinase
MRILIAPDSFKESLTALEAAQAIQSGFQEVFVQAEYDLLPIGDGGEGTVSSLADSLRLKR
QTAVVTNAFGKNKEIQYASDGQTAIFEMAEIVGLKDVPLNQQQPLRLSTRGVGELIRQLL
QQGVRHIIIGVGGSSTNDGGIGMAEGLGYAFYDQDNQKVEALGENLGKIATVDKTNVPIE
LIKAKITVITDVTNLLCGKEGASFVFGPQKGLKENELAVADQAMHDFYMRFAPQVIEASG
SSAGGGMGAGLLAFASGKIVSGIDYVLDLLEFDKRVQQADLVIVGEGRLDGQSLKGKAPV
GIARRVPEGVPVIAICGSVGKGSEKAADVGISAVFPILPAAVPLQEALQQATDNLHRTAK
NIASLLQVVHFQGGNR
>FECAFAII_00619 Beta-phosphoglucomutase
MKIKAALFDLDGVLVDTARYHYEAWLVLANQLSIPFTEKENEQLKGISRTESLERLLSFG
KMEQKFSEKEKSAFAEQKNNLYLQAIQKMDETSVLPGAIAVLEYLKKTNIKIGLGSASKN
ARLILEKTNLTSYFDVLIDGTQVSKAKPDPEVFLKGAQQLNVPPNACLVIEDSEAGCQAA
LAGNMHVLGIGENINLPSAEYVIPDLTVFDQVRSFWHLSEAVSRI
>FECAFAII_00620 Peptide methionine sulfoxide reductase MsrA
MTKKAVFAGGCFWCMVKPFEEQPGIISVTSGYTGGHVPNPTYEQVTTGTTGHTEAVEIEY
DPEVISYDQLVEIYWQQTDPTDALGQFADRGDSYRPVIYYNDEEERNIAERSKQALQDSG
RFDKPIVTKIEPRSEFYPAEDYHQDYYKKNKLHYNLYREGSGRAGFLRRHWGVKK
>FECAFAII_00621 Type 4 prepilin-like proteins leader peptide-processing enzyme
MLLYFIIGCCIGSFLCLTAQRIPLGHSIIYPRSHCVKCCRSLSWYELIPILSIIVQRFRC
RYCRCRLPFYYLLAEALCGGLFAWFFTFSSARNFSTFIWMLSALLFSLMDLFYFMVHSHT
LFCSWAILWIFWLQAGVFQWQSVLLTFIVGGVCLRYGQSYLGAGDTLLMLSWSGGLSLEE
LLQILFLASLFGISVFSVYFICHKKKLEKLPFIPFLSSALLIVLHLRY
>FECAFAII_00622 Xylulose kinase
MNVSIGLDIGTTQTKAVAFTDEAQEAASAYFRYPLIQETQGMAEQDQELIFQGVCTVIKE
VIKQLPSDTIIQFVSFSSAMHGLILLDEEKTPLSRMITWADNRAADEAEKLKYTVLGKEF
YRQTGTPIHPMTPLNKIKWLQNSQPELFKKTAYFVGIKDYIFYRLFGELISDYGTASGTG
YFDIHEFQWAEEVLDYLNIRIEQLPQVFPSTYQVTGLPSKTAAELGLPNDISFVLGGADG
PLSNLGLGAFGDTIAALTVGTSGALRFITTQPQFHPEMETFCYVLDQKHWVVGGATSNGA
GIFDWAGHTFLQEVVQSAKEKGENPYDALLSAIAFVPAGANGLIFHPYLLGERAPLWDAD
AFGSFIGLQRQHTEKEMMKAILEGICLNLYRILKGVCQENQLTEIRATGGFAQSPIFRQM
MADVLGYPLVFPTVTEASALGAVILGWRSIGKIQSISEAQELIELKEQVGVQETDHKKYQ
KIYPLFVSTQKHLAQTYQQFAQLREELADSEK
>FECAFAII_00623 DNA protection during starvation protein
MKFQQTKEVLNQLVADLSQMSVVVHQTHWYMRGPGFLTLHPMMDEFMDDLNAQLDEVSER
LITLDGSPYSTLREFADNTKIPDEIGRWDRTIPERLETLVAGYRYLADLYQKGIEVSGEE
GDDPTQDIFIEFKTATEKRIWMIQAHLGKAPEIDA
>FECAFAII_00624 50S ribosomal protein L13
MRTTYMAKPGEVERKWYVVDATDVPLGRLSTVVASVLRGKNKPTFTPHLDTGDFVIVINA
DKVKLTGKKATDKIYYRHSNYPGGLKSITAGELRAKNSRRLIETSVKGMLPKNTLGRKQF
TKLNVYGGAEHPHAAQQPEVLDITNLI
>FECAFAII_00625 30S ribosomal protein S9
MAQVQYIGTGRRKNAVARVRLVPGTGKITVNKKDVEEYIPHADLREVINQPFAVTETKGA
YDVFVNVNGGGYAGQSGAIRHGIARALLEVDPDFRLALKRAGLLTRDARMVERKKPGLKK
ARKASQFSKR
>FECAFAII_00626 Tyrosine recombinase XerD
MPTKLSNGKYKTNLRYPKKFREITGITSEKYQKVFPTRQLAIKAENAMKRKIETVLREEN
ANSLELKGKIKFKEFYESKWLPRYELGQTTRSKRAPSYVTISNTKDIFRLHILPMFGEYA
MNYLNSNTEIISDELTKKSKEYANIKIIKGYVRSMFDIAEILNYIEFNRTTKIIQCITAP
KKIALEERRIREGNQALSSEELIAWIEAVNTDLNNHLLTLHDYTLFMLTLYLGDRKSETY
ALQWKYIDFEKQTVRLKHALDKYQKKKFTKGRKDTVIQVPEIVMALLSKWKSVQAEQLLR
LKINQTPDQYLFTYTKPSGEVNCPVHADYLNYRINSIKRRHPELAHLSPHKLRHTYATIA
RQGGANMNQISSALTHSDISTTRIYVNTPDVVDKTVFEAFQRGLNKCD
>FECAFAII_00627 High-affinity zinc uptake system ATP-binding protein ZnuC
MLEVKKLNVCYNDFLALNEISLKIQEGALTGIIGPNGAGKSTLLKAMLNIIPHQGEVSIN
NEDINKKLVKIAYVEQKADIDFTFPIKVKECVSMGTYAGMKVFQRIKNAEWQRVSKALEK
VDMGKYSNHQIGELSGGQFQRVLLARCLAQNADFIFLDEPFVGIDLVSERIIMDTLKELK
HQGKTVLIVHHDLSKVKKYFDNIILLNRNLIAHGSVESVFNEENLKKAYGDTIFIGETNY
IESSKN
>FECAFAII_00628 hypothetical protein
MYFLGIDIGKRTHVASIMNEEGKVLLKGFSFPNTTEGAESLIERMVDYSGAPSDFVIGME
ATGHYWLSIFSYLHESDYLIHVVNPLQTDGWRKGTEIRKRKNDIIDSVLIADLMRYGSFV
ETVLSDENVFSLKQLSRYRTYLVGTASDFKRKIIAVLDQVFPEYATIFTKQGVFGKASKE
LLLAFSAPIDLENISSETLAQYLAELSRNRIKAEKADQLKQAASNSFGVKFAQEAFTFQL
RSMIEQLKFIESQIKETEREIKHIMDTLNSVILTIPGIGPINGATILGEIGDIQKFSNPK
KLVAYAGIDASVTQSGQYEATHNVMSKRGSPYLRKALFSAALVASQCDPVFSAFYQKKVS
EGKHHLTALGAVSRKLCYVIHAILTKNEPYIIVSD
>FECAFAII_00629 Manganese transport system membrane protein MntB
MLQNFINGLYDFHFLQNALITSVVIGIVSGTVGCFIILRGMSLMGDAISHAVLPGVAISY
ILGINFFIGAIVFGLLASIIITFIKSNSVIKGDTAIGITFSSFLALGVILIGVANSSTDL
FHILFGNILAVQDIDKWITIGVSVLVLVTVVLFFKELLITSFDPLMAKAMGMNVSFYHYL
LMILLTLVAVTAMQSVGTILIVAMLITPAATAYLYANSLKTMIFISATVGACSSLLGLFI
GYSFNIAAGSSIVLTAAFLFVISFLISPKQKFLRKKERKL
>FECAFAII_00630 Manganese ABC transporter substrate-binding lipoprotein
MMRKWKAVLGSLGILIALFIFGACSTNSKDKDTVASNEKLKVVVTNSILADITENIAKDK
IDLHSIVPIGKDPHEYEPLPEDVQKTSKADLIFYNGVNLETGGNAWFTKLVKNANKEENK
DYFAASDGIDVIYLEGQSEKGKEDPHAWLNLENGIIYAKNIEKQLAEKDPDNKKFYKENL
DKYIEKLDSLDKEAKSKFASIPNDKKMIVTSEGCFKYFSKAYNVPSAYIWEINTEEEGTP
DQIKHLVEKLRTTKVPSLFVESSVDDRPMKTVSKDTNIPIYSTIFTDSIAEKGQDGDSYY
AMMKWNLDKIAEGLSK
>FECAFAII_00631 Transcriptional regulator MntR
MVQIKTTTILIYLLAIQELSKRKKKLKNNDLAKVLSVSPASVSEMLAKLRYEDYLDIGFQ
LTDKGKKFIDDYKKGFK
>FECAFAII_00632 hypothetical protein
MAIGVIMIGLTLIAGYNFFKSFSDYFRKGE
>FECAFAII_00633 hypothetical protein
MTAGVTTGAFYKHFTSKEALFEEIIQPHINALINMYNEEFTKYLLNLENIDIEKSWRENF
NELDPFINYIFENKRIFDLVLFQSAGTKYQDIVEKITSFVTKKTVCCLDKLKTIGMINQN
LVFNEEEIHFYIYSFYATFYDILKHSYSKEKTMLLTRRLYQFSVPGWIELLS
>FECAFAII_00634 hypothetical protein
MSKINPLTLITLNIFFPVIIFLGKGNIFQVGCFIIATVLVLMFRKIKTCIYFILIYSVLF
LVMKIIDAIKIEFFTIFFGTSLYIVFRMLPVVMISWLLVSVYTSNELLSSLEKIHLPKKI
MLSITVVIRFFPTYRSEIRMIKESLKMRNIRLSFFQPLQYLEFLLVPVLIRATMIAEEMT
ANAITKGIESPVKRSSYYKTNMSLLDYIILFSVTIFFLSILI
>FECAFAII_00635 Putative HMP/thiamine import ATP-binding protein YkoD
MFEFNNVSFSYKDVKEQALVDLNFSIKKGSLTLITGSSGSGKSTLLKLMNGLIPRLYDGK
LVGEILFENNSLQSLTQESISKNIGYVSQNPRGQFFTTNTTSELVFSMENFGFTKEHMDK
RINELAELLDLSNILDKNIFSLSSGERQKISIGCSLSLNSKLIILDEPSSNLDFKATKKL
ADLLCDLKNKGFTIVIAEHRFYYLKELIDQVLFVKNRTVKTTTIQLLKTENNNALRKFDI
FNSSIEVPYIEKVSADVLKVEEITYENILKDINFDVKVGDVIGLVGKNGVGKTTLLRILM
KIIRPTKGKIIENKKNLSSPFLVMQEMDYQFFTESVRSELALGNEIVSKDQQEKILKKME
LYKMKDQLPFDLSGGEKQRLLVSIASLSKTNLFLFDEPTSGLDYINMERIADLIKDLKEK
GAVVIATHDPEFLYKTCNRIIYLKNGGIKKDIKLRVEDSTLIEQIFNDITK
>FECAFAII_00636 hypothetical protein
MKTKDYIFIGLATVISLVIYFFSIMVSSIGGAFGHSISPGIFGLLSGIIFVYISYNYPRK
GIFTIYTIVLLLFFTLMGGAYLPWFISSISMAILADIILSVFGYDRAIPQVVSWVLMQLG
SAAGQWIPIWFFTDRFRQDWIDRGQSAATMDAMIHYAVGIWGIISVLVVASLSMIGVLIG
RKVLKKYKK
>FECAFAII_00637 Iron import ATP-binding/permease protein IrtA
MKVYKKLFSYVPKMKYYGWLATLFSDFSVVLTVYGYYSIYKFLQSLIIVGDEYLAKSYAV
QTVAWLTLGALFYIFSGLFSHILGFRLETNLRKKGISGLTEASFRFFDLNSSGYIRKTID
DNAAKTHMAIAHLIPDSAQAIVTPVLSVALGFFINFKIGLVLIAMLVIGVFLLKKMTENT
NFIQKYQESLDVLSSETVEYIRGIQVIKIFGAKVTSFKALNKAINDYAKFAYKYSLSGKT
PFVLFQWLFFGIVCILIVPITFFITSLTTPKILAVDLLMLFFLSGIIFVSFMRIMYVSMH
LFEARYAVETLDSLYLEMKQDQLKYGNETQIKNCDIAFENVSFSYKEECVLENFNLVLEQ
KRIYALVGKSGSGKSTIAKLISGFYNVDKGQIKIGGKPLNHYSKDTIINTIAFVFQDTKL
FNQSIYDNVSIANPQAPASKVFDALRLAGCESILEKFPEREHTLIGSKGVYLSGGEKQRI
AIARAILKDAKIVIMDEASASIDPDNEYELQKAFQYLMKEKTVIMIAHRLSSIKSVDEIL
VLSEGKIVERGNHNELMAKHRVYKQLVTNYENANDWRLDNEKFL
>FECAFAII_00638 Beta-(1-->2)glucan export ATP-binding/permease protein NdvA
MKNFYKKKFALTDQGAEALTKASISSFFVYCINMVPAFIIMMLIDELVLENAKPRWLYFA
VSFVTLLFMYWLLDREYENLYNSTYKESAHLRVQIADDLSNLPLSYFSKHNLSDLSQTIM
SDVEGIEHAMSHAIPKAGGMALFFPFISVMLLVGNVKMGLAVILPTLFSFVLILLSKKSQ
TKANTKYYDTLRENSEEFQETIELQQEINSFNLSKKVQDRLFKKMEESERIHLKVELSTF
SVMALSSIFSYVSLAVVILVGVHLLLTGEVTILYVVGYLLAAIKIKDSFDSMKEAVLEIF
YLAPKIQRIRAMKETSIQEGSDSPLKSFDIELRDVSFSYDNNTPILDHISFTAKQGEVTA
LVGASGSGKTSILKLVSRLYDYDEGCILIDGYDIKRVSPASLFSKIAIVFQEVTLFNTSI
LENIRIGNSQASDEEVKKAARLANCEDFIEKLPDGYHTLVGENGSSLSGGERQRLSIARA
FLKNAPILILDEITASLDAENEKRIQESLNRLIQDKTVLIISHRLKSIEKVNKIVVMDQG
KLVDQGTHNELYRRSEIYKNLIKKTKLSEKFVYEKEAQSR
>FECAFAII_00639 Alternate 30S ribosomal protein S14
MAKKSKIAKAKKQMAMIEKYADKRQELKAAGDRTALAKLPRDSNPNRLRLRDQTDGRPRG
YMRKFGMSRIKFRELAHQGLIPGVKKASW
>FECAFAII_00640 50S ribosomal protein L32
MAVPARKTSKAKKRLRRTHQTVVKPEISFDEANGDYRRSHHVSLKGYYNGKKVIKGASK
>FECAFAII_00641 hypothetical protein
MEIIYPPLVEEGLKYYLETTQQSLDKCTFYRSMVERGIITETGLPTQQAIENGLVKDYYE
DQGLSFDDFLRIYPIFEEYDEELFQCIDGYWEIPVDMKENLVSQLESGELTFEDAQQIQA
YLEDR
>FECAFAII_00642 50S ribosomal protein L33 1
MRQNIILECVETGERLYLTSKNKRNNPERLELKKYSPKLRRRAIFKEVK
>FECAFAII_00643 putative GTP-binding protein YjiA
MGIPVTIVSGFLGAGKTTLINQALQVSPYPREEIIIIENEFGEVGIDHKLLVHSEERVLQ
LNNGCMCCSLRSDLLAILISLLETIEEHQQPISQIIIETTGIADPQPIIQTLLTAPQLRG
RVYIDSLLTVIDSDSFELIEREPQALKQLVMADRIFVSRKQNLNLSALKKLQREIKSINP
LSDIRMFTHSETIQKKDFYNLKKFNHPLVFESDSSENHYNGKYYHQHHQVHEFKSILLTS
DQDIKKDFLLQWIDWLILTNQGSLYRFKGLIALQEQDFIVAMQEVNEQVNFQYTTRQKDQ
TTIILIGKMLDEERIKQSFDKLLAESK
>FECAFAII_00644 hypothetical protein
MEKTDISSAYRRLKSPNIKTRKRALKIIKEHKRNKMKKLA
>FECAFAII_00645 High-affinity zinc uptake system binding-protein ZnuA
MKKISVGLIGIAALGLLGACSSTNDAKVSNDKDGKLEIVTTFYPMYDFTKNIVGDEANVD
LMVPAGSEPHDYEPSAKDMAKAHDADVFVYHNENMESWVPKAKESWKKAGPNVVEGTKDM
ILLPGSEEEDHDHGEEDHHHELDPHTWVSPKMAIKEVSNIKDQLVKLYPKKAKVFETNAE
KYLTKLKRLDADYTTSLKEAKQKSFVTQHAAFGYLALDYGLKQVPIAGLSPEEEPSSGRL
AELKEYVKKNKINYIYFEKNANDKIAKTLANEAGIKLEVLNPLESLTKEQMDNGEDYVSV
MEDNLKALEKTTMVAGEEVVPEKEAKDEKTVANGYFKDADVKDRELSDYTGEWQSVYPLL
KDGILDEVFDYKAKINKDMTAAEYKDYYTTGYKTDIDTINIKDNTIDFVVNGEHHQYTYK
YVGYKILNYEKGNRGVRFNFETDDAGAGRFKYIQFSDHGIAPSKAEHFHIFFGGESQEKL
YNELHNWPTFYPASLSKHEIAQEMMAH
>FECAFAII_00646 hypothetical protein
MVRKVLLSMDSKNIDAYRRYRFAKQMRLNGSTLADIAATLHVSIDTVHRVLKRDPDCCFI
KVNTGRSRRLAKRHNSLAN
>FECAFAII_00647 hypothetical protein
MSQYRHLTILERERIFLLHEEGFSISIIGNDIQHSPFTILHELRRNKKKTIHLPKRKKIM
LIEEKNADVITF
>FECAFAII_00648 Putative metal chaperone YciC
MKKIPITILTGYLGSGKTILLNHILYGDHGKEIAVIVNDIGEVNVDGVLVDKKGFKRTGE
KLVSMPNGCICCTLREDLIVELDQLVQFSDLNQIVIEASGISKPIPIIQAIILAKNPLDI
DLTQRLEIGAIIIVVDVKRFWDNFETGEKIQERKAEGNVVEEEQDIRGLLIDQFECCNIL
LLNNSDLVSTKTIYKINGLIAKLQSNAKIIRTIKGEVDLSKILNTNLFNIDETSYSVGWF
KELELGYQNHIPETEEYGISSFIYRNRLLLDAQKFAHLTDKNFPGNITRAKGFLWFAQHS
DFSTIFETSGSYKSIESLNYWVASLPKIECQMIIQKNPELKEAWHPLFGERINKLVFIGM
KMDQQCIKEQLEGCLTDSLNADNFRKISPFPWKKSNMFSQISLMKFLRKAGVKIGDVIII
GILIITSFIPLFVFSIEKENETTEDAIKYAIVRIDGKEMDRFDLDKINHKLVNYHPAKGQ
YNIVEIKDGRIRVKEDNSPDQIAVRTGWISKPGQTSICLPHKLVISIEKKESTDYYIY
>FECAFAII_00649 hypothetical protein
MNDVSNYKTILRINKQRFKCKHCGKTFLAEDSVSDRRCSIARRVKQAILELLSEPLSMSL
IARMKHISPTTVIRILRSLRPKTISLSQLLPEVVCFDEFKSVKNVSGAMSFVMMDGKTHQ
LIDIVENRQLNPLRDYFLRYPIKVREQVRLVVSDFYTPYRTLVKECFPNARIVADRFHIS
QHIGRAFTNHRIQVMKTFKKGDRRSKHLKKYWKLLQKNAWELKGQHRYWRPSFRDHLTEA
EIVDRLLSYDDSLKRGYEVYQDFLSVIRRQDVPEFVALLKEDYKELPEHYQPVFTTFKKY
QTEIKRALRVPYSNGPIECLNNHIKVLKRIAYGYRNFQNYRERIFLYRGKYFKKTKNTTQ
LTKARTTTRLDKIAV
>FECAFAII_00650 hypothetical protein
MSYSEFTKELLDILDLNLIFHEDAFRKERINDETCFVFDGTLTYQPEECFHRHYQNEQTI
IK
>FECAFAII_00651 hypothetical protein
MFYEHKDRYGSPGITQKLYDEGIEINKRVVAVLMREMNLCTRGFHRRKSSHGREKTIKEM
VKKC
>FECAFAII_00652 hypothetical protein
MNSLKEDFILAKAGNEEAVEAILKRFSSLIHKQSWRTGKYDQDCYQECMLAIYLAISKFE
IKE
>FECAFAII_00653 hypothetical protein
MSDNDERVNAQLIRFFEKVILNTANTYYKKQEEIQKHEQLDQLPPYLFTKDTIKFKQPIN
VLNVTLLVEDIKLAKILPLLKEPEQIFLIEKFIFDKTDKEIGKVLGITRQGATNLKHRLY
KKIQKMLV
>FECAFAII_00654 Arabinose operon regulatory protein
MFSDKEVLLKSLHVCLKLPIVVFNSEFSIIKEYRSDRTTYFFYDYKKLLTDNIKKTKDFH
FFTGDFNEMFLLYMFKTRYYLFGPFRANNIDKVFFKLKMNNLNVAMADRERLYNSLQNLT
LYSLGDIRDILILVHYFFTGKIEDLFHEPLIEYTENLSKTIEQIKIDNLLSQNYDPEIYL
FLYENKILEYVKNGDIRNLENMVFNLSNGIIPSVSGDTIRSEKNYSIIVFEKLAQTSITL
GMDIIEAYQSRDALIQENELAVSLPEVLKVRDSGIVYYTKEIGKTKIEHLSPLISSVVQF
IGLNIYKRITVKEIANYFSVSETKLRESFKNEMHITIYNYISKRKISTAKIMLKSNHTIS
EVSLGLGFSDSSHFSRVFKKYAGVSPKQYQLGLVDNFNNIS
>FECAFAII_00655 hypothetical protein
MRLYHLRSLEELRKLDFNKKFFWEISDLSCFVESERLSNGNNSVLNEYDKVVINKVKSLC
EEARESISHINGSNFKQTLFNLIKLDAKISSYLFFLIHDEFMDYQKLDQLIERESWEDYY
VGLTFSEKLNNYKLIDYKYLSESN
>FECAFAII_00656 C protein alpha-antigen
MVSKNNKRVFLEKTKKRVLKYSIKKLSVGVASVLIGVGLVLGTTELVKAQDEISPSSPLE
TAISSVQVGDKVASGNTFQENPGYTKNYNFSDLQFSPQELTGDTLKGNTIGFEVYGKHNI
AASTKNWEIRLQLDERLAKYVEKIQVDPKKGIGSSRRTFVRINDSLGRPTNIWKVNYIRA
SDGLFAGAETTDTQTAPNGVITFEKSLDEIFKEIGIDNLKTDRLMYRIYLVSHQDDDKIV
PGIDSTGYFLTDSDDFYNSLDVSENNPDQFKHGSVSAKYEKPNTQTKDGSGSTGANGAII
LDHKLTKNYNFSYSSSAKGTPWYANYKIDERLVPYVAGIQMHMVQADKVTYDVSFESGTK
VADLAIERREGHENYGIGSITNNDLTKLIDFANASPRPVVIRYVLQLTKPLDEILEDMKA
TAQVEENKPFGEDFIFDSWLSDTNKKLIQNTYGTGYYYLQDIDGDGNPDDKEESGDTNPY
IGKPELEEVYDVDTTVKGKVFIHELAGTGHKAQLVDKEGTVLAEKTIAPNEKDGAPISDT
VEFEFTGVDSSKLIAKDELKIQIVSPGFDKPEEGSTVIKESPKAVDKQTVVVGFKPDAKE
SIRNNKNLPEDAEYSWKTEPDTSNVTDSTKGIVTVKIGNRTFDVDVEFAVKASQAMENDA
TYVPITTTPETTVQSGKPTFDKPDVPLAKDAFSISDVYNKDFGNASVDANTGIVTFTPAK
GVGESEPITGTIPIKIVYQDGSVGTTDLAVTVSKDIYENPGENIPAGYHKVTFTAGEGTS
IESGTTVFAVKDGVSLPEDKLPVLKAKDGYTDAKWPEEATQPITADDTEFVSSATKLDDI
IENPGENIPAGYHKVTFTAGEGTSIESGTTVFAVKDGVSLPEDKLPVLKAKDGYTDAKWP
EEATQPITADDTEFVSSATKLDDIIENPGDNIPAGYHKVTFTAGEGTSIESGTTVFAVKD
GVSLPEDKLPVLKAKDGYTDAKWPEEATQPITADDTEFVSSATKLDDIIENPGENIPAGY
HKVTFTAGEGTSIESGTTVFAVKDGVSLPEDKLPVLKAKDGYTDAKWPEEATQPITADDT
EFVSSATKLDDKSDADKYNPEGQKVTTELNKEPDAFEGIKNKEDLPKDTKYTWKEKVDVS
AAGNKKGTVVVTYPDGSSDEVEVDVTVTDNRSDADKYEPTVEGEKVEVGGTVDLTDNVTN
LPTLPEGTTVTDVTPGGTIDTNTPGNYEGVIEVTYPDGTKDTVKVPVEVTDNRSDADKYE
PTVEGEKVEVGGTVDLTDNVTNLPTLPEGTTVTDVTPGGTIDTNTPGNYEGVIEVTYPDG
TKDTVKVPVEVTDNRSDADKYTPMVEGEKVEVGGTVDLTDNVTNLPTLPEGTTVTDVTPG
GTIDTNTPGNYEGVIEVTYPDGTKDTVKVPVEVTDNRSDADKYTPMVEGEKVEVGGTVDL
TDNVTNLPTLPEGTTVTDVTPGGTIDTNTPGNYEGVIEVTYPDGTKDTVKVPVEVTDNRS
DADKYEPTVEGEKVEVGGTVDLTDNVTNLPALPEGTTVTDVTPGGTIDTNTPGNYEGVIE
VTYPDGTKDTVKVPVEVTDNRSDADKYEPTVEGEKVEIGGTVDLTDNVTNLPALPEGTTV
TDVTPGGTIDTNTPGNYEGVIEVTYPDGTKDTVKVPVEVTDNRSNADKYNPEGQKVTTDL
NKEPDASEGIKNKEDLPKGTTYAWKEKVDVSTAGNKKGTIVVTYPDGSSDEVEVDVTVTD
TRSDADKYNPEGQKVTTDLNKEPDASEGIKNKEDLPKGTTYTWKEKVDVSTAGNKKGTVV
VTYPDGSKEEVEVTISVVDKKAPNKPQVDPITEGDQIVTGKTEPNAEVTVTLPDGSQHHG
TADKNGNFTVKVPKLEAGTKVIVTATDESGNTSEPTNVVVSSNKKDSGKNGSKGSKTDNQ
GSNSNQDKNRGKSQSSKVFPKTGESDSNIFTISGGLILLGTLGLLGYKNRKKENE
>FECAFAII_00657 NADH oxidase
MEKIVIIGSNHSGLAAARFLNLSDSNYEVILIDKKSEISYLECGTSLFIKGEVSNLEDLF
YQNRMTLNSEIKKLFLETEVDKIDIQNKKISCVKKDGTRFSQEYDKVILATGSKQIMLDI
PGNNLANIFSIKNFPNAKEIFKALDDSTIKKVGIIGAGYIGVEIAEAIRKRGKEVYLFDV
ADRVLSTYYDRSFSDKVEEILSKNGIHLCLSESPKKYLGRKKIEKIVTTSGTQYSMDMVV
QAIGFLSNSPIGEKELLRDVSGAYLTNEYQQTNIKDIYAIGDCATTFFTSINRSSVDFSI
SNALRTAYIATQHINNQDFTPSGSQFTNGFSIFNYNFYAAGLNLKTARLLSESIDYIEIE
DFIRPAFLRKNSRVKLRISFEKNTKRIVGVQLCSQEDLSGLLSMFSLAIEEQITLDKLKM
LDYLFHPSFSQPYNFILKAVTGLNIET
>FECAFAII_00658 Autolysin
MKKSLKLASAVILMSQLLIATPFHVLASENSTYKIAKERTETTEMSNSDVTAESSELLTT
SSSESSTTSNAESSTTSSSESSTTSNAESSTTSSSESSTTSNAESSTTSSSESSTISSTE
SSTTSSSTSEITSSKVTKPNHIESSKKEAPKTEGQTKTFSTPQQIESTESFQSQPILSGN
EEIHFDKNESVENFIMKIGESARKIGQKYDLYASVMIAQAILESASGQSQLAQAPNYNLF
GIKGTYNGNFVIMVTNEDLGNGTLYTTQSKFRVYENYEESFEDYAKLLTKGISGNKDFYA
GALKANSKTYREATKFLTGRYATDTQYYLKLNELIKTYDLTNYDKEVKGPQMSKTGYQVP
IHNYSITSLFGNRGNEFHRGLDMAATQGEPIHAVKAGKVVKAEFHYSWGNYVVIQHEDGS
TALYAHQQQYLVKTGDNVLQGQIIGYVGSTGNSTGPHLHLEICKDSSLSQSMLVDPKTLL
FGD
>FECAFAII_00659 hypothetical protein
MKERYGHLTVVEEITHNGYKKYRCLCDCGNETIVYRSNLLSGRTKSCGCGNYKNRHKYKN
LTNKTFGKLVAIKPTKLRSEGTVVWECQCLCGRKKLVSAKRLLKGDVKSCGCLKSKKHHI
ENKKFGLLTAKYPLDNNCSWKTKWVCHCECGSMCEISYSNLFFGHTQSCGCLKRQETRTC
VEGTVIECLTSKLPKNNTSGVKGVYRSKEK
>FECAFAII_00660 Riboflavin transporter RibZ
MYSYQEDAKVQKNRWWILIAISMFTFMSTLDGSIVNIALPTISDDMGIPMNQAEWVVSVY
LMIVCSCLLLFGKIGDSRGKIKVFRIGTLIFVLGSLLCGFNHSLGILLFARVVQAIGASM
TMATNAGIITEVFPIHERGRALGAIGAFVSLGSIAGPGLGGLILSQFSWAYIFWINVPVG
IVTMLIAEKFLPKDITMSGHTIDGGGFAAIAATIISFFGAIFLGQESGFFHPVPLVLFVI
SVIAFVSFLKVEKKAASPLISFGIFKNKIFTMSLITALLIFSSNFFVNVVIPFYLQNARG
LSPSYAGLLMMVFPLMMVVGAPLSGYLTDRVGPEILVLVGLGLLSVTQVMYMFLSVDSPL
WLYIVATAIMGAGNALFQSPNNTMVMSSVTIENLGLAGSMNSFARNLGMVSGISLSTTVL
YQAMSAKMGQQVTNYIANRPDVFLYGMKITFLGSFVLCFVAFFLTIWRIKKQGGIQKNV
>FECAFAII_00661 hypothetical protein
MNAGIADMNLIKKTLNDFTSNSISKGTGINLSTIKKLKSGERSVEKLNLLDAIKITEFAM
KNGKAEIEIWR
>FECAFAII_00662 hypothetical protein
MKIKIERNQKEKSPKKKKERVVSVGKHRKMVLALWLLLSCSLAFGVYKNFTAIDQHTTHE
KVVIKEKVVNTSGVESFTEDFAKEYFSWKNNKEAIEKRMSNLEQYLTENGLALIQDMVRA
DIPTSSEVQSVKILDVEKHSEEFVVSFLVEQHITEGKKTQSISSAYRVTIFEDENRNHLV
TSLPTMIGKPDKAKYEAKQVENDSEIDAKTTEEITDFLETFFKLYPSASEKELEYYVENG
AMRPINIDLKFSELENPVYLQNGKNFLVSTKIKYLDNVSKTTSYFQYKLVLQKNGNWKIV
DVK
>FECAFAII_00663 Gamma-DL-glutamyl hydrolase
MNLKKVGVISLTFLTISFMGILMCVGLLFGEDSEGNGSSGTSPGGTSVSEEVLKHRAMVE
KYAKESDITEYIPILLAIIQVESGGTMEDVMQSSESAGLPPNSLSTEASIKQGCLYFASL
VKRSKELGCDQDSIIQAYNYGGGYLDHVGKNGKKHSFALAESFSKEKSGGQKVDYPNPIA
IKENGGWRYNYGNMFYCLLVKQYLTTTQFDDKIVQEIFDEAFKYEGTAYVFGGSSPETGF
DCSGLTQWCYAKVDLKLPRVAQDQYDAMTHIDLKDAKPGDLVFFHSTYDAGTYVTHVGIY
AGENRMFHAGDPVGWTNLTENYWRQHLIGAGRYK
>FECAFAII_00664 hypothetical protein
MKKKLFRIVGIVFISILTLIVLLSLVGTVAEATGLVDDTVEAGNLYSKYSLNNYQLDFFV
DSSWDWLPWNWGDGLGKSVMYGLYAITNFIWTVSLYLSNATGYVVQEAYKLDFISDTAES
IGKNIQTLAGITENGLQTSGFYFGFLLLMILALGVYVAYTGLLKRETTKAVRAVINFVMI
FLLSGSFIAYAPTYITKINDFSSDVSEAALTLGTEIVVPNSESQGKDSVDLIRDSLFSIQ
VQQPWLLLQFDDSNIEEIGEDRVNKILSVSPDENKGKDREEAVKAEIEDNDNANLSITKT
MNRLGTVVFLVLFNIGISFFVFLLTGIMLFSQILFIIFAMFLPISFLLSMLPTYESLGKK
AIIRLFNTIMMRAGVTLVITTAFSISTMFFNISATYPFFMVAFLQIVTFAGIYFKLGDIM
SMFNLQSNDSQSMGRRVMRKPQMLMNRKLRQLNRNVGRALAFGGGAAVGNKLAKEQSKSK
FKPSGSSLRKNSRLPNDHEILSDLTKENPVSNNKKQSRMNLAGRKIGKVLDTQALVKDKT
KQVKDQVRNTPTNLKYNLHKGIEKSKKAPEEFKRGLFQEKADRVDLREKQRQRRNAKMDE
KRKILSEATNRQGKRRANIPIDKAAQPQKDMMLKKEAPKRIVRANLNPEIKRKLTSQEII
SKGKSQSASKKNSFQQVKQRSTLPKQTNQKVQKRMNHRPKSRSGEKK
>FECAFAII_00665 hypothetical protein
MYPIKYIENNLVFNQEGECFAYYELIPYNYSFLSPEQKYQVHDNFRQLIAQNREGKIHAL
QIATESSIRATQERSKKEITGRLTEVAKQRIDLQTEALVSMIGDSQIDYRFFIGFKLIAT
DEEVNLKNLKKSFFSGFQEFVYGVNHHLMGDFVSLSNEEIRRYTKLEKLMESKLARRFKV
RRVTPSDLMYLIEHIYGEKGTPFEEYEFQLPKKKLKSETLVKRYDLLRPSRCLIEEKPRY
LCMEHENHESYVAYLTINTIVGEMEFPSSELFYYQQQQFTFPIDTSMNVEIVTNKKALAT
VRNKKKELKDLDNHAYQSDNETNSNVLDALDSVDELETTLDQSKESMYKLSYVVRVSAES
VDELKRRCDEVLDFYDDTNVKLVRPFGDMMGLHEEFLPSSKRYMNDYIQYVTSDFLAGLG
FGATQMLGELEGIYFGYNVDTGRNVYLKPALASQGVKGSVTNALAAAFLGSLGGGKSFSN
NLLVYYAVLFGGQAVIVDPKGERGGWKETLPEIADEINILNLTSKPKNQGLLDPYVIMEK
KKDSESLAIDILTFLTGISSRDGEKFPVLRKAIRTVTQSNQRGLLQVINELRKEGSPVAE
NIADHIESFTDYDFAHLLFSDGSITQSISLDRQLNIIQVADLVLPDAETTFEEYTTMELL
SVSMLIVISTFALDFIHSNREIFKIVDLDEAWSFLQVAQGKTLSNKLVRAGRAMNAGVYF
VTQNSDDLLDERLKNNIGLKFAFRSTDIHEIKKTLEFFGLDREDESNQKRLRDLENGQCL
MQDLYGRVGVVQVHPVFEELFHAFDTRPPVQERME
>FECAFAII_00666 hypothetical protein
MKKIKSYTSIWAVEKVIYAINDFQLPFPVTFNQMAWFVLSLLFVIVFAHVPPLSMIEGAF
LKYLGIPVAVTWFMSQKTFDGKKPLGFLRSFISYHLRFKVTFAGKKVKEQKKRWDEPITL
VRSVNYVPD
>FECAFAII_00667 hypothetical protein
MEQMRVYIANLGKYNEGELVGAWFTPPVDFDEVKERIGLNDEYEEYAIHDYELPFEIDEY
TPIEEINRLCGLAEELEGTPVGEVASEIQHAFFNSFEEMVEHVDDIIYYPDCDDMSDVAY
FLIVEAGDFGEVPEHLKTYIDFDACGRDLEIGGNYLVTSRGVFEYPY
>FECAFAII_00668 Group II intron-encoded protein LtrA
MPKNKNETLCVEDLRHAEYYEMQNTFDDLYAKSKNGDIFTHLMDIILSRENILLAYRNIK
ANAGSKTAGTDGTIIKDIGKLPAETVVKKVRYIVAGSPHGYRPKPVRRKEIPKPNGKTRP
LGIPCMWDRLIQQCIKQVLEPICEAKFSENSYGFRPNRSVENAIKATYNRLQISQLHYVI
EFDIKGFFDNVNHSKLIKQIWAMGIRDKHLIFILKRILKAPIKMTNGTITYPEKGTPQGG
IISPLLANIVLNELDHWVESQWQENPVTKNYVVHINKSGSPCKSNAYKEMKKTKLKEMYM
VRYADDFRVFCRYKESAEKAKIAITQWIEQRLKLEVSQEKTRIVNVRKRYSDFLGFKIKM
IPRRKKLVVKSHISDKQFKNQKDKLVSQAKKIASPSKGKTELEETRLYNSMVLGMQNYYQ
IATNVNLDCMKLNRAVMAIFTNRLGTNKRGRLRKTGRQLTTKEATRYGKSKMLRYVAGEG
EPIFPVGYIQHRKPMAKVYLANCYTLEGRKFIHTNLSVDKLLMYQLMKLSLENRTIEYAD
NRISLFSAQHGKCAITLEEFQQANEIHCHHIVPTGAGGNDDYKNLILVKEAVHRLIHAKT
EETIQKYIALLKLNKVQLIRLNKYRVLAGNQELNLI
>FECAFAII_00669 hypothetical protein
MKRGIVMGIVKDIFLVFGGSMLGVTVMCLMNASAAADRAMEKKGK
>FECAFAII_00670 hypothetical protein
MAQRNLDYRLLKDRRNEYGVSQNKLATACGLSRPYLNQIENGGVTASIKTMRKIFDQLES
FNPDLPLTLLFDYVRIRFPTTDARKIIQEILHLKFEYMLHEDYAFYSYQEQYVMGDIVVM
LSHEEDKGVLLELKGRGCRQFETFLLAQKRSWYDFFEDCLKAGGVMKRLDLAINDRVGLL
DIPELTKKCQKEECISLFRTFKSYRSGELLKADEKDGMGNTLYIGSLKSEVYFCLYEKDY
EQYIKLGIPLDQTETKNRFEIRLKNDRAFHAIQDLLKGRSIESTTFSIINRYLRFADKVE
GKRRTNWPLNEQWGRFIGRNRKEIQLTSEPKPYTIERTLNWLGRQVAPTWKMAKELDRLN
RTTYIQDMVQNARLSDRHKKILEQQSMAIENLII
>FECAFAII_00671 hypothetical protein
MVYDELIGEIYWVIGKIQSDPELEEQLRRLKFDIRKNGVKVAGDPYLMNEETDARIEINQ
VIAEFERIADQAKEPDIRQYLLEMKAELEVNGITDE
>FECAFAII_00672 Modification methylase BanI
MLNSKAYIPQSRERIFLIGHSRDACTEQVFPIIGPSSTSDQNIRNLVNINPSNRGMGGQV
YGSDGVAPTLTGDEGIKIALPARDGISVAGLLPGKFEQGNRVYEVTGTAPTLSTKQGGTK
IMIRKNETEYQEVKPEDSVNLAFPNSTSRRGRLGKQSVHTLLTGDQQAIVTDQYQIRKLT
PRECWRLQGFPDWAFDRDSQVNSDSQLYKQAGNSVTVPVIFDIARRLKELDVHGL
>FECAFAII_00673 Modification methylase HhaI
MRFLDLFAGIGGFRLGMEQASHHCIGFCEIDKFARRSYKAIHDTSKEVEMHDITSVSDEF
IQSLGPVDILCGGFPCQAFSIAGKRQRFSDTRGTLFFEIARFTTLLRPKLLFLENVRGLL
NHEGGATFETILRTLDGLGYDVEW
>FECAFAII_00674 hypothetical protein
MTEKEQVTKIVKKYNKSIADLSENATAKEFKTVIKYVADQANEKQRKLVGLNKK
>FECAFAII_00675 Toxin PezT
MESNDSYLEYAKANKDKFISYIIKGKSPEVGRDAVFMAGSPGAGKSEVAIGLAENYDNHV
IIDADYFRTQFPDYNGKNSSLFQKASSWLVEQAFRYVLDHGYSFILDATFAILSAEKNIS
RALKKHFRVTIFYVYQDPKIAWKFTQEREIAEGRHVPKKAFINAFFKSRENIAKVKSKHP
DVLLHIIIKDYTNNISEVHYATDNLELFLPLGYSRKDLEVQLHD
>FECAFAII_00676 hypothetical protein
MTSKDYLSLFNFRVALGRMSELGYSMMFGEVEKNFFMKHIKGRGYVDTGGSVISEFYTPL
VPKGYDFLDSISKLEKMND
>FECAFAII_00677 Group II intron-encoded protein LtrA
MNKVKTNKTLRHSEYYGMTQIFDELYVKSDKKEVFTELMTIIMSDENIRLAYRNIKNNKG
SYTASTDKKSIRDIKTLSEDTFLTEVKVLFRCYKPRAVRRVEIPKPNGKTRPLGIPSIWD
RLIQQCILQVLEPICEAKFHNYSYGFRPNRSTHHAIATCNRLANRGKLHFVVDVDIKGFF
DNVNHSKLLRQMWTIGIRDKWLLGIIRSMLNAPIVLPTGKVEHPKKGVPQGGVLSPLLSN
IILNELDWWVASQWQNTTIETEKIMDRRDKGKGIDKTNQYRALRRTNLKEIYIVRYADDF
KIFCRKRSHADKIFHATKMWLKERLSLEISEEKSKIVNLKKGKSEYLGFELKLIKKGKKY
VVESHMSKKSMTRVKIQLKKQLRKVARPKNHCEQAKEIGLYNSMVIGIHQYYGIATCVNL
DCSKIAYTLKPFINHKLPTKKHGKILNTFIKSKYGKSKEMRWLNNVPIVPLNYVQFRLAV
PLSEGTCKYTESGRSKIHSKLKLDLALLLHMMRNSNYERSIEFVDNRISKYSAQKGKCAI
TGKFLEYEEIHCHHIVPVKQQGTDKYSNLIIIHKNVHALVHAIEEKIIHKYLNVLNLTNE
QIEKLNELRVKAGNSVLTV
>FECAFAII_00678 DNA translocase FtsK
MYKGHRIRAGDQHLVYHFVLGWLLALFIGWMSVFYFQEFRQFDISKLSLSTIEIVWSIKD
LVCLLGSLAFSGAMILLYIHFFLDHWRSLWHRQKLARMILENHWYEVKQTQSEGFFKDLN
SSRTRETISYFPKIYYRMKDGLLSIRVQISLGKYQDQLLKLEKKLESGLYCELVEKELKD
SYVEYTLLYDMIANRIGIDEVVAENGTLRLMKNQVWAYDSLPHMLIAGGTGGGKTYFLLT
IIEALLKSDAELFILDPKNADLADLGTVMPHVYSQKEEISACVEDFYERMMARSKAMKEM
SNYKTGENYAYLGLPPNFLIFDEYVAYMEMLTTKESAVILNKLKQIVMLGRQSGFFLILA
CQRPDAKYLGDGIRDQCATCF
>FECAFAII_00679 hypothetical protein
MEINVEHILDCLDQYGKGELTEEQLVKALTSDEKMFLIIHQGLLGENSDSEEDSDVLDWL
GEEESFFIVVEVNENLCRQAESILEEIGVEMPDAIEGFLNQLVETKQLPSS
>FECAFAII_00680 hypothetical protein
MRLTEGIVVDSGLTFGKLRFSALRREVRKQNEDGTIGNEVKERTYNLKSSAQGRMIQVSI
PANVPLREFAYDAEVELVNPIVDTVANYVFREGTTVNWFIKADDLVLKRQPNQGNPTNQN
ERKK
>FECAFAII_00681 hypothetical protein
MELKFVVPDMAETFGKLSYAGEGEIITEGYGRNTTVIGRSYHLYSSKQRADDIEVVVAAE
AGEKDFDQDQPLKAVNPHLVAKGYEIENRGFTDYVLYVDDLVKA
>FECAFAII_00682 hypothetical protein
MYKKQKKKLCVLTILSLAVQAIVGAIAPTITFADEITHPQTVTVELDLAHQYAVEGTFSD
GRPMSEVTVPHYAVYNGFKQDIFCIEPGVPIYNEFTPGYEKNPLPDMSDKAKLVSVLWKK
VGTDADTHIVAQKMIWQEVNGYTLHSIKRSDGSAVNIAAIEAKINQAIDDYQKKPTFHNS
TAKTVLGQSTTVTDTNNLNLSEFDEVVENAANIDYRVNGNQLIITPNANSKESGVLTLKK
SAGTGTPVAYKKAGQQTLMAGAIDKPNTYTIKIDVETEGSLKIKKVDKESGDVVPGTVFH
LDFGKTLPAKDVTTDKEGIATLDEIPHGTKVTITEKSVPAPYTIDTTPMTTTIKAGETIY
VTSKNAREKGQIILDKSGVETGSDLWNDNYSLAGNTFAIRKDSPTGEIVQEMTTDENGHA
ETPKEIANALELGTYYVTETKASHGFVNTFKPVKVELKYANQTVALVTSNVKGQNQEVTG
ETTLTKEDKDTGDKAQGKAVFEGAEYTLFTAKDGKAVKWSEAFKPELAKGTKGSDETVTL
TLDEKNQVAVKHLAINEYYWQETKAPEGYSLDETKYPVSIKKVDDSEKNAVITRNVTAKE
QVIRFGFDFFKFAGSAAGTTETGFNDLTFKVSPLEGTNEITGAEDEATTAYNEQLGFDGY
GKFENLPYGDYLLEEVEAPEGFQKITPLEIRSTFKENKEDFVKSEYVFTITEQDQKQPIK
TVTVPYEKLTNKAFSVSLNRLMLYDLPEEEDSLTSLATWKDGNKELTSLDSTELVDKLSY
NLHEIKEDWYVVAQAIDVDATKAAQEKDEKAKPVVIAETSATLANKEKTGTWKIQHKLTA
EQVLNKTIVLFNYVYENKEAFEAGDKPVAKDVSLNNQAQTVSCTVEHHVSIQTKAHLENG
SQTFTHGDVVDMFDDVSITHDVLDGSKEAFETILYALLPDGTNKEIWKSGKIDYEVNDKE
FTKTVLAKKVDTGKYPEGTKFTFAEINYDKDGNINGKHNEDLKEKSQTLTPKEVPTILST
PKQPETPTVPSGSQESSPTVKTFPQTGEKNSNVLLFIGFTLIFATAGYYFWNRRN
>FECAFAII_00683 hypothetical protein
MSTITTITMVASPLGLALFGALFDWQTTQPRLRDSLIFLEIQLENLHFLYTFLAAFFIPV
NYTSLINKKEG
>FECAFAII_00684 Ribosome-associated ATPase
MDFGNETVLKATGITKKYGAAKALDKVSIEIKRGMIYGLIGENGAGKSTFMRTIMGLISI
DEGSIELFGTTDLQAARRRMGQSIETPALYPELTARDNLRIQAANGGVSDREIEDLLKMM
RLENTGKKKAKNFSLGMRQRLAIANALITNPEFLILDEPTNGMDPAGMAEMREIIQRLVK
ERGITVLLSSHLLDELSQIATHYGILHEGHLIKELSKEELAQESRQFIKIDTSATEQAVT
VLDSLGYRDYFVQSSRVIQLFEGIDQVAAINQALVEAKVPVDGIHLVGQKLEDYFLQLTG
GNPHV
>FECAFAII_00685 hypothetical protein
MFNLLTAEKIKVWKSRKMWVSLGLMVVLPLFYSWNEWYMHTKYGNELNQATDTVINGATG
ILMVEKMAAWILLAFAAFACFYIGEEFQNGTIRNTLSLGRNRMTYYVSKLLVTLLITTLG
VVLITGLAMIAYTLAFGFGEVEGIKNYGNYVLKVFPVLLLLILATLSVPVALTFITRSTS
VSLLLSFLYIMGTAFVPGVFAKIKGLEFLTEWFTETWLMYTDFAQQATYSQAPKMILVSL
VTIVVSSALGMFIFQKSDIK
>FECAFAII_00686 Response regulator ArlR
MIIEDDEAVHSLLEEVLEQRYKLLDAYSGTEGKLLLSTYPVDLILLDLMLPGLSGEALLA
EIRQTSNVPIIVLSAKSDQRDKVSLLAAGADDYVTKPFDIEELLLRIGIQLRHQTSVQVK
DLSQRIYYKEILLDKESRDVNVNGVAVHLTGREFDLLKLFLEHPKKVFSRANLYETVWQE
PYFDSEKTVNMHISNLRGKLAKAHAVYIHTVWGVGFRFD
>FECAFAII_00687 Alkaline phosphatase synthesis sensor protein PhoR
MIKWLLLLVVIFMGSFIFFLQREIKRLTKKIATLSERQEYGGRLSVEFREKNLMDLVDAL
NTWVDENEQKGQAFQEMEENIRLSIVGLSHDLRTPLTAINGYVQLLEQVEDTEKREKYLT
IIKQSVARLLSMTDQFYDLARIETKQKEMDLHTLSFSKEVEEVFFSFYEQFSEKNIEVAF
AEHSINTTVLADPLMLLRVLQNIIQNLLRYADGQAKVTFSKEDSFIRLTVANPIKPGAQT
SVEKVFQRFYTENTSRTNTESSGIGLYLSKKLVEGMGGEMTARLDGGIFSISVKLRRV
>FECAFAII_00688 DNA mismatch repair protein MutS
MGQREFIVLIIIAVVILLVVLDIFSRLKVKETVRSNWGKIPYQPRFDKEESLKDAWLTEK
KFRSWDSEIDDLTWYDLDMFEVFEGINSTYSSVGSEALYQRLRSFDFGEDYQLEKLIAFY
QENPQLRERIQYQFARLGKKDHNFAKQYLADGKSKKIGRVGLFIFLGLLPLVGVGLLLLG
QVLGIYLAIGGLVFNTVYYLVKKQTLETELNSMSYLVSTISAANQLAKMTTPLQKELKQQ
TKPLRDIPKLGFSFRMKSGSEAELIFEYVNIMFMLPFISYHFVLTKLEKHSTEAIKLWEL
LGELEVAAAVLNYRTYMPITCRPEFTEGGVTAKDIYHPLLKEAVVNPVNWQKNTLVTGSN
ASGKSTYVKSIAISCILAQTIQTAIAEQFTLQPGHVLTSMAIEDDLFEGDSYFVSEIKSI
KRLLDQVASKERCYCFVDEILKGTNTIERIASSASVVRWLAEYPSLAFVATHDIELTEIL
KNYCENVHFEEQVTEGKGISFDFKLKEGPSRTRNAIALLKVLNYPKSIVEQAQKESLLFD
EQRQWYPFD
>FECAFAII_00689 hypothetical protein
MNKKDKNLSYKDLLYVIVVVAVGTFMILKVPELFR
>FECAFAII_00690 Daunorubicin/doxorubicin resistance ATP-binding protein DrrA
MANALEINNLKKIYGSGVEALRGIDLSVKEGDFYALLGPNGAGKSTTIGIITSLVNKTSG
KVNVFGYDLDKDLVRAKQQIGLVPQEFNFNPFETVQQIVVNQAGYYGVSRKEAMKRSEKY
LKQSNLWEKRNVRARMLSGGMKRRLMIARALMHEPRLLILDEPTAGVDIELRREMWEFLR
ELNENGTTIILTTHYLEEAEMLCRNIGIIQSGELIENTSMKELLSKLQFETFIFDLAPYD
TKPVIEGYACTFEDEQTIAVEVERNQGVNGIFDQLTRQGIKVLSMRNKSNRLEELFLKIT
EENNHTEEKNV
>FECAFAII_00691 Inner membrane transport permease YadH
MFNLYFTALKSLAIKETNRYLRIWVQTLVPPVITTSLYFVIFGKMIGGRIGDMGGFSYME
FIVPGLIMMSAITSSYANVSSSFFSQKFQKNIEEILVAPVPTHVIIWGFVIGGVGRSILV
GSLVTIISLFFVPLHVYSWFMVIITLLMTAILFSLAGLLNGIFAQSYDDVSIVPTFVLQP
LTYLGGVFYAISMLPPFWQAVSKVNPIVYMISGFRYGFLGTIDVPVATSMIVLVLFIVVL
YAVTWYLINKGRGLRS
>FECAFAII_00692 putative tRNA-dihydrouridine synthase
MTTNFWKELPKPFFVLAPMEDVTDVVFRHVVKHAAAPDVFFTEFTNSDSFCHPDGKDSVR
GRLTFTEDEQPMVAHIWGDKPEFFREMSIAMAEMGFQGIDINMGCPVPNVAERGKGSGLI
LRPEVAAQLIEAAKAGGLPVSVKTRIGYTEMSEMEEWISHLLHQDIANLSVHLRTRKEMS
KVDAHWEVIPKIIALRDQIAPQTLITINGDIPDRQTGEELAEKYGVDGIMIGRGIFKNPY
AFEKDPREHTEKELIGLLRLQLDLQDHYSEIIPRSITGLHRFFKIYIKGFPGANDLRVQL
MNTKSTDEVREILETFEKEHPTLFSEQ
>FECAFAII_00693 Zinc-type alcohol dehydrogenase-like protein
MSEKELMKVVGFYEGLPIDDPKSFIDEKEQIPVPSSRDLLVKVNAVSVNPVDTKLRQDNG
IRNALRILGFDGVGKVVAVGDEVQKFSVGDRVFYAGTTTRAGSNQEYQLVDERIVALAPK
NLSDEEAAALPLTSLTAYELLFEKFGLTPEENANRGKKILVINGSGGVGSILNQLAHWAG
LEVYATASPKNFEWLKKTGVDYPIDYHHDLSKSFRELGIDQVEYVAVLFDITRYFDQIKH
LVRPFGHVGTIVGIKEPLDIGVWKNQSISFDWEYMFAKTDYNYEIETQGEALAHIAALAN
EGIIRSTLSKVYSDGMNAKNLKQATKDVETGHMLGKVVVSGPFNG
>FECAFAII_00694 hypothetical protein
MPSFEFTLLTILGCTLATWLSRVLPFVLLKKFDLPQPLLEYLSFVPIVIMSALWFSSLFT
QNIGHLPQINLENALASVPTLLAAILSKSLLVIVLAGILSLSLIRLL
>FECAFAII_00695 Inner membrane protein YgaZ
MDEKLDIKTAIKDTLPTVFGYIGIGLAFGIVGKAAGFHPLVVTLMSLLVYAGSAQFITVS
MLASHSPLLSIVFSTFLVNSRMILMSMTIAPYFKKNRLLQNLLIGTLLTDESFALGMNKL
NYTGQKLNFRWMNTANWISYLTWVGSSLVGALLGNFITDPKKFGLDFAIVAMFIGLLYLQ
VISDRNTSKRLQLILIGLTLILVYVGLIFIPSNLVIVVVTLIGCGLGVWIKHAFF
>FECAFAII_00696 Xylulose kinase
MVGLKRKELAGRRFTRIVSVGGGAKNLAWLQIQADIFDATVYCLSVEEGPALGATMIAAL
GLGWFDTPESCCQNFIQYTDAAEPLLQNVEKYHKIYQQCRKIYPATKEICHDL
>FECAFAII_00697 hypothetical protein
MNNWLEYFPENVLERGYSYHLHGFVRHLNYTSKYLSATVSGTEDYKVVITWDEKTNMTCD
CLYAIEGKKCKHMAAVLFAYEERPIKKSNYSLSELSSLVSSASSSLVRELLTEILIEHPH
FIERFKVKMPFHAINYSDKLTTIIHKYDHIIKKNKNRKTAKFIMEMRKFIQEAVESLIQQ
NAYLPAFELINEVIATLETFYWEPEDERTLLLIEDCYYLWKELLAEAPHAEKRQMFSWFV
CQVDHTDASYSKRYSIKILKEDFREKEFSNQKKKIDKKLKKR
>FECAFAII_00698 Regulatory protein SoxS
MLKDLNQLIDYIEEHLTEGLSYKIIAENTGISEYQLKRIFTFIAGMSLMDYIKNRRLALA
NRDLLDGSRVTETAFRYGYETVEGFSRAFRDWSGYLPSEISRYGIQKSFPRLTFFIDVRG
GKSMEFRIEKKEQFYVAGVAKKVPVKFEGVNQEIQKLAQTITETQREEMHKLGDLYPNQV
INVSYGFDGDRLEEKGSLMHMIGFATTKENPYADLEMLAIEEHTWAIFPNKGPFPQTLQD
TWGKIYAEWLPSSDYGLVEAPEISFTKWGEDFSNVYSEIWIAVKAKK
>FECAFAII_00699 hypothetical protein
MAKYRIEEKPDFTVTGIGVELKSSNTDFVGLAAEKQAFEQKVIGNGTIDALKQAAENHYF
FTVNEPYNGKMMYYVGVQTSQDVPNTTRIIPFPKGTYLVVSALAESPEELRNDLTNTAFG
HVLREVEDYAYVGGPNAVVEMGVTNGKYMGEIWIPVVNKP
>FECAFAII_00700 Putative HTH-type transcriptional regulator YwnA
MKYSLQFSDAIHVLAYIEMFQDTRSLSSEMIASSIETNAANVRKIMSQLKKSGLIFTKTG
KPQPSLAKSPDQISLLDVYRSIEGNTQLIQVDPKTNPNCVVGANIQEALEESYARLQKKA
EEEMAKITLDSLIHKIAVLEKEKRPENTGLVERFL
>FECAFAII_00701 Quinone oxidoreductase 2
MHYLVTGATGGFGGYALEFLKKMVPQNEIYVLVRSEEKGEALKEAGFNIRIGDYDDLDSM
KEALKGIDRLLFVSGVPGNRQAEHKNVVKAAQAAGVSYIAYTSFADADHSISVLAPDHQF
TEKMIKDSGISHTFLRNNWYVENELPIIGQALKTGQFVYAAGNGKTGWALKREYAEAAAK
VLVESDSPEILELSGNLTDYEELAKALERATGKELEIIEASDAAFVENLKEAGFPQEAAD
MFLAIQHDIKKDQLAISSDDLEKVLGKPLTSLEAALKEILDQE
>FECAFAII_00702 hypothetical protein
MYKEVVKKPISFEYEEKFCEKAVLHQVIRRVK
>FECAFAII_00703 PTS system glucose-specific EIICBA component
MKAYLQRMGRSLQLPVAVLPAAALLVGIGNWWASYSNDIVAHFLQAGGNAVLGQLPLLFA
VGLALGMSVDKSGAAALAGLVAFEVPVNVLKTDSVATLLNIKPESVDPSFAQISNVFIGI
IAGLIAAALYNRFHEAKLPMALSFFSGKRLVPILAAFVMLLISAVLLLVWPPVYSALVSF
AKFILSLGWGGAGLYGFFNRLLIPTGLHQAMNSVFWFDVAGINDIGKFLASEGTKGVTGM
YQAGFFPIMMFGLPAGAYAIYRNARPENKAKTASLMLAAAFASFFTGVTEPLEFSFMFVA
WPLYVLHAIFTGISLAVSAFFHWTAGFAFSAGFVDYFLSLKNPIANQPLMLIVQGLVTAV
IYYFGFNFAIKKFHLMTPGREEADLSDDDTATTNSDNKYAAQASKIYAALGGADNVTSID
NCTTRLRLQVKDTGLIDQNKIKATGVPGMKIIDGKNAQVIVGTEVQFVADEMAKLHGGAA
ARPAQTNTVVKTETFAGETIEQDIYAIANGKLIPITEVSDDVFAEKMMGDGYAVLPENGE
IFSPIAGTITNIFPTKHAVGIQTDAGIEVLLHMGINTVDLKGEPFTLYVEEGQKVARGQL
IALVDLAAIQSAGKNTDMVVVFTNGDKVQSLEIEPARDVKANDKIGSVSNKA
>FECAFAII_00704 Levansucrase and sucrase synthesis operon antiterminator
MKIKKIFNQNAVLVDDGGQEKVAIGKGIGFDRKRNDLIFDRDVERIFVMEPEGQIKLQNL
LNQIDERFLFAAETIIDHAETVLMEKLNEHVLIALTDHIAFSAENINNGIVIRNKLLREI
EVLYSDEFSIAQWAVEYLTKELGIPYTYDEAGYIAIHIHSGRSGRNNNHRSIREVTIVSD
IIHLVESELETDIHSEPFSLNYSRLVNHLRLLLQRTHAQQYAVLDTEIVEMVKRKYPESY
KISKKIRVLLTKEYQLAITKEELGYLAIHIERLRSAIVQTNVNNHEEEKN
>FECAFAII_00705 HTH-type transcriptional regulator BenM
MDIRILTYFLAVAREKNISRAAKSLHITQPTLSKQLKDLEEELGVTLFTRGSREIQLTDS
GRYLYSKGKEILSLVEKTANNLTNDAIISGEIYIGGGETKAISFISDSLHSLIKAHPDIQ
FHLYSGNADDIIDKLDSGLLDFGLVIEPTNKQKYQSFRLPAQDRWGLLIHRNHPLAKQTV
IHPQELKTVPLIISRQTSVDSQLAEWLGFSIDQLSIVGTYNLLYNASLMVDNGTFGALAL
DGIINTYGTEKIFIPLDPPLQASLNLIWKKDQPLSPAARKFLDVLTEKYS
>FECAFAII_00706 Putative acetyltransferase
MTSLIEKQIVNKEIRVTDPLFEVIHQIQAENEEPLAALNTGYHEPADIRKRLENIISDKV
DDTVTVLLPFYTDFGKHISIGKNVFINRQVMFVDLGGICLEDSVLIGPRVNLITVNHLTD
PKERRGLSVKPIHIKKNAWIGAGATILPGVTIGENAIVAANATVTKDVPDNTIVAGIPAK
IVKPVERII
>FECAFAII_00707 putative oxidoreductase
MNDLSEKVIVIMGASSGIGEATTKLLAEKGAKLVIAARREDRLKAIKESLPEAELYIQTA
DVRDFAQVQAVIDLAMEKFGRIDVLYNNAGIMPTAPLVEGHRDEWQNMLDINIMGVLNGI
SAVLPIMEKQKSGHIISTDSVAGHVVYPDSAVYCGTKFAVRAIMEGLRQEQRQNNIKSTI
ISPGAVQTELYQTISDKKAALELHEAQKEWGLTSEDIASAVAFAIETPDRMSVSNMIIRP
TTQEV
>FECAFAII_00708 Autolysin
MKAKNLLFSVILLGNLAVANTTVLAEESTETVATQTSSSSETGIENDTESTLQSATVSEN
TISTEEPTTETTEQTQTEDSTSAEAQNNPENAEEITNQLTDGQTLTHTHQADLSEFENYT
GYAFYARSSANSQQAFIDSIASTAQSLASANDLYASVMIAQAIVESGWGNSTLASAPNYN
LFGIKGSYNGQSVTMPTSEYVNGQWITVNAAFRKYPSYKESLQDNVTVLKTTSFQPGVYY
YSGAWKSNTNSYKDATAWLTGRYATAPNYGSTLNNVIETYNLTQYDTAPTSTSPMYRLYN
RHTGEHLYTLNAGEKNYLPTVGWEYEGIAWQAPNSGQPVYRLYNPYSGDHHYTMAQSEIN
SLTKIGWRYEGLSFYSGGSKPIYRLFNPNEKTGTHHYTLSAKERDWLTPMGWRYEGIGFY
GY
>FECAFAII_00709 putative HTH-type transcriptional regulator/GBAA_1941/BAS1801
MSLEEISHLLYQIKLADQKIVQIFEENIGISLTRYEIMMRLKEENPLLQSSLQEKLQIDQ
GAVTRHLKVLEANGYVSRQRNPQNNREVYVALTEKAQKKIEHCEMDHKDTGSVLSPAFSD
VEMKQFLTLLDKLNTQLCNITTETKEVNNNGTKK
>FECAFAII_00710 Putative NAD(P)H nitroreductase YodC
MEQKNDFSTIMTGRRSVRVYDETYKIPHEEMLEMIKEATTAPSSVNMQPWRFVVAESEEA
KEILRPLIRFNTRQNDTSSAMVMIFGDMQCYEYGEEIYNQAYESGKMPKEVRDQQLAAII
PYYRVFQEKK
>FECAFAII_00711 Putative NAD(P)H nitroreductase YodC
MNDVVKVDSSLAAMQFMLVARDHGYETNPIGGFEADQLAEAFGLDKDRYVPVIILSIGKA
VEEGYESVRLAPEKITTFE
>FECAFAII_00712 Energy-dependent translational throttle protein EttA
MENLAVNITNLQVSFGNQLELSIDSLRVYQQDRIGIIGENGVGKSTLLKLIAGELFPDHG
KIQTEITFNYLPQLTYLAEAKDLNLELASHFQLRLEETSERKWSGGEERKIELIRLLSSY
EQGMLLDEPTTHLDRKSIDRLIEELRYYYGTLVFVSHDRYFLDELASKIWEVKDGEIREF
SGNYSAYLTQKELEKKTQLREAESIMKEKKRLEKSIQEKKKQAEKLEKVSSKKKKQQIRP
DRLSSSKQKDSVQKAIQKNAKTLERRLQKIGETTKPQQMKQIRFPVPKSLELHSRYPIMG
QNVQLERSGRTLLVNGDFQFSLGKKIAIVGENGSGKTTLLEHIRKQGEGILLSPKVSFQV
YQQKGYQMTSEESIIRFVMRQTEFSESLVRSLLNHLGFAQETLTKPLCTLSGGEATRLTI
ALLFTKPSNVLLLDEPTNFIDMATIEALEKLMQIYPGTILFTSHDSYFVERTADEVYEIK
GQKIKKVLTRNF
>FECAFAII_00713 hypothetical protein
MPTNKKEGIIFTTMMCFLMVLGMSAYNLWLHQDLHLSSLLIGLVPGFVVAFILDVFIIGV
LAKKIAFKLPVNPESKVQMILTISCLMVLGMVTCMSLFGVIMEQGIPDQLFSAYMNAWKM
NVIAALPLQLIIVGPLSRSVLKAIQSNE
>FECAFAII_00714 hypothetical protein
MNTLAYILLCVLLSKPRSGYELKQLITIFWEAHHSQIYTTLAKLDQQGYVTVLDKDEHSQ
KKIYHLTDEGRALVEEWIKEETPAPTQKDEFLAKIYAFSTLDKTTATGLLFTREQQLNKI
MQKNQKKLNDLSLDKKQEFGRYVVIQRRIMLCQQELQWCQQVREQMQQFFE
>FECAFAII_00715 Multidrug efflux protein YfmO
MEILENQIDIQEQTNEETKGKSSALVVAATCMIAFMGVGLVDPILKTIAAQLNATPAETT
LLFTSYMLVTGVVMLFTGFLSSRIGLKKH
>FECAFAII_00716 Multidrug efflux protein YfmO
MTGLFIIVVFAGLGGLSGNIGMLIGLRAGWGVGNALFVSTALATIVSILVGNTEKAIMMY
EAALGCGMAVGPLVGGVLGSGSWRYPFFGVAFLMFCGFIALAVLLPETEKPKRKVGLWEG
VKALSNHKLRSVGLIALLYNFGFFTLLAYAPFLLIGYSELEVGFVFFGWGVLLAIASIFV
APALERKFTTYRTILAAFVLFIICLLLLGAGTSMPVLVPISIVLAGFFQGIINTLLTTIA
MEIPGLQRNVASSSYSFVRFFGGALAPFIAGVIGEHIGESYAFYFAGAIVLISVCCIIYH
RNYFATNEEE
>FECAFAII_00717 hypothetical protein
MLEEYFQEVGLTLVELPIEFSDDRLIYRGYIKELPIINAEGETRKAMQQKIAGMYQVYRE
QLLAESAEEEKEKTMNLSMDELLRYYDGETFDGFSLLNEEETDLPGSW
>FECAFAII_00718 hypothetical protein
MFEILMIFFIYLISLNIAAFLGVGILSLFFQFKKRSIGSQREKWSQYFDKIGQKGLVTRL
HISYMVALCLLATINYYSFFDHSIAYTITLLIAGIFHLSYKYQLNKNHLNRTFR
>FECAFAII_00719 Gamma-glutamyl phosphate reductase
MTDLMQLGQQAKDSAQQLALMPTNRKNELLVQMAQTIKKNQQAIIEANHKDLEKAVENNI
SETMQDRLQLTPERINAMATEIEKIASLDDPIGKVDEMWTNTDGLRIGKKRVPLGVTGII
YESRPNVTTDAASLAFKSGNAVILRGGKEAFFSNQLLVQLLQQVLVSAGESPYAIQFVDD
TSHETAGQLMRLTEYLDVLIPRGGAKLIQRVKEQATVPIIETGTGNNHVYIDKEAQLSMA
VNIIVNAKASRPSVCNAAETLLIHSEIAPFFLPAIEKELVEHGVSLRADARALEYLETAA
LAEDTDWDTEYLDYILAVKVVDSLDEAIAHINRHNTKHSETIVTDSYAASQRFLNEVDAA
AVYVNASTRFTDGSVFGFGAEIGISTQKLHARGPMGLNELTSTKYIIYGDGQIRE
>FECAFAII_00720 Glutamate 5-kinase 1
MRKEIKNAKRIIVKVGTSTLIYPNGNINLAAIDQLAFVLSDLRNRGKEVILVSSGAVGVG
MHKLHLSERPTLIPEQQAAAAVGQAELMNIYNQRFSVYNQQTAQILVTRDVVDYPESRKN
VRNTLEQLLIMDTIPIVNENDTVAVDELDHLTKFGDNDQLSAIMAKLVAADLLIVLSDID
GFYSDNPTTNPEAQMYRYIDKIDEKILAQAGGAGSTFGTGGMQSKLKAASRIFEANSAMI
LANGKNPAIIFDILAGKEVGTLFKEDLK
>FECAFAII_00721 Deoxyuridine 5'-triphosphate nucleotidohydrolase
MRKRGFEVISKYKDQNINLPQRATHHAAGYDFEAAEEVVIPSIWKAGWKKGLETVADGLK
KDVSENEKQLKPTLVPTGIKAYMGEDEFLQLANRSSNPLKRFLVLTNGVGVIDSDYYNNE
ANEGHIMFQFTNFGFKDVVIKKGERIGQGIFLPFLKADQDQTTAQRQGGFGSSSK
>FECAFAII_00722 DNA repair protein RadA
MAKKSKVQFVCQNCGYVSPKFLGRCPNCGKWNTMVEEIEQDTTDRRTRTSLTGEKAKPTK
IADVVPKKEPRIKTKLEELNRVLGGGVVPGSMVLIGGDPGIGKSTLLLQVSQQLAAIGGK
VLYVSGEESAEQIKLRAERLGSINTEFYLYAETDMNEISRAIEHISPDYVIIDSIQTMTQ
PDITSVAGSVSQVRETTAELLKIAKTNGIAIFIVGHVTKEGSIAGPRMLEHMVDTVLYFE
GEQHHSFRILRAVKNRFGSTNEIGIFEMHEHGLEEVANPSQIFLEERLDGATGSAIVVAM
EGTRPILVEIQALVTPTMFGNAKRTTTGLDFNRVSLIMAVLEKRAGLLLQNQDAYLKAAG
GVKLNEPAIDLAIAVSIASSYKEKGTQPTECFIGEIGLTGEIRRVSHIEQRVKEVQKLGF
TKVYLPKNNLGNWEAPKGIEIVGVATLAETLKRVFR
>FECAFAII_00723 putative PIN and TRAM-domain containing protein YacL
MQKRVITLLMIIVGASLGISFLPSAWQAIGQQSNGWLNNTFTNSLLGALIFFLLSLLLAK
HISAIIKQVEQKLSEVSLTYLLFGAIGAIIGLTLGVVISTPLYNMEIPFVNSVLPILLMI
ILGYLGLRMGTTRIEEWKKVFGSRSKKIEQETASQVESQLLERKSGENFHKYKILDTSVI
IDGRIYDITKTGFLEGTLMIPNFVLYELQYIADSGDSLKRVRGRRGLDILNALQKEEGIS
VEMYDGDFEDISEVDSKLIKLAKLLDGVIVTNDYNLNKVSEFQNVPVLNINALANAVKPV
VIPGETMNVLVVKAGTERQQGVAYLDDGTMVVVEDGQHYMNERIEVVVTSALQTAAGRMI
FAKPAHAGRGIDNKKETEKKTKQSK
>FECAFAII_00724 Glutamate--tRNA ligase
MTKVRVRYAPSPTGHLHIGNARTALFNYLFARHNDGDFIIRIEDTDQKRNIEDGEKSQLE
NLAWLGMNWDESPENPGEYGPYRQSERKEIYQPLIDQLLASNRAYKCYCTEEELEAEREA
QRARGEMPHYAGTCANLTPEEQAEKEAQGLESVVRFRVPRNTEYAFTDMVKGAISFESDN
IGGDFVIQKRDGMPTYNFAVAVDDHLMKITHVLRGDDHIANTPKQLMIYEAFGWTPPTFG
HMTLIINSETGKKLSKRDESILQFIEQYRELGYLPDAMFNFIALLGWSPVGEDEIFEHQE
LIKMFDPKRLSKSPAAFDAKKLQWVNNHYIKAMDLDAFTDMCLPYLIADGRVAENPDEKT
IEWVKKIVSLYQPQMSYAAEIVDLSTLFFNEHPVLNEAAKEVLAGETVPTVLHAFKAQLE
QMEVVDAPTVKAAIKAVQKETGVKGKNLFMPIRVAVSGQMHGPELPETIELLGREKSLAH
LNQVLN
>FECAFAII_00725 Serine acetyltransferase
MSWFTRAIDAAKRNDPAARSTAEIVLTYPGFHALFWHRFSHFLYQHRLFLLAKINAQFWR
FLTGVEIHPGATIGTGVFIDHGMGIVIGETAEIEDDVILFHGVTLGGTGKETGKRHPTVK
QGAMLSANAQILGPVTIGKNAKIGAGAVVLKDVPDDATAVGVPAKVVRIKGEKVRRSE
>FECAFAII_00726 Cysteine--tRNA ligase
MIKIYNTLTRKKEEFIPIQKGHVGMYVCGPTVYNYIHIGNARSTIAFDTIRRYFEYRGYK
VDFVSNFTDVDDKIIRTANELGITAPEVADRFIRAFEEDTKALNVEPATLHPRVMDHMPD
ILAFIQVLVEKGYAYESSGDVYYRTRKFENYGKLSDQSIDELEVGASQRTGEEQQQKEDP
LDFALWKQAKPGEISWDSPWGKGRPGWHIECSVMATKHLGETIDIHGGGQDLEFPHHENE
IAQSEAKTGKKFANYWMHNGYVTIGEDDEKMSKSLGNFITVHEMIKNVDPQVLRFFMATT
QYRRPIRYSETTMKEAATNLQRLKNTFDNLKFRQETASENLADDADKIALLENLEQRFIE
EMDDDFNAANGITVVYELAKWLNTYLDQPKVSAAVLAQGEALFSQWLSIFGILFTAEELL
DEEIEQLIEERNQARSNRDFVRSDEIRDLLKEKGILLEDTPQGTRWRREA
>FECAFAII_00727 Mini-ribonuclease 3
MRDYTQLNGLALAYVGDAIYEIYVRDHLIDQGETKPNKLHRAATNYVSANAQAFLIQQML
EEHLLTEEEELYYRRGRNAKSHTSAKNADVTTYRVATGFEALMGYLHLTKQTERMEELIR
WCIQKVGEKNG
>FECAFAII_00728 Putative TrmH family tRNA/rRNA methyltransferase
MGKERTNKHQSKRGFEDKKQNRYSNKKQTGRNQSVSDQNEEALEDNFVFGHHAAVEALQQ
GRGNKLFLQEDSRGEKVEELKEIAREQAVPVKWVPKQKLETLSDHGVHQGVVLAITPYEY
LSLDQLIERTKEKKEDPFFLILDSIEDPHNFGSILRTADASGVDGVIIPKHRAVGITPIV
TKTSTGAVEHVPVARVTNLVQAVQQLKETGFWVFGTDMTGTNFQKWNAKGSIALVIGNEG
KGMSPGLKKEMDELLTIPMTGHVQSLNASVAAGLLMYQAFSQRQGE
>FECAFAII_00729 hypothetical protein
MKKQLLIVDGYNMIGSWPELVQLKKQDKMADAREALLHRLSNYAKYEGMEVIVVFDAQLV
PGIQQNYKKYQLDVVFTKEDETADSYIERIAGQLNDRLTQVTVATSDLAEQWMIFSQGAL
RTSAYELYKTIKKTEKTIAQENKDMHFIDFRRNSPWNEEQLKKLSQKLDDLMRKNK
>FECAFAII_00730 RNA polymerase sigma-H factor
MSEELLRAARNGDEEAFAALYQKYFPLLLRLKNTYYLRNYVSEDWEQEARIALYQALRTY
EKSKGVSFGSYYKSIISNQIYSLLRKQNALKRRDQKDEVSIDQKIETEGPDFLAEITLQE
PLAIQHLLLKEAIENCEIQFSKIEAKIFHYYMQGVDFVDMAECLAMDHKQVMSAYGRVKL
KIKKHLKFYNEE
>FECAFAII_00731 hypothetical protein
MPTTLASIKKDLEGRIGSPIMLVAQTGRKRQTERRGVLTETYPSVFVVDLDPEENSFERV
SYSYSDVLTRTVEIEFLTEAV
>FECAFAII_00732 Acetyltransferase
MEYQVKKFEELSTAEFYAIVKERIAVFVVEQQCPYQEVDDIDGQAWHTFFQDTDGKILAY
TRVYEEAESIHFGRVLVHQDNRKDGLGRKIVQETINMIQKNFPEKPIVIGAQEYLQAFYE
SFGFKAISDVYLEDDIPHIDMKKEQVAS
>FECAFAII_00733 Large-conductance mechanosensitive channel
MIKEFKEFIMRGDVLDLAVGVVIGSAFTSIVNQVVQGLITPLIGWFVAMITGTSDLEGAL
SILDWSPTKGVTFAFGNVISAIITFLITGFVLFLVVKAANRAKNLRSKEEQVEVEETPTA
EDYLSDIRDLLAKQVAEDNTHPVEQTNLSDTSK
>FECAFAII_00734 putative zinc protease
MVYQLAEGVNLHVLPTKQYKTIRIFIRFTARLQQEVITKRSLLSSMLETNSLNYPDQTKL
SAQLAELYGASFGLSVRKKGNLHWLNAGISFVNGEYVNDPNLFSQAVDFLKEVLFYPNIK
NHQFDQLTFDLEKNNLRLYLESLKEDKQTFASYALQELYFENSPEQKIPGLGVVEDLDKI
TASSLASYYQEMMANDQIDIFVVGDVDPDKAAEAVGQLPFESRETVYPDLFYTQPQVNIV
KERQVREPIVQAKLNLAYQTNVYYDEPERFALMVFNGLFGGFPHSKLFMNVREKESLAYY
ASSSVDTFRGFMSVQTGIDEKNRNQVLHLIHEQLESLRNGEITELELSQTKAMLRNQYLL
SLDSPQAAIEASFLDSWLPETKLSDEEWLKRMESVTIKEIQQVAEQIELQAIFFLAGGNA
NE
>FECAFAII_00735 Putative zinc protease AlbF
MNKTEYEQINETLYHEVLPNGLTVYLLPKNDYHKTYGLFSTNYGSIDNEFIPYGEKEKVK
VPDGIAHFLEHKLFEKEDGDVFQLFGKQGASANAFTSFTKTSYLFSTTDQVEKNLTTLID
FVQAPYFTEETVNKEKGIIGQEIQMYEDDPNWRMFFGILNNLYPTHPLHIDIAGTVESID
KITAQDLYTCYRTFYQPSNMVLFVVGKMEPEKLMKLIRENQEAKNFPPKQEIVRYFPENT
KEIIKQSALEAAITRDKFVLGIKGLDTLPQEGTELLRYKTAINLLFQMILGNTSRNYLAM
YNQGIIDDSFGFEFSLDREFHFADFSGDTDEPEKAAEKVKEIILGFADDPEVSETNLDLL
KKKMLGQYFQSLNSIEYIANQFTQSLFGDRTLFDLPEIIDSIQMKDVLAAGEAFISEEAF
SEFYMRPK
>FECAFAII_00736 hypothetical protein
MAFETIGEKLRQARLNKKISLDELQQITKIQKRYLEAIDNDDFDQLPGKFYVRAFIRQYA
EAVGEDGDHLVDVFDGKSKLTGSVPERPQPETVSTSRKAMHQEESHPSRFWTSLPVILLG
LVALAIVVVVGYMTWQDRQADPIIGDTASSLKVEGSVEESSSSEQSTQTKESSTVESTTK
SSEEKKMAIATGEDSGSAIAVNITDATKPVTLEFTAVNRVWLGVLVDNAYVYQGTLAANE
TQSTVLPETATNATITIGAASNATIKANGESVPVNPGENNQSPKNVNLTLQYAE
>FECAFAII_00737 CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase
MNLPNKLTVLRICMIPIFILVVGLPLDWGQFNVGDTTLAVTQLVGAVIFALASITDWLDG
KIARARGLVTNFGKFADPLADKMLVMTAFIMLVDQGKAPGWVVAIIVCRELAVTGLRLLL
VEHGEVMAAAWPGKVKTATQMVAIILLFINNIPFSLIGIPVDQIMLYACLIFTIYSGVDY
FIKNSGVFKGSM
>FECAFAII_00738 Putative competence-damage inducible protein
MKAEIIAVGTELLLGQVVNTNATFLSEQLADLGIEVYYQTVVGDNQQRLEELIALAETRS
ELILLCGGLGPTEDDLTKEATAAHLGKSLIQNTEGYKKLLAYFETTHRKMTKNNLQQSQI
IEGGVPLPNRTGLALGTFYQTDTHAYILLPGPPNELKPMFVEQVRPLLEERFPSEEKLIS
KVLRFYGIGESRLVTELKDLIETQINPTIAPYAKPNEVTLRLTVKTNDVQAGNQALLALE
EKIQERVGEYFYGYGDDNSLAKVVVELLKENKQTVTAAESLTAGAFQAALGDIAGVSEVF
PGGFVTYSLQTKAGFLEIDPELLAEYGTVSKECVEQMAIQAREIARTDYSVAFTGVAGPD
TLEGQSAGTVWIAISSKDGVVSEKYHFARDRAAIRYNAVMQGFDLLRKQLLRK
>FECAFAII_00739 Protein RecA
MADDRKAALDAALKKIEKSYGKGSIMKLGEKIDQQISTIPSGSLALDVALGVGGYPRGRI
IEVYGPESSGKTTVALHAIAEVQKNGGTAAFIDAEHALDPQYAQKLGVNIDELLLSQPDT
GEQGLEIADALVSSGAVDIVVVDSVAALVPRAEIDGEMGDSHVGLQARLMSQALRKLSGS
INKTKTIAIFINQIREKVGVMFGNPEITPGGRALKFYATIRLEVRRAEQLKQGTDIVGNR
TKIKVVKNKVAPPFKIAEVDVMYGLGISQEGELLDMAVEKDIVDKSGAWYSYKEDRIGQG
RENAKIYMANHPEMMAEVSALVRAAYGIGEEVAVPEDEKGQEELPLVEE
>FECAFAII_00740 Ribonuclease Y
MVFNILLAIIGLIVGLGLGFMVAKSRHEKEIAGAQSSAAGIIDSAKKEAETLKKEALLEA
KEENQKYRSEVESELRESKLELKSQENRLIQREQTLNRKDDSLEKRENSLESKEEALSSK
QQLIEEREKDVEKMIEDQQKELEKIAGLSKEDARDVIMKSTEEELNHELTLMVKESEQRA
KEEADRKAKNLLSLAIQRCAADQVSETTVSVVTLPNDEMKGRIIGREGRNIRTLETLTGI
DLIIDDTPEAVVLSGFDPIRREIARMTLEKLIQDGRIHPARIEEMVEKSRKEMDERIREY
GEEAAFEVGAHTLHPDLIKIIGRLRFRTSYGQNVLKHSVEVAKLAGILAAELGEDIQLAK
RAGLLHDIGKALDHEIEGSHVEIGAELAAKYKENPVVINAIASHHGDVEATSVISVLVAA
ADALSAARPGARSESLENYIRRLRSLENISNSFAGVESSYAVQAGREVRVMVKPEEISDL
DAVRLVRDIRKRIEEELDYPGHIKVIVIRETRATDYAK
>FECAFAII_00741 Pyrroline-5-carboxylate reductase
MKVGFIGTGNMAQAIIDGLLKKGTVSKEEVFVSSGHFENAQKFAAETGVHACKSNQEVAS
QSDIVLLAVKPKIIEKVLEELREYSQKVLFISIASGKSLTDLETALEDPQASIVRVMPNV
NVSVGAGVSAICKNEAATEEQLQQATMIFEAIGSVYPLAESDFSTFIGLAGSSPAFVYML
IDAMGRTGVLNGLSKQTATEIAAKAIMGSCQKFLSSDKNPWELVDQVSSPGGTTVAGVVA
LEEAGFIPAIIKGINTTIEKDLEMLNKK
>FECAFAII_00742 Phosphatidylglycerol lysyltransferase
MKNKRYLMLQWIKEHSLILKLIFFGSVLVFVANQVANIANGMSWQDIWQRMGQQSRMTIL
LMILAGLLGVTPMLLYDWVTIRVLEKQGKPKMERKEFLLAAWVTNTINNLAGFGGVVGAS
LRASFYGKQTNRKMVLATVSKVALFMLTGLSVWSFLTFIDVFFIQSESIFRSYWIWLFGG
SFLAPVIFFFAYLKRKTLFFEFYPKGLLGLLLASFGQWTGALAVFLIIGKLMRIDISMLS
IYPMFMIATLIGMLTMVPGGMGTFDVLMILGMSQLSVRQDVAVVWLLYYRLFYYVLPFMT
GLLLFITHTGVKINRFLDNIPRLFFQKVAHIVLVSAVYFAGIMMVLLSTITNLSAISRLF
QVLLPFSFNFLDQTVNLLVGFLLLGLARALSVKVKKAFLPTIALLSFGILNTITRTLSWQ
LILVYVLILLAVWLSRKEFYRTKFVYSWGAIIFDASLFGFLFIVYAIAGYHSGRFLVGRI
TGNHFILFPSDDVWFSGLIGLGISLLALVALYQYLAEDTTKLGSEYEKDRFDRLLETYGG
TATSHQLRLSGYSYFYYQEDDQDQVVFGYQIKGNKCFVLGDPVGNPKMMRAATNQFMKQA
DCLGYQLAFYKISESYVVMLHELGFHFTKVGEAGIVDLATEDLSRLSQQLEYQRLMKEGY
HFTWYDQLPEELHQAVNEVSQKWLQGAREKYFSVGRFDKSYVLSSGVGIVRKDQKVVGFI
TAQPMTKKQAGYDLLRVLPKESEELADYLLANLFIVYEKMGYSEANLGLAPLANVGETDF
SFFQEKVMHIVYNYGNFFYSFQSAYEKKLKYVDHWEGRYFAYRKGSNFGFATMQLLSLIG
KEKGNVPSLAEEVLTEL
>FECAFAII_00743 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase
MIEKAPAKINLGLDVLYRRQDGYHELEMVMSSVDLADHLFFEEITEDKIIVETNKAFLPV
DERNNVYQAALLLKNKYNIKTGVKIFVKKNIPVAAGLGGGSTDCAAALRGINQLWNLGCS
LEELAEIGLEVGTDVPYCVYGSTAFVGGKGEEIQVLPSMPQCWVVLVKPRMSVSTRTVFR
EVDTQAIQHQDIHGLAEAIREQDYQQMIKKMGNSLEDITGKRHPVIHQIKERMIKYGADA
ALMSGSGPTVFALCQHYSRAQRVYNGLKGFCEEVYLVRTLQ
>FECAFAII_00744 High-affinity zinc uptake system binding-protein ZnuA
MKKYLLTATVMIGALLFAACGNTNKEADKKEDLTIVTTFYPMYDFTKEIVGDEGNVKLLI
PAGTEPHDFEPSAKERAEISDADVFVYNSSDMEFFVDSLKDSVDSKQTLMIEAAKGIDRL
ESQEADEHEESEEGHGHSHEYDPHVWLDPVLAIKEVRTIAEELGEKYPDKKETFTKNADA
YIKKLEALDQKYSDELKDATNRTFVTQHAAFAYLANQYDLKQVAISGVSPDQEPTPSRLA
ELKEFVKKNNIKVIYFEENASSKVAETLSNETGVKLEVLNPLESLTNEQIKAGENYISVM
EKNLKALKESIN
>FECAFAII_00745 High-affinity zinc uptake system ATP-binding protein ZnuC
MRYIEISDLTFYYDDEPVLEDVSYHVDAGEFVILTGENGAAKSTLVKASLGLLKPSKGMI
KIAEKNQEGKKLSIGYIPQQVASFNAGFPSTVIELVRSGRYPRGRWFKRLSEKDHQHVQR
ALEAVGMWDMRNRRIGELSGGQKQRISLARIFATDPDLFVLDEPTTGMDEESRNEFYRLL
RHSAHVHGKSVLMITHDHEDIKQYADRQIRLVRKEDSQWRCFHMNS
>FECAFAII_00746 High-affinity zinc uptake system membrane protein ZnuB
MALLSYEFMRRAFLAAIFIAGIAPMLGVFLVIRRQSLMADTLSHVSLAGVALGFFLNLNP
TLTTMLVVVLAAVILEYLRTIYRTYSEISIAILMAGGLALALVLMNLSGGNSATSIQSYL
FGSIVTITWEQVIFLGILFVAIGILFFLFKRPMYVLTFDEDTAHVDGLPVHLMSMMFNVI
TGVAIAVMIPIAGALLISAIMVLPAAIGMRLGKSFNVVIAISVCVGFLGMLSGLTSSFYL
DTPPGATITLVFIALFLIVNIIKRILVAFRRKNN
>FECAFAII_00747 Pur operon repressor
MKVRRSERLVDMTQYLLNHPHELISLTSFAERYESAKSSISEDLGIIKKTFKERGYGTLE
TIPGAAGGVLFIPEISYEEAKKYIESLAERLSEQDRLLPGGYVYLSDLLGEPELLRQVGR
IIASKYLGEKIDAVMTVATKGVPIAQAVSYYLNAPFVIVRRDSKITEGSTVSVNYVSGSS
ERIEKMELSKRSLKRGSRVLVVDDFMKGGGTVNGMKSLIEEFESELVGITVFAESKFNGH
RAIDDYTSLLYVKDVDTQTKNITVVPGNYFSE
>FECAFAII_00748 Bifunctional protein GlmU
MDARYAIILAAGKGTRMKSKLYKVLHPVSGKPMVEHIINRVSETKPDEVITIVGHGAEQV
KAQLGERSKYALQAEQLGTGHAVLQAASFLEGKKGTTLVISGDTPLLTTETLNNLFEYHQ
GKNASATILTAQAENPTGYGRIIRDHIGIVEKIVEQKDATPEEALVQEINTGTYCFDNEA
LFDALSKVGTNNAQGEYYLTDIIEILKEEGHTVAAYQTDDFEESMGVNDRIALAKANEIM
RKRINQMHMVNGVSFVDSATTYIDAGVEIGPDTLIEAGVQIQGNTVIGSDCVIGSHSKIV
DSRIEDHVVIENSVIESSHVKKHADVGPYAHLRPKAEIGENVHIGNFVEVKNAQIGKGTK
VGHLTYVGDATLGEEINVGCGVVFVNYDGKNKHHTTVGDHSFIGSSTNIIGPVEVAKNSS
IAAGSTITDNIPEYALAIARARQVNKEGYAKKLPYLN
>FECAFAII_00749 Ribose-phosphate pyrophosphokinase
MSKHYFDPRLKIFALNSNRPLAEKIAAAVGVELGKSSVTQFSDGEIQVNIEESIRGSHVY
VIQSTSSPVNDNLMELLIMIDALKRASAKTINVVMPYYGYARQDRKARAREPITAKLVAN
MIQKAGATRMLTLDLHAVQIQGFFDIPVDHLMGAPLIANYFLEKGIKGDDVVVVSPDHGG
VTRARKLAEFLKSPIAIIDKRRPKANVAEVMNIIGQVKGKTCVLIDDMIDTAGTITLAAN
ALKEAGATSVYASCTHPVLSGPALQRIEDSAIERLVVTDSIYLPEDRKIDKIDEVSVGGL
MGDAIKRIHENKPVSPLFETKNK
>FECAFAII_00750 Thiamine transporter ThiT
MGKNRVWVEGTIVAALAMVLSLIPIQIGSSFSISLGQIPLTLFALRRGTKAGMLAGFIWG
ILHFPLGQVYYLSVVQVLIEYPIAYTFAGAAGLMASNVQKGYVDDNTKQIRKSIVFGALI
GALSRYFWHFIAGVVFWGAYALWGMNSWLFSFVMNGASGLSTAIVTIIVLLGIQQTTPSI
FVPDKRQEL
>FECAFAII_00751 hypothetical protein
MTESVYVHIDTTSNAVLTKGLTATDFANSIVHFPQNLLLLDPSASAGEYESHTGLKVIRG
TENIQRFFSSSRNRRGFDELKWIDFTDLTMLKELTPLEISELLYFGHMKTHLHSPFFYKL
QNNFVYFDLNDQLNRIYYRYLDEFYRIFASKLSSILSDKINVKKSFFKKETPVEKISVEL
LKEMRNLMQEGIIFSFDQVGLIDGKYRIPIYVIEDYIWKLKGTRYREEEIIATLIYSVTD
RHWQLVEDADLSYLPLK
>FECAFAII_00752 hypothetical protein
MEIKKVYFSQKMSLYSPIQQAKQPLPFFQSHQESRDAFWRSAKKQCAFKAVSKKYTVYFT
IAKSRGDVIFNNLLIEGETFEWKKFFRYMEACARFFIKENCCFLFQSPLSEEWLRIFHKN
GYQGTTQLNKKLVYHTALVLGGGGAHGAYQIGVWQALKEHDVNFEIITGTSVGALNGALI
LQGDMKKAVNLWKKLSTRQVLALPEMAAVEDLRERFYRERRQMTKTALIEGGVSSAPLEK
MVKDNLDLSLLKHNPKIRLYTVSTKLPELAEVVTDIQQTKTEEIPDWILASASFYPAMAY
RKIGKNKYADGGYRNKIPIDIAINKGATEAFVVDVQGPGPAKKIRMPDIFIHWKCQTLWT
LGSFLLFDSQRNQLNLQLGYLEMKKRLGYYYGNWYTFHSVKPARTYWRGFLSYLTKEIQL
ELSFFKSIKFWQKLRNLYKNRVVPETCGLAMLELLAKKHFLLPNEIYQVDMMIQMICQQD
IKSMPDDLLAQIGQLSTEEWRRYRKYQQKIQNERTKTVYFDYLLQGKRKDRLQHELLKQP
VDTLLILYLYYLKEEQPWHKNFHMKS
>FECAFAII_00753 hypothetical protein
MAQEFSYEIVEEIAILSENNKGWRKELNLVSWNGRPPKFDLRDWAPDHEKMGKGLTLTNE
EFEQLQKAIENM
>FECAFAII_00754 hypothetical protein
MKSMTGFGKAIRETKAYQLDIEIKSVNQRFLDVQIRSPKILNFVENDFRQLIKQQLSRGR
IEVFVNLAYIGKNEKQIVINWELIDSLITQLTDGIQQRYGSQNQVSISRMAERFALDENF
VTVEEKPEESMEELAQLALDTLKSALDSIEASREKEGQALALVLKKNTEEFKEVLKKLDS
FVEIYEKEFQIRYQKKLEEFLGAKVDEQRLLTELAILLERGDIHEELDRLAIHVQKLDEL
IEAQCPVGRELDFLIQEMNREINTIGSKSNAIEIKNQVVQSKTILEKIREQVQNIE
>FECAFAII_00755 hypothetical protein
MKYYDVTFHELSGKTVVKRDIPSEKNGFDVWKDACADYNENELFILINDGAYVTMNRKFI
VRIDTEEVEDPTEKARSRKDEIMGVVNTLSNMGF
>FECAFAII_00756 Guanylate kinase
MSERGLLIVLSGPSGVGKGTVRKAIFESEDNDFQYSISMTTRKMREGEVEGVDYFFRSKE
EFESMIEAGEMLEYAEYVGNYYGTPLSYVNKTLDEGKDVFLEIEVQGAKQVKEKVPDGVF
IFLTPPDLAELKSRIVGRGTDADEVIEERMKVAKEEIEMMALYDYAVVNDEVPLAVERIK
NIIASEHFRVDRVIGKYIKMLKEM
>FECAFAII_00757 DNA-directed RNA polymerase subunit omega
MMLKPSIDSLLDRVNSKYSLVILASKRAHELDASAQPTLDSFDSVKSVGQALEEIDAGNV
VNDPHPELKRERLKMEEEERQAQKEREQHELESRIREEQKM
>FECAFAII_00758 Primosomal protein N'
MTLTAEVIVDVPTMQTDQPFTYLVPSEMETALQVGMRVEVPFGNGNRHVQGFVMAIQKSE
ESANPSLKAVIRLLDLAPVVNEELLSLADYMKKITYAFKITCLQTMLPSVMKAEYDKLIY
PLADTPEVQVLFDQREVISWKEAEEEGSLSQLIRWRQEQLVDIKYEVHTRNKVKTIRLVR
SLLTEKQIEEEWAKLRQNAKKQKELLLCLSELSQEEPIAYFKNKGISTAVLNQGKEKGWL
EFIESERYRDPYKDRVFDQTTALELNAEQKNAVEQIITAGQQQKDQVFLLEGITGSGKTE
VYLQAIADVLSENKTAIMLVPEIALTPQMVERFKGRFGESVAVLHSGLSQGEKYDEWRKI
EREEAQVVVGARSAIFAPLKNIGLIIIDEEHESSYKQDETPRYHARDLAIWRSKYHHCPI
VLGSATPSLESRARAQKGVYQLLQLNHRAKAAAQLPAIEIVDMREEFQNHRTSTFSANLQ
EKIQNRLDKKEQTVLLLNRRGYSSFVMCRDCGFVLPCPNCDISLTLHMDTRSMRCHYCGH
EEPIPNRCPNCGGNKIRYYGTGTQKVEEELRELYPQARILRMDVDTTRRKGAHEQILQKF
GAKEADILLGTQMIAKGLDFPEVTLVGVLNADTSLNLPDFRSSEHTFQLLTQVSGRAGRA
EKAGEVVIQTFNPQHYAIELAKKQNYEQFYQQEMHVRHRGGYPPYYFTVKITASHPEEQV
AAKKIFQIANQLKEVLSPQSLLLGPTPSMILRVKNRYYYQLIIKYKHEPNLPHVLDEILN
GSQKEQRQGLFVAIDNEPLNFI
>FECAFAII_00759 Peptide deformylase
MRYPILIHPNDKLKRTAQPIDVITDETIALLDNLYETMIANDGIGIAAPQVGQNKRIAVI
EVDEGEKFELINPEIIEAKGESLDVEGCLSIPHVYGTVKRADEVTVRYYDRDGEEIEVTA
FGYLARAFQHEIDHLDGILFIEKMIQQIPEEELEEYMEEHLDD
>FECAFAII_00760 Methionyl-tRNA formyltransferase
MTKLVFMGTPAFSVPILEGLIESGYEIQAVVTQPDRPVGRKRVITPTPVKEAALKHGIRV
LQPEKISGSPEMEEIIELVPDVIVTAAFGQFLPEKLLQVPKLGAINVHASLLPKYRGGAP
VHYAIMNGEKETGVTIMEMIKKMDAGGIYAQESIPITKQDDVGTMFEKLSLLGRKLLLET
LPNILDGQKPVPQDESEATFSPNITREQEAIDWHKTAEEIDNQVRGMRPWPIAFTTYEGI
RWKLLSVEVLAETTDKAPGTIIRKDKKNLWIACGKQTVLAINELQPAGKGKQAVHDFLNG
SGQQVQIGQQVK
>FECAFAII_00761 Ribosomal RNA small subunit methyltransferase B
MKKIPKKMKKSVRYMALLTLERVNKGGAYSNLLLNEMIKQSELNQKDVGLFTELIYGTIS
HQRLLEFYVAPLIAKAKKVDDWVKTLLYLSVYQLEFLDKVPAHAILNEAVEIAKVKGNPG
TGKFVNGVLRNYQRQGAPDLQGIADPIERLSVKISLPLWMTKRLVDQIGYEETEKLGLSL
YQPSHASARVDTRRLSRDQAITVLQEEEITAEKSQVSPYGIVAKKGHLASSSLFHDGVMT
IQDESSMLVAPSMQIEPEHHVLDACAAPGGKTTHIASFLDPSCGGEVVALDVHEHKVKLI
EDNAARLGVSSAVYAQKMDAREVSKQFEAEQFDRILVDAPCSGLGLLRRKPDIRYKKQPD
ELANLPKIQLEILESCAPTLKSSGILTYSTCTILKEENQDVVSAFLERHPDFERIDVLTN
PMLQSSIEEKMLTLYPHQFYTDGFFICCLRKK
>FECAFAII_00762 Serine/threonine phosphatase stp
MQIEYQSDVGRRRNTNQDYASVFTSRSGLKLAVLADGMGGHRAGDIASQMAVTNLGEAWE
KQEAVDDEKIAQWFIQSIQEENMLIYQRGQEQPEYNGMGTTIVAAALSDDWFTIANVGDS
RAYLIREDKIMQLTEDHSLVNELVKSGEISEEMAVNHPRKNILTRSVGMPGTVEVDVSTH
LWQLKDRLLLCSDGLTNMLSEEEIGTIINQEGPLSHKVTELIDRANEAGGADNITVLLIE
YKEDSV
>FECAFAII_00763 Serine/threonine-protein kinase PrkC
MIELGKKLNGRYQITGNIGSGGMANVFLAHDLILDRDVAVKVLRFDFQNDQTAIRRFQRE
ALAATELVHPNIVSVYDVGEEDNMQYLVMEYVKGMDLKRYIQTHYPVPYETAVNIMQQIL
SAISLAHNHQIIHRDLKPQNVLIDNEGVVKITDFGIAIALSETSITQTNTMLGSVHYLSP
EQARGSMATKQSDIYALGIILYEMLTGSVPFDGESAVTIALKHFQDDLPSIKALDPNVPQ
ALENVILRATAKEPADRYKSAEEMSDDLSTVLSPARANEEKWQPHVMDNETKVITPLTED
APMPDSFKSMPLPKDKPENETLPEEEEVLPDPKKKGQKKWWLILLAILAVLGIGTAVFFA
SGGRGEVVVPDVSDLSEASARETLAKAKLEVATKTEEIADDKIEEGNVVKTDPAAGTTVK
QKREVTLYISSGTKKIKLDDYSGKSYEDAEASLKELGFSADLIQKEEEFSSEVESGMIIS
QSPSEDTEVDPKTDTITFTVSKGPETVTLSSHVGENYETVRNWLVTQGFNINNISATYDY
SDTVPSGSIISQDPASGEVVAEETYINFVVSQGTEPKLNDISGYTKSEAQSYLASVGAEY
IGHETSEYSNTVDKDKVIRTVPGAGTTITKGMVVNVIYSKGPDPASSSSEKDSSDSSSSS
SSSSSTSNSSKEESSSSTSSSASTSESSK
>FECAFAII_00764 Small ribosomal subunit biogenesis GTPase RsgA
MALIKGQIRKAISGFYYVYANGETYQTRGRGNFRNRKITPLVGDQVIFESENQTDGYLLE
ILPRKNQLVRPPVTNVDLGIIVTSIVEPAFSYNLLDRFLVTLEYESIEPIIFLTKTDLSD
DPEKIEEIKQTYTKIGYPVIVPNHTGDTTELIRYFPERLSVFMGQSGAGKSTLLNQISPE
LNLATGEISDALGRGRHTTRHVELIPIYGGLVADTPGFSSIDFLTIEAGELPRQFPEFVE
ASVHCKFRECMHAKEPGCEVKHRVETGGIAQTRYDNYLQFLQEIEKRKPMYAKKEGKRK
>FECAFAII_00765 Ribulose-phosphate 3-epimerase
MKIAPSILSADFANLQRDIELVEKGGADYIHVDVMDGQFVPNITLGPNIVQAIRPVTKLP
LDVHLMIVDPENYIPAFAKAGADIITVHVEATPHIHRALQMTKSLGVKAGVVINPGTPVS
MIKHVLPLADQVLVMTVNPGFGGQSFIEETVEKITELADLRRENNWTYAIEVDGGIVPET
AKICKDAGADVFVAGSYIYGAENPVGQIERLKEALD
>FECAFAII_00766 Thiamine pyrophosphokinase
MKILLAAGGNPQNWPQSLLSKYDAYVGIDRGALYLLQAGYPVDLAVGDFDSLSNEEQKEV
FAKAKEYTRSPAEKDDTDTQLGILKTFERYPQAEVTLIGATGGRLDHLLANLWLGMEPRF
KPFAHQLIIRDCQNYLSYYLPGEHIVRQIPDMKYLAYCCLTPVSNLTLKGSKYVLENKEV
EYPTSYASNEFLSDTAEFSFSDGMIAVIQSKD
>FECAFAII_00767 Cell shape-determining protein MreC
MKKFNPNKNIIITLVIVIIVVTILSVTAAQRANEGKPNFFQSIVNDSVAMVDKTISAPVR
WVRNGVASVHNLFSTYAENERLKEKIDSYDDVSQQNKNYEREIEALKKELELNQTLTSYE
KVTANVITRSPDSWQDMLIVDKGSKDGIEANMAVMSQKGLIGRVIEVNTASSKIELLSSS
NESSNHFPVRVSSANGEAFGLLKNYDEKLHALVVTQLTGDTDIKEGDVVQTSGLGGNSPA
NLPIGTVIKTKPDSYGLDREVYVKPYAEMYDVSVVTIVQRLAED
>FECAFAII_00768 hypothetical protein
MLKKETMKYYLPIVLFFLMLIDGHLTRMLGEWSKGTYMSNAHFLILALLCCSMAFEKRYL
LITTIVLGAIYDAYYIGVIGIYAVALPLIVWLMYVMKDVIHVNIFTEFFSMIIFVTGYEL
FTMVVQLIFKLAVVNNTYFITRFLGPTLLLNMIIFVLFIFPFKKLFSDE
>FECAFAII_00769 Secreted 45 kDa protein
MKKSLISAVMVCSMTLTAVASPIAAAADDFDSQIQQQDQKIADLKNQQADAQSQIDALES
QVSEINTQAQDLLAKQDTLRQESAQLVKDIADLQERIEKREDTIQKQAREAQVSNTSSNY
IDAVLNADSLADAIGRVQAMTTMVKANNDLMEQQKQDKKAVEDKKAENDAKLKELAENQA
ALESQKGDLLSKQADLNVLKTSLAAEQATAEDKKADLNRQKAEAEAEQARIREQQRLAEQ
ARQQAAQEKAEKEAREQAEAEAQATQASSTAQSSATEESSATQSSMTEESSSATQSSATE
ESTTPESSTEESTAPESSATEESTTAPESSATEESTTVPESSATEESTTVPESSTTEEST
TPAPTTPSTDQSVDTGNGTGSSTPAPTPTPTPEQPKPVTPAPAPSGSVNGAAIVAEAYKY
IGTPYVWGGKDPSGFDCSGFTRYVYMQVTGRDIGGWTVPQESAGTKISVSQAKAGDLLFW
GSQGGTYHVAIALGGGQYIHAPQPGESVKVGSVQWFAPDFAVSM
>FECAFAII_00770 Oligoendopeptidase F, plasmid
MSYSLNWNLDSIFSGGSHSDALNQRMKQLEDQMNEYYHRVTKWSPSSDNAEQLNAILQLQ
ETITNGFTQCSSYITALLSANVNDSDAKVLSGKLYAMLPRLQSAETVLSKKFAEISDNDW
NQMLSQSSFETIAFRLNEIRRDGSQLLSEAEENIINTLSLDGLNAWSSHYDTIVASISIP
FEQDGQVVELSAGQAFNKMMGDPDPKVRETLFAAWEEAWKEKAPLFTDTLNHLDGFRLSD
YELHGVTDFLQKPLEYNRLKKETLSVMWDTIQKNKQPLVNYLTRKANLFGKEKMEWQDQD
APIILGDLKEKTFSFDEAAAFIIENFNKFSPKMAKFAQSAFEKSWIEAEDRPGKRPGGYC
TELPETKESRIFMTYSNSVNEVATLAHELGHAFHSSTMWDLPSLNREYAMNVAETASTFA
ELIVADATLKVAKTKEEKINLLDTKLQNALAMFMNIHSRFIFENRFYEARQEGLVSEDKI
TEMMVEAQKEGYQGALATYHPYFWAAKLHFFIDDVPFYNFPYTFGYLFSLGIYAYANQKG
ANFEEEYIHLLRDTASMTTEDLAKKHLNVDLTQPDFWQAGIDMVTEDIQTFMELTEEFI
>FECAFAII_00771 hypothetical protein
MNSSKKQMKNGNIYLVIALIVVIILFYSSSQTYGQQSQVSRLESWLPNQPFKDTLAGIRF
NYGGSMVSIDHLGYAKFLEFFLRKGAHFGTYFILGGSLFLGVFPKLKIWWLTAILAWLSA
TGYAGLDEFHQMMTGGRTPMFQDVMLDSIGALTAVILCVLFAAFKKRL
>FECAFAII_00772 putative transcriptional regulatory protein
MSGHSKWHNIQGRKNAQDAKRGKVFQKLSREIYMAAKAGGPDPSMNPALRLVVDKAKAAN
MPNDNVERAIKKATSAVDETNYDEITYEGYGPGGVGILVHALTDNRNRTATNVRVAFTRN
GGSLGETGSVSYLFDRKGYIAIERDGLTVDEETMFEDVLEAGAEDLQTSPEVFEIYTAPE
DFAAVRDELEKEFTLAQAELTMIPQTTIDLNEEQKEQLERLVDKLEDDDDVSEVFTAAEM
>FECAFAII_00773 L,D-transpeptidase 1
MTRSSHRKKSKHVALLSVLGVLLVLISFYTYRSTYYTKHFLPNTEINGINVSNLTVEKAN
EKLKEAYSDKKLAIKEDGKVWQEVPKSELGYKDDFTSELSPILNEQNGWTWGMTYVSAAE
KQEIDPVSQNHQKLDTTVQTLTTKLTDLNKDRTPTTDATIEKAGDSFVIKPEVNGNTIDV
DAAVKQLKSAVNSGKDTIELTEFKEKPKVTSEDSSLKEQLASMNAIANVKATYSINGETF
QIPSSDIMSWLTYNDGKVDLDTEQVRQYVTDLGTKYNTSTNDTKFKSTKRGEVTVPVGTY
SWTIQTDSETEALKKAILAGQDFTRSPIVQGGTTADHPLIEDTYIEVDLENQHMWYYKDG
KVALETDIVSGKPTTPTPAGVFYVWNKEEDATLKGTNDDGTPYESPVNYWMPIDWTGVGI
HDSDWQPEYGGDLWKTRGSHGCINTPPSVMKELFGMVEKGTPVLVF
>FECAFAII_00774 L-lactate dehydrogenase
MTAAAEKKDHQKVILVGDGAVGSSYAFALVTQNIAQEVGIVDINTAKTEGDAIDLSHALA
FTSPKKIYSATYADAHDADLVVITAGAPQKPGETRLDLVNKNLKINRDVVTQIVESGFNG
IFLVAANPVDILTYSTWKFSGFPKERVIGSGTSLDSARFRQALAELVDVDARNVHAYILG
EHGDSEFPVWSHANVAGLQIYEWVKNNPEIDEEAMVNLFFGVRDAAYTIIEKKGATFYGI
AVALARITRAILDDENAVLPLSVFMNGEYGLNDIYIGAPAVINRQGIQKVIEIPLSDSEQ
DRMAASAKQLKEILDEAFAKLDAE
>FECAFAII_00775 Peptidyl-tRNA hydrolase
MKMIVGLGNPGTKYQYTKHNIGFMVVDKIAREHQATFKKNPFEAEVAEFFHNGEKILLVK
PQTFMNESGRAVGPLMTYFGIYPEELVVIYDDLDLAVGKIRLRQKGSAGGHNGIKSIISH
LNTNVFDRIKVGIGRPEGKKTVVQHVLSPFSKENQPLIEESMCQSVKAVEYLIEGHSFVD
AMNRFN
>FECAFAII_00776 Transcription-repair-coupling factor
MDIIQLVGKDPQVKEWVSNLEEKMPRQLITGLAGSAKTLLFARAFKKTNKNMIILMPNLY
YANQLAEDLQHVIPQDQIHLFPVDEVLSAEMAFSSPEARGERVATLNALQEKKAGIYLLP
VASLHKRLPNKKTWLQAQLNWHIGDEIDVENLPRQLTLMGYVREEMVAKPGEFSIRGSII
DIYPLTTTYPVRVELFDVEIDSMRYFEAETQRSIEKTEEIWVSPTSEQVYGPEDLEHGIE
QMQKMLEKRLAATTEEADREFLQDYFGQLTSSWQAGVPTEEAKFYSDLLYQESVTILDYF
PSNSLLVVDDYQRIMETNREIEREAAEWQTQKISELRVFSEQTFSADIQKIVQKEKFTTT
FFSLFQKGMGNLRFQAIHNFQYRTMQQFFGQMPLLKTEMDRWRKQKQTVVIFIPTKDRIR
KAEQMLRDEDILVVETEKNALIRGQVQLVEGALQAGFELPQEKIVAITEKEIFQKTTKKQ
TRRQTVTNAERLKSYNELKAGDYVVHANHGIGKYIGMETLEVDGVHQDYMTILYQNDDKL
FIPVTQLNLIQKYVASEAKAPRINKLGGSEWTKTKRKVSSKIEDIADDLIKLYAARESEK
GYAFGPDDAYQKEFENAFPYSETDDQLRSAAEIKRDMEKEKPMDRLLVGDVGYGKTEVAL
RAAFKAIKESKQVAFLVPTTILAQQHYETMLERFEGFPVNIGLLSRFRTRKQQKETIEQL
RTGQVDIVVGTHRILSKDIEFSDLGLLIIDEEQRFGVKHKERLKQLRAQVDVLTLTATPI
PRTLHMSMLGVRDLSVIETPPANRYPIQTYVMEKNPGAIREAIHREMGRGGQVFYLYNRV
ETIEQKVEEIQELVPEARIGYAHGQMTEAQLENTLFEFIEGQYDVLVTTTIIETGVDIPN
ANTLFVENADYMGLSTLYQLRGRVGRSSRVAYAYFMYEQQKILNEVSEKRLQAIKDFTEL
GSGFKIAMRDLSIRGAGNLLGAQQHGFIDAVGFDMYSQMLSEAVSRKQGKNSQVEKTTVE
IDLGVDAYLPETYVADQRQKIEIYKRIRELDSQEMLDELEDDLLDRFGEYPEEVAHLLTI
GQIKMDGDRALLETIRKQEAHIVFTLSKVGTKRYSVEQLFEALTATKLKASLGVEKEQMV
IRLTIPNQMEEAVWLQEIQKFVKALREQKYLSA
>FECAFAII_00777 Lipid II flippase MurJ
MDHKEMRRVMQGAFVLTIASFIAKVLSALYRIPLQNLVGDEGFYVYQQVYPIYGIAMTLA
LSGLPQFISKYVAERKNPFERKQALQNLYPLVFWTGVFLWLFVFAFSSWIAWMMGDIQLK
PLIQVVSFTFLLMPGLSFYRGNFQGRFLMEPTAVSQVVEQFVRVFVIVCSAFAFRKLGWT
VYQTGTAAMSGAVFGGLCAYGILHYYEQKIHGGALSFRRFPLFKQPSKPLIRRFLVEGGL
VSIYSGLLIFFQLIDSFFVKNALEVYGLSEYGAKIAKGVYDRGQPLVQLGLVIATALSAT
FLPALTRHLTNRIYRQFLQTAKIYLRLTTALALAASLGLALLLPYINYALFKDYAGNAAL
VLFVFSIAFTAVIQAYQSIAQSKNSFRPSLKGAGWGLLVKGLTTSFLTGLLGTAGASLST
LLGLGVTLWYFVRIETKELNAFWKERHFGRKLMFSLLCMTVVLLLYYGVLNIVFGPVTHR
STAFFVSVIGVGIGASVFIYAVIRLRLFTVREWLMLPFGKKILRLNKKIKK
>FECAFAII_00778 Heat shock protein 15
MRLDKFLKISRIIKRRSVAKEVADKGRIQINGKLAKSSSDVKVGDILKVQFGNKTLEVKI
TELHESTKKEDAQKMYEIISENRTETLEK
>FECAFAII_00779 Cell division protein FtsL
MTKKSNKIAALDTEYAKKKYAEFQQQQRQLIFRRRRLAAIFVGALVIFAIIGVQIFHDMQ
RMHQLNELRVEANTEMKEVNADVDQLHQDVSLLKDDEYVAKLARSKFFYSKDGEKVYPIL
ESNTDSSTNETDQSTSSTTAK
>FECAFAII_00780 General stress protein 13
MSIEVGAKLQGKVSGITNFGAFIDLGAGKTGLVHISEVSNGYVKDIHDVLSVGDEVTVKV
ISVNDDGKIGLSIRKAQEQPAESGEESRPKKYQQKDPRDNRNRPAQKKSFSRSQPSAQKE
DFDSLMSSFLKDSDDRLSSLKRNTEGKRGGRGGRRS
>FECAFAII_00781 tRNA(Ile)-lysidine synthase
MERMNVEKGGKKAPLLQQSFIRHGNEQGFWQQGSRILAAVSGGVDSMVLLHLLLQVQRQI
GFSLGIVHINHQLREESAEEAAYLRSYCEEKNLPLYVSIWEDPAKSAIETEARNFRYQEF
TRVMEEGQYDTLMTAHHGDDQIETVLMKIVRGGQLNTFSGIKEVQPFATGRLIRPLLSFS
KEDLYTYAAESQLVYFEDQTNQLLDIQRNRLRHLVVPQLKQENTQALRHFQQFSQQIQWA
DQVIQKYMGQLIEKEVEQWEEQFRFSAEMIEEMTDAERYYFFYSFFDKAFSKTGIILKEQ
QMESILDQWQQKKSQWQLSIGNNWILKREYHFVVLSKKEKQATSQTEDQRLLLIPEQGIY
LNETEWIGLVKPENAGDIKATDSWSLFSHDIWIPADVQLYVEKRKAGDRIKLTENLTKKV
SRYFIDQKVPNSQRQHAWIITDAKRNIYSLIPFAFSYLSIREETDKIHYILLYKYQKEAI
GRRT
>FECAFAII_00782 Hypoxanthine-guanine phosphoribosyltransferase
MLEKDIERILISQEEIQVRCKELGKELTEIYQNTNPLVVGVLKGAVPFMADIVRSIDTYL
ELDFMDVSSYGNATVSSGEVKIVKDLDTNVEGRDLLIVEDIIDSGRTLAYLVDLFKYRKA
KSVKIVTLLDKPEGRVVNIEADYVGFNVPNEFVVGYGLDYAEAYRNLPYIGVLKPSVYQS
N
>FECAFAII_00783 ATP-dependent zinc metalloprotease FtsH
MNKKNNGMMKNALYYVLVILAMVMVVYFIFGNNGQRSSDIEYSKFTEQLQAGKIKEFEVQ
PANGVYKITGEYKEQQTVANSGGLAILGSTDTTTTHFTTIILPNDTTLSQVTELAKENKV
ATTVKEESSSGIWVSLLLSFLPIVIIIFFFYMMMGQQGGGGGGGGRVMNFGKSKAKEADK
KANRVRFSDVAGAEEEKQELVEVVEFLKDPRRFVELGARIPAGVLLEGPPGTGKTLLAKA
VAGEAGVPFYSISGSDFVEMFVGVGASRVRDLFETAKKNAPAIIFIDEIDAVGRQRGAGM
GGGHDEREQTLNQLLVEMDGFDGNEGVIVIAATNRSDVLDPALLRPGRFDRQILVGRPDV
KGREAILRVHARNKPMADDVDLKVVAQQTPGFAGADLENVLNEAALVAARRNKKKIDASD
IDEAEDRVIAGPAKKDRVISKKEREMVAYHEAGHTIVGLVLSRARVVHKVTIIPRGRAGG
YMIALPKEDQFLMTKEDMFEQIVGLLGGRTAEEIIFNVQSTGASNDFEQATALARSMVTE
YGMSDRLGPVQYEGNHQVFVGRDYGQTKAYSEQVAFEIDQEVRKILMEAHDKAREIIEAH
RAQHKLIAEKLLEFETLDAKAIKSLFEHGVMPEGTESNDYPSEKEAKTFEEAKRALEEKD
AEKQAEEKRDFEEAKHELNEENKAEHDSDSQQSEDNHSDDQYK
>FECAFAII_00784 33 kDa chaperonin
MKDYLVKALAHDGFVRAYAVQATNTVAEAQRRHDTWHTSSAALGRTLVGSLLLGATLKGE
DKLTVRIQGDGPATGIVVDANGKGDVKGYIKNPHLSLPLNSEGKIDVRGAVGTQGMFTVT
KDLGLKEPFSGQTPIVSGEIAEDFTYYLAISEQIPSAVGLSVLVNTDDSIKTAGGFMIQI
MPGADEETISKIEEQLKTTPRISTLLDEGQTPEEILKGLLGTEELNILEKMPVQFKCDCS
KEKFAEAIIALGAEEIQAMIDEDHGAEAVCSFCNNKYKYSEEELDGLKKEALGGI
>FECAFAII_00785 putative tRNA-dihydrouridine synthase
MEHTWKIGNVEIPNRVVVAPMAGITNSAFRVTVKEFGAGLVVCEMISDQGIHFRNKKTLE
MLHIEETEHPLSLQIFGGNKDSLVEAAQFVEENTAADIIDINMGCPVNKVIKAEAGAKWL
LDPEKVYEMVQAVSSAVNIPVTIKMRIGWDEEHVFAVENALAAQSAGASAIAMHGRTRVQ
MYEGKADWEVLKEVKKHLTIPFMGNGDVKTPEDAKWMLDYVGADGVMIGRAALGNPWMIH
RTQHYLETGELIPEPTPAEKIATAKLHLQRLADLKGEKVACREFRTHAAYYLKGIPRAAK
VKVAINQTEKQQEINDLLDQFVEKAEKVLLKQTL
>FECAFAII_00786 Lysine--tRNA ligase
MTQEQQHQVEDLNDQMLVRRQKMEQLREDGIDPFGKRFERTHNSEELHELFDPRTKEELA
EMGLTASVAGRMMTRRGKGKAGFAHLQDREGQIQIYVRKDQVGDEAYEVFKHADLGDFFG
VTGQIMKTDTGEVSIKASEITILSKALRPLPDKYHGLTNIEQRYRQRYLDLISNRESFDR
FMKRSQIISEIRRYLDGNGYIEVETPVLHNEAGGAAARPFITHHNALDIDLYLRIALELH
LKRLIVGGMEKVYEIGRVFRNEGIDTTHNPEFTMLEAYTAYTDFNDVMNLTEGIIRNAAE
KVLGTAKITYDGQAVDLESDFKRIHMVDAIKEQTGVDFWQEMTLEEALALAEKHNVEVTE
AMGVGHVINEFFETFVEETLTQPTFVYGHPVEVSPLAKKNPEDPRFTDRFELFIVGREFA
NAFTELNDPIDQRERFEAQEKERELGNDEAHGVDEDFLEALEYGMPPTGGLGIGIDRLVM
LLTDAQSIRDVLLFPTMR
>FECAFAII_00787 hypothetical protein
MNDSIKKMLRITEKDLMITEVSYETLQKKKTLVVDAVLSPTPRACRSCGSTVVDGNGKAI
IVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKSCQVSLTTVIRTLKEFKSYLPKQSKKILPRVLMVDEFRSHASIED
KMSFICADGETGKLIDVLPTRKLPRLTSYFLGCTNPEEVEFLVTDMNAAYFQLTKRVLPN
AKVVIDRFHIVKHMNQAFNELRIREMNELRKAGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLEFSPPLKEAYPFFHELVEAFRDKDPDLFFSLLAELP
ETLDDSFREKLQNLLTYEEGITNAMIYPYSNGKIEAKNTHIKTMKRVSYGFKSFENMRIR
IFLINQLINVR
>FECAFAII_00817 S-adenosylmethionine synthase
MVERHLFTSESVSEGHPDKIADQISDAILDAILKQDPTARVACETSVTTGLVLVFGEIST
TAYVDIQKVVRETIKEIGYTRAKFGFDGDTAAVLVAIDEQSPDIAQGVDEALEIRDEDKK
DVLDEIGAGDQGLMFGFAVDETPELMPLPIALSHRLVRRLADLRKSNELTYLRPDAKSQV
TVEYDDQGQPERVDTIVISTQHDDAVDNETIRHDVIEKVVKEVIPAELLDDQTKYYINPT
GRFVIGGPQGDAGLTGRKIIVDTYGGYARHGGGAFSGKDATKVDRSASYAARYIAKNIVA
AGLARKAEVQLAYAIGVAQPVSISINTFGTGTVPEEELIAAVRENFDLRPAGIIEMLDLR
RPIYKQTAAYGHFGRTDVDLPWEHTDKVDALKASLAK
>FECAFAII_00818 hypothetical protein
MNDSIKKMLRLIEKDLMITEVSYETFQKKKTLIVDAVFSPAPHTCRNCGSTVVDGNGKVI
VVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKNCQVSLTTVIRTLKEFKSYLPKQSKRILPRVLMVDEFRSHASIED
KMSFICADGETGQLIDVLPTRKLPRLTSYFLGCANPEEVKFLVTDMNAAYFQLTKRILPN
AKVVIDRFHIIKHMNQAFNELRIREMNELRKVGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLGFSTSLKEAYPYFHELVEAFRDKDPDLFFSLLAELP
ETLDDGFREKLQNLLTYEEGITNAMIYPYTNGKIEAKNTHIKTMKRVSYGFKSFENMRIR
IFLINQLIKVR
>FECAFAII_00819 Multidrug resistance protein 3
MKKETNVTLVTVSIFIATFMTAIEGTIVTTAMPTIVGSLHGMEIMNWVFSIYLLTNAMLT
PIYGKLADKVGRKPIFIFGTLLFIIGSLFCGLSQSMIGLIAARAIQGMGAGAMMPVALTI
IGDLYSIEKRAKVLGLNSSAWGIASVFGPLAGGFIVETISWHWIFFINVPIGILLIILIW
LYLNEPKIIHESKPMDIFGSFSLMAMLVSLLLGFQLLGDEGMSPLVSALLLGSIVMLGIF
VFAEKRAKDPVIMMHLFKNPLFVVVNLAAALASGFLMGIDVYIPMWMQGVLGLNAAIGGL
VLAPLSLVWMVGSFLASKWMTQMKTHWVLRIGLLIAAIGGAWLYLMPFRSNYLWFFAIST
VIGIGLGVTMTTSTVSAQNSVSRDQLGVATSFNTLVRTIGQTVMVSIFGLLINGVTKREL
AAANLTNDADIMNKLVNPQTAKYIDADILLPLRKILYDGLHSVYLVGLLLVIIALVLTLF
VHEKSGKIKQ
>FECAFAII_00820 S-formylglutathione hydrolase FrmB
MAFIQANIYSNVLEMEVNLNVILPQTTKKVIGTSSEQETTDIPVLYLLHGMGGNHSVWER
RTSIERYVANYGLAVIMPSTDLGWYTDTVYDMKYWTFIAEELPEICHELFPQLTRKREKT
YAAGLSMGGYGALKLGLAKSENFAAVISLSGAVSVGNRMDDLLMVRKASFWEGIFGPLDQ
IEGSKNDPQYLLKELVKSGKPVPRFYMACGESDFLYQANQEMVSAMQEQGLAVTFEQGPG
DHNWIFWDQWIQRALAWLMEEK
>FECAFAII_00821 Tetracycline repressor protein class H
MEIKLSQAIIIQAAFDILAETQALSQLSMRNIANRIHVQAPALYWYFKNKQQLLQKMAET
MEEELALPDPTLPWNEQLLQYMENYYDLYTRFPCGAELEINTVPAFPSRLEHLEQMIQLL
VREGFSVTQSHQAIASLHNLLIGQLMDQQHEQQLRQKIMDGNEFLKETVLFMRNYVVENQ
LEGIKESMQSHAELNEKALFLTSAQTYIEGLCQQNKRRENEQ
>FECAFAII_00822 putative ABC transporter ATP-binding protein
MKLILRHAKKYKVAVFISLLSVAVMVAAALWQPKLLQQVLEAIITEDNDEMKTIGIYLIS
LALLGLAAGVTNTIFSAKVAQGVSADIREEAFRKIQTFSFGNIEQFSAGNLVVRLTNDIT
QIQNLVMISLQSLFRIPFLFIGAFILAMITMPQLWWIIVALIVTVFLITALSFTRMGKHF
MIIQKLIDRVNSIAKENLLGIRVVKSFVQEENQLKSFSKVSEDLTKHNIIVGTLFSVMIP
SFMLAANLAVVGAIFFVSDLVKDDPTLIGGIASFMNYLMQIMMAIIIGGMMMMMTSRAAV
SLKRIAEILDAEPDLTYLDVPEQELTGSVTFDHVSFRYPGEDTDTLKDISFSIKPGEMVG
IVGATGAGKSTLAQLIPRLFDPTEGKVEVGGVDLRQVNEKSLRQTVSFVLQKAILFSGTI
AQNLRQGKKNATEKEMEHASSIAQAKEFIEKLSDRYEAPIEERSSNFSGGQKQRLSITRG
VIGNPKILILDDSTSALDARSEKLVREALDRDLKGTTTIVIAQKIASVVKADRILVLDEG
RLVGEGTHEELVAGNRVYQEIFETQKGTEE
>FECAFAII_00823 putative ABC transporter ATP-binding protein
MTDLIKASKFFYHYLKRYKLSFFFIFITVIIATYLQVKAPQYIGEAFQELANYVGGLMQG
VDDKSKFVSVIWKLLLFYVLASAANFIYSILFTQVVGKSTNRMRIGLFNKLEKLTIRFFD
SHQDGEILSRFTSDLDNIQNSLNQALLQVITNAVLLVGILIMMFRQNVELAWATIASTPV
AVLIAVLIIRKARKYVDLQQDEVGKLNGYMDEKISGQRVIITNGLQEETIEGFLEHNQSV
REATFKGQAYSGLLFPMMQGMSLVNTAIVIFFGGWLALNGDLERSVALGLVVTFVQYSQQ
YYQPLMQISSGYSMIQLAITGARRLNEIFDEKDEVKPENGKAFDGVEKGLALQHVDFGYS
PEKLVLKDVSINVDKGEMVALVGPTGSGKTTIMNLLNRFYDVNDGSVVIDGIDIRDYDLD
ALRRHVGIVLQESVLFSGTIKDNITFGKPDASDEEVINAAKQANIHDFIMTLEKGYDTEI
SEENNLFSTGQKQLISIARTIITNPSLLILDEATSNVDTVTEARIQKAMDEAIKGRTSFV
IAHRLKTILNADRIVVLRDGEVIEEGSHHELLAENGFYAELYHNQFVFE
>FECAFAII_00824 Ribosomal RNA small subunit methyltransferase H
MLQTALHFSHTLLQEILQPGDHVVDATMGNGHDTVFLAEHIGKTGHVYSFDIQQQAIDAT
RERLEQRQLEERVSLFLQGHETLGEVIAEQQNLKAGIFNLGYLPKSDKAIITMPETTRTA
MEEILKRLVPRGRLILVVYYGHEGGEKELDMVDSFCSKLPQETYNVLNYRFINQKNQPPI
LYCIEKKR
>FECAFAII_00825 hypothetical protein
MTFPYSEGNKRYHSWNYALRNEFGGKIFKVPIDGGFDCPNRDGTVAHGGCTFCSVSGSGD
MIVAPEDPLPIQFQKEIDMMHQKWPHVQQYIVYFQNFTNTHAPVEIIKERFEQVVNLPGV
VGLSVGTRPDCLPDEVVDYLAELNERMYLWVELGLQTTFEETSKLINRAHDYQTYLDGVA
KLRKHNIRVCTHLINGLPGESLEMMKENVRRTILDSDIQGIKLHLMHLMRKTRMLRDYHE
GRLQLMSRPDYVNVICDQLEMIPKEIIIHRLTGDAPWDSLIGPMWSLKKWEVLNAIDEEL
LRRDSFQGKYDVRKKVSV
>FECAFAII_00826 Undecaprenyl-diphosphatase BcrC
MKYKTSFQVAGSFFLVLFFILGWIVKFHLSWLSGFDQWFTGIVRASYPDLNSYQLFMTKF
GNPLTVIILFACAALWMWYKKKRAETFWFVSGFIVIAGIINPVIKLFFMRERPSLAHLVV
ETSYSFPSGHAAGSMILYGSLLFLLPAFVQKRTLRTLLQLLMMFIIVSVGISRIYLGVHF
PTDIIGGYLLSLSWLCLTYPVYREKRKQIDNSYRKKDF
>FECAFAII_00827 Muramidase-2
MENIARKERRRLEQTKRFRKAKRGAAIVGTAMVGCSVAAPLVQPVPVQADETPVQFSARI
NTAAFITEIATYAQPIAQANDLYASVMIAQAVVESGWGSSALSQAPYYNLFGIKGSYQGQ
TVYMDTLEFLNNQWVNKKEPFRQYPSFAESFNDNAYVLRNTSFGNGYYYAGTWKSNTKSY
TDATACLTGRYATDPGYAGKLNNIIATYGLTQYDTPASGNAGGGATTGGNNTGSAGSTGG
SSNSGNTNSGSATSTTYTVQSGDSVWGISNKFGITMDQLIQWNNIQNNFIYPGQKLTIKG
SQENGSSTNNSGNNTNSSGNAGTSNGGQTTGAKYTVQSGDSVWKISNDHGITMAQLIEWN
NIKNNFVYPGQQLIVSNGGSSNAGANTGSNTGNTSGSSSSSSSSSNTASGTKYTVKAGDS
VWSVSNKYGITMAQLIQWNNIQNNFIYPGQQLTVSNSGSTNSTSGNTGSSTNTNNSSSVN
TGSSSSQGTYTVKAGESVWSVANKNGITMDQLIEWNNIKNNFIYPGQQLIVKGGTSANTN
TGSTTSAAKPNTPNTSATTSTSSTGNTMYTVKAGESVWSVANKHHITMDQLIEWNNIKNN
FIYPGQQVIVKKGSSQSTNQQSVTGSKTYTVKSGESVWSVADSHGITMAQLIEWNNIKNN
FIYPGQTLIVAK
>FECAFAII_00828 Leucine--tRNA ligase
MSYNHKEIEKKWQKYWAKTNTFNTHDDPEKPKFYALDMFPYPSGQGLHVGHPEGYTATDI
LSRVKRSQGYNVLHPMGWDAFGLPAEQYALDTGNDPAEFTQKNIETFRRQINSLGFSYDW
NREVNTTDPEYYKWTQWIFTKLYEKGLAYEAEVAVNWVPELGTVISNEEVIDGKSERGGY
DVVRKPMRQWMLKITAYADRLLDDLELVDWPESIKEMQRNWIGRSVGANIEFKVAGTDKS
YTVFTTRPDTLFGATYSVLAPELDLVREITTPEQKAAVEAYIEETAKKSDLKRTDLAKEK
TGVFTGAYAINPVNGKEIPIWIADYVLSSYGTGAIMAVPAHDERDFEFAQTFGLEILPVI
EGGDVEKAAYTEDGTHINSEFLDGMNKQEAIDKMNEWLEENGVGKKEVSYRLRDWLFSRQ
RYWGEPIPIIHWEDGTVTAVPEEELPLRLPKTKNIKPSGTGESPLANIEEWVNVVDPVTG
KKGRRETNTMPQWAGSSWYYLRYIDPHNKKELADYEKLKRWLPVDIYIGGAEHAVLHLLY
ARFWHKFLYDIGVVPTKEPFQKLYNQGMILGENNEKMSKSRGNVVNPDDVVETYGADTLR
MYEMFMGPLDASIAWSENGLEGSRKFLDRVWRLIVDENNKMRDRITTLNDGKLDKVYHQT
VKKVTEDYENLHFNTAISQLMVFINEAYKVDALPYEYIEGFVQLLAPIAPHMGEELWAIL
GNDGGISYAPWPTYDEAALVEDEVEVVFQVNGKVRAKSNVPRDLGKDELEKAALANEIVQ
EYIEGKTVRKVIAVPNKLVNIVAN
>FECAFAII_00829 Ycf48-like protein
MDQELFIIEVLSAKQKIIEKAKKRAKRIMFKLLSLVFFSGLLFFGAVSFLYRHMSAVVRS
AEGMQKLNNLYHFSWGVGGITIVVLIVFLLLIWLRYHQLSRHFDQWLSQRAQQFLHNKPT
SQDDDYLYFEKTSTSQAFRIQKSDCQLLLRSLDDLPIYLGESKSKFGMNTFHIFLLENEP
RWEKSQSSPGGYLTTKMSTLVTGFFLILLAGTIYYGRYTQPKMSSHINAASHMTMNSTND
THIQKTNEGLLADPKQKVNLTTQKINDLKLDTETHSLYMTTDSGANWVFVPIDSQWLRFG
EYTLTTGLIPEGYWMDNTYDISADFSWFIYSSGDDVRLLTSRDNGKTWQTSIITQSVQPI
RYRKAVFYGNDGLFICTSASGMSAETLYIYTTMDGGITWIKSGSTMINQPVQNVSFVTTS
LGFVSTRESLFYTNNGGRSFKESVLSIPENYQTGGIDLFQSPNEVTQISANTLETKFYLL
KKGPIDAGKMFACLFRSTDNGETWQFVQQLSQVEQGD
>FECAFAII_00830 putative ABC transporter ATP-binding protein
MEKKKTLNTRALIRFWKMIKPEHKYFYGLFLCSLFGNLLVVAMPLIMGIGIDDLLSEIRK
TGIGQLSFSDIKQALLFPVLLLIGCSVLSSITSFIQERTMAALSEKITLRVRKEITKKFK
TLPMSFFDNHQVGDIISRTTTGLNQLSQVLLTGINQFFTSVVTIAAAGLMLFYIESKLTL
LVLLLIVGSSIVTTKIANKNKQISEQNQYELGVLNNRMEEILAGNLVVKTFNQQAHAEAA
IHEVNKKQYNAFKRAQFMNFAIYPAIRFINQLAFIISAVFGAMLVLSGGVTIGFLQAYLQ
YINQISEPISTASYVINSIQSAMAAIDRIFEILDETDEIPDLPDARLLEQPKGKIAFKNV
QFGYTSDKILMNQVDFSVKPKQTVAIVGPTGAGKTTLVNLLMRFYELNKGKIEFDGLDIT
KLSRGELRRSFGMVLQNTWLFEGTVADNIAYGKMDATREQIIEAAEIAQCDHFIRTLPDG
YDTIISSENGTLSQGQQQLLTIARVILANPPVVILDEATSSVDTRTEALIQQAMEAVTKD
RTSFVIAHRLSTIENADMILVMKNGDIVEKGTHSELLQSPTLYASLYNSQFQIA
>FECAFAII_00831 putative ABC transporter ATP-binding protein
MSILKTFLQKNKGLALLTFVMICLQIAGTLGVPKLVAKLIDTGIASGEASVIKKIGVEML
LVAFLGTIAAVASSYFSALASARFGFQTREKYFRKFQQLSMKDISRFSSGSLLTRMTNDV
DNVQQMIVLFCQMILPAPVICVFTILMMFRYSLLLTWVTLISVVFYVWIVYRLMKRGAPL
SLSIQPKMDRITITLREFFTGINMIRAFDNQSYEEKRTNKSFADYANQMIKVNRIFAWVT
PIAFLLMGIVYASILWFGGNLVAEGALQIGVVTAVVEYSMLTLAYLMIAAMVLVIIPKSF
ASLRRIEEILQAEIEIEEETIKTVAEPTFDQTNAAAFEHVTFKYTEISDPVLEDIDFTIP
KGKTTAIVGGTGSGKSSLAKLLLRLSDPTIGKVTLGGIPLTQMTQEQIRSHISYVPQKAF
LFSGTILSNLQMGNEYASTEELSKAIKIAQLEELVDTLPDGLDSFVAQGGSNYSGGQKQR
ICIARALIKPAEIYVFDDSFSALDYKTDAALRAALHKHMSEKTLVIVAQRLSTIQQADNI
IVLDEGKIVGQGTHEELLSNCQTYQEFAKSQGI
>FECAFAII_00832 hypothetical protein
MKKMYTIGQVSELFDLPKSTIRYWDEQGLIRSSRQEENDYRLFDIDDIFMLYDIVFYRKL
DIPIKQMKNLYGKTLTELYETLDETERRIHKELVVMKQKQKEIREQKKQLKLMIDTNEEE
FPVEEIPFDCMISTEFEDIVEIKKFLPNYSSFGMMSMPASSSQTMYGFFIDPSEVHLFTQ
DVIWEKKDTAVYRRFLLKSEMNHAERNNILEIRERMYEKGWKTGEVIGQYLLTNTDENNI
RTEYYHAWIEMKK
>FECAFAII_00833 hypothetical protein
MQIRQLAKIAIHLQALKFERIILVVESTTTKGLNQLIDRITNGKIEKVVILYKSCLIRFG
YELSETLCNIWYRI
>FECAFAII_00834 hypothetical protein
MRNKFHKLLSMFLVMLIVINQFGNITVLAESLAEQPERSLTIEVDQEEAALGEQFQLRVR
GTPDLLNALVIDKSEDLIEGEVKQLNDYERLITYSSQHSGKYELTARSGDIQSNTVSIEI
SVPEESTSESFNVPEESTSESFNIPEESLSESFNEARSSEPSITQESQIERQEELLNYDI
GISAERPTLPSRHTQTLKGYIQGGAGDILEEYGEMVVRVPRASIGLIEFIRVEVADDSPL
KPLAFYQEGTDVVFPFTFDYEGLNEAAQSYTFSITFEVAFFQSGGTEPNNDFQVSLTYAE
RAANTEFSITPIPSSRPIFSKLYYGSREIDSQGNLGNLLIDGQDVTNSNKFILQVNYEGS
RKDGVVVTDVLPQGTTLAPNPTTWSSTGNREPISGGVRIAEVTNPGEANVRTHYVSEEFV
DKVSFNKETNTLVVDFGNLAEGQSYFIEYALEVTDVDLFNEGRQEDGFSRNRASMTYNNQ
VMSRDYRLRIPESNLPAISLRKSVDKNVINLNENELTYTLHVSMFSGTRNTLVIEDVLEE
GMEFVSFLSDIPSFIDAEVNNGIVRFSANNTIGGPTSFTLSFKVNVEAYAVGDQILNFAT
LVNSDNRLNTSTVRTRKIDGRIKVIKTDENGQRLAGAKFEILSSDSQVIQEGITAENGEF
LSEPLPVGSYQVRETEAPEGYLLDATVHDVFINEYSIEEVTLTIENILDTGGVELIKHAE
GSGEVLQGAVFELQNREGETLQTGLTTGEDGKLAIDGLAPGAYQLVETQAPIGYELDATP
IEFEIERSQTAVVELTKENRLTPGGVVLTKIDDQSGEILQGAVFELQNREGETLQTGLTT
GEDGKLAIDGLAPGAYQLVETQAPIGYELDATPIEFEIERSQTAVVELTKENRLTPGGVV
LTKIDDQSGEILQELFLSYRTEKEKRYKPV
>FECAFAII_00835 Serine-aspartate repeat-containing protein D
MTKENRLTPGGVVLTKIDDQSGEILQGAVFELQNREGETLQTGLTTGEDGKLAIDGLAPG
AYQLVETQAPTGYELDATPIEFEIERSQTAVVELTKANRLTPGGVVLTKIDDQSGEVLQG
AVFELQDANGTVLQSGLTTGADGKLAIDGLAPGVYQLVETQAPTGYELDATPIEFEIERS
QTAVVELTKENRLTPGGVVLTKIDDQSGEVLQGAVFELQDANGTVLQSGLTTGADGKLAI
DGLAPGAYQLVETQAPTGYELDATPVTFKIEKEQEVAIFLTKENRKVADSSDIRGNNPTS
SGNKHLPKTGETIISQFILSILGVLLVFISIKFRKKRNI
>FECAFAII_00836 hypothetical protein
MDFYQSLQLDPFILKQKIREAASKKEKCMYICSLFLRSLFIVLFAICFIIIITTLFESKH
KPYAVVLFCMLMSIRFVDFGYKISHSIIGLAIVMFSLLVAPYVQLIKWSVMGMLIHFILL
SSILMATASDPKMGNASLYGFSYLFIVYSLPKDSLNKNFFTQTSSLLFLFFCWFSVLLYR
KHREKNKDKSLFKEIFLKGMYSQEKIWMLIYAFGISLLIVAGEYVPFQRLMWAGFAFSSI
VSSYGLMSIGFKERAVDRIIGSLIGCVLFIGISQFIPFNWVGILGGLALGVCSTYRYKTV
FNSFGALAITASLFGVPGAVTIRIFENILGVCLGIMYIGVTEILIRKIREKHGLNH
>FECAFAII_00837 hypothetical protein
MSITVNILYTSTNGQARKFAEEMVERNIVKAIRAEEGNEKYDYYFPLEDPESLLLIDRWK
DEEAIEKHHKSEMMAQINELRKKYKLKMKVERFTDLP
>FECAFAII_00838 PTS system cellobiose-specific EIIB component
MKKALIICAAGMSSSMMASKTTDFFKQKREEVLVDAVSATEGDNMIKNSDFDLFLISPQT
TMFLDKFKKLGESVGKPVVSIPFQAYVPIPTGIQKLAEVIEENI
>FECAFAII_00839 putative licABCH operon regulator
MKQKEKLLLRYLIDHKKEYVTSQRLASELLLSDRTIRNYLQRIKELVEKNGGKIIAKPGY
GYQLHILQRLTFDLFLSRQEIVPGYAREPQGFYESEDRQKYILNQLLLEDAILFMDDLAE
ELYISRSSLTKDMQEIKERLIPYSLKIVSKHGQGTWIEGEERNRRHFIMDTFFGNHYGNS
LKEYLGQSRFFPDISFEELVIIILDETREAKLKVSDFIIQNLTLHLALGIKRLREGFEIK
ELGIEQEVSKRVEYQVAQRIVQRIEVIAGVSFPEEEIAYLTLHLMAKSNHKENQNDQELS
KELAKVLKRLSQEFHFSLVEDLQLFNGLLDHLSPMMIRLSRGIRIENPLTEEIKKENPKV
FDAVKRHFSNMPALKNYTINEDEWAYLALHLMAALEKERAAHKLHALIICATGYGSAQLL
KNRVVSEFGKNITVVSVKGYYEINETTLKGIDLIISSIDLSTMFFKIPVLHVSIFLNEDD
VRKIRKVVGESIPYHSSDRPIPAFSLQQKKQIYTEQLSEKFFKTYTYEPKKEEILHDLLQ
KLSINEEEGYIREMRKQIQQRENMGQIIFSDTVAVPHPAVPVGIETKVAVALIPSGMQWD
QYQEIHFVFLVSPSYVENEGITVVTKAIVRLVDQLKVQQEILAEPIFENFSSKFIKLIE
>FECAFAII_00840 Lichenan-specific phosphotransferase enzyme IIA component
MAEKINSETLQVTSFDIIFHSGNARTLIHEAFRSMRKEMFEEVEEKLRQANEEILHAHQS
QTQLLKEYASGTKIEMEIIMVHAQDHLMTTMTLLEVAQEMNYLYQKNK
>FECAFAII_00841 hypothetical protein
MQDTVKRKIELEKKQLSLKNMYFNRYLIVRYLTAFFFFMNMQWMILLLSAKSLGSSLPMI
LILAILPAVGEQVKLYRKHQTNVPWTKWYFLFQSVFNLLVIPVLFTSGFTFLYPFMANNN
GGQLFVFILVVSGIFASAFIQYRLKKISLNQDQQYIRIKQYEKALYLGKENN
>FECAFAII_00842 Lichenan permease IIC component
MFDFLQKYLMGPMGKIAQLKIVRAVMAAGMASIPFTIVGSMFLVLNILPLPFPFLEGFFN
ATFFKVSDLYMIVNTMTMGILSIYFAIVFAYELTSIERDEQKLNVNPLTGALLSVFAFFM
CIPELIMTDGKISLIASINETETVVNGIRMGSFVERLGTSGIFTAIIMSIIAVELYCMCV
KRNWVIKMPDVVPPGVSRSFTALIPTFVIAFVVMIINGLLVALGTDIFKMIAIPFGFVTQ
LTNTWLGVMVIYFLIHALWIVGIHGANIITSFLTPIVLANMAANAQGANYPLAGEFNNSY
VTVGGSGATLGLIIFIAFLAKSDQLKVLGKASLVPGLFNINEPIIFGMPIVYNPYLAVPF
FLAPMASATLAYFAIRLEIVKPMLAQMPWPSPVGIGAFVGSGGDWKAAVLAVICAIIAFI
IWFPFIKFYDNKLLNEEREKAAELASEKLK
>FECAFAII_00843 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--L-lysine ligase
MSFSLEDIRHLLLKENLLKEFVSTRGWHLDVPEKAEFLQLSYDSRKADASTLFFCKGMNF
KEEYLDSAIEQGIQYYVSEQPYENSAVGIIVTDIRKAMALLAMAFYDYPQNKLKVIGFTG
TKGKTTAAYFTKAILDHTTNKKTALLSTMNTTLDGKTYFKSHLTTPESLDLYRMMSEAVE
NGMTHLVMEVSSQAYKTQRVYGLTLDVGIFLNISPDHISPIEHPTFDDYFYCKRQLILNS
KTVVLNHESDYFDLLRETADLFQIPTITYGRSEESNYQVIRSDKGTHGFTLSSHEDRLAI
CDTAYDILLAGGFNQENAASAIIAAALTGASSQDAQDGLKEARVPGRMDQLIQSNGAHVY
VDYAHNYLSLKTLLKFAKNEHPDGRVIVVLGSPGNKAISRRHDFGKVLSETADIAFLTAD
DPAFEDPKKIAEEINEAITNPDLIVHYEMDRPEAIRRALAESAPQDSVVIAGKGVDPYQK
INGVDEPYEGDYAIVKRLIEE
>FECAFAII_00844 hypothetical protein
MTQEIKKLPVIFLGLFFITVGLNWFLLPHDIASAGVGAIGHLVETAFSIQRSVTVWSINL
MMLLLAAVLLGKSVFFKTVAGSLLFPVVLEIVPKVEMISSHFFSLISGSLLFSLGVYTLY
TVGASNGGITIPPIIFHKFFRLPMPQGLLLTNSLIVFLNYYVFGLLETLFVLLSITVSSL
FMKILIRLSPVSRKFE
>FECAFAII_00845 Lipid II flippase MurJ
MDNQRKPALDQLTPQEKMARGSAWMTASNIISRLLGAVYIIPWYAWMGENAKAANGLFNM
GYNIYALFLLISTAGIPAAIAKQTARYNSLNEYGTSRRLFIRALQMMGGLGLLFALFMYI
ASPWLAHASGGGEELIPTMRSLSIAVLVFPCMSVIRGYFQGNQEMMPYALSQIVEQVARI
FYMLLATFIIMKVMDGDYVTAVTQSTFAAFIGMLASILVLLYFLKKHQAYTSAFIHYSEN
KINIATKELLLDTVKEAIPFIIVGSGVTIFKLVDQFTFMKIMSASTEYSNAQLLDLFSIF
SANPDKLTMVVIALATSIASTGLPLITEAVTLKDRVGLAKLTSGNLQLFSFFMFPATFGV
MLLAYPLNTLFYTPDSLGSNVLIQASFVGLFLGLYMLVSNMLQGMFENKAAINYLVIGFL
VKLLLQYPAIRLFEVYGPLLATMIGFAVSCTLILKRIHEVARFKPSFVWRRTLLIFILTL
IMLLASWITKMIFGAFLNEDSKFQSLLLILVVAGIGALVYGYLALKIRLAERLLGPGIAR
LRHKLKIK
>FECAFAII_00846 Ribosomal large subunit pseudouridine synthase B
MRLDKFLADMGLGSRKEVKGLIKKGTIEVNGQVVKSDKAQVNEFEDAVTYLGEIITYQKD
FYYILHKPAGVISATQDNHDQTVIDLLEDQDYREDLFPVGRLDKDTEGLLILTNDGVFAH
QLLSPKKHVEKEYLAEVSGIMTEEDIRLFAEGLIIDGDEQTLPAKLQIDQVDQETETSII
RLILHEGKFHQVKRMVKAVGKEVLYLKRIRMGKFWLPKDLNKGQYRPMTKEELEQVREK
>FECAFAII_00847 putative multiple-sugar transport system permease YteP
MKKRKGFNHFFMNLWRYKALVLMAVPGMLWMIFFFYIPVMANVVAFKNFHISADGFLASL
RESPWVGWENFKFLFSSDQAFLITKNTILYNVAFILLNLLISVVFAIIMSELRNKRLVKV
YQTMSLLPYFLSWVIISYFVYAFLSPDKGIFNQWITGHGGEAVNWYNEPKYWPFILVFIG
TWKGIGYNSIIYFASVMGIDPTYYEAAMVDGASKWQQIKHVTIPQLIPLMTILTILAVGN
IFRADFGLFYNIPRNSGALYDVTQVLDTYIYNGLTSTGDFGMTAAAGLYQSVVGFVLLMI
TNTIARRFDSDSALF
>FECAFAII_00848 L-arabinose transport system permease protein AraQ
MKKKKVERVQVRSFNKTANFFSNIMIALFAISCILPFIFVIAISFTDESILSTHGYSFWP
EKFSIFGYTYLFDQMQDKIFQALFVTVLVTVLGTLINSTATSLYAYAISRSNFPFRRFFT
VFCLITMLFSPGMVANYLVMTNLLQLKDTIWALILPMAVSPFNIIVMRTFFKRSVSDSII
ESARIDGASELRIFVQIVLPLAVPGIATISLFAALGYWNDWFNALLYIQDDKLVPLQYLL
MKIQSNIQYLTQNSGAGSQLTGGLASVPGESARMAIVVISTLPIAISYPFFQKHFVKGLT
IGGVKE
>FECAFAII_00849 hypothetical protein
MKLWKKLAFTGVSALLLGTLAACGGSGSKDQAEASNSDTLQMYQIGDKPDNFDQLMEVAN
KRIEKEIGVKVNINYIGWGDYEKKMNVIISSGENYDIAFANNYVSNAQKGAFADLTELAP
KYAEKAYNDLDEAYIKGNLVNGKLYAFPVNGNVFAQQVLTFNKALLDKYDLSIDGIQSYA
DAEKVLKEFHEKEPNTAAFAIGQGFKVQGNFDYPLGNTLPFAIDLDGDDSKIINQYDNET
YIGLLRTMHSWYKQGLIPSDAATSNKDYPLEGNTWLMRGETQGPYDYGDTILTNAAKQEL
VSKAITVPLKSTAQAQMANFVVSNTSKNKEKSVELLGLLNSDPELLNGLVWGIEGEAWEK
VDGSDDKIKLLDGYQPNTHMSAWNTGNNKILYTQESITDDMIAKRDQSIADAETSPILGF
SFNTDSVKTELSNISNVMNQYLDGLNTGTVDPDETLPKLKDALDKAGYDKVLKEMQKQYD
EFRQE
>FECAFAII_00850 hypothetical protein
MLGKVLEELFIRIWVIIKLTLYFWIYTFAGGIIFGLGAAWKTVNELFYLYGFEYKEITIK
RGWNIYKRNFLRGNLLFSLFLSGTALLSYNLYLSVQIKGLIFLAIDFILLFALLCLFATY
QYSMILDSEYTISVPNLLKLSFISVFSSFSSFLKIIIGSGIILGVTWQFKGLILFGVIGL
LTVWNGTMTTHWREELDKQLESYE
>FECAFAII_00851 Sensor histidine kinase YpdA
MNKFRILFSKGTLLNRLLRKYAVIMIGVTMTATVIFSIHTWEQNQKQAENMTSDAVQSTS
RMLNDKTTLSRIIKNQLVGNSEKIENVTTYLTKPIDQYLMYVYEQQNSTDELVSFPNQIK
DLYANYEELSAIYIVLNQLPEYYESSRENKGGEIKKGTPKLLDAFYIKLPITQGGAESGS
IFIGFQKKELDMILENLTSFNGLSLYMISGTTNRLYTFHDNKIAKETFERQEMIITESLK
KNSQLPIDDLEKNNFVQHQELSDDYRILAVLDKKSVKIETGKNLAPLIIGIIILDNILLI
FLYKTFKRYSQQVSIVMQAMDQTAAGNLETRIDITNTEYELKELSIGINEMLDSINQFVE
DIYKLEIKQQDAHMRALQAQINPHFLYNTLEYIRMYAISEGSEELADVVYAFSALLRNNT
NQEKTITLKEELDFCEKYVYLYQMRYPNRVAYHFMIDPDLEKIEVPKFVIQPLVENYFKH
GIDFTRFDNALSVKVLQEGKRVRIIIKDNGKGMTEKRLKQIEEKLSHPKVELHGSIGLQN
VNERLRASFGSSYYMSLENNETGGLTVSITFKEG
>FECAFAII_00852 putative response regulatory protein
MYQVLLVDDEYMILNGLKKIIDWQSLGFQIVATAENAKEGLAVLEQRQIDLVVTDVTMPE
INGLEFIEAAQKERHNFEFMILSGYQEFDYLKGGMQLGAVNYLMKPVNKFELVESLKKIK
TRLDQQNEQKNQQEIYQELLFSQWLNEELDEISEEEIIGQISEKQHRIVLIQLARTHDTL
INRWLQERQQIFYYQRNYGDRVLITLLLEADEVDGFCCFVQENFPDQEWLISIGEETDSL
DKIPETFQQAKDNLQLHQFYGDKDEHVFYAVQAETKDQTIDFSSFRRVLQNKQLEVAQKM
ITDFFEQFQLAAMMPEDIRYSSFLLFMEIQRELIDLEDEEYLQGIEKIHQAKTVQELQQL
LLSFIKKHQRQKKYSDNVEKVIVILHQHYQEPLTLKEVSENLHLNVMYLGQLFKKETKKS
FSAYLNHLRMEKAKQLLLHSNQNINEIASEIGYNNTTYFSKLFKKIVGRSPKEYRENSGE
S
>FECAFAII_00853 hypothetical protein
MNIGQIDTRHATANQPNFSNGNCQPYTGVPFGMNYFAPQTTDQNGSWWFHPDDRVFQGYR
LTHQPSPWMGDFSHMLFTPINGKLQENTLFHAQSSYRPEESIFCPTHLSICQLRYGICST
LIPSMYGGILSIDYSKNDSGLLLSFPGRHQLFVIDPYTVEGKITHFAGSEDPDFSFYFIL
RFEYPLTIDELAVSNKNSDSIPLYFEQTKKQTIRFGTSFISSEQAAYNLELEQNQSKETY
LAHSQEQWQSYFDRIQLTHHDQQQLRTFYHNLYRVFLFPQTFYEIDPSGQKIHYDTTSRS
IKPGVLYTNNGFWDTYKTVYPLYSLIAVEKYEEMLEGFLNSYRESGYLPKWLSPDERGLM
PGTLIDAVIADAAVKDIRRDLMPEFLTAMEKGATVQSKHPNYGRQGTEDYLTYGYVPNHY
HESVNHTLDYAYSDFCISQVAKVLEEEEMTKKYQQQSLNYQNIFDYESGFMRSKDKDGKF
REPFSANRWGQDYAEGSAWQSSFAVYHDFSGLIGKYGGSERYKEKLIELCNQPPTFDPGG
YGFEIHEMSEMAAIEFGQLAISNQPSFHYPYLFSYIGQPEMAQPLLKQLMTQTFDDSPMG
YPGDEDNGSMAAWYIFNSLGFYPVTPGTGEYVIGMPLIDKAVLLLSNGKELTIEATPNRP
QQQFIHKIKRMDKEYTKLYFTHQDLLKGGTISYQLGIIPHPKKYQAKDLPFSLSNYN
>FECAFAII_00854 Arabinose metabolism transcriptional repressor
MNQPLYQTIFNDLQTAILTGELPVDSQLPTEKELSRTYKVSRITSKRALTELEQLGLIYR
VRGKGSFVKSASPEQILASPTKTRRILFLLPYVADLSVGDFSKGLNPVMQDKQIDVMMTT
LDFLQNKTAKELINEFDGLIYYALDTEQHLDLLFELSLKEFPVVILDKKIYELPFPTVLS
DNFQGGALAASYLIEQGHSKIAYLFGTQTHPQSVRQRYLGYLEALDKAGLTFHTSLDDKS
ATLDELLSYITKYEVTAFVCENDVVAIQTMNLLRQHGYHIPEDFSIIGFDDIQAAALVDP
PLTTIAQDFEQLGKLAGDALVTWLETKDRPSDSKFPVSFIKRQSTKEK
>FECAFAII_00855 hypothetical protein
MAYKDIPKSVQKFMEDITQKCGDIHADWAKNFTAAFANTLLTTVKKQNDGTTFLLTGDIP
AMWLRDSTAQVRPYLVIAKEDEELADMISGLVKKQFFYINIDPYANAFNEEANGAGHQTD
HTKMNDWIWERKYEIDSLCYPIQLAYLLYKNTGKTDQFNQSFIEGIKKILDVFKTEQDHE
HSPYTFVRDTTRKEDTLINDGRGAKTAFTGMTWSGFRPSDDTCRYGYLVPSNMFAVVVLG
YVEEIFQTILDDKEIVQQTQKLKKEIQEGIQNHGRTVNQKGQTIYAYEVDGMGNATVMDD
SNVPNLIAAPYLGYCSEQEEDYLQTRRTLLSKENPYFYEGKYAKGIGSSHTPEKYVWPIA
LAMEGMTTSDKSEKERILNLLVATDAGTHLMHEGFDVNNPENYTREWFSWANMMFCELVM
DYFDIRVEK
>FECAFAII_00856 Mannosylglycerate hydrolase
MKKKVYIISHSHWDREWYMAYEQHHMRLIELIDDLLELFEVDPSFNSFHLDGQTIILDDY
LQVRPEKRQAIQQAINEGKLRIGPFYILQDDFLISSESNVRNMLIGMEESRKWGTPVMLG
YFPDTFGNMGQTPQLMKQAGISAAAFGRGVKPIGFDNQVLEAENYSSQYSEMWWKGPDQT
AIFGLLFANWYSNGNEIPVEKEAALAFWKQKLADAEQYASTNHLLMMNGVDHQPVQKDIS
KAIHLANELFPDYEFIHSNFTDYLEAVQKDVPEDLGSVEGELTSQETDGWYTLANTASAR
VYLKQWNTKVQRQLENITEPLATMAYEVSGNYPHDQLDYAWKTLMQNHPHDSICGCSVDS
VHREMIPRFEKADEVGKYLAQDSLEQLTAAIDTTGFPKDSFPFVIVNTAGMDKTGEAEIT
IELERKRFAEGIPEQLYQELENLPKRKYHVETKSGATIPAILSEETVQFGYDLPKDRFRV
PYMARMIKVTLPLENMPAFSWETFALVEGEAKAEEKETMIHQSGRIIENGPLHLTIEKNG
TITMEDRKNKRKLNNLHIFEDIGDIGNEYIFKQPFCDQPILSSNKENSEVKVLVDTPEIA
KISILQEMEIPVSADERLEKEQQMVVEFRYRKAERSKEKRILQIKTIMTIRKDSKKIDFE
TTLDNQMKDHRLRVLFPTKLHVEHHEADSIFEVVKRPNHVSKSWENPTNPQHQQAFVNIH
DEEYGVTVGNFGLNEYEVTEDGQIAVTLLRSVGELGDWGYFPTPEAQCLGEHRFNYSIEL
HGPEEKFSTYLHAYAAQIPFSTQQIKHHEGTLISKQQYLTIKSETFAITALKRSKFSDKV
VVRGFNMSSHLEKLEITKDNGKTVILNLLEEPTKQAVVPIIQPYEIRTIGFEEENECMAE
>FECAFAII_00857 Putative fructokinase
MYGGIEAGGTKFVCAVSDGGEILEKLSIPTTTPEETLDQVFEFFDRYELKGIGIGSFGPI
GIDKTKDNYGYVLATPKKGWAQFDFLGTIKERYNIPAAWTTDVNAAAYGELKQGAAQGKN
SCIYLTVGTGIGAGVVINEEIFSGIAHPEMGHIWVKRHPDDHYEGTCPYHKDCLEGLAAG
PSIEARTGIKGQDLPQDHPVWAIQAYYIAQALINYTLTLAPEKIILGGGVMNQDHLLQKI
RQQFVELMGGYMETPQVSEYIVRWGLPNESGIIGSLLLAEHEHQK
>FECAFAII_00858 Ribosomal large subunit pseudouridine synthase D
MKITITLPMNHPETTIRDLLEKEWLVPRKVRHFLRIRKNVWINQQPALFHHEVKGNDQIT
LLFEETDYNYQEVQLGDAKHIRVLYEDEHLIIVDKPAGMKTHPNEPTENSTLLNHLAAYL
DTKQQRPYVVHRLDKETSGAVLFAKNPFVLPILGRMLEQKMIYRRYQAIVWGEIAKDMTI
TNKIGRDRHDRRKRVVDDKNGQSALTHVTVNKVLSEQTQVYCVLETGRTHQIRVHLAHKG
HPIVGDPLYQNRTAERLMLHALELHMIHPFTQEKIVGKALPGLWE
>FECAFAII_00859 Penicillin-binding protein 1F
MDFQSILEKIKAALISFWRWIRPYLGQFHRWRKRIWKKYHVNKLILLIGLICVLVTSIYL
FILAKQANVETLKSGLSQSTVIYDKKNEEAGTLYAQKGTYVELNAISPYIQDAVISTEDR
NFYEHHGFDIKGIARAAVRMVLSGGTSGGGGSTITQQLAKNAYLTLDQTFDRKAKELFLA
IEIEKKYSKEEILTMYLNNAYFGNGVWGVQDASRKYFGVDATNVTLSEAATLAGMLKGPG
IYNPIDHPKNANDRKNTVLSVMEENGKITKEQEQAESQTDISAYLNDTYDNSDSGYRYPY
YFDAVIDEAVNEYGLDEEDVMNKGYKIYTALDQDYQKQLEATYQNSALFPANASDGAMVQ
SASVALDPNTGGVQALVGRRGDHVFRGFSFATQMRRSPGSTIKPLSVYTPALEAGYKPSS
ILKDEPQSYYDAHNFDGTYQGEVPMYQAVAQSLNLPTVWLLHEIGLQKGYDKAEEFGLPL
AKSDKYYGLALGGLEKGVSPLIMAGAYSAFANDGQMYTPHLITKIVDSTGAVIVDNTNKK
PKQVISKETADEMTSMLLGTFSNGTAAAANPAGYTIAGKTGTTETNFDATKANDQWMIGY
TPDVVISTWMGYEESSKLHYLEGTSGNVVGKVFKSAAEGILPYTSKTGFSVADAYATGGQ
VVAADQVGNTGNSNGESGNWQDNLNQYGEQAKEGLKNFGDMVKEGVQGIGEAAKDLWRKY
QGE
>FECAFAII_00860 hypothetical protein
MSNIYDSANQIEREIRELPEFKALKEAYEKVQANEEAHKLFKDFQAMQIELQEKQMSGQE
FSDEDAMKAQEMAVKIQSEEVINDLMQKEQGFSTIINDLNRIIMTPVRDLYSE
>FECAFAII_00861 Putative multidrug export ATP-binding/permease protein
MEERIQKSYQKYHANAFQTLLHLYQGNYWRFAMSGLFFIIKHLPSWLMPIAIANVINAAS
SKDSSQLQAIYFNAFLMACLIGQNILTNYFHVKYHSTSIRQVEAGLRATLIKKIQELSIP
YQKELQSGRIQSKIIRDVEAIQTLSSQVFVSGLNIAVNLFVALGITLYKSPVVFMFFLLT
VPLAAFVTLFFRKRIRQSNSDFRQEMEETSAKVIEVIELAPIARAHGLEKHETTRLNKHF
TQIYEKGFHLDILQSVFGSVSWASFQIFQLICLIFTGILALQGRIQPGDVVMYQTYFTTI
VNSVSGMITLIPTISKGMESITSIGELLIAGDVETYHGKKKIQHLDGNFRFEDVSFLYPD
SLKPIIDHFSLEVKAGETIAFVGPSGSGKSTLLNLLIGFIQPTSGKIFLDDQPLDELDMR
SVRNYLAVVPQTTLLFSASIKENITYGLKNVSKERLDEVIEAAQLSSLIDQLPDGLDTLV
GEHGNKLSGGQKQRISIARALIRQPKIILLDEATSALDNQSEKKIQQALNYLTETPTTFI
VAHRLSTIKEADKIVVIDEGKIVEIGTYEKLLAQKGYFYRLKNE
>FECAFAII_00862 endonuclease 4
MFPLNLGIRAHDLDVRNREEIVQKVSQLHLSHIQFAPQKAFPEQLKLTDMTLGSAAYFGE
YFQKNNIELSILGCYINLSSKNQEVRAQALATFKQQIALCSAYQAKMIATETGSVSVGYT
KENFTEEAYQIARNSIIELVAHAENFGVTVAVEAGINHPIYNYQLAKRLIDEVASPNLKI
ILDCANLMHKENHADQEKVIRGALDNLHGYITALHLKDYIMENGKIRMVPVGKGCLDFRP
VLHYIKYERPLMYATLEATPEIYVPEAIEHLQFIYQDC
>FECAFAII_00863 Rhamnogalacturonan acetylesterase RhgT
MPTIHIAGDSTAAEKDENKRPETGWGEKISAYFSPEIQINNQAKNGRSTKSFIQEGRLAR
LASQFQPNDFLFVQFGHNDQKIQEERGTLPFGSYLKNLQIFFECAKKANVQMVLLTSVTR
RDYLENGTLNPDILGDYPKAMRAFAEKHHIPLLDVFSRSQELFQTFSKEETKKFYLHLIP
DTCKNYPEGLKDNTHFSPEGADKVARIIVELIKESRLPLANYLQKGV
>FECAFAII_00864 Uronate isomerase
MFLSDDFLLKDDWAKKLYHSYAKNMPIIDYHCHLDPKEIYENNNFSNLTEAWLGGDHYKW
RLMRACGVPEEKITGNASDFEKFLDWCQTVPKIIGNPLYSWSHLELKRFFGIDLLINEEN
AEKIWTQANEILAAPDFRRREIAKKSNVEVICTTDDPADDLHYHQLLAHEEPDLKVLPSF
RPDKALNIEKEGFNAWVTLLEEAADQTITTYQELIEVLGQRIEYFHQHGCRVSDHALDIL
RYKEADETVLEEIFQKARANKLLSSDEIDAYRTETLIHLTHFYHSHNWTMQLHIHAYRNC
NTQMLEKLGPDTGYDGMNDLSLTIPLQKLLNRAEETDQLPKTILYSLNPNDYPAILALMG
CFQKEQNGKLQLGSGWWYNDTRAGMRDQLTQFADGSALGNFVGMLTDSRSFLSYTRHEYF
RRVLCEFLGEMVMRGEAPEDEQLLGSLVQAISYTNAKNYFGFFA
>FECAFAII_00865 Altronate dehydratase
MLETLQPTMKLNRRDSVVVALTPIPKQTQLTIDQQTITTLEDIPQGHKIALGDLKAGDNV
IKYGYPIGHVTTDVTAGQWLHTHNVKTNLSGELDYRYEKDVHPSHYLFENRTFQGYLRKN
GKVGIRNDLFLVPTVGCVNGIAELIVKQFKEKHPDLGQFDHITILKHPYGCSQLGKDHQN
TREILADAVNHPNAGGVLVFGLGCENNTVPEFKKILGEYDEERVKFLVAQDVYDEIEQGV
ALLEELLTAAENDQRISVPLSKLNVGLKCGGSDGLSGITANPLLGAFSDYLIAQGGSTIL
TEVPEMFGAEQVLMARAENEEVFDSIVDLINDFKQYFLSYGEPVYENPSPGNKAGGITTL
EDKSLGCTQKSGSSPVVDVLQYGEKIRKPGLSLLQAPGNDLVAASALASSDCQLVLFTTG
RGTPFGSYVPTVKVSTNTTLFERKGHWMDFNAGVLLEQPMEVILESFVQKIIAVASGEET
KNEQNDVREIAIFKNGVTL
>FECAFAII_00866 Altronate oxidoreductase
MKKLTKELVKKNEAPVKVLQFGEGNFMRGFIDWQIQQLNNQQLFKGNVAIIQPLEQGLGN
MMNQQDNLYTVILQGLSNGEIVDTSEIITVVEQMINPYDEWDAYLSLAENDDLAYIVSNT
TEAGIQFVETDNLTDTPPQSFPGKLTAFLYRRFKLNKAGFTIIPCELIDRNGERLKEIIL
RYAEKWDLEPAFVEWLEKENVFCCSLVDRIVPGYPREDAGVFNQRHNYEDQLMVKAEPFM
LWVIEGPKELENQLPFKQAGLNVIITDDMTPYRERKVHLLNGPHTAMVPLALLAELETVE
EVMKDPLFSAYVDQLFNLELIPMLSLPKDELAIYADQIKERFLNPFAHHKLEAISLNSVS
KFSTRLLPVFKKYIEEQNQVPPLITVSLAALLLMYRGDQVKPHDDEKTISEFTDAWSDNG
TAIPRLLQNAALWGEDLSQIPNVTDTVQEIAAKIDQKGVRSVLQEMKGTMVHA
>FECAFAII_00867 putative HTH-type transcriptional repressor ExuR
MVTIKDIAKAAGVSHTTVSRALNNSSLIKNETKQKIRQLAKEMNYSPNYSAKGLVNQKKY
LIGLFFSSLHKGTSSNFLADSIAGIHSVLDTNYSLSVESIDVVDLTEINLQRYDGLIVMS
QSDDDQPFIDYLKEKEFPFVVVNRHINDPAVINVTADDAAGVMQAVDYGIGCGHTKIAYI
GGKKNFRSTKEREKGVLKSLKKASIPVNPAYFLTGDYSLESGLQNMEYLLSLSDLPTLVF
CGNDDIAIGALRAVHLAGLRVPQNISLIGFDDSPVVSYLNPPLTTVRKPLKEMCQEGTKL
LLDLIEGRTIEQSKIELSTLLILRESINYL
>FECAFAII_00868 HTH-type transcriptional regulator YesS
MKKSTVFYKIFLPMFLLGAVLVIGFSLFIYQNTYESIESSYLTDKKNLLRQVKTNVEWKI
RTIEYSFSTYGSTKNFSDIFKHPLTYTDYSTYSEIRKELNFIETIVMDDNNYDLVSLAGK
WGVINGSLSQLTEEEVEKYQQKYINNKNNLFWQKKNKGIEMVISLPMFEKEKYALGIATI
EKHTIEQVVGESGEDILSIENEVGNLFTTQTVKNKEQPTVLTDVDLDYNQLKVIREKDKT
YIVLKSDYNNWIYRLEVDSSAIGAMIRNLRIGLVAVSLTLVGLIGLLSYLFSDRFARPIS
QIQERLNLKSKGFSGKELDLVAQSVSRIIGEKEALSAHLVTQKPQLETLFVLSLFRNRVE
RRELDQRLQQFGYSSQNDCYYTALVQIDLLEDSHGGERDLLLLAINNMITEIVPKENRML
PIVLNEEMQATIYRMDKDDAEASKKVMEYCRLIQKRVKEYLNLTISIGISNRFETLNESK
QSVDRAKEALYYRVNTGPSSIIFYQEIVPAAHEKTLIRYPIEEQNRLFEAIRSGNQEVKN
LVHELIDALFAQNKNPLSREVVSVRLINELVQLGQLLGVDSKNFDNMKQIYVKALNNYHP
KELEKLVLEQLVLPITECSQAITDHEFKNLSENIMHIVYTEYDRDLSLDVIADRLHYNPN
YLSNVFKKETGEKFGDFVQNHRLEVAKKWLKETNLSVKEIAERLQYRNPQNFIRFFKKKE
SITPGEYRKKYL
>FECAFAII_00869 L-arabinose transport system permease protein AraQ
MKKKVSIGERSFTLFNNTFLILLALICIVPFLNIIATSFASTQEVVAKKFILFPTTFSLD
AYRYILSTPTIFRALAVSIGVTGVGTIVSMCATSLMAYGLSRKYLFGRGFVNFLVVFSML
FSGGMIPTFLVVRSLGLVNSYWAMILPVAVNAMNMIIMRNFFQALPDSLEESAKMDGCTD
FGVFFKIMLPLALPSIATISLFYAVTYWNTYMTAILYINDSSKWPIQILLRQIVIVSSGM
QAESSAVDVIPPAQTVKMAVIVIATVPMLIVYPFVQKYFVKGALVGSVKG
>FECAFAII_00870 putative multiple-sugar transport system permease YteP
MESVKKQEPFQLTLSKKEEKLRRRKKIIAGIKTNKFLYVMILPGVLYFLIFRYLPMGGLV
IAFQDYQPFLGIMGSPWVGFKHFIRLFTEPTFFTLLRNTLILFGLNIFVFFPMPIILSLL
LNEVTNKRLKNGIQTIIYIPHFMSWVIIVSITYVFLNVDGGVLNEFLATMGFEKISFLTS
PEWTRTVYIGQVIWKELGWSTIIYLSAITAVDTQLYEAAEMDGAGRLRKTWHVTLPAIRP
VIITLLILKIGQTLDLGFEHMYLLLNSLNRSVAEIFDTYIYTAGLKNGQLSFSTAMGLFK
GVVGLFMVILANKIAKKLGEDGVY
>FECAFAII_00871 hypothetical protein
MLQSLDKINGRLNRILQLVYLNFLWGGLVIAGLGVFTFGPASYAMVAVIRKWLRSKETFP
LTKTYFTYFKENYRETLLMSWIYGAIGIVLLVDLSFIHNWYLRIALYIAAFIYVLSALYI
FPIMAHYDWKGYFFKMKMAFLFGFSHLHYSLVLILSMVGIYLMIIQTMPGVLTFIGGSLF
FSAVTWTANSIFCHLEWKNSYTEKTEENKNIIKTVKEKIYEKSNARKIRS
>FECAFAII_00872 Lipoprotein LipO
MKKATLVKLGLSFAGILALAACGSSSSNSSSETEDGKAKITWLNILHHASPPTDTIVNLI
EEKTDTELTFNWIPDASKEERLTTALASDELGDIVTLQIAMLKNSSVRNALKSGVFWDVS
EYLKDYKNLSQISEDRIEAASIDGALYGVPIQKDYARAGLVIRKDWLDNLGLDVPTTMDE
LYEVAKQFTENDPDGNGVDDTVGFGDRAPSDIRYTSFKLFTSYFGAPNGWAVDDNGKFTP
EFDTEEYMKALNFSRDLFENGYLAQDFAVTQKTDQQEQFAQGRTGIYTGMVDIKNLKTMG
QGIQDDMELVPVNKISDGEGGGYHVWSEGNGIGGLLAFPKSQVKDEAQLKKLLQFVDDLL
EEDVYKLMTGGIEGTHYELNDDGSIEFIDMDLWQQEVQPLSSSRPSEVTFSFKDTDPEKE
FSNQLIKENEEFAVMDPSVPLDSPTNNEVGSEIEKIVIDATVQYIMGQLDEDGFKKAVED
WKAQGGDRITQEYEEAYKAAAQ
>FECAFAII_00873 Unsaturated rhamnogalacturonyl hydrolase YteR
MENWSKKLAKSIMERTPRLYEEKWYKGKWSYDYGVVLKGFQLLWERTQEKIYFDFIKDNI
DYFVQEDGTIRGYSVEEYNIDHVNTGKLFFLLYKETGEEKYKKAAELLSQQLANHPRTSE
GAFWHKEIYPYQIWLDGLYMGSPFYAEFIQNFSEEKDYQDVLRQFEISYKHLFDPKTNLL
IHAWDEKKVQPWADPKTGLSHHFWSRSIGWYLMAAADTYELLHEETDCSLLKEILEKTLA
ALLPYQEENSGTWYQVTTETKRKGNYLEASGSSMFVYAMAKGIRLGLLNKEEWLPQVKKS
HQGLLDEFVLETKEGWLNLNKNCQVAGLGGADQRDGSYAYYISEPIICNDQKGVGAFLQA
LIEVEAL
>FECAFAII_00874 Polygalacturonase
MYDILTFGASIDELNTEAIQQAIDAAASDGGGTVVVPAGEFLTGALFLKSNVELHLSAGA
VLKFSDDPKDYPVVHSRWEGVHRKVYASCIYAQNVENISVTGFGTLDGNGKKWWHTFRNE
PDNLAYPRPKLMSFHNCHRITVKDIKLIQSPSWTINPILCSNATFDNLTILNPADSPNTD
GIDPESCKNVRISNCHIDVGDDCIAIKAGTEDTYERIACENITITNCTMVHGHGGVVLGS
EMSGSIRNITISNCIFQETDRGIRLKSRRGRGGIVEDIRVSNIVMDNVMCPFILNLYYFC
GPRGKEPYVWEKKAYPIDERTPAFRRIHFSNITARNVHASAGFIYGLAEQFIQEITFDNI
DVSMAQDAVPGVPAMMTGIEEMSRQGFYIGFAGKVSFNQMSIENHEGPAFLLENTKEISI
EKFQSNQSENMDELVVRKNFAYAVE
>FECAFAII_00875 hypothetical protein
MFVKTLLMQLNDFLGAPSSRHTPSGKRLYREKQNGFMLEYYQLYLNELETVPALYAYPEK
EGPFPPVLYLHSHGGDFSVGKSELIHGAPYLASPSFAEVLTGMGYAVWSIDAWGFEERGG
ISESELFKQFLLTGKTLWGMRIYDVISLIDYLETREDTDTQRLATIGLSMGGLLSWWVTA
LDSRVKVCIDLAAQVDIEILLLHRRLDHHGFYYYVPNLLTAYTTLAIQEKIAPRPRLSLV
GKNDTMCLDEGVLKLRKGLDKKYQSMGSPENFSSFSLTGGHMETQEMRNIWKQFIREHL
>FECAFAII_00876 Pectinesterase A
MRMKDKLIIGKNAIDTPTDFETIQEGIDYLAGLPDSHPKVLIVKEGRYDEYIESRLSNFK
LVGAGTVVISGNRFAKQEYLDGSQLGTFRSATFFLEGSNVVLENLHIENTAGPGEKVGQA
VALFNSGDRVSLKNCRLSGYQDTLCTGPLPDLQKDGTPFCTPASANPEYCRQTYEYCWIE
GTVDFIFGGADAVFHQCHIHSLASKNPGYITAASTPKNQKTGYRFESCTLTAEPDTRNVY
LGRPWRPYANVLFEACKIGGHVHPTGWDNWDDKKNEQTVKFSERNNNYETSIKRPEWIHL
EKQGVQK
>FECAFAII_00877 hypothetical protein
MKRKWELLLGMVGGSLSLIFFGGLAVTLSNMSASEFKKSYQSLAVDHSTLSLENTFGLLQ
DMTGLFAVVLFISLAFLAVALFLTAKGKYLTTATGLYFITGFILLIGTQFIAFPFAFFYF
AAGAFSLYRVRMRKGA
>FECAFAII_00878 Beta-xylosidase
MQTIKVKNPILRGFNPDPNILRVKERYYIIVSSFEWLPGIRVYESKNLVNWSHTTDILTT
QVSLQGNPTNGSIWAPQISYADGLFYLVYTDVKSAGRPFKDVHNYLITASEITGPWSEPI
YLNSNGFDPSLFHDLETGKKWLVNELWDYRLDTPNKSSGIVLQEYDAEKKKLDGPIYKIF
AGTELAKTEAPHLYFRNGYYYLMTAEGGTGRGHSVTVCRAKNITGPYELDPGFPMLTASD
KPASTLQCTGHGSLVQTPSGRWYMTYLCTRPLNGAAILGRETAIQEVYWTSDDWLRLKDS
QTTPMEEIMIETNEEVQQEKDHQFMDTFEGELKKNWNARRILPNADWCDTKCRPGFLRLI
SGESLQSTFEHHLLAIRQTDFTFDAETAFEYMPNNFNQMAGLVLYLNESNYIYCYVTWNE
DKGKCLRMIESENGVAQIEDWTIPLTEKKTFLKVTVKKETAQFHLKDVSTEEWKKVGPQK
NMCILSGGFTGNFIGIAVHDLNKKRGSYADFEFFKYDGKDHL
>FECAFAII_00879 putative symporter YjmB
MLSQNAVTANTIKKEKKEFGISDKIGYMFGDLGNCFILGLVNSFLMIYYTNVLGVSGAIV
GTLFLISRILDAFADVMVGRLCDVSELTETGRFIPWIRKMKYPFCLVTVILFLPFVQHLP
MTVKIAYIFVSYIVYGIFLSTINIPYGAMAAAISSNPNDRTSLSTFRSIGSAIGGSTTGF
FIPILMYTHNKSGQQVVSGNHFFWISIGCAAIAFVAYMLTCKLTTERVRVVKNEKVSASQ
LVKGLLANRALIILVIVDIFIVINQILAGTNMTYLFNDYFHNKQAMSVALLFTYGTVVVL
APFATKLTKLFGKKEASVFALLASSCMYLLMYFLHITNAWVYLILLFIATLGSGLFNLMV
WAFITDVIDYHQYKTGLREDGTVYGVNSFARKVGQACAGAVGGFMLALIGYQSSTTGGAI
QSVLVQERIYTMANLLPAFCLFVSAIILLVGYPLNRSKTVFIGEELKKINER
>FECAFAII_00880 Exo-poly-alpha-D-galacturonosidase
MRTKKGIINALNFKTNDTQQDDTIILQKAIDQGAKEHLPVFIPKGIYLVGALFLKDKSHL
IFEEGAVLKGRTDIEAFPEIDTRVAGVEMKWPAAILNVLSAKDILIEGKGIIDGQGDHWW
ELYWGKDQKSGTRAEYDQKGLRWIADYAIKRPRACLLYHAEHVVVRDLIFQKSGFWNLQI
TYSNDVLVEKVIIRNNDGPSTDGIDIDSSTNVRVYECDLACGDDCIAIKSGRDGNGARVN
RKSSRIEVARCKIRSGYGVTIGSEVSAGVSDVYIHDIDFFQSDCGIRMKSSKERGGVIEN
IRVENLNMIDVQFPFSWIMDWHNEYNRKNSNDLAQMPESWQAVAEEIPESKQMTKVKDIH
IKNVQACLSPGYSLPSRAFDLVAFPEKPIEDVCFSHCQITAKEFGRIEAVQNLCFKSCDL
SIETGNTAANNTFDNR
>FECAFAII_00884 Phosphatase YwpJ
MKLIGIDLDGTLLNSDQSISQKNARTMKHLPEDCFPFICSGREVEDINNILKKSGLRIPA
VGLNGSVGFDGEKKIFESSFDKNDVKKIDSVLSKFPTKIYTNLGSYESQNYKNKMKKIFH
EVGSEFSIKELNYELEYEKSICSIPYNNIEEIIEKDAISIYKFFIFIPNRQLKANIFNHL
KKMLNVSVTESAPVNIEIVPQNVSKGVVFDRLESIYNLKKPLRIAIGDSLNDLSMFESAD
ISFAMGNSHQEIMKKADYVTVSNDKDGVSQAFERILTI
>FECAFAII_00885 putative metallophosphoesterase YhaO
MVKFIHAADLHMDRSFEGLTTLDKTVQEKLLKTNLTVLSNIIEQAIINNVDFVLLAGDNF
HQNRPSLKIQKHFSEQMKRLEKNHIPVFIIFGNHDFYQKERYWFSFPKNVHLFTSETVET
KKITIKSGETVSLSGFSYRQPWIQKDKVMEFPSRELTDYHIGLYHGEPGVSQKGNYAPFQ
PSKMQEKGYDYWALGHIHVPTVLNEKQTIVYPGAPQGHTKKEQASTSILLVELSKGSCQI
HPIKVAEVYWKTKEISLRKARTTKEVIVHIRQQLSKVEDGFSLIEIKLKDYDHLNTDVLE
RIQSGELLDYLLEEFSDRINDFFIWRISLIENTFYTKTPLAASAKLMEQLFQYYQTPQDF
QQILNEVYSHQEAARILSELPEYQEETLEKAKQLLNQDFLFEEDQE
>FECAFAII_00886 hypothetical protein
MKILRIEIAAFGKWRQKSFDFYSGNQLIYGGNEAGKSTIYQFIQAILFGFPSKGRKKKDY
TPKDGSAYGGKIWLKHPVYGEFAVERYKQQNRGKSKVWLGDQVGSDELLEKLIAPLTKEL
FQQVFTFQQEQLMELDHLREKELHDALISLGITGSSQVFQKRQEYYQKAQQLFKKKGQKL
LINQKLNEWKELQEKIHQKQEQEAYFGKLIQQEQEYESQQQQLLAQLKEANKQFSLARQQ
ELNFSLYEEWQSLKKNSTTGLPDEQLLLDLESFSKRYQQTNERLEELEATLEKHSGMDQQ
SARYYFYLEQEQELKDLQQLQFTAEQLNEEWQRLQIETRETNSELKILEQRWHWQKNPLP
EEFLYEEEWKHLLAEERRIADLESQISVRLQIAKEQQEMIEAEVNDLEETYPALLQNQSE
IAPVSSSKPYMLMAGGAIIIAGIFVPMPLKVILLLIGAGMIGYFFYKRQPKIKTKNDFSE
IKGMWQEKLGQLDLALAQLAEAEEKQKRTGEEKQILQQEVYRFADHRHLGKMDTLKLMKE
YGQEVIDYQKLYGVFERKHKREQEIQEKLRQIDQKFEFVKEWLPIQDKTISEKMVLLSRF
IQEMEQMKFARSYQQNTLLKQEINQLKKKQKVWIQEYSEQLTQAGLSYPSEVPVFLQKAK
QAEQQMKRYNELSEMLTPLFPEELTKEKLSVRLRQLKEKQSQLQQEEKEASENRQRLQLQ
VEELQRDGTLDELYQQASRQKAKLQELLEEWGALEIAGTFLGDLSTEMSERQLPQLLRAA
GDYLGILTKGNYQKILLKNDTLTLTDGYTEFPIYELSTGTKDQLIMAMRFAYLSLEANRS
ICPIIIDDGWLHYDHQRKYQLAELLAKFGEKYQIICFSSDKEMVSYYHEMNQIVKQLEGA
NNEKNS
>FECAFAII_00887 3'-5' exoribonuclease YhaM
MKKIRDLVIDEQFEQFVLIKSADVRIAKNGKKFIAFTFQDTSGTIDGKYWDASEEEINKF
TAGTVVFLNGKREVYQGNPQVKILHMRLTRVDEPGEPSLYMERAPLKKEEMEEEINQLLF
EITNAHWNRIVRYLLNKYQKQFFEFPAAKRNHHAFASGLAYHTLTMLHLGKSIADEYPEL
NRALLYAGIILHDLGKVIELSGPMSTEYTLAGNLIGHLVLIDEEITKACLALKISEADED
VLVLRHMVLAHHGLLEYGSPVRPRIMEAEILHQIDNIDASMQMMLTSIRQTEPGKYTDRI
FGMDNRSFYVPKDL
>FECAFAII_00888 Foldase protein PrsA
MKKKSIILAATSALAVLTLAACSGDTNKDIATMKGGTITVSDFYDEAKLESSNQSLVQRM
IIYKVFNNKYGDKVTDKQVDAEYDKQAKSLGDTFESQLEAAGYTKDTYKEYIRNNLAFEA
GLKAHVDITDDDLKTAWKSFHPEVEAQIIKLSSEDEAKDVKKSADDGDDFSKLAKDKSTD
TETKEDGGKVKFDSTTTTIPAEVKEAAFKLKDGEISDVITTTNPTSYATEYYVVKMVKNQ
NKGNDMDKYKDQLKDIATETKLSDNAFTTKVIGEELKDANVKIKDDAFENVLSAFTTTSS
STKDSSETTASTKSSDTKSTDSTKESSTEETTDSSK
>FECAFAII_00889 hypothetical protein
MIKNFFKGLLFGAAAGTVGGLLLAPRSGNETRKKLIEELEEATTLTNDLNNSLNHFKSAL
IETKETAESVIPAFQEAIKKDIEDFKFQAEPRITQINEQVEKLKADLPEYPEQI
>FECAFAII_00890 putative HIT-like protein
MENCIFCKIINQEIPSYKIYEDDKVYAFLDISQATKGHTLVVPKRHVADIFEYDPELAGE
VFSRVPKIAQALEKAFPEMKGLNILNNNRELAYQSVFHSHIHLVPRYSKEDDFSIHFVNH
QDSYGSEELKAIQETIVKQVSCDD
>FECAFAII_00891 ABC-type transporter ATP-binding protein EcsA
MSLIIDHVTGGYGHLPVLKDISFDVQPGEIVGLIGLNGAGKSTTIKHIIGLLEASKGTIE
INHLSLKKNTEEYRKQIGYIPETPSLYEELTLREHIEVTAMAYDIPMDIAMKRAEKLLET
FRLSNRLDWFPANFSKGMKQKVMILCAFLIEPSLYIIDEPFLGLDPLAINALLELMVEMK
KEGAGILMSTHILATAEKYCDRFVVLHNGEIRADGSLEMLRKEFQLPDSSLDEIYIALTK
EQAHE
>FECAFAII_00892 hypothetical protein
MSSFFQKRLARHQKKMMKYMRYVLNDHFVLVCLFLIGGVGLYYSNWLKTLQPPFAIGGLI
ISVFWMLCLFVGKMATFAEAADIVFLLPKEKEMQTYLERAFRYSCIFPLIFLILACGLAM
PLVVVSTEQSFSMFFVYLIILWSLKFSHLQIKRAELFRLDQQVIRYWKLGWFFSSLIFLF
LSFYWLIWAGIAGALVQASLYYWFLWKQQEKGLDWEKMVHVEEHRLHQIYQFINLFTDVP
EITAKIKRRRYLDPILTHIKRESKNTYLYLFARRLARGSDFSGLYFRLVIIGGLLIAGVV
DFYFSLIIGFLFLYLIGFQLLPLANQFRYMVLVQLYPIHKNQKKQAIQYLLTWVLIIASV
IFGLIAAVVLDGQQRWVPLAAYLIVTMLFVKLYVPTRLKKMSD
>FECAFAII_00893 hypothetical protein
MMEFQLDQEWRLRPIKGDTGKTYIGMRDEDKVFIKRNTTPMLAALSREGITPKLVWTKRT
GNGDTLTAQEWLEGRLLTPNEIGQRNDVIDVLYHLHHSNSLKTMLTRIGGRVMTPEKMLQ
KYEKELPEELQKNQFLQIVHRFLREQIPSIDKENLSVVHGDVNHRNWLVCKNYLYLVDWD
SIMFADPAVDIATILGNYVPLSSWNQWLISYGIRPTDEMLEKFHWYAAMNLLQEITRYCK
REDHRRMNEEILQLKRIFSG
>FECAFAII_00894 tRNA (guanine-N(7)-)-methyltransferase
MRVRNRPGAAEMLAAHPNFVISDPTLWKGKWNELFENDHPIHIEIGMGKGQFITGMAKAH
PEINYIGVEMQVSVVSIALDKLIEQPLPNLKLLHVDGSALTEYFADSEVDQIYLNFSDPW
PKKRHEKRRLTYKTFLAVDEQILRPNGEIHFKTDNQGLFEYSLASFSQYGMILKQVWLDL
HQSQFEGNIMTEYEEKFSSKGQRIYRVEAQFQDKTKKKSL
>FECAFAII_00895 Adenine deaminase
METTLRKYIEVASKKKPADLVIKHAKIVNVFTKEIMEKDVAICEGMIVGIGEYEGKSVHN
ANGQYLVPGFIDGHVHIESSLLSPSEFSKVSLLHGVTTVVTDPHEIGNIAGSTGLEFMIE
DARQTLMNIFFMLPSCVPVTPFETNGANLNAKKLAPFLQKPEVLGLAEVMNYQAVANNET
DILEKIQLMHQHKKKIDGHAAGIGMEELNVYPAAGIRTDHEATTAKEAKERLDLGMYLMV
REGTVAKDLASLLPAITPENSRRCFFVTDDKLINDLVKEGSIDHIVRQAIALGIDPLQAI
QMATLNAAECFDLKTLGAIAPGYQADFFLTDDLTKLPIHEVFYKGTLVVQSGQLQDHLFA
DHSNSYTCCLPKLNAQPLNPHSLELLLSSSQAHVIEIIPNSLVTKDLVEKVDRQGERFIP
SIEKDQLKIAVIERHHQTGNIGLGIVKGFQLKQGAIATTIAHDSHNLVVVGTNDEDMLYA
ANLLIQKGGGMTVVNKQQEIACVSLPIGGIMTQEPFSIVYEQLNELITKAHQLGAAKTFD
PFLTLSFLTLSVIPELKITDKGLFSFSRFQLIPPCGKTDEINTF
>FECAFAII_00896 ComG operon protein 1
MEIKRLSDQMISESFAKHAQDVYILPASEVFYIYFRYGKKRTFWKKVSSADGQQLISRFK
YLGQMDIGEKRKAQLGAFTYSLEKQEVRLRLSSVGDYLQRESLVIRLLYGTFETPHRCFS
SRDFATILQKTVRRGLYLFSGPVGSGKTSLMYRLALEEKLQVITIEDPVEIEEPFFLQLQ
INPKIAQTYDTLLRLALRHRPDLLIIGEIRDESTAHAAVRAALTGHRVFATVHARNLEGT
LVRIHELTKKKEELSECLAGVIYQELLEDANHHPSVLWSYQFMEEESVKKSWEESYEEAQ
ENIWQSELF
>FECAFAII_00897 Type II secretion system protein F
MKKLRKIFGSQNYSKGLTRSQQNQFAQTMGELLLSGFSLQESLYLLLTIRSFPPVILANI
QHQLKEGQAFSEVLSQIGYGAEQLVQIELAERHGNLPTTLLEIAKQFRLVEGFRNDLKKL
LAYPMLLLTFLLGILFSMRLFVLPQLIGSGMVMQEHWGIQLIQVFHWYVLLFILAVTLLA
LLVRYRLMKLSPVDQSEWISRQLLIGPIYSLYQSAYLSLEIGKLFHEGFELRQIIVCLKE
TKQESLIQHLASKLIQGLEAGMSLAEQFQNYRFLSEEFSKIVLQGEAKGSLGKELIFYSE
WTRKQLFKRLHHWMHFIQPIIFLGVAALILLVYAAVLLPVYGSIEEVLP
>FECAFAII_00898 ComG operon protein 3
MKKRKISYYSGFTLIEMLIVLLIISVLVLLFVPNLSRYRNHVDQESREAIIQLVDTQKEL
YALQNNGRVPTVEELLNEGYIKREHAEIYQRP
>FECAFAII_00899 hypothetical protein
MKAISNENMQKSISGLEGKVLASGYTLFESLLLILLLTTILSFPVLAFSAWKNELAVYQF
FGQFEKRIYSTQKIAIVNQIQTGFYWNSEENQIIFHVPNPDKINWEVLDIPDEITLKRHA
SITFAARTGNESSLKAYQFYWEEKERTITYQFQIGSGRYTKRIE
>FECAFAII_00900 hypothetical protein
MESLTALMIASVCVYLVSFGQLFLLQAEKKSGEELLFIRMIYEDIKTQRMYHKRPERREE
MIPYDIQIVDNNGVIEKVFVNMEKEAISIEKTSNSSIYAD
>FECAFAII_00901 hypothetical protein
MKKQVIPAFTLIECLIGLMILSSLLLTFNLLIQQTIQVSEFLQRKDQKEWLIFLAQLEEE
LKSSHNVSVKNQQLHYTIEDKQYIIERYQAMIRKRRTSGGHQPMLTSITELQLLEKEHTI
SFYVHFENGEDGYAIWTKNDQ
>FECAFAII_00902 hypothetical protein
MPYGQKTISRKCYKGSILFSVLLLFLLCTFLLMAALESYRLSMDLNIRIKNYYIAKIMKQ
MALSEQSTLAESSEGVFYYTTGSVTYQWVQQSLFLEVEVSPFIFRFTEEVKNDTDTSTE
>FECAFAII_00903 Release factor glutamine methyltransferase
MLPEKMEQGFNQNLEAIQLLQNALGTSFLEAYVENAENLIDDYQVRVVDGVPTKETTQRI
TALYEELKKLSFEPEEWRRLSQLLLLKGSQTEHLQANHQLTPDSIGFLFVFLIEQLYTNK
KAPVKILDIAAGMGNLLLTVLLNLSNAGYQTEGIGVDIDDTLLAVAASTSDLTQANVQYF
HQDGLQELLIDPVDFAISDLPIGYYPNDEKAKEFLTSTEEGHSYAHHLLLEQSMKYVKPD
GFGLFLMPSGFLETDQSEEIKKWFKEEGYLQGMIQLPDELFRNKQSQKSILILQKKGPQA
QQVKEVLLVKLASLKEPEKVTEFFNEFKNWKSSAL
>FECAFAII_00904 Acetate kinase
MSKTIAINAGSSSLKWQLYQMPEETVVAKGIVERIGLQDSIFTIKYGDNQKFEQIMDIEN
HEVAVKMLLDQLIELQILSSYDEITGVGHRVVHGGETYGDSVVIDEKVMDRIAELAEFAP
LHNPANLMGIKAFKKILPDILSVAVFDTSFHSTMPKQNYLYSLPVSYYEDFKVRKYGFHG
TSHRYVSERAAKLLNKPIEELKIITCHLGNGVSITAVDGGKSMDTSMGFTPLAGVTMGTR
SGDIDPAVLPYLMEKLEIDIDEMINVLNKKSGLLGLTGLSSDMRDLEKNYEKEHIRLAYD
IFVDRIRKYIGGYVTTMNGVDAIVFTAGIGENDGHVRSEIIKGMSWFGCEIDPALNELRG
EEVDISTKESKVRVLVIPTDEELMIARDVERLRG
>FECAFAII_00905 putative ABC transporter ATP-binding protein YbiT
MIIQAISIKKTIGGNPLFEDLSCQIEAGEKIALVGINGTGKSTFLQILTGREGVDSGVIS
RKKGLKIGTVEQELTVSEATVNHYLLHSAAEIQDLKQQMSRYEALMTEPDTNLEKCLARY
GELQHRFEELGGYVLEDRIAAILQGLGIPHRQEARLTELSGGERVKVALAKILAADADLL
LLDEPTNHLDLNSIRWLENYLQNTKKSVLVVSHDRQFLDQVTTKTWELEEGALIEYPGNY
SRFRVLKEARLAELTKNYELQQKEVQRLKVMIRRFRQWAHEGDNESFFKKAKELERRLAK
LTLVKPPPPPKNRLQSLSNGGKSGKEVFIIQNLHQQYADQVLFKDSSFAVYRGDHLAIIG
DNGAGKSTLLKLLLGEEKPYGGTIKLGSSLQIGYLPQQLQFADPDSRLLAYAITLTGNEE
VARRQLAKSGFYQSDVGKRIKDLSGGEKIRLALLKLFLEKINVLILDEPTNHLDSYAREE
IEEMLQDYQGTLLAVSHDRYFLQQHFQEALVIDQEQISRQPLGQLID
>FECAFAII_00906 hypothetical protein
MMRMTKITSNENYQRYHIAFSHAIGFTVAVDGTSLSKTVEFT
>FECAFAII_00907 Putative universal stress protein
MLQQYKKIMVAVDGSDEAELAFKKAVNVAIRNNGELLLAHVIDTRSFQTVSSFDGMLAEQ
ATEMAKQTLADYESNAKKAGLNNVTSVVEYGSPKQIIAREIPEDNQVDLIMLGATGLNAV
ERLFIGSVSEYVIRNAACDVLVVRTDLENQLPAKDHTKA
>FECAFAII_00908 hypothetical protein
MIRILMIIATLVLLFVSYYLFNKQDIFFVLINKNDKNQGFLQFYGAAYAVLGVMGILTAF
FNQRFIALVFLLIVIIVSATFSIRFAKKIAEPKQ
>FECAFAII_00909 putative AAA domain-containing protein
MQQPLAYRMRPRTIDEVVGQQHLVGEGKIIRRMVDARMLSSMILYGPPGTGKTSIASAIA
GSTNYAFRMLNAATDSKKDLQVVAEEAKMSGTVILLLDEVHRLDKTKQDFLLPHLESGRI
ILIGATTENPYITINPAIRSRTQIFEVKPLTEQDIQLAVEHALRDKERGLGQQAIQLDED
ALLHLSRATNGDLRSALNGLELATLSTPSDKEGRIHLTLSIIEECVQRKALTHDKNGDAH
YDVISAFQKSIRGSDVDAALHYLARLVEAGDLASICRRLMVIGYEDIGLGNPAAAARTVN
AVLAAEKLGLPEARIPLADVVVDLCLSPKSNSAYMALDAALADIREGKAGDVPDHLRDSH
YKGAKSLNRGVGYQYPHHFDQAWVNQQYLPDKLKNAQYYQPKDTGKYEQALGQQYYRIKE
WKKHPPKN
>FECAFAII_00910 Putative 3-methyladenine DNA glycosylase
MTDKQKIDEFFWNKTTPEVARDLLGMYLEHDTPEGRLAGYIVDAEAYLGPEDEAAHSYGL
RRTPRVRAMYEKPGTIYLYTMHTHRILNIITQPEGIPQGVMIRAIEPAAMIDQMSKNRGG
KTGPDISNGPGKLVEALAIPQELYGQSIADSSLRLVFEKKKTPKKINALPRIGIPNKGVW
TEKPLRFVVSGNPYISLQRKNQIEKDWGWRKENEKEGSINIFR
>FECAFAII_00911 hypothetical protein
MKKKDLLTYLDEIIEKQVTDYDVALDWDTKNHTIEIVVRLFAENKAQFEIDDAEGIVSQE
PIIEFEDGVLLFNPQKSVFDERNYLAVIPYEGKKGLAKSVADSLVEYLNEVLAQGQSDLL
DFLDEDDDEAVFELHWDNQQLAELVEVKQQNEADTYLPYPSY
>FECAFAII_00912 Ribosomal protein L11 methyltransferase
MKWNEVKVETESEAVEAVANILMEAGASGVAIEDSLDVEHFQSDQYGEILDKNDFTSLKE
GALVMAYFPETTFLPEILPFIKDRITQLPEFGLAIGKNKVTVSEVEESNWATAWKKYYHP
VRITRMLTVAPSWENYQTEDPLEKIITLDPGMAFGTGTHPTTSLTLTALETVLRGGETLL
DVGTGSGVLSIAAKYLGAKDVYAFDLDEVAVRSAKENMDMNEIAKDVHVSANDLLTGIEI
ESDVIVANILADIILLMIPDAWRLLKQTGTLIVSGIIEEKKQMVLDAMLEQGFIVDQIFQ
QKDWYAIILKKPEVE
>FECAFAII_00913 Ribosomal RNA small subunit methyltransferase E
MQRYFLKESYESKDYFVLEGENYHHIVRVMRMEPEDEVFLAFNDQIAIVAEITEITEEAV
YLKEIKKEENQKELPSSITIASGYPKGEKLDWIVQKSTELGAQAFLGFPASASVVKWDAK
KRMKRQQRLEKIAQEAAEQSHRQIVPSVELLETKQDLFERLDDYDVVLVAYEESAKQGEK
SNAAKILSETKPDSRILAVFGPEGGLSRDEVDYFVEHKGILCGLGPRILRTETAPLYLLS
AASYQWELMNPSFS
>FECAFAII_00914 GTP pyrophosphokinase
MTKEEILTGPGVIKLVSQYMGPEHVAFVEKACEYATAAHDGQFRKSGEPYIIHPIQVAGI
LADLKMDPHTVATGFLHDVVEDTEITLEDLREEFGDDVAMLVDGVTKLGKIKYKSHEEQL
AENHRKMLLAMAQDLRVIMVKLADRLHNMRTLKHLREDKQRRIAQETLEIYAPLAHRLGI
SRIKWELEDTALRYLNPKQYYRIVHLMQTKREEREKYVSGTVEDIRIATEELGIFAEIYG
RPKHIYSIYRKMKDQKKQFNEIYDLLAIRVIVDSIKDCYAVLGAIHTKWKPMPGRFKDYI
AMPKANMYQSLHTTVIGPAGNPVEIQIRTQEMHEIAEFGVAAHWAYKEGKNEKVEPDGMT
KQLSWFHEILELQDESYDASEFMEGVKGDIFSDKVYVFTPKGDVTELPKGSGPLDFAYSI
HTDIGNKTTGAKVNGKMVQLDYKLKNGDIIEIMTSPNSFGPSRDWLKLVATSKARNKIKR
FFKAQDREENVIKGHESVVKCITDLGFTPKDILTKNKLQEALDRFNYQTEDDLYAAVGYG
EVSPLTMANRLTEKERKEQKIEQQKQEAEEIMNQPKKEPDKMKVRHEGGVVIQGVENLLI
RISRCCNPIPGDDIVGYITKGRGISIHRRDCPNVQPDKPNVAERLIEVEWEDTSNTRKEY
DADLEIYGYNRSGLLNDVLQTVNALTKNLNSVEARTNKDKMATIHLTVGIQNLSHLKSIV
DKIKAVPDVYSVRRTNG
>FECAFAII_00915 D-aminoacyl-tRNA deacylase
MRAVVQRVSKAAVSVDQQEIGKIGYGLLVLLGIHETDTQKDVDYLVKKIAQMRIFEDEQG
KMNISVEDVGGQILSISQFTLFADTKKGNRPSFVEAARPETAIPLYESFNEGIRSRGITV
ATGQFGADMSVSLVNDGPVTIIIDSKNK
>FECAFAII_00916 Fatty-acid peroxygenase
MKEVPVVDIKITDLKKLYQKGYNMLEELRHEADAPVVKAKIFNKEAITIYGSSAAKVFYD
PRNFKRKGAMPKLVLKTLFGQGGVQTLDGAAHHHRKNIFMDLMTPERMEDYHRILDKNLT
QALEAQHGQFELFDLSKMVFFTSICEWAGINLSAISKDEVEKLAEYQISMISGTFTSPID
HIKGVENRKKSEKWAQGLIEEARQNPVAGKENVALYAFANATDLDGQLLPLEVAAVELLN
IIRPTVALTVWAALMGHALFSRPDLYQQLKNDFSTLQDPFIQEMRRYYPFFPMLPAISLK
EVEVDGYRIPEGSWVILDLYGTDHDERTVEAPDSFMIKRYVGKAKDISYKEEYEMIAQGG
GNFRQMHRCAGEWITLHSLRVFSDQLVNKFEFSVPEQDWTIPFNQFPTYPNSRALLYKN
>FECAFAII_00917 General stress protein 69
MAEIRIGHSQVYAEQLGLGANAVGGHNLFDGLEDETGKQVVRTALNSGINLIDTAYAYGN
GRSEELIGEVLKEKEYDRSRVVIATKAAHVPNKGRTFDNSPEFLKQSVEDALKRLQTDYI
DIFYIHFPDESTPKNESVATLHELKEAGKIRAVGVSNFTLEQLKEANADGYVDVVEDKYS
LIHRQAEKELFPYLEKNKISFVPYFPLASGLLTGKYELGEEKQFGEGDPRKRNPDFQGER
FREILTAVDVLRPIAKRYQATPAQLVLAWYMKNPRVSVVIPGAKRPEQVSDNVQALDLHL
SNEDYQTIDEAFRGF
>FECAFAII_00918 Histidine--tRNA ligase
MSFQRPKGTNDILPGESEKWQFVEETARLLFRDYQYNEMRTPIFEHYEVISRSVGDTTDI
VSKEMYDFYDKGERHVTLRPEGTAPIVRSFVEHKLFGPEYAKPFKTFYMGPMFRYERPQK
GRLRQFHQIGVEAFGSENPATDVESMVMALDFFKQLGITQIRLVINSLGDKETRQAYRQA
LIDYLLPFESELSEDSKRRLHENPLRVLDSKDKRDQKFVAEAPSILDYLSEPAQKHFDTV
VSMLDALAVPYEIDSNMVRGLDYYTHTIFEIMSDAPKMGAQATICAGGRYDNLVEELGGP
STPGFGFAMGIERLLLTMEAEEVVIPAFNELDAYVVALGDETNIEALKVVQAIRNFGFSA
DRDFMNRKAKAQFKTADKANAKLVLVIGEDELASQTINVKAMASRKEKSFPLEEIYEHFD
EVYDEMTLFE
>FECAFAII_00919 Aspartate--tRNA ligase
MAQRTIYCGLVSEQQLEQTVTLKGWVQKRRDLGGVIFIDLRDREGIVQIVFNPEINKEAW
EIADKCRSEYVIEVTGEVRRRGENAVNPKMATGEFEVIASEIVILNQAKTPPFQIEDDQA
ISDEIRLKYRYLDLRRPKMTKNIKLRNATTKAIRHYLDDNDFLDIETPYLGKSTPEGARD
YLVPSRVHAGHFYALPQSPQLFKQLLMNAGFDRYYQIVRCFRDEDLRGDRQPEFTQVDIE
TTFLTAEEIQTYTEGLIAKVMKEVRGIEVTLPFPRMTYDEAMARYGSDKPDTRFDMELID
LSDTVKEVEFKVFQMALENGGVVKALNAKGAADRYSRKDMDQLGQYVGQFGAKGLAWLKV
EEDGLKGPIAKFMGEATEAIIKATDAKPGDLLMFGADKSEIVAAALGAIRTRLGKELGLI
DESKFNFLWVTDWPQFEFSEEEGRYVSAHHPFTMPKEEDIPLLAEDPAKVYAEAYDIVLN
GYELGGGSIRIHTRELQEKVLETLGFTKEQMEEQFGFLLTALDYGFPPHGGIALGLDRFA
MLLAGEDNIREVIAFPKNGKAADVMSDAPSMVSPLQLFELNIDVTNIEE
>FECAFAII_00920 hypothetical protein
MKKTFENWAYHDYTTKLSVSIVYALIASVALNFFYQPGHIYSSGITGLAQILTTLSKSLI
GFEVPVSTTLYLLNIPLFVLAWLKIGKKFTIFTFITVTLTSLCIHILPETVLSTDPIICA
LFGGAVMGLGIGLALRNGLSSGGLDIVSITIRKKTGKSIGSISIYFNALIVFVAGILFGW
QYMFYSTLSIFVSGKVTDVVYTKQKKMQVMIVTKHPEKVVNEIQNCMRRGITIINEAEGA
YKHDKQTVLMTIVTRYELPLLREAMKASDPQAFVSIAENVQILGRFYEDGI
>FECAFAII_00921 O-acetyltransferase OatA
MEKQKRLKNSRYITGFDGLRSLAVVGVIFYHLLPTSMKGGYLGVPIFFVVSGYLITDLLR
QEWEQNGKINIWQFYVRRMKRLYPALVFMLVTASAYITLFQRGLLNNLRGVVVSSLLYVN
NWWQINNGLSYFDRFANESPFTHIWSLAVEGQNYLVWPILFVLLMVFVRKRKWIFYTVLG
TSFLSAILMMILYTPGGDPTRVYYGTDTRLFSIWLGSALAFVWPSTRLKKNIPKQAKNIL
NIAGGISLLALILCFFFLDDHYNFIYYGGMLLVSLLCVVLVAVTAHPGASLNRWLTNPVF
TWIGKRSYGIYLYQFPVMIFYEAKVTDIADHVLLHTLVEITLILIISELSYRYVERPLAR
FDYGRTFQVMKGWFSKPIISKSKPWVVPGTLLVAIALVGFVTAPKNAVTADQKQLQAKIA
ESKKLAEETRNNSENTTSSVDQAILDKYELSKAQGNKAQKLELTAFGDSVMLDAATDLQE
LYPKVVVDGDVGRQLYASVPYIEKLKEQDLLKDTVLIGLGTNGSFSEAQFDSVMDAIGDR
KVYWVNVRVPTKRWQNDVNAMLEQMTKKYDNMTLIDWYSYSNDHSDWFYDDQVHPNPEGM
THYIHLVSEALLGGSSSTNSSETNVTE
>FECAFAII_00922 hypothetical protein
MANEHYFYVLFCKDQTFYGGYTTDLSRRLEEHNNGTGAKYTRLQKRRPVKMIHAEVFSSR
SEATKAEAAFKKLTRKQKERYLQTHSTVLLPESI
>FECAFAII_00923 tRNA1(Val) (adenine(37)-N6)-methyltransferase
MLHEDERIDQLYAEDIKIIQSSKVFSFSLDAVLLAHFSRVPKKGKIVDLCAGNGAVGLFL
SKRTQAAIDAIELQPRLADMARRSIALNHLNEQMTVHTIDLKDSLSVVRHNSCDLVVCNP
PYFKGLPTNKTNPNKHLAIARHEIHTTLEEVIDISSKLLKTNGRFTMVHRPDRFLEIIQV
MEDYRIAPKRIQFVYPKPGKEANILLVEGIKEGKLDGFKVAPPLITYNMDGEYTAEIREM
LYGK
>FECAFAII_00924 1-acyl-sn-glycerol-3-phosphate acyltransferase
MFYRFMRGVVRVLLALVNGNARYENKEVLPQDENYILVAPHRTWWDPLYLAVAAAPKEFS
FMAKEELFKNPVLRFILTRSNAFPVKRENPGPSVIKTPVKILKSTNLSLIMFPSGTRHAT
ELKGGMALISRMSKAKIVPAVYQGPLTLGDLFKRQRVTVRFGEPIDLSDIKKTDKEGMAE
IERRTQAAFDKLDKEVNPDFKYEVKKK
>FECAFAII_00925 Nuclease SbcCD subunit D
MRFLHTADWHIGKKLQGYDLIEDQRHVLSSILDIAKEEKVEAIVIAGDLYDRSVPAVDAV
ELYNELMVDWNLKEKIPIFAISGNHDSSTRLSAGTPWFSYSNYFLRTQLAEAFEPVEFKN
VQFFFLPYFEPIAARLYFEDDNIRTIKQAVAKVIDKMQELFDSEKKQVLISHFFVMGSVK
SDSETKIEVGGLDSIPGELLTPFDYVALGHLHNQAALRQDNARYSGSPLKFSLSEINQKK
GVWIVDLTTGLELNFREIEPLHDIEEITASFKELLDPAFYQSVNRENYIYIYLTDRTIIP
NMMNQLRQIYPRILGIERANGRAEQTKRKRKVLEMKDPQKLAEAFFSEMTEEQLTANQEK
WLGETLQEIMEME
>FECAFAII_00926 Nuclease SbcCD subunit C
MKPKKLQLKNFGPFINETVDFSRLTEAPLFLISGKTGAGKTTIFDGITFALFGETSGRLR
SGKEMRSLFATPDEETSVTFSFEHQQMSYEIERKPEQVLAKRKGNGTKKQAAKVTLTIFD
GKGKEIKQITKRTEADQLIRELMNLDAKQFSQIVLLPQGEFRNFLVSSSSDKETVLRHLF
GTQFFQQFNERLKEKAKQQQQKLDHLEQELHLLQKRFVLVKEEEPAAGFEAVLAQWTNHQ
AILEKQITEEKEALTELQEKQKQLENSYYRFESLKKSYEEKTILINKQKELAAQKDEIEE
KKRWIGYYEFTQRLVEPIQRLQEIKVEKIELSQKSSEQTKKLAMTTQNYEEWQKNEANRV
RRQTKIKEAAQKLQNKQMMVPIVESLRSKKQDAEQLTISLDKEELNAEKLYQNLAIYQER
TRILQENLLDQEKLQEDRLAFGQLKYLDEKQQEIEKQKAKDTGSLAQIREELKKATEEIT
KNSQLLKEQTEQAEQLKSQWAKQQIARLQLFLRPGEPCLVCGSTEHPIQQLKHEQPNKED
ILKVEQQLAEAESAVERTQQIIAKSEAHENNLQQQLSDLEQKIMATNIQLAEQEEHLQQA
LKKAFPEITEQKTKTTLVVIEQSLDRRKSKMANARIELEEIRQQAEKLEQQLAVYKQQQT
EKNNQLQQLQGEIKSLEQQLQDTDSNCLEEEIRRLEKQLEEDSNQLAVEQKAGVQLLQDL
HTLRTQLDLQHEQIEKIDEKIEKEQERIAKKLESQSYFSTIEEICAFAQQQAQYKENQRT
VTSYHEEQLVTADRLRQLENIQLTETFPDTEEISQQLEEIRRMIEIKQEKIYGLQEQKIS
NQKIYDECLSIYHTSQTKLDELTQLQQLSQTFNGENPKKTSLERYVLQVYLQEVLQVAND
HLQRLTKNRYQFELADTIGSYRGKTGLEINIYDDQAGMSRSAHTLSGGESFIAALSLALA
LADVIQTQAGGVAIDALFIDEGFGSLDEEALEMAMEALETIESEGRMIGIISHVRELKER
VLQQIRIDTEGSGQSKIRYQLG
>FECAFAII_00927 RNA polymerase-associated protein RapA
MKWSIPEKVIARGRQYLQEGRVLSVVPDQEENVWHAEVLGSELYMVDLDGTAKEIDYCQC
PYWEEHKYCKHTVAVELYLRSKNLSRIMKKDQPMLEPVKATSEGEIIAKGFSRLKTQNNP
QAVQPLIIEYQVETIETNQYHPELSILALYLRIGSLASPKKTYIVKNIYDFLQAYTEKET
YTVNKQYQFRLDKRAFQKEDQKILTHLAGSAQTHQLLGTNGLQVKGKLDKRYLLLPVEQA
RFLLEQMNQTTRLHLQINEQNDQGIQFSDQNKPLSFKVEKFGEDYLLQALNDFDFFFMHY
QWGVIQGTFYSLTKYQQTVYQTWKQLIRRLEKPEVVFKKKELPSLFKEIIPLLSEIGDVA
IAPAVEEEVADIPVEFIFFFRKAKGKIQARVDFVYGEVIYSTDPKHEVSTEQAFQVLRDT
VEEKRVLDLFRMYRYQKNETGYERPLPSGEELYAFFRTELSVFRQFGEVRLGRKLRELYL
DAHKHQPKIEVTETGSWLDIRFDVTGIEEQEIDHVLQSLLRNDAFYTLENGQVLSFDSEE
FQQTSQVLQQLRESIRTEEGTIHVPKNQGLIIQNQLEKSNATFSESFQTMVQDLIHPERY
QAQLPKGLNATMRDYQKQGFRWLKMLGHYQFGGILADEMGLGKTLQTIAFLLSEKEERKS
FSALIVAPASLIYNWQAEVRKFAPSLSIQVINGNKKEREELLAKDTDIRVTSYASLRQDL
ANYQSQKIDYLILDEAQMVKNSSTKTAQALRELAVPQRFALSGTPIENNLEELWSLFATI
MPGFFPTKTKFRELAAEEIAQMIRPFILRRDKQTVLKDLPEKTEMNLYSALTEEQKTVYL
AYLRQMREEITSMDSEAFKKNRIGILAGLTRLRQICCDPRLFIEDYQGGSGKLEQVKDLL
VAAKENKRRVLLFSQFTGMLTILQEELAELGISTFYLRGSTKPQDRLSMVDAFNAGEKDV
FLISLKAGGTGLNLTGADTVILYDLWWNPAIEEQAAGRAHRIGQKNVVEVWRMISEGTIE
ERMDSLQQEKRELFQKVIQGNEEQLTKLTEEDIRMILSVGEIEE
>FECAFAII_00928 Putative HAD-hydrolase YfnB
MIKSVVFDVDDTMYDQQQPFRNAVKRVVPLVSDADMHPLYIRFRHHSDENFPKVMAGDWT
LEYMRAHRISQSLKDLDYPHITEEDGLLFQKIYEEELDNICLHEEVKKTLDFLKEKNVPL
GIITNGPTDHQTKKLKQLQLNNWIPSRNMLISQATGFQKPEKEIFQLAEKEFHMLPEETL
YVGDNYDNDVLGAKSANWQALWFNHRERKIEQTPICDIEISSFDQLLETMKTIFV
>FECAFAII_00929 Regulatory protein Spx
MLTLYTSPSCTSCRKARAWLQEHQIPFVERNIFSEPLNSSELKAILQMTEDGTEEIISTR
SKVFQKLNMDLDDLPLQELLELVQNNPGLLRRPIMIDDKRLQVGFNEDEIRRFLPRDVRQ
LELRQAQLMAGL
>FECAFAII_00930 Adapter protein MecA 1
MEMEHINENTIRVLIGHEDLEERGVSFLDLLGNHKEIENFFYSILEEVDIEEEFRGSEAV
TFQVLPKGDGLELFISKNLPDEEISQSEDSTVDSEDVSDFLRQQIIGSDPEEELSGSALE
EQERQATFAFEDFEQVIQLATDVELESAWTDLYLFEERYYLVVHFWMENLNQADVENQIA
RILEFAEKSDRTPETLNEYGQCLMARNAIERTKFYFV
>FECAFAII_00931 Competence protein CoiA
MLLAMNEYNKCCFAKHAEKGKKYYCRGCRKRVILKKGKKKCAHFAHQKSDNCSVFSERES
KEHLQLKECFMDWLGQSVEPVFLEAYLPRLRQRPDILLANLAIEIQCSRLSHQRFIERTQ
NYLNNSYQVWWILGNSFLGQSQFSLIEKSCCYYNRKRGVHCWKADLKKQKLYLYHHITET
VSGHISFCSSCWTFSSRDLKEIFTSNEIKMNQMKKIEKVSEDGKKWLTRQLIHKQKNTVS
IQEQCYLRHKHLLHLSSWIYQKSRFFFYLQEQVFLYRMLYEEALENQKVPDFNSWLCQIK
EHKREWLFPMIDEEMVYQQFFNECIHLSSLKK
>FECAFAII_00932 Oligoendopeptidase F, plasmid
MEVKQLPKREELPENLTWDLTKIFSSDQEFDEKYLELSEELKQSEKHKGTLDQGASQFLN
AIEFVLRVYRQTEVIYVYAHLKNDQDTGNTDYQALYARASSLFSKVSEAVSWFEPEILQL
SDDQIWQYFKEEPKLEVYRHYIQQIVDNRAHVLSAEQESLLAGAGEIFDASSDTFAVLNN
ADLVFPTIEGENGEIVQLSHGVYGQLLESTDRRVREAAFKGLYSVYEQFRNTFASTLGTH
IKGHNFKAKVRNYSSAREASLSNNHIPESVYDTLVDVVNKHLPLLHRYMELRKRLLEVEK
LHMYDLYTPVLGEAPITFTYEEAKEKALEALKPMGEEYMAIVEKAFSERWIDVVENKGKR
SGAYSSGSYDTNPYILLNWHDTLDQLFTLVHEMGHSVHSYFTRSNQPYVYGDYSIFLAEI
ASTTNENILTEYLLETEKDPRVRAYVLNHYLDGFKGTVFRQTQFAEFEHFMHTEDEKGVP
LTSEYLSDSYGKLNAKYYGPAVEEDPEIKFEWSRIPHFYYNYYVFQYSTGFSAASALAKK
ILNQEPEALENYLAYLKAGNSDYPVEVMKKAGVDMTQAAYIEDAMSMFEQRLNELEELID
RL
>FECAFAII_00933 hypothetical protein
MSHTQLIKDTLNILDLNIYFEENCLTKEKYKGQICLIYKGTLLYKPEECSHCLCVVPSRI
IRWGTTTVRLLLNDVSEYRTYLELKKQRFKCKSCQRTFVADTSVAEKHCFISQKVRWSVI
ARLKENTSMTEIARQKNISTSSVYRVMKRFYRPLNPFKQTLPKVLCFDEFKSVRSVASAM
SFIMMDGQSHALLDIVENRRLPYLERYFSRFSLATREAVQLIVIDMYAPYVSLVKKLFPN
AQLIIDRFHIVQHIGRTFLNHRVKETTVRLKGNSHSQRGLGKKLKRYWKLLQKEEAKLNY
EKRVWRASFKDYLTESEIADRLLAACPNLRQGYQLYQDILYAVKKRDQSLFEDCLTRDIS
GLPETYTTTLRTFKKFLPQIQNALHYSYSNGPLECLNNHIKVLKRNAYGFRNFYNFKLRI
MIRHGKTFLTK
>FECAFAII_00934 hypothetical protein
MIEIYLFVNPLGEYCFEMEQQLLQFIEEEYGTPSKEKMQFRFLPLVNLQTIGDVMQQKGI
SQNNLEERNHLFSMTYSAALDCKAAQFQGKKKGRRFLIKLQEAVGCNDIPYSQELAESIF
EEIGGDLNMFKEDRQSDFVKEVFFSDQKIAREMGITKHPSAVVYNYACDRDFGVLVEVKG
TSSLWRITELCKTTDNSYQVFNGEHLHTNDSQFHSRTSHLHLLSN
>FECAFAII_00935 Putative triphosphatase YjbK
MTQMLEIEYKSMLTKQEYEIFIAHYQLTDKDFRVQTNIYFDTVDEQLKKQNCGLRIRFVG
HQAEYTLKTPAEKGRLETTDTFITEEAEAFIFEKRLPRSGAVFQKLSDLNIDPASLIQTG
KLTTKRAEFPIEEGLLAIDESWGDNLHDFELELEVGDASVGKIAFINFLKRFSLPYRPAK
NKIQRMLEAKN
>FECAFAII_00936 GTP pyrophosphokinase YjbM
MERDWEAFLAPYEQTVSELKVKLRGIRKQFREQNRHVPIEFVTGRVKPVDSIVTKSQLRH
IPMGRLEEEMSDIAGLRIMCQFVEDIHQVVEIIRKRKDMKVLQERDYITNKKASGYRSYH
LVIEYPVQLISGEKKILAEIQIRTLAMNFWATIEHSLNYKYQGVFPEEMSERLQRAAEAA
YQLDEEMSSIREEIQEAQRLFSHGRGKSDDVYYRTLLKKESEREEAGDESSDRS
>FECAFAII_00937 NAD kinase 1
MKVAIVHNKEAKTIEVTERLNALLEQAGIQRDDHEPELVISVGGDGTLLSAFHHYSHCLN
DVRFLGVHTGHLGFYTDWRDYELEELVDSLRTNREQSVSYPLLDVRISYLDETPDQHFLA
LNESTIKRANRTMVADVYIKNELFESFRGDGLTISTPTGSTAYNKSVGGAVIHPSINAFQ
LAEIASLNNRVFRTLGSPIVIAHDEWLEIKLENTEDYLVTVDQLNVAKANIRSIYYRIAE
ERIHFASYRHMHFWHRVKDAFISED
>FECAFAII_00938 Ribosomal large subunit pseudouridine synthase D
MQFTWDYEKDHSQQVKYFLKEKGISKGLLAKIKFQGGQIKVNDQVENVLFSLAKDDKVTI
VIPAEGEHETVLLDETPIDIVYEDEHVLVVNKPAGVSSIPAQYHPNGTMANRVKAYYKKQ
GYENQVIHVVTRLDRDTSGLMLFAKHGFAHAKLDMQLREKKFVKKYQALVSGRLSDLSAH
GHIDLPIARDYSSLLKRMVSDEGRSAQTEYWIEKRLTEIALVDIQLHTGRTHQIRVHFSA
IGCALLGDDMYGGRMDLGIKRQALHCYDLRFYHPFTEELLEFKQPLAADMEAVVRRFEE
>FECAFAII_00939 Magnesium transporter MgtE
MDENQELEERFAQLTQDLRENNIQAFRNSFLEMHIYEQGQFYQSLTEENRQLIYSYLSPK
ELADMFDVIEEDNEHMKEYLDEMRPSYAADMLSEMYTDNAVDLLNTLDKKQIAKYLSLMS
ADDASEIKELLHYEDETAGAIMTTEFVSIVANQTVRSAMYVLKNEADVAETIYYIYVVNQ
EGQLVGVISLRDLIVNDDDAMISDLMSERVLSVHVGDDQEDVAQTFRDYDFLALPVTDYD
DHLLGIVTVDDIIDVIDDEAASDYSGLAGVNVEEINENPVKAASRRLPWLITLLFLGMST
ASLISHYEDLVSEASILAVFISLITGTAGNAGTQSLAVAVRRLAISDEKDHGFVRLVLAE
VLTGVVTGAVTGITIFLIVGFWKHNFILGFVIGMAMLFAITVANLAGSLIPMLMDRLGFD
PAVASGPFITTLSDLTSVLIYFNIASLFMGYFM
>FECAFAII_00940 CutC-like protein
MIKEFCAENYTSIPLAIARGADRIELCDNLAVGGTTPSTGVIEETLSYAGEKDIPVMTII
RPRGGDFVYNDIELKIMHTDLIEAKKLGTDGVVFGCLTPSGWLDEEALELLIETAEGLQI
TFHMAFDSIPEDRQFEAIDWLVEHGVDRILTHGGPADKTIVENFPRLKELIAYTDGRLII
LPGGGVTAENAAHVAKELNVSEVHGTKIVDLQL
>FECAFAII_00941 23S rRNA (guanine(745)-N(1))-methyltransferase
MLKKIDRGRQFLAENHQLFRCPVCQEEVKKSDNGLICKNNHRFDLSKKGTLYFLSHAVKT
EYDQGMFVPRRRMIQSGMYQPVIETIAQHLPEEVSLLDVGCGEGSFLNELSKLKKIQNAV
GFDISKEGVYAATEQSAEAFWCVADLTNLPFADQTFNAVLNIFSPSHYQEFQRVLSEDGE
VLKVVPQENYLKELRQAFYPNQPEKQSYSNERVVAKFAEAMKLTERQRVTYEFEIPEENQ
KDLLAMSPLEWQVEERIKADLYKNPLKKITIDIELLKGTKRKRFSSSF
>FECAFAII_00942 tRNA (cytidine(34)-2'-O)-methyltransferase
MNHIVLFEPLIPANTGNIARTCAATNTPLHLIEPLGFSTDDKHLKRAGLDYWNDVNITYH
SNLEAFLTFLGNRKLHLISKFAHKVYSDENFADGEEHFFLFGKETTGLPETFMRENEEKC
LRIPMNDEHVRSLNLSNTAAMIVYEALRQQGFPNLELTHHYENDKLD
>FECAFAII_00943 Putative phosphoserine phosphatase 2
MELYFTRHGKTQWNQERRFQGSNGDSPLLPQSYEEIKAFGKKVKYVPFKAIYSSTAKRAR
DTAEGINKELARPVEIFYTDKLRELGLGTLEGQSIDEMYQKYPDNLPNLRNHLDLYDPSP
FHGETIESAITRIETVVADAVARHKDGPLLFVGHGASLTAAIQWMTGKELSELREMGGLF
NSSLTILETEEPCRLLPYELKVWNQTDFLGTETAPEPLL
>FECAFAII_00944 ATP-dependent RecD-like DNA helicase
MQPEEMPYFVGTVAAIFFQNPSNFYKVLLVHISETTADYREKEIVVTGSFGDIQENETYR
FYGELVDHPKYGRQLKLERYEQEKPTTANGIVAYLSSEKFPGIGKKTAEKIVELLGEDAI
EKIIADPSVLKQISGLTKPKREMLAETIRLNHGMDQVIMGLNRYGFGSQLAFSIYQAYKN
ESLDIIEENPYQLVEDIEGIGFKRADNLAEQIGIAADSPRRIRAAILHQIFQHAVQTGDT
YVPAETLLQQTIRILETSRPIEIQPDQVATVIIQLVEEGKIQQEETNLYENSLYFSEWGI
GNSIQRLLSRKKEIHYPEKEVQKNIRRIEKIFGIQYGPSQEQAIAEAIRSPLFILTGGPG
TGKTTVINGIVNLFAELNGLELDPSKYTQEIFPILLAAPTGRAAKRMNETTGLPASTIHR
LLGLNGREKTPSVSTKELEGGLLIVDEMSMVDTWLANTLFKAIPTNMQVILVGDKDQLPS
VGPGQVLHDLLEIEQIPKMELNQIYRQGDGSSIIPLAHEIKEGRLPKDFTKNQKDRSYFR
SDAYQIEPLISKIVEKAKNKGFRAQDIQVLAPMYRGPAGIDALNKMMQEIFNPGKPGKKE
VHWNDTVYRIGDKVLQLVNTPELNVFNGDMGEITGIILAKDSEDKVDELVIQFDANEVTY
KRNEWNKITLSYCCSIHKSQGSEFKMVILPMVHQYQRMLQRNLLYTAVTRSKELLILLGE
EQAYVTCVANESASRMTTLKSRIMDNDKMNITLRTKLAAYEDSLVGNDPFEDGNYTKEPR
VVKEKLPVEDDSGTNETKNQVMETVEPDLFSSFVGEEKKEEVEPAVSKDFVLTAEVIDNQ
LVDPMIGMENSSPYDFIPAKNA
>FECAFAII_00945 hypothetical protein
MAKETEDKLAKLAKESGNDFKKLDEMEKEFKLNESPDVERDDREESKLEKTLDKAPIFPP
NTPNNPTNPGSPANP
>FECAFAII_00946 Transcriptional regulatory protein DesR
MITVVIIDDDPFVTKSLQTILESTKEIRVLGIGHCAKDALVLYETHRPDVLLTDIRMPKQ
TGIDAAKEILAKFPKAILLLLTTFKDEEYIREAFSIGVKGYLIKQNLQAIIPSVKSAYNG
QAVFGNEIIETFTQMMKNKPTIDSHAYASFSERELAIIKEVAAGKNNKEIADALYLSDGT
VRNYISQLLEKLDLRDRTQLAIYFYQHLQ
>FECAFAII_00947 Sensor histidine kinase DesK
MHKSRLLNETSFLLVISLLLLVSQGFVAMQVIYLLIAVLFTGVSYLLPTKPNWIFQVILF
LLCAFLPDLVLFLPATMRVIAPEESHLDYLFLLGFLLISTVGNHPPIKVAFVVILLFFSF
YLRKKDQRTTDLEKKYIVSKDTHWEKQQELSEQNKALALSQETQLALQIVEERNRIARDI
HDNVGHLLSSAILQIGALEMINQEPKLKEPLENLSATVHTGMDRIRQSVHDLHETSISFQ
HSLEFLIADFPSSVTIEGNLFEGLNETQQNCFLMVIKEALTNSIKHSHAKTVVLHFRTLP
AFYRLQITNDGTSPQKNSAPGIGLKTMRQRVQEQKGQVHIFQENQQFQLTIILPREGHQ
>FECAFAII_00948 putative ABC transporter ATP-binding protein YbhF
MIIEIDKLVKRYGDFVALNHFDLQVQEGEVLGLLGPNGSGKSTAINCMLSLLNYDKGTIK
LFGTTMTPENYAVKAMIGVVPQDVAVFDELSVQENIDYFCGLYVSEKEKRKALIEEVIQL
VGLEKYVSFRPGELSGGLKRRLNIACGIAHKPRLIFLDEPTVAVDPQSRNKILESIKELN
RQGATIVYTTHYMEEVEILCDQIVIMDQGQVIAKGTKESLKDMVRTADRLTIDIPLLPEN
VLSAIQRTIASDGIAYKKGQLQVTTTELNTVLLPILTILQEEKISYGKIATKEASLNDVF
LEITGKDLRD
>FECAFAII_00949 hypothetical protein
MFWHFYKYRTKILLRNKSMLFWTLAFPILLGLMFMAAFGEIDQGGNLETINTGIVIKADQ
TALSENFTTVLEQVEVNDKPLFEVQELSEVEANEKLNADDLAGFYLIDGSSVSLHVGQAG
MSQTLMKNVMDQFLQRIGIISSKVAEVENVDLAPIMTVFEQEVSFQEVHAGRNMSFKSFY
FFTLIGMAILYGTMWGVRNVQDQQANQSSNGIRLSLIPRKQSLVSIANLAASFTIVLTEI
YIMLAVFRFIYQVDFGERWQWLMIVTALGSLCAILLGTLVGNLIPKMNLVQKDSILISVT
IAMSFFAGMMGSEQVKYWIDLHIPIVGQLNLVNLISESLYKLYFYTDLASFYTNLLWLIG
FIFLFALGNAWMERGVRYDAL
>FECAFAII_00950 hypothetical protein
MTLYKTIWTLLKANKSNLLIGVIITVVATFFFAQNIDVENTSLQDAKIALISEEESPVVD
GLRKYLNDKETVVTLDGTSQKEIDDALYFNRVNIILHLPADFTEQVEVGKMATIKIQSRP
DAFSKTVVTQQVNTFLQTLILFQEEDKTIDAAMEQTQMALSVTGEVELSAGYSQRMKKLL
TGTTFNFLSYGLFLSIFSGFSVINLAFNRKEISKRNQSAPITKRNLNRKVTFSLISYSLL
LFSGFLLLMVLLVIHTSWDITVWYHILNTFLFLLPIISFSACITSLVKNSETSGGIKDIF
ITGSCFIGGVFVPAEYLPEMVSKIAAFTPTYWFVQNNNLISETLSYNQTFAESFWFNGCV
LVAFAAVFSMIQFILGKERNYRWQPNWAKN
>FECAFAII_00951 Putative lipid kinase YtlR
MKFHYHILINPSAGSGNGYKVAERILPVLKNKHIDYTLHYSEYKGHDAEIAETLAKETLI
PWIEEEQKTIDTFPLLIIVGGDGTLHQVLDTFYQMEVEFPVAYIPAGSGNDFARGAGLPK
NPKKGLQLILAAQSPEKVHIMAYEEKISEKKGIAVNNFGIGLDAAIVHATNHSSTKKRLN
KYNLGSFSYLFSILRALFTQKGFPILVDAGGKQLSFSNAFLCTATKHPFFGGGIAIVPTA
DASKPVIDFVVVERINFFKILWLILLLIQKKQLKSKYFHHYTTNRLRIVSTTPQHGQEDG
EEMEKRPFDITITTTKQLFWC
>FECAFAII_00952 Queuosine precursor transporter QueT
MQKTKSRQRLSVIVVNGIIMALYLALTILVAPVSSGPIQFRISESLNHLVVFNRKLLWGV
LGGVIVYNAFFGFGIMDVVFGGGQTLLSLGLTALLQNKVKNVKMRLVLNTIFFTISMGLI
AYMLVPTGGQAFWTTYGTLALSEFIVMAVSAPLMYYLDRALDFEKRV
>FECAFAII_00953 hypothetical protein
MLLKTLVYKKKDLTTVTETSTLEEALKILETSGYRCVPILDSSGNIFRGNIYKMHIYRHK
ANGGDMTLPVTHLLKNATKFIYLDTSFFKVFFTIKELPYIAVLDSENHFYGILTHSTLLN
MLSQSWSVEQGSYVLTIASTGKQGDLAAIAKIISKHSSIASCITLDIEKDEYIRRTLITL
PANTEAKVCETIVNHLEKKNYKVVEIENLQNQEA
>FECAFAII_00954 50S ribosomal protein L33 2
MAKKKAALACSVCGSRNYTKSVSEGKSGERLEINKFCKYCNQYTLHKETK
>FECAFAII_00955 Protein translocase subunit SecE
MKFLKSVKDEIKQVTWPSRKQLRKDTLVVIETSIIFGLMFYVMDTAIQSLFGWILK
>FECAFAII_00956 Transcription termination/antitermination protein NusG
MESFEKNWYVLHTYSGYENKVKANIESRAQSMKMADFIFRVVVPEEKETEVKNGKEKEIV
HKTFPGYVLVEMIMTDASWYVVRNTPGVTGFVGSHGAGSKPAPLLPEEVNHILRSIGMSL
RQNDLEVEVGEVVKIIEGAFAGLEGQVTEVDGEKEKLKVNIDMFGRETSTELDFDQVDKI
D
>FECAFAII_00957 hypothetical protein
MTEPIKNLCKRATAAALVLISLFALSGCQTTKINTTEVSDKEKTAESSKVIEKTTIPTLF
FHGYSGTENSFKGMLRRLEKNQQAVKELVLTVGTDGQIQATGDLSGKADNPMVQVLFEDN
KNNEWNQAEWIKTCLLYLKENYGIDKVNIVGHSMGGVSALRYLGTYGQDTSLPQVQTLTA
IGAPFNDFVDDSAQSLTDELAKGPAVVSNRYQDYQQMIGNIPITTRFFLIAGQLDETDLS
DGTVPLNSALAVYALLKQRGNEIEEKVVTGENASHSMLHENQEVDQLVSRFIWKE
>FECAFAII_00958 Lactate 2-monooxygenase
MEAGAFGYIRGGSEDEWTMKENTTSFNTKKIMPRILRGIDSADLHTSVFGIELDTPIIQA
PSAAQGLAHEKGEADTAKGVAAAGSIFSISTYANTTIKDAADAAPGAPQFFQLYMSKDDR
FNEFILNKAVEAGAKAIILTADSTLGGYREEDVINQFQFPLPMPNLAAYSEQSASGNGEG
KGIAEIYAAAKQGLTPDDIKTIKEITHLPVIVKGIQSPEDAVIAISAGADGIWVSNHGGR
QLDGGPASFEVLPKIAEVVNKRVPVIFDSGVRRGEHVFKALASGADLVAIGRPVIYGLNL
GGAEGVTSVFEHLNKELSITMQLAGTKTIDEVKNTKLMD
>FECAFAII_00959 L-serine dehydratase, alpha chain
MFLSIEELVDQAKAYPSVAELMIAVEMEMSGRSRSHIIEIMEKNLSVMEQSINEGKEGVT
SVTGITGGDAKKLDDYLNEADFLSGETILKAVRNAVAVNEVNAKMGLICATPTAGSAGVV
PGVLMAVRDRLDLTHEQQLEFLFTAGAFGLVIANNASISGAEGGCQAEVGSASAMAAAAL
VCAKNGTPHQAAQAVAITLKNMMGLICDPVAGLVEVPCVKRNALGSSQAFISADMALAGI
ESVIPPDEVVAAMYQVGRQMPSIFKETAEGGLAVTPTAKRLAEEILNKRA
>FECAFAII_00960 L-serine dehydratase, beta chain
MKDLRYRSVFDIIGPVMIGPSSSHTAGAARIGKIIRSIFGEQPDSVDIYLYESFAKTYRG
HGTDIALVGGLLGMEPDDERLADSLKLAYEAGMEVLFVPKSEKAEHPNSVKMLLKKGTRK
LSVTGISIGGGNIQISELNGFKISLSMGTPTLIVVHQDVPGMIAKVTSILSETNTNIGTM
TVTRESKGENAIMIIEVDDPQVEETVKRLKQLPNIDSVNYFD
>FECAFAII_00961 50S ribosomal protein L11
MAKKVEKIVKLQIPAGKATPAPPVGPALGQAGINIMGFTKEFNARTADQAGLIIPVVISV
YEDRSFTFVTKTPPAAVLLKKAAKIEKGSGEPNKNKVAKVSSDQVREIAELKMEDLNAAN
VEAAMRMVEGTARSMGITVE
>FECAFAII_00962 50S ribosomal protein L1
MAKKSKKMQDALKKVDSSKVYPVAEAVALAKETNIAKFDATVEVAYRLNVDPKKADQQIR
GAVVLPNGTGKTQTVLVFAKGDKAKEAEAAGADFVGDDDMVQKIQNGWFDFDVVVATPDM
MATVGRLGRVLGPKGLMPNPKTGTVTMDVTKAVNEVKAGKVTYRVDKAGNIHVPIGKVSF
DDEKLVENFAAIHDVLLKAKPSAAKGQYMKNVTITTTFGPGIHVDQASF
>FECAFAII_00963 50S ribosomal protein L10
MSEAIIAKKAAIVDEVSEKFTAAASVVVVDYRGLTVDEVTRLRKQLRDANVEMKVIKNSI
LSRAAKKAGLEGMDEVFTGPTAVAFSNEDVVAPAKIMDEFAKEAKALEIKGGIIEGKVSS
LEEITALAKLPNREGLLSMLLSVLQAPVRNVAYAVKAVADKEDGDAA
>FECAFAII_00964 50S ribosomal protein L7/L12
MALNIENIVAELKEATILELNDLVKAIEEEFGVSAAAPVAVAAAGGAAAAEEQTEFTVEL
TAAGDQKVKVIKAVREATGLGLKEAKAVVDGAPAPVKEGVSKEEAEELKAKLEEVGASVT
VK
>FECAFAII_00965 hypothetical protein
MKKKIIRLMLISLGIILILVVGYRLYLEYQTDIQLFLNPRASKAELLAHIRSHGTFASIL
LIVLTAVMCAVPGIPTSVVGVIAGLSFGPLTGAIINILGNALGNITAIFLMHRLKFLDKK
TETNHWVQAIRQMKHPKIGVMLGYMIPVIPSSMVNFAADAMKLPLQQIILSIVIGVIPSS
VLYACGGEALFHGYNKTAVTLVASVTVLVGLVVFIYKDRKKKQGKQKHK
>FECAFAII_00966 putative transporter
MKSNEKTPLTTSLILLLSITCGVVVANMYYIQPIGTKVAASLSVSTSAVGILTMLTQLGY
ALGLLFLVPLGDVVDRPKLIIRMVALSAVSLLAAFFAPSFTLFACASFLIGLLSIVPQII
IPYGAVLAGPKARGKVMGTLLSGLLVGILLSRTVSGIVASLFSWRMIYLFALCAVGILTL
LLYWKMPRSVQQSSTAVSYLDSLKSLPHLVASQRLLREAAVSGFFMFGTFSIFWSTLIFY
ISSPAYNWGTFEAGILAIFGLSGAVAAPIVGRLADSYSERKIVYMGLVMQTISFIALLVG
GSHLAILLLAIILLDVGNQFGQVANQTRVQGLGEAASNRNNTVFTRGAS
>FECAFAII_00967 hypothetical protein
MRSSKYTEHYTDTFITFKEIMRTVSNIYHNCVPDKIKNRRNTDQLKQRDTVIIACVIWGI
INGYTSQRATYRAVCSVLFPNGDFPSRSRFTRLSSNLAYTIKIIRYFFIKKLTKGELVGI
IDSFPSPLCKPVRNRQAKLLNQIAKVGYNSTKKSYFYGLKIHMIVTKTGFPITYSITNPG
VHDVKVLETLSEEANLPNILGDKGYISHKIHEKLALKGITISVPPRKNMDKSEKLDHSLL
GKQRKTVETVFSSLEKLGCQNFNSRSVKGLESRFESILLAYSVLLSRAQRRFEGTLRYSL
GY
>FECAFAII_00968 putative ABC transporter ATP-binding protein YbiT
MSILTLNNITQQFGDKILYEGVDLQLNAGEHLGLIGQNGAGKSTLIKIITGEILPDDGQI
HWQKNIHKGYLDQYVEVDETLTIEEFLKTAYAKEYEKEEKIAFLYQTYSETFDDSLLEKA
GKLQTELDQGVFYQIDTLVAEMSSGLGIDVLGLDSLLKNLSGGQRSKVILAKLLLENPDV
LILDEPTNHLDDQHIQWLTQFLQDFDGAYIVISHDQEFLDQITTHIADIEFGKITKYTGH
LKQALKQKEQNRESYLRQYHAQQKQIEKTEAYIRKYKAGSRSTMAKSRQKQLDKIERLTP
PASASKAVFDFPFSPIVTTLAVETTDLVIGYDRPLLAPINLTIRFGENIAIRGFNGIGKS
TLLKTLIGEIEKISGDFHFPDNTKINYFSQDLYWENPLETPLQYLSSQFPKATIKELRRQ
LAKAGLVNQLASEPLTTLSGGEQTKVKLAQLTMNQGNLLILDEPTNHIDQETKESLQDGI
QKFPGTVIIVSHEQEFYQDLVQRVIEIEPK
>FECAFAII_00969 Glucosamine-6-phosphate deaminase
MEIIRVKNAEEGGKKAFEIIKEGMNKGAKVLGLATGSTPVTLYKEMTSSDLDFSEMTSVN
LDEYVGLGGSDEQSYRHFMDVQLFDKKPFKETFVPDGKAEDLEAACKKYDQIIDAHPIDI
QILGIGQNGHIGFNEPGASFDGTTSVVDLTESTINANKRFFDKAEDVPTKAVSMGIGSIM
KSKEIVLMAFGESKADAIKGMIEGPVTNHLPASVLQNHDNVVVIIDEEAASKL
>FECAFAII_00970 hypothetical protein
MNDMVLTIPEIILRLGIAMLFGGAIGFERQYKNRPAGMRTHILVCMGACIIALIQVEIAS
GALRDALEYPQLAGTIRSDEARLIAQVVSGVGFLGAGTIIVTKQSVTGLTTAASLWAIAG
LGIAIGMGYYSIAIISFIGIAIALTVVKRVIHVPTTKKLEIQFIHRKETKDFLTDYFEEK
NIVIEDVNFDVKFVDDYRVYKNIYTIDLPKGLTYADVIEELSVHKNITKLHLVSIAQ
>FECAFAII_00971 AI-2 transport protein TqsA
MQSRFKQSKLFFWTVELVLTIIGVYFILQMPNIFSPILKMLSAIFLPLLVAGFIYYMFDP
IVVFLEKHRIPRVFGFLLTFLVVIILVVLTVMNVVPQLMEQTIQLTQSLPMYADETSKWL
NELAQREEFKNFNLEEQLASANLSLSNLFNIILVSLSASVSKIISFMMQFFILLFTVPFI
LLFMFKDGHKFIDALSHFFPKAIRKELRQTVKELNETLSAYISSTILDALIIGVMSFLAM
RIFDQPYSLLLAVICGITNIIPYVGPFIGAVPAIIVGLFISPFQALYMALSILVIQQLDG
NLIKPLLFGKSMNIHPLTIILVLIGAGSVAGILGMLICIPVYAVIKTIILNIRKIYLLRR
MEHVSEKLDSPKVLEETSE
>FECAFAII_00972 Ribonucleoside-diphosphate reductase 2 subunit beta
MSETYYEAINWNEIEDIIDKSTWEKLTEQFWLDTRIPLSNDLDDWRTLSQLEKDTVGHVF
GGLTLLDTVQSESGMDQLRKDVRTPHEEAVLNNIQFMESVHAKSYSSIFSTLNTKKEIEE
IFDWTNTNPYLQKKAERINEIYKHGTPLEKKIASVFLETFLFYSGFYTPLYYLGNNKLAN
VAEIIKLIIRDESVHGTYIGYKFQLGFNELPEAEQETLKDWMYNLLYELYENEERYTEEL
YDPIGWTEEVKTFLRYNANKALMNLGMDPLFPDTANDVNPIVMNGISTGTSNHDFFSQVG
NGYLLGHVEAMKDDDYLIGLE
>FECAFAII_00973 Ribonucleoside-diphosphate reductase subunit alpha 1
MSLKNLQDVSYFKLNNEINRPVNGQIPLNKDKEALVAFFEENVKPNTMTFPSIMEKINYL
IDQEYIEAEFIQLYSPSFIEKLYQFLDEQHFSFKSFMAAYKFYSQYALKTNDGSAYLETY
EDRVAFNALYFANGDEELALALADEMIHQRYQPATPSFLNAGRKRRGELVSCFLTQVTDD
MNSIGRSINSALQLSRIGGGVGITLSNLREAGAPIKGYEGAASGVVPVMKLFEDSFSYSN
QLGQRQGAGVVYLNVFHPDIIAFLSAKKENADEKIRVKTLSLGVIVPDKFYELTRKNEDM
YLFSPYSVEKEYGVPFSYVNITAEYDHLVANPNIRKQKIKARDLENEISKLQQESGYPYV
INIDTANRENPIDGKIIMSNLCSEILQVQTPSVINGKQEYEVLGTDISCNLGSTNIVNLM
QSPNFGQSVRTMTRALTFITDASDIDVVPPIQNGNKLNHTIGLGAMGLHTYLAKEQMEYG
SEDSLDFTNIYFMLLNYWTLVESNNIARERKQVFHNFEKSAYADGTYFEKYVTGEFQPKS
EKVKALFEGIFIPTAEDWNALKQAVMKDGLYHQNRLAVAPNGSISYINDTSASIHPITRM
IEERQEKKIGKIYYPAPYLSNETIPYYTSAYDMDMRKVIDVYATAQQHVDQGMSLTLFMR
SEIPEGIYEWKTTTKQTTRDLNILRHYAFHKGIKSIYYVRTFTDDAEEIGSNQCESCVI
>FECAFAII_00974 Glutaredoxin-like protein NrdH
MNVKIFSKNNCMQCKMVKRFLTENQIAFEEVNIDEQPEAVDWLKAQGFQSVPVITSDAET
VIGFRPDQLRKLAS
>FECAFAII_00975 hypothetical protein
MQTLAQAKQNFVYQVERIETEEKTKRHLQNIGIVAGSKIVVVNLSGNNAILLVKSHRVAV
SREILGQIFVNKKTASSESWTSLDQLKAGETGIVVAIHGQGAVKRRLMDMGLTRNVKIVI
RKLAPLGDPIELTVRGYELTLRKSEAELILIQREEKE
>FECAFAII_00976 Fe(2+) transporter FeoB
MNIALVGNPNSGKTSLFNLLTGSNQYVGNWPGVTVEKKEGSLKKNPNIHIQDLPGIYSLS
PYTPEEVIARDYLVQEQPELIINIIDATNLERNLYLTTQLLDLDIPMIIGLNMMDVIKKE
GKKINLEKLSYGLGVPVLPISVLKKQGIEKLIEKIQESAKKRPSIPVPCTYDPRLEAALH
EIEDVLGEQSGKKRWYAMKYFERDQKVREDYEIAVSQQKEIEQLIQLTEKLLDDDSETIL
VNERYEFITQLCTLCVVSNDSFQLSMSDKIDQIATNRWLALPIFAFVMWLIYYLAIQTVG
TMGTDWINDTLFGTWLPEHVGRLLAEWQVAGWMQELILNGIIAGVGAVLGFLPQLIILFL
CLSFLEDCGYMARIAFVMDRLFRKFGLSGKSFIPMLIATGCGVPGVMASRTIENEQDRRL
TIMVTTFMPCSAKLPIIALVAGAFFPHQSWVAPSAYFLGMTAIIFSGISLKKTRLFAGDT
APFIMELPAYHFPQWSAVLRQTYDRSKSFVKKAGTIIFVSSIVIWFSSSYNFYAQPVSED
QSILAFFGRILAVVFQPLGWGNWQGTVAAITGLVAKENIIGTFGILFGHAEVSENGREIW
QVLQHTYTPAAAYSLLAFNLLCAPCFAAIGAIHREMNAKKWTWIAIGYQCGLAYLVSFVI
YQLGHLLEGGQVALGTYLAILLMIGLVYVLFRQPKSKNQFYTILSLEGEE
>FECAFAII_00977 hypothetical protein
MATFLLSVLIFGSAGAIVYTRLKSGKNCDDCQTACPVKKEQIKR
>FECAFAII_00978 hypothetical protein
MSGKKKIVRPRYQQIAVDLAERIVENRYKVGEKIHARSTLASTYNASPETTRKAINVLVD
LGIMEVRHGSGAFVASKEKAKDFLLQYQDVQSIQDTKAEIMASVEKQQDELNHFSQLLDQ
LVNQTKRIHKMNPLLPFELSLSEKAMHLDRSISELNIWQATGATVIAISHNEELLVSPGP
YAKFTAGDIVHFIGNEYTLQRMTNFFYPEHQLAE
>FECAFAII_00979 Glycine betaine transport ATP-binding protein OpuAA
MVKVEVKHLTKIFGKKTQAALDMMNDHQPKTEILKKTGATVGVYDVNFDVKEGEIFVIMG
LSGSGKSTLIRLLNRLIEPTSGSIYIDGEDVSKLSKEELREVRRHKINMVFQNFGLFPHR
TILENTEYGLEVRGVPKEERQEKAEKALENSSLLSFKDQYPSQLSGGMQQRVGLARALAN
DPEILLMDEAFSALDPLIRREMQDELLDLQANVQKTIIFITHDLNEALRIGDRIALMKDG
EIMQIGTGEEILTNPANDYVREFVEEVDRSKVLTAQNIMVPALTTNIESDGPNVALTRMR
NEEVSMLMAVDRKRHLKGIITADQALEARKQKRPLIDFLDENVTVIGKDMVVSDIFNIIY
DSPTPLAVVEDGKLKGVVIRGSVIEALAETSEVSEHE
>FECAFAII_00980 Glycine betaine/carnitine transport permease protein GbuB
MNNLLNYQLPVANWVENITEWFTTTFSGLFSFLQTIGQAVMSGITNLLLVIPAPLFILLL
TVAAFFISKKRPGLTLFTLIGLWFIYNQGLWNDLMNTVTLVLLSSVISIIIGVPLGILMA
KSSKAQSIIKPILDFMQTMPGFVYLIPAVAFFGIGMVPGVFASVIFALPPTVRFTNLGIR
QVPKELVEASDSFGSTSRQKLFKLELPLAKSTIMAGINQTTMLSLSMVVIASMIGAPGLG
RGVLSALQRAQVGNGFVNGVALVILAIIIDRFTQHLNQPNNKKAAGATTQKSKKRQGLII
GAVVVVILGAIGIGSFSSAKETKRINLSYVEWDTEVASTNVVGEVLKQMGYDVTMTPLDN
SIMWKSVSNGESDAMVSAWLPKTHGSQYAQYKDQVEDLGANLTGAKVGLAVPAYMDVNSI
DELTDQAGKKIIGIEPGAGVVTAAENTIQKYDNLKDWKVETSSSGAMTVALGQAIKKHEP
IVVTGWTPHWMFAKYDLKYLEDPENGMGSEEQIHTMVRKGLKEDQPEAYKVLDNFHWSEK
DMEKVMLEINNGKDPQQAAKDWIKENQELVESWKK
>FECAFAII_00981 Bacteriocin piscicolin-126
MKHLKILSIKETQLIYGGTTHSGKYYGNGVYCTKNKCTVDWAKATTCIAGMSIGGFLGGA
IPGKC
>FECAFAII_00982 hypothetical protein
MEQFQGSAKMKKNAKQIVHELYNDISISKDPKYSDILEVLQKVYLKLEKQKYELDPSPLI
NRLVNYLYFTAYTNKIRFTEYQEELIRNLSEIGRTAGINGLYRADYGDKSQF
>FECAFAII_00983 hypothetical protein
MEEKNRLNAKQCSDQELKKIKGGAGTKPQGKPASNLVECVFSLYYLSN
>FECAFAII_00984 hypothetical protein
MQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEGDTIVGIHHKSAVITLVER
LSKAIIALKPEGRKAVDIENSINEWLQSVPKNLFKSITFDCGKEFSNWKSISNTNDIDIY
FADPGTPSQRGLNEHSNGLLRKDGLPKEMEFNQVNQGFISSVASKRNHIPRKSLNYQTPL
EVFLSYVNGKFCLA
>FECAFAII_00985 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIVAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYIEKRSTEGWTPDVIIGRAEREPSLVQ
>FECAFAII_00987 hypothetical protein
MEKMRQQLMEWGKELETFRLPHWEELPDLELYMDQVRTLVDRYLSPVIQGEKHPLLTSSM
VNNYVKLGLIPAPVKKRYNKEHVAFLLAITTLKQVLTIPEIKEGILFQGKTVGIREAYNL
FCDEQEAAVWMVSQLAQGKSHPQKFDQATPVEYIAVRAATLSFAMKLLAEKTIVLETEYL
KEEKTNEKQ
>FECAFAII_00988 DegV domain-containing protein
MKNNKIAILVDSGTDVPEELIKKYEMYMIPLKIIYKDQVYTDKIDITSEEIYQRLPEEIP
GTSLPDGESITEIFEQIKKDGYEKVLAVTISSGLSGTYNVVRLIAQQQEELEAYVLDTKN
IGIGAGFSAIQAAKWLEEGVEWDQLISNLNELVERTKVFFNVATLEYLQKGGRIGLVASI
VGTALKLNPIISCNEEGIYYTVGKARGRKKSLDKTVAYVKEKIGNAKVFNLAVAHGDAKE
EAIEMEARLKREFPQANQIYFGQISPALVVHTGPGLLGVGVQVLEG
>FECAFAII_00989 Transcriptional regulatory protein WalR
MKKVLVVDDEKPISDIVKFNLAKEGYDVYTAYDGEEALEKVAEVEPDLILLDLMLPKMDG
LEVAREVRKTYDMPIIMVTAKDSEIDKVLGLELGADDYVTKPFSNRELVARVKANLRRGA
TAAKEPEEAAPAELTIGDLTIHPEAYMVTKRGETIELTHREFELLFYLAKHLGQVMTREH
LLQTVWGYDYFGDVRTVDVTVRRLREKIEDNPSHPNYLVTRRGVGYYLRNPEQE
>FECAFAII_00990 Sensor histidine kinase WalK
MKRKVRFFRSVNFKIAITFILILLISIEIIGAYFIRGLERSTINTFIKDMNQTVESLATT
ISPELNRKDNADDEEVNANIKRFIENSATSDIIEIRVVDEKGIIRGTTDVNEQSAVGKKN
DYVDINDFTTKRYVALDNDDKRVNINVQPILSPTGDAVIGALYVKSNIEQKYSEINNTAV
IFFTASLIAAFISMIVSVLVARSITQPIGEMREQAIRIARGDYSRKVKVHGQDELGQLAD
TFNQLAERIEEAQDTMEAERNRLDSVLSHMTDGVIATDRRGKVITINDMAVSLLDIKNEE
AIGQSILTLLDIEEEYTLRKLLEDPNEMVLDRSTSTLESDQMILRVDFSMIRRESGFISG
LVAVLHDVTEQEKTERERREFVSNVSHELRTPLTSMRSYIEALSEGAWKDEEVAPNFLKV
TLDETDRMIRMINDLLNLSRMDTGNTQLQLEYVNFNELVNFVLDRFDMMVGNQEKNYKIR
REFTQRDLWVEVDTDKIIQVVDNIMNNAIKYSPDGGTITCRLLETHNNVVLSITDQGLGI
PKKDLNRVFERFYRVDKARARAQGGTGLGLAISREVIKAHRGAIWAESKEGKGSTFYISL
PYEPYEEEWWE
>FECAFAII_00991 hypothetical protein
MRISEKVVRIGLILMVALSIYFSYAIWLSPAGKSSINVDETNTQMIESQSNRKTSEVFLP
LHVTWHHSGMIQETNSENLVYRLQLIIDKARFGKLSEVVSGDKSQFEQVKNLNSGFELAY
NAPFLLREYKEAFDLDLDVSNLAKESENMYFTRIQFDQGNKKIRFLNYSNHLVYEANISL
NWTDINKELTAKDTKWTEMTTEPSTIDTQYATKHSIKLKKYSYILSQQPYTLFRNAFFQK
PDSVKNNDESNELIFYGGNETMSIHSETQVVDFRGELPEKKENASVFSESFPYISKLGSS
LGNLRYFDRSDNTIDYRIFVEGFPVFGTDSRGQIGVEVGGETNGSVQVNIQTSLNTIQVP
IPSDEEVELASTNEIIQQLKAKGADSNKIGSVIVGYTWQNVKETNRVVDLLPEWYVKYKD
NWYSANDLLEKLPGLEAN
>FECAFAII_00992 Two-component system WalR/WalK regulatory protein YycI
MDFKKIEWIFFVAFLGLNVFLFSSYHDAVYQENNVIRSNQTESIQQRLASDDITYTGKIS
SENKQGYYLSAEQTNLSTSLANYRKAGKSGLLASGVFLDGDVLTKSLSSSDAEKNVIDPD
KISSSLEDFLSNKDNILFGNDYVYTKNFSHLEEEPLEIQASQEYEGIPFNDDTAKIVLSL
EKNDNDYSITKYMQTHLSDIEQLREKTELYTEEEAINTLYINNKIPRGSKILWRQLAYSC
ILKVREKNVYVPVWHVAIETSDKVVQIESVNAFSNTIVTNNTVPKVEDQ
>FECAFAII_00993 Putative metallo-hydrolase YycJ
MAEEKPAFKISILASGSSGNSLYIESEKKRLLVDAGLSGKKITSLMAQIDRTPDQLDGIL
VTHEHRDHIHGVGVLARKYHLDVFANQQTWEAMEPLIGNVPVEQKHLFEMGKVRTFGDID
IESFGVSHDAAAPQFYRFHKENRSFVMLTDTGYCSDYMRGVIENADGYLMESNHDLEMLR
MGPYPWNLKQRILGDRGHLSNEDGALVMTDVIGNRTKRIYLGHLSKENNMKELAHLTMEN
VLKEKDFGVGHDFEIYDTDPDEATELFSI
>FECAFAII_00994 hypothetical protein
MKIALIGATGHAGSFILDEALSRDLDVTAIVRHPEKLPSDVPFIQKDLFELTTTDLASFD
VVVDAFNAPKGKEEMHQTSLSHLIEMLEGTDTRLIVVGGASSLFLDTEKTTRMIDQVPKN
APFYPTAFNMYEGLLKLKQSKNLHWTYISPASLFDPHGKRTGTYLLSDDYLQRNAAGDST
ISMADYAIALVDEILDEKHEKQHISVVSR
>FECAFAII_00995 PTS system oligo-beta-mannoside-specific EIIC component
MKEWLDRAFLPMITSVVNLRPLTALRNGMTYTIPIIIVGSLFFLFAHFPVDYIAQWIDKT
GFSMYFTQVYQATFDVIAFWIVFAIAYAYAKEEDIDRLPVGITALSAYLLLIQPLNTQID
TVWTGAEGILGAVTTGLIIGWGYARLVRLAKGWKQREKIPENVWQSFTSLIPIIVIVTFT
LIGSAVFQQLFRMTVVQGVWTYVQLPIQSFIDTLFGVLLLGFFVPFLWLFGLHGSAMVNG
LVSPVLQANSLANAEILASGQELTVANGGHIVTQQFLDQFMTVTGAGLTLGAVFFMTVFA
KSKKYRELGNLALLPAFFNINESIIFSTPIVMNPMMAVPFIFAPVVSGLITYSALYFGFV
PLFTAVQVPWTTPPILSGFLVGGVPAAILQGIVLSISFFIYFPFLKKIDSANCKKERQTK
NDGAAEKMND
>FECAFAII_00996 hypothetical protein
MSLKKYSFLSIFCYGLIFISPLILASIGLVKSTSELITATAVMYILGAVVLAIFYFKQRE
PLAIESAVKKASAPKIVIYGLVGIFVALILQSIAVMLESVLFGKATPSENTQNIIQMIME
APAFILATTVAGPIMEEFVFRRSILGIISRYSNFWVGAVISSLLFAFAHNDGHLLIYFFL
GFFFSLEYKATGRIWTSMITHVGMNTLVVLVQLAVQKGLV
>FECAFAII_00997 10 kDa chaperonin
MLKPLGDRVIIEVAKEEEKTVGGIVLASAAKEKPQTGTVVAVGEGRLLENGEKVPAAVKA
GDQVMFEKYAGTEVKYEGKEYLIVAGKDIMAIVE
>FECAFAII_00998 60 kDa chaperonin
MAKELKFAEDARAAMLRGVDKLADTVKVTLGPKGRNVVLEKSYGSPLITNDGVTIAKEIE
LEDHFENMGAKLVSEVASKTNDIAGDGTTTATVLTQAIVREGLKNVTAGANPLGIRRGIE
LATKAAVEELHNISTVVDSKEAIAQVAAVSSGSDKVGHLIADAMEKVGNDGVITIEESKG
IETELDVVEGMQFDRGYLSQYMVTDNDKMEAVLENPYILITDKKISNIQDILPLLEQILQ
QSRPLLIIADDVDGEALPTLVLNKIRGTFNVVAVKAPGFGDRRKAMLEDIAILTGGTVIT
DDLGLELKDVTIENLGNASKVVVDKDNTTIVEGSGEKEAIEARVQLIKNQIAETTSDFDR
EKLQERLAKLAGGVAVVKVGAATETELKELKLRIEDALNATRAAVEEGMVSGGGTALVNV
ISKVSAVEAEGDVATGIKIVVRALEEPIRQIAENAGYEGSVIVDKLKNVELGTGFNAATG
EWVNMVEAGIVDPTKVTRSALQNAASVSALLLTTEAVVADKPEPAAPAAPAMDPSMMGGM
M
>FECAFAII_00999 Tyrosine recombinase XerD
MWVEQTKDGRFKFIERYVDPYTEKTRKKSTTLTSNSPQAWKKAQKILDKKIKEALEDYNK
SDITFGELYKEWYEYYKQHVKRTSYLKVPMMMKHVSKHISDDTIVRNIDETLINKIIEDM
YTFGDLSLNYTKQTKTTLSVMLNYAIDRKYIQRNPALAVKIHPKKVEEEKRRLSMNKKYL
EKEEIDQILKQLYSNPRRKLHGIIAEFLYLTGLRYGELLALQMKDYEDGKISINGTLDYT
SVKMDNAIKTTPKNTYSQREVQLPNRAKELIESVIADNILAGRPTDPDQYIFISTSGTPL
ALHSFNAILHKVEEELELEKSLSSHIFRHSHVSLLSELGVPLKAIMERVGHSDANTTLSI
YNHVTKRAKQQVIDKLNSL
>FECAFAII_01000 hypothetical protein
MEKNLGQHIITCKNCGSNRVSVTSPRSNGCMLFFIGLMLLSFGFWIPIIGWLIMIPLGGI
MMLLSFFVPLLQKNYSVTCKACDNKFEVSKKQYQKYIKEIK
>FECAFAII_01001 hypothetical protein
MYLKLKEMLSEYNLKLIYMEMEEPGFYYPKPRIVFLNEKLHEDSSEAFHLAHELGHFIAS
HFEYSVLYDNSTTFHSKFETEADKIAIMILLNIFIENELTDETQFKLENFMKFYSINNKL
RTECFNVCQSYFKKKYSYAQ
>FECAFAII_01002 hypothetical protein
MITFERIKELAKKQGKSLNKVEEDLGYGKNVLYRLKNSNPSTERLQEIADYFDVSVDYLL
GREEKEAPKHVDLSEDDTVFSFDGKEISKETMRKAIAIAKALEENE
>FECAFAII_01003 hypothetical protein
MENKKTGLITVEIIGIDDATKKAERYIELLKEAKTLADELASKEFEIEIKQD
>FECAFAII_01004 hypothetical protein
MSRKTSVKISGDLEKIIKSEANKILKKGVDYTCPSCGKKIKISSGKNKCKYCGAEIDFKG
KV
>FECAFAII_01005 hypothetical protein
MKISIEAKPQEIAELLQAIGSSKEHTKRKHPESKIEYDPQTGEGKLIPQNK
>FECAFAII_01006 hypothetical protein
MKDYKLDFQSELPIEFVNEFKIEAPDKTRTLFTFNHDMILQEFEDDTVICVARDSEFLTI
YSNRKFNQTIPVRSKKVIIYFEE
>FECAFAII_01007 hypothetical protein
MNTPQIFNFEQNEVRTFLENDIPYFVANDVAKTLGYKNPSDATNKHCKKAVKTWGSDSLG
RRQSFKVIPESDVYRLIIKSNLPSAEKFEAWVMEEVLPTIRKTGSYSNVPQSFAQALRLA
ADLEEKNQLLEQQIAEYEPKISYLDTILSSTDTVATSQIAADYGMSAIALNKLLNELGVQ
HKVSGQWILYRKHMNQGYTKSHTSEIPKADGGTKVVMNTKWTQKGRVFIYNLLIAEGYYP
QMDLEEIG
>FECAFAII_01008 hypothetical protein
MTDIAEITQRDREKIKEYVESSKFLTYTMLAERFGISKSYLSLILNGKKTSAEANRIIDS
IITMYEL
>FECAFAII_01009 hypothetical protein
MKKPTLSELIEATEKAANPDDWYRQSLILEKFHGMSKTTLVEYCKEMETIPEFSEGIVRP
GHSTTFIHYHTFIWFLKWKDANKYRVKILSPSDVLKEAS
>FECAFAII_01010 hypothetical protein
MKITVPDELIADELTEQIVRKVLDALDERLKVMNKSVELPPYPNKSEVKKVLGIGDDKLT
HWINLGLKTQQWSKLDIRIERSELQRFLKENFEF
>FECAFAII_01011 hypothetical protein
MSYTLQQEHQILGLIKQRRKQLQDDRAALRKADELSDRQAELIASELEDLRMLEIKNREI
RL
>FECAFAII_01012 hypothetical protein
MKKTDTLFIGFILGLLVIVAHQSIIGGSLFAALMVLINLLDSKERSNYGTRRSAKNR
>FECAFAII_01013 hypothetical protein
MAREEALKIGKVIADNWWANSRPIILSKQHIDKQKAWQQIKSDSAGKH
>FECAFAII_01014 hypothetical protein
MEKELSTLDQYLIDPDWGKPKIEETSGRKIRCNLLTDEELACDQDDLGNFVSIWDHVYLI
HLSKHSNKPEYIYVIEDGLIDALEEYDRDNLIDISYYGPGKKYIAEMEAEFDE
>FECAFAII_01015 hypothetical protein
MSEIKGTTNFEKLFSRKLNKILKKKGNFDYLSWAHAWEIMKKNDPQATVTINEYKHYRVV
SGTHQDFLVEEYKPFLMDETGTYVSVSVTVKGHTETELFPVLDYRNQPVVKPNAMQINNS
LKRCFVKALALHGLGLYVFQGEDIPTPPRIDTKKLNMLETILEAFNEQMGKDMTKTLIEY
VNEQTDKLGLLADNVETIEQLSYEQCALMERAIAAKRKELDKK
>FECAFAII_01016 hypothetical protein
MFKPLIDSYSAVLKKFKGKDISATINEEVNIDRLKTMYDGYDGDRVIEIRFIDPRRFTVQ
QRNFIYALIGDIFIDTGMPTDFWKEFFYFRFEGVTGRKISLKDESSTTVSDANILANIIL
DFIFEHDIPFKNGYEILPQNEQYFFYKCLTNRVCCSCGKKNADIHHVDSVGMGNNRKKIN
NSGRRFMALCRECHTKIHVEGFTTFTTKRKLTAVVLKDSDLKRLGLNIIE
>FECAFAII_01017 hypothetical protein
MDIEGYEGVYQVSSLGRVKSNRPNYVINKGYVNKEGFIMKPSDNGKGYQIIFLSGKGFRD
RRYVHRLVAFHFLKEAYFEGAEVNHKNGDKSNNTVENLEWLSSDDNKKHARKNGLTNLKG
PSKLTDLQALAIKRLYTNKLMSSGEIMKLFNVSRHTVLNIASGKTFSFLED
>FECAFAII_01018 hypothetical protein
MADNKRYYYLKLKENFFDSDEMVLLESMPDGYIYSNILLKLYLRSLKHEGKLMFNDRIPF
NSTMLATITRHSVGVVEKAVQIFRDLQLIEVLDNGAIYMSDIQSFIGKSSTEADRKRKYR
KEIEEAKQNLITSGQMSDKCPDKTTPELEIELEKDIELEKDIENVTPPKKSKAKPIRHKY
GEYKNVLLSDEQMEKLKTEFPNDYQERIERLSEYCESSGKTYKNYLATIRSWARKEKSEP
KNASGAYKRTGRREKLPEWAIDQEAYQKKKALERANRQSKAPF
>FECAFAII_01019 hypothetical protein
MKIDYLELINEIASYKTGEEIEILRDVYEQLDEAGIERIKNDRSSWSKLRYYFALYIDAT
QLRNLAYTKLLFADCVKGLQKHLSELEQV
>FECAFAII_01020 hypothetical protein
MDLKTFTAQIELMHQEALRQSASYEDKWLNTFHGGRESALDQVLKLLKGECRDE
>FECAFAII_01021 hypothetical protein
MNKKAAMQRIIELTYSEDWQNDKEAASEVMRLGRAMWADKSNKPRPRKIAIWHGDKLLVT
GTAEQLASLTGLHEKIVRKRARCGYTDVKKRTFRYVEGSS
>FECAFAII_01022 hypothetical protein
MTTEEVIQMRIRNIQREIDDLERTKAVMVNETARKAIDLHIENLRREIRRLEE
>FECAFAII_01023 hypothetical protein
MSVDKKAAMKRIIELTHSENWQEDKEIVAEVQKLGKSMWTEKPKRKTPRKIAIWHGDRIL
VTGTAEQLSEITGLSKNIIWDRARSLWIDSKGRQFRYVEEKKC
>FECAFAII_01024 hypothetical protein
MLDMKIEDYRITSDSRNIVLSKVRRDEEGNIRYTEAKEESRADIGYFQTVSSCLKAIQRD
YVLSEERTIKSIIEYKKALENITRQFEQACEIEEEK
>FECAFAII_01025 hypothetical protein
MDELITKVEQWAKDKRLDQADPKAQFLKVAEEFGEIASAMARSNDELFKDSVGDVIVTLI
ILSMQKGTNVQECLEMAYNEIKGRTGKMVDGVFVKSSDLENSE
>FECAFAII_01026 hypothetical protein
MMMPKEIYSDALRGARNQLKMAKRTYEIRPTIENERRVKAIRRRCSIYGELQKEDSK
>FECAFAII_01027 hypothetical protein
MIPRFRAWDKKTETIQEIESISFKEKKLVIDQKSVTWFNSDYIRNSDEVELMQSTGLKDK
NGVEIFEGDLVEHDDNLNGDWETFEACEVVYDKDYAQFCFKWDAGNFLTDYRNLNVIGNI
YENSELLEEQR
>FECAFAII_01028 hypothetical protein
MNKQEAIKKLESIKAIGNDAIAACYNESINSGITLMKKIDEPQKPVIPQLVAGWLEKSTD
PFTKAEKIAYLIKSKDGDSYYFCDWFVRDGIVTQEQGEELLAWATRQSYETLLSLYNGYE
VEKEPLWAIKNADGNYLTKCALWGKDGVNYSFECNPSHRLLFTDKATADAAALLVNGTVE
EVVER
>FECAFAII_01029 hypothetical protein
MKLKDGFYASSHGIGGLMLDMPTKNPKTRKKSKFKVGDMVRCEAEEFVYPFRGYVKKILS
NSAIIRIENTMKCDRSTAKHKHYLAVARLVDMEVIKSK
>FECAFAII_01030 hypothetical protein
MQLLREVDFKQTRCNARDVLKNFRRLERMAGRSLIDIKSPIITDMPKAPKHGNKAEDAII
QMMDIETERDAILAALMALSLISRQILYYSFCVPDSFSNYRISREVGYSERSIQRMKSEA
LIEFAEAYKHGKIIAYK
>FECAFAII_01031 hypothetical protein
MKLSVEGTPEEIQELLQAIGSSKEQKVSVSNSDIDGICNCLNREKISNPY
>FECAFAII_01032 CRISPR-associated endoribonuclease Cas2
MYKPYMISYDLNNPGQKYDKVFEIIKEFGAYIKLQKSFWLVKTNLNPNQMCEKLNTVLDN
NDSLFICELQKNYQGRATEENWKFINEHIFS
>FECAFAII_01033 hypothetical protein
MDKEIKVTVKLDLTELKELLNKASDQVEQIKYQGMDRKRLIDIIEQQRLELIQKEAVCKE
YKKHLEQVIEYHSVEKYRSVVQKNRATSPDPRQDVSISIKTPVFNSVKSEKLESISTALV
EKAAEMNSLANEVSRLI
>FECAFAII_01034 hypothetical protein
MYFVIREATNGQYYFVIKSNNNEVVATSETYLTKYSAEQTINSIKNGITEDSQVIDMTK
>FECAFAII_01035 hypothetical protein
MRNYWYVSLSNKYPQPNADDPIRVVQSVQIKKKYSIVEMTREATPNEIDKCKLIYCGHGY
FSEQNIQTNIKKYH
>FECAFAII_01036 hypothetical protein
MSKLNPKQQAFADEYIITGNAYQSALKAGYKENYAKNAQEKLVEKGGKVSDYIQEKLKEV
QTKRHLTMEEALAITASIAKGEPQRFEVVKRDPYTNEIIEREVSEYSAGFKERNQALEHY
YKINAAFVDKQKVEISEIPTFIDDISSDDDG
>FECAFAII_01037 hypothetical protein
MMAKKLSEFLPPKFHSVWRATLNQDILNIVCKGGRGSGKSSDIAHIVTQLLMRYAVNAVG
IRYVDNTLEQSLYEQMKWAIEQQGVSHLFKFNKSPLKITYLPRGNYMIFRGAQNPERIKS
LKDSKFPFAIGWIEELAEFKTEDEVTTITNSLLRGELDDGLFYKFFYSYNPPKRKQSWVN
KKYETSFQPKNTFIHHSTYKDNPFISKEFLSEVEAARARNPRRAEWEYDGKAIGSGVVPF
DNLRIEAGSITDEMVANFDNIRQGLDYGYATDPLAFVRWHYDKKRNCIYAIDELYEVKCS
NRRAAQWIKSNKYHYQDIIAEVEPKSNAEMRNEHDISKIRQVTKGPDSVEYGEKWLDDLD
AIYIDPIRTPNIAKEFENIDYQTDRDGNPKPRLEDKDNHTIDATRYAFNDDMRKQPEPVN
VKKTIDTFKKLGL
>FECAFAII_01038 hypothetical protein
MEQNIQLLGQQRFDEEANLVYKVPVSQLPKIDMLDQQTGEVSEFINFKHEDMWKMIVGFI
KHHRERQVPRLKELKRYLNADNNIKRRPNKPDGRADNRIASDFANFIVSFKQGVLLGNPI
SYNGDKVIVERINRFASESNEDYHNQLMSRDAFGLGRAYEWVGRDEYGKETIAKFDAEQT
FVIYDNTKDRNSICGVHYFVEKFLDKSFTRIELYTNCGYNYYFTAKDDDLENAVLDEDGE
VQSYFDTVQINEWINNEERTSDFEHVMDSIDAYDLSRSEMANFQQDSSEAYLVIKGNPDT
ADDQEGDNSKLAVFQAMMQARMLVLGDKKIYDNNVAGAEPDAYYLKKEYDVAGMEANDSR
TVADILRFTSLIDFTDENIGSNQSGIGFRFKGWGSDNDRKNKERMVKKAIMRRLRLLTHS
WSIKDGLDKPRGLIDTVKAFFVSDEKQQEQLYNKVNEIQIQFTPNVPQSDEEIMSVIAGM
VGIVSDQTLCEMAERLTGVPFEEELKRLKKQAVSGVFDSDKETDTEVEEDESQRTDDEPV
SEEG
>FECAFAII_01039 hypothetical protein
MNLKEQMMNQYQKKDSEKIKDAIAEAMKIGRNEVLYGKDVITDDIRKEFQDGGFTVEDYE
DKHTIDAKIELVRFSW
>FECAFAII_01040 hypothetical protein
MKARKKPVTVEIVQLKMLSARSYRKCKEFVGEAWVDHNNMPNGLPGIETLEGTMEISDGD
YIIKGVHGEFYPCKPDIFLETYEIIEE
>FECAFAII_01041 hypothetical protein
MKSQDYFIKREKAWQEQQIKDDKKRMNEIKKRLQYAQDAIQKEIDAQWDSFSNGQKITRS
EAMKRADEMDVKAFARKAKKYVKEKDFSPTANKELKLYNLTMRVNRLELLKANIGLELIA
TFNDMDKYFSGELTSAGLKELQRQAGILEMTIAKSGYAKLVEQVINSSFRADGFATFSER
LWMYQAELKADLDKLLVRSVTMGRNPKQLAPELSKFLTEEGRENTKFNTQRLMVTETTRV
QTGIQEQSYRDADIDQFVFISEPTACRYCLPLNGKVFDLKDMSPGVNCAPMHPFCRCSTA
PYVDREAFEKSLKERGL
>FECAFAII_01042 hypothetical protein
MENEEAIVRAIASLNQILQNEKVLRVSVEIDSEWEDGIKSFDISVKYLPSGDINGAK
>FECAFAII_01043 hypothetical protein
MKKRLFMPMSLQFFSEPGDGGSGDEGQQGNLPAGSQETPPEAKEENTTGKTFSRDEVAKM
IAAETKKAVTAAEEKWRAEKDEAAKLAEMDDKEKADYEKQQLEAKLAEFERKEVLSKMSE
QASEMLSEKGATPTKEMLRLIVSEDAETTSNNVKTYLASVEAEREAIKAEYEKRLGGKVP
LDGNGATISRGAQLAKNANNQTKKPENDPWAIK
>FECAFAII_01044 hypothetical protein
MVYVKKSETFKEINFLKSQQFISFTKQVDHTHAGVVNGVLPAGSVYPANDGKAEGITIND
VDVSNGAQPVGVIIDGHILIERLPVKPSDAAQKAMREIKLYDASGKMIALPAAASGL
>FECAFAII_01045 hypothetical protein
MANIAELFSQRNVLDYVNNRQAPPLLGETLFPARKVQGLEFDILKAGTRIPTIASVHAFD
TEAEIASRVASRSAQELAFIKRKIQLKEKDLIALRNPRTAEEQAFLENEVYNDVFSMVSS
VNARVEKMRMEVLANGTVTLDENGLDLVVDYGVPSEHKATVDFAASSTDVIGLLTTWAGT
LDTTPTRILTSTKVRNAILQNAGIKAYFKDAGLLPTAGTLNQLLQQFGLPIIATYDAKYY
KENAQGVLVKERYFPENKLVMFGDENPGESIFGVTPEESRLLSGGTNDYQVGNIFAMVYE
SNLDPVGTWTKASGTALPSFPEADNVFQATVLAEG
>FECAFAII_01046 hypothetical protein
MTKYKVAKVFIDVHTKETYKVGQEIDLNKERFDEIEKNLEAFGGGFLEPIKIEEKQVKKP
TKSTKKKG
>FECAFAII_01047 hypothetical protein
MDETLEEVKRSLEVDNEELDKQLTDFIKRISSQLCVRLGFLESVPAALNYIVVECTIKRF
NRKGNEGMSSYGQEGESISYGKLLDDFEEDIFAYLKKQNGDTPPYRSVATFI
>FECAFAII_01048 hypothetical protein
MRYDTEVTFVIEKDGYYDPELGEHVEPTLDEKIKLANVTDLGTDRSKVLFGDIKQGAKVI
RLLRPYTKEWDYVLIFNKLKSKTEKFEIITERNLRLKNTFIVQEVIAK
>FECAFAII_01049 hypothetical protein
MKVSLGYKGVDELLKHLEEAVTLRDVQMVVKTNGAELTKRMQEKARFNGHWEGDVFVHPT
GFTRRSIRMWLLEGGFVAQVGPQSDYSPYLEYGTRFMSAQPFVGPAFNVQKAIFMKDMQR
LFK
>FECAFAII_01050 hypothetical protein
MIKTRDQSIFDELFKISQEKLGYKTYDYKPLDNVGYPFVEFENTQTIHEANKTDIKGTVI
VVLSVWGLQKKRKQVSNMASALFNEARLIEATEGYYWALNYQASGIQVMDDTTTNTPLKR
AVVTLEFRIR
>FECAFAII_01051 hypothetical protein
MEALKGIDVILLYRLLKKETQEAAWKMAFQTEHENGLSRDSDSTVTKDGNVQSLSPVEYD
FSATSIVAKGDSHVDEMKQALLNGDIIEIWEINKAEQGTDDNANKYKATYYQAYVSEFTP
SAAAEDNVELNLSFAVNGVGQDGYATLTEDQADVVQYAFKDTVKATSTGA
>FECAFAII_01052 hypothetical protein
MKLKIKGKEYSFKFGTKFVRELDKVMPFIDGNMEFGMGLSAKVLPELRSYNVNTLSRVLE
IANRTEEETITLDEMDDYIDEVKDIEKLFDEVLKELAESNAGKLAVRNLNQKLKEAEKQQ
AE
>FECAFAII_01053 hypothetical protein
MTNISDIERMTLYEYNIRMTAAQLSWLDKEKLIHELAWANQQVQAEKKVGKKTVPVYRSF
EEFFNYQKIEDSIMGVSELSKQDKKFQSLLTKANS
>FECAFAII_01054 hypothetical protein
MEQFSVEALLKATDSGFVKTFKDAQDAVKTFEKNSNSMTTAVGKVMQGTGAAMTKYITTP
LIGVGVAAAKVGGDFEEQMSRVKAISGATGKSFDELRQQAVDLGAKTAFSAKESAAGMEN
LASAGFSAQEIMKAMPGLLDLAAVSGGDVALASENTATALRGFGLEASEAGHVADVFARA
AADTNAEVGDMGEALKYVAPVANSMGISLEETAAAIGIMSDAGIKGSQAGTTLRGALSRL
ARPTKAMQDTMDNLGVSFYDADGKMKPLKTQVELLKKAFEGLTPEQQQNALVTLYGQESL
SGMMALIDKGPDSLGKLTKSLKDSDGAADDMARTMQDNMNSSIEQMFGAFESAAIVIQKI
LAPSIKKVADAISGLVEKFVSAPESTQKLVVAIGAIVAAIGPLIFMIGSVIIWINRVKVA
FKALSESSKLFSGLSKAMGLLTNPVFLVIAAVALLVVGFIYLWNTSEDFRNFWIGLWEGI
KSAVSSAVEWIQNAWKSTGEWFNNLWKSIKEGADNVWTTIQEAPGKVADWIKNKWTETKE
FFSNLWSSIANSASEMWNSLKEGVISVIDDLVSSAGEKWEGFKNTISTAWKTITSKIKSG
FDFILKYIGPFVSSFSDVFSNIVKAITSIFAEVKNIIVNAWEIIKSLIAAPLLFIIDLIT
GDFEQMKEDLDLIWNTLVQSVVNIWTSVKNIFTEYIGAIVNSAVSLWTGFIQSISNIWNE
VVYQATMIWIDLKLFFTNLWIDIKYSAIQMWINLKFSIIQTWIDTKYGAIELWNNLKQWF
FQTVNNIVQTLIKSWNSLKQGTIDLFNNTVQGAKDIWTSFKSWIGDLITGTKDNVIQGWK
NLKQGTIDTFNNLVNGAQEAWDNLVNAVSDTVDRVTGWFDNLKNIDLLAAGKAIMDSFLE
GLQNAWKSVQDFVGGIGDWIREHKGPIQYDRKLLIPAGQAIMNGLHKGLMGGFNDVQNTV
GSMADFIAELFNANPDVDIAANLKNANKNIGAQVEHKVNMGGSTKPAVFKFNLGRQSFRL
FLDDIAQAMGEGADINLEF
>FECAFAII_01055 hypothetical protein
MDQRENKMYSFKDTTINLNSSKRFLPTSAMMYDGMYLEDLIEGYQTLTVEGREMLSVEVE
QQEIQIGSIITNQKIPSRTLKITYKLEDRDPEKLQFKFKELLNYLYRNEDVEIRFHDELD
YYYYGRYTSTDTVPGDSNSIISSFNVFCADPLKYTKECVSDGYIGNPIQFPITPRKIEVT
LSMNNSIKITNGEQNITITDAAIKTGDVLVFDFSDEQVTVNGEDCTSMIDLESDFENFYL
KQGQKITSNNGKLKIFYRGATI
>FECAFAII_01056 Murein DD-endopeptidase MepM
MSETIYFFDHLQKLIKRKNKRSLIEVSQEKEISSDKSDLMKDTLYVTTKYDKEIEDARYM
AIRENESSFSLYRITKVSDPSETLEFTGLGFATNELDAYIIKDIRPSGQPLKNVLDRLIE
FTEGNWRVGHVEAMLPAVTATFYYVSVKEALKELQTLGMEFVFRCSLNSDGIKDKWIEVY
EQIGEESNTRFVYGSKALTVVREIDRSSISTSMIGRGRGEEVGDGYGRRIEFTDVEWKKS
NGDPLDKPKGQNWLEDPEATQKYGIPQKDGSMRKRETVVVFDDIDDPTELLKNTYSTLID
SARPLVQFKAEITGGDVIGNTVTIHRYDKGYHYKTRIYKTTFNRLTGQTNIELGDNLTQD
VRKQTASIVNNINSLESSKMTFYESTEIGKYQDDIMRGAGDNGGSIYWVNGIEAGVSDSR
EIYETVYMDGPNIPRSRFFMVQNNSGISFKQCKKGEWQTIQDVHNGDSTTAWTLDGTFNA
NFIRAGILSGILVQGVALKTFDDKDFQLVAEGGELSFEKQVKSTGLDDVHGERLGSIVST
YGSKGINGFAVWKEPNYIFSINAGDGGDRGNPIFQIPADVTADKRKYNLYGDGNFSEGNI
TIDGRLDVKELYVNGTKIDTNGGGNSGGNDNGWNGQYPPGVTTDRDKRYWQIWATAIGAG
FTQQAAAALLGNAQGESDANPTADEGNGAPGFGYGVWQWTDSSGATSGRVYMINLMTKAG
ISDDPDTITAQFKLLMWHAPNGQWIATSAYPYTWTQFMNLTDINTAAQAFVANFERPRDP
HPERTAWSQEWYDKFKDLEIPVSKGYMKPIADPITVTSEFGWRTSPITGAQEFHNGIDLV
NGNPNTPIFASADGEVIVAGDANYFDWYGNWTVIKHADGMYTGYAHQSRVDVSKGQKVTA
GQQIGLMGTTGPSTGEHLHFQFMDEFYPSSSGHFHNARDYIDF
>FECAFAII_01057 hypothetical protein
MAETQHKMVLSTTEPNNGINLVRIRQGDVLTQKFVVEVVEHGKLKTFEGLVPFFINTTKF
GENQPVEQKVQEYSPAQARLVYTLSEPDWQWGGENTAHFSFRSLNGDGTWSEQFSTQDFT
YRVISGISRSQLRDSGYVWTFEDLLRKFKDYMDQGKNDWEQWLEDNREILENIDPGGMII
NILNEAKGDYESLADRLNQKYQVPVGSSQIRETTRFFDYDTMKYVDLVPRNLNTVVNSVN
NSKFNFSFITDIHADNHNLRIDGVGYKDASYLRHWRAIPQFQKLGNKTDVMIYGGDNIDG
GLGSLGSDIGIIDEWSARHSMLGTLKRFTNAAVAGQEKPVIICKGNHDACFDPAWRKRKG
MLCNADFEEYWNGLYGGVLFPDKNAAIYRFDTCDFYEGGTGDKYTDGYSDTAPGAFSAKQ
INAFGEWLVNVPRNYHVALVGHTPLGLSKFPVRNENMISTLIEGFKSGSPVTIDWSKLGQ
PNDGSFGGLKTFAMNTKGAGVVVGYFCGHWHEQVEGAFGTVKMILCDVGFSHTASQVDTP
DELAFYKIEVDTATRKVTSKGVGRARDFTYNY
>FECAFAII_01058 hypothetical protein
MLDFQSKPNIFEEMSYEEAVKWLLRQAAIHYDGSDHDAHVLATESNAGFATPETVMQARG
RWLRDYKLPQKYPNILDIPPGKYATKAGWGADNPGGIEDDSFVEMMVFADHDLRKLIVAF
ARYSGEIYIKMTHNSEPVEGYNSLGWRRVYTASVLFEGELRKGQSVNLPDDTFRYQTLRI
HYTDGDGDFVEEVKRQRYARITKANLWNKSAGMTLIEFELTIEARKITMSNGRALDISSG
NVSNPAMSNDVKITKIEGVK
>FECAFAII_01059 hypothetical protein
MAHVIKKGSIKVPTQPKDYDLQATGLVFKSYDNQIALEFNVEQQNGTPADLLGANLRLLM
FIYDEVDGMITKEPIPFITKNLITESFLNGQVVYILPEAMKAYNGMVEAYVYIEYPDGST
SDNLGFTFRMKRSAIDGLAQDKADYFIADFQQLLDGVKQEATDAVNEVLAKVEAVSKNVS
SAQNDLTILEDRIDQTNQQIGDLGKLKKMYSNSIDFGGYDYSGNPNLMSKLKSSDFNVGY
HGSLTSDNEKLHFTSDGTGSIIMFTRINTPQLASGKTYTLSAKVRFDEGTTGAIDKLRLV
YRTSPGEKILLEANSTNITTDDVGKEITIKGTANVNYQITNLDRFYMSISFVDRDKINGG
FKLYDIKIEEGSTATPYQPNLLDDPYWLGKAPLGENIANKSVTFPIKSSAYSLYQANMEE
EFVLGQTYTITMKATKPPIQTFIVYNEDSGDYRYGNLEPVEGLVDTWGLTFTPQKVGVNY
PKRLTIIQYPQSTTGACQIDWLKIEKGDTRTPNISQFKYFGEGLKDSNNPNDYSWDVTPE
YTEKGLNDAVNVYDPQRVEGLKNFADGIQIAGDKVISENDCTVYTLTKDNSQSFIDGYAT
FIKHGKEVIVNGTVKFKKAYAFGVPLDDEVPDEFIARIVHGMLVGSSGGNSVAKAMYVRK
DLGTIVTNSDFVVNEWFTFNGHYWVGGK
>FECAFAII_01060 hypothetical protein
MKNIWKYGRTGGEYAGQVLDDMVMTVPFTDVPPLEGIRTDGEPLTIADQMFDPKLNQWII
LANALDHNDLNNLKAMYEALEHENDNLKQLNAKLMLNNVAIKQENTALKEKADSLAQINS
KMMLASLQNSKDISEIKEQLNPASKGGE
>FECAFAII_01061 hypothetical protein
MFSFSDVKMMYDWGCFTDDQVRLFVPLCITDEEADKIISKEESAS
>FECAFAII_01062 hypothetical protein
MINLGEWGAIAGSITAIVSLILLVIRPIVASFTKITKTLSQVSYNLELLTKDLESSKSDR
LMIHEELKKHDERLDTHAEKLVEHTQQIKTLFRERRK
>FECAFAII_01063 hypothetical protein
MNNKTFEVLKWFALVIIPALATFVGLVGKALNWQYTDICVVIITGFGAFLGSVLGVSNRT
YKMFSAESEEGGNK
>FECAFAII_01064 Autolysin
MKKKITITAMSLLTALFLLPINTFAYTINDEYNLAPNQGDSRLAIPNKIILHETGIDAPA
RNVAANMKNNYNGSNSYTTDVIGDGGIVYRVGEQGYVSWGAGNANPYAPVQIELQRTYDK
ALFEKNYRAYIEYTRDSAKKYGIPLTLDQGTSLFTKGIISHLWVTNYVWGNHTDPYGYLS
QMGVSKEKLAYDLAHGFTDENPTTSENKPVIDPTRAGAANPTLTDGTNHAHIDQFGEIEN
ANLHVAGWHIANYKYEYIFIMDYNTGKELARVRADGIYRPDVNQAYNTSGNVGYHVSFNM
RNFPSKKVYVMMRATNDPEGNTKGGAQDFHDKRWYLNIPKR
>FECAFAII_01066 hypothetical protein
MSRRQRRTYSKEFKQQIVDLYLAGKPRAEIIREYELTPSSFDKWMKQAQSTGSFKERDNL
TPEQAELIALRKKNKQLEMENDILKQAALIFGRKDK
>FECAFAII_01067 hypothetical protein
MCKILNISRQTYYYQAKPIENESDLEEIVQEEFIRNRKAYGTRKLKKCLAKRGLQLSRRR
IGRIMKRRGLTSTYTIAHFKGQRTACNEAKTANVLDRTFTQEQPLEAIVTDLTYVRVGKK
WHYICLILDLFNREIIGYSCGEKKDASLVKEAFGRIPYSLTDVKLFHTDRGKEFDNQTIH
EILNGFGITRSLSRKGCPYDNAVVESTYKSVKVEFVHQYQFETLAQLRLELFDYVHWWNY
LRLHGTLAYETPIQIRQQRLAKRILDNERGSDTSGEAA
>FECAFAII_01068 hypothetical protein
MRKYTFVFKKKVVSDYLNNEGGYKYLAHKYQINRTLVRHWVRIYNYHGWEGLVGGGKSYT
TKFKLDVIEYMETNGLSIQETAKKFNIGSNRTLSKWIEQYEEGGASSLESQKRGRKISMN
SKLNIPKKLKDESLEEEVIRLRAENAYLKKWNGNTFFDKNYKVL
>FECAFAII_01069 hypothetical protein
MSYRVQLIISEDVESQQFGTNVINKVINPALSINAPLIPTALSFSVTAVVSEIEDTEKIK
IVEIEVLNKNEKQIFSTGEVSVSLPPQVNDINFNINARNVLVEEAGEHYAVVKFNGTEIG
RQIFDIKVNKPVEKN
>FECAFAII_01070 hypothetical protein
MLDIVPSNTHRSGSLINFAAIFACASVILASPVVVDASSTPKTKNDNQLVITTKNEINTI
SSNDGKIFDVINTVLKRKAEINIKYDEDLNLYFFVIKTTSELFSSDYDVLDTLDNVLSDY
KYMGKSVVATLGE
>FECAFAII_01071 hypothetical protein
MFDFNEYLSISKQIESDDKYNSKESYRRTAVSRAYYSAFKKSDEYLKENYDIIYNGSSGK
GSHQTVWNLFSTVKELNTLGIHNSGYRMLEKRKCADYIPNETITKTDMALMNREAEKIIN
KLT
>FECAFAII_01072 hypothetical protein
MLMEGKTQLWFKFDPSNRFIKDFYKVWNSEVFFLAIEDSLLINLYYSNKELFQNSCCEN
>FECAFAII_01073 Aminopeptidase PepS
MLSDFNELLKKYARLIAETGVATEKGHTVVLQISVEQAPLARLITQEAYKLGAAEVIVQW
TDDQIQREFLLHAATDRIENVPQSKIDQADEWLEKGASRISVVSADPDAFAGVDSHRVAS
YQSANGKALMNLRKATQANKVSWTVVAAAGKQWAAKVFPELPEEKQVEALWDQIFKTTRV
YEEDPVLAWKKHDEKLAKKAEELNREQFSALHYTAPGTDIIIGLPKNHLWEGAGSYNARG
EKFMANMPTEEVFTAPDSHRVDGYISSTKPLSYAGTIISGMKFTFKDGKVVDFSAEQGED
VLAKLLDTDEGARRLGEVALVPDPSPISQSGIIFFNTLFDENASNHLALGSAYAFSVKGG
TEMSDEELAEAGLNRSQTHVDFMVGSDKMDIDGIREDGSTVPIFRNGDWA
>FECAFAII_01074 hypothetical protein
MARKKTITREQILAAAYEVAATDGFTRFTARNIANKMNCSTQPIYLEFKNMDDLRQALFE
QIYDHLQYEVFTVEHTGNTIIDLAFNYIHFARREKKLYRSLYLEEYGGGKEMQNFSYTYF
VNTVKRDPAYVNLSEEQIESLYNGTWIIATGIAALMSSSIIHPTDEQIEKMIQDSIDAIL
KFKEPIEID
>FECAFAII_01075 Flavodoxin
MALAKIVYASMTGNTEEIADIVAEAFENLDIEVEINECTQVDADEFEEADICVVATYTYD
DGDLPDEIVDFYEDLQELDLLGKIYGVCGSGDTFYDEFCKSVDDFDAAFAKTGASKGAEN
VKVDLNAEEEDIENLEAFAKELVAKI
>FECAFAII_01076 Methionine aminopeptidase 1
MITLKSAREIEMMAESGALLADVHKNLRDFIKPGITSWDIEVFVRNYIESHGGIAAQIGF
EGYEYATCISINDEICHGFPRKKPLKNGDLVKVDMCIDLKGGISDSCWAYVVGESTPEID
RLMEVTKKALYIGIEQAQVGNRIGDIGHAIQTYVEGENLAIVRDFIGHGVGPTIHEEPAV
PHYGEAGKGLRLKEGMVITIEPMVNTGTWKMKMDPNGWTAYTRDGGLSCQYEHTLAITKD
GPRILTSQGEEGTY
>FECAFAII_01077 hypothetical protein
MKVWNKIKQNENLMRFIETTQKRITDSEMSTTSVVVAYYLLLSLFPLIIAFGNILPFLHI
DQETVLTYLREVIPETVYQFIGPAIKDLLTQSSGGLLSVSALAALWSASQSINALQIAMN
KAYGVENRKNFLIVRFFSLIVIVLFMIAISGVTIVLGLGQLILDAIQPIVQIPVNFIDQF
QTLKWPITLVALFVIMFLIYLIVPNAQLKLKTIIPGTIFATVGWMLLSQVFSIYARYFAT
RISGYQIIGSFIVLMLWLNFAATIIILGGIINAVVQEYVTGHQIKKRRDPSRKWFNKLKT
KFSHKKK
>FECAFAII_01078 putative undecaprenyl-phosphate N-acetylglucosaminyl 1-phosphate transferase
MLVSFSMVIRFFLTILLSLILTPVFKIISVQTGMVDKPNERRINKVPMPSAGGLPIFISF
VISTLFLFRKIIPQSYIVPILIASLVIIVTGVLDDKYELTPKQKSIGILIASLIIYFVAD
IRIDSFTLPFIGYIQLGWLSFPVTIFWIFGITNAVNLIDGLDGLAAGISLIGLITIGIIG
YFFLHASTVYIPVVIFCLVASIIGFFPYNFYPAKIYLGDTGALFLGFMMAVLSLQGLKNV
TFVSSISLLIVMGVPVTDTFFAIIRRKANRVSFSTADKKHLHHRLISLGFTHKGAVLTIY
AMALMFSFTAMVMNYTGRIGTIILIIAMLFAAILLFELIGLINEKHQFILKTLRFLGNKE
YRTQVKQKYLKKWNRHIDE
>FECAFAII_01079 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MNNKLNQPILISIVTANSDKIFRTLDNFISTVKDETAVKIRIFDNNSLPEYKKRLTEYRK
YPYIDIYFHDENSGFGYGHNHNLIASDSRYGIICNPDILVDEETVTALVLLLKEHPECAM
LAPKILNEDGTTQHLIREQLAVFDYVLRFVPFKWVKKKFDKRLAVFECRGLPTDANSYVR
MISGSFMVADIDKFKEIKGFDERFFMYFEDNDLCLSFEKAGYKLLYTPFYAVIHFYGKGA
HRNAKLFRVFLTSMMKFFNKWGWRFF
>FECAFAII_01080 hypothetical protein
MKPEILVVVVLYQQLFSQSPAYGPLSKALSEKQIQLIIYDNSPQRQQNELFEKENIVYHH
DPQNPGLAVAYNFALSQADEGTRCLVTLDQDTRLVDDYFELLRKVTFTDECVAAVPMIFS
GSRQVSPLYSDRYINRTAQAVEVEGPTAERIMAINSGVAWSVKFLKKIGGFNPAFSLDFL
DHWLFWKVDQLEKTVEILPVRMEHDLSVLDYEKVSSNRYRSILQAENRFYHEYDQRHLSS
HRRQLLLRTAKQFLTVKNRHIWRMTLRSYVKNWKV
>FECAFAII_01081 Putative glycosyltransferase EpsH
MRSVCIATFNGGRYLREQLDSILSQLSAEDEVVISDDGSVDDTWDILTEYAEKDKRIQLF
SGPRQGLIANFGYAIQQTKGDLIFLADQDDVWLETKVKKITDYFEQNPDQLVVVSDLIIV
DSELQEIHDSYFSFRNSKEGWLNNVIRSHYIGAGMAFRSSLKPDILPIPSEVPMHDMWIG
LLGGKKTGFLREPLTLYRRHDLNASEIETHSKLRQKISWRVHLITALIKRKWFKR
>FECAFAII_01082 Glucose-1-phosphate thymidylyltransferase 1
MKGIILAGGSGTRLYPLTKATSKQLMPIYDKPMIYYPMSTLMLAGIKEILIISTPQDTPR
FKELFGNGNDLGLQIEYAVQESPDGLAQAFIIGEEFIGDDSVCLVLGDNIYYGGGLSKML
QRAASKDTGATVFGYHVNDPERFGVVEFDENMQALSIEEKPAQPKSNYAVTGLYFYDNEV
ISIAKGIKPSERGELEITDVNKAYLDKGKLSVELMGRGFAWLDTGTHESLLEASTFIETI
EKRQNLKVACLEEIAYRMGYIDKEQLLALAQPLKKNQYGQYLLNLAAE
>FECAFAII_01083 dTDP-4-dehydrorhamnose 3,5-epimerase
MKVTDTKLTDVKIVEMDVFGDHRGFFTESYSKAKFAEHGLKYDFVQDNHSLSAEAGVLRG
LHFQKGEAAQTKLIRVVTGAVLDVVVDIRKGSPTYGQWDGFILSEHNHRQLLVPKGYAHG
FVTLTPNVNFLYKCDNYYNAEADGGIAFDDPDLAIDWPIDPSRAIMSEKDHRHPTLKEFE
AENPFVYGEI
>FECAFAII_01084 dTDP-glucose 4,6-dehydratase
MKNIIVTGGAGFIGSNFVHYVVNNHPEVHVTVLDKLTYAGNKENLAGLPSDRVELVVGDV
ADAELVDRLVKEADAVVHYAAESHNDNSLKDPFPFVQTNIIGTYTLLEACRKYDVRYHHV
STDEVYGDLPLREDLPGHGEGEGEKFTAETPYNPSSPYSSTKAGSDLLVKAWVRSFGLRA
TISNCSNNYGPYQHIEKFIPRQVTSILSGIRPKLYGEGKNVRDWIHTNDHSSAVWLILTK
GRIGETYLIGADGEEDNKTVMELILEMMGQPKDAYDHVNDRAGHDLRYAIDSTKLREELG
WQPEFTNFRDGLADTIKWYEEHEDWWKKEKEAVEAAYAKNGQ
>FECAFAII_01085 dTDP-4-dehydrorhamnose reductase
MFLLTGGNGQLGTELRHLLDEKNLPYVSTDAKDLDITDAEKTMAYITELKPDVIFHCAAY
TAVDKAEEEAKELDEKINVDGTRNVALAAKAVNAQFVYISTDYVFDGKNKNVEYEVDDQT
NPLNEYGRTKLLGEKAVEEILEDYYIIRTSWVFGIYGHNFVFTMQRLAETRDKLTVVNDQ
FGRPTWTRTLAEFMVYVIEEKAPFGIYHLSNENSCSWYEFAKEILKDTDVEVAPVTSEEF
PQKATRPQYSVMSLKKTEALGFVIPTWQEALAQMLEAAKKMNK
>FECAFAII_01086 hypothetical protein
MEKQTRSARRKEKPKANQADSNLVLDLFLKLRYLIGVLVIVVIVTFNLNGSSLGVWDKYV
SQRDDGKKTDVIFGQNREVRSDEWLVQTPFYLSQAEEDFSLVNEDYSLNGQNMIIAYNSP
VKDITVIGKPFNWGFFFLGRDRGLSFYWAMKLVVMVLLGFEVLMILTKRKKALSLIGAFA
LTFSPAVQWWFMQHVGDLIFFTLGLMIAFYHYFYNHDKKWLRTLMMLLVVIFGIGFILVI
YPAHQVMLAYLLIFYFVGLLIYYSKKVSWDLLDVVLIGGAVLFIGGVMVHFWLTSKDALL
ASLNTLYPGKRVSTGGKWTIGEFFSFLTNWKIPFEDINYSNNSEVALFYHFFPTVFLASP
FVLFGKKDSEQKLLGRILMIFCLFSIFWITVGLPKWLAEITLLSYVPPLRAILTFSFAAC
LLSIWFIAYIWREDVIPIWYKFILLAVNAWSYFYAITHSKMDNYFSDFETIAVAVLGTVI
LAFALFGWRRLFYLAFVALVIVSGFFVNPVVEGTGAIFEKTLAKEIQKIDQQDPGKVWLS
EDELYNFTPTLGVKSFNTVRFYPDIAAWKKIDPKEEYEKYYNRYAHTRAFIAKEDTKFIL
DRPDMFSVTLNFEDAEKLGIDYVISKRPLTDYNQLYEAQFTQLYGPDKDGYMIFKVEYPD
YPDVPQTQTQENQLVVQ
>FECAFAII_01087 hypothetical protein
MKIIQAIVQKFVNKMSVGFLLLLLTLVFFVWTAGVGFPATLFIYNNSSLLIAFSVAILLI
LNVYKAKGVDFLYLGVALALFIFFSYFRELRNESLFGDLLFPLIILFCLVIKWIEWTKWD
RGIYLIVFTVFLGITLYRVFTEIQVPEGQSIWAPGNSLSDIWINTNTIGSSLMTLALLIS
GFASSFERWYVRIIGGIAVVAAFLGIWVCQSRGALVALIVFAILDLLPKSLMRVIRAPFI
AYTVTILLALPISYLAAVSEKVNLFTGREDIWHKFYQTLGEKSEQVLLGMKTFIFQRGNQ
FLGNHNSYNSILNIYGLIGFGIAALLLILFIGRLTLKADLSNGQMTFIWAFFAVMMQSFM
EDTLTSYPWVPIIYILLAMAVHRYDEPEVTEEFYVMEEAYDDMTYDDTSYEEQPDSAHSS
RIQRYH
>FECAFAII_01088 Teichoic acid translocation permease protein TagG
MFKDLYLFMKDIYQNRKLLLQFSINDFKSRYAGSFLGILWAFINPLFTVLIYWLVFGVGL
KAQMIDAKYPFIVYLVTGMIPWFFFSDAFASTTVVFREYTYLVKKVVFNIRILPTTKILS
NLYTHLFFILIGIAVALINGIYPSAMSLQLIYYLFCMCAFLTGLTWLTASIQPFLPDIMQ
LITIVLQLIMWTLPILWSPNQFDSGLVSILKLNPLYYVVQGYRESFLSEAWFWEHGTYTL
YFWVFTLVMFVIGSAVFRRLKPHFSDVL
>FECAFAII_01089 Teichoic acids export ATP-binding protein TagH
MTEYAIRLKDITKSYNMYAKPSDRFREALNPFKKSYHDVFYALKNVNVEIKKGEMIGFVG
ENGSGKSTMLKIITGVLTPTSGTMEIEGKISALLELGSGFNPEYSGYENIYLNGMVLGFS
REEVDEMVDDIIEFADIGDHIYQPVKTYSSGMFVRLAFAVAINVNPDILIVDEALAVGDL
EFQLKCMEKFTEIKNSGKTILFVSHDISSIRRFCDRSYWLKNGKVVEYGDTMEVTTNYEN
FLKKKSVKTVDRNKNQVERFAAPDIVDVTKAELLDKDKNPVDMLEQGEKLYVKVTYEVKD
DTIKNPVLGIALRTVDNFYVCGLNTLLDGIKIPWKKGENIFYLEYEKLGLLAGEYYFDVA
VFEENATVPLVYKTKYMNLFVSGSYIGEGIVVLDHKWEEGTHSNEI
>FECAFAII_01090 Ribosomal RNA small subunit methyltransferase A
MKYDFEMDLDEQSSVGKIAAQIKPGSKVLEFGPGNGRLTKHLIGAKQCEVSIVELDKELF
DFVSEFAQDGFYGDIESFEWANYYAGQTFDYVLFADVLEHLVDPGKTLKKVREFLNEEGE
ILITFPNLAHNSVMIDLFNNQLPWASYGLLDETHNSFYTHDGFQKVFEKAGLYINIEDYL
YLAVGDTELKSTYEELPEAVRYDFKMRPFGEVYQYFFSLMKHPVAQSSIAQPQNSNYVKV
LEVIQQTKQDEIIQQIPFNNFTGENETLSFHVSELAERMVFRFAQQPSFIEFSAEAAGEK
LTFIDSNAVVKTVNDCYLFDGKDLPEFFLTDIAGKEVTIHCHYRFIGELTPTMKELLETI
RPMAEVTKQLSEKNDELERENHYLIENNTRLDQTLKTTINRYCTLLESDEWTIKHRLGRR
KKETSKKIQEKELSLCIDEKIWDAETKILKIIGWGIANSDRQPLSYKLSADQSPFFEAIP
VLREEVNQAKQLAEGAKAGFELRILCEKERSFLVEAVAQNGQSWIIEM
>FECAFAII_01091 Chondroitin synthase
MQKKEIAVFIDQITRERATGDLLIVGWAIDEVTKEIPTIKVEKENVIAEATHVVRLDINH
LYNLDVKTQSGFKVRLSGKMRGKAILDFQTARHQNGIAVKLNGKYPYDDGIESSWERKKR
LLKKGINYARTHGVKKAIRRVKLELKPGSIDYAEWISRHEKPDLKEQRKEVQGFAYRPLI
SILMPVYNVEIKWLEKCIDSVLDQTYDHWELCISDDASTDPAIRKCLESYQAKDDRIKVV
FRQENGHISLATNSALEMAEGEFIALLDNDDELPPFALYEVAKVLNVHPELDLIYSDEDK
IDADGNRFDPHFKADWSPDTLMGNNYISHLGVYRTSIVKELGGFRKGYEGSQDYDLVLRV
TEQIPAEHIYHIDRVLYHWRTIPGSTASNGEAKSYIYDSGVKALTDALSRRNIKGSVHPG
RISGFYEITYDVLQEDLVSVIIPTKNGYEDLKTCVDSIIEKTSYPNYEIIIADNGSTDPK
MQELFAEYKHQLKDRFIVELIDIPFNYSRINNLAAEKANGKYFLFLNNDTEVIEPDWMTA
MVSYAQFDRIGCVGAKLFYPDDTTQHAGVLLGIGGVAGHALNNYDRTHCGYFGRLVIDVN
YLAVTAACMMVKAADFNAVNGFDEILEVAFNDVDLCLKVYELGRYNVYAHQAELYHFESK
SRGYEDTPEKQRRFAGEIKKMQDKWPSYIAHDPFYNDNLTKEGIGDFSLRPD
>FECAFAII_01092 hypothetical protein
MTYKHLTIDELTMIESYYLQHNKPVEIANRMGRAIQTIYNVVNKFKQGKTALDYWHQYKE
NKKKCGRKVIQLPAHEVDYIKEKVTLGWTPDVIIGRKERPVSCGMRTLYRLFSKGIFDID
TLPMKGKRKPNGHQEKRGKQQYQRSIHDRPDNYPDFNSEFGHLEGDTIVGIHHKSAVITL
VERLSKVIITIKPNGRKALDIETALNQWFSRFPKNFFKSITFDCGKEFSNWKAISNQHDI
DIYFADPGTPSQRPLNENSNGILRRNGLPKSMDFRKVNQTFISSVSNQRNHIPRKSLNYR
TPIEIFLSYVQEAFYSSLI
>FECAFAII_01093 UDP-N-acetylgalactosamine-undecaprenyl-phosphate N-acetylgalactosaminephosphotransferase
MNKNGEWNAARRIFIILMDVLVLNVSIYLSFLLKFQGEVPVRNLETFQHSAIFISIIFIA
LNILLGAYVFYNRMISDIVFITVIGQVLIALGIMVVTFAGRWFAFPRGVILISFILGTIL
LSVYRIVVYKLYLRVSRDKKVLIVGLEKDVAPAIQNFQSKKNNKHKVEAVAIDNYYENTK
KLIDDMDIVYLASKIPEDEKINIYQLVTKKEKKLFLNTTFENLTMINPNIMNFEDESIIE
ASGFRIQPEYELFKRLFDIIVSLILLILASPFMLITAILVKTTSPGPIIYKQVRITKNQK
EFSIYKFRSMSATAEAKSGPVLAKSNDARVTPVGKFIRAVRFDELPQIFNVLKGDMSIVG
PRPERPFFVDQFNEENPYYYLRHNVRAGITGYAQVYGKYVSDYNSKLRFDLLYIKKYSLL
LDLKILLQTIKILFDKMSSQGLDEDENISSLAEIDFSQEKIYR
>FECAFAII_01094 UDP-Gal:alpha-D-GlcNAc-diphosphoundecaprenol beta-1,3-galactosyltransferase
MENKNVSMLLSLYDKEKPEYLKEALTSIFEQTVMPKEIVLVYDGPINEKLQVVVTYFQQK
DPHLFTVVKLEKNQGLGIALAIGLEHTKNRLVARMDTDDIMEPQRLEKQLEIFQKDPEIA
IVGSNIEEFTGTLSNVIGKRIVPEYNNAIRVFSKRRNPFNHMTVMFDKKAILEVGNYQPL
SGFEDYYLWARLLKAGYKGYNIQETLVYARTGKDMYARRGGMKYLGSGLMGRYRIWKDGL
GSVKDFIIVSCGHIFISLLPNQLRGKFYQTQLRK
>FECAFAII_01095 hypothetical protein
MYSTDPKMKKIQQITLKMSQEIVDFCLKNQLLCYFCGGGAIGTVREQGFIPWDDDLDFFM
PREDYEKFYQLWVNSEKSKKYPIQKASKNYNDHNSFTTIRDADTTFIKTYQRDLDIVHGI
TIDIFPLDVAPVSKFSRKIQKLWALVYALFCSQVVPEKHGGIMATGSKILLSIFRSPRTR
YKIWSFAEKQMTKYNNEPTGYVTELCVGPKYMGNVYPAKDFESAVWVPFEDTEMPVPVGY
DNYLSQVFGDYMQLPPEKDQVSHHEAVYIDPEHPYTMYKGKYYLTKGAEKK
>FECAFAII_01096 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase
MITAIIIAGGVGKRMGQDIPKQFITIEGKPIIIYTLESFQHHPQVDRILVVCKSGWEETM
WAYIKEFNISKVKWVITGGSKGQESINNGVQFLKDYSEDDDTIIIHDGIRPLVDELVLSD
VIVKCKEFGNGVTSLPYNEQIFIKKTEETTEQYVDRNTLRRVSTPQAYQYGKLRAAYDRA
VKEDIGMTDSSYTNTMMVDLGETLYFAAGSDKNIKLTTTDDLELFKAYLKMKD
>FECAFAII_01097 GDP-6-deoxy-D-mannose reductase
MMTLIKQPMYQEDLAKVINHTPKIKQLHGKSVLMIGASGMIGSFLIDTLMAANEQLGIKI
KVYAMGRNRQKLEKRFASYLELDTFEIVEGDVTEPLPKEIQADYLIHGASNTHPKAYATD
PIGTIMTNLAGTEQVLKHAVATQPVRVLFLSTVEIYGENRGDIEKFTEDYCGYIDCNTLR
AGYPEGKRVSESLCQAYIAKHDLDIVIPRLCRTFGPTMLLSDTKASSQFILNAVEQKDIV
LKSEGNQYFSYVYVGDAVSAILHLLLEGEKGEAYNVSSENFDLRLKELAQQLADISGKQV
IFELPDEIEQKGFSKASTAVLENKKIKETGWKPIFPLNESLVHTVELVKGEKYNV
>FECAFAII_01098 putative glycosyltransferase EpsJ
MCEISIIVPVYKVEKYLRKCVDSILAQTFTDFEVILVDDGSPDNSGKICDEYAEKDNRVR
VIHKENGGLSSARNAGIDVARGKYLGFVDSDDYIDEDMYEILYENLKIHDADISSVELIP
FYGDRYKKANKEKKVIILNKKEAIKSVLEGTQFYAYAWNKLYRKELFKDNRYLDGKTFED
AYIIIDLLFQTEKIVVSNEEKYFYLQRNDSIMGKSFSMNNFDVIEAWQYNKEKILDAFPD
LHDSYYRRLCWAYFYVLDKMVLSSSYQQIPRKKTVIEFLKKNRNFILTYKGFTKSRKIAI
IALSFRVDWYRKLVEQKNKKN
>FECAFAII_01099 putative glycosyltransferase EpsJ
MCRISIIVPVYNVEKYLKKCVDSILGQTFTDFELLLIDDGSTDNSGSICDELAKTDNRIK
VIHKENGGLSDARNIGIEVAKGDFIGFIDSDDYIDEDMYAFLYNNILKYDAELSMCGIYD
VHKNKEIKKLTPFSQLVTKSEAIELVLDGKLVVANAVSKLYKKELFENVRYPKGKIAEDA
AVILKIINQCNKIHVDTSQKYYYYHRGDSITSKKFTKKDFDIIDVWNENEKWIIKNYPQM
YDKVHTRVCWAYFVVLDKLVLTEEKGLYQEKKQVREYLIDNFFFIIKNKRLTFQRKISML
LLTFGIAAYKIPVKYQYKKVKAVN
>FECAFAII_01100 hypothetical protein
MKKSRLEYSLINSSISMFIYILRIVIQFVGRSFFIYFLGAKYLGLNGLFTNILSFLSLAE
LGIGSSIIYSLYKPLAQKDESKVKALMNLYKKTYEFIGIFIGIVGVLIIPLLPLFIKNST
DIPHMYRYYVLFLLNSVLSYFFTYKRSLAIADQKNYLVAINDFAFLFFMNIVQVIALYFY
SNFTLFLIVQILFTLFSNINISRTVDKRYSYLKEKDVVSLDKQTKDEVKKNVIGNMSSKI
GGVIVMGTDNILISTFVNLTAVGIYSNYSLIVTSVQNLCKQITNSITASVGNFAVSNKKK
DSFELFKKHFFINHSLIFFSSILLLTLMNPFISLWVGAKYMLPMSTTILIVLNYSVQVYR
NTSFVFIESFGLYWSQRKKPIIEAGVNLLLSLLLLIVFDMGINGVLIGTIGSSLGFVIWY
EAFIIYKTVFEKRFIHFFLTFWRSFIELIISAIVVFLLNEYLANGGSTFLQFITKTLITI
VTTSILYLLLYFRREEFTFIKKILFRYILKK
>FECAFAII_01101 GalNAc-alpha-(1->4)-GalNAc-alpha-(1->3)-diNAcBac-PP-undecaprenol alpha-1,4-N-acetyl-D-galactosaminyltransferase
MKIAILSPAFSMGGASIVASKIAKGLIDSGHEVFFVSYLESEKPQVESKYYDLYEKKIFL
FKNFSRFHKILEYRLFGGFVPSRYIKKEKEQLKKVLKKEKPDVIIFNTFIPSVLFSEFLK
YEFPTVKLITWMHSDPDYSLNHIAKFYKKEYRKSFERVDSIVCLSQDTKEKLSLYNNHIK
VIYNPLTLSGSSLISNLDKKIISFTARYDINIKGFDYLCEVAKNLPVGWAIRIAGDGTEE
ERKELKRLIEKNGVLDKIICAGALFGDELINHYIESSIFISTSRSEGLPLVLIEAMTYGL
PVISFDHGGAKEILQDGNYGILIKNFDVQDMNNEIEKLSNNRLLMEKYQKFSLERAKDFN
EKKIIGEWQTLLNELGNEDVRN
>FECAFAII_01102 hypothetical protein
MRTSIKNFNLWKEWYLYIFFIGMIIRAINFYSLLPSTFDSIFFKLIGISGVLLLGIDFII
KFNKRKVTYNILLIAYMVILVITSFVHKEYGLGENLKTIMWAILQYFLIYQFAFENSDNK
RFFKRISWGFIYSWFVLVSMSMVLFFGKFGYEKYYNARHRIRIGFLESRLFGTFSDINNA
AIASLVVIVLILFYLYNKKVTGLNKIIFLINLPLQFIYIVLSGSRSTYVVSIIIVAISSF
IVVLKRNGTKKDLKNYILAIVSSIGSVLILFALFNATKILFQELLPHLKEINFFNFTERH
KELMNNSQHINNTQTPDNTLVRKDVAENTDISNARITIWKSAWEIFKTSWLIGVSPKNVV
SYAQSIIPDGYIAKVGIAIHNAYLNVLTSTGILGIIPFMAFLIKSFVLNVYRIIYNKCIG
KDYHFVYCLVILSYALYAALNNELVYENTVGTFVFWLFLGRVNSKNNSSYF
>FECAFAII_01103 UDP-N-acetylglucosamine 4-epimerase
MLNYLITGGAGFIGSTLANYLGKENNVVVIDDLSMGKKENLDESKHITFIEGDVADKNLM
EKVMKEYHFDYIFHLAAVASVADSVERPLETHRVNFDSALLLLELVRKYQSGLKRLVFSS
SAAVYGDEPTLPKKEESVIRPLTPYAIDKFAAEQYVLDYCHLYDVPTSAVRFFNVYGPNQ
NPNSPYSGVISILVDRYKKQLAGEKTEFTLFGDGSQSRDFVYIEDVIQALLLVAKEEKAL
GQQFNVGTGKSTTLLELIHSIDQILGTELALKYEAERSGDIRDSLADISKIRSLGYQPKF
DILNGMERYLKTEID
>FECAFAII_01104 hypothetical protein
MMSKNNTNGRNQFAMLTIDDLVPQDHLVRKIDAALDFEFIYPIVEATYSDLGRPSIDPVI
LIKLVFIQYLFGIRSMRQTIKEVDTNVAYRWFLGYSFEEKIPHFSTFGKNYVRRFRETTV
FEDIFAYILEQAVKAGFVTEDNLYLDSTHIKANANKHKFTKEMTHDEAKAYQDELEDEIN
RQRIEAGKRPFTLDLEKEVKLKERKISKADPESGYYVKGEREKQFAYSAHTSCDDNGFIL
STIITPGNIHDSQVAFQLVKQSKRLFPEINCVVADAGYKTPKFVHFLTHLNLRPCLPYSR
PKGKKGLLSKNEFLYDEYFDCYICPQDQMLAFSTVTREGYREYKSNPKECVNCPLLNQCT
KSKNHQRVITRHVWGDLMDEVEHLRLTDLNKSIYKKRKQTIERIFADAKEKHGMRWTKYR
GLEKVATHTMLVFAAMNLKKLATWLWKGKEPLFFCSKIRNEVDKKLFQARVTSLEQLLST
V
>FECAFAII_01105 Putative penicillin-binding protein PbpX
MAKGKHQKKQQISLSFLAVLLLAVSFFSTGIITGWQLTKQPQPQIYKTEPAQLASNLTSN
EQMLASKIDQLLQKSDYIGSIYVRKNNRVILEKGYGYANLRIKESNSPSLYYQIGSIQKA
MTALLILKQIQSGKITFDTKLSEFYPQIPGSQQISIKNMLYMRSGLHRTASPKKPMSDSE
IIQFALHHLKFTGYDTYHYEPLNYTLLTGVLIKLMNQPYETLLKKEIIRPLHLEHTDFYE
NVKNSPQHAVSYQMSATDDYSKALVEPETDIRNELGTGNISMSVYDLNKFFTSVLSGDII
PKELLFSLWQNNGDKHPYSGGVYSGNDYILAQGNINRFHAVAAMKKDTKDAIVMESNIQS
DKNIKLPATDLRNQIYELMEGVNLKS
>FECAFAII_01106 Endolytic murein transglycosylase
MSGNKQHPSKDKKEASKAATADIIDKRRNLRKKEDKIVRKIILVIALTLLIIGGFLGFTV
YRYVDSGLKPLDKSDDQLVQVEIPSGSSNKQIGEILEKDNIIKSGIVFNYYTKFKNLTGF
QAGYYQLAPNMTLDEIGKQLQEGGTSEPTKVADGKIAIPEGYDIDQIAERVAKVTGKDKK
EFLDLVNDETFFNELYQKFPELLESASKAENTKYRLEGYLFPATYDYYTSTSLKDLVIEM
VNKTNTVMQNYYSAIKQKNLTVQEVLTLASLVEKEGVKENDRKNIAQVFFNRIKANMPLQ
SDISVLYALGEHKELVTYEDTAVDSPYNLYTNTGYGPGPFDNPSEEAIKAVLEPAENDYY
YFVADTSTGNVYFAKTYEEHMELVQKYVNNS
>FECAFAII_01107 Transcription elongation factor GreA
MVEKVYPMTLEGKEKLEKELEELKTVKRGEIIERIKIARGFGDLSENSEYESAKDEQAFV
EGRITTIENMIRFAQIIDNDGVDADEVSIGKTVTFIELPDGDEEEYTIVGSAEADPFSGK
ISNDSPIAQALIGKRKNDEVTIATPGGDMLVKIVKVEQA
>FECAFAII_01108 hypothetical protein
MNSSWRFFVVVEALLLLFAVWQIVNNTGLLLLVIFGIFNIYLAMRKYPRTKFQNFQLILG
SLVIFFSLVNSPALWMMVVLAVLFIGLKGVEISGIDLTKNAFWRKKQIMMVQTEQLKTHN
NERKRQQLFGNQRIGNDVYEWDDINIAIISGDTIIDLGNTLLPKDDNIVIVRKGIGRTRI
LVPLGVAIRLEHATLVGNVLFEEEQFSLKNEQIKICSSDYDENPRRLKIITNTLVGDVEV
IRI
>FECAFAII_01109 Sensor histidine kinase LiaS
MMGRISKAMLAVYSGIAAFLIILFSLFTYFYASNQSHWWGELLRARLLYVPLIFHLMAIS
LGVGLIVFLLLSLIQKAKYGKIEEKLRALSSGNYESKLLHQPIPSASDDLYIKDIDMEIT
KIKEKMIEVSSELQIMTSRPQYVDGQTKEEILKLERHRLARELHDSVSQQLFAAMMMMSA
LTEQAEKSETPEMFRKQLKMVAEIINASQSEMRALLLHLRPVNLEEKSLKQGIEQLLKEL
QNKIQISLKWEVEDVKLTSSIEDHLFRIVQELLSNTLRHAKANELEVYLHKIDNNLLLRI
IDDGTGFNMNETKTGSYGLNNIKERVAGIGGTVKIISFKGQGTSVETKVPLMKEA
>FECAFAII_01110 Response regulator protein VraR
MIKVLLVDDHEMVRLGVSSYLSIQEDIEVIGEAENGRQGYEKAMALRPDVILMDLVMEEM
DGIESTKAILKDWPKAKIIIVTSFIDDEKVYPAIEAGAAGYLLKTSTAHEIADAIRATQR
GERVLEPEVTTKMMEKMSRRNDPVLHEELTNRENEILMLISEGKSNQEIADELFITLKTV
KTHVSNILAKLEVEDRTQAAIYAFKHGLVK
>FECAFAII_01111 Ktr system potassium uptake protein A
MKQNFAIVGLGRFGGSICRTLIEAGQEVLAIDSNEDRVNEYMNIATHAVVANAQDEMTLR
SLGIRNFDHVIVAIGEDIQASILVTLMVKEMGVPNILAKAQNEYHARVLEKIGADRVVHP
ERDMGIRIAHNLVSKNILDYLELSDKYSLAEIRVSNPKFFNKTLAELNFRQRFDLTVVAI
RRVDQTVIASPAADEYVRENDNLLVIGETGDVDILDDKMNQ
>FECAFAII_01112 hypothetical protein
MKLTVTPKAQKWFDSEIDLPETYGIRFFGKVYGKTEVHDGFSIGMSVEQPEHPVKKVEMD
GTLFFIEEADEWFFKGYDLLVDYDPNLEEPTYHFKKQ
>FECAFAII_01113 hypothetical protein
MYKLNEIVPVQLGNEKSAPEKGKPAAAKLAMRIKRENGSEVLIYNGINNYILQAILKELL
SNAL
>FECAFAII_01114 hypothetical protein
MLYDLLQTKHIYIVCGKTDLRKGIDGLASLIQQEYQLELYEDAVFLFCGNRQDRFKLLYW
DGDGFLLCYKRIENGKLKWPRTKDEVRTLTNQQVRWLLEGLSIDQPRAILPGKKGVF
>FECAFAII_01115 hypothetical protein
METTDTLLQLLQEAHKTNQAQQQTIQNLTTEIQLLNEKVNYLTNKLFGRSKETLFEETNG
QLNLFSDEEISVSVPEAAATIIPVKGHQRVVGTKADKIKHLPITEKEHLLPLEEQFCEHC
GSQMKDIGRTKVREEIRFHQAMLDCLTHYQHTYCCKSCEKEGLSSFKKAIVPKPLISNSL
GSNSLVAETIRMKFGQKVPAYRQENYWKQTHGLDISRDNITNWHIKAVQNALDPLGERLR
VYLNQEEILHGDETSYRVIESAKTDTYYWQFCTGKDSQHPIVYYHHDESRAGDVPKTFLK
EFTGYLHCDGYSGYNAVESVRLVYCFAHVRRKFFEAIPKGKKNTDIPAAQAVKQLDKWFV
LEKKWKDFSPEKRLSCRQQELRPLFIAFYEWMATIDPVAKSKLDAAVQYACKLRSGFEPI
FEDGRLELTNNRAERNIKELVIGRKNWLHSTSLEGARTSGIILSVYKTAELNGLNPVKYL
EFLFDKIPNLPVLSAETLDQLLPWNKDVQQHFSRN
>FECAFAII_01116 Glyoxylate/hydroxypyruvate reductase B
MSERIIYADRPFRDEFIEEIHTIAPGYIFKTELQPEDLQNVEISLGWNSDYQEKLLASST
LKWVQSISAGVDQLPLETFSKKHILLSNGSGIHSESITEHVLGIILGYSRGLFQAQKAQS
DMKWLGSSVHYQSIQGKKILIIGTGHIGKMIAKKCKALDMNCYGINTSGHPAEGMEKTFS
LNQLKEVLPEVDFVVNILPLTEETTGLFDQHMFEHFDPKSVFINVGRGASVKTQDLVQAL
NNQQLSFAALDVFEEEPLPQDHPLWKMDNVLITSHIAGLTPDFQKKLMAIFLTNLKSYFA
THELQTNQVKLSAGY
>FECAFAII_01117 hypothetical protein
MTTKQLIISSFIRFKDLKEARNVPFWKAIVYLLVLSIIMALPISFQVFQVLNNIQLDGQK
IATRIPDFTIQNGQLQTEEKEGFIYQTNSIIFTFDPEGKRTEQDISTDLMGNFVSVGMLK
NKLIIALPNTGTTSALLNNNQLELPYTNESLKNLTGKQLRSFLSEASIPLWIKVLTFIFS
IYPSFLNLLITLLFTNIAAFLYARFRLTKATFLDCLKTLIYSISLPTIIATILMVFLPSF
DTSAFIAFAGIFIFAQAVKGWAKISIN
>FECAFAII_01118 Cadmium, cobalt and zinc/H(+)-K(+) antiporter
MPTQPQRSSKKLFGVVVLNAVITLSEFIGGIMSGSLSLVSDAFHNLSDTLAIIFSYGAQK
MARKEANKKRTYGYQRLEILSAFINSFILIILSLFLTVEAFKRFTSPEKINSHLMLTVAV
IGLLANLFSVLLLRQEADESLNIKSSYLHLLSDTLSSVSVIIGAILIRFFDIYWIDPVIT
LIISIYILIEAIMVIKKAAAILIQSAPAIDYEKMEQEIEAIDGVKDVHHVHIWQYSEKII
IFDGHIDFEDQLLSEIEKIYPRIISLLKLKYGITHVTIQAETKAKDQKKLIFLNKDESY
>FECAFAII_01119 hypothetical protein
MKQYRQLKGYLEAKGYWEILVYLFFGGLATIVNFVSFALARQYFDLSMALSNSISWFCSV
LFAFVTNKLWVFHSKSPNFTHALIECGKFFFYRILSYGLDMGAMVLLINVMNSNEYVAKI
ITQIIVILANYIFSKLFIFKETEVFEEEVGQSEKDD
>FECAFAII_01120 Superoxide dismutase [Mn]
MTYTLPDLPYAYDALEPYIDEETMHLHHDKHHNTYVTNLNSAIEKYPELGEKTIEELLSD
MDAIPTDIKTAVRNNGGGHANHSFFWEIMAPNAGGEPTGEIKEAINEAFGDFSSFKEEFK
KAAAGRFGSGWAWLVMENGKLAITSTANQDSPLMEGKTPILGLDVWEHAYYLKYKNVRPD
YIAAFWNVINWDEVNKRFEAAK
>FECAFAII_01121 Cold shock protein CspD
MEHGTVKWFNNEKGFGFITVDGGDDVFVHFSAIQGDGFKSLEEGQEVEFTIVEGARGPQA
AEVTKL
>FECAFAII_01122 Transcriptional regulator LytR
MKRWQKVLLTLLGVFVLLIAGLSAYGIRFMGEASQTVNKISKNSNRISSKRSERVSIDDK
EPFSVLLLGLDTGGLGRTEQGRSDTMMVVTVNPKQKKSTIISLDRDIYTNIVGYGTVDKL
NHAYAFGGVEMAMDSIEQLLDIPIDHYVTINLDGMEDLINAVGGIKVNNKIDFTLDGVHV
PVGEQTLNGEKGLAYSRMRHEDPEGDIGRQRRQREVVTKIVNKVLSLDGVSNYRKILKAV
ENNVTTDLDWDDMLDVATNYTPAFETIKQDQLQGEGQMINDIYYQILGKNDLLSIQNELK
KQLNIKTSDTLPNLKNENASMMFFDDSEDGDSTNGDGSNSEGYTDYSSYSENTYDQYQDP
NTYYQQTEDTSQYYTPSQDTQSYDPYAGQEQNGYGYDQNNEYGTTSGY
>FECAFAII_01123 Tryptophan-rich protein TspO
MKMIKDIRFWVCVIGIVILGFLSGLLSGNPGKYYYSLQLPPFAPPSWIFGPMWTLLYILM
GISLYLLLNHNNKKQRNNLVGLFVIQFIFNFIWSALFFNLRNIFIAAIDITLLVIFLSVL
MYQLWLHHRLAMWLMIPYYLWVLFATLLNYSIYFLN
>FECAFAII_01124 GlcNAc-binding protein A
MKKISTLLFIGLVSLGLFGFSIPGFAHGYITSPGSRAYLGTSAAGNLNQNVGRAQWEPQS
IEATKNTFIDGKIASAGVSGFEPLDEQTSNRWHKNMVNPGTLNITWNLTAQHRTSTWDYY
ITKPTWNPNQPLKFSDFELITKIDDKATVPPKTVNQTITLPQDRKGYNVILAVWNISDTT
NAFYQVIDVNIQ
>FECAFAII_01125 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MAETIVKTGQTVPLKIKRLGINGEGIGYFKRLIIFVPYALPKEEVLVKITKATPRYAEGE
LIKVKKTSKDRVVAPCPVYYECGGCQLQHLAYQAQLDFKKDLLLQALEKFKPAGFRSYQL
LPTIGMDEPWHYRNKAQFQLRKNKQTQKIEAGLYEANSHQLVPITDCLVQEPRTQKVMNT
VVQLLNKFDAPIYDERTNSGIFRTIMVRIGVKTGELQVVFITRSKKFPQKNAMIREINER
LPEVVSIMQNVQAQKTSLVMGDETIHLWGKEAIEEQINEVTFDLSPRAFFQLNPQQTELL
YGEGIKALDVQPNETIVDAYCGVGTIGLSVAKQAKEVRGMDTVPQAIADAKKNAERLGYH
NTRYEVGTAEQVLPKWLNEGFQPDGIIVDPPRTGLDNALIQSLLKYPPKKLVYISCNVST
LARDLVNLSKKFKIEYLQSVDMFPQTARCEVVVKMTRLAD
>FECAFAII_01126 Regulatory protein RecX
MLTVTRISKGKGPFYRVDLSEGEALQVSEDVLVRYRLLKGRELDEETIQEIKKSSGADFG
FHLAMNYLSYQLRSEKEIRTYLKEKEILQEDRNKIVARLKELDLVDDLVYGESYVRTNMR
LSDKGPKKLAQQMQQKGLKPEIIEQALSQYTFEDQVQNAHQTAEKAFGKNHGKSQKELLR
KIQQTLMTKGFSQEVIQQAIADLPQEADQEIEYDYLVKQGDKLWRRNLRFEPKKRNLKVK
QSLYQKGFDLDMIQRFITEKEEESE
>FECAFAII_01127 Adenine DNA glycosylase
MNKEWEKWTDKETKEFQDQFIQWYEQEKRNLPWRYNRDPYRIWISEIMLQQTRVDTVIDY
FYRFMEWFPTIEELANAPEEKLLKAWEGLGYYSRARNIQAAAKQIMSEFDGEMPQTPEEI
SSLKGIGPYTTGAIASIAFGLPEPAVDGNVMRVVSRLFCIEADIAKASSRKIFDEAMRKI
IDEKHPGEFNQAMMDLGSAICTPTSPKCETCPIQAFCLANKRGIQTSFPVKTKKAKPKDV
YYISAALQNHSGAYYFEERDSQKLLANMWTFPMMEVTQEEYERLKKEWETKPEIDLFDDL
VAEEEQNLPFEKQELFVWQTRHLGEVTHIFSHLKWHVLLFYGRATEGAEQEFTENKTSKW
LKPDAFDSVVFPKVQMKLVDQLEKNRNNRNPF
>FECAFAII_01128 hypothetical protein
MGVPKEGEFVTIQSYKHDGKLHRTWRDTMVLKTSEHSMIGVNDHTLVTESDGRRWVTREP
AIVYFHKKYWFNVIAMIREKGVSYYCNLASPFLLDDEALKYIDYDLDIKVFPDGEKRLLD
VDEYEMHSKMMNYPNDIDFILKENVKILVDWINNGDGPFSEGYIDIWYNRYKQLSRK
>FECAFAII_01129 Acetyltransferase
MKVVQTKDTMSNIYLDAVRIRHQVFVVEQGVPLSREIDKDEAHCIHFVLYSDKKEPQGTV
RLLPLENGKMKLQRMAILSEYRHQGLGKILIEEAENFAKNQGYNTILLGAQSTAETFYEK
LGYTAYGDPFEDAGMPHIYMKKTL
>FECAFAII_01130 AI-2 transport protein TqsA
MFEKLRQSKLMFWSLELLIIAALIMISSEINFIFEPIGTFFSTLFAPVLIAGFLYYLLNP
IVKLLMKAKIKRIWAVAIVLLLLVAAIIWILLSVIPSLVQQISSLASNMPDFIKQVESWL
KEVAELPLFKEVDINKYFEQLDISYGTIIQQFLSGVSNSLGSIVGTIASATVVIITAPFI
LFYMLKDGEKLVPNIQQFFPEKRRNQIVELLGQLNKTLANYISGQAIECLFVGTFTFLGY
MVIGVDYAFLFGVIAGLTNLIPYLGPYLGLAPAFLVTVFNDPVKALLCCVVVLIVQQLDG
NIIYPNVIGKSLKIHPLTIIIVLLVAGNIAGLLGIFLGVPFYAICKTIISYIIKIVKEDK
QNENKKKIATTS
>FECAFAII_01131 Magnesium and cobalt efflux protein CorC
MNADPESQSLLAQILLLIVLTLINAFLAASEIAVVSINKNRIEQKADEGDVKSQKLLKIL
QNPNNFLSTIQVGITLVNILSGASLANTLSERLAPVLGGGTAAKNIANIIVLAILTYVSI
VFGELYPKRIALNKSEEVAKFTSGLIRLIGVVAKPFVWLLSASTSLLARITPMTFDDEDS
KMTRDEMRYMLENEGVLNNEELEMLQGVFSLDTKVAREVMVPRTDAFMIDINDTVEENVN
EVLSENYSRIPVYNEDKDKVVGILHTKNLLKAAHKFGFDNLDIKKIMQEPLFVPETVFID
DLLYEMKKTQNQMAILLDEYGGVVGLATLEDLLEEIVGEIDDESDEVENLYEKIDEHEYI
IQGRMLIDEFNEAFDSDLHMSDVDTMAGYLITALGMIPDEGEKLSFDVDNITLVSEEMEG
SRILKIRVIFHDPEETEAEPEEERRYFRKEFEDDEPRR
>FECAFAII_01132 Peptide chain release factor 3
MNNPKLKQQVDNRRTFAIISHPDAGKTTITEQLLLFGGAIRQAGTVKGKKTGNFAKSDWM
EIEKQRGISVTSSVMQFDYQGKRVNILDTPGHEDFSEDTYRTLMAVDSAVMVIDSAKGIE
AQTKKLFQVVKKRGIPIFTFINKLDRDGREPLELLEELEELLDIESYPMNWPIGMGKGLE
GLYDIYHNRVEFYRPENYQDERLVELDEDGLLPENHPLTENSLYEQVLEEVELIKEAGDA
FNQEKIARGDQTPVFFGSALTNFGVQTFLETFVELAPAPYGHKTQDDQMVSPYEEEFSGF
VFKIQANMNPAHRDRIAFVRICSGTFERGMDVWLERTNKKLKLSNVTQFMADSRENVEKA
VAGDIIGVYDTGNYQIGDTLFEGKLKVAYEELPSFTPELFMKVTAKNVMKQKSFHKGIYQ
LVQEGAIQLYKTYLTEEYIIGAVGQLQFEVFQYRMLNEYNAEVIMSPMGHKIARWIDPED
LDEKMSSSRNILARDRFDQPLFLFENQFAERWFADKYPNVKLKSLM
>FECAFAII_01133 hypothetical protein
METEWQRRERKKQKKEEMLRLCRLLDVKDWDKNEQIAQKVRSIIHKEEKVKNKDTRRTEN
EKRKVQKKREKSKS
>FECAFAII_01134 hypothetical protein
MKLVNVTNSHSRLVLNQLENTDAHLVKVYTAGNTTIVYTEAPEHNEILLINDKRKIQPKE
IEDAKNYFLDKIKDAVYHEDEIKVIELAGLVEISIPKHELGATLAV
>FECAFAII_01135 ATP-dependent Clp protease ATP-binding subunit ClpE
MLCQNCGKNEATIHLYATVNGQRTQLDYCQSCYQKIKNQQNGGLTNMAQNDPFGFGSLDD
LFRSMSRQMQQQGNYEQTPPTQFGGNNNFNGGQPPQGNTEGLLGEYGINITEQARQGDID
PVIGRDDEIKRVIEILNRRTKNNPVLIGEPGVGKTAVVEGLAQKIVDGDVPQKLMDKEVI
RLDVVSLVQGTGIRGQFEERMQKLIEEIRQAENVILFIDEVHEIVGAGSAGDGNMDAGNI
LKPALARGELQMVGATTLNEYRIIEKDAALERRMQPVRVDEPTVEETISILKGLQKRYED
YHHVKYTDEAIEAAATLSNRYVQDRFLPDKAIDLLDETGSKKNLTIQIVDPKTIEKKLQE
AEEQKVLASREEDFEKAAYYRDQINKLQKMKERQLTEEETPVITEKDMEKIVEQRTGIPV
GELKEKEQTQLKNLADDLKAHVIGQDNAVDRVAKAIRRNRVGLNKQNRPIGSFLFVGPTG
VGKTELAKQLAYELFGSQDSMIRFDMSEYMEKHSVSKLIGSPPGYVGYEEAGQLTEKVRR
NPYSLVLLDEVEKAHPDVLHMFLQILDDGRLTDAQGRTVSFKDTIIIMTSNAGTGKVEAN
VGFGAAREGVTRSVLNQLNNYFTPEFLNRFDGIIEFSALSKENLMTIVTLMLDDVNQMLA
AQQLHIEVPTNVKEKLVDLGYDPSMGARPLRRTIQEQIEDGIAEFYLDHPSIHELKAKLD
KDGKIIVTSKPERLAKESAEETAE
>FECAFAII_01136 Phosphocarrier protein HPr
MEKKEFHVVAETGIHARPATLLVQTASKFNSDVNLEYKGKSVNLKSIMGVMSLGVGQGSD
VTITAEGADEADAMAAIVETMKKEGLSE
>FECAFAII_01137 Phosphoenolpyruvate-protein phosphotransferase
MVEMLKGIAASDGVAVAKAYLLVQPDLTFSKATVEDTAAEEARLDAALAKSTEELQQIRE
KAAQSLGEAEAQVFDAHLMVLSDPEMVGQIKQNIKDNSVNAESALKEVTDMYIGMFEAME
DNAYMQERAADIRDVAKRILAHLLGVTLPNPSMINEEVVVVAHDLTPSDTAQLDRNFVKA
FVTDIGGRTSHSAIMARSLEIPAIVGTKEITAKVKEGDILAVNGIEGDVIIDPTDEQKAE
FEKAGADYAAQKAEWEKLKNAETVTADGKHFELAANIGTPKDLVGVHNNGGEAVGLYRTE
FLYMDSPDFPTEDDQYEAYKAVLEGMEGKPVVVRTMDIGGDKELPYLQLPHEMNPFLGYR
ALRISLSEQGDEMFRTQMRALLRASVHGNLRIMFPMVATLKEFRAAKAIFEEEKQKLISE
GKEVSDTIQVGIMIEIPAAAVLADKFAKEVDFFSVGTNDLIQYTMAADRMNERVSYLYQP
YNPSILRLIKNVIDAAHAEGKWAGMCGEMAGDQTAVPLLVGMGLDEFSMSATSILKTRSL
MKRLDTAKMAELADRALKECDMMEEVVELVHEYVK
>FECAFAII_01138 Processive diacylglycerol alpha-glucosyltransferase
MKVLLYFESEKMLAKSGIGRALDHQKRALTEVGISYTLDEKEDYDILHINTYGINSHNMV
NKARREGKKVVYHAHSTEEDFRNSFIGSNQLSPIVKKYLVGLYQKADYLITPTPYSKQLL
ESYGIRVPIQAISNGIDLEKYHPDPMKEQKFREYFKLSPDQKVIICVGLFFERKGIIDFV
EIAKKMPEYTFIWFGHVPMYSIPRNIRKIVKEDHPENVLFPGYIRGEIIEGAYSGADLFF
FPSYEETEGIVVLEALASKQNVLVRDIPVYNGWLEDSKNCYMGKTNEEFIRLIQQITNQE
LPSTTQAGYQTAKERSINKIGEELKNVYESVLNEKVSSKLKKVNQVKD
>FECAFAII_01139 Alpha-monoglucosyldiacylglycerol synthase
MKIGFFTDTYFPQVSGVATSIKTLKQELERHGHEVYIFTTTDPNADKLEKDVIRMPSVPF
ISFKDRRVVVRGMWYAYLVAKELELDLIHTHTEFGAGILGKMVAKKLKIPLIHTYHTMYE
DYLHYIGKGKVIRQSHVKYLSRLFANHTTGVVCPSERVIDTLRSYGVIAPLRVIPTGIDI
EKFKRSDITQQDISKLRESLGLQENHLMILSLSRISYEKNIQALINGFPQVISAYPNARL
VIVGKGPYVEELEELISELQLEEFVQFTGEVDNNDVALYYKAADYFVSASTSETQGLTYT
EAMAAGTPCVVEGNAYLNRLFDHPSLGKTFETDEDFAPALIDYISSEVPKDPKVLEAKLY
DISSTHFGEAMIEFYQDMVVYHEEEMRRKEEEDSIERIKIKLNSFKR
>FECAFAII_01140 2-hydroxy-3-oxopropionate reductase
MKLGFIGTGVMGSAVARHLLEAGHEVAVYNRTKAKADPLVTEGAIWADTPKAVAEQSNIL
FTMVGYPKDVEEIYYGQSGIFSADISGHILVDLTTSTPSLAEKIAKTAKEKGADALDAPV
SGGDLGAKNGTLTIMVGGEEAVYDQVLPLFKEFGTTFTLHGSAGKGQHTKMANQIMIAGT
MTGMTEMLVYAQKNGLDLKKVIETLSGGSAANWSLSNYSPRILKEDYTPGFFVKHFIKDL
KIALEEAEKMDLVLPATTQALKLYEELADKGFENDGTQALIKLWWPEGKIPEKKS
>FECAFAII_01141 hypothetical protein
MTHSQLVAIIKRLEAMVESADNELQVRRFEKEGVEKCTVTYDKATDTFELTETDTHQQYE
FDNIDIVAMEIYDLIQ
>FECAFAII_01142 UvrABC system protein C
MLKEKMKTLPMLPGVYLMKDRDGKVIYVGKAKRLKNRVSSYFHQNKQHSKKVLRMIHHIT
DFDFVVVDTELDALLLECQLIQHYRPFYNRQMNYFSNYNYVHITNKGFVLTDTPTARTYG
PFRLYKKMPSILRIMEETYQMPWLSEISLLALRVQLPDLQEMTFEQKKKELQGLFQGRNK
KLLTYLKKRQQHFIYQLNFEKAGMLQKDIELVTYFIRRIQEQKQFLRTPSLTFSMPLAAD
ESQKKHYLVCYGQLAETMITSGDVSPDFYYEKKEAHLSLKRQLSKEEIDPVQILISYRKK
LEKEQFEIELLNKKEAEKQLN
>FECAFAII_01143 Multiple antibiotic resistance protein MarR
MEPDLKTVNDYLVSVFNDILTIEESELKKSQFKDLSITEMHTIEAIGMYKKKTTSEVAKE
LSITVGTLTTAINKLVKKGYVERIRSEDDRRVVKLGLTKKGKLLFRVHQHFHREMVKNIL
DGMATEEQHALLDALKNLHDFLQDYK
>FECAFAII_01144 3-oxoacyl-[acyl-carrier-protein] synthase 3
MEQFGMITATASVLPEKIITNNDLSKMMDTSDEWISSRTGIRERRCVTNQETSDLCILVA
EKLIKQKNLNPKDLDFILVATMSPDYTTPSVAAQVQGKLGATHAIAFDISAACSGFVYAL
SMAEKMIRCGSTKGLVIGGETLSKLIDWSDRTTAVLFGDGAGGILLEANPQKKLLKEKLA
ADGTRSSSLTAGYQQNKNPFYSEDSEGSYYLQMTGRDIFDFAVRDVANNIQEVMKDKPVD
YLLLHQANLRIIEKIARKVKMPQEKFLTNMDKYGNTSAASIPILLDEAVSSGKITLGKQQ
KVIFTGYGGGLTWGSILMEL
>FECAFAII_01145 Acyl carrier protein
MVFEKIQEIIAEELGKETEEIKLTTDIQEDLEADSLDLFQIINEIEDEFDVKIETEDGIK
TVQDLVTYVEKQTA
>FECAFAII_01146 Malonyl CoA-acyl carrier protein transacylase
MKTAFLFSGQGAQYQGMGKDLYEEAVVKQTFDEASEILGYDMAELCFTENERLDQTQYTQ
PAILTVSIAYYRLLKEHGIIPDAALGLSLGEYSALVASNALSFTEAVALVAKRGAYMTEA
TPAGSGKMVAVMNAPIETIEESCHEASKYGIVSPANYNTPQQIVIGGEEKAVDEAVLLLK
EKGFKRMIPLNVSGPFHTAILEPAAKKLAKDLSQIQFSEPSFPIISNTTTEIMKKETIAG
LLEQQVMQPVRFYESIHKLKTIGIEQVIEVGPGKVLSGFMKKIDKTIPVLRVENKQTFDE
TIAIL
>FECAFAII_01147 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MDVKGKNVFITGSTRGIGKAMALAFAKAGANIILNGRGEIPKEKIEEIEAFGVKCVGVSG
DISDYEKAGQMIKEAEEKLGSIHVLVNNAGITNDKLVMRMDAEDFKKCLDINLIGTFNMT
QHVLKKMMKQREGAIINLSSVSGLIGNIGQANYAASKAGVVGLTKSVAREAATRGITCNA
IAPGFITTDMTEVLADKVKEQAEKQIPMQRFGQVEDIAQTAVFLAQNPYITGQVINVDGG
LVMHG
>FECAFAII_01148 3-oxoacyl-[acyl-carrier-protein] synthase 2
MNRVVITGYGVTSPIGNDADSFLNSLKEGTNGIAPITKFDASETGITLAGEVKDFPYDKY
FIKKDSKRMDMFSIYGIYAALEAMEMSGLDKEKMNQDRFGVIIGSGIGGLPTIENQVIRL
HEKGAKRVSPMFVPMAIANMAAGNIALRVGAKGICTAIVTACASGTNSIGEAFRNIKHGY
SDVILAGGTEATICEMGIAGFAALTALSESTDPNRGSIPFDENRNGFVMGEGAGVLVLES
LEHAQARGAKIYGEIVGYGANCDAYHMTAPTPDGSGASKAMKLAMEEAGVQPEQVGYINA
HGTSTPANDQAEAKAIQIALGENFRDTYVSSTKSMTGHLLGAAGGIEALATLLALEHQFI
PPTINVEKQDPEIDLTVVKNESKPASFTYAMSNSLGFGGHNAVLCMKRWEE
>FECAFAII_01149 Biotin carboxyl carrier protein of acetyl-CoA carboxylase
MDINEIRELVSQFDQSSLTEFDLREGQFELYMNKNKTSRGMNMVQTNETLPVSEPVNVIS
EQATTAPEIMKEKESAVFDGIEVVSPIVGIVYLQPAPDKPAFKKVGDQVAKGEVICIIEA
MKLMNEITSEADGVITEILVENESVVEYGQPLFRIQQK
>FECAFAII_01150 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ
MNIQEIKEIIPHRYPMLLIDRVEEMVEGERIVAKKNVTINEPFFQGHFPEEPVMPGVLIV
EAMAQAGAVALLSLEQFKGKTAYFGGLDKAKFRKKVTPGDTLYLEVEILKVKASAGIGKG
IAKVDGKKVAEAELTFMIG
>FECAFAII_01151 2-oxoglutarate carboxylase small subunit
MFSKVLIANRGEIAVRIIRACRELGIQTVAIYSEADAEALHTQLADEAICIGPAKAVDSY
LNVQEVLSAAIVTKAEAIHPGFGFLSENSRFASMCEECNITFIGPKSATIDAMGNKINAR
QLMQEANVPVIPGSTGVLSTVEEALEIADRIGYPVMLKAAAGGGGKGIRKVQSKEELPQH
FSSAQQEAAAAFGNDDMYLEKIIYPARHIEVQILGDRFGHVIHLGERDCSLQRNNQKVLE
ESPSVVISQTKREALGDAAVRAAKAVNYENAGTIEFLMDEEGDFYFMEMNTRIQVEHPVT
EMVTGIDLVKKQVEIAAGEPLNVCQEEVVFQGHAIECRINAENPAFHFAPSPGKIQNLLL
PAGGMGLRVDSAVYPGYTIPPYYDSMIAKIIVHGNTRFEALMKMQRALSEFITEGIITNA
EFQMDLISHPAVIAGDYSTAFLQEEFLPNWTPETEIGGA
>FECAFAII_01152 Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta
MALFKKKKYIRINPNRESKPANSPSVPDNMWAKCPNCKHILYTKDIGEEKVCPHCGYAFR
IGAWQRLALIIDEKSFEEWDTDLVTKDPLAFPEYTEKIKKMQDKTGLHEAVLTGKATIQG
IPFIIGVMDPNFIMGSMGTIVGEKITRLFERATKESLPVVLFTASGGARMQEGIFSLMQM
AKISAAVKRHSNEGLFYLTVLTDPTTGGVTASFAMEGDIILAEPQSLIGFAGRRVIEQTI
KQELPEDFQKAEFLLSHGFVDQIVPRMELKQKIHTLLELHTQKGWIDRG
>FECAFAII_01153 Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha
MDKTAHDVVQLARAKERWTSLDFFEEIFDSFEECHGDRLFADDEAIVGGIARLDGKPVTV
IGIQKGRDLQENIRRNFGSPHPEGYRKALRLMKQAEKFNRPVITLINTAGAYCGVGAEER
GEGEAIARNLLEMSDLKVPIIAIIIGEGGSGGALALGLADEVWMLEETIYAVLSPEGFAS
ILWKDGSRAAEAAELMKITAPELRELGIVDRVIPETFNGEQLPRYKVAHIMKKALIERLT
ELVRLDQHKLLEKRYKRFRQY
>FECAFAII_01154 Phosphoglycolate phosphatase
MFSNYKPTWMVEAIYQITPAQLKNLGIKAVLTDLDNTLIAWNNPDGTEELLTWILEMKNA
GIPVVVVSNNNSKRVARAIEKFDLLYVARAMKPLARGINIAKKQLDLADDEIVMVGDQIM
TDIRGANRAGIRSILVKPIIATDSWKTQFNRFWEKRIMAYLLAKHPDMGWRGGIE
>FECAFAII_01155 GTPase Der
MTEELQCIGCGAVIQTNKPGELGYTPQTALEKGLASGEVYCQRCFRLRHYNEIQDVSLTD
DDFLRLLNELGQKDALIVNVVDIFDFNGSLIPGLHRFVGDNPVLLVGNKVDILPKSLKKT
KLTQWMKERAYEAGIRPVDVLLTSAKKSHEMTELLEKIEEYRDGRDVYIVGVTNVGKSTL
INQIIKNTAGVQDVITTSQFPGTTLDKIEIPLDDGHFLIDTPGIIHRHQMAHYLGKKDLR
IIAPLKEIKPKVYQLNEGQTLFLGGLARFDFISGNRASFIAYVSNDVNIHRTKLEKADEF
YQKHVGGLLQPPRPDEVEAFPELVRFEFSVKEKTDIVFAGLGWITVTAPVVIAGWAPKGV
DVLKRKALI
>FECAFAII_01156 RNA-binding protein
MSLRGKQKRFLRSKAHHLQPIFQIGKGGINSAMIVQIEEALEKRELIKVSLLQNTDEIAE
EAAQVLEKEIDCEIVQIIGRVIVLYKPSTKEKYQRLSKEVKAI
>FECAFAII_01157 Nicotinate-nucleotide adenylyltransferase
MMNTQAKTFVRSQLFPEEMPQFLEKKKQVGILGGTFNPVHLAHLVMAEQAGRNLGLDRVF
LMPSYQPPHVDEKQTIDAKHRLNMLELAVEDNPFLQIETIELARGGKSYTYDTMKELTQN
NPDTDYYFIIGGDMVEYLPKWYKIDELTSMVNFVGIRRPGYTTDTPYPVIWVDVPEIDIS
STKIRQKIKEGCSIRYLVPDKVIDYIQNEGLYEYGL
>FECAFAII_01158 hypothetical protein
MNMDYSNEYTAYSRENLMQKIQMRMSEQRFKHVLGVEETAVALAKKYGASPEKASIAALT
HDYAKERPDEEFKMVIVRDGFDPELLNYNNAIWHGLVGASFVERELGITDAEILHAIRVH
TTGAAKMSLLDKIIYVADYIEPGRDFPGVQDARAIAWADLDEAVAFETKHTLAHLLAQEQ
QIYPKTIETYNYWVAKK
>FECAFAII_01159 Ribosomal silencing factor RsfS
MLADYFMICSANSERQINAITEEIIDKEEENKYEVKRIEGKEGGKWVLIDLGDVIVHVFH
APERNFYNLEKLWSDAPLVDLSEWLD
>FECAFAII_01160 Glycine/sarcosine N-methyltransferase
MAYETFAFIYDEVMDETLYQQWLAFSKRHLQEDTKNILELACGTGALAVAFAKDGYKVTG
LDLSEEMLMIASQRAYEEDASIQFVEGNMLDLSEIGQYQAITCFSDSLCYMKNRQEVQQV
FDEVYQALEENGRFLFDVHSTYQVDEVFPEYSYHYQGDNFAFLWDSYPGSEKHSIEHFLT
FFVEEQEGSGRFIREDELHQERTYPLESYLRMLENSGFSKVEAFSDFTDEAASEKSKRWF
FVAYKD
>FECAFAII_01161 hypothetical protein
MKSCGIIVEYNPFHNGHRYHVEMARKITGAEVVIAVMSGNFLQRGEPAIIDKWHRANEAL
QNGVDLVVELPVEWAVQSADYFAKGAVKILQTLDCDSLCFGTEEETSFDYSSFGRFVQEN
QDRIEEAFQELSDQTYSYPQKMTEVFRSLYPDITLDFSSPNHILGLSYAKENAKYVHPME
LHPIRRKSAGYHEKIITDQRIASATAIRHALEEGKRIAGLVPPQTEEDLSTCSLQTWESY
WPYLRYRLLSSTLLELTDIYQMTEGIESRMKTAAATADSFEDFVSKVKTKRYTWTRIQRL
SCYVLLNIKKQEIPVQQNKNYLRLLGFTDAGRRFLKEKKEISIYSRIGKKEAQEAELLVR
SDQIYQLGGNIPEQNFGQIPIRV
>FECAFAII_01162 putative transcriptional regulatory protein
MGRKWANIVAKKTAKDANNSRIYAKFGIEIYAAAKSGDPDPHANQKLRFVIDRAKTYNVP
KHIIDRAIEKAKGAGDETYSELRYEGFGPSGSMVIVDTLTNNVNRTAADVRAAFGKNGGN
MGVSGAVSYMFDNTAIFAFAGEDADEILEYLMEKDIDVRDVMEEEGQIIVYGEVADFHSI
QEALKEKGITDFSIAEIQMIPQNEVTLSPEDQETFEKMIDALEDLEDVQHVFHNVALED
>FECAFAII_01163 hypothetical protein
MNDSIKKMLRITEKDLMITEVSYETLQKKKTLVVDAVLSPTPRACRSCGSTVVDGNGKAI
IVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKSCQVSLTTVIRTLKEFKSYLPKQSKKILPRVLMVDEFRSHASIED
KMSFICADGETGKLIDVLPTRKLPRLTSYFLGCTNPEEVEFLVTDMNAAYFQLTKRVLPN
AKVVIDRFHIVKHMNQAFNELRIREMNELRKAGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLEFSPPLKEAYPFFHELVEAFRDKDPDLFFSLLAELP
ETLDDSFREKLQNLLTYEEGITNAMIYPYSNGKIEAKNTHIKTMKRVSYGFKSFENMRIR
IFLINQLINVR
>FECAFAII_01164 hypothetical protein
MEAKITLEPFERILSGYRKVEELAVNVTDCSKLAQKYARFGVEGYRLGNYVGTGYLNRYL
ECMVDRAPMLIYRQNYLIPLLFRRSDSAFRLFEEEYRMEAFFLLLEWSLKHRPEKILIER
NEKIDTKKNKVIDSAYLAFRVSEILDCGGYPISNFQSIDQFIEWNRIYRLIDNGGIGRHS
KVFDPEYPENMEELKMIISLVKLKYPETDLDLYIE
>FECAFAII_01165 DNA helicase IV
MNEKQLEQTHVDETIELIQIEQNMLDTKQQELTQEMNHSTKDTANHKIRAGSNEAFYESA
VEYRQHEQELLLKYHTLEAQQKRLQTLSVMKDSPYFARIDFKEDRETETLYLGIASLRDL
AEETIVIDWRAPIANLYYEGEIGPAFYETETDRIDVDLQLKRQFKIQEGRILSMVDTSEV
INDDFLLEILDESSSNHMKNIVSTIQKAQNAIIRDTTSKVMLIEGIAGSGKTSALLQRIA
FLLYHNRKWLEAENVLLFSPNHLFSDYISTVLPSLGESGVPTQTFKNYLVQLLPEFSLLD
EQQQESGFLLGEKDPIQVMKSGLTLVDQIDRYIQGITNYGPLFRDMKINGRTILSKESIR
QWYKETNEQLPLHHRLSLLQTKLLKKLGGLQKDETRQQWVKDLAEEQLQELYATDPNLEY
TEQKERSLRKKLANQIVRKRFRRIHRGIMNYQFVNITKQYLHFLQTVPLSLLTRHKISET
RWQEHLTTVRTHLRQRELRQEDAVLFFLLMRRTYPVTVTHKARYIFIDEMQDFAPSQVAL
LQALFPKANLTFCGDLNQNVFGNETIVGSLEDLFVDREVTRFQLTTSYRSTKEITDFANH
FIVKEHQVETTARKGDLPLLIQGTTDDIKLNWLADTIRTTQGKARYWRTAIIAKTQEECE
ALYAQLPDELKQQVQLILNESDFMKRSIILLPAFLAKGLEFDRVFLWDVDAEHFSSQQDK
LILYTMCTRAMHELTLFTSNNESPLLNNMDISSYEKKVL
>FECAFAII_01166 Zinc-transporting ATPase
MTHFKKFLLTLLIGGIALLSEFVFHQPALAFAIVAFTGGILAFLMFLEMIKTLRSGRYGV
DVLAITAILATLAVKEYWASLMILIMLTGGDSLEDYANKRAGKELQSLLDNTPRIAHRFK
EGKLQDIVIDEINIDDQLLVKPGELVPADGRVTKGESSVDESSLTGESRPETKKPGDQIM
SGSLNGDGSIQMIAEKRAADSQYQMIIKLVEESKEKPARFVRLADRYAVPFTLIAYLIGG
ISWWFSKDPLRFAEVLVVASPCPLILAAPIALVAGMSRSSKNGIVVKTGTTIEKLARTKT
IAFDKTGTLTKGILEVEAIQPVNGIKKEELLLYAASAEQESSHILARSLVNNVKNSQLYP
VSQLKEVTGQGIQAVVNNHEVKIGRASFVSAEEIETSNTAIYVTIDRSFAGTILFSDQIR
PEAAKTIKELRKLDVKNLMMITGDGSAIAQTIAEKVQLDSVHARSLPQDKLTILESIPKD
QRPVAMVGDGVNDAPALAAADIGIAMGAHGSTAASESADAVILKDDLLRVAKAVVISRDT
MRIAKQSVLIGIFICIFLMLIASTGLIPALFGAVLQEVVDTVSILSALRAKKDPAIFPDS
VPKTNIV
>FECAFAII_01167 putative tautomerase.1
MPFVHVELVEGRSPEQLENMMKDITEAVHKNTQAPKEHIHVIINEMKKGTYGVNGEWKK
>FECAFAII_01168 Threonine--tRNA ligase
MIKITFPDGAVKEFESGTTTLAIAESISKSLAKKALAGKVNGKLVDLTRPIEEDASIEII
TPDHEDALGLVRHSAAHLMAQAMRRLYPNIHFGVGPAIDSGFYYDTDNGQNQVTAEDLPA
IEAEMMKIVKENLPIERRVLSKQEALEIFASDPYKVELISELPEEEVITAYQQGEFIDLC
RGPHVPSTGRIQVFKLLSVAGAYWRGNSNNQMMQRVYGTAFFDKKALKEYIRLREEAKER
DHRKLGKELDLFMVSPEVGSGLPFWLPKGATIRRTIERYIVDKEVSLGYQHVYTPIMGDV
ELYKTSGHWDHYQEDMFPPMDMGDGEMLVLRPMNCPHHMMVYKNTIHSYRELPIRIAELG
MMHRYEKSGALSGLQRVREMTLNDGHTFVRPDQIKDEFKRTLELMVAVYADFNITDYRFR
LSYRDPNNTDKYFDDDAMWEKAQAMLKAAMDELELDYFEAEGEAAFYGPKLDVQVKTALG
TEETLSTIQLDFLLPERFDLTYVGEDGENTHRPVVIHRGIVSTMERFVAYLTEVYKGAFP
TWLAPIQATIIPVSVDAHGDYAYEIKERLQMKGLRVEVDDRNEKMGYKIRASQTQKIPYQ
LVVGDKELEDATVNVRRYGSKETAVEDLNIFIDAMEAEVKNYSREN
>FECAFAII_01169 putative HTH-type transcriptional regulator YbbH
MSVISRIESMMEDYSSAEKKLANYIIGNIEKVPTMTANELAEASGLSAPTVVRFSKKIGF
QSLTDFKITISTELQTGIDEGFSDIEANESFYSIKNKLGNNAQVAIKETVDILEEETIQK
VVECLESAETVFLYGVGASSLVVEDILQKWSRVGKPIIFEKDIHVLLPQLVSNEKKKVLW
LVSNSGRSADVVALAELAKSMNIEIIALTQFGNNPLSKIADVLVQTSRPKEITNRSAATN
SLLAQFATIDIIFYFYMAKNEKLSEKVKKTREAIQEYFMDSK
>FECAFAII_01170 Penicillin-binding protein 2B
MMKDFMKKILNTSWLEKIRKGAQEPKNKTFRRSHVPFRLNFLFFIIFTLFVALIARLGYL
QIVNGEEMEARVKSTSTITVQESTPRGMIYDSTGKALVTNKANQAITYTRGTQVTAKDLL
EIATKLNSLIDVPVDENLTDRDKKDFWLADPKHLKEATKRLSAKEKQLGNSEQYSAMVNK
VTADEINLNEEQLKIATIFKRMNSAYELNTVYIKNSGVTDQELAVVAERASELPGVSTGT
DWTREYNAASSLKSILGSVTTEKQGLPADEAEKYLAKGYSRNDRVGQSYLEKQYEDVLQG
TKTQYEVSLDNEGNVSNQKEIFSGEKGSNLMLSMNAEFQSKVEEILKRNYQTLINNGKAQ
YSPGAYAVAMNPQTGEVLAMTGFSHEQGSKEITENALGTITSAFAPGSVVKAGTLTAGWA
SNAISGNQVLIDEPIRLQGASEKSSVFNRSGQVALDAVKALELSSNTYMIKVALKMLGLD
YTPGMGLPSLDEEAKAYQQLRDSFKEFGLGTTTGIDLPNESPGISRSVDYMKKFNADNGK
EWYTPGNFTDLAFGQFDTYTPIQLAQYASTVANGGKRVQPHLVKAIYGNDENGNLGEVKK
EIGTTVENTVNISAENMAILREGFHQVVHGTDPYTAAKPLASAKMDLSAKTGTAETVAEG
HPDITTVNSNIVAYGPTDNPEIAISVVLPNLLDEQDHMNLTIAKEIMDAYYDMFMAK
>FECAFAII_01171 hypothetical protein
MSHTQLIKDTLNILDLNIYFEENCLTKEKYKGQICLIYKGTLLYKPEECSHCLCVVPSRI
IRWGTTTVRLLLNDVSEYRTYLELKKQRFKCKSCQRTFVADTSVAEKHCFISQKVRWSVI
ARLKENTSMTEIARQKNISTSSVYRVMKRFYRPLNPFKQTLPKVLCFDEFKSVRSVASAM
SFIMMDGQSHALLDIVENRRLPYLERYFSRFSLATREAVQLIVIDMYAPYVSLVKKLFPN
AQLIIDRFHIVQHIGRTFLNHRVKETTVRLKGNSHSQRGLGKKLKRYWKLLQKEEAKLNY
EKRVWRASFKDYLTESEIADRLLAACPNLRQGYQLYQDILYAVKKRDQSLFEDCLTRDIS
GLPETYTTTLRTFKKFLPQIQNALHYSYSNGPLECLNNHIKVLKRNAYGFRNFYNFKLRI
MIRHGKTFLTK
>FECAFAII_01172 5-amino-6-(5-phospho-D-ribitylamino)uracil phosphatase YitU
MNKKLIAIDLDGTTLNQDSMITSKTKETLKKAINAGHHVSIATGRPFRMSHQFYQQLELT
TPMVNFNGALVHIPNQHWDGERETLINREIAFEILSQKKQLNLDFIAAENRDTFFIDSFD
FFDEKIFASSRPGEKNLLSPKNLTTNPTSLLVRTDKRFAGAVSAELTRQFGSYVDVRTWG
GPTAILEIVSKGIQKAKGVQEIANYLSIDQKDVIAFGDEHNDLELLDYAGWGVAMANGTD
QLKGIANDVTPLSNQEDGLAVYLEKLLKL
>FECAFAII_01173 Guanine/hypoxanthine permease PbuO
MKRLYNLKLFDGFALFYLFFIIIVFHQKKIQGVELFMEKFFGLKKNNTNVSTEIMAGVTT
FFAMSYILFVNPTILSASGMPFQAVFLATIIASIIGTLVMGLFANVPYAQAPGMGLNAFF
TFTVVFGLGYSWQQALAMVFICGLINIFITVTNIRKMIIRAIPESLQHAIGGGIGIFVAY
VGIKNAGFLSFSADQSAISSSVVEGGKATNVTINGGIVPALANFDNAPILLAVIGLVLTA
ILVVKNVRGAILIGIVATTVLGIFMGVVDLSSIDWQTNSLGNSFKELGTTFGAAFGSEGM
QSLFSDSSKIPQVLMTIIAFSLSDTFDTIGTFIGTGRRTGIFSKEDEIALEDGRGFKTKM
DKALFADAIATSVGAIFGTSNTTTYVESAAGIGAGGRTGLTSVVVAVLFALSSLFSPLIA
IVPNQATAPALILVGVMMMASFADIKWLDMEEALPAFFASIFMGLCYSISYGIAAGFIFY
TIVKVIKGKYNQVSVALWIVDILFIINFIILATI
>FECAFAII_01174 hypothetical protein
MNDSIKKMLRLIEKDLMITEVSYETFQKKKTLIVDAVFSPAPHTCRNCGSTVVDGNGKVI
VVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKNCQVSLTTVIRTLKEFKSYLPKQSKRILPRVLMVDEFRSHASIED
KMSFICADGETGQLIDVLPTRKLPRLTSYFLGCANPEEVKFLVTDMNAAYFQLTKRILPN
AKVVIDRFHIIKHMNQAFNELRIREMNELRKVGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLGFSTSLKEAYPYFHELVEAFRDKDPDLFFSLLAELP
ETLDDGFREKLQNLLTYEEGITNAMIYPYTNGKIEAKNTHIKTMKRVSYGFKSFENMRIR
IFLINQLIKVR
>FECAFAII_01175 Putative metabolite transport protein YjhB
MEINWRKNLVIAWIGCFFTGASISLVMPFIPVYVEQLGTPKDQIELFSGLAISVTAFASA
VVAPIWGNLADRKGRKLMMIRAAAGMTLTMGSLAFVPNAYWLLIMRFWNGILSGYIPNAT
AMIASQAPREKSGWALGTLSTGAIAGNLIGPSMGGALAQWFGMENVFLITGALLMITTVL
TIFLVKEDFHPIEKKDLISTKEIFSKMDHLSILIGLFITTLILQIGITTISPILTLYIRE
LSGSTENILFVSGLIVSIAGVSAVFSSPKLGKLGDKIGNQKVLIGGLILSFCCYLPMAFV
TTPLQLGILRFILGFSTGALMPSVNTLISKITPQEGVSRIYSYNQMFSNFGQVLGPMLGS
TVAHAYNYSAVFIVTSLFVLSNILLSLFNFRKVLRSRL
>FECAFAII_01176 hypothetical protein
MRYIVTLFWAVVLGQVVGYIGAALTSGTYDFTLTTIISFIAGVIILLIGAVAPRKETSAH
S
>FECAFAII_01177 DNA polymerase III subunit alpha
MFFPQLYTITSYSLLQSTIRIREYVQEAKKQGYTSLAITDKDVLYGAPEFYRICVEEGVQ
PIIGLHLSYTYEEKNYGLLAYAKDEIGYQQLMKLSSRKMIQEKLELAEMTETDHLAFVVP
ANHSVSEAFNKEDNFFGHWQFLLENVFTRNFYIGLTENTPDQLPEWYQYVIKENYSLCAL
HPIASLQQEELFALEVMKHIKEGSQIPLENLSASLPLTANVYLLSEQEMIKRFEKAGLSQ
AVIGAQRLAESISFEFQFHQKLLPHYPVPNGKQAGEYLRELCYSQVERRITDYTKEYQER
LDYELSVIHQMGFDDYFLIVWDVMAFAHRNKIVTGAGRGSAAGSLVAYVLEITDVDPLEY
DLLFERFLNPERFTMPDIDLDIPDNRREEVLNYVREKYGQYHMAQIATFGTMAAKMVLRD
AARVFGLSQSEANRWSKAIPNQLKITLTQAYKTSHQLVELVQASEKNQLLFKTAVILEGL
PRHVSTHAAGVVISDKNLLELVPLQRGSDEAFLTQYTMNEVEAIGLLKMDFLGLRNLSII
DFTLKAVKRVEGYEIRLKEIPLNDAKTLLLFQRGETSGVFQFESAGIRNVLRRLDPENIE
DIAAVNALYRPGPMQNIDTFIARKKGKEAIRYPDDSLIPILKNTYGVIVYQEQIMQIAST
MAGFTLGQSDILRRAVSKKKKDVLDEEKSHFVSGALQQGYSEKTAATVYEYIEKFANYGF
NRSHAFAYSFVGFQMAYLKAHHPGAFFTSLMNSVRHNTSKLKEYIAEARKNKLKLSSPSI
NQSNSSFELVNKEEIRFGLTAIKGIRRDFVEDILNERKQNGPFQSVDQFLIRIDKRWLKL
ELLQSLTAVGVFDELSPNRKQLMLDLEGKIQNIVYSGGSLDLLGIMALKEEEVADYTLEE
RLKLEEEYLGIYLSGHPAEGFDRLRLAKQVQLITDIVPNQPVNLLVMIKEVREIRTKKGE
LMAFVEGTDSSGEISVTVFPTLYRKYRNLFAVDRVIFVQGRSEISKYNQELQLIGESFAD
PNQLEAQYPSQTCYLRITEEREDPEIMKQLQVIFQKHPGYIPVVMYHEKTQRKVVLSDAY
WVDDSKSIKRQLIYLLGEDNVVFK
>FECAFAII_01178 ATP-dependent 6-phosphofructokinase
MKRIGILTSGGDAPGMNAAVRAVVRKGIYEGLEVYGINYGFAGLVAGDIRRLDVADVGDK
IQRGGTFLYSARYPEFATEEGQLKGIEQLKKFGIEGLVVIGGDGSYHGAMALTKRGFPAV
GIPGTIDNDIPGTDFTIGFDTAINTVLESIDRIRDTATSHVRTFVIEVMGRNAGDIALWS
GVAGGADEIIIPEHDFDMASVAKKIQEGRDRGKKHCLIILAEGVMGGNEFAEKLSEFGDY
HTRVSILGHVVRGGAPSARDRVLASKFGAYAVELLQEGKGGLCVGIHDNEIVASDIIDTL
ENNKHKPDLSLYDLNNSLSF
>FECAFAII_01179 Pyruvate kinase
MKKTKIVSTLGPASNSVEIISQLIESGANVFRFNFSHGDHEEQLSRMTMVREAVKKTGKD
VGILLDTKGAEIRTTVQGTTEADFGRAGYIKFEVGDQTRISMDPEHVGSKEKIAVTYPGL
FDDVHVGGHILFDDGLIDMQIIEKDEANRELVVEVKNAGMLGSRKGVNAPGVSISLPGIT
PKDADDIRFGLDNDIDFIAASFVRKAQDVLDIREILEEKDMTHVQIFPKIESQEGIDNID
EIIKVSDGVMIARGDMGVEIPAELVPMVQKRIIKKCNAAGIPVITATQMLESMQENPRPT
RAEASDVANAVFDGTDATMLSGESANGDYPVEAVSTMARIDQEAENALSELGTFQLNEFD
KTDVTETIGLSVARAAKNLGVKTIVAATESGYTAKMISKYRPDADILAVTFDERTKRGLM
LNWGVYPTVAEKPSTTDEMFELAAKKAVELGFASEGDLILITAGVPVGERGTTNVMKIQM
IGSKLLEAQGVGQKSVVANAVIASSAEEAVKKAKDGMVLVVPSTDKEYMPAIEKAAAVIV
EEGGLTSHAAVVGIAQDIPVIVGAKGATTTITEGELITVDSRRGIVYRGETTAI
>FECAFAII_01180 HTH-type transcriptional regulator GltC
MNTKDIEYYVQIVKQKNFTKVANYFRVSQPTITYALQRLEKEFDTVLITRDRSHHELIVT
PSGKQLFLHAQTILQEISTARAEITQLQKKKLRFGMPPIIGNEYFPKLSSYFIKHELMNQ
IEITDGGSRDLYGMIRQGRIDLAVLGSTQPIVDQYLETELLLDKRFMIVVPPTHPLSKQD
TVSFKDIADEQFVLLNEHYVHPAAFTKLSKQTHTHPKVVYQSNDLTILKSMVRENVGIGF
LAEIAVHPEDHLVCLPLSDEVQPRFLISLAKRTQQIVTPLQEQVVQVIHEFVTAQKNSSS
>FECAFAII_01181 hypothetical protein
MKWSLLELRKYQETPLTFHETLDLKAALMKRDNLILDVAPVEVEGLVSVDKKGYIVHYTV
QTTLTVPSTRSLEPVELPMDFSVDEVFMTEEQFQSRDEQMSADEILLIEGPLLNLAESIE
DNILLAIPMRVLTKEEEAATELPKGNDWEVVSEEEYQRRKMEEAENKIDPRLAKLSELFD
SKSKDDDNK
>FECAFAII_01182 50S ribosomal protein L32
MAVPARRTSKAKKAKRRTHYKLTIKGLNECPNCGEMKKSHHVCANCGYYDGKDVMSKEA
>FECAFAII_01183 6-phosphogluconate dehydrogenase, decarboxylating
MSKQQIGVVGMAVMGKNLALNIESRGYSVALFNRTGAKTTAVVEEHPDKNFKATYTIEEF
VESIEKPRRILLMVKAGPATDATIQELLPHLDKGDILIDGGNTFFKDTMRRNEELANSGI
NFIGTGVSGGEEGALKGPSIMPGGQKEAYALVAPILEQISAKAEDGAPCVTYIGPNGAGH
YVKMVHNGIEYGDMQLIAESYDLMKNILNLSVEEMADIFKEWNQGELDSYLIEITADILT
RKDDEGTGKPVVDVILDAAGNKGTGKWTSQSALDLGVPLPLITESVFARYISAYKEERVQ
ASKILSRTNDFEFTGDKKELVEKIREALYFSKIMSYAQGFAQLRVASKEFDWDLPFGEIA
KIWRAGCIIRARFLQKITDAYDKNPEIENLLLDDYFVEITKKYQQSVRDVVALAVQAGVP
VPTFSSAIAYFDSYRAERLPANIIQAQRDYFGAHTYERVDKEGIFHYSWYHEE
>FECAFAII_01184 Response regulator ArlR
MSNILIIEDEKNLARFVELELKHEGYNAEVHYNGRTGLDAALNNEWDAILLDLMLPELNG
LEVCRRVRQVKNTPIIMMTARDSVIDRVSGLDHGADDYIVKPFAIEELLARLRALLRRID
IEGDKNVAKQTTITYRDLTIEKENRVVRRGNEVIELTKREYELLLTLMENVNVVLARDVL
LNKVWGYETEVETNVVDVYIRYLRNKIDVPGEESYIQTVRGTGYVMRS
>FECAFAII_01185 Signal transduction histidine-protein kinase ArlS
MIKPKKSEKRELKGPSLTIKWAFASSFFIFVVFTIFAVITYKSSINLIVAKERNNVERTI
SEVASRLANSDEELTLVNTYRNLTKATNDGDEVVDHTSLVEGNLMKIDSFIAELGQPSMD
LYVYDLDENLIFKTHENSRNLIQTTRKVPTIVTLEGKTGFLSIQPIYSKGTREKIGYAQS
FYELSSFYDIRNKLLLTLIVLEVVSLILSSILGFFLSSYFLKPLKVLRDTMDTIRKDPQS
DIHMPEIDTNDELADLAEIFNEMLDRMRLYIEQQEQFVEDVSHELRTPVAIIEGHLSLLN
RWGKDDPEILEESLSASMQEISRMKSLVQEMLDLSRAEQVDVHYANETTKGKEVTYQVYN
NFKILYPDYVITLDDDLTKEVTLQIYRNHFEQLIIIILDNAVKYSTTRKEVHISISSTLN
EFEIAIQDFGEGIPKEDLNKIFNRFYRVDKARARTKGGNGLGLSIAKQLVENYKGRILAE
SVVGQGTIFRIFIPIAKAEDK
>FECAFAII_01205 Transcription antiterminator LicT
MKESASCFVLSYRGGELTVYVMKKLNHNAVLIDDDGIEKIAMGKGIGFSAKVSKPFDVED
ADKLFVLDSKEKIKRFSEIVSQIPIEFMDFAEEVIELITARISSPLDSNIYITLTDHIYF
AIQRKREDRDVTAIMLPEMRFLYPNEYDIAVEVVERINHRYQTELGSNEVGFITMHIINA
ELGEPNSLKSLKIVEMTTTILSHLEKSYSNVYDKESLTYHRLMVHIKFLVKRLIYQEETP
VENIGFFTETFKHSKAYCTALKIKDIIEQQFQLAIQENEIIYLAIHLARIY
>FECAFAII_01206 Carbohydrate deacetylase
MGKVIFNSDDFGYSHGVNYGIMDAYQRGILTSTTLMANMPGFEHAVKLRKEMPRLGVGVH
LTLTCGKPLLKTVDTLIESGEFRSLSYYQHPFNIDKDQLYQEWNAQIQKIYHAGIIPTHL
DSHHHTHTLDENQEVVVTLAKKYDLPVRSNFERKDEVRHVDYFEPCFDVVGETDEKKRQI
NTSVEEYLASLLMILREDKTIEVMCHAAYLDQELLNGSSFVYPRTHQVEFLIHSAFAQKV
KNDPLIELVTYEDI
>FECAFAII_01207 PTS system N-acetylglucosamine-specific EIICBA component
MNVKSNVQKLGRAMLLPVAAMPLAGLIMRLSADDMLNIPVIGAAGNAVFGNLDILFAIGV
AIGFVKNKDKGIPALTGFLAIATLKKGLEIMDPEVNMGIFGGIISGLVAAWTYNRFKEQK
LPVVFSYFAGEKFPLTMVMILQTIAAVFLGFIWPLIQIGIDNFAKLLVDMGALGVGIFMF
LNRLLIPFGLHHVLNTYIYYDLGSYTSPSKEVFRGEMTRFINGDPQAGLFLSGFFVVMMF
GIPAICLAIYKAAYKENKEMVKGIMGSGAGTSFIANITEPVEFSFMFLSPMLYVIHALFA
GLAGIVCYLFNIRIGFTFGACIVDYLINFRIATNAILILPIGIFFFALYYVTFYYLINKR
NIQTLGREAKAEFGNEVTLEETELGLASKNYEYMATKMLQAFGGKANILDVYSCNTRLRV
EVVDPTMVEEQRIKQLGISGIIKPTEKNYQIIIGLEVTYVMAEFNKLLEE
>FECAFAII_01208 Maltose-6'-phosphate glucosidase MalH
MMKKQIITIAGGGSTYTPGIVQAILNNEKRLPLSEIRLYDIDEERNMDMYLIVKFMLKRK
GFSNIRIRATDDPKLAFTGCDFVFSQIRVGGLEMREKDEKIPLKHGLVGQETCGLGGFAY
GMRSIKGLLEIVDHIQDYAPKAWILNYTNPESIVSEAVRRKYPNVKMINACDMTISIEET
IAVNYGYDRKNWIVTYYGLNHFGWYTSIYDKELQREIMPEIIEKLITKEMQVADFNIGDK
TWQKTFQMMSVITKNFPSNIPNNYLEYYLYPDMVVEHTDKEYTRANMVMDGREKNTKEMA
DKIRRGIVEEVLNFNFGEHGQYIVDIAISLLNDDRRRFMLIVPNQGAIPNLRSDAVAEIP
AYVGATGVEPITLRKPISDFHKGLMEAQVAVEKLLVDAYFEGSYQKALQAFTLNQTVPNA
RVAKKILDEMIKVNKKYWPALK
>FECAFAII_01209 PTS system glucose-specific EIICBA component
MHFFKTRNILKAVASGQIIPLTAVKDEVFSSKMIGVGYAITNHDGYIHAPVKGIIDNIFP
TRHAITIESESGRKILIHMGLDTVELEGSPFQIRVESNQEVKEGTLLAIIDLKKLEQAQK
DTVIIVVSPGIFEGNLLKQNQEVKIKDSCFEF
>FECAFAII_01210 Lichenan permease IIC component
MEKLMKWVEEKLVPPMAKIGTQRHLLAIRNGVVSTLSLILIGTFFMVFINLPFPGWNEFI
APYSATIVLPFRMTMGLMAIYATFVMGSDLAKSYGLDSVTGGILSLGTFFMLQVPVNVLT
PEEAPLGWVLPMSSLGASGMFAGILSMIFAVEVYRFFKNRNITIKMPEQVPPAVARSFEA
LIPGAVILTITWLIRSVAGFDVNAALLSLFEPLTNILGNNLLGVLLPMFLIHLLWSFGIH
GMSIVGAVVRPMWLIMLDENAKALADGTAATQLPYIAPEQFYQWTVTIGGAGATIVVSVL
FIFFCKSKFLKEVGRFSIIPGIFNINEPIIFGAPMMLNPYMFIPFNLVPLVLTIISYFAV
KLEMVNRFTVLPTWTLPAPIGGYLSAGNDWRVVILIMINTLIAFIIYYPFVKAYDKKMLS
DEQSRGENEVQTV
>FECAFAII_01211 hypothetical protein
MYWLILFFVFIFLLTASHLILNMLATYHIQINRWIWALASFLIVILPKIIVPHMNVLFSW
GTYVLCGIFAINFMIEQHRWFVTSKL
>FECAFAII_01212 hypothetical protein
MKTILFAPAVFNLAETTRMIEVAKAMKDRYYCVFFGFSKTFAPLITESGFEYHLLAPILT
KKQEEQIIKFDQLRTLKNPFTKEMVASRITSEQSLIAKFEPRLIVTGSNVTIFLSARNKK
IPLVYVKPYALSEPFFQSEHALMPHELRFFGPLSNPLWHWTKKRIVNTRWIPNAFKHAAQ
KEMLPLPKTSLQMMDADLNLITTPKLFLEEEQLPENYRIVGPIFAKLSTSLPEEVLTFIQ
RKQQERKRIIYFAMGSSGNPRMLRKILFFLQKQPDLAVIAPIDYLLDDIQSDSEDLLITE
YLSSHLLHEFIDFSFIHGGEGTVQTACESGKPFIGVGMQFEQSCNIDYCVKYGNAIALTK
PVTERKLQIALREVSSPKIRQQARTLQAVFPINGPQQAIQEIETFLSNHPI
>FECAFAII_01213 hypothetical protein
MIKVDGALLKEYRKKKGLTQVQLAEGICEQATVSNIENKNMSPGINILSALCKKLNVEIS
DILVETEEDKIRKKINEIQSLNSVSKYQESYKILQTIDQEKVSNSDLLNQILFYQGLLDH
LYAKKPDAALFYFNQVLEQTTETDIHHLQAAANVAMIYLSKGELDFAKVYVERTLKILSE
TDFDNLMVCIVYYDIATYYRKIEDYDKAIQLCEKGIEYNKKHKSTYALEYLLYEIASCHK
QLGEDDYLERYMDAKKIARFNGNDYAVKVIENDLK
>FECAFAII_01214 Glucitol operon repressor
MKNSLVNIEKRQKEILELLQQTEQLSTFELAESLDVSISTIRRDLNLLEEKNEIIRNYGY
CSYNYKNQTDFDQSGPERIKQAIAREASKYINDYDTLFINSSSTALKTLDFLQSNHLTVI
TNNVKINYSPHKDNCSYILTGGEMRFPKEALVGDIALNTISSVNADICIIGCSGVDVVHG
VTTKILNESTINEMMVNKTIKCKILVADHRKIGLTSKFKIADISVFDYLITDKFCSEKVL
EEIRNTGIKTIQVDSF
>FECAFAII_01215 putative L-ascorbate-6-phosphate lactonase UlaG
MSKTVNEVTKEKWLVETFPEWGTYLNEEIETEVVDPGTFAMWWLGCTGIWLKSHEGTNIL
CDLWCGTGKRSHGNGMMKKGHQMMRMSGVQNMQPNLRTQPFVIDPFAIKNVDALIVTHIH
SDHLDIHTAAAVHQNCPEATFIGPKEVVRTWQKWGIPEEKTITVKPGDAVKIKDINVVAL
EAFDRTALVTCEDPEEVLKGKMPQEMDQIAVNYLFETSGGNLYHAGDSHYSNLFAKHGNE
HKIDVCLGAYGENPRGITDKVTSVDMLRMAESLNAKVVIPVHYDIWSNFMADPKEITEIW
KFKKDRLKYGFKPYIWQVGGKFIYPTNKDDLEFNFYRGFEDVFSIENDTPFPSFL
>FECAFAII_01216 Mannitol-specific cryptic phosphotransferase enzyme IIA component
MLKYFFDHQLIHYPDKEITDWREAIAESCLVLIDKEIIDETYVEEIIHCVEKYGPYIVIA
PQVAMPHSSEKSDGVFGTAISFTKLKQPIRFESEGENEEKTASLFFTLAAKDPEEHLENI
QKLSELLMTDGLVERLISTNSIDDYQVVMAEYN
>FECAFAII_01217 Ascorbate-specific PTS system EIIC component
MGEFLLSIWTYFATNILTQPAYLIGFIVLLGYILLKRPLHECIAGFLKATVGYFILTVGS
GGLVNNFRPILVGLKERFNLDAMVTDPYFGQNAVDAGLMETFGRTFGDVMILLLIAFVLN
ILLVRFQKYTKLRSVFTTGNVQVQQAATAFWILLFCFPDLGRIQVLIFMGLILGCYWAVA
SNLTVGITQELTEGAGFAVAHQQMFGIFIFAKLAEWMKKRDEKKNRSIKQDKKIEDIKLP
GFLSIFNENMVATSLLMLFFFGIILIVLGKDYLIQAQFMQEGQSFLFYIMTTSLNFAVYL
AILQLGVRTFVDELTQSFQGISNTILPGAVPGIDVAATFGFGSPNAVTIGFLFGALGQFL
MIGLLILLKSPTIVIAGFIPLFFDNAVIAVYANNRGGFKAACLFPFLSGIIQVGGSALFA
TWIGMSTYGGYIGMFDWATAWPLFTVIMKVLGYAGIAVVVIGLLAIPQLQYRKNPDGYFL
IVEDYDTYAEKQRV
>FECAFAII_01218 Ascorbate-specific PTS system EIIB component
MRILVSCANGSGTSLMMMRSVEKAMKELNVPITKIHHCAISEGKSSAGQYDVVFTPVNFL
NMFTQAEKKGVTVIGIKNVMSVKEISEKFAETKWYQKNK
>FECAFAII_01219 3-keto-L-gulonate-6-phosphate decarboxylase UlaD
MSRPNLQIALDHNDLEHALGDVMKVGDVVDIIEVGTILCLQEGQKAIRCIRSMFPDKKLV
ADTKCADAGGTVASNVAKAGADWMTVICCATIPTMEAAQKEIGELQVELYGNWTFEQAMD
WHNIGIRQVIYHQSRDALLSGETWGEKDLSKIKKLIELGFNVSVTGGLNPHTLHLFEGID
VYTFITGRGITAANDPMKAAQNFKDEIIRIWG
>FECAFAII_01220 L-ribulose-5-phosphate 3-epimerase UlaE
MAQIGIYEKALPKDISWKERFSLVKEMDFDFIEMSIDETDERLARLDWSEEKIAELREEM
FSSGVRIHSICLSAHRRFPFGSADPEKKKAAKQLMKKAIHLAHNLSVKVIQIAGYDVYYE
EKSMNSREDFIEGIKESVKEASKYGIILSVEIMDDPFMNSISKFLEIKEQIHSPFLQVYP
DLGNLSAWPENNPARELEKGIDYITAIHLKDTYPVTKEYSGQFRDVPFGSGCVDFLGLLR
HLKRLDYDGTFLIEMWSEKSQDFRREIQQAKDYLSSKLKEAGYDVL
>FECAFAII_01221 L-ribulose-5-phosphate 4-epimerase AraD
MSCEEKIAAMKQRVLEANLALPRYGLVKLTWGNVSEVDRELGVIVIKPSGVRYECMQADQ
MVVTDLSGNIIEEDSLKPSSDLPTHVVLYQTFEDITAITHTHSTHSVMWAQAGRDLPAYG
TTHADAFYGKVPCTRQLTKEEVREAYEVHTGNVIVETFKERKLDPNEVPGVLVYGHGPFT
WGDSPMKAVENSLILDEICLMAKENELINPNICEIPQYLLDKHYFRKHGKYAYYGQ
>FECAFAII_01222 hypothetical protein
MNIDSLMIDEISELYKSVGWTNYTKDTARLARAFEQSESLIKRNGEGKIIGIVRWITDFA
TIAFIQDILIHPRYQRQGIGKVLLNEALEKITSYGPVQIELLTDDTEKTKKFYESVGFVQ
VKEMGGISYVIDTRRKKVLFGNDK
>FECAFAII_01223 hypothetical protein
MDYTVEFDSELLKQFPQEEHFMYKEAISHKVTEYLEHNFFRIKPVRTRSAKGIYEMKVKI
NKKNYRIAFALKKNHVFIFYISSNLQKIVFDKEVSKKIK
>FECAFAII_01224 hypothetical protein
MYYVEVKTKGVKNKQYVKGISNEYPLLGSWKEAAPFSKPCAIKIKNELEKELTCGKAVVD
IIEK
>FECAFAII_01225 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIVAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYIEKRSTEGWTPDVIIGRAERTFSCSVSTLYRRFKTGEFNVL
HLPMQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEGDTIVGIHHKSAVITL
VERLSKAIIALKPEGRKAVDIENSINEWLQSVPKNLFKSITFDCGKEFSNWKSISNTNDI
DIYFADPGTPSQRGLNEHSNGLLRKDGLPKEMEFNQVNQGFISSVASKRNHIPRKSLNYQ
TPLEVFLSYVNGKFCLA
>FECAFAII_01226 Transcriptional regulator MtlR
MQQLTKRERQLLIYLVEMSEPVTIKKLAEKENVSVRTIKYDLDDIREWLNERKQVLYSKR
SQGIWMNISSSDRIKLKSELMDVNRFEIFADQSLRIKRLLIMLLVTKEAITGMKMANALD
VSKDTIMNDLDVLENNFLKEGLTLNRQARKGFWIIGEERLVRLTIEEILQKEFTDYDIYK
LMSLLLNGGETEYFEMYSATATPIQEVFNQVIIRMRHLLEFENLEKLNYAELLNILIRVT
IATVRLRKEATIGRYQLVAEQELDKNDLSYRVMQQVFDYYQLPLFEDEYHYIYSDTFDTI
HQQDVMKLVENVIYKVSKAINHSFYQDPQLLTNLYAHLSMRLSRKKKFVNEYNPFKEDIK
QKYPELFDAIKQAVRQEISEQNILINDSFVAYIALHFLVSYEREEDLRSVRAVYICSTGL
GVTSLIKQKINEELNNITIVAFASVLNAQEMIATKDPDLVISIFPINGIDRPFIKVHPLP
TEQDLKKIQQIIKKILASSNQQERHNLNLRETSINKDTLEDFSKELILKAYTIYERLLVI
LEAELIQEYREAFLLHVFLMVHRITFDQQYMAEGRQVDQIILDKGTLVGKIEAVFAENNL
GINQSEISALFSYIKEGASS
>FECAFAII_01227 hypothetical protein
MKMSDEALKIIEESQNREKLKQVIDLIEERLVEHAIVPTELQWTILINHLNEMLKRSQRK
ETIPVVDRDLFKEVSKEAITISDEIVRSIGNLTDDEIYVLSIHFETAKNN
>FECAFAII_01228 hypothetical protein
MKLFVGIDVSSEKLDVCFLTDDNQLSILSEISVANDIEGASFIRETILEFNNSYHFDQIV
IGMESTSMYSFHPSMFFHEDEKLKKLNTLVTIENPFRVKQFSRMFDENKTDRNDALRIAD
FLRIQRFTTSPIKEEKYMALQRLTRTRYQLIKQLIRTKQHFLENLTYKCNTLAREMRDES
TSLFSATLISLMTEDFTLDELAELPLEAFCDLLQEKGKGRFKQPEKIAKAIQRAITMSYR
LGALAQESINVVLSVLVREIRALEKNIKELDKAIEQVIVVIPEYQCLTSIPGVGKVYAAG
LIAEIGQIERFEDQTKLAKYAGLSWKVNQSGNYQSQNTPLTKQGNRYFRYYLVEAANSVK
NYLPEYKAFYQSKYKEVPKHQHKRALVLTARKFTRLVDTLLRKHQLYTPPRSVIEK
>FECAFAII_01229 hypothetical protein
MIKVVIADRMGKGQNVAKGVEAAGGKAVVVPGMGADMRLGDVMQQEHADMGISFCGSGGA
GALTAATKYGYPERHGMRSIEEGITAIKDGKTVLGFGFMDQEELGKRLTEEFIKKHGK
>FECAFAII_01230 hypothetical protein
MSVQKTIQQKVIVSGKGETKQHAFASALAEIQNKIMEQSNVLLRIEPVNVDILKAVENKY
TERFLFFFFPRQRISYEVELSVTVAVTEIKLADISFSQQMTEDPNGIAIPFVTKKI
>FECAFAII_01231 hypothetical protein
MDFVIILVKSVIIGGLLGFAASVGAARMFHAPNTQGLGAFRTLGEMNACMGDPASHFSFG
LGFFFNAWASSVGAGAFTQDVTHRIIPNWAAAALLAKNKDVTQTMHDPKKMGIIGAVIGA
VVVAFLNTTAAAIPEALQVTAVSVLVPAATILINTVMPVIFWLAALDAGKRTGFWGTLFG
GIAQLIMGNAVPGVVLGILIGKGVDESGWNRVTKSMMIAIVLLFIFSGFFRGFDMEMIKS
FQLQVPNWLDNLHNIFSVK
>FECAFAII_01232 hypothetical protein
METTEEQAKVLEAKRQKSFWFADWSFPLIVGIMSAAVFAGTHMYVMYGVGAFNEVSIVAM
LKAGLDGGSYGAAAAFGASFLFARILEGSLVGILDLGGSILTGIGIGVPAILLSMKIAAP
IDNFALSLLTGLVLGLIVGGIIVLIRKFTINQSNSTFGADVMMGAGNSSGRFLGPLIILS
ACAASIPIGIGATLGALGFYAWKKPIAGGAILGAMILGAIFPAVN
>FECAFAII_01233 Deacetylase
MFDTLIKNGRLVDGSKIEVAIEKGMIKAVAAEINQPAQEVVDLEGKYYLSAGWIDDHVHC
YEKMNLYYDYPDQIGVEKGVTTVIDAGTTGAENIREFYQLTKSVKTNVYALMNISKWGIV
KQDELADLTKIQEDLVSTALAELPEFIVGIKARMSKTVVGENGIKPLELAKKIQTENNDL
PLMVHIGSAPPELEEVLSRMERGDVLTHCFNGKPNGILDPKTDQIKNFVWDAYNNGVVFD
IGHGTDSFNFHVAETALKAGMKATSISTDIYIRNRTNGPVFDLATTLEKLRVVGYSWEEI
IEKVTAVPARNFHLKNKGQLAVNYDADLTIFEIVENEKELKDSNGFTRIAKEQILPIKTI
IGGVIYDN
>FECAFAII_01234 D-glucosaminate-6-phosphate ammonia lyase
MTISYGKFDLKEVINASGKMTILGVSKVSESVLAAQRFGGEHFFEMSDLAIKTGAYLSQL
LKVEDAQIVSSASAGIAQSVAALIGQGDMYHVYHPYTEKIARREIIIPKGHNVDYGTPVE
VMVAQGGGKVIEAGYANMCTPEHVSMMITEKTAALLYIKSHHAVQKSMLTVAEMVEVAKA
HRLPLIVDAAAEEDLFKYSEMGVDLVIYSGAKAIEGPSAGLVIGKKKYIQWIRLQSKGIG
RAMKIGKDNILGFTQALEDYLKNGSESGDSMKQRLAPFVNAINQLPDLSAKIVQDGAGRD
IYRASVTINGDKSAKEVIQELKARNPAVYTREYQANNGIIEFDIRSVSQNEMEKIIKRLR
EIM
>FECAFAII_01235 2-dehydro-3-deoxy-phosphogluconate aldolase
MSVIPNYYKNRVCLNVLAHSVENAKACYEAAEGHVVLGVLSKNYASDEAAIEDMKRYQDA
TNNALSVGLGAGDPNQSQMVSRLSGVLQPQHVNQVFTGVGTSRALLGQNDTVINGLVSPT
GKIGYVNIATGPLSSQAPAAEVPIETAIQMLQDMGGTSIKYFPMKGLAHREEFKAVAEAC
AKYEFYLEPTGGIDLSNFEEILKIAIDAGVKKVIPHVYSSIIDKETGDTRIGDVKILLSM
VKKIIH
>FECAFAII_01236 PTS system mannose-specific EIIBCA component
MKKIIAITSCPVGIAHTYMAAENLEKAGKAVGAEVKVETHGSIGIENELTARDIEEAAGV
IIAADTKIDKSRFGGKPLITVGVQEGIHHADELVRDILAGKAPVYKSTEAIISSENKSES
ENLGKKIYKSLMNGVSYMVPFVVTGGLLIAISLTLGGTATPEGIKIPEGTIWATMNSIGS
IAMGLMVPILSAFIAQSIADRPGLVPGFVGGMLAANGALYGSDANAGFLGGIITGFLAGF
IALGIKKVRVPKALQSIMPIIVIPILGSLAVGFVFIYVIGEPVALLFSSLTHFLAGMQGG
SEIVLAMILGAMIVFDMGGPFNKVAFLFGSGLIAEGNYSIMGPIAVAICIPPLALGLASL
ILKTKFTKTEREAGKASLAMGLFGITEGAIPFASTDPLRVIPSIVIGAMTGSVIAMLSGV
TDHVAHGGPIVAVLGAVDHVAMFFVAVIAGIAVTVLMLRILKPTLQQTAVAAANGVTVAD
LSETETSDVYTKTETFDSITDIMSDEAIVLGETATTKDGVIEDLVQRLEKTAAITDKTRF
KEVIYDREHESTTGIGMGIAIPHGKSAYVLKPTVAFARSQSGVDWHSLDGKPAHMIFMIA
VPENSQGDMHLKILQRLSRKLMDDDFRQALMEAPDKTTVHQLLSEM
>FECAFAII_01237 Transcriptional regulator ManR
MNQRQQSLIYQLSENNNYITTKKLAEHFHVSERTIHSDLNTIETWLRDKHLPLMFERKKG
TGILLNGLPHEREQLKRALNEETQTEMDKKQLRQLLIFHLLVAKDGFSLEELSEKLYVGK
RTIRKELTELQSFFEYHHLQLVSKTKLGTFLKGDEQEKRQLLVKTLRNMQKEDPQSPSLK
EFFAKDTLKVIQHTLQDVFYENHLEQPNGLASVEIHIYFMLERMKQYQKVKLSKDENEVV
EHTQAQKLSSQILAKLATIYPIEFSPDEINYLALRIANLFTNSQAATRFQKESSALADHL
IEQVEQFLGYSLKEDQLLKQNLRSHLSSTYFRLHYGLQISNPLTKNVFSTYTQLFLVLQL
ILEDYFEKENFYVPQEETAYLTIHFQAAIERHKHQKSRRYQTVLVSEYSKAMATFLEARL
NRELPELTIMDLVEYKPELKRQDFPSVDFILATLPFKHISIPVIEISPMITETDLAYLTK
YMLEHVPIKKKKTFDLASFTHPFLIFPQLERTDPADILNFMGNVLVEHHYVEPEFIDSVL
ERDSHSSTRVAPFVTIPHGNPLYVKHSMISIATMKEPVLWHGEQIRIVLLLAIKKNDLKH
AEFKKIFSVIHYLEKQPEQMAQLMQSNHPLEILTLLSSYE
>FECAFAII_01238 Glutaredoxin arsenate reductase
MKKIYFLCTGNSCRSQIAEGYARKYLSPSMFEIRSAGIETHGLNPRAIKIMAEDGIDISK
QTSDLIDRDYFTQADLIITLCGDAKDKCPAVPNNHEHLHWDLKDPAQAVGSEEEILTEFR
KVREGIKRKVLDLNQRTSIV
>FECAFAII_01239 Alkanal monooxygenase alpha chain
MKKIGFLSFGHWMEQGSLVKSAQDAYLQSIDLAVEAEKIGVDGAFFRVHHFAPQIGSPFP
LLAAIGAKTSKIEIGTGLIDMRYENPYYMAENAGLTDIITQGRVQLGVGRGSPEQVLDGW
KYFGYDYSEEEIKEVTRERTLEFLELLEGKPFEEPNPQPMFPQGSGKLRIEPYSEGLRQR
IWWGAGSQQTAIWAAQHGMNLQSSTLVNYESHEPFHIQQANQLRAYKEAWKQAGHDFEPR
TLVTRSIQPITTDLDRRLFGQDGSPQQDAVGYLAYHRNPTIFGKTFAGEPDQLIKELAED
EAIKEADTVLVTIPNTLGVEYNMHLLETIVKDIAPELGWR
>FECAFAII_01240 putative HTH-type transcriptional regulator
MYSIGQVSEMFGLPVSTLRYYDKEGLFPDIQRVSGIRKFSENELEALRVIDCLKKSGLEI
KDIKQFMEWSKEGSKTFEVRKELFEKQKEVVEKEIAKLERVLAMLNYKSWYYEEAIKAGN
EEAVLTMIPDDLPQHVKEAYVHSH
>FECAFAII_01241 hypothetical protein
MNKELNITQEWDKVFPKSNQVNHRKVSFPNRFGITLVADLYEPKEVSEKKLPAIAVSGPF
GAVKEQSSGLYAQTMAERGFLTIAFDPSFTGESGGVPRYVASPDINTEDFQAAVDFLSVQ
KNVNPERIGIIGICGWGGMALNAAAIDTRVKATVVSTMYDMTRVTANGYFDVMDENARYE
MREELNAQRIIDFKQGDYARAGGVVDPLPEDAPQFVKDYHAYYKTDRGYHVRSLNSNDGW
NRTSGLSLMNAKLLHYIPEIRHAVLVIHGEKAHSRYFGEDAFKELKGDNKELMIIPGASH
TDLYDQTDIIPFEKMATFFEENLV
>FECAFAII_01242 Tagatose-6-phosphate kinase
MILTITMNPSIDSIYFTKHFELGTMTRFDSPVRYVGGKGINCGRASALLGSSVILTGFLG
GYFGSMIQDMLKNENLFDLHFLPIAEESRGAVTIMHDDETQTELVEAGPEIADTTIKKLM
NDIKLISKNNYLSVITINGSVNNPDPFLYAKLLQYIKEQIDPSTYILMDISGQHLREVLA
SKYKPMFIKPNIHEFSDIIHQKITQKSDIKHHLKTNPLFKDIDVIMISCGSYGAVVKVKE
EFWNVEIPKIPIINTTGSGDATVGGFAHSLEQNYPLKECVRYAMACGMSNAQQSEVGKVI
PADVKNLAKSIKITEMK
>FECAFAII_01243 Lactose phosphotransferase system repressor
MLKKERQEQIITLLEKDFYLTNSEIANKLGVSEMTIRRDVTELAKKNKVKKLYGGVERKE
PYNRELSTQEKIDTNVAEKKYIGQVMNSMIPDNSTIYVGAGTTILYALPFIQKKNLFVIT
NSLIAFNYLKNHTSYRILLTGGEFSPITEEFIGEVAERSFESLNVDISFAATNGIFDNNV
TTAQFIEGNIQNAALNAAKIKCIVADYSKLNKSDVYTFRKLTDFDYLITDNHLSEQDFNH
YSKYLTILKEPKNDTDNHDEPIH
>FECAFAII_01244 PTS system galactitol-specific EIIA component
MKYKEMFVPSLIQLAVEVKNKEEAFLIAAQQLEKMGYVNENYLNGLIAREREFPTGLITK
YLNIALPHSECEYVEKPFVFVMQLKNPIYFYQMGDNQEMTVENLFFLGIKEPKEQVGLLQ
AFMNLFMDETFVENYKKQETPQNIYELITNYI
>FECAFAII_01245 PTS system galactitol-specific EIIB component
MKNRLIVACGSGVATSQTIASKIQSMLEDDGIAFPVEAVDYKSIQNELLTAGIYVYVAQP
DEEVLEQAKDLGIEVFPGIPFLTGMGVEPIYDSIKELVQ
>FECAFAII_01246 PTS system galactitol-specific EIIC component
MEVFQTIINYVLNLGSAIFVPLIILILGLLAGMKLKKAFMSALTLGIAFSGMSMVIGYMS
NAVSPASEALAKNTGISLPALDLGWTGAASITWSWSYAFIFFAVTIGVNFVLLLFNWTKT
LNVDMWNVWGKALTAYLVYYVSGSLAAGFLTAMVQVILELKLGDMFQKHIQDLTGIPLVT
VTHFMTSAAVLLLPFNMIMDKIPALNKRADTNALKKKIGIFSENSVMGFIIGLGLGFAAA
YGVSGSLNLAIQTATALSLFPMISKMFMQSLSPLADAMSEFMKKRFKDREVYIGLDWPIL
AGRSEIWVTAILLVPVFIGYAIILPGNQVLPLAGIINYSIAVGGLLLTGGNLARMLILGI
ITMPIYLYGATYLAPILSDLAEKSGAVEGIKKGQLITWSSIEGPEFRVLFAEAFNRNILA
IVGCVIFLGLFVLLYKYMIKAKVPSERYAELQK
>FECAFAII_01247 hypothetical protein
MKREETDKIKWTVALCGTLLLFLYGLFTQNIIINLLVIFFALVIYKYGNHVLFREYDEKR
KRKIEESMKIKEATKEILREKSFIKR
>FECAFAII_01248 Methylthioribulose-1-phosphate dehydratase
MSDGRMLFERERQDMARIVRVIFERKNTNVAGGNFSFKTTDDQGKDYIIMTPTMMSEAYL
GEISPAQVLVVEPRTRRIVDGVGHLTREINMHEAMYETNPAIKAVLHAHAPNAMFWATTG
LPMPNLTEATAKVKEIPVMDFEPNCSEELAELTSDYVKKQHLELPHMLLLNSHGVLINTG
GESGIEAIHKALQILDTVEWNAEIAYKQTIFQALGITDGFYSKGEKIGGLEELKHKTAIY
NKSVIAAGGD
>FECAFAII_01249 Putative hydrolase MhqD
MTYIFEKGTSGKHLILLHGTGGDEHSLLDIAHFLAPNSTLLSFRGTVQEDGMNRFFKRNG
LNQFDLDSLEKETDKLHEKIKEISEKELIPLSDWLLVGYSNGANIAAHLLLERETELNKG
LFFHPMSLGVHQSRSTLEDKTVWISYGDNDPIVSPASFKELADQFETRQANVTIQLTVTG
HQLTMDEIKQAREWTDHLLTK
>FECAFAII_01250 Putative ring-cleaving dioxygenase MhqA
MDTQIRGIHHVTAMTSSATKIYRFFTDILGMRLIKKTVNQDDIETYHLYFTDDTGAPGTD
MTFFDFPNQPKGKKGTDTISRASFRVPSDAALDFWLERFEKYDVTHSAINERFGKKYIEF
EDFDNQYYQLISDENNQGVAAGIPWKNSNVPTEFAITGLGPVFVRVSQLEHIRLILEKIL
GFKETDHSGDFYLFEIGEGGNGASIIIEHRTDLPKAIEGFGNIHHLALRVADKEALEYWI
QVINKIELPNSGFVDRFYFQSEYFLAAHHVLFELATDGPGFLEDEPAESAGEKLSLPPFL
EERREAIEAYVRPFDTSDANKKRE
>FECAFAII_01251 HTH-type transcriptional regulator GmuR
MPKYEEIANILRERIRSKEYPLDSFLPNQVDLVKEFGASRMTIKKAINILAMEGLVYSQR
GSGTKILNHPFMQKDTSPANEYEGLSLQMKRRHRSLKSQIIHFDVEFPNQYIQERLMIDA
EQPVYNIHRLRILDGEPYVLEHTFMPVHLVPGLKKEHLLASIYDHLHQELNVHFAGAYRA
ISADKSDEYDQQYLNCAENDPVLEVQQVVYLKDGQPIEYSSSRNRFDVRNYSVLDVRST
>FECAFAII_01252 PTS system oligo-beta-mannoside-specific EIIC component
MNGFMDKLSEKIMPLANLLGQNRYLTVLRDAFMLSFPLTMFGSIVVVINNLPFFSDATKG
TLSNLFGNGQNATMSIMSVFVTFGIGYYLSKSYDVEGIFGGAVSFASFLILTPFAMKTAG
GEDVTGVLSLDRLGAKGMFIGMIAAFLAGEIYCRITKRGWQIKMPDGVPPAVTKSFAALI
PAVVTLTIFLVINAVMTGIFNANLHDVVYEVIQKPLTGLGSSLPATLIALFFVQFLWFFG
LHGQIIVNSVMDPIWNTLMLDNLEAYQHGKELPHIITKPFMETFTVGIGGSGMTLAVVLL
MAFVLKKKQYRDVGRLALAPGIFNVNEPAIFGLPIVLNATILIPWVVAPLIVTTFNYLVM
AAGLVPAPTGVSVPWTVPIIASGVLATNSWLGGMLQVIDFVIVAFIWYPFLKVLDKQPDL
DIA
>FECAFAII_01253 6-phospho-beta-glucosidase GmuD
MKTYTFPENFWWGSAASGPQTEGRVSDDGKGENIWDHWYELEPEKFFDQVGPEKTSQVYT
KYKEDVQLMKETGHNTFRTSIQWSHLIPEGTGEINQKAVSFYRDYFTELLDNGIEPFVNL
YHFDMPLPLQEKGGWLSRETVDAYVSYAAACFELFGDLVKKWFTHNEPIVPVEGGYLYQF
HYPNHINMKEAVQVGYHENLASAKVIKAYHEGGHDGEIGIILNLTPSYPRDETNPEDVKA
AKIADAFFNRSFLDPAVKGEFPQELIEIVKELAIMPEIHEGDLELIRENTIDLLGINYYQ
PRRIKAKETPINHEHSPMPDDYFDNYDMPNKKMNPYRGWEIYEKGIYDILTNTRENYGNI
KCYISENGMGVEGEERFVNSEGIIEDDYRIEFVTDHLKYVHQAIQEGTNCVGYHMWTCMD
NWSWTNAYKNRYGFIAVDLAQDGKRTIKKSGRWFKTVSEKNGFDA
>FECAFAII_01254 Putative universal stress protein
MVDTYRNILVAIDGSEKAEKAFLEAITIAKRNQATLHILYVNEVTGNYFGDFAFVTTSLQ
EELDEVAENQMKEHRNLAIEKGLTDIETYVLYGYPKTLIANFHESKEPIDLIVMGATGLN
AVERALVGSTTSYVVNHASCNVMVVK
>FECAFAII_01255 hypothetical protein
MISSDGIRGYNDAIILSILNKNDSYGYEISKTIRERTNDSYVIKETTLYSVFARLEKNQL
IVSYPGEVTHGKKRTYYKITEIGRNLLEEKKQEWLTTKDVVDQFLEGN
>FECAFAII_01256 hypothetical protein
MDTIRNYLDSLFIGVPQSTEIDKLKTDLLANMEDHYHELMGEGKNEQEAIGTVISTFGSI
DELLEELDVEKKHQADETETNTASIYLSEAENYWKEYRAASLQVASGVLFISLSFASFLF
FCSAGYVFMGISCLIFGIALAVGFFIASGMKITRLNHFLHHRKIPEKVLAEAKEKEEEYQ
RSFGFSLIAGIGLCIFSLFPLLASLMWYMDGSIGASIFFVTVGTGVFLIIYGSLVRHSYR
QFTQSAYYW
>FECAFAII_01257 Regulatory protein Spx
MLTIYSSRTHSYHLMANWLKDHQMPYRERIFTPKQPLTRKEIFYLLSLTENGFDDLLAKR
SIDYKNLKDQIDQCTTSELVDLIVSHFTLLQRPIITDGKKLLVGFNEDSMRLFIPVQWRR
SQLKSVYNDFTWVSNLENSTDLDDEFLNYYI
>FECAFAII_01258 hypothetical protein
MKLEDKKVILKKIKRLPDQIDGYTICSFKKDRSIKAYTQNTEKGIIYFLHEEGYDTQTFM
FTEKKEFHKQMKKLIEKEFPRSHKLYVNQQF
>FECAFAII_01259 Hydroxymethylpyrimidine/phosphomethylpyrimidine kinase
MEDQYVQAMTIAGSDSDGSAGMQADMHTFFTRNVYGVSVMTACVAGNSYGIGASVTLPTD
FIDKEFELIAKDFQIRAAKTGMLADSKLIETVVKNYQKYDFGPLVVDPVIVTKHGNLLLE
ESALQSLKEKLVPLAEVLTPNFYEAEKLTGRTLAAEEDFVQAAKELQDMGAKNVMIKGHH
AKNAQQETVNDYVLFESGKSFWLNAPFYPTDRINGTGDSLSACIAAELAKGKTVEQAIRL
AKDYVNRAIREEINVGHKYGPINHWAAGELE
>FECAFAII_01260 Major cardiolipin synthase ClsA
MVSSIITALYLLNALIALVAILIKPRDVAAIWAWLLVLFALPGVGFVLYLFFGRGLTDKK
KFYLRQSDLKELENFQSFRGDTIEHYDPDMGDKDKQQFVDFFSSLNRMPLTRMNSVTLLT
DGQEKLDSLLQDLKKAKHSIHIEYYAFVTDNIGQQVLHVLEEKAAEGVEVRILYDAFGSH
GTKAKDFNRLIKNGGHVHTFVTSQRALLRFRLNYHDHRKIVVIDGKISYTGGFNIANQYV
NTTKKFGYWRDTHIRIFGAASSLLQLRFLTDWNVSVPEEKKVGYHLNYFFKKADRDESKL
ADTSIQLVSSGPNNEREQIKLSFIKLITSAKKRVWIQTPYLVPDESVIAALKIATASGVD
VKIMIPNKPDHPFIYRATQYYARQLIKENVQILVYENGFLHAKTLIMDDEICMVGSANQD
IRSYRLNFETSAVIYDPEFLEELATQFKEDETHCSSMTTETVKEMSNWLLFKQQISRLFS
PIL
>FECAFAII_01261 Calcium-transporting ATPase
MENKEQAQQAVYKETIDSLMQQTQSSTDGLSTTQAKEKLERDGLNQLKEKPKKPTWKLFL
ETFKDAMVIVLLIVALIQMVMGDYIEFLVIFAVLMLNSIISVVQTKKAEGSLEALKNLSA
PDARVIRDGKEKTIPANELVVGDIVLLDAGDYVPADGRLLDAGSLKVDEGMLTGESTSAE
KEVTDITSTVPIGDRTNMVFSGTIVTYGRGKFLVTSTGNNTEIGQVAGLLESTTEQVTPL
QRGLDKFSKKLSLAILALSLLILGIQLFRIYLGEGTGDMTADIVSAVMFAVAVAVAAIPE
ALQSIVTIVLSLGTNKMAKRHAIIRKLPAVETLGSTSIICTDKTGTLTQNKMTVVDYFLG
NGDTGDFTNDPSKWTADERRLIEISVLANDASISEDGTKLGDPTEVAFIDFSEKLNQPYQ
EIRNNYPRQAELPFDSDRKLMSTGHTIDNKNYLFVKGGPDIVFQRSKKVLLNGEVVPMTD
ELMKKFQEQNEAFSTRALRVLAFAYRPLDNFDLSFEDEDDLILVGLLAMIDPPRAEVTQA
VTEARSAGIKTIMITGDHKTTAVAIAKQIGIFEEGNLALTGTELDELTEDQLNEVLEKVT
VYARVSPENKIRIVRAWQNKGHISAMTGDGVNDAPALKQADIGIAMGTGTDVAKDAAAMV
LTDDNFASIVSAVEVGRNVFDNIKKAISYLFAGNLGAIIAIIFALVADWSNPFTALQLLF
INLVNDSLPAIALGTEKAEPATMNRPPRDPNSGIFTDKTLISVTYRGVLIGIAVIFAQWL
GMQHSPEFGVAMSFSTLIWCRTLQTFPARSNTQTAIQAGFFSNRSVLLAVVVCSALYCLT
MIPGLKEVFSIPSAFGLTEVFTCMGIALVTIVLMEITKLIIVRVQGNK
>FECAFAII_01262 Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE
MNEKEWDEFAEEYYEIQQESQVTIAEDVKNYLKTEKVLPAETAADVAGGSGRFLSLAKEI
NRYDLIDFSSGMLENAKKEAEKNELPNVSFIKQSLEEFIQSNETYEMVFTAANPALVHLI
QLEKLMKKSSKWCVIIRVVESIDDVFYPIEKQLGMIEEDPNTSPVVMDQFETYLIDEGFK
VKKKDFTYFTQESITEELMKLYYDAYAKDPVVTRYIRKLFSEKREILSTTKLTYRLLLWS
ADKKRTFHDS
>FECAFAII_01263 Hydroxymethylglutaryl-CoA synthase
MKIGIDRLSFFIPNLYLDMTELAESRGDDPAKYHIGIGQDQMAVNRANEDIITLGANAAS
KIVTEKDRELIDMVIVGTESGIDHSKASAVIIHHLLKIQSFARSFEVKEACYGGTAALHM
AKEYVKNHPERKVLVIASDIARYGLASGGEVTQGVGAVAMMITQNPRILSIEDDSVFLTE
DIYDFWRPDYSEFPVVDGPLSNSTYIESFQKVWNRHKELSGRGLEDYQAIAFHIPYTKMG
KKALQSVLDQTDEENQERLMARYEESIRYSRRIGNLYTGSLYLGLTSLLENSKSLQPGDR
IGLFSYGSGAVSEFFTGYLEENYQEYLFAQSHQEMLDSRTRITVDEYETIFSETLPEHGE
CAEYTSDVPFSITKIENDIRYYKI
>FECAFAII_01264 Acetyl-CoA acetyltransferase
MKEVVMIDAARTPIGKYRGSLSPFTAVELGTLVTKGLLDKTKLKKDKIDQVIFGNVLQAG
NGQNVARQIALNSGLPVDVPAMTINEVCGSGMKAVILARQLIQLGEAELVIAGGTESMSQ
APMLKQYQSETNEYGEPISSMVNDGLTDAFSNAHMGLTAENVATQFSVSREEQDRYALSS
QLKAAHAVEAGVFSEEIIPVKISDEDVLSEDEAVRGNSTLEKLGTLRTVFSEEGTVTAGN
ASPLNDGASVVILASKEYAENNNLPYLATIKEVAEVGIDPSIMGIAPIKAIQKLTDRSGM
NLSTIDLFEINEAFAASSIVVSQELQLDEEKVNIYGGAIALGHPIGASGARILTTLAYGL
LREQKRYGIASLCIGGGLGLAVLLEANMEQTHKDVQKKKVLSAYAI
>FECAFAII_01265 3-hydroxy-3-methylglutaryl-coenzyme A reductase
MCKKKKFYQLTPSERRSQLIEKNVLTQETALIFQEQTLSEELSDHMIENQVSEVEIPMGI
AQNFQINGKKKWIPMATEEPSVIAAASNGAKICGNICAETPQRLMRGQIVLSGKSEYQAV
INAVNHRKEELILCANESYPSIVKRGGGVQDISTREFMGSFHAYLSIDFLVDVKDAMGAN
MINSILESVANKLREWFPEEEILFSILSNFATESLASACCEIPFERLGRNKEIGEQIAKK
IQQAGEYAKLDPYRAATHNKGIMNGIEAVVAATGNDTRAVSASIHAYAARNGLYQGLTDW
QIKGDKLVGKLTVPLAVATVGGASNILPKAKASLAMLDIDSAKELAQVIAAVGLAQNLAA
LRALVTEGIQKGHMGLQARSLAISIGAIGEEIEQVAKKLREAEKMNQQTAIQILEKIREK
>FECAFAII_01266 hypothetical protein
MKKKQKQKLLNQFRPSLDGVRGQLFRSLEEESLRRYGLPLQVMLDPKNRQILTIGLAGKT
NEDTRINVPIDDNFNTVLKRIRSGENGIFERFRDNLLIEIVSYWNDQRLKNDEPTAQAVA
TPVTEETVSVPEEKTEKPKADTTENTRSTDTNAALSFADFSKAVAEYPKFYTEQNEHEVV
INEKNADEPRKLATISMTTENEFVIEKALERKYKVKLTLIPLIEQFAATAITDR
>FECAFAII_01267 hypothetical protein
MDPIERLNSLSEEVTQTFHSDFVFLIDAEKIQHFPARNWTHDQIIEELKKRFDHSLMVKP
WHEHEVIYSPELPVFALIPKK
>FECAFAII_01268 Glyoxal reductase
MNSLTSTYRLSNGYEIPVVGFGTWQTPDGDVAVSSVKEALAAGYRHIDTAQGYKNEESVG
QAIKESGIPREEIFLTTKLWNANHSYELVMSSFEESLKKLQTDYLDLFLIHWPNPVAFRD
NWEQANADTWRAFEELYEAGKIKAIGVSNFLPHHLDTLAKTAKIMPMVNQVFLAPGELQT
TVVEYAKKHDMILEAYSPLGTGKIFDVPEMKQIAEAHDKTIAQVALRWSLQHEFLPLPKS
VTPSRIKENTELFDFELTEEEMKQIDQLDGVVGKAKDPDTTQF
>FECAFAII_01269 hypothetical protein
MDIYLKKAILHIIDRETGSPVFSQKELDLTKEYIRDFLQKKIQKISSAQTKTGQLAEESM
IVESLKIAQENFVEASEAIVQRWFDIYQESEEAPSADVFVVLYELDTVMYLSLLKVNYRE
AYTHFVEADEAGIDNRLILNRAILGAKTQKADEAFAVNLTDWTYELIEKKYEFSGKKELY
FSGRVIESVPAPSLEENVKVIQKVAKHLGKKFETEEFDIMADLKEAVYDTIEEKGRLDHE
MIAEKVFKENITAKMAFKEEVQEQGFVPEAPPVKEVQEISEKKFGKQKFKLSNGIELIVP
VDVYRNPDLIEFVNNPDGTISVMIKNVDEVLNRL
>FECAFAII_01270 hypothetical protein
MKKLIGVLVVLGIFLGGSFAAYHYFYGGEAYYTKITTNGEMSATQADNGEKFTTYTYKQA
AYNKDGEKKQVTLREEREHPLKMNAYLKLKVNPRKGVLSWEEIKASEVPKNAAEKIDN
>FECAFAII_01271 Elongation factor Tu
MAKEHYDRSKPHVNIGTIGHVDHGKTTLTAAITTVLGKKGLANPQDYASIDAAPEERERG
ITINTAHVEYETEKRHYAHIDAPGHADYVKNMITGAAQMDGAILVVSATDGPMPQTREHI
LLSRQVGVKYLIVFLNKVDLVDDEELIDLVEMEVRELLSEYGFPGDDTPVIKGSALKALQ
GDPDAEAAIMELMDTVDEYIPTPERDTDKPLLLPVEDVFSITGRGTVASGRIDRGAVRVG
DEVEIVGIKPETQKAVVTGVEMFRKTLDYGEAGDNVGVLLRGIQRDDIERGQVLAKPGSI
TPHTKFKAEVYVLTKEEGGRHTPFFNNYRPQFYFRTTDVTGTITLPEDTEMVMPGDNVTI
DVDLIHPIAVENGTTFSIREGGRTVGSGIVTEIEA
>FECAFAII_01272 Phosphatidylglycerol lysyltransferase
MLKNTIQWLKNHLGLFKTIFLISVIVIIVGELMSIGKTLSIQQLGETFATIPVWKSGLML
LIGLISVLPMVGYDIILNRMLEQKQNPRYLFETSWLINTINNIAGFGGFVSVGLRSELYG
QKKESRNVIQALSKVFLFLMAGLSIYSLLSFLLVVFTPVAPFLKQYWIWLIGGGLYFPVV
FLFTTFKKKGFLGGTSLKTQGQLLLVSLLEWTGVLFSFLSVGYLMEIRIDLWQTIPLFIA
ASVIGIVSMIPGEIGSFDVMMIIGLSAIGVPREIVVVWILLYRLFYYIIPFLIGIVFFFK
NIGSTFDQRYSGIPKQLATEIAHKIVVVLLYFSGIMLVLSATIPQAFTEFRWLHSLNPLK
FHFIIQFPSILLGFLLIIMGRGIAARVKRAYLPTIFLIVLALLYVLLSDFSFTPVVFLSI
LLLIILASKNELFREQLIYSWEWRTIDGIIIGALSLLYIVIGVYNLPDFPHRRHHFISFF
LFPSEKIWFSGLLAIIAVSFMIVLFVHFLQGEKKQIGEAFNEEKALKILTTYGGNSDSQL
IFLKDKRMFAYEKDGEPTVLLQFACFNNKCIVMGDPSGKKEDFPEAIEAFIEETDRLCYL
PVFYETSEEIVMILHEFGYDFIKMGEEAYVDLNSFTTSGKKMKGTRAVLNRIEREGFTFD
VLQPPFSTEQMSTFKNISDNWLGSRKEKGFSLGFFSEDYLQRAPIAVVKNTQEEIVAFAT
IMPTYTNNKVGTIDLMRYDSKKAPSGSMDFLFLHLFAYMKEEHIQWFNLGMAPLSNVGTS
RKSFLQERIAYLVYEFGSHFYSFHGLREYKSKYATNWVSRYTLYSRDSWIAYVMIALLII
DNAPVEQTQGRISGLKKWIRRKY
>FECAFAII_01273 2-hydroxymuconate semialdehyde hydrolase
MKKEKKYAKMPDGSEIYYEKSGQGFPLFLLHGNDGSGRFFSEQVPVLERYYTVYLVDSRG
HGRSTNEASMLNFQLMAEDLNTIMLLEKIDQADFLGFSDGANLALVFASSFPKKVHRLIL
NSGNTLVKGVRFSARVISNIHYAWVWLLSLFRPSLRKNLLVIKLLLHDIGLTENDLKKIN
SPTLIIVGKKDVIKLKHSLYIAKTIPKASFVLVKEQGHELARKDPERFNREVLQFLSET
>FECAFAII_01274 hypothetical protein
MKRKRLSIIRILFYMIILTVIGAVLFLGGRTYRSVKRVESYQIEITTAAKNYHMENYENL
IKAIILTESKGKGTDLMQSSESLHGEAEIIDNPADSIDQGVKYLAEMIVEAKK
>FECAFAII_01275 hypothetical protein
MEKRQKMENQEVGYTTKDWMLRFVKGMFIGSGFILPGVSGGALAAVFGMYERLISFLAHL
TKNFKENVLFFLPVGLGGVTGIFLLSFLVSFLLGAYETTILWFFVGCIAGTVPALWKEAG
KKGRDTSDVIIMVVTFVLAYLFLLYGAQLFDGQVDQNFGTWLIAGGLIGLGMIVPGLSPS
NFLVYMGLYKAMADGFKEVRLEVIVPIGIGGILCVLGLSKIMDYIFSKAYSKLFHFILGV
VFASTIMIIPTDYAGLGVAGVLACPVLFIAGTALGWWMSRLEEQYK
>FECAFAII_01276 putative cation-transporting ATPase E
MNGLTQQEVVQKMASGQQNDYQEDASKSTKQIFSDNILTLFNFLNFGIGICLLFVGAYSN
MAYLAIIVVNIVIGIYQEIHARNLVRKLSIVSQSEVLVIRDGKEQSISTKELVLGDLVKI
GAGEQIPADLQVISGRAEANEALLTGESDLIVKETGAELLSGSFLTSGSVMAEVIRVGAD
NYAVRLTSEAKTHKAIRSELVDSIRKVSKFTSFVIIPLGIILFLEALFIRDASIKISVIA
SAAALLGMLPKGLVLLISIALTTGVTKLAKKRILVQDMYSIETLAHVDTLCLDKTGTITE
GKMSIQRVEALHPLYEKAIPEIMGTYLAESSDNNITMRAMRDYFELSNRYDVTNKVAFSS
DRKWGAMEFPELGVVYVGAPERLVEEDRLPDSLKTAQANGYRVLMLGIAPNQQLNEEKPA
FVEPVALFEIDDPIRKNAQETLAYLHEEGVDLKVISGDNPFTVSNIARRAGLPNYDAYVD
LSQITEEMEVREAAHRYTVFGRVSPQQKKLLVNELKESGRTVAMTGDGVNDVLALREADC
SIAMAEGDGATRQIANLVLLDSDFTTLPEVLFEGRRVVNNVTKVSGIFFIKTIYSFILSI
ICAVTAIGFPFIPIQITLIDLAIEGYPSFFLSFEQDKRKITYRYLPTALINALPNALLVV
VNIIAVYLLGKTFAWGNAETTTLMYYLLIGISCMAVVKACYPFNPLRIFLAVTTIVGIYV
AAMLFHGILEVNLGLGESVGYFFVFMLVNIVLRVLYWKADIQNQLLKRVAN
>FECAFAII_01277 DNA primase
MAQRIPQEVIETVRSQTNIVEVIGQYVQLKKSGKNYLGLCPFHEERTPSFSVAEDKQIFH
CFGCGKGGNVFTFLQELEGLSFPEAVVKVADFEQIPLEDQWRQRTIAVQNPESATGKLIA
AHEKAAEIYHHMLLHTKAGQPALEYLQSRGLSLELIEEFNIGFAPNERSFLQQVFKNESI
SNELLERSGLFVTHDDGRMSDRFYQRVMFPLRNSQGQTIGFSGRWLAPEKGQEKDQPKYL
NSPETELFNKRQVLFNLDKARSDIRKNGEILLFEGFMDVIAAWQAGIKTGLASMGTSLTA
QQIQQMEKLTKELVFCYDGDNAGFEATNRGIELLRQNSRLALSVVVVPEKLDPDEYLRKY
GEASFQELVAHGRETVFTFKSRYLKQGKNLDNEKDKIEYLEELLVELSRVVSPIEQDMYL
SQLSTEFQIGRETIQKQLRDLRRTNQQNRQEPQESQHTQVTRQETARKKRPLTQVEKAEQ
ILLYRAFKEVSVRNILKEREFQFIHDAYAEVYFLFDAYVSQHYEFNLAEFLDFLQDENLR
RLVVEIEYLPVAEESSPREIQDLLDVISKSGLADEITLKKQMQQEARRTGNKQLELELTI
EIINLTKQLKQAK
>FECAFAII_01278 RNA polymerase sigma factor SigA
MANGTDKKTYEAAVAAFIKENKPKRQVVYDDLSNQLATPFTLNADEMDKLIQKIEDAGIS
VVDENGDPSIHSLKSAEKKAEQAKTEDLSAPTGVKINDPVRMYLKEIGRVSLLTAEEEVA
LALKIEEGDQEAKQRLAEANLRLVVSIAKRYVGRGMQFLDLIQEGNMGLMKAVEKFDYRK
GFKFSTYATWWIRQAITRAIADQARTIRIPVHMVETINKLIRIQRQLLQDLGREPTPEEI
GAEMDLPTEKVREILKIAQEPVSLETPIGEEDDSHLGDFIEDQEATSPAEHAAYELLKEQ
LEDVLDTLTDREENVLRLRFGLDDGRTRTLEEVGKVFGVTRERIRQIEAKALRKLRHPSR
SKQLKDFLE
>FECAFAII_01279 hypothetical protein
MNDSIKKMLRITEKDLMITEVSYETLQKKKTLVVDAVLSPTPRACRSCGSTVVDGNGKAI
IVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKSCQVSLTTVIRTLKEFKSYLPKQSKKILPRVLMVDEFRSHASIED
KMSFICADGETGKLIDVLPTRKLPRLTSYFLGCTNPEEVEFLVTDMNAAYFQLTKRVLPN
AKVVIDRFHIVKHMNQAFNELRIREMNELRKAGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLEFSPPLKEAYPFFHELVEAFRDKDPDLFFSLLAELP
ETLDDSFREKLQNLLTYEEGITNAMIYPYSNGKIEAKNTHIKTMKRVSYGFKSFENMRIR
IFLINQLINVR
>FECAFAII_01280 Mid-cell-anchored protein Z
MMKKCPNCGSKKMEQNTICPDCGHQITAEDQQIKESIEETNTDAAMQDKSTEDAVFPDTE
LNDPIEWSELKDLPLESVMELFEKAEPEDEEPPAHDQVTNIEKNEQKKATVHETSEESGK
NQEETLESKQKRRVAELKEIVDNEEENSILSAYIKAHREDTKEEHAKELLKMISEKIAQE
NKVEPEKEQETEKDSDRENATGKETVKIKDVKTDITEKTEVFTEKQLEKEKTNKLPEAEK
KEILENTDKKSTEPDEINSESDAENQSVSKEGTDLEAKIEKEENQPKLFEAEAKSITIVP
DTEKTHQESNLEKTDPDKAQKKKSKKVPYLVLAAVLLLGGGSWAYYDHHQKVEAEVAAEA
KRQQQMEELHEKLAAFYTDDHHQFIRADMIHQDLSKLKNDLSSLKNEKGYSELETTYQDI
QSKIRDIQKVNEWFIAPAIVDDHLADDIKLKADKEIQAIETDNTDFGKLIQQAQTEAKNQ
YAELQTAKEKTAIVFKDGKVVDSATRDQYKTAKEAVEKVKNTDLSAQLNEQLKQVDKMLT
DKEKKEEEEKKKAEEAKKAAEEQAKQAAQAAAAAQAAQQAAVAQAAQQEAASSTPSSSNS
ANQPIKSARASDIADASNPAWTWAPGVQSKVIATCIQRGYIVEGGYRLEKARIENGEGYY
NLYATSTKSALMKGIGESALPFYIVTINCKTGWFGGNGSN
>FECAFAII_01281 Conserved virulence factor B
MNDLLATIFTGIIIDENEKNYFVQKNGQTFGLSKSEGEHKIGEAVEGFGYQNQKHENRIT
TQIPKSRIGHYAFGIVTATRKDLGAFVDIGLPDKDFVVSLDELPTMTELWPKKGDRLMIS
LRVDAKDRIWGSLADEKIFKSLSKYGTEEMKNKDVIGTAYRLKLTGTYVLTEDFYLGFIH
PSERYNEPRLGEQIKGRVIGVRPDGVLNLSLKPRAYEAISDDAQMILTILERSADQQINF
TDKSDPEEIMKAFGISKGAFKRALGNLLKQGLITQENGVTKLVKKSN
>FECAFAII_01282 Ferric uptake regulation protein
MNAISAMKKTKQQLHEAGFKLTPQREATLLVLLENEKEHLSAEEIFFLVKKKSPEIGLAT
VYRTLEILTELKIVDKVSFNDGLARYDLRKEGAKHFHHHLLCLNCGTIEEVEEDLLLEVE
QVVEERYHFLVKDHRLTFHGICQECYEKEKRNQSV
>FECAFAII_01283 hypothetical protein
MKKKKETSPSECLDGFFFAQIMEKDYQNEAVSDMIERHEGDYYERANQRLSPLLEY
>FECAFAII_01284 Tyrosine recombinase XerD
MKEQINDYLHYLNIERGLSANTRQSYERDLEQYLHFLQEQKIASWQDVDRFLVIRFLEKL
HEEKKATATVTRMISSLRRFHQFLRQERITDHDPMQHIDTPKKAQKLPSTLTLTEVEKLI
EAPDTTKTLGIRDRAILEVMYATGMRVSELIGLKLGDLHLSLGLVQTVGKGDKERIIPLG
DYAIQWLERYLDEARPLLVKDASEMHVFVNNHGKGLSRQGIWKNLKQLVREAGIYKEVTP
HTLRHSFATHLLENGADLRTVQELLGHADISTTQIYTHITKKRMTDVYKQHFPRA
>FECAFAII_01285 hypothetical protein
MLTHYRKENRKIAMGLLSFHKKLTGKTSLLKEIDTYESEDDYELFFFTPEGSTNIQGIIG
IYWATNDQLIIHDISLNPSYRGENMGFQMLDELQEKYPDVSIRATEITEPYIGKWLAKKK
KKE
>FECAFAII_01286 Segregation and condensation protein A
MASKEKEERVNELTEINIKLDVFEGPLDLLLHLIQQMEIDIYDIPIATITEQYMNYIHTM
KTLELAVAGEYLVMAATLMAIKSKTLLPVQEFVTDDEELWEEDPREELVTQLLEYRKYKY
AAERLTEKAEERSLYYTKEPMNIDGLADAEKPLKRGQVKKIDLIRAMQKILERKKFSQKV
EKTITPDDTTIEERMVFIEERIKRNAHGCTFDSFFESPSKSEVVTTFMALLELMKKGQII
AQQKENYESIMLYPAVGDTEHDEIK
>FECAFAII_01287 Segregation and condensation protein B
MTKLSELEALLFIVGEEGISNEELSGLLNLSEAEVTSLVKELKESYTQNSHSALHIFETE
SHYVLTTKKELAPLLKRYAQGTSNTLSQAAVETLAIIAYKQPITRAEIEQIRGVQVSGAV
QRLAAHKLIEEKGRVEGPGRPILYGTTGYFLDYFGLKSLEELPDTQEMEISLEEDVSPDL
FFDGMNKGE
>FECAFAII_01288 Ribosomal large subunit pseudouridine synthase B
MERLQKVIAHAGITSRRKAEEFILAGRVKVNGQVVRELGIKVGKHDTVEVDEVPIYQEEY
GYYLLYKPKGVISAVADDKGRKVVTDLLPMVKERIYPVGRLDYDTSGILLLTNDGDFAQR
LTHPKHEVDKVYVAKVKGIATKSMLAPLTKGIKIEGRKTSPAKFQILSVDPKTNHSIVEL
TIHEGRNHQVKNMLQAVGLPVQKLKREKYGDLTLQGLRPGDYRELNKKEVSSLLNHSK
>FECAFAII_01289 Riboflavin transporter FmnP
MKNTRVQKMVAVAMFAAIALVLQYFAFPIMPAFSFLKIDFSDISVLISMFLFGPAAGVAT
AFLRSVLHLLTTGFSPDNLVGDTASFLSTTIFTFPIYYFFSVKKQHKGRNKFLGVITGTI
ALTIFMSIANYFVITPLYLMFLGLNATQMLGMSLANYVLIGIVPFNLIKGFIVSAVFLVL
HAQLLPWLSRKQHQFEQRHTAVK
>FECAFAII_01290 hypothetical protein
MEQTKKKKFQMPSAYTVLFIIIAVIAVLTWFIPAGHYSVDDAGNIVAGSYERVQQNPQGL
WDIFMAPINGMLGVPAGELTKETPAAIPISFFILVVGGFLGIINKTGALDAGIASVVKKF
KGKEKMLIPVLMLLFALGGSTYGMAEETIPFYALLIPVMMAVGFDTVVAVAIVLVGSQVG
CLASTVNPFATGVASQAVGISMGEGIGLRFLMFVILLAISIVYVYRYASKIEKDPTKSLV
YNQRKEDMKHFDIEAIGRQEVITKKQKHVNVLFFITFGIMIISLIPWTTLNANFTIFESL
TNWLTNLPVLGTVLGKSMLPLGDWYFPEITMLFLVMSIVVAITYGMKESEFVSEFLAGAS
DLIGVAIVVAVARGIQVVMNNGLITDTILHWGEQGLSSLSSSVFIIITFIFYIPMSFLIP
STSGLAAATMGIMGPMGEFAGVGKDLVITAYQSASGLVNLITPTSAIVMGAVAIARFDVS
VWWKFTGKLIAILFVAICVILGVAAMF
>FECAFAII_01291 Putative dipeptidase
MKKFVTEQHHEQALESLSELIRIPSVLDEADSGQGHPFGKKVIEALDKVLEISEKLGFRT
FKDPEGYYGYSEIGSGDELFGILCHMDVVPAGDENNWETKPFDPTIKDGWLVGRGSQDDK
GPSIAAMYAVKALIDAGVEFKTRIRFIFGTDEENLWRCLEKYNEKEEGITQGFAPDAEFP
LIYAEKGLLQAYLTGPGTNEFSVKAGGALNVVPDAAPYSGEKLSEVKEALKKHEFDFEEQ
GEGIVVLGKSIHAKDAAQGVNAISRLAIALSEVFDFGPINFLGKLVQENATGEAVVGKTE
DEQSGELTMNFASLEITPEQTKIGVDMRIPVTFKKDDLVAKLTKTAEKYGLTYEEFDFLD
SLYVPLDSELVKNLLGTYRDITGDMTEPFVSGGATFARTMNQCVAFGAMFPDTPDFMHQA
NERWELSSMYKAMEIYAEAVYRLCAK
>FECAFAII_01292 hypothetical protein
MKIFRRILIGLVIILGLLGGAGYYYIQQNTYEPSSEAQVLVKEGKNKEDYLFFEGEKKNH
GKSPLLIFYPGALVEPESYSIWAQDLAKNGFSVAIVKMPLDLAVMGGNKADKVKEDFPNS
DYVIGGHSLGGVMASRYVNKNHSDKHLKGVFFMASYPDKKGTLTESAVPVLSITATKDKV
LNQEAYQEAKQYLPERTEYVSINGGNHGGFGSYGEQKGDGEAEISNADQQTVIVNTLENW
LKKLK
>FECAFAII_01293 hypothetical protein
MSLLCKLVPERCIACGLCQIEAPDIFDYDEEGIVLFAQEPEAHQQFVMPEEETYVKKAYQ
KCPVRAILLENKI
>FECAFAII_01294 hypothetical protein
MIVFILSLFSSGHKLRISSLYQLLVGKRTTSVLIYGFTHELLFIHNSFPELKQDKFYQIL
QKIAQQGWIEINENEAKLTPAGADMLSEHQIEHTGLRFDRYGRTGETSWRLIKFAVQVIS
NLATGIQDYLPAETSPFYTFQLKKWLSESQLPREILIDTAYESLVQLFSEIPEEAADFLA
NQLSGNERTGLLPYQLAKNNDESAVYLQQSRCIHLLLAQIEKRPDSLWHALIDSLLQQNF
NQSMMITKQMFMNGQTIDQIMAIRHLKRGTVTDHLIEWALFFDDFPYEWILSAETIERLE
PNKDSVREWRFSEWNVDGQLDYGEFRLYQIYLLRKEAIQNVNK
>FECAFAII_01295 ATP-dependent DNA helicase RecQ
MLINELKKYFGFDSFRPGQEEIIQALLDGEDTLAILPTGTGKSLCYQLTGYLMEGLVIIV
SPLLSLMEDQVTQLQKRGEKRVAAFNSLLSQSERRYVLRHLSQYKFLFLSPEMLTNPSLL
EHLKKQNIALYVVDEAHCVSQWGVDFRPEYQQLGKIRKLLGNPVTLALTATATDLVARDI
RHVLFDRPPKEIRQSVNRQNISLFVRKTQQKEQELEHFMERAQGAAIIYCATKKEVERLY
HLFRERFTVGYYHGGLDAAQRRQLQQQFVKNQLQFLIATNAFGMGIDKSDIRYVVHYDLP
DSLENYVQEIGRAGRDQEESAAILFYQSGDERIHYFFNQLSREQRQSFELYLEYATEQAP
FDELQKKWMELIQQSEKPENWVERLKRQEKEKEFRLQQMLRYINEENCRRKFILAYFGEK
LSEKPQNCCDIDGAKAELLPKRKLFSKTEQLHWETILLNLFKKNMEH
>FECAFAII_01296 N-acetylmuramoyl-L-alanine amidase sle1
MSRKDRHQSTENNETQEPWEQPIYDTDDEVSSRSSQRQQKKGNTLFLSLFLILLVLCIAI
PAGAYFWIRNGSSNNATAATSSETSTSVVESSTSTTKEESTETSTVESSTIAEESTVSQD
TGVTSESSIAAETTPTSSSEATYQAGDSSSNAAETTPSSSAAAGSTTTVQAGEGPKQVAE
RAGITTDQLFELNGLDPNNFMLYPGQELRIK
>FECAFAII_01297 Cytidylate kinase
MTQISIAIDGPASSGKSTVAKILAKELNYIYTDTGAMYRAVTYLAITNNVSFSDEEGLVS
LIKKYPISFSQQEDGQHVFIASKDVTLEIRQPDVTKAVSEVSAHGKVREELVAVQRKIGE
RGGVVMDGRDIGTAVLPNAEVKIFLVASVSERAERRFKENQEKGIPTDLETLTKEIQERD
HYDSTRDVSPLKQAEDAVRIDTTGKSIPEVVAAIKAVVLKKGYLLF
>FECAFAII_01298 30S ribosomal protein S1 
MTEFDQNQENNQSMEDAMKSVQEVKVGDVVKGEVLVIEDKQVIVGIEGAGVEGVVPAKEL
STLPVEDISEVVKVGDVLDLVVISTIGKDKENGSYLLSKRRLDAKKVWEDIERDFQEGKV
IEAPVTNVVKGGLVVDVGVRGFVPASMVEDHFVADFSDYKGKTLSFKIIEIEPSENRLIL
SHKAVVENEREEKKKEILSTIHEGDVLSGRVARLTDFGAFVDLGGIDGLVHVSEISHSHV
AKPSDVLAVNDDVNVKVLSINPEQERVSLSIKDTQPGPWSEIDTKAPVGTVLDGTVKRLT
SFGAFVEVFPGVEGLVHISQISHKHIATPHEVLHEGDEVKVKVLEIHPEEHRIALSIKAL
EEKPASEEEPKNVESYELPEENTGFTMGDILGDALKEEVEEKATDDSEK
>FECAFAII_01299 GTPase Der
MANPTIAIVGRPNVGKSTIFNRIAGERISIVEDTPGVTRDRIYAKGEWLGREFSVIDTGG
IDLGDEPFMDQIKHQAEIAIEEADVIICVVSGREGVTDADEMVAKILYRSNKPVILAVNK
VDNPEMRNDIYEFYSLGLGDPYPVSGSHGLGIGDILDEAVKYFSEETEEEDDDTIKFSLI
GRPNVGKSSLINAILGEERVIVSDIEGTTRDAIDTHFVSESGQKFLMIDTAGMRKRGKVY
ENTEKYSVMRAMRAIDRSDIVLMVLNAEEGIREQDKRVAGYAHEAGRGIIIVVNKWDLVK
KETNTMRDFEQEIRDEFRYLDYAPIVFVSAVTKQRLERLPEMIEQVSMNQNLRISSAVLN
DIIMDAVAINPTPTDKGKRLKIFYATQVAVKPPTFVVFVNEEELMHFSYERFLENQIRKA
FTFEGTSIRIIPRRRK
>FECAFAII_01300 DNA-binding protein HU 1
MANKAELIEKVASATDLTKKDATAAVDAVFSTIQDALANGEKVQLIGFGNFEVRERAARK
GRNPQTGEEIEIPASKVPAFKPGKALKDAVK
>FECAFAII_01301 hypothetical protein
MELDYQVEDALTKVFYGETLVSQLRELSIDQPILFLTNQRYYDLFADKINPLFANQANND
WYICANTQCNHLTELKNLLDFVKRYPENQSMFIIGFGNEGIMDLAGFFQKHTTLDSSLWM
IPVSIRSLSRALTPQRTILQLPNRVVLQTINLPERIVYDQTISERQVDGKQIDFLTFICC
GMICAHRFLQNLYKNYPNKKQLTTRPFAGMIEEMIYFYQLEAENLSNYGKLFEQAFYLTE
NGHLLSASMKKFLGMMFHFVWNLQAYPFDFQLKNFFVWLDLLGYPIHWLEQISKMEYLEK
VLFLAEKSKKILVLEKIGIIDGYQHPNEKELLRTMTVFQQIVSEIRGN
>FECAFAII_01302 Beta-barrel assembly-enhancing protease
MNTNSEKMLQALSDEDLSQAQIFLEKALKEDPADILAELGEELLAIGFLIEAKQIFEQLI
NQYPENDGLNIPLAEIAIEDNEIDLAFEYLEKVDKQSDYYPQSLLAIADLYQVIGIPEVS
EAKLKEAAGLLPDEPLIQFALAELYFSVDRFKEAAVVYETLLASGINEISGISMQERLGQ
SLSMQGEFEAAIVPLEEALKEERTDDRLFQLAFTNLQLKENQQAINYLEELREVNPHYQS
LYLYLGQALQEEEMIEEAQTVLEEGIKENPYQVELYHLASENAFRLHDRQRAEELLLKAL
EVGDKQDETLLTLSNLYLDDERYEDVIQVINQMEETANPYAEWNLAHAYNELEDFTVAAV
HYEQAYHELSHEPDFLKEYAFFLREEGQLKRAQELLTYYLTLEPGDMEALSLLDDLTER
>FECAFAII_01303 hypothetical protein
MLIDVREKKNFLTWMVNHVSFSRREVFWILNYLANHEAILSNVHFVEGANFADRGLQISD
LSVEGEPMKLFLQGKEFTDTDQIFHEIRLNWKKPLYVECIFENAWQTREYLSILEDNPFS
SWDSSVSEEDTELIERYFQEKEEEAKLKMLYAQIDQALEDGDRDAFLKLSDEVNRKILLQ
TQKKSNRVSEHNN
>FECAFAII_01304 hypothetical protein
MVKRKTVKEVLFIIIGTSIYAFGLVYLNIANHLAEGGVSGITLILRALFGIDPAYTTLLI
NIPLILLGGKILGKRSLAYTVLGTLSLSFFLWIWQRVPLEINLQHDLLIVSLLAGLVAGV
GSGIVYRMGGTTGGSDIIARILEQNYGITMGRSLLAFDIIVLLASLTYIDLKRMMYTLIV
SYVFSRVIDSILDGGYSAKGLLVVSNKSEEIAPLLMTGLQRGVTFLSGEGAFSGNSKKII
YMVVSSSELTEAKRIVHEIDEKAFLSIINVHEVEGQGFTYLKPQTRLLKKL
>FECAFAII_01305 hypothetical protein
MDKKRSLYSMQQEVDEYIQQFKVGYFSPLAQMARLTEEVGELAREVNHTYGEKSKKASEP
VNSVAEELGDVLFVTMIMANSLNIDLTEVFEKNMEKFNQRDHNRFERKDE
>FECAFAII_01306 CCA-adding enzyme
MKLKQLPLEYQKAIPVLKKLENAGYEAYFVGGSVRDILLNQPIHDVDIATSAFPEEIKQL
FPKTIDIGIEHGTVLVLENDEQYEITTFRTESTYQDYRRPDHVEFVRSLAEDLKRRDFTI
NAFALKEDGEIIDLFDGLQDLEEQILRAVGNPHERFHEDALRMMRGLRFVSQLGFKLEEE
TFYAIKENHELLGKISVERINVEFIKMLLGNERAAGIHAFIETECYICCPGLKEEGEALL
RFAELPSVPLKEESQAWALLISQLDLKENEIRSFLKSWKCSNQMIKDVQALVQGLRQRET
GALEPFELYFLGKKHALQVEELMIYFDETPQMDAVGESYDRLPIKSLSELAVDGKILLEE
TGKKPGKWVSEALQLAEKAVVEQRIKNDKKQVLDFLSKEKLI
>FECAFAII_01307 hypothetical protein
MSKEMTALKFYFRNGETWTINRRHIGDLWIKQITTSFGRINGSEFVEIHPCAGFKIEIFH
EGDAVATHDINLGGLEMGMFNRALKYEDIERMEILYRNGTPDLVYFPYLDKGTEGLDNQY
QSTKISEKTGNLYIVINPDQRVEDVYGEFFE
>FECAFAII_01308 hypothetical protein
MRESFEQQKKLLHDRYGALSMDDRRQILCKLRKRNILMYRQLERLKHDLLRLESKRVQCE
LEGNQTQVEVVETKILKKKEQFLKMLTQNKK
>FECAFAII_01309 Sodium, potassium, lithium and rubidium/H(+) antiporter
MEFAELVIVFAVTITLSNIASRILPMIPAPLIQIFLGVVLGLTEWGQSIDFEPELFLVMI
IAPLLFREGEKADISSILKNFGTILFLAFGGVILTLVGVGATLSFLLPSVPLAACFAFGA
ALGPTDAVAVSSLSGRVNIPKKAMHILEGEGLLNDASGVTAFQFALGALITGSFSAVNAG
MSLVVSSIGGALIGFLLVWFKQKIIHLIEKASAQDVTGYLLIELLLPFLAYVLAEAFDVS
GIIAAVAAGILQASGFRKISVFDAELSSLSHSTWTTIAFTLNALVFIFLGIELTQVFSPV
WGDGLYPNGLLLAIIVLISVMLFVIRFISISLFYVFKDGSKKFKKQLNEILILTFGGVKG
TVSLATIFILPFSINNMMFYQRSLLLFLTAGVILVTLVIGIIVLPMLTETEEAKSTDLNA
LMILEEVVEVLRKEIKEIDRNTKEFLATEAVIENYQERIRDLYLEDLTDDEKQEVQEIQA
LILSIERDGLDESYRSGKLSSNGYRFYSRFLSRFEHSITSQILSFIGFWFIVVRRLMRIV
LHPKMFWQRRYADRQTFISDEDIQEIRETYQKNTQLIIESLDNLTDIYDETMVQFFIQQR
KLEGIKMNSGNLISSWMIQQDSLFTKKMLRGYYLERKIIDEYEVAEKITTFSANSYRRNI
NLLESYTMNKPSDNFSFRFAFRAKSKKTSPIK
>FECAFAII_01310 Energy-dependent translational throttle protein EttA
MLKELKVTDLKKTYGEKDLFDQISFLVHEKDRIGLIGTNGTGKTSLLNIIAGIDSSDGDR
QTVFYPTDYRIGYLSQAAEFSDELTVLQAVFQGNSPLIQTVRAYEEALIELGENGEDPDV
QKRYAKAEEQMNKEDAWTTDTNAKIILQKLGISELDKKISTLSGGQKKRVSLAQVLIDEP
DLLLLDEPTNHLDYEAIEWLENYLKQYRGALLMVTHDRYFLDRVANRIFELSFGKLYEYK
GNYEAYVLEKAERDRVEVEQEEKRKRLYKQELAWMRAGVQARGTKQQARINRFEDLKENL
YQVNQEDDLELNLATQRLGKKVLEIKDGSYRINDQTLLEHLDLLIQSRERLGITGKNGAG
KSTLLNILAGRIPLDSGTMSIGETVHLAYYTQENEEMAPDKRMIAYLQEAAEEAKTADGS
QIGVAELLERFLFPRFMHGTLIGKLSGGEKRRLFLLKLLIQQPNVLLLDEPTNDLDIATL
TILEDYFRSFPGAVITVSHDRYFLDKVADKLLVFQGNGKQELYYGNMSSYLLKQKETQQP
AEKAKPKIQSKEPAEKKKLSYMEQKEWETIEDEIAELEEKISLLQEEMNHQGDNFTRLQE
LQNDVSETEAQLEEKMARWEYLSEWVED
>FECAFAII_01311 Thymidylate synthase
MEQAYLDLGRKLLEEGHRKEDRTGTGTLSLFGYQMRFDLQKGFPLLTTKRVPFGLIKSEL
LWFLKGDTNIRYLLQNKNHIWDEWAFERYIKSPDYNGPDMTDFGHRCLTDPEFNEEYKKQ
SKLFCEKILTDDSFAETYGDLGHIYGYQWRHWETKDGGFIDQIKQVIEAIKKTPDSRRLI
VSAWNPEDVPSMALPPCHTMFQFYVQEGRLSCQLYQRSGDVFLGVPFNIASYALLTHLIA
HETGLAVGEFVHTLGDAHLYINHIEQMKEQLSREIRAFPTLVLNQEKQSVFDFEMEDIQL
EGYDPHPAIKAPIAV
>FECAFAII_01312 Dihydrofolate reductase
MLAAIWAQDENGLIGKEDRLPWRLPNDLKFFKQMTEANTLVMGRKTFEGMGSRPLPNRQT
IVLTRDSSYKAEGVHVMHSVEDVLALEKETDGIFFIAGGSAVYQEFLPFCTILYRTVIHH
VFDGDAYFPPVDWSDWSLINTSQGEMDEKNRYPHQFETYQRNENPVKSGTGELTI
>FECAFAII_01313 hypothetical protein
MEKTKFNRTYEILNEVFNAVTHGIGTGLSIAGLVVLLVKGAHLHSSLHIVSYAIYGSMMI
LLFLTSTLFHSLIFTKAKKVFQVFDHSSIFLLIAGSYTPFCLLSIRGWLGWTLFVLIWLF
AILGIIYKALTLHKRERVSKVSTIIYIFMGWLCVVAAVPLYHSLGMTGVILMVAGGLSYT
IGAFFYSLNSIRYMHVVWHLFVMLGAGFMYFSVLFFT
>FECAFAII_01314 DegV domain-containing protein
MTNVKIVTDSSCTMEKNVRDALGIRVMPLSIMIDGTVYPDDDQLDGERFMEMMAKAKNLP
KTSQPPIGEFISMYDELGEDGSEVISIHMTKGLSGTVEAARQASNLTKTKVTVIDSDTTD
QGLSFQVIRAAELAKEGKTVEKILEEVKKVQDNTKLYIGISTLDNLVKGGRISRTTGLLS
SVLNIRVVMNFAHSELIPVTKGRGKKTFDKWFNNLKNELKELPNVRQIGISHADAKELAQ
EFKEGLQELFPDMHIPVLHTNPVIATHTGKDAFAIMYYVD
>FECAFAII_01315 Spore germination lipase LipC
MKLTKRHLILVLFPLLIAIIIYAGLAASIPKAGPLMKPVTTVREDPNKKEKLHYIAIGDS
LTEGVGDQTKQGGFVPLVANDLKDRYNLTAVETENYGVNGERSDQILKRVKTKEEIRNNI
KTADFITLTVGGNDLMKVIQNNLFGLTVNSFKKPLKNYQENVTELLEEFRSLNKTAPIYI
LGIYNPFYLNFPEITDMQTIVNNWNKGTETVTKKMPNCYFIPINDLLYQGLNQEVGVTEE
GTDQTTSTTENLNGIKNNVLYEEDHFHPNNLGYQLMANAVRDQLIETQNQWLEKEDDQ
>FECAFAII_01316 hypothetical protein
MKTRSDVSSNKTKKTNYWKFAFLILLGVVLGSTVFLGSRIFANREPELPEIPALTERQGD
PVLTINSNKEKVNQIISFFLSEYQKDSDIEYKFYLENEALLNGTFEVLGFPIDFYLYFDP
YVMENGNVQLKARSLSIGTLSLPIKDVMNMIKRNYKLPDWIEVNTDDLTIMLRLDQFRMQ
NGMYIKADKIDLVNDDIRFSLYLPKDTSDASNNSNTNKTSTSSTESKTKENKKSSDE
>FECAFAII_01317 Peptide methionine sulfoxide reductase MsrA
MERAIFAGGCFWCMIQPFDTLPGIHTVMSGYTGGHVPDPTYEQVKSQTTGHTEAVEIIYD
PTLISYEQLVELYWQQTDPTDAFGQFEDRGDNYRPVIFYLTEEQRIIAEKSKKQLAESGR
FEQPIVTKIEPAQPFYLAEEDHQEYYKKHPENFKRNHARRAAFIEENWRNEG
>FECAFAII_01318 hypothetical protein
MNRSFFHYLMTLRGGGTHDALSVFATEAGKDIQFPKHSSSYEEISNYLELNVDYLPSMDI
FDEAWEKYLENNHDI
>FECAFAII_01319 Signal peptidase I V
MTKKQRYINRFWLVFKYLLVSVFLAFMLRGFLFIPVPVEGNSMENVLKQGDMVVMEKFSE
IRRFDIVVFQLADGTIYIKRVIGLPGENVSYQNDQLKINGKVVKEPYLTKNLKSDHANAS
YTTDFTLQELTGQSKLPEDNYFVLGDNRRVSKDSRSFGTINKTDILGKARFVYYPLDEIK
WIQ
>FECAFAII_01320 Folate transporter FolT
MNTLIAKDVFRLPEMNARLLSTSALLLALDVILYKIAIGPAYFQITFGFLSMALMGYLYG
PIWAGLLEMLSNTLNFTIFGSGTFQAAFLITAFLGGFINGLFLYHKKINLPSVIAAQLLI
MIPVSLFINSWLMSVLFGADFKVIFLGRFIRNMIQIPIQIMVVYSFIKTLEARKVFKRAV
>FECAFAII_01321 hypothetical protein
MNSMVFVNFPVADVNRSVAFYEKLGFKKNEEFSTEEAGSMVWDDTFWIMLLSHDFYKKFI
KDKEIADNKKTSGALISFSVENADEVKKFAQIAKENGGTFHEVDMGMPEEEMFSLEVQDL
DGNTLEPVWMKM
>FECAFAII_01322 Ribosome biogenesis GTPase A
MTIQWFPGHMAKARREVSEKMKYVDIVFELVDARLPLSSRNPMLDQIIQQKPRLVLLNKA
DLADPQQTKLWQEYFRKQGHLALAITAQESKGIKGLVPAAKEALKEKRARDAARGIKPRA
IRAMVLGIPNVGKSTLMNRLVGKKIAQTGNKPGVTKGQQWLRLGNELELLDTPGILWPKF
EDEEIGKKLALTGAIKDQLVHLDDLAIYGLDFFARYYSGRISDRYGLSIEQEEKLAPELL
MDITAKRGYKEDYDRGSELVVHDIRQGKLGRYTLDRCEEMEQKSDD
>FECAFAII_01323 Ribonuclease HII
MTESIQSIKERLKSIQRIDDPTLESLRNDPRKGVQQALASFERRLKKEALIKEKYEEMFC
FEKQGYAQGHQWIAGIDEVGRGPLAGPVVAAAVILPKNEIILGLNDSKQLSEKKRELLYQ
QVQEKALAIGIGIVDQQTIDDVNIYEASKLAMIQAVEKLSIVPSYLLIDAMTLDLPIQQE
KIIKGDARSVSIAAASIIAKVYRDQLMKEYDVLYPGYGFSHNAGYGTKEHLEGLERQGIT
PIHRKSFAPVKKYLQ
>FECAFAII_01324 DNA processing protein DprA
MYQIEENLLKLAYTKGISSQGKWALANWMMQYPYKEIGFEDIIKIGKITKHRELFRKSWQ
EIHANWGKIQSKQSFITCFDPKYPPQLLHLTYPPIVLFYNGDLSLLSCNMLSVVGGRHTS
ALAKKTVYYLLKPVIEAGYVIVSGCAKGIDTYGHQAAISHGGRTIAVIGTGIEQVYPAEN
RDLQEVIANDHLLLSEYPPQSGPKKHCFPMRNRIIAALSKGTCVFEAKKKSGSLITAQQA
LDLGRTVFSVPGNILTEHSTGCHHLIQDGAVCTVSGEDILAEFKE
>FECAFAII_01325 DNA topoisomerase 1
MAYKYLVIVESPAKAKTIEKYLGRNYKVMASVGHIRDLPKSKMGIDFENNYEPHYISIRG
KGDVIKSLKAAAKKAQKVYLASDPDREGEAIAWHLAYLLGLDLKEKNRVVFNEITKDAVK
AAFKEPRTIDVDLVDAQQARRTLDRIVGYSISPILWRKVKKGLSAGRVQSVALKIIIDRE
KEIREFVPEEYWSIDGNFKKARKKFKANFWGIDGKKKKLPDAQSVKEVTARIDGTDFEVK
KVEKKERKRNPANPFTTSSLQQEAARKLNFRTRKTMMVAQQLYEGITLGKQGTVGLITYM
RTDSTRIADTAKAEAAAFIEDTYGKEFSRHDHRKIKNAQGAQDAHEAVRPTSVLRTPDEL
KQYLDKDQLKLYTLIWSRFVASQMTPAILDTMKVTLEQNGVIFIANGSKIKFKGFMQVYV
EGRDDGKEEKENILPELEEGDVVQSVDIEPKQHFTQPPARFSEATLIRALEENGVGRPST
YAPTLDTIQRRYYVKLTQKRFEPTELGEIVNSLICEFFPQIVDIHFTAEMEGDLDKIEEG
TEAWVKVVDRFYKPFEKELTNAEEKIEKIQIKDEPAGFDCDVCGHPMVIKLGKYGKFYAC
SNFPDCRNTKPIVKEIGVTCPVCHEGQVIERKSKKNRLFYGCSRFPECEFTSWDKPVGRN
CPKCDGYLVEKKVKGGKQVVCVNGDYEEDIQK
>FECAFAII_01326 Methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase TrmFO
MKMVNVVGAGLAGSEAAWQIAQAGVPVRLYEMRPVKSTEAHHTSNFAELVCSNSLRGNSL
ANAVGLLKEEMRRLNSVVITSADETAVPAGGALAVDRDSFSETITRKVKEHPLVTVINEE
ITEIPEGITVVATGPLTSHPLAESIKAFNGSDGFYFYDAAAPIVDKATIDMDKVYLKSRY
DKGEAAYLNCPMTEEEFKAFHEALINAEVAELKSFEKEKYFEGCMPIEVMAQRGFKTMLF
GPMKPVGLEDPKTGKRPYAVIQLRQDNAAASLYNIVGFQTHLKWGEQKRVFRMIPGLENA
EFVRYGVMHRNSFMNSPELLKPTYQSTKREDLFFAGQMTGVEGYVESAASGLLAGINAAR
LAKEMEPVEFPQETAIGSMAYYITHAEGKHFQPMNANYGLFPELPERIRDKKARYEAIAQ
RALKANEAIKTELEKTAIPNE
>FECAFAII_01327 Tyrosine recombinase XerC
MTEATWEQKFLRYLIVERGYSEKTKEAYEEDILHFKHFLEESGDADLLKAEYFTVRVYLS
ALADHRPSYSRNSISRKIASLRSFYQYLLKEEVIKENPFSYVHLKKKNLRLPRFFYENEM
QALFDSVAGDSPLDLRNRALLEVLYGSGIRLSECSSLSVSDIDFDSEVMLIHGKGNKERY
APLGSFAQDALQEYFREGRQVLMTKYHEEHDIVFVNHHGKPITPTGIEYVLNQMIKKSSL
DSDIHPHMLRHTFATHLLNNGADLRTVQELLGHANLSTTQIYAHVTKESLQKNYRSFHPR
A
>FECAFAII_01328 ATP-dependent protease subunit HslV
MVESPFHSTTICAVEKDGKFAMAGDGQVTMGESVVMKGTAKKVRRIYNGEVVVGFAGSVA
DAFTLEEKFEGKLNEYNGNLQRAAVELAQEWRTQQSMQKLEAMLIVMNDKEMLLVSGTGE
VITPDDGILAIGSGGNFALAAARAMKNYAQNDMSAKEIAENALNIAADICIFTNHNIIVE
EL
>FECAFAII_01329 ATP-dependent protease ATPase subunit ClpY
MYELKQTPRQIVSELDEYIVGQHAAKKSVAVALRNRYRRLQLDEKMQQDITPKNMLMIGP
TGVGKTEIARRLAKIVNAPFVKVEATKFTEVGYVGRDVESMVRDLVENAIQIVEKEQYSR
VYTSAKKNAEKRLVKILVPGIKKEQKQSTNQFEQMMNLFNASQQNTAEPQEEVTEDIRIN
RRTVLEQLQKGLLDSREVTIEVEDQKKPAPMMNNGLEQMGIDLNETLGALTPKKKVERTV
TVKEALELLMKEESAKLVKDADIHSEAIKLAEESGIIFIDEIDKITSKSQQSGEVSREGV
QRDILPIVEGSQVNTKYGIIQTDHVLFIASGAFHLSKPSDLIPELQGRFPIRVELDDLTA
EDFVKILTEPNNALVKQYVALIGTENVSVTFTKEAIERIAQIAFDVNRDTDNIGARRLHT
ILEKLLEDLLFEAPDMQMGEITITEAYVDDKLGSIAANEDLSRYIL
>FECAFAII_01330 GTP-sensing transcriptional pleiotropic repressor CodY
MTDLLTKTRKINTLLQQKNTFDMQADLPYDKMAVTLGGILDSNTYIIGSDGVLLGYNERH
DVNNERIKTMFVEKQFPESYTDTVAQLMKTEANIPITSDITAFPVESREKYPFGLTTVVP
IFGAGERLGTIILSRMEQSFADDDLVLAEYGATVVGMQILYQKSRSIEADVRSATAVQMA
INTLSYSELKAVQAIFEALDGDEGRLTASNIADSIGITRSVIVNALRKLESAGIIESRSL
GMKGTYLKVLNSRFKDELAKHSY
>FECAFAII_01331 Aldose 1-epimerase
MTVIIQNDQLIAEIAEHGAELISLKSKEHGLEYIWQGDPAYWGRHAPVLFPFVGRLKDDQ
YVYQGKTYQMGQHGFARDMDFEVIEHGQEMASFILRSTPETLEKYPFDFELVISYELGGD
GITVHYQVANTGEKEMFFSIGGHPAFNVPLEEGLSFEDFYLAFSPLKSRLRLPLKGPFID
MDQKTLGQTNTNLALNRELFEQDALVFETRGLNAYAIRSEKSSHSVTLSYKDMPYVGIWS
PYPKEAPFVCIEPWCGIADTVNSSGNLMEKVGINQLGAHEIFKTKYSITVK
>FECAFAII_01332 Glycerol-3-phosphate acyltransferase
MKLILLLILAYLLGSIPSGVWIGKLFFKKDIRQHGSGNTGTTNTFRVLGKTAGIVVLLMD
ILKGTLATCLPMIFHLSGINPLWFGVCAILGHTFPIFAGFKGGKAVATSAGMLLGFNPVF
FVYSCIIFIVSLFCTSMVSLSSMISAVLITLSTIVLPYVAPVILAKPNWLLTIIAFLVSS
FIFYRHKDNIKRIRNHTESRIPFGLNSSKKKS
>FECAFAII_01333 hypothetical protein
MSVKNPTQETIFNYLEEAKNIAVVGLSNKPERTSYMVAQVLQDNGYKIIPVNPLLAGEEI
LGEKVYANLTEIDDPIDIVDVFRRSEFLPEIAGDFLKTDAKVFWAQLGIENKEAAEMLRK
AGRTDIVMDRCIKIELGKLKENQK
>FECAFAII_01334 DNA topoisomerase 4 subunit B
MAKKVNNEYNDSSIQVLEGLEAVRKRPGMYIGSTDSRGLHHLVYEIVDNAVDEALSGYGS
EIDVTIHEDNSITVADSGRGMPVGMHASGIPTVEVIFTVLHAGGKFGQGGYKTSGGLHGV
GASVVNALSKWLIVTIVRDGVEYQQKFKNGGKPDGTLKKIGKTKKANGTTVHFLPDDTIF
STTKFSYEILAERLRESAFLLKGVKISLSDLRGEEPVKEIFHYEEGIKEFVDYLNEEKDT
LTPVVYFSGEKEGIEVEVAYQYNDGYSENVLSFVNNVRTKDGGTHEAGMKAAMTKSYNEY
ARKVGLLKERDKNLEGSDFREGLAAVLSIRVPENLLQFEGQTKEKLGTPVARTVVDNVIS
EQMGFYLQENSEMSQMLVRKAIKAREAREAARKAREESRNGKKRKKGESLLSGKLTPAQS
RNPKKNELYLVEGDSAGGSAKQGRDRKFQAILPLRGKVINTEKAKMQDILKNEEINTMIY
TIGAGVGPEFSIEDCNYDKVIIMTDADTDGAHIQVLLLTFFYRYMKPLIEAGKVYIALPP
LYKVSKGQGKKQVIEYAWTDDELAAMIKKVGKGYMLQRYKGLGEMNAEQLWETTMDPTSR
TLIRVRIDDAAQAERRVTTLMGDKVEPRRKWIENHVQFTLEEDGSILDKKEDTEISPSVS
NDLLDEERADKNENNQLFEVE
>FECAFAII_01335 DNA topoisomerase 4 subunit A
MENRQEVQELTLEEVMGDRFGRYSKYIIQERALPDIRDGLKPVQRRILFAMNKDGNTYDK
GFRKSAKSVGNIMGNYHPHGDISIYEAMVRMSQDWKLREVLIEMHGNNGSMDGDPPAAMR
YTEARLSKLSGEMLADIEKETVDLVWNFDDTEKEPTVLPARYPNLLVNGSTGISAGYATE
IPTHNLAEVIDGTIYMIDHPQASLEKLMEYIPGPDFPTGGILQGKDEIKKAYETGRGKVI
LRSKTKIEAMKGNKQQIVITEIPYEVNKATLVKKMDEIRLNKKIDGIAEVRDESDRTGLQ
IVVELKKDANAQGILNYLFKNTELQINYNFNMVAIDHMTPHQVGLKDILRSYIEHRKQVI
TKRSQFDLAKAQKRQHIVEGLMKALSILDEVIATIRESKDKKDAKKNLVDVFQFTEEQAE
AIVTLQLYRLTNTDITELQKESESLIAQITELNKILSNDKELFSVMKKELREVKKNYSSA
RLTTIEDEIEEIKIDTQVLVAQEDVIVSVTREGYVKRTSLRSYSASKPEEIGMREGDYLL
YSGELSTLDHVLLITNKANVIYRPVHELPDLKWKDAGEHISQTISNLSVDESILAVFPYQ
KIQAEKTFVFISKNGLIKQTRMTEFEPWRTYKSRPLSCMKLKAEEDELIAVYLKEDQPGL
DVFLVTHQGMGLRYPLTDVPVVGAKAAGVKSMNLKDGDRIINGLLVLAEGDTPIVIVTQR
GAVKRMLAQEISQTSRAKRGVTVMRELKKNPHRIIYMSEGRSKEITLMNQKGQQLTIDPT
DFPIGDRTSNGSFAMDEKKGGEVIEVIDAPEIFIES
>FECAFAII_01336 Formate acetyltransferase
MEQWNGFKGTKWKEGVDTRDFIQNNYTEYRGDDSFLEGPTEATEKLWDELQKLNDIQFER
NGVYDMDTEIVSTITSHDAGYLDKDLEKIVGLQTDKPLKQAFMPFGGINMANNALKSNGY
TPNDELTHIFTDWRKTHNQGVFDAYTAEMRAARKNKIITGLPDAYGRGRIIGDYRRVALY
GIDYLMEQKKKDHDMTGYHTMSEEVIRLREEITEQYRALAQMKEMAAKYGYDISKPAANA
KEAVQWLYFGYLAAIKSQNGAAMSIGRISAFLDIYIQRDLDNGVITEKEAQELIDHLVMK
LRMVKFARTPEYNQLFSGFPIWATLSIAGMGLDGRSLVTKNDFRLLHTLTNMGPSPEPNL
TVLYSEHLPEGFRTYASRIAIESSSIQFENDNQLREQWGSDDCAIACCVSGTVVGKDMQF
FGARANLAKTLLYAINGGVDEVTGAQVGPEYRPITSEILDFEEVKHNFMNMMDWLAELYV
NTLNIIHYMHDKYSYEAAQLALMDSDLQRTFATGIAGISHAADSLSAIKYAKVKAIRNEK
GIAVDFEVDGDFPKYGNDDDRADELVSWILEYFMGQIKRHKTYRNSKPTTSLLTITSNVV
YGKNTGNTPDGREAGKPLAPGANPSYNAEQSGLLASLNSTAKMNYGCALDGISNTQTINP
SGLGKEQDTRIENLRNVLDGYFSKGAYHLNVNVFSNDLLRDAMENPMKYPNLTIRVSGYA
VKFRDLTREQQLDVLMRTSHDRM
>FECAFAII_01337 Pyruvate formate-lyase-activating enzyme
MEEKTIGYVHSIETFGSVDGPGLRFVVFMQGCRMRCQFCHNPDTWNIGGGKEYTADELLD
KAERFRPYWGDKGGITVSGGEPLLQIDFLIELFKKAKERKMHTTLDTCGKPFTYEEPFFS
RFQELMKYTDLLLFDIKHIDNEEHKKLTHWDNENILEMAQYLSKINKPVWIRHVLVPERS
DYDEYLIRLDNFIQTLSNVDRVEILPYHTMGKYKWETLGLKYPLEGIEPPTKERVENAKR
LLHTEEYTKYLTR
>FECAFAII_01338 putative manganese-dependent inorganic pyrophosphatase
MSKILVFGHQNPDTDAIGAAIAFSHLQNELGKETEAVALGTPNEETQYALDHFQLSAPRV
VESAKAENADVMLVDHNEFQQSISDISEVNILAVVDHHRIANFETANPLYYRAEPVGCTS
TIILKLYKENQVTIPKEIAGIMLSAIISDTLLFKSPTCTPEDEAAAKELAAIAEVDLNTY
GLEMLKAGTNLSDKSAAVLLDLDAKSFPMGSSNVRIAQVNTVDLNEVMDRQAELEAAMED
EMKANGYDLFVLVVTNILDSDSELLVAGKGKEKVEEAFQTTLTNNRALLKGVVSRKKQVV
PQLTAVFS
>FECAFAII_01339 hypothetical protein
MNYYSKNKENFYQKLTDDPLFSSLTDYLYEHREQETILRELKKEFSQNKFSHFLDLLIDA
GLIKREERRYHLNFPIFDPKDYLQQATSAAETIAEQLKRLSVDEQKLAMGEVIWAYCFED
ERKEAYFYGVRNSRETELLRTTAGNEKYRFITLSSIEHFPLTLANYFFVQKNQLPVTKAF
KELAELIGDVNESYFFDQIEVIVDRIRKNKYKNRRPSIFHQSLLVTNTIKEEESFTLELP
IVEKNNFEIELPTLDPSLTMEEMAFLKRQIFSELSKKFIPHAFSYIKEYGTVLVSKT
>FECAFAII_01340 hypothetical protein
MEIQRRTTNFLHLGSFFATLTILFFLCYSYLKTSHAPSSALGWLLLDHSDITEAEENPFF
LILSSLCGLLFSVYFGAYFFHRHPGTLNEASSVLIAFKTFSFLAILFYSFNHNTLFFFIM
NGLVVILSIFTYFIFSLIFSQLKCPLFFRLVPVTCFIYSLFSFFVLALMPLTNPFDDPSR
RKSVGYALHRQSRCIYVAKKKQTK
>FECAFAII_01341 hypothetical protein
MIDPKMLGMIFLINFAYITLNTLRFMLTMKGYRLIAPLVSMVEITIYIVGLSLVLDRLDN
PLNLFVYALGYAVGISVGILIEDKLALGYIMVTTILPANSAEDKSLPGILREHGYGVTQT
SAMGLEGERLVLEILSPRKSERELYRLIKEIEERAFIISYEPKYISGGFWTKKVRKRQGK
>FECAFAII_01342 hypothetical protein
MKTVNRVFCASHVLSLLLSIYLGVYSIQQPIEVENIVFQMSLTDGLILSVFFFLILFIGN
IFGSVASFLNFSIYPLLSLALGVVGLCSLCLFPEPFSPAFILFGTLNLFQTTVGAWLLWR
SGNLMKIGE
>FECAFAII_01343 Arylesterase
MNPIILKRSVHHIPVLEVVLKELREERIPVVIYYHGWQTSKELVLTQGRKIAQQGIRVIL
PDAMNHGERKQPVSSIPSYTFWDSIYGNLFEFDTLIKHLEKRGLLHDQLAVGGVSMGGMT
TCALLAKHPHIVAGVCLMGSPAPLEYGKEIVRRASEYNYVVPKDYFDLISWVKSYDLSLQ
PEKLAGRPLFFWHGQADEKIPYIQTERFVEKNRHKSYGKEIVFRSSKTQRHMVQIPLMEE
ASTFLAKNLIKKYK
>FECAFAII_01344 putative HTH-type transcriptional repressor ExuR
MPTLADVAKRANVSKMTVSRVINHPEQVTDELKELVFSAMAELDYRPNIAAKALVTNRSQ
IIKLFILEEIDTTEPYYMNLLMGIAKRIGKAHYSLQLVTNDAFDVGSCDGYIITGVRKKD
FDWIDRLEKPVVLFGENSEGYDYVDSDNEYGTAKATQYALERDYQTIIYIGIEVDEPFEI
SRETGYLSVMKEVDLPSKILRFPNHSTEVERYMTENWADFTDKTCFVCSSDRLALGAVRG
IINAGGHLPEEFGVIGFDGVFLDQISSPKLTTIKQDIIRMGEVCGEMLLKKIEEKGASQG
YRRFFPELVIRETTN
>FECAFAII_01345 hypothetical protein
MKEIRRKHFRFPAYDDELGVKLTNDKKRVLFDGQEDLLTEQNQSPFEQMKEFHFTNTNTE
KIRRKRRATNGLKSAPRKENLEKHKGKLPDYTGHYQSEITSTGRKKLFGDSSRSVRQSET
RTESKHTTRNASVDTKVRERSYFVPKYVPASIIPDPRESKISEDHLIESMKKTDDSYLLF
DTEPTPYQEKRNGEPSVRTFNRTKTLEETKQSEEKKSKKSHGILERSLQGLIDDQGNSLG
ENSYFK
>FECAFAII_01346 hypothetical protein
MKKLNLFTELCGIILGAGIYGLAVTGINIPSKLADGGVTGIALLLHNLFGFAPSVTSLLF
NLPLLLISLFLFGKHAFLRTIVGTFALVFFLHLWESLHIHFAVDSLLINSLMTGILSGIG
CGLVFRFGGSTGGTDIIYQAIEKYFHIKIGKSLFLITFGILVVSLLYLDLTHFLYTLLSC
SILSYTLNKVKYLEIGSVLPQLEAKQTTETFEPLDPLEQLEH
>FECAFAII_01347 hypothetical protein
MRAADLLTILTKSPKKTEYQGVFLAQEQKLVPVTMVQINKANQFIFLFEHGKAPLAMKDI
FLFLMKNREKAVYYQSKEELIPLYGVKEIENKVVI
>FECAFAII_01348 Choline transport system permease protein OpuBB
MNNFIQTLSERKGELLEAAFQHLSISLISLLIAALIAIPLAIWAANHKKMAEVLLQITGV
LQTIPSLALLGLLIPFVGIGTVPALIALVIYALLPIFQNTYIGLAEIDPSIEEAAVAFGM
SRMRRLLKVELPIALPVIISGIRTALVLIIGTATLAALIGAGGLGTFILLGIDRNTPVLT
LIGAISSALLAIIFSGLIRWLQHKKPRYSIITLAAVVCLFGGVSLYQSALFKNETITIAG
KLGAEPEILIQMYKELIEDNTKTEVELKPNFGKTSFLFNALDQGQIDIYPEFTGTVLESL
VKVPEAMKSADLTKEKTYDEAEELLNKQFDMTLLKPMAYQNTYALAVKRSFANEHQLKKI
SDLAAISDQIKAGFTLEFIDRSDGYKGIQEAYGLNFSSVQSMEPSLRYQAINNGDVNIVD
AYSTDSQLKEYDLVTLEDDRGLFPAYQGAPLMKKDFAKEHPEIVKALNKLSGKITEDQMI
DMNYQVNVEKKKPTEVARIFLKNEGLVKEEDQ
>FECAFAII_01349 Carnitine transport ATP-binding protein OpuCA
MTKLIEFKHVQKKYDGKYVIDDLNLAIKKGEIFVLVGPSGSGKTTTLKMINGLSKPSAGD
IYFKGKSLNEYNLQKMRWNMGYVLQQIALFPTMTVKQNIEVIPEMLGWEKQKRADRVDEL
LQKVGLSPDIYRDRMPRELSGGEQQRIGIIRAIAASPDVILMDEPFSALDPISRNSLQEL
VLSLHEELGTTIVFVTHNMEEAIKLGDRIAFMKDGEIIQCDTTRAVIDES
>FECAFAII_01350 hypothetical protein
MTPPEQLLMNPKNDYVRHFFDEPKQTKEWRVEDLVVNGYFLNEIPENARQQVCFDTPMKE
VYSLLSVYPSIVIVEKQRSIGSLTSKEIFAFLSREEEGNENI
>FECAFAII_01351 Glutathione amide reductase
MKTYDAIIIGSGVSGLSAAYGLKEAGKTVLVVEEDLWGGTCPNRGCDPKKVLLSAVEARN
RVKQLSGKGFNEIPTANWEELQKFKRTFTDPVPESRKKQLAEAEIDHLSGTARFLDDSSI
EVNEEVFHADYLVLATGQRPTILPVEGKEYLKTSADFLSLPVLPKEIIFIGGGYIAFELA
TIANAAGSKVTIVHHNQRPLKEFEASLVEEAVHQMEASGIQFAFGVETQKIISEGTRYRL
VGKETELVADMIFCATGRQPNTESLALEQANIVFDKHGIAVNDYLQTSNPKIFACGDIVS
RKTPKLTPVATFEGNYVAKRITDATSEPIKYPIIPTIVYASPKLAEVGVTKSHASSSDQV
VEMDLTSWFTYHRVNEPVAKAELTFDQQNYLIGAAVISEQADELIDDLTLVINQKLTKKE
LDSYIMGYPTLASDLSYLLK
>FECAFAII_01352 Riboflavin transport system permease protein RibX
MKKNLYPAVSMAFILIIWQIVVIVWKIPAFILPGPAAVFSALAADAQVLLSHSVTTLNEA
VLGLVIASVLSFITALAMDYWKFLEMSFYPLLVISQMLPIMVLGPLLTLWFGFGMLPKVI
LVVLISYFPIVVSFSDTLRKVSKEQIIFLKTMGADTGKIYRIYKIPAGLSGFFSGLKVAA
TYCVSGAVVGEWLSAQAGLGYYMIRVKNSYQIDKVFAAIICVILLSLLLNGACSLLKKGY
YRMLYIF
>FECAFAII_01353 Formylaminopyrimidine-binding protein
MKKLWLLLPLLLLLSACGTAKETSSKQEIKDLKKVTLVLDYVPNTNHTGIYLAKEKGYYK
EAGLNVQIIEPGDNSTSIGLVGADKAQFGVSYQEDVTYAHADGQNIPVKAIATVIKHNTS
GFATLSDSNIHSPKDFEGKTYAGWQSPSEEAVLKAVMEKDGGDFSKLTMVGSNGEGPESL
GKSSDIQWYFEGWDMIKAKEAGIELNYIPLKELDERLDYYTPVIITNDQLIKSDPELVQS
FMDATKKGYQEAIKDPNDSAKLLQKYAKENDRTFLEESQAFLSKNYTDDPENWGLMEEKV
WRNYTAFMQENGLIKQDVPSQELFTNQFIK
>FECAFAII_01354 Aliphatic sulfonates import ATP-binding protein SsuB
MSIQISHLNVVIENLKILEDIHFTIPKDTFTSIVAPSGAGKSTLLKTLTGVQPMTSGTIK
VDDQKVTGLHTAFSYMPQEDMLLPWLSVYQNVTLYQKINHLTINEEQVRDYLDIFGLNGY
EHFLPEQLSGGMKQRTALLRTIMNPSSYLLLDEPFGALDAMTRGQMQDWMLKLPKKAKRT
TLLVTHDIEEAIYLSDRILVLSARPAHVIAEIQVPEKRRSREWLLQQSELKQTIYQLLAG
ELDVK
>FECAFAII_01355 D-aminoacyl-tRNA deacylase
MLSDAHCHLDGSQSLALLQQEHTILTIINCDSPEEWKENRQLAASKTQALSYGIHPWKAD
SYTFEQVEPFLKKARIIGEIGLDNIWTNVPMTTQKKVFERQLAFAAINEKPVVLHTKGCE
KEILNYIQAYPNHYLIHWYSSLDYQQDYIDLGCYFSIGLDLKKNPAVWQLAKAVPIDHLL
IETDGLHAAEWALGGIFSEKDYVSLLEEQLKTIAEIKELSVEEVKKNTYQNLERFIRLGK
>FECAFAII_01356 hypothetical protein
MTSLKTLLFGTTLAAGAAFFMGTTAHADEAYTVQSGDTLSTISQKYVGDNSLINAIAESN
SISDINLIYSGQQLTIPTEGSAQAAAEPQAAVQEAPVQAEQPVVQETVQTEKQAAPVAET
QPAPAVTETAATPASTSSAKEWIAQKESSGSYTATNGRYIGRYQLDSSYLNGDYSAANQE
RVAEQYVTSRYGSWEAAKAFWEANGWY
>FECAFAII_01357 Chromosome partition protein Smc
MKKKFITGGIVVAFLCLIGYTGTRYANEIILWGGETDIDTINENLTQLDHTLTDKEQAIT
DLTARLAQKEQTLQDSKADVQEYQTKVNELENQKNQSAAEKQNLESQLVSKDAQLQSKQN
EINVKLDEINQKNDEINHLNADWTARLQEAQAKLSELQNTVNGLNQQIATLTQEKTNVET
QLTDTQKKLDEATAENSSLKQYIQKLEKAKDEVEDTADKSQQIVEEHLRK
>FECAFAII_01358 hypothetical protein
MEKKYGTVDKIRTLQVSARPLIRFSLNGVNCLIASHSLNFLAEVDEGMKLVVTGYYNNRK
QFVVRSYHVLGKPKIVVEYEKSLYPRKKVRQDERIN
>FECAFAII_01359 Fosfomycin resistance protein FosX
MQNSSNKLPKTYNHIAFKIDEQDIDSFVSKIQMLGLTVEPGRSRVKGEASSIYFYDYDNH
LFELHTGTLQERLKSYNSTT
>FECAFAII_01360 hypothetical protein
MNKHNRKITNNKELILLLIGIWGIFLLFNMYMPTMRADDVVYASRLDELGYLGASIEHYK
TWSSRIIIELFLMFFSKHFMLWKLLNSTIMLGIVVLLCKYVESIKYFV
>FECAFAII_01361 hypothetical protein
MNDFTTEIVQTLVTKGDLNELFRSHLEKAINTLLRTELTAFLDYEKYDRTGFNSGNSRNG
SYFRSIKTEYGELTLEIPRDRNGEFKQQTLPAYKRTNDTLETTIIHLFEKGVTMSEIADL
IEKMYGHHYTPQTMSNMTKVLTEEVNAFKSRALNDKYVAIFMDATYIPLKRQTVSKEAIY
IAIGIREDGTKEVLSYAIAPTESTYVWNELLQDINSRGVQEVLLFITDGLKGMKDTIHQI
YPKAKYQHCCIHVSRNIAHKVRVKDRKEICDDFKAVYQANSKEEANTFLSGMIEKWKKNY
PKVTQSLIENQDLLTFYDFPPSIRRTIYSTNLIESFNKQIKRYSRRKEQFQNEESLERFL
VSIFDTYNQKFLNRSHKGFQQVTDTLVSMFTE
>FECAFAII_01362 hypothetical protein
MNYQWPVAFSLLTFYPFFQLLRGEEINRKIYWVSIPLLIFLTNQEQVNACFFVLTSIVSL
YLIVNGRYNYKLSVFSIISLAELIFSLTTPGNALRAAHEINKWFPEYKNFNFLNKLDLGI
SSFGKPFF
>FECAFAII_01363 hypothetical protein
MNILFLLLFFLIFLLTYRKCQNYYVRILTALPFFLNLIIYFGNTMGQSFTYVNGNKRAMI
WSSSNLNNLFTELGTKLSLFYPGTWIATLVVLALLLCLIVGIYLSFDNKKTSIFLVILMI
MGFCSRLIMGFSPTVWASGMRTYYILYVVIAILVLMAVKELMKSMSVQKNEFMQFGLTVL
GICTFIITVINR
>FECAFAII_01365 hypothetical protein
MEKYDGEFSGLGMILGVLIGLAFGRFLLGFMLGIICGIAMDWAANLWNDYHDN
>FECAFAII_01366 Glutamate-pyruvate aminotransferase AlaA
MMREFEKSNKLEGVSYDVRGPVLEEAERMQEEGISILKLNTGNPAPFGFEAPNEVIRDLI
MNARDSEGYSDSKGIFSARKAIEQYCQLKHFPNVTINDIYTGNGVSELITMCMQGLLDNG
DEVLVPMPDYPLWTASIALAGGTPVHYICDEEAEWYPDIDDIKSKITSRTKAIVIINPNN
PTGALYPKELLEEIVEVARQNNLIIYSDEIYDRLVMDGLEHIPIATLAPDLFVVTLNGLS
KSHRVAGFRVGWMVLSGDKSHVKGYIEGLNMLSSMRLCSNVLSQQIIQTALGGYQSVDEL
LLPGGRIYEQREYIYNAINDIPGLSAVKPKAAFYIFPKIDTKRFNILDDEKFVLDFLHEH
HILLVHGGGFNWNQPDHFRIVYLPKMDDLKQTAKKMREFLATYRQK
>FECAFAII_01367 hypothetical protein
METLIESFGTIIKEIRKEQKMTQKMLSHDICSQSVLSRIENNEELPNVLVMMQICQRLGV
TIDHVMNLSRKTTRTNDKLFELLDSCFQKRDYRKLEQVLKSSDISENLYQATDFQRYYYY
LGVCEFTLRQNISQSLYYLKEALSYSSQKERIHVSDTEIQLISCIGKIYGVAGKTAEARY
YLSRSIQLLHQSADERSKSEFSQIFYNYGNFLFHQNEIDEALEQVNQGIYWAQEKNSYYY
LNDLFVLKSLIYKRKEEPERAAFYEGLAQAVKQISKNL
>FECAFAII_01368 N-acetylglucosamine-6-phosphate deacetylase
MRTFIYADKFFLASGVKHAGYLEITDGLFGEYTKELPEGEVNIIDQSGKWIAPGLVDTHI
HGYMNHDVMDNDAEGIKVMSEGLLSCGVTSFLPTTLTSSKERLKDVAETIGKMYQEAPGA
KIKGIYFEGPFFTEEHKGAQNPSYFGDPDLDTFHEWQEASGGLIKKIALAPERQGVEEFV
KQVTEEGVVVSLGHSNATLEEAQKAVEAGASVFVHAFNGMRGLNHREPGMVGALLSLEHV
FSELICDGHHVHPNAAGILMEKAGHDHVALITDCMMAGGMPDGNYNLGEFPVVVKEGTAR
LESGNLAGSILKLKEAIKNVVDWGLATPEQAVMMASLIPAISCKIDDTCGKIAQGRDADF
IVLNPDMTLEATYLDGVERFHA
>FECAFAII_01369 hypothetical protein
MNLFDIFRSTLTDMSIVSAITSTVFIILLGFVCRKKGIFSESVGKILSKVVLTVALPALA
FRAFMQDINTELLMQGINVLIWGLVIYIILILVSKPFFLSYKGDKQTTLRVLTIFGSTTF
FGTPIVSAIYGPVGVMYSSIFNIGYRIFLYSYGYIKMSGLKMEAKNIKAMFVNPIIIATF
AGLFIWLFQGYLPQVSVTGAEGEISQVAFLRIDQTAPWLFQPMDYLAGLSSPLAWLAIGA
TLGEVSFKKAASEKTSWYYSLVKVVFVPALNIVILAVLTATNILPVNFEALATIVIMMAT
PAATVAAAYAISFDREALLASNASLLSTIFAVVLTPVWIVVLQMIHGIGLFS
>FECAFAII_01370 Phenyllactate dehydrogenase
MRIACYGVRPNEIDFFEKLNIYHYDLSLYEELLTHDNIVSAKDHDAVLLRGNCIADETNL
AKMQEYGIRYVFTRTVGVNHIDLQAAADFGMTVARVPSYSPNAIAELSLTFAMMLLRNTA
YTTIRTSFKDFRVDEQMFSREIRNCTVGIIGTGRIGLTEAVLFKGLGAKVIGYDIHQTEA
AKKVLTFHSLEELLAKSDIVSIHVPHIPGENDQMINEGFLAQMKKGSILINTARGELQDN
EAILRALKSNHLAGFATDVFANETEVFFRSFKPWETIPDPAIQQLVEMYPRVLVTPHVGS
NTDEALSNMISTSFENFREIIETGKTKNEVSLPKARQLR
>FECAFAII_01371 Transcriptional regulatory protein DcuR
MMTNVLIIEDDPMVAELNRTFVESIPNMNVIESFRNVEEGKKYFRQKNADLLLLDVYMPG
ESGIHFLSWLRQQGNDIPVILITAADDIETIKNVIRYGALDYLIKPFTLQRFQLAIEKYL
AFSQTIQTTEKADQKLIDQVFNHTTPIHEIPSFIDLPKGLSKLTLKKISAFILKEDTIFS
TKELAQKSSLSRISVKKYLNFLVEQDILNERIKYLEIGRPLTCYELTKNGRKKLTDYC
>FECAFAII_01372 Sensor histidine kinase DcuS
MYLNGIETISSVTPLFSNDRFLGAVATLRNRSEVMKLMEELGGTKQYINSMRAQTHEFMN
KLHVISGLIDLKKYEEVTHFIQQLNQNYKKEIGQVSSLIKVPAIAGFLLGKINEAKEQSV
EMLLESDSFIPKMEMDDSIHSLLQVLGNLLDNAKEAVLQKHERNGQVRIHLNYDTEAEVF
IVTVCDDGVGISEEISEKIFTLGFSTKGINRGFGLNLIHSIVKRHGGFLEFSKQTNGGTI
VYLELPKKEDQNDDKCPDNRR
>FECAFAII_01373 Sensor histidine kinase DcuS
MFPFFKKKPLKLQNTIILVVCFSTFVSLIVSAILIRNFILSMNRSSVSDKISSIAKIVAN
DKLIQKKLQTGDPTHAIQGITNEIMIASNLDFIVVMDPEGIRYSHADPSYIGLPFSSHED
VKKVIGGQEFFSEKEGMLGFGFRYFVPIYYDQEIIGAVCVGLTNNTIDNQVKDGQKMIVF
SLIIGLSVGIIGAVFLAQKMKKVLLGLEPQEIAEQLSEKTIIENEVDEGILAISSDKTIL
LINTPAKNIFYQTEQLLDFEVGKKSVIIYMTFCLKRRLSIKRPFGLNPCI
>FECAFAII_01374 putative membrane protein YuaF
MIGGIALETIYWYTLLICAGLAVLLIIFGDVFDFDGPLDPMLIIPWLTFTSLFGFLGERL
TDQSSLFLFIASGGISIVLVFLLNFYILMPMKHAESTMSSSEKTLEGQVAVVITPIPVRG
MGEIQLKSVTGSISRPACFYSPQEQTAERGTKVLIIEIKERICYVMPYESMIKA
>FECAFAII_01375 Inner membrane protein YqiK
MEIPVVFIAIAIAALILLMLLIVFVAKYQTAKPDEALIISGSYLGSKNVHIDESNNKIKI
VRGGGAFVLPVFQRSNRISLLSSKLDVSTPEVYTEQGVPVMCDGTSIIKIGSSVEEIATA
AEQFLGKTREELENEAREVLEGHLRSILGSMTVEEIYQNRDKFSQSVQEVASVDLAKMGL
IIVSFTIKEVRDKNGYLDSLGKPRIAQVKRDADIAEAEALKETRIKKAQAEKESQAAELQ
RQTEIAESLKEKELKLATYKQEQDVAKAKADQAYNLESARAQQQVIEQEMQIKIVERQKQ
IELEEKEITRREKQYDSEVKKKADADRYAKEQEAQAQKVKEVTEAEAERFRVEALAEAEA
NKTRLAGQAEAEAALAKGKAEAEAKQKIANAFKEYGEAAVLSMVIDMLPQLMREAAQPLG
NIEKISVVDTGSSSGETSGANRVTNYATNLLSSTQETLKATTGLDLKEIVENLSTRGTTS
QVNMYEAPKEAEQNSMKEE
>FECAFAII_01376 hypothetical protein
MQFGRFRLGMRTIKSALAVFLCILFFHLTQRGIPMIAALSAVFSLRQDLTTTVSFGKSRI
IGNTLGGTLAIIYFFVKSYFHNDFLVELILLPILVIIVIVVSDGINNNSGIISAIATLLL
IALSIPQGESALYAIQRVLDTFIGTFIAIGINFFLRPPETEKKEELSEDLVELQKKERLL
RTNLQEIEAKIQKQKKNSED
>FECAFAII_01377 hypothetical protein
MRIGMRTVKTVISVFFSMVTAGSLSLLYWPAAGIIALLSVGNTKRSTLRTGMNRIAAFIL
ATATALFSFFAVGYTIFGFSLFLFLFIPLASRFKLTEGIVVNSVLVTHYLVEENMSWQLI
GNEAGLMAIGLVFALLANVYMPDRTKQLKENQIQIEKEFRNILRQMAEFLLSENKEDVQI
KCEHLLTFIRESQEDAREHQENYWLRQPLYYETYFSMRRAQANVIKDMLENLERIQQPAY
YGKHIYGLLIYTAETFSESNDGRQILTRIEEVYVLYRQMPLPTSRPEFEDRAELFQFLQS
FKSFIEIKAEFSQQKIQK
>FECAFAII_01378 1,5-anhydro-D-fructose reductase
MKKYQWGIVGLGTIAHEFAESFNQETSELTAVASRTSEKAENFAHRYNIPKAYGSYQEML
DDAEIDIVYIAVPNRQHIDHILAALEAGKHVLCEKAITMNKKELADAMREKNLILAEAMT
IFNMPLYQQLRSIMDTGKLGALKMIQAPFGSYKEPDPKNRFFNPELAGGALLDIGTYAVS
FARFFLSSQPEVVASTMVPFETGVDEQSVTILRNKENELAAVSLTFQAKMPKVGIVAFEN
GYVTIADYPRADRAEILFTDGTKEFIESGNTSEAMNYEIKNMVHMIEGDLPNRSLFLTKD
VIEILDQMQVLWKNM
>FECAFAII_01379 hypothetical protein
MHQVYIDLIMSVLLEQFETEKNFLDEYLLISPEQWQKWKDGEKNLPSEAMQKVKNLFTDY
EWMLTQKILRQTIIFPEKRNVAVAEYKQIKTRIAQKWLSSKAAKVELIPLKNNQQAGRYL
DLKVSIQYDEWGYDDILNFRLPADVQKQIEGEKIELLDWVNENLEETYVHEANGEREEQR
KDFSSE
>FECAFAII_01380 Putative carboxypeptidase YodJ
MNKFLGFGAVVIMIAAMGYVIFSDDDSHVQAGNQAVERTSTKTTASKEKNSQTTSSKVKD
KETKDRTSKQLPDVKTDDWKLVLVGPDHKLEKEIDESTQLASLSNGYLIDKRIAPEYEAF
AKAAEAAGFPLVMVSAYRSVSSQQQVFEQNVQDVMSRQGVSEEEATKITKETITEPGYSE
HHTGLAVDVVDQNWYNSYPSTVLDASYGDQPGAKWIADNAAQYGFIVRYPKGHEDITKIT
YEPWHLRYVGKENAEYITKHQLTLEEYLNELNEK
>FECAFAII_01381 Exo-glucosaminidase LytG
MAKKKWKKQKRKNIRWPAVVAGVAVILLAFVFSLKNLSSPFTDNQQENEAQSHQQFIERL
VPHAQELQDGYGVLPSIILGQAILESNWGKSTLASKYNNLFGIKAYGDQKKVSLETKEFV
NEEWITIQGDFKVYDSWEQSMDDHTQLFVQGVDWNPALYEKVITATNYQEAAQALQDAGY
ATDPGYAQKIIQVIETYQLNQYDRR
>FECAFAII_01382 hypothetical protein
MAEQFTPEIMTELRKDIVRVPEIILEASGIKIFGKLIRSIIFTTDIAIIRNTNANAVIAV
YPFTPHPAITKSIIEAADIPVFSGVGGGLTQGARSSYMSMFAEAQGSLGVVLNGPTPLET
VKEVCRVVDIPVISTVTSKYTEIDEKLAAGISIINISAGKETAEAVRHFRKKYPELPIIA
TGGPTEESIAETIQAGANAITYTPPSSGELFSRKMEKYRETEKKNHE
>FECAFAII_01383 Putative ABC transporter substrate-binding protein YesO
MKKRMRIILALSVMLFFLTACGQEDDKKITLNMAWWGSQVRHDATVKVIELYEEKNPHVT
IDYEFYDYEGYYTKLGTLAASDDIWDIFQLNNQFPQYINQIEPLDEYVEQGIIDISNADE
SYLATTTYDGQLVGLSNGVNSFAIAYNKNIFEQLNIPEPASNWTWDEFEQISYQITEELG
IYAISRFEDFIAGCIIQIPQVEKGLNFYNREDLSNSLGFENPDYLTDFFQLRKNLVDKGA
HPEPGGGAASTTDLSFQAVRDREAAMVFLSSNQLTEILSGAPEDMEIQLINPPRRKADGE
SGIPLRSSQMLSMAKSSAHKEEAAKFIDFFQNSEEANEILKGERGVPIMSNIREQLARAD
DATLQATFDYLEMISDMDNGEVNVFDSALNPEIQDQYNLLVEKVIYEEVTAEEAAESLYE
FASNILG
>FECAFAII_01384 Lactose transport system permease protein LacF
MKKEKLKRFLDQDNVVGYVFASPFILGFLLITVIPMILSLYYSFTDYRLGNPVSWIGLDN
YIKMLSDARFLNSIRVTFLYVFASVPVKLIFGLLIAYLLTRNIKGTTFFRSLYYVPSLIG
GSISIALVWRELFSKNGLVNIFLERLGAPALSWFSDQKLVMIPLVLMSAWQFGSAMIIFA
AGIKEIPGSYYEAAEIDGANKWQTFYKITLPLLSPIILYNLVMQTIAAFMTFTQAFIITQ
GGPNDATNFYALYVYNQAFSFNSMGYASAISWIMLLIMGAVTFLIFKSSKKWVVV
>FECAFAII_01385 L-arabinose transport system permease protein AraQ
MNNTVTKWFQYGFILLLGLVMIYPVLWMIAGSFKTDQEIMSGSLNLIPETFQWENYAKGW
AGFAGISFFTFFRNSFVISAVSTIGTVLSSTCIAYALSRIDFKGKRFWFVVMLVTMMIPA
QVILIPQFIIYNRLNLVGTYVPLILPHFFGQAFFIYQIMQFMVSIPKELDESAIIDGCSK
YSVFTKIIFPLLKPSIITTIIIQFYWKWDDFMGPLIYLNKPRSYTVSIAIKLFADAGSST
TYASMFAMSTLSLLPVFLIFLFFNKYLVQGISTSGLKG
>FECAFAII_01386 hypothetical protein
MKKPIEEMFLYKLNYYVCRIFLTSLISNALFALVLGCLFTLGLVLSARVVYLIYFLMMYP
SYYLSVHYLAEKKVCWRKGKIKRMCFIITLFQLFVIIFAVDWYLLVGKIGAWYLIPFLLC
LLLFVSHSFFSTLIDICKEDKADSLVYLIKRNIWLLSKNVKGFLWYLCLLYGLFWCIQHD
FLLTALLYPGLPFVTVFCLKEKENDFK
>FECAFAII_01387 Putative oxidoreductase YteT
MKKKYVQVGLGGRARFFYEAIASTYHQTCELVGFCDVSQTRMDYANRILVNKYGQKKVKT
CMPSQFEQLLDDVRPAEVIITSVDRTHHDYIIRAMKKGYDVICEKPLTIDEEKAQEIITV
QKQTGRSLRVTFNYRYAPYHTKIKELIESDVIGDVFSIHFEWLLNTQHGADYFRRWHRNK
HNSGGLLVHKSTHHFDLVNFWLNSRPQKVFAFGGLNFYGMHNAEKRGVEIFYSRCYGSEL
AKADPFAIDLSANEELREMYLEAEKDSGYIRDRSVFSDDISIEDTLGVTVKYETGAILTY
SLNAYMPWEGFNVSFNGSKGRIEMKVIEKSYINAGGDKKDEGAAVLQSIHVYPMFGEPYE
VIVEQEAGGHGGGDPRLLDDLFGEEKEEDPWNRAATHVDGILSILTGIAANHSIASGKAV
VIDELVSLKE
>FECAFAII_01388 Xanthine phosphoribosyltransferase
MKELVERIQKDGRILGEGVLKVDSFVTHQVDPVLMEQMGKRFAEVFKEQGITKVVTIEAS
GIAPALFAARELDVPMIFARKAKSLTMDEELLTASVYSFTKQVTSTISISRKFLSSEDKV
LIIDDFLANGQAAKGLIELCQQAGAQVEGIGIVIEKSFQDGRQLLEEMGLRVVSLARIAS
LTNGQVEFLEEDA
>FECAFAII_01389 Uric acid permease PucK
MEKETQNGKAAVLGLQHLLAMYAGAVAVPLLIGTGLGFNQEQMTYLISIDIFMCGLATLL
QLTVNRFFGIGLPVVLGCAIQAVAPLILIGTNEGVGAIYGSIIASGIFVVLVSGVFSKIK
KLFPPIVTGTVITVIGLTLIPVAIEKMGGGNATAADFGDKTNLLLAFVTILLIVGVQMLA
KGFIRSIAVLIGLVGGSILAAFMGMIDLSAIGDAPLFHVPQPFYFGKPTFDVWSILLMII
ISMVSMVESTGVYFALGDITGKNVGEEELKKGYRAEGLAVILGGIFNTFPYTGFSQNVGL
VQLSGIKTRKPIYFSAFFLIVLGLFPKIGALAQIIPEPVLGGGMLVMFGMVAVQGIRMLL
EVDFSNDKNLLIVAVSVGFGLGFNVTPTLFSQMPQTLQMFTGNGIVMSSITAIILNLIFN
GLKKDEEILEEAFKK
>FECAFAII_01390 N5-carboxyaminoimidazole ribonucleotide mutase
MTAKISVIMGSTSDWETMKEACQILDEFGVSYEKKVVSAHRTPDLMFEYAQNARKKGIKI
IIAGAGGAAHLPGMVASKTTLPVIGVPVQSRTLNGLDSLLSIVQMPGGVPVATTAIGKAG
AINAGLLAIQMLSMYDLELEAKLAERRSMLAKTVIESSDQLG
>FECAFAII_01391 N5-carboxyaminoimidazole ribonucleotide synthase
MVKPLLPGSTIGIVGGGQLGRMMAISAKEMGFKVGVLDPVSDCPAAQVADWHIESVYDDT
FALKELARRTDVITYEFENVSVEALNAILPMSFIPQGTDLLAITQDRLLEKSFLETNNIV
IAPYATIVSPTDIQDAIDGIGYPCVLKTTRGGYDGKGQYVLKSRADLAPAMDLLREGTCV
LEAWIPFEKEISIMVAGNGQGDFTTFPVVENIHHNNILHETIAPAAIDQDVIEEAERIAR
VIAEAVSLSGVLGVEMFLTKTGGLYVNELAPRPHNSGHYSIEACSMSQFDAHIRGICGWP
LGEKVRLISNAVMVNVLGEQLLESYRLIENKPDWQFHFYGKKQAKKGRKMGHITILTEDI
QQTLEEIKQTNIWD
>FECAFAII_01392 Adenylosuccinate lyase
MLERYTRPEMGNIWTEENKYRAWLEVEILADEAWAELGEIPQEDVKKIREHASFDIDRIL
EIEKLTRHDVVAFTRAVSETLGEERKWVHYGLTSTDVVDTAYGYLIKQANDILREDLKRF
TEIIGEKAKEHKYTVMMGRTHGVHAEPTTFGLKLATWYSEMKRNIERFEHAAKGVEAGKI
SGAVGTFANIPPFIEEYVCKQLGIRPQEISTQVLPRDLHAEYFSAMALIATSIERFATEI
RGLQKSETREVEEFFAKGQKGSSAMPHKRNPIGSENMAGLARVVRGHMVTAYENVTLWHE
RDISHSSAERIILPDTTILLNYMLNRFGNIVKNLTVFPENMKRNMSATFGLIYSQRVMLK
LIDKGMTREEAYDLVQPKTAYAWDNQVQFRPLLEEDPTITSVLSKEEIDDAFDYHHHLKN
VDVIFKRVGLE
>FECAFAII_01393 hypothetical protein
MEDAIKQGQLFLSELTAEERSCLYNDLLSIKDVYLCNKDTSFYTFRKIRRATKRCAECRK
RTFLYQTEHKGELSISQIHEQKRFKNHYRIQILFNGQEMEYAFLENLLQHLHNQHFSYNS
QAIYA
>FECAFAII_01394 Phosphoribosylaminoimidazole-succinocarboxamide synthase
MEKKELLYEGKAKKIYLTSDENLIWIEYLDQATALNGARKDQISGKGELNNQITSAIFRY
LTQRGIKNHFIEQLSKTEQLAKKVQIIPLEVVIRNIAAGSFSKRLGVPEGKEFIKPIIEF
YYKDDQLDDPFINEEHIYFLQLAKPEEISELKAQALAINEILTELFAKVGLVLVDFKLEF
GRSNGQILLADEVTPDTCRLWDERTNEHMDKDVYRRDLGDLIPVYQEVYNRLSELTEEKE
RV
>FECAFAII_01395 Phosphoribosylformylglycinamidine synthase subunit PurS
MYFVKVYVTYKDSVLDPQGEAVKKAVHRMGYETIEDIRIGKYFEIQLADAEEPIDTVIET
ICDKLLANVNMETYRYEIKKMEEV
>FECAFAII_01396 Phosphoribosylformylglycinamidine synthase subunit PurQ
MKFAVIVFPGSNCDADMLWAVREIMGADAEFVRHDESSLEGFDGVLLPGGFSYGDYLRCG
AIARFSTIMEEVIRFAEEGKPVFGTCNGFQILTEAGLLPGVLRRNESLHFICKTVPLKVN
PKTAFTSEYEADEIIYLPVAHGEGNYFCDEETLQELKKNNQIAFTYNDNINGSVENIAGI
TNKAGNVLGMMPHPERAVEDLLGSEDGKRFFASILKNFGKVTV
>FECAFAII_01397 Phosphoribosylformylglycinamidine synthase subunit PurL
MKTLKEPTAEEIKKKRIYAEWGLTDEEYRMIEEDILGRMPNYTETGLFSVMWSEHCSYKN
SKPVLRKFPTSGPHVLQGPGEGAGIVDIGDGLAVVFKAESHNHPSAVEPYEGAATGVGGI
IRDIFSMGARPIALLDSLRFGELDNPRTKYLLEEVVAGIGGYGNCIGIPTVGGEIAFDPC
YEGNPLVNAMCVGLIEHKHIQKGQAAGVGNSIMYVGAKTGRDGIHGATFASEEFNQEEEQ
QRSAVQVGDPFMEKLLLEACLELILHHSDSLIGIQDMGAAGLVSSSAEMASKAGSGLILT
LDEVPQRETGMTPYEMMLSESQERMLICVKSGEEEKIQELFQKYDLDAVTIGKVTDDGQY
RLYHQGEEVANLPVDALAEDAPVYHKEMKEPARIVEFQQLAPYQPVIEEPGQVLLDLLQQ
PTIASKRSIYETYDSQVQTNTVVRPGSDAAVMRVRGTNKALAMTTDCNARYLYLDPKIGG
QIAVAEAARNIIASGGKPLAITDCLNYGSPDKPEVFWELSTSADGIAAACETLGTPVISG
NVSLYNETDGQAIYPTPMIGMVGLIEDHKHITTQEFKKSGDLIYILGKTFADFDGSELQK
MQLGRIEGVIRNFDLSIEKRNQELVLTAIQNGLIESAHDCSEGGLAIALAESAFKHQLGI
SVQFELSSAQLFAETQSRFVLTVAPENKTRFEEMMGDAAVLAGKVTDEAIIEISATDGQI
KIETAVARKCWEDAIVCLMK
>FECAFAII_01398 Amidophosphoribosyltransferase
MSYEVKSLNEECGIFGVWGHPDAASVAYFGLHSLQHRGQEGAGIVSNDRGKLKGHRDLGL
LSEVFKDQRKLQQLTGEAAIGHVRYATAGNGSVDNIQPFLFKFHDQSIGLAHNGNLINAR
SLRKELEENGAIFHSNSDTEILMHLIRRSEETDFLNKLKSALNEVKGGFAYLLMTETAMI
AALDPNGFRPLAIGQMKNGAYVIASETCALEVIGARFIRDVQPGEIVIINDEGIQIDCFT
KDTQLSICSMEYIYFARPDSNIAGINVHTARKNMGRNLAKESPVKADMVVGVPNSSLSAA
SGYAEASGIPYEIGLVKNQYIARTFIQPTPELREQGVRMKLSAVRGVVEGKKVIMVDDSI
VRGTTSRRIVHLLKEAGAKEVHVRIASPPLKYPCFYGIDIQTRKELIAANHTIDEIKECI
GADSLGFLSEEGLIESIGLEKDAPYSGLCMAYFNGDYPTPLYDYEEKYQESLKEKVSFF
>FECAFAII_01399 Phosphoribosylformylglycinamidine cyclo-ligase
MNSMANAYAKAGVDVEAGYEVVERIKKHVKKTERLGMMGAIGGFGGCFDLSVFQLKEPVL
VSGTDGVGTKLAVAIEADKHDTIGIDCVAMCVNDILAQGAEPLYFLDYLATGKNDPLRLE
NVVKGVADGCVQGNMALIGGETAEMPGMYSGNDYDLAGFAVGIAEKSQLLTGETINPGDV
LLGIASSGIHSNGYSLVRKIFFEQQQFSLSSKLPELKKTLGEELLEPTKIYVSSLLPLIK
EKKIKGAAHITGGGFVENIPRMLPESMAAQIKLGSWPILPIFGCLQKYGEIPEMEMYEIF
NMGIGMVLAVEESKVKEIVHEIEQAGEKVYEIGKVIAKEKHRVVFIGEER
>FECAFAII_01400 Phosphoribosylglycinamide formyltransferase
MRIAVFASGNGSNFQALADYLSKKGLESSIDWLFCDQPEAYVLKRATALSVPADCFSPKE
FDSKKEYEEAILHKLKEKKIDLIVLAGYMRIIGPVLLKNYDKRIINIHPSLLPAFPGLHG
IRDAFEAGVKETGVTIHYIDQGVDTGPIIRQEKVRIEQEDTFDSLEEKIHRVEHRIYPEV
ISEIIENGGYLK
>FECAFAII_01401 Bifunctional purine biosynthesis protein PurH
MTRALISVSDKTGIVAFAQGLIEQGVEIISTGGTKHALDKAGIKTLSIEEVTGFPEMMDG
RVKTLHPKIHGGLLGRRDLPSHMEAMETENIQPIDFVCVNLYPFKETIMKPDVEIAEAIE
NIDIGGPSMLRSAAKNHEFVTSVVDPSDYEEVLSELRQYGHTSLSFRQKLAAKVFRHTAA
YDALIAQYLTDWVEEKEPEKLTLTYERKQTLRYGENSHQAAAFYQSALLEKYSIAAAKQL
HGKELSYNNIRDADAALRIMKEYDEPTVVALKHMNPCGIGTASTILEAWEAAYEADPVSI
FGGIIVLNREVDLPTAEQMHKLFLEIIIAPSYTQEALELLQKKKNIRLLTVDFAQEENQN
REETVSVLGGLLVQDQDLAIENEEEWKVVTKRKPTPAEAKALAFAWRAVKHVKSNAIVLA
NERQTVGIGAGQMNRVGSVKIAIEQAQEKMEGAVLASDAYFPMDDSVEYAAKHGIKAIIQ
PGGSIKDQDSIDMANKYDLAMVFTDVRHFRH
>FECAFAII_01402 Phosphoribosylamine--glycine ligase
MNILVIGAGGREHAISKKLLASPKVDTVYCAPGNPGMTKDGINCVAISERDHSALIHFVK
KEAIDWSIVGPEVPLLNGIVDDFMAEGLKIFGPTKAAALIEGSKSFAKQLMDTYQIPTAK
SRSFECYEKAAAYIKENGAPIVVKADGLAAGKGVVVATTVKEALDAAEQMLNQHRFGDSS
KKIVVEEFLAGEEFSLLAFVRNTKVYPMVISQDHKRAFDNDKGPNTGGMGAYSPVPQISK
KMIEKAVEEVLKPAALGMKELGRSFTGVLYAGLIATKEGPKVIEFNARFGDPETQVVLSR
LKSDFAQVIDDLLENRTVELKWQQEGYNVGVVVAAAGYPEEYETGMVLPDFLEEELSVYY
AGVSSNNGKLVGAGGRLYLVEAYGETIKEAQKKIYTALMDKTTDGTFYRTDIGEKAANSE
LIVK
>FECAFAII_01403 Oxidoreductase YdhF
MKKIQLGTSDQKAAAVILGCMRINNAEDPVKVIETAYENGIDFFDHADIYGNGECEEIFA
DALAKTSIKREDLFIQTKCGIVPGVMFDFSKKHIIESVEKSLTRLKMDYVDALLLHRPDT
LVEPEEVAEAFDELERSGKVRYFGVSNQKPMQIELLKKYVRQPLVANQLQFGLKHTGMID
QGIHVNMTDEASIDHDGSVLDYSRLHDMTIQAWSPYQYGFFEGVFIGNEKFPELNQTLEE
LAAKYQTTPTGLASAWILRHPANMQVIAGTMNVGRIKEIAQASEINMSREDWYELYRAAG
NILP
>FECAFAII_01404 putative response regulatory protein
MYKVFIIEDEYLIRNNLREQITVLGSYYPITYVGEAGDGEMALSSIIDLQPDIILTDIQM
PFMDGLTFSKEARKLLPWTRLIFISGFDDFDYMKGAIQVQADDYLLKPIKSSELKQAIEK
AVTALDLQQKETHTSSDLVFELKKNHFLNGLFKGSLTISETLKLAESFNRSLAGKKMTVL
LAANQVSTDFEDYAHLSDYLKFLFRENQQVIFSAVSSRFIKFLIVDSLEENVIETSYQVA
QTLVHELEKGQKNNFSVAIGPVAERISELPASFEITQMILETASSLKEQIISYEDLIQEA
KLPVDSVFYFDLSLDLSSLSKNEVSKYIEHLTKPQGTPTRTRLYRLFVLTKLLQHVCLKE
KKIPQEMVHCTSTSQRLAISADDSLYRSTVYMFISFLTALPSQPSRNKYQPILNHALDFI
KENFTDPDMSLTWVAQQVALSPSHFSTIFSQSFNQTFIDYLTEQRIELAKKLLQQSDYRI
SDIAFEIGYNDPNYFSYLFKKKQGISPKEYRTQLFLKNKNN
>FECAFAII_01405 Sensor histidine kinase YehU
MTKNLSIKQIFAQANKAMLLFAVIPLLLSILLYSQQLLIYQQTIANIQKADAIALKVDQK
VLESMWDLISGQVTVDEFNEENILEELRNDIREIKNNTNTLKEISTLDVSLRTIDTLGDY
QNELINNILAKDFMDTNEEIINQVDSVTQLLSDILQDFVRVEIDLASKKNTTLVRSLILL
TIVELGVLSTIFFYAKKNRRFLERKVQEPINQLIEMSEQLSSGNLGFRLTLPETLELQTL
TASMNKMAEDLNQSLRENALKQYHLAQSEVRVLQAQITPHFIYNSLDAIISLIEQDCFEE
ALTMTHALSGFFRTSLSKGQDWIPLEKEISHINDYLVILKIRYGHMLDYKIDIPETLFPV
SILKMILQPLIENAVYHGTKYVRHKGFIRITTCKIDEMIQFKVIDNGIGIPAEKLAEIRK
ELAKGIDSDFSIGYGLYNVNKRLLLYYGNDQKPITIDSKYREGTTVTLMIPLSPKTIGGN
KHV
>FECAFAII_01406 ABC transporter periplasmic-binding protein YtfQ
MKRVLFFLALVVIAYQMMGCTPNTKEAPDPLVVGFSQSGTESSWRKKHTESIITALEKED
YQVLYRNGYMNQERQIQDIRTFIAYKVDMIIFTPLQESGWDSVLKEAKRAGIPVILVDRH
IQTNDPELFVTHIGPSFKAEGNRAGLFVSNHFTNSKKQEIRILELAGSENSTPTKLRSEG
FLESINRKPTLKKDGTIDHKPPMTIVHRIVGDFIRMKGKDQMKRYLETNDLSEIDVLYSH
SDEMTHGALAAIKETSIKPGEDLIIVTIDGQEDMIEKLRSGIVNCVVECKPDVGWYVANT
VTRYFGNIQTGKTLPKDIFISETVFSQQNIANIPTRNY
>FECAFAII_01407 Multiple sugar-binding periplasmic receptor ChvE
MKNKFRKIVGTIAILTASILLSACGNSGSADDSTGYVGIAMPTKSAERWIADGNNMVSEL
EKLGYKTDLQYGEDKVENQVAQIENMITKGVDTLVIASIDGSALTDVLAKAKEADIKVIA
YDRLLMNSENVDYYATFDNFGVGVSQAAYIEEHLGLKEGKGPFTIELFGGSPDDNNALIN
YNGVMSVLQPYMDNGQLVVPSGQTSFSQIATLRWDGSTAQARMDNLLSANYTDQTLDAVL
SPYDPISLGIISSLKGVGYGSESKPLPVITGQDATVAGVKSIIAGEQTQTIFKDTRILAK
NTIEMIKAISDGEEVPVNDTETYDNGVKTVPTYLANTVSVDKDNYQAELIDTDYYKESDL
KN
>FECAFAII_01408 Xylose import ATP-binding protein XylG
MADCILKMADITKKFSGIRALDCVNLMIERGEIHALCGENGAGKSTLMNVLSGLYPYGSY
DGEIFYDGKLCQFKDLKDSEEKGIVIIHQELALSPYLSIKENIFLGNEQAERGVIDWELT
EKKTYELLNKVGLSIDPNLLVSQIGVGQQQLVEIAKALSKSVRLLILDEPTAALNEEESA
NLLRLIRELKEQGVTSIIISHKLNEIVDIADRITILRDGQTIETLENEMISEEHIIRGMV
GRDLVDRYPERKPDIGEVYFKVEDWTVYHPLDHERIINDHINLHLKKGEIVGIAGLMGAG
RTEFAMSLFGHSYGSKISGRILKEGAEISVKTVPSAIANGLAYVSEDRKSLGLNLLMDIR
ENVTLSSLDKISQKGVLDKEKEVTEAENFRKKMRIKTNSIHQIVSSLSGGNQQKVVLSKW
LMTQPDILFLDEPTRGIDVGAKYEIYTIIEEMAANGKAVCLISSELPEILGMCDRIYTMN
EGRITGEVSREDADQEVLMKLMTKEEVG
>FECAFAII_01409 Xylose transport system permease protein XylH
MEQAKNLTDKKEKKLNLKSRAADLFGRYSMVIILAGLLIAFQLMTDGIFWRPLNITNLVL
QNSHILVLAAGMLLVVLLGHVDLSVGSVMAFVGAIAGMMMVNRQMNPWMTVIACLAVGGL
IGAWQGFWVAYAGIPAFIVTLAGLLMFRGLTQVVLGGQSLAPFPAVFQKMSTGYLPDLSE
GSSLHFLTLILGMIITIVLVVGQWRTRNRRKNHLFEVESPTAFLVKAVFTAVVVLGITYI
FASYQGYPIILIILGLIVAAYGFLTNKTVAGRQIYATGGNRKAAELSGIKTKRITFWVFV
NMGVMAALAGLVLAARLNAATPQAGTSMELDAMAAVYFGGASTSGGIGTIMGAIVGGLVM
GVLNNGMSILGVGVDWQQAIKGLILLLAVVLDLYNKKKRTT
>FECAFAII_01410 GMP reductase
MKVFDYEDIQLIPNKCIVNSRSECDTTVTLGKHTFKMPVVPANMQTIIDETIAEFLAENG
YFYIMHRFDEAARIPFIKKMKKRGLITSISVGVKKEEYSFIEKLAEESLNPDYITIDIAH
GHANSVIDMIQHIKKYLPETFVIAGNVGTPEAVRELENAGADATKVGIGPGKVCITKIKT
GFGTGGWQLAALRWCAKAARKPIIADGGIRTHGDIAKSVRFGATMVMIGSLFAGHEESPG
ETKVENGIVYKEYFGSASEFQKGEKRNVEGKKIWIQHKGSLKDTLVEMQQDLQSSISYAG
GRDLEAIRKVDYVIVKNSIFNGDTI
>FECAFAII_01411 HTH-type transcriptional regulator NorG
MWEKVEKKQGPIYRQIMEQIMREIENGRINPGSQLESERKLGQLFGVNRSTVVHALEELR
ELGVLTSKRGSGWFVNQTEWGKFAVPRIDWRQMISPRYEQTDWYEQKIREAKQIQKTSFL
DLYASEMPDELLPNFEFPSYSLEEILAEEKEMDLLGYTPLRNKIKRYLESKFELAFSPNQ
LLVTGGGQQAIFLILQTILSAGEGIAVESPSFFYRLPLFKASGTRLFGIPMDEEGIDLEK
LKESIHKNKLKAVLINPNFQNPTGKVMSQKRREKLVELCRQYRLPIIEDDVFTDLSFLNQ
EEVLPIRTIDPDNVLYVGSLSRVLGKTTKIGWVIGPETFISQLAQAQEMMEFSMNILTQI
TVANVFNEAIDLKMQDVRKKLKEKSRLISAWGDSQSFFKLHSILGGYYAWITWDGKKLDP
ELAEKVVDMGLGIAPSLLFGQDINGIRINYSRLDENQIPLFYSKMKILEKWLTE
>FECAFAII_01412 Pyruvate dehydrogenase E1 component subunit alpha
MANKKAPIDFQALLDEVNADFPVYQALDQDGNVVNKDLVPDLSDDELVELMTHMVWSRVL
DQRSTALNRQGRLGFFAPTAGQEASQLASAYAFDKEDVLLPGYRDVPQLVKHGLPLSQAF
LWSRGHAAGNSYPEELKALPPQIIIGAQYVQAAGVALGLKKRNKKNVVFTYTGDGGSSQG
DFYEAINFAGAYHANAVFYIQNNGYAISTPREKQTAAKTLAQKAVAAGIPGIQVDGMDPL
AVYTVSKMAREWAISGNGPVLIETLTYRYGPHTLSGDDPTRYRTKDTDDDWQKKDPLIRF
RKYLTEKGLWSEEKEEQVIEATKEEIKAAIAEADKVPKQKVSDFLKNMFEVSPQSIKEQI
AIYEAKESK
>FECAFAII_01413 Pyruvate dehydrogenase E1 component subunit beta
MAQKTMIQAITDALALELENDENVVVFGEDVGKNGGVFRATEGLQEKFGEDRVFDTPLAE
SGIAGLSFGLALEGFRPVPEIQFFGFIFEAMDEVVAQMARTRYRMSGTRNLPITIRSPFG
GGVHTPELHSDNLEGLIAQSPGIRVVIPSNPYDAKGLLISSIRSNDPVVFLEHMKLYRSF
REEVPDEAYEVPLDKAAVTREGTDVSIITYGAMVREAIKAADNLAKENISVEIIDLRTVA
PLDVETIIQSVEKTGRVVVVQEAQRQAGVAAQVVSEISERAILSLEAPIGRVSAPDTVFP
FGQAENVWLPNAKDIEDKVKEIAEF
>FECAFAII_01414 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MAYQFKLPDIGEGIAEGEIVKWFVKPGDTINEDDTLLEVQNDKSVEEIPSPVTGTVKNVI
VPEGTVANVGDVLVEIDAPGHEDNEGDSGVAAESQTPAKPAAEPTVDTESAGSSSEGVFQ
FKLPDIGEGIAEGEIVKWFVKPGDTINEDDTLLEVQNDKSVEEIPSPVTGTVKNVIVPEG
TVANVGDVLVEIDAPGHNSAPSTSAPSAEAPKEKVETSGSASVVEAADPNKRVLAMPSVR
QFAREKDVDISQVTATGKGGRVTKEDIENFLAGGPSSAPAKSEAPEAAAPKEAAPAAESK
PAAPAKPFKSNLGDLEERVAMTPTRKAIAKAMVNSKHTAPHVTLHDEVEVSKLWDNRKRF
KEVAAANGTKLTFLPYVVKALTATVKKYPVLNASIDDANQEIVYKHYYNIGIATDTDHGL
YVPNVKDADRKGMFAIADEINEKAKLAHDGKLSAEDMRNGTITISNIGSVGGGWFTPVIN
YPEVAILGVGTIAQQPIVNAEGEIVVGRVMKLSLSFDHRIVDGATAQQAMNNIKRLLADP
ELLMMEG
>FECAFAII_01415 Dihydrolipoyl dehydrogenase
MVVGDFAVELDTVVIGAGPGGYVAAIRAAEMGQKVAIIEREYIGGVCLNVGCIPSKALIA
AGHHYQESLDSEMFGVTSENVKLDFAKTQEWKENKVVHTLTSGVGFLLKKHKVETIEGEA
FFVDDHTLRVIHPDSAQTYSFNNAIIATGSRPIEIPGFKFGGRVLDSTGGLALKEVPKKF
VIIGGGVIGAELGGAYANLGAEVTILEGSPQILPTYEKDLVKLVEDDFKKKGVTVVTNAM
AKEAVDNGDSVTVKYAVDGKEESVTADYVMVTVGRRPNTDDMGLEQAGVEVGERGLITVD
KQGRTNVPNIYAIGDIVPGAALAHKASYEAKIAAEAISGKKVAVDYKAMPAVAFTDPELA
SVGMTIKEAKDAGIEAKAYKFPFSGNGRALSLGKTEGFIRLVTTIEDNVLIGAQIGGVGA
SDMVSELALAIESGMNAEDIALTIHPHPSLGEIVMDASELALGLPIHI
>FECAFAII_01416 hypothetical protein
MQEYQYPLDLDWTTDEMVIVMKMWEDLERANEKGINNEAFLKTYQQFKTVVKSIGEEKRL
GREFEKASGYSLYRTVQQAKKNPNKTLRMNG
>FECAFAII_01417 Fructose-1,6-bisphosphatase/inositol-1-monophosphatase
MEQMIDHIKSWLEEAGEKIKSSQQTLTISQKSNRTDLVTNVDRNIQNFLIEKIHSFDPEA
KILAEEEGCNQLSDLDGRVFIIDPIDGTLNFVIEGENFCIMLAVYESGVGKLGFIYDVMR
NELFWGGKGIGVYKNDEPLPRPANKSLSEGLLGVNSYLFGHNKYGIREIAESSMGTRMYG
CAGLELVAILKGNHIAYISNLSPWDYAAGNVLLEEFGMVTSGLFGTPLTFEKREYYLAGT
SCAYAEIADLLKKEG
>FECAFAII_01418 GTP-binding protein TypA/BipA
MNYRNDIRNVAIIAHVDHGKTTLVDELLKQSDTLDAHTQLQERAMDSNALEKERGITILA
KNTAVDYKGIRVNIMDTPGHADFGGEVERIMKMVDGVVLVVDAYEGTMPQTRFVLKKALE
QHITPIVVVNKIDKPSARPEHVVDEVLELFIELGADDDQLDFPVIYASALNGTSSLSDDP
ADQEPTMAPIFDTIIEKIPAPVDNSDEPLQFQVSLLDYNDYVGRIGIGRVFRGTIKVGDQ
VALIKLDGTVKKFRVTKLFGFFGLKRLEIQEAKAGDLIAVSGMEDIFVGETVTPVDHQDA
LPILHIDEPTLQMTFLVNNSPFAGREGKFVTARKIEERLMAELQTDVSLRVEPTNSPDAW
TVSGRGELHLSILIENMRREGYELQVSRPEVIEKEIDGVKCEPFERVQIDTPEEYMGSVI
ESLSLRKGEMQDMVHTGNGQIRLTFLTPARGLIGYSTEFLSMTRGYGIMNHTFDQYLPML
PGQIGGRHQGALVSIDTGKATTYSIMSIEERGTVFVEPGTEVYEGMIIGENSRDNDLTVN
ITKAKQMTNVRSATKDQTSVIKKPKQLTLEESLEFLNDDEYCEVTPESIRLRKQILEKNA
REKASKKKK
>FECAFAII_01419 ATP-dependent DNA helicase RecQ
MNDLLKQYFGYDEFRPGQKEIIQKVIDQENVLGIMPTGSGKSICYQLPALLLDGLTVVVS
PLISLMKDQVDAANQLGIPATFINSSLDGYETARRFQEIDRQQYRLLYIAPERFIMPDFI
QAMKRWNVRMIAIDEAHCISQWGHDFRPSYLQMANQLDQLPNRPVIVALTATATVQVAAD
IKRLLKIPENNHIQTGFERENLRFQVIKDQKKEQYLIEYLKINKNQSGIIYAATRKEVDR
LYHLLKKFDFSVGRYHGGLNENERTEMQEAFLYDRLQLIVATNAFGMGINKSNVRFVIHY
QIPGSLEAYYQEAGRAGRDGLSSEAILLFSPQDIQVQKFFIQQSQREEGQKQKEYEKLKA
MTEYVYIESCLQQYILNYFGETSSPCNRCGNCLDDREIVEVTTEAQMVLSCLKRMGENYG
KQMLMKVLAGSKEQKLQALGFGHLSTYGLMKNQSQKETMQLIEYLISNGYLLTINGEYPV
LKVTERGIQVLKGQESVYRKEPKKVQQLSDEETDTLFEVLRELRTDLASEAGVPPYVVFS
DSTLKEMSRIRPSSRLEMLQIKGVGQSKLDKYGEAFLSRIKNADSNVLDK
>FECAFAII_01420 hypothetical protein
MDSLSKKLAIQVLNDEAERIKRLIRNQNNSLCISQCKAFEEVVDTQMYGFSRQVGFAVRI
GVIGKNEGQLMLSELERELNQLYSEVYQEIYDKKEVGKEE
>FECAFAII_01421 putative peptidoglycan glycosyltransferase FtsW
MPKKVKKRHLLDYSILIPYLILCVLGLIMVYSSTSYLLLENGQNPSASVINQSIFWVLSL
IAIALLYKMKTDVLKNQRLIMAAIAVLTILLLIVVFFGKEINGAKGWLQIAGFSIQPAEY
LKIISIWYLSLTLSKRQNSVQKDFLGTVKRPLAMVIGLTALVAILPDFGNAAVIFLIILV
LLLASGVNYVYTLIVGVGGFCLSTFTIWLINITNGKILPGRLQYIYNRFAIYQNPFSDEL
NKGHQLVNGYYAMFNGGLFGRGLGNSIQKKGFLQEAQTDFIYAIVVEELGVIMGILILAL
LFFMIVRIVLVGIRSKDPFNSLLCIGIGAMFLIQVFVNLGGITGVIPLTGITFPFLSQGG
SSLLMLSICVGFVLNISADEKRKSLGL
>FECAFAII_01422 2-oxoglutarate carboxylase small subunit
MKKVLVANRGEIAVRVFRACTELGIKTVGIYAEEDEYSVHRFKADEAYLVGQGKKPIDAY
LDIEGIISIAKECGADAIHPGYGLLSENLNFAQRCEEEGIIFVGPKLHHLDIFGDKIKAK
AAAIEAGIASIPGTDGPIASIDDALEFAKQYGYPIMIKAALGGGGRGMRVAHDEKSAREG
YERAKSEAKAAFGSDEVYVEKYIANPKHIEVQILGDTHGNVIHLFERDCSVQRRHQKVVE
VAPCVSMNEQQRQKICQAAVQLMKYVGYVNAGTVEFLVEGDDFYFIEVNPRVQVEHTITE
MITDIDIVTTQLLIAQGLDLHKEIGLPQQEGIKLNGSAIQCRITTEDPLNNFLPDTGKID
TYRSPGGFGVRLDVGNAYAGYVVTPYFDSLLVKVCTHGATFETAIQKMERCLKEFRIRGV
KTNIPFMLNVITHPEFQSGNAKTTFIDSTATLFEFPRLRDRGNKTMKYIGEITVNGFPGI
ESGEKPFYEEPRMPKDLITRTDYVTAKNVLDAKGADALVEWIKGQENLLLTDTTFRDAHQ
SLLATRVRTKDFKQIARLTGEGLPELFSSEMWGGATFDVAYRFLNEDPWQRLRKIRSLMP
NTLLQMLFRGSNAVGYSNYPDNVLVEFVKEAAAQGIDVFRIFDSLNWTPQMEKSIQAVRD
TGKIAEAAICYTGDINDPSRAKYNVQYYKDMAKELEQLGAHIIAIKDMAGLLKPQAAYRL
ISELKETTDLPIHLHTHDTSGNGIITYSAASKAGVDIVDVAMSAMSGNTSQPSMSSLYYA
LVNGPRLPEITIENAQKLNHYWEDVRMYYKPFENGLNAPETEVYMHEMPGGQYSNLQQQA
KAVGLGHRWDEIKQMYHTVNLMFGDIVKVTPSSKVVGDMALFMVQNDLTEEDIYEKGETL
SFPESVVTFFQGELGQPVGGFPKKLQKIILKGRPALNERPGLLAESVDFNEVKKELAEKI
GYEPKQDEVLSYLMYPQVFLDYQKAYNQFGDVTLLDTPTFFQGIRLGETINVQIERGKTL
IIRLDEIGEPDIEGNRVLFFNLNGQRREITIKDNSIISTVQTRLKAEPTNREQIGATMSG
SVLDVLVKKGDNVKKGDTLMITEAMKMETAIEARFDGEVAHVYVSSGDTISSGDLLIEVT
EK
>FECAFAII_01423 hypothetical protein
MKRLGLFWLILLLVIVAFYMEPVLFPPKLEVKENSDQQISNQMTTWKYQELKATGFSTYI
GKPIDQLEKDFGQAYDRLTSGFGFETRYYENKASHLTFEANIQDSRVTTVKVLQTGPADI
APFYLGMTMQDLTKITTIYTNFTFEYHDTEVGIELMEEDMNYRPLIAFDNDTFAILFFDQ
TTNGLFSVVYLDKDSLLKLLPYQVFGEGLPHYQADKSADWESINRVKERKSTTLLNMLRR
EDELPIYNQTLAFQNHSQLLLHDFLTRPEEILSEERMADWQKSLGSAQTTVKFSLTNDEL
EKLISKQKLENTSGLFIHPAIDATFSFLYWYSDPYNHDRFMDPGTDSVGIAFSKENMLVL
LQEENGESSDSSDR
>FECAFAII_01424 hypothetical protein
MIAVIVNEELFQLEDQCLQVAEMIKKSKTMASYLEHKQSMEESAKVCQLKEAFLSKKEAF
ENVAAYGEYAPDYREKKRAVRKAKRQLDMDEHVAAFRYSETQLQSLLDQIVQVLAEEVSN
EIKVDAGSPFFETKKHFGCGGNCHAIRQ
>FECAFAII_01425 hypothetical protein
MQLDNSEFEITKRRGLIVWVYSLKQLKNLKKFGLLHYVSRRMKYVVLYLNEETLEETEER
IRKLHFVRNVERSYRPDIEMNFAEKIGNKTVLKDEGFEIEELNTEIRLAEHL
>FECAFAII_01426 Ribosomal RNA small subunit methyltransferase D
MRIISGNYGGRRLKSLAGANTRPTTDKVKESIFNMIGPYFDGETVLDLFAGSGGLAIEAV
SRGCSHAVCVDKNYQALKIIKENIEITKEPEKFTTIKLDADKAIERLAAEKQQFDYLFLD
PPYAKQKIIDQIHKMEELGLFSKTAVIVCETDKTVELPETVAGFHQIRKQIYGITAVTIY
RKEGNQ
>FECAFAII_01427 Phosphopantetheine adenylyltransferase
MKRALFPGSFDPFTKGHLDTVERAAKLFDEVVIGVFINTSKKSLFPPEERMTLITKAVSH
LPNVKVMHQENQLTVETAKEIGADALIRGIRSIKDFEYEREIAQMNHHLYDELETVFLLA
KPEYSHVSSSILKEVLHFGGDVSSYLPPVINEALAGKRESNES
>FECAFAII_01428 Lon protease
MKAKQWLKTVLIIIFGMLIIGFVVVPLPYYVESPGATIDLKELITVNDKEDKGSGSFSLT
SVGIRQATGFLALKAKMTPFEELISEEELTGGATNEEYNQMQQYYMDSSQNAAIEQALKL
ADKPYKMEFKGVYVMSVEKTSNFFGKLSVGDTVTKVDGKSFQSTEAFMDYVKSQKVGQTI
EISYLHNGEEKTASGDLIELPTDKKAGIGITLTDHTEIESDTDVRINSGSIGGPSAGLMF
TLEIYEQVTGKNLRHGKQIAGTGTINSEGEVGRIGGIDKKVASADKAGVEIFFAPDDTIS
DDVKKEYPEIKTNYEEAKAAAKKLNSSMKIVPVKTVQEALDYLEKMK
>FECAFAII_01429 ComE operon protein 1
MIVLIFCIASGFLLSNLLFYRETEETAAKEILSSFSSSGEDPSAEGNDVEEDARPKVMYT
DIKGSVKEPGIYSFSSEERVYDVLKRAGGLLEEADSDRINFSAKIEDQQVLYIPAVGEEL
PEHLDQLASSEGKQPTADSEPPKININTATPSELQQIPGIGSVKAQEIIRFREENGSFQK
VEDLQEISGIGEKTVEKLKNFVTIK
>FECAFAII_01430 hypothetical protein
MIVRKETLKKPMLNVYLQNKISGIHIMNTAVSGNNSQALRERFAKDVLSYTADKVFILIG
TNDLAEHKQLSKETYQKICSG
>FECAFAII_01431 hypothetical protein
MIVQLKKDYSSDHAFFITPPAVDETKQKYRNNKLIKEYISVLTEVAKRHDCEVSIFIRNF
LNKWIRRIFIMG
>FECAFAII_01432 tRNA-specific adenosine deaminase
MLEKSSKACDTNKEKVTDKSHNERIPWDQYFMAQAVLLSLRSTCTRLEVGATLVREKRII
AGGYNGAVSGDVHCIDEGCYVVDGHCLRTIHAEMNALLQCAKLGIPTEGSEIYVTHFPCL
ACTKALLQAGVKGINYLHDYRNDPYAQALIEQLGVSVHQVALDSQHFSKLQNELTGKHV
>FECAFAII_01433 ComE operon protein 3
MSSVLERHVRNRLIFPAITSMIICLLYYTDNWGYRLLLAGIFLWFSLKEGRFIAYLCILC
SITVSISYRLQEYSFLEEKTTSAQITVFTDTIRANGNFLTMEGRLSENKQKLQLSYQVNT
EAELKTWLNFRGKGIELTAEGEFISPAKKRNLYNFDQEAYFRNHRISGRFQIQKIEQITM
QNHWRNWLQRKRGSFISFVQSEFPQKTSVYINSLLWGYKDAGFREPEEIFRESGLLHLFS
LSGLHIQFYLGWLYYLFRRIGWPLHVSIIPLSLLTICYVSIAGSSISVLRASLLFLLRLL
VKLLNKHYSTMDLFAVVFWLLLLFDPRFLFHAGGQLSFFMSFLFILISFDGDWLKKTASH
VLFTMITMPLIVWHFYEWPILGSLFTLLIAPVFKFLFLPGVLFLTLFNRWLPETLLLLIE
EGLILFERIIDFSSGSSLIIGRLPLVLSGMYIFGLLICMDRLKEQPVKHLFYVGLFSFIF
LTLPFLRFSSTIAFIDVGQGDSIFLQSPFRKETILIDTGGQLHFEREKWAQGMIRPPAER
NIVPYLKGQGISVIDKLILTHDDTDHVGELPTLSQHFTIKKIYIGWGAGRNEPLQRHLSE
AQKNGTEIIEIKHGDRISGYYDLYVLTPFEKGEGRNEDSIGLWMEYNNRRFLFLGDLNQA
MEKQLLLIYPNLKADVVKLGHHGSRTSSNTDFLSHIEAKHGIISCGVNNRYGHPHSEVLE
TLEENQIKTWRTDQQGMITYRWHPVFHPHGLVETMID
>FECAFAII_01434 hypothetical protein
MVSNLSIQAELQKIRKEKLASCYLILGTEKFLQDQVRTEIVKKIQLEGEDDLNFLSFDME
NASLDEVVAEAETLPFFGDQRLVFVENPYFLTGEKVNNGIEQNTDLLTAYLKEPLESTVL
VFFAPYEKLDERKKVTKQLKKTAIIINVQQLNEKEVRQYLMNTLENSSIKMERSAIDLFL
RLTDLDLSKMMRELQKLVLYGQNQQQITVREVEELVPKTLEHNIFDMTQYILKGKTEQAL
RLYEDLVMQGEETIKINAILLSQLRLFLQTKFLVKIGYQQANIAETLKIHPYRVKLAMQE
VKKFDEHLLVQLFDQLVEMDYQIKTGQIEKELSFQLFVLRTGQLLRNR
>FECAFAII_01435 30S ribosomal protein S20
MPNIESAIKRVRTSENANVKNSSQTSAMRTAIKKFEDAVASGADNVDALYKEAVKAIDMA
ESKGLIHKNKANRDKSRLSKKIAK
>FECAFAII_01436 hypothetical protein
METFEGLLIDTYVLQEQPMMLTGINLQLEDRVINGLLKDRYLAKYILRLPLNKYVLEVSG
KWNRRNQLVIKKMLIKNIDEYIKIIGTPE
>FECAFAII_01437 hypothetical protein
MESWLFLGIILLVAILAKNQSLMIAAAFVLIMKLIPASRSFFPWLQGKGINIGVTIITAA
ILIPIATGEIGLRDLLEAFKSPIGWVAVFCGGLVAVLSSKGVGLIASDPQITVALVFGTI
LGVVFLRGIAAGPVIASGITYCILQVFALGK
>FECAFAII_01438 Zinc-transporting ATPase
MTNQKKAFAATIGCLLFMIFGFIFDRFSLTITPLFYISAIIIGGYKQTSEGLKELWNDRT
LNVDLLMALAAIGACLIGNYFEGAMLTFIFCLSGALEEYTTNKSQKEITALMNLQPQKAQ
LLKENGQMQEVDVSQLKVDNLVFVAKGAAVPIDGFLESTQATIDESALSGESVPVEKYLG
DEMYAGTLNQGNPITIRVTKTSSETVFAKIIQLVEEAQNTPTQTASFIERIENNYVKLIL
LAVPLMILLPHFFLGWSWDESFYRGMVLLVVASPCALVASATPASLAALSNSAKNGILIK
GGIHLEKLSELKAIAFDKTGTLTKGKPVVTDSFFFDEKDLAQQLLVAMEQKTTHPLAHAI
LQYFDCTIPEEIQYLPIEEITGFGLQTTYLGAQWKVGKHAYDPETMIISKEIAEMIERLE
NQGKTVIYLSKDQQLIAVLGLLDIPKANTQQVISYFKSQNIHTSMITGDHSGTAKAIAEQ
VGIEHYYASCTPEEKTQLVKKENELYQVNAMVGDGVNDAPALAAASLGVAMGQGTDAAMD
IADIVLMKSDLNKFVYSHRLSLKMRRIIKQNIIFSILVILLLIASNFLQFLNLPLGVVGH
EGSTILVILNGLRLLRPLPDLSDSSKKCKSCPLYKARLSSVK
>FECAFAII_01439 Undecaprenyl-diphosphatase
MFFANIIKAVILGIIEGITEWLPISSTGHLILADEFIKLDASSQFMSMFNVVIQLGAILA
VVVLYFHKLNPFSPSKSTVEKKDTWTLWFKVIVACIPAIIIGLPLDDWLEANFHKFLPVA
IVLIVYGIAFIIVEKRNKNKTPRWTSLNDFTYQAALLVGLFQVLALVPGTSRSGATILGS
ILIGASRFVATEFSFFLGIPVMFGASGLKIVKYLAEGNSFKMEETVVLLVGTFVSFVVSV
LAIKFLLSYLKKNDFTAFGWYRIILGIILIGYWFIAM
>FECAFAII_01440 Putative phosphoserine phosphatase 2
MTETTLYIVRHGKTMFNTIERVQGWCDTPLTKQGQEGIHYLGRGLKNVDFSFAYSSDSGR
AIETARIILGEHSKGKEIPYFIEKRIREWCFGSLEGGYDMEMWGVIPRVLNFKTYDEMFT
TEVSFEQIANAVYNLDTAGWAETYETLRDRVWTGFEDIAHHCEKNGGGNVLVVSHGLTIA
FLLNLIDPKQPVRAGLLNGSVTKVTYANGRFSIHGINDTSYIDNGKTHSRDSFL
>FECAFAII_01441 putative metallo-hydrolase
MHIERLKTGMIEENCYLVYNEEALLIIDPGEDAERIKQEIKKTNQQPVAILLTHTHYDHI
GAVEPLRAYYQIPVYVSPLEQKWLGDPILNLSGLGRHDDIADVIVSPAEYEFEMKTYTLG
NMSFRVVPTPGHSIGSVSFIFDDFVVSGDALFRGSIGRTDLYTGNLEQLLHSIRTQLFVL
PDEFAVYPGHGDATTIEQEKRTNPFFNR
>FECAFAII_01442 putative ATP-dependent helicase DinG 
MIKQSKISVRHLVEFILRRGSIDNRKKSNHTALEGARIHRKLQKDAGENYEKEVFLKTTV
QLDEYYLIVEGRADGIFKRDGIYYIDEIKTSEPRFEDLEPEQVELFFHQARVYAYIYSQE
HDLQEINLQLTYFQTAEEVITRKVEHQTREQLETFFKKLTEDYKEWLVFQENWRTVRNAS
LMALKFPHDEYRKGQRELAVAAYKTIRTKQKLFVEAPTGTGKTISTLFPALKAVGEEEGE
KIFYLTAKTITRQVAEDAMTALKDTGAEVKSVTLTAKDKICFLDETTCNPDQCPYANGYY
NRINEGLWDLLNHENQITREVIETYARKHTLCPFELSLDVSIWCDVIIGDYNYLFDPTVY
LRRFFEDEKNEDYLFLIDEAHNLVNRSREMYSAELSYEKTKRSKEAIPKEFKKLHRRFNK
LLKEFDSIREIAKEDHWDYHHQKAPAESLVKAGYQLSEKIKEWLAEFPEHPSQEQLLPYY
FDLLHFLKVSEFYDDHYETTVEKTYRDLIVKEFCIDPSLFLEQSLDKGKSSILFSASFSP
LSYYQETLGGQKSLAYKLPSPFPEGNQQVFIANYLETTYRKREHSLAKLVETIHAFADGK
VGNYFVFFPSYQYLDLAVEAFRQQYPDSNVLIQETDMNEEERERFLTKFQTNPAETLIGF
CVLGGIFSEGIDLRGDRLIGSMIVGVGLPQMNHEQELIKSYYDEKEHLGFAYAYQLPGMN
KVLQAGGRVIRGMADQGIVVLADQRFSSFSYRRLFPQHWQTAREVRSVGELEEGIQRFWL
SKEAVNQKNEE
>FECAFAII_01443 hypothetical protein
MAKDASFDIVSEVNTEEVKNAIQQTTKELSNRFDFKDSTVEIKLENSNLVVLSDDDFKIE
QIKDVLFGKLIKRNVPIKNIHFSESEHALGGKARQTADLVNGIDRENAKKITTAIKNEKL
KVKAQIQEDQIRVTGKNRDDLQAVIALLRKLDLPIELQFTNYR
>FECAFAII_01444 hypothetical protein
MLVSKIMTAYHKNERLKKIVVILITGLTAAVALNYFLIPANVFSAGMNGIAQIISSLLYE
WFHIKIDTGTFIFLLNIPVFVLGFLKVGKRATILSFVNVVCVSVMTMLLPVGQITDNILM
NALVGGVLLGLGVGLSLKMGFTTGGMDIISLVLSQTTGKTVGNYMLILNGIIVVIAGFFF
NWESALHTIISIYAMTQVIDAIHTSHQKVTAMIVTVKPEEVTEELAKRMVRGMTLLPSVG
GYSKKQGNMIMMVITRYEMYDLDQIVHEIDDDAFINILPTHSVFGRFANENEQKMYRTTG
VLPEIKNRSQKK
>FECAFAII_01445 Iron-sulfur cluster carrier protein
MSEANQERSGQEIELIKERILAALEMVIDPELGIDIVNLGLIYDIEFNPENGETVIKMTL
TTMGCPLADILTESIHDALKEVPEVTKAEVKLVWYPAWTTDKMSRYARIALGIR
>FECAFAII_01446 hypothetical protein
MKLIKLWEADLKKAYQLQTSFGPNESGFINNAYGYTFAEFLDYVKKCEKTSLGIDLPESY
VPATVFILESDEHEYVGIFNLRHKLNETLRNGAGHIGYGISPNYRKKGYATQGLALVLQE
AKKIGIDEALLSVNKKNLGSLKAQQKNGAAIYREDEKEYYTKIKLM
>FECAFAII_01448 hypothetical protein
MTSLKTLLFGTTLAAGAAFFMGTTAHADEAYTVQSGDTLSTISQKYVGDNSLINAIAESN
SISDINLIYSGQQLTIPTEGSAQAAAEPQAAVQEAPVQAEPVQAEQPVVQETVQTETQAA
PVAETQPAPAVTETAATPASTSSAKEWIAQKESSGSYTATNGRYIGRYQLDSSYLNGDYS
AANQERVAEQYVTSRYGSWEAAKAFWEANGWY
>FECAFAII_01449 Putative universal stress protein
MSKRYQNIMVAVDGSRQSIKAFAEALDLAKDNEAHLFIVSIINKVELTHSAYAFSKIYAD
EKQRTEVAMLKKINDAKEYGIAEIHAIVETGDPRNLIANVIPGQENIDLIVMGATGKGAI
QQALVGSTASYVVSHAPCSVLVVK
>FECAFAII_01450 hypothetical protein
MVRPQEVRAPKEKIEILAIIEDGTQTKKGYSIALVKWKGKKGVALRWDGDNQQDKGFPVT
ANGYHPAWFVLPDKFMELYSYDYARAAASIKALDKLTEEQNEMEEK
>FECAFAII_01451 hypothetical protein
MEAGKVLQEVKALCADKKYEEAKSLIEKNKENLEEKYPIAQEFIELKQGTILHRFKHFFG
ITE
>FECAFAII_01452 hypothetical protein
MIAIGQFVFYIPFFIMISILFYYIKWTKKKFSVLLASLPAVYFTYQIFSFRHWETTSVLI
THIIELTLSVIFLIIWIYFLYKNQN
>FECAFAII_01453 hypothetical protein
MDHVVLEIDLHLINNIRVIYYVVSNSVEQRVLTNKINGILAKKDVHRFNNGEGSYYSIPV
EKIIYTTVKVREDLDTKKAYEPIFTTY
>FECAFAII_01454 hypothetical protein
MNPYEQLIQDLIDGKIEKIDVKREELMAFREAWLKLENRKYVVGKASLNGNVTYHYDPTR
LF
>FECAFAII_01455 hypothetical protein
MNQEELFQKVKEMIKNGNFDGAKRFIEEHKEQLGPYKEKAQNLLKDVNIDSVKNKFKNLF
K
>FECAFAII_01456 hypothetical protein
MKVIKYLIGLAAISGILLFGLKYYTEGSYGEIPGILDQLNPLVEKGEVYVKTQKPEEVNE
YGTARYVQKAADANGKERTVEFNGLSVLKENHYLKISNKGAHIETYEEVPREKVPEKALA
IIG
>FECAFAII_01458 hypothetical protein
MEKFTHKKMDPNEIPIIFVRDCKGNVQGKVSINEWNERRRPATLNELEIKLYRQSLVYYA
DQEYEKATDLLKFLIARTEYTRFEYIERLANIYHIMNEPVKEYQLLDTVLSVAELIALPA
GLEKKLVRRLLRVKQQLSDQEK
>FECAFAII_01459 hypothetical protein
MKKKTFKKLLFLGGTAALLLSGTSYYLHIHSPEHTMNTAQKSSTQKTKKTKEKAEVLLDV
PLESQFDSPSLENGCEVTSLSMLLSFYGYETTKNQLAEQLDYVPVFNADGTHGDPNEGFV
GDISGGDWAMVVYVPPVASLAQQIVQTDYHTFPKTDAQLDDIKKALSKGNPVWTSVTINF
EVPDETDFMTWTTNNGEVRVTPLVHACVVTGYDKENIYVNDPYGVKNRAVPINDFSAIFT
AMGGQMLTLEKS
>FECAFAII_01460 hypothetical protein
MTEEMINLGEQYACKPIGFTKTVIGEVVSKMTNCAVVKVAQCAAEDQELLDEKASMVVAK
YDTFE
>FECAFAII_01461 hypothetical protein
MVTFFTVLLFLFVVVMFLFLWLVRKEIIYRTVRNRWVYLVIPFLVSLVIWYTLISHPTAD
ELAKGILSAMIFISFLLDSRGITEEGLVLNSFDKKGVPFSEINKIVLYQPKGSKIVKMNF
FRNGWRGPMLKFSASLEELVPFLSQRLNDEAEIDIMIDPE
>FECAFAII_01462 hypothetical protein
MTTFTDTLKNRRSIYHLGRNVSLSNEELTTLIKEAIKESPTAFNAQSTRAVILFGDAHEK
LWEITEEALRPLTPTEAFPNTQNKLAGFKNGYGTVLFFKDTDVVKGLQEQFELYADNFPD
WSEQSNGIATANTWVALVDKGLGANLQHYNPVIDEAVAKEWNIPSNWKLRSQLVFGSPET
PAGEKEYMNDADRFRVFG
>FECAFAII_01463 Di-/tripeptide transporter
MEKQQDKGFFGQPKGLSTLFFTEMWERFSYYGMRALLIYYMYDTVANGGLGLPRATALAI
MSIYGSLIYMSSIVGGWVSDRVLGAKRTVFFGGVFIMLGHIVLALPFGVSTLFVSMALII
IGTAFLKPNVSGMVGHLYSKTDLRRDAGFSIFYMGVNLGALLAPLIVGTIGQEYNYHLGF
SLAAIGMFFGLLQYIIQGRKTLDGVGTTPPNP
>FECAFAII_01464 Di-/tripeptide transporter
MTTEERKGFIRNLIIALVVIAAVFGGAQLTGHLTIDFFVNTISVLGIILPLYYFIKMLTS
KDVTAEEKPRVWAYIPLFLAAIIFWSLQEQGSSILALFASERTQSTLFGVTIQASWYQSL
NPIFIFILTPVFVTMWTKLGERQPSTVVKFSLGLLFAGLSYLLLMLPGMLYGTSGKVSPL
WLLGSFFIVVIAELCLSPVGLSVTTKLAPRAFESQTIAIWFLADASSQAINAQIARFYTP
GTESAYFGIIGAVAIVGGILLFTVKEPIKKLMGSIH
>FECAFAII_01465 hypothetical protein
MNDSIKKMLRITEKDLMITEVSYETLQKKKTLVVDAVLSPTPRACRSCGSTVVDGNGKAI
IVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKSCQVSLTTVIRTLKEFKSYLPKQSKKILPRVLMVDEFRSHASIED
KMSFICADGETGKLIDVLPTRKLPRLTSYFLGCTNPEEVEFLVTDMNAAYFQLTKRVLPN
AKVVIDRFHIVKHMNQAFNELRIREMNELRKAGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLEFSPPLKEAYPFFHELVEAFRDKDPDLFFSLLAELP
ETLDDSFREKLQNLLTYEEGITNAMIYPYSNGKIEAKNTHIKTMKRVSYGFKSFENMRIR
IFLINQLINVR
>FECAFAII_01466 ATP-dependent helicase/deoxyribonuclease subunit B
MSLQFILGNGKKDHRQVLIDEASAWLDQDASNQVFFLVPNYSKFEQEQEILAEMRRRSGK
KTFSTTNVQVFSFYRLAWYLLQQTTLLTGNELSESGSAMILRQILEKNEEELTIFRGEIN
KRGFIRQLQELYSELRTGNIQPEDLMLLFGDSPNAEDQQLKMKDLKLIFSAYDSELTQRA
LTNEDALSILANYMQTQDFNNVKFIVSGFSRINGQEYQLLQAMMEKGQLVVDLLLDRPYT
ADLPEVLTLFHETGKLYFRLFQSARERKVPILVDRFAPEQTRPTELQLLQTMWEETSSQK
KAAVHKIGGQEHLHLWEAENPTEEVRQLAVEIRRLVSEENYRYRDIQVLTKNMSLYGNIL
RPIFQEMAIPFYIDEEQMMENHPLIEWINSLFALDRYSYRLSDIMRFFKTELFLSTEAET
ELDEWKQERDEFRKKLDITENVALAYNYQGTYWTREKDWQFVAYDFEAEQIEDVQYLEEQ
SNTIRRLFQKAVPVFLKKIKKSKTGQEAANVFYQFLIQSGVQQQLLFWRNQEVDRGNLEA
ARNHEQTWGALIDLLDEYVVIYGESAFDWSLFQEIITSGLENLSYGKIPTAIDQVRINRL
ELVRPNQAAVTFALGLNDQVFPDRKETKGLLSSEEREVLNQALPDGQFLFDPSKESISFE
PFQAYLVFLSGTDRLYLSYAQSYDTDGSLKMSPYLRRITEYLSVPVERKEHLTIESDPNC
YVGTYRSGINTVNRIYRLALDEKKPVPKHWQKLKELVLNSSWRNFALQIFESQEHLNVPV
SMPEKMAEELYGKEIYTSISRMENFYNCEYKYFMQFGLKLKERTVYGLTPAATGDFYHES
LDRFFKLLFSNQLSLVNMSDAQRRDFTEKVLQEVFGELRFEILDSSARMNYIRYQLGQTI
QKVTWALQKQSKNTGMHPLQTEILFGQIAGAKGITGLELPLSNGGKLHVRGKIDRIDVAS
EQEDTWLSVVDYKSSGRSFDVTEAYYGMAMQLLTYLDVALMDAVRLTGKAAVKPAGSYYL
HVHNPVLTETDDVEKNTLKKFSYDGVFVDDPALLEVLDHSLEAKEQSLIYPVKKNAKDEY
QKGSFSKDKFFTEEELQLFMAHNRENMRLAGDAITSGEIKLNPAYKDKQRIACEFCPFRS
ICTFDVMLKENNYHRLEKIDKEEALRRILKRSEEE
>FECAFAII_01467 ATP-dependent helicase/nuclease subunit A
MNQIPLKPQNERFTDDQWQAIFDQGDNLLVSASAGSGKTTVLVRRVIEKLKMGFDIDELL
IVTFTEAAAREMKERIQEALQESVNSESDPVRRQHFTKQLVLLPTANISTLHAFCLTVIR
RYYYLIDIDPVFRMLTDETETILMKEDVWDELREALYAENDERFFQLTMNFSNDRSDDGL
TNLVFSLYEFARANPDPQKWLEQLSDNYRLPEGLAKSRLYQKQIRPLVLADIYQCVQLYE
QMTQLAQGEGLEKMHEQVAGEQQQIKNIYEAFSQDRLEEAYAGLEQLTFSTFKSSRKAEL
KEISNEVKGMRDKAKKLIQQISKSYFPVSPSQMEELTDKALPLVEEMTKVTQSFMDGFSM
RKREKGVLDFNDLEHLALQILTEKTKDVWLPSEASKHYRKKFKEVMVDEYQDVNQLQEAI
LYWLREPDDTKGNMFMVGDVKQSIYSFRLADPSLFIGKYENFSKKEGGRRIVLAENFRSR
KEVLSFTNLIFEQLMDPAVGQINYDEAAKLIQGFSDFPENEQFEPEIMIYEKEQEESEIE
IPTDDILEDKTEGELFMTGLKIRQLIDSSFMIYDKKSKKSRPIEYKDIVLLTPTKKNNLT
ILEIFKTLDIPLEMNDAQNYFQATEIRTMISLLQLIDNPYQDIPLAAVLRSPIVGLIEPE
LASIRLANRAHTYYDAVLAYQASNEDELAAKLEHFGKQLEHWRELARRSSITDLLWDIYY
ETGYLEYVVGLPAGAQRQANLYALVDRAKAYEQSSFRGLYQFVRFIEKMQEKDKDLAEPV
ISIEDNAVRVMTIHASKGLEFPVVFLLDMTKEFNLQDLRNRYAFEEKLGAGIRYMDPETR
VLYDTLPFQAIKLAKQNKLLSEEMRKLYVGLTRAEQKLFIVGSYKNKEQMIQTWSEAADH
EELVFDPALRLKGRSSLMNWIGYGLIRHPEMQKYLEEEISTSLLQHSNAQFSISWMNQQS
IIEQRQLLAEKELVNLDQQMKEDETLLADSLQKRLAYEYPYQASSQTTSYQSVSEIKRLF
EDPDDTQESRLTLESSQNKAASRQFRYTQEQLAEPKFLQKDRQVSAAAVGTATHALLQLL
PLEMPTTESIHQKLQELVRKRLVDEKVAKKVDVSSIIWFFQTELGQQLIANKENVKREQP
FSMLLPADEVFQDYPNQEDELLIHGIVDGYLEEKDHLNIYDFKTDFILHPDDPAEIDAIV
QKYQGQLRLYQQAMSEALNKPVENVFLILLRVKQIININK
>FECAFAII_01468 HTH-type transcriptional regulator YodB
MELTQTEFVLCPKFEKTFSILGKKWNGLIIDVLLENGPQRFVELAAKIPMVSDRVLVERL
KELEKEGIVTRNFACSEKSRSEYLLTEKGADLQKAMRQIQVWSEKWITEEECG
>FECAFAII_01469 Phenylalanine--tRNA ligase alpha subunit
MSLQAQLESLKEATLVKITAAQDLNELNQIRVETLGKKGPITEVLRGMKDLSPEERPKVG
SFANEIRDLLTEEIERKKQVLEEEALNAALAKETIDVTLPGRKVKHGTRHIVTQIMEEIE
DIFVGMGYQIVEGYEVESDHYNFERMNLPKDHPARDMQDTFYISDEILIRTHTSPVQART
MEKHDFSKGALRMISPGKVFRRDTDDATHSHQFHQIEGLVVDKNITMGDLKGTLEVVMKK
MFGEDREIRLRPSYFPFTEPSVEVDVSCFKCGGAGCNVCKYTGWIEILGAGMVHPNVLKM
SGIDPEEYSGFAFGLGPDRVAMLRYGVNDIRNFYQNDLRFLSQFKGE
>FECAFAII_01470 Phenylalanine--tRNA ligase beta subunit
MLVSYKWLNRYVDLSNVTPKELADKMSVTGIEVEGVTVPEEGLKKIVVGEVKECVPHPDS
DHLSICQVDIGEDELSQIVCGAPNVKVGIKVIVALPNSRIAGNVKIKKGKMRGQVSNGMI
CSLQEIGYSDSVIPKEYAEGIYYMPQEAVNGDPVFPYLDMDDSIIELSITPNRADALSMR
GVAYEVGAIYRQTPTFDDEKLVESSRPASDKIQVEVEDKEAVPAYQIRIIEGVRIQPSPQ
WLQNLLMNEGIRPINNVVDVTNYILLLFGQPLHAFDYDKLKSKEIFVRRAKENETLVTLD
GESRELTTDNLVITNGKEPVALAGVMGGLDSEITNETTTVALESALFDPISIRRTAKQFN
LRSESSARFEKGINHATVGEASEVAAAMIVSLAGGEVLQGAVKGSEIKAEDVSVKISLER
INQYLGTSLVVKEVNEIFEALGFSYEEKEYVYSVVVPPRRWDIQIEADIIEEVARIYGYD
QLPSTLPSGETVAGSLSKEQETTRKIRTIFEGSGLSEAISYALTTEEKSRQFVINESNIT
RLDWPMSEERSVLRMNLISGLLDDISYNTARKNTEIALYEIGRVFFQENDPRTHLPQEVK
HAAIAISGIWEEKDWQTKAQNVDFFTIKGLLENLFEQLGITEDVHYQTVTEMKEMHPGRT
AAIYLGEKFIGFVGQVHPTITKSYDIPETYVAEFDLSAIVEAAQKGIVFEAVTKFPAVSR
DIALLVKETVTNQELTEVIRSAAGRFLTDIQLFDVYQGENIEKGHKSMAYSLTFVNPEAT
LTDEEINKAMEKVEKALVENLEASIR
>FECAFAII_01471 Tryptophan--tRNA ligase 2
MKNIILTGDRPTGKLHLGHYVGSLKTRVAMQADEDNQLFVMIADMQALTDNAKNPEKVSS
NVLQVALDYLAVGLDPAKSTLFIQSQIPELAELTMYYLNLVSVGRVRRNPTVKTEIEQKK
FGESVPTGFFIYPVSQAADITAFKANLVPVGEDQKPMLEQTQEIVQSFNHTYGEVLVEPK
GVFPPKGMGRLPGIDGNGKMSKSLGNGIYISDPADVLQKKVMSMYTDPNHIHVQDPGQVE
GNMVFTYLDVFGTDKEAIEEMKAHYRRGGLGDVKIKRYLIDVLEAEFAPIRARREELEKD
PSAVMEILRKGSEEAAKVAAQTLSEVKSAMGINYFH
>FECAFAII_01472 Glutamine transport ATP-binding protein GlnQ
MAMIKFDHVDKYYGKFHALKNINLEFEKGEVVVVIGPSGSGKSTMLRCINGLETISSGKL
LINDTDLHDKKTKLTEVRKNIGMVFQHFNLYPNKTVLENIKLAPIKVLKQDQATAVKNAE
KFLKTVNMLDKKDSYPSMLSGGQQQRVAIARGLAMNPEMLLFDEPTSALDPEMIGDVLDV
MKKLAHDGMSMIVVTHEMGFAKEVADRVIFMADGEVLEDSRNVRDFFENPNEVRAQQFIS
KVINH
>FECAFAII_01473 ABC transporter glutamine-binding protein GlnH
MRRLKKIRLIFLLGIAFLALAGCKGNGLANEDILERSKSTNEIIWGVKYDTRLFGMMDIE
SRTVQGFDVDIAKAITKKILGDNGKTEFVEVTSKTRIPLLKNGNIDAIIATMTITDERKK
QVDFSDVYFDAGQALLVKKGSQIKSVDDLNASTTVLAVKGSTSAANIRQHAPDAKILELE
NYAEAFTALQSGQGDAMTTDNAILLGIADENPEYELVGGTFTNEPYGIAINKGQENFLKA
VNQALEEMHADGTYDKIYQKWFPNETEGKVE
>FECAFAII_01474 putative glutamine ABC transporter permease protein GlnM
MSELIQTYGPIFVDGFKITLFSSVLALVFSLIIGTLMAIFQLSKNKVVSALAKAYVEFFR
NIPLLIIVMFFYVVVPIYWFNLDGFQAGTIGLTIYTSAFIAETVRSGIQTVPKGQTEAGL
SSGFTYSEIMRYIVLPQAFKIVIPPLGNQFINLVKNSSILAIVAGLDLMYQGDLIASETF
NTFDTYIIVGLFYLVITLPLSYLMVYLEKKWAVRS
>FECAFAII_01475 putative glutamine ABC transporter permease protein GlnP
MDFSGAFSWMNIRFLLEGLKVTVEVSLFSIIFSFLIGGLTGVIRFANIPFFSKILGVVID
IIRNLPLLLIIFFTYFALPQIGIQMNIFWSAVAALTIFESAMLSEIFRAGLNAVPKGQME
AGLSTGLTYVESMRTIVLPQAFKSMIPAIVSQLISLIKDTSLAVIISLPELSHQARIIYG
QNTNYVLPMFIIMTLMYFVVCYALSLLSGYLEKRRYSY
>FECAFAII_01476 Glutamate racemase
MKKRMIRLTDNRPIGFIDSGVGGLTVVKEALKQLPNENILFVGDTARCPYGPRPAEQVIQ
YTWEMTDYLVEQGIKMLVIACNTATAVALEEIKAALSIPVIGVILPGTRAAVKKTQNKQV
GIIGTIGTVKSQAYEKALKEKVPELTVTSLACPKFVSVVESNEYHSSVAKKIVAETLAPL
TTKKIDTLILGCTHYPLLRPIIQNVMGENVQLIDSGAETVGEVSMLLDYFNLSNSPQNGR
TLCQFYTTGSAKLFEEIAEDWLGIGHLNVEHIELGGK
>FECAFAII_01477 Ribonuclease PH
MRHDGRKAQELRKLELQTNVFKYPEGSVVIRFGDTTVICSATIENSVPPFLRETGTGWVT
AEYSMLPRATSTRNRRESSKGKLSGRTMEIQRLIGRSLRAVVDLEKLGERSIIVDCDVIQ
ADGGTRTASITGAFVALKLAIEKLLREKELSEDPIKEHLAAVSVGILPDGTCVTDLDYQE
DSAALVDMNLVMTESGKFVEIQGTGEEATFDGEQLNEMLFFGKNAIEDLIKEQKHALLTE
FAQNDERIEETKTIIIATRNPGKAEEFRNMFKEAGYHVKTLLDYPELPDVEETGSTFEEN
ARLKAETIAQLLDQPVLADDSGLKVDALGGMPGIYSARFAGEQKSDAGNNAKLLYELTDV
PDEKRTAQFHCTLVFAAPKKDSLVVEAEWPGRVARIPSGENGFGYDPLFIPEGKKQTAAE
LSSEEKNKISHRAQAMKKLSAEWKQWLEGER
>FECAFAII_01478 Putative metallophosphoesterase MG207 
MRYLVVSDNHGDRDILVDLVDRYRSEVDIFFHCGDSELEASDPLWDTFQVVQGNCDYGPG
FEQKKVIQTGQDTVFMTHGHLSNVRFGLTQLAIEARAATADMVFFGHTHQIGCEMDQKIL
FLNPGSISQPRGPIQIPSYALIESLDDQISVQYYNRAHQAVEELAFSFSRER
>FECAFAII_01479 CBS domain-containing protein YkuL
MIGPIVREMLLENQETFLIPAENVANVMYHHPLSHGLLVLSKVGYSKIPVLGKDDHFVGL
VSLSDVVNKMIDLQTISMDPLEGLTVADVTETDVPTIDENWELEEVLHLLVDSPFLPVVT
EDRIFKGIITRKELLKAVNFMVHELERRNILSPKIEELKEQIDIVS
>FECAFAII_01480 putative MscS family protein YkuT
MFSLLATAGTTDSSGETLTDQAVSKVNAFQRFWDGIDWDAILAAFIQKSLYLIFLIVLFW
ILHRVGKYLIDKSFNQYSKKAILNESRLKTLHSLLNTIFHYTLGFFFIYAILSAIGVPIG
SLLAGAGIAGVAIGLGAQGFMSDVITGFFIIMEQQMDVGDYIKLANLTIEGTVVSVGIRT
LQLKATDGTVHFIPNRNITTISNLSRANMQVLLDIRIVPEEGYDKIYEIIDRVNRTLAEK
YQEELQTEPSIFGLVDLGNSNFAIRTVCYALNGKQYALKEEFLSSYVKELTASGFTIPNS
PIAVGK
>FECAFAII_01481 Branched-chain-amino-acid aminotransferase
MQIDWNNLGFSYIKTPWRFIAKWKDGQWEEGELTEDNYLTIHEGSPALHYGQQCFEGLKA
YRRKDGKVNLFRPEQNSRRMNQSARRLLMPMVPEKMFVDAVKQVVKANEDFVPPYGTGAT
LYLRPLLIGVGENIGVHPAPEYLFVVFCTPVGAYFKGGLKPTNFIVSDYDRAAPKGTGAA
KVGGNYAASLLPGTEAKELDYSDCVYLDPATHTKIEEVGAANFFGITKDGKFITPQSPSI
LPSITKYSLLQLAEERLGLQAIEGDIFIDDLDQFAEAGACGTAAVISPIGGIYHNNNLHV
FYSETEVGPVTKRLYDELTGIQFGDIEAPEGWIEVVE
>FECAFAII_01482 Enoyl-[acyl-carrier-protein] reductase [NADH] FabI
MSFLEGKKIVIMGVANKKSIAWGCAEAMLKQGAEIIYTYQNERMKKSLVKLVGEEAFTVE
CDVSSDESIEKAMNAIGEYAGEIHGLVHAVAYANKEELSGNVSDISRDGYQLAQDISSYS
LIAVSKYAQPFLAPNSGIVSMTYLGSERAIPNYNMMGIAKASLEAAIRYLAAEFSPKGIR
VNGISAGAIKTLAVTGVKDYQKLIQLSESRTPDQQGVTIEEVGNACAFLISPLSSGIIGD
IIYVDKGVHLS
>FECAFAII_01483 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ
MSYVLSATEVMELIPNRYPICYIDYVDTLEPGKKIVATKNVTINEDFFQGHFPDNPVMPG
ALILETLAQAGSILILKSEEFLGKRAYIGGINKAKFRQKVVPGDVLKCHFEITKMKGSVG
TALSAAYVDDKKVCECEFTFIVNQNA
>FECAFAII_01484 Putative peptidyl-prolyl cis-trans isomerase
MKKNKVILSISLAAALLFAAGCSANNTTSSSSSTESSKSTSTAESTTASSVDLNALELPQ
LTKDVAENEDLVEMVTNKGTIKIKLFPEHAPKAVENFMTHAKDGYYNGLTFHRVIKDFMI
QGGDPKGDGTGGESIWGEGFETEINNHLYNIRGALSMARSQDPNSNGSQFFIVQNTDDMH
DGLLKDDYPQAIIDAYKNGGYPSLDGHYTVFGQVIEGMDVVDAIANIETDSSDKPKEEVK
IDKINILQEAKQK
>FECAFAII_01485 hypothetical protein
MGKLGISIYPERSTFEKDKAYLDLAHKYGYKRVFTSLLQINDDKEKVLSEFKEVVDYANS
LGMEVMVDINPALFEQLEISYDDLSFFHKMGAYGVRLDIGFTGAEEAKMTRNPFGIKIEI
NMSSGTNYVDNIMSYSPNTDNLLGSHNFYPHRYSGLGYEHFVFCSEKFRKYNLNTMAFVN
SQSAEFGPWPTQDGLCTLEDHRDLEIATQVKHLILTGLIDDISIGNAYASEEELKEMAEA
FNADYPTLKVDTEEGITENERICLFDNLHSYRGDRSEYILRSTMTRVYYKDKDFPPHNTR
DMHHGDVLIDNEGYGQYKGETQIALKDMKNDGRVNVVGRISDDELFLLDFLKPWSSFKLI
ENKK
>FECAFAII_01486 hypothetical protein
MTYKHLTIDELTMIESYYLQHNKPVEIANRMGRAIQTIYNVVNKFKQGKTALDYWHQYKE
NKKKCGRKVIQLPAHEVDYIKEKVTLGWTPDVIIGRKERSVSCGMRTLYRLFSKGIFDID
TLPMKGKRKPNGHQEKRGKQQYQRSIHDRPDNYPDFNSEFGHLEGDTIVGIHHKSAVITL
VERLSKVIITIKPNGRKALDIETALNQWFSRFPKNFFKSITFDCGKEFSNWKAISNQHDI
DIYFADPGTPSQRPLNENSNGILRRNGLPKSMDFRKVNQTFISSVSNQRNHIPRKSLNYR
TPIEIFLSYVQEAFYSSLI
>FECAFAII_01487 Thermostable monoacylglycerol lipase
MKLWMKILLGVALALIVALVFAGNYFYNYAVVPSEKDFLDEDTPGTTQTSKETDAHKWFS
SKENRSDWTITSKDGLKLSAIYLPAETKSEKTALVAHGYMGNAETMTNYAKMFHDMGYNV
LVPDARGHGKSEGDYIGFGWPERKDYVQWINKVLENNGKSQEIVLYGVSMGAATVMMTSG
EKLPDNVKAIIEDCGYSSVHDELAYQLDDMFSLPAFPLMQVTSLVTKVRAGYFFGEANAV
EQLKKNQRPMLFIHGDEDTFVPFEMLDKVYRATKGPKEKYVVKGAEHAEAYKTDPEKYQQ
VVQQFLSQYVH
>FECAFAII_01488 Glyceraldehyde-3-phosphate dehydrogenase
MTVKVGINGFGRIGRLAFRRIKEVSDDIEVVAINDLTSPTMLAQLLQFDSTHGTYPGTVT
ATEDSIVVDGEATRVYAEPDASKIPWAKENGVDIVLECTGFYTSEEKAKAHLDAGVKRVV
ISAPAGAMKTIVYNVNDDTLDENDKIISAGSCTTNCLAPMAYFLNNEFGIEVGTMTTVHA
YTSTQMLLDGPVKGGNLRAARSAADNTIPHSTGAAKAIGLVIPELQGKLQGHAQRVPVVD
GSLTELVSVLKTKVTADQVNEAIKKHTVDNPSFGYDDRQIVSSDVIGTTQGSIFDPTQTE
VTTAGDFQLVKTVAWYDNEYGFTCQMIRLLEKFANL
>FECAFAII_01489 GTPase Obg
MSMFLDQVTIDVKAGKGGDGMVAFRREKYVPDGGPAGGDGGRGGDVILIVDEGLRTLMDF
RFNRHFKAQPGENGMSKGMHGRGSEDTYVKVPQGTTVRDAETGALLGDLIENGQTLVVAK
GGRGGRGNIRFASPRNPAPEIAENGEPGQERKIELELKVLADVGLVGFPSVGKSTLLSVI
SSARPKIGAYHFTTLVPNLGMVTTSDGRSFAAADLPGLIEGASQGVGLGTQFLRHIERTR
VILHVIDMSGMEGRDPYEDYLAINKELSTYNLRLLERPQIIVANKMDMPDAPENLVKFKE
QLNKEKEDEFADDIPVFPISGVTRQGLDALLNATADLLEVTPEFPLYEEELEEETVHYGF
NPEGPEFQIDRDSDATWILSGEKIEKLFQMTNFDHDETVMRFARQLRGMGVDEALRARGA
KDGDLVRIGEFEFEFVE
>FECAFAII_01490 hypothetical protein
MSKRVIILNFQVESQAYQAFSEIKKLHAVRSIKGEQMAVVSHDPNGTHQFKIEDFIDFTG
NNKSSTGGLIGMLVGVLGGPLGILLGWFAGGMIGATQDAKEIKDAQTVFDFVGNKIGEGA
TGLILIADEEDNRPLNQLVMMELGGEITRLDYEDVEKDVHDAKEAENHAKEAAQKTWKDK
HPQTSNDNESSGSSN
>FECAFAII_01491 Ribonuclease Z
MELQFLGTGAGVPAKHRNVTSIALKLLDERNEVWLFDCGEGTQMQILRTTIRPRKIGKIF
ITHLHGDHIFGLPGLISSRSFQGGDTPLEIYGPKGIEEYIKVSLGISQTRLSYPLKFIEL
NETAPIFTDQQFSVYTKKLNHGIDSFGYRVVEHDHKGELQVDRLKELGIPAGPLYGKLKQ
GETIQLEDGRTINGKDFVGPDKKGRIVTILGDTRKTHNSVVLAENSDILVHESTFNKDEA
RMAHNYFHSTTHQAAEVAKEAQAKRLLLTHISARYLGKAALELEKEAQEVFENTTIMKDF
DSIEIPFREEEEA
>FECAFAII_01492 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MNLEDKVVLVTGSSGGLGAQICYEAAKQGAIVISCARRMAFVEGVRDECRRLSGKEAYAF
KVDVSNPESVDELYEKVMEEVGRVDILVNNAGFGIFEDFLTFDLGKAYDMFEVNILGMMV
LTQKFAIDMAERRQGHIINIASMAGKMATAKSTVYSATKFAVLGFSNALRLELKPLGVAV
TTVNPGPIETNFFDKADPSGSYLEKVGQIVLEPAKLAKMIVRNMRHPKREINQPFILEVA
SKFYTLFPTIGDYLASGIFNKK
>FECAFAII_01493 hypothetical protein
MKKQSNVILGFVLVLIIVLFAVLNNKNVPVSFGFTSFSAPLILVIIGSALIGALIVFLTA
SATLWQQKKQIKQLTQEMSEYQTELQKKIEEAKEEQQREFRNERAELEAAYQAELQAKTA
QISQLKAPEEQKTQSPKQSFNYFD
>FECAFAII_01494 Single-stranded-DNA-specific exonuclease RecJ
MRQANFDWKLSETEPSESFLQMIRELKLSPFVGKLLWQRGYHEEKDINRFLHPKEQELHD
PYLIHDMDKAISRIQEAVISGEKILVYGDYDADGITSATVMKETLELLGAEVEVFLPNRF
EHGYGPNQSVYQEKIEEGIQLIITVDNGVAGNDAVAYAQQAGVDVIITDHHELPENLPDA
YAIVHPRHPAGHYPFPDLAGVGVAFKVASALLEEPPAEFLDLVAIGTIADLVSLTDENRI
LVSLGIDAIHHSERIGLQALFEESGVKMRDADETTIGFSIAPRLNAIGRMGDPRPAVSLL
ATFDEEEASVQAKKLNEINEERKAIVEQITQEALAMVNKENHIHLLVNRGWHEGVLGIVA
GKIMNETGKPTLVLTLKEDGSAKGSGRSIEALNLFEMLDQMRDLFTYFGGHHAAVGLTMP
SENVTILQEKMNQYIVDHQIDLMRGPELRIDEVLLPNEVTVERIDELKLLAPFGTDNPLP
QFLFRQVQAENIKRIGANQQHLKFVLSDASSQLDAVAFGFGTQEEELLNNQVDVVGKLSI
NEWNGRKKPQLMVSDFSVGGLQVFDWRAKRFREQSRTSEGSLYLAFDSSTLKFVPEIIQE
AAIVFEGLDSVKAIIEKRKPNSLVVMDCPDDLADLKEVFRSYSFNRVYLMGISPDEAYLN
GVGTREQYAKLFKLIHSQERIDIRHKIKAIAQYLRIPEKLLIFMIQVFFELKFVTIENGV
LQKVASPESHPLTESRLYQRRLNKIKVEEFLLLSDIPTIKKWLTT
>FECAFAII_01495 Adenine phosphoribosyltransferase
MDLKDYIASIPDYPSKGIVFRDISPLMADGDAYREATKQIVNYAKEKRIDMVVGPEARGF
IVGCPVAYELGVGFAPVRKKGKLPRETIEVTYGLEYGTDTLTLHKDAIKPGQRVLICDDL
LATGGTIKATIELIEQLGGVVVGCAFLIELMDLHGRDKIKGYDIITLMEY
>FECAFAII_01496 hypothetical protein
MKSMRRLGLVLTVLFLGIIIGNFGIRPALLVFVPLFTLWFMLWDEKKYRQSERRRIHEDH
FYHEPYYRSRQS
>FECAFAII_01497 LexA repressor
MARQTESRQIEVLRYIHEQVTQKGYPPTVREIGEAVQLSSTSTVHGHLARLEKKGFIQRD
PTKPRAIELTKQGLEKIGIRPTTIPVLGVVTAGEPILAVEDASDFFPIPPNLSSEEGSLF
MLTIRGDSMINAGILDGDNVIVRKQETAQNGDIVIAMTAEDEATCKRFYKEKNFFRLQPE
NDLLEPIILDQVSILGRVVGLYRSHIY
>FECAFAII_01498 hypothetical protein
MLSPEKIERINELARKKKENGLSKAEEQEQINLRKEYLEAFRSGMRHHIEGMKVVDPEGN
DVTPEKLKEIQKKKGLHNRNDNF
>FECAFAII_01499 Transketolase
MFDKIDQLGVNTIRTLSIEAVQKANSGHPGLPMGAAPMAYALWTKHLKVNPTTSKNWADR
DRFVLSAGHGSAMLYSLLHLAGYQVTIDDLKQFRQWDSKTPGHPEVHHTDGVEATTGPLG
QGIAMAVGMAMAEAHLAATYNKENFNVMDHYTYAICGDGDLMEGVSQEASSMAGHMKLGK
LIVLYDSNDISLDGPTSKAFTENVGARYEAYGWQHILVKDGNDLEAISKAIEEAKAETDK
PTLIEVKTVIGYGAPKEGTSAVHGAPLGEDGIKMAKEVYGWEYPDFTVPEEVAARFHQTM
IEEGQKAEDAWNEMFANYKKAYPELAQQFEDAFDGKLPENWDAELPTYEVGSSQASRVSS
KEVIQELSKAIPSFWGGSADLSGSNNTMVAADKDFTPEHYEGRNIWFGVREFAMASAMNG
IQLHGGTRIYGGTFFVFVDYLRPAVRLAAIQHTPVVYVLTHDSVAVGEDGPTHEPIEQLA
SVRCMPGVQVIRPADGNETRAAWKVAMETTDAPTILVLSRQNLPVLPSTKEVADEMVKKG
AYVLSPSQGETPEGILIATGSEVDLAVKAQKELAEKGKDVSVVSMPSFDLFEKQSSEYKE
SVLPKSVKKRVAIEAAASFGWERYVGTEGATITIDHFGASAPGTKILEEFGFTVENVVNT
YNQLS
>FECAFAII_01500 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIVAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYIAKRSTEGWTPDVIIGRAERTFSCSVSTLYRRFKTGEFNVL
HLPMQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEGDTIVGIHHKSAVITL
VERLSKAIIVLKPEGRKAVDIENSINEWLQSVPKNLFKSITFDCGKEFSNWKSISNTNDI
DIYFADPGTPSQRGLNEHSNGLLRKDGLPKEMDFNQVNQGFISSVASKRNHIPRKSLNYQ
TPLEVFLSYVNGKFCLA
>FECAFAII_01501 Autolysin
MQELKTRSARHHRPKRKMVINKKAIAPLIGTSLLVGPMMVTAVPQHVHADEQGSQTVADP
QAFIDQIGWSASEVAASNDLYASVMIAQALLESAYGTSGLASAPNYNLFGVKGSYNGQVV
YMATKEYVNGQWVTMNEPFRKYSSYWESFQDHANVLRSTSFSTGDYHYAGVWKSNTTSFY
DATAYLTGRYATDPNYGAKLNSLINTYNLTRFDTPSTGSATTTTSTTTTTTTTTSTSSSS
TTDVNTNNGQTYTVVSGDTLWDIAQKFGMSVDDLMAKNGMSMSSYSLLVGQELNV
>FECAFAII_01502 Cysteine synthase
MTAIYNSVTELIGKTPIVKLNKIVPEDSADVFVKLEFFNPGGSVKDRIALSMIEKAEHDG
LLKPGDTIIEPTSGNTGIGLSMVGVAKGYKVIIVMPETMSIERRLLMKGYGAELILTPGA
DGISGSIREAERLAKENGYFLPLQFENEANPLVHEKTTGPEIHQAFGVNGLDAFVAGIGT
GGTITGAGRELKRVYPKIELIGVEPAESAILEGKEAGPHKIQGIGTGFVPKTLDTSVYDK
VLSISGDEAMETAREVGRKEGILVGISSGAAIAAALKVAKELGKGKKVLAVVPDNGERYL
STALYQEI
>FECAFAII_01503 Peroxide operon regulator
MENKLVEEVIEKLKKENIRITPQRYAVLEYLIEHHSHPTADEIYKALEHRFPNMSVATVY
NNLRLFTSIGFVQEMKYGDASSRFDFSSKRHYHVICENCGKIVDFHYPGLEDIEMAASRL
TDFEINEHRLELYGLCPDCKESAKKAQM
>FECAFAII_01504 NADH oxidase
MKVVVIGCTHAGTAAVKSILKNHPEAEVTVYERNDNISFLSCGIALYVGGVVKDPAGLFY
SNPEELSSLGATVKMEHDVTDVDTENKTVTAKDLKTGETETVSYDKLVMTTGSWPIIPPI
SGIDAKNVLLCKNYNQANEIIAQAKEAKRVVIVGGGYIGIELVEAFVESGKQVTLIDGLD
RILNKYLDKPFTDILEKELTDRGVTLALGENVTEFITDEEGKVKQVATPTDTFDTDMVIL
CVGFRPNTKLIEGKVDTLPNGAIKVNEYMQTSNPDIFAAGDSAVVNYNPSGTQNYIPLAT
NAVRQGLLVGNNLTDHKMAYRGTQGTSGLYLFGWTIGSTGVTKESATLNDLEVQATVFED
NYRPEFMPTTEKVMMELVYEKGTNRIVGAQFMSKYDITQSANTMSLAVQNKMTVEDLALS
DFFFQPHFDRPWNYLNLLAQAALGEIETAQ
>FECAFAII_01505 hypothetical protein
MNKEYFVQQDAFLEDYKSASKKLTINIDELADQVLSQLNETQEEYYTMPANDAKDNVSHR
FPFSRRIYSDENDGTLNTEYTYEGQPYVLETDDDL
>FECAFAII_01506 hypothetical protein
MDKRQLLIEEYLDLANEIIHRNKPEMEKEFAGFTLNELEVIEHIGKIPDPNVTKLANASY
MTRGAISKLTKKLIARGIINTYQSEENKKEIYFQLTPIGQKIRNRHEQLHQKWVQRDATV
FENMSKEEFDTVFRFIGRYREFIRSSK
>FECAFAII_01507 Tetracycline resistance protein, class C
MYSFTNKHSKVFGYVSVLFTGLGFTIVSPVLPFLTPPYSHSIHQQAFYITLLMSVYALAA
FLSAPILGSLSDHFGRHPILIISLLGSSIGYLLFGLGNSIWMLFLGRIIEGLTAGEISTL
YAYFADITEPNERTKVFGWMGALVGIGTTLGPIIGGLLAELGNSVPIFIGALFTFLNAVY
GYTFMLESLPIKKRSVDLSFSHVRPFHQLQQLFKISSVIPLLTAGFAVWLAAGSLQSIFS
QFSIDAFQWKAGLVGLSFSLIGILDTVSQLFIMPRLLKKFSEQQITRIGMFSEILAYLFI
TLSGILLLPILFLFGIICYGFGDSIFTPVFNGQLSNSVSDNQQGLVMGGTQSIQSLSRVI
GPLIAGQLYAAAPFLPTVFGFLLMIFAYYHYNKK
>FECAFAII_01508 DNA replication protein DnaD
MLNLENYLSAGQTVISNLLLKNYHRIGLQSEEFLFVLQLHMAQLEGDTFPDLQMIAMDMG
IKQDQIFQILDRLVTNGFIKIETTIVNGKKADRYNLYPIYDLLGEYLKTQEKKYEEKTQE
KEIQSVYQLFEQEFGRPLSSIEFQRIGQWLEEDHYQPEILKLALREAVLNQAYSFNYVDR
ILLSWERKNLRTKQQVEEDQKRRKQQLLQREVEQSAQQEELPKVSLKNWLEE
>FECAFAII_01509 Endonuclease III
MLSKQKTMEALETMYGMFPEAHGELKHNNPFELLIAVILSAQATDVSVNKATPDLFASFP
TPDALAEASIDEIILKIKTIGLYRNKAKNIKACAQQLIERFDGQVPTSREELMSLPGVGR
KTANVVLGDAFGIPAIAVDTHVERVSKRLRICKLDATVMEVEETLMRKVPQELWVKTHHT
LIFFGRYHCTARNPKCEVCPLLSICQDGKNRMRLKEKALKKKPRL
>FECAFAII_01510 hypothetical protein
MSYLIVCLIIIICLHHLFLSKTIPRYSKNKKAEKFCLLLNKFTLIAPILAFIIFSVLLST
TLKGKFMERSSHAMILTFLWLLFTRIYIFLMSLKPPKSISLCLVINGIFLLSLIIFITPL
DRYVTYLYNPLEYWTYFIGILEGIIFYIGYFPNKNNNFYFYRNKL
>FECAFAII_01511 hypothetical protein
MNDSIKKMLRLIEKDLMITEVSYETFQKKKTLIVDAVFSPAPHTCRNCGSTVVDGNGKVI
VVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKNCQVSLTTVIRTLKEFKSYLPKQSKRILPRVLMVDEFRSHASIED
KMSFICADGETGQLIDVLPTRKLPRLTSYFLGCANPEEVKFLVTDMNAAYFQLTKRILPN
AKVVIDRFHIIKHMNQAFNELRIREMNELRKVGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLGFSTSLKEAYPYFHELVEAFRDKDPDLFFSLLAELP
ETLDDGFREKLQNLLTYEEGITNAMIYPYTNGKIEAKNTHIKTMKRVSYGFKSFENMRIR
IFLINQLIKVR
>FECAFAII_01512 Penicillin-binding protein 1A
MANEQTRSSRRQKQPTPKKSVKKNSGKGSGKSSGTHKKGLFIKILLGILSFFCILFLAGV
GLFWYYAKDAPELTDKKLDATVSSKLYTQDGELFEDLGAEKREKISANELPKTLEDAIVS
VEDRRFYKHIGVDPIRIIGSALSNFTSGGLQGGSTLTQQLIKLSFFSTSAEDQTLKRKAQ
EAWMAVRLEQKKSKQEILTYYVNKVYMSNGLYGMETASEMYFGKKLSELSLPQTALLAGM
PQAPSAYDPYVYPDQAKKRRDTVLYTMLQNEKISQTEYDQAVNVPVTDGLQELTQSDDNT
KIVDNYVKEVINEVQEKTDKNVYTDGLEIYTNLDLDAQKKLYDIVNTDQYVSYPDDEMQV
ASTLIDTNTGKVKAQIGGRHIAEDVTLGNNLAVNTSRDFGSTMKPVTDYGPAFEYLKYST
GKTITDAPYNYEGTSTPVGNWDNQYMGTITLRQALYLSRNVPAVKLFNEVGSDKVASFLK
NLGIEYSTIHQSNAISSNTEEQDGTKYGASSLKMAAAYAAFANGGTYYKPQYVNKIVFQD
GTEETYEPDGKTAMSPETAYMITDILKDTITEGTGTNAQIAGLYQAGKTGTSNYTDDEYA
KLGISSGVYPDILFAGYTPNYSISVWTGYNKKMTPVTSESSHVASDVYRELMQYVSANVT
NTDWEMPSGLIRVGGELYYKDQYTARSNAITPSTTIPSSSYVQTPGSSTTETTTQSSSST
SQSESTAESSKESTTAETSEPASSTTVPSSSSEESSTPSSSAPPASSSEPATSGADAAND
HTPSSSTSASGNR
>FECAFAII_01513 Holliday junction resolvase RecU
MVLRYPNGQPYYKNASPVEKIQEKRNQITEFGNRGMRFEEAINESNKYYLSRGLAVIHKK
PTPIQIVKVDYPKRSAAVIKEAYFTQASTTDYNGVYRGFYLDFEAKETKNKTSFPFKNFH
AHQIEHMKACLEQNGVCFVLLWFSSLKRCFYLNSVHLIAYWDAQKEKGRKSLPLSLIEEL
GIEIKTGISPRIPYLDAVDFYLSTLSIEGESKNGK
>FECAFAII_01514 hypothetical protein
MDKSKVIYVSGYRSFELGVFKENDPKIQVVKNVLKKELHQLAEEGLEWVLVSGNLGVELW
AVQIVAELKEEYPELSLGILYPFSDFGNNWNEGNQEKKQLAEQLADYVEAVSHQPYQSPS
QLKNHTRFILEHTVGCLLIYDEEFPGKTKYFFEDAQNYQADHPYEIRLISMDDLQNFSE
>FECAFAII_01515 Cell cycle protein GpsB
MANLVYSPKDILQQEFKTKMRGYDPVEVDEFLDNIIKDYETYSKELLALQEENDRLSAKV
AQLSKTQGAAQTRVQQTEAPKSAAVTNFDILKRLSNLEREVFGKKLDQQASAVKPAQPNP
NNYTNADTSLDDNEKTRQF
>FECAFAII_01516 Ribosomal RNA large subunit methyltransferase L
MEKNRKFNLVATAASGLEALVGKELRDLGIECQVENGRARFEGTMETIATANLWLRTADR
VKIVVGEFDAYTFDELFENVKALPWEDFLPLDAAFPVAGKSIKSKLYSTPDCQAITKKAI
VERLRTYYHRPASVPLTETGAHFQLEVALLKDHVMVTLDTTGPSLFKRGYRLEKGGAPLK
ENMAAALIMLTNWRKDRPFYDPVCGSGTLCIEAALIGHNIAPGFNREFACESWDWFSQEI
MENVRSAAEEKADYDIELDITGSDINGRMIEIAKANAEEIGLGSSITFKQQAVKDFKTDK
EYGVIVANPPYGERLGEEETVRKLYKEMGDVFRPLKTWSKYILTSDLAFEEFYGQKATKK
RKLYNGALRTDLFQYWGTRPPRKKEKDE
>FECAFAII_01517 Carboxypeptidase 1
MKEKEFLQEVKEINLLQQALGILDWDTQTGMPEKASAYRSEVDSYLYSIYFSKKIGPKIK
EAIRYFSEHPEELSEVGTAVFAKVKEEYDLEHRVPEDLMRKYTAAVSSAHGQWQKARETQ
QFSDFQHALNQNIELTKQLIPYWRKDEKTNYDVLLNQYEPGMTVEILDKVFDQLKEGILS
IRRTLQEKGTEPETDFLNRRMTKKQQKRFVVKVIEQLGYDFSRGRLDDTVHPFMTGINPN
DARITTRWNETDFKMAVFGVIHEAGHGMYEQDIDDKYAYTPVYEGTSMGIHESQSLFNEI
IIGSSRSFWKKQYPFFQECAEGTFDDIPFDKFYRSLNHTKSSLVRIEADSLTYPLHIIIR
YEIEKMIFNEGVDVAELPEIWNQKYEEYLGIRPTNDVEGILQDVHWSGASFGYFPSYALG
YMYAAQLLHSLQQEIDVENVLASDDYSPIKNWMSEHIHQYGASRKPNQLIMDATHEPLNP
QYLIDYMKDLYFNVYQVK
>FECAFAII_01518 hypothetical protein
MDKLQVIADYSMDQLAHDQTGHGSDHTKRVVKLAEKILETEPQADRFVTLAAAYLHDTID
DKVVKNENEAKQQLRVFLRSLPIVEEQISMIFSIIENMSFSKNLSEAAELSLEGKIVQDA
DRIEALGAIGILRTAYFGGGHGHPIFDPELYPQTFKDKENYRKGTTVINHFYEKLFLLSD
KMNTDYGYEEAKRRETFMREFLEEFFLEWSIDDENFTPDNWIKNNKK
>FECAFAII_01519 hypothetical protein
MEVVTEVVSSKIFRIIFRKSYFWNTVYQEVVSLPFSSESQGTISKNSFSCLMNIVTCDSE
LAGEHRLFGRIGL
>FECAFAII_01520 Putative pyridoxal phosphate-dependent acyltransferase
MSSKELTMYLEKELDQLKEKGLYNTIDILESENGACIIVDGKKMINLASNNYLGFANREE
LKKACIEATETYGVGAGAVRTINGSLKIHQQLEEKIAEFKGTEAAIAFQSGFNCNMGAIS
AVMTKEDAILSDELNHASIIDGCRLSGAKIIRIKHQDMKDLEKKAKEAIESKKYKKIMYI
TDGVFSMDGDIARLPEIIPIVEKYGLITYVDDAHGSGVTGKGAGTVKHFGLSDKIDMQMG
TLSKAIGVVGGYVAGSKTLIDWLKARSRPFLFSTSLTPGAAAAALASITLMQEHPELVEK
VWENANYFKEELKKVGYNIGMSETPITPVILGDEKVTQTFSKKLIEHGIYAKPIVYPTVP
LGTGRIRNMPTAEHTREMLDEAVAVYQKIGKEMEII
>FECAFAII_01521 putative epimerase/dehydratase
MKKVLVTGCLGQIGSELITRLRQELGSENVIATDIRMPEVIEKNDIFEILDVMDYEKMRS
IAEQYQVDTLIHLAALLSAVAEAKPQLAWNLNVTGLVNALEVAREFQLKFFTPSSIGAFG
PNTPKDHTPQDTLQRPTTMYGVTKVAGELLCDYYYVKYGVDTRGVRFPGLISYATLPGGG
TTDYAVDIYYSAIKEGKYTSFIDQGTSMDMMYMPDAIDAIIKLMNADPDRLVHRNAFNIS
AMSFDPEEIKASIQKIIPDFEMDYDVDPVRQSIAESWPNSLDVSCAQEEWGFSPKYDLDV
MTKDMLEKLKEKLVETV
>FECAFAII_01522 Serine/threonine exchanger SteT
MEEYQATPVKEVKIENELKRTMGFFTALSTVMGTVIGAGVFFKAASVAEVTGSASLHMFS
WFLGGMISVCAGLTGAELAAAIPETGGMIKYIERIYGNTAAFLLGWAQVVIYFPANVAAL
SIIFGTQFVNLFGLSQSMIVPVAVTAAVSILLINFLGSKAGGAFQSITLVCKLIPLFVIV
IFGLFRQEGVDFQLFPIQAGENLSFFSALGAGLLATMFAYDGWIHVGNISGELKKPAKDL
PKAISLGIIGIMIVYLLVNAVFLRTASIDGVAGNSNAASDVAKMIFGGFGGRLVTVGILI
SVYGTINGYTLTGMRLPYVMAKENNLPFSKLFAKLHDKTKVPVAAGILELVIAIGMMMIG
GFDTLTDMLIFVIWIFYTMVFVGVILLRKKEPDLFRPYKVPMYPFIPLVAIIGGTFIVSS
TLITQTFLASMGIVLTLAGIPIYLYLKRR
>FECAFAII_01523 hypothetical protein
MLNMYFVFGVPIFLLFLYATIAYVRKRTTIHYLGFILLIISGFMLVFNLQTWQQALLEMD
KMTPHALSKVLGYPVYLIWLPIFISGCLVLLNIYRGVRRIVQLRKSK
>FECAFAII_01524 hypothetical protein
MASYIEPIRFALIVFPFLALAISSVFFIYEYRKYGTFLVTRAVILYSFVFYLLCAYFLVI
LPLPAKETVAQMTGPKMELHLFASWQHFRDNTVLVLSEPSTYLPAMKQSVFLEPAFNVLL
LIPFGIYLRYYFRLSFMKTMIASFCLSLFFELTQLSGLYFIYPRPYRLFDVNDLVTNTLG
GIIGFVVTPLFTFMLPTRRRMDELSYEKGKTVSLTRRLVAYLIDWTFLSLINLVAAIFFK
IAFDSGAVTSHIWWLLLEVGVYFMIVPFITNGWTLGKKIVRIRLVEEDRERISLKALMIR
YGYLYFLFYGLSWLGQLLQQIMNSTTNTVLQMSAVFISLGVLLLQGIFILNILLSFLRKK
RILFYEKASHTYTVSTIGQTKDDDSRN
>FECAFAII_01525 DEAD-box ATP-dependent RNA helicase CshB
MNNFDIFRFKPFINEALTAKGFKQPTEVQERLIPLIAKGKNIIGQSQTGTGKTHTFLLPL
FEKINAEKEEVQVVITAPSRELAAQIYEAATQIAKFSTPEIRVSNFVGGTDKQRQLNRLH
HQQPQVVVGTPGRILDMMNEQALKIHTAFAFVVDEADMTLDMGFLNEVDQIASRLPEKLQ
FLVFSATIPEKLRPFLRKYMENPIIEEIKPKAVISEDIENWLISTKGKDENQMIYQLLTI
GHPYLAIVFANTKQHVDEIADYLKNQGLKVAKIHGDITPRERKRVMRQVQNLEYQYVVAT
DLAARGIDIEGVSHVINAEIPEDLDFFIHRVGRTGRNGLKGTAITLYSPNDEQAIDAIEK
LGVSFEPKEIKNGEIVKTYDRNRRAKREKSKDVLDPTLIGLVKKKKKKIKPGYKKKIDWA
IAEKNKKERKIERRQQSRTARKNKKNSHK
>FECAFAII_01526 Acetyltransferase
MKKIVGADEWIRAASCFLRYQVFVLEQGIPAELEFDGKDIPQQTYYLFLDQKRPVATLRY
EKKTPTCFKPERFCVAKEYRGKGLGGQLLEAAEKRAVSEGCQTSYVVAEMTAVDFYEKQG
YHTCTEPFIEDEVLCIGMKKSLA
>FECAFAII_01527 Alanine--tRNA ligase
MKQLSSAQVRQMFLDFFQSKGHTIEPSASLIPVNDPTLLWINSGVATLKKYFDGSVVPEN
PRITNAQKSIRTNDIENVGKTARHHTMFEMLGNFSIGDYFKNEAIHWAWEFLTDPKWMAF
DPEKLYVTVYPKDTEAKRIWHEEVGLPLDHIIDVEDNFWDIGAGPCGPDTEIFYDRGEAY
NDLAEDDPENYPGGENERYLEIWNLVFSEFNHKPDNTFEPLPHKNIDTGMGLERMVSIVQ
DASTNFETDLFMPIIHAVEKLSKQVKYGENPVTDISYKVIADHIRALSFAIGDGALPSNE
GRGYVLRRLLRRAVMHGKKLGIEQAFLYRLVPVVGEIMVSYYPEVLQQKEFIEKVIRTEE
ERFNETINEGLEILNQVIQEVKNENGTTLAGKDIFKLYDTYGFPVELTEEVAEDEGLKVD
HAGFEKEMDAQRERARSARSTEKSMGVQSALLTDIKVESKFIGYTEQESDSQLLVIVKGE
SLLNEVAEGEAQMIFDQTPFYAEMGGQVADQGWIMNEVGEIVAVVTDVQKAPNGQFMHTV
EVKAPMSEGQTYHLLIDQSMRNRIIKNHTATHLLHKALKEVLGEHANQAGSLVAPGHLRF
DFTHFGQITSDELAEMERIVNEKIWEAIPVETIETDIDTAKNMGAMALFGEKYGHDVRVV
NIGGWSIELCGGTHVANTENIGIFKIVSESGIGAGVRRIEAVTSKEAYELLEEEEKQLKQ
VATIVKSPQLKEVVSKAEQLQQQVRELQKENEQLASKLANQQAGDVFKDPETINGKTIIA
AQVKVKDMNQLRQLADQWKQKNISDILVLANEQEGKVSLLAAMTKESNEAGLKAGDLIKA
IAPKVGGGGGGRPDMAQAGGKNPAGIPDALKAAKEWVAQQ
>FECAFAII_01528 Pantothenate transporter PanT
MNSRNKTFRLVLRAILLAIIIVQAMVPWLGFIPLGFISLTIIHITVIIAAVVLGPKDGMV
IGLFWGIATIVRAYAMPTTPFDTLVFTNPIISVVPRVLVGLVAGLVFHWIYQKNKSITIS
SAFAGVLGSLVNTVLVLGFMGLFYTGATADAYGVDSALLFKTLAGVAAINGIPEAIGAGI
ITPLLAKALFAATPLKPE
>FECAFAII_01529 Ferrous-iron efflux pump FieF
MAKKQEEKKKQIPQQRTKKGVLAGILGLVTNLILFVSKLMIGLFSGSVSIMADAVNSLSD
TASSILTLIGFKIAAKPADQEHPYGHERFEYISGLFVSIIITYVGFQFLESSAEKIIHPE
NVSLTPIVFFVLIISIFLKFAQGKMYQVIAQSIDSETLRATATDSYNDVFTTLAVLLSAA
IEWVTGWRIDGYIGFALALYILYSGLTMLRIFVYELLGSRPTPAEIEEMEEHLNACDDIL
GYHDLLVHNYGPNKRFASVHIEVDESMNLNVAHKIIDLIEKDFKKSLDVELVCHLDPMPV
DNEKYYNILRQLKQILLETGTGLNIHDFRVIHQGKTLQFDVVVPEKFQFVDTELERILRS
QIEEKIGDYQLEITFDHNYLLY
>FECAFAII_01530 14.7 kDa ribonuclease H-like protein
MLKVYIDASTKGNPGPSGGGILIVYQGKQEQLSIPLSIGTNHQAEFEVFLKTLEFLKKND
LQNETIFCFSDSKTLVSTVDKNATKNELFLPYLQRIQELLSEFSLLILQWLPENKNKGAD
NLARQALHKQLKEKKTL
>FECAFAII_01531 hypothetical protein
MKKNIRWQPELAHTIIYWSLTLIILFFSLILSLENTGPYWKSNFVLGIFLVFLFLGLRRS
FILKSNSVIIRYAAFWKDREISVGQIRSLTPTNTGVQMMLQDEKAPSVFMMRKKDQVVLF
DHFEKNGPKSESIPYPYTKKRKS
>FECAFAII_01532 Cold shock-like protein
MTTGIVKWFDNKKGYGFISYDDTEEIFVHFTAIEEEGFKTLEENQVVEFEIIEGNRGTQA
AHVKKGNVQTTDTSMHE
>FECAFAII_01533 Formate--tetrahydrofolate ligase 1
MKNDLQISQETELEPIVEVASKLDLKEDDLELYGKYKAKINFSGINRSKDNAEGHLILVT
SINPTPAGEGKSTITVGLGDALNKINKKSVIALREPSLGPVMGIKGGAAGGGYAQVLPME
DINLHFTGDMHAITTANNALSALLDNHIHQGNELNIDARRVIWKRVVDLNDRELRKVIVG
LGGPIQGVPREDGFDITVASEIMAILCLAADLEDLKARLARIVVGYTFDRQPVTAGDLKA
EGALALLLKDAIKPNLVQTIYGTPAFVHGGPFANIAHGCNSILATKTALRLADYVVTEAG
FGADLGGEKFLDIKVPNLKKAPDAVVIVATVRALKMHGGMKKDELKNENLDALKVGFANL
KRHIRNMEQYQLPVIVAINEFVTDTDNELTLLEHLCENQGILAKRASVWADGAEGGVDLA
KAVVRLIDRKEANYKPLYRLEETIQEKTETIVKKIYGGNGVVFSKKAQKQIEEFTKNGWD
KLPICMAKTQYSFSDDPSLLGAPEDFTITIREIIPKLGAGFLVALTGDVMTMPGLPKKPA
ALNMDVTNDGEVLGLF
>FECAFAII_01534 hypothetical protein
MKTTFIRKTGFYGMGSSIQLRINNEKRSVLSHEQKITLDLEVPFTMQVTFYWLKSPVYTV
KEAKPAYVITMNYLILQIYPFLFLATGLGAVFLQNLFFSFFAVIVLIAFFFYIKNRAYLI
KEENYGKL
>FECAFAII_01535 hypothetical protein
MANSDLFLISFNRIEKWMRDEMGNARNMGFTELVRRLAQRKQLMIRKYEDDLLQLAQLRN
AIVHDRIAVDFVIAEPNDWTVKRIQLIEQELIQPETVLPRFAKRVTGFEQDLPLLELLKI
VAEKRYSQFPLYNKGKFVALITLRNIGFWLAKESQKGPVDLTNKRALDLIIQNGKYTNYH
FVPAKTHIYEVEAMFREQGTLEAVLITKDGNPDGNLLGIVRPRDIYKQIEKD
>FECAFAII_01536 Lipoprotein signal peptidase
MLIIYWIFSALLVGVDQLVKWWITDNLALGETKNLIPGILSLNHIRNTGAAWSMLEGKMW
FFTIVTLIAVVVILTLMIKNREKGNRWFMIGLSLILAGAIGNFIDRIRLGYVVDMFQTDF
MSFPIFNVADVTLVCGVICMLIYIILDEKDQRKK
>FECAFAII_01537 Ribosomal large subunit pseudouridine synthase D
MTELKTTIHHESGRIDKVLTNLFTDYSRSQIQLWLKNGAVSVNGQPVKANYKVKQGDEIT
VLIPEPETLDVVPENIPLTIVYEDEDVAVINKPQGMVVHPSAGHTHGTMVNALMYHIKDL
STINGVIRPGIVHRIDKDTSGLLMVAKNDQAHESLAQQLKDKTSLRKYVALVHGEIPHEK
GTINAPIGRSKENRKMQAIREDGKSAVTHFTVLERFEGFTLVELKLETGRTHQIRVHMKY
IGYPLAGDPVYGPKKTLKGNGQFLHAQMLGFTHPTTNEKMIFEAPLPEVFEKTLEKLRKN
IAF
>FECAFAII_01538 Bifunctional protein pyrR
MQAKEVVDQVTMKRALTRITYEIIERNHSIQDIVLVGIKTRGIYIASRIAERLKQLEDID
IPVGELDITLYRDDKKENPEEPELHSSDIPVSLEGKEVILIDDVLYTGRTIRAAMDAVMD
FGRPRKISLAVLVDRGHRELPIRADYVGKNIPTSRAEEILVEMQELDGQDRIMILKEED
>FECAFAII_01539 Uracil permease
MSEKKGFHNDDVVLDIHDRPTPGHWVGLSLQHLFTMFGATVLVPILVGIDPGIALVSSGL
GTLVYLFTTKGKIPAYLGSSFAFIAAMQLLMKTDGYPAIAQGAVTTGLVYLIVALIIKKI
GSAWLDKILPPIVVGPVIMVIGLGLAANAATNAMYNQGTYDFKYIAVALITLGLTIFFNM
WLRGFLGLIPILLGIISGYIVALLFGIVDTKPIVDAAWFAVPNFEIPFVQYEPKLYLGAI
TTMAPIAFVTMTEHIGHLMVLNKLTKRNFFEEPGLHKTLTGDGLAQIVAAFVGGPPVTSY
GENIGVLAITRVHSVFVIGGAAVFAVILGFVGKLSALILSIPGPVISGISFILFGVIAAS
GMKILIENKIDFDKKKNLLIASVILVVGIGGLVFEVGTFTLSAMALATVLGIILNLILPE
TSRSEEN
>FECAFAII_01540 Aspartate carbamoyltransferase
MIIKSERISLKHLLTVEALTDQEVMGLIRRGQEFKQGANWTPQKRQYFATNLFFENSTRT
HKSFDVAEKKLGLEVIEFEASTSSVQKGETLYDTVLTMSALGVDVAVIRHGDENYYDELI
QSKTIQCSIINGGDGSGQHPTQCLLDLMTIYEEFGHFEGLKVAIVGDITHSRVAKSNMQM
LKRLGAQVFFSGPREWYDDEFEVYGHYMPLDELLDQVDVMMMLRVQHERHDGKESFSKEG
YHQEHGLTVERAKKLQKHAIIMHPAPVNRDVELADSLVEGLQSRIVQQMSNGVFVRMAIL
EAVLNGKA
>FECAFAII_01541 Dihydroorotase
MKTLIKNGQINTRKNMTTPAEIWIEDGRIKAIGTGFSEAEFDEVFDAKGQLITPGLVDVH
VHLREPGFTYKETIEAGTRSAARGGFTTVCAMPNLNPVPDTAEKLRQVYDIIRKDAVVKV
LQYAPITENLRSEKLVDQEALIEEGAFAFTNDGVGVQTAGTMYLAMKEAAKNNKALVAHT
EDESLLFGGVMHAGKKAEELGLPGILSVTESSQIARDLLLAEATGVHYHVCHVSTKESVR
VIRDAKKAGIHVTAEVSPHHLILIDEDIPEDFGFWKMNPPLRGREDREALIEGLLDGTID
CIATDHAPHGLEEKSQSFMKSPFGIVGSETAFQLIYTHFVETGRFTLEQVINWLAVKPAE
IFGLNAGTLTVGAPADVAVFDITQTCTIDKEDFLSKGENTPFIGWKVKGETQMTFVNGKL
VWQKGE
>FECAFAII_01542 Carbamoyl-phosphate synthase small chain
MERLLILEDGTVFEGKAFGADASVFGEIVFTTSMTGYQETITDQSFNGQIITFTYPMVGN
YGVNRDDYESISPTCKGVVVKEHARVASNWRNQMTLDSFLKQKGIPGISGIDTRALTRKI
REVGTMKASIVDAGDSFEHAFDQLKATVLATNQVQQVSTNKPYPSPGTGRKVIVIDFGLK
HSILRELSKRNCNLTVLPYNTDAETILALSPDGVMLTNGPGDPKDVPEAIEMIKKIQGKV
PIFGICLGHQLFALANGADTYKMKFGHRGLNHPVREVATGRIDFTSQNHGYAVDEATIDP
EKLIVTHVEVNDGTVEGVKHRDYPAFSVQFHPDAAPGPHDALHLFDEFMEMMDAGKEQ
>FECAFAII_01543 Carbamoyl-phosphate synthase large chain
MPKRTDIKKIMVIGSGPIIIGQAAEFDYAGTQACLALKEEGYEVVLVNSNPATIMTDKEV
ADQVYIEPITLEFVSRILRKERPDALLPTLGGQTGLNMAMELAASGILEELNIELLGTKL
SAIDQAEDRDLFKQLMKELNQPIPESEIVNTVEEAVDFANKIGYPVIVRPAFTLGGTGGG
MCENEEELRIVSENGLSLSPATQCLIERSIAGFKEIEYEVMRDSADNAIVVCNMENFDPV
GIHTGDSIVFAPSQTLSDHEYQMLRDASLSIIRALKIEGGCNVQLALDPHSFNYYVIEVN
PRVSRSSALASKATGYPIAKLAAKIALGLTLDEMKNPVTGTTFAEFEPALDYVVAKIPRW
PFDKFENGERLLGTQMKATGEVMAIGRNIEESLLKAVRSLEIGTHHIELPELADITDDDL
IQKVVRAQDDRLFYVAEAIRRGYTIEELADLTKIDLFFLDKLLHIVEIEQQLKQQPLDDK
ILKTAKQNGFTDKKVAELWEINEEAVRQMRKENDLIPVYKMVDTCAAEFESKTPYFYSSY
EYENESSRSEKPSILVLGSGPIRIGQGVEFDYATVHSVKAIQQAGYEAIIMNSNPETVST
DFSISDKLYFEPLTFEDVMNVIELEQPIGVIVQFGGQTAINLAEPLTAAGVKILGTTIED
LDRAENRDLFEQALKELDIPQPLGDTATSKEEAVVIASRIGYPVLVRPSYVLGGRAMEIV
ENQRDLEDYMEHAVKASPEHPVLVDRYLLGGECEVDAICDGETVLIPGIMEHIERAGVHS
GDSMAVYPPQTLSESIKKTIEDYTIRLALGLNCVGMMNIQFVIHENEVYVIEVNPRASRT
VPFLSKVTGIPMAQIATKAILGEKLKTLGYENGLYPETKEVHVKAPVFSFTKLQKVDTYL
GPEMKSTGEVMGSDRQLDKALYKAFEASGLHLPEYGAVLFTIADETKEEALELAKRFTEI
GYSLIGTKHTAAYFEKNGLVVETVAKISEEAAEKNVVDLIRDGKTQVVVNTIDKDRGNAS
KDGFIIRREAVEHGIPLFTSLDTADAIVRVMESRAFSTNPI
>FECAFAII_01544 Dihydroorotate dehydrogenase B (NAD(+)), electron transfer subunit
MKQEMMEIVQQKQLAPKIFEMTLKGDLVKEMQQPGQFLHILVPRADLLLRRPISLNHIDH
ETNTCRIIYRVEGEGTRVFSTLSAGDHLDVMGPLGNGFDLSNLHTGDEVFIIGGGIGVPP
LYELSKQLVEKGIKPTHFLGFATRSRLL
>FECAFAII_01545 Dihydroorotate dehydrogenase B (NAD(+)), electron transfer subunit
MPHEVVYYEKEFNRLGETRIATDDGTYGMHGNVGNLLLGTKTEPTAVFACGSNGLLKTVE
QLFSSHQNVQLSLESRMACGIGACYACVCHTPEDETGTKSVKVCDEGPIFKIGEVII
>FECAFAII_01546 Dihydroorotate dehydrogenase B (NAD(+)), catalytic subunit
MNENPLAVKLPGLELKNPIMPASGCFGFGKEYGKYYDLNQLGSIMVKATTPNARFGNPTP
RVAETPSGMLNAIGLQNPGLDVVMHKLLPELEEYNELPIIANVAGACEEDYVEVCSKIGE
APNVKAIELNISCPNVKHGGIAFGTDSDVAFQLTQAVKKVSSVPVYVKLSPNVTDIVPIA
QAIEAGGADGFTMINTLLGMRIDLKTRKPILANQTGGLSGPAIKPVAIRLIHQVASISSL
PIIGMGGVQTVDDVLEMFMAGASAVAIGTANFTDPYICPKLIKELPVRMSELGIESLERL
IKEVREERER
>FECAFAII_01547 Orotidine 5'-phosphate decarboxylase
MNQLDQRPIIALDFSTRQEVEDFLRFFPKEEKLFVKIGMELFYQEGPEIVRYLKEAGHNV
FLDLKLHDIPNTVEKAMRGLAKLGVDLTCVHAAGGIRMMEAAMRGLEEGTPEGGKRPLLL
AITQLTSTSEEEMHADQLIEVSLEKSVIHYASCAKKAGLDGVVSSAWEVEAIKEMAGDEF
VCLTPGIRPEGTVAGDQTRVVTPSQAKKIGSTFIVIGRPITQSTNPYKAYQTIQTEWS
>FECAFAII_01548 Orotate phosphoribosyltransferase
MNVEQSIAKDLLEIEAVFLNPSNPFTWASGIKSPIYCDNRITMSYPKVRKEIAKGLASKI
KEAYPEVQVIAGTATAGIPHAAWVAEILDLPMVYIRSKAKDHGKGNQIEGRIFEGQKMVV
IEDLISTGGSVLEAAEAAKREGADILGVAAIFTYELPKGKANFEKAEIPLMTLTNYSVLI
EAALEDRYIDEQELTLLKEWKKDPENWQI
>FECAFAII_01549 5'-deoxynucleotidase YfbR
MGLNEFILGLNNLETITRAPGFFKYTEHTVAAHSYRVASIAQVLGDIEEANGQPIDWKLL
YEKSLNHDYTERFIGDIKTPVKYASKELRGMLQTVEEKMTDEFINQEIPAEFQEVYRRRL
FEGKDETVEGELLAISDKVDLLYESFDEIIKNNPEKVYKEMFIEAVTTIKSFEHRPSVQY
FFKEIFPELLNQEFYGKEAFLETVSTIVKKEEK
>FECAFAII_01550 Carbonic anhydrase
MKKNMDVEWGYSGDKGPENWASLCDWFARGAEFPLQSPIHLTKGEETKIEGDTLSFHYQK
QRFTDKEFKNTIHLVPFDQLSYVEFKKERYYLTDIHFHLPSEHIINGKQEDIEFHFVHMN
SKKENLVVGVMYQLMVQEGWLYNQENGESWNLEKHEHWVNPDVFFPEQKSHFHYIGSLTT
PPTSGPIQWFVMDHVGKLNQEFLLPFDGQYARPNNRPIQPLNGREIYYFEEFEQ
>FECAFAII_01551 Hydrogen peroxide-inducible genes activator
MNIQQMKYVVAVANNGSFREAAKKMFVSQPSLSAGIKELETELGITLFTRTNRGAYLTEE
GQDFLNRAEKILVQLDTLETHYLTSEKRDNFSIAAQHYDFLGPLTAQLLEEFKDEIKQFR
IMETTTARVIEEVKEQHSEIGIIYMNEHNQAGIRRYLQQGELSGRSIGKFKTHIFLRQGH
PLAEHAEITKEELLSYPQVRFTQDGNNFPYFYEDLIEIPDQETVIYTSDRGTLMNIVLET
DAYASGSGIVIGRIREHLRLIPLAEGELNEFYIIYSAKRPLSEIAQRFIKELTRLLDQQS
>FECAFAII_01552 hypothetical protein
MSFDGVFTHAMVNELRETLLSGRISKIHQPYENEIVLVIRSRGKNHRLLLSAHPSYARVQ
ITQIDYQNPDNPPNFVMMLRKYLDGAILEDIEQIENDRVIHFHFAKRNELGDLQNIILIV
ELMGRHSTIVLVNRETGKILDAIKHIGSSQNTYRSLLPGVEYVAPPKQEVLNPFSSEKEK
IFQRLSQTELDPKAIQRQFQGIGFDIAQELTKRLLERPNEKMVVWDEFFSAISHQPIPTF
YETENKDFFTPIAYQVLSEQASAVTAYPTLSQLLDSYYHEKAEKDRAKQQGGELIRKIEN
ELKRNKNKLKKREQTLKESENAENYRRNGELLTTFLTQVPRGAKEVVLPNYYEEDRPIKI
ALDPALTPNQNAQKYFHRYQKLKNAVKLIGEQIQEAKDEIQYLESVLSQLEIAGPMDIEA
IKEELTSEGYLKKKNLKKQKRKKPSQPDQYFSSDGTLILVGKNNLQNDQLTMKTAKKTDY
WLHAKNIPGSHVIIKSDKPSDETITEAAELAAYFSKYRYSAQVPVDLVQVKHIRKPNGAK
PGYVIYENQKTIIVTPEEEKITAMKQNR
>FECAFAII_01553 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIVAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYIEKRSTEGWTPDVIIGRAERTFSCSVSTLYRRFKTGEFNVL
HLPMQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEGDTIVGIHHKSAVITL
VERLSKAIIALKPEGRKAVDIENSINEWLQSVPKNLFKSITFDCGKEFSNWKSISNTNDI
DIYFADPGTPSQRGLNEHSNGLLRKDGLPKEMEFNQVNQGFISSVASKRNHIPRKSLNYQ
TPLEVFLSYVNGKFCLA
>FECAFAII_01554 hypothetical protein
MFVIWEVVKSRVQEMNEHFSVSFAENPSKYFRRLVFLLILSLLLTVAMFLLPEKIREEQV
NSLVYSSIPTSKLKPFDYSKADQKIKQSRAISVMFSKPNGKTYQDMLDVFNDPELMEELN
RPIFYYPIVYDVHELEQKYNIRTDEVTFIFFDGGKEANRITAGKGGITDFDKELIPELNR
LPLANIKQLEEELDRTGVTSQNSEIAN
>FECAFAII_01555 hypothetical protein
MKNKRLITVVVIILVYLAGAFIYGKASGEKESTSTNQTKKTTVVGVLQYVSHPALDEIYR
GIKDGLKEEGLKEGENLEIKFQNGQADQSKLATMSQQLVQSDPDALIGIATPAAQSLANT
TSSIPVVLGAVTDPVGAGLVASLEKPGGNVTGVSDQPPVTSQIKLASDLLPNAKKVGILY
ASSEDNSKYQVAQAEEAAKKEGLESVKYAVPSTNEIAQTVQVMSRQVDFIYVPLDNTIAN
AMQTVVKEANKANIPVIPSVDTMVEQGGLATIGINQYQLGLQSGKMAAELASGKEKPETT
PVYTFDQGDTVINQSQADRLGIIVPQSMKEKAKIITDDSQQETSKEDDK
>FECAFAII_01556 Autoinducer 2 import system permease protein LsrC
MIVSAISQGMLWAILGLGIFMTYRILDFPDMTTEGSFPLGAAVCVTAITHGVAPIVATLL
GVGAGMIAGLVTGLLYTKGKIPVILAGILVMSGLNSVILFVMRTPNLSLLNHPILQDSFH
RFGLPDYFDTVLLGFISLGILIAVLLFFFNTDLGQGYIATGDNETMARSLGIKTDRMKIL
GLTLSNGVIALSGALIAQNDGYADVNKGIGVIVIGLASIIIGEVIFQELTLAERLIAIVV
GSIIYQLLILVVIKLGFDTTYLKLFSAIILAICLMIPQLKKALNLKTGFEKEA
>FECAFAII_01557 Bicarbonate transport ATP-binding protein CmpD
MTDILTIKNGRKVVNNGMNEEKVLLDEINLTIREGDFITVLGGNGAGKSTLFNTIAGTLQ
LSQGSISFKDQLITKDSEEKRARFLSRVFQDPKMGTAPRMTVAENLLLAQKRGQKRKFRL
RNLKNQKEDFFRLCQEVGNGLEQHLDTPAGELSGGQRQALSLLMATITAPELLLLDEHTA
ALDPKTAKALMRLTNQRINEQKLTCLMITHRMEDALKYGNRLIVLQKGKIVQDISEKEKQ
HLTMGDLLQFFEEVVD
>FECAFAII_01558 Shikimate dehydrogenase (NADP(+))
MISGQTKLAGLFADPASHSLSPLMHNTAFEANNIDAVYLAFQVNPMNLKQAVESIRTFDM
LGVNLSMPNKTAVIPYLDEVSQEAQLIGAVNTIVHEKGRLIGYNTDGAGFMQSVQEAGIS
IKKKKMTLLGAGGAAKAVTVQAALDGAEEIVVYKRNNQTFAQVKETFEQLSYRTSCKIKV
RDFADTHQLRKDLKESCLLVNATDIGMGKKINQSPLLDISMMHENLAVFDLIYAPRETRL
LKEAKKVGAKGYNGLGMLIYQGAIAFELWTKEKMPIHVIEKLFD
>FECAFAII_01559 Regulatory protein MsrR
MSRMDRYKDIHKKAKPLKRDTGSIFARRERKRTRMENEEDATRIYEREQHSFEHLNQYEQ
QIYRDAPRAEEQQKNKKFFNRQKKNKPLKPRRKRSWKKIILSILLVLILYSGISFFIGKY
VAEHDTSLEAATSETFHGQKATNGAHNILILGSDTRGEDAGRADTIMVLQLDGPSHKPKL
ISFMRDSFVTIPGVGQNKINSAYAYGGADLVRQTLVENFGIDCQYYAKVDFKSFEKVIDA
LFMNGVKIDAEKDLNLDGVDIKKGVQKMDGHVLLQYARFRMDEQGDFGRVRRQQQVMNAI
FSQLKNPLNLIRAPYAAGKALGYTSTDVTAWFLTKNLFSIARGAGGIDRISVPVDGSWNY
GQSDYAGSILEIDNQMNQSAITDFLNK
>FECAFAII_01560 hypothetical protein
MDIYLNFKNESREAIAFYEKVFQTEASGITTYGEMPGIEQMNLPEEAKNLITNARLNIYD
TLVMFADTPEGIGPELVVGNNVSLVIQTRNEEETKRLFESLAEGGKIEMPLDAVPWAQLY
GMVTDRFGINWQINQE
>FECAFAII_01561 DNA topoisomerase 3
MKTVILAEKPSQAKAYAETFQQQKRHEGYYEISDPLFAGEVTITYGFGHLVDMVAPGAYE
ERWAKWSLENLPIFPETFRYEVPMDKRAQFSIVKRELQSADTIIIATDGDREGEAIAWSI
IRQANAFSKEKNYLRLWINSLEKEAIYEGFKNLQPGKNYFPKYKEAQARQNADWLIGMNG
SPLYSLLLQRKGIDGSFSLGRVQTPTLYMIYQLQEEIKHFKKETYFEGEGLITTNKGQFS
GKIVPKKAFKTQEELTKEIEKLGAHLGKQNGRILEVTKKEKRLHSPRLFSLSSLQTKMNQ
LMKASAKATLDAAQGLYESKFLSYPRTDSFYITENEHQYLVKHLQNYKKFLGIEEVQTTE
IKAKKRYVDAKKVQEHHAIIPTKTIPTPARFAKLSKLQQAIYLQVLRTTVAMFAADYIYE
ETTVMTGVQQLKLKSIGKIPLQQGWQEILRIKSKKKEAQTLPPIVENEEAEVELKSMEKE
TQPPKPYTEGTLITAMKTAGKTLDNDEAQEILKEVEGIGTEATRANIIENLKQKHYIEVN
KNEITVTPKGITLCKAVANEPLLTSAEMTARWEGYLRKIGKQEGTPSVFLENIKKFILHL
LAEVPNQIDKVDFSDEISGTRQIKAMEKKNDQLGRCPKCKKGIVMLYPKIATCLNPECDF
KLWPTVAKKKLTKTNLRDLLSKGKTSKVVKGFTGKKGKFDAVLVLKEDMTIGFSFPWIEN
SGTKAVDGNKETSRKNNENEVE
>FECAFAII_01562 hypothetical protein
MKKVHSFLNYLMGAITIVAVYQAFLKYPDYGTKLLSLTHNQTAYSPTLILSTLTAGAKSA
TYFFHKTTSMLKRKKQRKQLLVVVAAMIIIYFLPVITQVFHQYFG
>FECAFAII_01563 hypothetical protein
MKKMKKYKIRKSGNSDVTTIPPEVKEFMGVQTGDAISYVFQSDGSVRMIKAQEEPDIDSL
VDSIMNQYEDALKDLVDL
>FECAFAII_01564 Toxin Doc
MRYLSTKEIIKINAKVILRHSPGEMIGVKDANALDMAVKQPSQAVFNQELYPEIYEKAAI
LAINLAKKHPFHNGNKRTALVAMLLFLQLNNCPVAFSRQEAVDFIIMITTSSLDFDSLKS
KITSYLRQTAIK
>FECAFAII_01565 L-lactate dehydrogenase 2
MKKTSRKVVIVGTGFVGTSIAYAMINQGISNELVLIDVNQEKAEGEALDLLDGMAWGDEN
VAVWSGGYEECKDADIVVITAGINQKPGQSRLDLVKTNASIMRQIVKEIMGSGFDGIIVV
ASNPVDILTYIAWNESGLPTSRVIGTGTTLDTTRFRKEIALKLKVDPRSVHGYILGEHGD
SEVAAWSHTTVGGKPVFEIVEKDHRIAQDELDVIADKVRNAAYEIIDRKKATYYGIGMST
ARIVKAILNNEQAVLPVSAYLTGEYDEKDIFTGVPSIVDENGVREVVELSINEEEKAMFS
KSTSALREVLNTVL
>FECAFAII_01566 hypothetical protein
MRLLSYYIVAANFFGFIFSSKLLVVLSGDIGVNICHLSVMRIQEFVSIKNYNNNYYN
>FECAFAII_01567 HTH-type transcriptional regulator ChbR
MRNEESIETLQREQGMNINDLNLAYHLQTPPKIHRGDLFQQGNIHISKHRRYAEVPEHTH
DFVEINYMYSGTCLQIINGERIEMEESDVVIIDKEATQRIEYTGQEDILINILLKEETLS
TEILNHLASTNNLLSSFLINASKEKGEHTQFIHFRGGKTSRLTHLIENMLLIYFDTYSHK
IRSLNLYTSLLLIELTHLLEQQSFSSADGCAENEMLRVLDYIDKHFTSCTLKETAAHFGY
NPVYLSNKLKMYFDASFQELVLKKKFDFALELIQETSFSLEEIANRIGYKQTTSLFKLFK
KYSTCTPNEWRNKH
>FECAFAII_01568 hypothetical protein
MNKKMMKFSLLSVSLILTSAGAVTSAIPSMSATYATRSLSAVELLTTAPSFMVTIFVLIS
SFIARKIGQKQTVIIGLVIASICGILPLFSQSYSIVLASRAGLGIGFGLINSLAVSMIAA
FYHGDERASMIGFQSAFQGFGAALMTFVAGQLVQFGWQYTFLVYAISLPILVLFVLFVPT
PETTELQSHGTAPTRQVIKTNPKMISYGIFLLLVIVVYNAVSIKLATVLTTYSLGNETNA
ANILTIMQLASMAAGVCFGWLQTKAHRYMLTLSLLLMGIGFVLIATVINLYVIGFGAILT
GISFSLFIPYLFNQVSIQAPKYAESFNTSILLVGANLGTFIAPYGLLFLSFASLGSKTLA
VFVNGSILLLISALISLLVVHRTNRKTVIRVDEEIKEQLTTK
>FECAFAII_01569 hypothetical protein
MTNEKHKDRWLWYPGDFEIRHGLLQNFQREERGFDWPAYWYMDDCHRNVKFKRYYFLDQP
SMFKVTIQGVGYVEINGQKHPCGKWLTCPAGKAKIRIFVGHTSGLPAMFIEGDEVKSDIG
WTASNFIEEYPAGWSPLYVDIAKDPNQIYYQKECVHPVTETEIGGGILFDFGRAVNGCVE
LISLDDHIESITLCYGESDVEAMDIDYCYYKQIGMTRKMKARKRAFRYLFIPEVSTGMVQ
LQVFHEFLSLSKQAAFSSDSSLLNQIWSVSEEAFKLCSDLFFIDGIKRDRWIWSGDAYQS
FMINQYLFFDEEINKRTILALRGQNEIKQHMNTIVDYSILWLIGIENHYMMTKDYEFLRI
VYPKMQSLMRYLMEQTNELGFIYGRAKDWIFIDWSEMDKEGTLAAEQVLLLKAYHSMITC
GDILAETYGENENYHTHLYQEKYQLLKQNLFDYFWDEELGAFIDCYESGRRNVTRHANIF
AVLFDFANKDQQQSILKNVLLNDTITQITTPYFKFYEQDALCKLGQTNIVYQTILDYWGG
MLSHDAVTFWEEYDPTQTGNEKYSMYGDPYGKSLCHAWGASPIYLLGRYFIGLYPTKPGY
EEFMIQPNLDSFETLNCTLPIKDGKISLEKTKDKIVITSDRTGGTVKMNGKSYPLLAKQP
LVLTSYSKINA
>FECAFAII_01570 Ascorbate-specific PTS system EIIC component
MDKLLNLFVSIVSQPSILVSLIALLGLVLQKKKFSEVIQGTIKTFVGFLVLIGGAGLISN
SLTPFASMFQTALHTQGVVPSNEAVVAIALQQYGTPTALIMLVGMIVNILLARFTRYKFI
FLTGQAMLYVSCLTAVILVSAGFTANLWMILLGGVFEGTLLTITPALCQPFMKNITGNNQ
VALGHTGNIGYASSGWIGKFFGNKDRSTEDIKIPKSFSFLRDSTVSIMLLMSIVYVALAL
LAGPGFVERELSNGDNAVIFALIQAGTFTAGFVIVLQGVRMVLAEIVPAFQGIAKKLVPD
SKPALDVPIVFPYAPNAVLIGFFVSFFVGTLSMFAMIGLQTTVIIPGVVGHFFCGAASGV
FGNSTGGRRGAVLGSAFNSLLISWLPLFILPVLGDLKIASSTFADTDYLVPGLVLGKLGE
YGQIALTVGIIAFFLLVVLSSFLFAGKRTNIVSKEQN
>FECAFAII_01571 hypothetical protein
MKIFAVCQSGLGTSFMVEMNIKQALADLGADVDEFEVSHTDVGSVSSDMADYFFIEHSLK
DTLTSIPDEKLVPLQSIIDSEEVKEKVTKILSKE
>FECAFAII_01572 Ascorbate-specific PTS system EIIA component
MNYKISYLLKTPREISLEKAAEIIEVNTSEAIKQLTPFAEYVDDTRIRIKKFRAIDWAEK
FLDITRFEAVYTEQERRDLLYLMVYSTATSVSVFHFQDFLQVSKGTVLSDIKKIRNELEV
EDCQLSYTRKTGFRLLGSEAILRREAKNRTARLMQSLAGRFGLTYLTATLSIDYYAKVRD
LLDKTISLSDLRFAPNRMDELAYYLSLTTIRIGKTSMELVKDAELLASLAVTDISRQVLT
GLGYSEHQNSEIIFFSLCLASIVEGDVQEPALDFLLECSSEVIHRMEFLMAVEFASFREL
LMNVFYHLVPAYFRISYSFYLPNVMIDQIKHQYASIYEMTRKALLPLERRIGKSIPEEEI
GFFTILFGGEIRKADAEERNRKIRAVIVCPSGISSSLILKSELQQLFPMIFFTETNSADR
LHEVDETSYDIIFSTVPLTLTDKKKSLYVLHPIMTDLEKNQLINQVQRDWLIPGFSMPSA
QELLSALLPYIELKEGVDEEKLYQVLNRKMNKLLEKKEDQRPMLSELLTEEMIQLSDQPK
NWQEAITFAAQPLLSENKIEESYIKAMIERVEQYGAFIHIGDHIALPHARPEDGVNEVGM
SLLKLQQPVDLLDNPAHPISLFICLAAIDNEAHLRALANLTKLLSNKQNLQDLLHASTKE
EILAIIRKGDE
>FECAFAII_01573 hypothetical protein
MTNYDGEKHKRLRGSMAPKTEEEVALAGTNSGETEDKEESLAGTNSGETENKETALSGSN
SVEEETKPNEPNHFEKDIEKAVEDVKEKFEELTSKNKHDHH
>FECAFAII_01574 putative oxidoreductase YhhX
MLTIAYLGNGKSTNRYHLPFSRKLTNKINIKKIFSPSEPVWKTFEDIEYTDQLSDLWDDP
EIQLVVITTPSQFHYEYGKMALEHGKNVLVEKPFAETSKEAEELFALAKEKGLFIQCYQN
RRFDSDFLTVQKVIESGKLGDILEVEMHYDYFRPEVPENTHEFSTANSYLYGHACHTVDQ
VLSYFGEPDDISYDVRQLLGKGRMNDYFDLDFFYGNMKISIKSSYFRIKERPSFVVYGKK
GMFVKQTKDRQEEHLKMFYMPDHEDFGIDLPEHYGVLTYIDEQGSYHEEKVISEVGDYSR
VYEGIYETLVNGAEKVIKDEETILQMKILEEGIKSIQESEGKI
>FECAFAII_01575 putative HTH-type transcriptional regulator YbbH
MLIEEKLTKQELFTTTEKRIVDYIRRNIEAAVYMTIEELAKATYTSHSAIIRLCKKMGFS
GFKEFRFELGREVHQLIAQFNQTIDPNFPFSSEDSTQQIAKKMADLSIQSIKKAQLQIEH
EDLDQIGKVLNKAQRIFLFAKGDSQITARKFQNKMVKLNKFLIMAEEYSDSSWNAANLTS
EDCAIFISYSGRIHHYERIMTYLKHVEAPTLLITGNQHSEMAKQADMCLVISQEEYDFAK
VATFSSQIAFDYVLNTLFSVIYSQNFEENIRNLKNKQELMQKGLLKEYRKT
>FECAFAII_01576 hypothetical protein
MKPKKRKLLDLLMLFLLLSGIGILAYPFVSDALNNYLDQQIISHYQQQAVKENEEVMAKI
QENMTKKNQQLAKEGGNPGADPFTKKKEPAKKDRTYFEKHTIGILTIPEINVHLPIFDET
NTVLLEKGASLLEGTSYPTGGENTHAVISSHRGLPQAKLFTDLPKLTLGDSFYIEINGRT
LAYQVDQIKTVEPTDTKDLRIEKGQDFVTLLTCTPYMVNSHRLLVRGHRVPYHAKEVQKE
VQKVSENKRFFLYGLLAACILIFLLLIYLFRQSFKIRNRS
>FECAFAII_01577 hypothetical protein
MKNHKKINVMLGVLFLILPLLTNSFGAKKVFAEETAAQVILHKKKMTDLPDPLIQNSGKE
MSEFDQYQGLADISFSVYNVTQEFYAQRDKGASVDAAKQAVQSLTPGTPVASGTTDADGN
VTLSLPKKQNGKDAVYTIKEEPKDGVSAAANMVLAFPVYEMIKQADGSYKYGTEELDTIH
LYPKNTVGNDGTLKVTKIGTAENEALNGAEFIISKEEGTPSVKKYIQSVTDGLYTWTTDQ
TKAKHFITGHSYDIGNNDFAEASIEKGQLIVNHLEVGKYNLEEVKAPDNAEMIEKQTITP
FEILANSQTPVEKTIKNDTSKVDKTTPQLNGKDVAIGEKIQYEISVNIPLGIADKEGTQN
KYTTFKLIDTHDAALTFDNDSSGTYAYALYDGNKEIDPVNYSVTEQTDGFTVSVDPNYIP
SLTPGGTLKFVYYMHLNEKADPTKGFSNQANVDNGHTNDQTPPSVDVVTGGKRFVKVDGD
VTSDQTLAGAEFVVRDQDSDTAKYLSIDPSTKAVSWVSAKESATVFTTTSNGLIDVTGLK
YGTYYLEETKAPEKYVPLTNRVAFTIDEQSYVTAGQLISPEKIPNKHKGTLPSTGGKGIY
VYIGAGVVLLLIAGLYFARRKHSQI
>FECAFAII_01578 hypothetical protein
MKKLGWLSMCLFLLLFKPAFTQVATETETEMVQITLHKLLFPNGQLPKNHPNDGQEKALL
QTYRGLNGVTFQVYDVTDSFYHLREKGKTVEEAQAEIAKNGASSGMFTAEATTTTLNNED
GIASFSLAAKDQEKRDKAYLFIESKVPEVVKEKAENMVVVLPVHGQNNQKLSTIHLYPKN
EENDYPDPPFEKVLEEPRNDFTIGEKITYSLHTTIPVNILDYQKFELSDSADEALTFLPN
SLTISSNGEKLTEGFVIHKKPHGFDVLFSIPSLEKYAGKKLTISYQMQLSSTAQANKEIN
NNGTLDFGFGVSTKKVSVYTGSKQFVKIETNKPDKRLAGAVFLIKNKAGNYLQQTANGYK
WTKNESDALHLISDKNGAFSISGLKTGSYRLKEIEAPSGYILSETEIPFTISTFLSEDKE
ADSILKVVNKKENSRPFLPKTNETKNTLLGVVGMVFASFAIWLFIKKRTGVKK
>FECAFAII_01579 hypothetical protein
MNARGNVQKDITPLDLVLVVDWSGSMNDNNRIGEVKIGVDRFVDTLADSGITDKINMGYV
GYSSEGYSYSNGAVQMGSFDSVKNQVKSITPSRTNGGTFTQKALRDAGSMLSVPNGHKKV
IVLLTDGVPTFSYKVQRVHAQSSSNYYGTQFSNTQDRPGNTSLISRIYDAPDQNNLSRRI
DSTFIATIGEAMALKERGIEIHGLGIQLQSDPAAGLSKAEVESRMRQMVSSDEKGDLYYE
SADHATDISEYLAKKAVQISATVSNGQINDPIAEPFIYQPGTLSVKSVGTSPTTVTPSIS
IEGNTIKSNQIYLGKDQEIQIHYQVRIQTENEDFHPNFWYQMNGRTTFQPNIDTNELAEF
GIPSAKAPGVSLHIKKLWEEFDNNLADRPDQVTFEIQREHTTNAAAWKNGYIRIIKPAKD
TTNTWERADIDKLSANSGESYQEILSLPQYNNQGQAFSYQTIKELPVPGYDSQQIDAMTW
KNTKQFTPLNLKITKNSSTGEKDLIGAVFKLTGDSIDTLLTDHGDGTYSLPENVKLQKEM
TYTLTETKAPEGHGLSKKTTWEIKIASDGTVTIDGKTVTTSDDTIQLTIENPFVEVPVAV
RKYAMQGTDKEINLKGAAFSLQKKEANGTYQPIDSQTTNEKGLASFDSLTPGKYRVVETA
GPAGYDTSPGNYEFQIDKYGKIIYTGKNTEMTNNVWTLTHQNRLKAFDLTVHKKEDNGQT
LKGAKFRLQGPEMDLESPKDGQETDTFLFENLKPGTYTLTETFTPEGYQGLKEPVTIVIH
EDGSIQVDGQDHESVLSPGAKNNQISLDITNQAKVPLPETGGIGRLGIYLVGMIGCAFSI
WYLFLKKERGGS
>FECAFAII_01580 hypothetical protein
MTTTGKKLKVIFMLIILSLSNFVPLSAIADTTDDPTVLETISAEVISDQSGKKALNIKLN
ANNTSAEKIEKEIGLVENYLSDVERKEGDGYAYQVNSGKITLEISSNTKQTIDLSFPIDP
ALYHSQANKLIVDNKEYDIIDETENKKDTDVSVPKPDEIEEESSKENENSVSPFTLPTLS
LPAVSVPSNQTIPTEYTTDDQGTYPKASWQPTGNTNVLDHQGNKNGTNQWDGINSWNGDP
NDRTHSYIEYGGTGNQADYAIRK
>FECAFAII_01581 hypothetical protein
MEKIIRILSISDKWMTKKELAKRIGSSESTFVRYIEEIKIRWGTDVTIQSSQKLGYRLEH
LNVPAYLNVLMEMSQSSTNSRLLNEIIVNPGKTIEYYCEKISISRSSFTRKLKQCNQILE
SYLLKVIVDQGFQLTSLKSELQLRIFVTFFFLSYYGRRTLPFPIEKKKIKEIMVKNNCQM
NLFQEESPYEQSFFIMYFVVHLMRESQGTPFEWKAGDSYVQLINIDKKDFLILKNLLGKL
KYSSYIKVVNYFVNTIFSEFSEKEKNEISEQIRKNMSYCSFSSADCKEKNEEYVVQLLTQ
IYFFSRIFPYDTTHLTIRATYFAQQMQHRQIRLYAGFRAELQFYSTLLNQNLIYYLSSYI
FWMLIGNPEIHHYTSDKKILIISDLSLRHSQYIEEYISDILAVHKIHSETTAITEDQLSK
YNLLEYDLIVTNQPILNAHVPHILIDDSVSFANEEELIRLFEL
>FECAFAII_01582 hypothetical protein
MTMKGYPRIIRDKGEMWMPKETFFNLSNAKKQRIDDLLLEIFCSQHISQVKVSEIVDKMG
MSRGAFYKYFQDLEDAYLYTIKSSSHIVHQDILKFISENKQHFFLGIEKYLEWCCDLDHE
SIYWQRLYLLTQRNDQQTTKRRELSADSPMNEKWLELLRINHFSIQSSEEAVSFLYFSMT
LVMNTLTDLIANNWTKEELLKDFRYKSRWIAEGIQ
>FECAFAII_01583 Putative hemin import ATP-binding protein HrtA
MKKILTMKKVTKTFGSGHTKVSALKAIDFYVKEGEFVSIIGPSGSGKSTFLTISGGLQTP
TSGEIVINGHSLTELPEKKRADLRFKEIGFILQSSNLIPFLTVKEQFELVDQVTSKKEDS
TKIDSLLQSLDIQSLKNSYPKDLSGGERQRVAIARALYNEPSLILADEPTASLDTDHAYE
VVKLLVKEAHEKQKATIMVTHDVRMIQWSDRVYRMEDGYLTEEEKKKE
>FECAFAII_01584 putative ABC transporter permease
MFLAIKEIRYSKLRYGLIVGIMFLIAYVVFMLSGLANGLSEEFKKAIDDWDAQEIVLSED
ANQVFAASQLTRGDLKYIEGGEKAPIGLYSGAIKGKNKENVTVFGTTKEAFLLPKLTKGH
EFKTKNEIIISQNLADSGYKIGDTIKIGSYDDPLTIVGIFPETYYAVSPVIYASLDTWTA
LKYGQQPFASEEEQPINGIVIKDSAKISKEKASKGLQLLTIGTFIESIPGYSAQNMTLNA
MIYFLFLVVAAVVGIFMYVMTLQKTAIFGVMKAQGIKNFFIAKSLVAQSFIVGVVGVLLA
LLFAYLTSLILPSAMPFAVFWSQWLLYSGILIIVAMLGGLFSIRTITKVDPITAIGG
>FECAFAII_01585 Response regulator MprA
MIKLLVVEDDKVLSNNIKEILAAIGEITQVYDGSEGLFELESGVYDLAILDLMMPEMNGY
EVLAKIRKEKIQPPVLILTAKDSLEDKIEGFERGADDYLTKPFYREELIMRVKALLKRSL
GLFDENVLKYKDISCDLKSNEVLYKEQVLPIQGKEFELLVYFLQNKGIILTKEQIFDRIW
GFDSDTTITVIEVYMSNLRKHLRSTGLDKEIKTLRNVGYILQRV
>FECAFAII_01586 Sensor protein SrrB
MNGDITRKQRSRFFATNVAAFAFIFFLLGFITLQILNQSAYRETDLSLEKINFDSRTVQL
EIQRYQQGDPFLNPTQTEQNRTNMEQPLMEPSNDRFNTQVILWSKNGEILNKAAIGGRFN
QIKELKMDTKNLNTIQNIELNEDSGSSALSFRSITKKAETNQDGVAYIQILENTNQIKNS
LATFRTIMILCMIVFWILSIGISYYLSSLSMRPIILSWRRQKEFVENASHELRTPLTIIQ
NSLEHLFTKPNHTIIEESESIAQALSETRRLTGLTSDLLTIARNDSDQQLLSKQMINTQE
YIEQLVKPFQEMATIDGKEFILHNDATLEVPIDEKKIHQVLVILLDNALKYTNPEDKIIL
DSSVNHKEWLIHVKNTGPSISEEDQARIFDRFYREDQSRAKETGGYGLGLAIAKQVIEQH
HGQISVSNYLPQGVDFKVQLPLKPKK
>FECAFAII_01587 Stress response protein YsnF
MEEKNLTVIGSYSTREEALSVIERLRNEGYERDDIVIYTTDEAASRLGFDGLSGIDVETD
ENRMDGEEDRSLWEKIKDTFSFDTYDSETATPENDPLYQYRGDISDGKFVITVKGYRQPE
TTEDTMDTQDTVSPASTMGTGLETGTGTDPMDVGGTTGFQNTTDPLNMTPGTDPMDVPGE
TDTMGTSKTEDIDRKPNLDDDTIQLKEEKLDVNTHDVTTGEVDIHKHVVNDTETVEVPVK
REEIVIERKPVTDQSSQGTDENLEDDTITIPIKEEQVDVSKHTVIREEVGIHKEEHEDVE
KVTEDVSREELDIDTSGDVHIEDRNKKS
>FECAFAII_01588 Tyrosine recombinase XerS
MDSKTRKQLQEKLKQRTHLLPSVFQQFLEENRSSLSLGSRYEYAKDFHLFTDYLRKVFSE
EVDDQLIIHLEKQDYQNFLAKIYRHTRSFQTTANQETEQLFENSYYGISRKQYSLNHFLR
FLYQKGLIEEEISLLGTSLPETTKAAPRYIDAELFKDFEHLFIPIEGFQTSREASFEEKN
RPRNLAITAILLYCGLKIHEVVELKRKDVSLTKQILNLNRKENRLNKVPIPKEAMPFLEN
YFKLTAQNTDENSFVFRSSHDQQISPRTIRQILSKITVYKNVSPELCRKTYRYYAELYLD
DADAVNYLCGNRYLSSHSFQDIWEKMVDFSYHELAAFVRVSSI
>FECAFAII_01589 4-chlorobenzoate--CoA ligase
MMETITYSPLNLFTNFQEAAANFSETPIIFDEPLSAFPELGLETTYKKCCESVLKRAYQL
AHLGVKSGDKVIIYKSSAFDTYLLAVSVSYLGAVPVMTSYHLPTTTMEVFIDRLEDPFIL
FDDETKKRVREISNGTKSKQIPILYLMEQPALSVSQSFLDKNEISYMTHTSGTTGIPKLI
CHSAHSMGWRTKWQKTVFTKISEKKLIAFHISPVHSRFNIGISSLMSMGFPMMPLANAQS
SKVVHMLEAHRPIALETHPNNFVQWRFTAKEHPEAFSGIRYYHSTFDAINNQTMKTFLRT
SMAQDAVFLQVYGQSECGPMILKAHTLESLKTSDARDMGVGLEDMTSARITDSVGNVLPE
NTDGHIQLLSKGRALTYYKEDARFQENVYGDWWDSGDYGFMDKHGHLFLKDRQVDLIETI
NSTLAIEDFLLDSLDFLAEVVIVRDKNHSPQPIISLSPDKEMDWNRWWEQVHELPRLNVP
IIRDFDAIPRNSYNESATASNRERIKITKVLTI
>FECAFAII_01590 Pyridoxine kinase
MKRILTIGGSDPFAGGGIQTDLKTFENFGLFGLSALTSIGALDINERFMLESISLELLKR
QLVSIDKMTSLDGIKIGLLNSSEAIMVVRDFIKTKQNIPIILDPVLAFKETEAVINQLYI
SQLIEELFPLVTMITPNLAEAALLSGQALPSSLTEMIHLAKELTASGTKNIVIKGGTRMA
GDEAVDLLYSIDHYEVFSHKKIDTTTVNGAGCAFSSAITANLVLGADFTKAVAESKKFVA
HCISNGVLMNDHTGSVWSGGIQKGGMRNEN
>FECAFAII_01591 Thiamine precursor transporter HmpT
MKTKQLTIYAMLIALTVALSLTILIPVPATNGFVTLCEAGIYTAAFLYGPTGGLVVGASS
GLLIDLISGYPQWAVFSLVIHGLQGYVAGSFSKSSTRMWGLGLLLGSLVMIIGYGIAGWI
LYDWPAGVASIPGNIFQNLIGMGLAFPITASLQRIQARKQY
>FECAFAII_01592 hypothetical protein
MKLSEKELKDQLTEIVNDILAEAHLKKGDLFVLGCSTSEVVGGHIGKNSSAEVGQWIIRT
LKELLDPKEIALAVQGCEHLNRALVVERTVAEAKNFEIVSVVPALHAGGACSVAAFDQFN
DPVEVEHVVGQAGIDIGDTSIGMHIKHVQVPVRPRLKTLGQAHVTALRSRPKYIGGPRAN
Y
>FECAFAII_01593 Oligo-1,6-glucosidase
MIQEQKWWKEAVGYQIYPASFKDSNGDGQGDINGIREKLNYLKDLGIGFIWINPIYQSPF
VDNGYDVSDYQDIEERFGTMEDFDLLLKEAHELGIKVIMDLVINHSSDQHQWFEESKKSK
ESPYRDYYIWVDGVDGKEPNNWTSIFGGSAWEYSHETGQYYLHVFAKEQPDLNWESEKLK
EELFNMIRWWLDKGIDGFRLDAISHVKKDEYSVKATENPFSPFQNVSGIEEHLTDLKHVF
EEYDIMTVGEASGVTAEEGPQWVGKDGYFDMIFEFDHIHIWQQEKEGQLDVLKLKHALSA
WQTSLDGIGWNALYMENHDVPRAVSVFGDTRPDFWAMSAKAIAMMYFFLQGTPFIYQGQE
IGMTNMPFESIDQVDAVDSKRLYKRLLAEGKTREEALDIIRETTRDNSRTPMQWTSEQYA
GFSTHEPWLITNPNTKTINVEQQEYEPESVLQFYKNMIRIRQTNKGLIYGSYKEYLHEHP
QLYVYERYLEDEQYLIMVNLTESLADYELPKEADQSWTLLLSNSSSGEFEAKGILAPYEA
RLYKTNK
>FECAFAII_01594 hypothetical protein
MENFSLTENRTFSRLEKQMIWKKPKSHRTSAEEWRIASEIKGNWQDPEMKISNVLLEGDA
GSGKTQLAKALSADLQLPYTKVTCFADMDKSDVFGALLPVVDSNKEQDQELLEAIYQTDT
LEAVLTLIQNHYGIDPFSAKEKLAELVQRIEADYPDAIHYSYYPSEIVRAIEKGYLLEIQ
EPTVIRDASVLVALNSALEPNGMLNLPTGIIRRHPDCVIVITTNRNYQGNRPLNESLRDR
MQHAEKMDLPALEVMAERAMAKTMIQKQELLLKMAEIIRLLDETAKANAIKGVAGMRSYF
YWANTYKQGQDLLQSIYPKVLYKLSTDSDELAILEQALSDSGLLLELQDILRKEKWGHPQ
SEHTKERTISAEEANERNITENAEEILRLDEKKSLSAEEPNEGEEKQEETIEKNEIPPQM
QKERSSDIEGKNQKEQQTGDDSQEMSASDMEAHDKEIKKQLNKEARQIMKETIHEKEGLI
VHRPAFQGKTPEARELHMQVMPIVESLSRQILELLDNEQTETYQKGKYEGQRFNASKVAY
GDLRNFDKKNPPHEQPSLAVAVRIDESGSMIRDDRIEAAKKAAIAIAEFSKKVDIPLLIY
GDTADRSSREKTSLFSYKEFEDGFQWLNEKLVTMKPRQNNRDGAALRLAAEKLNRQSATT
KLLLNISDGQPKALPDYTGKKAKEDIQSVLKEYERQGILFVSAAIGQDKEEIKSIYGESR
FVDITDLNEFPKQMIQLIARYL
>FECAFAII_01595 hypothetical protein
MEIPTNLKHKPVIVVEDYDKVDGRNALNMDAKGLSLGLAQWNDRGKVDISGKVWRHTGEK
WSRQSEELPITRILDLAILAAQGSLYFQDAYRYEKFYDPENPVVDIIGLQGNRMTVEVDT
KNPKIDEDIILYYDTLQKDGELIGERFRILKRLLDELGY
>FECAFAII_01596 DegV domain-containing protein
MKLAVVTDSSAYLPERIKNHPDLFVIPIPLIMDGKIYNEGIDIEADEYYGLLKNSKDFPT
TSQPVVGEVLGLYEELKEKGYDTILSIHLSSGISGFVNTLFAMKDDISGVTVIPYDSKIT
SMPMGHMVEAALDLNDEGQSLDEILAHIDRIRDNTYAYLIVDDLNNLVRGGRLTNGAALI
GSLLKIKPILTFSEGKIVLFEKIRSSKKAFARAEEIIGRRNNEIQPPVKLYVIHANNLEV
AIAEKEKLQKKYPNAEIEIGHFGPVIGTHLGEKAIGIAISAQ
>FECAFAII_01597 Lipid II flippase MurJ
MNKKLMQGTFWLTFANLLCKVLGVVYLIPWLSMMGNNQDGMLATTLYNVGYLPYGLFLML
GTVGFPNAIAKKVAVATKEGDNAACRLIFRSTINIMFVIGIASAALMYLFAPLLAGISPI
ANVNNGILAIRSLCPSLIAIPILSAMRGYFQGKNDLRPYGTSLIIEQAVRVIVILAGTYY
LRVLTDGTILEAVLISTVASFFGGLAAIIHMYIVGRRKDFFELKDFLISSRYFERENRSA
SVSIIRETLPFIFVGSVITIVQMIDQVTMKPLLHFFRPEIADQQLEFLFSRASVNPNKLT
LILISMVGTVAISSLPILSTMKKKDRIQIEKTVGDSFSIALLILLPSLTGMSLLAGPLYT
LFFGYDPESVGYFQMALLASLFFSLFTILSTMLQSLNHHRFAIRLTVEAIILKVIFQVIG
LGLVGGYGMSLSNGLAFGIVFVRGYHFMCKEYRIAPLAKISNFFLKTFRSTLIMLAVCFA
VFFLLNQRLSMESKSYAMIYCVAVGSIGGLVFLFSQFGKNGFRMLKNVKHHSRSKE
>FECAFAII_01598 hypothetical protein
MTKLYLLLLVACLFIVAYIPRLFPMLYFTHRKVPSWFSDWMKYVPVALFAALAFKDVFIT
HEHLDIAWNIKIAAMILVAGVAYKTRSMALSVLTGLASVFLLSML
>FECAFAII_01599 Inner membrane protein YgaZ
MNKKKSAPWLQALHAVMPLCISYIPVGLACGVLLQKVGFDPLLSGLLSILVFSGGAQFLV
ASMLTTQASFATTLLMVFFLELRYTLLGASLAGFMKKEKRTFLAVFSQSLNDENYAVNYL
KFSTDPSWNKRKALYVNWFSMTAWAGSNMIGNFFGSVIRVDADLVHFALTAMFIFMFIMQ
MKSALLIFTGLFSGVLGVVFMVLFQNTFGLIAATVIASFAGFMLEKAFKKEKAKKLRDRG
KDVNEPLFNFPEQEANHHD
>FECAFAII_01600 Zinc transporter ZitB
MENFKKSGMFSVIAALGANILVAISKFVGYAISGSAAMLNESIHSIVDCSNQILLLFGDK
QANKGQSELHQFGEGRAKYFFSTIVAMMLFFGGGALGVMEAFEKLTHPSHEVGNPIIVIA
ILLFGLVIEGSSLRVAMKEIKELNTEKLSTMRFLRESRHSEILIIFTEDLCAVIGLVLAL
AGTILTYATGIAAFDAISGLLIGFLLMGAAIFLAKEFYSLIIGESVTASDLSKIKLAFER
PEISRLIDIKTVHLSPTEILVAAKADIVGNKENEAYSVINDIEKNMRQSLPDKKMYIYIE
TDKYDPNYSRK
>FECAFAII_01601 hypothetical protein
MKKIIYSLLAMSVSILILTSCSTTYTQSASNQKEEVKTSQKATITLQENGQNFSEKEVVF
KKGDDLLSILKRNFEVKEDNGFITSLEGHSQDEKNQLYWMFTVDGKSATTGAKEIKLNDG
QSVIFNLSKL
>FECAFAII_01602 hypothetical protein
MSTNKIAQLSLLSAACVAGRIAFQFIPNFQPMTAIFLFIVLYLSLKDALIVMSLSIAISS
FYFGVGPWVIGQWISYTVVLSLFSIVCLRKTVQRNLWLKGVCFFLAGMVYGIGMTVFDTL
LYRLPQPWIYYLQGVSFDLMHSIGNVVFFLVFLPVVKRFYNHSGGKNEKNNL
>FECAFAII_01603 hypothetical protein
MNEHDEAEWTKNEEQTEDHEETNTSLEEQTSNPLDDTEEIPMLEETKIHEKEKVTPTNTN
TAENTHAYEITENPGYLEGKEQDHQDIVSLIETAEAELADLRMRKDLIESDFPQLLESYD
RFILNEEPISTIGKTSLIEYFTYELLKPLNDIGLERSNSAYDTWKTRHFSINYTLNGQNE
LVFSFVLPTIDQRYQVESMSLLNVSPETMEINVQDDRVLSLIRHWSVDRVFSAGQITIFN
HKLNQLLAHARTLGFTVNQTLLDNTKPLRLNLQSEFELTNEVLDDIFIVAMKNPSYDMEK
INETTYQVRLDKGQSLTITTNEKDQTVLSISSGDYPRSVIDFFINYEFLVPLMVRKS
>FECAFAII_01604 hypothetical protein
MKEPDTNANYEPDELEETNADQDTGQESSSFYDIKEKASMNLSQLLEDLQAFEKAVREED
IPEIYRLYNGRLNEELKRSSNENHEIDQLLMRKIHDRFLQEFPFMEQVENISPTMSYYKI
GTYYHDRPTVGIDASLPEIFVLPKIDEEWEKYSQPESTDYDKKINELDAKVITAQTEIER
LDEQIKEINRQMTDLNDNKGFLNRKKIEEEIQELEKKKQVLSNEKLGWLPYIETPETIQQ
QKEALKQEARADQLRAAIVEKEQRQIRRYFGSKEGFGQAIHEFLMNYLGNENPNNQSNEG
GSEYE
>FECAFAII_01605 hypothetical protein
MKKRQKKKNAYKHYIRSIFTGYERMLEDPELEQLTFTYLNEETQLTRDEHQRIHFTTRDL
PSK
>FECAFAII_01606 hypothetical protein
MKKIGFDSEKYIEEQSAYILERVNHYDKLYLEFGGKLVDDKHAKRVLPGFEEDAKIKLLQ
KLKDQAEILICVYAGDIERNKIRGDYGITYDMDILRLIDELRGYGLLINSVVITRYSGQP
ATKVFINKLERRNIKVYKHSEIEDYPVNVEKIVSEDGFGKNEYIETTKPIVVVTAPGPGS
GKLATCLNQLYHESQKGHAAGYSKFETFPVWNVPLKHPLNIAYEAATVDLKDVNMIDSFH
FDAYNKVAVNYNRDVETFPVIKRIIEKITGKESVYQSPTDMGVNRVGFGIVDDTVVQEAS
KQEIIRRYFQTECDFKKGLIDEEAVNRIKLIMEEVGLRPEDRNVVVPAHDYADKIQAQSP
TKDPSAVIAIELPDEVIITGRTSSLMDASAAVILNAVKHLAHIADDIPLLSPLVLETIQG
LKSKTLHSSLDALSINEVLIALSISAVTNPIAQVAYDKLAELEGAQAHSTVMVNKNDEQT
LKKLGIDITCAPVYPSENLYYQ
>FECAFAII_01607 Nucleoside permease NupC
MSYLLGIIGLFVTLGLAFLISSNKKAIKLKPLIVMFVLQLVLGFVLLRTTFGTAVVSVLA
KMFDHLLAFAGQGVDFVFAGVANKGSAPFFLSVLMPIVFISAIIGILRYIKILPLFMKAV
GLGLSKINGMGKLESYNGVASAILGQSEVFISIKKELPFLSEKRLFTMSVSAMSTVSMSI
VGSYMALIDSKYVITALVLNLFGGYILASIVNPYVLEEKEDELIIEENKEQTFFQMLGEY
ILDGFHVAITVAAMLIGFVALIAMINAIFHGIFGITFQEILGYIFAPLAFISGIPWKEAV
DAGSIMATKLVTNEFVAMTELANGNFHFTERTTAIISVFLVSFANFSSIGIISGAMKGLN
EEKGNLVAKHGLKILLTATLVSFLSAIVTGLLV
>FECAFAII_01608 Guanylate kinase
MNYCYVFIGPSGSGKTSLAEAIFQPEQKIITYTNRSPRPGEKDQEDYYFVSDNTFNQMIK
GNEFAEWDQYAQHKYGSSKAEIKKKLTVGNCYAVLTANGFWHLYEYFGTVVRPIFITISK
ETLQSRLKKRGDSSEQISARLAVYVEDLAQLKRLKAIPSLLVVSNDGAFQEAADKIKKGL
LI
>FECAFAII_01609 hypothetical protein
MYIRQTRKEEVEEVVEIINAAADFIASQGSPQWQNGQKPTKETILNDIERKESYVLIVED
QIAGTAALVSGVDPVYTKIDGSWKESTGPYLSIHRVALAESTRGKKLAKPFLEHLLTIAA
SKNIQDIRIDTYPANEPMEKTIYSAGFTYQGMIEFPFEHGERKAYQIIIN
>FECAFAII_01610 hypothetical protein
MYYPYLRGKQFDLLALKEALSRGLLSNKIQPVIEPVRDSATLKNVIELFQKKHHPIAVIQ
NPQVGQFKLFDQHVHSWTVKENSSVVPAQILTPENLSEVLDSPPAFLVFDGQHYPKDTEV
WKQLAGVDSKFLIPDTSRFRIWLPENKIVIRDSFQTRKHVESYADKTDDFFSDDYLFFHA
DGYIGFSDFTIEGSRYFDKGFPSRALAIHLTYIDAYGNIRVKHFVSDSNDSAKDQALKFL
EAGDKMKKWIMRHHHQLLITSGMIELLALYQQQKFPGLGVLKKWSLMHHLELISHLLDHP
KDWLKYYSKVQELYEVIQ
>FECAFAII_01611 hypothetical protein
MKTPLTIEIESSLYQYCIEQGGLVVEEVTMPDDQGIVDTLSCLTKFDGSREWRCYELKVT
KADFRSTAKLSFVGHYNYFVLPSKLYEEVKTEIPTGIGVLVYRPYTVEEEMPASGTFLIA
KKAAKKELAVPEEALTNRFMASLFREVRKAKQMERGVKYFPKDQLYKELKRRSENQDPFS
NERYYERFLEEIASQAINELQEEVIALQHDYEYLRQQQQIRRLPTEPLE
>FECAFAII_01612 L-cystine transport system permease protein YecS
MYFPLIDFSLMWTSLPFVLQGLVYTLGIGFVSFLLGNLVGLLLTVLGLLDWLPLNVFIRF
YLSFFRGIPALVLLFLLYFGLPYQLSALTASVICFTITSSAFIGEIYRGSLAGVSSGQWD
AGLASGFSFFGVLKYIVLPQAFRISVPALSNVAMDLVKGTSLAATITVPEIFQKAKIIGG
RTFDYFSLYILVALIYWVICIGIEKVQQYLEKRSIHQSI
>FECAFAII_01613 putative ABC transporter extracellular-binding protein YckB
MKKKRLFALITSAFFILSACGTAAANQEDNSWSNVEKKKELVVATSGTLFPASYYNDQNE
LVGYDVDLAKEVAKRLNVKISFKEYNVDGQITSVSKRESDFAANDFGITKEREKKFSLSE
TFKYSFDSMIVRKKDDSGIHSLEDLKGKKAAGEPNTSYMRLAEKHGAKLVTYDNATNDQY
LSDVANGRTDVILNDYYLQKMAVSALPDIPVKILENVYFNENESGFLLKEGNDALKKKID
GVLKEMKEDGTTKKISEKYFQTDVSVKPKETMAESVSE
>FECAFAII_01614 6-aminohexanoate-cyclic-dimer hydrolase
MNDATELAKELKEKEFSFQELVTDIQKKIKKQNHELNAFVALEPFESNSHELLIPQSEKG
PLAGIPFPLKMLGQEKKGWLATSGSRLFETHRASHTSNYVRQAEAIGLVPFGQTNAPEFG
FKNITDPVIYGPARNPWNLECTPGGSSGGAAAAVSSGIVPLAGASDGGGSIRIPASFCGL
IGLKPSRGTMPVGPYAWRGWQGAAIDFGLTVSMRDTEALFYGMRSIHSGAPYQVSPVEWQ
THPRKKRLKIAFCVDSPIHSQISEEAVLAVKKAVDFLGKEGHDLTEIPYPLDGRKLITSY
YQMNGAETAAMIRSIETGIQRAVRKEELEPISWTLFQYGQKLSAATYIDSLHVWDEAAIV
MENLHQEYDLFLSPTTAFTAPKISEDLQSDAIRAQMEHISDCSEVEGLDVVSSMFEESLK
ITPYTQLANLTGQPAISLPTHLTKENMPLGIQFMAARGREDLLFQIGYLFEANHQFHLPN
PWK
>FECAFAII_01615 Dihydroorotate dehydrogenase A (fumarate)
MSLETTFANHIFANPLMNASGVHCMTTQELDELAHSEAGAFITKSCTINERKGNPEPRYF
DVPLGSINSMGLPNLGFSYYLEYALAYEKVQENQNQPLFFSIAGMSVQENLEMLEKIEKS
GFNGITELNLSCPNVPGKPQLAYDFEATYETLKEVFSIFSKPLGIKLPPYFDFAHFDQMA
DILNQFPLTYVNAINSVGNGLYIDTEQEAVVIKPKEGFGGIGGEYIKPTALANVRAFYTR
LKPEIQIIGTGGIRTGQDAFEHLLCGASMLQIGTELHKEGPEIFSRIIKELTQIMSEKGY
TSIDEFKGKLRTIS
>FECAFAII_01616 hypothetical protein
MKKTVIYTSLFAALFLAACQSNTNQGTSGNTSSSSEQRSSQVSDSSTKASTSSSSQTKSS
SEASTQSDIKVSAARAIELFQDKYPDTAITSLELDSDWGSYFYKIEGVDDQKEYEARIDA
QNEKMETENPETLDRDEQNGQKKKEDGLDVDKLITIEEAAKIAVDKVGSGTATDWDLDKD
LGTTYWEVKVKDGNQSTSVKINSQTGEVLSTEQDD
>FECAFAII_01617 Cyclopropane-fatty-acyl-phospholipid synthase
MLEKTLYNQLFSRSFSLPVEVNYWDGTTKQYGDTDTPPQIKINIHEEIPMKEITSNASLA
LGEAYMDHRIEIEGSIQALINDAYQQANSFLRGKDYLKWLPKKEKHTKQKNKEDIHAHYD
LGNDFYKLWLDPTLTYSCAYFNTPEDTLEQAQINKVHHILDKLFIKEGETLLDIGCGWGT
LMFTATKEYNVKATGITLSEEQYDLITKRIKEEHLEDKCRVLLMDYRELKGETFDHITSV
GMFEHVGSENLEGYFKVVKDLLKPKGTALIHGISRQQGGATNAWINKYIFPGGYVPGVTE
LVDNITKNDLQLIDLESLRRDYQLTLEHWTKNFHQVQDQVTKEMGDSFYRMWDLYLQACA
ASFESSNIDVIQYLLVQPGNNDIPMHRA
>FECAFAII_01618 hypothetical protein
MQTFPLNYFSALRTPTQVFAGRKLLSWPKFFLIFVFLVSLMVMPVTLFYANQIQAIPLEQ
FLSVHSLIDEQGTQKFSELELSETGLQASQQTIAVTPEILVGVSLSEKQQSDHGTFIDFE
KEQWVIQQKDKSGIRRYTMNYSPSFQPDSVRTPEDFQRFLEREFYASNRPTIILSYSLSL
GLVLFVMTSLILFGASFFLWMTRKSQLSSIHTFKESANLMLNVMGIGSMAAAVVGFIHFD
FILMLSVQTTITVLLLLWVFVKTRFKDKRVE
>FECAFAII_01619 Maltose transport system permease protein MalG
MKKFHSSARFQKRLSHFFTYFFLLILSVIIIYPLLITASTAFKSGNIAAFSLDLSSDWTL
GNFTRLFSETLYGTWYKNTLIISVLTMIVQVTVVTLAGYIYSRYRFIGRKSSLMFFLVIQ
MVPTMAALTAFYVMAFLLEALDKYWFLTMIYIGGGIPMNTWLMKGYFDTVPIDLDESAKL
DGAGHFRIFFQIVLPLVKPMLAVQALWAFMGPFGDFMLAKFLLRTPENQTVAVGLQTFIS
DVTNQRVSLFAAGAILIALPICLLFFFLQKNFVTGLTSGGTKG
>FECAFAII_01620 Maltose transport system permease protein MalF
MQQDKTSNINEKKITLCSLIPGMGQFVNGQAFKGIVFFAIFVLFIGQMLLGGFHALVGLV
TLGSIPMEDHSLFILIEGTLQFIITIIFLIFYGLNLLDAYRVAKMRQEGKKINRTMKEVI
HNIGDEGFPYLLTLPAYLLMIFTIIFPVLVTLFTAFTNYDFNHIPPASLIDWVGAKNFFS
IFFLSSYRNTFFAVFSWTVIWTLCATTLQITLGILTAVVAHQKFIKFKRIFGIIFLLPWA
VPAFITIMSFSNIFNDSVGAINTQVIPFINQLPFVDISAISWKTDPNWTKVAIILVQGWL
GFPYIYVMVTGILQSISEDLYEAAKIDGANAWQRFSNITLPAVFLVAAPTFITQYTGNFN
NFSMIYLFNNGGPGSVGGGAGSTDILISWIYKLTTGTSPQYSMASAITLIISVIVICVSL
LVFKKTNAFNMGD
>FECAFAII_01621 Maltodextrin-binding protein MdxE
MKKRSVKQLGLGLISLGILGGLAACGNGNSSAEGEADEGKTLTVSVDSGYKDYINEIKNT
FEKENDVKIKLVEKDMFDQLESLALDGPAGKGPDVMMAAYDRIGALGQQGHLAEVKLGNE
AAYDETDKAQVTYDGKIYGEPAVIETLVLYYNKDLVDTAPSTFKDLENLSKDSRFAFESE
AGKNTGFLAKWTDFYYSYGLIAGYGGYVFGDDGTNPSDIGLNNAGAVEGISYATDWFKNV
WPKGMQDIKSAGDFASQQFMSNKTAAIIDGPWQAQTYKENNINYGVAKIPTLNNGQPYQP
FGGGKGWVVSNYAKNKDLSQKWLDYVTNQENQEKFFEMVNEIPANQQARETAKAKNDELT
TAVIEQYETAQAMPNIPEMGEVWTGAENLMFDAASGSKTPKESADEAVKTISEAIEQKY
>FECAFAII_01622 Intracellular maltogenic amylase
MDTAAIYHRPESEYAFLYTNTRFRIRLRTRKNDIKKVYVLCGDPYTITTEKWYQKQRPMK
KCLSTNVHDYWEIEVTSETRRLQYAFHVVGEDNTDCFYGDQGIFPYRENVITEPNFYFRI
PYFHQIDRFTIPEWVKETVWYQIFPERFANGDKANDPEHTLPWGSKDPDREDFFGGDLQG
VRDHLDYLTDLGVNGIYFCPIFKATSNHKYDTIDYYEVDPAFGDKKLLKNLIDEAHKRGI
RIMFDAVFNHMGVHSPQWQDVLKNGEKSIYKDWFHIRFFPVDSYQMTDLPETAENIPYDT
FAFTPFMPKLNTANPEVQKYLLDIATYWIKEFDIDGWRLDVANEVDHHFWKKFREAVTEI
KPDIYILGEIWHSSQAWLQGDEFHAVMNYAFTDSIKDYFAKKKITASQMVSGMNHQQMLY
RDQVNEGTFNLLDSHDTARILTLCQGNKELMKSVMAFMFLQKGSPCIYYGTEIGMTGEDD
PDCRKCMIWEKEEQDLELFGFIKELVSLRKQLSKIISEGSTQWLIVYDREDKLYFTRELE
GQIIYVYFNQSKEPWVVEQENEVILSQNCQLLEDGKAEIRQYGFLIMC
>FECAFAII_01623 hypothetical protein
MFLGPHHIAAGGVSGLGILLEAALGFDRAIVILVLNIVMLVLALLFLGKKPFFKVLFGSL
FFPLIIAIVPETMITSDRLLSVIFGSAIFALGVAILYKNNSSSGGTTIPPLIFKKYFHLN
TSIGLFFTDAFVVSLNLFVFGIEEFLYAILSIAITSIVMTYIETGINRKKSVMVMSEHYL
EDIRLRLSAEIGRGLTLLEAKGGYNRKSKEVLLIVVTDHEFSRMKPLIEEIDPSAFVIVS
SVAEVMGRGFTYHPIE
>FECAFAII_01624 hypothetical protein
MHKGTEIDFVLNDSLKALELYQTIFDEIQLIEATDYPRGNNEVIFTLYGTRFHMLDENTS
LGLTAPTAEHPNTIWFNIIVSDIEDTHNKALRNGCVEIQEMTEMMDFGVTNSMFRDPFGY
LWMLHQVHREVSFEERKQLFEKYM
>FECAFAII_01625 Organic hydroperoxide resistance protein OhrA
MKKMYSTKMINTGGRSGEVHNPDRTFELNIAAPGKRVENATNPEQLFAAGFSACFNSALE
LIKQQKNISGASTVSAQVSLYSESETSFVLGVEIEGSIEGLSLEETQELLEAAHKVCPYS
KATAGNIEVTLKAVSE
>FECAFAII_01626 Organic hydroperoxide resistance transcriptional regulator
MEDLYLVNQVCFPLYAASKEIIRHYTSLLKPLNLTYTQYLVMLVLWEKKKTSVKELGNDL
CLDSGTLTPLLKKLAEKNYINRQRETGDERIVNVTLTPQGAALQKQAEGIPQKIKSYLPL
EQEELDTLQHLTRKMLDNFHQDQKKG
>FECAFAII_01627 hypothetical protein
MTVYQRFLANEKIRRLTVLLFVVFVLFLVRSMITTILLTFIFTYLMIHLVQIIQRFVRIP
TGVLAIMIYTLIVYLIYLAFTKYIPMLIHQTFDMIQSVIDFYEHQPKDADPVLQYIHTYI
ERNDFFEQLQNGASIALGYLQDIGKMAVAFAMSFILSFFFMIEKKKTIVFSRLFLKSEFS
WFFQDIYYFADKFVNTFGLVLEAQFVIALLNTLLTTIALAVFGFHQLLSLAIMIFILSLI
PVAGVIISCIPLSFIAYSQGGIRDVVYILITILIVHLIESYVLNPKLMSSKTELPIFYTF
VVLLVSERFFGVWGLIVGIPIFTFFLDVLKVKKIPNHLPKETDIP
>FECAFAII_01628 hypothetical protein
MRYSTILISTFAALSLSLTINQTVHTEEIETAKWTETKWANVNRITFQDEFSSFNSGVAK
LRKGQTATIKAKIDYSGDLAPILQSAVTFENVDPALSIGYDENTLTIQHKQAIFTFTVTL
NQDLLKPALFTVKVSDGLPNDHHHLTPYSQRQTIEQDSAIDSGGDLVEEPTDKPENENKP
EVPPTENPDGEQKPEIEPGEEPDTETQPEPDNESKPEITPGEKPDVDPEEKPDVTPEPDT
DSGNQTVPETNPDTDNETENPEKPEVAPEEKPDVTPEPDTDSGNQTVPETNPDTDNETEN
PEKLEVDPEEKPDVTPEPDTDARDQGIPEKINKKTIQEDGKKESKKSNLAILKINEEQLN
KKSRIFDSAQSAETLKSSKDTTFASPETKNKQLPKSGESQNKVILWSGIILLSIATMLSA
KRFKQNRSL
>FECAFAII_01629 hypothetical protein
MQTQEAIKTFLLKKKSNTKLDIFLFLSEHRFFITTQYLADHFHMSESNFLLYIKELEQDF
ERLNLTELHIDKQKPFLKLNFEGIDPAYCYYRLFGRYCNESVSYQILTSLFSCQTNSIIS
LSQQTNYSASYLYTKMKKINAFLALYGLSISFSNNGRKSFSGKEVQIQYAALDIYWNIFS
STATEFYDEDPQVVAFMMNTFFKKEVLDRLNSGMIDKLYFLLKICKENFPATSVKDVQKE
FTEYEYIDFFIDPSVDILRPNLPICREQRILVNILARLSITKIESEETSLEQYKLLKKAN
VPHVLYSREMVESFCTVFDLFIPEKEKILYSLAFARNKLYNGFLNFNQPNTPLPTFMLYQ
EHSVLKEVQTAIEQFYMDFREQNQHLLPVILEKENVQWMVEDLVHLYDRYKKQPRIVIGV
NYTRDFYISKDLIVKIEQIFSNESIKIQNDFMENCNIVISDCPLKQLPSHIKKIYILKGI
ITPEDWKKVIMRISEYIFELKEEALMDQSKKENQVTS
>FECAFAII_01630 Mannonate dehydratase
MEMTFRWYGSQEEKITLDEIRQIPAVKGIVGTLMDIPVGEVWPRERIKELKEEIESRGLT
LKVIESVNVHDAIKIGLPSREQYIENYKQTIRNLAEYGIEVICYNFMPVFDWVKSDLDYR
LEDGSSTLAFISDDIPDDPREIVARIEHSSNEFELPGWEPERLAHIKSLLEAYASVDEEK
LRENFAYFLQSIIPTCEEVGVKMAVHPDDPPYSIFGLPRIVKNREDLDWLCRIVDSPYNG
ITLCTGSIAEDPENDVYGILAEFCQRDRIPFAHVRNIKFLANRDFYEAPHKSEYGSLDMY
RILKTMYDNGFNGYIRPDHGRMIWNETGRPGYGLYDRALGAVYLNGLWEAIEKGNKSKDN
>FECAFAII_01631 Polyol:NADP oxidoreductase
MIDLNNWRNFIPELSQKEVEIPHFDRASLRENGQKNPVWIHFGGGNLYRGFHAEIAQRLA
DLGELSTGVIVCETFDEEIIERAYQDFDDLILEVVMPSSGEFVKRILAATADSLYCHPDC
SEHFDKMIRHFENPSLQLVTFAITEKGYRLKDTNNKYIGPIAVDIKNGPKKPSHTMSILA
ALLYKRFLSGAWPIALVSTDNFSQNGSQLRTSLLTIAKEWQKEGYVQNTFIQYLSNEEIV
AFPWTMIDRITPNPSLSVSKMLAKEGFSNMSIFQTAKGNNIAPFVNTEDIHYLIMEDHFP
NGRPKFEKAGVFLTDRATVDKADTMKVTTCLNPLHTSLAIMGCLLGYRSIAEEMKDPDLS
LLVSEIGYNEGLPVVESPGIIDPKIFLEEVITVRFSNPNIPDMPQRIATDTSQKVAIRYG
ETIKKYMEIEVKDPQTLVFIPLTLAAWLRYLIGIDDQGKPFIPSPDPLLTDFQHKLSDIQ
LGTQDTSHIHEKMAPILSNKEIFGVDLYQAELGRKIEEMFIKMVAGPNAVRKTLQDYLQE
HGGNLSWK
>FECAFAII_01632 HTH-type transcriptional repressor RspR
MKSSLQSQAYQAIRKQIIYADLEPGRKISEKALEEHLAIGRTPIREALIQLRQQELVYTI
PQSGTYVSKINLVSAENARFVREQLEEQIMIECCSKLDTQTRIVLETILEEQEKAVKIND
ERAFFRADNLFHEACFEIAGRKEVWNWLDDHNTHLERFRWLRVTIQGLPWETIMEQHYDL
LKALVDKKPEEARFQTGLHLHMMLKEQETVTQRYPEYFQQ
>FECAFAII_01633 Alkyl hydroperoxide reductase subunit C
MSLIGKKIEEFNAHAYHQGEFLEVSEKDLMGNWSILCFYPADFTFVCPTELEDLQEQYST
LKSLGVEVFSCSTDTHFTHKAWHDTSDAIGKIEYVMIGDPSHQISRIFDVLDEEQGLAQR
GTFIIDPDGIVQAMEINADGIGRDASALIDKIRAAQYVRTHPGEVCPAKWKESGETLKPS
FDLVGKI
>FECAFAII_01634 NADH dehydrogenase
MLDKETKQNLEQYLALIESPIVFSVSLDNSENSQKLAEFTKEIAEMSPKISWEKRDSMRT
PSFSINPVGKESGIVFAGIPLGHEFSSFLLAMLQISGRAPKISESLSLKIKKITQTLHFD
SYVSLTCHNCPDVVQALNILAVLNPNITHTMIEGGMFQKEIDDKKIMAVPTVFLNGEEFS
SGRMTIEQIVEKITGPLIEEELFEKEPYDVLVIGGGPAASSAAIYAARKGIRTGLVADSF
GGQVVETLGIENMIGTSYTEGPKLMQQVESHVRSYPIDIMMNQQAVSLNKEQHFINIGLA
NGISLKAKTAIIATGAHWRSINVPGEKEFKNKGIAYCPHCDGPLFKGKEIAVIGGGNSGV
EAAIDLAGLAKHVYVLEFLPELKADQILQDKLVSLANVTVIKHAATKEISGTNQVESLSY
IDRRTMEMHTLAVSGVFILVGLLPNTDWLDGTIEMNPRNEIVTEKNGATNIPGVFAAGDC
TDSPYKQIIVSMGSGATAALGAFDYLMRT
>FECAFAII_01635 hypothetical protein
MAQNRIFTTSFASVYPMYVAKAERKDRIKEEVDEIICWLTGYSQTELEYQLQKQVTFEQF
FAEAPVPNPSRSLITGVVCGVRVEDIEDNLMKEIRYLDKMIDELAKGKKMEKILRS
>FECAFAII_01636 hypothetical protein
MFETIKQNIQKYALLRAAVYIISGIAIVLNPSAVFHFIGYLITAYLVLLGLLNLFEAYRF
KRKTGSWSIGLFSGLFFLILALIVYAFAPAIVSILPILLGLAVIINSLFQLFFSMNTKAK
SWSVYSSILLLIGGFVLLFNPFKSLMLLFQIFGFILIFMGIQEIINFIRIRKMTIR
>FECAFAII_01637 Na(+)/H(+) antiporter
MEFIGILCLILISTTIGSHISRRLGIPAVIGQLLVGVLLGQAGLNWVKPDILVHDFSEIG
VILLMFLAGLESDLSLLKKYFRPGMFVALLGIIFPVVFGWLTGKAFQVSGNEAIFFGIIL
AATSVSISVEVLKELNVVNTKEGSTILGASVVDDILVVLVLSFSLSFLTGEASSNASLPL
VLIEQLIYFVFIFLLVKWIAPFLLSFAEKVYANSSIIIVSLVICLGMSYVADLVGLSSVI
GAFFAGIAVSQTKVKEEVYHNVEALGYAVFIPVFFVSVGLEVDFSDFSEQLLFISILTLV
AILTKLLGGYFGAQIAGFSQHSSLMVGAGMISRGEMALIILQIGQQSQLIEPQYYSPLVI
VILLSTLISPLVLKYFTKKVYEV
>FECAFAII_01638 Beta-lactam-inducible penicillin-binding protein
MKRSDKHGKNRTGAYIAGAVILIAAAGGGYFYYQHYQETQAVEAGEKTVEQFVQALNKGD
YNKAAEMTSKKAANKSALSEKEILDKYQNIYGAADVKGLQISNLKVDKKDDSTYSFSYKA
KMNTSLGELKDLSYKGTLDRNDGQTTINWQPNLVFPEMEGNDKVSLTTQEAARGNIIDRN
GEPLATTGKLKQLGVVPSKLGDGGEKTANIKAIASSFDLTEDAINQAISQSWVQPDYFVP
LKIIDGATPELPAGATIQEVDGRYYPLGEAAAQLIGYVGDITAEDIDKNPELSSNGKIGR
SGLEMAFDKDLRGTTGGKLSITDADGVEKKVLIEHEVQNGKDIKLTIDAKAQKTAFDSLG
GKAGSTVATTPKTGDLLALASSPSYDPNKMTNGISQEDYKAYEENPEQPFISRFATGYAP
GSTFKMITAAIGLDNGTIDPNEVLTINGLKWQKDSSWGSYQVTRVSSDVSQVDLKTALIY
SDNIYAAQETLKMGEKKIRTGLDKFIFGEDLDLPISMNPAQISNEDSFNSDILLADTGYG
QGELLINPIQQAAMYSVFANNGTLVYPKLIADKETKDKKNVIGETAVQTIVPDLREVVQD
VNGTAHSLSALGIPLAAKTGTAEIKEKQDVKGQENSFLFAFNPDNQGYMMVSMLENKEDD
DSATKRASELLQYLNQNYQ
>FECAFAII_01639 Regulatory protein MsrR
MKVSQKIILSILLLLTLVVGYFSIEFIHGFSSAKQSSTVKKVEPKSVPTTLNVALIGSDA
RSKDENGRSDSLLVAQYNQKTQQAKLISIMRDSYVDIPGYGMNKINAAYSYGGVDLLNQT
LKENFKFEAPYYASITFQDFIDCVNELFPGGVKIDAEKSLDLDGVYINKGEQVMDGNTLL
QYARFREDKEGDFGRIRRQQQVIKAISQQLKDVTSIFKLPKAVGKLLGSIQTNLPESVLL
DCGMDFLKDIC
>FECAFAII_01640 putative peptidoglycan glycosyltransferase FtsW
MKKRKKIDWWILGPYLTLSMIGLLEVYSASSYRLLQADENTKSLLLRQLIFIFLSWSVIF
LARSVKLHYLLHPKIAGYGLALSIFFLVLVRIGIFGVTVNGAQRWISLFGIQFQPSELAN
LFLIFYLSWFFRDGNSSPKDLKKPFLITVGITFLILFQPKIAGALMILSIAWVIFWAAAV
PFKKGIYLIVTFSALLIGAAGGVLYLGNKGWLPQMFNHAYERIATLRDSFIDSHGAGYQM
THSFYALYNGGIFGRGLGNSITKKGYLPETETDFIFSIITEELGLIGALCVLFLLFSLCM
RIFCLSSRCKNQQAGLFLLGFGTLLFVQTIMNVGSIAGLMPMTGVPLPFVSYGGTSYLIL
SLGIGITLNISSKIQAEELPLYRPEKQ
>FECAFAII_01641 hypothetical protein
MLKISYKPSTDSKEMKKEYETVNDFLQGQYLEVPPLQDHFVVTTVTLDGKEIEMPDQTIS
GLFNYFNK
>FECAFAII_01642 hypothetical protein
MFERSPSELTERENYKLLIGSVIPRPVAVVTTKSAKDIVNIAPFSYFNIVSSNRPILSLA
IQRKQDAVKDTAKNILETREAVIHILDEDNVEEVNKTAANLPNEESELYLTDLTLTDSVI
ISVPALTEAKVRFETSLYEHVEIRNKNKVTADLFLLEVQKYHLNETVYDDKTGRIDPRKL
NAVSRLAGNDYAAIGEIFTIARPE
>FECAFAII_01643 Putative N-acetylmannosamine-6-phosphate 2-epimerase
MDTLEQIKGGVVVSCQALENEPLHSSFIMGRMALAAKEGGAVGIRANTTEYINEIKRIVD
LPVIGIIKRDYDGSEVFITATEKEVEELLETQAEIIALDATSRKRPTEKTTAELVQMIHE
HGRLAMADISTFEEALQAQEDGFDLLSTTLAGYTEYSRKTQTPDFDLLNQIIEQVDIPVI
MEGHTDSPEQVEKAYELGAFSVVVGSIITRPQLITKRYVEAASKANN
>FECAFAII_01644 hypothetical protein
MADELSELVVKKIKTGTSSGYDLYKQENEPLPKVGQLDVVLNGKNEPVCIIKNINVTILP
FSEVTKEHAWKEGEGDRTLAYWRKVHAEFFKHAYKEALNIEFTEEKLVVYEEFEVIFF
>FECAFAII_01645 1-deoxy-D-xylulose-5-phosphate synthase
MSTVLHVLDAINSPADVKKLSVEEMKQLAEEMRQKILQKDSDVGGHVGPNLGVVELTIAF
HYVFDSPKDKIVWDVSHQSYGHKLLTGRKNGFEKGHYREVSGYSNQHESKHDYFTVGHTS
TSISLATGLAKARDLKKESGNVVAFIGDGSLSGGLAFEGLNNGGVLQSNLIVLVNDNEMS
IDENHGSLYKNLAELRQTNGKSSNNLFKAMGFDYRYVDNGNDLETVIRLFEEVKDIDHPI
VLHVHTEKGRGYQPAIDNKMKYHWHVPFDLSTGEAKQVTSGETFNMIIMDYLDKKMQTST
APIAAVNAAIPGAFGLKTFQEKHPDHYFDVGIAEQHSITFASALASQGVRPVVFQSSTFL
QRAYDQLSHDLAINENPVIILVGGGTISASDRTHQGTFDIPYLSSIPNIKYLAPATKEDM
ISMLDWAFEQTAQPVAIRIPTHGVEHGTAIANDYSIPAYQTVNNGGKVAILALGGFLELG
KETVKAFRKKGIEATLINPGTITENDVETLDKLKETHELVITLEDGSLSGGFGENISRYY
GDSSMNVLNFGAEKEFTDSVPVGQLYERYHLTPKQIVEDSLRVLNIQ
>FECAFAII_01646 hypothetical protein
MLENYIERNIFRKVYLCEQLFEFQEIDIEQTAISLRVTTPTILHDLESLAECLEYCIKEQ
VREKHKYKLVFKHGIALSELTQFLYGQSYFLKFLSYYFNGIFTSTELADLEFISLSKVYT
IKKIVLDFFKENDYLKNKEIIIPEFDSRNILLALVRYVNWEGYENKNPYVEEACNELIDY
VETHFFKRRYSEDEKSFIIRGIEIAIGRKAFPLGLKEEDKKSAETKPLFQLVCQGLEEQK
GILDLQEEDVYYIFSLFNSRNYTNENMELLRKDFEVVYKNFVLNDLSLNELILQIISIAE
IDDAENFIFKQSFLQFVRTLWADGQVFLPERIYLLSEKEQLLYGKIVEILEEWKKKNQIQ
LRWNENFIRKFVKSLSLINSEQAGRQEIEIFVVSESSVKQFFYRTQFHLYAEEGIAEINP
ILFRSLEELPDECLCAKKRVVLCDAASYQNGLETEKTKIYPISLKGANIHLYHIAQELHL
LKKHIS
>FECAFAII_01647 Glutaminase
MEVKELEQLIGKNFHYYQTGQVADYIPALAEVDPKQLGMAIYDLDTKQLIEGGDADVRFA
IESMSKVPVLLLAIKDNGIEKVFQTINTEPTGFAFNSIMNMEINHRKHPMNPFVNAGAIA
TTSLIAGKDADEKFERILSFMKEICDDPNITLNEEIYHSESRTGDINRSLAYYMKGNQMI
EGDVPEILDAYFRQCSLNVTATGIAKLAAVLANKGIAPWNGKQIITEESATIVKSIMTTA
GLYDESGEFSVHVGVPAKSGVGGGLMAAVPNRYGIGVFSPALDPFGNSAAGIQLLKDVVK
ELDADIFE
>FECAFAII_01648 Glutamate/gamma-aminobutyrate antiporter
MQQSKTKIPAKKLTFFGFLAMTISMVVSLYEYPTFATSGFSLVFFLLLGGLLWFIPVALC
AAEMATVKGWEKGGVYTWVSRTLGKRFGFAAIFFQWFEITVGYLTMLYFLTGALSYATGI
GAIQNNKYLKLAILLIIFWAILLSQLKGTKYTSLIARIGFVAGILLPALVLFGLGIHYVA
SGAPLQTILSMKTLIPDFSKLPTLVVFVSFILAYMGVETSASHANEMENPKKDYPLAMFV
LVILAIILDTFGGLTVATTVPQHGLSLNTGVIQSLEFLLRHIDPNLAWIAKILAILVCLG
VIGEIASWVTSPSKALHVAAEEGLLPEYFAKENTHGVPAHLMIANGIVATIWAAVFTLSG
GGNNLSFLAAMSLTVVIYLMLYFMFFAGYLKLVFKDDSLERAYQVPGGKVVKVIVACLGL
LTSLFAFCISFVPPASIAAGQHGIYETILIVSYLIVLVIPFTIYACRHKFQHAEK
>FECAFAII_01649 Ammonia channel
MNTLPINTGDTAFMILCTAMVCLMTPGLAFFYGGLARKNNILTIMSQSFLSVGITTIMWV
FGGFGLAFGRDIGGVIGNPADFFLMRHVTSFPNMFHGATIPFLMFFLYQLMFIVITVPLM
TGAFAGRLNLKGYIILVIFWNLLIYFPVCHWIWGGGFLDQMGFRDFAGGAVIHTTAGFGS
LACILTLGQRKIPLGERSQHSSLMAAAIGTGLLWFGWFGFNSGGALRADEQAVNAFGSTF
IALAFAMITWLIIAKVKGNGFDFVDVLTGSVAGLAAITPCAGYVEAKSAMLIGIIAGIVC
HAAVDFRKKKQWDDALDVWGVHGMGGFTGTILIGIFASNSHLLTNPSSWYFLGIQVIGVI
ITAVYAYVLTTVILKSAMHFTTITTTKEEQEEGLDFFFFGNKLN
>FECAFAII_01650 hypothetical protein
MNDSIKKMLRITEKDLMITEVSYETLQKKKTLVVDAVLSPTPRACRSCGSTVVDGNGKAI
IVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKSCQVSLTTVIRTLKEFKSYLPKQSKKILPRVLMVDEFRSHASIED
KMSFICADGETGKLIDVLPTRKLPRLTSYFLGCTNPEEVEFLVTDMNAAYFQLTKRVLPN
AKVVIDRFHIVKHMNQAFNELRIREMNELRKAGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLEFSPPLKEAYPFFHELVEAFRDKDPDLFFSLLAELP
ETLDDSFREKLQNLLTYEEGITNAMIYPYSNGKIEAKNTHIKTMKRVSYGFKSFENMRIR
IFLINQLINVR
>FECAFAII_01651 hypothetical protein
MGFIWALIVGGIIGAIAGAITNKGSSMGIIANIIAGLVGSAIGQALLGTWGPTIAGMAII
PSLIGAIILVLVVSFFARKL
>FECAFAII_01652 Stress response regulator gls24 
MENKNMNTTNGSVLANEKGENRMMNGELTYEDKVIQKIIGYALKDVDGLLTLDGGFFSNM
AEKLVNTDNVTAGINTEVGKKQVAVDLDVIVEYGKDIEDIYNQIKELISTEVNNMTHLDV
IEVNVNVADIKTQEEYQKDQETVQDKVTEAAKSTGQFASRQTDKAKSAVGKGAQKVKENN
EPRVQ
>FECAFAII_01653 hypothetical protein
MKELFSAYKLPIIFGGLGLLLAVLWLTIGFFKTLLIIIMTAIGAGIGFYLKQSGIVDQFF
KS
>FECAFAII_01654 hypothetical protein
MNKGLKIIGVIMSLLLLSVFLAIALINAPYIMPEQLERFRFFTLTNYYMQQYIFWAAVVF
AVLAIIILLVVLFYPKSRGTFVMKREDGKLTIDKKAIEGLVRSHLHEEEFIHSPKVRIRS
TKNRIHIHVNGDLKRTSSLVGKTGVLMQDIEEEVTKVLGTKETVKVAVTYSGYEEQEDTR
DYKHSRVE
>FECAFAII_01655 hypothetical protein
MMKRLYYSLIITIGYLIVSNLGNMVFGISKEFSWTTTLWESLFFFIFVFLLQNYRKK
>FECAFAII_01656 hypothetical protein
MKFKTLLLKFVVLGISAVFILFGVLFYTQIATSEKGFNFDWQTTLFVSVIYFALLLGIVI
AYFLLKLLKKIEDNQAFSTQSLNILKKIERTILFIGFAFFGLLPKFMKVADLDDAPGLML
VGIAVVFIPFAVYTLTSVLEKLLEHAILLKTDHDLTV
>FECAFAII_01657 hypothetical protein
MAIIVNLDVVLAQKKMSVTELSEKVGITMANISILKNGKAKAIRFSTLEKICQVLECQPG
DLLTYKNDSNTIPEE
>FECAFAII_01658 hypothetical protein
MPFIVYFFLSLLVIYIPLPTFFLLVNRLAEQHDTIAALTKLCLLLFVCLDYFTSYYWLKQ
TRVKKRYYFFLVFFNLFEFLIHCFLLHQYHTIHLWIIWVFKVVVLFCMFTFPISRKFREA
LFY
>FECAFAII_01659 hypothetical protein
MGFIWSLIVGGIIGAIAGAITNKGSSMGIIANVVAGLVGSALGQALLGSWGPSIAGMAIV
PSLIGAIILVLIVSFFARKL
>FECAFAII_01660 Stress response regulator gls24 
MNNNNKNNNNKMNNQKPVSAHPDPTTPNQSNGVNDEKNKTAPVSAHPDPVVPNVQQGVEE
KKHDAEKHAPHHPGTPESKVPEQHDAIDPSKPVEEQKHPSDHAKAQEKLSSDHTNGQGKL
GSDHTNNQGKHDSEQEDSMRGELNYEDKVVQKIIGIAIEQVDGLLSANGGFFSNVAGKLV
NTDNVTAGIETEVGKKQVAVDMDVIVEYGKDIEKIFEEMQEVIGKEVKNMTHLEVIEVNA
NVVDIKTKEEFEKDQETVQDKVTDAAKKTGEFASNQTDKVKSAAGSGAQKVKENTEPRVQ
>FECAFAII_01661 hypothetical protein
MKELFSTYKLPIIFGVLGLILAVLWITVGFFKTLLILIMAAIGVAIGFYLKQTKILDHYF
KS
>FECAFAII_01662 hypothetical protein
MNKGVKTIGVIGTLLLLSVLLFAILLSATYPLPFQLEKFRFFSITNSYVQQYVFWLAVAF
AILTIITLLVFLFYPKTIGNFLLKHGDGELTLDKKAIEGMVRSHLHEDEFIHSPKVNVKA
TKNKIAVNVKGELKRTSALIGKTGTLMKEIENEVQHILGTKEPVKVSVKYTGFEEPAKRS
NDRKRVE
>FECAFAII_01663 putative oxidoreductase YghA
MTEPKLIDPRNLYHTEKFPKQDQDTPALQQNMIPVPDCGEESYEGNNQLENRRVLITGGD
SGIGRAAAIAFAREGADIALQFFPGEEKDAEEVAKYVKDAGRKIVLLPFDLRDEQAPKEI
IDKAVSELGGLDTMVLNAGQQISCQSIAELPLEQVKDTFMINIIAMFALVKEAVPHIPAG
GAIVTTTSVQAFNPSEHLLDYAATKASIANFTIGLAKQLAPKGIRVNGVAPGPIWTPLQL
DEGQPSDSIPEFGQQSLLERAGQPGELAPVYVFLASNKASYVTAQIYGVTGGEAINL
>FECAFAII_01664 Cobalt/magnesium transport protein CorA
MRYYFVDEEKNVIETDEKKYNWLVLDSAKPEEIEQAIEEFELPDDIFVGTEYPEEVSRME
RLYETKLEHPFSLVVINLDQSDNRIEKKLTPISFVLSDNLLITCIDRKTEFVDRLLTKHG
NHLNSFEKIITYTLLDIYTHYVKELREMKKRIDALDKAARKTTENEELYKQADLERDIVY
IDHTLRDQRETMDQLWNSETFIKRLDDEQLLYDVHLRQRQTEKMIEIYRDLLESIGDLFN
GMMDNNLNHIMKYLDSAALIISVPALFAGIWGMNTGGLPGKSSALGFILVVFGSLIAAVV
LGYHLYRKDYTN
>FECAFAII_01665 hypothetical protein
MEITMSKNAVETLIEKVGENTKIALALINDSDPFLRDKGAFAKGSFFQIIPFVSEFGEYA
TKIEHPLLDIYTSKLEQNYFGKRLNMDFNKQLDSFSLENEIAVLDYNIKLKNCFFS
>FECAFAII_01666 General stress protein A
MNKKEIAVVASCNTKFVPHLAALFVSVLDNCNPSKFVRFYVIDDDIDFESKQLLRFSVKN
ARMNSDVEFLKINKEFFTNVVISDRIPETAYYRIAIPELFRGTEVERILYMDCDMIALQD
ISKLWRLDFGDSIVAAVEDAGFHQRLEKMKISAKSMRYFNSGLMLINVKKWLDENITQKV
LDFIEHNPEKLRFHDQDALNAILHDRWLPLHPRWNAQGYIMAKAKKHPTAAGEREYEETR
NNPYIIHFSGHVKPWSKDFEGPTKKYYEKYAGMTAFRCVAKFPKYPKYAKVQPKTDVVVK
>FECAFAII_01667 General stress protein A
MEKRYGVVPVVTASDENYAPYLSVMIATALENCNKTRRIKFYVIDDGLSEYSKEGLEETV
NKYSSNASIQFLTVEKDIYEDFLVSDHITTTAYLRISLPNLLAKEDYKKVLYLDSDVLVL
DDIVKLYDEPLNGKTIGAIIDPGQVKALERLGIDSDDLYFNSGVMVIDIDQWNKKEITEK
TIHYLSENGDRIIYHDQDALNAVLYEDWEQLHPKWNMQTSLIFERHPAPNEKYERQYKEG
NEKPSIVHFTGHDKPWNTLKDHPYTNLYLKKLAHSTLTKVGEINE
>FECAFAII_01668 Sugar phosphatase YidA
MKLAAIDLDGTLLDRNGKIPEENIQALRKFDENGGIVTVATGRNSISAKDIFSELGIGGY
LISSNGSLIAEMKDGKMAKVLRRSKIDSDTLRKAFFYAQEAKISIIASRETQDDQLTFDE
SNLVKDDPYYEHFNLQNHSFDQILNMLEDPSLSYLKLALTDKSEEKLQKLQRDLQADGIQ
SVFSDPHFLEITPTGITKAHSLVFLADYLGIESSDIMAFGDQENDIAMLNYSGLSIAMGN
AQRQVKEIANQVTLTNEEAGVAYILKNFY
>FECAFAII_01669 hypothetical protein
MLVIIDMQNHILDPNSEFYIPESDQLAERIAQRLAKARQNNEYILFTRDIPVELKDKEEE
REDLQLIPLLSPQENERVIKKYYFTIPPETLAEIQETLFESKEEQKEIEVVGIETNLCVL
SNLIGLQSAFPEADFFVDPMLVSSRKHGESALELLKDFNVSIVES
>FECAFAII_01671 hypothetical protein
MPFIAILFDLVAAAAYFLQLNYQTSGILFIGMIFQGVITLLLLVMMLSYKGKRYARIQTK
VFVKYVSIRYGIIILSFLVNAIVLFLYVLNYLDINPLIFSR
>FECAFAII_01672 hypothetical protein
MITLVRVLFWVPAVALVASIVYLMNWNKERFYLAILTLPAIYFMWKVFNYNYFEPDSVFI
EELSGLVLSLLIVILYLIRLNKKH
>FECAFAII_01673 hypothetical protein
MSIEEAILLDTLRCRLNFLRTGRSLSQVAVSSALSIPLFKYRKYEEGEEIPSIIELIYIA
DFYDISVDYLIGRSETASKLK
>FECAFAII_01674 hypothetical protein
MRLWHEKLISKLPRQQLLGQHRECCALRGNGWGKKHATVDYVFHYSPYRLFQYHQLVMDE
MEKRGYSPAPEWKNPMYRGKSCEAFFDLPTVERNVPIYPEHDEVYLAECLANLEQKGIYL
T
>FECAFAII_01675 hypothetical protein
MSREVGDEPKLEYAFSFAREDEDNPKTYDILA
>FECAFAII_01676 Cold shock protein 2
MNNGTVKWFNADKGFGFITGEDGNDVFAHFSAIQGDGFKTLEEGQAVSYDVEDGQRGPQA
TNIVKA
>FECAFAII_01677 hypothetical protein
MTFYNKDIQYRVTLDTDLNLFVVFDKENTNHVATGVTIEQAVQELKKSA
>FECAFAII_01678 Phosphorylated carbohydrates phosphatase
MNKIKLFIFDMDGLLLETGRLAYRAYVKSAQKYDYEMRKEVYYLLTGQTEMAIREQMGIL
YGEDVPYIKWREAINQYKEKIVKEDKRVYTKKGAEEILSFAKERGIHTIVASSNTRVKVE
MYLKMENLYALFDQIISGDDVKKGKPEPEIFLKACSKMNIPPSEALVFEDSIAGIEAARR
AGILSFLIKDHLIGLPDHNGKHKLKVDVSLYESNKADYEFYDLHQAKRFLESKGLYL
>FECAFAII_01679 Mannonate dehydratase
MKWGFRWYGEKGDSIPLKYVRQIPGINGIIGTLLTKMPGDVWEISEIEELKASVESQGLE
LLGIESVAIHDAIKAGTDERDYYIDNYIRTIKNLSRCGVRLICYSFKPIFGWAKTDLFNE
NNDGSYSLLYDQKIVDQMEPGEMYQLIHSQSKGFKLPGWEEERLKKFAQLEKLYEGMTEE
ELFENLTYFLEKVIPVCEKADVKMAIHPDDPPWELFGFPRVTKNLGDLKKILNAVDSPYN
GLTLCTGSLGANPENDLVEIIHEVGSRIHFVHFRNVEFLGERKFKETAHPSTEGSLDMYH
IMKALVQEGFDGPIRPDHGRTVWGEVAMPGYGLYDRAMGLTYMQGLYEAISKEKPLGEHY
E
>FECAFAII_01680 PTS system mannose-specific EIIAB component
MLEIMIVTHGKLSEGLKDAAEVIVGTSSHIETMCLESGEDIQTFGEKVKEKLTMINTAEP
MLVFVDLISASPYNQALLAVNELTEEKKAATYVIGGVNLPMLLEAINHQMLHTPIEEAVE
QIVKQGKDNLTVWHASAEEKKLDEDDF
>FECAFAII_01681 hypothetical protein
MGKAARGWPSRQTFIRNTSSILTMLEMIRTIDDPSVAYAFVDEGCYGEKGLDSVRSGMKK
EAILFYLDSVGADTPLQFSGNYFSNKEQWLKQVDKLKEKNVNYIFSARKKQAQFFYLTKT
DLRGKTFNWQNANQIIALFR
>FECAFAII_01682 hypothetical protein
MKKNELFRDWEFRYRYIYRKRRTKKSKQRFLSALVSDIYSMRTDVTVIAYDTLAYRSKNI
YVGDIEKAEKVICTYYDTPVHALGSYFMFDWKDQRKKTIYSILLSFILLFSLGWWGMMIY
NKNPHHVFDLLSV
>FECAFAII_01683 PTS system sorbose-specific EIIB component
MGVVNLARVDERLIHGQVMVTLSQKSGVNSIFVVDEVVAKDKFMRDLYKNAGSRTGQKTI
VITPEKAKFYWDEYQFKEYNCILIAKTVQTIYDLVKHGIPMEELNIGGIAQKNPDTDLLV
TKSVYLNKSDAEKLKEMNEQYGVKNIYFQATPSAPKTGLKDVLNKFDLS
>FECAFAII_01684 PTS system mannose-specific EIID component
MAEIMDNQTGAPEEITKKDVTKAYLRWHFANEIPHSFERYLAPSLLYGMMPILKKLYKDE
DSLKAAYKRQLLFFNTQLSWGGGVITGLMSSMEQQRAEEEYEEKEILMQDDLMYNTKAGL
MGALAGIGDAIDSGTVQYIFIAIAVPWAQQGSPLGALFPFICFGLYQVLLGVFFARQAFT
MGRNATGLMQNTGVQTAIEMLSVLGLFMMGVLAGNYVKVESSLKFAISGREFVIQEILDQ
IVPGILPLAVVMGVYLFYTKKGLKVTQALLWLTGILIVLAGIGIL
>FECAFAII_01685 PTS system sorbose-specific EIIC component
METLSVVQSLLIALWVAAVMSRWLGGGATLTLRFSPLMTGLVVGLIMGEVAQAMIVTAAL
QMIYMGVFSPGGSMPAEPSIAAAIAVPVALLGDLSPEAAIAVAVPVGLLGSYLYQFRFFI
NTFLGKYTDKAVEDLNTKAMARSIILYPTVASFLLFVPLVFIALYLGAPLIADVIKALEG
TVVIHILEVVGGGLAAIGIATTVYVIGRKDYLVFFFLAYFMSVVLKSLDITMVTYAIFGI
IIALIFVQSQKGKQVQPATSNNNSASFDDEDDYDDGF
>FECAFAII_01686 putative oxidoreductase YbdH
MGYSANLARIDFGVIPTLASNCAPWTPLAVMYKENGQAEGKTEHFYRQAAFFITDPQLVI
DSPVPYFIAGLADTLAKWYESELILEQDFLQDESFLKLAQDTAKICKEEILNHSAKAIQD
MAQRKLTSEFKQLSEIIFAVAGLVGGLGDKYARNAAAHAMHDAISKYIPESHRFLHGEKV
AYGIFYQLALEGRWEKIDELYPLYRELELPVSLEQMGLFPKDKQIIDKMAEFIDSKEKVH
LIPIEVTQKSLIQSMMELEGYIRKI
>FECAFAII_01687 hypothetical protein
MVNGLKVKTGPQFYLYEEGGISKVSDLLKSYGAKRVLVTHGTVSWEKALPKLVFLNDETI
QFFYHRYSGECSYAEARRIATIIKKMKSIS
>FECAFAII_01688 Phenyllactate dehydrogenase
MPDYHIAIVNSSSFGRVFPHHLERLKSVGDVHFFTVDQEIPGKELAELLKGFNIIIASVT
PFFRRDFFENKDELLLISRHGIGYNNIDLKAAKEHQTIVSIIPALVERNAVAENNITNLL
SMLRRTTQAQARVKDDRWEDRAEFVGRTLFNKTVGVIGAGNTGSGVIEILRNGFRCDVLA
YDPYKSDLYIESFGAKKVELQELLEQSDIICLCANLTEENYHMISDKEVDQMKENVYLSN
SARGALVDEEAMINGLKSGKIAGYATDVLEEEPGRQDHPYLAFEQVVITPHISAYTRECL
EAMGEKCVRDVEQISQHLLPERSVQTKSNYIKG
>FECAFAII_01689 6-phosphogluconate dehydrogenase, NAD(+)-dependent, decarboxylating
MEIGVIGLGKMGLNLALNLKEHHHKVQGLDISSTAVSQARENDIPAYQEISEFLATFEQK
KIIWLMLPAGEITENMLRKLFPKLGPGDIIIEGGNSYYKDSIRRAEEFQKNEIGYLDCGT
SGGIEGARHQACLMIGGDKETFLSVEQLFKDVAIERGYLYAGASGSGHFLKMIHNGIEYG
MMQAIGEGFQLVQKSEYAFDLEQVARVWNHGSVIRGWLMEIMEDQLNEHPNLSNYRGIVS
ASGEAKWTVETALEMAVPVPVIATSLFMRNLSQEEDSFSAKVVSALRNGFGGHEIVEKGE
>FECAFAII_01690 HTH-type transcriptional regulator MurR
MSVSIRLQIKTMYNDFSPKEQAIADYILENPSKVSHSPISNLASELGIADSTFFQFTKKL
GYNGFKDFKMAMLIQENDLSAISIHENIQKTDTELTMAQKVFESSISTLNDTKKLLQQKD
LKKAATIINESKRVYFFGVGGSEIVATDAYHKFLRSPIATSHSTDYHIQLMEASLLTEKD
CAVLISHTGQSKETIHIAETVRKTGAKTIVITSQANSSLAKLGDVVFISISEETEFRSEA
LASRISQLSILDSLYVILMFYNEKESRRSIAKVRHTISEIKE
>FECAFAII_01691 hypothetical protein
MKAIHISLLFFASALILFAIHLCSQPYINNNGILVEPAFFCLPLGFLSLLASAGFGFVAF
FKRSKQQI
>FECAFAII_01692 Acetyl esterase
MKWFKRIVIAVPVIIVVILVTVFLINQITPKPISLLVRKQFDTSEKEQVYARPDDFQQKI
EQIDIKKEISYPSKYKNNNMDIYTPKVEKKKLPILFWMHGGAYVGGDKNDCRDYLEYLCS
DTQQIIVNIDYERSPEAKHPTPVIQLNEAIQAAKKEIKDQADWSNISIGGNSAGAQISGE
YLLALQNEEIKKADHLDPTLENKQITKFISLSGLLDPSALTQVSDKISSFLYEKCGWAYF
DNKDFEQSEKVKSLALVRHADRWTQNTFLTDGNTNTFTKQMEEVTSVFEKAGVKVTKVDY
AEKNAVLNHEYQFDFSNKQAQETYQKLVMFFKE
>FECAFAII_01693 hypothetical protein
MRTKQVLKGALVILFAVSTSVPQWTVYGESISSESESREVETTETTDAGNETKSSTSQTE
TNTETTVETSVTSTDQETTATTDNQQTEEATATKMSNDESSSAKVSDKENGTENDDIGKG
ENFNGKEYLNYFGKQMTEILNGPTEDIKSKLIELLVTELAVNDYGVDKEIIKHLIATYLL
YDIAFAKNSVLMSMLGGTDDGTTPTENTGFYPNTKQLHQTVLNKQDGKMMDVYAYYVDQG
SDKTVMIHGGFRGNWNNGIVTEEYNDFYKAGYNLLFVDSRATGNSGGDYVTYGQYESDDV
LYWINQEVRERPSQKILLYGGSMGAATMMSVLAKDIPVNVKGIIENCGFASIDEQLRFTY
SQTVAPALPDAIKNQLDIIGDQEHEDLFMGLLKQYYFDQEMHLDTKAALPTIGMSDSLPK
LIIHGTADDVVPVSNAQKLYELSGGYKDLLLVEGAGHGKAQEVDHAAYTKHVTDFLKVVF
HDQINVKYVDENNKSLLKDQDEIQLYGAYGENYMTEQKTFEGYELANVEGPTEGIFNETI
PTIIFYYKKIPVAPPKKQDPTENADNKGKNEPREDQSSDDTQPIQMTVKVQKKTDAKKRM
LPKTGEKKHSLLIYSGGFLSVSTIITWIWRRKRG
>FECAFAII_01694 Streptothricin hydrolase
MSNTADAIVVIDLQKGVCFDSSPIHELETVTALVNKRIKTYETIGKPVIFVQHEDAQLVP
QTKPWELLSELSIPEHSYFVRKTHANSFYKTNLSVLLTELDCHSIELCGAQAEYCIDTTV
KFAHGLGYQLMMCRGATTTYDNPFMKAKETIAFYEKIWDKRFLTFLEQ
>FECAFAII_01695 Regulatory protein Spx
MMIKLYTGSGCSSSRRAKRWLIVHDIPFIEQNLIRQPLTKNEFIHLLKLTNNGVTEMLST
HSISYKNLVHRIDELSLSELYIEIRTSPSLLKKPIIYDQSAKLLTGFSEDKIRMFLSKTK
RKQELNELLLSGHLVDFKENNLFAMS
>FECAFAII_01696 hypothetical protein
MRTIQRKLRELNTILKNYHLSCSLKKGNPIEGEEYRIRYFFHLMYWQSFDENHSDILSSI
KNKRQLLEKFAKHAPYTRSIDRKKWISLLRISLQRMKQGHSITYVPEEMNKFVHPLITKE
EFTHYILEPFFEANFWSMNHITPTEQAYLYFMFGVMNTYLEEDLLDTPDKVQESWGWIES
SIVENFEKNFKICFTTSEKNYLYVNLAMIHLYSRVFGTKKKVDAFGKSAEDRDFQHIFPV
MYPIMQQFFSGVARRIPELNTYYEKNRRLIFQYCMLVRDIFIKHEQPVIFYIQSKYGKTQ
ELWAKKRILSMTERPIKYSASADQLPDIVISDYPIDKKAYDQTNTQIFYWNGQPTKNDWA
RLKAEIIKIRNEKNRSILEKLDFVN
>FECAFAII_01697 hypothetical protein
MFEEFIDINERQVYQFLNYCYERDEKLYVVKDIALDLNYTLAKMNSVIQQAESFCERYPE
YKLSFLSENKMIKVEFSSQFLLSKVYSILLEGTIGYILLDSLYKGTYQSLENLSQKII
>FECAFAII_01698 hypothetical protein
MKKTATVLFVILGLSIIAAMIGISTSANERANENLSFTVKTDRIVYDMTQQVITIPVKPN
KSVNASDVHAVLTYGWDGNGSSEKVIGEVYLKDVQWTAGIEYTIMISAELSIDEIKSKDK
VDLIVFYDGQMTITENLKPSSWTVVGPPSSTDSTSSESSTENTSGESSTESTSSESSTEN
TSSESSTESTSSESSTGSTSSESSTESTSSESSTGSMSSESSTGSTSSESSTGKVNNELD
LVPIIPTKEQKRNAGSNLKSVLKQPDFVSRGIDHQEKAKETDNRKSDLPETGSRTLNKLI
TWMGVLLILIVGASYFRSLFHRVK
>FECAFAII_01699 hypothetical protein
MIRIIRLIGSVLIVLVGFVLGILVNNALADMFIGNSEWIGAIAGTVGHLAVFLLALFLAS
KVEGKRIEDYGVSVRGKDWGYLAGGLVVGIGVFLLITSPLYLTGAYRLDSGNANIVPLIT
SFILFIAVGASEELLFRGFFQHQMLRFGPLIAMIGSAALFALLHGLNPNMTFLAVFNIFL
AGCFFSALIYSTGSLFTAIGAHITWNWTQGAILGIPVSGTQEQGFFSTLIQSQNTIITGG
NFGAEASISTTLFLLVLIVGLLLYAYKTKRMKKYTAVYQ
>FECAFAII_01700 Foldase protein PrsA
MGNFLKKQLLIMCLSACAILLFSGCSKSNETIATFKGGTLTVQDFYDNPKVKSNNQTLLK
KMIVFKAFDDVYGKEISSKEVTKEYNEQIKKLGPNYKEQLKAVGQTEETYKKLFKQMLAF
QYGLKANVKLTDKDLDTAWKEFYPEVSTQIILFSTKEEADKAKKEANEGENFSKLVQAYG
KNKTLKETDGKMNFDSTNPEIPTEVKKAAFKLKNGEVSDIIPVTDPTTYQQSYYLVKMVK
KQDKGSNKDKYKSELEKIATEAKTLDTEFMDKTIRKVMKKDNVTIKDPYVKNIFK
>FECAFAII_01701 Fructose-6-phosphate aldolase 1
MGESYMEIMLDTANTKSIYSCQQFLNLTGVTTNPTILKKEGASNFFSHMKEIKKIIGQIP
IHIQTIGRTEEEMIEDARVIIEELGKDTFIKVPVNQAGLQAIKKLKKEGYLITGTAIYTE
LQGYLAINNGADYIAPYYNRMQNQGIDAMKVIDSLRTEIERTQRPTKILAASFKNCEQVT
TAIRSGAHAITLGKELLDQVLEMPSIDKAVRGFQEDWVQTFQAETIGELKKVADYF
>FECAFAII_01702 PTS system glucitol/sorbitol-specific EIIA component
MTIFETVVTDVGIEAEVFRKEKIMILFGDEAPETLTDYCYKIELNQVRKEITCDMKLCFD
KQMYVITAVGDVVQTNLNELGHITIKFDGSHEPELPGTMYVEDKEMPHLRKGTIIKIDQE
DQNGGKLYGNHA
>FECAFAII_01703 hypothetical protein
MKLFVGIDVSSEKLDVCFLTDDNQLSILSEISVANDIEGASFIRETILEFNNSYHFDQIV
IGMESTSMYSFHPSMFFHEDEKLKKLNTLVTIENPFRVKQFSRMFDENKTDRNDALRIAD
FLRIQRFTTSPIKEEKYMALQRLTRTRYQLIKQLIRTKQHFLENLTYKCNTLAREMRDES
TSLFSATLISLMTEDFTLDELAELPLEAFCDLLQEKGKGRFKQPEKIAKAIQRAITMSYR
LGALAQESINVVLSVLVREIRALEKNIKELDKAIEQVIVVIPEYQCLTSIPGVGKVYAAG
LIAEIGQIERFEDQTKLAKYAGLSWKVNQSGNYQSQNTPLTKQGNRYFRYYLVEAANSVK
NYLPEYKAFYQSKYKEVPKHQHKRALVLTARKFTRLVDTLLRKHQLYTPPRSVIEK
>FECAFAII_01704 PTS system glucitol/sorbitol-specific EIIB component
MYGDIKIVRGNGGYGGPLIIRPTKDKHKFIYVTGGGERPMIVDKIEELTGMESINGFKTS
IPDSEIALAIVDCGGTLRCGIYPKKGIPTINIVSTGKSGPLAQYITEDIYVSAVGLEQIQ
PLMETDDNKETVNTASPDKKYKYDTSKKITEQKAEQQNWIAKIGMGAGKVVATFNQSARE
AVDTMIRTVIPFMAFVSLLIGVIQGSGIGNVFANIMAPLAGNAVGLTIIGFICSLPFLSP
LLGPGAVISQVIGTLIGVEIGKGNIPPQLALPALFAINTQNACDFIPVGLGLEEAKAETV
EVGVPSVLYSRFLNGIPRVIIAWVASFGLYS
>FECAFAII_01705 PTS system glucitol/sorbitol-specific EIIC component
MDIITKFAEGFMRLFQTGAETFISWMTGIVPVVLMLMVAMNTLIAFLGEDRVTKVAKLSA
KNPLTRYLVLPFLSAFMLGNPMSFTMARFLPEYYKPSYYAAQAQFCHTSNGVFPHINPGE
LFVWMGIAQGIETLGLNSMELAIRYLLVGLLMNFIGGWITDFTTGFVCRQQGIVLSKKVE
LSVD
>FECAFAII_01706 hypothetical protein
MNDMYLFIVFAASAYVLQAVISWKQLKHFNQTYSELRRKGKVAIGKRPGKIRSGTIVMLA
IDDHDQVLEVRKMQGVTSLAKFHSLPVYAGEDIHYIDRYHPSVRAEDRLTQAALENAREV
YLRIEAGNEKSEQPSLPFIAMLNNFRIWKSTIKEKRSDKRWIS
>FECAFAII_01707 putative licABCH operon regulator
MTLVNRWYQLLKLLVTHKKVSIQEVQKEIKTSNQTIKKDIGELNEEIAGIAKIIQKNKHF
ELEIYDFDFFDEIMQGKLKTASDFNSASKRIAYLLNRLIETEDFLRMDDLSEEVGVSRGT
VVKDLKTLKEMINDFDVKITGTPNKGLRIIGDELELRLLLFYFVSPYFSETKTEQFLEEK
QAIKHFQKKTNASKQEITLLTKVIGISLNRISSNYLLKKPINRYSGCFEYIQEFNELINQ
LEEIYELTLSQYEKDFISFPLNIINTSITMIRKANSDLRLYFDPMMMRIRRLDLIDLDES
FLYQEMKQHLSLLINRVIFRYRLTDLFYGEIEKKYPFSYQIASECIQALEAILQHKISKV
EISYLTLYLELAFRYQKEHFSSKKVAIVHTTGKGTALMIQRQIKRILGRDIQITHVSEEQ
YEKVDLNKYFAVFTTIPLKNVNEETPVIHLTNLFDDSWLRAQWQKAKKKRLAGFHSTVFF
YQIWKEKKTYQEYLNKLVAPLIRGYYVDEEFEKRILKREYQQSTFVNKEFAFPHTTNQLS
QHIVLSVGLITDQGLAETGGNGVIFLFAIPEEMTAEVENELFELYDILFELIKMGIDEFI
ELAPTQESFLKLIKSKGERLHE
>FECAFAII_01708 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MSDWLDIAGKVVIVTGGSSGIGRSIVENLLKQNAQVANFDVTECRIQHENLLSLKVDVSS
KTDIEEGIYKVMKHFKTIDGLVNNAGINIPSLLIDRNHPKSKYELSEQVFDKMIAVNQKS
VYLMSQAVGRILVQKGSGVIVNLSSESGLEGSEGQSCYAATKAAMNSFTRSWAKELGKRN
VRVVGVAPGILEETGLRTQEYEEALSYTRGISVEQLRNGYSRTSTIPLGRSGKLQEVADL
VCYYLSERSSYITGVTTNISGGKTRG
>FECAFAII_01709 hypothetical protein
MKTLDAIALTLLIVGGLNWLLVGLFELDLVAMIAGGSTTIFAKIIYIVVGICAIYCLKFF
PMITRKVDERY
>FECAFAII_01710 hypothetical protein
MHKGIYAGLLGTVILFSACGYKTKNSVKESSAAISTTEVGSTKSTSTTSITNTSTGNVDS
QHSQSSIQSFSISSTSEMQESTVPSLPLENSDKALLFLIAHRSELQSDDIVISFYQKIDR
DYLFTASSKQIRSQGGSGSVGFYRVSPEGSITMTDANGTPF
>FECAFAII_01711 18 kDa heat shock protein
MANVPSIRDMFPDFNDVFSPAFNDFLGVSSYPKVDLVENEKEYKLTADMPGCDKEDTTVE
YSDNTLTISANHESHTEDKEDGNYVRKERHSVSYKRSFYLPNVDEEKITGTFKNGVLKLV
LPKTAYQPKETKKIELN
>FECAFAII_01712 hypothetical protein
MNDFTTEIVQTLVTKGDLNELFRSHLEKAINTLLRTELTAFLDYEKYDRTGFNSGNSRNG
SYFRSIKTEYGELTLEIPRDRNGEFKQQTLPAYKRTNDTLETTIIHLFEKGVTMSEIADL
IEKMYGHHYTPQTMSNMTKVLTEEVNAFKSRALNDKYVAIFMDATYIPLKRQTVSKEAIY
IAIGIREDGTKEVLSYAIAPTESTYVWNELLQDINSRGVQEVLLFITDGLKGMKDTIHQI
YPKAKYQHCCIHVSRNIAHKVRVKDRKEICDDFKAVYQANSKEEANTFLSGMIEKWKKNY
PKVTQSLIENQDLLTFYDFPPSIRRTIYSTNLIESFNKQIKRYSRRKEQFQNEESLERFL
VSIFDTYNQKFLNRSHKGFQQVTDTLVSMFTE
>FECAFAII_01713 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIVAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYIEKRSTEGWTPDVIIGRAERTFSCSVSTLYRRFKTGEFNVL
HLPMQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEGDTIVGIHHKSAVITL
VERLSKAIIALKPEGRKAVDIENSINEWLQSVPKNLFKSITFDCGKEFSNWKSISNTNDI
DIYFADPGTPSQRGLNEHSNGLLRKDGLPKEMEFNQVNQGFISSVASKRNHIPRKSLNYQ
TPLEVFLSYVNGKFCLA
>FECAFAII_01714 Tyrosine recombinase XerC
MAFLFVSLNYTNGEDINDDGSRKKVEKVGGDTRPEAEAALRKVLSDIDETGQYFLGTDTR
VKQYLDFWMEEYVKLNLKYNTYENYRFTIKNHINGYLGKKKLTDLSPALLQNFINAEFKK
GYSKKTMTITHSVLKNALNMAVYPWGLIKQNPMLYVKIPKYEARPTTKKDLKIISLEDFD
HMLEITPEGHPFYIPLNIGFYTGMRVGEVCGLTWDDVDFSNGTITVEKQMVKNDGAWVYG
TPKTSSSNRTIFIGQTLLAILKKHKKQQLENRMKYGKLYIDSNAVCTKEDGELVTPSVVK
WNTRRISNALSLSFNFHSLRHTHATLLLENGAKMKEISERLGHSRISITMDTYSHVTDKM
RNETVDIMENLRKNS
>FECAFAII_01715 Elongation factor 4
MDIKKMKERQEQIRNFSIIAHIDHGKSTLADRILEMTHTVTSREMQDQLLDSMDLERERG
ITIKLNAVELNYTAKNGETYIFHLIDTPGHVDFTYEVSRSLAACEGAVLVVDAAQGIEAQ
TLANVYLALDNDLEILPVINKIDLPAADPERVRQEIEDVIGIDASEAVLASAKSGIGIED
ILEQIVEYVPAPSGDLDAPLKALIFDSIYDSYRGVVLNVRITDGMVKPGDKIKLMSNGKT
FDVTEVGVFSPKAVARDFLMVGDVGYITASIKTVQDTRVGDTVTLADNPAAEALPGYRKM
NPMVYCGLYPIDTSRYNDLREALEKLQLNDAALQFEPETSQALGFGFRCGFLGLLHMDVV
QERLEREFNLELITTAPSVIYHVNKTDGTTATVDNPADFPEPVTIQDVEEPFVKAQIMVP
NDFVGAVMELSQRKRGEFITMDYLDDYRVNVVYNIPLSEIVFDFFDKLKSSTKGYASLDY
EMSGYQKSKLVKMDILLNGEKVDALSFIVHRDFAYERGKAIVEKLKKLIPRQQFEVPIQA
AIGQKIVARSDIKALRKNVLAKCYGGDVSRKRKLLEKQKEGKKRMKQIGSVEVPQEAFMA
VLKMDEDEPKK
>FECAFAII_01716 hypothetical protein
MDQKDFRENLELKPVTQEHIDQFNELLSYVFQVTEADIEESGFENKRAFIRSKKPILEVS
KVFGWFHENKLISQIAIYPCEVNIHGARYKMGGVTGVGTYPEYANHGLMQDLIIVALDNM
RKNKQWISYLYPYSIPYYRRKGWEIMSDKLSFKIRDTQLPKQIPVSGMVERLPVDHPDVF
SVYDKFAQQNHGALFRSDFHWEEYWRFENEDERTAAVYYDSNHEPRGVLFYWVAEEIFHV
KEMFYLDQEARNGLWNFISAHFSMIYWVHGDIYKNEPLAFLIEDSQIKEQIEPYFMARIV
DVKEFLQRFPFVGTADAFHFIIEDPVAPWNNGVFALTWDEQGQVRVLNEPIGKSVRLDIQ
TLTCLMMNYRRASYLARIERLETDEETLKSLERIIPNMEAYFSDYF
>FECAFAII_01717 hypothetical protein
MKIYFAAPMFAKSDLLYNQQLVKEIRELSSELSIYLPQENEAINDKTAYADSRMIALADT
EKVLASDLMIALLDGLTIDAGVASEIGVAYAKGIPVIGLYTDTRQQGGTHPKKIAALQET
AENQFHYLNLYTIGLIKLNGKVVSSEIELLSEVKRFLDGGTFSD
>FECAFAII_01718 hypothetical protein
MIKEIKKVQIALLAFGVFVVCYNFYEFITQKYSTSQGITFIVESLLGIALIFMPQVILKV
FKLKIPAAIVLFYWFFLFISVFLGTGMHLISIISFWDKILHAVSPMVLTALGYGLIGYLM
KDAEISKTSPWLFLLFGFAFAGLCGVFWEFWEFLCDQFLGMNLQRFAASDGTLFVGRAAL
MDTMGDLLTNTIGAALMGLFAWSQSKKDERYFESYKLEKVKNT
>FECAFAII_01719 Chaperone protein ClpB
MNIEKMTTTLQEAIAEAQQIAVTRKHQDIDIAHVWKIFLQSNHFGRNFYTDAGLDVESFE
HEIDRLLDEYPVVSGGNVQYGQNLSQNFFRLLNEADQIRESFGDEFLSTEVVILALMKLK
NYPLTVYLNKNGLSEKELRKNIEEMRGGERVTSQNQEEQYKALEKYGVDLVQQVKSGKMD
PIIGRDEEIRDVIRILSRKTKNNPVLIGEPGVGKTAIVEGLAQRIVRKDVPENLKDKTIF
SLDMGALIAGAKFRGEFEERLKAVLKEVKKSDGRILLFIDEIHNIVGAGKTEGSMDAGNL
LKPMLARGELHLIGATTLDEYRQYMEKDKALERRFQKVLVKEPTVEDTISILRGLKERFE
IHHGVNIHDNALVAAATLSDRYITDRFLPDKAIDLIDEASATIRVEMNSMPTELDQVTRR
LMQLEIEEAALKKESDDASKKRLKNLQEELAELREEANAMKMQWETEKEEVNSVSAKRAE
IDKAKHELEDAENNYDLERAAVLRHGTIPQLEKELKELEAKAKDSEIKMVQESVTENEIA
QVVGRLTGIPVTKLVEGEREKLIKLNETLHKRVIGQDEAVDAVSDAVIRSRAGLQDPNRP
LGSFLFLGPTGVGKTELAKALAENLFDSEDHMVRIDMSEYMEKHAVSRLVGAPPGYVGYE
EGGQLTEAVRRNPYTIVLLDEIEKAHPDVFNILLQVLDDGRLTDSKGRVVDFKNTVLIMT
SNIGSQLLLEGVTADGTIPEAVAEQVNTLLRGNFKPEFLNRIDDTILFTPLSLDNVKGIV
DKMVAQLAQRLEHQEILLTISDEAKTWIAENAYEPAYGARPLKRFITKEVETPLAKEIVA
GHVMPKSKVTITLLDGQLHFKTEELEEIV
>FECAFAII_01720 hypothetical protein
MSSKGTKTKIILNLLLLIVIFAIIYYLINQSFADIFAELLSTSVVVLAAAVILGTVYQIA
EGRSIKEIAEPFAPNFTTKDGFLTSSYIAFYRIVSFGTGTLISEIYFYNKKGMKLSQGAG
VTALHMIMYKLAVITYALAGLVIQFSLFYSNGPSMIWFIIAGILLTIVIVAFLLAMSVSL
NVQIFFVSLSNKLFKSERLRKWVDTCNQQIYSLRETVQTIIQDRTALLRIYLWNMLKLVF
WYVLPYLILIENHPKIDFLLTISFISFAVVLSGVIPTPAGIGSFEFVYLLLFRPVVGTVD
AVSSLLLYRFSSFILPFLYGFVYVIAERRRVIKEEIIEVKKENKENQG
>FECAFAII_01721 hypothetical protein
MDVLLHNPLWFYLFIVNFYLFCLMGYDKHQARTSGWRVPENNLIFVSLLGGGLGGLISRK
VFHHKTRKKKFTIGFAAGVLVDLILIYFFH
>FECAFAII_01722 Diacylglycerol kinase
MEKLLVFYNKSSGKDEGEKLARWFQDYVKEKQPELYVELAETGPSIDDAELVKKAEAIEA
DTLVIIGGDGTIHHIVQAFQKTLSQYHVGLLPGGTVNNLARVLEIPLKKEEAADVILEGN
VRKIDYGQVNDEVIISTLTIGILADTAVWISQEEKQRYGSWIFIKKFFKLLLKKKKYHLD
LETDEEHWKGKSQLLTVTMSNSVGGFTNFDDSATLDDGKFHVTIVPSLDIFRFIFYLPRI
MRGKFYTIPGITYFTAKRMKIQAQEKSVGTRTDGDTTDDLPVELSVVSKGLTVYSPKKEE
KA
>FECAFAII_01723 Peptidase T
MYENLLPRFLRYVKTETRSDATSKTTPSTQTQVAFAQELKKELEELGLADVFYNEDNGFV
MGTLPSNVDHEVRSIGFISHMDTADFNAVGVNPQIIENYDGESTIVLDAEERYTLNTKDF
PNLKNYEGHTLITTDGSTLLGADDKSGIAEIMTAMEILINNPSIPHGTIKVAFGPDEEIG
VGADKFDVEQFDVDFAYTVDGGPLGELQYETFSAAQANITIQGKNVHPGTAKDTMINALQ
LAIDFHNQLPADEVPEKTEGYEGFFHLMALDGNPEEASMSYIIRDHDREKFEARKAQITH
IQEELNQRFDQERIKVDMYDQYYNMKEIIEKDMSIVELAKQAMIELGISPVIEPVRGGTD
GSKISYMGIPTPNLFAGGENMHGRFEFVSLQVMEKATDVIVKIAELNTKS
>FECAFAII_01724 GTP cyclohydrolase 1 type 2 
MTISGRTFIQKFESYCPQWLAEEGDPVGLHIGTLDKPIQRVMMTLDVRPEVVEEAIKKKI
DLLIAKHPPIFRPVKRLVTDQPQEKMYADLLKHDIAVYAAHTNMDIIWDGLNDWFCELLG
IEVESYLVKTHEIHYKKLAVYVPVDHAQKMREVLAAAGAGTQGDYTGTSFTSIGHGRFTP
EAGAQPAIGKVGKTEQVQEAKVEVILPETIEKQVIQAMRSAHPYEEPAYDLFAIDEPVEM
FGLGRVGELPQEISIEAFVEQVKEAFQLDGLRIVQPKNAKSSVKRIAICGGSGEKFYPQA
IAQRADVYITGDIYYHTAHDMQSAGLIAIDPGHYIESLCKQRFIEKFESWKQEENWDINF
FVSETNTNPFQFN
>FECAFAII_01725 tRNA (adenine(22)-N(1))-methyltransferase
MNHLDLSQRLAAVGDFVPESARLADIGSDHAYLPVALILRGKIEYAVAGEVVQGPYESAR
KQVKKDGLEDRITVRLANGLDAIQPQDGITAVTIAGMGGSLIRDILEAGKLNQRLSGQER
LILQPNIGERTLRSWLQENQYKIQSEKILEENKKIYEIIVAEKEQKPVTYNEMELMFGPF
LLEEKSEIFKSKWTRELQQRKAIREQLKQAANQEARQKQIEQEIQMIEEVLKP
>FECAFAII_01726 hypothetical protein
MNDSIKKMLRLIEKDLMITEVSYETFQKKKTLIVDAVFSPAPHTCRNCGSTVVDGNGKVI
VVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKNCQVSLTTVIRTLKEFKSYLPKQSKRILPRVLMVDEFRSHASIED
KMSFICADGETGQLIDVLPTRKLPRLTSYFLGCANPEEVKFLVTDMNAAYFQLTKRILPN
AKVVIDRFHIIKHMNQAFNELRIREMNELRKVGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLGFSTSLKEAYPYFHELVEAFRDKDPDLFFSLLAELP
ETLDDGFREKLQNLLTYEEGITNAMIYPYTNGKIEAKNTHIKTMKRVSYGFKSFENMRIR
IFLINQLIKVR
>FECAFAII_01727 hypothetical protein
MRAIFSSISVVGLFFLLAGCGSADSNTGSVDSIDAGQTVKTSSTKTERQSIFVGTIESIT
QVEAEEETLQLKLVDVMAKEDPANMGTSFSNDGVILNATAEKISVDINELKIGDKVQFTL
VEMPIMTMSIPPQVPGDSIIDVSLNK
>FECAFAII_01728 Primosomal protein DnaI
MEDVGKELKRIISKRNYQEKYAEMIAEVLNDADVQAFLSAHQEELTQADIEKSYAKLYEF
VQEKRKYQKNDPTMIAPGYEPKLTLNFHYVDVTYVPTEALLARQRQEEIRSRVKAMDMPK
DIQSASFENFERTDGRGYASLEALDFVEKYTADPKGYHKGLYLVGSFGIGKTYLLGATAR
ELAIAGFTTTLVHFPTFAVEMKQAIGKDQVAEKLDAVKRSPILMIDDIGADAMSSWIRDE
VFGVILQYRMQEQLPTFFSSNFTMDELEQHLSVTQRGDEEPLKAKRIMERIRYLTKEIEM
TGRNRRNG
>FECAFAII_01729 Replication initiation and membrane attachment protein
MENAWKELQPKNIYQGRKAAPLREDSKNALLYLYQPLIGGEALSIYFTLLSEISQESGKG
PEGMHADLLSSLGCGIPQFYDARKKLEGIGLLDVYFKEDSDLGPRFIYELLEPLIPKAFF
KDSVLAFLLLEKVGERRFQKLTQFFEPKRHTAEGYQKITKKFLDVYRFNEAVYAANQENI
ESLNKSFEESESVALLEADSTFDWQFLNDWLAKKHIASLDDPIIKQVDMYHQLYGFDELT
LGELISQSYDFSEQKVSEKELQKAILAMQRRPVKQTKETVAVSENSNEPSSNEHLTNAAL
QLIKEAQSIPPMKYLEAIKSEKGGYVSKQENWLLQDLVSQSGLSSSVINVLLNYVLVIKN
NASLNASYVNTVANEWAQKKIATAEEAIQHIRQISNQAKQSKQKKQTNYQTGKRNVRREK
LPDWVNQPKDEKQISSEKKAEIDRRFKEYLAKKEGDI
>FECAFAII_01730 Transcriptional repressor NrdR
MRCPRCQHNNSRVIDSRQADDGRAIRRRRECENCSFRFTTFERIEAAPLLVIKKNGEREE
FNRDKILRGLIRSAEKRPVAMEQMEQIVNHVENRVRSLGENEVSTNLIGEYVMEDLVDLD
EIAYIRFASVYRQFKDMSVFLKELQDIVDKAKENNKENNKENN
>FECAFAII_01731 hypothetical protein
MGSLKNQKDKVVGNAKEKIGEMLNKENLIDEGRTQSETAEEKEKQYQARIDEIEDQQAEE
EAKRQDLTQERKNPTPDRSKTPLPESDHIPDEQKIEEQRMKHYTGIEEKL
>FECAFAII_01732 Dephospho-CoA kinase
MSELSKAKNRKVGFVLGLTGGIATGKSTAAKVFQSHGFPLIDGDVIARETVEPGTLALRK
IVSVFGQEVLQPDGQLDRGKLGMIVFPSKEKRQKLDQLLDPFIRKAIKDQIASLSSNHPL
VIVDIPLLYEGHYDHYMDAVAVVYTTPETQLQRLMKRNQLTLEQAQQRISSQLPIEEKKQ
RADILFDNNGTKEKLVGQIENWLFANRFL
>FECAFAII_01733 Formamidopyrimidine-DNA glycosylase
MPELPEVETVRKGLERLVVGKTIQKVQVLWPKIIEQPETPIFEASLVGETIQSIGRRGKF
LIFHLDHCELISHLRMEGKYQFTKENTPIDKHTHVLFFFEDGSQLRYNDVRKFGRMTIVE
KGASATYRGIMKLGPEPLPDSFLLADFANGLKKSHKAIKPLLLDQRLVTGLGNIYVDEAL
WEAKIHPEQPANTLRPKEVEQLRLSIIDVLDRAIEAGGTTIRSYLNALGESGGFQVALHV
YQQTGKPCIRCGTPIVKTKVAQRGTHYCPNCQRLKIAK
>FECAFAII_01734 DNA polymerase I
MTKNKLLLVDGNSVAFRAFFALHNSLERFKNRNGLHTNAIYAFNTMFENVMQKEQPTHVL
VAFDAGKTTFRTEMYAEYKGGRSKTPGEFKEQMPYIRDLLTGLGVQYYELPNYEADDIIG
TLAEKVDKDQFDVVVLSGDRDLTQLASKEVKVDITVKGVSDIESYTPEHVAEKYDGLTPK
QIIDMKGLAGDASDNIPGVTKIGEKTAIKLLKQYGSVEGIYEHIDEMKQSKMKENLINDK
EQAFLSKKLATINTSAPVDVSIDSLKYEGKNLDKLVPFYKEMDFNQFLSKLNIVEEEVKM
DDILFEVVHEFKEEMFTTDMALYVEMMGDNYHTEEIVGVAWGTEKKIYVTNDLSVFENRA
FHSWITDPTRLKKVYDAKRTYVALNRYTGKTKGIDFDVLLGAYLLDTNEKSTDIEGIAAH
YGYNDIQSDEAVYGKGAKKGLPEEEELFFAHLARKVAAINALTPKLSQELAEKNQEDLFR
KMELPLSIILAEMEISGIKVDATRLQEMKGEFSARLREIEQKIYEEAGEEFNLNSPKQLG
VILFEKMGLPVIKKTKTGYSTAVDVLEQLREQAPIVEDILTYRQIAKIQSTYVEGLLKVI
QSDGKVHTRYVQTLTQTGRLSSVDPNLQNIPIRLDEGRKIRQAFVPREKDWLIYSSDYSQ
IELRVLAHISNDEHLKAAFLEGQDIHASTAMRVFGIEKAEDVTPNMRRQAKAVNFGIVYG
ISDYGLSQNLGISRKAAQQYIDTYFEKYPGVKEYMERIVREAKDQGYVETLYHRRRYLPD
INSRNYNIRSFAERTAINTPIQGSAADILKIAMIELDKRLKETGLQATMLLQVHDELVFE
VPEKELESLDKLVKEVMEQAVSLHVPLITDSSWGKTWYEAK
>FECAFAII_01735 Inner membrane protein YbhL
MNNPSTSMSGINRFYAKVYGFLGMGLALSAVTSYLALWVFPLQLATFINNFPLGFVGLWI
VELILVMVLGVKAQKNPSLAIGGFIAYSLLNGITLAVTLAYYDIGTVTQAFLTATLMFMG
MSVVGVTTKRDLSGVGRAGQAALIGVIIALVLNIFILRSSVVELFISLLLVVIFAGITAY
DNQSIRNIYVQTNGTAHSGIAVFMALKLYLDFINLFLAFLRIFGRNN
>FECAFAII_01736 (R)-specific enoyl-CoA hydratase
MNIGKPRKLGKTINEIEEGDSLSLTESIEDNQLLLYLGLTNDANPLYIQHDFAQKTEYQQ
PIVPSVMLMGIITSAISKHLPGPGSHVVNFSVNFIEPVFHYETLTFQFEVIKVDKMKDVV
TISVEAENTNEDRVLDAVVMVQPPQVPELEIAIESEGELNE
>FECAFAII_01737 UDP-N-acetylmuramate--L-alanine ligase
MENQNKLYHFVGIKGSGMSSLALVLHEQGLNVQGSDIEKYFFTQRDLEKANITILPFNAD
NVKPGMTIIAGNAFPDSHEEIQRAKELGLEVIRYHDFIGHFIQNYTSIAVTGSHGKTSTT
GLLSHVLSGVRPTSYLIGDGTGHGDPQAEFFSFEACEYRRHFLAYSPDYAIMTNIDFDHP
DYYTSIDDVFTAFQTMAGQVKKAIFAYGDDAYLRKLKANVPIYYYGVTENDDIQARNIER
TTSGSAFDVYHGDEFVGHFTVPAFGKHNILNALGVIAVAYFEKLDLKEVAEEMLTFPGVK
RRFSEKIVADMTVVDDYAHHPAEIKATIDGARQKYPDKEIIAVFQPHTFTRTIALMDEFA
EALDLADKVYLCDIFGSAREEQGNVKIEDLGAKIKKGGEVIKENNVSPLLDYHDAVVIFM
GAGDVQKFEQAYEKLLSSTTKNVL
>FECAFAII_01738 hypothetical protein
MEKSEQRNLKDWNQLLNFLAAPEEGNFEELTAPTLILAGNCLPILADKAAQMYLNGQVDQ
LFLVGGVGHATRILYENFEKQGFHFEDGMSESEICRQYLKEVYDLPDKAFLIESKSTNSG
ENATFSLEILHSLGAVPEKILLMNDPTLQRRTRATFEKVWQNEQTIFANAVPFVPEILHF
SEEIIFTAKELNHQWPKEYFHALVLGEMERLHDDENGYGPKGKDFIPHIDISEEVWSSYT
RIKESIKTDFSRT
>FECAFAII_01739 Protein SprT-like protein
MTQEELQQLVEEISLKSFQLPFKHQAMFNPRLRTTGGRYHLNDHHLDFNAKLFEESDEET
IAGIIKHELCHYHLHLAGRGYQHKDMDFKYLLKKTGGLRYAPALTKKQIKMEYYRCQDCS
ATICRKRRIDVRKYRCGRCHGEIKWIETKREDFNEAQKIR
>FECAFAII_01740 30S ribosomal protein S1
MTENLNQTIIQLVQKELSDYRPKQLTTVLNLLNEGNTVPFIARYRKEMTGSLDEVQIREI
EERYAYLENLEKRKTEVIRLIDEQGKLTPELEAEITQAVKMQQVEDLYRPYKQKRRTKAT
IAKEKGLEPLAKWLMQLTDGEVQSEAEKYIDKEKEVSSAEEALHGAHEIIAEQVSDNAKF
RTWIRSYTYNKGMYVSNVKDEQADEKGVYEMYYDFAEPVHKMVSHRILATNRGEKEDILK
VFFQVDEAAILAYLDRQIVKNPASPSSSFVREAYQDSYKRFIQPAIERELRNELTEKADE
QAIAIFGENLRNLLLQPPLKGKVVLGFDPAYRTGCKLAVVDATGKVLAIEVIYPHKPAAQ
AKREAAGPAFIQLINKYQVDMVAIGNGTASRESELFVAEQLKSADHKTYYAIVNEAGASV
YSASEIARKEFPHLQVEERSAVSIARRLQDPLAELVKIDPKAVGVGQYQHDVSQKRLAEQ
LDFVVETAVNQVGVDVNTASPQLLQHISGLNKTTAQNIVIYREENGEFTARTQLKKVPRL
GPKAYEQAIGFLRVPGGKNILDNTGIHPESYSIAKEILTSVQLSEKELGTEEAVEKLTRL
SVEKLAESLSVGEETLADILAGLTQPGRDMRDEMPAPLLRTDVLSMEDLKPGMELTGTVR
NVIDFGAFVDIGVKQDGLVHISKLSKKFVKHPTDVVSVGDIVTVWIEQVDTKKGRISLTM
LSPYEE
>FECAFAII_01741 Serine/threonine-protein phosphatase 1
MKSLIYAIGDVHGKHELFEKLIHYYDPKIHQLVLLGDLNDRGPRTKECFLLGKQLVEETG
AIYLRGNHEEYFLQFLQSPEDWYAPYMRNGGKETFESLIHPGASEEYSPTEISMMIQSRY
SELIKFLVQRPLYYEWENYLFVHAGVDLTKKDWRKTSLRDFIWIREPFHEGKNNTGKTIV
FGHTITPMLHGDMQTTDLWIQDHKIGMDGGAVFGGSLHGVVFDKEGILQDIEYQNNEGPW
HGI
>FECAFAII_01742 Thiosulfate sulfurtransferase GlpE
MDYQVLLYYNYTKIEEPEEFAKNHLAFCKSLDLKGRILVAEEGINGTVSGTVENTTAYMK
AMKADPRFADTMFKIDPSEGHAFKKMFVRYRPELVSLKLEEDIDPNQVTGAYLSPQEFKE
AILDEQTVVIDARNDYEYDLGHFRGAVRPDIRSFRELPDWIREHKEEFMEKRVVTYCTGG
IRCEKFSGWLVREGFKDVGQLHGGIATYGKDPEVQGELWDGKMYVFDERIAVDINQVDKQ
IVGRDWFDGTPCERYINCSNPECNRQILASIENEEKHLGACSIECAKHPRNRYVQDHGIS
PEEAELRFTALIK
>FECAFAII_01743 hypothetical protein
MFTNEIKIMLYVDDVEKNATFWRAVGFAEKDRQEMDGTLIIEVGVEDSQTSFLLYDRAFV
ESHSPGTATSAPSLMFYSKDIFGLYKKMQTQSVTLGDMVQLGEEYVFNFADPDGNYFAVT
GK
>FECAFAII_01744 L-cystine uptake protein TcyP
MTTLITVLVVLVFAALLYVFYRMQKRHTKFSTRVFTALGVGIVFGGLLQLIFGVDDKVVT
QSMEWIGIVGQGYVSFLQMLVMPLVFISIIGAFTKMKVSEKLGKISATVLTSLLGTTAIA
ALIGIGSTMLFGLQGAKFTQGAAETARISELATRQETVENLSIPQQILSFIPKNVFADLA
GSRATSTIGVVIFAAFVGIAYLGVKRKAPKEAAFFSDLVDSLYKIIMRIVTLVLRLTPYG
VFALMTNVLATSDFAAIVNLGKFVVASYVALLAVLIVHSLILIGAKVNPINYFKKAFPVL
SFAFTSRSSAGALPLNIETQTKALGVDDATANFSASFGLSIGQNGCAGVYPAMLATIVAP
AAGVNVFSLEFILMLVAIVTISSFGVAGVGGGATFASLIVLGAMNLPVAIVGLVISVEPL
IDMARTAVNVSGSMVAGIVTSARIKDLDRDVINDDSKVIDVNA
>FECAFAII_01745 hypothetical protein
MEIRRQKEVVEAFHYDMRLPNQEVETDLKVGFSPLKETIENYPKEHSIVGARLEFRLVFD
TYVLSGSVSQINHILNRKIEGQNDVTQEEVDELVAPLFDIVRRMSYEVTEIALDQPGVKL
NFQSEKQE
>FECAFAII_01746 Phosphoglycolate phosphatase
MKNYIWDFDGTLFDTYPAMVDGAWQALKDFGISMDKKEIYFKMKKYSTSYLINESNLNAR
EFNELFHRYEKESTEVSRPFPETKQVLEMLKDNGGRHFILTHRLTESTWGLLKEHRLAHL
IEEVVGIDQDFPRKPDPASLNYLIDTFHLERTDTMMIGDRRLDIEAGKNAGVATCLYDID
HFLGEIPADYVVGNLNEILTLQSIIKK
>FECAFAII_01747 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase
MKLVLLRHGESEANFENYWTGWLDVALTEKGKEQAAVAGQKMLEAGLQFDAVYTSVLKRA
ILTGQVALEEMGQLWLPIIKTWRLNERHYGDLVGKNKDKMKEIYGKDQVKTWRRGYTEVP
PLTAENRFDRRYDHLDPHLIPYGESLEMTVNRIIPLWQDHLAPKLKDRQDLLVVGHGNSI
RALTKYLEDVPEDQMDTIDIPNAQPIQYTLADDLTILDKKIL
>FECAFAII_01748 hypothetical protein
MMQTWLERLIRFQQNYHKLMQGRYAKFDQLNRGLLIAALVFSLLSRWLPYRIGQLLFIVF
FGWMIFRFLSKKIYPRLNENQRYLKYLDRVKEKYHQIKNKKQVKMDRKSYTFFECPNCHQ
KQRAPKGKGRIRVTCKTCGIKFETNV
>FECAFAII_01749 hypothetical protein
MNFLVVLKDTLIERSTFLYVQLQENKTLLHFSPEFHLEGLTLGEIYQAEGLSAVLHFFKV
ELELPVKDYIELSLESWDRAVVELFPEGLMIDTNDGKIHLTAAELQKQMRYQIDDENSFS
IFRRQQKILKSFLKVISKKRNLIKTTQLLKKYPGLLHTSIQFPQLITMIHRFIRMQQLPS
KKLFLPLTDTFRVVNREDKKKVIVIDFTRNRNVLHQVAMEKAN
>FECAFAII_01750 hypothetical protein
MKDLVALNLHMIVTIVDGGMGEDVIDFSKEAGAAGGTILHGRGSGVHDSGKFLGLDISPE
KDIVLTLVPDSLTNKVMDAIGQGINIDIPGNGICFSIDVDKVIGITKIHQYREIIGMQEL
LDENNDREKSES
>FECAFAII_01751 hypothetical protein
MSFWQQVIDGIEIVTMEVILAVAPIVILFVLMNIISFRMRKKRFFDIMKGFLITTIGLIL
FLHGVNMAYVPVGQHLGSAIAGLPYNYILVPLGFLMGFLVGFAEPAIHVMIKQVEELSEG
RIRSKIMLMVISIGIGAAVGLSMWRLLVGFSLYYFLIPGYGLAFILGRKVDKIFLAMAFD
NGGVATGPMCSTFILSMSVAIAAQIEGRDPIIDGFGVVAMIALTPILSTLVLGYIYKRKD
EKDRIEKERLQKLGESK
>FECAFAII_01752 hypothetical protein
MLKNFKEVIAAILPMTVLIVILTFVFAPLEGEDLASFLVGAAIMMIGMTLFLFGADYSMM
EVGDLVGKYMIKKKSLTVLVSLGFAIGIVITIAEPSVQVLGQQVYDISDGEIGRVLLIGI
VSVGTGVFLAFALLRVVFKLSYYQLMAIGYIGVLIASFFTSSEFMPIAFDSGGVTTGPVT
VPFILALAGGMTSMIKQKKNENDSFGMVGIASLGPILAVMILGVIFQ
>FECAFAII_01753 Lactose transport system permease protein LacG
MKNMVEKETIERPNVKKQALELRSTIGSVLKYTALSILSFISIFPFVWMVLGMTNTPVDI
TSGKIKIGSNLIINFQNLFSNELNFTRSLWNSAMIALVTTVFALLISSMAGYGFEIYQSK
RKDLIFNILLLSMMVPFAALMIPLYRMFSQLNGTVLGINSFLVVILPSVSTAFLIFFFRQ
NVKSFPKDLVEAARLDGLKELSIFFRVYMPTAKNTYAAAAIITFMSSWNNYLWPLVALQS
PDKRTVPLVLSAMGASYTPDYGMIMAGLVIATLPTAIVFFVLQKQFVKE
>FECAFAII_01754 Lactose transport system permease protein LacF
MKQKDLFKNGHAFLILPVILISIMVFIPMVLALITSFQSGPPVNMTFNGLGNYQRMLTDA
TFKKAFFNTFLYLLVQVPIMLFLALFISNLLNDKKLKYKGLFRTAIFLPCITSMVSYSLI
MKSLFSQSGLVNNLLLGIGMIDTPIGWLTHPIWARVLIILSITWRWTGYNMIFFLSGMQN
IDSEIYEAASIDGASKWQQFIKVTIPNLKPIILFTSITSTIGTLQLFDEVQNITGGGPAN
ATTTLSQYIYNLSYKFTPNFGYAAAVSFVIVSFIVILSIIQTKVGGESR
>FECAFAII_01755 Lactose-binding protein
MNIRKLIAGVVCLAAASGFLTGCGSASSTADKEEKVTVWAWDETFNIKAVNEAKKVYENE
ETEIEVVTMSQDDIVQKLNTALASGNTEGLPNIVLIEDYRIQGYLTSYPDAFANLSAIVK
EDHFAPYKFAVNKVGDKIYGVPFDSGVTANFYRTDLMAEAGYTEEDMENLKWDEYIQVAR
DVKEKTGKKIAEVNPSDLGRVRMIMQQAGEWYTSEDGETVTIQDNASLKYGLELFATLLK
EDLVEQTSDWNAGVTAIQSGAVASSPTGAWYSSTIQGAENQSGKWKIAPIPALPENLQKA
QASNLGGAGWYVIKGVAGEDSAKDFLEATFASNEELMGTLAKEIGLVSTMLSANEQEAYQ
EASEFYSGQKIFDDFSTWTSEIPEVNYGHETYAIEAVVAEALHRIINGEETDKVLADTQK
QVEAQLAN
>FECAFAII_01756 putative response regulatory protein
MPIRVILIDDEQTILDGMKQLINWSEHGFQLIGTFSSPLKALDFSLVHAIDIVVTDVMMP
ELNGIELSRLLKQQQPETQILILSSYDEFDMVKDSFKEGVADYLLKPRLSPDFFLNSLTA
VSQKIKKKPNKSPITNRYEQICENLSQQIAGQTRPLLDPLLFEHTLFFCYIPKNGHSVQN
KALNKNSRSPIH
>FECAFAII_01757 Arabinose operon regulatory protein
MDSDDSFTIYPVSTFSEESGYVINTDSKDTLRKFVQKFRQEVFPGDFFVVSDSFAIQDIN
EIFQEIRNCTKGQRFYHKGKNLAYQHELLPLLTNHEQQASSYLTKIVHKDYALAVKELEN
FFTTILEQPIDPAYLKHEAINRFYALLNALADEHVGNEELSLLKIALPSLLADAEYFEDF
SILVKETLEKLTHFSANAKKDNFDILTLIYEFVQENYEKEINLQLLSEKYHFSYSYLSAI
FTEKFGINFSKYLKKVRISKAKLFLTETRLTLTEICEKVGYTELGYFSRVF
>FECAFAII_01758 Sensor histidine kinase YehU
MRKKIKEHELFAKLLFILFIGLFLQAIVISLFIYHRSRDAYIQLFNQSNDVVLKKIQSEF
ESLNDTIENTLAAFDSNPAVKSYFSNDPAQHMEQLQQLRTIQKMNDSLSKIHPMIDYDVL
IFGENGRTFVGNDMLTAVSADSFFQSAIAQRVNERAADTQMLFAHHGLTLRDKKAPSVFF
VKKLKNTLNHVYGYAVLSISSKQLANLFQSVVNPEISKISFMNEEQTIIASNEENTIGSR
SMIFKKLTVGETTISNGQQLTRLPLYRQDCTLLSQVDLHSLSNQMGVIFPIILYNIVTLA
FAGSLVFMYLDRHTKSIYRLIDSLKRLEEDGLKATVPVQGSHEVQLLGNTINQLLSNAQH
HYEQTIQDEKKKRSLEIQTMQAQIQPHFIYNTLTSLKFLIWQKKTDEAVQGIDSFITLLR
STIGKKEEVIPVKEEIKSVQSYIDLLSMRYGERISAKIMIPDELQSLSMPNMILQPIIEN
AYLHAFHNKTQGFITVYGKTKNQLLLFEVIDNGDGFDTENTKQKNDHFSGIGISHVDERI
RLMYGDAYGLTIQSVIGTGTTVTICLPLLPKNQSEYQK
>FECAFAII_01759 Prephenate dehydratase
MNVSYLGPESSFTYQAACQLFPTEQLTAYASIPVCLRALFRKQVDLAVVPVENSLEGAVH
HTIDLLSKHPEVEVKSEIVLPIKQQLLGNPATKITKILSHPQALAQSQQFLETHYPNVPL
VATESTTAAAMYVAEHPKEDAAAIASLETAQHVGLEILAENIQDNELNQTRFWIVGDRKM
TSQQSAPVKMSVILTLPANRPGMLHKMLAAFGWREINLSKIESRPLKTSLGEYFFVIDLL
LDRPMTLVENALQEIKMLGGESQILGCYPVLTVEETRR
>FECAFAII_01760 Shikimate kinase
MASILLIGFMGAGKTTIGKGLAQCLQKEYVDLDTKIEEHIQLSIAEYFHYYGEKSFRKVE
SDILRKLSNEDKIIATGGGIVQSAENRRFLKTQPIVLYLEAEADCLVDRIQQDETSIRPL
ALGKTREEIKALLAQRLSWYEESATHRINTTNQTPEKIIDTIIERIKSI
>FECAFAII_01761 3-phosphoshikimate 1-carboxyvinyltransferase
MQLLQQIHGLRGTVRIPADKSISHRSIMFGAIAEGTTTIQNFLRAEDCLSTLHAFQQLGV
EIEEEEEVIKIHGRGSHSFVQPTESIDMGNSGTTIRLLMGILAGQPFTTTLFGDASLSKR
PMGRVMEPLREMGADLQGEENDQYLPITVTGTRSLSPIRYNMPVASAQVKSALLFAALQA
EGTSVIVEKERSRNHTEEMIRQFGGRITVEDKTIIVTGPQKLTGQQITVPGDISSAAFFL
AAGLLVPESQLLLKNVGVNPTRTGILDVLEEMGAAITQTNHNEQNQSADLSVKTSHLKKA
TIGGEIIPRLIDELPILALVATQAEGITIIKDAEELKVKETNRIDAVAEELQKMGAKIKA
TADGLIIHGPTPLHGAKVSSRGDHRIGMMLQVAALIADGPCELEGAEAVSISYPAFFDDL
AELVSGGEAHG
>FECAFAII_01762 Prephenate dehydrogenase
MAQHVFIVGLGLIGASMALCIRQTNPELIVVGWDSQSKTREQAVEQQIVDYVASDFETGA
EQADVILLAVPVRTTLAYLDVLERINLSDHVIITDVSSTKQQVVTSAEQKNLRFVGGHPM
AGSHKSGIQAADAKLFENAYYIFTPLEKTKKDVEKLQELFCGTKAKYVTLTAREHDRITG
MLSHFPHILAAGLVNQAEQFNQEYPRAKQLAAGGFRDITRIASSDPVMWTDILLSNKQIL
LERLADWQQEMTQIAEWIMTENQSEIFSFFNRAKESRDQLPVHKQGAIPAFFDLFIDVPD
EPGVIAEVTGLIGKAGVSLINLKIQETREDILGILQISFKNQQDLLQAKRIIMSNTSYHC
WIK
>FECAFAII_01763 Chorismate synthase
MRYMTAGESHGPELTAIIEGLPAGLPLSEEEINHELARRQAGYGRGGRMKIEKDRVRITS
GIRHGKTIGSPVTLVVENKDWKNWTTVMSVAEVPEKDQSLRRVARPRPGHADLVGGMKYH
HRDLRNVLERSSARETTMRVAIGAIAKKILEELDIIVAGHVICLGGIQAEIPGNISIQEI
KEISEASEVRVVDPAVEQRIKDLIDQTKKNGDTIGGIVEVLVGGVPAGLGSYVQWDTKLD
AKIAQAVVSINAFKGVEFGVGFTSGSLPGSEVMDEILWEEERGYFRRTNNLGGFEGGMTN
GEPLVIRGVMKPIPTLYKPLQSVDIDTKEPYKASVERSDSTAVPAASVVAENVVATVVAT
ELLSKFPSDSLVELKAAVKEYRDYLKHY
>FECAFAII_01764 3-dehydroquinate synthase
MLTVHVDNQKYDIHIEKGALEQAGSWLQTIWRPQKVAVITDTNVAPLYAEKIMFQLRQAN
FEPVLSIVPAGETSKSLEQAAELYDFLADNDFTRSDGILALGGGMVGDLAAFVASTFMRG
IHFVQIPTTLLAQVDSSIGGKTAVNTNKAKNLVGTFSQPAGVLIDPEVLKTLPVRRLREG
IAEIIKSAAIADATLWKQLNELKDEKDLLEHAVPIITATLEIKRKVVEEDVFDQGNRLIL
NFGHTIGHAIENTAGYGVVSHGEGVAIGMVAITSHAEKIGLSPTGSTAALERILQKFHLP
ITYDLSHPDELFHAITHDKKARGSQLNIILLEKIGQAKIVPVPTETFKDYLGGL
>FECAFAII_01765 Phospho-2-dehydro-3-deoxyheptonate aldolase
MIVIMKKEATEEQIKKVVDHIEKEGFKVSIDQGTERVVIGLKGDTRSLQEGAFTRYEGVE
NAVRILNTYKLTSREFHPGNTVVDVDGVKIGDGSFVTMAGPCSIEGLDQIRECARMAKAG
GAKILRGGAFKPRTSPYAFQGLEEEGLKYIRQAADEFGMKVITEVMDEGHIDMVAEYSDI
LQIGARNMQNFKLLSAVGKTGKPVGLKRGISGTINEWLNAAEYIAVEDKSPVIFIERGIR
TYETATRNTFDLSAVPLMKKLTHFPVIVDPSHGTGIWELVPPMARAGVASGADGMIVEIH
PDPANAWSDGPQSLNEKTYSRMMKEVAIMKEAMEKIQTLD
>FECAFAII_01766 Beta-galactosidase small subunit
MKNTVNKSHMDTEKVAIVFGDCTLGVKSGNTHYIFSYTRGGLESLNKNGKEWLYRETLPV
FWRATTDNDRGSGFGFKSGMWLGAGLYPKVKEIEVLVDNKKIDLPIAPVNNQYSSNEYAE
TVEIIFTLEINTVPKTQVTISYQIAGEGKMLVNMHYYGQKGLPELPALGLRFIMPTKAKF
FEYEGLSGETYPDRMAGGVEGIYKVAGLPVSPYLVPQECGMHMETKWVELTRNQTLDNTD
KDQEDFSLRFEQQDTPFAFSALPFKAEELEQATHIEELPPERRTVLTIFAKVRGVGGINS
WGADVESPYRISSEEDHEIGFIIQ
>FECAFAII_01767 Beta-galactosidase large subunit
MKANIKWLDDPQVFRVNQSNAHSDHVCYATREEVETTSSLKQSLNGSWRFCYSPNPSVRP
KTFYKKDFDACSFDEITVPSHIELANYDKIHYINTMYPWEGHVFRRPPFTTSPEKEAEGI
FSAAKDNPVGSYLTTFRLEEGLKGKQISIHFAGVEQAMFIWLNGHFIGYAEDSFTPSEFD
LTPYLEEENILAVEVYKRSTAAFLEDQDFFRFFGIFRDVFLVARGQNHLEDLWIKPRLDD
KCQNGKLEVDLSFEQVAKNSQLNVAILDPDGKEIYQQQYPLKEQMTIRIDGFENVALWGH
FQPNLYKLELETIDEEKRVTEYIDYSFGFRKIEIKDKIIYFNGKRMIINGVNRHEWHPKK
GRAITIEDMEKDLAIIKNAKINGVRTSHYPNQITWYYLCDQAGIHVMAETNLESHGSWQK
MGAFEPSYNVPGAVPQWQAAVLDRAKTNFETLKNHPSILFWSLGNESYAEENIRQMNDYF
KKVDPDRLVHYEGNFPNPAFEDSISDVKSCMYAPPEEIIDYLENKAEKPFILCEYMHDMG
NSLGGMDSYMTLLDRYEMYQGGYIWDFKDQAIQVTDPITGREVMRYGGDFDDKPSDYEFS
GNGIVFADGQEKPAMQEVRYYYEKYSK
>FECAFAII_01768 Bifunctional alpha-galactosidase/sucrose kinase AgaSK
MDITHRKTDKNFILFDEKSRVFHLRNTFLSYLIKIEESNVLAHIYFGKPVKQYKDNKNYP
RRDRGFSGNVPLNPDRSLSKDTLPQEYSSHGSMDFRTPASIIQRKNGSDLLDLRYDSHYI
TDGKPEIEGLPQTYVMDKSEAQTLVISLKDRETAIYFDLFYTIFTDRAVITRSVKIRNET
GETIKLEKAASFQLDFAHTRRFDEVIALPGAHVNERQISRQSVLSGTKVFESRRGTSSHH
MNNFIALVHHHTTENTGEAIGLQFVYSGNHSFELEKDQINQLRVVGGINSHRFSWELNAG
QSFQTPEMILSYSSQGLNKMSQIHHELLRERIARGRHQFAERPILVNNWEATYFDFNSEK
IKAIIDEAKELGIEMFVLDDGWFGKRDADNSSLGDWFEYEGKLTNGLREIADYAHSKGLK
FGLWFEPEMISVDSELYRTHPDFLMQEPGRMPSASRSQHVLDFTRLDVRQTIEKQMRKIL
DTIPLDYIKWDMNRSLSDVYSITLDPQRQGEVAHRYMLGLYELLEHLTTDYPEILWEGCS
GGGGRFDAGFIYYMPQSWTSDNTDAVERMKIQYGTSLAYPISSITAHVSAVPNHQTDRST
SLKTRGETAMSAVFGYELDLTKLSPEEKKQVKDQIISYQTIRPVIQYGHYYRLASPFEEN
IAAWMFVSPKQDEAIVFLGRILASAQPAFHEVYLMGLDDEALYQEQTSKRIFSGAELMTV
GLYFPDFQGDFQTELLHFKKL
>FECAFAII_01769 HTH-type transcriptional regulator LacR
MVGIRDVARKANVSPATVSRVLNNDQTIHVAQTTRQRIVEAAAALDYDISTRKYIKKRMP
SIGVISTIGKASEEQDIYYKHLRVGMEEEARRLHLGMNRIYNLSDNPKQWEDLDQLGAVI
VVGTVTKESITALLKQNMQIVVVDNPDIQQEVDMVYADLERMTKTVLELFLENGHKRIAY
IGGYKVDMDEFGGKQISINEKRMRAYQHFMIDHHLEKYMSYHLGGWTEKQGEVLATNLLE
NESPLPTAILVGSDPMAIGVYRALKQKNIQIGEEIVVASFDNIETIANLSPGLTSVQINA
KSIGQAAVRMALERIDGIRDEPIILTYPARLIVRESFIPRTKRY
>FECAFAII_01770 Acetyl esterase
MKKKILKFIGWFFGIILGIAFAIFLAFQLSPRPGAFLINHMFSNTVQITDKKTFDQAEKN
VAKKTDLTYESKYKENTYDIYYPKNSKGPVPVLFWVHGGGFVGGDKSGVKEFATKLVSDA
NIAVVAMNYELAPDSEYPNQVLQVNELIKDLLAEEKDDKLLDMEQLFFGGDSAGSQIALQ
YAAIQTNDAYAKQMKIKQLLPKDSLKGTISYCGPVDLKLTAQQHSDDRFMKFFVKTVAWS
LIGTKDWKTSEQLKEASVADHVSKEFPPTYITDGNAYSFQEQGQALENRLTELKVPVQSL
FYTDTKKEITHEYQFDYTLKESQNCYQQTLDFVNKYK
>FECAFAII_01771 hypothetical protein
MDQKEKMKELIKKKQGGGRSKQMETPKNDRKNMRKGPKIFNK
>FECAFAII_01772 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MTEQQIVKKNERYTVEIVDLSYEGMGVAKIDGYPLFIENALPGEEVEILVVKAGNKFGYG
KVETFITQSPDRQPVENNALLRIGIAPLAHLKYEQQLVFKQKQVEHVMAKIAKMPEVPVL
PTVGMAEPFGYRNKAQIPVRRIDGQLATGFYKKNSHDLVPIEDFYIQDPVIDQAIKVVRD
ILQRFQVRGYNEEKNEGQLRHIIIRRGHYSHEMMVVLVTRKEKFFKSKEIAEAIHEELPE
VVSVIQNINEEKTNVILGDKEKVLYGRDYIEDQLLGKTYRISAKSFYQVNTQQAEYLYQT
AIEFAELDKKDIVIDAYSGIGTIGLSLADRVDKVYGMEVIPEAIEDAQFNALNNKIENVH
YEVGKAEKVMKKWQEKGIKPSVIVVDPPRKGLDHHFIESAIEMSPERIVYISCNPATFAR
DAKLFAEAGYAVKKVQPVDLFPQTHHIELVASFVKGE
>FECAFAII_01773 Diacylglycerol kinase
MKKARVIYNPTSGKELLKKNLADILQALEEAGFEASAYATTPEPDSAKNEACRVAELGFD
LVVAAGGDGTINEVVNGIAPLEHRPKMAIIPAGTTNDYARALKIPRDNIKAAAEVIKKHQ
TVKMDIGLSDNSYFINIAAGGYLTELTYEVPSELKSIFGYLAYLAKGAEMLPRVKPIKMR
LKYDEGEYIGNASMFFLGLTNSVGGFEQIAPDAKLDDGKFSLIIVKTANIFEILHIAALM
LNGGRHVDDPRIIYTKTSSLFVETEDDINRPVMINLDGEYGGEAPMHFQNLHQHIEFFAN
TDQIPDEAITGTDEEELEVVSKEFVKEVERLTDEDIDGDGKIADETPNQKN
>FECAFAII_01774 Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B
MNFETVIGLEVHVELKTNSKIFSPAPAHFGAEPNSNTNVIDWGYPGVLPVMNKAALEFGM
KAALALNCEISKDTHFDRKNYFYPDNPKAYQISQFDQPIGHDGWIEIEVEGKKKKIRIER
VHLEEDAGKNMHGIGGYSYVDLNRQGTPLIEIVSEADMRSPEEAYAYLEALRSIIQFTEV
SDVKMEEGSMRCDANISLRPYGQEEFGTKAELKNLNSLSFVKKGLAFEEKRQAKVLLSGG
EIQQETRRFDETTNKTVLMRVKEGSSDYRYFPEPDIPKFVIDDEWIQKVKASLPEMPASR
RERYIREFGLPEYDAMVLTLTKEMSDFFEAVLENGADAKQASNWLMGEVSAYLNSEKLEL
AETKLTPENLAGMIRLIADGTISSKIAKKVFRELITNGGEAQEVVEKNGWVQLSDPNKLL
PIINEILDNNQQSVDDFKNGKDRAVGFLVGQIMKATKGQANPGVVNKLLKDELAKR
>FECAFAII_01775 Glutamyl-tRNA(Gln) amidotransferase subunit A
MTELHNRSLEELHHMLVSKEITVQDLTKTTFERIKETEPEVEAFITLNEEKALEQAKALD
EKGIDESNVLAGIPIGIKDNIVTKDILTTAASKILYNFEPIYDATVMDKIYQADMIPVGK
LNMDEFAMGGSTETSYFKKTKNAWDPTKVPGGSSGGSAAAVAAGQIPVSLGSDTGGSIRQ
PAAFNGIVGMKPTYGRVSRFGLIAFASSLDQIGPMTRTVKDNALALTAISGYDEKDGTSS
GVSVPDFAEGLTGDIKGMKIALPKEYLGEGVAPGVKEAVLKAAETFRSLGAVVEEVSLPH
SKYGVAVYYIIASSEASSNLQRFDGIRYGYRSENVKSLDDVYVNSRSEGFGEEVKRRIML
GTFSLSAGYYDAYFKKAGQVRTLIKRDFEKVFADYDLIIGPSSPTVAFGIGENINDPITM
YMSDILTIPVNLAGLPGMSVPAGLSEGLPVGLQIIGNYFDEKTMYQAAYAFEQATEFHKQ
QPAILGGKDE
>FECAFAII_01776 Glutamyl-tRNA(Gln) amidotransferase subunit C
MAISEEQVKHVAKLAKLAFADEELASFTDQLGKIIDMVEMLEEVDTEGVPFTSNVVETVN
VMRQDRAQAGWNRDELLKNVPETEDGFIKVPAIIDNGEAGA
>FECAFAII_01777 DNA ligase
MEHEMTIDEAAKRAEELRTRLNQWSREYYVEDKPTVEDYVYDKEYAELVAIEEQYPDLIT
SDSPTQRVGGKVLEGFEKVTHDIPLYSLNDVFSKEELIAFDQRVQKAVGRVVDYCCELKI
DGLSVSLRYEDGNFVRGATRGDGTVGENITENLKTVRSVPIKLKEPMNIEVRGECFMPKR
SFVQLNQDREAEGKDIFANPRNAAAGSLRQLDSKITAKRNLDTFLYTVADFGPMQAKTQY
DALEELEKIGFHTNREKRLCHSIDEVWSYIEEYHDKRVDLPYEIDGIVIKVNEFSLQDQL
GFTIKAPRWAAAYKFPPEEVETLIENIEWTVGRTGVVTPTAIMTPVRVAGTTVSRASLHN
GDYIKLKDIRLKDTVLIYKAGDIIPEVSQVVLDKRPKDSEEYQLPTHCPVCGSELVHLDE
EVALRCINPKCPAQMKEGLNHFVSRNAMNIDGLGPRVLEQMYDKKLVADVADLYKLTEEE
LLTLDKIKEKSANNILTAIDNSKDNSVERLIFGLGIRHVGAKAAKILAEHFGDLETLSKS
DYESIIALDTIGDIIADSVVTYFSNEEVHELMNELKQAGVNFEYKGLRNAQLQEVESPFK
EKTVVLTGKLTRFTREEAKETIENLGGKVTGSVSKKTDIVVAGEDAGSKLTKAQELGIEV
WTEDQMADALAKSRSVEE
>FECAFAII_01778 ATP-dependent DNA helicase PcrA
MSSKAELLNGMNPRQKEAVLHTDGPLLLMAGAGSGKTRVLTHRIAYLIEEKEVNPWNILA
ITFTNKAAKEMKERVNAILASGGEDVWVSTFHSMCVRILRRDVDFIGYNRNFTIIDSSEQ
LTLMKRILKELNIDPKKYDPRSILGTISQAKNSLQTPQDFAKMQGSYYEEIAAKCYAAYQ
KELQYNQCMDFDDLIMNTIRLFEEHPDSLTYYQNKFHYIHVDEYQDTNHAQYTLVNLLAG
RFRNLCVVGDADQSIYGWRGADMQNILDFEKDYPDAAVILLEQNYRSTKNILSAANQVIE
NNSNRKPKNLWTENKEGNKITYYRADNERDETRFIVDRMQEEIRSNHRNYGDFAILYRTN
AQSRVMEETLLKANIPYKMVGGHKFYDRKEIKDILAYLNVLVNPQDSISFERIVNSPKRG
IGPGSIEKLRSFASLHEWPLLEAAQNVDLANIGGKAGQQLGAFGEMIQEVTQMIPYLTVT
ELTKEVLDRSGYLEDLKIQNTLEAQARIENLEEFLTVTQEFDKQFEQQNEEDADAPEEKL
TVFLNDLALVSDIDNLEEDASQVTLMTLHAAKGLEFPVVFLIGLEEGVFPLSRALMEESE
LEEERRLAYVGITRAEEALYLTNAFSRTLYGRTQYNRPSRFVEEIDQELLEIEGMRPTPK
KTPVFAKKTAYSYKQPETAVVPSKSATGGENNSWKPGDKVKHKKWGLGTVVRVSGTSKDL
ELDVAFPSQGVKRLLAAFAPIEKA
>FECAFAII_01779 H(+)/Cl(-) exchange transporter ClcA
MEKKGKIKKLDKTQIYFILKGIFVGLLTGIVVSLFRLSIEKLSDLVRSIYEMSREQPIYL
IGLAICCILAAFFVGYLVKNEPDIKGSGIPQVEGQLRGELSMNWFSVLWKKFIGGVLSVG
AGLFLGREGPSIQLGASIGQGAGQLFRSPSSEEKILISSGASSGLAAAFNAPIAGLLFVL
EEIHHSFSPLVWLTSFASAITANFVSLYFFGLRPVLYLGDLPSLPLKYYGSLVILGVLLG
ILGFIYQNVLLALPKFYNRLPLPAYFHGFVPFLLILPIGYLWPSTLGGGNQIVLAFGHAS
LPIIMIIGLFVLRFVFSMISYGGGLPGGIFLPILTLGALIGSFYGNIMVDFGMDPIYIKD
FVVIAMAGYFTAIGKAPLTAIILVTEMVGSLNHLMPLGLAALVAYIVNDLLGGNPIYESL
LERLLGNTQTASLKGARTTFDFPVTAESSLDGLMVRDFNWPKNMLLISIRRGNQEILTHG
DTIMNVGDILVILTDEANLPRIKQEIEAKSSITNLKQSF
>FECAFAII_01780 PTS system fructose-specific EIIABC component
MNIKDLMVKEAMIMDLQATDKKGAIDEMVQKMFDAGRISDIETYKEGILAREAQTSTGLG
DGIAMPHAKNSAVKEATVLFAKSQKGVDYEALDGQPTYLFFMIAAPEGANDTHLQALAAL
SRLLIDADFVGKLKEANTPEEVQDLFQTAEEQKEAEEKAEQETQAAEASAHPERKFVVAV
TACPTGIAHTYMAEDALKKKAKEMGVEIKVETNGSEGIKNRLTAEDIARAEGVIVAADKK
VEMNRFDGKELINRPVSDGIRKPEELINLALSGTAPVFHGDGKESSSEEGNADGTIGQRI
YKDLMNGVSHMLPFVIGGGIAIALSFMIDQFIGVPHDQLSNLGNYNQAASWFNQIGQAAF
GFMLPVLAGFIASSIGDRPGLIVGFAAGALANTGGAGFLGALIGGFLAGYVIVFLRKLFK
NLPKSLDGIKTILFYPVFGLLITGFLMLLVNVPMKAINDALNGFLTSMSGSNAALLGALL
AGMMAADLGGPINKAAYVFGTATLATTVATGGSVVMASVMAGGMVPPLAIFVATRLFKNK
FSKTDQDAGLTNIVMGLSFVTEGSIPFAAADPIRAIPSFIIGSALTGGLVGAFGIKLLAP
HGGIFVVFLLSHPVMYLVFIAIGAVVSGVIYGLLRKAPAVAEA
>FECAFAII_01781 Tagatose-6-phosphate kinase
MIYTVTLNPSIDYIVRVDGLKLGDLNRMKEDFKLPGGKGINVSRILKRIDSQSTALGFLG
GFTGEFISKWLEKEQIQSLFTTVKEDTRINIKLKSDTETEINGLGPSISDEEIDELKQAL
GTVGQGDIVVLSGSAPASLRKGFYQELIDIIREKGADFVIDTTGDDLKNALVKKPLLIKP
NNHELAELYNTTFQSVEEIIPYGKKLLAEGAQNVLISMAGDGALLFTEQGTYKTNVLVRP
LKNSVGAGDSMIAGFIGAYSRTKDPIEAFKWGVACGSATAFSDDLAARELIDELLPEVEI
TKID
>FECAFAII_01782 HTH-type transcriptional repressor GlcR
MLTEERRQKILDLLEQQKIVKSQDLVNLLNASESTIRRDLQELENSGFLERVHGGAKKEQ
LLNFEQNMSEKSLKNVHEKQQIAKSAAETINDEDVIYLDAGSTTLEMIPFLQGKQITVVT
NSVQHAANLVDLELATIILGGTIKLATNAVLGSNAIEQLKNFHFNKAFMGMNGAHLEQGF
TTPDPEEAAVKRLAMKNSEETFVLIDHTKFNQLSFTSVAPLEAATIITERCPLEFVNEFR
EKTTIKEAIQ
>FECAFAII_01783 hypothetical protein
MDKQLYYRIMVPASLLSVCLFFVPNFPIRSVIGFLVMFGGMGLYYYLLHKERKPASVYMK
KTRSENKKR
>FECAFAII_01784 hypothetical protein
MIGEDKLLMTIQLTDLNEEEKKQEISDWAILTRLLIQPTFIRSFTQQADPYDLRKLQEKI
MLASVRDESWLVVGNDENECSFRLEDNQLLIKNVLSISVFKEKQFLIRDFIQKKMIAHGV
FAYMRAYSEFIYHNTKQISQRLLFEKKDEIEHLPKMKQQNGEVVVDCNQFPGYDLFYQGL
CFTSCWEMYYSRYYHQIIPKPIFLDIQQVEKVKELENEVICIQLYRDPFNWQKPNNQMFQ
SYFRDQLGFDHLAWDNGVGLLKPPFVEYIYTDHTIQSVQYQNAQMQPVPKKNASFFVTKS
YDIQQGDYKERRVRGTLNAQAYFPWVDENRSRMMCYKVIDPTVALDNGIEAYCYYIREYL
EVEVTDEKYQEYLLSLRIYVPSESLSELPLKEIKHRLSDVTFKRIKKKRRSIQFDVKKGE
QHLRVQFLDYRELEQLITLQKI
>FECAFAII_01785 hypothetical protein
MGLKFERTDNLDKLFESFAVDPEKTVAPKEEIDRFLKPQPQNEKKKDKKQK
>FECAFAII_01786 putative GTP-binding protein EngB
MKVHQAEIIISAVAPKQYPDTQLPEIALAGRSNVGKSSFINTLIDRKNLARTSGKPGKTQ
TLNFYLIENALHFVDVPGYGYAKVSKTERAKWGKMIETYLTTRDQLRAVVSLVDLRHKPS
QEDIQMYQFLKYYDIPVIVVATKADKIPRGKWNKHESEIKKALDFDRNDTFILFSSVTKQ
GKEEAWAAIEQAIES
>FECAFAII_01787 ATP-dependent Clp protease ATP-binding subunit ClpX
MYDNPSSNETVRCSFCGKTQEEVKKIVAGPGVYICNECIDLCKEIIDEEFYEEAVREFTE
VPKPLEILEVLNNYVIGQDRAKRSLAVAVYNHYKRVNQQAQENTDDVELQKSNICLIGPT
GSGKTFLAQTLAKTLNVPFAIADATSLTEAGYVGEDVENILLKLLQSADYNVELAEKGII
YIDEIDKIARKSENVSITRDVSGEGVQQALLKILEGTVASVPPQGGRKHPHQEFIQIDTT
NILFIVGGAFDGIETIVKNRMGEKTIGFGTQNQKLSEDESVMQHIIPEDLLKFGLIPEFI
GRLPVMAALEKLTTDDLVRILTEPKNALVKQYQKLLSLDNTELEFEPEALRAIAKKAIER
NTGARGLRSIIEEIMMDVMFDIPSNENIEKVIITKEAAELSGEPTVIYKDSEKKAG
>FECAFAII_01788 Trigger factor
MTATFEKKGTNDGVLKFTIAQDEIQKGLTTAFNKVKKSLNVPGFRKGKVSRQVFNRMYGE
EALYEDALNAVLPEAYEAAVKEAGIDPVSQPKIDVESMEKGQDWVITAEVTVKPEVKLGQ
YKDLVVEKQDREVTDADVDARIKREQEAQAELVIKEDAAAENGDTVVIDFEGFVDGEAFD
GGKGENYSLELGSGSFIPGFEDQLVGHKSGESLDVNVTFPEDYQAEDLAGKEAVFKVTIH
EVKAKEVPELDDEFAKDVDDEVSTLDELKEKYRKELVETKEKAADDAKDEAAIRMAVENA
EIVELPHVMVHDEVHRSMDEFLNNMQRQGISPEMYYQLTGSTEEDLHKQFEGEAEMRTRT
NLVIEAIAAAENLQATEEEINAEIQELSETYNMPIEQIKRVLTEDMLEHDVTMKKAIELI
TGTATEAKE
>FECAFAII_01789 hypothetical protein
MKPIDFPEKYENLMRVAQQALANQQYQQAKELFQRAYELKESFEANSLLVFCLYELDEKK
EALKQALLHEKQYLQNEEFAEFYFDLLISTQDFLYARKLIASTDFYEAFEQRVIEKIQFA
EELSGQMERQKIKALHNKSEELPSLEPARQLASIDEIEQLPYHEFIQTASKLIVSPEVHI
LARAKLLETLRQLNECHPVFYLTIEEKLVKVIPKDLPKPQQQASYQQLCVFSDRYGNEDA
LLSSVLKEEFTLQSAIVYPVYDTYIEDPKRWFQLTVEACTGKTMYEGTEDEKQDFLKKRE
KILQQMIFFH
>FECAFAII_01790 hypothetical protein
MSELSNENKEQEKDKQQQPAVGPDSNFSQKVLSSFEREPLTPEEIKKKQRKWKKYTDTRN
EPPKANDFPKYFYAGFFIRMFAFLVDLLCIGAITRLTLGIAKNLGWLNFSDSYLSLYGFT
ALLIYLAYFILLTKFNHGQTIGKMIFGIRVISFDEEELSWSTVLVREGACRFILKFPLLM
LGYLPAVFNQKKQHLGDFFTNTSVVTINLIKAFNQEVNS
>FECAFAII_01791 Putative signal peptide peptidase SppA
MNKRRWAAVLIAAGLFVVSLVSASLTKPQENDQIEGLNSWLYGDEELAPNVLEEGDSTQK
IVKLSVDGTIAAGGSSGLFASEGYNHKNFMEQLKAIEEDPTVKGIFLEVNSPGGGVYESA
EIAKKLDTIRKEHDIPMYVSMKNMAASGGYYISAQADKIFATEETVTGSIGVIMSGLNYS
GLLEKLGVEDTTVKSGALKDMGSGTRPETKEEEAVLQAYIDSAYSRFVAIVSEGRNKSEE
EVKKIADGRIYDGVQAKEVGLVDELGFPEDALKAIRKEQQLEDAELVEYSSTPSGFASTW
LGSKLAEFQGLKPSETSQILSVLENLGTAESPKAMYYYGGE
>FECAFAII_01792 hypothetical protein
MDSKIEIMTLGMLKKQLSKFEASAGVSDDTKIFLDTGWDSIQEIAPDALEVAQAREFTVE
DELTKESFSGYAREEKAERFDTSEQSETVIVIKNLY
>FECAFAII_01793 Glutamine--fructose-6-phosphate aminotransferase [isomerizing]
MCGIVGMIGLKNVTPGLIDGLEKLEYRGYDSAGIFVSDGTTDYLVKAQGRIQNLKNKINI
DTTGNIGIGHTRWATHGQPSEENAHPHTSQSGRFVLVHNGVIENFEELKIAYLANDHFIG
ETDTEIIAHLIETFAKDTTTQEAFLKALRVIKGSYAFALIDRTAPDVIYVAKNKSPLLIG
LGDGFNVIASDAMAMLAHTKEFVEIEDEEMVTVTSEKVIIQNFAGDIVERSSFEAQVDAS
DIEKGTYPFYMLKEIDEQPIIMRRIAQKYVTEDNRVSLDQKLVDTLSDSDRIYIVACGTS
YHAGLAGKQTLEKLTQIPVEVHLASEFGYNTPLLSKKPFFIFLSQSGETADSRQVLVKIN
RLGYPSLTITNVAGSTLSREASFTLLLHAGPEIAVASTKAYTAQIAVLTLLAKAIGDKKE
FETSLVFDITHELSLVANAMESVIAQKDYLEELAEVYLSDTRNAFYIGRGADYNVSLEAA
LKLKEISYIQAEGFAAGELKHGTIALIEEGTPVIGIISEEVTGAHTRGNLKEVESRGAKT
LVIVSEGLEKESDQLVLPTVHPYLTTLTTVVPTQLLAYYATLLRGFDVDKPRNLAKSVTV
E
>FECAFAII_01794 Phosphoglucosamine mutase
MGKYFGTDGVRGEANKELTPELAFKLGRCGGYVLSQHEEEGKRPRVLVGRDTRISGQMLE
EALISGLLSVGIEVFQLGVISTPGVAYLTRLQKASAGVMISASHNPAQDNGIKFFGADGF
KLVDDQELEIEALLDAEVDELPRPSAEGLGTVEEFPEGLLKYSQFLVQTINGDLSGLTIC
VDAANGATSTSVNRLFADLETDFYTMGTNPDGLNINDGVGSTHPERLAEMVVEKGADAGL
AFDGDGDRIIAVDELGNIVDGDKIMFICAKYLAEKNRLKKDTIVTTVMSNLGFHKAVEGI
GLKDVVTQVGDRYVVEEMRKNDYNFGGEQSGHMIFLDFNTTGDGMLSGIQLLNIMKQTGK
KLSELAAEVTIYPQKLVNIRVSDKNGAMDVPAIKKVIEEAEAEMGSEGRILVRPSGTEPL
LRVMAEAPTDEKVNYYVDKIAAVVKEEIGLD
>FECAFAII_01795 CdaA regulatory protein CdaR
MISKEKRTSILYSFIALLFSIALYFNANGQSVPNTLSGNEAYNQTVTGVPIKISYDSKRY
YIHGYENAVTVKLSSANRVQLNAEANEDTRMFRVTADITKLGEGTHEVPLKIQNLSSAVT
AKIEPSTITVTVEKKVIKDFDVETLIPSTFTPSGYELDDTSVSPKKVSITTGDKTLAEIK
RVVADVDASMVTDDGINSEVPIQALNAAGEVLSIVSDPVQVTVRADSIKPSKSVRLYGIQ
QGTPAAGVESYDFSFSKLEAEVSGSSDLLASIGDSIAVPINVSGINHRTTRKIEIPVEEG
LSIKPESVSVEITPVLQTSSSSSASTSSRTQENTSTSRSISSADSGTEPSTTTISSSSES
GTSSSTTSTEETSETSESTQMSRTNSSEN
>FECAFAII_01796 Cyclic di-AMP synthase CdaA
MSFQIGELFNLDYWQQMFSGDLFSLNFLVNILDILVVWYLVYKLIQLLRGTKAIQLLKGV
AIFIVIRIVAEIIGLHTLSWLMNQVITYGVIAAIVIFQPEIRRGLEHLGRSSLFKQSKSE
QQEDEKMILSFDKAIQYMSKRKIGALITIERHTGLDEYIETGIALDADITGELLINIFIP
NTPLHDGAVIVKEGKIAVASAYLPLSESMLIPKEFGTRHRAAVGISEVSDAITIVVSEET
GDVSITLDNELMAGLSQQEYLAILRRELIAEEKTKNKKNVIQSFLDGMTKGGDRK
>FECAFAII_01797 Pyruvate synthase
MRKMKTMDGNTAAAYISYAFTEIAAIYPITPSSTMAELVDQWSAAGKENVFGQPVKVVEM
QSEAGAAGVVHGSLKTGALTTTYTASQGLLLMIPNMYKIAGELLPSVFHVASRAVTTNAL
NIFGDHGDVMAARQTGFAMLAESSVQEVMDLAPVAHLASIEGEVPFLNFFDGFRTSHEIQ
KIEVLEYEELAPLINQEKLASFRKRGMNPNHPTVSGTNQNPDIHFQQRETINPYYDKLPE
IVQKYMKEINRLRGTSYDLVTYYGADDAEEVIVSMGSVAQTIEQTIDYLNANGRKTGFLN
IHLYRPFPVETFVQKLPHTVKTIAVLDRSKEPGAGGEPLLLDVQSALYDSELRPAVIGGR
YGLGSKDVTPDQISAVFDELKKDPSIRKKRFTIGIVDDVTYQSLEPKESLDLTEPQTFQA
KFWGFGSDGTVGANKSAIKIIGDHTDKYAQGYFYYDSKKSGGLTVSHLRFGDTPIRSAYL
VEHADLVACHTPAYLHSYDLVKGLKPGGIFLLNTLWSDEQLETHLPLKLKRYLAENNIRF
YTINAMRLAQEVGLGRRINTAMETAFFKLADIIPFDEVLPLLKEEALKSYGHKSMAIVEK
NIQAIDRTTELLHQVAIPDHWRTLEMPEKINKRNTGYIQEILEPVNAQEGNQLSVGTLVA
NGMTTGEMPLGTASMEKRGVALEVPEWISDRCTMCNECAFVCPHAAIRPFLADEEEMEEA
PEGFIVREMRGADGVKYRIQVSVEDCTGCGLCVEACPAKEKALVMKPYEEQKEQAVNWAF
AMTLRQKANPVKGKNTVLSTQFNQPLLEFSGACSGCGETPYVKLLTQMFGDRMMIANATG
CSSIWGGASPASPYTTNECGQGPAWSNSLLEDNAEFGYGMLLAAQTRREALASSIKEVLP
KVSEELRELMEDWLVHMFESEGTQQRAAKLQAAIESERSIFPELEDIYKRKDLFVKNSQW
MIGGDGWAYDIGFGGIDHVLASGADVNILVLDNEVYSNTGGQTSKATPASAIAKFSASGK
YASKKDLGMMAMTYGNVYVAQIASGANQMQTIKAFEEAEKYPGPSLIIAYTPCITHGLLG
GMKESLKEAKEAVSSGYWSLYRYNPTMVEKNKNPMTLDYKKPDFSAMPDFMRKQVRFSSL
DNANPNLAKALFEKTVHDAKTRFYNYAALTGELEKIKKRLEPEESIDVPVKTRKEKTTDL
EAEERRAARRAARAERRKKMEQATKEKKEK
>FECAFAII_01798 hypothetical protein
MDISVIDATKTNTQKGILYGSSNAPKKMVEFINLACPYCRQWFEESYELLEEAVQSGQLQ
RVIKLFDKEKESLQRGNVMHRYLTISDGQKAIKEIKQIFDTQDEWKHLSLQEVADFAVDK
LKLTEQKDEQLSQAVINEAEQAHIRFVPTVILGKEIFDESISIEELKELIQTK
>FECAFAII_01799 hypothetical protein
MRNLSNRNKILIIIVVIAVFHLGTNAVLSRIILGPKPPRPEITRGEFDFRLEYEVDGERI
VIEDTIVALFDGFSADAGSMAWYRTWRLHLASDRRSRNILLDELEDGRRIYYVPESANYS
MGDVQKKREPNPNWYPFNGVTIEYPRNKTPEIGAKFISGLEDLYDRFGIRLISWEHDPPI
ENRFE
>FECAFAII_01800 hypothetical protein
MEYNGSMRIVQIIFWITSGIVIIGGVFLMLPSLIFPFFALISPKIPEPEITYGEFPFRIE
YELDGQINIIEDTVIAEFNGCEFSAGSMKRERRWRSRLASGREDLPFGDDLGIYFSRGSA
QYYMGENVQSMSLKPHIALRNLEEGFKREVDFILGESGYIRTVLNFGEAQEVLTQYGITL
INWEISEPIVNNFGD
>FECAFAII_01801 hypothetical protein
MRAVHVNPTIEITMIGHSKGGAEAANSVAINTNAIIFNPATVNLSAYELDSNTYTANMVA
YVVEGDALNVVFGGVYTYWRINHVR
>FECAFAII_01802 hypothetical protein
MKEKPINKWSLYKNSMFGVVIFGVCAGLFLFILLQTVTLFSSNPTYGWRDSIALGMFAGG
YGFLLLFSILTLSPIHGLIQLWK
>FECAFAII_01803 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIVAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYIAKRSTEGWTPDVIIGRAERTFSCSVSTLYRRFKTGEFNVL
HLPMQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEGDTIVGIHHKSAVITL
VERLSKAIIALKPEGRKAVDIENSINEWLQSVPKNLFKSITFDCGKEFSNWKSISNTNDI
DIYFADPGTPSQRGLSEHSNGLLRKDGLPKEMDFNQVNQGFISSVASKRNHIPRKSLNYQ
TPLEVFLSYVNGKFCLA
>FECAFAII_01804 hypothetical protein
METVRLWIFMKNFRSALRYVILESKSGYYLIDTDHYTFWGGYLFPIFNWIIPHKVMKINL
PAEEINRLILNKDLQRKREKEHSNVAWIGPAFAVVTSSIVGPMLESIYSDFSIGIRYLFV
TLSIAVLLCIKGYVSKKNKDILTLIGVNNLSSTKIILFPESIKEGSRLLIIFIMLILFSV
LFGVMFIDYYLSN
>FECAFAII_01805 hypothetical protein
MCFFTTFTIIMIAVLFIFLDIAKRNTAFLLYRVLLRAGLITFISIVGFFLFTVIVFIWRT
TAPPLPEITYGEFPFSLEYEIDEERILIEDTVIAEFIGSFRGNVTTQPRRSWSIKLLNNS
GELKAFHYEFLIIESEDVTITLSSGSAGYFMNDGGSKPQLTVRDRIAGFMHFSHYDLEEA
RKILAEYGITLINWEYAPPIRNFFNDYY
>FECAFAII_01806 hypothetical protein
MVDKFIGLASRKQPGVINVEVLTRGWSDLFSDNHKFINSNWDVWLVYVIPELELSRFGLE
FENRCL
>FECAFAII_01807 Putative sporulation transcription regulator WhiA
MSFAADVKKELTGLEVHREHAKAELAALLRMNGSLGIVNQQFILNVQTENAAIARRIYSL
LKDHYQVRSELLVRKKMKLKKNNVYIVRLKQGTKDVLMDLDIMDGMMFNGHVSDEIMGNS
QKMRSYLRGAFMASGSVNNPETSRYHLEIFSIYEQHNQDICDMLNYYGLHARTLERRNGY
ISYLKGAEKIADFLTLIGATNSMLRFEDVRIVRDMRNSVNRLVNCETANLNKTIDAASKQ
IENIELIEAKVGLHALPEKLQEIAELRLQHPEVSLKELGEMIPSGAISKSGINHRIRKIN
EFAEKLREEAV
>FECAFAII_01808 Putative gluconeogenesis factor
MKMKTYRIRKPKIVVVGGGTGLPVILKSLRNQGADITAVVTVADDGGSSGAIRESIAMAP
PGDLRNVLVALSDMPQFYEDIFQYRFKKEDQFLANHTIGNLIIAAVSEMRGSTYEAIQLL
AKMMHVDGHVYPSSETPLTLHAVFKDGTTAVGESKIAINRKTIDRVYVCNTNDKSEAKAA
RKVVSAIMDADMVVLGPGSLFTSILPNLVIPEIGEAMLKTTAETVYICNIMTQKGETEHF
TDADHIRVLHKHLNQPFIDTVLVNTEKVPEDYMDPEIYDEYLVQVAHDFNGLRNEGCRVI
STDFLELKDGGVFHDGDKVVEELFRLVFGSKY
>FECAFAII_01809 Nucleotide-binding protein YvcJ
MTDNLQLVIITGMSGAGKTVAIQSFEDMGYFCIDNMPPRLIPKFWELIKESGKVTKMALG
VDLRSRSFFEEIQNMLIEIENTNFIDTSILFLDASDEELVARYKETRRAHPMAMDGLITE
GIRKERAILDDLKAQASVIIDTTTLTPRQLREKINESFKSKGDQGFRIEFVSFGFKYGLP
IDSDIVMDVRFLPNPHYIPELRPLTGKDQPVYDYVMSFDETQSFYHKFLDLLETVLPGYI
KEGKSSLTVAIGCTGGQHRSVALTERLANALGKNYKVNVTHRDKDKRKETVNRS
>FECAFAII_01810 Aspartate racemase
MENFFSILGGMGTMATESFVRLINHRTKATKDQEYLNYVLFNHATVPDRTAYILDRSEEN
PMPFLLDDIEKQNLLRPNFIVLTCNTAHYFFEELQAATDIPILHMPREAANELVRQHTTG
RVAILGTEGSMKAGIYEREVKNLGFETVIPDTALQEKINYLIYHEIKESDYLNQELYYEI
LEEAVERLNCEKVILGCTELSLMHEFAEDNHYPVIDAQSILADRTIERALAERSEALDTA
SEK
>FECAFAII_01811 D-aspartate ligase
MMNSIENEEFIPILLGSDMNVYGMARSFNEAYGKICQAYASDQLAPTRYSKIVNVEVIPG
FDKDPVFIETMLRLAKERYSDKSKKYLLIACGDGYAELISQHKQELSEYFICPYIDYSLF
ERLINKVSFYEVCEEYDLPYPKTLIVREEMLVNGHLEQELPFEFPVALKPANSVEYLSVQ
FEGRKKAFILETREEFDLILGRIYEAGYKSEMIVQDFIPGDDSNMRVLNAYVDEDHQVRM
MCLGHPLLEDPTPASIGNYVVIMPDYNEKIYQTIKAFLEKIEYTGFANFDMKYDPRDGEY
KLFEINLRQGRSSFFVTLNGLNLARFVTEDRVFNKPFVETTYGTNQSDKARLWMGVPKKI
FLEYARENEDKKLAEQMIKENRYGTTVFYEKDRSIKRWLLMKYMFHNYIPRFKKYFHVKE
G
>FECAFAII_01812 UvrABC system protein A
MANDKITIHGARAHNLKNIDVTIPRDKFVVVTGLSGSGKSSLAFDTLYAEGQRRYVESLS
AYARQFLGQMDKPDVDSIDGLSPAISIDQKTTSKNPRSTVGTVTEINDYLRLLFARVGHP
ICPNDHIEITSQSVDQMADQVMALPERTKIQVLAPIVVKKKGQHKKIFERIQKEGYVRVR
VDGEIYDLSEVPELEKNKKHDIAIVIDRIIVKEGIRSRLFDSLEAALRLADGYALVDVIG
EEEMLFSEHYACPYCGFTVGELEPRLFSFNAPFGACPDCDGLGVKLEVDQDLVIPDRTKT
LSQGAIVPWNPISSQYYPQMLAQACESFGIDLDTPFEELPEEHQEIILNGTDDLFHFHYE
NDFGGVRDVETTFEGVLKNIERRYHDTNSDFTREQMRLYMTELTCQTCKGYRLNPQALSV
QINGTNIGQTNELSIQKAVDFFSNLTLSEQEKVIAKPILKEVNDRLSFLENVGLDYLTLS
RASGTLSGGEAQRIRLATQIGSNLSGVLYILDEPSIGLHQRDNDRLIGSLKKMRDLGNTL
VVVEHDEDTMWAADYLIDVGPGAGEQGGQIVAAGTPEEVANDENSLTGKYLSGKKSIPVP
KERRKGNGKAIKITGASENNLKNISVEFPLGEFVAVTGVSGSGKSTLVNSILKKSLAQKL
NKNSAKPGKFKTISGYESIEKIIDIDQSPIGRTPRSNPATYTSVFDDIRGLFAQTNEAKM
RGYKKGRFSFNVKGGRCEACRGDGIIKIEMHFLPDVYVPCEVCHGKRYNSETLEVHYKGK
SIADILEMTVEDAVEFFKHIPKIHRKLQTIVDVGLGYVTMGQPATTLSGGEAQRMKLASE
LHKISNGKNFYILDEPTTGLHSDDIARLLHVLQRLVDAGNTVLVIEHNLDVIKTADYIID
LGPEGGEGGGTILATGTPEEIINVKESYTGHYLKKIMV
>FECAFAII_01813 UvrABC system protein B
MIERDTSRHFELVSKYQPAGDQPEAINQLVDGVVGGKKAQILLGATGTGKTYTISNLIEK
VNKPTLIIAHNKTLAGQLYGEFKEFFPNNAVEYFVSYYDYYQPEAYVPSSDTYIEKDSSV
NDEIDKLRHSATSSLLERNDVIVIASVSCIFGLGSPFEYQKQVVSIRQGAELDRNQLIRD
LVSIQFERNDIDFQRGRFRVRGDVVEIFPASRDERALRVEFFGDEVERIREVNALTGEVL
GETEHVAIFPATHFVTNDEHMEHAVANIKAELEQRLTVLRNENKLLEAQRLEQRTNYDIE
MMLEMGYTSGIENYSRHMDGRKEGEPPYTLLDFFPEDFLIVADESHVTMPQIRGMYNGDR
ARKQMLVDYGFRLPSALDNRPLRLEEFEKHVNQIIYVSATPGPYEHEQTDTVIQQIIRPT
GLLDPVIEVRPIMGQIDDLVGEINERVEKDQRVFVTTLTKKMAEDLTDYFKELGIKVKYL
HSDIKTLERTEIIRDLRLGEFDVLVGINLLREGLDVPEVSLVAILDADKEGFLRSERSLV
QTIGRAARNEEGKVIMYADKVTDSMRLAMDETSRRRTIQQKYNEEHGIVPKTIIKEIRDL
ISITKESEDDTKEAVQVSYEEMTKEEKDTLLMKLEKEMKDAAKALDFETAANVRDMILEL
KASK
>FECAFAII_01814 putative glutamine ABC transporter permease protein GlnM
MKRKHLFHSFVFLMTGLVTLAFGHVAQADNTTTAESSTSETMQKIEPKKDVYVIASDSAF
APFEFQNAKGEYEGIDVKLMENIAKLQGFNIRMDYRGFSAALQALESGQADGMIAGMTVT
DERKKSYDFSDSYFDSGIQLAVKKGDTSIKSYEDLKGKTVGAKVGTESAEFLSDHESEYG
YSIKYFDAADQLYDGLKVGAIDAMMDDYPVIGYAIKQGQELETPIKKESGGKYAFAVKKG
QNPELLNMFNEGLKELKRTGEYDKIIKEYVADGSETSSESSTADESTFLGLIQNNYQALL
KGLWRTILLTLISFALAIVIGVIFGLFSVAPIRALRTIASIYVDIIRGIPMMVLAFFIFF
GLPGIVGFTIPDFLAGVITLTLNASAYIAEIVRGGINAVPVGQMEASRSLGLSYNRTMQK
IILPQAIRIMIPSFVNQFVISLKDTTIISAIGVVELLQTGKIIVARTTQSTYVYLIIAIM
YLILITALTKLAKVLEKKVK
>FECAFAII_01815 Arginine transport ATP-binding protein ArtM
MAEKILVEHLVKKYGDNTVLNDINVSINEGDVVCIIGPSGSGKSTFLRCLNRLEEPSDGE
IIIDGAHLMDKSTDINLVRQHIGMVFQHFNLFPHLSILENIILAPMDLKKESREEAEKKA
IKLLQTVGLEDKKDMYPEMLSGGQKQRVAIARALAMNPDIMLFDEPTSALDPEMVGDVLN
VMKKLAEQGMTMVIVTHEMGFAKEVANRVMFIDDGNFLEDGTPQQIFENPQNERTKDFLN
KVLNI
>FECAFAII_01816 Carbohydrate diacid regulator
MGQLSDNQQLCQERINPLLELLERVFSYYGQALLTVHRQQIIILVNRISRASLLSLLDKI
QTKFNKMYQLQLNFGIGSLCYTEQETPQSFLHAKQVCEWIAFHQSVNEIRFFEDLDLGIV
LPAIPSDQRTLYVKRILKSLTEEEVHLFKKTLACFSKNNGSIKNCSEELFIHKNTLQYRL
NKFHSLTGYTPRNYDDYHILKLAFLLVQT
>FECAFAII_01817 Chaperone protein DnaJ
MATKRDYYEVLGLSKGASEDEIKKAYRKLSKKYHPDINKEPDAEEKFKEVSEAYEILSDP
QKRAAYDQYGHAGTDPNYGAGGAGGGFGGFGGFSGGGFGGFEDIFDSFFGGGGRSVDPNA
PRQGADLQYTVDLSFEEAIFGVEKEIKYNREEICHTCGGNGAKPGTQPTTCHKCHGAGTI
NVERQTPLGRVMSRQTCDVCHGTGKEIKEPCPTCHGSGHEKKAHSVKVNVPAGVEEGQQM
RLAGQGEAGENGGPFGDLYVVFRVEESDIFDREGSEIYYELPLSFVQAALGDEVQVPTVH
GDVKLKIPAGTQTGTNFRLRGKGAPKLRGGATGDQHVKVKLITPKNLNEQQREALRAFAE
AGGIKVEEQQEDGFFDKFKDAFGGKKRK
>FECAFAII_01818 Chaperone protein DnaK
MSKIIGIDLGTTNSAVAVLEGNEAKIIANPEGNRTTPSVVSFKNGEIQVGEVAKRQAVTN
PNTISSIKRHIGEAGYKVDVEGKSYTPQEISAMILQYIKGFAEDYLGEKVEKAVITVPAY
FNDAQRQATKDAGKIAGLEVERIVNEPTAAALAYGLDKTDRDEKILVFDLGGGTFDVSIL
ELGDGVFDVLSTAGDNHLGGDDFDNKIIDYMVAEFKKENSIDLSQDKMALQRLKDAAEKA
KKDLSGVSSTQISLPFITAGESGPLHLEMTLTRAKFDELTADLVERTKVPVRQALKDAGL
SQSEIDEVILVGGSTRIPAVVEAVRKETGKEPNKSVNPDEVVAMGAAIQGGVITGDVKDV
VLLDVTPLSLGIETMGGVFTKLIDRNTTIPTSKSQVFSTAADNQPAVDIHVLQGERPMAA
DNKTLGRFQLTDIPAAPRGIPQIEVTFDIDKNGIVNVSAKDLGTQKEQKITIKSSSGLTD
EEIERMVKDAEANAEADKARKEEVDLRNDVDALLFSVDKTLKELEGKVDEEEVKKAETAR
DELKAAVEANNIEEMKTKRDALNEIVQNLTVKLYEQAAQQQAQENPEAAQGGADDVVDAD
FEEVDGDDK
>FECAFAII_01819 Protein GrpE
MKENQEELDKEMTDAQPEPEIDVEAAEDSGISEAEAEEFETAKLKAELEEMEDKYLRARA
EIANMANRGKNEREQLQKYRSQDLAKKLLPSIDNLERALATEVSDDQGAGLKKGVEMVLE
SLRNALEEEGIEKIPAKGEAFDPNLHQAVQTVPATEDTPADTIVEVLQEGYKLHDRVLRP
TMVIVAQ
>FECAFAII_01820 Heat-inducible transcription repressor HrcA
MLTKRQNDILRLIIQHYTSSGVPVGSKTLMSEGVKASSATIRNDMKALEDEGLLLKTHSS
SGRIPSALGYRYYVDHLLKPARVAEDDLLLIRQSLGREFHEINEIIKQSAEILSELTSYT
TFSLGPEIKDRRLTGFRIVPLNNRQIIAIVVTDMGNVESQVFTLPEYMGSQELEKMVQIV
NDRLVGDPLMTVYHKLRTEIPMILHKYFQTTEGMSQLFDTVLGHVFEDKVYVSGQMNLLD
YEPRQDLDQFKSMFSFMKDSDGLTQMITPMDSNIHIKIGAELGNDLLQNMSMIQASYEID
GHGRGTIALLGPTSMPYSRMFGLVDVYRRELAAKLADYYRSLDLSNS
>FECAFAII_01821 Oxygen-independent coproporphyrinogen-III oxidase-like protein
MIETINPAENKVSAYIHIPFCEHICYYCDFNKVFLEGQPVDEYVEMLLNEMKIMLESHPT
ANLETLYVGGGTPTSLSAKQLDRLLSGAREILPFQNGNEFTVEANPGDLTREKLQVMKNY
GVNRLSMGVQTFDNRLLKKIGRKHTAEDVYQTMQFLEAENFTNVSIDLIYALPGQTLEGY
LDTLEKALALDLPHYSLYSLILENKTMFMNWVRQGRLELPDQETETRMFEETIEAMEKHG
RHQYEISNFGLSGHESQHNLMYWNNDHYFGFGAGASGYLGDIRYRNKGPIQHYLRPLRAN
ERPVLEEEKLTRKNQIEEEMFLGLRKKTGITKKHFYDRYQKTIESVYGDVLRELEQEGLL
VNEEDRVYLTPRGTFLGNNVFERFLFEK
>FECAFAII_01822 hypothetical protein
MKIAFHIFADFDLMPKVSFAITVYREAVKAPCSSDDNKQAFLELGFLDSKYAAYFNELVL
ERDFKKVENRHDFST
>FECAFAII_01823 putative protease YdeA
MKTAITFLLEEYADWEGAYITSTLNQNEKWQNKTASIQSEVTSIGGLKTKIDYLIEQIPE
KVDLFIMIGGNSWDIKNHHLYQIIDKLLKTDVPVAAICGAVDYLAQSGLLQGYKHTGNAQ
FPWLESENYQNKEDFIEQQAVKDRNLITANGTAPIEFTDLILQAVHFETEEIREKTIRLY
KLGFYDYYKKYGDPFS
>FECAFAII_01824 hypothetical protein
MKKLGFILLLVSLFLVGCTSPSKENSDPSATTDKSSIRQTSSAEKSSTQKSASTETNTSS
TSSKVSEPNTSSTSSSTVETNISSSTIDTTSSQSSQSIDPLAGYSDLQIEYARVWLAIRG
NTFRDTSGDFELHVIHYPAGTPIAPYDAGSAVYPKDVVMLTGKYSYQGVLVYSSNHDGTI
TSYPVPSHWQMPADQTSYPAFIRETTQEIIDNASVVAIPTGNPNDVKQLIDVTVIDN
>FECAFAII_01825 Microcin C7 self-immunity protein MccF
MISYPLLERNATIGVTAPSSGVSEEHHSLLESALKRMEEKSFQVVTGKTLWTQDKEKSGP
ARKRADEFNQMMQDENIQMIFPTWGGELLIEILDFVDFDALQPKWIVGYSDISTLLLAVT
LKTGIATAHGTNLIDLRGEYLDETTAMWESVLKTREGESILQQSSEKYQKVWPHEHSSSS
VFHLTEPTNWQSVSGDAVRMKGRLLGGCIDTIRHLIGTPYGDVQSFKRKYNDGKPILWFL
ENCELSSVDLRRSLVQMKLAGWFDGSSGIMFGRSAAEDLLDYKMKDVYEDLSKELKLPIL
YDIDCGHVPPQLTLINGAYAEVAVEDRKATVLQTFI
>FECAFAII_01826 Prolyl-tRNA editing protein ProX
MIDLAKKFLHENIYFELYHHRAIYTNEDALVIKKEQGFTGTETKSLFLKDKKDNNYVYLT
FTTKQTDFKALGKIVGKRLSIVSSERMEEQTGQKQGAVSPFGYEKQIPIIIDEELLSNEK
LVFAPGRPDQTMVIQTVDLNKIIQLLEMPIFLMPANEKNN
>FECAFAII_01827 Intracellular iron chaperone frataxin
MEKFQPIINQIKEKEHQQKIKDLFAKITETYPQLDTTVKWNQPMFTDHGTFIIAFSFAKN
HFSIAPEKAAIRALEKNIQEAGYVYTDNVIKVPWKSVINWELIEQLISFNIEDKKGHDKF
WR
>FECAFAII_01828 hypothetical protein
MKDFYSVNELAEQLGVTTRSIRNYLHEGKLKGTKVGGQWKFSERNLFEFLYGDQAEEAAK
EMQRFMLNAPITMRFNLQYRDFTAINQFREQLVQYHNDVYANKKDRLLQYDLYKDNHAEI
LIGGNFNYVVNFSQWINEKLLIQTDISLVS
>FECAFAII_01829 Glucose uptake protein GlcU
MGLLIALIPAVGWGIQPLILKKIGGRPTNEILGTGIGAVLVGLLVQLFASPAGISVTTFL
ISLLSGAFWVIGQTGQYTSFNLIGVSKTMPISTALQLVGTSLIGVFAFGEWSGSMGKIIG
AAAIILLVFGSALTAISDDPGKKGGITKGISLLASTSIGYWVYSALPKLVDASGLSIFFP
QMIGVFLGAVIYVIFRKPTAFSEDKSWKATIVGAIFSVSALAYIFSANENGVATAYIITQ
LNVVISTLGGMYILHENKTPKEKKLTIIGLLLIVVGSMVTVFI
>FECAFAII_01830 Glucose 1-dehydrogenase 4
MYKELENKVAVVTGGSKGIGTAIAQRFGKEKMNVVVNYNSDKEGAEKAVKAIEEAGGKAV
SVQADVSSEEGIQRLLDTALENFGTLDVWVNNAGMENQHPTHELSLEDWERVLKVNLTGV
FIGTKAALNYFTENNKKGNIINMSSVHEQIPWPTFAHYAASKGGVKLFTETVAMEYAPKG
IRINSIGPGAIRTPINAAKFDDPEQKELLESMIPLGRVGEPKEIAATAAWLASDESSYVT
GITLFADGGMTLYPSFQGGKG
>FECAFAII_01831 Riboflavin biosynthesis protein RibF
MNIIKIRHPYQSEQIPEDDVVLVLGFFDGVHIGHQKVIKTGMEIAQKEGLKLALMTFNQH
PSIVFKKIDPSSVKYLTSLKQKEEKMAALGIDYLYEVDFTSSFAHLAPQEFVDQYIVGLH
AKYAVSGFDYTYGPKDIADVAHFPEYAKGRFKIVTVSKEEEQGEKISSTRIRGLLDSGQV
KEAAKLLGCTYEVEGVVVHGDARGRLLGFPTANVKVKSTVHLPKEGVYVSEIKIGETWYP
AMGSIGHNDTFGEGRELTVELYILDFNQDIYGEHVAVRWNQFLRDQVKFSSVEELIEQLK
EDEQATAEYFSQQ
>FECAFAII_01832 tRNA pseudouridine synthase B
MDGLLPLWKERGMTSHDCVFKLRKILHTKKIGHGGTLDPDVDGVLPICIGKATKVIEYLT
DSGKIYVGEITLGFSTTTEDRSGERVETKPVDMSLSEKKIDEVMASFIGEITQIPPMYSA
VKVNGKRLYEYARNNETVERPVRKAQIYRFIRTSELTRDEVTGTISWRFEVECGKGTYVR
TLAVDTGKKLGYPAHMSDLTRTASAGMSQKDALTLEEVAQAVKNGTIDDCLLPIEKGVER
FKRVDITDEVWQKVKNGMRLDYTVFALPEMPSEEIALFYKGKVVSIYQPNPKEKNKLKPS
KVLRNEE
>FECAFAII_01833 Xylulose-5-phosphate phosphoketolase
MLTQHFKWMRKSHDLSWRNDYPSLNLIASSTVFQQDHNGYSHQDPGILTHLAEKKAEFIR
EYLPADANTLLAVMDKAFRSSEKINLIISSKHPRAQFYSAEEAAVLVNEGLKIIDWASTA
KEEEPELVIAAAGTESNLEALAAVTLLLEEFPKLKIRFINVVDLLKLRHPSQDPRGLSDE
EFDQYFTKDKPILFAFHGYETLVRTIFFDRHNHHLMIHGYKENGDITTPFDMRVVNELDR
YHLAKDAALKIKGSQAEDFAKKMDQKLQEHQNYIRENGIDLPEVLDWKWKNLDQ
>FECAFAII_01834 Xylulose-5-phosphate phosphoketolase
MIGDGEAETGPLAGSWFSNVFINPVIDGAVLPILHLNGAKIANPTILARKSDGELANYFN
GLGWEPFFIEGNDSEKLNPVMAEKMDQAIEKIKSIQKEARLKTATDVVMPKWPVLIVRTP
KGWTGPKEWDGEPIEGTFRAHQVPIPVDQEHMDHADALLRWLKSYEPEKLFDAQGRILEE
IREIAPTGDQRMAKNPITNGGIDPRPLIMPDWKKYTLQFEKPGSVKAEDMTELGKFVREI
IEKNPENFRIFGPDETKSNRLNQVFKTTNRQWMEKIEPENDEWLSPSGRVIDSQLSEHQD
EGFLEGYVLTGRHGFLQVTNHSCEWLTLC
>FECAFAII_01835 Xylulose-5-phosphate phosphoketolase
MDYSSKEYFDKMTAWWRAANYLSVGQLYLKDNPLLRRTLKPEDVKKHPIGHWGTIPGQNF
IYVHLNRVINKYDLNMFYIEGPGHGGQVMVSNAYLDGSYTEIYPEVTEDETGMQNYSNDF
HFLEALLLMQHQKHQVLSMKAESLDTLFHMQSELY
>FECAFAII_01836 Ribosome-binding factor A
MANYRDRRVGQEILKEVNDILRKKVRDPRVENVTITDVKVTGDLQQATIYYSILSDLASD
KKTAQDGLNKASGLIRRELGHNLSIYKTPELFFELDESVVYGNHIDELLRDLNKD
>FECAFAII_01837 Translation initiation factor IF-2
MGNKRIYELAKELKKSSKDVVEKAQQLGIDVKNHMGAITSNDEKKLQQAFKNPSTKQQAA
QQASRKPANQQPNDQRKKETTNNQQKNKNNRSYQDRGQGSGQVNQGKKPTTNQNNTGNTS
SQNRQGTSQGGNQNRTNNNNKPNNNNRGKFNNNNRNRYNKKGKKGKQQQSTKPAVPPRKF
RELPDVLEYTEGMNVADIAKKIHREPAEIIKKLFMLGVMVNQNQALDKDTIELLATDYGM
EPQEKVQVDIADIDKFFEAEEVDPDKLVSRPPVVTIMGHVDHGKTTLLDTLRHSRVTSGE
AGGITQHIGAYQIDIDGKPITFLDTPGHAAFTSMRARGASITDITILVVAADDGVMPQTV
EAINHAKAAGVPIIVAVNKIDKPGANPQHVMQELSEYELIPEAWGGETIFVEISAKFGQN
IEELLEMILLVAEVEDLKADPTQRAIGTVIEARLDKGKGPVSTLLVQEGTLHVGDPIVVG
NTYGRVRVMTNDLGRRDKEAGPATPVEITGLNDVPQAGDRFVVFEDEKTARAAGEERAKR
ALLENRAATSRVTLDNLFESLKEGELKEVNVIIKADVQGSAEALAASLKKIDVEGVRVKI
VHSAVGAINESDVTLAAASNAIIIGFNVRPTPQAKVQADTEEVDIRLHRIIYKAIEEIET
AMKGMLDPEFEEKITGQMIVRETFKVSKVGTIAGAYVTEGYIRRDSGVRVIRDGIVIYEG
QLASLKRFKDDVKEVKMGYECGAMIEKFNDIKVDDVIEGFIMEEVKND
>FECAFAII_01838 putative ribosomal protein YlxQ
MNTVNRQKAMNLIGLAMRAGKLITGEELTIAEIRKQKAKLVFVATDASENTRKKIKDKSS
YYEVPCFELFSEAEITQMIGKPRKVFGIMDAGFAKKTKELIEG
>FECAFAII_01839 hypothetical protein
MKQRKIPLRKSVVSGEMKPKKEMVRITRSKEGEVSIDPTGKMPGRGAYVSLEPEEVQQAW
DKKILDRVLETTLTDEFYQELLDYVTHQKARKELFGK
>FECAFAII_01840 Transcription termination/antitermination protein NusA
MSKEMLNALDALEAEKGISKEIVIDALEAALVSAYKRHYGQAQNVEVEFDQKKGKIHVYA
VKEVTEEVMDSQLEVSLKDALLINPAYEIGDTIRFEVTPKDFGRIAAQTAKQVILQRVRE
AERTIIYNEFSAYEKDIMQGIVERQDKRYIYVNLGKIEAVLSKQDQMPNEFYQPHDRIKV
YVSRVENTSKGPQVFVSRSHPDLLRRLFEQEVPEVYDGIVEIVSIAREAGDRSKVAVRSN
DPNIDAVGTCVGPKGQRVQAIVNELKGENMDIVEWNEDPAVFIANALNPAQVMDVIFDET
NPKACTVVVPDYQLSLAIGKRGQNARLAAKLTNHKIDIKSESDMTEFYENQEQQKETEEL
HDEAIVQSDLTDDEYETIAFNNETVEEKPEA
>FECAFAII_01841 Ribosome maturation factor RimP
MSSVVETVTEMVTPILDEQNFELVEVEFVKEGKSWFLRVFIDKEGGIDIEECAFVSEKLS
EKLDAADPDPIPQAYFLEVSSPGAERPLKKESDYEKALGDYVHVSLYQPVDGEKQYEGFL
QSFDAEQLTLKIRIKTREKELTFDRKNIAKARLAIQF
>FECAFAII_01842 DNA polymerase III PolC-type
MSEKRDLFEKLLEQIQLEEAEKNHPLLTAGEMDSVVVHRKSRLWEFTLHFSKILPIMLYR
SLTQHLTIAFKDIAQVKLNILADDQTFDEQLLQDYWAQALENQQCDTPLAQQVLKTQVPV
IKDRKVILPIDSTGAISYLKQQYLPLVEELFVSYGFPKFRIEPEVDEQQAERVLKLFEER
KQEQAEAFMKQAAESLVVHEQKKKERKEQSPALEGPIHIQLGRNIPADEPTTPMISIVEE
ERRVTLEGYVFDKEVRELRSKRKILTLKITDYTSSFIVKKFSNGEKDEQVFDAISVGSWL
KVRGSIQEDTFVRDLVMNAQDIIEVKHTPRKDYAPEGEKRVELHVHSNMSTMDATNSISD
LVAQAGKWGHRAIAITDHGGAQAFPEAHSAGKKAGVKILYGVEANVVDDGVPIAYNDAHE
ALSEATYVVFDVETTGLSAVYDTIIELAAVKMYKGNVIESFDEFIDPGHPLSRTTVDLTG
ITDGMVRGSKSEEEVLRMFLEFSKDTILVAHNAAFDMGFLNTSYARYGIPEAANPVIDTL
ELARYLYPQFKRFGLGVLSKKFGVSLEQHHRAIYDAEATGHLAWIFVKEAMDNHNMLYHD
QLNEHIGEGDSYKRARPFHVTILAKNQAGLKDLFKLISMSNVEYFERVPRIPRSQLKKMR
ENLLIGSACDKGEIFEAMMQKGVEEARNRAKFYDYIEVMPKAVYAPLIEQELVKNEHDLE
EIIQNLVEIGKSLDKIVVATGNVHYLNEEDAIYRKILINSMGGANPLNRHSLPDVHFRTT
DEMLTAFHFLGEETAKEIVVENTNKIADICEEVIPVKDELYTPKIPGSEDEISELSYTKA
KQMYGDPLPEIIQKRLKKELNSINGNGFSVIYLIAQKLVHKSNEDGYLVGSRGSVGSSFV
ATMTGITEVNPLAPHYYCPECQYSEFFEDGTYGSGFDMPEKQCPKCGARLNKDGHDIPFE
TFLGFHGDKVPDIDLNFSGDYQAEAHNYTKVLFGEDYVYRAGTIGTVADKTAYGYVKGYE
RDNNLQFRSAEVDRLAKGATGVKRTTGQHPGGIIVIPDYMDVYDFTPIQYPADDQNSEWK
TTHFDFHSIHDNVLKLDILGHDDPTVIRMLQDLSGIDPQTIPTDDPEVMRIFAGPEVLGV
SQEQIYSKTGTLGIPEFGTRFVRGMLEETHPTTFAELLQISGLSHGTDVWLGNAEELIRR
GDATLAEVIGCRDDIMVYLIHAGLDSGMAFKIMETVRKGQWNKIPDELRETYLSAMKENN
VPDWYIDSCSKIKYMFPKAHAAAYVLMALRVAYFKVYFPILYYCAYFSVRADDFDLVSMC
KGKDAVKQAMKEITDKGLDASVKEKNQLTVLELANEMLERGFKFGMIDLYKSDAVNFVIE
GDTLIAPFRAVPSLGTNVAKQIVEARKDGPFLSKEDLATRGKVSKTLIEYMNDNGVLKDL
PDENQLSLFDML
>FECAFAII_01843 Proline--tRNA ligase
MRQSKMLIPTLREVPNDAEVLSHQILLRAGYIRQVSAGIYSYLPLANRVLEKLKRIMREE
FEKIGAVEMLMPAILPAELWEESGRYETYGPNLYRFKDRNDRKMILGPTHEETFTDLMRN
EINSYKKLPLNLYQIQPKYRDEKRPRFGLLRGREFIMKDAYSFHATEESLDETYKDYEKA
YTEVFKRCGLEFRSIIGDGGAMGGKDSKEFMAISEIGEDTICYSTESDYAANLEMATSYY
VSKKSHETQLELEKVATPNVKSIDEVADFFSVEPQKIIKSVLFIADEQPVLVLVRGDHEV
NDVKLKNFLSADFLEEATEEEAQKYLGAEFGSVGPVGVSDDVKVYADRYVQDLANAITGA
NETGFHYKNVNPERDFTVLSYEDLRFVQEGDPSPDNNGVLAFTRGIEIGHIFKIGTRYSE
SMGATVLDENGREKFVIMGCYGIGVSRLLSAIVEQHSDEQGINWPKGIAPFDLHIVQMNL
KDEYQTNLTNELEEAMTKAGYEVLVDDRNERAGVKFADSDLIGCPIRITVGKKAVDGIVE
VKIKKTGEMVEVRKEELVNTLPILLNQGE
>FECAFAII_01844 Regulator of sigma-W protease RasP
MKTILTFIIVFGILVIVHEFGHFFFAKRSGILVREFAIGMGPKIYGHQAKDGTTYTLRLL
PIGGYVRMAGNGDDETEMAPGMPLSLLLNSDGIVEKINLSKKIQLTNAIPMELSRYDLED
ELTITGYVNGDETEVVTYPVDHDATIIENDGTEIRIAPKDVQFQSAKLWQRMLTNFAGPM
NNFILAILLFIILAFMQGGVQVTNTNRVGEIMPNGAAAEAGLKENDEVVSVDGKEIHSWN
DLTTVITKNPDKTLDFKIEREGQVQSVDVTPKSVESNGEKVGQLGIKAPMNTGFMDKIIG
GTRQAFSGSLEIFKALGSLFTGFSLDKLGGPVMMYQLSSEAANQGVTTVISLMALLSMNL
GIVNLLPIPALDGGKLVLNIFEGIRGKPLSQEKEGILTLAGFGFLMLLMVLVTWNDIQRF
FF
>FECAFAII_01845 Phosphatidate cytidylyltransferase
MKQRVVTAAVALVLFIPIIWIGGIAVELTAAILAVIGVYELFRMKGLTLLSFEGVLSAVG
AVLLVLPKERWFFFLPENVSTFMLFYLIVMILLGTSVISKNTYTIDEAGFPVLVSLYVGI
GFQNFVNARTESLAVLIFGLFIVWATDIGAYMVGRRYGQHKLSPDISPNKTIEGALGGIG
SAVVVAFLYLLLYPAKELFNHGMFVMLLMTIIFSAVGQFGDLVESAIKRHYDVKDSGNIL
PGHGGILDRFDSLLFVFPIMHLFGII
>FECAFAII_01846 Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)
MLRFFPQKNKYIQEKSEFQFNTDGPIPQHIAIIMDGNGRWAQNRRLPRVAGHKEGMETVK
KVTKKASRLGVKVLTLYAFSTENWKRPKDEVSFLMQLPVDFFDTFVPELIKENVKVHVMG
YENVLPEHTQDAVRRAIEQTKNNTGMVLNFALNYGSRAEIVTAVQEIAEEVAKGEIHAEE
IDDELIAKHLMTGFLPKELQDPELMIRTSGEERISNFLLWQIAYSELYFTKALWPDFDGA
HLEEAIASYQNRDRRFGGVKKTEDEKGDQS
>FECAFAII_01847 Ribosome-recycling factor
MADAIMTEAKEKMKKAAQNLQRELGQIRAGRANASLLDRITVNYYGAPTPLNQMASIQIP
EARVLMITPFDKSILQDVEKAIMASDIGISPTNDGNVIRLVIPQLTEERRKELAKDVKKE
AENAKIAIRNIRRDAIDEYKKQQKNGDITEDDLRGLEKDVQTLTDNSIKEVDKIAADKEK
ELLEV
>FECAFAII_01848 Uridylate kinase
MVTPKYQRVVLKLSGEALAGDAGFGIKPPVIKEIIQEIKEVHELGVEMAIVVGGGNIWRG
QIGAQMGMERAQADYMGMLATVMNALALQDTLENVGVPTRVQTSIEMRQIAEPYIRRKAE
RHLEKGRIVIFAGGTGNPYFSTDTTAALRAAEIGADVILMAKNNVDGVYSADPKVDANAV
KFEELTHLEVIAKGLQVMDSTASSLSMDNDIPLLVFNLNEHGNIRRAILGENIGTTVRGK
>FECAFAII_01849 Elongation factor Ts
MADVTAKMVKELREMTGVGMMDAKKALVEVEGDMEKAVDLLREKGMAKAAKKNDRIAAEG
LASVAVKGNTAAIVEVNSETDFVSKNEMFQDLVKEIAELVAENKPADMEAAMKIKTDKGT
IESDLIEATQVIGEKISFRRFEVVEKDDNAAFGGYLHMGGRIAVLTVLDGTTDETVARDV
AMHVAAINPRYVNESQIPEAELEHEKTVLTEQALNEGKPANIVEKMVEGRLKKFKAEIAL
VDQPFVKDPDMTVEKYVASKGATVKTFVRFEVGEGIEKREDNFVEEVMSQVKK
>FECAFAII_01850 30S ribosomal protein S2
MAVISMKQLLEAGVHFGHQTRRWNPKMKKYIFTERNGIYIIDLQKTVKLVDAAYDYMKSV
AEEGGVALFVGTKKQAQEAIKEEATRAGQYFVNHRWLGGTLTNWDTIQKRISRLKQINAM
EEDGTFEVLPKKEVAGLNKERERLEKFLGGIADMPRIPDVMYIVDPRKERIAVQEAHKLN
IPIVAMVDTNCDPDEIDVVIPSNDDAIRAVKLITSKMADAFIEGNQGEDQVVEEDFTEEN
TATSIEEIVDVVEGDNSSAE
>FECAFAII_01851 Arginine repressor
MRKAQRHLLIKQVIEEFPIRTQEELLNKLGHYGVTATQATISRDIRDLKIVKAPDENGVS
RFVLFREKGTPETRTEEEDRLVQMIEDIVLKVERVHFLTIVNTLPDNAHLFASVLDEIKP
PSIVSTIAGFDTIMVISENEEDAKRVEEFLHHPTEVSLF
>FECAFAII_01852 2-aminoethylphosphonate--pyruvate transaminase
MYKLLTSGPLTTSETVKNAMLIDHCTWDQEYKEITQWIRKKLLDLAQVSEGIYTTVLMQG
SSSFGVESVLSSVIRPEDTVLICSNGAYRQRMINMCECLKLNYTVYEVSEHQILQAHVIT
QLIEENPSISALAMVHSETTSGILNNLEEIAAVTQERDLLFIVDAMSSFGGIPICVAELG
IDFLISSSNKCIQGVPGFSFVLANKAELEKRKNVSRSLSLDLYDQYRVMENENGKWRFTS
PTHTVLAFQQALKELEAEGGIETRYSRYLANNHVLRQKMTEMGFQPFIQEYQGPFITSFL
YPKDWRFDFNHFYQYLKQNGFVIYPGKISDHECFRIGNIGEIYPEDILELTAIIKDYKEN
VND
>FECAFAII_01853 Phosphonoacetaldehyde hydrolase
MIKTVIFDWAGTTVDFGCMAPVHAFRNAFLEKGIQLTDKEIR
>FECAFAII_01854 Phosphonoacetaldehyde hydrolase
MGKLKWDHIQQLLSLPSVKKQWIAIYGQLPQEKEVEELYQQFEHYLFKDLVKHSTLKPDT
LETIERLRNAGINIGSTNGFNAPMMTIVAETAKKERYSPDFMATFEDVEGYGRPFPYMIH
KNMQYFKNKSVDEVIKVGDTVSDIQEGKNAGVLTVGVIEGSSLMGISYDEYQKLEMGKKI
V
>FECAFAII_01855 Arginine--tRNA ligase
MNNKDLVAKAVYDAVKDDLTLEQVEQLLENPKSAEHGDVAFPAFSLAKVYRKAPQQIAAD
LAEKIDSANFEKIEVVGPYLNFFMNKELISKKVLQTVVKEKEHYGDSNIGNQGTVPIDMS
SPNIAKPISMGHLRSTVIGNSIGFIMEKIGYQPIRINHLGDWGTQFGKLIVAYKKWGTEE
AVKAEPINELLRLYVQFHEVAETEPELNEEARAWFKRLEEGDKEAIQLWQWFRDESMKEF
NKIYDLLEVRFDSLNGEAFYNDKMDEIVKLLEEKHLLNEDKGAEIVDLSAYDLNPALIKK
SDGATLYITRDLAAALYRKRTYDFKQSLYVVGNEQSYHFKQLKAVLKEMGFDWSDDMHHI
PFGLITQGGKKLSTRKGKIVLLEEVLNEAIQSAKEQISEKNPDLENKDAVAKQVGVGAVI
FHDLKNDRLNTFDFNLEEVVRFEGETGPYVQYTHARAVSLLEKAGFVPSETADYALNDDT
SWEVVKLVQKYPETVLSAGEKYEPSVIAKHAIKLAQAFNKYYAHTKILADDEQKEARLAL
VYAVTVLLKEDLRLLGLHAPDKM
>FECAFAII_01856 Carbamate kinase 1
MAKRKVVVALGGNAILSTDASAKAQQEALMETAKYLVKFIEQGDELIISHGNGPQVGNLL
IQQQAADSEKTPAMPLDTCVAMTEGSIGYWLQNAMGEVLKEKGIDKDVVSLVTQVIVDEN
DPSFKNPSKPVGPFYTEEEAKEQMNADSTVTFKEDAGRGWRKVVASPKPISIKEARVIET
LVDQGVITVSVGGGGIPVVETATGLEGREAVIDKDFASEKLAEIIDADLLIVLTGVDNVY
VNYQKPDQKKLETVTVSEMKQYIDEKQFAPGSMLPKVEAAIAFVEAKPNAKAIITSLENI
ENLLASEEGTIIVAD
>FECAFAII_01857 Ornithine carbamoyltransferase, catabolic
MKESVFQGRSLLAEKDFTKEELQYLIDFSEHLKDLKKRGIPHHYLEGKNIALLFEKTSTR
TRSAFTTAAIDLGAHPEYLGANDIQLGKKESTEDTAKVLGRMFDGIEFRGFSQKMVEELA
EFSGVPVWNGLTDEWHPTQMIADFLTIQENFGTVEGITVAYCGDGRNNMANSLLVTGAIL
GANMRIVAPKELQPEEEIVKMAEGFAEKSGAQLMITDDVDKGVDGADVLYSDVWVSMGEE
DKFEERIKLLKPYQINMEMVEKTHNTDRLIFLHCLPAFHDTNTVYGEQMKERFGITEMEV
TDEVFRSKYARQFDQAENRMHSIKAIMAATLGNLFIPRV
>FECAFAII_01858 Arginine deiminase
MDKPIHVFSEIGKLKTVLLKRPGQEVENLTPDIMDRLLFDDIPYLPIAQEEHDNFAKTLQ
NEGVETLYLEKLAAEAIDAGNVKEQFLNKMLDESHIASNAVREGLHEFLLSMETQEMVDK
IMAGVRTKDIEVRSSSLYDLSADDDYPFYMDPMPNLYFTRDPSASMGNGMTVNKMTFEAR
RRESMFTEYILKHHPRFANKGIEVWLDRENPDHIEGGDELILSDKVVAVGISQRTNAKAL
EKLARHLFAKNSGFEKVLAIKIPNNRAMMHLDTVFTMVDHDKFTIHPAIQSKDGKMDVFT
IEPDGDDIKITHSDNLHETMKAALGLDDLVLIPTGNGDEIVAPREQWNDGSNTLAIAPGV
VVTYNRNYVSNELLRSYGIKVLEINSSELSRGRGGPRCMSQPLVREDLK
>FECAFAII_01859 Global nitrogen regulator
MRVNKIDFHFSKLRYQPDFEHFSDEEFQQIKEHTVLRSYKKGQILFDDGDPRQRLYILTK
GLVRLERYDESATYYYYDYVNTNNLFPMSGMFGEETYTYTAQAMTDIETFYLPVSYYEKL
ARKNPEQLIYMIQKISKVVEIHELRIQIGLTSSAFDRVKQNLFILKEELGVPTKDGHITI
PYPITLKELAVNSGTTRETAGQVIKQLRDSGLLDYDKKRFTFCKTATTPAMRE
>FECAFAII_01860 tRNA N6-adenosine threonylcarbamoyltransferase
MNEELILAIESSCDETSVAVVRNGTEILSNIVASQINSHKRFGGVVPEVASRHHVEQITL
CLEDALVEAGVSAEDLSAVAVTYGPGLVGSLLIGISAAKAFAWAHQLPLIPVNHMAGHIY
AARLVKPFQFPLMALLVSGGHTELVYMQEDGSYEIIGETRDDAAGEAYDKVGRVLGLSYP
SGKEIDQLAHQGKDNYHFPRAMIHEDNYDFSFSGLKSAFINLVHNAQQRGEDLDKNDLAA
SFQASVIDVLITKTLRACQNYPVKQLIIAGGVAANQGLREGLQDALAAKLPEVELVIPPL
RLCGDNAAMIGAAAHVEMQKRNFASYQLNADPSLVLSE
>FECAFAII_01861 N-alpha-acetyltransferase RimI
MICRKKDFDEAYLAECVWMISENAYPHGSPWTKMQFLADIQQPHSDYLLLAEDNQICGFI
GYSKVIDEVEITNIAVAVSEQGKGHARHLLQLLITEQIKDSLHVFLEVRLSNEAARKLYE
SEKFRILGKRKSYYRNPTEDAIIMSRKLKTETMK
>FECAFAII_01862 N-alpha-acetyltransferase RimI
MLKKFRAYARSFFQDKMIYTEKTVEQIDRRYVLRELTTEDIKELLDVEREVYNGELPWTK
SAFISELKSPLPHLYLGIFDNGRMIGFIGSRAFGLDCHITNIAVRPAYQRKRIGSLLIDE
IENFAIMNRCETMSLEVRMSNQDAQRLYRKLGFQATTIKKRYYTETKEDALDMIKLLENE
>FECAFAII_01863 tRNA threonylcarbamoyladenosine biosynthesis protein TsaB
MYYCTSFAFGIFILRIKKYATMEGENVIAERIKYMITLGIDTANQTLAIGVVEDEQILGQ
IQTNIKRNHSVTLMPAIDQLFADLQISPKDIDRIAVSDGPGSYTGLRIGVTTAKTIAYTL
DKELVGVSSLKTIAANCIGVDNIIVPMFDARRKNVYAGAYRWKENRLETVLEDVHISASD
LFTQLQKLNEAIYFVGSDCHKFFSEIKEILPSAMINTVPAWDIPSGVTVAQLGALVEPVA
EKQAFLPRYLKRVEAEEKWLETHTPGDESYVEKI
>FECAFAII_01864 putative HTH-type transcriptional repressor ExuR
MATIKDIAQLAGVSPATVSRVLNYDPDLSVGLATKQKIFEAAERLNYTKHRKNAANTKQT
LRLIQWYDDTEELEDLYYLSIRLGIEKKAEEANVTLLKETWDSISDLPADGTIALGKFDE
AQLLEMKGSQNALLLVDSDGTSQGIDSLVVDFKSSVQKVIEHFVSHKAQHIAMLAGTEYT
KKNHQRLKDPRIMAFQQVLAEKGYDEGPIIEADFSVESGYQAVKQYLKTNPHVPDALFAA
NDALAIGALKAIQEKGLVVPEDISVMGFNDVSVAKYVTPSLSTVKVYTEWMGELAVETIL
QLSNSKAPVSRKIIVETELIIRESTK
>FECAFAII_01865 Galactose-1-phosphate uridylyltransferase
MSISQTICDFATLAIEAGGWMEMDRLYLQNRLLGMVGEDALESIEVRPVKEESVDLLDQL
VAKARENGVLSELPAEQEIFEAQLMDFLTPPPSVVNAFFAQHYSKSPEEATEYFFNLSKK
NDYIKTRAIAKNIKFPAESEYGELEITINLSKPEKDPKQIAAEREAVKVDYPTCMLCMEN
EGYRGRLNYPARTNHRIIRMNLDGESWGFQYSPYAYYNEHSIILSEQHRPMKITKETFAR
LLRITEVLPHYFVGSNADLPIVGGSILSHDHYQAGRHEFPMAKAPIEKLIKLEDYPQVIA
GVVKWPMSVIRLQSTEKNLLIEAANSVLEKWKAYSDETVSIRAFSADGTPHHTITPIARR
RDNYFELDLVLRDNNVSEEHPDGIFHPHKDVQHIKKENIGLIEVMGLAVLPPRLKPELVE
VEHFLLGEENQMAEYHRPWAEQLKKEHPDLTKDTVTDVVQKSVGQVFARVLEDAGVFKRD
EKGQAAFERFTAIL
>FECAFAII_01866 UDP-glucose 4-epimerase
MTILVLGGAGYIGSHAVDQLVQKGYQVAVVDNLLTGHKQAVHPDAHFYEGDIRDKEFLRS
VFEKEPIEGVIHFAASSLVGESVEKPLMYFNNNVYGMQILLEVMHEFNVNKIVFSSTAAT
YGEPKESPITEDTPANPKNPYGESKLMMEKMMKWCDQAYGMRYVALRYFNVAGAKADASI
GEDHTPETHLVPIILQVALGQRKALAVYGDDYDTPDGTCIRDYVQVEDLIAAHILALEYL
KEGNESNFFNLGSSKGYSVKEMLEAAREVTGKEIPAEIAPRRAGDPSRLVASSEKAREIL
GWKPEYTDIKAIIKTAWDWHVSHPNGYEE
>FECAFAII_01867 hypothetical protein
MKKFVSGILVGSLATAAAVAGLVASVKKTVIDPIDEKEAMIEENRKKAMRKRVSR
>FECAFAII_01868 hypothetical protein
MKIGIIGAGPRGLSVAERILHNNQDRHSLELFLFDPNGPGGRVWRLNQPPELLMNSVSQQ
VTLFTDETLSSGGLVTQGPNLFQWSKGPATDYIEQTVTKNKQLIIEEINRLEKDQQSTRC
LYGLYQRWFFSKLQEEFPASIQFVYSLVKKVSKRKDGYLLQTDQQSYSIDQLVLASGHWE
NDETEEERVWVDYAKKNVLLYQLPSNPADVDLSKIPPKENVFLRGLGLSFFDYVGLFTVS
RGGRFENEKGKLVYHPSGKEPIVYSGSRRGLPYYPRGRNQKQGGAMAWPRLLTKENLEQW
HQSGFLTGETFFDYLKKDVELFYYKKIIEEYHLPIPKKNFEHDFLSLSSEECLGKHPALI
PYRWDWSYLETPLAYQNEPFSEASRIFIEGQIKEAEKGNCTGAFASTFDALKDWRDPIRQ
AIEWHVFSAKEYKEILWGWFTHLNSFLTIGPPIIRTKELAALIDAGIFHLIEPPFDIQQK
HNRYVISLQDKEISSRYLIEARLPQTSFSRSSNPVIKNLKENKLVRPFSFSDNTGSYHSE
AIDVERGTNRVIDASGEIQSDFYCYGIPVEGVDWLTAAVARPYTDPWNLRQADKIAQLIL
TDK
>FECAFAII_01869 hypothetical protein
MIKLKRVYLDAEKEDGYRILVDRFWPRGISKEKAQLDLWLKEIAPSNEARKTFDHVPERF
ASFAKKYQQELIFEEEKKQAIFKLSQLMKEHPVITFVYGAKNEHQNHAVLLKKFIEMEAC
K
>FECAFAII_01870 Thiosulfate sulfurtransferase GlpE
MVLWVINIILLLIVLAIILWEVYLRVMAKRSATTLTEEEFREGMRKAQVIDVREKDVFDA
GHILGARNIPYTVLKDSLGSIRKDQPVYIYDQKKSLSIRTANKLRKAGYQEIYLLKGGYD
GWSGKIKSKKV
>FECAFAII_01871 Glucokinase
MDKKIIGIDLGGTTAKFAILTPEGEIQQKWSIDTNILDDGKHIVPEIIESINHRLNLYNM
KAEDFIGIGMGTPGSVDSEAGTVIGAYNLNWTEVQFVKKLIEAGTGIKFAIDNDANVAAL
GERWKGAGENDPDVVFVTLGTGVGGGIVAGGNLIHGVSGAGGEIGHITVDPEGFECTCGK
RGCLETVSSATGVVRLGRFLAEEYAGDSKLKAMLDNGEEVTSKDIFEMAQEDDPFALMVV
DRVCFYLGLACGNLGNTLNPSSIVLGGGVSAAGEFLRSRVEKYFKEFTFPQVRESTKIKL
AELGNEAGVIGAASLALKFA
>FECAFAII_01872 hypothetical protein
MESLYDVQQLFKKFGIFIYVGARIYDIELMTIELRNLYDSRLIDHDTYMTAWRILKREHR
IEESRKKGNL
>FECAFAII_01873 Rhomboid protease GluP
MNYQQQIKLRAWLRRPLWTYAFLGIQTAVFLMMELFPRLEIPYYAGMYGPYLVHFNEWWR
LVTPIFIHFGLMHFVMNSLILYFMGQQIEAIYGHWRFFLIYMFSGIMGNTASFAFNEANV
LSGGASTSIFGLFGALFILGFHFKHNPAIQQLVRHFLLFIVLTFVFGLLDTSVDVWGHVG
GLIGGLVLGNVLGLPKQQTSYSIHQRILSTLVFVFLFVICILLGLKKYGLLV
>FECAFAII_01874 5-formyltetrahydrofolate cyclo-ligase
MDQLKVRLRRKGIEKLKNLAKSGKKKEKEQRIYKQLFASEYWKSAKVIGTTLSNEFELDT
QPVIQRAEKEQKKIVVPKTLPKRQMAFYEMDEQSVLVRSSFGVLEPQSEKLYLPEMIDLL
IVPGIIYNRAGYRIGFGGGYYDRYLNNFHKKTCSLVFREQLNEQWQPESFDQKIQQLFID
>FECAFAII_01875 Iron-uptake system permease protein FeuC
MKKIYWTFYFLLFVLVILSIGSLMIGTPFIYLDQLFATFIGKESSSLALIVREFRVPRLL
ISLLAGACLGVSGYILQGVTRNELADSSILGINAGAGFLVMLYLGFFSHYSLPFLLLVVA
FLGGVLAACCVYLAAYDRNGFLGMNRILLSGIAVNAGLSALTLLCTIQLSKENYGFVNAW
LAGSIWGASWPYVWALLPWAVILIPLGGLYAQRIVLLSFGQERAQGLGLNVAKSQKILLL
LAVALASGSVAVTGSLSFVGLLAPHAAKLVVRKENNWTFVLSGLFGSIFLLSADMVARVI
LPSGEVPTGILIALFGAPYFLYALFIRQKHALNS
>FECAFAII_01876 Iron-uptake system permease protein FeuB
MRTMKKNRLLLLVCFVLLIIFFVALSNGAATVEKADFWQALFDFDRSKQSHQIIRNIRLP
RVAGAFLVGSCFALSGALMQGVTRNPLADSGLLGINAGASLAMALSFAFWPKASDFSVFL
MSLAGSFAVTLLVFGFLQFSKMGMNPLQLILAGVAISSFFTAISQALTQFFNLQQDLAFW
FVGGAANITWKQLAVLFPLYILAVLVSFSLGKAISLIHLSETHALALGSHPKRTRLIVFC
LVAVLAAIAVSLVGPVSFIGLLVPPVVRGMVGTDYRYVLPVSFLVGGGLVMLADFTARMI
NPPFETPFGLVIALIGVPFLLIQVRREQR
>FECAFAII_01877 Ferric enterobactin transport ATP-binding protein FepC
MTRLRAADIAAGYENKKIIENMSVTIPEGKITSLIGPNGSGKSTLLKSFTRILPVKSGKI
IVNNSDISTYSSKELAKKIALLAQTSEHPTGMTVEEVVSYGRYPYQKLFSGMDTQDHEAI
EWALDATGLAGFRMRDIATLSGGQTQRVWIAMALAQETDILILDEPTTFLDPAHQLEILQ
LLTEINQMKQTTILMSIHDINHASRFSDYLLAMKNGKLITEGTPEEVITKECMKKIFEID
ATIVTLPRTNKPVFLTYDLLPKEQEDQL
>FECAFAII_01878 putative siderophore-binding lipoprotein YfiY
MKLKTKVFTLSSILLLAGVLSACSPSSDKETATTANSTTSSNSTHTVTDTLGHKVEIPNA
PKRIIGSYLEDYLIALGEKPIAQWTVGSGSIQDYLQDDLKDVPTISYDLPYEKVLSFEPD
LLLISSSATVEGGKYEQYSKIAPTYVVKNGTDVTWEEQLKDVGKALAKEKEAEKIISDYQ
KSIKKTREELADKIENKTAAVLWVTNNSAFMVSKNRSSGRIVYDDLEFGVPDLVEEVSKK
ATSDWSAVSSEKLAELDADYIILVNSDKDAAMFNEPSWKNLKAVTDNHVLQFGPESSWLY
NGPIASQEMVNDIKEKLN
>FECAFAII_01879 Dihydrofolate reductase
MFISMWAQDKNGLIGKNGLLPWRLPNDMRFFREHTMDRILVMGRKTYEGMGDLSLPYRHI
IVLTTQPNFRTKENAEVMHSIDELLSYSQTISEDIYVSGGSRIFQELLPYTGRIWRTLID
STFEGDTYIGNIDFSDFALIEEYEGITDQENLYAHRFQKWERVKNRVASKEE
>FECAFAII_01880 50S ribosomal protein L33 1
MRVNITLECTSCKERNYLTSKNKRNNPDRLEKQKYCPRERKVTLHRETK
>FECAFAII_01881 hypothetical protein
MPWNMKDFPASMKNLDKLTRKKAIDIANALLDEGYPDNRAIPIAIDQAKKWYEDASESEK
RTFEKEKNPSKTDEHDTNPRAGKLLDSDVIVEYEEEQWIVKSKGAKKASNHFDTKKEAIE
KGKQVAQNKESTLFIYKKDGTKEKEIDY
>FECAFAII_01882 Asparagine synthetase [glutamine-hydrolyzing] 1
MCGIVGFVNDKDNKKTIINTMMDRIVHRGPNSSGEYIDKHVALGFRRLSIIDLEGGTQPI
YNEDRTKIIIFNGEIYNYQPLREELIAAGHVFQTHADTEVLLHGYEEWGTELLQKIRGMF
AFAIWDNEKNELFGARDHFGIKPYYYAEMNGTFMFGSEIKSFLPHPDFNKELNKEALKPY
MTFQYSPLNGETFFKDVYRLPEGHYYTYKDGKIDIQQYWDADFETKETHSRQEWIEKIDE
TVQASIEAHTVSDVEVGSFLSSGVDSSYVTSVLKPDHSFSIGFDDKTYNEAIEARKLTEL
LDLDNTAAVIDGDMSFKAFPLIQYHLDEPDSNPSCVPLYFLANLASQSVRVVQSGEGADE
LFAGYQTYGFHTNSKFIRVIAQGLKKLPKGTRYNLGRKIGKMKNFHGRIHLYESLAPAKE
YFIGHARVFEESEASEVLTPKYQTAPSVDEIMTVHYEKTEGIKDEVNKMQYVDLHQWMPK
DILLKADKLSMASSLEVRVPLLDIEVMKLAQQIPSKFLLNQNNTKDIFRQAANKHLPEEW
SNRVKLGFPVPIKAWLKEEHGYEQVKALFEADFAKEFFDQEKIMKLLDDHHEGRKEEQRK
IWTIFSFLTWYKVYFVDETIPQAEAIDYVTV
>FECAFAII_01883 hypothetical protein
MMSKNNTNGRNQFAMLTIDDLVPQDHLVRKIDAALDFEFIYPIVEATYSDLGRPSIDPVI
LIKLVFIQYLFGIRSMRQTIKEVDTNVAYRWFLGYSFEEKIPHFSTFGKNYVRRFRETTV
FEDIFAYILEQAVKAGFVTEDNLYLDSTHIKANANKHKFTKEMTHDEAKAYQDELEDEIN
RQRIEAGKRPFTLDLEKEVKLKERKISKADPESGYYVKGEREKQFAYSAHTSCDDNGFIL
STIITPGNIYDSQVAFQLVKQSKRLFPEINCVVADAGYKTPKFVHFLTHLNLRPCLPYSR
PKGKKGLLSKNEFLYDEYFDCYICPQDQMLAFSTVTREGYREYKSNPKECVNCPLLNQCT
ISKNHQRVITRHVWGDLMDEVEHLRLTDLNKSIYKKRKQTIERIFADAKEKHGMRWTKYR
GLEKVATHTMLVFAAMNLKKLATWLWKGKEPLFFCSKIRNEVDKKLFQARVTSLEQLLST
V
>FECAFAII_01884 Choloylglycine hydrolase
MGLPGDLSSVSRFVKATFTKMNAASGDSESESISQFFHILGSVEQQKGVCDTGEGKYEYT
IYSSCCNVDKGIYYYRTYEDSQITAVNMNKEDLDRHELVSYPVIKEQQINYVN
>FECAFAII_01885 hypothetical protein
MNDFTTEIVQTLVTKGDLNELFRSHLEKAINTLLRTELTAFLDYEKYDRTGFNSGNSRNG
SYFRSIKTEYGELTLEIPRDRNGEFKQQTLPAYKRTNDTLETTIIHLFEKGVTMSEIADL
IEKMYGHHYTPQTMSNMTKVLTEEVNAFKSRALNDKYVAIFMDATYIPLKRQTVSKEAIY
IAIGIREDGTKEVLSYAIAPTESTYVWNELLQDINSRGVQEVLLFITDGLKGMKDTIHQI
YPKAKYQHCCIHVSRNIAHKVRVKDRKEICDDFKAVYQANSKEEANTFLSGMIEKWKKNY
PKVTQSLIENQDLLTFYDFPPSIRRTIYSTNLIESFNKQIKRYSRRKEQFQNEESLERFL
VSIFDTYNQKFLNRSHKGFQQVTDTLVSMFTE
>FECAFAII_01886 Choloylglycine hydrolase
MCTAITYATKDHYFGRNFDYEMSYNEVVTITPRNYRFDFRKVKNLDKHYAMIGIAAGVSN
YPLYYEATNEKGLSMAGLNFPGNADYKELQEGKDNVAPFEFIPWILGQCSTIDEAKELLA
TINLVNIDFSEKLPLSPLHWLLADKEKSIVIESMKDGLHLYDNPVGVLTNNPPFDYQLFN
LNNYRSLSNGTRV
>FECAFAII_01887 hypothetical protein
MRKYTFVFKKKVVSDYLNNEGGYKYLAHKYQINRTLVRHWVRIYNYHGWEGLVGGGKSYT
TKFKLDVIEYMETNGLSIQETAKKFNIGSNRTLSKWIEQYEEGGASSLESQKRGRKISMN
SKLNIPKKLKDESLEEEVIRLRAENAYLKKLETLIQEQDLSKKKSRLKQSFSSKKNLN
>FECAFAII_01888 hypothetical protein
MNLLLSIAQLAKSTYYYWVKKLDKPDKYSKIKQEITAIVKESRNSYGYRRVTLALKMKGY
TINHKTVRKLMSQMGLTCQIRIKRYKSYKGTVGKIAKNVLKRNFSVDTPNKKWVTDVTEF
KIKGRKIYLSPILDLFNGEIISYSISTSPTYKLIEEMLQQAIKKKGTGGSLILHSDQGWQ
YQMPQYQKKLKENNIIQSMSRKGNCLDNSVIENFFGVLKSEFFYREKFRSIEIFQSKLNE
YIRWYNNKRIKLKLNGLSPVEYRKQSIK
>FECAFAII_01889 Autolysin
MKKKITITAMSLLTALFLLPINGFAYTINNEFNLGVNEGSSQVANNQYILLHETANETAT
GRNEAQYMQRSWTSAYTAYIVGDGGIVYQVGQPGYVQYGAGSYANANSPVQIELQHTHDK
ATFEKNYKAYVELARDSAIKYGIPLTLDTPYNQPGIKSHLWVTQNIWGDHTDPYGYLSEM
GISKEKLAYDLAHGFTDKNPTTSKNKPVVDPTRAGAANPTLTDGTNYAHIDQFGEIEHAN
LHVAGWHIANYKYEYIFIMDYNTGKELARVRADGIYRPDVNQAYNTSGNVGYHVSFNMRN
FPNKKVYVMMRATNDPKGNTKSGAQDFHDKRWYLNIPPR
>FECAFAII_01890 hypothetical protein
MILPDKYYQVIKWTVLTVLPAASVLVATLGKAYGWNGTDMTVLTINAVATFLGVITGVSA
YNLKK
>FECAFAII_01891 hypothetical protein
MINLGEWGTIAGSITAIVSLILLVIKPITASFSKITETLSKVNHNLDLLTKDLESSKSDR
LMIHEELKKHDERLDTHAEKLVEHTQQIKTLFRERSR
>FECAFAII_01892 hypothetical protein
MFSFSDVKMMFDWGCFTEEQVREFVPLCITDEEADKIISKEESAS
>FECAFAII_01893 hypothetical protein
MKNIWKYGRTGGEYAGQVLDDMVMTVPFTDVPPLEGIRTDGEPLTIADQMFDPKLNQWII
LANALDHNDLNNLKAMYEALEHENDNLKQLNAKLMLNDVAIKQENTALKEKADSLAQINS
KTMLASLQNSKDIAEIKKQLNPESEGGE
>FECAFAII_01894 hypothetical protein
MAHVIKKGSIKVPTQPKDYDLQATGLVFKSYDNQIALEFNVEQQNGTPADLLGANLRLLM
FIYDEVDGMITKEPIPFITKNLITESFLNGQVVYILPEAMKAYNGMVEAYVYIEYPDGST
SDNLGFTFRMKRSAIDGLAQDKADYFIADFQQLLDGVKQEATDAVNEVLAKVEAVSKNVS
SAQNDLTILEDRIDQTNQQIGDLGKLKKMYSNSIDFGGYDYSGNPNLMSKLKSSDFNVGY
HGSLTSDNEKLHFTSDGTGSIIMFTRINTPQLASGKTYTLSAKVRFDEGTTGAIDKLRLV
YRTSPGEKILLEANSTNITTDDVGKEITIKGTANVNYQITNLDRFYMSISFVDRDKINGG
FKLYDIKIEEGSTATPYQPNLLDDPYWLGKAPLGENIANKSVTFPIKSSAYSLYQANMEE
EFVLGQTYTITMKATKPPIQTFIVYNEDSGDYRYGNLEPVEGLVDTWGLTFTPQKVGVNY
PKRLTIIQYPQSTTGACQIDWLKIEKGDTRTPNISQFKYFGEGLKDSNNPNDYSWDVTPE
YTEKGLNDAVNVYDPQRVEGLKNFADGIQIAGDKVISENDCTVYTLTKDNSQSFIDGYAT
FIKHGKEVIVNGTVKFKKAYAFGVPLDDEVPDEFIARIVHGMLVGSSGGNSVAKAMYVRK
DLGTIVTNSDFVVNEWFTFNGHYWVGGK
>FECAFAII_01895 hypothetical protein
MLDFQSKPNIFEEMSYEEAVKWLLRQAAIHYDGSDHDAHVLATESNAGFATPETVMQARG
RWLRDYKLPQKYPNILDIPPGKYATKAGWGADNPGGIEDDSFVEMMVFADHDLRKLIVAF
ARYSGEIYIKMTHNSEPVEGYNSLGWRRVYTASVLFEGELRKGQSVNLPDDTFRYQTLRI
HYTDGDGDFVEEVKRQRYARITKANLWNKSAGMTLIEFELTIEARKITMSNGRALDISSG
NVSNPAMSNDVKITKIEGVK
>FECAFAII_01896 hypothetical protein
MAETQHKMVLSTTEPNNGINLVRIRQGDVLTQKFVVEVVEHGKLKTFEGLVPFFINTTKF
GENQPVEQKVQEYSPAQARLVYTLSEPDWQWGGENTAHFSFRSLNGDGTWSEQFSTQDFT
YRVISGISRSQLRDSGYVWTFEDLLRKFKDYMDQGKNDWEQWLEDNREILENIDPGGMII
NILNEAKGDYESLADRLNQKYQVPVGSSQIRETTRFFDYDTMKYVDLVPRNLNTVVNSVN
NSKFNFSFITDIHADNHNLRIDGVGYKDASYLRHWRAIPQFQKLGNKTDVMIYGGDNIDG
GLGSLGSDIGIIDEWSARHSMLGTLKRFTNAAVAGQEKPVIICKGNHDACFDPAWRKRKG
MLCNADFEEYWNGLYGGVLFPDKNAAIYRFDTCDFYEGGTGDKYTDGYSDTAPGAFSAKQ
INAFGEWLVNVPRNYHVALVGHTPLGLSKFPVRNENMISTLIEGFKSGSPVTIDWSKLGQ
PNDGSFGGLKTFAMNTKGAGVVVGYFCGHWHEQVEGAFGTVKMILCDVGFSHTASQVDTP
DELAFYKIEVDTATRKVTSKGVGRARDFTYNY
>FECAFAII_01897 Murein DD-endopeptidase MepM
MTQEFIYAYKKMPDDLSVNGSSLVDWEDLPEINRVLNGQYRFYGNYSRSGQYRSYLKKGN
FIKAKVPDGSWQYFEIYNVKKNLTSVSVTARHIGFMANKNFIVKSFTDNGNGSQIMTNLK
NSLAFDQKFNYLSNVGTTHQFTARQVAPVEAIIGSNNGNQNLTGVTSAELDMDNYDLKLV
KQIGSDNGFRIDFGINLEAIEEEIDEESIVNSLYLVGGVPDNDYDEDKEPIEYGYLEIDG
VTNENRRIAKRENGDCKTVDELIKWGKTLFDNDRIHEPKATHTVSMVALEHTLEYDDMYQ
ELASLHFGDVAHVRAKELDIEIKERMVEYTYFPTLGKYKDIVLGNDLSLYTSAVNTQAQE
LKKKIDNRTETLVQNVLNATAWITGNSGGHVVFRPEKAPSEILIMDTPNVANAKRVWRWN
LNGLGYSDNGVNGPFGIAMTSKGEIVADFIKVGTINAEVFETSFNAYGDVLKLVKGTLQI
WKENKKIMEITKKGMEFWNTKESIGTIGTTDSAGNPFPGASTPTPLEDNSLVIRTNGDGK
YILISPAVGKGFVLLGNGKAIYFGDLDVQGTFTVKGKEIDGGNSGGNDNGWNGQYPPEVT
TDRDKRYWQIWKMAIGAGFTKQAAAALLGNAQGESDANPTADEGNGAPGFGYGIWQWTDS
TGATSGRVYMLNLMTKAGISDDPDTITAQFKLLMWHAPNGQWLVTSAYPYTWTQFMNLTD
INTAAQAFVANFERPRDPHPERTTWAQEWYDKFKDLEIPASKGYIKPIADPIRVTSEFGW
RTSPITDAQEFHNGIDLVNGNPNTPIFASADGEVIVAGDANYFDWYGNWTVIKHADGMYT
GYAHQSRVDVSKGQKVTAGQQIGLMGTTGPSTGEHLHFQFMDEFYPSSSGHFHNARDYID
F
>FECAFAII_01898 hypothetical protein
MSRQFMNPDEPNFIWKNRNAVIDMNCIIEAELPDIMPNKRYETYTIQGRSGELTETFDDY
EPFDLEIEGITIPHSKLREVKRWLTGKSQLITHNDPDKYLEAICSMDKEVPFENEWGFFY
TFDVTFRCQPLKRKIGEAPKIFHSSVMDIFDHGDEIAHPYLEIESNGGDITIAVGDKSLT
ILNTLAATIVVDTQLGKAIQEGLNLFTRGDWPVLQPEWNQVKISGKFKEVRFWNRSVYL
>FECAFAII_01899 Chromosome partition protein Smc
MAGKESDVVLNFKTNGEVSYSKTIKEINKEMNLAAAEYKNQVSAMDKDATQTEKLRAAKQ
KLEKQLGLAEQRSQMLREEYEKSVKETGEYSAESEKLYKQLLNSETGENKLRTALEQTND
ALKEQGDVSVDTAKKLQKIEETGEKVKGVGEKMSVGVTAPIVAAGAAGLAAFGEVDEALD
TIITKTGATGDQADRLSQSFKNVGSNTHLPLQTVGEAIGEVNTQFGFMDKKLEDSTNYLL
QYAEINDTDVSQSAISARQAIDAYGLEYDDLNSVLDVTTKTSQNTGQSVDDLMQKAIDGA
PQIKQLGLSFGEGVTLLGQFEQSGVDSSAALSSLSKATVAYAKDGKSLSQGLGELQDKVK
NAGSETEAINAAAEVFGTKGGPRMADAIRRGTLNLEDLAKTAGESGGAVGDTFDATLDPI
DQADQAMNNAKLAMADVGEAVQVSLLPFFEKATSLLQEFSKWWGSLDQDTKNWIITIAGI
AAAVGPVLIVLGSLMGSVTKIVGGVKRFIGVWQGLAGLFGISGGWFALAVIAIGALVTGL
IWAYNNVKWFHDGVNSFFKGVSDVAVEIFNFLGGYFGGFFDGVIANFNNFYNAGKRIFSG
FLDFITGVFTGNWSKAWQGLVDIFGGIFDGIVAVGKAPINAMIGLINGFIGGLNNIKIPK
WVPGVGGKSFSISKLPYLAQGGHLINGQAIVGEAGPELLTAKNGKTTVTPLSDEEKRRGI
GGKVSGGSIEQHIHIGKVDANNPSELDRMNRKFAKANKQAIRDLGGVPI
>FECAFAII_01900 hypothetical protein
MARLSDYGINVEDLKNSATVTIQGVEFPISFTMQTMEFIADVYGGDYSQFESDMNAMLSK
KEGQISSANLSPSDLKIMRALIYAMLRTGGLEEDPETIFKFLGMSGEVLSAYSTCMEIFA
SQTFQVEDLKKSKKPQDFQKTQAKRKVNKKNRKR
>FECAFAII_01901 hypothetical protein
MGKQDTFYFEGLDDILIAMMATPDSVGTAPTYSEVVRLPIATKIGVKGNGTALEKWASSK
MFRRVSRETKHEIALDHVGIPIAVMDEIKGMIAKSGVTFSKNTAREFPYLAFGFIGNIEG
GGKKAVWYPNTQLSNVIDEEYATAEDETKIDDVTANFVSTGLKYNNVMYASFDSNREEAT
MDLFGKFIAQPVYDEEQWKTLAKVGGAG
>FECAFAII_01902 hypothetical protein
MPSNKNGFSEISDYLGNLSRVDPKKLSLESLEEAAKFYLEQLLPNIPKSLLKKKHMSEQI
KVVVEEDRVKVQFEETAFYWRFTENGTTKQKAQHFASGTYEQNKEKIEEIMTKKILDLWE
G
>FECAFAII_01903 hypothetical protein
MSISFDELKTALKSTKLPVFRDKARLGTMYPYIVYSNVSNSKKMASGKVYKKLPYYQVSF
FTLGTEQDLVVIEQALQNAGIPYSDFTGIQGDENDDTVTNYYTYVRCVENAK
>FECAFAII_01904 hypothetical protein
MPKRQTNNLRWKAELLDIKTGTDGNDRPTTIYEFKRLIFYEELGVTSQEKYLSQQAKTDV
VRRIKVRWDKSITEKLSALKIDSVTYNITRIYTNPDAREMELSLAYVD
>FECAFAII_01905 hypothetical protein
MEEQTKELSLEEKFKSHIHFEEGMDDSLLSFYLNMAKDYVKTATGGQQEYLILMVAGIAY
EYRVSEDELDKAMNAMTPFIVQGAIQNAEETD
>FECAFAII_01906 hypothetical protein
MDKELLKKMKARREQRLTELREKVESGELREADLEAVKEEIDSVIDELNGIKDELGADSG
TDETDDNTDDQSNSTDSDESRSGEDNDQEEDSDSEDSSENRSGMITQQQRDGLLGSIKNG
LARAKMTNKQKDQQLRKAFANFVVGNISEAEARALGIEAGNGSVTVPEVIASEVITYAQE
ENLLRKYGTVVRTSGDVKYPILVKKADANVNKKERSTDIAETAIQFDEILLDPAEFDALA
TVTKKLLKMSGVPVEDIVVEELKKAYVRKEINYMFNGDDAGNENPGALAKKAVAFEKPLD
LTAAGAGQKLYDALIEFKNTPVTEVMKKGRFIINRAALTAIEKMKTDDGFPLLRPFTQAE
GGIGYQLVGYPVDWTDAADKKGEPDTPVLYFGDFSAFKIQEVIGALEIQKLVEKFSGKNQ
IGFQIYNLLDGQLVYSPFEPAVYRYEITKPVGG
>FECAFAII_01907 hypothetical protein
MKKKEIRTIDITNLSTRSDEETHTRTISGYAAVFNSPTLLWDDLSEVIAPGAFARTISNS
DVRCLFNHDWSNVLGRTKSGTLRLEEDERGLKFEVDLPDTTVARDLVKSMERGDINQCSF
GFVPTEETWDYNSEPMLRTIHEVELYEVSIVPLPAYEDTEAALRSRDELEKNVEERKKLI
KKINQALEA
>FECAFAII_01908 hypothetical protein
MKLRDRLSNAVYSFMEKRGYIEDMFGHYTRYGQRYVTDSSIMESSDVYELVQDISNQVAL
SSPVVIGPDGNEVKDHHLLKILKNPNDYLTGFEFTKLETNTLLINGETFPLTDRDQLHLA
YGVTTKINERLQEEFEMNGQKIPGQMIRHIKNIGTDSLKGAGIIDLARNTLEGVLSAEKV
LTDKYTKGGLLAFMLKLDAHINPNNSAQTKIVKAILDQLEGTQNDSDHSVKMIPLGKGYS
IETLKSPVDDAAILNYLGVYKKDLGKFLGINVDTYQSLMKTDIEKAMMYLHNKAIKPILK
NKSEHYTALFFMPNSGYRVEWKINILDFVPYSTKTNIGYNIVRTGITSPDNVAEMLGFPK
QNTPETQAIYISNDLSMIGQKNATDDSLPTNDQNLKGGDGNEEEGNSHD
>FECAFAII_01909 hypothetical protein
MIEPGVNYADLFAKEVRKKPGKYPKTVRLAVDRWYRWKKRKDIWFDVDRANEMMDWVESF
IVHTKGDMVGKPFILEPWEKFIYSWIYGWVRENEKGQIVRVTREAYVQIPKKNGKTLIAV
GALGYAMYGEGALSVNCYACASDFAQAQYAAQPFADSILNNPVLLDGTKIFKGPKGTVSS
ITYEYLDGDLALKNKFIVQTKNIENIEGSNPYFVCNDELHKQEKMEQYDNFKSAQISLPQ
PLMFNISTAGKGSSSVGMRVYREAKEVLKRDDNDSSFVLIYEPNKGYDWTDRKVWEMCNP
NWGISVDLSALESAFKTAQRSAHSKAEFLTKHLDVFVNGADNFFEQDQVEPCLVTTQELG
NLSGEPCYIGLDLSRTRDLTCVSLNFPTWDEDGKAVLKVKQLYFIPNEDLEFREKEDNVP
YSDLAEQGFVEFCDGKMIDQDQILQYIEDCMDLYDIQQVNYDPAMSDKLVEKLENLGLEC
VEVAQYPKVLNAPFDDVERLFYEKRIQFDNPLFLYCTLNVVAITNINGQKAPSKRQSKKK
IDGFVAFLCGHKETMNQMTDIDSDELDDYLSSIYR
>FECAFAII_01910 hypothetical protein
MTTKVQRKAIVDEKVSAEKARILKIMNLSDLYTITLDPLIESYLDIFEIYQHKYLLWKEK
GFPETQKFTNKSGATNQSKHPLAQQVETWADKKMKALDLLGLTNKAKTGRQITGGSTARK
DEEITRPEEKPVDELAAHRNKWRKKAGTEK
>FECAFAII_01911 hypothetical protein
MKYCQFDGCTNKIAKGIYCTEHKRSSRSRKKKQQAKSVYHHENKPFYRTQAWKDMRQFIY
EREGGHCQRCGQFIFGKRAHVHHIVPIKDNELLKLDPNNLMLLCSKCHPIVENETEDKKV
FPSYFN
>FECAFAII_01912 hypothetical protein
MAMIKIRTSITGTEYWDSEKKKTVVVPKGQEPDFEATEEKGILSDGKTFVAVNGELITNS
SEILDSDGNTAADFDGDEATNDQSTEDTDELDNMTAKELRAYAKKHSIDIPGAVRAKGDI
INLIREAE
>FECAFAII_01913 hypothetical protein
MNDFHEAVLTFDVPTGMGQVYKKAIEDDNSRHWIKNEIKDADGNIVISDIKPSWNGNHCS
VSIDNSLTIEKYSGAIIDRTERKTHLTIALISRTLPNLKEQVEWYERMGAKVISTNYKGE
NQNGNDQN
>FECAFAII_01914 hypothetical protein
MIKENQKIRYAILKEIENGNYENLDFGILGISEEQFNDQLNFLKNESYIVGGTYSSNVLL
PATYRFLKLTEKGEIFLAENSTFSKTYKMAKEIRDWIK
>FECAFAII_01915 hypothetical protein
MRFQWLKDYQELDEQILYLKWNLNKSKLELNRWVNGDLADVRIEKNSRTSSLEENIQKIE
NELELLIEQKEEMLLLIDSFSGIDNQIVKMKYVDQMSLEDIAEFVGYSSSYIRQRHAEIR
KTLNFLDEYEHRQADRLKKENEIDFYNSKKYKEQLSLF
>FECAFAII_01916 hypothetical protein
MKKCFFVTPIGTDDSPERKNSDTVLNHIIKPVCESVGFEVVRVDQLHTVDRIDHTITEYL
SNSDLVIVDLTYHNANVFYEFGYRQALGLPLIPLITEGESIPFDVNTLRTIYYVTNDLDK
VENVKNKLLETIKHMTFETPQKPITNETNIDNTLLLNIIDKLEDIETAVQVRNDKETERI
AELMSKYSHPQKSAEAEIFSSVFGPIMQMAAQDPNSLKNISDAFGNVES
>FECAFAII_01917 hypothetical protein
MTRTLLLIAGILIKELKKQQSLVAYYKGLYEGEKLKTQHCQKHH
>FECAFAII_01918 hypothetical protein
MNKQEAIKKLESIKAIGNDAIAACYNESINSGITLMKKIDEPQKPVIPQLVAGWLEKSTD
PFTKAEKIAYLIKSKDGDLYYFCDWFVRDGIVTQEQGEELLAWATRQSYETLLSLYNGYE
VEKEPLYEVIIGDLYLIKKFNNRNDFCFDTSCSLCAWEKSAYQLTEVEIKEIDERYWPFA
VPVEEVTK
>FECAFAII_01919 hypothetical protein
MIPKFRAWDKRKNVMRDVAVLHFTKNGKTNFIEYWINPTELKSYHVRNIDLMQSTGMKDK
NGVDIFEGDIVLVSVRNGFDYLDNKVCIVKNSIDYSGLVCATVDEDLEYQIFNTELFEEY
TYEVTGNIYENSELLEEQR
>FECAFAII_01920 hypothetical protein
MIKKLVQFSMDLYDIESGATLSVESDHLIINFGGKRQIILWVVDDVLFPEIVHDFEESKA
VEFEIVKKVMELIEKYEEDSE
>FECAFAII_01921 hypothetical protein
MDLITQYSDIILKKIMMKIQKEKKSKERAELVKLEMAETGAGVRSSRHWKAAANIEFYYN
EIQKGFDQMRELDRQTNWSKKLHQDRFKFVEKYKEILEEYLRRTANDKKTRSIQHGFI
>FECAFAII_01922 hypothetical protein
MLDMKIEDYRITSDSRNIVLSKVRRDEEGNIRYTETKEESRADIGYFQTVSSCLKAIQRD
YVLSEERTIKSIIEYKKALENITRQFEQACEIEEEK
>FECAFAII_01923 hypothetical protein
MDKKAAMKRIIELTHSENWQEDKEIVAEVQKLGKSMWTEKPKRKTPRKIAIWHGDRILVT
GTAEQLSEITGLSKNIIWDRARSLWIDSKGRQFRYVEEKKC
>FECAFAII_01924 hypothetical protein
MDLKTFTAQIELMHQEALRQSALYEDKWLNTFHGGRESALDQVLKLLKGELQDG
>FECAFAII_01925 hypothetical protein
MKIDYLELINEISNYKKGEEIDILRDVYEQLEEAGIEGIKNDRSSWSKLRYYFALYIDTT
QLRNLAYTKLLFVDCVKGLQKHLSELEQV
>FECAFAII_01926 hypothetical protein
MTEHRSYYAIIPANVRYDKRLKPNTKLLYGEITALCNERGFCWAGNEYFADLYGVNKETI
SRWVSDLIKFGYLNREIIYKEGTNQIINRYLRINQYPIDEKRNTPIDEKVKDNNTSINNT
FNNTKEYIRELPPSKKSKAKPVRHKYGEYKNVLLSDEQMEKLKTEFPNDYQERIERLSEY
CESSGKTYKNYLATIRSWARKEKSEPKNASSGYKRTGRREKLPEWAIDQEAYLKKKALER
ANRQSKAPF
>FECAFAII_01927 hypothetical protein
MFKPLIDSYSAVLKKFKGKDISATINEEVNIDRLKTMYDGYDGDRVIEIRFIDPRRFTVQ
QRNFIYALIGDIFIDTGMPTDFWKEFFYFRFEGVTGRSISLKDESSSTVSDANVLANIIL
DFIFEHHIPFKEGYEILPANQDYYFYKCITKRVCCICGKTGADIDHFDKALGRRKRKEVD
HSEYTFAALCRIHHTEKHKIGVINFKNKYQIKGIKLNQETIKKLNIGG
>FECAFAII_01928 hypothetical protein
MSESKGTSTFEKLFSRKLNKILKKKGNFDYLSWAHAWEIMKKNDPQATVTINEYKHYRVV
SGTHQDFLVEEYKPFLMDETGTYVSVSVTVKGHTETELFPVLDYRNQPVVKPNAMQINNS
LKRCFVKALALHGLGLYVFQGEDIPTPPRIDTKKLNMLETILEAFNEQMGKDMTKTLIEY
VNEQTDKLGLLADNVETIEQLSYEQCALMERAIAAKRKELDKK
>FECAFAII_01929 hypothetical protein
MKKELSTLDQYLTDPSWGKSNIKETSNRKIRRNLLTNEELACDQDDLGNFVSIRDHVYLI
HLSRKSKKPEYIYVIEDGLIDALEEYDRDNLIDISYYGPGKKYIAEMEAEFDE
>FECAFAII_01930 hypothetical protein
MQELVILKNKEAVTTSLQVADSFEKEHKNVLRDIEKLKEDVLNFEQMFVEGNEPDSYGRN
RRVFFISRDGFFLLAMGFTGKKAIYFKQKYIEAFNEMEDVIRKNTVPQTIEDMMIYQLEE
MKDVKKDVSMLKDTMRISGQQEFEIKQKGNMKVMGVLGGKESRAYEEISKKVFLKFWSEF
KRTFSIPRYGELPRKRFDDAVSFIEMWLPETAIRMEIDQLNRQQRLFGDENE
>FECAFAII_01931 hypothetical protein
MDTFTTKDWITIGISFIALLISTINLLRDQKHINLRISKQRLIKRIETYDAELAFPKQQI
GVSIDFRFLNSSKHSIGYYDLVFRDGYSKELLPCTYKFALRPEIAKQELLGITISDQTTH
LNFMDSNYGVIPANSYIFKEVVVYPKSEKIRVNINLQNTV
>FECAFAII_01932 hypothetical protein
MEFFIELMKTIFVFFLFIGLPLIFTFVFREPLIIALAALGIAVLRFVFGE
>FECAFAII_01933 hypothetical protein
MGKFNRALVFSAPLIIYALGLWGSRQALIGTIVYMVWIFMGLDEAEYRAKKPVGRD
>FECAFAII_01934 hypothetical protein
MQYLEAKIPIPEGYVIISQVDYEELKKADDTGRWMTLPEVLERINRKYDWFTSRVLKNPR
YRNIIDIEKNKNGFVYYPVEGRDTYLFLRSKTLEFLETNFSEILRR
>FECAFAII_01935 hypothetical protein
MSENLDLKIRAEMRKRRMTFKELAALVGISGAYLSDILNGNRDGKKAQEHIETVKKILGI
>FECAFAII_01936 HTH-type transcriptional regulator Xre
MSLVTKIKELADEKHVTIAEVERQVGISNGQIRRWDKASPKSENLKKVADYFGVTTDYLL
GNNNVPKWATKEEVVELDKLLDSNVNMSYGGETLTPEQIQRVKDILIATFWDIVKEDKEK
GKKM
>FECAFAII_01937 Metallopeptidase ImmA
MDTINLVEELKRKYQSANPFYICEKMGIKIQYVPFIENPKGQFQEIRDRAIIFLNDELRD
SEERFYICAHELGHAIFHRGLSSYYVSTRTSRSKSESEANCFAANLIVSLYKEDNDQYPK
KIEELKNLYGLPESAYRFLI
>FECAFAII_01938 hypothetical protein
MKKVSVMLLLSTALLLSACSNNKKAELTDATSNQETKVSKTKEATETSSSTSKSTSKTDS
SSTVTSSNQATAEPSPTVISSSQDTIQTAPQEETYEQMKQRTLQSTPADRANWSNKEWEA
FGVALYENGLTTDDTGNIISQDQKEQQAASQQNPEAQQTSAQQDADTLSLTDFVNKYGMS
PVAWKVQNGMSEEEALRTTQQKTSGEVQLGFSKYGIQ
>FECAFAII_01939 hypothetical protein
MKFIKFGIIGLLAVTVMGGCGSSTAETKESKNYSETNSTIKEVDSDQTAEFATIAEKHIK
EIYSIDNLKMDLKSIKVTQFPDDKNAETGEEYKNVYNGTGDFTWQDKKYNFSLIYSKKDA
TNYTVLYLYSNLDPNKGVDTPLESDQ
>FECAFAII_01940 Putative defective protein IntQ
MAKKEIDKRIKKHLTKKGEEKYQFSLYLGVDPLTGKKRKTTRRGFSTPLAAERALKRLEA
DIQEKGLQASTAQKSKKFEYVYSLWFENYKKTVKESTWSSTKQIFDTHILKVFGDKFIDK
IDVFFCQEAVNTWSDSHPKIFKKIKNYTSNVFDYAASLQIITSNPMKLVSVPRGEALDIE
DKNIEFYTKEELIEFLEAIRNDDDERYLFFSLLAFTGIRKGEAFALTWSDIDFKSKTLNI
NKTVTRGYQGRLIVNTPKSKSGKRKIYLDNDLISLLRKYYTKNKTIVTIQSENLIFHHDG
LLYNPTVSRSWLNVIYKHHPELTKRITTHGFRHTHASLLFESGASLKDVQERLGHADIQT
TSNIYTHVTETQNKKVINNFVAFMKNSTQGESRGESKNILG
>FECAFAII_01942 hypothetical protein
MRRKVYTKDQILKAAYDVVAKEGFKGFTARNIAKKMGISTQPIYLEFKNMEDLKNTLLDS
IFEQLKEDVFPIERTGDKIIDLGLNYIYFAKKHHSLYMALYIDEHGDGKKMHDFSYNYFR
EIVKEDERYNQLSDEYVDALHTGTWVAVTGLASLMSSNIMHPTEEQIIALIKRTIDSILA
LDNPEIIR
>FECAFAII_01943 hypothetical protein
MENETDVIYIHPQKRIVSQKRKYFYLGFTGVFFLFIGLLSNTPTDNWSGLLTILTSPSNL
LTDYFALGGFGSAFINVGILTLLSVLLAYRHKVILNGPLFASILTVTGFSFFGKNLYNSI
SIILGVYLYAVFVNKPFSQYIMIGLFGSALSPVVSYITFGMRFPLLIGILLGNLAGIAIG
LLLPPLAAQTLVFHRGFTLYNIGFTSGLIAMTFTAVLRLFSYSIVENTLVFNEYHFPLIW
IIFGFFSLTVGIGFYYNSFRLLGIREIFDSSGKLTTDFIANSGIGATLINIGLVGLMLSS
YVLLVGGQLNGPVIGAILSAVGFSAFGCHLKNSFPILVGIFIASLFGTFHEITSTGMLVA
AVFGTGLAPISGFYGSFYGVIAGVLHIALVHNVSTLHGGLNLYNSGFSTGFVAGILVPIL
DNFTAVRKEKKTLGKRIIKKNHR
>FECAFAII_01944 hypothetical protein
MEKELSKRIIDELLTYLYSHEITEIRIGVEFAEEGLFIEIQGTAETQPEDLDVLADLLNN
PRDPSMEIYYQELLGNPRHDREDYHLLGSLIDDVEIMYAQPIINIKIFRRASHSYY
>FECAFAII_01945 hypothetical protein
MTTKHEEIHNGVIFPAGEKNEAYAQVFTGQSYLNMLVNDPEVSVGVGNVIFEPGCRNHWH
VHKDGYQILLVTGGEGWYQEEGKPARRLMAGDVVVTHKGIKHWHGATKDSWFEHLAITAG
NSEFLEPVTDEVYEGLENQ
>FECAFAII_01946 hypothetical protein
MAEKQTAGRDQLGDFAPKFAELNDDVLFGQVWSREELSAHQRSIITISALISGGNFEQLP
AHLKIGKQNGITSEEIAEIITHLAFYVGWPKAWSAFSLAKEIYLEENSEDKKEA
>FECAFAII_01947 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIVAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYIAKRSTEGWTPDVIIGRAERTFSCSVSTLYRRFKTGEFNVL
HLPMQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEGDTIVGIHHKSAVITL
VERLSKAIIALKPEGRKAVDIENSINEWLQSVPKNLFKSITFDCGKEFSNWKSISNTNDI
DIYFADPGTPSQRGLNEHSNGLLRKDGLPKEMDFNQVNQGFISSVASKRNHIPRKSLNYQ
TPLEVFLSYVNGKFCLA
>FECAFAII_01948 hypothetical protein
MNIAASRKLINFISIIGLGLSIALTIYFINLGVFKDLNALRGLVGDSIILGPIIFVFIQI
LQVVIPIIPGGISTAAGVLIFGPYAGFIYNYIGICIGSIIIFLLGRRYGKPFILSMISDK
TYNKYIGWLDNQNRFEKLFALAIFLPVAPDDALCLMAGLTNMSVKRYTLIILIAKPLSIF
LYSMALIYGGQYLSGLLG
>FECAFAII_01949 Glycerophosphodiester phosphodiesterase
MNYLKRSLGNAWDFLKGTQAYFRDVLLMHGFILFICLPLLSSTTRFILHRGAIDYLSYDN
IPSIFSQHPGVLLSLIVVLMTILLLVYFEFTFLLMSVFFIKKKEPISLKQLLHLTILQLK
KVRPITFLFFLAYFLLILPISGLSFNSDLLSKIKIPAFIMDFIFANRWIIVSSFLLVYIF
LGYIGIRLIFALPEMILRDRPFRAAIRESWSLTKSRLLAITGQFIVIGGTILLLSSLGYI
VVILAQSMVEQFFPDYALISAVFAMTLLQGILLFNIVMSTVGIFYIIVDFMDDEGFLPEI
PKWFIPQAPNLRFSALKNTGLTLFAVFFGIGVCLYNMDYLTSAVQTKPVTVSHRGVSTQN
GAQNTLEALEKTSRDYHPDYVEMDVQETKDGHFVVMHDANLRHLTGVNGTPQDLTLKELT
NLTVTENGVQAPVCSFDSYLEKAHKLNQKLLIEIKTSKKDSDDLVERFVHKYRKVILENH
HILQSLTYQTVSDLKEAEPNFYVGYILPFNIVGPPVTPADFLTMEYSTINRNFINSAHQD
GKEVYVWTINDSDAMSRMMFYGVDGIITDEMGLLNESVKQTDEEITYSDKLLNFVLGVG
>FECAFAII_01950 hypothetical protein
MPKRKSSGKMGIILAVISAIPAILAIVRAMKESRES
>FECAFAII_01951 hypothetical protein
MVKAEVGRSYICKPIGVSHELIGCIERTYINTAVVYVESYDQRDYQLINESKYRMLVKFC
DISAPAELVS
>FECAFAII_01952 hypothetical protein
MTFTKTNMQYRVAFDTTSNRFMAIDAQNENNVAFGITIEQAVRALNESR
>FECAFAII_01953 hypothetical protein
MTYTHLTTDELVIIESYFKMNQSVAKTAHCLNRSRQTIHKVYLFFKQGKSALEYYQQYKK
NKSNCGRRPLVLPEEQSEYIQRKVVQGWTPDVIVGRAAFPISCSARTIYRMFKKGLFDSS
DLPMKGKRKPNGHQERRGKQTFRRSIHEREKDYSQFSNEFGHLEGDTIVGLKHKSAVITL
VERLSKVIITLKPCGRQAIDIEKKLNQWFESVPKNLFKSITFDCGKEFSNWKQISNVNDI
AIYFADPGTPSQRGLNENSNGLLRRDGLLKSMDFNSVDEFFIQSAASKRNNIPRKSLDYR
TPLEVFLSYVSIDDLSNLI
>FECAFAII_01954 hypothetical protein
MRSSKYTEHYTDTFITFKEIMRTVSNIYHNCVPDKIKNRRNTDKLKQRDTVIIACVIWGI
INGYTSQRATYRAVCSVLFPNGDFPSRSRFTRLSSNLAYTIKIIRYFFIKKLTKGELVGI
IDSFPSPLCKPVRNRQAKLLNQIAKVGYNSTKKSYFYGLKIHMIVTKTGFPITYSITNPG
VHDVKVLETLSEEANLPNILGDKGYISHKIHEKLALKGITISVPPRKNMDKSEKLDHSLL
GKQRKTVETVSDCRQSPFYG
>FECAFAII_01955 hypothetical protein
MMSKNNTNGRNQFAMLTIDDLVPQDHLVRKIDAALDFEFIYPIVEATYSDLGRPSIDPVI
LIKLVFIQYLFGIRSMRQTIKEVDTNVAYRWFLGYSFEEKIPHFSTFGKNYVRRFRETTV
FEDIFAYILEQAVKAGFVTEDNLYLDSTHIKANANKHKFTKEMTHDEAKAYQDELEDEIN
RQRIEAGKRPFTLDLEKEVKLKERKISKADPESGYYVKGEREKQFAYSAHTSCDDNGFIL
STIITPGNIHDSQVAFQLVKQSKRLFPEINCVVADAGYKTPKFVHFLTHLNLRPCLPYSR
PKGKKGLLSKNEFLYDEYFDCYICPQDQMLAFSTVTREGYREYKSNPKECVNCPLLNQCT
KSKNHQRVITRHVWGDLMDEVEHLRLTDLNKSIYKKRKQTIERIFADAKEKHGMRWTKYR
GLEKVATHTMLVFAAMNLKKLATWLWKGKEPLFFCSKIRNEVDKKLFQARVTSLEQLLST
V
>FECAFAII_01956 hypothetical protein
MKKILGLIVIILIAFIGWKGWDYYQSTYVGKDYYAVVKAPMPAETDIKADNGEVIGRGFK
YNVDAYAENGEKRQLDFDVITSGDSANGSAYPEGTILQLKASEKRIIEKKVITSDKVPSS
VKEKLGLS
>FECAFAII_01957 hypothetical protein
MNDSIKKMLRITEKDLMITEVSYETLQKKKTLVVDAVLSPTPRACRSCGSTVVDGNGKAI
IVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKSCQVSLTTVIRTLKEFKSYLPKQSKKILPRVLMVDEFRSHASIED
KMSFICADGETGKLIDVLPTRKLPRLTSYFLGCTNPEEVEFLVTDMNAAYFQLTKRVLPN
AKVVIDRFHIVKHMNQAFNELRIREMNELRKAGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLEFSPPLKEAYPFFHELVEAFRDKDPDLFFSLLAELP
ETLDDSFREKLQNLLTYEEGITNAMIYPYSNGKIEAKNTHIKTMKRVSYGFKSFENMRIR
IFLINQLINVR
>FECAFAII_01958 Glucose-6-phosphate isomerase
MAHIHFDYSKVAPFVNEQELGYMQSQVTAAHNELREGTGAGSDFRGWIDLPTNYDKEEFA
RIKEAAKKIQSDSEVLVVIGIGGSYLGARAAIDFLNHTFFNLLDSNTRKAPQIFFAGNSI
SSTYIADLIEVIGDRDFSVNVISKSGTTTEPAIAFRVFKELLVKKYGQEEANKRIYATTD
KAKGAVKVEADAEGWETFVIPDDIGGRFSVLTAVGLLPIAVSGADIDALMQGAADASKAY
SSDKLEENEAYQYAAMRNILYRKGKVTELLINYEPGMQYFSEWWKQLYGESEGKDQKGIY
PSSANFSTDLHSLGQFIQEGRRNIFETVVKVEKPRKSITIPEQAEDLDGLGYLQGKEVDF
VNTKAFEGTLLAHTDGDVPNLLVKIPEMDAYTLGYTMYFFEIAVGISGYLNGINPFDQPG
VEAYKKNMFALLGKPGFEDLAKELNERL
>FECAFAII_01959 NADP-specific glutamate dehydrogenase
MTNATEYVQAIQEKLHQKDQGQEEFLQAIDEFMPTVMSFLDTHPEYIEKNILELLTEPER
VIQFRVPWQDDEGNWRVNRGYRIQYNSAIGPYKGGLRFHPSVNLSILKFLAFEQIFKNSL
TGLPIGGGKGGSDFDPKGKSDNEIMRFCQSFMLELSKHIGPSIDVPAGDIGVGAREIGYL
FGEYKRLKKYDTGVLTGKPLDFWGSKIRTEATGYGLVYYVKHLLNEEKDSFNQKTVFVSG
SGNVAIYAIEKVQELGGKVVTCSDSSGYIYDPEGIDVKLLKEVKEINRQRLTEYANQRPS
AIYHAGESVWTLKEKADIALPCATQNEIDESLAEILVENGIKIVAEGANMPCTVKAVSVL
HEAGVWYCPGKAANAGGVAVSALEMSQNVQRLTWEREQVDEQLDQIMETIYHTCRQTAAE
YGDEKNLLLGANVAGFEKVAKAMAAEGLV
>FECAFAII_01960 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MEKLYDVIVVGAGTSGMMAAISAAEQGARVLLIEKNKKAGKKLLMTGGGRCNVTNNRPVD
DLIAHIPGNGKFLYSTFAQWNNFDIMNFFESQGVHLKEEDHGRMFPVTNKSKTIIEALLN
RLKELDVTLLFSTRVEKLIHKEHKIYGIRTEFEEFHAPAIILTTGGRTYPSTGSTGDGYK
IVKRVGHTVTPLYATESPLISDEPYIQEKTLQGLSLQDITLRVLNKKGRVLTEHTMDLLF
THFGISGPAALRCSSFVNKELEKTGEPVTLSLDCFPTQTKQELIHILTEKSKATKKNLVN
AWHGILPERLLVFFLERLEMDHLTGQQASQKQIQDFVQLCKEFKLSINKTFPIEKSFVTG
GGVSLKEIYPKTLESKIIDGLYFAGELLDVNGYTGGFNITAAFATGHVAGMNAGQRA
>FECAFAII_01961 Cys-tRNA(Pro)/Cys-tRNA(Cys) deacylase YbaK
MAKKKIVKTNAIRMVEQKKIPYTEHEYEWDESHLSASSVAEQLPESQSRIFKTLVAVGNV
TGPLVAVIPGEAELNLKKLAKVSGNKKVEMLHLKDLEATTGYIRGGCSPIGMKKLFPTYL
DQIAESYEQIIVSAGRRGLQMELAPQDICALTSGQFADIKQ
>FECAFAII_01962 3-dehydroquinate dehydratase
MVRVKGLNIGSGRPKICAPLIGAVREEVLREAVLAREAGADLVEWRVDHYREVFSFDEVA
ETLVLIHEMLDGLPLLFTFRTLAEGGEQDISIRQYRDLYEHVIHTGLVDMVDIELFKVES
LGKRLIEEIKSLNIPLIISSHDFKETPADPVLLYRLNVMEHFGADIGKLAVTPNNERDVL
RLMELTRRANAFVSMPIITMSMGNLGKISRLVGGTTGSVMTFGSLSSDSTSAPGQLPVKA
LKQIIQLLNEPL
>FECAFAII_01963 Ribosomal RNA large subunit methyltransferase I
MKVKVKKRASNRLKKGYPLIQKEDLAHPQKETTQWVELVDSQNQFIAKGYLGKQNKGIGW
VLSQQNIPFDQSFFEEFFVKSKEKRTFFFSDDSTTAFRIFNGEGDGIGGLIVDYYAGYAV
FSWYNETLYAHRELLIQAFREIYPEIIGGYEKIRFESVNLPESQFIYGKEAPEPLIVKEN
GVKFAVYLNEGLMTGIFLDQKEVRGSLAEGFASGKTVLNMFSYTGAFSVAAAMGGAIETT
SVDLAKRSLKKTQEQFEVNGLDVDQQKIIVMDVFEYFKYAKRKQFLYDMIVLDPPSFARN
KKKVFRVAKDYGELVKDSLDILAEDGILIASTNAANVSIEQFQTMIEEEFHAKNVSFEQL
ALYRLPKDFQTTDTFLEGNYLKVFVYQIKNNH
>FECAFAII_01964 Lipoteichoic acid synthase 1
MKCIKTPAFLNKRLGFFSLLVVLLWLKTIFAYLVDFHLGIESGIQYFILFINPIATTLLL
LGIALYIRRPRVAYITMMVIYFLLTLLVFSNVTYYREFTDFITINTILGAGKVASGLGES
AIRLFRPYDVIYWIDFIILTVLLIAKKIKLDPRPIRARMAFAISTLAVMIFSGNLFMAEA
DRPELLTRTFSRDYLVKYLGLNAFMVYDGVQTYQTNQVRAEASPNDMKEVENYVKEHYAA
PNDDLFGLARGKNVIYIHLESFQQFLIDYKLTDENGLQHEVTPFINSLYHSNSTFSFDNF
FHQVKAGKTSDAETLMENSLFGLNQGSLFTQLGGKNTFQAAPDILSQTQGYTSAVFHGNA
GTFWNRNETYKNLGYDYFFDSSYYDVNDDNSFQYGLHDKPFFQQSVQYLERLQQPFYSKF
IAVSNHYPYSKFTNDEAGFPLANTNDETINGYFATANYLDTAVQEFFNYLKESGLYDNSV
IVLYGDHYGVSNSRNKNLAELVGKTSSTWTNYDNAQMQRVPYMIHIPGQTQGGINHTYGG
QVDALPTLLHLLGVDTKNYIQLGQDLFSKDHEQLVSFRDGDFVTPKYTYYGGTIYSNETG
EAITEPTEEVQNEIDSLKEKVDKQLAVSDQINNGDLLRFYTNSGLDPIDTSDYDYKNGLE
KLKEAEKSLGDKSTSVFSEHNGQSTVDLYKTQTYQELHGTTTSSSE
>FECAFAII_01965 hypothetical protein
MKIIRYATARLIYYKKQTILYCLFSSFSAFLLIACLTLYHLQSALANQVQDRLSFIGASA
STELLPALELASRFYIKGIFSLFFLFAFLFIFFFYYSVRQNKQELINWHLTGLSKTKLFL
FIFWQLFFPLFLCCILVLLWIVSFQSVYEALLQRINFLVLKTTELPDIRDILTSVSGLTI
PMDQQTFFTIDFQNDLFFTDILKGFAQTLIGLSGCCLILSLFPFTFFIHHLQSRRPGRNE
T
>FECAFAII_01966 hypothetical protein
MKPEYLIHAEHLTVILCPLEKQHKILEHLKKEVLVAKLDNFAIIQKNWPMFPYLNLKDHV
LLDVPEKEIKQDRLAYQEKLDISPSLLNCAAAELTSFEKVKLQLLHALLSKRNNIVIEDT
FDELSVLEIQELLHLLSYLAHEENQGILLFTHDATIAQSPYIDRLEPAG
>FECAFAII_01967 Alkaline phosphatase synthesis sensor protein PhoR
MRYLYQQLLAFCGMVALILLIVGVSFTQLTKQTIEENNYQQLFGYAESVEKTTQTYADTL
PQFSQDQAFQNALLLTEQVLTEQNVNFIFIDKNERVIYPTNTALLNFTLTADQWKNLRNG
RQEKFTSNKNILGQAQATSYALVPFNLNHEFYGALVVSQPARNIDNSVRPITLNLFKGFI
FSSIVAVIASYAFAAFQVKRINRLRNATKEVTNGNFDVQLPVHDKDEFDELADDFNKMTN
SLKESQAEIEEQENRRRQFMADASHEMRTPLTTINGLLEGLEYNAIPENQRENAIKLMKN
ETERLIRLVNENLDYEKIRTNQISMVIKKFNGTETLKNIVAQLEAKAEAAGDTLTLKAVD
DIDVYADYDRFVQIMVNIIQNAIQFTENGQITITLEKGYLETIITIEDTGIGMSEQQMKS
IWDRYYKVDPSRKNTKYGESGLGLPIVQQLVRLHKGKLEVESELGKGTKFAVRLPDVEIK
KE
>FECAFAII_01968 Transcriptional regulatory protein SrrA
MNILMIEDNQSVSEMMQMFFLNEGWEATFKYDGKEGLDAFLENPQHWDMITLDLNLPTLD
GMLVGREIRKVSSTVPIIMLTARDSESDQVIGLEMGADDYVTKPFSPLTLIARMKALHRR
SELAEAREEAVVSDDHFDIETSHFKMNTKTREAYLDNRPIEGLTPKEFDLLFTLAKKPRQ
VFSREQLLELVWDYQYFGDERTVDAHIKKLRQKIEKVGPQVIQTVWGVGYKFDDSGVA
>FECAFAII_01969 hypothetical protein
MIFFSIGILFLIIGSLFRILPSKGNLPFYGYHSPLAAKTDAHWRLAQKTSGNWFFLMGLL
MALIGYYLKTSGHTNYFLIEMLLLVFPIMPIFIMTEKKLQKYDLETGGNDNEYFND
>FECAFAII_01970 Putative phosphatase
MSNYRAITFFDLDGTLLDAKSKITPEVAKAMNALKENNVLPVIATGRTEAEIHSIMEDAG
ITSAVTMNGSFIRVDGEEIYSQTFSSEECQKMYDHVQLNGHELSYYNDQKIWCTGHSQTM
INAYDFIHSDVPEIDPLGFKENTVNMLLILSQSGDEYYHEHFPELTFYRNGPYSIDTVKK
GISKGAGVKRLQKELQLEKVPTFGFGDGPNDFALLEACDNKIAMGNAYDGLKELSTFITK
KNTEGGIVHALKYFDLI
>FECAFAII_01972 hypothetical protein
MLMEGKTQLWFKFDPSNRFVKDFYKVWDSEVFFLAIEDSLLINLYYSNKNYFKIPATKTR
MKKDVYFLFDIVTDVPDARSDHRRYDYLKYTFVDPERYKD
>FECAFAII_01973 hypothetical protein
MNDFTTEIVQTLVTKGDLNELFRSHLEKAINTLLRTELTAFLDYEKYDRTGFNSGNSRNG
SYFRSIKTEYGELTLEIPRDRNGEFKQQTLPAYKRTNDTLETTIIHLFEKGVTMSEIADL
IEKMYGHHYTPQTMSNMTKVLTEEVNAFKSRALNDKYVAIFMDATYIPLKRQTVSKEAIY
IAIGIREDGTKEVLSYAIAPTESTYVWNELLQDINSRGVQEVLLFITDGLKGMKDTIHQI
YPKAKYQHCCIHVSRNIAHKVRVKDRKEICDDFKAVYQANSKEEANTFLSGMIEKWKKNY
PKVTQSLIENQDLLTFYDFPPSIRRTIYSTNLIESFNKQIKRYSRRKEQFQNEESLERFL
VSIFDTYNQKFLNRSHKGFQQVTDTLVSMFTE
>FECAFAII_01975 hypothetical protein
MNDFTTEIVQTLVTKGDLNELFRSHLEKAINTLLRTELTAFLDYEKYDRTGFNSGNSRNG
SYFRSIKTEYGELTLEIPRDRNGEFKQQTLPAYKRTNDTLETTIIHLFEKGVTMSEIADL
IEKMYGHHYTPQTMSNMTKVLTEEVNAFKSRALNDKYVAIFMDATYIPLKRQTVSKEAIY
IAIGIREDGTKEVLSYAIAPTESTYVWNELLQDINSRGVQEVLLFITDGLKGMKDTIHQI
YPKAKYQHCCIHVSRNIAHKVRVKDRKEICDDFKAVYQANSKEEANTFLSGMIEKWKKNY
PKVTQSLIENQDLLTFYDFPPSIRRTIYSTNLIESFNKQIKRYSRRKEQFQNEESLERFL
VSIFDTYNQKFLNRSHKGFQQVTDTLVSMFTE
>FECAFAII_01976 hypothetical protein
MKRILFISLSNLLLLTACGTSASKNIPSDTQISNSIDSTISTNEKNSPVETSDIKVSTSA
KNRVKKLSARLLYFKQTLN
>FECAFAII_01977 hypothetical protein
MNNETIILGKKYICQPIGLKQKVVGEVISKLENCVVICVDEYHDVDRNEILEKCGKVVAK
YTHVYELETTEYLYNYSNKYEHTLVS
>FECAFAII_01978 Free methionine-R-sulfoxide reductase
MWTEKQKKDAYEILLLQQQGLLEAEDNWLANLANSSALLNETLPETVFAGYYLFDGNELI
LGPFQGRVSCTRIKMGKGVCGESAEKQETLIVDDVKTHANYISCDSAAQSEIVVPMVKEG
NLIGVLDIDCGVTKGYDEIDQAFLEKYVDLLLANFNINAFSFINN
>FECAFAII_01979 Alpha-acetolactate decarboxylase
MTEKILYQHGTLGALMAGLMDGTETIAHILEKGTLGLGTLHGLDGEVIFLDGVAYQGRSD
GSVAQLDGSELTPYAAITDFTPDTSFSVSKTADGEQLKKDILVREAGENLFLAVKITGLF
KNMHIRIMPKQEKPYRRLAKISESQPEFQQSNVQGTLVGFFTPELFQGVAAAGFHLHFID
DTHTFGGHVMDFEVAEGKVEISRISSLVQHFPVDDPTFVHETIDYADLAAEIQQAE
>FECAFAII_01980 Acetolactate synthase
MDEKMKQGSKSVVESLINHHVDYVFGIPGAKIDGVFNELEDQGPELIVTRHEQNAAFMAQ
AIGRITGEPGVVIATSGPGASNLATGLVTATAEGDPVLAIAGQVKRSDLLKLTHQSMDNA
ALFQPITKYSAEIQDPETISEVIANAYRMAKSSKKGASFISIPQDVVDAPVQGNVIKPLS
DPKLGSASADDIRYLAERIREAKLPVLLVGMRGSSEKETLAIRQLVGKTALPVVETFQAA
GVISRELEAHFFGRVGLFRNQPGDMLLKRSDLVIAIGYDPIEYEARNWNAEKDARIIVID
EAPAEIDPFMQPERELIGDISATLDLLTGSLEPQQVSEDAKEYLASLQAELTERDIVQSK
GEAGILHPLEVINTLQSKVTDDMTVTVDVGSHYIWMARHFRSYEPRHLLFSNGMQTLGVA
LPWAISAALVRPNTQIVSVSGDGGFLFSAQDLETAVRKKLNIVHLIWNDGHYNMVEFQEK
MKYQRASGVDFGPVDFVKYAEAFGAKGIRATSVEELEKALEEGFATEGPVIIDIPIDYRD
NEKLGETILPDQFY
>FECAFAII_01981 hypothetical protein
MNDFTTEIVQTLVTKGDLNELFRSHLEKAINTLLRTELTAFLDYEKYDRTGFNSGNSRNG
SYFRSIKTEYGELTLEIPRDRNGEFKQQTLPAYKRTNDTLETTIIHLFEKGVTMSEIADL
IEKMYGHHYTPQTMSNMTKVLTEEVNAFKSRALNDKYVAIFMDATYIPLKRQTVSKEAIY
IAIGIREDGTKEVLSYAIAPTESTYVWNELLQDINSRGVQEVLLFITDGLKGMKDTIHQI
YPKAKYQHCCIHVSRNIAHKVRVKDRKEICDDFKAVYQANSKEEANTFLSGMIEKWKKNY
PKVTQSLIENQDLLTFYDFPPSIRRTIYSTNLIESFNKQIKRYSRRKEQFQNEESLERFL
VSIFDTYNQKFLNRSHKGFQQVTDTLVSMFTE
>FECAFAII_01982 hypothetical protein
MKEQRFDKNVYMEFFYWLYQSLASSLCFWCVNILYIAAAFLLSIDGRNVFSFIFSLLFIG
PGCIESIKYFV
>FECAFAII_01983 L-arabinose transport system permease protein AraQ
MPFIQWLGMILLIVLALLTIIPFLWMVSASFKANNEVFTIPIQWIPKTWHLENYLVIWSR
IPLVTFFKNTAFLSVVITLIQLFTSSFAAYGFSKLNFKGRDILFLAYIGTIAVPWQSYMI
PQFIMMRKVGLTYTLWSLVLLQAFNAFGVFLLKQYYSSIPDSLCESARIDGLSEWGIYRK
IILPLTKPAIASLTIITFVNTWNDYMGPFIYLSSTENKTIQLGLKMFIGLFDAEYALIMA
ASVVSVLPVAFIFLAMQKYFVEGIASSGMKE
>FECAFAII_01984 hypothetical protein
MNDSIKKMLRITEKDLMITEVSYETLQKKKTLVVDAVLSPTPRACRSCGSTVVDGNGKAI
IVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKSCQVSLTTVIRTLKEFKSYLPKQSKKILPRVLMVDEFRSHASIED
KMSFICADGETGKLIDVLPTRKLPRLTSYFLGCTNPEEVEFLVTDMNAAYFQLTKRVLPN
AKVVIDRFHIVKHMNQAFNELRIREMNELRKAGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLEFSPPLKEAYPFFHELVEAFRDKDPDLFFSLLAELP
ETLDDSFREKLQNLLTYEEGITNAMIYPYSNGKIEAKNTHIKTMKRVSYGFKSFENMRIR
IFLINQLINVR
>FECAFAII_01985 hypothetical protein
MLDPVDTEKYETILLPRKEKWGLLILENSVLAKKDVITKEDFANVPLLISKRPEIQRMFA
DWLGIKKEQLLITGTYNLIFNVFALIENQVGAALVIEGAVSHLSKRVTFVPLDPMIETNC
MLVWKKNRILSPVVNELIHRFKEAFEQ
>FECAFAII_01986 HTH-type transcriptional regulator CatM
MELRLLKYFWTIAEEGTISQAAEVLHLTQPTLSRQLKELEEELGTELFVRENRKMILTEA
GYFLKKPSRRNFRFNESNHSRIREQKKTIIQRPIYDRLCGS
>FECAFAII_01987 HTH-type transcriptional regulator AdhR
MNIKQVSEEKGISADTLRYYERIGLIPPVNRTKGGIRDYTEEDLKWVDFTICMRNAGLSI
ESLIEYIRLSSEGEATVFERRKLLIEESELLTKEIAEMQECLERLQGKIKKYDRVLSRNK
MECIK
>FECAFAII_01988 Putative metabolite transport protein YjhB
MTTYQRKVLLSTSAGIALENMDIMFLAFSLSSMITSFHISGTQAGFISTITNLGMLIGGI
FFGIIADKYGRVKVFSQTVLLFSIASLLMYFASNIYLVYLFRFIAGVGAGGEYGACMSLI
SESFSKKQIGRASSVAGIGAQVGAALAAILAAVIIPTFGWKMLYVVGVLPVLMVLFIRRG
LTEPKEFKSVQSAEKKTKLSRLFESKHLAWQTCGLSIMVTVQIAGYFGLMNWLPSIMQNR
LGLSVSGSSLWMVSTILGMSLGMMTFGIIMDKLGPKLAFSLFLICSSLSVYLLVLAHSQW
SLVAAAVIVGYFINGMYGGYGAVISSLYPTEIRATANNFIMNLGRAVGGFSSIVIGFLMD
HYSLTAVILFLSGIYLVSLLVLTTLTGVTALRESLQH
>FECAFAII_01989 hypothetical protein
MQTFLTKVSQKKIKMIHLLLETERWCSIEELQNELKVSSKSILNYLTDLEELFQKYPDKV
ILKNENNRRFSMEKQENFPIYIIYLHFYRKSYNYHLIEFMYQHPEKNLEDYADAQYTSVS
TVFRYAKLLVKYFEMTDVKE
>FECAFAII_01990 hypothetical protein
MTEAESALSQAEANPTKENYATASAAIQALPENKQELTSRLAAIDSTIKAKEAEEERKKQ
EEIARQQAEQAQQEAIAQQQAEQARQEAIAQQQAEQARQQSAAEQASQQAQAAAPEQNNE
QTVYVTPTGSKYHTHKCGNGTYTPATLSEAQARGLTPCSKCYGN
>FECAFAII_01991 hypothetical protein
MNEDVQKSRGNRLNEKREKLTKWTCKLLFLVYYLERHLLFFYVSEEFYYYSITFELVSIT
FGARG
>FECAFAII_01992 hypothetical protein
MNKSRIRILDIFMAIILVVGIGIFSYPFVEDSLNDFLAQQMIIHYQKQASNKNSEEIKKQ
QEKMTKKNQQLAEQNVSPGIGSFNQAVDAKALKDLPSNAFFMEHMLGVIEIPKINVSLPI
FDQTTEIFLQKGTSLLEESSYPTGGKNTHAVLSGHRGLPEAKLFTDLPKLKKGDQFFIQI
NGKTLAYQVEKIQVVLPDEVDSLGIQKGRDLVTLLTCTPYMVNTHRLLVTGHRIPYQAKE
AKKAIQGIDQWKKWKFFIWFIGILLGSIGLVWLLIAYLDSLAIAKRNYPLSFYVKNTNGR
PIEGMVFSVKTLNGKHYITREKVPFVKASDEYGLVRFSDLKGRNYRLQHEELLLKIHVKH
KHSKQFSMKLKKGRYKLRKEKEVYYLIEKE
>FECAFAII_01993 Fimbrial subunit type 1
MTGFDENTGVALYDPAESALTFTTDTEGSISVNGLIDGNYTLVETKAPDGYQLTNPQKET
TFIVKNGKLQQTTGIIHGADEANLGNPNGVVNRENTTTDNMITVENVQNYGDFHFIKQDV
NTQEKLADAEFSILRAKDPTVKLMKKIANLASGEYPYAWSDEVTGSDWEEVKLISDSEGK
FSIEGLKQGAYCLQETKAPEGYALPKNEAAYTEFTVDDDPTTSDETTIDNQPKGILPSTG
GMGIIVFILVGTALVGGAVIYFKKRHQETEA
>FECAFAII_01994 hypothetical protein
MKNIKTKIWTFLGTAIMLLPFVLGLGTAEVSAAVSPTPENVTVNLHKLKFTSAPENQINN
GTELTFPNSEPLNGVEFNVYDITATYYPSKDTAVPADATPFASVTTSGEGLANLTLPGKS
DGKDAVYVFVETPKPGVETSPNIVLSLP
>FECAFAII_01995 hypothetical protein
MLPVTDSSNHKLTTIHLYPKSEQKIPAALTLTKTVENKQTDFADGDKVPYLITVTIPENI
NEIGTYTIKDTADPQLWLEPETIDFLIGGDKIHTFHTQKIKHGFVLSDSGKDLSSFAGKK
LTIRYQMTLKENSEKTTFDNDVRLTTDNQTVETHLAIQTGGKQFVKVDRQTKQKLADAQF
LVKKNDQYLAQENGINHWVAKDDSRATIFTSSKDGTFSVHGLSFGSYELVEIKPPKGYIL
SQSTILFEVEKGSYDPLHPIPLEIINEPKANPTNNGKTPVQMQTNGPSNEKNGGSCPKTS
EEMLGGFSILGLLLVLSTGTAWFYKKQQKGNNRREIK
>FECAFAII_01996 hypothetical protein
MKKTKNVRVDIFAVLFFILLVFFIGSPTVSARESPITFTLHNRMFESDKMPSISQNDGIN
IPDNFQGVKGLNGVTFAIYDVSDEFYKLRSEGSSVEDAQRKLAQKSDSEKILAENVTKTV
DEEEGIASFSASDKDEQGRDAVYRFTEIKTSD
>FECAFAII_01997 hypothetical protein
MIKKTQNKIQRICQKHFVSRLKAVSKRKYLHPIMISIILIFTFLGSLSSIYVNVYTETSN
FANQTTEETNSPPYSEIQSIESTNQSSNNETTSTTSSTQLIDPTEKEITAAKAAGEKAYS
ETGRSQTFSTVAATANFNGHTIPDGYTVIYAKDGVIVAVNGSMSADKTALQGVTKAIAFI
DNRPDIHNLFIGSTVNGTTITFPKSIYMGVATAGNTIDSVTPNADKSYSFTPSTWGGLPA
GGGMSTFSIGIQLANDIPFTGYSIKNGQIVDGKGNVSNFPTYQAATVQVNANRTGTFSYT
VNGGAAKIGTYGTTLSGIHVGDKVVITPTAVTGYSFAQTNGSFTALESNVDTVTYTGKQT
PITIKYQDYFGQMIAPSKIMNLTYGSAAQDLTTNTPTINGYTFTAVSAIETKNQSAMSVL
ASLDTNGNVIVKDANGKQISEVILYYKTNATVSINANGSKYYDGLSVVPIVKYAFNDKTE
STSLLNNDLSIDQITWNPTDFKAMNEKGVEVTAPTEIGTYTSWQLTKSGLAKLAARTNYL
FTIVQTSDVYTIKQISGAVELSGSKTYDGKAGVPSIHVKLAEGVTSSLTPVQVALSSMDY
TADAQSAKNMVNAGSYTIKLTNSGIDKVKAANPKLSFTDIANTSGTYTIYKANAVITVDD
AAFNYDAQSHSISVGNLHVTGVVLGESLDYTLTVNSRTDIGSQIVTISLGEGSVNNNYTI
IATDTAKLTINPTLLLPSTGGIGLLPFVFLGLIFIFSGFFYFIHRKKKAGEQR
>FECAFAII_01998 hypothetical protein
MVYTYTEQEKMKVLDTFMNDGKVKQVPSSTKKKYILLKEVLKRFDHGVTYTETEVNSILL
NVFSSGDYVEQRRYLITFGFFKRSSDGRAYQMMGIEN
>FECAFAII_01999 Tyrosine recombinase XerC
MEKTDRFKKQISSTGRITWYFQAYRTTRRGFNSKREAQLAYLEMEKQQRLKKKIVASNDK
FSVVGEQWFQYYRSLNEQKEITYDKREEQLKIIVRWIGDKKLSDLTPECLQELLFTLKEC
GVNGTNVGYAKNSLQSLIQVLNMIFKYCQRKNLISENPMKSVRMPKYQLTVTDLKEAINN
IEDKFLTVDELRTFLNYGIVHEELPMSVLFHVLFYTGCRVSEALALQPGDIDFKRNEILF
YKQTAVKGKSKDFRIETTKTVSSARRVLVTPLVMEKLQQLIKALGEMRQHYRFIIEETYL
FVYLDSSKRGVPYRREYVNDHVKRCVNRSGINKPFHTHLARHTMASLVAEHCSWEVLKDR
LGHTDQTTSKIYRHLTSNEKVKPLIAFSSLES
>FECAFAII_02000 hypothetical protein
MEVKTNVNSLEIEFYSILQKKLEDYTEKLLAVSHLPLVLTNTDLKRLFQISDSTLNRLVK
LGEFPPCWYGIRGHYFRDDVLEWMRKSDSNDYREKLRLLRSL
>FECAFAII_02001 hypothetical protein
MKQGIADIKIIKEILEKSTANAIAFGTGINLSTVKKLKSGERAEEKLNLADAIKITEFGM
KNMPTKIEIWK
>FECAFAII_02002 hypothetical protein
MSNMKQNKRYIPFIPLTTIKAAASGDSIAMSIVLSKYQNYISRLAMKPVYEEEKGMVMYV
DEYMRRQLETKLIEKILEFDTTR
>FECAFAII_02003 hypothetical protein
MGDSEETHIQHTFDSFCKKVVCNEALNIQKKYARFRQRQISMEILEQKGLGTEFYYLEPN
LNSSGTFIVLGMKIFISNEELANAIAALPSQRQEIIFMSFLIGLNDREIGDIIGKSLGSV
WYQRQMALEELGKYLGVKYEAK
>FECAFAII_02004 hypothetical protein
METTDTLLQLLQEAHKTNQTQQQTIQNLTTEIQLLNEKVNYLTNKLFGRSKETLFEETNG
QLNLFSDEEISVSVPEAAATIIPVKGHQRVVGTKTDKIKHLPITEKEHLLPLEEQFCEHC
GSQMKDIGRTKVREEIRFHQAMLDCLTHYQHTYCCKSCEKEGLSSFKKAIVPKPLISNSL
GSNSLVAETIRMKFGQKVPAYRQENYWKQTHGLDISRDNITNWHIKAVQNALDPLGERLR
VYLNQEEILHGDETSYRVIESAKTDTYYWQFCTGKDSQHPIVYYHHDESRAGDVPKTFLK
EFTGYLHCDGYSGYNAVESVRLVYCFAHVRRKFFEAIPKGKKNTDIPAAQAVKQLDKWFV
LEKKWKDFSPEKRLSCRQQELRPLFIAFYEWMATIDPVAKSKLDAAVQYACKLRSGFEPI
FEDGRLELTNNRAERNIKELVIGRKNWLHSTSLEGARTSGIILSVYKTAELNGLNPVKYL
EFLFDKIPNLPVLSAETLDQLLPWNKDVQQHFSRN
>FECAFAII_02005 hypothetical protein
MLYDLLQTKHIYIVCGKTDLRKGIDGLASLIQQEYQLELYEDAVFLFCGNRQDRFKLLYW
DGDGFLLCYKRIENGKLKWPRTKDEVRTLTNQQVRWLLEGLSIDQPRAILPGKKGVF
>FECAFAII_02006 hypothetical protein
MYKLNEIVPVQLGNEKSAPEKGKPAAAKLAMRIKRENGSEVLIYNGINNYILQAILKELL
SNAL
>FECAFAII_02007 hypothetical protein
MKLNGLQHIGIPTKDFGASKIFYESLGFSLINEEMNVGSKVGFFELNGTIIEIWEDKTTE
CRGAIDHLALDTDDIDEVFNSIQDLGYELLDKNIMELPFWENGIRYFNFYGPNHEIIEIS
QMKK
>FECAFAII_02008 Sucrose-6-phosphate hydrolase
MQKIFYKPKDFWFGDCMPFYKDGTFYLFHQRDTRNPKPLTDPFGWSLVTTTDFVKFEEYG
EVIHRGGNDDIDQYIYAGSIVQGINEYLALYTGHNRKAKLDGKTSEVLMIASSKDLIHWK
KDGEAAKLVPQEGYDKNDWRDPFAIFDQDHGKYVLILGARKPASKKKPTGRLVYFESEDL
KDWNFKGDYWANNEFNMIEMPDIFEIDGTWYLLFSEYCEDKKTKYRVGAGLFSDWKSPVD
EAFDGKAYYAARTVGTNETGRFLTGWVATKEGENDQNNWDWGGALVPHQIIQKTDKTLGV
KLPEKIIENFKEITPFSSFKLEKEFGKKERVIVPKIEDYFLFETTLTITSLTKEFALKLF
VDSDTQEGYEFRISLINNQLTFGKTPNYPWPQMFDKGLQRPLFLEIGKEYELKLIVDDTI
AVLYIDNVALSTRMYDKVGTALSMTVTEGAIKVDKLDYSINYECGF
>FECAFAII_02009 PTS system sorbose-specific EIIA component
MEFIITSHGNIAIGFVDTLKMFFGDNLNCHVVTLGDAGIEEFRENIEKIVSQVKNQEVMV
FADLIGGTPFNEFAKRSEVFQNGFQLLGGMNLGILIEAVNLRLQGKKSDDIIENLRNMNT
IACLADMQRHTNEEDE
>FECAFAII_02010 PTS system mannose-specific EIIAB component
MDEKMKGIIHVRIDDRMIHGQVATQWTNQLSANRIMVINNEVANDDVKKAVVRLAAPPNV
RTSIITREVAVKNILSGKYEGQKVLIVAVSPIDVKFLIDNGLPITSVNVGNLSRRNGTER
IRPTINITEEEREAFKELISDGVEVTVIQTPRDSKEFLKDFIY
>FECAFAII_02011 PTS system mannose-specific EIID component
MNKKLTKIDKQVIFRWILNGATSLNYEKMEGLGYAYSMLPFIKDTYKDDPEGMKQSVLAH
LQFFNTTPYTAPYIIGMNVGIEKEEKNKSLEAVSALKTGLMGPLAGIGDSVFVVIPWTIF
GAIAANMALEGSFVGIILWILASILLRITAYPLYLAGKESGASLLTQIETKLKSITDAVS
ILGLMVVGALIATVVKVNVGFEFKQGDLTMTGNEIFDQVMPGLLPACVVAIVYYLLGRKV
KPVYVILLILVVSIALRALNILK
>FECAFAII_02012 PTS system sorbose-specific EIIC component
MAFWQTFLVVLYGFFINWDKEGPKIGTSQPVVAGFLTGLIMGDIQTGLYIGGTLQLMTLG
ITSFGGASVPDYQTAALIGTYLAISTNQDASIGITLAIPVAMLIVQLDVLKWSTNIFFQQ
KAEKFAQKEDYQKLEWMQYLASINTSFVSGIPVLLTVILGPTLVGSAINYIPEWVTGGLK
VAGGLLPAVGIGMLLKYLPTKDYFAYLLVGFVLAVYFQIPILGISLLGAAIALIVYKNRS
NNTQVAPAATGGFDEDE
>FECAFAII_02013 Transcriptional regulatory protein DagR
MKKKMKDEVLEYIKNNLKYYDFSAQDIAMKFCIKRNVASHYLNQLFSDGKLLKNDSVRPV
MFKYNQQKPKDCFSKFIGADISLKSTIDKCKATVMYPPNGLPLIIKGNSGVGKSFLASLI
YQYALDRKVIHNDAKFVVVNCADYANNPELLSAVLFGYKKGAFTGAEKDTAGMLSSANGG
YLFLDEVHNLSAENQEKLFLLMDSQKYRKLGESVQWEYANVRLILATTEDKNTSLLATFR
RRIPAEITLPDYNNRSTSEKIQLLFEFLKDEAITIDSKIFCSIELFTDLLSKTFEGNVGE
LRNEIKLLCAEGYLGNKRKSSIYLGDKLDSGFWIDPEISIDLKKMFLKSLSEIDLIELFQ
NHISIEESMSQLRDRILKECAGSSEYNYLESDEFIALRNYVVNKISPIIDSTGLCLLDEF
LADISLFIMFIDVIEETSRNFLLSKFRKFRMKNDKQKLLANEIWSSLEVEESKQELLLKW
ILFLVKKFYVKIPETHCLIVMHGKITASAIARETNKLLNTYVYEAFDMPIEGETSDLINL
INNFCKSIDTTNGLILLVDMGSLEQMYEKIESNVIGDLVILNNVSTALAIECGIQVCQKK
PISHFYQMDFDSFQVKVQYYKGLSQKKNVIVSCLSGEGISEKVKDILKRYLDNQVEILIF
DFNALKKIAKEKDTMIFKNTICVLSTTEFYIQGIDCLNLENLINGNQTLEKLNKYMDSDS
CEFCLNELVKLFTIEGASTKLRFLDSKKVFNEIEKVLYLYEKYYDVKIPSFLRINLFLHL
SGMIERIMIGDGITNEHLKEGAQLFDTFLNVSKDFFSEIKDIYCIEIPKGEYELIYTIFE
QTIF
>FECAFAII_02014 Putative fructokinase
MVFGAIEAGGTKFVCAIGDKDLNIFEKVSFPTTTPKETMNLVLDFFNHHKDDLEGIGVGS
FGPIDIHCESKTYGFITSTPKLAWQDFDFIGSLKKQLNIPTAWTTDVNASCYGEYVSGNG
RGLSSVVYYTVGTGIGGGAIQNGNFIEGFSHPEMGHMLVKRHNKDNFSGTCPFHGDCLEG
LAAGPAIERRSGKKGQEVTENDVTWEIEAYYIAQCAYNTTLMLSPDVIIFGGGVMKQKHL
KKKVQDKFIELINGYVAIPDVDNYIMTPKLLDNSGIVGCLALARDVKEKS
>FECAFAII_02015 PTS system glucose-specific EIIA component
MLNFFRKNEISVVAPATGVFEKLEKLSDPVFSKGMMGQGFAIDAKNETIVSPIDGFVSSI
FPTKHALGIKTKSGIEILVHVGIDTVELNGEGFDIKVQEGQKVKAGDILMTINFVVFEKN
HKTKDVIVVFPDYQDEIFIPKLEEVKQGQELFVLG
>FECAFAII_02016 PTS system trehalose-specific EIIBC component
MDYKKIAEDVLENVGGKENISSATHCITRLRLILKDKSKANMEMLEEIEGAKGVLFNSGQ
LQVIFGTGIIEKVYKEFVELTGAKEVSVSEMKDEGVNNSGNRLQRAFKVFSDIFIPIIPA
FIGAAMVLGIRSLITTPGMFGMDGSFADHNVFLNDLSKFLGIIATTFDYLPVLVMYSATK
RFGGNPILGLLVGFVMIHPGLANRNDFVMGTIKPDYWHLFGLSIPAVAFQGGVFPAILTS
WFLAKVEKITNKYSPQVLAYILVPTVTIVLANFALFLVFGPLGNFIGNVLGGIIDFLYMK
MGAFGAFVFAGALQPLVVTGTQHAIQGIEANLVATTGFNYIQPIWSVSIIAQGGGCIGMY
LLFKKKSKDRDIAISSFIPTLVGITEPAIFAVNLKYSIVPFVCSFIGAGFGGAFMKIFDV
KAIGQGLTVLPGLTIANPVLPYIFGNLIAFILPIIFILAYDKYKVFIPEAKHRKFAEKTD
SKKLPVQVK
>FECAFAII_02017 Beta-fructosidase
MEKLLIKSNNHQLYYQPKDVWVGDVMPYGKEGKFFIYHQRDTRNPVPFGEPFGWALATTK
DFVHFEDFGESLLRGDDNERDQFIYAGSVFEANGKVHAFYTGYNREFLAQGKTSQVLLHA
ESDDFVHWEKSETALELEPQEGYDIRNWRDPFVVWDDEKEEYLLILGARKGQDKHLQTGR
LVEFTSKDLTNWEFKGDFWAPGLYTMFEMPELFKIGDWWYLVYSEYSDGNKILYRMSQSL
EGPWIKPKDEAFDGRAYYAGRTAYDGKRRVLFGWVPTKDQENDKNNYLWGGTLVPHEVYQ
KEDFSLGVKPIDEVWNAFINLHDIADVEIETADTREEVTLVKNSGTLFNLETTISFDENL
SDFSLRLYKNLETDESYEYRFNLDEGRLTFDKNPCYPWFQYMDKGLIRPISLKPNQSYKL
KVIVDDNIMTLYIDGIALNARVHGCFGQAITITATNGSMTAINTKFSNEIKK
>FECAFAII_02018 HTH-type transcriptional regulator DegA
MKKIGIREVAKEANVSPTTVSRVLNDRGYLSEETKRKVFDAMKKLEYYPNELARALFKNE
TYTVGLIFPTITNPFHAELIQDIEFELSSRGYKVLLCNSLNNPTKEKEYLTMLRKNQVDG
IIVGTHNKDIADYDIPGLPIVAIDRSLGENTVTVSCDNYRGGELATQLLVNHGCQNILCI
RGDSKIKLPANSRTLAYKDVLNKFMLEPLVLEVPFVKEINEKNEIIKTYLETHPNIDGVF
AGDDLLASLAINNLGSSGKRVPKEVKVIGFDGAQQTLIYNPELSTIQQPIDQISKVAVKK
LLNMIKGEKETDELSLPVKLIKKNTA
>FECAFAII_02019 hypothetical protein
MCKVLNISCQTYYYQAKPVEDESELEELVQEEFIRNRKAYGTRKLKQCLANLGLQVSQRR
IGRMMKQRGLRSTYTLAHFKFHSSTCNEAKTANILDGTFLQEKSLEAIVTDLTYVRVGKK
WQYICLILDLFNREIIGYSCGEKKDATLVKEAFAKIPYSLNNVQLFHTDRGKEFDNQTID
EILWAFNITRSLSKKGCPYDNAVAESTYKSVKVEFVHQYRFETLANLRLELFDYVHWWNT
IRLHGTLGYETPISFRQQRLAQRILDNELGCDTGGEAP
>FECAFAII_02020 hypothetical protein
MSRRQRRTYSKEFKQQVVDLYLAGKPRAEIIRDYELTTSAFDKWVKQAQTTGSFQEKDNL
IPEQVELIALRKKNKQLEMENDILKQAALILGRKDK
>FECAFAII_02021 hypothetical protein
MVDKIQFNQVIEEFIKVNNLMTHIQKRPIRITNDLKLSTSMIHLIDVIGNYPETSITELA
DRLGVTKGAVSQQIPTLEKMNLISISQKKGNKKTKLVSLTKYGRKVYESHNYLHEELYSS
INEALESFSPDQISTIKQILEKVSYTINEYQVSLTRKED
>FECAFAII_02022 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIVAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYIEKRSTEGWTPDVIIGRAERTFSCSVSTLYRRFKTGEFNVL
HLPMQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEGDTIVGIHHKSAVITL
VERLSKAIIALKPEGRKAVDIENSINEWLQSVPKNLFKPITFDCGKEFSNWKSISNTNDI
DIYFADPGTPSQRGLNEHSNGLLRKDGLPKEMDFNQVNQGFISSVASKRNHIPRKSLNYQ
TPLEVFLSYVNGKFCLA
>FECAFAII_02023 hypothetical protein
MDKYNVKTSFQKWFSAINFSGLSENSQSLISDFDFYSKKLDFQTTLKVLLHAVYEELPSY
REIDRAFLDQRLCKELGIDSLCYSSLSRRAPEIKQEVLMEIFTQLVARISAQQPSSKTTS
LQLIDSTTIPLNKAWFPWAKFRKTKSGIKLHLNLCYLDKTNQYPESFTMTNASEHDRNHL
EVLVDKTQATYVVDRGYFDYKLLDKLNRDGYFFVTRTKSNTKITILDQIEVADTTTRDGT
IISDQQVILVGGVNHVTERFRLVTVLTKGQKILRMVTNLFDVSPNEVADMYQARWQIELL
FKHLKQNLTIKRLYSHSEQGAINQVILTLIATLLTYVIKIELNTTATLFQLKRTFHYLMF
EPAEEWFKRYRPG
>FECAFAII_02024 hypothetical protein
MLTLDDIKTIKHLRNNRDQSIDQIRKAMNINWRTAKKYADSDQLFITDPTRKNKSMMDDG
WGEIIGSWLEEDLRLRRKLRRTAKAIHEQLKPLGFPGSYRTVCVYISQWKKQRYDETNYQ
AVDRLDHPIGEAQVDFGTMEVMHEDHMKDIQLLIMSFPYSNATSASAMPAQNQECFLEAL
KQLFNQCGGVPKTIRIDNLTPAVKKTKSKFEEAQLTDEFLRFTIHYGCDVQVCNPRSGHE
KGHVENKVGYVRYNFFSTSPIMDSFESLNKQLEEQLKADRKRTHYSKHQLIEDLWKKENK
ALHSLPQEDYPIFKEVEAKLNRYHEMKLDQTVIHIPKAYGYSQLTVVLTWNKFKVLTPHG
EILMNEYRPYMNKKRLIPWSDIMKQWSNKLNVVSYSRYWKYLPARLQNYLAIDNNHLKYR
RIKQLLSLLATYDIQQINEQFYELVVQEDAPSDFDVNWSNYDALTKTGGVQK
>FECAFAII_02025 Insertion sequence IS5376 putative ATP-binding protein
MIGQTLEDYCKKLRLSHIITNIPRASFEAPEQFITDLFRLELETRQQIKLERMEKLAKFP
VPKSLKNYEWHEDIFLPSHLDKETLVSLDFLKRQENIVCVGSPGTGKTHLAIALGRKACS
EGVSTKFFRVNNLVEQLENALKKQQLASFKKRFETTELIILDEMGYLPLTKEGAELLFQL
ISDWYEQKSIIITSNLEFSQWNRVFMDSRLTAALVDRLIHHAHIISFKGESFRLKNSLSK
SY
>FECAFAII_02026 hypothetical protein
MKIKIERSNKEKIPKKKKERVVSVGKHRKMVLALWLLLSCSLAFGIYKNFTAIDQHTTHE
KVVVKEKIVNTSGVENFTVDFVKEYFSWKNNKEVIEKRMTNLEQYLTEEGLALSQDMVRA
DIPTSSEVVSVKILDVEKHSEEFVVSFVVDQKITEGKKTQSISSAYRLMIFEDEKGNHIV
TSLPTMIGKPEKAKHKVRQVKSDSKIDSKTTEEITEFLETFFRLYPAASEKELEHYVEKD
AMQPINTNLKFVELVNPIYKQKGKAIQVIVGVEYLDELSKTTSVFQYRLKLYKNENWTIS
NCE
>FECAFAII_02027 putative endopeptidase p60
MNLKKLSIISLTFLTISFVGILMCVGLLFGEDGEGSGSSGTSPGGSSVSEVVLKHRSMVE
KYAKESDITEYVSILLAIIQVESGGTMEDVMQSSESAGLSPNSLSTEASIKQVCLYFSSL
VKCSKELGCDQDSIIQAYNYGDGYLDYVAKNGKKHSFALAESFSKEKSGGQKVDYPNPIA
IKENSGWRYNYGNMFYCLLVKQYLTTTQFDDKTVQGIFDEAFKYEGTAYVFGGSSPGTGF
DCSGLTQWCYAKVGLKLPRVAQDQYDAMTHIDLKDAKPGDLIFFHSTYDAGTYVTHVGIY
AGENRMFHAGDPVGWTNLTDSYWQQHIIGAGRYKQ
>FECAFAII_02028 hypothetical protein
MKKKLFRIVGIVFISIVTLTVLLSLVGTVAEATGLVDDTVEAGNLYSKYSLNNYQLDFFV
DSSWDWLPWNWGDGLGKSVMYGLYAITNFIWTVSLYLSNATGYVVQEAYKLDFISDTAKS
IGKNIQTLAGITENGLQTSGFYFGFLLLMILALGVYVAYTGLLKRETTKAVRTVINFVMI
FLLSGSFIAYAPTYITKINDFSSDVSEAALSLGTKIVVPNSESQGKDSVDLIRDSLFSIQ
VQQPWLLLQFDDSNIEEIGEGRVNKILSVSPDENKGKDREEAVKAEIEDNDNANLSITKT
MNRLGTVVFLVLFNIGISFFVFLLTGIMLFSQILFIIFAMFLPISFLLSMLPTYESLGKR
AIIRLFNTIMMRAGVTLVITTAFSISTMFFNISATYPFFMVAFLQIVTFAGIYFKLGDIM
SMFNLQSNDSQSMGRRVMRKPQMLMNRKLRQLNRNVGRTFAFGGGAAVGGKLATSSTKGK
GSSKINRVSNRKNHSARSINELNSDLKKQEQPVGTKKESRINLVGRKVGKVLDTKEIVKD
KAKQAKNQVTDAPTNLKYSLHKGMEKTKKVPEDFKRGPFEEKANRGELREKQRQRRDAKM
DEKRKVLNEAWNRHEKGRENVPIKKEIKPQKNELPENRSLKPRVQVHSNPEIKRKLSSQE
VIPNGSTQPLSKNNSFQQVKQRFTFPKRTNQQVQRKKNTRPKPKPGEKR
>FECAFAII_02029 hypothetical protein
MTQVHFTFESEEIQAIINESGANDTAKTLMTIMFNQLMEEQRNQYIQANAYERSEERQSQ
RNGYYDRSFTTRIGTLELHVPRTRDGKFSPTIFERYQRSEKALIAAMIEMVISGVSTRKV
TKTVELLTDGATVSKSFVSNLMKQLDPFVFEWRNRSLEGSEYPFFMCDALYMKVRENHRI
VSKGVYIGIGIDSDGRRTILGFDVQDGESEDNWDTVFQSFVQRGLFGVKLVISDAHKGLV
KAVRKNFLGASWQRCQAHFLRNIFDKLPKKVSSDVKDELKSIFKASELELTRERKEHFLE
KYGCDSKLSAACDILENGFEDAIQILSFPENIRRRIRTTNVLERLNEEIRRRERVIRIFP
NINSITRIIGTLLMEKDTEWLASPRKYLEFNSNNI
>FECAFAII_02030 hypothetical protein
MYPIKYIENNLVFNQEGECFAYYELVPYNYSFLSPEQKFQVHDNFRQLIAQNREGKIHAL
QIATESSIRATQERSKKEITGRLKEVAKQRIDIQTDALVSMIGDSQIDYRFFIGFKLIAT
DEEVNLKSLKKSFFSGLQEFVYGVNHHLMGDFVSLSNEEIRCYSKLEKLMESKLARRFKV
RRVTPSDLTYLIEHIYGEKGIPFEEYEFQLPKKKLKSETLVKRYDLLRPNRCLIEEKPRC
LRMEHENHESYVAYLTINTIVGEMEFPSSELFYYQQQQFTFPIDTSMNVEIVTNKKALAT
VRNKKKELKDLDNHAYQSDNETNSNVLDALDSVDELETTLDQSKESMYKLSYVVRVSAES
VDELKRRCDEVLDFYDDTNVKLVRPFGDMMGLHEEFLPSSKRYMNDYIQYVTSDFLAGLG
FGATQMLGELEGIYFGYNVDTGRNVYLKPALASQGVKGSVTNALAAAFLGSLGGGKSFSN
NLLVYYAVLFGGQAVIVDPKGERGGWKETLPEIADEISILNLTSKSENQGLLDPYVIMKK
KKDSESLAIDILTFLTGISSRDGEKFPVLRKAIRTVTQSDQRGLLQVINELRKDGSPIAE
NIADHIESFTDYDFAHLLFSDGSITQSISLDKQLNIIQVADLVLPDAETTFEEYTTMELL
SVSMLIVISTFALDFIHSNREIFKIVDLDEAWSFLQVAQGKTLSNKLVRAGRAMNAGVYF
VTQNSDDLLDERLKNNIGLKFAFRSTDIHEIKKTLEFFGLDQEDQSNQKRLRDLENGITS
I
>FECAFAII_02031 hypothetical protein
MKKIKSYTSIWAVEKVIYAINDFQLPFPVTFNQMAWFVLSLLFVIVFAHVPPLSMIEEVF
LKYLGIPVAVTWFMSQKTFDGKKPLGFLRSFISYHLRFKVTFAGKKVKEQKKRWDEPSTL
VRSVNYVSD
>FECAFAII_02032 hypothetical protein
MLQNLDSLYQSLSKTEERLEEIIQQEIKLKDYQVEVDSAMSRMNKSYQNLYSERSSSSRE
IFSDITGIEATIQPNRDFNNYVKELRACINKEDTFDSEFGSLIDKLTKNSITNQDIYNDI
LDIRVSGESSIFSDKKLINSIRKLNDAQVLELQTLKPNDLVVIRLELNGKKVSLSNASAG
QKTSAILSMILAYGNSPLILDQPEDDLDSQLINNLIVRSIITKKENRQILIVTHNANIPV
NGDSEWLISMGDSKEISADQCGSVDEPNIKPRICTVMEGGEDAFTNRAKRYGFKQIVE
>FECAFAII_02033 hypothetical protein
MVGNKWYKCDLHIHSTASQCFQDKKVTAKEWVEECLNKGLDCVALTDHNTGENIDEYKKV
AIENGLDFFPGVELTCGENGTHLLVLFDKSACTNDISDFLTKMGIKREDWASAAACSMKS
VLEVIDFAEHEGLLVIPAHIDEFNGISSAKFGNLGKIFESENIYAVQTVQKEFFENRSQM
IPSSKRDTIYDSVNARYDGRVGKDTLESWYKSVVEAEKNNMTFLSFSDNPHSKGNSKHGL
WGIGTRYSYIKMKDEPDLGSLRDALMLGETRVHSDFSNFSINENEVLLEKLSFSGTTLST
KEVVVEFSDNLTSIIGGRGTGKSCITRFLVYVLGKEAELDQFSEIQSDYQNFAQIEHNGS
GIFLKDTIVKLNIFYKGTKYQIIRTQDRHSIYEFTQENGLVEKETERLRMISDKVSIYSQ
KQIYEISKNQTSILELLDGYNSDLISEYKNEIETCVNEIRKLNWDIVSVKKEIQDKAKVE
LEIEDLKKQVEKLSHKSYKDVYDEYSKETDIYRELKRDVEALKEIPKNLTDSVDKIDFGN
GIKVTDEIDEHRGELIKNLVTNRAKIQTIINEMSDEIDSYRAELNKSDWKVNYNEVSKRY
QRGIKNLVKSYLKMN
>FECAFAII_02034 hypothetical protein
MEQIRVYIANLGKYNEGELVGAWFTPPVDFDEVKERIGLNDEYEEYAIHDYELPFEIDEY
TPIEEINRLCGLAEELKGTPIGEVASEIQHAFFNSFEEMVEHVDDIIYYPDCNDMSDVAY
YLIVEAGDLGEVPEHLKTYIDFDACGRDLEIGGNYLVTSRGVFELM
>FECAFAII_02035 Group II intron-encoded protein LtrA
MPKNKNETLCVEDLRHAEYYEMQNTFDDLYAKSKNGDIFTHLMDIILSRENILLAYRNIK
ANAGSKTAGTDGTIIKDIGKLPAETVVKKVRYIVAGSPHGYRPKPVRRKEIPKPNGKTRP
LGIPCMWDRLIQQCIKQVLEPICEAKFSENSYGFRPNRSVENAIKATYNRLQISQLHYVI
EFDIKGFFDNVNHSKLIKQIWAMGIRDKHLIFILKRILKAPIKMTNGTITYPEKGTPQGG
IISPLLANIVLNELDHWVESQWQENPVTKNYVVHINKSGSPCKSNAYKEMKKTKLKEMYM
VRYADDFRVFCRYKESAEKAKIAITQWIEQRLKLEVSQEKTRIVNVRKRYSDFLGFKIKM
IPRRKKLVVKSHISDKQFKNQKDKLVSQAKKIASPSKGKTELEETRLYNSMVLGMQNYYQ
IATNVNLDCMKLNRAVMAIFTNRLGTNKRGRLRKTGRQLTTKEATRYGKSKMLRYVAGEG
EPIFPVGYIQHRKPMAKVYLANCYTLEGRKFIHTNLSVDKLLMYQLMKLSLENRTIEYAD
NRISLFSAQHGKCAITLEEFQQANEIHCHHIVPTGAGGNDDYKNLILVKEAVHRLIHAKT
EETIQKYIALLKLNKVQLIRLNKYRVLAGNQELNLI
>FECAFAII_02036 hypothetical protein
MKRGIVMEIVKDILLVFGGSMLGVTVMCLMHASAAADRAMEKKGK
>FECAFAII_02037 hypothetical protein
MAQRNLDYRLLKDRRNEYGVSQNKLATTCGLSRPYLNQIENGGVTASTKTMRKIFDQLES
FNPELPLTLLFDYVRIRFPTTDARKIIQEILHLKFDYMLHEDYAFYSYQEQYVMGDIVVM
LSHEEDKGVLLELKGRGCRQFETFLLAQKRSWYDFFEDCLKAGGVMKRLDLAINDRVGLL
DIPDLTKKCQKEECISLFRTFKSYRSGELLKPDDKDGMGNTLYIGSLKSEVYFCLYEKDY
EQYIKLGIPLDQTETKNRFEIRLKNDRAYHAIQDLLKGRSIESTTFSIINRYLRFADKVE
GKRRTNWPLNEQWGRFIGRNQKEIQLTSEPKPYTIERTLNWLGRQVAPTWKMAKELDRLN
QTTYIQDMVNNTRLSDRHKKILEQQSMAIENLII
>FECAFAII_02038 hypothetical protein
MIGKIQSDPELEEELYRLNFDIRKNGVKVPDDPYVIDEETDARMELNQVISELERIADFA
KEPDIRQYLFEIKAELEIEGITAE
>FECAFAII_02039 Modification methylase HpaII
MTFLDLFAGIGGFCLGMEQAGHQCIGFCEIDDFARQSYKAIHDTSKEVEMHDITSVSDEF
IQSLGPVDILCGGFPCQAFSIAGKRQGFSDTRGTLFFEIARFAAILQPKFLFLENVRGLL
NHEGGATFETILRTLDGLGYDVEWQVLNSKAYVPQNRERIFLIGHSRDACTEQVFPIIGS
SPTSDQNIRNLLNINPSNRGMGGQVYGSDDVAPTLTGDEGIKIALPVDDGISVAGMLLGN
FEQGNRVYEITGTAPTLSTKQGGTKIMLRKNETEYQEVKPGNSVNLAFPNSTSRRGRLGK
QSVHTLLTGDQQAVVTDQYQIRKLTPRECWRLQGFPDWAFDRASQVNSDSQLYKQAGNSV
TVPVIFDIARRLKEVKTDDL
>FECAFAII_02040 hypothetical protein
MTSKDYLSLFNFRVALGRMSELGYSMMFGEVDKKFFMKRIKGRGYVDTGGSVISEFYTPL
VPKGYDFLREISDIGGLNVNTEG
>FECAFAII_02041 Group II intron-encoded protein LtrA
MNKVKTNKTLRHSEYYGMTQIFDELYVKSDKKEVFTELMTIIMSDENIRLAYRNIKNNKG
SYTASTDKKSIRDIKTLSEDTFLTEVKVLFRCYKPRAVRRVEIPKPNGKTRPLGIPSIWD
RLIQQCILQVLEPICEAKFHNYSYGFRPNRSTHHAIATCNRLANRGKLHFVVDVDIKGFF
DNVNHSKLLRQMWTIGIRDKWLLGIIRSMLNAPIVLPTGKVEHPKKGVPQGGVLSPLLSN
IILNELDWWVASQWQNTTIETEKIMDRRDKGKGIDKTNQYRALRRTNLKEIYIVRYADDF
KIFCRKRSHADKIFHATKMWLKERLSLEISEEKSKIVNLKKGKSEYLGFELKLIKKGKKY
VVESHMSKKSMTRVKIQLKKQLRKVARPKNHCEQAKEIGLYNSMVIGIHQYYGIATCVNL
DCSKIAYTLKPFINHKLPTKKHGKILNTFIKSKYGKSKEMRWLNNVPIVPLNYVQFRLAV
PLSEGTCKYTESGRSKIHSKLKLDLALLLHMMRNSNYERSIEFVDNRISKYSAQKGKCAI
TGKFLEYEEIHCHHIVPVKQQGTDKYSNLIIIHKNVHALVHAIEEKIIHKYLNVLNLTNE
QIEKLNELRVKAGNSVLTV
>FECAFAII_02042 DNA translocase FtsK
MYKGHRIRAGDQHLVYHFVLGWLLALFIGWMSVFYFQELRQFDISKLSLSTIEIVRSIKD
LIYLLGSLVLSGSTMLLYIHFFQDHWRSLWHRQKLARMILENHWYEVKQTQSEGFFKDLN
SSRTKETISYFPKIYYRMKDGLLSIRVQISLGKYQDQLLKLEKKLESGLYCELVEKELKD
SYVEYTLLYDIIANRIGIDEVVAESGALRLMKNQVWAYDSLPHMLIAGGTGGGKTYFLLT
IIEALLKSDAELFVLDPKNADLADLGTVMPHVYSQKEEISACVEDFYERMMTRSKAMKEM
PNYKTGENYAFLGLPPNFLIFDEYVVYMEMLTTKESAVILNKLKQIVMLGRQSGFFLILA
CQRPDAKYLGDGIRDQCATCF
>FECAFAII_02043 hypothetical protein
MEINVEHILDCLDQYGKGELTEEQLTKALTYDEKMFLIMHQGLLEVGNDAEEDFDVLNWL
GEEESFFMVIEVNESLCREAETVLEEIGVEMPDAIEVFLKQLVETKQLPIAVND
>FECAFAII_02044 hypothetical protein
MRLTEGIVVDSGLTFGKLRFSALRREVRKQNEDGTVSNEVKERTYNLKSSAQGRMIQVSI
PANVPLREFAYDAEVELVNPIMDTVANYVFREGTTVNWFIKADDLVLKRQPDQGNSTNQN
EGKK
>FECAFAII_02045 hypothetical protein
MELKFVVPDMAETFGKIRYAGEGEVLTEGYGRNTTVIGRSYHLYSSKQRADDIEVVVAAE
AGEKDFDQDQPLKAVNPHLVAKGYEIENRGFTDYVLYVDDLVKA
>FECAFAII_02046 hypothetical protein
MKKPRFKNWRLLATLSLLCQTIGGSLGPTIAFADEITHPQTVTVELDLAHQYAVEGTFSD
GRPMSEVTVPHYAVYNGVKQDIFCIEPGVPIYNEFTPGYEKNPLPDMSEKAKLVSVLWKE
AGTDVDTHIVAQKMIWQEVNGYTLHSIKRSDGSAVNIAAIESKINQAIADYQKKPSFHNS
TVKTVLGQSTTVTDTNGLNLSEFDEVVENIANIDYRVNGNQLVITPNANSKESGELTLKK
SANTGTPVAYKMAGQQTLMAGAIDKPNTYTIKIDVETEGSLKIKKVDKETGNVVPGTVFH
LDFGKTLPAKDVTTDKEGIATLDEIPHGAKVTITEKSVPAPYTIDTTPITATIKSGETIS
VTSKNTREKGQIILNKMGVETGTDLWNDKYSLAGNTFAIRKDSPTGEIVQEMTTDEKGHA
ETPKEIANALELGTYYVTETKASNGFVNTFKPVKVELNYVNQTVALVTSNVKGQNQEITG
ETTLTKEDKDTGNETQGKAEFKGAEYTLFTAKDGQAVKWSEAFKPELVKGTKASDETVTL
TLDEKNQVAVKHLAINEYYWQETKAPEGYTLDETKYPVSIKKVDDNEKNAVITRDVTAKE
QVIRFGFDFFKFAGSAAGTAETGFNDLTFKVSPLEGTSEITGAEDEAITAYNEQLGFDGY
GKFENLPYGDYLLEEVEAPEGFQKITPLEIRSTFKENKADYTKSEYIFTITEKGQKQPIK
TVTVPYEKLTNKAFSVSLNRLMLYDLPEEEDSLTSLGTWKDGGKELTDLDSTELVDKLSY
NLHEIKEDWYVVAQAIDVEATKAAQEKDEKAKPVVIAETTATLANKEKTGTWKILHKLTA
EQVLDKTIVLFNYVYENKKPYEAGDDPVAKDASLNNQAQTVNCTVERHVSIQTKAHLEDG
SQTFTHGDVVDMFDDVSITHDVLDGSKEAFETILYALLPDNTTKEIWKSGKIDYEVNDKE
FTKTVLAEKVDTSKYPEGTSFTFKEINYGKDGNINGKHNEDLKEKTQTLTPKKVPTTPSA
PEQPEIPTVPSDSQESSPTVKTFPQTGEKNSNVLLFIGFTLIFATAGYYFWNRRN
>FECAFAII_02047 hypothetical protein
MKQNDGRIIWKNQSELKLILTINEFIEKHGITSSRQYQKKLSENPNSAPSMWFINKKYGS
WENLLISIGRENTGYGKWARMSEQELLEIVEAFIKCEKITSQRMYEQKSVGKNIPSLSTI
KKMLGDIRPLFKEKNDGSRFTDFELLLELKNEIIRLKLQDDLSMTKFRKLVQSPKLPSVD
TIMKRTNKNWEELMAEIGFDYRRIKIYKQRNNLSKTKKTK
>FECAFAII_02048 50S ribosomal protein L19
MNPLIEELTKEQLRSDIPAFRPGDTVRVHAKVVEGTRERIQLFEGVVIKRRGAGISETYT
VRKVSNGVGVERTFPLHTPRVAKIEVVRYGKVRRAKLYYLRALHGKAARIKEIRR
>FECAFAII_02049 tRNA (guanine-N(1)-)-methyltransferase
MKIDVLTLFPRMFEGPMGESIIGKAVDKGLLDINISNFRDYSDNKHQTVDDYPYGGGAGM
LLKVQPIYDNIQAIEKAAPDVKKRVILLDPAGKRFDQKMAEEFSQEEHLVFICGHYEGYD
ERIRTLVTDEVSLGDYVLTGGELGAMVMIDATVRLLPDVLGNQTSAQTDSYSTGLLEHPQ
YTRPAEYKGMKVPEVLTNGNHKLIEEWQLKESLRRTYQRRPDLLETLEWTPQMTKFLEEI
KKEEQEKTADEAK
>FECAFAII_02050 Ribosome maturation factor RimM
MTEYLNVGKIVNTQGIKGEVRVISTTDFPEERYKKGTVLTLFQDGKAPVELTVKSHRKHK
NFDLLSFEGHPSINDVEKYRDGILKVSKDNSVDLAENEFYYHEIIGLHVLEDGTELGKVK
EILSPGANDVWVVQRPKKADILLPYIASVVKEVDLEAGVVRVEIPEGLIDDED
>FECAFAII_02051 hypothetical protein
MRKKMLFIPFALLLSACSSVTQESDNTHLSSSISETVTSPEKSSTKTASTTEQTMATSNN
EKKTALDQLKEQQPNVPMPLDVPVSSGYLNIAATHTKQGYSILYYRTDRPLGLNADELNQ
ETPIATYLYQYGFASSQETIQVLQPFEIDTNGQQVDLGSRITGYQQGAAGSSFLEWQEGN
WRIRIRGNNIEGQDPLLLAKEIVAYLEENSLPAPEQFGKITVDMGDTTNRAVEVSWQEPK
NAYTITHQDPMSALKMAVSMKRL
>FECAFAII_02052 hypothetical protein
MKDLSDLVLTIVRPLVTYPDQVKLDVVESKDFYEYNLTVAPEDIGRIIGKQGRVAKAIRT
IVYGVRINAPKKVRLNIIDDKEK
>FECAFAII_02053 30S ribosomal protein S16
MAVKIRLKRMGSKKSPFYRIVVADSRSPRDGRFIETVGTYNPLKDPAEVVLKEDLVLDWL
SKGAQPSDTVRNILSKEGVMQKHHEAKFSKK
>FECAFAII_02054 Chromate reductase
MTKKIGFFIGSLRKDSYNKKVAEAFAKLLPEGYESVFVKIDDLPFYNEDLETPEQAPAEW
TRFREEVRGLDGVVFVTPEYNRSVPAVLKNALDVGSRPYGHSVWDHKPGLVVTASPGGIG
GFGANHHLRQSLVFLNVPTLQQPEAYIGNVANLIDENGNIVEGTLSFFQTILDAYLDFSN
KLTE
>FECAFAII_02055 Dihydrofolate reductase
MRKIIFYGAISLDGYLATKTDDLQWLFDTPTGKQTTYEAFYETIDTTIMGRKTYQEAKKY
LETEAIYPEKKNFVFSTHAQLQLPDAEVVNEDPVAFLKNLQMTEGKDIWVVGGGRLIKPL
LEHQMIDEWYIQITPVLLGDGIPLFQKGTYEARFEMLDTTRFGEFIELHYVRK
>FECAFAII_02056 DNA-3-methyladenine glycosylase 1
MRCPWSEQTESMRQYHDTFWGVPEYDDQKLFRKLMLDINQAGLSWQTILNKSEAFDEAYD
RFDIKKVANYGETKISELMENKGIIRNRRKIEAAVQNAKAVLKIQEEIGSFSEYLWSFSN
GKIVDSSYHSQEEVPTTSPLSDELAKDLKKRGFKFIGSTTIYAFLEAVGIINDHLDSCFR
KEEVVRIGRKGE
>FECAFAII_02057 Signal recognition particle protein
MAFESLTERLQQAMGKIRKKGKVSEADVKEMMREIRLALLEADVNLQVVKDFTKRVRERA
VGAEVLESLSPAQQIVKIVDEELTITLGSETAELNKSPKIPTVIMMAGLQGAGKTTFTGK
LANYLKKNENARPLLIAGDVYRPAAIDQLKVLGQQLDVPVFDMGTEVSPVEIVRQGMELA
KEKKNDYVLIDTAGRLHIDETLMDELKQIKELTQPNEILLVVDAMTGQDAVNVADSFNQQ
LGITGVVITKLDGDTRGGAALSIRSVTGAPIKFIGSGEKLTDLEVFHPDRMASRILGMGD
MLTLIEKAQQDYDEKKAEELAQKMRENSFDFNDFIEQLDQVMGMGPLEDLIKMIPGMNQV
PGIENVKVDPKDVERKKAMVYSMTPAERANPDLLNPSRRRRIAAGSGNSVVEVNRMIKQF
KESRKMMQQMSKGDMNIPGMDQMFGSGVKGKLGKMAMNRMIKKNKKKKKKRK
>FECAFAII_02058 hypothetical protein
MEIEKTNRMNALFEFYSTLLTEKQMNYMELYYADDFSLGEIAEEYEVSRQAVYDNIKRTS
KILEDYEKKLHLFSNYIVREQVLENMTAYITDKYPEDKKLLEYVQQIQAIEE
>FECAFAII_02059 hypothetical protein
MIGISACLGGLACRYDGQKKEVPELMELVETGEAVMVCPEVIGGLPIPRDPAEIIGGNGF
DVWKDQAKVWTTSGEDVTEAYKNGAIKAYQKLQEKHIDLVIMKEKSPSCGTHSIYDGSFS
GIKKMVPEWLLLILFSKK
>FECAFAII_02060 Alkaline phosphatase synthesis transcriptional regulatory protein PhoP
MKKILVVDDEPSIVTLLTFNLEKEGYKVTSATDGGEGLELALEQSFDFIILDVMLPTMDG
MEITQRLRQEKNETPILMLTAKDDQVDRIIGLEIGADDYLTKPFSPREVLARMKAIFRRI
EPRKQSKDEAEPEYLSIGQITADLTNYQVTVDDHLIELTPKEFELLVYFMKRKDRVIDRD
TLLDRIWNFDFAGQSRIVDVHVSHLREKIERDPKHPKYLVTIRGFGYKFQEPKR
>FECAFAII_02061 Alkaline phosphatase synthesis sensor protein PhoR
MKWKKIYERLFFLILLVSLFFGGWQLISHYFQQQIVEQQESYLTKKAQLLIRQLDVENLQ
AAQNKTALEEFVHQSNERITLMDATGKILFDTNNETLNEQRNSRPEIKAVLNGGNLGSAL
RKSTTLNEDLLYVALPVKKSGQLEAILRIAEPTSGFLPRTESFRRWVFFFFLSFFLVLAG
MIYYLIYQKNQPLKTVLPVLKKMVQNPNQAEVIMQTPDQWEELYQTINALSEQMSKMYRA
CTTTEEQLYTLLNELMIGVFLIDDADSRLLLLNPKMQLHLNVVSYQPEQRYTEVIQEPKL
IQLIHQVTPEHPLIHQEITLTEGRQTLDLSLRYFTNSEGTGQILGVAYDLTKVRRLEKLQ
KDFVGNVSHELKTPVTSLIGFTETLLDGAKDDPQTLTSFLEIMQKDAIRLDKLIREIIQL
SKDGENSYEIQTIYTEPYFQQIVQNYQPIIEKKRLTIRLIGKNEPFTTKTDILYPIIKNL
IENAVQYSKSDSEIIIRYQATDDLSFSVQDFGIGIDIEDQERIFERFYRVDKARSRHSGG
TGLGLAIVKDYVQLLNGTITVDSHLGTGSTFTVTIPKM
>FECAFAII_02062 putative cation-transporting ATPase E
MKNKWINRSKKKKVTQRSSDKVIRLFPSYKEGLTADQVKERIEKGAANNSVDPTFKTNQQ
IVLENIFTYFNLIFLILAILLCLVESYKNLTFLPVIIANTGIAIFQEIRSKKILDELNVL
NTAKVNVIRDGIEQTIDIEDLVIDDIVILETGYQIPADAEVVEGKLQVNEALLTGEADEI
TKEIGDPLMSGSFIVSGKAYARLDKVGADSYISQLTVKAKTMGEGEQSEMIASLNQLIKW
IGIIIIPIGILLFSQSYFFNGNTIKESVVAMEAALIGMIPEGLYLLTTIALALSATKLAK
QRVLLHNMKSIETLARVNVLCVDKTGTITENKMSVQKMIVSKKQEIISQSDQLEACIADY
AKAMAGDNATMEAVKAYFTKTTDQSYHHVIPFSSVQKFSSVALADKVYVLGAPEMVLRDQ
LPEYAEEFVSFAEKGYRVLVFGVYDGILEEPVLTEAVTPLGYILIANPIRKEARATFDYF
KKQQVAIKVISGDNPLTVSNVAVQAGISHADQYVDASKLSEEEYEAAVEKYTVFGRVKPE
QKKIFVQLIKRNNTVAMTGDGVNDILAMKEADCSIAMASGNEAAMQASQVVLLDSDFSRM
PEVVAEGRRVVNNIERSASLFLVKNIFSFLLSLFSVIFALTYPLEPSQITLISLFTIGLP
SFLLALEENKKRIRGKFIMNVMEKAVPGGLTDMIVVGALVICGVTLNLNKTDVSTASTML
LIAVGFLVLYKICSPLNKFRSQIILFCASGNFFSVIFLHKLFSITGISAVSLLLLSILFF
SADSIFRHLTTLVEYLFERKNEKEQKPFSRVAKKFLSIFKREN
>FECAFAII_02063 hypothetical protein
MDNHTRKLLGLTDKHLFFDEEWLIEKEYKGVQAQFIKGKLDDSSSYCEHCRSVRIIRNGS
YTTRTQMLKVKEKLTILELKRTRFLCHDCGRTFSAKTDLVDEHHQLTKELKQVILMELYE
NQSRKLIAKKYFVSDGTVTRILREATKHYQPRMNFLPTVLCMDEFKSMNSVSGSMSFICV
DGTTNQLFTILEDRRLYKLTQYFLRFPRKARLKVKYLVMDMNASYCQLLKTVFPNAEIVT
DRFHIVQHINRSFNQLRVQIMNRFRTSHSENQKKYRRLKRYWKLLLKDSTTLEPLKRHYH
RLFKRPISQTEIVDELLSYNEELRTAYHFCQLLRYYFVKRGTEGFQETLKTISSTLPQSF
KKKFTIFHRYQSGISNAFKVSHSNGVTEGLNNKIKLIKRIAFGYRNFYNFRARIYLQRLY
TF
>FECAFAII_02064 hypothetical protein
MSHTQLIKDTLNILDLNIYFEENCLTKEKYKGQICLIYKGTLLYKPEECSHCLCVVPSRI
IRWGTTTVRLLLNDVSEYRTYLELKKQRFKCKSCQRTFVADTSVAEKHCFISQKVRWSVI
ARLKENTSMTEIARQKNISTSSVYRVMKRFYRPLNPFKQTLPKVLCFDEFKSVRSVASAM
SFIMMDGQSHALLDIVENRRLPYLERYFSRFSLATREAVQLIVIDMYAPYVSLVKKLFPN
AQLIIDRFHIVQHIGRTFLNHRVKETTVRLKGNSHSQRGLGKKLKRYWKLLQKEEAKLNY
EKRVWRASFKDYLTESEIADRLLAACPNLRQGYQLYQDILYAVKKRDQSLFEDCLTRDIS
GLPETYTTTLRTFKKFLPQIQNALHYSYSNGPLECLNNHIKVLKRNAYGFRNFYNFKLRI
MIRHGKTFLTK
>FECAFAII_02065 Phosphate-binding protein PstS 1
MKKVLFTLGMMGILLAGCGSGSGNTDGSATQNNSSDSNEQVKIVAVGSTALQPLVDAAQE
SFVQENPNYQISVQGGGSGTGLSQVEAGAVTIGNSDVFAEERDGVDASKLVDHKVAVVGM
APIVNKDTDVKDITKQELIDIFTGKITNWKEVGGKDQKINVVNRANGSGTRATFEKWGLD
GATPVQSQEQDSSGTVRQLVSQTPGAISYLAFSYLDDSTQALSIDGVEPKEENVADNSWG
IWSYEHMYTNGKPSPEVQKFLDYMMTEEIQEGPVKELGYLPITMMEVERDHEGNIK
>FECAFAII_02066 hypothetical protein
MRRKAVIDRLYLFFWFFPIVLLPFTWVNAVVQGAEILGLIQGSGFVVSRNFPALIVFYLV
ISVGLLLPKSLINHYNWQLLYFSCLLVFTSTFSLLPRLIIGPNGLSESGLKDLAYSSMYF
LTIKPWFYLVIASFILATFFYFWTEIRIKSERSVSIKNNY
>FECAFAII_02067 hypothetical protein
MIKTCWKNLPLLLSFVPYVHFALLLDFRYHSVSGFITLIFLSLFAGYYFQRNRRIISLFI
ANIISTVTSYLFCANFTEWRYFYHPLKPTQLILLLAGIYLVPQILGSLWAVALSYKKARH
P
>FECAFAII_02068 hypothetical protein
MLFYSNFILIVAILLLLNIWIFDRSRNSSIGFRTKRSLSSKKNWVYSQTIFYGGIVLISL
LSSTLYSLNIIDVSTSNSISIIGIIIAAIITQLFLVFGEKKRSKK
>FECAFAII_02069 hypothetical protein
MTQVHFTFESEEIQAIINESGANDTAKTLMTIMFNQLMEEQRNQYIQANAYERSEERQSQ
RNGYYDRSFTTRIGTLELHVPRTRDGKFSPTIFERYQRSEKALIAAMIEMVISGVSTRKV
TKTVELLTDGATVSKSFVSNLMKQLDPFVFEWRNRSLEGSEYPFFMCDALYMKVRENHRI
VSKGVYIGIGIDSDGRRTILGFDVQDGESEDNWDTVFQSFVQRGLFGVKLVISDAHKGLV
KAVRKNFLGASWQRCQAHFLRNIFDKLPKKVSSDVKDELKSIFKASELELTRERKEHFLE
KYGCDSKLSAACDILENGFEDAIQILSFPENIRRRIRTTNVLERLNEEIRRRERVIRIFP
NINSITRIIGTLLMEKDTEWLASPRKYLEFNSNNI
>FECAFAII_02070 hypothetical protein
MNDSIKKMLRLIEKDLMITEVSYETFQKKKTLIVDAVFSPAPHTCRNCGSTVVDGNGKVI
VVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTTQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKNCQVSLTTVIRTLKEFKSYLPKQSKRILPRVLMVDEFRSHASIED
KMSFICADGETGQLIDVLPTRKLPRLTSYFLGCANPEEVKFLVTDMNAAYFQLTKRILPN
AKVVIDRFHIIKHMNQAFNELRIREMNELRKVGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLGFSTSLKEAYPYFHELVEAFRDKDPDLFFSLLAELP
ETLDDGFREKLQNLLTYEEGITNAMIYPYTNGKIEAKNTHIKTMKRVSYGFKSFENMRIR
IFLINQLIKVR
>FECAFAII_02071 Choloylglycine hydrolase
MCTSITYVTSDHYFGRNFDYEISYNEVVTVTPRNYKLNFRKVNDLDTHYAMIGIAAGIAD
YPLYYDATNEKGLSMAGLNFSGYADYKEIQEGKDNVSPFEFIPWILGQCSTVGEAKKLLK
NINLANINYSDELPLSPLHWLLADKEKSIVIESMKDGLHIYDNPVGVLTNNPSFDYQLFN
LNNYRVLSSETPKNNFSNQISLNAYSRGMGGIGLPGDLSSVSRFVKATFTKLNSVSGDSE
SESISQFFHILGSVEQQKGLCDVGDGKYEYTIYSSCCNVDKGIYYYRTYEDSQITAIDMN
KEDLDSHKLISYPIIEKQQIKYIN
>FECAFAII_02072 hypothetical protein
MKLFVGIDVSSEKLDVCFLTDDNQLSILSEISVANDIEGASFIRETILEFNNSYHFDQIV
IGMESTSMYSFHPSMFFHEDEKLKKLNTLVTIENPFRVKQFSRMFDENKTDRNDALRIAD
FLRIQRFTTSPIKEEKYMALQRLTRTRYQLIKQLIRTKQHFLENLTYKCNTLAREMRDES
TSLFSATLISLMTEDFTLDELAELPLEAFCDLLQEKGKGRFKQPEKIAKAIQRAITMSYR
LGALAQESINVVLSVLVREIRALEKNIKELDKAIEQVIVVIPEYQCLTSIPGVGKVYAAG
LIAEIGQIERFEDQTKLAKYAGLSWKVNQSGNYQSQNTPLTKQGNRYFRYYLVEAANSVK
NYLPEYKAFYQSKYKEVPKHQHKRALVLTARKFTRLVDTLLRKHQLYTPPRSVIEK
>FECAFAII_02073 hypothetical protein
MSNLENKEEKVVNKIVSVVNKLDKELDELDTLSENPEKKHNLKKWLVERKAIHEIKKVLH
EADKYEKYDEKELDKEFKEINDLLL
>FECAFAII_02074 hypothetical protein
MMDQKAFIESIDSTIDRLKKEIRFYNRVIGIGNIIKIVLSASIPILIDQASEHRSLLLIV
SIASAIITIIQSGMSAFNYQDKVQTSTELLMKIEKEKLLYITKTSPYNKTDEENFHLIVT
TLQTELNDIISDFNQVNN
>FECAFAII_02075 hypothetical protein
MRKYTFVFKKKVVSDYLNNEGGYKYLAHKYQINRTLVRHWVRIYNYHGWEGLVGGGKSYT
TKFKLDVIEYMETNGLSIQETAKKFNIGSNRTLSKWIEQYEEGGASSLESQKRGRKISMN
SKLNIPKKLKDESLEEEVIRLRAENAYLKKVRNLDSRTRFEQEEIKVKTILQLKKEFKLN
LLLSIAQLAKSTYYYWVKKLDKPDKYSKIKQEITAIVKESRNSYGYRRVTLALKMKGYTI
NHKTVRKLMSQMGLTCQIRIKRYKSYKGTVGKIAKNVLKRNFSVDTPNKKWVTDVTEFKI
KGRKIYLSPILDLFNGEIISYSISTSPTYKLIEEMLQQAIKKKGTEGSLILHSDQGWQYQ
MPQYQKKLKENNIIQSMSRKGNCLDNSVIENFFGVLKSEFFYREKFRSIEIFQSKLNEYI
RWYNNKRIKLKLNGLSPVEYRKQSIK
>FECAFAII_02076 hypothetical protein
MNDFTTEIVQTLVTKGDLNELFRSHLEKAINTLLRTELTAFLDYEKYDRTGFNSGNSRNG
SYFRSIKTEYGELTLEIPRDRNGEFKQQTLPAYKRTNDTLETTIIHLFEKGVTMSEIADL
IEKMYGHHYTPQTMSNMTKVLTEEVNAFKSRALNDKYVAIFMDATYIPLKRQTVSKEAIY
IAIGIREDGTKEVLSYAIAPTESTYVWNELLQDINSRGVQEVLLFITDGLKGMKDTIHQI
YPKAKYQHCCIHVSRNIAHKVRVKDRKEICDDFKAVYQANSKEEANTFLSGMIEKWKKNY
PKVTQSLIENQDLLTFYDFPPSIRRTIYSTNLIESFNKQIKRYSRRKEQFQNEESLERFL
VSIFDTYNQKFLNRSHKGFQQVTDTLVSMFTE
>FECAFAII_02077 hypothetical protein
MRKYTFVFKKKVVSDYLNNEGGYKYLAHKYQINRTLVRHWVRIYNYHGWEGLVGGGKSYT
TKFKLDVIEYMETNGLSIQETAKKFNIGSNRTLSKWIEQYEEGGASSLESQKRGRKISMN
SKLNIPKKLKDESLEEEVIRLRAENAYLKKLETLIQEQDLSKKKSRLKQSFSSKKNLN
>FECAFAII_02078 hypothetical protein
MNLLLSIAQLAKSTYYYWVKKLDKPDKYSKIKQEITAIVKESRNSYGYRRVTLALKMKGY
TINHKTVRKLMSQMGLTCQIRIKRYKSYKGTVGKIAKNVLKRNFSVDTPNKKWVTDVTEF
KIKGRKIYLSPILDLFNGEIISYSISTSPTYKLIEEMLQQAIKKKGTEGSLILHSDQGWQ
YQMPQYQKKLKENNIIQSMSRKGNCLDNSVIENFFGVLKSEFFYREKFRSIEIFQSKLNE
YIRWYNNKRIKLKLNGLSPVEYRKQSIK
>FECAFAII_02079 Autolysin
MQIELQHTHDKETFEKNYKVYVELARDSAMKYGIPLTLDTPYNQPGIKSHLWVTQNIWGD
HTDPYGYLSEMGVSKEKLAYDLAHGFTDDNPTTSEDKPVIDPTRAGAANSTLTDGTNYAH
IDQFGEIENANLHVAGWHIANYKYEYIFIMDYNTGKELARVRADGIYRPDVNQAYNTLGN
VGYHVSFNMRDFPNKKVYVMMRATNDPEGNTKGGAQDFHDKRWYLNIPQR
>FECAFAII_02080 hypothetical protein
MELKKLEVPTSSITEVKRSPMDVFAQARDAGTGVYIFNREKVAGVMLTQEQYETLLQELD
VLRQTVKVERKEPKEINEEPINKTASVVSNAEGMEELAQTLQHSLITGVTITAKNLDERM
VALGFITKKTGFGGVVDMLSELMETGKINYQLRRKPQNRTIIAEIIGEQNSQSQLMDKII
IKKIFLHEL
>FECAFAII_02081 hypothetical protein
MLLLKTLQERGYLDVHPPEVKIVFFFRYEHQEARRLAGVLNKTLRHRKRISIHVCTRNKP
PRYADLVIIDHFFPLDHNEDQKTYLYHPSFGIERLLTDINYWLGKNR
>FECAFAII_02082 hypothetical protein
MRWQKLLSKNAQNLFSLINLMKDLIWRKADLAEELKIDVKTVDRHLKRLAESDCPIQLIL
HKKTVQLVYDQGYSEPYLLFVFLIQSPPFCLLKNLLLNEPYEQKYDRSTQERLRKWFGEY
HLSFSYKKAQIFGSERKVRYLLFCFLKDFPHFFADDGEQSFSEMFIQLLKQRKDPAEIEI
LGDSRTLFFELFPELLFREEQILPIKEKNYLAILRLSCNQITEKRWKRIEETQDYRKLTI
VTEKLDSLFWLNSEFESESKSKLTKVLYQE
>FECAFAII_02083 hypothetical protein
MIVALLAGGHVLFEDIPGVGKTLLVKALAKAVQGTFSRVQCTPDLLPSDILGFSVYNSQS
KEFEFRPGPIFTTILLADEINRTTPRTQSALLEAMAENHATIDNNTYPLDNHFFVLATQN
PIEYEGTYPLPEAQLDRFLFRLQIGYPSFDDELLLLLDKFEKVLDNLNEVLNSYEIEEIK
TNVANVFVSPEVASYALQLVSATRSHAAIQLGISPRGSLSFIQAAKAYALIHGRNYVTPK
DLQDLVPYVFSHRLIFYDRSLKEDEKKQIIHTLVAQIPIPVR
>FECAFAII_02084 hypothetical protein
MEKIKDYFINFVLFLVYFIIVLFALVFNNSLGWFLLAFFTLYVSWSLISLSSFLKKLSVT
CTLQPLVYRKKSMQVIFSIAKKRTFSLPLPRLQIGFPAIFAEKNKRF
>FECAFAII_02085 hypothetical protein
MILTNKPQEVQLLWQPKERGCHETLTVIFTAYDSLGLFRKSAKREISFPVTVLPAFCKIQ
AEKLQRVLEKKQQLNAYQRGLDFREHRAYRPGDSFNRIDWKLSAHTQEWLYREYDYQEEE
CSPLFCFWGSPSPKFEPLLDLYFSLWHLRKEKQPELLILGNRAFHGKDPGHTYFASLEAG
DEKAFFAHLKKYAKKQIVLFVPENSPEVSEAIETLSKDRTVYLVYFVEKQLMVQEKDKIC
SLPGGEWIDD
>FECAFAII_02086 hypothetical protein
MTIKREKWLRGVYSFVILSVGAPIFVVANQLQNSYLLILTIGVLCLIVCCIPKKWVRLLL
SLPVMIGCLFLYFPSKTFSILWILQFFSSVTEEFFHLSQGKLYYLPEKTAFFLIMLLIYL
FITLTVDYDYWYAPFLSLMAYFMMLTVFRKKDLLYEMIAVVTVLFVYLAARQFFSIRLLS
GNTRFQSLTTVLLICFLTFSAILPLYLPKVHQSLEETSEPIREYLNDEGLYDTLHEYQLT
GSARTGFSENDEQLGGPLYDNGEVVFTANQKGNGYWKIENKNHYTGSGWIEDQDAPIQPI
QEFPVDITSYQTVIEDKENITLTLKKQVFLPYPYGNTTLTDFSLASGQTLYYLPESQRFI
PVPNESTRSATLQTERLVFTREELKSSQLKADDLENQQTNLQLPKSLPKRIEDLAVELTK
NEATLIRKVEAV
>FECAFAII_02087 hypothetical protein
MVVLLRTLGIPARWTKGFTNGLRTGTDNQGNEEYSILNSHAHSWPEVYFPGFGWLPFEPT
PSFANPMGSQPVAETTETVQPAIEQPNESENMAETISSERSEVIPSEETTLTPAYKIVLF
SLGVCLSVLLFFLLLFRKSLRWTSYLIYLHFFASTNTIAYQKLLNPLETLVPRKPAESLQ
EYSLRIEQEFKLDLRFIRLTTQYEAEIYGRQADPVKFDKKTYLEITHIIRKMVYKKILTK
GSRFKK
>FECAFAII_02088 Copper-exporting P-type ATPase B
MNGNDMEKKHEHKKEVVNKESTESHEKQMEMKHDHSQMDHSMHMGHNHGDIANSKQMDHS
MHMDHEHGGMDHSMHMGNFKQKFWLSLILAIPIILFSPMMGMEFPFQVTFPGSDWLVLIL
ATILFIYGGQPFLSGAKMELKQKSPAMMTLIAMGITVAYIYSVYSFIANLLNPHTHVMDF
FWELATLIVIMLLGHWIEMNAVSNASNALQKLAELLPESVKRLTKDGKEETVSLKEVNEG
DRLIVRSGDKMPTDGVILKGETIVDESAVTGESRGIKKQANDKVIGGSINGDGTIEIEVT
GTGENGYLAKVMEMVRKAQGEKSKLESLSDKVAKWLFYVALIVGILAFIAWLFLTDLPNA
LERMVTVFIIACPHALGLAIPLVVARSTSIAAKNGLLLKNRNALEQANDLDVIMLDKTGT
LTEGKFTVTGVEVLDDAFNKNEILQYLGALEANANHPLAVGIMNYLKEHEIKPYQAENLK
NLSGVGLEATVKKQQVKIVNEKEVERLGLNVEQALLKPYQEQGNTISFLILENHLAAIVA
LGDVVKTEAKEFIRTLKERKITPVMLTGDNKNAAQAVADYLGIEEYYGGLLPDDKEAVVQ
KYLDQGKKVIMVGDGINDAPSLARASIGMAIGAGTDIAIDSADVVLTNSDPKDILHFLDL
AKQTRKKMIQNLWWGAGYNILAIPLAAGILAPIGIILSPAVGAVLMSLSTVVVALNALTL
KIR
>FECAFAII_02089 putative copper-importing P-type ATPase A
MATAETKMDTFVITGMTCANCSARIEKELNGQPGVVNATVNLATEKASVKYEGTTTEKLI
QSVENIGYGAILYDEAHKQKIAEEKQAYLKKMLFDLILSTVLTLPLMLSMIAMMLGSHAA
IVHFFHFPIVQLVLSAPVQFYVGARFYKGAYHAIKTKAPNMDVLVAIGTSAAFALSIYNG
FFRGHPQDLYFESSSMIITLILLGKYLEHTAKTKTGNAIKQLMSLQTKTAQVIRNGKEET
LAIEEVVVGDQLVIRPGEQIPADGRIISGSSAIDESMLTGENLPVEKNPDDTLFGGTINT
NGLLHMEVTQVGKQTVLAQIIQMVEDAQGSKAPIQKIADRISGIFVPIVLVIAFITLIAT
GLITGDWQLALIHSVSVLVIACPCALGLATPTAIMVGTGVGARNGILIKGGEALEAAAHL
DSIVLDKTGTITEGKPKVTDLVGSKEVLSIFYTLEQASEHPLGKAIVEYGKLQEAATYDM
IDFTAHPGAGISGTINGVRYFAGTRKRLIELNLSFDEYQEHALELEQQGKTVMFLADEKQ
VIGLIAVADQIKLEVKQAIKQLQNKGLDVFMLTGDNKLAAETIGKQVGIDPKHIFAEVLP
EDKAAYVEKLQKDGKKVGMAGDGINDAPALALADVGMAMGSGTDIAMETADVTLMNSSLA
SIAQTIELSRLTLRKIKQNLFWAFVYNTIGIPFAALGFLNPIIAGGAMAFSSVSVLLNSL
CLNRHMKK
>FECAFAII_02090 Copper chaperone CopZ
MKQQFSIEGMSCNHCAARVEETVSALDGVQKVKVNLKKANGTVKFDETKVQSEKICQAIN
GLGYKAEVI
>FECAFAII_02091 Transcriptional repressor CopY
MEKVKTPVKISDSEWEIMRVIWTLGQTTAQEITQILADSMDWKPATIKTLLGRLVKKEVI
WTEQEGKKFIYYPAVSEMETVRSATENLFSHICAKRIGETIADLVEEATLTQEDINEILK
QLEQKQPVDTIECNCIPGQCECKQHQ
>FECAFAII_02092 hypothetical protein
MKIIVIGQSGSGKSTLARKIKEITDFPLLPLDLLWHTTDYSIQAKKWFLQEQQLFMVSNP
SWIVEGNYTSTLEERIKEADKIIWLKVPRYLAIYRVVWRSLKRKINKKSRPDMPESFSEK
LNREYLEFLSFIWHFEENNEPKIQQLIQVANARNKLIILKTRREKQEFLTKLKIESKNN
>FECAFAII_02093 hypothetical protein
MNDSIKKMLRLIEKDLMITEVSYETFQKKKTLIVDAVFSPAPHTCRNCGSTVVDGNGKVI
VVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKNCQVSLTTVIRTLKEFKSYLPKQSKRILPRVLMVDEFRSHASIED
KMSFICADGETGQLIDVLPTRKLPRLTSYFLGCANPEEVKFLVTDMNAAYFQLTKRILPN
AKVVIDRFHIIKHMNQAFNELRIREMNELRKVGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLGFSTSLKEAYPYFHELVEAFRDKDPDLFFSLLAELP
ETLDDGFREKLQNLLTYEEGITNAMIYPYTNGKIEAKNTHIKTMKRVSYGFKSFENMRIR
IFLINQLIKVR
>FECAFAII_02094 Inner membrane transporter YcaM
MNNKQLRWFTVALIAFNMVWGMGNVVNNYAQQGVSVVTSWLLILAIYFIPYALIVGQLGS
AFKDSKGGVSSWVENTTSNKRLAYYAAWTYWVVHIPYLAQKPQAILIAGGWAVQGNGNIV
NTMSVQMVAVISLIIFLAFLYLSTKGLSTLKVIGGLAGTAMFVMSILFILLAVTAPFINP
TMEFATPHMNQVKTYIPTFDFSYFTTVSMLVFAVGGAEKISPYVNSTRNPAKEFPKGMIF
LAAMVGICAVLGSVAMGMLFASDNIPKDLMANGAYSAFQILGNYYGIGNSLMIIYALTNM
IGQISALAFSIDAPLKILLADADPEFVPNWLRKRNRKGTLVNGYLLTGILVGIIILLPIF
GIKDMNELVKWLTNLNSVVMPMRYLWVFLAYMMLNKAYKKFNSEYKFVKNPKIGFIFGAW
CFAFTAFACILGMVPKVDYTADPKAWWFQLFTNIITPIVLILLGMILPAIARRDKNKEIT
EPETVVQP
>FECAFAII_02095 Cadmium, zinc and cobalt-transporting ATPase
MKSYRLEGLDCANCAMKIEKGVQKINGVKEATVNFTSGKLTIDAEEDHLATIEQETKKVV
KELEPDVKVTEIDKEKVSEHGNEKERNTLFRILFSLAGIALLLLFDFNEPIRLIGYLLIY
LLIGYDVVKKAVMNIVKGKIFDENFLMSVATIGAMLIGEYPEAVAVMLFYQIGEYFQGLA
VSHSRKSIRELMAIRPETAHVQTTEGLMTVNPEDVQIGQFVLVKPGERVPLDGTIIEGES
LVDTSALTGESVPKSVYVGETVLSGFINKNKPFLVQVEKSYENSTISKLLELVENASSKK
APAENFITKFARYYTPVVVGLAVLLAVLPPLVVSGAAFSEWIYRALTFLVISCPCALVIS
VPLSFFGGIGGASKIGVLVKGSNYLELLAQTETVVFDKTGTLTKGDFSIQTIDTKIDPKK
FMQYIASAEQFSTHPIAQSVLEGYAGPLLPTTNIQEFAGEGILAEVDGKQVLAGNHKLME
RFEISFPLSQEIGTLLYLAIDQSYSGYLVIADTLKEDAVDALVQLKQAGVKNTVMLTGDS
KKIADHIGKQVGVDKIYSELLPEDKVQRLEEILQRNNKKTAFVGDGINDAPVLARADVGI
AMGGLGSDAAIEAADVVIMNDQPSKIAEAIHLAKKTLKIVKQNIVFAIGIKILVLALGAF
GFASMGDAVFADVGVTVLAVLNAMRSLHVKKEDE
>FECAFAII_02096 Inner membrane protein YccF
MSCLGNVIWFIFGGLIGGLSWLAAGILWCITIIGIPIGMQCFKIASLSFAPFGKEVIYHQ
SGMSLIVNIIWLIVSGLPIALAHVVSGILLCITIIGIPFAKQSFKLARLALMPFGAEIV
>FECAFAII_02097 hypothetical protein
MMEIRWAVKEDLPQINQLITDHPESFVKAKTAADLNDKNKLLLVAVTKEKRIIGFAQADV
QQSEERVDQRPSGKLIQHTLVTKENTEEIQKKFAEYLMLEAKKRRIKSIFAQF
>FECAFAII_02098 Acetylxylan esterase
MKKRILFIGDSITDAGRDRAEATDLGKGYPLLIAGKLISQYPTMKFECMNRGIGGDKIAD
LQVRWQEDCLALQPDYVSILIGINDTWHNTSDQAIFGTEKSAQQFESVYRKLLNELQTAE
ICNIILMEPFVLPITDDRHGWRKDLDPKIQIVRKLAKEYGALLVPLDGIFNALGIAYGFS
KYTREDGVHPTIGGHEIIAQSWIDAIAAVDFFSGDKNERKKSEK
>FECAFAII_02099 Asparagine--tRNA ligase
MEQIQIIDSKNHVGETVTIGAWVANKRSSGKIAFLQLRDGTAFFQGVVVKSEVSEEVFQT
AKNLHQETSVLVTGEIREDSRSKFGYEIGITNVEVVSESHDYPITPKEHGTDFLMDHRHL
WLRSSRQHAIMQIRNEIIRATYEFFNQHHFVKIDPPILTGSAPEGTTDLFETNYFDQKAY
LSQSGQLYMEAAAMAFGKVFSFGPTFRAEKSKTRRHLIEFWMIEPEMAFTHQEESLEVQE
QYVAFLVQNVLDHCEYALDVLGRDKEVLKTYTKLPFPRITYDDAIELLKKNGFDDIEWGE
DFGSPHETFIANSFEQPVFILNYPKAIKPFYMKPHPTREDVVICADMIAPEGYGEIIGGS
ERATDYDFLLEQIRNHGLDEKEYSWYLDLRKYGSVPHSGFGLGLERTVTWIAGIDHVREA
IPFPRLLNRIYP
>FECAFAII_02100 Aspartate aminotransferase
MELSKRTKRLEPSVTLAAAAKAKALKAKGRDVLSLTVGEPDFATPENIQEAAIEAIRNGK
ASYYTPTAGIPELRQAIVDYLKKNYGLVYEPSQTVVTDGAKFALYTLFQTILDPQDEVII
PVPYWVSYGEQVKLAEGLPVFVKGEESNSWKVTVEQLEQARSEKTKAVIINSPSNPTGMI
YSKNELQAIGEWAVKNDILIVADDIYGRLVYNGNEFTPIATISEAIKNQTIIINGVSKTY
AMTGWRIGYAVGNPVIINGMIAVASQSTSNPTAVSQYAAVEALKGEQDTVEEMRNAFEER
LNTLYPLVAELPGVSLEKPQGAFYLFPNVKETLRMCKYENVTQWVEDLLEETGVALVTGE
GFGAPENVRMSYATDRATLEEAVRRIKQFIESKSQN
>FECAFAII_02101 hypothetical protein
MKKKQTKEKTINRVLLGLIVFLLAVIVISSIFYLRSSRPAVQAKKEAVEIAKKYANLEET
DHFYWFTRKKTYFSLTGTNDKGKEIAVIIPKSGEKVKVLDQTKGLTENEAKQTIAAAHPE
IQIEKAALGMYDDQPVWEVVGKETNGKLNYYLIGFESGDEVKTIKGI
>FECAFAII_02102 putative ATP-dependent helicase DinG 
MKPRTYAVVDIETTGTNPKEDRIIQFGCVMIESGRITSRFSIDIHPGRKISKQIQHLTGI
TNQRVQKAPYFEDVAQTIYNLLADTIFVAHNIYFDYNFLNHELMRCGLPSLKIPGIDTVE
LAQIFLPTEPSFRLADLSESLGFIHENPHQADSDAEVTGQLLLLIEERMRKLPIITLEQI
ARLSRHTGMDTSRFIYHVIEEMKEKPEPLDPSLEIVDGLALQKKEVELFTSVHYGERTYP
RKKQAKEKMFGKTLMYRKEQNRLMNAVYDHFTKDESKDLMIEAATGMGKTIGYLLPLSYL
ATPEKPAVISTVSLVLQQQIIEKDIPLLNQLLDQPIQPVIIKSYRHYIDLQRFKGTLVEP
PEQKQYALYQMAVLVWLTQTKTGDLDELHLTNLNHSFFADIAHRGIGFLARNQSFYEQDF
VRFLQKKIRQSNFLIVNHAFLVQETQRKEPLLPASPFLLIDEVHHLPEIAEKVNDKRLSI
NYFHKQIQQLEEPNQLFDRIQSYLPKEHEALRWLSIYREELSALCEAQICMAEGLMSLVS
GKQPNGQYPEEVMMTKEMLDQLPLESGTAIDHLQLFYQEIQQLQSQMRLTFEIIQESWTN
QMRIDLASLYSLFDQLDKQYLLMDQWLEDWRDHLIHWFVPGNTAQQMIFHLHDFQAAMLP
STVWYPRYDRILYIGGTLKIGPNRHYLSKRLGIEAAPLKVIASPYDYEKQARIYVPKEAP
AVHQVSNQAYIDYLETALTGLIEQEDRPILVLFTSHDVLQKVYQKMHLSMLEKGREILAQ
GFGGSREKLLKRFILSEKSVLFGADSFWEGVDLPGDALQIVVVTRLPFDNPLRPMVKARN
AYLESEGINPFYQESVPKAALKLRQALGRLIRTETDRGVLLILDRRLVTAKYGARIIHAL
PKKVPIKELAMEEIYQDIHEFLKKNEEGS
>FECAFAII_02103 Cold shock-like protein CspLA
METGTVKWFNSEKGFGFITAENGNDVFVHFSAIQGDGFKTLEEGQAVTFDVEEGQRGPQA
TNVTKA
>FECAFAII_02104 hypothetical protein
MSKKEKLISLVVLVCLVLLVTVIGYQKYHENIRPTKESSPASTVETEPISSQKE
>FECAFAII_02105 hypothetical protein
MKKRLLWCLLSLSLSLTSQPVFAEETQRFPITGTRLYKNVYVQTPDLDSAIPETEERSLQ
PRFGYFWYCPTCDYESCWHFLHSTAAAFAFTHTQKYDGHHPVIYEV
>FECAFAII_02106 hypothetical protein
MAKKDKELLSQLTSEGAKGPFVTIMLNTHVAHQDVEKDQIKFKNFAKEAKKRFEKKYSEH
DWSPFQEKIENLLGDPSFWRSATTSVAVIITADQTYIHRLSIPVDDQYYVSDLPYLLAII
KNGQFNYSYYLLGLNRDSMKLYEVSNKQVKEVSLPEGAPVDVVTALGSELTGGGLNFSSN
GGGGARDGVTFHGVNPKDEEVEIDWVNYYQAVDTYLKDSFENPEQWPIYLFALPENQTMF
KKIAKNPYYCADVAISASPAQLSFRDIEEGAKKLSSELAAQESKEYNKLLDKKFIDQLVD
IVPAAKEGKVSHLFIATSNLADGFGEDPETEYDRRQVLNALADDVIINGGKVFILDQKDA
PDEKSLTAILRY
>FECAFAII_02107 hypothetical protein
MHLIMIFSLLSIISLFAFSASRLLDAETQPIPVKVRKNDR
>FECAFAII_02108 D-alanyl-D-alanine carboxypeptidase DacA
MSIKKTRLVLLLASLILCLASFLPAVAVQAEDTFKVNAKAAFAVDAQSGKILYDQDGEKT
MGIASITKIIGLYIVLDQVKEGKLSWDDKVSISDYAENLSVTPDLSNVPLHKENTYTVKE
LFDSAIIQSANASMVALAEKISGSEAKFTERMKEQLKDWGIKDATIVNASGLNNSYLGEN
RPEGTGENDENQMSAQDVAIVARHLILDFPEILDVSSTTTQMFGENTQSPVEMVNWNWML
PGFVNYKEGVDGLKTGTTELAGACFVGTITKNDQRIITVVLNADGHAENPSARFNETARL
MDYCYDNWSEKELGKANASIPSLKTIDVKDGKESTVPVVLKSPVKVWVRNDMDTGKLTIT
PTLDKKQVTDNEIQAPMDKGTKIGTATITLAEDKLGYLEDNNAPSTEIITDKTVEKANIF
VIGWRRVAEFFGNLF
>FECAFAII_02109 hypothetical protein
MNLTRDLIFLVLYLIGVFSIVYWRKQKKDPSLFFYSSTWTFAVILTYFVVLEIFYSTFYF
LIPLVFFSIFAFSYFSEKRRLLNGLLFNIFLISFGIYLFVLLYETQNIFLGGLIALITIP
LLLVFLFGIYGLIVFLFWNGVTVLRRESHSLANLLTLILAIFLTLFLVFDFFLLKYLPQW
INALFFCIPLILIYLFIVFYNFLTVSFLYQFNRPRYNQDFIVVLGAGLINGETVSPLLAK
RINKAIAFYWAQSRATLNPPILLMSGGQGADEKVPEAMAMKQYAMEQGIPERDILVETNS
TTTLENMRYSKEIMDQQMKGPYRAIFSSNNYHIFRAGLYARQAKLKANGIGAKTAFYYLP
NAFLREYIAILMMNKKRHMIICGLLFAGSAFLSLITLLF
>FECAFAII_02110 Chloride/fluoride channel protein
MEKQLPSPVRILMYMLKWLVVTAILGVFMGSLSAFFLNSLTFVTDIRLAHPWLLYLLPVS
GALFAYLYAYHGGLSSRGNNLVIDQGNGGEEKIPLRLIPLTLFGTITTHLFGGSVGREGT
AVQMGGALADNIAHLFRLDKAEREILVISGISAGFSSVFGTPLAGTLFGLEVLAIGKVRT
EAIFPSFFAALFANFMTESYGVSHLHYQMGVIPEWSMLLFFKVFVAGIAFGLIGWVFSRS
IVFLKARYAQWIPHPVWRNTIGGAVVVAAALILQTQRYLGLSLPLLQESFNGQAHAYDFI
GKLFFTVLSLGAGYQGGEVTPLFEIGATLGAVLAPLLHVSVPFLAGLGFIGVFSGATNTP
IACFVMGIELFGSQAAAYFFMICLISFMCSGNSGIYSAQQVAVKKGILFLPIVKRIKEKN
KV
>FECAFAII_02111 hypothetical protein
MEQTMKPYQYFFIKREVEQLLNAYSSVNDSKTVQTVQALAAEKIRDVLGYEPSEIDTFLT
TVLDVKLTKTQAERALEELKQIVQPFMQPSKPQIEKLFRKVKKLKQPAWNEIDLQAHTYI
GWNDPGTQKKFMVYYEDGKLKGISGTLSPTINKGICAICQKTSNVSLFLSTTKAGSDGTY
TKKGNYICHDSDQCNQQLTKLAPFYEFAERVKK
>FECAFAII_02112 Ribonuclease Y
MTEKWREDEEYMSYVEDLLETEAVKKLANYTQHVHSTRLEHSISVSYYSYLLAKKWGGNA
KATARAGLLHDLFYYDWRTTKFDEGTHAYIHPRIAVKNAEKITDLSDLERDIILKHMWGA
TIAPPKYKEGYIVTFVDKYCAVKEAAQPMSASMRKRWQRYFGKESSI
>FECAFAII_02113 Putative TrmH family tRNA/rRNA methyltransferase
MKEIQSAKNPRIKELKKLHKKKYREEKEEYLLEGFHLIEEAASSDAEIKELFVTQRGMKE
WGDWLAANKEISTFLVSDEVMDAVSDLPTPQGILAVMALTAEGTPDFSGGWLLLDNVQDP
GNVGTMIRTADAFDMAGVLLGKGTADIYSTKVLRSMQGSNYHLPVLQKDLTEVIPLMKDK
GFTVYGTELNEEAHALDKVEKSDNFAIIMGNEGQGVSQEILSLTDQNVYIPMKGNAESLN
VGVAAGIVLYHFSL
>FECAFAII_02114 Acylphosphatase
MRKVKMNVQGRVQGVGFRYMTKMVADQLGVTGTVKNEDDGSVTIEAIGNDDIIQKFIEEV
KKSPSPSGRVQYVDVQEDPMIEERKKFDVVG
>FECAFAII_02115 Membrane protein insertase YidC
MNKWKNWLLGSGLVSILLFLSGCVRMDSNGNPDTSGIVYRVLVHPMGQAITYLVENFNWS
YGWAVIAMTVIVRIIILPLGISQSKKTMIQSEKMQALKPQVEAAQQKLKAATTREEQMAA
QAEMQQVYRENGLSMTGGIGCLPLLIQMPIFSALYFTARYTEGIRESSFYGIDLGSPSMV
LVAIAGVAYLLQGYISTIGIPEEQKKTMRTMLIVSPAMIVFMSISAPAGVTLYWVVGGVF
SCLQTFITNVMMKPRLKAQVAEELKQNPPKQVVTPRKDVTESAKPANNKQATKQIKQPKN
STNNKGRNAGKQQKRK
>FECAFAII_02116 Tagatose 1,6-diphosphate aldolase 2
MKKMSIEKQERLKRLTDEAGIISALAIDQRGALKKMINQYKEATSEDIIQFKQMVSQYLT
PYASAILLDPEYGLPAAALREKECGLLLAYEKTGYDTKIPGRLPDLLNIWSVKRLKEAGA
DACKFLLYYDVDEPAEINVQKQIVIERIGSECEAEGIPFFLEILSYDATIGDPSSLAYAK
VKPHKVIEAMREFSKERYQVDVLKVEVPVNMRFVEGYGQETCYSQAEASAYFYEQSKVTE
QPFIFLSAGVNATLFQDTLRFAKQSGSTFNGVLCGRATWAKGVAPFVTEGEEKASSWMLE
EGKQNIKELSTLLEETATPVYVDR
>FECAFAII_02117 PTS system 2-O-alpha-mannosyl-D-glycerate-specific EIIABC component
MTIIHEENIFLQQPLDSQEEAFKFLAKQTFCLGIALDEKEVYQKLLEREKEGTTGIMSGF
AIPHAKSQTINEPSMIIATLNKGIEWNSLDRQSVDFIFALFIPDSEAGTTHLKLLSLVAR
SLMRKEVTEQLRKAKSKTEIATILTKEIGEDL
>FECAFAII_02118 PTS system fructose-specific EIIABC component
MGKYQLIAATGCPTGIAHTYMAQEALEQAARKKGIKIKVETHGQIGIENELTAEEIKQAD
AVIIAADKDVHSERFAGKRVIDVSVSTGIKDAQRLIDEALAGKGTVLADNEAADTLEPEA
MSGANFGRSIYKNLMNGVSHMLPFVVAGGVLIAISFAVWGIYSFDPDHAQYNATAAMVKA
VGDAAMGMMVPVLAAYIAEGIAKRPGLVVGFVGGIVAMNGGTGFLGGILAGFLAGYFILF
LQKLLTILPKQLDGLKAIFLYPVIGVAFIGIVMSLLAGPMKAINEGMMSFLAGFEHSNPL
VLGVIVGCMCAFDMGGPVNKAAYVTGTALLAQGNTTFMAGVSAACIAPPLITGFATLLFG
KYFDTNDRNAGLVNFILGSTHITEGAIPFAAKDPIRVLPTMMLGSSIAAVLTYLFGVQVP
APHGGFLVLPVVTGKIQWVTAILIGSIVGGVILGLIQKKRVTDKDKKMDNKAANRTVIEK
GRAGDLS
>FECAFAII_02119 ATP-dependent 6-phosphofructokinase isozyme 2
MSIYTCTMNLAIDLFIETEEMHPFMVNRTKEDDIQANGKGVNVSLVLKMLDFPSTALGFS
AGFTGKYIEDYLQQKQIQTEFIEVPGMTRINVFTQVNQTGEEYKLVNQGPKIPQTAVHNF
LNQIRALQAEDYLCVSGSLPRGLSPKVLIEISRICQEKGIHLIIDSSDQEAMDCLPYRPF
LLKPNEEELSSWFGRKMVTDEDYFVYGQRLVELGAENVLLSLGEKGAILFTKDRVFRGNS
PKGKVVNTACAGDTMLGAFLAGYMNRRPLDETLRKSIAAGSSTAFRKGLTDFLDVEELSK
QIKIKEERFETWENIN
>FECAFAII_02120 HTH-type transcriptional regulator GlvR
MDHKLSETEQYLWNFIEHHILEIPNYSIVKLSEQANVSTATIVRTMKKKGYEGFTSFKHH
LKEGENKNINFSFLDKVDKGIRRAILKNEQEVVRTINMLEIGNIEDAIQRIKFADRVFVF
ARGFSEMIGQEMLVKLQLTGKNCQMHTDPEIIKSISRKLTKKDSVIFVSLNGETKELVTA
AKNCYDAEIGSILVTANHSSTLKDYCEINLVGFKSEGSYFPDYEVRSRLPLQIIARILLD
AYVLRMGEN
>FECAFAII_02121 UDP-glucose 6-dehydrogenase
MKKLSQKRLAQIIIDSRKSLKMTQQQLAVATGINRALISRLESLDFIPSIQQLESLAEVL
NFEPTDLFINESNKSNRTKHQSKNIAVAGTGYVGLSIATLLAQHNQVTAVDILPEKVKQI
NNKKSPIQDDYIEKYLAEKNLNLIATTDGAAAYREADFVVIAAPTNYDSKQNYFDTSAVE
SVIKLVLEVNPKAIMVIKSTVPVGYTESIRKKYNTKNILFSPEFLRESKALYDNLYPSRI
IVGTDQTDKTLREASHTFADLLQEGAIKKDIETLFMGFTEAEAVKLFANTYLALRVSYFN
ELDTYAEMKGLNTQEIIHGVCLDPRIGTHYNNPSFGYGGYCLPKDTKQLLTNYNDVPQNM
ISAIVDSNRTRKDFIADRVLELAGTYEANSSWNAEKEKEVVIGVYRLTMKSNSDNFRQSS
IQGVMKRIKAKGATIVIYEPTLENNTTFFGSKVINNLDDFKNISHSIIANRYDSNLDDVK
EKVYTRDLFQRD
>FECAFAII_02122 UDP-N-acetylglucosamine 4-epimerase
MLELNTSLSNRTILITGAAGFIGSNLVLELLRTQSSIKIIGIDNMNDYYDVSIKNYRLSE
IETEAKNHPGSTWNFIKGSIADKATIDFIFDNYKPSIVVNLAAQAGVRYSITNPDMYIES
NIIGFYNILEACRHSYDNGESGVEHLVYASSSSVYGTNKKIPYSTEDKVDNQVSLYAATK
KSNESMAHAYSKLYNIPSTGLRFFTVYGPAGRPDMAYFGFTDKLRAGDNIQIFNYGNCKR
DFTYIDDIVEGVKRVMQCAPEKIDGEDGLPIPPYHIYNIGNNTPENLLDFVDILQQELIA
AGVLPEDYDFESHTELVPMQPGDVPVTYADTSALERDFEFKPSTSLRDGLRKFAQWYKSF
YEV
>FECAFAII_02123 hypothetical protein
MTQVHFTLKSEEIQSIIEYSVKDDVSKNILTTVFNQLMENQRTEYIQAKEYERTENRQSQ
RNGYYERSFTTRVGTLELKVPRTRDGHFSPTVFERYQRNEKALMASMLEMYVSGVSTRKV
SKIVEELCGKSVSKSFVSSLTEQLEPMVNEWQNRLLSEKNYPYLMTDVLYIKVREENRVL
SKSCHIAIGITKDGDREIIGFMIQSGESEETWTTFFEYLKERGLQGTELVISDAHKGLVS
AIRKSFTNVSWQRCQVHFLRNIFTTIPKKNSRSFREAVKGIFKFTDINLAREAKNRLIHD
YIDQPKYSKACASLDDGFEDAFQYTVQGNSHNRLKSTNLIERLNQEVRRREKIIRIFPNQ
TSANRLIGAVLMDLHDEWIYSSRKYINFDK
>FECAFAII_02124 hypothetical protein
MERTARLKKNTIWALVFQITSIVCGMILLRLILTKYGSEVNGMISSINQFLQIISFLQLG
VGAVMQSTLYKPLAEKDNLMISQILASGGKFYRQIAYILLVYVGLLLAVYYVLVPNEFGR
SYTMAMIATLSINSFAQYYFGIVNTLLLSADQKIYITYIAQTIAFISNTVACALLISLNT
EILMVKLITAIIYLACPIYYRWYVDRNYNIKRNVSYDKEPIPQKWNGVAQHVASVVLDST
DVVVLSIFSNLIYVSIYNVYNLVIYGVKQLFMAMTNGVQALLGELWVRKEIEVLYKTFAW
FEWIVHTLTVFIFGCTGILIVPFIQVYTRGVTDANYNQLSFAALLVTANALHCLRTPYHV
MIKAAGKYKETQNSFIIASLLNLGLSLILVKPLGLVGVALGSLISITYHTLWSANYNSKY
LLKWPMKKFYKQLFVNILTVVLSFGATSQLKMMSITYLDWIVLAIKCAVIVFICIILVNV
LFYRRYVVKIISKIIVKIKKI
>FECAFAII_02125 hypothetical protein
MKEKINILMFSLTLVAFTIFCAFSLNQNYWLNWLGILIYLYAICTWHWRKGDSIFSLYTI
FFTLFLLFSYGQCIMWAFGIGTDRGIGTTVVAYGTGIIPSESDMIMVKWYSCISMFVFHI
GALLFTRKTTLRKVSWYESGDADADRKFLFKIGCIISIIVVPIVFVSKLLEVRIALVHGY
NALYYGDYATQSGYLQIILYLFFPALICLLIGSNFSKVITRFVFIIFALYSLLGIMSGDR
GSWLYSSIILIWAYTQYKGTFNYKKLIKWLILAVIGIYILNVITKARDGGGLSKLTLKDF
TSVFDSDDSPLVDSFFEMGGTMSIITFFLISGNGIYPFANTYLTSLLGSISTRMLSMFGI
KFVLLADWFSQDYLGITWGTGFSMIAEAYVNGGYIGGIVYIFIIGIVIGKILSNSIDNQD
IENHPMKMFLAITTANIIMGFPRAASYLIVKNFVYGVLIILLINFFLQQFNKRL
>FECAFAII_02126 GalNAc-alpha-(1->4)-GalNAc-alpha-(1->3)-diNAcBac-PP-undecaprenol alpha-1,4-N-acetyl-D-galactosaminyltransferase
MRKLTFVIGIMGKGGAERVIANLANNFIQDNWEIDIITIYGNRQDYELNRKIQVHPIICK
SSFRAFRPLERFKELRKKIREIQPDLVISFLADVNIHVIISLLGVKQKLIVSERNDPQRN
PEEPWIRKIRDFLYKNVDGIVFQTPDAKKYFSKINDKKVKTIIIPNPIKENLPYYNKTTS
SKKFITACRLDKQKNLPLMIDAIGKLIHEGYECELDIYGEGGLKTELESYINHNGLTEFV
HLKEFTNKIHEKMQNAAGFVISSDYEGISNSMLEALAIGVPVIATDCPVGGARMYLGDRN
EIGHLVECNNLDKLTDAMRRVLLDRESVVRKAQKGIKLRKELTSKNISNIWYEYLNQFF
>FECAFAII_02127 putative glycosyltransferase EpsJ
MSVKISVIVPCYNVEKYIDECINSLINQTLKDIEIILLNDGSTDNTLAILKKYEKLDSRI
KVYEHKNMGLGPTRNRGIKIANGEFLAFVDSDDFVSNTMFESLYNCAIAENADIAIGEVG
IFSDREIERVKIRKSLTNLKTIELATYNKKEFFKQFYFNRLYSHNAWDKIYRRSLVLEFN
LSFGDNKIIFAEDNWFQLQVFMTNTRICFVDKLCYYYRQQNNSIMHKPKSNLVFRHGNMI
ADYEKLIRQNGNNIIDKKACMLVAFDVLIMEIFNQKNVGGTCEDYKNALVSLKHHKILRE
NISNIVRMKAYELEPNMRKKLALVTISIMFNFKMYKTAYNMLWRIYNR
>FECAFAII_02128 putative glycosyltransferase EpsJ
MKNPMFSIIVPIYCVEKYLKDCLDSIRNQTFKNFEAILVDDGSPDECPEICDYYSQIDGR
LKVIHKKNGGIIDARKTGVTSAMGEYIVFLDGDDWLANTYLEKYAEVITKYNPDIICSGY
FASHSNKIRKRELSCSFGYYDKDKIINLIYPKLIEDEHGEYFRPQLWAKAFRTTLYKEQQ
QVSGQVSVGEDHACTKPCIYHANSIYMMEKCLYYYRINENSITKKPQPYYWEGPKAIGEH
FEKQIDMNKYDFQDQVYRNVTHNLFNVAVSQFNKQDKYLNIKKDIIQNLSDEYYTRAICK
CKYKDNWKGISAKFALKNKWVFLIYIYNKLIKR
>FECAFAII_02129 Phosphatidyl-myo-inositol mannosyltransferase
MMEAMASGLPCIASKIRGNVDLLVEGKGGYLVPAKDAELVAECLRELINNKSLRKYMGNE
NLSRIKEFEVSIVKKRIKEIYEEVIGESVK
>FECAFAII_02130 N,N'-diacetylbacillosaminyl-diphospho-undecaprenol alpha-1,3-N-acetylgalactosaminyltransferase
MAKYYNKKILIMANNDDGLYRFRGMLIKNLVDQGNEVIVSLPKGKNIPKLIELGCQIIET
PIDRRGINPKTDFKLFFNYCNILKKIKPDMVIAYTIKPNIYGGLACRLRKVSYALNITGL
GTAFQKKGVLKSLIVFLYRLAAKKSKVIFFENFENMKTFQTLQIAKQSKYKLLNGAGVDV
EHFSYLEYPKDEQVHFLFIGRIMKEKGVDELFEAMKNLYSEEKNCVLDVLGYFEEDYGIK
IEKYEKEGWLKYHGYQSDIRPFVERAHCFVLPSWHEGMANTNLESAASGRPIITSDIPGC
KEAVIESKSGYLCERKNSCSLYNSMNKFLKLSYEQRINMGKMGRNYMIKKFNKKKVVDET
IKSLFS
>FECAFAII_02131 putative sugar transferase EpsL
MMRKKTFYQLFGKRILDILLSGIALIVLSPIILIVGFLVRIKLGSPIIFKQERPGKSEKI
FSMYKFRTMTDERDHNGEYLPDEIRLTKFGKMLRATSLDELPELWNILKGDMSIVGPRPL
LVEYLPLYSEKQRKRHNVRPGLTGLAQVNGRNAISWEEKFDLDVYYVDKISFFNDLIIII
QTCKKVIKKENINTINNNIPEKFKGS
>FECAFAII_02132 Putative pyridoxal phosphate-dependent aminotransferase EpsN
MKSKRILLASPHMSEEGYEKEYVKEAFDTNWVAPLGANVNGFEKELAEYVGASHAAALSS
GTAAIHLALKAAGVGKDDIVICQSLTFSATANPILYQGAIPVFVDSDYETWNMKPEHLRT
ALEKYPNTKAVLVVHLYGLSANLDEITKICKEYDVTLIEDAAESLGTTYKGKYTGTFGDY
GIYSFNGNKIITTSGGGMLVSNDKEKVEKVRFWATQSREKARHYQHNEIGYNYRMSNIVA
GIGRGQLKVLNERIEKKRYIHSFYKKELSKLSNIQFMPENNWNEPNYWLSVITIKGINAN
HLIDELDKNNIEARPVWKPMHLQPVFKNYDYIGDDVAETLFDLGVCLPSDTKMTDEDLKY
VVSTIKRVINDA
>FECAFAII_02133 Phosphoglycolate phosphatase
MIKAVIFDLDDTLVSEYDYVKSGYKCVARRLAVQKIFPATFDEIYRVLLDLFAEDSKNVF
NRLYDYFEIPYSKKEIKELVNVYREHKPDINFLENADTLLTELRSRGYKLGIITDGYAIT
QRNKLDALKVDYLVDYICITDELGRELWKPHPISYLLLLEKFNLKAQECIYIGDNELKDF
ITAKSIGMQTIKIERVNGIYRESSLKFKRFYQADKKIRSLWEIKNFLGVIS
>FECAFAII_02134 D-alanine--D-alanine ligase
MNILILSCGRRCELVNAFKTALNNNEMEGKIIGADCSELAPALYMCDEKIVLPKVSESNY
IEELIKVIKFFEIKLIVPTIDTELSTLSRNKKYIENETDSVVLVSSEKVIDICENKILTS
AFFEQNGFKTPEILNSSEITKFPVFIKPLNGSSSVNTFIVNNEKELLFFSEYIDNPLIQE
YILGEEYTIDVCLNFDSTPVSIVPRKRIATRGGEILKGQIIKDRELIETTKKMLEKLNAI
GHITIQCIKNEKGIFYLEINARYGGGAPISIKSGANSPEYIIKMIDSKKNLRYRENYLDK
MIALRYDQAIYLDEKGNVYND
>FECAFAII_02135 UDP-N-acetyl-alpha-D-glucosamine C6 dehydratase
MFILTRRRKIATLVFVDSLLLIAANIAAAKFMKPFVSIPMDLILISIGLSIGFYLFYGSL
FKVFTRINRYTNLREIIAIFSSLSASAASSILILLFINRRYSLRLVIFAYLLSLLLIIGS
RLIWRIYIETKNMRYVSADSAKNTLIVGAGEGGRILYNSFLGSKTAQDIHVVGFVDDDPN
KRNTYLSGKKVLGALKDIPELIEKYDIQMVTIAIPSLSRKKLRRIFELVESARVKVNTMP
SIEELASGKISVSKLKTIDVVDLLGRDEVKLDIESIKDQITDKVILVTGAGGSIGSEICR
QIIQFNPAKLLLLGHGENSIYLIDRELRTHHQNCPTEIVPIIADIQDREKINEIMEQYHP
DIVYHAAAHKHVPLMEYNPKEAVKNNIFGTKNVAEAAKAAKVKNFVMVSTDKANNPPNVM
GSTKRIAEMIVTGLNEEGCTKFSAVRFGNVLGSRGSVIPVFREQIAQGGPITVTDFRMTR
YFMTIPEASRLVIQSGALAKGGEIFILDMSEPVKIVDLAKNMIRLSGYSEDEIEIIETGI
RPGEKLYEELLLDKERNDEAVYEKIFVGNIKGYSIQKVMDFVKSLPQDDEQLAKDIVTFA
NASNR
>FECAFAII_02136 Tyrosine-protein phosphatase YwqE
MIDLHCHILPGIDDGAENLEASIAMAEKAIQQGITHILCTPHHNNGKYSNEKSQVISLVA
SLQAELEKRQLPLTLLEGQEVRITGTLIEDIHRDEILFTDLDDTYLLIEFPTLEVPLYAE
RLFFELLELGKTPVIVHPERNAHFREDPNHLLPFLDMGCLAQLTAPSYVGVFGKDIQKTA
KTMVKHNLVQMTASDAHGVSKRTFYLKECYEQIAKDFGKEKVVQMKQVAKDLINGDEISY
PDYEEVKKKKFGLF
>FECAFAII_02137 Tyrosine-protein kinase YwqD
MARTQKQKAAQTHAVSLITLTNPSSPIAEQYRTIRTNIQFASAAGQQIKTIVVTSSGPGE
GKSTTSANIAVVFAKSGQRVLLVDADLRKPVVYKTFQLNNTSGLSTALSSSGSVADVIQR
TPVENLSILPSGPKPPNPSELLSSPRMDQILAEARQLFDVVIFDMPPVVAVTDAQIMSSK
TDGTLLVVRENTSRKESLSKAKELLEMVQARVLGVVYNGAEHSKDAGYYYGN
>FECAFAII_02138 putative capsular polysaccharide biosynthesis protein YwqC
MEETISLKEIFETLRKHLVTIIISMFAGLAISGIVTFFILTPKYSSQAQLIVTLPQSDTA
NVNDVNTNLQMINTYKDMIVSDLVLNEVKDRLETEDNVKMTAEQIKDAISVNQSQNSQMF
SIQAISTNAVTAQQIANTTSQVFQENAKDVMNVDKISIISGAVANTTPVSPNNKLNLVIG
LVLGMMVGVGLAFLFELLDRTVKDEKYVTDTLGFPILGTVPEMSAKELNAGIRKKGPAPA
RPKATNDKTAPSRRSRSRV
>FECAFAII_02139 Transcriptional regulator LytR
MARRRRKSRGKKIFLIILAVLIVLVLAIVGVGAKLYLDLSHSIEKTYESVERTQGERTKP
VDLDKQESFSVLLMGIDTGDLGRVDQGRSDTMMVATVSPEDKQTTIVSIPRDTYVDIVGR
DTKDKINHAYAFGGAAMAMDTVQKYVDIPIDHYVSINMKGLKELVDAVGGIEVNNDLTFS
QDGYDFTIGKITLNGDQALSYSRMRYEDPNGDYGRQERQRKIVEGVAKKVLSLNGVSNYQ
SVLNALESNMKTDMSFDEMKKIALDYREAFGTIKQDQLQGEGFMQDNISYQKVSDQELDR
VKKELKDQMNLENK
>FECAFAII_02140 hypothetical protein
MEKPFVKSLTAVAVGAGAIAICLFGYHINNQRQHQQRITYAESAITNQKDTLTSLSKEVD
KLYSTKEKIFLNPEITEETITSLSNKLSSVKLSADDYDIKESELPKEAVAIQDEKKAIVT
QLDSAESKLKIQTAVNDLFTKNVSNWQQAVDDVIIKEKVTSADVARVRENMSFFKDSPWK
TVVMQYLGFADTQIAQVTQLDQLFDTMLKDGQVTATATYDQYLTALSQIEQIRNEKISAA
YATKAQTVAEQMGYSNISY
>FECAFAII_02141 Glycine--tRNA ligase beta subunit
MAKDLLLEIGLEEMPAHVVTPSMKQLEEKTAKFLDENQLTYDTIETFSTPRRLAIKVTNI
PERQADSEEEVKGPAKKIALDADGNWTKAAEGFVRGQGLTTDAITFRELKGVEYVYVTKY
THGKEAKEVLTGLADVIKSLTFPVTMHWAEYDFEYIRPIHWIVALLDDEIIPFEILDIKT
DRASRGHRFLGEDVTFAHAKEYEEKLNEQFVIASPQKRKEMIITQANELAEKNHWIIDLD
EDLLEEVNNLVEYPTVFSGDFEEKYLSVPEEVLVTSMKEHQRYFEVRNDQGMLLPHFISA
RNGDRVKLENVVRGNQKVLAARLEDAEFFYNEDKKASIDQYVEKLKTVTFHEKIGSIYEK
MQRVQVIARIIGEQVRLSEEELMDLQRAAEIYKFDLVTNMVGEFPELQGIMGEKYALLKG
EKPAVATAIREHYMPISSEGDLPETTVGSVLAIADKLDSIFSFFAVGMIPSGSNDPYALR
RQAYGVVRIIESKKWAFPLSVLQETISEVISKDADRFGIGLSAGQQQVIDFIKGRLRQLL
TTKNIRHDVIEAVLNAEQKDLTKVFAAAQLFKQHLADEDFKPSMEALTRVVNLAKKAELE
KQSEVDPELFENEAEKELYKAVEGMKTSFADQTINENYDQLVSLRPLIENYFDQTMVMAE
EPAVRKNRLTQLNQIAAMALSLASLDQIITK
>FECAFAII_02142 Glycine--tRNA ligase alpha subunit
MSKKLTVQDMILTLQKFWSSNGCMLMQAYDTEKGAGTMSPYTFLRAIGPEPWNAAYVEPS
RRPADGRYGENPNRLYQHHQFQVVMKPSPENIQELYLESLRLLGIDPLEHDIRFVEDNWE
NPSMGCAGVGWEVWLDGMEITQFTYFQQVGGLPCKPVTSEITYGLERLASYIQEVESVYD
LEWADGVKYGEIFKQPEYEHSKYSFEVSDQDLLLSNFDRFEKEAKRCIDENLVHPAYDYI
LKCSHTFNLLDARGAVSVTERAGYLSRIRNMARAVAKIFVAEREKLGFPLLNKNTANPEN
VKEAE
>FECAFAII_02143 DNA repair protein RecO
MSQLAESKGLILSSRNYKEKDKLVKIFTESSGKMMFYIKGIHRQNQPLAPALLPFTEAVY
IGNFRSEGLSFLSSVKDVHAFRNIQEDIFLSGYGTYLLNLVDAAIEDHQYDPHLFQFTQQ
ALQRMDQGDDAEIITNIFEVQILQRFGIAPIWTHCVVCGETKGKFDYSSKSGGVICEKHW
PMDEHRYHADPRAVYFVRMFSAISYDKISGIHLKEETKQAIRDLIDQLYDEYVGIHLKSK
KFIDQMKSWAHVLKTPEKNMPEKEIPEKEE
>FECAFAII_02144 GTPase Era
MPEHKSGFVAIVGRPNVGKSTLLNRIVGQKIAIMSDKAQTTRNKIQGVYTTPEAQLIFID
TPGIHKPKHRLGDFMVEAAYSALKEVDAVLFMISADQKRGRGDDFIIERLKNVHSPVYLI
INKIDKIHPDELLGIIEDYSTQMPFAQVIPISATEGNNVERLMDVLVSEMPEGPQYFPDD
QVTDHPEYFIVSELIREKVLFLTRDEVPHSVAVVVDSMKRNENDKIHIQATIIVERDSQK
GIIIGKGGKMLKQVGTKARKDIENLLGDKVFLELWVKVQKDWRDKKVYLQDFGYRKDEY
>FECAFAII_02145 Undecaprenol kinase
MDSKDKNVEKNKHFLMSVEFAVQGVKTVFEEERNMRKHVAFGILALFMGVIFQLDRIEWL
WLLLAVFLVWIVEIINTVFENVVDMFTDFHFHPIGKKIKDMAAGAVLVTACFAVIIGLIL
FVPKIYHLLFN
>FECAFAII_02146 Endoribonuclease YbeY
MDETNQVSEEKMKEIDDLLQFAASYLKLPEETEMSVTFMDNAAIQVINRDYRGKDAPTDV
ISFALEEEGEDEIPVIFEDGENPLPRVLGDIMISIERAAEQAEAYGHSYDRELGFLAVHG
FLHINGYDHMTPEDEKEMFGLQKEILDAYGLKR
>FECAFAII_02147 Cyclic-di-AMP phosphodiesterase PgpH
MLNKTLQKLQEKLGKAALPFLLFLFFIIICGVTFSSVKQKANDFREGQVAEESIRANKTI
ENTEETEQKRKLAAEAVTPEYTYQKDLADDQNNRIKQLFELIDKTNDAINKSYDEKIDKA
KEDENIPKPTTEERIAALKKNFENVNAENVAFYQKLPNNFYSTIFEMTETEIHTVRDESL
KLIDEQMSKQVRESELEAFKQEAEEQIQYLNVTPAQQQMIRYLVDQGIVVNDVLNEKKTE
ELKQSAREAVQPVMIFQGEIIVREGNQIDASAMKKLELLGLTNQTTSIFPLIAMVLAVLL
QIGVLIYNSLQFQNAGERTKYVLFYVTAMSVSIVLMKFFQLFQTEQATYIPLFYPAAFAP
LVLSFFLNRRAGIMAGIFQAVSALFIFYDSIGTNFLTIILMSYVFSGLMATIVRRKRISE
QGLSAAMWVIIFPVMMDVILIVYQGMSFGDATTWLMLVCGFTGALFSFLLTIGLHPYIEL
MVNDDSVIVLNELSNPNHPLLKQLLEEAPGTYHHSMMVANLSANAVAEIGGRSLLTRVAC
YYHDIGKIKHASFFVENLPSGAENPHNFLLPEDSKHIIFGHVTDGAKILEDYNMPQMVID
ICKQHHGTTLMRYFYIKAKERNPEVTEEQFRYPGPKPQSREAGIVNIADSCEAAVRAMDH
PTSEKIESFVHNLIEERISDGQLDDSGLTLKEIRKVEKSLISGLSSTFHSRIKYPKMKTE
VEKIKEEQEE
>FECAFAII_02148 PhoH-like protein
MTEESSSLEIRLTAADDVSMLLGAHDKHIKLIEETTETTIHTRGEIIQIIGEQSQISLAA
SVIRTLQELIKRGIHVSTPDVVTALKMGQKGTLDYFVEMYEEEIVKDRNGKPIRVKNSGQ
KKYVESVAKHDIVFGVGPAGTGKTFLAVVLAIAALKKGEVQKIILTRPAVEAGENLGFLP
GDLKEKVDPYLRPVYDALYQIFGLDHTNRLMERGVIEIAPLAYMRGRTLDDAFVILDEAQ
NTTVAQMKMFLTRLGYQSKMIVNGDTSQIDLPRGTTSGLVHAERTLKQIKKIDFVNFEAS
DVVRHPVVAEIIKAYEKADLHQE
>FECAFAII_02149 Branched-chain amino acid transport system 2 carrier protein
MEETKTYSWKQLLMVSSLIFGMFFGSGNLIFPVHLGQMAGSNWISAGVGFAISGALFPLL
AILAVVVTKSDGLYDLAKPVGKWYAALFLILVHLTIGPFFGTPRTAATAFEMAAKPFLPE
KYDSLGMFLFSALFFLLAYFLTVHPTRLVKYVGKYLNSLFLALLAIIFVVSLFQPMGNLN
QSAADSYQTNALTNGVLEGYNTVDAVALLALSVTFVHAVRDLGFKDKKVTELTAKAGSLS
VALEVMIYFGLVLLGAMSLNKMSLSENGGTALSQITNFYLGNFGASFLGVMVTLGVFTTA
MGLVVSFAQDFHKLFPKVSYMTWLRLTTFVSFVVANAGLDNIIQWSLPVLMLLYPLSLSL
ILLSLTAKFFQKSSFVYQVTMFFSAVPAVLDMLANSPALVSQQTVVASLLGFYHHYVPFA
ALGLGWVVPTLLGYAGSLLFYYVYRVSGYKQEASELPEE
>FECAFAII_02150 hypothetical protein
MSLLSRLNDDMKAAMKAKDKESLQVIRMIKSSIQNEQIKEGHDLTEEEELTVLSREMKQR
RDSLHEFEEAGRDDLAEKVKSEIVIVEKYMPEQLSDEEIRQLVQEAITQTGASSMKEFGK
VMGAIMPKVKGKADGNQVNAIVKELLQS
>FECAFAII_02151 30S ribosomal protein S21
MSKTVVRKNESLDDALRRFKRSVSKAGTLQESRKREFYEKPSVRRKKKSEAARKRKKF
>FECAFAII_02152 Zinc-specific metallo-regulatory protein
MKKQTLIEQSLETLKNNGFKYTKKREALLTYLVKRNRYVSAKEVFDYMNQEFKGVSYDTI
YRNLHDFAEIDLLEETDLNGEMKFRFHCCQGEIGHHHHFICTVCGTTKEIHMCPMNYFEE
QLGGCTIEGHRFEIFGRCENCQ
>FECAFAII_02153 Putative pyruvate, phosphate dikinase regulatory protein
MSSDSTEIVTFFVISDSAGETATKLAQATMAQYPTVEFNLFRRTFVTDEKTLRQALQDAL
EEKALVLHTLINQELIEITRSFCEEHQLFSFDVMTPPISEIERLTGIKPIRQPGALHLLN
ENYFKRIKAMEFAVKYDDGKDPRGFLEADVVLLGVSRTSKTPLSLFLANKNLKVANLPLI
PQAHIPKQLWEIDPKKIVGLTNNPDILNNIRKERMRSYGLNPDTAYSDIEKIRAELDFAN
DLYEKLGCVVINVASLSIEETASLILNALDLEDHSYYGTETTDKND
>FECAFAII_02154 HTH-type transcriptional repressor CzrA
MPDTQKSKVEKVSQLFKMLSDPTRLKILLYLKDGEQNVTAITQAVEMEQSAVSHQLRLLR
ENHVVKSHREGKAILYSLDDSHVLDILNQTLKHVEHQ
>FECAFAII_02155 Phosphoglucomutase
MSWEQVYEQWVHEENLEKNLKKQLNDLGEDPEKLEDAFYAPLEFGTAGMRGILGPGINRM
NIYTVRQATEGLARFMDTQGEETKRRGVAIAYDSRHQSPEFAMEAAKTLAHHNIPSYVFE
SLRPTPELSFAVRHLKTFAGIMVTASHNPAAYNGYKVYGEDGGQMPPADADALTKYVREV
SNPLKVEVLSDEEAKHSGLITIIGEEVDAAYLEEIKAVTIDRELVETMGKDLKLVYTPLH
GTGKMLGERALKQAGFEQFVLVPEQAVADPDFTTVKSPNPEEHSAFEYAIRLGEKEGADL
LIATDPDADRLGAAVRLPDGSYEVLTGNQIGALFAQYILEAHQSRGTLPENAAVLKSIVS
SELPTAIAEHYGATMFNVLTGFKFIAEKIQQFEENHSHTFMFGFEESYGYLVKPFVRDKD
AIQALLLLAEVAAYYKKQGKTLYDGLQTIFETYGYFAEKTISVTMSGQEGSAKISALMEK
FRKEAPTEFAGAKIIQTEDFKELTRTDREGNVEKLTTPPSDVLKYTLEENGWIAIRPSGT
EPKIKFYIGVKGSSTEDAAEKVASYEAIIKKMTEE
>FECAFAII_02156 Thioredoxin reductase
MYDVIVIGAGPAGMTAALYASRSNLSVLMIEQGAPGGQMNNTAEIENYPGFDSIMGPDLA
YKMYESVSRFGTENAYGIVQDIKDHGSHKEVICEDKSYEGKTVIIATGCIHRKLGVPGEE
EFAGRGVSYCAVCDGAFFRNKRLVVIGGGDSAVEEAIYLTQFASEVVIVHRRDELRAQKI
IQDRAFANEKISFMWDTVVDEIVGNEMVVTGVKARNVKTGNEFDLAADGVFIYVGLDPLT
APFREAGLTNEAGWIPTDNEMKTNMPGVFAIGDVREKDLRQITTAVGDGGIAGQQVYKYL
ESLEETTA
>FECAFAII_02157 Aryl-phospho-beta-D-glucosidase BglH
MGFRKDFLWGGATAANQCEGGYDEGGRGLANVDVVPIGKDRFPVITGKKKMFEFDEDHFY
PAKIAIDMYHRYKEDIALFAEMGFKTYRMSIAWSRIFPMGDEKEPNEAGLKFYEDVFKEC
QKHGIEPLVTITHFDCPMHLIKEYGAWRSRELVGFYENLCRVIFNRYKGLVKYWLTFNEI
NMILHAPFMGAGLYFEEGENEEQIKYQAAHHELVASAIATKIAHEVDPENKVGCMLAAGA
YYPYTCNPEDVWASRKSDRENYFFIDVQSRGEYPAYALKEMERNGIQIEMEPGDAALLKE
HTVDFISFSYYSSRVSTTDNELLEQTAGNIFASVKNPYLQASEWGWQIDPLGLRITMNDI
YDRYQKPLFIVENGLGAVDTPDENGYVEDDYRIDYLAAHIQAMKDAVELDGVDLLGYTTW
GCIDLVSAGTGEMKKRYGFIYVDRDNQGNGTLARSKKKSFNWYKKVIDSNGENLSND
>FECAFAII_02158 putative 6-phospho-beta-glucosidase
MAKGIKIATIGGGSSYTPELMEGFIKRYEELPIREIWLVDVEEGKEKLEIVSQMSQRMWD
ASPYEVKIYATLDREEALKDADFVTTQFRVGQLDARIKDERIPSYYGMIGQETNGAGGIF
KAFRTVPVVLAIVEDMKRLCPNAWLINFANPSGMVTEAVIRYGKWDKVIGLCNVPVMAMM
TEPAMLGKKKEELIYKFAGLNHFHWHKVADNKGNDRTPELIDRLYDEDNGLPKNIFDIPF
FKEQLKQMNMIPCGYHRYYYREEEMLEHALEEYQTIGTRAQQVKETEAELFELYKDPELD
HKPEQLQKRGGAYYSDAACETIASIYGNKETQIVVSTKNEGAVPDLPADCVVEVTAYVGA
QGARNVAFGSLPAAERGWLQVMKNMELLTIEAAVTGDYGTALQAFTINPLIRSGKTAKRI
MDELFIAHQQYLPQFKETISLLKEEGIEVQDELARELSSNTHIMEEV
>FECAFAII_02159 HTH-type transcriptional regulator MurR
MLLREKIKEISFSPSENEVIQFLLSDSPALGEMTIQEIAERCYVHPSTLIRVAKKMGFDG
WVSFRNAFLAETAYLEGNFQDVDANLPFSTTDGIMTIANKMASLEQMTIHDTLSLIHHDQ
LQKAKQLMLQAKKIVIFASNSNTLISQDFMLKMKRIKMDVTIVTTFGESFYEAYNCTSDM
CGILISYTGENNVILRTAEILKQNDVPILALTSIGDSTLSAMSTAALRLTTRERLYSKIG
NFTINTSICYLLDVLYSCVFAENYQQNLVHLISVGQKFDKRPISSAIMKEPFNFENKEVE
>FECAFAII_02160 PTS system beta-glucoside-specific EIIBCA component
MGKYQELASKIVENVGGKKNINSLTHCITRLRFKLKNEEKANDEILKNMDGIVTVMRAGG
QYQVVIGNHVPVVFEEVIKAGNLTFDEAVSTEKMRPFDMLIDGISGCFQPFLAILAAGGM
IRGLTALLVFLGAFDRGSGTFVMFDNIGDSVFQFMPVIIGLTAARKFKVNEFVGMLLGAA
LMNPNLSLEVLSGAAEAPLTTIFSGTIFEAPIYQTVFGIPWIARNYASSVIPIIFIVLLA
SQIQKPIKKLVPEMIANFFVPFFTVLITMPLGFLLVGPAFTFATDILMAGFETLLALSPV
IYGAIVGFFWQILVMFGLHWAIVPMGLMQFSVNGWQNIMTPVAVVSFGQTAALTALYFKL
RNPKDKAIAIPAIVSGIVGITEPAIYGFTLPRKKIFIFTCVGGALGGAYSGLMNLTSWNQ
GGLGIFTIPNYIRPDGDLTDVINVLIGIAIAMVVSFALTFFFWKDEAGETDDIQKRSGKE
IVKTPIQGQIAPLNAAKDAAFAQGTLGRGILIYPEKGEVRAPFDGTVMTLFPTKHAIGMV
SETGLELLIHVGLDTVQLEGKYFESLVQQGERVKQGDLLLRFDKKKIEKEGYSLETPVIV
TNYTDYLDILENQGETVGPDDALITALT
>FECAFAII_02161 Transcription antiterminator LicT
MLIEKVLNNNVVITRDERNQEMIVMGKGLAFKKKVGDPIFDSCIDKKFQLTNDGLSQQFQ
ELAQAIPLEYLEISCEIIEYTKEALQVHLNDSVYIALTDHLYTAIERQKMGIFVPNVLLY
DIKQLFPKEYAIGKKTVKKISDKYHIKLSEDEAGFIALHLVNAQGIQNQQDNTYLFTTTI
QDILNIVRCYYKITFDEDSVHFFRFVTHLRFFLTRVLDGAKSEDGEVSEELFQVIQKKYK
DTFGCVEKIADFLTGAFDYQMSTDEKMYLTIHTARLVHENRCK
>FECAFAII_02162 putative multidrug resistance ABC transporter ATP-binding/permease protein YheH
MDENYQSEWTKSIPLKEQKKIIKRLMKFAKPFRRTFIVAILFAFALSVINVLLPRIIQTF
MDDHLAKQSATTQVILFFAGMYLFGVIVKSIIWFFQWYLYSMASLKTYQYIRVKLFEKLH
TLGMRYFDQTPAGSTVSRVTNDTETLFEFWYVFLMVLTGIFAVVSSFLAMFQINGEIALW
TLVFLPILGIVIWYYQKFSSRIYRNMREKLSQLNTKLNESISGMRIIQQFRQEARLAKEF
EQVNNEYLDTRYAMIKTNSILLSPIINFLYALAIALVLTLFGIDALHSPVEVGLIYAFTT
YVQGFFNPMSQMMDFLSIFTDGMVAGSRILKIMDTEEYAPQQNPGADQMITSGKIEFRNV
SFSYDGEHNVLNNISFVANPGETVALVGHTGSGKSSIINVLMRFYEFYEGQILIDDHDIR
EYPMEELRKKMGLVLQDAFLFYGDIAGNIRMMNPAITDEQIRHAAEFVQANKFIDELPKG
YHSKVIEHGASYSSGQRQLITFARTIVTDPKILVLDEATANIDTETEGLIQEGLAKMRQG
RTTIAIAHRLSTIRDAELILVLDKGHIVERGNHETLLAQNGLYADMYKLQSSGI
>FECAFAII_02163 putative multidrug resistance ABC transporter ATP-binding/permease protein YheI
MSIFRKLGWFFRQEKKHYLIGVFSLFAVALVQLVPPKVIGIIIDEIADKNLSVKIIFGWI
FLLIIAAFLQYLFRYIWRTNIWGSAARLEKELRQQLFKHFTEMDNLFYQKYRTGDLMAHA
TNDLNAIQNVAGAGILTFADSVITGGTTIIAMILFIDWRLTLIALIPLPLLAVTSRVLGS
KLHEAFRDSQEAFSSINDKTQESITGIKVIKTFGQEKEDLADFEEKIEDAIIKNKRVNFL
DSLFDPFITLIIGLSYVATIILGGKYVLEGTISIGQMVSFISYIGMLVWPMFAIGRLFNV
LERGNASYDRVNELLHEKTHIVEQLGAVQTPAKGELNVAISSFNYPKEESPALEQIKFAI
QEGETLGIVGKTGAGKTTIIKLLMREYDYYQGKIQFGGRSIKEYSLNALLGSIGYVPQDH
FLFSMTIRDNIRFSNPKLSEEEVEHAASLAFINNEIKELPKGYDTLVGERGVSLSGGQKQ
RISIARALIKNPELLILDDALSAVDAKTEEAILHNLKEIRKEKTTIIAAHRLSSVMHAKE
IIVVDQGKIIERGTHHELLALGGWYEQMWEKQQLEAKIEGGEA
>FECAFAII_02164 hypothetical protein
MLSTGIVVLIAIIALLIGAVGGFFLARKYMKDYLEKNPPVNEDMLRSMMMSMGQKPSEKK
IRQMMQQMKNQGKK
>FECAFAII_02165 Divalent metal cation transporter MntH
MNNQSNKQFHKHRLIEHTNGLSLAEVNGTVDVPKGKSFFKTLLAYSGPGALVAVGYMDPG
NWSTSITGGQNFQYLLMSVILMSSLIAMLLQYMAAKLGIVTQMDLAQAIRARTSKTLGVI
LWILTELAIMATDIAEVIGAAIALYLLFDIPLVIAVFITVLDVFVLLLLTKVGFRKIEAL
VVCLIFVILFVFVYQVGLSNPDWHSLFAGFIPNSHTFSDSPVIGGETPLTGALGIIGATV
MPHNLYLHSAVSQTRKIDHQNEEDVAQAVRFSTWDSNIQLSMAFLVNALLLIMGVAVFKT
GSVQDPSFFGLYEALSDPSAMSNGILIAVAKSGILSTLFAVALLASGQNSTITGTLTGQV
IMEGFIHMRIPIWLRRLVTRLLSVIPVLICVLFTSTKGTIEEHTALNNLMNESQVFLAFA
LPFSMIPLLMMTNSQAEMGSRFKNSFIVKLLGWFSVISLTYLNLRGLPGQIESFFGEQAT
SAQLALADHIAYVIIVLVLLLLAWTIGDLYKGNKKYEQLLQETVEEIE
>FECAFAII_02166 hypothetical protein
MLNTLKPLINQLTKKHTYFILGIALLFTIIRLYLYSKAIYGTDMSATYDDQLLIRYAQNI
LDGKWLGEYTTTTLSKGISYSLFLVLAHKLHLSYAVLFGMFSIFASILVALAFKPIVKNK
YLLLSIYFYFLFSPISFTHEYSTRTYRNALVIPAVEIIIACLLAIYYRKYGSSRKLLQWF
LGLSVAFPFFWFIREDSIWLLPFTVVALGISFVQILLGQDFSFKEVKKLKKRLFLLSKRE
WLKLSLFLLPIVGFSIVYQWIEYKNETTYGIATINDRSSGEFGRLMKQLIRIDDETNLNK
ENSEIWVSHAALNKALAASPTFHTVSTRIDELYTTHAWTQGGKVKELPGDIIFWALRDVV
SESGYYQNNAKETNDFWKKVNQELEEAYHKGTIKKKKEFYLMGSGDGKTMSDLPIVFDFL
QSGYAYAWRYKDFHQGGNYSFGTQEQVKQAQELLNLPLMENWIDSNEPRTPNFQLTKSAK
VANVIIKIYQVLAIPVLIASIAGILLMILGTVFAKADRAYYSSSLIVVTGLILTQLVFLF
GVSWFCSYAPEKKDYFLSVYTGAGVPLTQFIVVTSMLVFSKLNLKKALSSK
>FECAFAII_02167 hypothetical protein
MYFLGIDIGKRTHVASIMNEEGKVLLKGFSFPNTTEGAESLIERMVDYSGAPSDFVIGME
ATGHYWLSIFSYLHESDYLIHVVNPLQTDGWRKGTEIRKRKNDIIDSVLIADLMRYGSFV
ETVLSDENVFSLKQLSRYRTYLVGTASDFKRKIIAVLDQVFPEYATIFTKQGVFGKASKE
LLLAFSAPIDLENISSETLAQYLAELSRNRIKAEKADQLKQAASNSFGVKFAQEAFTFQL
RSMIEQLKFIESQIKETEREIKHIMDTLNSVILTIPGIGPINGATILGEIGDIQKFSNPK
KLVAYAGIDASVTQSGQYEATHNVMSKRGSPYLRKALFSAALVASQCDPVFSAFYQKKVS
EGKHHLTALGAVSRKLCYVIHAILTKNEPYIIVSD
>FECAFAII_02168 putative endonuclease 4
MLLGSHVSMSGKKMLLGAAEEAASYGSSTFMIYTGAPQNTRRKAIEEMNIDAGKAYMAEN
GLTNIVVHAPYIINLGNTIKPEMFPFAVQFLREEIVRAEALGATQITLHPGAHVGAGTEA
GIARIIEGLNEVLTKEQTAQIALETMAGKGTEIGRTFEELAQIIDGVKLNEKLSVTFDTC
HTNDAGYNIKEDFSGVMEEFDKIIGLDRLKVLHINDSKNPQGSHKDRHANIGFGTIGFDT
LNKIVHDPMFDNISKILETPYVGKDKKKAYAPYGKEIAMFKAQTFDPEVFPELLAEEVIL
>FECAFAII_02169 Penicillin-binding protein 1A/1B
MPRKNTRKKQNRRKKEKWFVPKIIFRVFQSLTVFITVLLLMFAALGIGIGAGYFAYLVED
TQLPTKKALQTELGNITETSKIVYADNTEISKIQTDLMRTTISSDKISPLLKTAIISTED
EYFDKHQGYVPKAVLRALVSEATGIGSSGGSTLTQQLVKQQILTDETTFKRKANEIILSA
QVEKYFSKDEIIATYLNVSPFGRNNKGQNIAGVQEAAKGIFGVDAKDVTLPQAAYIAGLP
QSPITYSPYTNTGALKEDLSAGLARKDFVLFSMYREGQITKEQYEEAKAYDLTKDFLPQQ
IAEQTDREFLYYTVMNEATRIIAQQLAEKDNADMSDSSVSDAYYQKAQQTIQNKGYTIHS
TIDKDVYAALQNGVENYGYMLDDGAGSQVETGNVLMDNRTGRIYGFVGGRNYSQNQNNHA
FDTERQAGSSIKPVLVYGPAIDMGLIGSESRVSDYATTWQEGENAGEKIVNATNEGSNTF
QTVRESLEWSNNIPAYHLYQDVLNSGGSKQYAYEHYLAKMNYPANDNWGVESAPLGTVDV
TTLQQTNGFQALANGGVYEEGYIIDSITDNAGNVIYKHESNSVRIYSEATASIMNDMMRS
VINAKITTPFKDAISSLNGNLGKADWVGKTGSTNEYRDSWLIVSTPSITISSWAGHDDNT
GMDSKARIRSANYLANLINQAYQAKPDIFGTDEKFELSSDVMKKKVSGFTGQTPGKVTVN
KKSIQTPGKTVESLWAKNGPKKSAFKFGVGGTDENYTDYWNTASAYARANQATKESDEKD
D
>FECAFAII_02170 Catabolite control protein A
MEKQTITIYDVAREANVSMATVSRVVNGNPNVKPATRKKVLEVIDRLDYRPNAVARGLAS
KKTTTVGVIIPDVSNMFFASLARGIDDVATMYKYNIILANSDGNDQKEVNVLNNLLAKQV
DGVIFMGHHITDEIRGEFSRSKTPVVLAGSIDPDEQVGSVNIDYVSATKDAVNKLAKSGN
KKIAFVSGALIDPINGQNRLKGYKEALSENNLPYSEGLIFEAQYNFKDGLSLVDRIHNSG
ATAVYVSDDELAIGILDGLLDRGVKVPEEFEIITSNNSLLTEVARPRLTSITQPLYDLGA
VSMRLLTKMMNKEEVEEKTIILPYGIEEKGSTK
>FECAFAII_02171 Xaa-Pro dipeptidase
MNNVKINELRQWMAQHQVELAYISDPGHIAYFSGYESDPHERVLALFIPLEQDPFLFTPA
LEVEDAQNSSWAYDVRGYLDSENPWEIIGKELRARYGQPGNVGIEKNALTVERFDAISDI
LTGTDSYTDLTSIIQRLQLIKTLEEKDKLIEAGKWADVAFEIGFKAVKEGVTEQAIIAEI
EYQLKKQGVSQMSFDTLVLAGANAASPHGTPGNTKISPNELVLFDLGVVWNGYCSDATRT
IAYQKPTDFQEKIYNITLEAQLAAQEAVRPGVTAGELDQIARNVINSYGYGEYFNHRLGH
GIGTTVHEFPSLVEGNDLVIEEGMCFSLEPGIYIPEKVGVRIEDCVYVTSDGCVPFTTTP
KELLVLEK
>FECAFAII_02172 hypothetical protein
MAKKGGFLLGAVVGGTAAAIAALLLAPKSGKELRDELAAQADDLMDMASDYTDMAKEKST
ELTGIAKEKAQDLSQQAGDLAGSVKQKVSESADEAGSESDDILLNLKEQSADLSNRFKKT
AEDMKKPADELGSIAKDTSEDIMIDVKDAAGKAGDTVNEGMSEAKPVADDSKEMMKMAKE
DAKEAKKEIKDTMTDSSTNH
>FECAFAII_02173 hypothetical protein
MSGGEIAGLIAAIAFAILVVFIVRVLLQVSKTLEKVDQTVAEANTTIEIVTKDVDLLSRQ
VEGLLVKSNELLLDINGKVATIDPLFTAVADLSESVSELNHSSKNIATKVGGIGKTTAKA
TVAGKVGGTAMKFFKNKKHTETTGGK
>FECAFAII_02174 UTP--glucose-1-phosphate uridylyltransferase
MKVKKAVIPAAGLGTRFLPATKAMAKEMLPIVDKPTIQFIVEEALKSGIEDILIVTGKAK
RPIEDHFDSNIELETNLSEKGKTELLKLVEETTDVNLHFIRQSHPKGLGHAVLQARAFIG
NEPFVVMLGDDIMEDEVPLTQQLIDDYERTHASTIAVMQVPHDETSKYGIINPGEVLEDG
LYNVKNFVEKPDPSKAPSDLAIIGRYLLTPEIFDVLSEQQPGAGNEIQLTDAIDTLNKTQ
RVFARKFTGKRYDVGDKFGFMKTSIEYGLTHPEVGAPLREYILSLGKTLEAEGSKIDHNP
KGITEIKEEKKK
>FECAFAII_02175 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MNYRVAVLGPGSWGTALAQVLAENGHDVRIWGHRASQVEEINTQHTNQRYLPDHYLPDSI
QAFTNMEDAVKDADAVLFVIPTKAIRSVAKELVPKLNTKPVIIHASKGLEQGTHKRISDI
LLEEIPAEKRKAVVVLSGPSHAEEVAKHDITTITAASTDAKAAKYVQELFMNNYFRIYTN
PDVIGVEMGAALKNIIAIGAGAIHGLGFGDNAKAAIMTRGLAEISRLGVAMGANPLTFIG
LSGIGDLVVTCTSVHSRNWRAGNLLGQGQPLEEVLANMGMVVEGVNTTQAAMELAQMMEI
EMPITQTIYEVLYEQKEIKTAAKEIMLRDGKKENEFSLTIF
>FECAFAII_02176 Prolipoprotein diacylglyceryl transferase
MLAQINRVAFELVGIPIYWYALIIVSGIIIAMWLSSREAVRVGLKADDVTDFMLWGLPIS
IIGARLYYVLFDLPQYIADPIQIFNIRSGGLAIYGGLIAGAITLYFFTKYHFISLWTFLD
IAAPSVLLAQAIGRWGNFMNHEAYGPDTTRSFLESLHLPQFIIDNMYIEGIYRQPTFLYE
SLWSLIGFILLLFLRKKPHLLKKGEVLLCYLMWYSFGRFFIEGLRTDSLYFLGVIRISQL
LSAVLFVGTLILFIWRRKKGNLPDYDRSLGKNQQII
>FECAFAII_02177 HPr kinase/phosphorylase
MSEVVKVSQLVKKLSLEIVTGDEKSLDRVIVTGDISRPGLELTGYFNYYSHNRLQLFGSK
EISFAERMIPEERLIIMRRLCSEDMPAFIISRGLPAPEEMIQAANENGIAVLRSPISTSR
LLGELSSYLDGRLAPRTSVHGVLVDVYGLGVLIQGDSGIGKSETALELIKRGHRLIADDR
VDVYQQDELTVIGEPPKILEHLIEIRGIGIIDVMNLFGASAVRGSMQVQLAVYLEAWAKD
KKYDRLGSEDTTVEIAEVGIPQIKIPVKTGRNVAIIIEVAAMNFRARTMGFDATKTFEER
LSRLIEENSGND
>FECAFAII_02178 hypothetical protein
MNDSIKKMLRLIEKDLMITEVSYETFQKKKTLIVDAVFSPAPHTCRNCGSTVVDGNGKVI
VVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKNCQVSLTTVIRTLKEFKSYLPKQSKRILPRVLMVDEFRSHASIED
KMSFICADGETGQLIDVLPTRKLPRLTSYFLGCANPEEVKFLVTDMNAAYFQLTKRILPN
AKVVIDRFHIIKHMNQAFNELRIREMNELRKVGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLGFSTSLKEAYPYFHELVEAFRDKDPDLFFSLLAELP
ETLDDGFREKLQNLLTYEEGITNAMIYPYTNGKIEAKNTHIKTMKRVSYGFKSFENMRIR
IFLINQLIKVR
>FECAFAII_02179 hypothetical protein
MSYFQRILVNTLTFISLAVLFPAMVHVSSIWTAVLASFVLSVLNMFVKPILTILSLPFTL
VTLGLFTFVINAAILKMTSFFVGAEHFSFSSFGAALLVAILMSLVNVIVSEHNSRK
>FECAFAII_02180 hypothetical protein
MMKKKLTKSNKNVVLTGTLAGIGEYIGIDPTVIRVLYVFLSLVAFGSPIILYILLALIIP
SARSARTNYGHNNAYYEKNNYREQTREQTKKRKEAEKIDDDEWSDF
>FECAFAII_02181 Chromosome partition protein Smc
MKERERILDLVKKGILSTEEGLDLLESMATEKDEKQIKKEADKVTASHKEKDQASQLIDK
LENGEEEISEPVDPKERERQDQENLEKILDELATEANKTSARLDEVNAQFADNKAARNEK
QEALMQLNTKEELGELTEEELAQRQTLEAEIKELEASGDTLLEEQLKLEAELKDIRKNQW
SEKKETFTDKFELPDDWKDQATDTLNQVGEKMSEAGSQLGKFLKKTFQTVSETVNDNMEW
KDVSLRVPGIATTKFEHEFYYEAPAASILDIKAANGNVTLKTWDSNDVKVEAKIKLYGKM
GAEPFEAFSERSQIEVNEDHISFQIPNKRVRADLVFYLPKRVYDHAAIKLLNGNIMIETL
EAKDIYTKSTNGNIIVDQLTATMLEVEGVNGNIDIRNGNILDSIIETVNGTVTFGATAEN
LSVSLVNGDVRLTIKEDNLKKVEASSVNGNVKVALPDGIGLEGHAKTSLGSINSRLSNYE
VVREKKERTNQMLQFRRVSDGEIAQVQLSTTTGSIYLKDTDK
>FECAFAII_02182 hypothetical protein
MNVLIILVGILAISVLLIGGTQGMYILLGLFINLGIFFLLLFGYHQKWPILALSVIGFLL
IAVVILFFINGYNLKMRAAFVSILIFLFCFLLLLPITDFLAIQGFTSVELEELSGLDKTL
AIDFRLLTRSLLLISLSGAVLDASVAISSGTFEVYQANPQLSFYQLRHSSFAIAKKILAS
TVMTLLFAFMGSSLALILWFIDLDIPFQQVINEKSFVLEYTMAILTTLSALLVLPLTCVT
TAYLFTKKKEQLKME
>FECAFAII_02183 hypothetical protein
MQKKISIITIFFICVLTSWVIQHQAALYEVPVIEIEKVRIKEDHQLITGKLMNTDQKGES
IYLSVPYQKNQIETANIKARQMYLVQMHGDEWQLVAKKNDGWLFFFTSIFIGAMLLIGGK
QGLFALGSLIINIVLLLLLLLIFTKTEGISLLNISILFVVIGMIISILALDGWNRSSIIK
ISAAVTSVFLAFFICLLTMNHWKDQGLRYEELNYLTRPYRSVFLSSVLIGTAGGTLDTVI
TVIATLEELTKRQPEITAKQLWLSGRQVGRDVIGSMTNILLFVYISGSVPSLLLYLGNQW
SFKETIEQHLSLEFLRVIAGSLGIVLSIPISVLFFLTVRRLKR
>FECAFAII_02184 Phosphate-specific transport system accessory protein PhoU 
MLRTQFEEELLNLHNQFYEMGMMVSSAVHKSVRAYIKHDKILAQEVIENDININNMETRL
EKKSFEMIALQQPVTTDLRMIITVMKASSDLERMADHAVSVAKSTIRVKGQTRIPEIEKE
ISDMSDYVKKMVDNVLVAYVKTDEKDARTIANMDQRVNDYFNRIYNATIKNMQENPETVI
SGTDYLNVASYLERIGDYVTNICEWIVYLATGKITELNTNHNEIF
>FECAFAII_02185 Phosphate import ATP-binding protein PstB 3
MTKEIISSKDLHLYYGKKEALKGIDLSFNQGEITAMIGPSGCGKSTYLRSLNRMNDLIPN
VTITGSVLYKDKDIYGPKTDVVELRKEIGMVFQQPNPFPFSIYENVIYGLKLKGEKDKKV
LDQVVEESLKAASVWDDVKDKLHKSALSLSGGQQQRVCIARVLAVNPEIILLDEPTSALD
PVSTGKIESMLLELRERYTMIIVTHNMSQASRISDKTAFFLDGHLIEYNDTKKIFMNPEK
QETEDYISGRFG
>FECAFAII_02186 Phosphate import ATP-binding protein PstB 3
MKKYNWNETNVITMPKEKEVALYTDDLHVWYGDNEAIKGVDLEFEKNKITALIGPSGCGK
STYLRSLNRMNDGIANTKITGKIMYQGVDINAPQVDVYEMRKRIGMVFQRPNPFSKSIYD
NITFALKQHGEKNKKKLDEIVETSLKQAALWDQVKDSLDKSALALSGGQQQRLCIARAIA
MKPDILLLDEPASALDPISTGTVEETLVNLKEDYTIIIVTHNMQQAARISDYTAFFYLGK
VMEYDKTNKIFTRPKIQATEDYVSGHFG
>FECAFAII_02187 Phosphate transport system permease protein PstA
MNAKRSDKIATGVLYIVSGIIVLILAALLLYILVRGIPHISWSFLTEPSKAYQEGGGIGI
QLFNSIYLLLITMIISFPISLGAGIYLSEYAGKNWLTDVIRTSIEILSSLPSVVVGLFGF
LVFVIQFQYGFSIISGALALTVFNLPLLTRTVEESLQAVHYTQREAGLALGLSRWETVIK
VVVPEATPGILTGVILSSGRIFGEAAALIYTAGQSAPALDFTNWNPLSVSSPISIFRQAE
TLAVHIWKINTEGTMPDGVSVSAGASAVLIIAVLLFNFGARAIGKRLYRKMTSA
>FECAFAII_02188 Phosphate transport system permease protein PstC 1
MEDVKKVLLTKSKRSKMEQRGKFISFLCIALIVLVVLSIFYFVASKGLATFFTDKINVFD
FLFGTDWNPSQIGANGKPMVGALPMITGSFIVTFLSAIVATPFAIGAAVFMTEISPKNGT
KILQPVIELLVGIPSVVYGFIGLSVIVPFVRSIFGGTGFGILAGTFVLFVMILPTVTTMT
VDALKAVPRHYREASLALGATRWQTIYKVVLRAAVPGILTAVVFGMARAFGEALAIQMVI
GNAALMPTGLTTPASTLTSILTMGIGNTIMGTVENNVLWSLALILLLMSLFFNIVIRMIG
KKGELK
>FECAFAII_02189 Phosphate-binding protein PstS 1
MKKLKLFLPIIGLAILLSGCSKWIDRGESITAVGSSALQPLVETVAETYQTENPGKFINV
QGGGSGTGLSQVQSGAVDIGNSDLFAEEKSGIDASALVDHRVAVVGITPIVNKDIGVKDI
SMENLKKLFTGEIKNWSEVGGKDQPVVILNRASGSGTRSTFEKWVLDGETAVQAQEQDSS
GMVRQIVADTPGAISYVAFSYVSDDVDTLNVNGVEPTDENVTTNKWTIWAYEHMYTRDHP
KKLTKEFLDYILSDEVQDNIVGELGYIPVSHMKVERDWQGNIVKE
>FECAFAII_02190 Major cardiolipin synthase ClsA
MKIIVDNFFTILLIMNILLSFIIVFRERKETAQTWAWVLVLMFIPVVGFILYIFLGRGIS
KEKIFDLKIQGKIGKNLEIEEDKQALMRGLYPHPPTGQVDVKQLIYMLTVFESTLYTTKN
EITLFTDGREKFDALIEDIKQAEDHIHFQYYIYRSDALGEEVRDALTEAARRGVKVRVLL
DAWGSTQVSSSFFQNLKKAGGEVAFFFPLFVPYINPRINYRNHRKIVVIDGKIGYTGGFN
VGNEYLGLVKKFGYWRDNHLRIYGEAVYTLQNRFLMDWNSQHTKEVGYSPKFFPSIHSTG
DIAVQIVTSGPDTEHEQIKMTYLKMISLAKREILIQTPYYIPDGSIHEALKLALLSGVKV
HIQIPNKPDHLLVYWATYSFAAELIEYGARIETYENGFIHAKTMIIDGGIVSVGSANIDV
RSFRLDFEVNTLVYDERMASRVRKAFFEDSKISTHLTKEMYENRGIIIKMKEGLARLISP
LL
>FECAFAII_02191 Cell division protein FtsX
MDTMIRTFFRHLLESIKSLKRNGWMTVASVSAVTITLTLVGVFMAVIMNATKLAQDIEGN
VDVSVFVDIGTKDEEMKKLEKELNDLDHVKKVEFSSKEQELKKIQNEMGDSWKLFEGDNN
PLYDVYVVSATDPSYTKQVAEEAADLKNVSRSDYGGASSDRIFQIAGAVRTWGLVAAALL
LFVAMFLISNTIRITILSRQREIQIMRLVGAKNGYIRWPFFLEGGWIGLIGAILPILIIT
FGYAWFFQLINPSLLRSHYSLIHPQNIVWKINLLMVGIGVIIGSLGSIISMRRFLKF
>FECAFAII_02192 Cell division ATP-binding protein FtsE
MIEMKDVMKKYSNGTTAIRNLSIVIEQGEFVYVVGPSGAGKSTFIKLMYREEKASKGTLN
VAGHDLIAIKNREVPYLRREIGVVFQDYKLLPRKTVYENVAYAMQVIGRKPRDIKKRVME
VLDLVGLKHKVRVFPSELSGGEQQRVSIARAIVNTPKVLIADEPTGNLDPENSWEIMKLL
DRINAQGTTVVMATHNSTIVNTIRHRVIAIENGRIIRDQAEGEYGYDD
>FECAFAII_02193 Peptide chain release factor 2
MAEPGFWDDSEAAQKVISENNANKETYDQFHSLAEELEEIELMVEMLQEEPDAAMQEEAE
TRINALDEKMKTYELSMLLDGPYDRNNAIVELHPGAGGTESQDWGSMLLRMYTRWAEQHG
YQVETLDYQAGDEAGIKSVTLLIKGHNAFGYLKSEKGVHRLVRISPFDSAKRRHTSFCSV
DVMPELDETIDIEINPDDLKIDTYRASGAGGQHINKTESAVRITHLPTGTVVASQAQRSQ
LKNREQAMGMLKAKLYQLEVEKKEQEAAALRGEQKEIGWGSQIRSYVFHPYSMVKDHRTN
VETGNVQAVMDGDLDLFIDGYLKMHLQ
>FECAFAII_02194 Protein translocase subunit SecA
MANLIRSLIENDKKELKRLDSIAKKVEAYADQMAALTDEQLQAKTAEFKGRYQKGETLDQ
LLPEAFAVVREAAKRVLGLYPHHVQLMGGIVLHDGNIPEMRTGEGKTLTATMPVYLNALT
GEGVHVVTVNEYLATRDSTEMGELYNFLGLTVGLNINSKSSDEKREAYNCDITYSTNNEL
GFDYLRDNMVVYRHQMVQRPLNYAIVDEVDSILIDEARTPLIISGQAEKSTALYTRADNF
VKRLKEEEDYKIDVQSKTISLTEAGIEKAEETFGLDNLYDIENTALTHHLDQALRANYIM
LLDIDYVVQDGKVLIVDQFTGRIMDGRRYSDGLHQAIEAKEGVEIEDETKTMATITFQNY
FRMYKKLAGMTGTAKTEEEEFREIYNIQVYQIPTNRPVIRDDRPDLLYPTLQSKFHAVVQ
DIKDRYRKGQPVLVGTVAVETSELLSDMLNQERIPHEVLNAKNHFKEAEIIMNAGQKGAV
TIATNMAGRGTDIKLGLGVRELGGLAVIGTERHESRRIDNQLRGRAGRQGDPGMSQFYLS
LEDDLMKRFGSERIKSFLDRMKIGEEDAVIQSKMLTKQVESAQKRVEGNNYDTRKNVLQY
DDVMREQREVIYKQRQEVIMEEKSLSKPLMNMVKRTISRVVDAHTQLEKENWNLESIIDF
AGSTLVHEDSITLADIEGKTAQEIKEYLNERAQEVFNTKAAQLNGPEQLLEFEKVVILRV
VDSKWTDHIDAMDQLRQSIGLRAYGQNNPLVEYQTEGYKMFEDMVGAIEYEVTRIFMKAE
IRQNVQREQVSQGTASHSEDGDAKENSNTSAKKQPIHVNKVGRNDPCPCGSGKKYKNCHG
KNAN
>FECAFAII_02195 Ribosome hibernation promotion factor
MFRYNVRGENIEVTEAIRDYVEKKVGKLERYFSDAPDATAHVNLKVYTEKTAKVEVTIPL
PYLVLRAEETSPDLYASIDLVVDKLERQIRKFKTKINRKSRETGMNTADATALFNEEDEN
ENDSELDIVRTKRLSLKPMDSEEAVLQMNMLGHNFFIFEDAETNGTSIVYRRKDGKYGLI
ETD
>FECAFAII_02196 hypothetical protein
MRCSCCSKDIVQNLTFSEIIGVSKYRLPQTCSVCRAQFHLLETRGCSGCQKPIHFNLEST
KKKVKSIPVYCSDCQEWKKKYPTYDFQHRAFFVYDENMKAWLNQYKFMGDIRLAGTFAYK
WTQIKKEYPTYIYCPIPLSEKRRTERGFNQVSEMLKAARIPFQMLLKREKHLLAQAKNTR
KERLEMPQPFELAVTFSKIQNKKILIIDDVYTTGQTLFHAADCLQVAQPKIIRTISLAR
>FECAFAII_02197 ComF operon protein 1
MNHFWGRRLLTRDIKAIDCEEVNLPNYEKIAAVERLGNWILCHRCGMRTSVIDGQLADYG
YFCTHCLYLGRCDTQQDLYLFDQPEAKPREVVFFWTGQLTEKQTEIAKRILCHSEKRHHL
IWAVTGAGKTEMLYPILVETLKAGGRVAICTPRVDVCNELFLRYRYVFPEEKITLLHGNT
ATAYTFTSFVICTIHQLYRFYRSFDLIVIDEIDAFPYNGDAGLAHAVQTAIKPDGRFIYL
SATPDKKLLKEIKQTFDIHKLALRFHRRLLPEPVLVFMNNWRQKCKNKKKIKSLVRIIHQ
LIKENHILLFCPSITMMHRLKATLQEALPRYEITDVSSRDNQRAEKVQKMREAKYDILLT
TMILERGVTFERISVIVLGADHPVFTKSSLVQIAGRADRKGPYTNSQVYFFYEEKTAAIR
KACQEIKEMNEEGKKML
>FECAFAII_02198 PTS system cellobiose-specific EIIB component
MAKKTIMLVCSAGMSTSLLVTKMQKAAEAKGIDSDIFAVSASDADNNLANKDVDVLLLGP
QVRFMKADFEKRLEPKGIPLDVINMADYGMMNGEKVLDQAITLIGE
>FECAFAII_02199 hypothetical protein
MQERMKKYDAITHYLKNNGGSQVTLTFTQFDELLFPSNGLPKTARESTDWWANDYKHPEK
GAYGWINAGYEVVVINLDKEYVVFNKLVKSSWLFD
>FECAFAII_02200 IMPACT family member YigZ
MIERYRTIKENGQSEIEIKKSRFICSLRRIESEDQAKSFIQEIKKEHWKANHNCSAFIIG
EKNEIQRSSDDGEPSGTAGVPMLEVLKKNQLINVAAVVTRYFGGTKLGTGGLIRAYTHAV
SQALSDIGIVEGTLQQEISVMITYPQLGKLQNYLELQHFFIKEIQYTDQVSVICAVDEKS
ADHFKESIIELLNGQVQFEEGPVSYHEQLVTDHI
>FECAFAII_02201 HTH-type transcriptional repressor YvoA
MSNQLPVYIQIHDQLKNEIEQGIWKVGDRLPSERELAVKFNVSRMTLRQAIQNLADEGIL
ERKIGSGTYVAREKVQEKMSGATSFTEIMESQNRVPSSRTISYFLTSPSSSEMEKLNLSK
DDTILRMERIRFADDVPICFEVASVPQKLIDGYSKAEITESLYRTLEEKGGKKIGPANQT
ITAVLASEKIADYLEVKRGDAVLRLRQISYFEDGTPFEYVRTQYVGNRFEFYLEK
>FECAFAII_02202 hypothetical protein
MKWKEKVDEAAEKLYDLVKSEKYNIEVNIPKKGGKAVQVKSKRPTNHTKKWMAKNR
>FECAFAII_02205 hypothetical protein
MMSKKNKDVEVRIEEVKKDIKGKNYEVTQLFIGKKMIGEILAYGPKEYEIFFGEEDFGKE
KSLENAIETVIRHWNLHE
>FECAFAII_02206 Beta-glucoside kinase
MGILVFDFGGSAVKYGCWDGKEIKGKGQFATPESWEEMKAQLFQVYKKILVSFEVEGIGI
SSPGVVNNEKQVIEGISAIPYIHGFNIFRDLETLFQLPVTIENDANCAGMAEFYEGAARD
YQDVAFVVAGTGIGGALFTKGQINKGAHLYGGEFGLMFLNGDKTFSKLGTAVQMAWRYCE
RKGLDKNSYTGKDVFELAETGDAIAKEEVESFYTYLTKGLFSIQFSFDPEVIVLGGGVSA
KEGLIDEIKSRMKKLTEQFDLHDFEPQILLCEYRNDANLVGAAANYLAVRQGEN
>FECAFAII_02207 putative N-acetyltransferase YvbK
MIEELNKKDLPWSLLLDADPDKEKVQVYVSRGSGWIWKEKEKTIGVLIYVAREKEYEIVN
VAVAPTYQGKGIGGKLLETAFQKLSQLASSQTQIIIRTGSTSSAALHLYQKMGYVEIGRV
KDYFIHHYSEPIFENGDQLRDQVILAIHLPKNSFN
>FECAFAII_02208 Putative membrane protein insertion efficiency factor
MKKILIYLVRGYQRFISPAFPPSCRYYPTCSNYMIKAIQTHGALKGTVMGTARILRCHPF
VKGGIDYVPLTFQLTRNKKDKKEPDYKKVVKNTSSTER
>FECAFAII_02209 hypothetical protein
MSNQRYILLTLIKILVVILLLILLFVAGTMIGYGVIGGGNPFKVFQPSLWIHIRDFFH
>FECAFAII_02210 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1
MEEIIVRGGNQLNGTVRIEGAKNAVLPILAASLLAEEGITTLDNVPILSDVFTMNQVIRH
LNVDVDFDEQKNQVTIDASRQLEIEAPYEYVSQMRASIVVMGPLLARNGHAKVAMPGGCA
IGKRPIDLHLKGFQALGAKIIQKNGYIEAIADELIGNTIYLDFPSVGATQNIMMAAVKAK
GTTIIENVAREPEIVDLANILNKMGAQVYGAGTETMCIEGVDHLHAVNHSIVQDRIEAGT
FMVAAAMTQGNVLIADAISEHNRPLISKLIEMGAEIIEEEGGVRVIGPKHILPTDVKTMP
HPGFPTDMQAQMTAIQLVAEGTSVVTETVFENRFQHLEEMRRMNAHVKIDGNVAIMDGNH
ELQGAEVYATDLRAAAALVLAGLKANGITRVRNLNYLDRGYYNFHIKLQQLGADVERVDM
DQTSAEKTAQTIA
>FECAFAII_02211 hypothetical protein
MQVYGIDAVLRIVSHLAFIYLAFWSLRSLRIETFFRPMHNTQIRMAIVLFSIFLGYTASN
FFLEVIALCRNLFVSL
>FECAFAII_02212 ATP synthase epsilon chain
MDQYLTVNVVTPAGLVYDHHAAIVVARTTAGELGILPKHAPIIVPLTIDEVRVKRTDSDT
HVDWIAVNGGIMEVRDNVVSIVADSAERERDIDVSRAERAKQRAERQIEEAKAKQDTNEL
KRATVALHRAINRIKVSKHS
>FECAFAII_02213 ATP synthase subunit beta
MSSGKIVQVIGPVVDVEFSLDQSLPDINNALVVYKNDENKSKVVLEAALELGDGVIRTIA
MESTDGLQRGMEVIDTGKAISVPVGKETLGRVFNVLGDTIDLETPFPEDAERSEIHKKAP
AFDELSTSTEILETGIKVIDLLAPYLKGGKVGLFGGAGVGKTVLIQELIHNIAQEHGGIS
VFTGVGERTREGNDLYYEMKDSGVIEKTAMVFGQMNEPPGARMRVALTGLTIAEYFRDVE
GQDVLLFIDNIFRFTQAGSEVSALLGRMPSAVGYQPTLATEMGQLQERITSTKKGSITSI
QAIYVPADDYTDPAPATAFAHLDATTNLERKLTEQGIYPAVDPLASSSSALAPEIVGEEH
YKVATEVQHVLQRYRELQDIIAILGMDELSDQEKVLVSRARRVQFFLSQNFNVAEQFTGL
PGSYVPVEETVKGFREILEGKYDDLPEEAFRSVGRIEDVVEKAKTLGY
>FECAFAII_02214 ATP synthase gamma chain
MGASLNEIKTRIASTKKTSQITRAMQMVSASKLTKSEASSQKFQVYATKVREIVTHLTAT
QLNDIASENPRGDINYNSMLLSRPVKKTGYIVITADGGLVGGYNSSILKQTMSILEEDHQ
SPDDYVMIAIGGTGADFFKARGINLAYELRNLSDQPSFDEVRKIVNMATTMYQNEVFDEL
YVCYNHHINSLTSQFRVEKMLPISDLDPEEATTFEQEYIFEPSKEEILSQLLPQYAESLI
YGAIVDAKTAEHAAGMTAMKTATDNAANIIDELTVSYNRARQGAITQEITEIVAGASALE
>FECAFAII_02215 ATP synthase subunit alpha
MAIKAEEISALIKEQIENYQNVLSVEEIGTVTYVGDGIARAHGLENAMSGELLEFSNGSY
GMAQNLESNDVGIIILGDFESIREGDKVKRTGKIMEVPVGEALIGRVVNPLGQPIDGLGE
IVTDKARPVEAMAPGVMQRKSVNEPMQTGLKAIDALVPIGRGQRELVIGDRKTGKTSIAI
DTIINQKGQDMICIYVAIGQKDSTVRTQVETLKKYGAMDYTIVVNAGASQPAPLLYIAPY
AGTAMGEEFMYNGKHVLIIFDDLSKQAVAYRELSLLLRRPPGREAYPGDVFYLHSRLLER
AAKLSDDLGGGSMTALPFVETQAGDISAYIPTNVISITDGQIFLESDLFYAGTRPAVDAG
LSVSRVGGSAQIKAMKKVAGTLRLDLASYRELEAFTQFGSDLDAATQAKLNRGRRTVEIL
KQKLHAPLAVEKQVVILYALTHGFLDSIPVDSILDFEHELFEYLDTNHSDIFETIRTTKD
LPEEEALNSAIQEYKDMFLATKGNNSSTEDKLKSIQNA
>FECAFAII_02216 ATP synthase subunit delta
MKLDKYTVGRRYGKALFELAIDSNKAEEIYQDLVSLRQIYEQVPGLGNMLSDVRLEPHEK
REIMDKLVSGYDGIVKNFLEVVYAYNRMDDLLFMIEEYERRYDEHQGLLLGSVTTAVPLS
DEQRIQLEKNVAKTMNYQSVELKQIVDSSIIGGAIVEANHRVIDGSIRTQLENMRNQLNR
>FECAFAII_02217 ATP synthase subunit b
MLNQLAIAEVGNAMLGNVIVVSGSFLILLALLKHFAWGPISDILKKREDKIANDLDSAEQ
SRINSAKMEQEREQQLLASRSDAADIIKNAKESGELSRQNILKDAQEEAARLKSKAQADI
TVERDSALNSVKDDVAELSLQIAEKILNKELSPEMHESLINQYIEGLGSSNETR
>FECAFAII_02218 ATP synthase subunit c
MNYIAAAIAIMGAAIGAGYGNGQVISKTIESMARQPEMSGQFRTTMFIGVALVEAVPILG
VVVALILVFGV
>FECAFAII_02219 ATP synthase subunit a
MDERSLTFHIGPIWFDGTVCIMVLLTCLIVFFLAYFFTRNLKLKPTGKQNAIEWVIDFSR
GIVTDNLPRKELSNFHLLAFTLFLFVFVANNIGLVTKIVLPNETTLWKSPTADPFVTLTL
AFIMILLTHLFGVKKLGFKGYFVNSFLKPYSFMFPMKLIEEFTNLLTLALRLYGNIYAGE
VLLTLIAKMVISLGWFSLPLAIPLEMVWIAFSLFIGSIQAFVFVTLSMVYMSHKIEVEE
>FECAFAII_02220 SsrA-binding protein
MPKGEGKLIAQNKKARHDYSIIDTMEAGMVLQGTEIKSIRNSRINLKDGFIRVRNGEAFL
HNVHISPYEQGNIFNHDPLRTRKLLLHKKQIIRLENELKNTGITVVPLKVYIRNGYAKVL
IGLAKGKKSYDKREDLKRKDIDRQIDRTLKNFSR
>FECAFAII_02221 Ribonuclease R
MTKETIKEKILFFMESSRKRSFSMEEIAEGLGFQKSDDFKLLVQTIAQMEREQSIVFNKK
GKVKLPLKPILIEGTFRANERGFGFVTIDPEEDDIYIPKEATGFAMDGDTVAIDIMKRAN
TDMDRGAEGKVVEIRDRATTQLAGEFVAYSEEEIQETDLYGVVIPKDRKLNQFKVYAAAE
GVRPVDGSIVLIELTHYPEKGYATSLEGIIKQVIGHKNDPGMDILSIVVANGIPTKFPDD
VLSEADEVPDQISEKDITGRRDLRNQLIVTIDGEDAKDLDDAVTVKKLDNGNYFLGVHIA
DVSYYVTQGSQLDREAYERGTSVYLTDRVIPMIPQRLSNGICSLNPHVPRLTMSCEMEID
PNGQVVSHDIFPSVIQTTERMTYTAVNQILEDQDEETMQRYAQLVPMFQEMGELHRILET
MRIKRGAISFEDREAKILVDAEGHPNDIQLRSRGIGERLIESFMLAANETVAEHYNKLNL
PFIYRIHEQPKEEKMQRFFDFASALGILVRGTKGTITPKDLQHVIEGVEDKPEAAVINTM
LLRSMQQARYSEDNFGHYGLAADYYTHFTSPIRRYPDLIVHRLIRSYSEDKSESNQSSWA
TELPEIADHSSKMERRAVETEREVDSMKKAEFMMDKVGEEFDGIISSVVKFGLFIELPNT
VEGLIHINELKQDYFHFVENHLALVGERTGLTFKIGQKVRVKVVKADPDERAVDFELVSA
EEVTALERPKTRNGKSGKREGKQAGKRPERNGKKNKRYSDSKQTFGKKKGKKPFYKGVKK
KKKKK
>FECAFAII_02222 Carboxylesterase
MRRVRQLPKPLYAKHGKRAVLLLHAYSGSPNDVRMLARFLEKADYTVYAPLFKGHGTMEP
YDILQEKAESWWADTKKAIHFLQSEQFSDIAVLGLSMGGIFAVRALEEESVIGGGFFCSP
LSPVKTNVPENFEKYVRQVLKTAGKSEKEINEKAVAYRSLAEQQLMDIQDQAAIVESRLS
DIQQPIFLAQAGKDEMIDPNGVFETARKLSRQRVTLRWYPESGHVITVGTARRELEKDVL
EFLEKLPWNEE
>FECAFAII_02223 putative protein-export membrane protein SecG
MYNLILGIVIVLSIVMVIAIMMQPSKQNSAASAFTGGADQLFGKQKARGFEAVMQRSTAV
MGAIWMILLFVLAYLSSK
>FECAFAII_02224 hypothetical protein
MEIKEEKNRLALFNDEQQEIGEMTWSDAGPDIMIIDHTFVDPAYRGQKLAEKLVYTGVEL
ARRDGKKIIPLCPYAKKEFEKKPEYQDVLRQS
>FECAFAII_02225 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
MVIFYFILILIIIGISYHFLSYFYAKKLVRAGVQRGYDWYEDTGHRLMDPAAVTSVEKKR
QKLEEECESFWEQGTPKTIKSYDGLKLAGQMFIHPNKQNKWVICVHDYRSTGKRDMSHIG
KRYAEKGFNVLVPDLRAHGESEGEIIGMGWLDRLDLIAWIQLILDEQPNASIILHGGSMG
ASTIMMASGEKLPSAVKGFILDSGYVSVYAEFRYMLSKITVFPKKMVMRYANHYAQKYAG
YSLKQASATRQLGSNHLPLLVIHGERDHFVPTEAAYTIQNATAGDKALLLVPEAEHLEAS
MKDPKTYWTVIFSFIEQRITMN
>FECAFAII_02226 Pyrimidine-specific ribonucleoside hydrolase RihB
MRKVIIDCDPGIDDTLALSLAVKSPDIEVVAITVVCGNVPADIGTQNVLKCLERCDRLDI
PVYQGMEKPLKQPFISAQDTHGMDGLGETNFPMILRKQAEPLHAVDFLADYFKEKTNTSV
IALGPLTNIAFALKVNPNIGKHMDRFVSMGGTYKSHGNCSPVAEYNYWCDPEAASYVFEN
LKQTIEMVGLDVTREIVLTPTILEYCCQMNPEEGEYLKAITRFYFDFHWKQERILGCVIN
DPLAVAYFIEGAICEGFKSFTAVETQGISRGQTLVDRYEFWQKPANSKIMTKVDTRLFFR
KFLTVLLNAQEETIMKDLERLKMG
>FECAFAII_02227 hypothetical protein
MNKNKMATRVLTVMALCIGINYIGGTIALWLRLPIYLDSIGTIFAGALLGPVPGMLTGLS
SGILSGVTTDIFSLYYSPIQILTGLLAGLILPRYLGKDKNSLKLLLLALILSVPGTIVSS
IITVQLFGGITSSGSSMIVQLLHGLGLSQTTSVILVQAGTDYLDRLLSIVVVSLVITMLP
QRLIYSKRKIG
>FECAFAII_02228 putative succinyl-diaminopimelate desuccinylase
MKKEEKIAILQEIIRIKSVNGNEGEVAAYLNKLLAKHDITGEIVSYRDGRDNLIARYQKG
QSGKVLGLSGHMDVVAAGDESSWTYAPFAAEIHGNRLYGRGATDMKSGLAAMVIAMIELK
ESGKPFNGTVKLLATVGEEVGELGGEQLTKAGYVDDLDALIIGEPTNYSLMYTHMGSINY
TVTSHGKEAHSSMPDQGYNAINHLNEFITKANAEMNHLAETIENPVLGKTIHNVTLISGG
NQVNSIPSHAQLQGNIRSIPEYPNDKIIALLQSIVNELNQETDYHLELMIDYNKIPVKAD
PDSPLIHCIQQQFSQPLPLVGAAATTDAAEFTKANHSFDFVVFGPGVVTLPHQVDEYVEI
DNYLDMIEKYQGIILSYLA
>FECAFAII_02229 hypothetical protein
MNDSIKKMLRITEKDLMITEVSYETLQKKKTLVVDAVLSPTPRACRSCGSTVVDGNGKAI
IVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKSCQVSLTTVIRTLKEFKSYLPKQSKKILPRVLMVDEFRSHASIED
KMSFICADGETGKLIDVLPTRKLPRLTSYFLGCTNPEEVEFLVTDMNAAYFQLTKRVLPN
AKVVIDRFHIVKHMNQAFNELRIREMNELRKAGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLEFSPPLNELNPKS
>FECAFAII_02230 hypothetical protein
MNLLLSIAQLAKSTYYYWVKKLDKPDKYSKIKQEITAIVKESRNSYGYRRVTLALKMKGY
TINHKTVRKLMSQMGLTCQIRIKRYKSYKGTVGKIAKNVLKRNFSVDTPNKKWVTDVTEF
KIKGRKIYLSPILDLFNGEIISYSISTSPTYKLIEEMLQQAIKKKGTEGSLILHSDQGWQ
YQMPQYQKKLKENNIIQSMSRKGNCLDNSVIENFFGVLKSEFFYREKFRSIEIFQSKLNE
YIRWYNNKRIKLKLNGLSPVEYRKQSIK
>FECAFAII_02231 hypothetical protein
MRKYTFVFKKKVVSDYLNNEGGYKYLAHKYQINRTLVRHWVRIYNYHGWEGLVGGGKSYT
TKFKLDVIEYMETNGLSIQETAKKFNIGSNRTLSKWIEQYEEGGASSLESQKRGRKISMN
SKLNIPKKLKDESLEEEVIRLRAENAYLKKLETLIQEQDLSKKKSRLKQSFSSKKNLN
>FECAFAII_02232 Enolase
MSIITDVYAREILDSRGNPTIEVEVYTESGAFGRGMVPSGASTGEYEAVELRDGDKARYG
GKGVTKAVDNVNNIIAEAIIGYDVRDQMAIDKAMIALDGTPNKGKLGANAILGVSIAVAR
AAADYLEVPLYHYLGGFNTKVLPTPMMNIINGGSHADNSIDFQEFMIMPVGAPTFKEALR
MGAEVFHALASILKARGLATSVGDEGGFAPNLGSNEEGFEVIIEAIEKAGYVPGKDVVLA
MDAASSEFYDKEKGVYVLADSGEGEKTTDEMIKFYEELVSKYPIISIEDGLDENDWDGFK
KLTDVLGDKVQLVGDDLFVTNTQKLSEGIEKGIANSILIKVNQIGTLTETFEAIEMAKEA
GYTAVVSHRSGETEDSTISDIAVATNAGQIKTGSLSRTDRIAKYNQLLRIEDQLGEVAEY
KGLKSFYNLKNK
>FECAFAII_02233 Triosephosphate isomerase
MRKPIIAGNWKMNKTASEAKEFAEAVKNKIPSNDKVDSVIGSPALFLQELMTSAEGTELK
ISAQNCYWENSGAFTGETSPAALADLGVHYVIIGHSERREYFHETDEDINKKAKAIFANG
MTPILCCGESLETYEAGKTAEWIEGQITAGLADLSAEQVSNMVIAYEPIWAIGTGKSADA
QIADEICGVVRQTVEKLYGKEVSEAVRIQYGGSVKPENIAEYMAKENVDGALVGGASLQA
DSFLSLLDAVK
>FECAFAII_02234 Phosphoglycerate kinase
MAKKTVKDIDLKDKKVLVRVDFNVPLKDGVITDGTRIKAALPTINYVLEQGGKAILFSHL
GRVKTEEDKEGKSLAPVAKRLGELLGKEVTFVPETRGEQLEEAIRNMNDGDVVVFENTRF
EDIDGKKESKNDTELGKYWASLGDVFVNDAFGTAHRAHASNVGIASTGIPTVAGFLMEKE
IKFIGEAVEEPKRPMIAILGGAKVSDKIGVIENLIPKADKILIGGGMTYTFYEAKGIKIG
NSLVEADKVELAKELIEKAGDKLVLPIDNVCAPEFSNDVETQVIEGDIPDGLMALDIGPA
SVKLFADTLQGAKTVVWNGPMGVFEMSNFAKGTIGVCEAIANLEGATTIIGGGDSAAAAE
QLGFADKFTHISTGGGASLELLEGKELPGLAAINDK
>FECAFAII_02235 Glyceraldehyde-3-phosphate dehydrogenase
MTVKVGINGFGRIGRLAFRRIQDVDGIEVVAINDLTDAKMLAHLLKYDTTQGRFNGTVEV
HEGSFNVNGKEVKVLANRNPEELPWGELGVDIVLECTGFFTSKSAAEKHLTAGAKRVVIS
APGGNDVPTIVYNTNHETLTGKETVISGASCTTNCLAPMAKTLNDKFGVVEGLMTTIHAY
TGDQMTLDGPHPKGDFRRARAAAANIVPNSTGAAKAIGLVIPELNGKLDGAAQRVPVPTG
SLTELVTVLEKEVTVDEINAAMKEASNESYGYNTDEIVSSDIVGMTYGSLFDATQTKVMT
VGDKQLVKTVAWYDNEMSYTAQLVRTLEYFANL
>FECAFAII_02236 Central glycolytic genes regulator
MLDEIKMIESVAPDIIEVLQERYKILRNIYWMQPIGRRSLSESMGITERVLRTETDLLKN
LNLIDTSKSGMTLTTKGEEVYQSLENFMDQLLGTHQTEQQLAEYFGNQRCIVVSGNSEEQ
TKVADAFGEALSEALDRLLPEGENIIAVMGGTTMAVVAEQLSNLENKKRHNLFVPARGGI
GEAITVQANSVSARMAAKANGNHRALYVPEQLSLATYNSLLNEPSIQEVLNLISEANCVI
HSIGRALHMAARRKMTEKELVMLKQANAVAESFGYFFNEKGEVVYKVPRIGIELQDLEKV
PIIMAIAGGKSKAKAIRAYMKNAPKQTWLITDEAAANEILKGVTL
>FECAFAII_02237 RNA polymerase sigma-54 factor 1
MKFEQNFSQKQQQTQKLAMTQQLQQSIQVLQYNSEELLAFVENQAMENPLVEVVEPEWQP
DYIKASSSSYEGEETNYLNQIPDTKGSLFDSLIEQVHLNYRDTFLRKIVLYLVEYIDLNG
FLTISLEEAGKEIGATPIQMLDALTLIQQLEPAGVGARSLQECLMLQTERDDYAPELAYI
VLEECFEELVERKWKEIAQRFSVDLHAVQQIFDYLQTLSPSPGRIFDRSSELYIIPDVRV
LVDDDKNVQVISNRKNQPNIRFQESYFKQMSQQADKETENYLKERKQEFEWLKKTILQRG
DTILRVAQVIVSRQKAFFIDKERPIKPLTLKEVATEIDVHESTVSRAVNGKYLETDFGVF
ELKKFFTTRIPTNSTEQTEDLSADTAKKKLQELVDQEDKNKPLSDQKLVELLKKDEIAIS
RRTVAKYRDLLGIPSSSKRKRYDN
>FECAFAII_02239 Peptidoglycan-N-acetylglucosamine deacetylase
MKRNYLVISIIALSVLLFFEITSVASLITEVKGQTHSSEHSSQSFKQSEQSTIKSQSTET
ANVKEAIQESAEKVQSQSSQSTQDSTKTSRDPAVKSVAISFDDGPGATTTPQLLRILKEK
NVHATFFVLGENTAQHPEIVKQTAEAGHEIGNHTYDHQNLATLSAQSMTEEVTKADTEIK
KVTGKTPTFVRPPYGSVTNVGATIIQRPIIEWSVDSEDWKTRNPDLILQKIQATVYDGAI
ILFHDIYPETIRAVPQVIDYLKEQGYRITTVGDLLGHPTAVENYYGRNDHRPVQ
>FECAFAII_02240 Anti-sigma-V factor RsiV
MYSQKENLKKLKKTYKEQAIPKGLKEEIRQRFIIEEQSFIKAKRRKRRLQGFGVSLAIVM
ITTSSLLFNSQVRSFAEDLPILGSVIELILGERFTDRSEKIDIQVPKINTQNEKENKTIH
GLNQKYFREGQADFEKAEKEYGNFETDHYQVLGDYQKIVDDNRFLVIERQITQTAADSHV
EKRYDTIDKKNSVQLSLPLLFKDDTYLSVLTKEVKRQMAEQVKEDPSKYYWTEQDIQEGT
IEKPTLVTPTRSFYLNKEHQLVLTFSQYEIAPGYMGTPEFVIPKSVTKTILASEDYLDH
>FECAFAII_02241 RNA polymerase sigma factor SigV
MIFTGYKKKRQIEKYRHLLNGLIETDYQKMFRITMNYVHDKEEALDVMQDSFHKALNYFE
KEKEIEHFSAWFYRILIRTALDSWRRQKRTPVDLFEIQDIPQQLPLETSVAELHMILDKI
DSPEKEILILYFFEGFRLKEIATILDMNENTVKTKMYRSLNALRQILE
>FECAFAII_02242 putative DNA-directed RNA polymerase subunit delta
MEISVFEGANKSELSMIEVAHAILEQRGDVMDFSDLANQIQNYLGKSDSEIRDSLAQFYT
DLNIDGSFISLGDNRWGLRSWYAIDSIDEEVNHGMDEEDEDTPRRRKRKKVNAFINDDED
AIDYNDDDPEDTDLTEEDDDDLFDDDDDEDEEIAAYNSDLQEIGADDPTDDEEDLPGNIE
EDLSIIDEDDDDEDYEEEEFSDSEKE
>FECAFAII_02243 putative beta-barrel protein YwiB
MELSQGTPISIKLRTKVKQQGEVQDFYFDLKGQMVTIGDTLYIRYKEIQEETGDEIPVTI
KLVPDGHVQLIRAGEMRMRLKFGYKERLETSYRTPYGMIQIATFTKELHVSLKDRPTGGK
VRIDYDLFMGPEKIGEYYLTLDFTA
>FECAFAII_02244 Octanoyl-[GcvH]:protein N-octanoyltransferase
MNPAIRLDQHIYQKNDFSPFALTDILTEYSKEHQQIFLHFWQYDCTVILGMKDVRTPFLS
DGIQTLKDAGYAPVIRNSGGLGIVSDEGILNISLIFPQSDTKKITIDDAYEQMLLLTKYA
FPKAPIQAFEITHSYCPGTYDLSIHGKKFAGIAQRRIKNGISVMMYLSVNGNQEKRGQVM
KRFYQSALKEDFGTNGYPAVDPATMATLEELLDQPLFVKEVKEAFAKAFEKLYSASDLQD
STDWLKKEIQLEQWNNQIQRMEQRNNIKELHYDNPL
>FECAFAII_02245 Deoxyguanosinetriphosphate triphosphohydrolase-like protein
MTTPYKYQMLPMEKVFRDPVHNYIHVQHQVILDLINSKEVQRLRRIKQLGTSSFTFHGAE
HSRFTHSLGVYEISRRICDIFSRNFSKEKIGNGGWDDQERLVTLCAALLHDVGHGPYSHT
FEHIFHTNHEAITVEIITSPETEVYQILNRVEEGFPEKVASVIQKTYPNPQVVQMISSQI
DADRMDYLLRDAYFTGTEYGTFDLTRILRVIRPYEGGIAFSMSGMHAVEDYIVSRYQMYV
QVYFHPVSRGMEVILEHLLHRAHELYQEDASSFELHSQLLLPFLDGSFTLEEYLKLDDGV
LGTYFTQWSESADPILNDLAKRFLNRKPLKSATFSGNRDSKLVQELTLLVEKVGYNPVYY
TAVNSSYDLPYDFYRPEQGRHRTQIEILRNDGTLIELSQVSQLVAALAGQEQGDERFFFP
KEMVDPSLRDHYDLFDETYQEFASHIRNGALIEIN
>FECAFAII_02246 Sugar phosphatase YidA
MSIKLVAIDIDGTLLNEKREVTKEVKEAIAAAVAKGVSIVLCTGRPLPGVQEQLNELNLF
QDNDYVITYNGALVQQTKSGKIIARHGLTHEDFLEIEVMARRVGSHLHSIDDKAIYTPNR
DISAYTIHEASLVKMPLKYRTPEEMTPDMNIVKMMMIDEPEILDAAIARLPQTFRDKYTT
VKSAPYYFEVLNKEASKGAAVANLAQHLGIDQDEIMAIGDNENDLSMIEYAGLGVAMGNA
VSLVKEAANVITSSNDEHGVAEAIKKYVL
>FECAFAII_02247 RNA pyrophosphohydrolase
MDKPIFGEKKQFADYQTRYAAYIVIERDQQIAVIEAPNGAFFLPGGEIEGEETKEEAIVR
ELIEEMGIVAEISSYLGEADEYFYSNYRATYYYNPGYFFVADSWKRIGEPTEKTNKIWWV
SPQEALVKLKRGSHRWAVERWIEKNKN
>FECAFAII_02248 Lactoylglutathione lyase
MKMAHTCVRVKDLEASIEFYQKAFGFEESRRRDFPENKFTLVYLTLPGDDYELELTYNYD
HGAYDLGDGYGHIAIAADDLEKLHEQHKAAGLEITDLKGLPGTAPSYYFVIDPDGYKIEV
IRG
>FECAFAII_02249 putative isomerase YddE
MNLDYYVVDAFADEVFKGNPAAVYVLEEWLPEGTMQKIAIENNLSETAFTVKKNQEFELR
WFTPDREIDLCGHATLATAFVLFNYYKIPDETIKFSTQSGNLFVTRIKDYYYMDFPSIMP
KKVPILSEYEEAIGAKIKEAYLARDLFFVLEDEKTVAKLQPDFTAIKNFELGIGVIVTAE
SVQKDFVSRTFFPKLTINEDPVCGSAHSNLIPYWAERMNKTKLSAYQMSSRGGDLECELK
EDRVIIGGKAVLFSKGTSFI
>FECAFAII_02250 Delta(1)-pyrroline-2-carboxylate reductase
MKIINFEEVVASFSFEEAIQVMKKCFFDYESGKISQNPRLVEILPDGKGKNMFAMMPAYL
GENRYFGTKVITAFPDNHQYHLPSHLGEIFLFDAQNGLPKALINANAVTWIRTAAVSALA
TDYLANPHAETLALIGAGQQALSHLTAISTIRPITTVFVYDILEERRNTFIAKAKKQYPK
ITFINAISVEDAVRPAEIICTLTSSKEAFLQKEWVREDAHINAVGTFTPDTREISTSLME
TSQIYVDDYSAALTESGDLLIAMAEGDLEESCIVGTLGELVSEKKTFYKGESRPTIFDAV
GLAIEDLCCAEYIYNKLEKGALK
>FECAFAII_02251 HTH-type transcriptional regulatory protein GabR
MPINSYDNYPLTWRPDKQKLKRPYYRSLIQQLEQDILKNKLQKNTQLPSQRELADYLDLN
FTTVGKAYKYGIEKGLLYTNIGSGTFISPNVFESITISTNEVTEHIIDFGLVSSFEECNK
FVVPFIQSTSNNPNLVGLLNYQDPKGTNFQLTTAANWLKTQGVIPSLESLSIVSGVQNGL
AITLSALFSPGDRIATDRYTYANFIELAQLYHLEIVPIDFDEQGMRPDILIQECRKKKIH
GVFLMPSCNNPIGFQISHKRREQLAEVIEKEGLWVIEDDIHSFLTTYYQHTIIPPFQNLL
PNQTIYLAGMTKFICSGLRVAYLVVPVHVQSKIEQAIFNINVKTSGLDVEVITQILHSNE
ANRILETKLSLTKRANQLFDSLFKVEKPTNRVPYYRILPVDPEIDPKIIENDFLANGIRL
YHSRRFTTRAQPDAFVRISLSSNNLEILASGLSIVKEKIKKYEL
>FECAFAII_02252 Potassium/sodium uptake protein NtpJ
MIKQSKQIKKRLPAVQLLALGFFLLILVGGGLLTLPFFSNSGHGTNFIDALFTATSAVCV
TGLTTLNTAEHWNSAGQFLIMLLIEIGGLGFMMVPILCFALIKKKVSLSTRIILKEALNL
EEVSGVMKLMLYILKLAFVIQLIGTVALSFVFVPEFGWLKGIWYSLFHAISSFCNAGFDL
LGDSLANHQQNVYLIMVVSALIISGGLGFIVWRDLLEYHQKKKMTIHSKIALTVTGTLLL
GGFVVFFFTERNGATLVEGNMFQRLANTFFMSVTPRTAGYYSVDYLHMSHAGLILTMFLM
YIGGTSGSTAGGLKTTTLGVLLIQMRSMLKGRTRAEAFGRTIRQGAVLRALTLFFVTLTL
CVVAIMILSVTETIPKTSGIEYIAFEVFSAFGTVGLTMGLTPDLTAIGKLIIIALMYIGR
VGVLTVVFSLMTKAQRTQSKYKYPEESVMIG
>FECAFAII_02253 V-type sodium ATPase subunit D
MARLNVNPTRMELTRLKKQLTTATRGHKLLKDKQDELMRQFILLIRKNNQLRQEMEESMT
EAMSDFVLANASITEPFIEELFVLPAENVDLSIVDKNIMSVKVPVMNFEYDEQLTDTPLE
YGYLNSSAELDRSIDRFTTLLPKLLELTEIEKTCQLMASEIEKTRRRVNALEYMTIPQLE
ETIYYIRMKLEENERAEVTRLIKVKNMGTTD
>FECAFAII_02254 V-type sodium ATPase subunit B
MIKEYRTIGEVVGPLMAVEKVAGVKYEELIEVRMQNGEIRRGQVLEVQEDKAMVQIFEGT
SGINLRDSSVRFLGHPLELGVSEDMIGRVFDGLGRPKDNGPEILPEKHLDINGEVINPVA
RDYPDEFIQTGISAIDHLNTLVRGQKLPVFSGSGLPHKELAAQIARQATVLDSSDDFAVV
FAAIGITFEEAEFFMEDFRQTGAIDRSVMFMNLANDPAIERIATPRMALTAAEYLAYEKG
MHVLVIMTDMTNYAEALREISAARREVPGRRGYPGYLYTNLATLFERAGRIRGLKGSVTQ
IPILTMPEDDKTHPIPDLTGYITEGQIILTRELYKSGIQPPIDVLPSLSRLKDKGTGPGK
TREDHAATMNQLFAAYAQGKQAKELAVVLGESALSDVDKIYAKFAERFEKEYVNQGFYTN
RSITETLDLGWELLSMLPRTELKRIKDDMLDKYLPEGK
>FECAFAII_02255 V-type sodium ATPase catalytic subunit A
MQIGKIIKVSGPLVMAENMSDASIQDMCLVGDLGVIGEIIEMRGDVASIQVYEETSGIGP
GEPVRSTGEALSVELGPGIISQMFDGIQRPLDTFMEITQSNFLGRGVQLPALDHEKKWWF
EPTVEAGETVSAGDVIGIVEETKVIKHKIMVPNGIKGTIKTIEKGSFTIDETVCVIETEN
GDKNLTMLQKWPVRRSRPIKEKLNPDAPMITGQRVIDTFFPVTKGGAAAVPGPFGAGKTV
VQHQIAKWADVDMVVYVGCGERGNEMTDVLNEFPELIDPNTGESLMERTVLIANTSNMPV
AAREASIYTGITIAEYFRDMGYDVAIMADSTSRWAEALREMSGRLEEMPGDEGYPAYLGS
RLAEYYERSGRVIALGSEGREGSITAISAVSPSGGDISEPVTQNTLRVVKVFWGLDSSLA
QKRHFPSIDWIQSYSLYSTEVGKYMDHILQADWASMVTEGMRILQEEQQLNEIVRLVGID
SLSDNDRLTLEVAKSIREDYLQQNAFDDVDTFTSREKQFKMLKMILTFGEEGRRALSLGA
YLSEIMDGTVSIRERIGRSKYIPETELEKLDQIIGEIKQTMQTIVSEGGMSND
>FECAFAII_02256 V-type sodium ATPase subunit G
MTHKIGVVGDKDSVLPFKLFGFDVRYGTTKQTVRQAIEEMAKNEYGVIYVTEQCAALSPE
TIERYKEQMIPAIVLIPNHQGSLGIGLEEIQKNVEKAVGQNIL
>FECAFAII_02257 V-type sodium ATPase subunit C
MEYHELNPLIRGRELELLSNETFERMIQTNSVEALGEILKSTIYSPYIYDGYEYDFEQNL
LKEQSRLFRWLKESAPEPEIVWIYTMRYTFHNLKVLTKAEMTNQNLDHLYIDDGFYSLET
LKDAIHTQVSNELPESIMDSIREVRDYFEESTILQGIDVIYDRQFLTEQRRLADKLGYQE
LLTEVIAFIDLTNITTMARGILQKRTYGFMTTVLSSSGSIEKEVFLNFVDKDMEDYTNFL
LETDYADFLRPVIREGNLDLVKLEQLKDDYLSSLYQEAQTQAFGPLPLLAFLNAKEVESK
NLRLLVIGKRSHFEPETIRKRVRQVYDA
>FECAFAII_02258 V-type proton ATPase subunit E
MNAIEKIISQMNEAAEQERAALEQEERMKIDQNFEQKRTQIETEHQKQKEKQIELLEKKY
RQLRNRQQVEVRQENLNAKQEFLRRLFADAIAEMENWDESEQIQFIKNSLYSLPLTGKVT
FIAGEKSAAYLSQTLLDEWNNELPFMMVLSDETVADQAGFLINDQGVQYNFLFSSLVQDI
QGTMSFEIANQLFE
>FECAFAII_02259 V-type sodium ATPase subunit K
MMDYLISQNGGMVFAVLAMATATIFSGIGSAKGVGMTGEAAAALTTSQPEKFGQALILQL
LPGTQGLYGFVIAFLIFINLGNDMSVVQGLNFLGASLPIAFTGLFSGIAQGKVAAAGIQI
LAKKPEHATKGIIFAAMVETYAILGFVISFLLVLNA
>FECAFAII_02260 hypothetical protein
MAVTKMEKVTLISDKRNQERILQAVQGIQNVEIRDLYQNRTNNQWVEKYFPDTTIIDKEA
KLSALGNRLKDIQEAIQFIQHHGDSRQKKLHLKRQELSLQDLEANYSEENFMNKLEEVLD
LKEKWEQLTEKRDRLEEEEEWLLHWQQLDIAPSMYASKTTIFEMGTVSAANFESFKEELS
KLDDVYMEEIDYTPKQVYLSYVALKKSVAAIEEIAGKYGFNKETYPYEQNPKEKLQETKQ
QLSIVHEQQKKITTALGQCSGYIQEFEWVEEVTLAVAEREKVKERFIHATYLIVLQGWVD
AEEKQNLMHVLNETVSEEDIYVSFETPNSEEIQQEVPTKLKNHPLIEPFELLTEMYSLPK
YEEVDPTPWMTPFYLVFFGMMVADVGYGLLMLIGTILAQKLFVLPRGMKRFVKFFEILSV
PSIIWGLIYSSFFGQALPKELFGIRLPFPILSTTDDVNTILILSVIFGLIQILVGLFVAA
KENIRRKDYLSAVSDGFAWQGILIGIVIALIGVMLIKNTAFVYLGAGLSIIAALCILIVP
IIQSPSKVKGAAKGAYNLYGLTGYIGDLVSYTRLMALGISGGSIGAAFNMLVAFMPPAAR
FSVGILLIIALHALNMFLTLLSAYVHGARLQYVEFFGKFYTGGGRAFDPLKTAEKYVNIN
HKKKNNK
>FECAFAII_02261 hypothetical protein
MLEALEQIRKAEEENEKRARTLRQQLKTYAEEKEQELEIIQTNSRQQLKQLVEEKEQFEK
QELEKEKMKLKAEADKVQATLKDQYQKHQSQAIGAIIERVKETYGRH
>FECAFAII_02262 Gamma-glutamyl-gamma-aminobutyrate hydrolase PuuD
MKPIIGIAGNQLIRATDTFQGNQVSYTPQGFVDAVLDAQGLPLILPVMSPDSAPQLIEKI
DKLILAGGQDVSPQLYMEDPHPKLTETNIQRDQFEQALILEALKQRKPIFAVCRGLQLLN
VVLEGTLYQDLSLYPKWSVKHEQQPTAPQFATHEVKIVSDSLLSDLLPDSYFVNSYHHQA
VKDLSPLLKAIAFSNDGLIEAVQSKDNMHKILGVQWHPELSHRVDSSEQRLFDFFVNEF
>FECAFAII_02263 Fructose-1,6-bisphosphatase class 3
MDRYLDLLSEKFPTTEDVITEIINLEAILQLPKGTELFLSDIHGEFPAFDHILRIGSGNL
KEKIKDLFSEQMTETEISQFTIFTAYPEYVLTTDWYKKQDKSQLIHRLIDLLRFTTVKYT
RSKVRKGLPKEYSYIIEELLYIDDRINGKKDYVKKIIEQLVLMKEEEKFLTKLAQTIQKS
VIDHLHIVGDIFDRGTQAAKVMDRIMDFSSVDIQWGNHDILWIGAYCGSEACLLTLLRIA
ARYNYLFELEKEYGLNLRPLFSFAHQTYQKNPVFTPKNRKDLSEREQEELEKIHQALSIL
QFKSEHQLLNRRPEFKMDDRKLLEKINYEESTIVLEGQLYELKGTCFQTIQPDDPKKFLE
EEQKVIDSLMYSFQHSLRMQKHMTFLIEKGGMYLTNNQHVLFHGCIPVDEKGQLLAFELD
QSYRGKELLGFFEKQITESAKDLTANEDLATDLIWYAWSGPFSPLFGKSKMATFERYFLT
EPHTHVEKSNPYYHLRDEEWFSEKILAEFDAKEEGSAIINGHTPVKVKKGESPIKANGKA
FVIDGGLSKAYQKTTGIAGYSLLCNSYGFQIVTHYPFLPIEQQFAKKSDQTNVKKVIEQQ
LPRKLNRNTTKGMELQQQITQLQRLLDYRKDD
>FECAFAII_02264 hypothetical protein
MRKFWIITKDVYLKNVKSISFLIMILVPFIMLGIIYVAGNFAQQNSDVNKIGVLADNEQI
SQQMSQVKTDDFEFKAVDSEEKAQKELSEEKIDAYLVVSTENDKINGMLYSENSLGQSTQ
LLIQQQLTGLQSMLRASQLGISPEEVASLSQQASLTRQKVNFDSKGKMTVGEDNSTVQYV
VSYVATIVLFIIILTYAQIIAQEIASEKGTRIMEVILSSTTAQKHFYGKLTGVLLVALTQ
MALYGIIFGIGYSQFKDMEMVKNILDGISLDNLIGPFLWYSLLFMIFGILIFSVLAALCG
SLVNKAEDTAKAILPVTYLSLGGYMLGLILGASDPNNIVIRITSYIPFLSSYIMPVRLAN
ETVGMGGALISLLVLVAVTFLLMILSANMYKSNVLVYSEGGLWSSLKQSISIMRNERKKA
>FECAFAII_02265 ABC transporter ATP-binding protein NatA
MLEVKDLVKTFGNYTAVDHVSFQIPDGKIMGLIGQNGAGKTTTFRLILDFLTQDQGEVLW
NGHHLGEKDYDVIGYLPEERGLYPKVTIQDQLLYFAELRGKSRKEIEPKIDFWMEKFQVK
GKKTDKVKSLSKGNQQKVQLIATLIHEPKLIILDEPFSGLDPVNAELLKDGILELKKHGS
CVIFSSHNMDNVEKICDHLIMLRNGKMVLNGKVHEIRESFGRTKLFLESGLSQQEVEEIE
GVKKVILHEDNTLEITLEDPEAGKEIFTRATQFGYIPMFNQQPPTLEEIFKLKAGEIDA
>FECAFAII_02266 UvrABC system protein C
MNERIKNKLALLPDQPGCYLMKDKNGTIIYVGKAKILKNRVRSYFTGSHNTKTERLVSEI
EDFEYIVTESNIEALLLEINLIKKNDPKYNIMLKDDKTYPFLKITNEKYPRLVITRKVLK
DKALYFGPYPDVGAANETKKILDRLFPLRKCKPSQTKEPCLYYHLGQCLCPYYFDVDPKV
YTKIVDEVKKFLNGGHEKIESEIHQKMEKAAENMEFEKAAEYRDQIRAIETIMTRQKMTN
TDLLDRDVFGYAIDKGWMCVQVFFVRQGKLIERDVSMFPFYNEAEEDFLTYLGQFYQENE
HFIPKEVLIPDTIDKPSVEALLATKVLQPKRGEKKKLVELANKNASVALNERFDLIARKQ
ERTIGAVERLGNAMNIPTPIRIESFDNSNIMGTNPVAAMVVFIDGKPARKEYRKYKIKTV
NGPDDYASMREVIYRRYSRVIREGLPLPDLILIDGGKGQVDVAKDVLENQLGIDIPIAGM
AKNDKHKTNELLFGIDLAVVPLERNSPEFFLLQRIQDEVHRFAITFHRQLRSKNSFASRL
DEIEGLGPKRKKMLLKEFKSLKNITAATTEELQEIGLPKNVAQNVFDKLHQE
>FECAFAII_02267 Thioredoxin
MSQVITDKTFNEETDKGLVLIDFWATWCGPCRMQAPILDQLEQEYDEEEFRIAKMDVDEN
PETPQQFGIMSIPTLMLKKDGQVVEKAVGVHSKEQLRQMIDQYL
>FECAFAII_02268 Endonuclease MutS2
MNNRILETLEFEKVKQMVRQFVVTAQGKEELAELVPVSEKQTITNWLQETEDGLKVQRLR
GGIPIPKLENIRPHMKRIEIGADLNGVELAQVSRVLSTTSELNRFIDDLSDSEIEFARLY
MWADQLVTIPVLSRRLKEAIDEDGRVTDDASPELKSIRQNIRRSEQAVREQLDGIVRGKN
AKYLSDAIITMRNDRYVIPVKQEYRGVFGGVVHDQSASGQTLFIEPKQVVDLNNRLRQYQ
IAERNEIQRILSELSAELVPHRQEIIHNAYVIGKMDLMNAKARFGKEVKAIVPGISEDNH
VVLKQARHPLIDQEKVVSNDITIGKDYQAIVITGPNTGGKTITLKTLGLLQLMGQAGLPI
PAGEESQIGIFEEVFADIGDEQSIEQSLSTFSSHMTNTVDILSKVNEKSLVLFDELGAGT
DPQEGAALAIAILDDLGKKSAYVMATTHYPELKVYGYNRANTINASMEFDVDTLSPTYRL
LIGVPGRSNAFEISSRLGLDTEVIDEAKQLMNDESQDLNEMITDLENRRKMAETEYLEMR
HFVSEAQELHDDLKEAYSYFFEEREKEMEKAKKKANEVVSEAEEKAEKIIADIRKMQQQI
GQGNVKEHQLIDAKTQLANLHQEETLKKNKVLKKAKEQKTLKPGDEVLVTTYGQRGTLLR
KNGNQWQVEIGILKMNVSEDELTPVAPQKEPTQRVIHAVRSESSSHVPNQLDLRGKRYEE
ALSEVDQYLDSAILAGYPQVTIVHGKGTGALRKGITDYLKNHRSVKSFEFAPANQGGNGA
TIVKFK
>FECAFAII_02269 hypothetical protein
MLSLLILFLLLIAFFSGARRGFALQIIFAIGYVLSFIAAQHFYKPLASHLELYIPYPAVT
PTSKLAFFDQVFAFHLDEAFYAGTAFLIILLIGWLLTRFVGVFVHGLTYVPILRQVDWIA
GGILSLIMAYVTIFLILQLLAFVPLDVVQNQFGEHSFARFIVERTPFLTNKMYELWVTNI
LN
>FECAFAII_02270 Cell division protein ZapA
MAHEKTRYKAVIANQTYTIIGRETKHHMDIVTKLINEQLAELKQLSPQMDNEQAAILMAV
NALSDQLKKQERILELEEETAELKKKMIKFTELENRVKRIEAIENEAREVLKENGQADHT
IKNHVEAQQILNEKRKGQIKQKSSN
>FECAFAII_02271 Ribonuclease HIII
MSNVIIKATNDQLSQMKAYYRSYLLNKQIPYTSFAAKKDGTTITAYTSGKVMFQGTNAAI
EADKWGEAQDKQAKPAKTASSLPKNISQLSVLGSDEVGNGSYFGPLTVCAAYVKRDQLAE
LRKLGVRDSKELKDSQIIQLADILKKTIPYKLLVLSPEKYNEIQPKYNAVRMKVALHNQA
IHLLLKKIEPEKPEAILIDQFTPEANFKKYARLEKNQLQEKLYFVTKGEQYHLAVAAASI
ISRASFLEELHKASAEAGITLPSGAGTKSDQVAAKLLEKGGMPMLEKYAKLHFANTEKAL
KLLKK
>FECAFAII_02272 Sporulation-specific N-acetylmuramoyl-L-alanine amidase
MKKIIGAFVFAIIIIIICFQIDVFGQKKIVGQTVSSTNSTVTKTKESFDDTEQETLIKIG
KNDRTLYTDDSLTTPLATINGGELAEFLSETKNAYQIKTNDGYTGYLALEDGTKVTKNIQ
TKPEELSDAVIVLDPGHGGNDTGALSNDEQTEEKDITLSTAIKVKKALEDAGATVYLTHT
TDELVQLGDICDYSEEKKADVFISLHADSTEYANEATGITTYYYYGQEETLAQTIADSFT
DLPLDSRGISTGNYQVLRENLQPSILIEMGYMNNDSDLKELVTDSYQQQIAASLTQALTT
YFQ
>FECAFAII_02273 Biofilm operon icaADBC HTH-type negative transcriptional regulator IcaR
MVHRYNKDTQQKILKEATDLFMSKGYLGTSTREIAQKVGITQPNLYHYFGDKEKLYTAVL
ENHLKDVGKALREIVQTSETGFQVTLTKMAQFLIETHLVDLFLMLHDLESNLSKETRDHL
FFLWKKNYREPFEEIFSANQSVLRNGISKEIAARHFFLVLAPYITRSKRPVEEPLNVAQL
IDLYLNGVLGEA
>FECAFAII_02274 Putative hemin import ATP-binding protein HrtA
MKAIEFKEVEKSFQDGDQVVKALKETTMSIDKGEFVAIIGPSGSGKSTFLTLAGGLQTPS
SGSVFINDQEFSNQKESERVKLRFKEIGFILQASNLVPFLTVKKQLLLVDKIKHEHRQKE
AKELFEQLGVDKLINKYPEELSGGERQRVAIARALYNDPSIILADEPTASLDSEKAREVV
DILAKESKDKNKATIMVTHDTRLIDKCDRIFMMEDGVLKEKE
>FECAFAII_02275 putative ABC transporter permease
MFLALNEIMHSKLRYALVAGVMFLIAYLVFFLTGLAYGLAQDNRTAVDKWEADSIVLSKD
ANSNLGMSMITKKIAEEVEGGKVAYLAQTPGVVTSKDSTEEGKINVSFFGIDKNQFIMPN
LVEGKAFDNDDEAVGDISLKEEYGLAVGDTVKLSGSDKTFKLTGFTDHAKFNVSPVLYTT
INAYQEIRFEKEDTSENARINAIVVRGKISNLPEDLEQIKISKFINELPGYNAQVLTFGF
MIGFLIVIAAIVIGIFIYVLTMQKINIFGVMKAQGITGGFIARSVVAQTFILSFVGILLG
LLGTVGTSLVLPDAVPFQSNWLFFGVISLLMLVVAVLGALFSVRTIVKIDPLKAIG
>FECAFAII_02276 NADH oxidase
MKIVIIGASHAGITAALNLRKLQPKAEVLLIDEDHKDGLGYVSNGINLYLKGKIRSLAEV
AHNMRTLQESGAKLITEWRVTELDPDKHQLILASKEGKNETITYDKLIVATGSSPVTLYK
QIEAENVYTYKNLVQSKQVLAALKEAKEVVIFGAGYIGLELADALRNKGYIIHLVDYMPN
VLSRYFDKDMINSFQNQLQTKQINFYPNEFLIDWKKSEEKVVSVQLLSQAIKADMVIFSA
QTRPNTTLLKEKVALYEDETVIVNEYLQTSDPDIYAIGDIVPVSFDKNKRHLFLPLVTRA
VHMARAVALTLSGQPTAYDLRQKITAAVIIDYFLGTVGLTEDEAPFLEQNTGSCSGEFDL
FPQYDEENKTVNAKLIYHPDTLEIIGGQLISQEFLLSDLNLLADIVKHKTTIPQLAVEDF
GFLSEHTSRFHYLNELAFKVLAKRANSNRVDKRL
>FECAFAII_02277 hypothetical protein
MELFSLLEKNEQRQIKLFQLLLEEKGEISVNNVLTRLSVDRATLKEDLFYLQANLENIKQ
LEIVIQEGNILLIRHGNIAAVDVYYHCYLRYSTKYQILLYLLENGSFDRQKLVMELNISS
ATLSRRVKELNDSLNEFHLKIKSGRLTGPESQICYFYFQLFWFGRPYLENKKEYSDLSGN
TFLDLLQKEFSFTITEEGRLKFEIWLSIMKKRMRCTKKSKPDYSNLPVGLFQTTQFLLDL
HTFLTRYFFQYAFPWNQNETLVFYLFMISNFTLDTHNSHVQEFLISEKYKDDVVAQLNRT
FKQSIEEYFSFYVFPEEISQKIALTVMQNHAHFAYFRGWMNIFGQEGLKQRLTEVEDKQF
LVLCERLVRQTFAIVDFTEVDEENARFELFARYASILRTLIKQLELRLQIAYDLPYERLM
ADIVKEIIQEQLLNTIKYDLVEYEKEKQYDIILTSQLKEYPSQKSAKVFVFTSNEYNYDF
PYLNQFLKECYLEKLNLRMNKT
>FECAFAII_02278 hypothetical protein
MLLQNKFSFFRSFFFTSLFVLSIFIFSPSAEAVGATPPAISYDPYTYENIVPPNGGRSAV
NGGKLVQLTGANQLPKLTATYLNDGSNDPWKGGTVRFHWESHVKLTNVLDLVNITAQGFA
FVAIINLPEHVSSSDVLKAIDWNNAYLYIAGAPIKVTSGSLLSAGSHTLRFGMGSWDTNT
LLADIIAIITRGEFNVDDIPLQFDVTANVAKMTENGDKYDTSPNKILTKGKLQPSMSKKA
VFSVDFYDSNNIIQDRMFNSILAPAAGRFYPKLTGGNLNPGAYAFSASAEINTWNSYIST
SDSTGKYNTFADTTEYVDGNNQNLPGSTNSRTLTMGLTEGRFDQLPFSRFDRVVNYFTGK
NVTQGAILTHTPASTSGLNQTANIVYSGKDAQGGLLSPVALKVLEQYKLDGTVLPTNLTA
DSQWGKLLSSASYQVTANWSATELKKGSIHYRLYSKGTQKLATGWTDQLFQTIQSNNGGV
NTATSTLPALASGQYYFDYRLVDDVLTNMYPSFAYKWQSEQAGITTLPQITVANFPSVSA
DSQLKNLSRQPETGDPLSALSGDTIQENVTFTLTKSGDAITDKKITISLPENTTYINGSL
KLNGTTIADTGIQQGVSVPADLLSKIGDTIHLTYNYQLNTVDTSVQSVSILTKAAVLSSN
ITLADGAKLPNPVVQTSAKTILVPKQELTLVNVPDDFTFGNDLPKPLKTSYYEAKGDFSF
DVRDTRLPSTSPWQLTGTLTSLFKNDQGQELSGTKLYFNHSGSKQLIQQGQNTLIYESDG
TAKGEVLVDFPDTDGLLLEVNSSTNAQPGATYQGMVTWELTAGPTS
>FECAFAII_02279 hypothetical protein
MKTSILLGGIIASLLFFSWQEPVQADTKSSGTITFYDLSPVPHPSGSVNGASKQQTQLPI
YKESNQHGVFPETNEEKIRFLYLIIGIELWLLAWLLLWRRKEKEDEHVATK
>FECAFAII_02280 hypothetical protein
MNQSKRLFVSFFSILSLFFIFPSISQAKDSAGDFGIKPVFPENQIDKAIGYFDLLVAPEQ
NQTLEVIISNSSDEERTFEVSVNPAVTSDGGTIDYSQKNPTLDETLPFDVRDVLLIAKKE
INVSAHAETTIPIEVKIPAKSFKGRVLAGIHVSPKEEAETENATEGAQIKNRIAYNLAVV
LQESQETIEPDLKLLSGDLDEVNAKPTVQLRFQNPQPRIISNLIFTSKIFYENQLYIENT
SNEFLVAPNSNFHLNLDLAGDKAKAGDYRAEIIAKSGDSNEWRFTQNFTIKKEKAQKVNE
NSVFAVQEQSFPWLYAGLVAAVLVLWLILLFLWVHKKKKKGETT
>FECAFAII_02281 hypothetical protein
MKKNMIGTLLLSTLLLGGLATPAFAEGQATSKGDITFTEPTNTVEPLNPTDPSKPVEPAD
PENPATGQTGSLTLDVVPELPFGTHEIESGTKTYQVDASKNDTPYLQVSDRRGVGADGQA
QGWNVTVSVSDFVNGSQVLQGAELDFGTSTVKSTSDNESTGPTSQTVTGLSKASAATPIF
TAAKDQGLGTWLSVYDPANITLKVPKAAAGTFTADLTWNLVAGPVA
>FECAFAII_02282 4-hydroxymandelate oxidase
MEKTYQAGTNEGIVDFINMEDLEIAASQVIPAGGYGYISSGAGDLFTYQENERAFNHRLI
IPHVLRDVELPDTTTHFDEEMLTAPIIMAPVAAHGLAHVKAEKASAKGVADFGTIYTASS
YASCTLEEIREAGGEKAPQWFQFYMSKDNGINLDILEVAKRNGAKAIVLTADATVGGNRE
TDRRNGFTFPLPMPIVQAYQSGVGQTMDAVYKSSKQKLSPKDVEFIAAHSDLPVYVKGVQ
SEEDVYRSLESGAGGIWVSNHGGRQLDGGPAAFDSLQYVAEAVDKRVPIVFDSGVRRGQH
VFKAIASGADLVAIGRPVIYGLSLGGSTGVHQVFDFFKTELEMVMQLAGTQTVEDIKKIK
LRENRFI
>FECAFAII_02283 hypothetical protein
MKEVQLIRKSELSEGGCNACGVVEATSYTLKLDSNQAIISELTVGGLVDSLALAEGFTGE
DIYEMFSEVRQLKKGEKCIEVHHESPNVRFKRGDNEMIFKNHVSDHTELYEIVNQILSGI
FELGPYEFKEENGNPKLNEEWQETIETQRNNPHLFQ
>FECAFAII_02284 Malolactic enzyme
MLTGLNLLNNPFLNKGTAFTKEERAKYGITGMLPSTVQTLEQQSVQAYGQYLSKQTDLEK
RIFLMNLFNTNRTLFYKLMGEHLVEFMPVVYDPVVADSIEQYNEIFLKPQDAAFLSIDEP
ENIKASLKNAADGRDIRLIVVTDAEGILGMGDWGVNGVDIAIGKLMVYTAAAGINPAQVL
PVSIDAGTNNEELLNNPLYLGNRHARVEGETYYEFIDQFVQSATELFPELLLHWEDFGRG
NAAAILEKYEDQITTFNDDIQGTGIVVLAGVLGGLNISGEQLKDQIILTFGAGTAGVGIA
NILLDEMIRQGVPEEEARQHFYQVDKQGLLFEDTEGLTPGQIPFARKRSDFTNADELTNL
EAVVKAIHPTIMIGTSTQPGAFTEEIVKEMAAHTPRPIIMPLSNPTKLAEAKAKDLIEWT
DGKALVGTGIPAADVEYNGVTYQIGQANNALMYPGLGLGLIASTATRVNAEIISQASRAL
GGIVDVTKPGAAILPPVAKITEFSQTIAETVAKSVVAQNLNREEITDIKEAVESAKWVPE
YKSLED
>FECAFAII_02285 Citrate-sodium symporter
MAQKTTTATAVEEKKKEGFWSTKITGVSLPLYLIMVLVLIIAMALGKLPTNMIGPIAVLV
IFGNLFHFIGTKIPIVKSYLGGGSVFAIFASAAIATFGILPEYVVKSTENFVSNMGFWDF
YIAALITGSILGMNRNLLMKASVRFIPVALISMVVSFFAVGLVGMLIGNGFANSVLYISL
PAMAGGVGAGAVPLSTIYANVLGTDASSIISRLIPATAMTNVLAIIGAALVARAGQSMPK
FNGNGKLMEKGDLGDGKPRTVKPSIPQLGVGLMVSLTFFILGQIGNYFVPKVHAYAFMII
IVVICKIANLLPEYYEDAAIMFNNLIVKNLTAAVLAGIGIALLNLNVLASALTWQFVVLC
LTSVIAISVVSGFVGRLFGLYPIESTITAGLCNNSMGGTGNVAVLSAANRMELIAFAQMG
NRLGGAIVLIISGFLMQLLS
>FECAFAII_02286 hypothetical protein
MRLEDAEALREINADQLGYDIPLTVTVRQMKKLLKEPEKNFFLVYEDPTSKKAAGYVQAE
SYESIFSDPMFNIMALAVSKYAEKRGIGKALMTGVEEEAKKRGITTIRLNSAEYRVEAHQ
FYEHIGYHSDKMQKRFLKIL
>FECAFAII_02287 hypothetical protein
MIGLIYFVVIVLANTVGAISGMGGGVLIKPILDLIGAHSVAGISFYSTVAVFTMSIVSTV
RQVSSGKSLNWQIVGWVSSGAVVGGVVGNIVFEVFLQLFENEKHVQLIQIFLTVLTLVFA
FFYTKHHQPKFHLTSWTWYLICGGVLGFLASFLGIGGGPVNVSLLMLMFALPIKEATLYS
LSTIFFSQLAKLVTIALTSSFMRFDLSMLFYVIPAAVIGGLWGARFSRVLSPKKVTFIFQ
VIVLVVLLVNCYNAFVILQTLGESRLTQVKITETYCSK
>FECAFAII_02288 hypothetical protein
MDKAEFTNFYWKYYLHLENEFINTTDFVMLDENNFKTFSIEYQKLLLAIGSECEIIFKEL
CGFDSSSNKSITDFKAVIKSSELMCLDNGVRVMNSLTLTSLKPFGDGWPEDTPDWWKIYN
RVKHGRSSNYKEANLENVLYALASLYLLEEYLHKKVILEGEVDFISPESNLFTLSWERKH
SSMQKVTFEKVDSNYVAPLIDFKEQEEI
>FECAFAII_02289 hypothetical protein
MPIIKNVNELTERVKFKKTKRVKDEDGQMVDSEETVFECWANVRSQMLKDVLASVGTILE
GTLTFIIRYDQDYELTNDMKVAWKNKSYKIISINEGTAFKDYTTIIAKQIS
>FECAFAII_02290 hypothetical protein
MVILDSIKKSMRIDHTIDDDFIQQLIDTAGEYIKSAIDSSATDKDMDNYQQFDLAVSLLT
QHWYLNRQEASSERIPVTVQALVQQMRGAYYANH
>FECAFAII_02291 hypothetical protein
MNNEEEKEKRLTEEAELTADSPKVEKENEKQPTDGKTISGYALKFGQPSKDLGGFVEVIT
PEALKEVDLSNVFLLYGHDYSKPLASVKAGTLKLNVDDTGLHFEAELTDTTYSNDVYENI
SKGVVDSMSFGFVLGLDSFDKKEDGTIERSIDKIKALNEISVVTVPAYDSSNVQVNKRSY
ESFMSNNQAKQTNNSLESTSKAQKESNNMEKTLIDNEKTELRGYEEYIRSQGEVRDGVTT
VNAAAVVPEEVIGEVFDLKRSNYNLAQYATVKTVSNGQGKYPVATNQQAVLATKAELAEI
GDIDAEMFTSVDYKVETRAGKIALSNEVVEDSAVNIVQEVKDQLAKLVENTDNKHIMDLL
KTFTKKTAATLDDLKQLYNVALDPALNKMVILNQSGYYHLDTLKDSDGRYILQPDVTAPS
GKSLFGMPVVLIADTLFANPKAGTFPMIMGDIAQSIFVARRNQVTTQWEKFDYYSQGLAV
IVRNDYKKIDQNASVYIEFTPVVTPKV
>FECAFAII_02292 hypothetical protein
MAFFKARQNTTGDPFLQHVVSIQSDDYTTSFTSVRALRNSDVFAAVRIIASDIASSPIQL
VKNNMPQADNELVKLLNEKPNSEMDGWHLKFALAVNMLLNGNSFAEIKRNGEKVEEIHLL
PNSSVTVTQLDNGTLSYQIGDKKRRVKSSDILHFKYFTQDGLTGLPPLYALRDELKIQQA
GNRTLHNFFTRGVSGSGILKVHKSDLDGSAKNAIREKFEEANGSSSGDNALRTIILDETM
DYKTLEINTDVLKLINSNDWNTKQIAKAFGVPIERLGVENEHSSTVQSNLQYIQSTLIHY
FNVFVSELDTKLETNIRFNSDQLLETDPETKVKNVLDQVKGSLLTINEGRSKMGLPPMDG
GDRLLASLNFTYLDTLEKYQLKEQEGVTPVE
>FECAFAII_02293 hypothetical protein
MNFIQVKNFLSNYIHTVLLLLGLVCVLVAITLLTNVYYGLLALGIVLIGVAVMLNTEQKG
G
>FECAFAII_02294 hypothetical protein
MNDYIEKVLSGKLIAPKKIIQACERHISDLERSKSDSFPYVFDEEQATKAIKFIELLPST
DGKAIKMLGFQKFILGSLYGWRTKEGNYRRFNRAFTSMSRKNGKTYIASGMAANALIMEQ
EPAEARQVLFVSNALKQAKLGYDMLSNSLRNVVKSSKFLRPQLKIMNSKIQHLPSNSFAM
ALASETSTLDGFAPTTAILDEWHEAKTRKTYNVIKSGMTQQKNGLLCVISTAGLDLNVPM
YEEYLLLDRVLKGEEQADRYFIAIWELDDPEEIHDQEKWIKANPIFESEEIKKVMIPTIQ
DDVNLALKQNNLNSVLVKNFNLWRQASEDSYMIAEDWQATEVEPQDITGKPVYIGVDLSK
TDDLTSVSWIVPLDNGELYCDSHSFVATKYGLQDKEKRDGLPYRELEKAGECSITQLESG
IVDYDQVFQFIQDLIQENDLECMGICYDPYNANSLISKAEKANYPMLEVRQGTITLNVPT
RTFREQVYEGNVIHNKNTILTHAVNNAILKTDNNGIQINKSKNSNKIDPIAALINAYVFA
MDYFTTTEGAKADNEFYTSEEFSF
>FECAFAII_02295 hypothetical protein
MGHPKILHDTKGNISSEEKAIRVDAREELFKQQPLINITPPDWMAASARSEWNRIVPTLK
KDYPLSEADYGSLVAYCLAFARMKTAEAEIRKSGTFITCENGVKKANPAVRVQSQAMSDL
KKQATSLGMTLESRSKLALNKVKNDEPEDPFKELMNS
>FECAFAII_02296 hypothetical protein
MHMESIRYFDGEKHIEYSNTQEDVDFISFEEDKITKVNFKDGTCLKIVSPYIEYKSKWEQ
DDSDERDRFGW
>FECAFAII_02297 hypothetical protein
MLNIISTNKAPNFQYTDEMDRFLMNTLAFSVGLVTEDYSTFDPEVLKIMEEEPDWLQESV
AWCQSLVVGSLVDSGNYDDTGELMDEFNCLLNLYDRARQRELTSNEDNLFLNIHDKFLAL
LLTDDELITNLLEVE
>FECAFAII_02298 hypothetical protein
MAHKHKLDSILDFPEASEREDNIIELKTWMSRLRCNKDDQIKSNSVVNAELILTNDSNLA
GTIAYNEFSGYIHLLKDSPWINRTAGEWEDSFEDALTAYIEENYNVVFDDNKIHKAVVNV
ARKNVFNPVKERIEKVKWDQQPRLETLFIDLLGVDDNLYTREVTKRWIVGSVARIYKPGI
KFEIVPVLDGPQGIGKSTVPALLYTDDFFTDSLDSLGEKKDDYMQLQGNVIIELGELSSM
NKTKIEQIKNFISAKIDKIRPPYGRNVIAWARQCVFIGTSNDGQYLKDDTGNRRFYPLPC
KNKPKMNPFKTKDEYFLQVLAEAKVLFDKGQRIYFSPDEDKEVLEIAKDYQEDAKMENPI
KEAITKYLEMEIPYKWEEAPAWARRSYYQNYPDSKCNEKNLQHFYNGATMQQEFYLVDSV
LTADILEAVFDKQAKDLLNGRSDAETKKIALIISSIPGWERKQLPKRNKRRGFYNKSNAY
ENKNRAGKYKK
>FECAFAII_02299 hypothetical protein
MANNYQAATELQKSGWSIYPLSPGTKIPIKGSSGWNDATNDSNQINEWWTEDATRNIGLM
LEDHQMVVVDLDQHSETRNGVENYKKLASMYDPFPSTYTEITPGKGIHFFFKIPDGVIIQ
QETGAFADIFGRDDKGKSLSGIDIITKGVPIAPTMIISRSVGRAYEPIENVSLNNIAPAP
DWLVNLLLKKPQEIKTQYRPVAKTGTAKKLDMIVQGAGEGSRNDHLTKLCGWLLWHGVDN
QTLAELIYTANAYNEPPLKDKEVNQIIRSMIKKDLRGKAHGS
>FECAFAII_02300 hypothetical protein
MYKTKLLNQLDSLELEEINQGIAELENNIGKTYFGNSFNEKLTVLYVLKKHAEHKIICRE
INELKNQILTAWLNITDMQEARVKTFNTWVKYQNQLKGAEFVRDGLKYELEQLKLMEVSE
>FECAFAII_02301 hypothetical protein
MKRNLIIGSILIGGIFGLLPLIAKIAIFAGLALYLFTAYDEYDYQLRTGGHK
>FECAFAII_02302 hypothetical protein
MAFKSRKKEAEAFQDWIFDIIKELRQSTGLEGFQVFRMLDKEHQKEAMTKLSHAITEPKP
VDYIKANVIANKAVSTIYGHSKMVKKKDMTPEMLVDREPILDETVELMTVKEKYGLQFSV
SEKIYNRSAELQTT
>FECAFAII_02303 hypothetical protein
MKTEIWNGHIIRFVDINDEWWAVAKDVAEALGLKQVTRAIHSLPKDGVTTSKVIDSLGRT
QDVNIINEKKYLPHGIQKP
>FECAFAII_02304 hypothetical protein
MESTQNKAIEKVLSTILTEDTAAELANLEGKALEETFECLYEQMDYQKLLPQEPTVSGVL
RGLNDLVQAEFKERLSIEEYQEILYQQVELLASLLGLELEDVE
>FECAFAII_02305 hypothetical protein
MELKIDKLTLDDPAFKIIDDRVVQQVEQTQGTLLSLLEKKYQFPKYMNKAQAAKYMNVSY
NTMMQKYVPNGLKLIIVDGVVRISQDECDRFMEEYQK
>FECAFAII_02306 hypothetical protein
MNGGENVARKKYPEAVETGQRIRLARIEKGLSMEQLGGKLSPPASKGAVSNWENGYNLPN
NTRLKQLSKVLDVSTTYLLNGSYTLRDMHMMPEIKRNVLEKQLKKTIEKNNSIIDSNLSN
AINNIEEDNLTVSQKIYLTNAIKYLKTGSRIEFPDGSTPIAYLAALLNTLLRYDSLINDS
EKNTDEKKEYQEFYENDLLKEFTALVTELNKHYSK
>FECAFAII_02307 Transposase from transposon Tn916
MATFKQYETKKGKFWLYEAYLGMNKMTGKPDKVRRRGYKTKKEAQLALSRLQVDYDKNGI
KKANNETFKEVYDLWLETYKTTVREATFMKTEIKFRKWILPKYGNLRVNEVTVKKAQQIV
NSWAETTDQYKVLHSTSKRIFSYAINLGIIETNPLDNVLMPKRTTTKHKEKVKVYSKEQL
ITLFDYLNSKPETYRNDFDKTLLRFLFYSGVRISEALALNWSDIDFQENTVTINKTLSQS
KNGYKISDPKTDCSAGVLPLDERTISILKKWQINQRKYMLTLGVTDPTMIFCGIYKELIT
HHAIYARLITICEKAMVPFLGVHVARHTHASMLLDAGATMVEVQTRLRHTKISQTIDCYG
HLAKETKEKTVEKLVQHLNID
>FECAFAII_02308 hypothetical protein
MTEHNHSHDHEGHEHITLVDDQGNETLYEILLTVDGQEEFGRNYVLLYPAGVSEDEDVEL
QAYAYIENEDGTEGELEQIETDAEWDMIEEVFNTFMAEEEE
>FECAFAII_02309 Putative pre-16S rRNA nuclease
MRVMGLDVGSKTVGVAISDPFGWTAQGVEIIRINEAEEEFGFDRLKELVAQYEVDRFVVG
LPKNMNNSIGPRAEASMSYGEKIKELFSLPVDYQDERLTTVQAERMLVEQANTSRAKRKK
VIDKLAAVMILQNYLDGSGKQLF
>FECAFAII_02310 hypothetical protein
MGFTDETVRFGFDDSRKKEVSETLAIVYRALEEKGYNPINQIVGYLLSGDPAYIPRYRDA
RNLIRRHERDEIMEVIVKDYLSNHGVNL
>FECAFAII_02311 DNA-entry nuclease
MSKKTTKAIVGIVAAVIAGAFGVSTTQKDSDIFQQITTIFDSTPQASQVADVPEYDGKHQ
EIEINGNQPEFTKEDLSLSKGTWESYSNIDKLNRVGQANAMLGKDLFPTEKREPLYIDPT
GWKQKKLSDGQWLYNRSHLIGFQLTGQNNNIKNLMTGTRSLNAPYMLAHENDIAAYIKET
NHHVRYRVTPHFEGNELVARGVQLEAESIEDKKIEFNVFIYNVQDGYTINYETGQATKTK
N
>FECAFAII_02313 hypothetical protein
MTGKELDLLLDTCLLAGKIMMESNAEMYRVEDTMSRIALASGNFRLVSYVTQTGLFIGLD
RTSTIRMEQITNRSINLEKVVKVNDLSRKYVASELTLEELYCELQAIDRDRSFFPVWLQI
VSAAVISGTIMVLFGGKMTDLPVTLVIGGLGYAAYLYSLKFFRIKFLSEFLSSLLIGIAA
IYSVRFGLGSNQDLIIIGCVMPLVPGVQITNAIRDLLAGHYVSGVSRGTEAMMTATMIGF
AIAFIFQLFY
>FECAFAII_02314 hypothetical protein
MGTIFIQFSFSFLATAAFAVITNVPRRSLICCGLSGAFGWMIYWICVQIGGSAAFGSLLG
SLGVAFISDLFSKRLKMPVTIFNIPGMVPLVPGGLAYQAVRNLVTESYREAAHYAVQAIM
IAGAIALGLVLSEVFNHNIRNFKVKRDAIMMKRKKRLFK
>FECAFAII_02315 hypothetical protein
MYKRQLLELIRVNLLYVNPQLTNKAREKGKKGKRLTIYLLSQNLFSGLIFLLIYGFAMFA
MNFVKLPGFFTYYVALFGMLGLTQSISVIYNIFFEGNDLQVFLPLPFGQEQVFSAKILVV
ALTIIPFVFPLLVMFILTGWRADLGILLTIIISILLFSLFLIILFCLASLIVFGLARTAV
FKKHRKTVSSILLGSSMLIAFAGIMWMNHQTGTIENELTDRHPISILLPFYDAASQPLSQ
QGLLGWGILAITALGFFLAVKQLIVPKLTEQLTDSNSEFKIKRTHKKNQNVHQLLFSYNA
QLVKEPNLIMQVLSSSLLTPIIFILAFALGGEIKLTDLDNKLIGVVFLVGIALAFLTVNQ
TSFISNLISLDQENFLFIRSLPISMNQYLKEKFRFGWILQSFLTGGIALLSGLSFQLPLF
FIPSLLFGSLFGCYLLSLRYFARDYRLLLLNWTNINQLFNRGSGSLGLVATMMGSLIISI
ILIVLYGMLALFYPFWLVNIPVIGLVLILSALWIVYYQRTFWKKFE
>FECAFAII_02316 ABC transporter ATP-binding protein NatA
MIEFINVSKSYGKKQALKDLSLSIRQGEIFGFLGHNGAGKSTTIKSLVSIIEPSSGTILV
DGMKLTENRLSIKQKIGYVPDSPDIFLQLTAGEYWDLISAAYELDTQKKEKRLAELTALF
DMYSHQNETIASFSHGMRQKTILIGTLLPDPDIWVLDEPLQGLDPQAAFDLKEMMKAHAA
KGKTVIFSTHVLDTAQQLCDKLAILKKGELIYQGAVSELLNGSPDETLEKIYLKMAGRQA
TGDGPYV
>FECAFAII_02317 Accessory gene regulator A
MVTRIFILDDSLVFEKMLVEILEESRILLSPWKFEIVQGLNVIQFVEFIKNNEIYSSDIF
FLDIDLNAYYSGIELGEMLREKNEKCKIVYLTSHPNKAITVINRKITPSGYLIKEFTYEK
NKKSIQSYLLKEKENYPVQHATKKRWTTVRYGNSDHYIHYDEILYLMSMPGYKNKIGLVL
KDEEILVNGTIKKYKKSLEYEYLCKDLKAYIINTENITSISRVNEIVTFANGEQLEMGKR
SIDKLKNFMQEKIENESF
>FECAFAII_02318 Putative two-component membrane permease complex subunit SMU_746c
MLRFLILSGYFELMMYLQVSGKLDQYINVHYRYLAILSMILSALLALVQLYLWVKNGKAE
EKAHEHDHDHGLSKPYQRGIAYVLLALPVIVGTLFPTVSLDTTIVEAKGFNFPVSKESVG
DPEMQTQYLKPDTSIYFNKSDYLDQMNELKEKYGDKQTIKITDENYLEVMELIYNYPSEF
IGKKISYEGFVYQTPNDSNTDIFLFRFGIIHCVADSGVFGLLTHMPEGVTVKNDEWYKIE
GTIQSDYYQPFKREIPSVVVTNAEKVSAPKNQYVYRSF
>FECAFAII_02319 Putative two-component membrane permease complex subunit SMU_747c
MFSFIPNSVLQMSTIFLSIVIEALPFVLLGCLISGALQVFLTPERVKRWLPENRIFSIFT
GSILGFFFPSCECGIVPIVHQFVKKGVPVHTAFAFMLTAPIINPIVIFSTFIAFGNSWQM
ASWRVIGSFFVALVIGVWLAYFQKDAVLKEKITSKVAENHHHHVHEEEQSEKNEPKNQLI
HQTGHVLTHSIDEFFDTGRYLIIGGLIAAAMQTYLPTRIMLTLGSTKILAIIIMLLLAFT
MSLCSEADAFIGSSLLSLFGTAPVAAFLVFGPMVDIKNLLMMKRYFTGRFILSLIGLIAL
SVIGFTLFI
>FECAFAII_02320 Thioredoxin
MKQTTNLTEVQDILQQSSVAVIYLSMPNCSVCHAVRPRLEELLTHYDIPALHLDAFETPE
VASKFEVLTAPVVLIFHQGKEVFRQARFIDFKKIRYLLDELTAEDDSLSYEEIFRTK
>FECAFAII_02321 Redox-sensing transcriptional repressor Rex
MKDHIIPKATAKRLPLYYRYLRILNNAGKKKVSSTELSEAVQVDSATIRRDFSYFGELGK
RGYGYDVEDLMHFFAKTLNDDQLTNVALIGVGNLGSALLKYKFHQSNSIRISCAFDVNEE
IVGRIVDGIPVYPMEDMSEQIKIQQIEVAILTIPAERAQEVVNQLTEAGIKGILNFTAAR
LNAPSDVLIQNVDLTNELQTLIYFLHSDANAHSENTAE
>FECAFAII_02322 putative ABC transporter ATP-binding protein YheS
MILLQANQIARHFGAEVLFENIHLEISTGARVALVGRNGAGKSTLLKIIAGIEAPDEGKI
AKNKTATLGYLAQDTGLDSNETVWNEMLKAFEQVRQMEERMRELEIFISEGTPDTPAYSS
YLKEYDRLQHDFSDRNGYGYENEIRSVLHGFKFDSSFYDQKIDTLSGGQRTRLALARMLL
QHPDILILDEPTNHLDIETLSWLENYLQSYTGALLIVSHDRYFLDKVVNEVYELSRRKMR
HYKGNYSKYLDLKAEQLASEWKAYEKQQTEIHKLEDFVARNLVRASTTKRAQSRRKTLEK
MDRLDRPQGDEKQANFLFSIEKPSGNVVLQIEDAAIGYNNVTLSEPINLDIRRQEAIALV
GPNGIGKSTLLKSIIHQIPFIRGKETLGTNVTIGYYDQGQADLHTNKTILAELWDEHPTT
PEKEIRSALGAFLFSGEDVEKPIPLLSGGEKARVALAKLAMNKENFLILDEPTNHLDIDN
KEVLENALIDYDGTLLFVSHDRYFINRIATKVVELSENGSKVYLGDYDYYLEKKQEEEEI
AELLAQDEPESAPAPTNKSDYYQSKEQQKLIRSLQRKITQVEEEMARIDEWIDQLEQEMV
APENLEDHVKLNELNQDLEAARQDQETKLTEWEELSLELEEYEN
>FECAFAII_02323 Unsaturated chondroitin disaccharide hydrolase
MLDKVMFEEIIHPEKWINECYKELMEKEWNNEIERCRRHTERLIKRISNSQYQFPSECPI
KGRYPLRDNIGWTEGFWTGINWLLFEKTGDPLFQQTAEKADIDFIHRIDCQIITNHHDLG
FLYSLSTVADYKITGNRKMKEASIDAAETLLQRFWEKAGVIQAWGDPSDPSQQGRMIMDC
CMNLPLLYWASEETGNQKYKKAAQAHIQNAADYLVREDGSTYHTFYMDVKDGKPRYGSTH
QGYSDNSCWARGQAWGIYGFALSYRYLKEQKYFDLSKILANYFMNRLPEDTICYWDLIFD
DSSREEKDTSSMVIMVCGLLELIESGLLDKTEKNLYQSAVWKIMRQLKERYATTEEEDGF
LTQSVYNKPKNNGVNTPCIWGDYYYLEALVRMTSNWSSYW
>FECAFAII_02324 hypothetical protein
MKHPVPLLRTRQDYFDLFKKINQPLQPFYRASGAQIDYIHQGVGYGNKIAGMEGFSRVLW
GAGPAIDQLDERWLKLILSGIKAGTDPSHPDYWGEIHERDQRMVEMPAMLLALYHHEQLL
WKKLDTGEKSQIIHWFSQIFEYECADGNWQFFKIIVGTIIQKFGYPVKESALKEAFDNIE
NCYLQNGWYRDSSRGRQDYYNPFAFHYYGLIYSVLEPEKPISQIYKNRAIDFSRDYIHFF
AEDGANVPFGRSMIYRFAVSSFWSAMLWADLLPFKLGEIKGLVNRNIRWWMQKEIFDEKG
ILNIGYTYPQLTLTEPYNSTLSPLWLNKIFLLLALPEDHEYWTAKEMPMPIREGTKLLSE
ANLLIQHDNGHTFFLNAGQLGPNFHTLTNEKYLKFAYSSQFGFSIPRANQLKAEMAMDSM
LGIQRADTYITTSFKNESIKTYGQFIVRNNVRDIVCKKEVLASTWEPTLQAKIRTWLIPF
EGWQIRVHKVELDTEYVLYETGFAIECSPEKEGIIIEEDKENYRVSEAGFSGIICLSDDT
IKRKSTAIMGLPNTNLMTWENTFIPGLEGTFGKGTHWLGTGVVAHQDRDYSLEVWNNRPK
IDFDGTTGLTIQNKNNKKRLKLC
>FECAFAII_02325 Unsaturated glucuronyl hydrolase
MNEQTKEWSRKILNVASEKIDAELDRMGNKIPYISYNGKYTDVIKDRGIDWWTNGFWSGI
LWQLFHKTKREKFKEAAIQQEQLLESALYHFSDVHHDVGFLFLPSAIAHYQQSQNKHSRQ
LGLHAATVLAGRYNISGNYLVAWNDHKPGWMIIDSMMNLPLLYWASRETGDPRFSKIARQ
HADTTAKYLVRKDGSTGHIAEFDAESGKYIRLLGGQGYNENSCWSRGNAWALYGFALSYR
YTKNPYYLAIAEKIAVNFIQKIEKTGYIPLIDFAVKDSNIDTSAGVCAACGLLELAGYVS
SVRSKMYHEAAINILQKTEKHYANWNMDEDGIIGGGAEAYHRELTYNVPLIYSDYFFIEG
LLRLEQSELAIW
>FECAFAII_02326 Lactose transport system permease protein LacG
MTKQKIQSRIFTYVIIVFGALIFLMPYLYMIVASTQSNQEILSGGINFKFGDMLLKNWQA
IMARYNYPLIIWNSIVIAVISTVLATASSTMAGYALAKYRFMGNKLLFNTVMLSRMVPFF
TTLIPLFYIMSRLGLSNTYAGVIIPSIASTTSVFMMRQYSSQFPTALMEAARIDGANEWV
IFTKIAVPILSPTIITSGLLIFMGSWNQYLFPLVMLSDKDKYTVPLIIKNMTVSSTGEPI
NYGAIMLILATSVIPMVLIYVWAQSKFKENDIGAANK
>FECAFAII_02327 Lactose transport system permease protein LacF
MMQSSLPSKTIKNSKKKATDTSHKKSAYGLVTPFVIFFIVTILIPIIISFAFSFMKIGYS
FEFVGFDNYLAIFRDPLFIKSYTNVLIIMAGSIPITMLLAIYFAVLLNSAQLKGKGFFRT
VYYIPTITSTVAVASVFMTFFNPTGLFNGFLNALGINGVQWLTNPFWIRISMIITMIWLS
VGYNTILFLAGLQGISKEIYESAEIDGASKFRQFFLLTIPMLKPIILMATVLATINGLGN
FNIPNIFFGTSNGPENSALVVGVNLYKTSFEMVDFGKASAIAWTMVFVSVILSAIQFKFG
GDKND
>FECAFAII_02328 putative arabinose-binding protein
MKKRYKLVIALLNITLLFSLSACGKTNEEVTANIADPMIKKATTLEVYVANGKLTNYVEN
AAKIYNRKTGANIDLKIVNVASGTATVQMITPKLVTHEDMPDIISMADTSAAGVLEKFQD
AFYSADEYGFYDKYGDQFYDQKLNILRQQTSNETIIPWASDFTPALCYYQPKKFAEIGVD
FEEISSWEEYIQVAKALKEKTGSFGIALPESGDQELFINMLAQQNQSLLDEEGNIRLNTK
EAKHAAKLIKEMIDSDIVHFYGAQDAEKAFQESAMFVAGGWYATNMSLNFPDASDKWRMA
PLIPFSKENPGKGAVSGGSSFYVPKDAKNPQVAQQFLTFMLTDEECLANALELGVATSNS
LAYQTEAAEKKFDY
>FECAFAII_02329 Bifunctional transcriptional activator/DNA repair enzyme AdaA
MLTNNQSSNLVKKTLTYSIDTHLHLSAAPYFRLLINESANLYAEFAHKSIELDNPSLLFI
DKQQEVQIFSTQKETQTFIIIQFYFDEQLLAHITGQSFSIDQEITSIITFLKNEQFKIDY
LKHSKPAISYDQEINSFFILCQQMSIHLLSLLVTYCLQKIQLSSLPRHYQQELALLTIPS
NEKVIPKKKHILYSDELVDPIIRYLEEHLSENFLLEQLAQIFFISPASLKKHFRKVNGKS
VISYFKELKMEKAKRLVLENELTYTEIADILGFHSIHHFSSAFKKYTGLSPSKYYLSLK
>FECAFAII_02330 Coenzyme A disulfide reductase
MKVVVIGGVAGGPSFATRFRRLNEAHEIIIYERGENISYASCALPYYLGGVITDRDSLIE
RTPEILKTKNNIDVFTKHEVTAIDPSTKRLTVKDLSTNEEIKTDYDKLIISSGARPDYPD
IPGVFEAENGFVLRSVTDADRIKSFLEEKNPQHVVILGAGVMGLELAENFKHRGLDVTLI
DQLPQVAFPYDPEIANLVYDKLLKEGLAVHLETRVTEIRDKGREIVLSDGSVLSADMLIF
AVGVSPKNEVVKATGIQLSDTGQIIVDDQLQTNLPDIYAIGDIIETTSVVTGQPIQSMLS
SAANRQGHMLADILNGTPMRYRGYIGAGVAKIFDHTASYAGMTEHELKASGITNYKTVFI
TPFDHAYFYPEATRLNLKLIFDADSGRILGGQAFGEKGVDKRMGELSVAITGNLTVFDLP
DLELPYSPPYSTTRDPLNIAGYVAINQMTNIVETIKASDIPENDLKEAFFLDIREPNKAP
SGSISATKNIPMNELRDRINEIPKDKKVYITFRRGLNTYTSARILAGLGIKAILIEE
>FECAFAII_02331 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIVAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYIEKRSTEGWTPDVIIGRAERTFSCSVSTLYRRFKTGEFNVL
HLPMQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEGDTIVGIHHKSAVITL
VERLSKAIIALKPEGRKAVDIENSINEWLQSVPKNLFKSITFDCGKEFSNWKSISNTNDI
DIYFADPGTPSQRGLNEHSNGLLRKDGLPKEMEFNQVNQGFISSVASKRNHIPRKSLNYQ
TPLEVFLSYVNGKFCLA
>FECAFAII_02332 GTPase HflX
MEEKVIIVGVETEANQRYFSESMEELVQLTNTASGEVVFTITQKRPQVDRQTIIGKGKLQ
ELVQQADAHEADLIIFNHELTPRQSQLITDAVGLPVIDRVQLILDIFAMRARSKEGKLQV
ELAQLEYLLPRLVGQGKTLSRLGGGIGTRGPGETKLETDRRHIRNKIFAVKKELKEVEAH
RERNRQKRKNSEIFQIGLIGYTNAGKSTILNLLTQADTYSKDQLFATLDPLTKRWRFAEG
FEITVTDTVGFIQDLPTQLIDAFHSTLEESQNMDLLLHVVDASSPDRILQEQTVLKLMDE
LNMKEMPILTVYNKADQIDPAMFTPTLFPNVLISTQTKEGKMALIEAIKRQLMELMTPYT
LSVPSNEGQKLSELRRQTMVLDEAYMEETNEYEVKGFAKTNSKWLRKNQ
>FECAFAII_02333 tRNA dimethylallyltransferase
MEKVLVIVGPTAVGKTALSVELAQLFGGEIISGDSLQIYKNLDIGTAKIKEEEMNNVPHH
LIDVIEPTQRYSAADFQHSGRQLITEIANRGHLPIIAGGTGLYIQSLLYDYQLGATEEAN
PEIRKKYETLAETIGSQALWNQLKEKDPAAAEKIHWNNQRKVIRALEVLETTGHSITAPK
EEPKQLYDYLMIGLDTKRSILYERINQRVDLMLAEGLVAEARKVYELGEVQASQGIGYKE
FFPYFEGKETLEEATEQVKLHSRRYAKRQLTWFRNRLDAQWFDLISEPNQKSQIEQTIKK
WLEAE
>FECAFAII_02334 Glycerophosphodiester phosphodiesterase
MLQIYAHRGSSGTHPENTLPAFAEAVRVGADGIELDVHLSKDGYLIVMHDEEVDRTTNGK
GLIREKTLEELKKLNAGGKFSKEFPAAKVPELREVLGLLLQKNYRGMLMIEIKTDQYEYP
GIEEKLAETLKSRDWPFQHAYCSFHLDSLEKIALLEPEIQLDLLMSTSDKKIQLAAETPY
IEGVHPKNTWLFEHPVQAADFPKAIRAWTINDEEEMAKCQELKIDGIITDFPEKALRWKQ
STKSR
>FECAFAII_02335 hypothetical protein
MIVGITGLIGVLTGAVVVYIGMILQMRHLENKEQRRRELELKVKEIETLNQLNKKINEIL
QKRTTLMEEYVSFDAFDDCYITIDDFAYLQSFSAQNSFYLPNYILDELFKNISHRKVILS
PDETMKIGGYAYKGGRVILENFTDSLTEMINEKKAQLKTMTRQPIGFFSKDDVWS
>FECAFAII_02336 ATP-dependent Clp protease proteolytic subunit
MNLIPTVIEQSSRGERAYDIYSRLLKDRIIMLSGQVTDDLANSIIAQLLFLDAQDSEKDI
YLYINSPGGSVTAGMAIYDTMNFVKADVQTIVMGMAASMGSFLLTAGTKGKRFALPNAEI
MIHQPLGGAQGQATEIEIAARHILQTRERLNKILAERTGQPLEVIEKDTDRDNYMTAEQA
KAYGLIDEVMENSSSLN
>FECAFAII_02337 Putative acetyltransferase
MERFIASNATVIGDVTLSEDVTIWYQAVLRGDSNWIKIGQRTNIQDGTIIHVDHDAPVDI
AENVTVGHQCMLHGCTIEKGALIGMGTTILNHAVIGENSLIGAGSLVTEGKVIPPNVLAF
GRPAKVIRPLTKEEIQKNKENIQHYVEIGRMHAQGKFKEQR
>FECAFAII_02338 hypothetical protein
MEQFLNEKITEAKREVDRLTHVCQTKPFDSADFFENEFQIERLAAQIEVYELILKKVIEE
NIDVQ
>FECAFAII_02339 putative ABC transporter ATP-binding protein
MKKTFSSLKRLARYIRPYRETFLLVILFTVLTVAFNVALPYVTGLPTTEISRNIANGESI
NFSYIFKCLIWITVVGIGYCISQLLSGVLMTNVVQSAMHDLRRDIEEKINRLPVSYFDKN
QQGNILSRVTNDVDAVSGALQQAFIGIVNAILGITLAAAMMFYIQPMMALISMIMIPTSI
WISKRVINASQKYFQSMQNSLGELNGYVQENMTGFSVLKVYGREKETLEGFKKVNHSLKY
FGFRAAFISGLMMPLVQLTAYATYIGMAVLGSFYVITGAIVVGQLQAFIQYIWQISQPMG
NVTQLSSVLQSASAATKRVFEILDEPEEKENKVDASLPETILGDVTFDHVDFAYDPKKPL
IQDLNFEVKAGQTVAVVGPTGAGKTTLINLLMRFYDVDKGAIRIDGIDTKSMSRSDVRSL
FGMVLQDAWLYQGTIADNIRFGKLDATDYEVVDAAKTANVDHFIRTMPDGYDMAINSEGD
NVSLGQKQLLTIARAVVSDPKILILDEATSSVDTRLEALIQKAMDRVMEGRTSFVIAHRL
STIRDADLILVMDQGQIIEKGTHESLLAQGGFYEKLYNSQFAEEAE
>FECAFAII_02340 putative ABC transporter ATP-binding protein
MKLMWHYTMRYKKFLFFNFICVFGFILIELGLPTILARMIDVGIRNDDFDYVKQQGIFMI
VITVIGIILNILLGYFGSRITTNIVADIRDDLFEKIQSYSHQEYENLGVSSLITRTTNDA
YQIMLFLQNILRIGFMAPMMFIVSLYMVMRTSVTLSLYVVGALPLLLLAVVAIAKVSEPL
SKKQQKNLDKINSILRENLSGLRVIRAFVNEKFEEKRFAVVNENYASSSKSLFRLMAVAQ
PGFYFLFNIVMVLIIWSGAVQIDAGELRVGDLIAFIEYIFHALFSFMLFASVFMMYPRAA
VSAGRIQEALDAKPSIVEDPNGISDTKTKGYIEFQNVTFAYPGHSQEPVIRNVSFTASPG
ETVAFIGSTGSGKSTLIQLIPRFYDVSEGKILIDGVDVRDYRLSKLRDKIGFIPQKALLF
TGTIADNLRYGKEDATQEEMERAAEIAQASEFISRKPDGFNEHLSEGGSNFSGGQKQRLA
IARAIIRRPEIYIFDDSFSALDYQTDAKLRARLKKETTESTVLIVAQRVGTIMHADKIIV
LNEGEVVGMGTHRELLEKCPIYYDIAASQLSKEELA
>FECAFAII_02341 hypothetical protein
MIYKVYYQETKVRNPKREETKSLYIEAKSDVDARQRVEENTPYNIEFVQLLEGSHLEYEK
ENADFSLVEF
>FECAFAII_02342 Ribonuclease J 1
MKLSIKNNETGVFAIGGLGEIGKNTYGVQFQDEIILIDAGIKFPEDDLLGIDYVIPDYSY
IIQNLHKVKALVITHGHEDHIGGIPYLLKQANIPIYAGPLALALITNKLDEHGLLRDAEL
HEINEDTIIRFRKTSVSFFRTTHSIPDALGIVVKTPSGNIVATGDFKFDFTPVGEPANLH
KMARIGEEGVLCLLSDSTNAEIPTFTKSEKTIGHSILKIFSKIEGRIIFASFASNIFRLQ
QAADAAVATGRKIAVFGRSMENAIVNGQRLGYIKVPDGTFVDAHEINRLPANETMILCTG
SQGEAMAALSRIANGTHRQIQIQPDDTVIFSSSPIPGNTTSVNHLINLLSEAGAEVIHGK
INNIHTSGHGGQEEQKLMLRLMKPKYFIPVHGEFRMLKVHASLAQDVGVPAENCFIMENG
DVLALTSDSARPAGHFVAGDVYIDGSGIGDIGNVVLRDRHLLSEEGLVLAVATVDIKKKE
ILAGPDILSRGFVYMRESGEMINEAQRILFHALRECLNGPDCSEYKLKEAMTGALQPFLF
ERTERHPMILPMVMTPDEE
>FECAFAII_02343 Cold shock-like protein CspLA
MENGTVKWFNAEKGFGFISREDGSDVFVHFSAIQGDGFKTLEEGQAVTFDVEESDRGPQA
ANVVKA
>FECAFAII_02344 hypothetical protein
MGKRLIKEVPTSSLPRERMEIYGAEALSDQELLAILLRTGQHPYSVMSIAGNLLKTFGGL
ASLRQATLHELEEIRGIGRVKAIEIKALIELGRRIQTDHERAAPPVRTSYELAQQLILEM
KDHKQEHLVCIYLDTKNQVILKKTVFIGSLNQSVAHPREIFHYAVRYCAARIVLAHNHPS
GNVIPSQQDMNFTKRIQKCGEMMGITVLDHLIIGRKRYFSLREEGMMEEK
>FECAFAII_02345 Phosphorylated carbohydrates phosphatase
MKYNAVIFDMDGLLFDTELVYYEATQVVADKMGFPYDKDLYLKFLGVSDEEVWANYHMIF
SEFGKTSVQRFIDDSYQETLERFSQGAVQMKPGVLELLSFLEEHQIPKVVASSNQRAVIE
LLLKKNNLFERFETIVSAENVQRAKPDPEIFLLANQKLGTAKKETLILEDSQNGILAASA
AEIPVVMVPDLLPPSQELIKKTAGVVSSLHEIPALLK
>FECAFAII_02346 Folylpolyglutamate synthase
MTIEEAIEWIHSRLPFGSRPGLDRVEALLEVVGHPERKVKTIHIAGTNGKGSTVAYLRSL
LEEAGLTVGTFTSPYIETFNERIAINGKSIPDNDLIQLVKKYQPLIKQLDQFEAVAGITE
FETLTAMAFDYFLMKKVDVAIIEVGLGGLLDSTNVAVPMLTGITTIGLDHTEILGDTIEE
IAAQKAGIIKQGVPVVTGNIAPEAFTVIQQTAKAKNAPLYVYGENYKINYLHPDEMWGEV
FEFFNEIGKIPQLTTPLLGQHQAENAGVAIELYFVYCQLEKLPFREKDVLKGLKKSRWPG
RMERLSNEPLVVLDGAHNTHAMNRLVENLKKEFKGYQINILFSALRTKNVREMLERLQQV
PNVHIYLTTFEHPKAIELSEVSDLASERVSIVSLWQFGLADILEKMTNEDVLVVTGSLYF
ISEVRHLLIQLGGDHEV
>FECAFAII_02347 Valine--tRNA ligase
MTEENNLSTKYNPQEVEAGRYQHWLEQDLFKPSGDKKAKPYSIVIPPPNVTGKLHLGHAW
DTTLQDMLIRQKRMQGYDTLWLPGMDHAGIATQAKVEAKLREQGISRYDLGREKFIDQVW
EWKEEYASHIREQWAKMGLSLDYSRERFTLDDGLSEAVRKVFVTLYEKGLIYRGEYIINW
DPQARTALSDIEVIHKDIEGAFYHMSYELADGSGVVEIATTRPETMLGDTAIAVHPEDER
YQALIGKKVILPLVNKQIPIIADEYVDMEFGTGVVKITPAHDPNDFEVGNRHDLPRVNVM
DDDGTMNELAGKYAGMERFAARKAIVQDLKEIGRLIKIDTMIHSVGHSERTGVVVEPRLS
TQWFVKMAPLAKKAIDNQETDQAVEFFPPRFNQTFLRWMENVHDWVISRQLWWGHQIPAW
YHKETGEMYVGMEAPADSENWVQDPDVLDTWFSSALWPFSTMGWPDTESEDYKRYFPTST
LVTGYDIIFFWVSRMIFQSLEFTGERPFENVLIHGLIRDEQGRKMSKSLGNGIDPMEVIE
KYGADALRWFLSNGSAPGQDVRFSYEKMDASWNFINKIWNASRFVIMNIEGMTVEEIDLS
GEKSVADRWILTRLNETIERVTELFDRFEFGEAGRQLYNFIWDDFCDWYIEMSKEVLYGD
DAVSKQTTRSILVHTLDQILRLLHPIMPFVTEEIWEHIPHQGNSLVVAEYPVVRPEFDDE
TASKGMEVLKELIRAVRNIRSEVNTPLSKPITLLIKTNDAKIDQFLVENTSYIERFCNPE
ELTISSEITAPDLAMSAVLTGAEIFLPLAGLINIEEEIKRLEKELEKWTSEVKRVQGKLS
NERFVSNAPEEVVEAERAKEKDYLEKQTAVKERIESLRTIQ
>FECAFAII_02348 Redox-sensing transcriptional repressor Rex
MREKTDTLPKATAKRLPLYLRYLKMLDDSGISRIKSNEFSEITQIPSATIRRDFSQLGEL
GRSGYGYDVPFLIDVFNNILNTKEEKRIALVGYGNLGKALKHNNFRRNENLNIVCVFDND
PALINRVIDGEMIYPIDRFAEIAKAKNVTVAISTVPSKYSQSAIDEIVKGNVTAILNFAP
DRVTVPAYVNVQYIDLTTELQTLIYFDENYSEVFS
>FECAFAII_02349 putative tRNA sulfurtransferase
MKYSEIMVRYGELSTKGKNRKSFIMQLAQNVRQALKDFPEIKIHADRDRMHLLLNGADGQ
LVIPKLAKIFGIQNFSPSIRVEKDVEVLKQAVQDIMKEIYTGKETFKIIAKRSDHQFELT
SNELNQTLGNAVFDIFPHIQVQMRQPDIPLRVEIRRDGAYLSYETIKGAGGLPVGTSGKG
MLMLSGGIDSPVAGYFAMKRGVEIEAVHFASPPYTSEQALQKAKDLTAKLAPYVGTIHFI
EVPFTEIQEEIKKSVPQGYWMTITRRMMLRLTDEIRRIRHGLVILNGESLGQVASQTLQS
MVAINEVTNTPIIRPVATMDKLEIIEVAEQIDTFNLSIQPFEDCCTIFAPPQPKTRPQLE
KVHQYEERLAIDEMIQRALAGLKMEEIQAESSNEKTEEFSELL
>FECAFAII_02350 Cysteine desulfurase IscS
MIYFDNSATTPIFPQSLDAYVKTSQRIIGNPSSLHDLGNQANRLLQQARKQIADLIHVEP
EEIYFTSGGTEGDNWVLKGTMIEKREYGNHMIISGVEHPAVSETAEQLKELGIEVSIAPV
DKRGFVRVDELKELIRKETVLVSVMAVNNEVGSIQPIQEISDLLDDFPKIHFHVDAVQAI
GKVPFSQWLTERVDFATFSAHKFHGPRGTGFIYWKKGRRLAPLLTGGGQERNQRSGTENV
PGIVAMVKALRLSLEIKEQKPEQTQRLKVALINALKTYEKVTIFSEGTDYAPHILCFALK
GIRGEVLVHALEEKQIFVSTTSACSSRKHMASSTLHAMHVPNDLATSAVRISLDENNSLA
EVEQFMIIFKQLYKKFSAIN
>FECAFAII_02351 Septation ring formation regulator EzrA
MGNNVIIGIVIAIIIVAIVVFLVSYLMKKKNQDRLDALEKRKEELFDLPVIEEVDDVKKM
HLVGQSQNTFREWSQKWNDISTSSFAELESQIFEVENLNESFRFLKGKKAVVEAEATMDQ
MEKQVTEIREGLKELRETEERNSLAVQQALDVYEELKEKVREDEHEYGPALFELQKQIKV
IEKEFTQFVTLNTSGDPVEAREVLDKAEKHTYEVEALMKKIPPLYEELHTTFPEQLEEIS
DTYEKLMEEQYVFPEEDLAEDIAKVSRRIENSLANLEKTEVETVEFENRETADLIDSLYD
ILEREMEAQRYVKTNQSTIAEYIKHTTKNNRQLLIELDHTSQSYTLNHNEIGRVRGFQTE
VEEMERQNEQMIPQIRQHEIPYSEVRTFYKTVFKVLEDIEKQQVEIDDSLHELRKGEKEA
QEKIDTFEFKLRSLKRFVEKQRLPGLPNDYLEFFFVATDRIEELSVVLNKIRVNMEEVNR
LVALCEEDLELLDKKTHDLVDAAALTEQMLQYANRYRHTHEEVREAIDKSYYLFNKEYHY
QEALDEIGTALERVEPGAFKRIEDFYFNHPDLV
>FECAFAII_02352 hypothetical protein
MEAETPFQKVETFHKTFDPRRPEIPTAFTENEAHTRAAFKIEELVEFVAATSPNKEQLHE
AVMLLHEALDKAEEKILGKTQWGSDPLVEQVDALTDILYFTYGSFSLLGIVPDRIFEIVH
QANMGKLFPDGKPHYDPVTNKVLKPENWQMEYAPEPKIAAEIQRQIQEAIAKKKSADIGM
CTNEKE
>FECAFAII_02353 Stress response protein YhaX
MIKAIFFDIDGTLVTNRSKALESTKQAIEYARKNGILCGVATGRSPVKIKEIIDELELDM
YVVYNGQLVFTADRTIIDHPFEQKVLEHIVEFADENHRQIVFGARNRLDGSTTMLLGQSI
FIKRLVSFLPRKFPVRLMKKILQVFSPHRQKDRYETLEILKEPIYQCILLSPESEQKKLE
HRFPECTFQRSNTYTVDIIPKGGSKLLGIQAFANAVEIEMEEIMAFGDHYNDIEMLKGVG
IGVAMGNAQIEVKHAADFVTQSNEEDGIYEGLKHFGLIY
>FECAFAII_02354 hypothetical protein
MIRIGLTSFKEHDKLTGKKNNTLYEYAGFLPLVELDTAYYGIPRKSSVENWISEVPESFR
FVVKVYQGISGQGDWKPYYQTEEEMIAHFLDVMSPMVDAGKMFCFLVQFPSSFKCTKENV
QYLRKLRKWFEGYPVSIELRDYSWYSDEFLERTRNFMSRAAFSLAIIDEPQLLNTTIPFD
PFVTNPNFALFRFHGRNAQGWQANDKEWRKKRTLYRYSEKELQELAHEVKVVDSKTKEVG
VIFNNNSGGDAAENALALQKILNIKPDGLNPTQMDLF
>FECAFAII_02355 L-asparaginase
MKKILVLHTGGTIAMKENMLTGGVSPDVANPLLDAEITIPKHVELLVEDIFNLPSPHIMP
SHMLVLKERILSAYASGISGVVITHGTDTLEETAFFLDTTIGNKLPIVLTGAMRSSNELG
SDGLYNFESAIRVASCEEALDKGVLVVMNDEIHSARYVTKTHTTNVATFRTPTLGPIGLV
TKNRILFLQELLETKRLDISAVDGTIPIVKAYAGMQGDLLEAIAHTKVDGLVIEALGAGN
LPPQALAALEKLLVQKIPVVLVSRCFNGIAEPVYDYEGGGKELEKMGIIFCNSINSQKAR
LKLLIAVNYGLSGEELISFIQN
>FECAFAII_02356 hypothetical protein
MAKKYTKKHEVSYYECDINQTMTFPSMLGVVIKTSEDQSDQLGRGSEFVNSFGLTWVITN
YSMEINRLPRVGEVISVTTQAMEYNKFFCYRNFWIHDEDGKELVKIESVFVLMDFVNRKM
SSVNEEIIAPFESEKIKKIKRQEKIEKIDSGFMLPYRVRFYDIDSNQHVNNAMYFNWIID
VLGYDFLTTHVPEKVIIRFDKEVEYGNEIESHFEQIPIENGVKTKHEIRMQEQLYCEANI
IWKNK
>FECAFAII_02357 hypothetical protein
MDIQTVLSDLKLNGKVIPVVGGDVNQTYRIKTEHRAYFLKIHPNVKKGFFEAEVDGLKEL
SAFVRVPDTYMLGETSEGAYLLMEWIEPGKGDQRDLAAALANLHQQTAPQFGFRKDNYLG
TLVQKNSFEEDWWTFFFKDRLESQISLAEETNRWNVQRQEKYLRFKERVLKSVEPKKITP
RLLHGDLWSGNVFFDQQGHPVFVDPAVSYGNREQDIAMSQLFGGFRPEFLDAYQTIFPLE
KGWKDRLPIYQLYYLLAHLNMFGESYGSQVDQLLENF
>FECAFAII_02358 Aminopeptidase C
MKAITPDMTTKFNKQFQANIKQQALQRAVVKNGITASAENVSAHVENTPVFSIDLATGKV
ANQMQSGRCWMFAALNTFRHKMLNQFHLKEFELSQNYTFFWDKYEKANYFYENIIATGKE
AIDSRKVAFLLATPQQDGGQWDMIVSLFQKYGVVPKSVMPESANSSNSRDLNNYLNKLLR
KDAVVLRKMVAQGETLDAIEEKKEEMLESIYNFLAISLGTPPKEFDFEYRDEEKNYHLDR
GLTPQIFYDKYIGVKLDDYVSVINAPTKDKPFNRSYTVEMLGNVVGGKEVKYLNVDMETF
KKLAIAQLEEGESVWFGCDVGQSSTRTSGIMALDAYSMDDLFDTDFTMTKAERLDFGESL
MTHAMVLTGVDLVDGQSTKWKVENSWGEKVGKNGFFVMSDAWMDEYTYQIVVRKDLLTKE
QLNAFNEEPIVLSPWDPMGALA
>FECAFAII_02359 hypothetical protein
MKNLIAGGFLFVGGGILMNTDNFGNVIPFLGAACALIGVGMLIYFVFSDDGKYG
>FECAFAII_02362 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
MKIVFLHGLGQDEQSWKDVISYLPNSYSCKSLSLFNHLNSTDTATLDDLTKYIEVQLNQI
KEPFILCGLSLGAVIALNYLATPSPYLKKVVLVAPQFESPNRLLLTFQNIYFYCVPSKIF
EKLGLSKKQTLTLLRSLETLDCKKQLRTSRLPKLILCGTKDHANKPAAKRLYKLSTNGRL
LFIKNGKHELNREKPEIMAQAMRSFIENS
>FECAFAII_02363 hypothetical protein
MYLKITEQAQERLQKYIDEGATVILDLDDGVGEYSKMGVCSLDTSFRLLLLDKEQRKNDY
KLQLDSDIGDVYIKDYSKMYMDEHMTLSLDPRLGVFTLESPSGSLDSHVQLVDLRPEKFS
GIKQ
>FECAFAII_02364 hypothetical protein
MSKRTRRTFSQEFKQQIVNLYLAGKPRVEIIREYELTASAFDKWVKQSKTSGSFKEKDNL
TPEQKELLELRKRNQQLEMENDILKQAALIFGRRDK
>FECAFAII_02365 hypothetical protein
MCRILGLSRQSYYYQSKPKKDESELEEVVAEEFIRSRKAYGSRKIKKALSKRGIQISRRK
ISRIMKNRGLKSSYTVAYFKVHHSTCNEAKTTNVLNRKFLRDNPLEAIVTDLTYVRVGKK
WNYVCFILDLFNREILGYSCGEHKDAVLVKKAFSRIKQPLTEVEIFHTDRGKEFDNQAID
ELLTTFDINRSLSHKGCPFDNAVAESTYKSLKVEFVYQYTFETLQQLDLELFDYVNWWNH
LRLHGTLGYETPVGYRNQRLAQRILDNELGCANASEAV
>FECAFAII_02370 hypothetical protein
MASKRVAGTIMLHLEDGTKKFLVHSIDDKLEFALAELSEGKTGLANILNFLKEIVHIDVS
KISLMELTNTHIKEENVPLFVFETEQKNQREELGEGYIWEEPGQMRSVLGTYEVEGVPFF
>FECAFAII_02371 General stress protein 13
MTYKIGQIIEGKVTGIQPYGAFVSLDNETQGLIHVSEVQSGYTKNIHSLLKVGQPVTVQI
IDIDEYSKKISLSLRTLEKTNPAVPYRRKRYFTNKNRKIGFTTIAEQLPIWIEEALSELE
RKENKK
>FECAFAII_02372 Cystathionine beta-lyase PatB
MIEFDKQISRKDTESVKWDAIAETYQMDDLLPLWVADMDFLSPGGVAKAFSEYIKHGIFG
YATLSDKLYQAIIHWERQHHAVELTKENIVFTSGVLTSLAAAVQTFTKPGDSILIHDPVY
PPFSSIIETNQRHIVRSSLLEKNNHFIMDLSDMEKKIEENNVKAMILCNPHNPGGRVWSK
EELKQLSELCLKHQVILFSDEIHQDLTLFDHTFTSMLTIDPNLDDLLVAFTSATKTFNLA
AIKNSMVFIKNPEMKADFEKHLVMNQQHEINTFGLIGTQAAYETGGEWLSQLIPYLEKNV
QTVNQFFEQYLPKVRIMNPEGTYLMWLDFTAYISDDQELENTLVRKGKVVLNPGITFGPS
GHGHMRLNIACPEETLLEGLNRIKYALETID
>FECAFAII_02373 Putative peptidyl-prolyl cis-trans isomerase
MAFPQLDLKSEKGPKAVIKTNRGDITVQLFPELAPKTVQNFIELSKKGYYDGVIFHRVIP
DFMIQGGDPTGTGMGGESIYGESFEDEFSRELFNLRGALSMANSGPNTNGSQFFIVNNTN
VPANMLGQLEGAGFPSEIIEAYKGGGTPWLDFRHTVFGHVLEGMDTVDEIANVQRGPQDR
PVHDVVIETIEISE
>FECAFAII_02374 Ferredoxin--NADP reductase 2
MEIYDITIIGAGPVGMFAAFYAGMRQAKTKIIDSLPQLGGQLATLYPEKYIYDIPGYPAI
KASELIDQLEKQLTTFNHTFHLKEEVLSLTREDEVIEITTNKGIHYSKAVILALGNGSFQ
PRKLNLDNAESFENHGLDYFVNDLMKYAGKKVAIAGGGDSAIDWTLMLEPIASEVYLIHR
RPEFRAHEHSVSRLKSSSVNLLTPYLIDGLSGNNGELTDIRLKKVKSDETIDLMIDSLIV
NYGFSSNLEHLSSWGLDSTRNAITVKSDMSTSIPGVYAAGDICTYEGKVKLIATGLGEAP
TAVNNALHYINPKERTQPGHSTSLYDKNLRPS
>FECAFAII_02375 hypothetical protein
MVVKTETLEEKARELLKERGVTVEDIAQLVMFLQKDYISDLTLADCTESVNSVLTKREVH
NAIITGIQLDILAEKKKLMSPLQHIIEDDEGLYGIDEILALSIVNVYGTIGFTNYGYIDK
VKPGILKELNSHDGVHVHTFLDDIVGAIAAAAASRLAHKEPEKRSRLTQ
>FECAFAII_02376 hypothetical protein
MKNSRWQWMEYAGLFSLFLTLISLAVGVTINFRPLYVFDIGHLQILDYTSLDQETLLKNF
DHLMNYLNNPFKTILSLPDFPVSASGAHHFYEVKILFLVDYAVFFITLIPSILFIKYLQK
NDRLWRLIRPFQIGMLLPVVFGFFMMIGFDRFFILFHETFFNNDDWLFDPVTDPIINVLP
EEFFMHSFILFFVLLELFFAVFLFLGKNSLKQTKKKELV
>FECAFAII_02377 Acid sugar phosphatase
MDYKGYLIDLDGTIYRGTQPIPAGKRFVEELQKRKLPFLFVTNNTTKSPETVANRLADEF
DIHVAPETVYTATLATIDFMKADGKGKKVYVIGEAGLIDLILAAGFTWEEEAPDYVVVGL
DNYLTYEKVVKATLAIQKGATFIGTNPDKNIPTERGLLPGAGSVISFVETATQTPPIYIG
KPEAIIMDKAVEVLGLQKEEVIMVGDNYETDIQAGIRNNIDTLLVLSGFTKEEDVPGLPI
PATYVKQSLDEWSF
>FECAFAII_02378 hypothetical protein
MSAKQNEQQNVEHKTEIAKKKSSAEQETTVTEELTAALEEIVEEPKAEKVKGELVTLLDD
SNFLIGERHYRLVSDYREGFNAEKLGERYSDVLARYDYIVGDWGYEQLRLKGFFQADNRR
AHPDQRIDSLEDYLYEYCNFGCAYFVIERIGGKKEKTTQRRKKKKNHNRAYIDEKKGPVA
SNRKKPVIKNRKTESAKTSEKVKKQEQPKQVEKTKTAFTIRKREE
>FECAFAII_02379 Trifunctional nucleotide phosphoesterase protein YfkN
MEKIVILHTNDLHSHLENWPRIRRFLDQRKRENEKKEKTTTIAVDLGDFVDRWHPLSEAT
NGQENILLMNEVGYDAATIGNNEGVGNSKEELNHLYDHAEFDIILDNLFDKNTLQPPAWT
KPYKIITTKHQTKIGLIAFTAPFPLTYNPNGWDIRNPYDILPELVEDLRSQVDVLVLMSH
LGIQDDFQIAKEIPAIDVILGSHTHHLFREGHVINDVQIAAAGKYGQYVGEVHLTIDEEK
KILKHSAKAIPTETMTAFTEDEQEINSYLERGHELLKEKEVADLPFSLSLDIFNEHSFIQ
VAFEAVKERGKTEAAILNSGLFLTEIPKGRVNQDQLHTALPHPMHLLNVTLGGNDLIRLV
LEIEKNRNFLRNYPMKGMGFRGKIFGQMVYNGITYDSINHQVFWKNKPIDLNKNYTFTTV
DHLMFVPFFPTIEIAGKNEFLFPEFIRSVVGDYLKAHYPIK
>FECAFAII_02380 hypothetical protein
MSDYNETTTDFRVCFFYFYSTVKMNVPDFLARLIYRILYLYNLLQGRKNSEIELVSMEEK
AAYGMIKIKRGERVHGKNSDFTYE
>FECAFAII_02381 tRNA-specific adenosine deaminase
MVNTNLDAVEKEKWMRLALAEAKKAEMLHEVPIGAVVVLDGKVIGRGYNLRETTQDATTH
AEMLAIKEACEKVGSWRLEDAALFVTLEPCPMCSGAMILSRVAEVYFGAYDPKGGTAGTL
MNLLEDERFNHQAYVEGGILEDECGMILTDFFRKLRQRKKKLKKDWSTNEK
>FECAFAII_02382 Leucine-rich protein
MKMDKLLALYPQAQKKNSPASEADILSFAIDDAFIWIKQDSLSQQETSLLKALFPVINDQ
KKHPWYHYLFKDASCVQEKSFRLIQLHVESKGEFLKKEWQDTILELFRYSADFFFYTDTD
ALLVEQINRDYLDATEINGIFLSLDADFDTTTSVFVGSFHSPGTDLVPLFAEERKIFLTE
QNNLYTHSRTFSMQDVALHYYTKDTVKDSKLIKSYIELIKQNEMEVIIQELWNELGNVSS
AAKTLFLHRNTLKYRIEKFQEQSGFNLKKANDLLFCYLLLLHEHN
>FECAFAII_02383 hypothetical protein
MKTSTKVTIGLSVAAAASVATAVVVSGKVMEKIHHMTTRTKVKKFVYDKFDGNEKLLEIV
DGLSDSDLDSLMGMLAKIKSGKKKISVYGDSIKDSTEDVKDRLMHFVEKMM
>FECAFAII_02384 Ribosomal RNA small subunit methyltransferase F
MKEEATTLPQQFIKKYRLLLGEEASDFFSALEQGSVKKGFRWNPLKPAGLDMVQTYHSEE
LQPAPYSNEGFLGTVNGKSFLHQAGYEYSQEPSAMIVGTAAAAKPGEKVLDLCAAPGGKS
TQLAAQMKGKGLLVTNEIFPKRAKILSENIERWGVSNAIVTNHAPAELVPHFSGFFDRIV
VDAPCSGEGMFRKDPNAIKEWTEESPLYCQKRQQEILSSAIKMLKNKGQLIYSTCTFAPE
ENEEIISWLVENYPVTIEEIPLTQSVSSGRSEWGSVAGLEKTIRIWPHKDQGEGHFVAKL
TFHGQNQMHKEKKTRKKSKVQMTKEQEKLWTEFSNDFHYEATGRLLVFNDHLWEVPELAP
SLDGLKVVRTGLHLGDFKKNRFEPSYALALATKKIENIPCLPITQKEWQSYTAGETFQRD
GNQGWVLLVLDKIPVGFGKQVKGTVKNFFPKGLRFH
>FECAFAII_02385 hypothetical protein
MGRVTNYSKEYLLFKSMVYVEEYGMKSITARELAEFCGCSTYPIYTHFKSISGLKEKILE
EITVYFENYLAECSSDDVLSIVYLLKDFFSIHESIREIIAKSDLDMDSLFKRPFFSYVKG
HTKIKEEKSLELVWLNALGSLRSDDSSQDFLEMMNAVWDKNEVTDEYLENILKEQSP
>FECAFAII_02386 hypothetical protein
MLIEARKKELLVLQMVIQKNNCSLQELSNDLHIPKRTIKELIRKINVSLKQFLLIDEFIY
SNHKGEIQTKETDQTKKLAVFSKLKLCYLKESNRFNYLMLLINYPQTAVPKKYLLEQLYI
SPSYLEKLTKQLNHSLKKFHLRILSVKNCCTLEGNELSIRLYLYFFLSDTFGGNDWPFSS
LELNALKMNSTDEQIEKISKQEKNIYLLLTLFILRNKQQAYFPKTSSEITELMDLLQHTH
DYSEYFTSFSVSRPCEETETERAYFNYFFYCFFPNQISFRQKQEIGFLFSTSKNLICRQV
GQLMTYLTQQFPLNHLENKIPIYFYFLVLAVVFFELLGESSSSFSTLCFPEATSNHSSSF
IQEKKLREKIDTIFSKNGERNQISQYLSQLIQHLLQTETKEQLLIHLQITKQFTGNYHLQ
SHLQQLFRKDAVKITAYSEHADLIITDQHEKISDETETFYLDTTHNTVLFGKLIKAVHEL
YMKKGYENKTKRM
>FECAFAII_02387 hypothetical protein
MYGYGMYVFLDPTFLLVILGLVISGIASAYVNSTFRKYDQVRSKNNVTGTQAAQYILQSQ
QINNVGVQQIAGDLTDNYNSGNKMLSLSQATAQSTSVAAIGVAAHECGHAVQDASGYVPL
KIRAALVPAANFGSMISFPLIMVGVLLSWNSTLINIGIFAFSLALLFQLVTLPVEFNASR
RAIQILSEGGLLTEEEVPMARHVLFAAALTYVAAALSTFLQLLRLILLFGGNRRD
>FECAFAII_02388 hypothetical protein
MTLPNCPECGSEYTYEDRGLLICPECGNEWNKEEQETVIEDGLVVLDANGNRLLEGDSVT
VIKDLKVKGASGAIKQGTKVKNIRLVEGDHNIDCKVEGFGPMKLKSEFVKKN
>FECAFAII_02389 putative bifunctional oligoribonuclease and PAP phosphatase NrnA
MTVQQEIVDTIKKYDKIIIHRHLRPDPDALGSQVGLAELLRESFPEKEIRQVGETIEGLR
FLAEMQEVEDVFYQGALVIVTDTANSPRISDQRYQLAEKLIKIDHHPNDDPYGDLVWVNT
KASSCSEMIAEFALMFPESLKMNVKAARLLYAGIVGDTGRFLYPSTTSRTLEIASILRNY
PFDASALNREIEQMPMKVAKLSGYLYQNIQVDENGAGRIILPQEILDKYGIDDSETASIV
SLPGVIDEVLAWGIFVQQPSGYYRVRLRSKGPIINELAKRHHGGGHPLASGANAKDLAEV
EEIYKEIQDICQSYKSRKTE
>FECAFAII_02390 Cobalt-dependent inorganic pyrophosphatase
MATKHDLILEYIESLPVGNRISVRSIAKELNVSEGTAYRAIKDAENVGLVSTIQRVGTIR
IERKLKKHIERLTFGEVVRIIEGDVLGGAAGLDKVLNKFVIGAMTKHAMERYITPGSLMI
VGNRAEVQKLALEDGAAVLITGGFNTTAEIAKLADDLEMPILRTSYDTFTVATMINRALS
DQLIKKDIMLVSDIYMPAEKTHYLQQTDTISDYQRLSEETQHSRFPVVNRHHRLMGIVTA
KDVLGKSPNQIIDRVMTKEPISVKKTMSIASVSHQMIWDGLEVMPVVSDDLTLEGLITRQ
DVMKAMQLVQRQPQIADTISDQISGNIHTIDTDREGNRLENPKFKFVVAPQMVNGVGTIS
FGVLSEIISDVAQKTMVMNQKRNILIEQVNLHYLRLIQLESELDIRPRVLEIGRRSAKLD
IEVFIENTIVSKAIVVCQVMERS
>FECAFAII_02391 hypothetical protein
MKITYHGHSCLTIEMENGQRVMIDPFITGNPLTDLTAEEVKTDWLLITHGHSDHIGDMIP
IAKENQATIISIVEIADYANSRGVDSFGMNIGGKHAFPFGVVKFVHAQHSSSYEVDGIVQ
YMGEPSGIIIQAEGKTIYHAGDTAYFSDLGLLAEEFDIDVAFLPIGDNYTMGPEDAAKAA
QTIRAKKVVPIHYNTFPVIEQDPESFVELLEDSEGKIMSVSETLEV
>FECAFAII_02392 Cys-tRNA(Pro)/Cys-tRNA(Cys) deacylase YbaK
MSQTKVERYLEEQKISYQPLDFSHVVEESFTEELQKRGIDPALICKTLVVKGNKTGVIIA
LIPLNDHLDYKKTRQVTKDRKVGFPGMDFVLMHTGYPHGANTPIGIKLAHPDYCFLADSS
LKEKEEVIVSSGEIGRSLRIKVADLEKIVHPIYADLIS
>FECAFAII_02393 Ribonuclease J 2
MSTIKIIPLGGVRENGKNMYVAEVGEDIFILDCGLKYPENELLGIDVVIPDFTYLEENID
RVAGVFLTHGHADAIGALPYLLSKISVPVFGTELTIELAKLNVSRNEAAKGFKDFHVVDE
HTEIDFGETVVSFFRTTHTIPDSVGINLKTKEGSIVYTGDFKFDQTAIPMYQTDYARLAE
IGKEGVLALLSESANAENPQPVASEAQIADEVFDTIKYWEGRIIVACVASNLQRVQQVLD
AAEKAQRKVVLTGQDFERIIRTAMRLEKLQLPSEDLLVTLKDMKNYDPEELIILETGRMG
EPIKSLQKMANGTHRNVKIEEGDLVYITTTPSIAMETIVAKTEDIIYRAGGTVKLISENM
RVSGHANPNDLQLMINLMKPTYFVPVQGEYRELAAHADLAHAVGMPYKNIYITGRGDVLE
YKNKRMSVAGTTSAENVMIDGLGIGDIGNIVLRDRKILSEDGIFVAVVTISRREKKIISK
PQITSRGFVYVKASRDLMKESSNMIETIVEKHLESNDFEWSKLKQDIRDQLGRYLFEQTK
RRPVILPVIMEATQRRNKK
>FECAFAII_02394 hypothetical protein
MNFMKRAWKSTKVKWGRSLLLFAVFTAILIFVLAGLTIRSAAEEAANQAQKEVGATVTLS
ANREASFKKQEQTSSSGSTTEERPDPGSFSLTPVSLTDAEKIAELDNVKSYSFESSASAM
AKDGITAITSSDSSEDSSETTDAGGEPAGGMGGNPQMTQADFQISGVSATAQNSNFSDGT
AKITDGEGIDDSDKGTNNVVIDSTLAETNDLAVGDTFTITSTEDEDTTYEMTIKGIYESS
ETSGSMGMKFNFMNPSNTLYTSYTFANELNGTSDDNTIDSAIYTLSDPDKMDEFLKEAEK
LIDTDTFSLQSNDSMYQSMLEPLNNVASFSKNVVLLVAVAGIIILTLIIMITIRERRHEL
GVLLSLGESRSKIILQLFTEVAICMILALGVASLSGNVVANAVGQQLLDQQTETTTQNQQ
APGGGQMPGNRQEQGGQRDGQQGTTNNPFAVSDQVSELEINVKPAQLGLLAGVAFGISLF
SVFLASIGILRLNPRKILLN
>FECAFAII_02395 Lipoprotein-releasing system ATP-binding protein LolD
MLRTEQLGFWYQDPQDALYKDVELNFEAGKMYAILGASGSGKTTFLSLISGLDAPKEGKV
YYQDRSLNKIGLRSYRKNDVSIIFQAYNLLPYLSALDNVIAAMEITKTKQENYRQVALDR
LARVGIDEILAKKQVTKLSGGQQQRVAIVRAICCEHQLIVADEPTGNLDETTSQDIVKLF
QEIAHEQNRCIIIVTHEIEVAKSCDEVFELKNKKFQKIEV
>FECAFAII_02396 hypothetical protein
MADLKGRSKDMKDKVVGEGKEAYGKATDDKSKETEGKAQSLGADIKEKARNLGDEVKDKF
SRKDEKK
>FECAFAII_02397 Isoaspartyl dipeptidase
MKIIRQIEVFAPDYLGKMDVLIAGGKILAVEEQLEGGYEGVEVEELSGEGKVLTPGFIDC
HFHILGGGGEGGYQNRTPEVTLSQLTTAGVTTVVGCLGTDGEGRDMTALISKAKGLEAEG
ISTYVYEGSYRLPVKTVTDSIIKDFLTIDKIIGIGEIAVSDHRSSQPSFEEFARAVADAR
VGGMLSGKAGIINVHLGGGKRKLELLTRIVEETEIPITQFLPTHANRTPELFEACVAFAK
RGGTIDFTASEDPDFWEKTDGEVRFSKALKRLIEEDVSLDNFTMTSDGQGSLPYFDENNH
FLGLGVGSAKALLVGIKEAVQKESIPLEIALRAITSNPARILKLDKKGKIEIGADADLCI
LDKETLDIDTVIAKGEIMVQEKEVKVWGTFEKSF
>FECAFAII_02398 hypothetical protein
MKKTNSSGKPKRDFTKLSTPHTYVIIFGVVIFAWILTFVVPAGKFSTQDIEYKDANGETS
TRTVLRQDSFRYAYELDKSYVFDQLEELQDHPAEREKLDVPEKGLEKVIADGEKNLTQEK
LDEISLTDDVLYDQYGENIYDTSKKLHKTAKIWGTDDFGGFGFLNFVFEGLVSGDKYGSA
VGIAALILVVGGAFGIIMRTGAIDAGIYAFISKTKGLERLALPLLFFAFSFGGATFGMAE
EVIPFSMVMVPFVIALGYDSIVAVTVTYVASQVGNATSWMSPFSVAVAQGIAGIPVLSGA
TFRLIMWVVVTALAAGYMMIYAEKIRKKPESSLTYKSDDYFRSHIKKTSDENKKFMLGHK
LILLEMLVVLVWIVWGVTQKGYYIPEIASQFFVMGLVAGIIAVLFKLDGMKVNDIASSFQ
SGAADLAGTAIVVGMAKGILLVLGGSDASVPSALNTILHGIGTALTGVPAVIGAWAMYIF
QSLFNLVVTSNSGQAALTMPIMAPLADLVGVSRQVAVLAYQLGSGFMDAFTPVSASLIGV
LGVARIEWAKWARFQIKMQGFLFVLGTIFIMIAIAIGLQ
>FECAFAII_02399 hypothetical protein
MSLCYFDYYHQLEEKLRIEEPLMLQAGTWIAKQINQGGRLQIYASRTLSGVAFEFWDQTP
DLVPSILIENPAGGVYETLEGAGQAIIDQLSVKSEDIFLLLSNEGRNPAIIELAQWIKEN
GHPLIIVTGFDLSRSIKSQHSSGLRLFEFADLVLDNHANLHDAVLTLPNLDPAICGTASL
ATIFLLQQVLYFTAKQLVQDTSGK
>FECAFAII_02400 hypothetical protein
MGKLVAVAQSLLDILKWLMEGSNWIFVLPLLLISLFIMFRMVRKKETFLIFIWYAASVGV
ATLMVELALGSWEACVFALFFAVLYLIIYIPYMKRKSRIGRKGRHTTTFSSTDSLEQSRR
TRRRR
>FECAFAII_02401 UTP--glucose-1-phosphate uridylyltransferase
MKVKKAVIPAAGLGTRFLPATKAMAKEMLPIVDKPTIQFIVEEALDSGIEDILIVTGKEK
RPIEDHFDANIELENNLREKEKTELLALVEETTQVNLHFIRQSHPRGLGDAVLQAKAFIG
NEPFVVMLGDDLMKDDIPLTQQLMMDYEETQASAVAVMRVPENETSKYGIIDPKTDSEKG
RCRVKGFVEKPEMGKAPSNLAIIGRYLLTPKIFEILETQEPGAGNEIQLTDALQTLNQTE
AVYAREFKGKRYDVGDKLGYMKTNIEYGLQHSEIGTSLSAYIIQLSKKLRTES
>FECAFAII_02402 hypothetical protein
MKLFVGIDVSSEKLDVCFLTDDNQLSILSEISVANDIEGASFIRETILEFNNSYHFDQIV
IGMESTSMYSFHPSMFFHEDEKLKKLNTLVTIENPFRVKQFSRMFDENKTDRNDALRIAD
FLRIQRFTTSPIKEEKYMALQRLTRTRYQLIKQLIRTKQHFLENLTYKCNTLAREMRDES
TSLFSATLISLMTEDFTLDELAELPLEAFCDLLQEKGKGRFKQPEKIAKAIQRAITMSYR
LGALAQESINVVLSVLVREIRALEKNIKELDKAIEQVIVVIPEYQCLTSIPGVGKVYAAG
LIAEIGQIERFEDQTKLAKYAGLSWKVNQSGNYQSQNTPLTKQGNRYFRYYLVEAANSVK
NYLPEYKAFYQSKYKEVPKHQHKRALVLTARKFTRLVDTLLRKHQLYTPPRSVIEK
>FECAFAII_02403 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MKQKIAVLGPGSWGTALAQTLAENGHDVRIWGNVPEQIDEINKYHTNQHFLPDLTIPESI
IGYKELAEAVDNADAILFVVPTKAIRSVAQELIGKMNTKPIIIHASKGLEQDTHKRISEV
LAEEIPEEKRQAIVVLSGPSHAEEVAVHDITTITAASIDQKAAAYVQKLFMNDYFRIYTN
NDVIGVETGAALKNIIAIGAGAIHGLGFGDDAKAAIMTRGLAEISRLGVAMGANPLTFIG
LSGVGDLIVTCTSVHSRNWRAGNLLGQGHKLEEVLENMGMVVEGVATTKAAVELAQQLGV
EMPITQTIYNVLYNGEDIKKAAKGIMLRDGKMENEFSLR
>FECAFAII_02404 Fructosamine deglycase FrlB
MLKFNEEEQIKAIKGALALRPQVEEIIDKLYAEKFDAVYYLGIGGTYASSMQAVTYMNGK
SNLPVFVQHAAEYYTTGNKRLTKDSIVILSSVTGTTQEVVKAVEQIKKVGATLIGFIDKA
NSKLSQLCDFVVTYPAPGTEQIKFFMAADRLMYLNGEFEAYSEYYEQLERYLPTGLVEAE
KKADAFGLSFAEKHRRDSMHYFIGAGNQWGAVYSYAMCYWEEQSWLPSKSIHAAEFLHGT
LEIVEETTPVTLFLGEDEQRVLSERVAKLLPKICSNYTLIDTKDYPVEGISEKYRGRVLS
FLLMHVVTQRIDAHVEQLNCHPLEIRRYYRQFDY
>FECAFAII_02405 Glutamine--fructose-6-phosphate aminotransferase [isomerizing]
MFTMQDYIYEEKEVLSTILKKNDFSTREHMKKTVNLLILATGSSYNACLAAKPALESYGD
LTVDIQEPFYFFNYGKLSPSIDTVIAVSQSGKSASTVEAVKMIQKQGLPVVAITNDVQSP
LALEAAQIIDLGAGVESVGFVTKGYSATVLQLLLLGIGIGISKNKISKKIEQDYMQQLRK
IINHLPAIIQKTEEFFDGYQSLFRLAQRFVTIGYGPNWGTAKEAETKLTETIRVPSQGFE
LEAYMHGPYLEADASHLLFFIEGESVNKERSQKLQRYMSRYVGETLTITTKKARNEKTLG
LAIECDEYLSVLALVVPFQLFAYKTAVAKGIDLNKKIFEDFDTVLKSKL
>FECAFAII_02406 PTS system mannose-specific EIID component
MKNSEIKNSKITKKELNHVFWRSFQMEFSWNYERQMNMAYVYAMIPILKKLYQSKEEMAA
ALKRHLEFFNTTPHIVTLILGITAAMEEENKDDPEFDVTAIDSIKTSLMGPLAGLGDSFF
WGTLRLIATGVGTSLAMQGNILGPILFILIFNIPHILFRYLATGWGYRLGTGFLKKIQAN
GMMESLTLGASIIGLMVVGAMTATMITINIPLKIGSGENAVTVQSIFDDIVPNILCLGAF
GIVFYLLKKEVKPLTILIGLAFFGIFGSWIGIF
>FECAFAII_02407 PTS system sorbose-specific EIIC component
MIVQAVLLGIVAFVAQSEYALGTSLLSRPIVTGLFTGIVLGDVKTGIIMGATLELAFIGS
FSVGASIPPDVVTGGILGTAFAITAGAGTETALLLGLPIATLTLILKNIYLGLLIPIMNH
KADNYAEEGNYKGVEHMHLLAGIGLSLMLGVVVMVSYMVGSNTIGNLLNMIPDFVQKGLS
VATGLIPALGFAMLARLLINKQVAPYFFLGFAIASYLEIPVTGVAIFGAILAVVVVNIMN
VRQLPLQTTAGEVEEDEEF
>FECAFAII_02408 putative phosphotransferase enzyme IIB component
MIVLTRVDHRLLHGQVAFSWTQTIGADCILIANDDVPTNEIRKTTIKLAKPQGVKLVIKS
IDDSIAALKSGVTDKYKLFIVVESIEDAYKLAEAYPEIKTINLGGIKAKPGTRSIGKAVN
ILPEEEERLKRLIDKQIEVEIRQVPADKKVDVREVL
>FECAFAII_02409 PTS system mannose-specific EIIAB component
MDREIILASHGKFASGILDSLELIYGKNHSITVFDCYTDENFDLAETVRQLFMRYKDKEI
IVLTDLFGGSVNNEFLQYINRDHVYLVAGLNLPLLIELVSRLDAEVETTVLIQQVLTDSK
KMIQFCNERLNQKIEEDEF
>FECAFAII_02410 Transcriptional regulatory protein DagR
MLKKEILCYLENQTAFFDLEHMNEVFTAQRLADHFGVKRNTVSHYLNQLNDEQLLVKINS
RPVIYFHKEAFEKQFFKLRTNFYFSIDDLKEEQPFFAQPKDLFSFMIGYDASLKESIEQI
KTALYYPDGGLPLLITGESGTGKSYLVNLVYQYCLLHDLLEDSAPFITFNCAQYADNPEL
LTSNLFGHVKGAYTGAEENKKGAFEAADGGILFLDEVHRLTPEGQEKLFTYLDQGVIYRM
GEPNLSRRIKTRLFFATTEEITSHFLTTFIRRIPIRIELPALNQRSRNERLELIYSFFLE
EQRKMGSPLSVSGPALSLLTSQKLSGNIGELKNIVKVSAAKAYAEQREQPEIHVTIHHLQ
KELLAQPITKNTAQQGIYITQDQTLEQLMEKQQPEQQRIVKSFEQILIDFKKNNCLLYSC
EGKLKQEVIQLFDFLLFETSRQEKHELLVYWTQSIRETFRQMETAYQIKFDGNSVYALSY
YLYQRSTIKWLPEEHDIIQLIKELEQQVSQSYPSSYHYVQRILELSKIKLDIEDTSMDRI
LLTIYLKKAKWSKEKRLPKAMIAAHGYATASSMANVVNRLLQEDLFESFDMPLDVTPQQI
ASEILDYCENSDVSNGLIILVDMGSLKEIHQFFKKQLSVPLLILNNVTTPLAITVGECLQ
KNVSLEEIAEETVRQIQPEWRLLYPEENKPKALITTCFTGIGTAVHLSELLEKSLPTACQ
LKIIPYEYQQLKDKKNSDPLFSIYEVVGMIGTTDPDITNIDYLSLEDLISGEKMSVLAEW
LDTTMNASEKEIFNQRIIRNFSLEKVLDSVTILDTEKVMGEIDHFMRELEVQLNRSISNP
KKLALYVHVSCLIERLIRQMPIETYQGLEKWKQCQKEGLSAIKSAFSVIEEHYSVMIPNS
EIAYIYDILSEDTEFLSIEEEF
>FECAFAII_02411 hypothetical protein
MKSDKYKNRKHTSWKTFREIIGSYLAVVVFLPLLYMAMTEQTRFIGVDTQYIAETGFLFI
FILIFAFYKSFHTK
>FECAFAII_02412 putative ABC transporter ATP-binding protein
MIQLLRYAKDYRKQIILGPFFKFLEAVFELVLPLMMASLIDNGLKMNDRGKIIEMGLWMV
AMSVIGLICAIICQYYASVASQGFGTELRNQLIKKINTFSHNELNHFGTDTLITRMTNDI
NQLQLALAMVIRLLIRAPFLSIGSVVMAFVIDWEVGLFFLALLPIFSIILFFIIKKTVPL
YQKVQEKLDQLNEHVSQNLSGVRVIRAFAQTKKETEKFDKSTNDLANNYLRVSNISALLS
PATTLIMNVGIICLLTVGGIKVNIGSLQQGQVLALINYMNQMLLALIVVSNLVVIFTRAE
ASGNRVKEVLDTENSILEAEVSTTPDFSSEAIIAFDHVDFRYTPDSGLSLQNITFQLKRN
TVLGIIGPTGSGKTTLTQLIPRFYDVSSGTVIMDGMDVRSWQLDHLRQQIALVPQTSVLF
TGTIRENLQWGKKDATEKECWEALKIAQAEEFVRQLPNGLDTKVMENGKNFSGGQKQRLT
IARALIAKPALLILDDSLSALDYQTDLDLRKALQTYLGSTVIIISQRVRSIQEAHHILVM
DQGKIAAQGTHEELLAQSAEYQEIVASQEEE
>FECAFAII_02413 putative ABC transporter ATP-binding protein
MKVKKLSLQTLRRFIPYLTAYAKDIWLAVILGIINGIATVVMTLQIGQSIDQMIGEGQVR
FNRLFHLLILFGGIVLINVVSQWLIQVLSNRLAYLSVAKLRKDAFAHLNRLPLRYYDQNS
HGNIVSRFTNDMDNISIAISAAFNQLFSGVAIIILSFIFMMRLSPLLTLVVLCSTPIIFL
VSWIVARASQTNFDRQQRIIGDISGFVTERIGNQKIVKAFQQEEASQQQFELLNADLYEK
GQRAQFSSSLTNPSSRFVDHLAYLSIGLVGGLLALKSGSSITVGVISSFTIYSSQFSKPF
IELSGITTQLQTAFSGLERAFDLIDQPEEKPDLPDAYALEPKNIKGKVSFDHVSFSYDPK
QRLIEDFNFTAYPGQTIAIVGKTGAGKSTLVNLLMRFYDTTKGTITVDDHDIRSIQRDTL
RKSFGMVLQDTWLFDSTLRENLRFGNPEASDAEINDALKASYMYEFVERLPEKLDTKIGG
QGLKISDGQRQLLTIARTMISNPPMLILDEATSSVDTLTEKKIQQAFLAMMEGKTSFVIA
HRLSTIKNADQILVMDQGAIVEMGTHDELLQKDGYYRRLYQAQFTAQ
>FECAFAII_02414 Folate transporter FolT
MKKHRLDARMIAIMGLLIALMVTLSRLVAIETPFIKISVTFIPQVIMGILFGPFWSGIGA
VLADLVGMALFSKSAFFIGFTLNAFIEGAIYGFFFYRKEITWKNAILATLSVTLIINLFL
TPLWLALMYHVPLFSWVVWAPRLLKTVIWLPIQSIAIYYVGRSIPYKKILRSLAIHAK
>FECAFAII_02415 Methylglyoxal synthase
MKIALIAHDRKKPMMVKLATAYKTILEKHELFATGTTGQRITEATGLPIHRFKSGPLGGD
QQIGAMISEDQLDLVIFLRDPLAAQPHEPDVTALIRLSDVYEIPLATNIGTAEVLLRGLE
AGFLDFRRIVHEIDKHPLSF
>FECAFAII_02416 Trehalose import ATP-binding protein SugC
MVEMALKNVYKKYDNAENYSVTDFNLSIKDREFIVFVGPSGCGKSTTLRMIAGLEDISEG
ELNIGGKVMNDVAPKDRDIAMVFQNYALYPHMTVFDNMAFGLKLRKYDKADIKKRVDNAA
EILGLTEYLKRKPAALSGGQRQRVALGRAIVRDAKVFLMDEPLSNLDAKLRVAMRAEIAK
LHQRLETTTIYVTHDQTEAMTMADRIVIMKDGFIQQIGTPKEVYDTPVNMFVAGFIGSPA
MNFFNVTLKNGVITDGHGLKLRIPEGKNKVLVEKGYEGKEVIFGIRPEDIHSEQVALEAS
PEAVVKSEVVVSELLGAETMLYTKTGSTEFISKVDARDFHKPGEIVDLAFNISKGHFFDK
ETEQVIKLP
>FECAFAII_02417 Niacin transporter NiaX
MRKNSVRKLTISALLIGMGVIIPMVMPKIMIPPASFTLASHVPLFIAMFFTPGVAVAVAL
GTTFGFFLTTPVIIALRALSHLVFALIGAWYLQKHPSIVLKNGQFTFANWRFQGFNFVIG
VIHSLAEMLVVSIFYFIGNMPETYYSQGYFYTVFILMGIGGLIHSLVDYNIAYFIAGTLS
KYFDIPVFTAAKKENRKESIQGYAKKTTY
>FECAFAII_02418 Ribosomal RNA small subunit methyltransferase A
MSEYREIATPSRTKEILLKHGFSFKKSLGQNFLTEPNILRKIVETAQIDEHTNVIEVGPG
IGALTEQLAKHAKQVVAFEIDDRLIPVLADTMQPYDNVTIVHQDILKTDLSTAVRETFHE
ELPLKVVANLPYYITTPIMMHFLESDLVVDELVVMMQKEVADRISAEPGTKAYGSLSIAV
QYYMEASLAFIVPKTVFVPQPNVDSAILKLTRRDIPAVEVTDEKAFFRLTKAAFQQRRKT
LWNNLQHSYGKDDQTKAWLAKSLETAGIDPKRRGETLSLQEFAALSNAMSENMQ
>FECAFAII_02419 Ribonuclease M5
MKIQEIIVVEGKDDTRRLREVVDADTIETIGSAINEEILMQIEHAQETRGVIVFTDPDFS
GEKIRKIIMEAVPQAKHAFLPRTQAKPKKKGSLGVEHASDAAILEALKKVVTPDISQTAV
SEITRQDLLDYGLIAGAQAKEKREKLGDELRIGYTNGKQLEKRLKMFRITPKELAQAMKI
VEEQHE
>FECAFAII_02420 D-aminoacyl-tRNA deacylase
MIFDSHTHLNAEQFNEDIPETIQRAQEMGVTKMAVVGFDTPTIEKSLQLSHDYPNIYSII
GWHPTEAGSYTKEIENKLQEQLTLPKVVALGEIGLDYHWMEDPKEVQDKVFRRQIAIAKE
MNLPISIHTREALEDTYQILKEEDVRDIGGIMHSFSGDYEWAKRFLDLGMHISFSGVVTF
KKALDVQEAAANVPIERLLVETDAPYLAPVPFRGKRNEPGYTRYTVEKIAELRNLPTEEV
AAQTWTNAHRLFGLSEHG
>FECAFAII_02421 Serine/threonine exchanger SteT
MKGKLKREINLFGALATVMGTVIGAGVFFKTAAVTASTQSTSLTLLAWLLGGFLTICAGL
TVAELATAIPETGGAVKYIEAAYGKLPSFLLGWAQSLIYFPANIAALSIIFATQLTNLLQ
LSTDYLLLIAVITAVSVTGLNLLGTKVGASVQSVTLIVKLIPIAVIVIWGLLTPGQGTVQ
LFPIEAGKDVTFVEGLSSALLATLFAYDGWLGVGAMAGEMKRPEKDLPKAIILGLSFVTV
VYLLINFVFLKTLPIDHLAGNLNAASEASDVIFGGIGGKLVTIGILISVYGALNGYTLTG
IRVPYAMALEDELPFSKQLTKLSKKFTVPYVPAVFQLAVACIMMSLGSFDFLTDMLIFVM
WLFSLLIFIGVFILRKKAPELPRPYKVPLYPIVPIIAILGAIFILGMTMMTQTKLALIGI
GVTLIGIPVYYQKKKKRSEE
>FECAFAII_02422 hypothetical protein
MDFKRSYPKLADYLSNRVDFSRKEQQQSHWHWFTLILFGLMTVATLSQKLILLTLFIAIV
ALIKGPVMILWGMLYSFLVGLFPPIGILLSAIFFLLNIGTFTKNWRMTLVGIYFYFYPFG
VMALSEVMHWDNHWFIAGSLLLGLILLHVMLTKLYQHYGIGRTIFWYVFSIPFALLTALL
PSRLKTKIKGYHKIK
>FECAFAII_02423 Methionine--tRNA ligase
MAEKETFYITTPIYYPSGKLHIGNSYTTIACDAIARYKRLMGFDVFYLTGVDEHGQKIET
KAEELGVKPQEYVDKMAADVKKLWKTLDISYDKFIRTTDDYHKAAVQKIFDRLLEQGDIY
LGEYEGWYSVSDEEFFTETQLAEVYKDDEGNVIGGKAPSGHEVELVKEESYFFRMSKYAD
RLLEYYEEHPEFIQPESRKNEMINNFIKPGLEDLAVSRTTFTWGVPVKSDPKHVVYVWID
ALSNYITALGYGSEDESLFEKYWPADVQMVGKEIVRFHTIYWPIMLMALDLPLPKKVFGH
GWLLMKDGKMSKSKGNVVYPEMLVERYGLDALRYYLLRAVPFGSDGVFTPEDFVSRVNYD
LANDLGNLLNRTIAMINKYCDGLVPDYASLVTPFDSELSTTAANVVGRYHDAMEKMEFNT
ALAEIWVLISRANKYIDETEPWVLAKDEEKKAELNSVMIHLAESLRIAAILLQPIMTETP
EKIFNQLGLDSETMNLEGLHFGEFPSGTKVVAKGTPIFPRLDMEEEVAFIQEKMSEGTQT
NEDTVKWDPEETELVSTKEKQIKFDVFEKVELKVAEVINCQKVEGADKLLQFRLDAGDSQ
DRQILSGIAEFYPDPSELIGKKVVIVANLKPRKMRGQISQGMILSAEAPDGSLQVIEAPK
SMPNGSEIA
>FECAFAII_02424 hypothetical protein
MQKKHLFFTLSIAFLSLAHLIFSYFYIRMYGYFNLHGHLNSFMTAAWILRFIIDVYIVIC
GFFAIREERYKVLPFYLLFFLFNLILPFIFHI
>FECAFAII_02425 Bifunctional NMN adenylyltransferase/Nudix hydrolase
MNRFASKEEEKLYYEHKASEEEFLNWYQKQERPEYDKPSLTVDIVLMCYNKEEDQLKVLL
IQRKGHPYRNSWALPGGFVQKDESTGESVLRETKEETGVVISKENIEQLHTFSTPNRDPR
GWVVTVSYLAFIGEEPLIAGDDAKEVRWFTLERHSNKIHLSSGEVAISLDLVTGESSGKD
TLAFDHSQIILKAFNRVVNKMEHEPQVLQVLGKDFTITEARKVFAKFLGIDYKTIDHSNF
KKAMLQYFDEIGERPVGIGRPSKIYQLKPGHHE
>FECAFAII_02426 hypothetical protein
MLKAFKFRMYPTEEQKQQLIRTFGCARFTYNHLLKKRQKSWQQTGVANFSLTPATLKKEY
PFLKEVDSLALANAQLNLDRAFRNYFKGRASFPKLKTKKSMWQSYTTNNQTRTIYLENGY
LKLPKQKELIKINQHRPVEGSIRSATISARYNEEFYVALLCDVSPVKKESLAKWIGIAYH
PKTLIQTSRPLEVTLPKFHQTEEKLQHAQRKLNVKVRSAHHRKIRLDQASNYQKQKRKVM
DLYLKQKNQREDYLEQLSGKLVKQYDYLFVESFPKEEAHADFSIHDWHKLITKLRYKSQW
YNKKFLLINTDGAEESNSVRKSQVVEKMGRHSVIKG
>FECAFAII_02427 Oligopeptide transport ATP-binding protein OppF
MPNKLLEVKGLKQYFNVGKKNEVHAVNDISFHIYEGETFGLVGESGSGKSTTGRTIIRLN
EPTDGEILFDGQDITKIKDKKGLTKFRHDVQMIFQDPYASLNPRMKVRDIIAEGIDVNGL
AKSSEERAKKVDDLLRTVGLNPSHGTRYPHEFSGGQRQRIGIARALAVKPRFIICDEPIS
ALDVSIQAQVVNLLQDLQKEHQLTYLFIAHDLSMVKHISDRIGVMHNGLLLEMGTSDEIY
NHGVHPYTESLLSAIPLPDPDHERKRRRIKYQPEPDDGQVRQLREIAPEHFVYATEQEVP
YYAKKLKRQKESLLVAN
>FECAFAII_02428 Oligopeptide transport ATP-binding protein OppD
MTKILEVKDLEISFDTYAGKVRAIRGVNFHLNKGETLAIVGESGSGKSVTTRSIMRLLSS
NANIDAGQILFKGNDIVGKSEREMQKIRGKEIAMIFQDPMTSLDPTMPIGKQVAESLRKH
NKVSKKEGQKAALELLKLVGIPEAEKRINSYPHQFSGGQRQRIVIAIALVCYPEILIADE
PTTALDVTIQAQILELLKEIQTKIDTSIIFITHDLGVVANVADRVAVMYGGRIVEVGTSE
EIFYNPQHPYTWGLLGSMPTLDSANDRLYAIPGSPPDLLNPPKGDAFYPRNEFAMKIDAE
QEPPFFELSKTHKAATWLLAPQAPKVTPPEEIQRRWAIFKEKQKHTYGQGGIADAK
>FECAFAII_02429 Dipeptide transport system permease protein DppC
MEMIPKRYETVADIPADEFLPLQKNTEEEREQITAPSLNFIQDSWRRLKKNKAAVISMVL
LLVIILISVITIFVSPHDPTAQNVAYINLPPRIPGINIDGLNGKAMVGGELVDKYAQANV
PSNVNFFLGTDGLGRDVLSRLFMGMRISLLIAFIAALLDVTIGVAYGLVSGLLGGRVDNV
MQRFLEILSGIPNLVVMILMLVVFEPGIFSIVAAMAITNWIPMARIVRAQTMKLKDQEYV
LAGLTLGESRMKIAFKHILPNISSVIIIQMMFSIPSAIFFEAFLSFIGLGLTPPSASLGT
MLSEGYKTFLYLPYLLWIPAVTLSVIMIGFNLLADGLRDAFDPKMKE
>FECAFAII_02430 Oligopeptide transport system permease protein OppB
MNSYIKYVLKRVFFMIITLWLIATITFFLMQLLPGTPYTNQERLSPETIEMLNKQVGLDK
PVIVQYGIYLSNLLQGDFGISFQFKNQPVAHLLAGRIGPSLQLGLQAIIFGTVLGTILGT
ISAMKQNTWADTSSTLVAILGRSIPNFVFAVLLQYIFAIKLQVLPIAKWDGFVYTILPTI
ALAMSPLADSARFIRTEMVEVLHSDYVELAKAKGLSRWEIAFKHGLRNSLIPLMTLLGPL
AVALMTGSLVVENIFAIPGIGEQFVKSITTNDYPTIMAVTILYSFMLIFVILIVDLLYGL
VDPRIRVSEGSRG
>FECAFAII_02431 hypothetical protein
MKKKSIPYAVAFLLILVILIKNLINHSFTLIQLSNDLFLWSLPFLIIGGFLWVFSSGFFD
HFQRSVHLARTRNRKKKPEFSSLSSASYGMYSFWLIIAGILIALSAIFMLFSLLG
>FECAFAII_02432 Dipeptide-binding protein DppE
MKKKFTFGLVAVCGLVLAGCYGGSSATSSSSAKSGSADGGGVFNLVVPQEMPTADLSVAT
DTISFTALNNVYEGIYRLDEDSKPQPAGASELAEVSEDGLTYKIKLREDAKWSNGDPVTA
ADYVYGWQRTVDPATASEYAYLYAPVENAEDITAGKKDKSELGIKAVGDYELEIKLTKQT
PYFQYLLAFPSFFPQKQSVVEENGDAYASASDKAVYNGPFTLEDFDGPGTDTEWTYKKND
HYWDKDTVKLSEIKVSVVKESSTALNLFKDGQADDVILSGELAQQNANDPAYTSVKEART
SYIEFNQREKNSPFNNVNLRKAISYSIDREALVKQVLGDGSVVSTGLIPSDMVKSPTTNE
DFAKEAGKLVSYDKDKAKEYWEKAKKELGVDSLEFDLMASDDDSSKKVIEYVQNSIQENL
DGVTVKPTPVPFSVRLDRSTSGDFDAVLGGWAADYADPSSFTDLFVTGNSYNRGRWSNAE
YDEAVKAASSTDAGDEQARWDDFQKAIKIISDDMGVVPVYQKAEGHLVNEKIKGIVHHAA
GASWDYKWTYVEE
>FECAFAII_02433 hypothetical protein
MIISEFDRNNPVLKDQLSDLLRLTWPEEYGDSSAEEVEEMMNPERIAVAAVDQDELVGFI
GAIPQYGITGWELHPLVVESSRRKNQIGTRLVNYLEKEVASRGGITIYLGTDDLDHGTTL
SQTDLYEHTFDKVASIQNLREHPYEFYEKLGYKIVGVLPNANGWDKPDIWMAKTIIPRPN
SQ
>FECAFAII_02434 Glycerol dehydrogenase
MSQSVFLPNYTIGTDAYEKANGIVKEYGTKVVLIGGKTALSKAENKIKVALTQEIEVVAS
LWYGGNSTYGNIEQLIQHESVQKADVLFAVGGGRACDTVKVIGEKLAKPVFTFPTIGSNC
SPVTAVCVIYNEEGVMDGLFFPSKPPVHTFIDTAIIAEAPDKYLWAGIGDALSKEVESTF
SARGDDLGYTDRLGIQIGKMCIDRLLTYGTQALKDSADDRPSYAIEQVVSDIIVTTGLVS
VLVNNNYNSAMAHSFYYGTTVLEKMEGYLHGASVSYGVLTLLMMDQQFDLFDKIYVFMKK
NQLPVSLTDMNLNVTTDLEAILDKAMATNDIKHVPYEITREKFKQAILDVETYHATQESQ
QGYKKIS
>FECAFAII_02435 putative dual-specificity RNA methyltransferase RlmN
MEKQSIYGLTNEELINWFIENGEKKFRAAQVWEWLYQKRVSNFTEMTNLSKQLIEKLSEH
FIINPLKQMVVQEASDGTVKYLFELPDKNMIETVLMRQEYGLSVCVTTQVGCNIGCTFCA
SGLLKKNRDLTAGEIVAQIMMVQHYFDERNLGERVSHVVVMGIGEPFDNYDNVMDFLHII
NDAKGLAIGARHITVSTSGLAHKIKEFANNGLQVNLAISLHAPNNEVRTSIMRINRSFPI
EKLMEAVDEYLEKTNRRITFEYIMLNQVNDRPEHAQQLADLLKDKKKLAYVNLIPYNPVS
EHDQYSRSPKADVLRFYDVLKKNGVNCVIRKEHGTDIDAACGQLRSKQMKKTVAK
>FECAFAII_02436 DNA translocase SpoIIIE
MAQKKRPTKKRKKTKKTKKQKQQQEQMLTIGVGFALILFAVFGFLKLGFLGILIANGFRI
IAGNTYQILCLLLAVLGFWIVIKNTEFSIGKNRRWFGGILFYFGILLLLHAHLFGKLHTG
EPNIMGTTWDLLASDIKQSQVDNNVGGGMIGAILYHFTYFLIAQPGSYLAAVLLLAGGAF
LFSNLEGYQLLNGIQSIGERVQELLEGDPAKQARKQAAKEERMKQRAEAKEARRLAAKEA
AEKEAAEYEKKKAVSQQRENTADEWQEPENTEPEQLSFVPIDSFQENIHPANLEKPVPDT
PKQTNTAEGFSDELPEDDGTSLEFEIEAEQENQDYELPTVDLLDSIPTVDQSDEYKKIEK
NIGVLEQTFQSFGVDAKVVKASLGPSVTKFEVQPAVGVKVSKIVNLTDDIALALAAKDVR
MEAPIPGKSLIGIEVPNGKISMVSFREIIEAQPNHPDKLLEVPLGRDVSGRVQTADLSKM
PHLLVAGSTGSGKSVAINGIITSILMRAKPHEVKLMMIDPKMVELNMYNGIPHLLTPVVT
NPRKAAQALQKVVQEMEERYEKFAATGVRNISGYNEFVQQKNLENGTKHPTLPFIVVIVD
ELADLMMVASNEVEDAIIRLAQMARAAGIHMILATQRPSVDVITGIIKANVPSRMAFAVS
SGTDSRTIIDSNGAEKLLGRGDMLFLPMGENKPIRVQGAFISDHEVERVVQFVTDQQEAH
YEEKMMPTDEVETTGAPEQPQDELFEEAKALVVEMQTASISLLQRRFRIGYNRAARLVDE
LEAHGVVGPSEGSKPRKVFIEQEETSETLPDDNDM
>FECAFAII_02437 Aryl-phospho-beta-D-glucosidase BglC
MEHKELTSFPKDFLWGSASAAYQVEGAWQEDGKGESVWDRFVRIPGKTFKGTNGDLAVDH
YHRYKEDIALMKEQGLKAYRFSVAWTRIFPNGRGEVNQAGLAFYERLIDELIENDIEPML
TLYHWDLPQALQDEYNGWESRQIIEDFTHYAETLFEAFRGKVHYWISLNEQNIFTSLGYL
LAAHPPGVTDPKRMYEVNHIANLANASVINKFHELEMPGKIGPSFAYTPNYPIDSNPENV
LAAENAEDLMANYWMDVYMWGKYPIAAMRFLEEKGWAPTIEAGDAELLESAKPDFLGINY
YQTATNAFNPLNGVGAGKMNTTGKKGSSEETGVPGMYKKVENPFVERTNWDWEIDPEGLR
IGLRRITSRYRMPVLITENGLGEYDKLTEDKQIHDDYRINYLQSHVKAIKEAISDGAEVL
GYCTWSYTDLLSWLNGYQKRYGFVYVDQDETQEGSLERYKKDSYYWYQKLIEENGENL
>FECAFAII_02438 L-cystine-binding protein FliY
MKKTSFLFALIAGLLLFAGCSNKKTSADNWATINEEKKIVIGLDDTFVPMGFRDKDGKLT
GFDIDLAKAVFEQYGITVDFQPIDWSMKEFELNNGTIDLIWNGYSKTPAREKKVQFTKPY
MENDQVLITPKESGITNFGQMNNKRLGAQNGSSGYDVFTKQPEVLKEIVKNQDAVLYDSF
NEALIDLKSRRVDGLLMDKVYADYYLKQRNELEDFNITKGSYESEDFAVGARKSDSTLVK
KINEALDQLEKTGEFQKISDKWFGEDVTPRN
>FECAFAII_02439 Glutamine transport ATP-binding protein GlnQ
MIELKKVNKAFGEKKIIKDLNLIIPDGKTLAIVGPSGGGKTTLLRILAGLESSDSGEFYL
DGVPFNPFELKMKEQVVGVVFQDFQLFPHLNIFENITLAPKMVLKQTKEEYTKKAEELAA
SLGISDLLNIYPYQLSGGQKQRVAIARALAMNPRVLAYDEPTSALDPELRQQVERLILSL
KEDGVTQIIVTHDLVFAENVGDQLLKVSPIH
>FECAFAII_02440 L-cystine transport system permease protein YecS
MEYLIEVMPQLLVGALTTLKLFLFTLIGSLPLGIVLALGLSLHFKPLRYLLQTYVWVMRG
TPLLLQLIFIFYGLPTIGIVFDRFEAALIAFILNYAAYFAEIFRGGIQSIPQGQYEAAQV
LQLSPFQTVTKIVIPQVTKIVLPSVGNEVINLVKDSSLIYILGLGDVMRAGKIAMERDAT
LLPLLGVAIIYLTLTGILTIVMKQVEGKLNYYR
>FECAFAII_02441 Prolyl-tRNA editing protein ProX
MSRATEQEAYELLKKLGISFQKVDHPAITSVKNVPFSLPGPQVKNLLLKSRKGKQIYLVI
LPDEKHADLKQLAEQLKEKRLSFVSEEQLPDLLGVPAGTVTPLALMHDKEKKIQVVIDAA
IDRQDTVGFHPNINTTTLIMDFSDFEKILVYLEHLPVYENL
>FECAFAII_02442 Collagen adhesin
MKKCRNIILSMLFIITNITSLIPVHVYADAGRDISSNVTSLTVDPTNITDGGNIKVKFSF
DEKKQNIQPGDYLWINWPSEGNIRGEGFQKEIPLMIENKNVGTLTVRKDSAQVVFNENIK
NLDSVEGWGQFEIQARNVTDTGEENTGPFTVTSGDKTATVNVTKPASGSSSSVFYYKTGD
MLPEDTKHIRWFLNINNNGTYVEQPVKISDEIQSGQRLDPSTFEINQIHLGEQKVYRGEE
GIQQFLQDFPSATFNFSVTDNYIEITIPKNFVNLRKIMVSYKTIIENPEQINFENHSEAW
FKEFNKPAVDGESFNHTVKNISASGGVNGTVRGELKIFKYINDTEIGIPNVTFELRRADE
QPIQGQSSILLTSNEQGEASIKGLQVGDYVVKEKEAPNWIDFDPLSSNELKFSINENDTE
GVSLPIYNKKKVTNITATKIWNGGTTPRPSIYFKLFRASTNNWEPVPDAETKRLDNGITS
VTWEDIQQYDDSGNEYTFKVQEVDQNGNDYVPSGYQKIENGLVVTNENKEVISVSGQKTW
EDNENQDGKRPTTITVNLLADGQPIQHKEVSEKDDWRYRFTNLPKYRDGQEIIYTVTEDN
VPEYSTTIDGYNIKNSYTPEKTNISIPGSHITPWKNFPEKTEREKIRNLFSQKLQIFAHT
GESSEQRSNYISKRAVPKQITNKSKSILPKTSSKKSSFAVIIGLLIVTICAGIFLQKYKK
V
>FECAFAII_02443 Lactococcin-A immunity protein
MSKSEEIENMVLKLYDLVLNPEIKEKERILLIDAKTGLEKGQYYPKVINNLERSLRPLAI
RGELSKPVSPFYMEISTIGKFEKELGRGMASAPITFGHL
>FECAFAII_02444 hypothetical protein
MIFPKVNEASLNKGSFFHIYENEDFELYNILSQKEVIENQIICHPIIYKSIFKYAFFASN
DFQRMEITDCIFENCDFSGCILTKSMLHRVKFVNCKLTGTKLMESYIGNTLFENCKMDYV
NLSGSNIKESTFEHSVLSSADFVDCSLTKIMFSTNDLENASFFDTDLKNIDLSSNSFEMI
EVRSEHLKNCTLNQLQALGFARKFLQIKVV
>FECAFAII_02445 hypothetical protein
MNNILGKKIELKKGILGTIVVVLGLLGLLFAPSIISIFSLTITGFIAFTLVFGKKDTKKM
FSKPVAPVKNIAKYFFINVVISAAVSVFLQQILKWGLTGNPINEAFSPLLFIILPIMILG
EELFSVYFLAIFSSKFSIPVASFLSAIIFGFIHYSTYDNGNILHTVAHILLIQGVARLLF
NQAAIKSNSIITSWAVHVIFDFTAILLVVLFS
>FECAFAII_02447 hypothetical protein
MKMATFGKFDTTIVPSEIGEKFKINTHVMFTIHGKSQTGTISKQLKNSAVVEIDETAENA
NLMTQSKGVVIVNYKELKKI
>FECAFAII_02448 Uracil phosphoribosyltransferase
MGKFQVIDHPLIQHKLTIIRDKNCGTKVFREVVDEIAMLMAYEVSRDMPLEDIVIETPIT
ETTQKTLSGKKVAIIPILRAGIGMVDGILELIPAAKVGHIGLYRDEETLEPHEYFVKLPE
DIDARQLFVVDPMLATGGSAIMAIDALKERGASNIKFVCLVAAPEGVKALQEAHPDIDIY
TASLDEKLNEHGYIVPGLGDAGDRLFGTK
>FECAFAII_02449 Carboxylesterase NlhH
MTDRISLEKEAVAFSDANAPHPRIYELAPEEGRVLLEEVQESPVNKYSVDIEDLMVDTGE
WGKLNIRLVRPEGNMDKLPVIFYIHGAGWVFGSAQTHDKLIRELAVRTNSVVVFPEYSRS
PEAKYPTAIEQNYAVLQQLNKLAKSKNLDLENLIVAGDSVGGNMATVMTILTKERKGLPI
SKQLLYYPVTNADFDTDSYHEFGENYFLTREGMMWFWDQYTTNEEERAEITASPLRANIN
ELNDLPSAMILTGEADVLRDEGEAYARKLRDAGVPVTQVRFQGIIHDFVMVNAMDQTKAT
RAAMALSTSWIKKKE
>FECAFAII_02450 Serine hydroxymethyltransferase
MVDYKTFDPDLWAAIAKEEERQEHNLELIASENFVSEAVMAAQGSILTNKYAEGYPGHRY
YGGCEFVDIVENLAIDRAKELFGAKFANVQPHSGSQANTAAYLALVEPGDTILGMDLSAG
GHLTHGSPVNFSGKTYHFVAYGVDPTTEVIDYNVVRILARKHQPKLIVAGASAYGRTIDF
AKFREIADEVGAKLMVDMAHIAGLVAAGLHPNPVPYADITTTTTHKTLRGPRGGMILTND
EALAKKINSAVFPGIQGGPLEHVIAGKAVAFKEALDPAFKEYSEQIIANAKAMVKVFNQA
IGTRVISGATDNHLMLIDVRELGINGKEAESILDSVNITVNKNSIPFETLSPFKTSGIRI
GTPAITTRGFKEEDAVKVAELVVKALQAKDDNAQLDEVKTGVRELTEKFPLHKK
>FECAFAII_02451 hypothetical protein
MINWLLSHSFSMIQCYQVNLLSVNEKLSVTNRNRRDTNIWQFVFDGKNKIVGK
>FECAFAII_02452 Threonylcarbamoyl-AMP synthase
METKRYDETELQEAAEALKEGELVAFPTETVYGLGANALLPNAVKKVFSVKGRPQDNPLI
VHVASFEQVKEYVDNFHPAAEKIVKNFWPGPLTLIFKIKKDTLPSVVTGGLSTAAFRIPD
NKKTLEVIELSGVPLVGPSANTSGKPSPTTADHVYHDLQGKITGIIDDGATRIGVESTVL
DLSDPTAMPMILRPGAVTKEQIEAVIESPVAIDQHLVKENETPKAPGMKYKHYSPDTRVL
MVRDGDWSTAVQWAKNKKIRAGVIASPEIADQVRTDTAAVYMYNDNSVEAAAKGLFAGLR
GLDEPTLGLDLIFVQVYPETGLGNAYMNRLKKAAGQNYFEK
>FECAFAII_02453 Release factor glutamine methyltransferase
MGKMTYREVLSRASSFLEDHGKEAYSIQFLFLERKQWKKLDWLLHMNEEISEEEQRLIET
DLRLLLADHPPQYLLGYADFYDHRLKVTEATLIPRPETEELVEWCLDETPGVPLEVIDIG
TGTGAIAISLKAARKNWHISAVDLSEEALEVAKENAQKEGTKISFYHGDTLGPVMDQQFD
VIISNPPYISRNEWELMDESVRSFEPKMALFAENDGLAIYEKIAVEAPSVLKSNGKIFLE
IGFRQGEAVKKIFQQAFPDKKVAIKKDLFGNERMIQVYG
>FECAFAII_02454 Peptide chain release factor 1
MYDQLQAIEDRYEELGELLSDPEVISDTKRFMQLSKEEANTRETVEVYRRYKEVVQGITD
TEELLGEKLDDEMAELAKEELSELKKEKEVLEEKIKILLLPKDPNDDKNIIMEIRGAAGG
DEAALFAGDLFNMYQKYAEAQGWKTEVMEANVTGIGGYKEVIMMITGDNVYSKLKYESGA
HRVQRVPSTESQGRIHTSTATVVVMPEAEEVEIDIEDKDIRTDIYHASGAGGQHVNKTAS
AVRLTHLPTGIVVAMQDERSQIKNREKAMKILRARVYDKIQQEAQSEYDANRKSAVGTGD
RSERIRTYNFPQNRVTDHRIGLTIQKLDQILAGKLDEIVDALIMYDQTSKLEAMQNG
>FECAFAII_02455 Thymidine kinase
MKKSMAQLFFKYGAMNSGKTIEILKVAHNYEEQNKPVVLMTSGIDTRDGLGVVSSRIGLK
RNAMPIFEETDVFDVIQKMESKPYCVLIDEAQFLKKKHVIAFTRIVDELDIPVMAFGLKN
DFRNELFEGSKYLLLYADKIEEMKTICWFCHKKAIMNLHYIDGNPVYEGDQVQIGGNEAY
YPVCRKHYFHPSMITEGE
>FECAFAII_02456 hypothetical protein
MGIKKDYHHQGLGTKLFKEAEGYAAKHYKYLQVKTVDEGHYSIYDQTICFYESLGFSRLE
VFPNLWDEWNPCLVLVKKLEQK
>FECAFAII_02457 hypothetical protein
MPISFVKDREEKGKCVREILLDLPEWFGLPESTEKYIEESSKLPLWCEKRKEEYLGFITL
SQTSEDTAEIYSIVWE
>FECAFAII_02458 Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE
MTKNIFDSIANHYDSPDRQALAKIIREELTTYLPRDSHQKVLLDYGGGTGLVSLPLAERF
KELIIADASETMLKMAEEKIQAADLKNVRTIHADASVEFPAVQANLILLSLVLLHIPDTE
NILTKLYEILAPGGQLIIVDFDKNEQISHPKVHNGFSQEELNNRLEKTGFVSATSHTFHR
GEKLFMNKNASLFLSISQKA
>FECAFAII_02459 Signal peptidase IB
MKEFLKNWGILILVLAAILLARVYVFTPVTVNGHSMDPTLSDGQRLISSKISNYERMDII
TTKEPGDEERMIVKRIIGMPGDTVKMENDQLTINGKKYDEPYLDEFKKEFSEDKLQGEYA
YSSGFQAQAESSSTFTSDFEYTVPKGKYLVLGDNRLISKDSRMFGLVDKDMIQGKVVFRY
WPLSEIKIM
>FECAFAII_02460 hypothetical protein
MTFLLDLINGVHKFLGYLDISPKYLNRGYTILSVIPTLYLLRIVYGLWQNQNYLQFFLYG
LAFLVLVYFTVLNVFYYFLDKNTKADVTQLFVKYLPDEAFNIQTEESIDNGNSIDKVNTQ
EVMVSYDEDYQLKLAENMRYLIGNGEIKTNELGRMDGFLVDRNTLYPYYYVKKTGEKEYV
LNIGRSYSDMEKVGTIRLDSTEDTLEPVGLFIVGGDFVKDGLRYHEPYRLKLIAKKAQSQ
EEPVVYSRSQRRRHS
>FECAFAII_02461 hypothetical protein
MRKVAPILKPIAVLTISTIVATTTGIVNSSSYRAPSSSSSTVEETTPTTSVSTSEPTTTE
SLNETTTTSTWDDTTTSSSYDETYTTDSSSETSNTVPDGTPSDSTNPSTSPDTSASSETI
PSSTTVDDNTQNDDAARTAQQNQDSGNTQTYNQQAGDSQ
>FECAFAII_02462 hypothetical protein
MINAQQIVEKMKNQKINYDTVLKKMIMQWEKEEVKPKILIHTCCAPCSTHTLEFMSQYAE
ITLFFSNSNIHPKSEYLRRLHEQKRFVDQFNEKTDHHVALIVDEYRPNEFTKMVLTNHLE
NEKEGGARCSACFNMRLDLVAQKAQELGYDYFGSALTISPKKNAALINQIGMDIQKIYGT
QYLPSDFKKNKGYERSLQMCKEYDIYRQCYCGCVFAAKQQGCDLKEINREAKAYLKTSTV
VFEEN
>FECAFAII_02463 Potassium/sodium uptake protein NtpJ
MHVDLFFRRLQRRGQKFAANHFSSIQIIVFYYILMTVLSLVLFYMPIFREPDSHVSFVDM
LFMAISTVSVTGLSTFDINSVFNDNGIILLEILFQVGGLGIMMISTAFVIFSKRRITLKQ
RQLIMTDMNQPRLSGIVRLIRITFAILIWFQLLFGTFFSIYFYYRGYFDRWRDAVFYGFY
QAISAVTNSGFDVTGDSIKPFAHDYFFLILIMFLIFVGGIGFPVLMECREWLLYKRSNAK
LPFRFSLFTKLAVLAFVILFVSGTVLIYLLEKDHLFQDSNMSVKWINSMFYSITTRNAGL
QIHDLGDFQITTLIIFSLLMFIGCSPSSVGGGIRTTTVAIIGLYLYSFLKSEDNINIFGR
RIDQDDVRKSVVVFMLSLGMCFFCIVFLSATEEQTLISIIIEVTSAFGTTGLSLGITGDL
SVVGKITIATLMFIGRIGMLYTLMLFVPKETRDLGYEYPSEKIIIG
>FECAFAII_02464 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MGIRSHFAIAVGKTSQWALKTFFKGGSSLPGKLALKVDPHILDSLAKDYQVVVVTGTNGK
TLTTALTVNILRQQFDEVLTNPTGANMVQGIVSTFLQAKPKKGQKKFAVLEIDEASLSKV
TEYMKPELFLFTNIFRDQMDRYGEIYTTYKMIVDGAAKSPNATIISNGDSPIFNSIETVN
PRKYYGFDHEEDREQMAHYNTDGVLCPNCHHILHYKMITYANLGKYYCPNCDFKRPELDY
RLTDMVRMDNVSADFVIDGHEYGIEVGGMYNVYNALAATAVAEYFNVDPDKIKQGLGYDE
KVFGRQEVININGKKCTLVLVKNPVGINQVIDMIGLAPYPFSLVALLNANYADGIDVSWI
WDGNFENFADMDIPAVISGGDRHTDMTLRLKVAGIPENKLTETKELPEVIEKIKELPTEH
VYILATYTAVLQLRKELAAQGFIKGGMNRG
>FECAFAII_02465 Cobyric acid synthase
MANYELNIAHLYGNLMNTYGDNGNLLMLKYIAEKMGVSCHTEIVSIHEPFDADKYDLVFF
GGGQDFEQLIISKDIQKKKDSLINYIENDGVMLAICGGYQLLGHYYMGANGEKIQGISAL
DHYTLSQENNRFIGDIVIHNEEFNETYYGFENHNGRTFLGEGERPLGKVVQGQGNNGEDQ
SEGVIYRNVFGSYFHGPILARNENLAARLIRLALEQRYGKELDLPYLEGQTA
>FECAFAII_02466 Mannitol-1-phosphate 5-dehydrogenase
MRAVHFGAGNIGRGFIGEVLAANGFEITFVDVNHTIIDALNERKEYEIELADESKEKITV
KNVKGINNQTNPEKVIQEIAEADLVTTAIGPNILPFIAELIAKGIQEREKEGSTTSLDII
ACENMIGGSAFLEKEVYKYLPETSFTDKYIGFPNAAVDRIVPLQHHEDPLFVQVEPFKEW
VIDDSQRKNKKIQLKGVLYVDDLEPYIERKLFSVNTGHATVAYTGALLGYQTIDEAMQDA
LVVAQLKSVLQETGSLLIAKWGFDAEQHHAYIEKIIHRFQNKNISDAITRVARTPLRKLG
YQERFTRPVRELQEHNLTCPHLTATMGIIFNYYDPEDEQSRQLHEMKIHENLEQLIQEVT
GINDPKTIGNIKQNVNRYAKQVA
>FECAFAII_02467 Mannitol-specific phosphotransferase enzyme IIA component
MQSLPFDMIELNRSFKTKEEAIRYCGQMLVEAGCVDEEYIDAMVDRDKMLSVYMGNFIAI
PHGTDEAKKYVKKSGICVVQVPDGVDFGTEEEEKIATVLFGIAGVGDEHLQLVQQIALYC
SDMDNVVQLADALSKEEVTENLAIA
>FECAFAII_02468 PTS system mannitol-specific EIICB component
MERTIPKNNISLKARVQKLGSTLSSMVMPNIGALIAWGVLTALFIPDGYLPNEAFATMVS
PMLTYLIPLLIGYTGGKVIAGDRGSVVGAIATMGVIVGTDIPMMLGAMIMGPLGGYAIKK
FDQLFQKRIKSGFEMLVNNFSAGLIGFGLALLGFSAIGPVVDALTQAMAKGVEIILSAHL
IPLTSIFIEPAKILFLNNAINHGILTPLGTEQVAEAGKSILFLLEANPGPGLGVLLAFTL
FGKGAAKSSAPGAMIIHFLGGIHEIYFPYVMMKPLLFLSVIGGGMSGSFIFQLMDAGLRA
PASPGSIIAILAMTPFNSYLPVILGVIVAAAVSFGISAVILKADAKDTNEDFEKSVQETK
AAKQASKGAQGIPQGATFSGVQKIIFACDAGMGSSAMGASILRKKVQEADLPQTVTNQAI
SQLTDDSNTLIVTQVELQERAKQKAPSARFVSVENFLNSPRYDEIIQELSSKQKTSVSEI
ENEPAEEFLSANIKQIKEILLVHDDRSGSATMGMTVLKDILDKNHLTIPLRKVNIQDLKD
EPDSLIVAKESLAEKVQMAAPQSIHLSVNSMVNPQKYESIAQYLKQTA
>FECAFAII_02469 ABC transporter ATP-binding protein NatA
MTLLIKNMNMKRGKKRVIRQLNLLVESGEVAALIAPNGFGKTTLLNGIAQLLPTTYDQLS
LHNISPTAYTDYRRSFFFLESTNQLSDYLSAVDYLTLIKYYWQSKVECQTVFQRLKMTEY
LTLPIGKMSLGMKQHVLLAAYLISDSSVMLFDEPLNGLDPGSIDILNSLIRQWQKEGKTI
LLSSHAIANIQSICSKACFLKNGEIVTESSNMEEILAIYRKLYEV
>FECAFAII_02470 hypothetical protein
MSLLTFERNLLLKNKVNFLFPLLLVVLFAFPLFFDHKLAYTEFDELNHNYEEMQRLIETL
KEDENEKEFVESLEKSNKLIEAILHAKNTGNVQQMVEATYHYEKDILDRLISGQRQGIPI
IEQQKRVELLRYMKEHQIQRYSIFDLPAHLSLANYYENIFSGMISSFLILCITALFLSSI
ISYEKRKQVISLVNLLPDSMVKKHSIRFTIYYGAAMLSLVMPFLIVSILVIIKNGLGDFR
YPVGTIIGQEIRILPMYEYLFQSFLFLLLWVLFLSTISFLLSALFEHSLVNLLGTLLCLF
LAEYRLFSSIGWIESISHYLPTSYVDFQNVIIGGDIFSPLASEQVTFMNGILTLGIWSIV
LLFIGMGTIYIKKSY
>FECAFAII_02471 Mannitol-specific phosphotransferase enzyme IIA component
MIQLPAEKILLDQSYQNWKEALTEIGQWMTQQGGIKPAYIQSMIERQEKASVYIGNFVAL
PHGTDKDEEVVEEGIYLVQVPDGVDFGTKEEPKIATLLFVVALKKEHQLAVLQDLAFFCS
DIDQVMALSDAETIEEVQMIFEHGHI
>FECAFAII_02472 Transcriptional regulator MtlR
MYLSPREKQLLAEFLSSPSPVSIQKMMNLLKVSKRTIYRELDNLEVSLKSVNASLKKAAR
GSFVIEASEEVLEQLKENTDGKSNDLSTAKRQHAILAELLLTTEPLSLAHFMESYRISNT
TFYADIKQLEESIRQLPLEIIRNQGYEIEGPEKYRRLLTANVLELEINEYELFHSISFDA
SLNYFFRFVDPQHLSLARKVIGEELIQKKTNLSDRKLEHLVLMLTLTMERVTKNHLLTNE
TYNSLANKELLQTAKRLFSRIASETKQLYPVNEIVFFAGLLNDFTNSFDQNFFEETFDTQ
LAYLVKQLIQEVSEETNVHFYEDETLYKMLLTHLSGVFSRAVLQEETLTNPILEKIMVQY
EEVANAIRKAVERIFQEKKLSEEEIAYMVLHFANSLERSPKESNISIAGFSPSGLASTSM
LELRLKRYFPFIQQIHFYRIADLKKIDLQEEYDVVISTSILPGYGGKYILVSPLLLEDEV
KQLKEAFSHIEKKKRQKITYNSNNEWMIEDTYEETMHFMDQINQLLGRFFIQELDNPETI
SETIRSLFPYFPEGLVTDEEVVHRRLLKRYEQAPIGIPHTNMGLFHTSSSLISKPIFCIF
NLKHPLTIEGMDRQPVDLSRMLVMLAPSPIQEKDGILLGKISGAIIMNDLNTEIFRSGNK
EIVYQLLAKILIEEIKK
>FECAFAII_02473 PTS system mannitol-specific EIICB component
MKFKAGYEMLVSNLLVGLTGSVICIIGIVFIEPVLNSVHLLLASVVSWLVTMNLLPLVSL
ILEPLKVLFFNNAINHGVLTPLGIEFSQTVGYSSLFLMEANPGPGLGILLSILCFAEKQE
KVNASGALMIHAIGGIHEIYFPFVLLRPYLFLAVMAGGASGTLIFQWLDTGLAAPVSPGS
LLVIFANAPYPQLAGVSIGIAISTFVTFICAAILLKLPNKEKENKTVKERGEILEPSIIH
SVIFACDSGMGSSAMGAALLKKKLAAEKIDLSVGYSSIYELNNQVNQLVIVQHELAGLAR
EKVPQSQIYVLDHFLETDILLSRIKEAIQFPKREEKKEIADITEQKTSPANIVFLYKNNR
RGSQTMGMTILSQLAKKAKKQFVISKESIEKIKIQEETIYIAQRELAVTEQLEEKIPRLV
LVEHWVATNEYEKLVKGEI
>FECAFAII_02474 PTS system mannitol-specific EIICB component
MKQLRKAGHHLNEMIMPNLSLFIAWGILSLATKGVSGDLHTTLEEVCHWMIQLLLPILIS
YSGGKSVGGQKGAVAGAIASLGLIARSNAPQIVGAMIIGPLAGIVYEQNNLFLDSM
>FECAFAII_02475 putative mannose-6-phosphate isomerase GmuF
MQEPMFLKPVFQEKIWGGSRLRSVFGFDIPNDKIGEDWAISAHPHGVSVVENGEFKGKRL
DELWSEHKELFGHPSEPVFPLLIKILDAEDDLSVQVHPDDAYGMKHEGELGKTECWYIID
AEPGAEIIYGHHAKTREELAEMIKDGRWDDLLKKVPVKKGDFFYVPSGTIHAIGKGIMIL
ETQQSSDTTYRVYDYDRKDAQGQTRELHIQQSIDVTTVPAKTPELQIKEVRKGNSSIVTY
LETEFFNVYEWDIKGITSFKKQAPYTLMTVIEGAGDLVVDGKTYPLEKGTSCIIPNGVSE
WAVQGELAIIASEPGK
>FECAFAII_02476 D-alanyl-D-alanine-carboxypeptidase/endopeptidase AmpH
MYPHTKQLILKKMEEGFYPGVAVAFIKENQVETFTAGFAQVVPEKQLMTEDLLFDAASLT
KVVATTSLVLRLLEDGKIELDQPLHKYLPEFENQTITLRHLLTHTSDIKTWIPNRDKLSQ
EELIAAYLKLEPGEQLGKEVKYTDAGTILLGLMLEEIYQETAVEIFQEQVLEPLGMMNSL
FLPFPSKKIVPTEQLPSGEVLRGQTHDPKARVLAEHAGNAGLFIDLKDSITFVQMYLNKG
KIRNGRFLEEETIDSLLQDQTPKKNGYRSLGWDLKKDVEDGHAILFHTGYTGTFFLIDIK
TQEALIFLSNRVHPVDHRAEYLICRDEIVENFLKEKAVLPK
>FECAFAII_02477 Catechol-2,3-dioxygenase
MKDFQLGAATYLKSVAIRVKDRDKMIDFYKNVVGFDLKREENELAILGTEEAGSEMLLLE
ESPRANDHMGVIKKLNRFSLIIPSTEEMADILCRIRKMNYPIKEALEDHGRMGILLVDPE
ENELEIYHEENKNDQREIPETMDQEALLRKSEEKFSKLSTGSYFEKIHLNVTNLTKERQF
LNHVLGLKVHNEEEGIHVLNEGDFHVGLTEASGGAIDLPTDEVIGLDFLKFMIDTESMEG
LIAHLQQLSVDFFLDKKHTVLTIYDAIGIEWWFVSEPKEKNKTDIRCDA
>FECAFAII_02478 putative ABC transporter ATP-binding protein
MAGAQQMQQGQQVTKFPIDFDKIAQIIATVIVMYLISAVFNFLQQFIMTRVSQRTVYELR
HDLEAKMNRVPISYYDTHTNGDIMSRAINDMDNIASTLQQNLTQFVTSAVTLIGVIVMML
SISWQLTLVALLMIPLSLIIVMIVAPKSQVFFADQQKSLGLLNNQVEETYGGHTIVKTFN
HTEKDQEVFEKENQNLYAAGWKAQFISAIIMPLMNFVKNLGYVFVAVLGGVKVANGNMTL
GDVQAFLQYTTQFSQPITQLASLMNTIQSTVASAERVFEVLDEEEMSNEKSGLPEEKDTP
YKVRFENVQFGYTPDNLLMTDFNLDVKPGEMVAIVGPTGAGKTTLINLLERFYDVSGGSI
RYDGVDTRDLSRDELRAQFSMVLQDTWLFTGSIYDNIKYGNDDATDEQIIEAAKAAHVDD
FVRKLPEGYNTVLNEDASNISQGQRQLITIARAFLANPDVLILDEATSSVDTRTEILIQK
AMNRLLENRTSFVVAHRLSTIRDADNIIVMNHGSIVETGNHDTLMEKDGFYADLYNSQFS
EEEAS
>FECAFAII_02479 hypothetical protein
MSKTNTRPSHGPAGGPGHGGPGRNLGVKGEKPKNFWGTVRRLFGYMSKRMVAIIAVFVLA
IAAVIFQIQTPKVLGKQPQKYSKV
>FECAFAII_02480 putative ABC transporter ATP-binding protein
MLKIVKRISLTSAIAAAVFMVIQVLADLYLPTLTSNIIDKGVAQGDVDYIWHTGFVMIGF
SLISILAAIANTFFATRESQKLGKQLRTDVYKKSESLTKDAFDKYGTASLITRTTNDVTQ
IQMVTQMFLRMMINAPITLIGASILAYQKDHQLTKIFLVVIPVMIILIGGIMYFAVPLFK
SMQKKTDRLNLVFREGLTGVRVIRAFDKTRFEENRFDLANKDYTNTAIKVNTIVALMMPM
MTLIMSGTNVAITWFGGHYIADMTLEVGNLIAFMTYAMQILISFMMLSAIFIMVPRAQAS
ADRINEVLDEKIGIHDPENPKTVSFAGKNATLAFNHVNYRYHGAEKLALEDIDFQAKSGE
IVAIIGGTGSGKTTLVNLIPRLYDIESGSIQINGTDISDMTQYNLRELMGFVPQKAVLFS
GTIRDNMQYGKPDATDEMIWKALEIAQAKDFVSEMEDGLDSHVEQGGGNFSGGQRQRLAI
ARALVKTADIYVFDDSFSALDFKTDANLRQALKTNMKESITVLVAQRVSTVMDADMILVL
DEGKLVGKGTHEELLATNETYQEIVHSQLREEDLA
>FECAFAII_02481 hypothetical protein
MPTQTFFHLPKEKQKRLIEAARIEFSRVPLKEASIANIVKLADIPRGSFYQYFEDKEDLY
FYYFETMRRDSSKDMLQLMKESDGDLFKGFESYFSKMIYEILEGENASFYRNLFMNMDYR
ASRKVAPHTSRQKTPHDPHKEHKQDAKELLELIDRTKLKVKNDHELELLIQLVMNTVFTT
IAHSYRLFSTSEDYSVEQAISEFNLKLSWLKNGVYK
>FECAFAII_02482 Thiosulfate sulfurtransferase GlpE
MAQSISVQDFNKLPLDADSIVLDTRNTLDYTKNHLSHSLSIPAAILPRQLKNLDPKKLYY
ILSYTGRRSEALADQLTANGFRAVYIIGGMEALQSSVA
>FECAFAII_02483 FMN-dependent NADH-azoreductase
MASVLVVKGHPLTAEESRTVKALTSFLTSYKENHPDDEVTVLELYRDDIPEIDEELLSGW
EALRAGAEFTSLSESQQQKIARFNELTDQFLAADKIVIANALWNLNIPTKLKAWFDTVNV
AGKTFRYTENGPEGLVTGKKALHIQSNGGVYNGQDFASQYVKGILNFVGIDQVDQLFIEG
IDYDPDRADELMQNALDKAAALGKSF
>FECAFAII_02484 AI-2 transport protein TqsA
MEGKNKKNRPVSWFWRWFLNNQVVTALLVVLLILLIVFLFTKVSYLFAPIWQFLAIVGLP
IILAGILYYLMNPVVDYFEKRKVPRLYSIIGLFVLVVALIAWGSVVIIPKIQEQTVSFIS
NFPQYVDTIDNKLTEILRDPLFNQFREQLETAGDKFMNSAGDMIQDISKSTVQSLGSFVG
AVATILVALLTMPFILFYLLKDGKQLAPYFVKFLPTRMQKPTLNVLSEMNSQVSSYIRGQ
LTVAFAVAIMFMIGFAVIGLEYAVTLGIIAGFLNLIPYLGSFLAMIPAIFLAIVAGPFMI
IKVLIVFAVEQTIEGRLISPLVLGNQLAIHPVTILLVLLTSGKLFGIIGVILGIPVYAAA
KVVITHVFEWYTTISSLYEENPLKKQKE
>FECAFAII_02485 hypothetical protein
MIQAKITEIGTEAINKEEPMLILFDKTATAALRKYSVIQEVSKDEPFSLKAGGTIAFDDQ
VYTIDYVGPMANGNLKTVAHVSLIFDACPEEGQIANGIYLHPHRLPAIGLGSQIFYN
>FECAFAII_02486 6-phosphogluconolactonase
MIEKIILGTYTRRESKGIYTIDLDTEKEELANLSLAVEENSPTYVAKSKAGNLYTVTSVD
GLGGAGAYDKDFHFLNAVTESGAPLCYVAVDEARQLLYGANYHKGEVNVYHILGDGELKA
ADSIFHQEATGPHKNQDHAHVHYTDLTPDQRLVVCDLGTDRVYTYDVSENGKLNLVTTFT
AEPGTGPRHLVFHPNGQFAYLFGELDSTVRVLSYNKETGAFEELQKISTLPEEFDGENGG
AAIRISNDGKFLYASNRGHNSIAVFAVFEDGSHIQNKQIISTEGDFPRDFALDPSNNFVV
CANQNTDNLTLYRRHPETGLLELLKKDVYVPECVCVYFDR
>FECAFAII_02487 hypothetical protein
MNQQDVLDRLREELNIPFFDGKIEDKEYSEEEYQKLKADLQNYFEQYVQNVEN
>FECAFAII_02488 hypothetical protein
MLPNIGYYVQSIDQIVKETEAIGEGMHPKYEVIRNAIDEGKTSELDKSTLEEIILLFEEG
TKKYRAMLMKVSTLRPPAKAMGIHKNFEKAYLSYVAGCEEMIQSIDLESGVDEDLFNTSE
AKQDQATDQLTAAIQKMTNLLLKK
>FECAFAII_02489 Lipoteichoic acid synthase 1
MKRYISRLSTKQKKILKGTAAIISIFFLVVFSNLFLQWCQNDLSVDLALKFAFSWHTEKF
FLACLVLLIILIFLIALAGSVPLGSLTYVVAIGVLGFANYMKMSYRQEPIYPDDLKMITE
IGLLKDMTGTMLFTVILAAAGTVIGLFCWYMFRSLKKGRRFQLIRLTTLLVAIGLLGYIS
NFNNPDNLLRKAYNKTALWIPYSQKMNYYNTGFIGGFLYNLKVEPMDEPEGYSKEKIKEI
TEKYQKLADEKNKTVEEESPNIVFVMSESFSDPSRLNGVEVSGEPLADYYEVADQTYSGN
MLSQNYGGGTANIEFEALTGFSMALFNAQLTTPYTMLVPKMDQLPSIVSALNAQSYQTTA
IHPYNTSMYKREDVYQTLGFDQFISERTMTYTDTIENNPYISDESAYKEVMTLLKEEKTP
QFIHLVTMQTHMPYDGKYDNLDYPAKTSDGSGTLDLENYLQDISYSSTALKQFTEELKNL
SRRTLVVFWGDHLPGIYSDTIQAKNDKQTLHETQFLMFDSKGELEKQTTHDAITSPFYFA
ANLMEQTNQTTNGFYQLLLSLEQELPAFERELYYQNGQWYKEAQFNRSQQEIYDEYQLIQ
YDIVAGKQYSLADGFFEHE
>FECAFAII_02490 Hydroxypyruvate reductase
MYHVHLIDAIPEQEIEKLQGEYFKIIDDLPAEGIVIRSTKVKDEWLTPDLLAISRAGVGV
NTINVEKASENGTIVMNTPGVNANAVKELVLCCLLLSSRPIIEASRMVQTLTGPNILEQA
ENKRSAYVGRELQGKTIGLLGLGAIGTKVALSCYSLGMDVLGYSIRDAQLDYVRQADLET
VLSTSDYIVVMLPLTEDTKGLIDQANIEKMKKDAVLINVGRSEIVDKYAVMQALEKQHLA
KYLTDFPEEEFLENDRILMLPHLGGSTQEALADSGRLAVEALKDYLLFGTVREAVNYPSA
RMFFQAPFRFTIFYQKKTNILAEIFSLLNENELAIADISRNHKNEHVYILIDIDSTDFEQ
LNQVKQQLEKISGVRKVRLLKKPERP
>FECAFAII_02491 L-arabinose isomerase
MLNIGEKEFWFVVGSQHLYGEEALREVKKHAQEMVDELNENGQLPYPIRLQELAVTADTI
TKIMKEVNYREEVAGVITWMHTFSPAKMWIRGTKLLQKPLLHLATQYNESIPWKTIDMDF
MNLNQSAHGDREYGFINARLNKQNKIVVGYWKRPEIQKEIADWMDVAVAYNESFGIKVAR
FGDNMRNVGVTEGDKVEAQIQFGWTVDYFGIGDLVQVIDRVSDEEVDQLFEEYKELYTFD
YGDYEEKTWEEHVKVQAQQEIGIRRFLEEGGYNAFTTNFEDLYGMKQLPGLAVQRLMAEG
YGFAGEGDWKTAAIDRLLKIMARGKDTGFMEDYTYELASGQEAILESHMMEVDPTLAATK
PRIVVSPLSMGDREDPARLVFDGKAGEGVVVSMADFGTHYKLLINEVEAFEPTTEAPNLP
VARVLWKTKPNFHEGVHSWIQAGGGHHTVVSLNLTTDQIETWAKLVELETVVIR
>FECAFAII_02492 L-ribulose-5-phosphate 4-epimerase SgbE
MLEQLKEEVYQANLDLPKHGLVKYTWGNVSAFDPETRYFVIKPSGVSYEEMTADDMVVVD
LDNHIIEGKLNPSSDTPTHAVLYRSFPQIGGIVHTHSTWATIWAQAGLDVPAMGTTHADT
FYGSVPCARFLTQQEIDSGYEYETGKVIIETFKERKIDPLAIPGVLLHGHGPFTWGKDAQ
SAVMNAVVLDEVCKMNLFTRQLNSFSEELPQRILDKHYLRKHGKNAYYGQNK
>FECAFAII_02493 Ribulokinase
MKEVNAQSMLDVIDGRTSLGIEFGSTRIKAVLIDSSFTPIAAGSYEWENKLENGIWTYSL
EDIWKGLRVSYRKMAAEVFEIYGENLTTIGSIGFSAMMHGYLAFDSKEQLLVPFRTWRNT
ITEEAERILTEKFQYNIPQRWSIAHLYQSILNKEEHVKEINFLTTLAGYVHWQLTGEKVL
GVGDASGMFPIDPSTKTYHQEMKNIFGQLIEKAHVAIDLDHILPKVLVAGEEAGKLSESG
AYLIDPTGNLRPGIPVCPPEGDAGTGMVATNSVAKGTGNISAGTSAFAMIVLEKELENVH
PEIDMVTTPSGELVGMVHTNNCSSDINAWVSIFEEFTNSLGMEISRDKLFTVLFNKALEG
DTDCGGLLSYGYFSGENITGVNEGRPLFVRTPGSRFDLANFMRIHLASAFGAMRIGMDIL
KSENVQIDRLVGHGGIFKTPEVGQRILASAMEAPVTVMDTAGEGGAWGIALLAAYMMDRH
GKSLENFLAEDVFGQDQGITITPSAEEIAGYQIFMRRYREGIDIEKTAIHQLQEKGVIEN
AGTTERRSIPSKS
>FECAFAII_02494 putative metabolite transport protein CsbC
MKKEKKVSSSFIYFFGAFGGILFGYDIGVMTGALPFLQHDWGLAGKASLIGWITSSVMLG
AILGGSLSGLLSDKLGRRKMILLSALIFMAGSVLSASAPHNGSYFLIAARILLGLAVGAA
SALVPAYMSEMAPARLRGRLSGINQVMIASGMLLSYVADYLLKGLPETMAWRVMLGLAAV
PALILFFGVLALPESPRFLMQSGRLEEAKRVLNYIRTPKEAEQEFEQIQLNVKQEKTTGT
SWHTLFLEKYRSLVIAGIGVAVFQQFQGANAIFYYIPLIVEKATGHAASDALMWPIIQGI
ILVAGSLLFLVIADKFNRRTLLKIGGSVMGLSFILPAVLGTVLDAHTNSLLILLFLCIYV
AFYSCTWAPLTWVIVGEIFPLAVRGRASGLASSFNWIGSFLVGLLFPVMTASMSQEIVFG
IFGIICFLGVLFIQEIVPETRGKSLEEIEQSASKKTYPKRISIHHS
>FECAFAII_02495 Arabinose metabolism transcriptional repressor
MAKYQDIAEEIKQKILREEYEVNTTIPSEFKLQEIYDVSRHTIRQAIAVLVNEGYLRKEK
GSGTYVDDSYKKEKTPLNRTKTIGVITTYLSDYIFPSIIRGIENELRESGYSLLLASTNN
DHELEKECLKKMIAYGVDGLIVEPTKSNQYNPNLALYVALREQGIPMVMINAAYEELNAS
YICLDDVKVGFMAAEYLIKKGHQRLLFITKIDDLQGKYRMKGFISACEQYNVRFLTEDII
TFTTETRETIAEKTVQRLKEEQALDGIICYNDQIASLMLDKLTENGYHIPDDLSIVGTDD
SSLSHLGNKKLTTLTHPKEKLGQDAARWIVTTIEKGQAQPNILYEPVLVERETVKENEK
>FECAFAII_02496 Extracellular exo-alpha-(1->5)-L-arabinofuranosidase
MMKTLYNNPIVRQRADPWVYKHTDGYYYFTGSVPGYQVIELRRAKSLNELEHAASLIVWQ
AHEEGPMSELIWAPEVHYINGKWYIYFAASNHKTIRDESHHHRMFVLENQHIDPMNTDWI
EKGQIKTKRETFSLDGTTFSSQGKLYYVWAQQDPEITGNSNLYLSEMDNPWTLKGKQILL
SIPEYEWEKRGFSVNEGPAVLTRNGKIFITYSGSATDENYAMGLLWADEHKNLLLKESWH
KLSEPVFVSSEKNKQFGPGHNSFTVSEDGCFDILIYHARPEKNQKGDPLDNPNRHANAQC
FTWNEQGFPEFGEPVPYAL
>FECAFAII_02497 Intracellular exo-alpha-(1->5)-L-arabinofuranosidase 1
MKVKIREDFTVGEISSRLFGSFVEHMGSVVYTGIYEPGHETADGDGFRQDVLSYVKELEL
GVIRYPGGNFTSGYDWVDTVGRKEQRPKKIDLAWRGIEPNSFGLHEFFKWISHVQAKPIF
TVNLGTKGIDEAKNLVEYCNFPKGTFWSDLRIKNGQKKPFGVKLWCLGNELDGPWQVGAK
SAYEYGRLANEASKVMKLVDDSIETILVGSSTPRLPSYPEWDRIALEEAYENVDYLALHN
YIDKYDEEDLTKPPKNERDDTATYLAKAYRFDRQIEEIVATCDYVKGYLRSEKTMYLAFD
EWNVHAQPEKRHRDFEVGSPIDWCYFTMEDTLLFGSLGLAILRHADRVKISCQSLLVNTI
PLILTDAKGQAWRNPTYYVMQHLSKYAKGQVLKQQIICPVYDCEKIKNVPYVDSVIVDNG
NQLTIFLINRTNEQQKITIEHDFNLLDQGEHYTLTSSDLLDKNTREEPEKIKPEINYFSI
EKHDELNVGIEKYSWNVIRIKKM
>FECAFAII_02498 hypothetical protein
MKIVETKLYGQLIVVSDYILLGILWVIVCLPVITIVPATCAVFYVMAQWKGEGSGNIIYF
FFQGIKQHFGKNLFLSLLTIIIYFLVNQLLEEQTIVLSISGYVVLLIYSMFLLSWIYVIS
ENKDITFLQIFEQSAWKVFFDFLRNILCCVLLLGFVLLIFLFPPFIFIFAGGVWKLVSII
LTIGNER
>FECAFAII_02499 L-arabinose transport system permease protein AraQ
MAPESSITVTVNSRKAVSGKKIIRTISMLVILLVIAFPFLWLIISSFKHEKDIISFPPRI
FADSYTLDNYIKVWTTIPLLDYIKNTVIFAGGTVITSVFFDSLAGYAFARMRFKGKSVLF
YFVLLTMMIPFQVFMIPLFIEVNLLGMLDTYAGLIIPRMTTAFGIFMMRSFFITLPDSLE
EAARIDGLSEFNIFLKIMLPLSKPTLLSLGIFTLMNSWNDLLYPLILTSSSKMRTLPAGL
ALFTGQNISFYGPVMAGTVISMLPLLVVYIFAQKYFVQGTAMSGMKE
>FECAFAII_02500 Lactose transport system permease protein LacF
MNGFTKYWNRPDRAAYLFLTPSFLVLLLFTVIPLLGTFAISFTDLNIFFTSRNFVSFENF
TRIFSDERAVNSLIHSLYFTVLETPTQIIVGLLAAVALSKNTRFNRFCRSTFYIPVICSL
TSIAIIFSMLLDPNVGAIPYLFSQVGLPIPQFFRDPTLAMPTVAIMTVWKNFGVTMTILL
TAIQGISPSLYESAQMDGATNRQQFFNITLPQIVPSLGFCILTNLIGSMQVFDQVYVATA
GGPQFKTETAVQYIYSRGFTAPYELGYASALSSVLFIIVATIAISTNVYMSRKEKQMK
>FECAFAII_02501 sn-glycerol-3-phosphate-binding periplasmic protein UgpB
MKGKKWLIGSLLVAATGILGACGGGSSAESDSDKEVTLTFWNGFTASDGEILQEIVNEFN
KTNDKNIKIEMDIMTWANLNEKLPTAISSKKAPDFIALNYPDFAQYVENGAVQPLDDFWE
YDGVDKSDFKETAIELGEVEGKQYFVPMQVQGMYMYWNNDLFKQAGLDTEQPPTTWEELT
EMAPKLTDSSKNVSGFVFNKDGTAPLYNWMLANGGKLVNDDYTKSEFASPENLKTLKAIQ
KMIHVDKTGPESISGAEMDNLMNAGQLAIEINGPWLNNGLKANEIDYNVTTLPQGSDSDK
KTAILDGVGYAIPASTDNNKKEAVYEFLKYWNTTEIGKKWSIENGFPAYLDSVAKDEEVK
NDPIVSELSKQMDYAEPYLPGFTQISAINNDIINPLIEKLLAGEDPETLMNDADDAINQL
LQK
>FECAFAII_02502 Intracellular exo-alpha-(1->5)-L-arabinofuranosidase
MEATMLISSVKRVGKVDPRLYSSFIEHMGRAVYEGIYQPDHPSANKSGFRQDVIHLVKEL
NIPMIRYPGGNFVSGFRWEDSIGPIANRPRRLDLAWRTIETNEVGIHEFYNWCQHVGAEI
NMAVNLGTRGVDAARNLVEYCNFPKGTYWSDLRRSNGQESPFGIKTWCLGNEMDGPWQIG
HKTAEEYGRLAEETAKAMKLVDDSIEVVLCGSSNRQMPTFGDWELTVLDQAYDQIDYLSL
HQYYGNQKNDLSHYLARSLDMDRFISEVTAMCDTVKAKKHSKKQINLSFDEWNIWYHSAE
QDEQAAPWQIAPPLLEDNYNFEDALLLGCLLITLLKHADRVKIACLAQLVNVIAPIRTET
NGEAWRQTIYYPFMQAAVYGQGEVLSPQIRSANYATEDFEEVPYLESIAVINDKELVIFA
VNRGEEEMNLTVHLSELSLEGVIDFSEMSGFDTKATNLPKSEQVKPSHSTNVKAEDGKIN
CLLKPLSWNVVRCRLSDEGGTKNER
>FECAFAII_02503 hypothetical protein
MQLQINEESLPVYEALASKTRIKIIQLLSKKKMNVKDLAKELGVSSAITTMHVKKLEEAN
IIKTEKVGQQKISSLRVDKIDISFPEKIFNAFDTKETSIPIGHYTNYAIEPTCGLATIHD
FIGKVDEPRYFMDPRRMDARILWFTSGFVEYQAPNFLNTEDTLEMLEVSVEISSEFPFSN
DNWPSDITFSLNGVELGTWTSPGDFADIRGKYTPDWYPDNLNQYGLLKTIRITKHLTNMN
GEPLSNITINDIPKEQDTWHLRIEVKDDAKHVGGCTLFGKGFGNYDQDIKLKVYYS
>FECAFAII_02504 NH(3)-dependent NAD(+) synthetase
MSLQTEIINELGVKPTIDPKEEIRKSIDFMKAYLKKYPFLKTFVLGISGGQDSTLAGRLA
QLTMEEMREETKDENYQFIAVRLPYGEQADEEDAKAALDFIQPDVSLRVNIKPAVDAQVQ
VLSEAGVGISDFNKGNIKARQRMITQYAVAGERAGAVLGTDHAAENITGFFTKFGDGGAD
ILPLFRLDKRQGKQLLQALNAPEKLYTKIPTADLEDGKPMIADEVALGVTYNEIDDYLEG
KEVPAQAQEKIEAWWNKTQHKRHLPISVLDDFWK
>FECAFAII_02505 Nicotinate phosphoribosyltransferase pncB2
MNNTYPDDSLTLHTDLYQINMMQTYWELGRADLHAVFECYFREMPFNHGYAVFAGLERLV
NYLENLTFNDSDIAYLRGLEVYPEGFLEYLQNFEFKATVRSAREGELVFANEPLIQVEGP
LAHCQLVETALLNMVNFQTLIATKAARIKSVIGEDPLLEFGTRRAQELDAAVWGTRAAYI
GGADATSNVRAGKIFGIPASGTHAHSLVQSYGNDYEAFMAYAKTHKDCVFLVDTYDTLKS
GVPSAIRVAKELGDKINFQGVRIDSGDMAYISKRVREQLDAAGFTEAKIYASNDLDEATI
LNLKMQKAKIDVWGVGTKLITAYDQPALGAVFKLVSIEDDEGKMMDTIKLSSNAEKVTTP
GKKQVWRITRNFDGKSEGDYVTLWDEDPREEEAIFMFHPVHTFINKTVRDFTARPVLQDI
FIEGKRVYELPALNEIKEYTKENLDSLWEEYKRDLNPQKYPVDLSTECWNHKMAIMERMK
KSVAELHTEA
>FECAFAII_02506 hypothetical protein
MKLIETPVNSNLNIKTFYPKVVEFFFGNTAINYYKLFSLDRTQLLLVDTYDKKQVVMINT
KKKITRQEIDYAIHHVLKMTREDVKVHVGVKQELERAGIQFKRPNKDIVVIEQKNTKDSI
>FECAFAII_02507 HTH-type transcriptional activator mta
MEYTIKKMSEISGVSPRTLRFYDEIGLLKPARINSSGYRIYGKKEVDRLQHILFYRTMAF
KLDDIQEVLDNPSFDHQKALIKHQQMLLEKRAQIDTLLTTVQQTLDMYEGGRKMSDKEKF
EGFKQQKLKENEESYGQEIRQKYGKKKVTASNEKWMNMDKETYEEMQTVEKQMLFDLTLY
LKEPEDESLADRIFQAHKKWFSYSWPEYQPKAHKGLGMMYEADERFTAYYDERSGHGAAK
ALNEIIQKKA
>FECAFAII_02508 Catabolite control protein B
MANIRDIAKLTGYSVSTISRVINGHPYVDEEKRKEILAVMKEVDYIPNANARQLSYGKTK
SIGVILPYTNHPYFDQLISGIIEAAFDYDYKVTLLPTGYHKEKERRYLEEFAAKAFDGLI
ITSRANTLDDLLAYQKYGPLVFCEEIKGKQASCVFIDREQSITEGLTYLKQQGIKQLGIT
LGRSGRLSYNSKITLQLCHQLFPSFDESLVFWDCIDAEKGKQAGFFFKELGVDGVFTNSD
MVAAGILQSYLQDKTPVVIGRDNLLISELLGFPTIDHHLEACGEMAFQLFLTEKKDKVKI
PYTFIQR
>FECAFAII_02509 hypothetical protein
MNTYVEITDGTTNNYFYAFVEFKGSVLTLYSFQGLNRNIVKEIPMNEIENLTKDIYWGGQ
RISFSHEGKMYQFFECGPAVVDYLQENLFV
>FECAFAII_02510 hypothetical protein
MTQVHFTFESEEIQAIINESGANDTAKTLMTIMFNQLMEEQRNQYIQANAYERSEERQSQ
RNGYYDRSFTTRIGTLELHVPRTRDGKFSPTIFERYQRSEKALIAAMIEMVISGVSTRKV
TKTVELLTDGATVSKSFVSNLMKQLDPFVFEWRNRSLEGSEYPFFMCDALYMKVRENHRI
VSKGVYIGIGIDSDGRRTILGFDVQDGESEDNWDTVFQSFVQRGLFGVKLVISDAHKGLV
KAVRKNFLGASWQRCQAHFLRNIFDKLPKKVSSDVKDELKSIFKASELELTRERKEHFLE
KYGCDSKLSAACDILENGFEDAIQILSFPENIRRRIRTTNVLERLNEEIRRRERVIRIFP
NINSITRIIGTLLMEKDTEWLASPRKYLEFNSNNI
>FECAFAII_02511 hypothetical protein
MMEEFIRKNISDEYADFYEQSNEKDKFQMDVSILAILAFSENKQPVTAKKETVFSEGKIK
TRYILEVETKFKN
>FECAFAII_02512 hypothetical protein
MLFNETQLWFKFDPSNRFIKDFYKVWNSEVFFLAIEDSLLINLYYSNKNYFKIPAAKTRM
KKGVYFLFDIVTDVPDARSDHRRYDYIKYTFVDPERYKD
>FECAFAII_02513 hypothetical protein
MFDFNEYLSISKQIESDDKYNSKESYRRTAVSRAYYSAFKKSDEYLKENYDIIYNGSSGK
GSHQTVWNLFSTVKELNTLGIHNSGYRMLEKRKCADYIPNETITKTDMALMNREAEKIIN
KLT
>FECAFAII_02514 hypothetical protein
MLDIVPSNTHRSGSLINFAAIFACASVILASPVVVDASSTPKTKNDNQLVITTKNEINTI
SSNDGKIFDVINTVLKRKAEINIKYDEDLNLYFFVIKTTSELFSSDYDVLDTLDNVLSDY
KYMGKSVVATLGE
>FECAFAII_02515 hypothetical protein
MSYRVQLIISEDVESQQFGTNVINKVINPALSINAPLIPTALSFSVTAVVSEIEDTEKIK
IVEIEVLNKNEKQIFSTGEVSVSLPPQVNDINFNINARNVLVEEAGEHYAVVKFNGTEIG
RQIFDIKVNKPVEKN
>FECAFAII_02516 hypothetical protein
MRKYTFVFKKKVVSDYLNNEGGYKYLAHKYQINRTLVRHWVRIYNYHGWEGLVGGGKSYT
TKFKLDVIEYMETNGLSIQETAKKFNIGSNRTLSKWIEQYEEGGASSLESQKRGRKISMN
SKLNIPKKLKDESLEEEVIRLRAENAYLKKWNGNTFFDKNYKVL
>FECAFAII_02517 hypothetical protein
MCKILNISRQTYYYQAKPIENESDLEEIVQEEFIRNRKAYGTRKLKKCLAKRGLQLSRRR
IGRIMKRRGLTSTYTIAHFKGQRTACNEAKTANVLDRTFTQEQPLEAIVTDLTYVRVGKK
WHYICLILDLFNREIIGYSCGEKKDASLVKEAFGRIPYSLTDVKLFHTDRGKEFDNQTIH
EILNGFGITRSLSRKGCPYDNAVVESTYKSVKVEFVHQYQFETLAQLRLELFDYVHWWNY
LRLHGTLAYETPIQIRQQRLAKRILDNERGSDTSGEAA
>FECAFAII_02518 hypothetical protein
MSRRQRRTYSKEFKQQIVDLYLAGKPRAEIIREYELTPSSFDKWMKQAQSTGSFKERDNL
TPEQAELIALRKKNKQLEMENDILKQAALIFGRKDK
>FECAFAII_02520 Autolysin
MKKKITITAMSLLTALFLLPINTFAYTINDEYNLAPNQGDSRLAIPNKIILHETGIDAPA
RNVAANMKNNYNGSNSYTTDVIGDGGIVYRVGEQGYVSWGAGNANPYAPVQIELQRTYDK
ALFEKNYRAYIEYTRDSAKKYGIPLTLDQGTSLFTKGIISHLWVTNYVWGNHTDPYGYLS
QMGVSKEKLAYDLAHGFTDENPTTSENKPVIDPTRAGAANPTLTDGTNHAHIDQFGEIEN
ANLHVAGWHIANYKYEYIFIMDYNTGKELARVRADGIYRPDVNQAYNTSGNVGYHVSFNM
RNFPSKKVYVMMRATNDPEGNTKGGAQDFHDKRWYLNIPKR
>FECAFAII_02521 hypothetical protein
MNNKTFEVLKWFALVIIPALATFVGLVGKALNWQYTDICVVIITGFGAFLGSVLGVSNRT
YKMFSAESEEGGNK
>FECAFAII_02522 hypothetical protein
MINLGEWGAIAGSITAIVSLILLVIRPIVASFTKITKTLSQVSYNLELLTKDLESSKSDR
LMIHEELKKHDERLDTHAEKLVEHTQQIKTLFRERRK
>FECAFAII_02523 hypothetical protein
MFSFSDVKMMYDWGCFTDDQVRLFVPLCITDEEADKIISKEESAS
>FECAFAII_02524 hypothetical protein
MKNIWKYGRTGGEYAGKVLDDMLVSVPYTDQPPLEGIRADGEPLTIADQMFDPKLNQWII
LANALDHNDLNNLKAMYESLENENGDLKQINAKLMLSDVAIKQENTALKEKADSLAQINS
KMMLASLQNSKDISEIKEQLNPASKGGE
>FECAFAII_02525 hypothetical protein
MASSLYNLALDFSKELNYTKAIMARQGDKGITVTVKPFLNGLQMDTSGGTFTLKGTTPSN
RYVDNVATSVTSEEVTFSLDGTFMSEAGYYKHCYVEYRKDNQILTTQDIIFFSLGVSDIS
QGQADEYVSQLEELIRKYNETFDAFMAEIKGRVDSLNQQITDLTGQAKTLQDKLDALKEE
ISKLGNLQVMYSNSIDFGDYDYSENPNLMPYITEPWVGPLLGNGHTVKDSVKRVITHTKT
RTANSGDILSLGLGIPCTAEANNRYLITTLRPSTTYTLSVTMSVGSDWTGETNTIGVRLR
YLNEQGGIELPINALIPANVERDKMVTHTFTGITKDNVTSITNCYVEIFSLNSEYKGTVS
VSYDVKLKAHYPNLLDGPYWLGKVPLGENIADPTVVFPHKTSEYMVYGRRNTENYIADQT
YTISMKATKLTVQSFAVYIAAGRVKVGDMKPTEGLANTWELTFTVTKQHIDSGVTNYLEI
YQYPSATKGAVQIEWLKLEKGNTRTPNISEYKYRGTGMRDSNNPKDYVWDLAPEYVEDNL
ATDIKISEITGKANNYTDGKVSEINSQLTASINEVDTTAKDAQTKANANATAIDELDNKI
DERINDTATTTLTVTNGNTGSAKLYREGKTVSIYFVALNGKSSGGNDSTILTIPEGYRPP
ISFEQLVGSIDRSTLNSAQLSIGADGAIKWRRNSSYGSDYTFAITYTI
>FECAFAII_02526 hypothetical protein
MIDNLITIYDKNDANNLAEHLYDTQGLGALSDWLTATVSNKLNGAEIFQGTYSINGTNAD
LIVDGRIIQCYVDENRAKQRLRIYYAKTSVIGNTIEVKAEPIFNDIRKSVLNKYDSGTEK
ITATQAWQNAKVLAKPAIPSQFSFSSLVDTLANVKIEKANFLEFFGGKEGSILDRFHGEF
LKDNNTLRHEKSLGTDHKIKAIYTKNLTGLDLEIDAQSVLVGVYPFISSSSEGEDEITLP
EEVIFTDYVDDYPAGYVSFVDFKDKATDVATLREAAKDWLKTNIDKQKPQVSGSIELVPL
RHQRGYEKFVDLEKVSMGDGVDVYHPQLKVNMSARIVEYTFNVLTNSYDKLVVGNVKTNF
LENTENNVSNLINDAIDQLKNGGEISDLLNDIVDHQTDMITGQNGGYVLLDPKEAPSRIL
IMDTPDKNTARNVLQINNAGIGFSKTGINGTYETAWTLDGGFNASFITAGEIVGITIRGT
TLISDGADYRTSIANGKMTWYSKKVNKDIMELEARDYVSADAGIVSYTMKTGGGFMIRNP
QGNLVFSTWDNGNNRPFLSFGAPNFRYSNASYVTSGDGSSLSINGSAGNSWEFKVAGRTM
KFTSDGMLTLPGCFFGSWEDGKLARFEQSTVQVYKDFTVRGTKNSTVPTEHYGQRLLNAY
ETPEYYFADYGEAVTGDNGKVRVDIDPMFAETVNLSRYMTHVTPTELVLCAVTHEDIDHF
IIETSKPNVLVRWNLVAHRLGYEDIRLKEDTAYDSTVLDQKRF
>FECAFAII_02527 hypothetical protein
MTDCIHSIIDGFPDYLHKLALAERPTIPSPKRQRVETSVLGRLGGLVQDYSFEDMSFTLH
YNYLEDVEDHQAFKQSFYIMRHWLNYAKKLEFSDDPNVYYVIQTIDIGDAENDIVEWGEF
DVNITAKPFARVQEDVLITVDKPQSFNLLNNSLEESFPKIIITPSATSCQFILNDYVFSF
EGLVAGTDVVIDSDLMLCYEEQSDGDILDRSNKMKTMQYPTLQVDINHFNCTGLSKIQIY
RNGLR
>FECAFAII_02528 hypothetical protein
MNDSIKKMLRITEKDLMITEVSYETLQKKKTLVVDAVLSPTPRACRSCGSTVVDGNGKAI
IVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKSCQVSLTTVIRTLKEFKSYLPKQSKKILPRVLMVDEFRSHASIED
KMSFICADGETGKLIDVLPTRKLPRLTSYFLGCTNPEEVEFLVTDMNAAYFQLTKRVLPN
AKVVIDRFHIVKHMNQAFNELRIREMNELRKAGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLEFSPPLKEAYPFFHELVEAFRDKDPDLFFSLLAELP
ETLDDSFREKLQNLLTYEEGITNAMIYPYSNGKIEAKNTHIKTMKRVSYGFKSFENMRIR
IFLINQLINVR
>FECAFAII_02529 Chromosome partition protein Smc
MAKKRTEAEVTFIANDDGLKSTLKEISAELTKNRAELKLEQAQLQQTGSESDKLGSKLSS
LEKQYELQSQKVEVTSQRLANAKKYYGENSTEVQKLERELINQQTAQQRLSNEIDKTSNA
LAQAKGEIQTYESTMQQLDSEQKNVQASASLIESEYKKWQATAGQSASEAEKLAKAQEYV
SQQSENAEKTIDILRRQLEATQSEFGATSTEAMQMEAKLNDAEREFEELGQAAKNVDTTN
LDDIGSKIDMNNLMEASDVLSDIGDKLTELGKQAVDSANSVGSSQSKIQANFGLSKQEAE
ELTNVARDIYYKGFGESLDQSTDALILVKRNLGDLNNQDLQNITEQAMVLENTMGADMDE
TLRGVNGLMVNFGLSAQDAMDLMVSGTQNGLDKTHELGDNMAEYSQLWSQMGYSADETFG
MLQNGLDAGAYNLDKVNDLVKEMGISLTDGRFEQNMDMFSESTRKAFEEWKNGGGTQKDV
INSMIQDFSNMDGQYDQLNKASTIWSALGEDNAMKVVQSLTDVNHTFDDVSGSAQKMNED
STTPLQELNGKIAELKDSLAPIGNTIIDALEPVIDFLGKMADAFNNLPQPVQDFIVAIGG
LTAAFGILLPAILAVSYLFGPMMLIIGGIIAVIAGVIVAIKNWGAITDWFSGLWKKFTDW
LGDTWESIKDGASSVWDGVKETWSGFVDWVQDIWQGVSDWFGELWSGLVEGASNIWQGVQ
ETWQTFVDWVSNIWNGVKEVWSIIWADIVGIVQIPWTLITSLIQAGINIIVGIFDVAGQL
LGAAWQAVWTPISDFLKNTWDTMTQWISIAWNGIVTTFHTIFDPVVAWWNGIWTAISTTA
SNIWNSISATASSIWNSIKNTITSLVQAAATVIQNIWSTVSSWLGGIWNSISSTASNIWN
SVTSSISNAINAAKSAIQSVWNSISSWISGIWNGIKNTALNLWNGITSTISSKVNDGKNA
ISSGWSNLTGIVSDIFNNVKSTIANIWEGIKKTVSAPIDWIRDKISGIFDNLNISIPHIP
LPEFIMEGSFNPLKGQIPHLRVKWHAKGGIFTKPTLLGGMNGVGEAGPEAVLPLKRSVLQ
EIGDRILSSTSVSSRAQTIQPVNNYEFNFTIDGNADEVTMKQTTQQIIDSITKIQNDNAS
AWR
>FECAFAII_02530 hypothetical protein
MNEDYSKIELNDGTILNLEPKLNIKKLLMINRDFNTDEFAKMTVGKGSMDISVIQGAKAV
YIAYRQANMTDYISFDEFIDKWDFDMATASYIYQLMMFKQARDAYQKEFEKANKEKKLQK
>FECAFAII_02531 hypothetical protein
MAKTKTVVTTFDNVSIKRIAFNFKNAGNAIATNCNGQLDGETEMQTVVKKCGATEVKSKS
KPINMTVTITAHVPMEVYRRFNGLKQDGRIKPGIYSYGPDSVGEDFSLAAEIVDDFEENR
KLVGMLACTSNTGLTFSIENGADEVAALELETKVMQDEFGKFYHEAIVAELEEDLTDQWM
TNLSADVIKKTSVVTTTATQSQ
>FECAFAII_02532 hypothetical protein
MIVKAKNSWELKINGHDELLVRMERYSSESERLINEALKSKGSAIAVDRITEKIPVSEAD
LRRGHQHAKNSRPLKTQYINLGFIIRPTRKFEYLKYPDLGIGTSKRNQPDEFMRRGLGLA
LDPITELLIRQFDKLNK
>FECAFAII_02533 hypothetical protein
MVIDNSKEKERLNKQISAIKTSLEEHFGLKLFQDSVGEDELPDDFNYFILETGEIEMITE
PKYSVGQNLYLTFYSENREDLTGDSLDIISLIQNRSIRFQRMDPNHLKLENQDRYIDQLV
FTFRRLLKSDCQG
>FECAFAII_02534 hypothetical protein
MANNRRLEETFNDGWLKILTQTTKRNELGKKIGVEDTEITSLKFRNLSMRDSDITAMDAM
GSKLTKKVKTPFHPIAKKFNKDQYFIVIDSMRYNVIYADYDNFYIYFYLESVGEYGD
>FECAFAII_02535 hypothetical protein
MTPEQVTEELLIAVKDNIYVTWNEEDESIKKMIAKNAVYLQSKVSTTLSFSPESLEYGLL
IERCRYDWNRALDEFEQNFASELLGFIQHYALQEYIAGDVNGE
>FECAFAII_02536 hypothetical protein
MKYILCQPAINRFKWELEVCLTNLKKLGIKDIVLLFSRHDDQIPIFFEKEYGVEVHVYDD
LRDDKEYIPSIKPYLWWKYLEEDHSREDDRYFYIDSDVIFNKRINLRKLPSKDDVWYCSD
CCSYLSLDYIRSCENGENILKDMANIVNVTVESLETINTNSGGAQWVINRPKANYWKKVY
LDSNRLYRYLRGQKTNIQIWTAEMWAQLWNMMYFNIGPKVHEELDFCFATDPIEKVKEVK
ILHNAGVTTNDEDLFFKGRYVTSTPFDEDLSFVNKKKCSYAYVKAIKAVVR
>FECAFAII_02537 hypothetical protein
MTVKNLKGVTAASDQLMKAFKDGNEESFSAAMVSLSKEIQDKILEEATAKNQDQLVLMNR
GQRVLTTQETKFYNEVVKNEGFAGVEELVPATVFERVFEDLEQSHPLLQKITFVNTTGVT
EWIVSRGVNPAWWGKLCEAVKKVLDNGFDVINMKQFKLSGYIPVCKAMLDLGPVWLDRYV
RTVLVESLRIALEQAIVDGTGKDMPVGMMRDMSKQTSGEYAEKKAEPITALDAVTMGGLM
ARLSKFNIEGVNDPIYRNVNPSDVVLIVNPTDYWSKVFPAKTVLTANGEYVQVLPVPVSD
LQSTAVPEGKAVIGVASDYFMGVGSTLKIEASDEYHFVEDERIYLAKQYANGQPKRNDSF
IVLDISALGTTTTTTKPTTTTTTTQA
>FECAFAII_02538 ATP-dependent Clp protease proteolytic subunit
MTTMKTFLAVKNEGAVPQIFIQGFIGSSWFFEGNTDKGIKNILDSLGDQEEIEVVINSNG
GDVFQGIAIGNLLKSNKAKVNVVINGLAASAASIIAMAGDTIKIYNNAQLMIHRASTYGE
GNVDDFRTIADQLESIDKSVKASYKTRFNGTDEALQELLEKESFMDAETALSYGLVDEII
DAENSSGTEAKKEQSVEEILNDVKEKRAEKIAAFTAALNKTFGQGDVK
>FECAFAII_02539 hypothetical protein
MGIFQKAVGYFTKKATVPLEEYFCKLQVDFVYRKFAIETCIDLIANAMSKAEFKSYEDGK
NKKNDLYYRLNVAPNKKNNATEFRKKLIRRLIFYNEVLIVSPSNNSSEIFIADSWDVTEY
ALKDDVFSQVQINNIVLDREFLESDVIYIKYADQQIRQLVDAYYQAYGKLISSAMNVYKR
SNARRYVLKGNLFRPQDNTTQDQINKMMTSQFKAFMEADNAGAVFQLQNEYTLEDFSGNF
QSNSRDIKNLIDDIFEMTAAAFHVPKNLLKGDMSGLSDQVDAFLMFEIIPIAELIQDAFN
ASLYEVEEYLSGNFVRVDTTMIKITSFKDLVDAIDVGIRNGVFTINEGRERVGNDRSDKA
MADEIFITKNNQQVSKGGEANDDNENISSSKE
>FECAFAII_02540 hypothetical protein
MNQFLSYKHIENWFKAIEEGTIKVCKEQLLLKNYLEERVFTREDIYFDKQMVEDSINIPA
QYFPFELIPWEKFLQCFIYGVRWKKDKTLVFNRYLSLMGRGNGKTGFASWNNFFLLTAKH
GIKNYDIDIYANNESQAKTSFDDVFKVIKDHPDLDKKVFKATKEVIQNIATNSKLRYNTA
NARTKDGKRPGANRFDEIHENEDYSMINVATSGGGKIRDYREFYDTTNGHVRGGPLDDII
EESKMILSGELGIDKDGAEFSSLFPFICRLDNDNEVDDPDMWEKACPTINYNADLKRKMF
QEYSQMQRNAGLRLTFMTKRMNRPMEDTRFAVASYDDVLHTKEKEFPEKMDEVIGTVDFA
DRRDFASVGLLGKYDKDVYFTQHTFIHESALRLQNIKREVIDISIDQGKSQIVHGKNIEA
DYIVGWFLEMSNKYYIKKIAMDMYRAKILKPALEEAGFTVEIVRSGSVTHGMLKDLVDDL
FINQRLFFGDDAIMRWYCMNVYEEHISNGNIRYEKIEPETRKTDGFFSFLHGLNFLDDIY
DSAPVTVTNSSVENTGTGFTPLVF
>FECAFAII_02541 hypothetical protein
MFKNELSQNRYREKLRRSLISQLESQKTNIEPFLDNVDRYISLWETAISLEEDISENGIR
LENGKKNESVALLVSVNKQMGLMLDKLAITPELVGEANESIPEL
>FECAFAII_02542 hypothetical protein
MIINDNGREYDTEKIEEYSSYTQGLIKRLIYVRYVGIRDLLSDNCCSKYKVNQVREALNK
DNNVERIKNVFGYSIEEINYYIDFAEAFIPMVR
>FECAFAII_02543 hypothetical protein
MTEEFYRWLLQLTREDRLVKFYQSPKWRRLREKAMKRDHYECQECRRLGKYHRVENVHHI
KEVKDRPDLALDLDNLICLCVEHHNEVHGRYLTALDKQEKKIESFANFDASERW
>FECAFAII_02544 hypothetical protein
MYRPQYLEQKYEVITVHKGNGEKVYEYRRPIKSDTYKRKENNEVIPLYGKRIAKH
>FECAFAII_02545 CRISPR-associated endoribonuclease Cas2
MYKPYMISYDLNNPGQKYDKVFEIIKEFGAYIKLQKSFWLVKTNLNPNQMCEKLNTVLDN
NDSLFICELQKNYQGRATEENWKFINEHIFS
>FECAFAII_02546 hypothetical protein
MKLSVEGTPEEIQELLQAIGSSKEQKVSVSNSDIDGICNCLNREKISNPY
>FECAFAII_02547 hypothetical protein
MQLLREVDFKQTRCNARDVLKNFRRLERMAGRSLIDIKSPIITDMPKAPKHGNKAEDAII
QMMDIETERDAILAALMALSLISRQILYYSFCVPDSFSNYRISREVGYSERSIQRMKSEA
LIEFAEAYKHGKIIAYK
>FECAFAII_02548 hypothetical protein
MKLKDGFYASSHGIGGLMLDMPTKNPKTRKKSKFKVGDMVRCEAEEFVYPFRGYVKKILS
NSAIIRIENTMKCDRSTAKHKHYLAVARLVDMEVIKSK
>FECAFAII_02549 hypothetical protein
MNKQEAIKKLESIKAIGNDAIAACYNESINSGITLMKKIDEPQKPVIPQLVAGWLEKSTD
PFTKAEKIAYLIKSKDGDSYYFCDWFVRDGIVTQEQGEELLAWATRQSYETLLSLYNGYE
VEKEPLWAIKNADGNYLTKCALWGKDGVNYSFECNPSHRLLFTDKATADAAALLVNGTVE
EVVER
>FECAFAII_02550 hypothetical protein
MIPKFRAWDKRKNVMRDVAVLHFTKNGKTNFIEYWINPTELKSYHVRNIDLMQSTGMKDK
NGVDIFEGDIVLVSVRNGFDYLDNKVCIVKNSIDYSGLVCATVDEDLEYQIFNTELFEEY
TYEVTGNIYENSELLEEQR
>FECAFAII_02551 hypothetical protein
MIKKLVQFSMDLYDIESGATLSVESDHLIINFGGKRQIILWVVDDVLFPEIVHDFEESKA
VEFEIVKKVMELIEKYEEDSE
>FECAFAII_02552 hypothetical protein
MDLITQYSDIILKKIMMKIQKDKKSKERAELVKLEMAETGAGVRSSRHWKAAANIEFYYN
EIQKGFDQMRELDRQTNWSKKLHQDRFKFVEKYKEILEEYLRRTANDKKTRSIQHGFI
>FECAFAII_02553 hypothetical protein
MDKKAAMKRIAELTKSESWQEDKEIVAEVQKLGKSMWTEKPKRRTPRKIAIWHDDRILVT
GTAEQLSEITGLSKNIIWDRARSLWIDSKGRQFRYVEER
>FECAFAII_02554 hypothetical protein
MTTEEVIQMRIRSLQREIDDLERTKAVMVNETARKAIDLHIENLRREIHRLEE
>FECAFAII_02555 hypothetical protein
MDKKAAMQRIIELTYSEDWQNDKEAASEVMRLGRAMWADKSNKPRPRKIAIWHGDKLLVI
GTAEQLASLTGLHEKIVRKRARCGYTDAKKRTFRYVEESS
>FECAFAII_02556 hypothetical protein
MDLKTFTAQIELMHQEALRQSVSYEDKWLNTFHGGRESALDQVLKLLKGECRDG
>FECAFAII_02557 hypothetical protein
MKIDYLELINEIANYKKGEELDVLRDVYDQLEEAGIEGIKNDRSSWSKLRYYFALYIDTT
QLRNLAYTKLLFVDCVKGLQKHLNELEQV
>FECAFAII_02558 hypothetical protein
MTEHRSYYAIIPANVRYDKRLKPNTKLLYGEITALCNERGFCWAGNEYFADLYGVNKETI
SRWVSDLIKFGYLNREIIYKEGTNQIINRYLRINQYPIDEKRNTPIDEKVKDNNTSINNT
FNNTKEYIRELPPSKKSKAKPVRHKYGEYKNVLLSDEQMEKLKTEFPNDYQERIERLSEY
CESSGKTYKNYLATIRSWARKEKSEPKNASSGYKRTGRREKLPEWAIDQEAYLKKKALER
ANRQSKAPF
>FECAFAII_02559 hypothetical protein
MFKPLIDSYSAVLKKFKGKDISATINEEVNIDRLKTMYDGYDGDRVIEIRFIDPRRFTVQ
QRNFIYALIGDIFIDTGMPTDFWKEFFCFRFEGVTGRKISLKDESNTTVSDANVLANIIL
DFIFEHHIPFKEGYEILPANQEYYFYKCITKRVCCICGKTGADIDHFDKALGRRKRKEVD
HAEYTFAALCRIHHTEKHKIGVINFKNKYQIKGIKLNQKTIKKLNIGG
>FECAFAII_02560 hypothetical protein
MSEIKGTTNFEKLFSRKLNKILKKKGNFDYLSWAHAWEIMKKNDPQATVTINEYKHYRVV
SGTHQDFLVEEYKPFLMDETGTYVSVSVTVKGHTETELFPVLDYRNQPVVKPNAMQINNS
LKRCFVKALALHGLGLYVFQGEDIPTPPRIDTKKLNMLETILEAFNEQMGKDMTKTLIEY
VNEQTDKLGLLADNVETIEQLSYEQCALMERAIAAKRKELDKK
>FECAFAII_02561 hypothetical protein
MEKELSTLDQYLIDPDWGKPKIEETSGRKIRRNLLTNEELAWDQDDLGNHVTIWDHVYLI
HLSKHSNKPEYIYVIEDGLIDALEEYDRDNLIDISYYGPGKKYIAEMEAEFDE
>FECAFAII_02562 hypothetical protein
MQELVILKNKEAVTTSLQVAESFEKKHQHVLRDIDALKKDVSNFGQMFVEGNEPDSYGRN
RRVFFISRDGFFLLAMGFTGKKAIYFKQKYIEAFNEMEDVIRKNTVPQTIEDMMIYQLEE
MKDVKKDVSMLKDTMRISGQQEFEIKQKGNMKVMGVLGGKESRAYEEISKKVFSKFWSEF
KRTFSIPRYGELPRKRFDDAVSFIEMWLPETAIRMEIDQLNRQQRLFGDDNE
>FECAFAII_02563 hypothetical protein
MNFFHLTIFQWMSIISFILSTFLTGIKIKGMRPQLEVELNASYFAADMIYTKVIISNYST
EPAMLVNLELSSANLNRRWSATPFKKLIAKGGSVDDNRIYSEAVPLNIPPKSAISCYLAF
EVGKINFNKLLNHQTKMIFTLNRTQIHKIVDIKNTNFPIEKLVKELN
>FECAFAII_02564 hypothetical protein
MGKFNRALVFSAPLIIYALGLWGSRQALIGTIVYMVWIFMGLDEAEAEYRAKKPTEGAD
>FECAFAII_02565 hypothetical protein
MQYLEAKIPIPEGYVIISQVDYEELKKADDTGRWMTLPEVLERINRKYDWFTSRVLKNPR
YRNIIDIEKNKNGFVYYPVEGRDTYLFLRSKTLEFLETNFSEILRRQADGKI
>FECAFAII_02566 hypothetical protein
MTDIAEITQRDREKIKEYVESSKFLTYTMLAERFGISKSYLSLILNGKKTSAEANRIIDS
IITMYEL
>FECAFAII_02567 hypothetical protein
MNTPQIFNFEQNEVRTILVNDEPYFVGKDVASVLGYSNTKDALSRHVDLEDKMGSRITTS
GQSREMTIINESGLYSLILKSKLPSAKKFKRWVTSEVLPAIRKHGGYLTPEKVEEALLNP
DTIIQLATQLKEERTGRLIAEQKIAEYEPKISYLDSILSSTDSVTISQIAADYGMSPQQM
NKLLHKLGIQKKVGNQWLLCKKHMNQGYTKSHTTEIPKADGGTKIVMNTKWTQKGRLFIY
ELLKKEGYYPQMDLEEIG
>FECAFAII_02568 hypothetical protein
MNTYEIIKDLAKRKKISIRQLEINFGYSNGYLAKWKNNTPNSDELSRIADYFDVSVDYLL
GREERETPKHVDLSEDDTVFSFDGKEISKETMRKAIAIAKALEENE
>FECAFAII_02569 hypothetical protein
MYLKLKEMLSEYNLKVVYMEMKEPGFYYPKPRIIFLNENLYGETAEAFHLSHELAHFSAS
HFEFSVLYDTSTTFHSKFETEADKIAILILLNIYIENELTDESQFNLEKFMEYYSIQNKL
RYTCYAVCQCYFKKKYSYARQYV
>FECAFAII_02570 hypothetical protein
MEKEILIKSPGKTLIKVTDDSISIIRKGFINLVNQGIKGEKTIPFKNISAVQLKKPGMSN
GYIQFTLLGGNESRGGILAATKDENTVMFTKKYWNEMENLKKYIEKQQSILDNNSKETQI
SSADEIKKYKELLDEGIINQEEFDFKKKELLGL
>FECAFAII_02571 hypothetical protein
MDGIFGFTGIVLFIIGLIMLIVRFIKKTNKKTPMILLIIGIIFTTVGFSLSSSNEANDNN
KQESSSSDTQTTTSNSSNKSLTQFEEFLETNNHDWGAFLDSYYSITPATEQNTAFTKYIS
GKTYTFEGTVIESMTTRIAIIADKEYDDKSWNDISATPKVSYVIFAKDLNNADTFTKGDK
VTFTGEISSRGSNIEKSYAQWDMINSKVSKK
>FECAFAII_02572 hypothetical protein
MDNSNEKLTKKEYLELIVEGGIGAIPYIGGVVQSLYFGSKNEKRFKRIEKFYKNLNESLE
NIRDQIPEDVFNLENKDQLIGIFEGINDEVEKSKAQNKIDMYKNLYKNCLLRINNASWDN
EEYYLLVLNQLTSIEIQLLACLMSRGNENFTGNISMSGYSQELIDGSLNRLSDFGLLEKT
ISSIVLGDVGKQNMGYKISHLGIQFINSTLT
>FECAFAII_02573 hypothetical protein
MIKVIFKRITELPEFRLFVDYWYVWFFIVALLIGLDVILERKLK
>FECAFAII_02574 Tyrosine recombinase XerC
MARLVKRGNSWQYEISYKKDDGKYTKIRKSGFKTKGEAKDAANELEYNLNKGLKGDRKNL
LLSDYFEDWMQLYKEGTVSPITYRKYEDTLMNIKKYMPAVLISDLDRVGYQRFLNKYAKD
HVKSTVIKFNNHIRASLKDAVEEGLIPFDPTRKAVIKGKDSLKPKEDKYLDYDQFKSLMK
LVEENLSAQYSSPMLVLVAGATGMRFAELLGLTWEDIDFEDQIITINKTWNYKLNEWGKT
KNETSNRKISIDKHTIDLLKKFKINQKELFENFEIKNPHNFVFFNLKNGLVSSNAVSKYL
RKKLKELGIEKQFTLHGLRHTHASILLYQGVNILSVSKRLGHSSLETTMSTYLHIVRELE
DQDKEKINTVFDSLYKNDN
>FECAFAII_02576 hypothetical protein
MNDKPKEKVYAERLDSSKKNREKITKEAIQDHKKENPKTKENKKFKFTKKEDLL
>FECAFAII_02577 hypothetical protein
MTNKVRELGVSSIEEMFDLATYAFNGADTPERRERFRTLAENSWNYGFFDEEDRLTSQVM
ATPFPVNFYGQEYLMAGIGYVASYPEARGQGGINQIMEKILEDCRDRKVSLSYLAPFSYP
FYRRYGYEQSFDKISYQLNSRDVPFIKKKSGKIKRMDFEDAKAAIRRIYEQMPENQRAGL
KREDWWYTYKFKQKGNYQFALHFDDNEEATGYIVYQLATSSFIIAEWGFLDHDAFCSLVR
FVSSHNGAFETFEYSCGYGGNDQNYLLENPFASVMITPYMMARIVDISLFLENYPFKKRQ
AAFALQIEEDHYAKWNEGIVEVTIENGKNHLSKVEQTKLPIVRGSIQHITQLLLGYRKVE
ELVFQERIQVTKEYEETLSSILPQQQPILNDYF
>FECAFAII_02578 hypothetical protein
MEITKKLNIPASFFYDKVMDSVLFDVRKATGKSVTRKQLKNLEYVKQFSQNNRARIKIEE
VIENQSYKFRTSTTKNEFVVHYQIKPLDDSTCEVHYTEKMESYGMLQKLNDMLLGTILMY
FKRRRFKKMLDMIEATY
>FECAFAII_02579 hypothetical protein
MIKNGLFLCSIGSLIVLYSLNPHSQRYDLYSMVTGLFLTGLGIYFFMKGKKREEAKEKNN
>FECAFAII_02580 hypothetical protein
MITIASAMQQDEIKELLEGYNEEGMTFTFKEKQGIKLFFETSAEDPEVAAKKAKELIKAQ
PWGTVLYFQSTAV
>FECAFAII_02581 PTS system N,N'-diacetylchitobiose-specific EIIC component
MNGLSSWMEKYILPVAAKIGAQKHLVALRDAFIGTLPATMAGSVAVMINAIIRDLPQQFN
STYADSLAADKGIFAVLNVIIGINGFVWNGTLAIAGLIFAFSWGYNLARAYGVNDLAGGI
VGLATLIQGISFGPALSAALDVNVPSNVADAINSSEIGATIADGTLSVGLWGWLKLDHLN
GNAYFTVMIMGAISVIIFCKLMLANITIKMPDSVPPAVSKAFAAILPATIALYVIAIINY
IVGRVADGQLIIDLVQKYIAEPFLGLSQGLGAVLIVTVFVQVFWFFGIHGPNVLAPVLEG
IWGQAQLINIDIFQKGYNGKTGTPAVLDAIEDGKAYMWVRGSFDAFAWFGGSGGTIVLLI
AILIFSKRADYLTVAKLSIGPGIFNINEPVMFGLPIVLNAIMFIPFLIAPVVATAIGWTA
TYLGLVAPVSQQVTWVVPPFLLSFLATGADWRAPIVTLVCMVVTFLIWAPFVISANKMDP
AAGEQQ
>FECAFAII_02582 Lichenan-specific phosphotransferase enzyme IIA component
MEDQQNLEAIMGLIMFGGNAKSDAMEAIAAAKIGDFELADRKIADAEESLIQAHHAQTDM
LTQEAQGNHMQVTLLTVHSQDHLMTSIAFTDLAKEIIELYRRVYSE
>FECAFAII_02583 PTS system cellobiose-specific EIIB component
MAKKTIMLVCSAGMSTSLLVTKMQKAAEEKGMEADIFAVSASDADNNLESKNVDVLLLGP
QVRFMKAQFEQKLAPKGIPLDVINMQDYGMMNGEKVLAQAENLMK
>FECAFAII_02584 Transcriptional regulatory protein DagR
MKERQEEILQLLTENQQGLTASDVAERLTIDRSNASRYLSELYKAHHIVKTAGRPVVYSL
PTEKSKSDEVHVDSSTQVTFETLVGENDSLKVSIQQAKAAILYPPRGLHTIIFGETGTGK
SMFAECMYHFAIDSEMLSADAPFVSFNCADYAQNPQLLFGHIFGIKKGAYTGAAQDSPGL
IAKADGGILFLDEIHRLPPEGQEMLFTFIDKGIYRPLGESAQVHEASVQIIGATTESSES
FLSTFNRRIPMAITLPNLASRSLDERYEIISLFIKQEANRLNQRIDIEKEAILAFMLYDA
EGNIGQVKRDLKLVCAKSFLHYRTHHEKKLIIRKEELSLQVQKGLLKIKEIPERLDRFMD
SKSQYLTFEPGFADVVWSQDPERNMQVYNDIEEKVTSLSETGVENIDLETLISKDVDAYF
QTYVKELTKSSIPKDLLPDEIWRLTNQLYDVAEKRLDRIYNEKARFAFALHLQSTLDRVR
EGHMIVHPDLNNVRKNFKREFQVAIDLSTIIEEEEQVEIPFDEIGFISMFLSINLGESEP
VKENKVDVLILMHGRQTASSMLEMAQELLGTKVGKAFNMPLVMEVQTMYEEVLQYVKNYQ
EHLTNGLLLLTDMGSLNTFSDLIYEETGIRTKAITMTSTMIVIEAIRMASVGRSLEDIYQ
NIQLSFESIVRDQFKAEKSETLQRKKAVIVTCFTGEGVAAKLYQRIMPVINQNKVELIQM
QFLERESFKKHIDALLEEYEIKAIAGTVDVDYQNIPFFSAYDVFDDEKLNILKRIADDEI
PTAKIVDSLAGSLSDVFSIDELIRSLQKTVQQIQTDLSIIVEPGVDTGIVIHLAFMLDGL
IKQESHRQFEKLSIFSKIYRLEMDIVRANLMALERKYQVKIPEDDIAFLTQMFLENKIKK
>FECAFAII_02585 putative ATP-dependent RNA helicase YfmL
MNEFVQVFPENWQKKYEDKGFISPSLIQRAVFQPLSNKQSIVAVSPTGSGKTLAYLWPLL
LNVEPGEASALVIFASSQELAIQVADVAREWGKDKELKVQSLVGGANVKRQIEGLKEKPE
ILIGTPGRILELMKAKKIKAHQVKTMVFDEADQLFDAGNSQIIDQILHQAPTEYQLAFFS
ATADRSLESIEKITGKTFETIDVTAEDDSRKGLRHYFLRVPIRKKDDYLRRLTHIEDFHG
LIFFNQLTELGVMEEKLLYRGVPVGSLASDQNKLLRKAALEQFKKKMVRALLTTDVAARG
LDITGLPYVVNAEVPLSEEAYLHRSGRTGRMGNEGIVITLVQDNNLRDLKRLLRPSNITL
EEIFLYGGKLQTEQPTKEDAAPAVNKKYAKTFSGKEQNPEYNKEKIRKKVKNKSKKERNK
GARRK
>FECAFAII_02586 1,5-anhydro-D-fructose reductase
MINLGIIGTNWITHQFVQAALSTKKYELTAVYSRHLEKAQEFGSHYEGDIEFATDLKTFF
NITHMDTIYIASPNSLHFSQAKQAILAGKNVIVEKPAFSTPKEMDEIIHLANEHNVYFFE
AARNIHESGFKKIADYLPLKDEIIGANFSYMKYSSRYDQVLDGEEPNIFSTHFSGGALID
LGVYLVYAAVAWFGMPKEVHYFPRKISTGVDGLGWGILRYENFDVSIQPGKIGDSYLPSE
IYFDSGTLVMNGVNAIEQAQFHDRAHKEIIDLAVTAAENPMADEAEDFANVMAHPKDPAW
GLLYEEWIELARNVNQVIYDLRKNGGIKFDADNEEDF
>FECAFAII_02587 Sugar fermentation stimulation protein A
MKYQQVEIAFFIDRPNRFIAHCMKKDGEIIIAHVKNTGRGKEVLIPGAEVAIVFAPGPKR
KTAYDLIAVKKKGDWFNIDSQLPNRLAIDGILDGTILLPGLTGPFTVYKREVTYLHSKFD
IYLETVVGQKAFVEVKGMTLENKAIGAFPDAPTLRGLKHIGELTYAAQDGYAAYVLFIAQ
FEHLHLATIHEEMQPALADMVRHAQQSGVQILAYNCQVSADEVTVKQAIPFDVDIPFEDP
IQ
>FECAFAII_02588 hypothetical protein
MIKKMIYFLGSLITVLSSFIYLKKKKQAEKSEGLSKYQGTWFFSDSQQKQQLQITSDYTF
LINGQSLGTSVVEIDEYRLVVRDQYGFYLIFSYPEQTLYDESADTSYKLLSEK
>FECAFAII_02589 Diphtheria toxin repressor
MTPNREDYLKIILELGGDTTKVNNKQIVSSLDVSAASVSEMISKLVKEELVEHSPYQGVQ
LTASGLQKASSLIRKHRLWEVFLVEHLDYSWNEVHDDAEVLEHVTSEHLADHLENYLNHP
EHCPHGGSIPKKEEVVHEERRQTLESYPVGTKVRIARVLDEKELLDYLVTIDLNINEEYE
IVDIAAYEGPITIQNDRKKIPVSFKAASTIFVDKI
>FECAFAII_02590 Glucose-6-phosphate 1-dehydrogenase
MSNEKNVLFTIFGGTGDLAQRKLYPSLFRLYRKGNLGEHFAVIGTARRPWSDEHYREVVK
ETIRALNPSDEEATTFASHFYYQSHDVNDSTHYQTLKELSDRLDGHYQLNGNRVYYLAMA
PQFFGTIVSHLKSQNIMTKNGFNRLIIEKPFGSDYQSAFELNQQIREVFPEQDIFRIDHY
LGKEMIQNISAIRFANNIFEAQWNNRYIDNIQITFGENLGVEDRGGYYDHSGALKDMVQN
HILQVVALLAMEPPVAFSEKEIRTEKIKALKAIRIYNEEEVLENFVRGQYAQGELDGVQF
KGYREEDKVDAQSETETFVAGKFTIDNFRWSGVPFYVRTGKRLTEKGTRINIVFKQVPVN
VFKTSVDEPCDDTTLPPNVLTIYIQPTEGFSLSLNGKEVGQGFETEPIKLEFRNSAEMVE
NSPEAYEKLLLDALNGDGTNFSHWEEVAQSWHIVDVIRKAWDQTQPDFPNYKAGSMGPKA
AFELLEKDGFEWIWQPDNWYRERGKLND
>FECAFAII_02591 Isoleucine--tRNA ligase
MKMKETLQLGKTKFPMRGNLPNREGEWQKEWEENRIYQKRQELNEGKPSFVLHDGPPYAN
GNIHLGHSLNKISKDIIIRSKSMSGYRAPYVPGWDTHGLPIEQVLANKGVKRKEMSMAEY
LEKCREYALSQVDKQRADFKRLGVAGDWEHPYVTLDPSYEAAQVRVFGKMAEKGYIYKGL
KPIYWSPSSESSLAEAEIEYKDVKSPSIFVAFNVKDGKDILDEDTAFVIWTTTPWTLPAN
QGIAVNPKFTYVLVEADGRKFVVAKDLLETVQSEIGWENVTVLKEFAGQEMEYMTASHPF
YERESLVILGDHVTLDAGTGLVHTAPGHGEDDYIAGSKYKLSVVSPVDSKGLFTEEAPGF
EGIFYDKANPMITDLLKEKGALLKLDFFTHSYPHDWRTKKPVIYRATPQWFASIDKFRQN
ILDEVEKVEWVIPWGKTRLYNMIRDRGDWVISRQRAWGVPLPIFYAENGEAIITPETIEH
VAKLFAEHGSIIWFEKEAKELLPEGFTHPGSPNGEFTKEKDIMDVWFDSGSSHEAVLRQR
PELSFPADMYLEGSDQYRGWFNSSITTSVAINGVAPYKSVISQGFALDGEGRKMSKSLGN
IIAPEKVIKQFGADILRLWVSSVDYEADVRVSMDILSQVAEVYRKIRNTMRFLLANTEDF
DPKKDTVSYNDLRSVDKYMTVRLNQVIKEIREEGYDKYNFMHIYRTVMNFLTVDLSSFYL
DFAKDVVYIEAEDDYQRRCMQTVFYQTAVALTKLLTPIIPHTAEEIWSFLKEEEEYVQLS
EFPGYEEFANQEELMDTWTAFMDFRDNVLKALEEARNSKLIGKSLEAKLTVYPKQQVREM
LKALDADIAQLLIVSPDYFEVMAADEQVPDNAMVFDDVAITVEKADGETCDRCRQVRKDV
GVDEKLPHLCGRCAKIVEDFYPEAVAEGFEEK
>FECAFAII_02592 Cell division protein DivIVA
MALTPLDIQNKTFPTKMRGYNQDEVDDFLDLVVRDYEELTQRNRELEKAVKHSEEKLEYF
NELKDALNQSIIVAQDTADKVKTSASKESEVIVTSAQNKADELVANAEKRAHQLTTDAEE
KARKILTDATEKARQLATETEDLKKKTRVFHQRISLMLESQLEQVKSPEWDEILQPFSSY
VTDSHEVIKEVLAKQLDNENDTDVNSDTGVIEAPMTAFDTQAIDISIVPGENENE
>FECAFAII_02593 hypothetical protein
MDANVYQHFRADERTFIDSVGDWIEQVQGQYAPYLTEFLDPRQSYILETLIRQSSDLRFM
FYGGYEQAERKRCLIFPDYYEPVEEDFETALYEIHYPSKFASLSHGKILGTLVGTGIKRS
YFGDIISDGDRWQVFIANEVDHFVAAQVTKIGKVAVRLEPIKYTEMIMPKDSWTQERGTV
SSMRLDSVISEIYNISRQRSKQLIEAGKVKVNWTENTRPDFVLELLDIISVRGYGRVQIQ
ELEGKTKKEKYRVLFGVLRK
>FECAFAII_02594 Cell division protein SepF
MPLLNRGAIANFFGLADEEEYEYQDYPETTKKAVQPTKKNTTQNQSTHSVSAANTHEKQK
TATSRPVTHESIQPAEKKKVIELHQSPTKTVAKERTASRTSTQPKANLAGKITVMEPRAY
SEAMAIAKRIIAGEATLVNFHLVEEKQARRIVDFLTGTVYALDGDIKRVGDEIFLCTPTG
MEIDSSTAQSFADANLFDL
>FECAFAII_02595 hypothetical protein
MIADNLQKIKQEIQDSCALVHRDPKEVTLVAVTKSVESAQAEELVRAGVMNCAENRVDKL
LEKKQDLFDFPEIKWHLIGNLQRRKVKLIVNEIDYFHALDSLRLAEEIQKRLEKELSCFI
EVNVSGEESKHGISPDELLPFVESLAACTKIKVVGLMTMAPKEASDEQIHKVFGTLKELR
DLVQAKGYAHAPCSELSMGMSQDFQIAIEEGATFIRVGTALFKDE
>FECAFAII_02596 Cell division protein FtsZ
MEFSIDNNINDGAVIKVIGVGGGGGNAVNRMIEENVKGVEFITANTDVQALKNSKAETVI
QLGPKYTRGLGAGSQPEVGQKAAEESEQSLREALDGADMIFITAGMGGGTGTGAAPIVAG
IAKELGALTVGVVTRPFTFEGPKRGRFAAEGIARLKENVDTLLIISNNRLLEVVDKKTPM
LEAFREADNVLRQGVQGISDLITAPGYVNLDFADVKTVMENQGTALMGIGVASGEDRVVE
ATKKAISSPLLETSIDGAEQVLLNITGGLDMTLFEAQDASDIVANAATGDVNIILGTSIN
EEMGDEIRVTVIATGIDESKKERKSSRPARQAQMQSPAQKTVLDMDQAKPTSSEEENSFG
DWDIRREQNVRPRVDDSNFDNIEKKEFDTFNREETKSHGDDELNTPPFFRRKK
>FECAFAII_02597 Cell division protein FtsA
MAKTGMYVGLDIGTTSVKVVVAEYIDSQMNIIGVGNAKSEGINRGIIVDIDKTVQAIQRA
VRQAEEKAGIQIKGVSVGLPANMLEVENCQGMIAVNGDSKEITDEDVRNVASAALVRSIP
PERQIVSILPQDFTVDGFEGIKDPRGMIGVRLEMYGLLFTGPKTIIHNIRKCVENAGLIV
NEMVITPLALTESILSDGEKDFGTIVIDMGGGQTTTAVMHDKQLKFTNLDQEGGEFVTKD
ISIVLNTSFNNAEALKINYGDAYPERTSPDEEFPVDVIGQSEPVKVDERYLSEIISARME
QIFNKAKDALDQIEALELPGGVVLTGGAASLPGVVDLAQEIFGVNVKLYVPNHMGLRNPV
FTNVISIVDYSANLSEVYQLAKIAVTGETSAARQMVVEQETTNTYESYEAPEETIYDEPE
PKESGENVKNKIKGFFTNIFD
>FECAFAII_02598 Cell division protein DivIB
MSKKKEPKKLSHPSSDENNLTPWQKANRKYLAEQEMKNQEPKKEDITLDTPLSDSEEEKT
VQEEQQEESQSEKKIEFFEEIKQKKNGGPYNGSFLNRLPNLKSQRHKVLFRRLALIITVL
GIPLIFLIYYVSPYSKLQAVAVSGNKTVNSQEIISDTKLSLGENVWGQYFHRSTYIDRLK
KAQPRIETANIHFKGMNEFDLDVTEYKEIALIAKNNQYYPVIENGTVLDEKVANPTKNLP
ILEEFKDSAKIKELTKQYNQLSSELQKAISEIKYTPRASNKNLIQLNMNDGNQVIVNINN
LANQMKYYSQVAKDMDEKGVIDMEVGIFSHPYGSTQETEESGQSEETTESEENADQTNES
SEEAETQKAQTPGSSSTNGSSDSNDSSETSQIEDNPSTTPSSLNEN
>FECAFAII_02599 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MKILVTGGGTGGHIYPALAFVNYVKTQEPNAEFMYVGAKRGLENKIVPDTGMPFHTLEIQ
GFKRKISMHNIKTVRLFLKSIRQAKKILSDFQPDIVIGTGGYVSGAVVYAAAKMGIPTVI
HEQNSVPGVTNKFLSRYVDRIALSFKDAASFFPENKAVLVGNPRAQEVADTKKSDILKTF
DLDPEKKTVLIFGGSQGALKINQAVSVFLSEYIPSSYQVLYASGDRYYEEILNKINPEIQ
NISVQPYIKNMAEVMASSDLLVGRAGATSIAEFTALGLPAVLVPSPYVTNDHQTKNAMSL
VHAGAAKMIADNELTGESLSQTVNEIMGDEELQKQMCRASKEQGIPDASKRLYDLVKQII
KK
>FECAFAII_02600 UDP-N-acetylmuramoylalanine--D-glutamate ligase
MKKISTYENKKVLVLGLAKSGVSAAKLLHELGALVTVNDGKPFDENPEAQELLSLGIKVI
TGSHPIELLDEEFSLMVKNPGIPYSHPLVAKAQEMGIPVITEVELAYEVAECPIIGITGT
NGKTTTTTMTGLLLNAGADQGIARLAGNIGYPASGVAQEAKSEDKIVMELSSFQLMGITD
FRPHIAVITNIYEAHIDYHGTRKEYVKAKWNLQKNMTEKDYLILNWNQSELQELAQRTKA
RVLPFSTKEVLEDGVYADDYSIYYKKEKIMEISELGVPGKHNVENALAAISVAKLYGISN
EAIRETLHFFHGVPHRTQYVGEIQGRKFYNDSKATNILATKMALSGFETSKVVLLAGGLD
RGNTFDELIPSLKGIKAMVVFGQTKEKLMDAGKKAGIETIVTADSVEQAVPLALENSTDG
DVVLLSPANASWDQYPNFETRGNRFMEAVNRLK
>FECAFAII_02601 Phospho-N-acetylmuramoyl-pentapeptide-transferase
MEWTQALIPIVSSCAMTIAAMPLFIGYFQMKKQGQAIREEGPKWHNSKAGTPTMGGLVFL
IGSILTGIWVGAWQKQLTPTLFILLFVLALYGVIGFLDDFIKIFKKRNMGLNSKQKLIGQ
ILGGIIFYLVYRSEGYPGVLNFFGLDLPLGIIYGIFALFWLVGFSNAVNLTDGIDGLVAG
LGSISFAAYGLIAWHQHQYDVLIICLSVLGGLLGFFVYNRKPAKIFMGDVGSLALGGLLA
AISIMLNQEWTLLLIGLIYVMETASVMLQVTSFKLTGKRIFKMSPIHHHFEMCGWSEWKI
DTVFWLISIVTSLITLWIVW
>FECAFAII_02602 Penicillin-binding protein 2x
MSLKNKIRRFMEKKNLNPMNNRKKVGIILFATSIGLFFLFAVRFSYIVIGGHVAGTSLAE
KTKQLYQGSEVVKAKRGTIYDRNGVALAEDASSYSIKAILSKTYTSGDKKLYVEEKNFDK
IAEILHKNLSIDKKDALNILEDGAKKELYQVEFGSYGKNISQETKQNIEADMKKEGVAGL
YFVDHQARMYPNGVFSSHFIGYAVPDKDENGLVGKLGLESAYNDILSGKDGKIIYQKDNF
QNPLPGTVAEEEKAVDGQDIYTTLDSRLQSYLETLMDQVNEEYQPEELTAVLMKAKTGEI
LAMGQRPTFNPETMEGLTGKDAIWRNFLVQDSYEPGSTMKVFTTAAAIEEGEFNENETFQ
SGKIQVEDATINDHDFGEKGVLTMRQALSWSSNVGMVILEQRLGGRWYNYLQKLGFGQST
HSGLDDEVNGALPTLNIVDRAMSAYGQAVGVTNFQMMKAFTSIANNGTMIQPRYISKVVD
PQTGEERTTQTEVLGQPFSKETTEKVREYMRDVVESENYGSAYGVYSVPGYNVSAKNGTA
QIASDTGGYQTGDTAYLYSIVEMVPSEDPDYVLYLTMKHPKTYDRMALAKIANPLMKRAM
DFKETEEDSDTETKTEKVSVADYRNLEADVAAADAQKSGLQPVVIGNGKKVQKQSTANGD
QLISGEKLILYTGGDKLMPDVTGWSKADIMKLGKILGIEVSFDGDGYCVKQELAPYEKIT
EDKLSFTLEE
>FECAFAII_02603 Cell division protein FtsL
MAELKKMQDYEYDLPELVDQPEQQMPDSSSNQEIILPQSPAKRLKQISALEKIAVASVAI
AIVALCVLTVMLRTNISGAEKEITSIQTEINDKKQEKTSLEQEKNELSRTERIKQIAEEK
GLSINDDNLRKVK
>FECAFAII_02604 Ribosomal RNA small subunit methyltransferase H
MTETFQHYTVMLKETVDGLNIKPDGVYVDCTLGGAGHSEYLLSQLSSKGHLYAFDQDQKA
IDHAKLRLASYVEQGMVTFIKANFRELEERLSEHVDKVDGILYDLGVSSPQLDEAERGFS
YHQDAPLDMRMDQSAPLSAYHVINEYSYHELVKIFFRYGEEKFSKQIAREIERVRKTKPI
QTTGELVEIIKQVIPAPARRKGGHPAKRIFQAVRIAVNDELGAEEASLEQAIRLLKVNGR
ISVITFHSLEDRIVKSMFKEYSTVQDLPPGLPVIPDEFQPELKVITRKPILPSEEELTEN
NRSRSAKLRIAEKIRMKEE
>FECAFAII_02605 Transcriptional regulator MraZ
MLMGEFQHNIDAKGRLIVPSKLREELGEKFVLTRGLDGCLFGYPMSEWENLEAKLNEMPL
AKKDARTFVRFFYSAATECELDKQGRINIPSTLRNYAALTKGCVVIGVSNRIEIWDETRW
QDFSAAAEENFDEIAESMIDFGL
>FECAFAII_02606 hypothetical protein
MGTFTPLILFWYIYPVIVLFGCQFLVKLFSLNRRFKIKAPDLAIPFLWGGMHALSRNTGT
ISILPFFFISVLLMGICIAVFQAYYYEEIIYPRYFKMTWRLVFLLTIVLYAVLIIVNILS
YL
>FECAFAII_02607 hypothetical protein
MIKYFTLDNEKLRNTGKETDQTIWYCVERPNQEEIHQLTHQFEIPSDYITSILDDAENSR
TEEFNQSKLTKPALLLLQYPFAKTSPSGYFQVDTYPLSIILTPKKKLITITNHEPLFLKK
VFSQTFPKSDISPNLNIFFQFIWQVTLSYNSYLATLQSQCDTLEAKLQVSTENKQLYQIM
DIQKSLVYFREATSANLDALKELAQNKLFQENHALKNHLRDVLVETEQAMTTSRIQLKLV
EQMNQTFSAIVSNNLNNIMKILTSLTIILTIPTIVGSIYGMNIKLPIAERDDAFIWLVLL
TLFICIVTTYYLKKGKFL
>FECAFAII_02608 hypothetical protein
MREKKQTSTFAKVTKFVIWTMLILTIGSVVLTAVMSVM
>FECAFAII_02609 DNA repair protein RecN
MLQEISITNFAIIPELRLSFHEGMTALTGETGAGKSIIIDALGLLAGGRGSSDYIRQGAE
KCVLEGLFELPKQEGFSELMVELGIETDEDNLIVRRDMSLTGKNVCRVNGHIITLANLRR
IGSYLVDIQGQNEHQELLQPESHLALLDRFGDVAFQQKKKSYQQEYISYRELEKRVRKVQ
QNEKSYVQRIDMLHFQQEEIAAADLQVGEEEKLKEEREKLSNYQKIADGLAAGYGALTNN
EQNSVDGVGLAVSELQGIAHLDVEYEAIYENIQSAYYLLQDAIGDMSRQIDLLELDESRL
EEVTQRLELIRQLKRKYGESIESILAYYDEITEELASSDFSEGQLDKMKEELEQKELLLQ
QQAADLHEARKKIAKELEKSILHELKSLYMENTEFEVRFLKEENRQLNHDGFDQIEFYIT
TNPGEPLKPLVKVASGGELSRMLLALKTIFSSEQGVTSIIFDEVDTGVSGRVAQAIADKI
SQISKYSQVLCITHLPQVAAVADYQYYIVKAVIDGRTQTSVSELKTKEREEEIARMLAGS
EITKLTLEHAKELLKLAKRT
>FECAFAII_02610 Arginine repressor
MRKKDRHRLITRLLSEQDIRKQEEFVEILKSKGISVTQATISRDIKELKLIKVPASDGGY
RYSIPAETNEDVNTKLEKLLKDAFVAVDQMEKFVILKTLPGNASAAANLIDKRYKKELFS
IINDDDNVLMITRTEDQAVLLKKDFLHYL
>FECAFAII_02611 Hemolysin A
MEKERVDVLAVKQGLFETREQAKRSVMAGLIYNEKNERFDKPGEKIPVSSELRVKGKKLP
YVSRGGLKLEKALKAFDLSVEGKTLLDIGASTGGFTDAALQNGAKMSYALDVGYNQLAWK
IRQDPRVVVMERVNFRYAKPEDFTLGIPEVAVIDVSFISLKLMLPPLHAILKEEGEVIAL
IKPQFEAGREAVGKNGIVRDPQTHQKVLEDILSFAAQGGYDVLELSYSPITGGEGNIEFL
AHLRKVPESGTINSAINMAEVVSNAHEQFDHK
>FECAFAII_02612 Farnesyl diphosphate synthase
MRLTDFSAIHLPAVEKEILSFLDEHTTDRGLYDAMSYSVKAGGKRIRPLLLLTAVASFDE
PIDVPVYQVAAALEMVHTYSLIHDDLPAMDNDDLRRGKPTNHKVFGEALAILAGDGLLTG
AFQLISMAHLGNSPKLLLLQQLAVCAGSQGMVAGQAADIEGESKKLSLEELAFIHERKTG
HLIRYALLAGGILAKQPEEILLLLQRLAEHLGLAFQIRDDLLDVIGTTKTLGKTAGKDER
MEKNTYPRLLGLEKTREALEIELLSANKIIDKLEEDVFSFDGGLMRQMIKQFDVEK
>FECAFAII_02613 Exodeoxyribonuclease 7 small subunit
MENPTFEESLQELEKIVMQLEQGDVPLESALDSFKRGMELSKHCQDTLAKAEETLTKMMT
ESNEEVDFDGNEES
>FECAFAII_02614 Exodeoxyribonuclease 7 large subunit
MAQEYLTVTTLTKYLKRKFDADPYLERVYLTGEISNFRLRANAHQYFSLKDDHAKISAIM
FKGAFQKLRFQPKEGMKVLVVGRISLYEAGGSYQIYVEHMEPDGIGALYQELEERKEKLM
KEGLFQGPKKMLPRFPKRIAVLTSPSGAVIRDIITTVKRRYPIVQLVLFPTVVQGNQAAD
NVVRNIQRVEEMGNFDTMIIGRGGGSIEDLWPFNEERVARAIYQANTPVISSVGHETDTT
IADLVADVRAATPTAAAELAVPVLSEELMRIQERQARLQQAFVRQIQRKQERFERARRSY
VFRQPERLYEGQTIKLDQLKQRLYQATQQIYHAKEKQTIALSHQLEQVAPLYRVKAARQE
TAYLEKRLEEKIQQYMKQQQQRFAQAVQSLDLLSPLKIMGRGYSYTTLNDQVVKSVTEIH
QGDLLTIHYQDGIVKGQVQEIDKGE
>FECAFAII_02615 Bifunctional protein FolD protein
MAELINGKELAEKMQAEIAEKIQKLKDNGIHPGLVVLLVGENPASQIYVRNKERVAKEIG
IHSLVERYPETISEDELLAEIEKYNQDPSFHGILVQLPLPKHIDEEKILLAIRPEKDVDG
FHPMNLGRLLAGKPDKIPCTPYGIMKMFEAYSIDPAGKRAVVIGRSNIVGKPMAQLLLMA
DATVTVAHSKTENLAELAQEADILVVAIGRGHFVTKEFVKPGAVVIDVGMNRDANGKLIG
DVKFDEVEPIAGWITPVPKGVGPMTITMLMYQTVKSAEAFGAGE
>FECAFAII_02616 N utilization substance protein B 
MNKELSRHEIREMALQALFPLDFNADLTKEDAIFNAIELDHRDMINEDESEFVPVYLDTL
VGGVCAKKDELDKVIEKHLKNNWHINRISKMDLVILRIAIFEMTYVTDVPAAVALNEAIE
LAKTFSDDRSRKFVNGVLSNVLKELEAGA
>FECAFAII_02617 Alkaline shock protein 23
MADEKNLILNANQDLGEIVIAPEVIEVIIGIAASKVEGVYGMRGTFASNVTELLGRAAHG
KGVYLANEEDGLKVDLYCYLEYGVSVPKVAMEMQERVSQQVLFMTDIDLSEVNIHVVAVV
PEKLEQPTIEELFEDEEEENE
>FECAFAII_02618 Aminopeptidase YpdF
MMLRVEKLRKKMQEENLDSFLVTSPYNLRYLTNFTGTTGLAVITLEKAFFITDFRYTEQA
AAQAQGFEIIKNVGPIFDEVANLVRKEELHSLAFEETTVSFLEYSVLEEIIDAELVPVSQ
MIEELREVKDEEEIAIIEKACHIADMAYDHILKMIQPGMTEIEVANQLDFYMRSLGASGV
SFDTIVASGLRSAMPHGVASKKIIEQGDLITLDFGCYYEGYVSDMTRTFAIGDPGEKLKE
IYQIVLDAQLAVIDAAKPGMTGVQLDAVARDYISKHGYGEAFGHSTGHGIGLEIHEGPNV
SSRAEKQFVPGNVITDEPGIYLPGIGGVRIEDDLLITEDGNRVLTRSPKELIIL
>FECAFAII_02619 hypothetical protein
MSWLWTLIVGAVIGAIAGAITSKGNSMGCVTNIIAGLVGSSIGQAIFGEWGPKAAGMALI
PSILGAVILVAVVSFFFGKRS
>FECAFAII_02620 hypothetical protein
MVQSINTKVDLVIDATSFTGLTDYGQIMIGDNGFEFYHARDRRKYIQIPWEEVDYVLASV
MLKGKWIPRYAIQTKKNGTYTFSSKEPKKVLRAIREYVDEDRMVQSLSFFDVVKRGIRSM
FKRK
>FECAFAII_02621 PTS system mannose-specific EIID component
MAEEKIKLSKKDRLAVAWRSTFIQGSWNYERMQNGGWAFSMIPAIKKLYKTKEERSAALK
RHLEFFNTHPYIASPILGVTLALEEERANGAPVDDVAIQGVKVGMMGPLAGVGDPVFWFT
VRPMLGALGASLAMGGNILGPIIFFLGWNIIRWAFMWYTQEFGYKAGSKITDDLSGGLLQ
DVTKGASILGMFVLAALVQRWVSIKFLPVVSTVKLDKGAYIEWDKLPSGGEGIKSAFEQV
NNGLALSPEKVTTLQDNLDQLIPGLAALGLTLLCMWLLKKKVSPIVIILGLFVVGVVGHV
IGLL
>FECAFAII_02622 PTS system sorbose-specific EIIC component
MSIISIILVVLVAFLAGMEGILDEFQFHQPLVACTLIGLVTGNLEAGIVLGGTLQMIALG
WANIGAAVAPDAALASVASAIILVLGGQGVKGVPSAIAIAVPLAVAGLFLTMIVRTIAVP
IVHLMDAAAEEGNIRKVEMWHIIAVCLQGVRIAVPAAALLFIPAQTVQSFLESMPAWLTD
GMAIGGGMVVAVGYALVINMMATKEVWPFFVIGFVVAAISQLTLIALGALGVALALIYLN
LSKMGGSSNNGGGSNSGDPLGDILNDY
>FECAFAII_02623 PTS system mannose-specific EIIAB component
MVGIILASHGQFAEGILQSGSMIFGEQENVKAVILKPSEGPDDLRAKLEEAVASFDNQDE
VLFLVDLWGGTPFNQSNTLFEEHKDKWAIVSGLNLPMLIEAYASRFSMESAHEIAAHIIE
TAKDGVKVKPEELEPAEAPKAAVEDAQPKGALPEGTVVGDGKIKYVLARVDSRLLHGQVA
TAWTKAVQPNRIIVVSDAVSKDDLRKRLIEQAAPPGVKANVIPISKMIEVAKDPRFGNTK
ALLLFENPEDVLTAVEGGVDIKELNVGSMAHSVGKVVVSKVLSMGQEDVEAFEKLEQKGV
KFDVRKVPNDSRDNMDDILKKAKAELAKA
>FECAFAII_02624 PTS system mannose-specific EIIAB component
MDIRLARIDDRLIHGQVATVWSKQTGVERIIVISDVVAQDKLRKFLLKEAAPPGITANVI
TVQKMIQIYHSGLLSRAKVMLLFTNPQDVEAVVRCGVQLKSLNIGGMSFTEGKSMITNFV
SVNQQDIDSFRYLNSQEVELEIRKVPADRKILLMELLAKIKKV
>FECAFAII_02625 Transcriptional regulatory protein DagR
MAKRIDRIYMYVKEKTAHLTKAEYDQGVTTQEIAEVLGIQRTNSSKDLNQLVREGKLIKT
DGRPVRYIYQTLVTHVKPVTKHVVSYKETPVSEEKNTLQIDTKDIFAKIIGANGSMKNSV
EQAKAAILYPPRGLNCLITGPTGSGKTYFAHAMYHFAKAHHVIDEETELIVFNCADYANN
PELLMSHLFGYAKGAFTGADEEKMGIIDQADGGMLFLDEIHRLPPEGQEMIFYFMDHGTY
SRLGETTKSHEANVRIVGATTEDPGSSLLETFVRRIPINIKLPAFEKRPANEKVDLVKIM
IAHEANRTQRKISLTEDVAKALIGSVTYGNIGQLKSNIQLVCARGFLNHMQSPEISITID
DLTEGIRSGLIQLASNRSAMAELSKILEPKITVAPNDTIMKIQSDSYELPYNLYDIIGDK
AALLKSDGLDQEAINHFISTDINIHLKSFYKDHGFSFNADSKLAEFVDPKIIEVTNQIYV
MVKRSLPYEFQQNFIYAMSLHISSFLKKINLGEERHTNDNIREMAFDFPDEYAVAKEVRS
YIETYFQVEIPESEDYYLTVLLVSLRANQASGRIGVVVAAHGNSTASSMVQVVQQLLDAE
NVRAVDMPLDMDPKTALDRIERNVQEVDEGSGVILLVDMGSLASFNSQIQRDTGIPVRTV
DMVTTSLVLETVRKVSVLGTDLDMLHESLKNFRGYAEISSVESVQEAKPIHKKKAVLAIC
ASGEGTAQRIKELIERAVNKRQETELEVLALSIVEVKEELPVIQKEYQIIATTGITDLNI
QAPFIPLERFIDQNIEVILDQLLMESELEETEFISLDEESAKNTCVEFISDNFIFINGSK
LIDPMWQFSTQISQTTGIGDEEYGFKINLVMHTAGMIERIIRNEPLTVEENELTNTTNDP
LYSQLAASVVLLEDQIKVKVPIEEMYYLLRLVHNQLDKKEYTVP
>FECAFAII_02626 50S ribosomal protein L27
MLLSMNLQLFAHKKGGGSTSNGRDSESKRLGAKRADGQTVTGGSILYRQRGTKIYPGVNV
GIGGDDTLFAKVDGVVRFERKGRNKKQVSVYPVAQEA
>FECAFAII_02627 hypothetical protein
MIKGTFKRNDAGQIVSFTLTGHADAGPYGSDIVCAGVSALAISTVNGIASLAGFEPIVEM
NEEEGGYLYTEVTSGMTQEQNNIAEILLENLLLGLQSIEAENSEYIQIKTINDK
>FECAFAII_02628 50S ribosomal protein L21
MYAIIKTGGKQVKVEVGQAIYVEKLDVEAGEKVVFDEVILVGGESTKVGAPTVAGATVEG
TVEKHGKQKKVVTFKYKPKKHSHRKQGHRQPYTKVVIDAINA
>FECAFAII_02629 hypothetical protein
MEYPKELIQEASLRMNGRPVEGFIAGQGPLHPKLMLVGEAPGKTEIDTHVPFSGQAGKEL
MQALSSTGLTREEVYITSAVRSRPYRVTHRINKRTQQSETVYPNRTPTRSEVFAHAPILD
YELMKVQPKLIATLGNIGLQRLLGKEYTVTKNHGQLYTGPVLQLTEQKDAYEWSEKNYRI
LPLFHPAAIFYNRSLVPVIHQDWQVLASLLQQY
>FECAFAII_02630 C4-dicarboxylic acid transporter DauA
MFKNYVSSLKKEFSGYDLSRFQKDLLAGITVAAVALPLALAFGVSSGADAAAGLITAIIA
GIVIGGLSGGFYQISGPTGAMAAILMSIAATKGMQGVLLATFLAGLFLLAAGLFRLGTLT
SFIPAPVITGFTSGIAIIIALGQIDNLFGVHSEGTNVIEKLSSYQTIGFPINTASLIMGG
LVILGMFIYPKKWAKRMPSSLLAIILATAVMLLFHLPVATVGKIPQTLISSNRLNMGDFS
FSALQQVAVPAISIALLGMIESLLCGASAGRMANKPLDSNQELMAQGIGNLLLPFFGGIP
ATAAIARTSVAIKSGAQTRLAGMIHAVVLLLSMLVFAPVMSQIPMPALAGVLIVTAWRMN
EWETIKELFTNKYWSAVLLFILTMICTVIFDLSIAIVIGVIGGCVFFVVKSAAITISLET
IDWQRMGLPETEKLNNWTVVYISGPLFFMSSEKLKNKLEELNHHDGVIFSMRGVPSIDLT
ARAVFDEFQEKAEQRGQTIIYTSLQPEVEKQLSHLWEHTFTHQHQTVAHALTALHAKYTA
ISH
>FECAFAII_02631 hypothetical protein
MTILSRILVTLVAIEFFYIMYIETVRTDSDTTSRVFKMSKEELSRKSVQTLFKNQGVYNG
LLGVGLLYGAYLSSASKEITSMLLISIFFVALYGSLTSDRWILLKQGGLALLALLSIFL
>FECAFAII_02633 Putative O-methyltransferase
MRNEMMHRPVVKEELLDFMRTQQKKLPGELGKLEEEAHVAEVPVIPHETVVFLKFLLGQL
QPERILEIGAAIGFSSSVMATTIGENAHVTTIDRFDVMIEKAKKNYERLGLTDKVTLLEG
QAADILPELSGPYDFIFMDSAKSKYIEFLPECLRLLRKGGVLMVDDIFQGGTILLPDEEI
PRGKRAIHRKLNEFLRVVMDHPDLTSTILPLGDGVILMTKESETIEL
>FECAFAII_02634 hypothetical protein
MSPYYAQGNLIYVRPKNTNEILVGDIITYYENSGKKISTRRVIAVENNHEDFYTKADTKT
YIEPGVVKKRNIIGSPIFQIPYIGLVLSKTAFAWIQGLFFTIAFCLTGITAWNTFVELKK
KRRRTQKFL
>FECAFAII_02635 hypothetical protein
MSFFNNIYNKKESFYLRIKWSIIIILSLLFLTGIAYFFYFIFSPADSNQMKEIKDSWVFY
TKDDPDFKFDSKYTRTIPTVDKDETFIMETTLEKPLDEANLLIKGNHQWITVYLGEKILY
QRKDYQEESNPGLSLAVIDLPANYIGKKLTLTVSSPYQNYAGLPPKVYLGTTGPLISFIY
SQSVPQVLTMIIAVFIAIGTFFYTIYLMYKQKRLEYSLILLSCFALALGFEAVSEDILSG
ILFEPFVHSFLSHLFIILTSAFIICYYWSRMFYYKKWYGIFCTFQLLIFIGVLLYATFTP
AELPELMPIANIASVISTLVTSLACIGEAYKNNRFYVACTPWIVLVAIIHCLIYIQTALG
IYQTTINWSTILYIIILIVIISYNLIDHILNTDKDRRQVDFLKIKNDLLEQHYEQLRQHI
QEVNTLRLEFVQEMENLQDLMHTDQTKAKNYVEKILEEAKNFEMLCSFCNHQVTNLILAR
YQKLAAKRNIQITFQADLPEELPINDDDLAQLLIHALEHSFRETHAIENPLYRKIYLSIH
EQEEHFVICCEHSAHYDTNLFSRGITEELDDQERFDLMMMKDVADRYTGTLTQEKDTFID
RITVQLSRNYPNPV
>FECAFAII_02636 Lipoate-protein ligase LplJ
MIFVPNENHDPRINLAIEQYLLQEMPLDEPILLFYINEPSIIIGRNQNTLEEINRDYVEE
NGIHVVRRLSGGGAVYHDFGNLNFSFIMPDDGDSFRDFAKVTQPIIQALHELGVAGAELK
GRNDLVIDGMKFSGNAMYATNGRMFAHGTIMFDSDINEVVNALKVKKDKIESKGIKSIRS
RVTNIKPFLPEEKQKMTTEEFRQEILLKIFGVESVEEVKTYELTDEDWKKINRISEEYYR
NWDWNYGKSPDFNFSRQKRFSIGSIEVHLNVSEGMIKEAKIFGDFFGLGDISDVEKKLVG
QKYDKASLSKIVSQIDVKKYFGAIEPEELLTLLY
>FECAFAII_02637 Ribonuclease BN
MKLTVLGCLGAYPYKNQGTTGYLLQSDGFNLLIDAGSATLIKLQEHLDPLDLDAVILSHY
HHDHIADLGVLQYYWQLHPKRNPETLLSIYGHTKDSIHFEELTLENVSKGHPYFEAEELK
IGPFLITFMETIHPVVCYAMRIVEETTGKVFVFTGDSGYLESFADFAKDADLFLADTYLF
EGNEHHHAHFTSKEAGELAKSANVKKLVLTHLPQFGDLEQLKNEAQKAAGKGIDIELAAV
DKVFNI
>FECAFAII_02638 hypothetical protein
MNNRIPISEYRKKARVSLENQWGINTWLVFLSIIFTSVIQNFFDGFSPFPEESMQQHLLS
FLVDNLLLFAFNYALFYIALVVVRGGRPKSNLLFSVFQRKYFGSILGINLINSVINWLLN
SLIFLPMFLISGVSTYMQLLFSSNAVPTGVMPEDFLDISFVLSMIGMIFVSALIMSIVGG
LFQFAAWTKFDYPDLSVIQCLKYGWFLLKDRIGTYILLQLSFIGWYLLGAIALFIGLLWV
IVYVNVSVAEFYEQARIEKGGPDAYFT
>FECAFAII_02639 Putative aminopeptidase YsdC
MDTKEEQLLIDLTSAKGVPGNEEEVREVFREYAKPFADDIFYDGLGSVIAKHGAGGGPKV
FISGHMDEVGFMVTKITEKGFLEFQTLGGWWGQVMLAQQVEIKTREGKIVHGVIGSKPPH
VLTPQVRNKPYEIKDMFIDIGASSQEEAKEWGIRPGDMVTPYIEYKRMNGSKYLLAKAWD
NRIGTAVSLRVLENLSKEAHPNVLFAGSDVQEEVGLRGARTSTHLVNPDIAFALDTGTAG
DTPGMTPKEADSILGKGPQILIFDASMIPHKKLLNFVIDVAEEMDIPFQYTVISGGGTDA
GQMHLTRDGVPSVAITVPVRYLHSHTSVIHEDDYLNTVKLVTELVKRLDSETVEKIRSYE
>FECAFAII_02640 hypothetical protein
MKKKLFAIFGPVVLAVGLLFVFFTSSYQVDISNPETIRRASSSMSVNVLKGDAIKNYALS
EKQYIPFFGSSELSRISPFHPSVLAEKYQRNYRPFLLGAPGTQSLSQYMMMRSAGDAMKN
KNVVFIISPQWFVKNGVKTDYFNTYYSELQTYDWLFSMKKVTPADRYLARRLLTFSKVKE
NDTLTAILQTIKKGKLPLPESLNQLRSQWNMLKREDEVFSNIGLKDRQQKIDHESKRLPK
QYQETELSILANQIGERETTNNPFGLKNDFYTHRIRAHEPELKQSQKNWDYRFSPEFSDF
QLVLDQLAKNHNEVLFIIPPVNEKWSDYTGLSQEMLQGFAKKIKFQLNSQGFNRIADFVN
QAGTNYFMEDTIHLGWKGWLAADQQIRPFLEENHITASKYHLDDAFFSKSWQHQIPDKLQ
LK
>FECAFAII_02641 D-alanine--poly(phosphoribitol) ligase subunit 2
MEEQILSILEEITGTDEVRKNRDIDLFDEGLLDSLASVQLLVELDGELDIQVPVSEFERE
DWSTPNKIIQQATALKG
>FECAFAII_02642 Peptidoglycan O-acetyltransferase
MMLPHMIPYAEPFYFFLLAIALVPIVLSLLIWEKRLPVYQSAVTLFFLFVSFGGNYWQQG
AALIGYVLWQTILVWGYFVYRQRKNQTGWFFAAVILAIIPLFLTKVTPFFEHGKASLLGF
LGISYLTFKSVQMIMEIRDGMIKTYKPFRYIQFLLFFPTISSGPIDRYRRFEKDQLHPPV
RDKYVDLLGKGVQNIFVGFLYKFIIGYYFGQVLLPVVGRIALQHGGISWALVGYMYVYSM
YLFFDFAGYSLFAVGTSYMMGYQTPINFNKPFLSWNIKEFWNRWHMTLSFWFRDYVYMRL
MFFMMKKKFFKSKIVMSNIGYFALFLLMGIWHGLTWYYIVYGLYHACLICLTDAWIRFKK
KHKEQLPSNKFTHGLAVFLTFQAVCFSFLIFSGFLDKLFFS
>FECAFAII_02643 D-alanine--poly(phosphoribitol) ligase subunit 1
MEIKTIIEAIDDWGINEPDRVAYQADETHTFGELKQASDALAYYLEKKVEGDGPIVVFGN
LEFEMIVSFLGVVKSGHAYLPIEEHTPKERILSIFRVAKPSMVISIGDWIEDIPSVPVIT
KKEFQEIKKIPVGFYPRNSVKGTENFYIIFTSGTTGEPKGVQISHDNLVSFVQWTMEDFG
IKPGMHFLAQAPFSFDLSVFSIYPALVSGGMLKPLNKAVVQDFRQLFATLPALKLNVWVS
TPSFMDICLMEPTFNGENVPELDMFLFCGEELTKKTAESLLDRFPNARIYNTYGPTEATV
AISSIQIDQHVLDSYDRLPIGYVKKDTKVSIVQEGKPVSKGETGEIIIAGPSVSKGYLNN
PEKTAAAFFCQNDLASYHTGDAGRLDEYGLLFYEGRMDQQVKLHGYRIELGDIEHYLLQD
NRIKQAVVVPKYQGTKVQQLVAFVVLENKTKQPDFQLTKSIKEQLLEVVMDYMIPQKFHY
VDLLPQTVNGKIDRKKLTAEVNPE
>FECAFAII_02644 hypothetical protein
MNKWRSNPKLNYWGKFIIRTIFYSAVLLFLIYLYHYKNIQGGTFIYNEF
>FECAFAII_02645 Bacitracin export permease protein BceB
MLYKLAVKSFFRQSRGYLVYFFSLTLSVMIYYSFSAMTYDQSLVRRASQDTSIDGGLSFG
GFIITVVLLFFVFSANRFFLNRRQKEIGIYQLFGMNKLQISGIYVLEIMIIGLFACISGI
LLGIIFSKLFSMILVRMMDMDLTSPFFISIPSVVDTLFAFFIILLAVSVYSIWKIWRYPM
IRSFGEKEQADSSTMRFRTRHRLLAVIGLLLLTSGYFGASHFREITSWMISYHYLDTLVF
FFPFLIFFVCVVGTYLFFCYTFRLFLIILSKWKIYYYGINFLIMGNTQVHLLKSWRTNSL
ITVILGISLMTIGGTASISTILSYQEKVSSPMDYQFDVETEKKIKPILAEEGQKITKEIT
LHYKVIGSIYSQNLEEPMFQTANLITETQYQAFRKVNPDLPNISLKSPGHTVLLDQMQTL
FRNISLYGSSIGLPDNQELKIQQMLPSVLGDETMVYLSPVLIVDDTVFEKAKGVDYQVVN
VDVSGGNNEKIDERLSNDLSIKWLNAVYYSYDIVNGSLQGEISTKKLPDDQMKEAQFSQE
SSRLNFSSSYSKLRAVNRRIGINIFVTLFVGMIVIIATGSILTVRQLAEAEEEKENYHLL
TKLGIPQRRIRRMIFEQNALTFFPPMILGITHAVFAINVFTQYIKTADYWLAYLVSGLLI
LIYLLLYVITSQLYCRIIEE
>FECAFAII_02646 Bacitracin export ATP-binding protein BceA
MEKMIEVKHLSKSYGSKLSPVKALDNISFTVEEGEFVGIMGPSGAGKTTLMNILSTINLP
TMGSVSIQGKEITKMKNSELSDFRRKKLGFIFQEFNLIDTLNAKDNILLPLAVERMTKEE
MEKRVRHVAQLLNIEELLKRYPDELSVGQRQRIAAARALVVQPQVIFADEPTGSLDSKSA
TELLNYLKTMNQKEKATILLVTHDPYTASYCDRILFIKDGVIFSEVVRRGTRREFFEKVI
DMQATIGGGGKMNAV
>FECAFAII_02647 Anaerobic ribonucleoside-triphosphate reductase
MKVNYEEKTVVTQQPETSQMKVIKRDGRHVDFDEQKINEALIKAEKKIHGSLSPLTYEKI
QMIADLVVQEIKSRFAENVKIYEIQNIVEHILLEKNEYELAEEYINYRTKRDFARSKATD
INFSIEKLINKDQTVVNENANKDSNVFNTQRDLTAGIVGKSIGLKMLPPHIANAHQKGDI
HYHDLDYHPYTPMTNCCLIDFKGMLNNGFKIGNAEVESPKSIQTATAQISQIIANVASSQ
YGGCSADRTDELLAPFAELNYKKHLKDAEEWIDSPERQKEYAKAKTKKDIFDAMQSLEYE
INTLFTSNGQTPFTSLGFGLGENWFEREIQKAILQIRINGLGSEKRTAIFPKLIFTLKKG
VNLNPEDPNYDIKQLALECATKRMYPDILNYDKIVELTGSFKVPMGCRSFLQGWKDENGQ
EVNVGRMNLGVVTLNLPRIAIESKGDQNKFWQLLSDRLEIMKDALLYRVERCKEAIPANA
PILYMYGAFGKRLSRTDSVNELFKNRRATVSLGYIGLYEVASAFFGGEWETNPEAKAFTL
DIVKELKANADAWGDEYGYHFSVYSTPSESLTDRFCRLDTEKFGIIENITDKEYYTNSFH
YDVRKNPTPFEKLEFEKDYPKYCSGGFIHYCEYPMLQQNPKALEAVWDFAYDKIGYLGTN
TPIDHCYQCGFEGDFKPTERGFECPECGNHDPKTCDVVKRTCGYLGNPQARPMVHGRHKE
ISSRVKHMK
>FECAFAII_02648 Anaerobic ribonucleoside-triphosphate reductase-activating protein
MRNPKPKEWLAKDYSQNYIADYKPFNFVDGEGVRNSLYVSGCLFACEGCFNKAAQNFRYG
KPFTPELEEQIIADLRNDYVQGLTLLGGEPFLNTDVCLQVVRRIRKEFGTTKDIWSWTGY
TFDELLQDSEDKLELLSQIDILVDGRFELSKRDLKLQFRGSSNQRIIDVQKSLESNQVVI
WEKCTDATETYEQIKKQDLI
>FECAFAII_02649 DNA polymerase IV
MMELQFPLHNDTSRKIIHIDMDAFFASVEERDHPEFRGHPLVIARHPSDTGGRGVVTTAN
YEARKFGIHSAMSAQKAYELCPQAIFKPGDHHKYSDISKQVREVFYRYTDIVEPVSIDEA
YLDVTENKINCKSAIKIARMIQADIWESVQLTCSAGVSYNKFLAKLASDYQKPRGITVVA
PQDAVPFLKALPIEKFHGVGKKTVPRMHELGIYTGKDLYECTEMMLIRNFGKMGYSLYRK
VRGIHDSPVNVTRERKSVGKEHTYGQPLQTEEAVLTQLRQLAEKVEEALRRVQKHGKTVV
LKVRYTDYSTVTKRVTLPEYIYKKEALFYQASLIWEEILGVEKGIRLLGITLTNLDPMTY
ENIVLPLWENQEI
>FECAFAII_02650 Ribosomal RNA small subunit methyltransferase I
MYNQKSFKGNPVYGDLYLVPTPIGNLEDMSYRSVRMLQESDLIASEDTRNTQKLLNHFEI
HTPQKSLHEHNYKERVPQLIALLKEGKTIAQVSDAGMPSISDPGHELVLACIKEGISVIS
IPGPTAGMTALIASGLVPQPFLFYGFLPRKKKEQKETLKKLKEQTVTLIFYESPYRITAT
LTNFLEIFGNRQVVLCRELTKVHEEYLRGSTEELLAYIEEHPVKGECCLLVEGNLFEMPV
TEVDEELGTLKEQVEAKIASGEKPNAAIKAVALKNGLKKQEVYRQYHELD
>FECAFAII_02651 Initiation-control protein YabA
MDKRSLYDGLNQLESELRNTLTELVEMKHALHEIVEKNTTLEMENQRLREHLRELNQVAQ
APAENVKQELSKSRMNLEKIYEEGFHVCYDLYGSRRDNDEPCAFCLEVIYRESGR
>FECAFAII_02652 hypothetical protein
MVEVVGVRYRDAGHIYYFAPGDSEYVYSDKVLVESQQSLHIATVVLPKKEIDPNDLPEAI
RPILHKASQAELEKDKKNKKDAYDALKIAKEKVQLRELEMKMVKAEYTFDRNKLIFSFTA
DGRIDFRELVKDLAAVFRTRIELRQIGVRDEAKIIGGIGPCGRPLCCSSFLGDFVPVSIK
MAKDQSLSLNPTKISGLCGRLMCCLQYESEEYETAKKELPDFGKVIATPDGKGKVVGLNL
LSRIVSIRLTGRENPVEYEWDELKEFIQVGEMNG
>FECAFAII_02653 DNA polymerase III subunit tau
MNQEINLAQMQPIVYQQLQRSFEHGRIAHAYLFEGEKGTGKHEVGIWLAQHLFCTQMKDN
LPCGKCNNCQRIEKKEHPDVLVIEPEGQTIKVDQIRRLQTEFSRSGYESRKKVFLIKEAE
KMNSSAANSLLKFLEEPPGDFLAVLETDAVGRILPTIQSRCQVLHFQELSKEALIHRLQE
EQIPLEKAKLLAFLTNSLGKAVEISQDEWFNDAKDLIYQWFVYLQKQDTQAFIYVQKKLV
KSFKEKTQQFTGLSVLMFYYQEAQRQAVANGEYGKVKQINQIIERILIAEQKLRSNVSFQ
AVAEQFVLHTIF
>FECAFAII_02654 hypothetical protein
MKIILAIIQDKDSNRLSNELIDANIRATKLSSTGGFLKAGNSTFIVGIEDDRVEEALEII
KKTCESRKQFVSTPVTLDISMDGGVPYPVEVEVGGATVFVLPVEGFHQF
>FECAFAII_02655 Thymidylate kinase
MNGLFITIEGPDGAGKTSILNELYPLLKEVAKTEIIQTREPGGIPIAEEIRAVILDPKND
RMDERTEALLYAAARRQHLVEKVLPALAKGKIVLCDRFVDSSLAYQGAGRRIGVTEIARL
NEFATEGTTPDFTLYLDVDSDTGLRRIKKNRQNQIDRLDSEGLEFHQRVRHAYLKLAEEN
PERIHKVDARKSFEEVLQTSYHTIIEQYPQFFEN
>FECAFAII_02656 Recombination protein RecR
MQYPEPIAKLIDSYMKLPGIGQKTATRLAFYTIDMKDEVVNEFAKSLLSVKRDLHFCSIC
GNITEEDPCEICRNPSRDRSVILVVEEPKDVMAMEKMREYHGLYHVLHGVLSPMEGTGPE
DINISSLLQRLHDADVKEVIIATNATTEGEATAMYLSRLIKPAGIKVTRLAHGLSVGSDI
EYADEVTLLKAVEGRREL
>FECAFAII_02657 Nucleoid-associated protein
MMRGMGNMQGMMKQVQKMQKEMAEAQELLNKTEFTGKATNELVKAVFTGDRRMKDIQINE
EVVDPDDIEMLQDLVVMAVNDAIAQIDVETEKKLGKYAKGLPGF
>FECAFAII_02658 DNA polymerase III subunit tau
MAYQALYRVWRSQRFEDIVGQKAVTQTLKNAIVSHKTSHAYLFTGPRGTGKTSAAKIFAK
AINCPNSKDGEPCNECEMCRSITAGTQEDVIEIDAASNNGVEEIRFIRDRANYAPTKAAY
KVYIIDEVHMLSTGAFNALLKTLEEPKESVIFILATTEPHKIPATIISRTQRFDFKRINT
ADIVEHLEFILKESTISYEPAALNVIARSAEGGMRDALSILDQAISFSEGTITLDDAMQV
TGSLTDEMMDSYLSACVKKEVPEALETLNQILAAGKESRRFLEDMLQYCRDLLMYQQAPN
LVEEQSSTIRSTFTELAQTVSADQLFSMIKILSDTQNEIRFTNSAAIYLEVATVKLAQLP
SASVPSADVAFADDQIVKQLQQEIKELRNEIKELRSNTGIENTKVQPVQQTNHKKQTSTY
RVPTERVYKVLREATRQHLNQVKEVWEDLLMSLSVTQRAMLKASEPVAAGPTGLVIAFDY
EIVCQRAANDEELQLSVHNNLSRMIKDYAPDPVYITRESWPELRRNYLTQAQEEGTENSF
ASEDSEGEIELLPQEQEVPEETLVVKAEELFGSEAVTVVDD
>FECAFAII_02659 hypothetical protein
MGLIKAATSMVGGGLADQWLEVIEPDNMSDTTVMTKGVKVRKDDKRGSNRKGTEDVLTDG
TVVHVYPNMMMLLVDGGKIIDYTAEEGYYTIKNDAAPSMFNGTLKEAIAETFDRFKFGGV
TPQKQQVFYINLQEIKGIKFGTSAPLNYFDNFYNAELFLRAHGTYSIHVVDPILFYTNAI
PKNKTQVEINDINEQYLAEFLTALQSAINQMSADGQRISYVPSKSLELSKYMDTALDDSW
RELRGMEIVSVAVASISYTDDSVKLINMRNEGAMLGDPSVREGYVQGSIARGMEAAGKNE
AGAMTGFMGVGMGMNANGSYLSQAAQNNQEQIKQQAEKQNQQTAQGNADTWTCPVCGTEN
SGKFCSNCGAAKPVENVQPKLQMRCSECNEIVDLSNGIPKFCPNCGKPFKGIPVN
>FECAFAII_02660 hypothetical protein
MDVLTHKCPNCGGPLTFDPKDQKFHCEYCLNIYTEEEVSQYEQKQKEARMAGEESKEEPS
PTEDFTFTAQEQLADMNEAERKAVDEAGGFSDTADESADNTAAIDLFLCPNCGAEIVTDA
TTAATYCYYCHNPVVLSGRLSGEFLPNKVLPFAVEKEEAINRFLAWTKKKWFVPKAFFNK
DQIDKLTGVYFPYWATDAEVDGAMQANGTVIRIWRIGDIEYTETKQFAVSRAGKLSFKEL
VKNALSKNTQQKMVEGVQPFPLDKAIDFKSQYLAGFQAEKRDIEYEAIKSQIQSELKDYS
EKLLKDTANGYTTLTGVRTSASITNEVNNYVLLPVWLVTYRSNDSSKKVYYYAMNGQTGK
VSGVLPISQKKLGLTALGIFAGLAILFLIGGYLI
>FECAFAII_02661 hypothetical protein
MMKKFFLFFLLLVSVGWPVATHADTATVNDEAGLFTTDQIQSLEQQAEKLNEKIKGRVLI
VTTTSNSEEPRDFADNYLRDAVGNDQNGSVLLLDMGQREIYISTSGNMIDYLTDSRIDSI
LDDVYDQMTNAAYYNAAKAYLSKSATYVEDGVPGGHYRVDEETGKITRYKVLTTVEIIIA
VVLALILSLVFYFVTVSRYQLKSGIYKYPFREKSSIKLTEKTDRLTNSFVTTRRIPKSPP
PGSGGGGSTTHSSGGGTFGGGGRSF
>FECAFAII_02662 Anaerobic regulatory protein
MIFLDESLDGGASLDSRVLKEYLDKNDFPIIRKGYHKYLTFEGMEDSHTYILKEGTVKAS
VISNDGREFNLRYIKDLEIVSLLKDEYSQFIDSPYNIRVESEYAEFYRINRVRFWQNINQ
DPKLQHYVKEYYRYRLLYSMKKMQQMLLNGKLGAVCTQLYELYDLFGVRTEEGMLIDFSI
TNEEIAKFCGISTASSVNRILKQLKKDGIITVKDHHIVILNMDLLEDNIIF
>FECAFAII_02663 hypothetical protein
MNYWMNTIINRLETAYQTRFDMKASLVFLNDAYQNSIELIKAVDENPTNECEEFLNLFMS
TRDLFIRQLVDRYPSNYHDVEVQIQKLKAYSA
>FECAFAII_02664 Bicyclomycin resistance protein
MEKKLFNKYFIGITLINFIVYLIYYLLMVIMAVIAQDTLHASLSQAGFASGIYIIGTLLA
RLFMGKQLELFGRKFTLRGGAIFYLLSTLAYLYTPTIGALYLVRFLNGFGYGTVSTATNA
IVTAYIPASKKGEGINYYGLSTSLAAAVGPFLGMILLNMTDFRFIIWFSIVLVFFVTIAC
LVFPVKNIPLSEEQKISLRSWNINSFIEKKALFITGIAFLMGLSYSSVLSFLSSYTKVIH
LVAAGSFFFVVYALVITFTRPLTGRIFDVKGEQYVMYPSYLFLTAGLFLLSVTTNSVTLL
ISGALVGLGYGTFMSNGQAVCLKIVREHRISIALSTYFIGLDLGLGVGPYLMGMLKSLTS
FRGLYVIAGVIPLICTALYLVNGRKHSHEAEGELIESLKNEI
>FECAFAII_02665 hypothetical protein
MKHVKALVVKAIMIWAILWVVLTGLYGVSFMDSTIVGVIIVVMIYVLGDLLILRKVGNIA
ATIADAGSAAVILWLYLYFMNDTVDIWMKVLIPALLIGVAEWFFHKWLLSQGIVPDERKM
E
>FECAFAII_02666 HTH-type transcriptional repressor GlcR
MNYLKNNQFARVTDLIELVNYSEATIKRDLVFLEKSGLIRRVRGGAMLIDNRKIDVPYLM
KITKLEEETEKRKIADTASSLIRDDMVLFLDSSTTSLHLVRNLARFDGLQIITNGIVTAA
MLSEYTTAKVSVLGGAIVPKRATINGSKAYNDALSYYADLAIMSCRGLDFSQGVTETHEG
EAMVKKAFRKQSDRLAVLVTQQKIAHKFMHQAIAFHEIDYLVTSKELTKEQYAKVKEHHI
ECLYG
>FECAFAII_02667 D-tagatose-1,6-bisphosphate aldolase subunit KbaY
MLYTMKELLKVAKENQFAVPAFNICSYDMMKAIIEEAERLEAPVILEIHPDEIAYLSDEF
VAAVRAYAYTSKLPIVIHLDHGGTIEDVLRAIRNGYSSVMIDASLKSFDDNVQITKKVVA
LAHAVNVSVEAELGTIGNNGSAEGGAETIIYTDPDQAKIFVKETGIDTLAVAIGTAHGLY
PKNRTPKLNIDLLKELNQQIDLPFVLHGGSGNPDAEVSEAVKYGVAKVNLSSDLKSVFFN
ALREILSENPSMYEPNAIYPAANKKVQEVVKHKMEILNTVGKASLY
>FECAFAII_02668 PTS system fructose-specific EIIABC component
MKIVGVTACPTGIAHTYMSAEKLEVTARNLNHQAKFETQGVKTENQLSEQEIKEADAIIL
AVDKEIELDRFAGKKVKRVSTSRAIKEPQVVIDEALRDIGVFVVSNEKEPAANEKKPTIY
NHFMNGVNYMLPFVIAGGIIIALSFAFGITAADPNSADYNVLAAAFSRIGGDTAFAMMVP
ALGAGIATSIAGKAGFAPGIVAGLLASTGGSGFLGGMIGGVLAGYICDFLANKISVKKEF
SAIYQLIVVPFLSILIIGLLMVFVIEQPITWVLDALTNWLNSLGNTSGLLFGLLIGIMMA
ADMGGPINKSTSTFSIGLMSAGVNAPIAACMAAGMTPPLGIALATLLFKHKFTKEERTSG
QSCWILGASYITEGAIPFAVSDPIRVIPSLMTGSAVAAGISMAVGVTSMAPHGGIWVMLI
PNVMNNLPMYVLAIASGTVTTAFMLGLLKKTVKEKKQDKWTKNENLTNEVEA
>FECAFAII_02669 PTS system fructose-specific EIIABC component
MRFDQLIAEELIVFDPSIDSKGSLFERIGDVLKKTNKVRNVQKVVKALFKREEEISTGIE
DGFGIPHAKSKYVTKPALCFFHTAKLTDYSGIDEMPIEYIFAIVVPEKSADMHLEILSTL
SRRLMNADFRKGIKEATTPADIIRQISQE
>FECAFAII_02670 50S ribosomal protein L31 type B
MKENIHPDYHPVVFMDSTTGFKFLSGSTKTSQETVEWEDGNTYPVIRVEVTSDSHPFYTG
RQKFTQADGRVDRFNKKYGLKDANAAE
>FECAFAII_02671 Transcription termination factor Rho
MSDYLTMAELENKTLKEVYSYAKEFKIPYYSKMNKKELSLAVIRAQAEKQGFYYMEGILD
IVGQDGYGFLRPINYGPSAEDIYISASQIRRFSLRNGDKVAGKARPPKESERYYGLMHVE
SVNGKDPEEAKERPHFPALTPLYPQRQLQLETTPQRLSTRMIDIFSPIGFGQRGLIVAPP
KAGKTSVLKEIANGITENYPEVELIVLLIDERPEEVTDLERSVKGDVVSSTFDLQPQNHT
RVSELVLERAMRLVEDKRDVVILMDSITRLARAYNLVVPPSGRTLSGGIDPAALYKPKKF
FGAARNIEEGGSLTILATALVDTGSRMDDVIYEEFKGTGNLELQLSRELSERRIFPAIDI
KKSGTRKEELLMPSEELEEIWKLRKNMTGDSLEYTEQLIRFLRKTKNNQQFFKEFQDVSF
GKKNPTRNLKR
>FECAFAII_02672 UDP-N-acetylglucosamine 1-carboxyvinyltransferase
MKKIVIKGNRPLAGEVTISGAKNSAVALIPAAILADSPVILEGVPDIQDVHSLIEILEIM
GATVHFSNNILEIDPREVVSIPMPHGKINSLRASYYFMGTLLGKFGEAVVGLPGGCYLGP
RPIDLHVKGFEALGAEVTNEHGAMYLRTENKGLRGNRIFMDVVSVGATINVMLAAVKAKG
QTVIENAAREPEIIDVATLLNNMGAKVRGAGTDVIRIEGVETLHGCRHFMIPDRIEAGTY
LALAAAVGNGIKVKNVIFEHLESFIAKLQEIGVHMKISEDEIEVYPSKELKPANIMTYPY
PGFATDLQQPLTALLLMTTGTSEIIDTIYAKRVNHVPELARMGADITVEGNMIIVNGPNK
LHGTEVVASDLRAGACLVIAGLLAEGTTTIYNVDYILRGYDHIIEKLTALGASIEMIEEV
GAE
>FECAFAII_02673 Fructose-bisphosphate aldolase
MPVVSGAEFLKAARKGGYAVGGFNTNNLEWTQAILEAAEAKQAPVLIQTSMGAAKYMGGY
KICKDLITDLVEAMNITVPVAIHLDHGDYEAALECIELGYTSVMFDGSHLPFEENLKLAK
DVVEKAHAKGISVECEVGSIGGEEDGIIGNGELADIEECKQMVATGIDYLACGIGNIHGQ
YPENWKGLAFDHLQAIADAVGPDMPLVLHGGSGIPQDQIEKAISMGISKVNVNTEFQLSF
AAATRKYIEAGKDKEGKGFDPRKLLAPGKAAIVEDAKSHIDWFGSANKA
>FECAFAII_02674 CTP synthase
MTKYIFVTGGVVSSIGKGIVAASLGRLLKNRGLKVTIQKFDPYINVDPGTMSPYQHGEVF
VTDDGAETDLDLGHYERFIDINLNKYSNVTTGKIYSEVLRKERKGEYLGATVQVIPHITN
EIKEKIMRAAKMTDSDVIITEVGGTVGDIESLPFLEALRQMKADVGTDNVMYIHTTLIPY
LKAAGEMKTKPTQHSVKELRGLGIQPNILVVRTEQPVSQSVKNKLAQFCDVEPEAVIESP
DVDTLYSIPLVLQAQGMDQIVCDHLKLDTPEADMTEWKELEERVLNLKKKVRIALVGKYV
ELPDAYISVVEALKHSGFAYNSDIEIDWIKAQELTRENVEERLKDADGILVPGGFGDRGV
EGKIEAIRYARENDVPFLGICLGMQMACVEFARNVVGLEDASSAETNPDTANNIIDLMAD
QENIENLGGTLRLGLYPCKIKKGTKTAEAYDGADVVQERHRHRYEFNNKYRQLFEEQGLV
FSGVSPDNRLVEIVELPEKKFFVGCQFHPELISRPNRPQKLIKAFVGASLADHETK
>FECAFAII_02675 hypothetical protein
MKEKDCFYDKLYKLLLQVGKSSSLLGGILSIIMFVLFFYLLFHLKFFSNDFLICLGLTLA
MFISSLLCGLNFFCTHKGLKK
>FECAFAII_02676 Glutamine synthetase
MVKKQITGEEIKRIIEEENVRFLRLMFTDILGTIKNVEVPVSQIDKVLENKMMFDGSSIE
GFVRIEESDMYLYPDLSTWMIFPWESAHGKVARLICDIYNPDGTPFAGDPRGNLKRALKD
MRDLGFTSFNLGPEPEFFLFKLDEDGGITTTLNDKGGYFDFAPTDLGENCRRDIVLELES
LGFEVEASHHEVAPGQHEIDFKYADVVDACDNIQTFKLVVKTIARKHGLHATFMPKPLFG
INGSGMHCNMSLFNDEGNVFYDKDGELELSETAYHFLGGLLKHARAYTAVCNPTVNSYKR
LVPGYEAPVYVAWSGRNRSPLVRVPESRGLSTRLELRSVDPSANPYLAMAVLLQAGLDGI
RNQITPPAAVDRNIYVMDEEEREAAHIQDLPSTIHNAIKELRKDNVMIDALGQHIFSNFV
EAKRLEWAAFRQTVSEWEREQYLELY
>FECAFAII_02677 HTH-type transcriptional regulator GlnR
MGEKELRRSMSVFPIGTVMKLTDLSARQIRYYEEQDLVHPERSEGNRRMYSLNDIDMLLE
IKDYLSEGLNMAGIKRVYEMAQAKKQEAKNKKPLTDHDVRQIFRDEILAQGGLSKTGHYQ
SQGLQRQFFD
>FECAFAII_02678 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIVAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYIEKRSTEGWTPDVIIGRAERTFSCSVSTLYRRFKTGEFNVL
HLPMQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEGDTIVGIHHKSAVITL
VERLSKAIIALKPEGRKAVDIENSINEWLQSVPKNLFKSITFDCGKEFSNWKSISNTNDI
DIYFADPGTPSQRGLNEHSNGLLRKDGLPKEMEFNQVNQGFISSVASKRNHIPRKSLNYQ
TPLEVFLSYVNGKFCLA
>FECAFAII_02679 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
MSKNRPFTVDHVGSFLRPQSIKEARKKVQEGLLSKEELRAIEDQEIKKLVEDQKAVGIKG
ITDGEFRRGFWHLDFLEELNGIEGYVPETGYNQTFHGKAAPAYNIRVVDKLSFNPNHPFL
KDFAFLKEVVETDDTFVAKATIPSPTMILRQEILSNDGSSKIKEIYPDLSDFYEDLSSTY
KAAIHAFYEKGCRYLQFDDTNWAFLADQTKREALLQKGIDPKEMAHICTEIINNALEDKP
EDLTITTHICRGNHASSWLFSGGYEPIAEELFSTNYDGFFLEYDSDRAGDFTPLRHWSNK
ESKVVLGLVTSKFPDLEDTEKIKERIKEAQQFVPLENLSISPQCGFASTEEGNHLTEEEQ
WKKIQLLQQVAKEVWL
>FECAFAII_02680 Putative defective protein IntQ
MPKIKNIYQDKKTKKWFFRAYLGIDENGRKVQKTKRGYASQKDAKIAYDKYMETHDFNKT
IPNQLCSTNQMTFEEFYKDRFVKWYERQVKSQTYENAQFIFEKRMQFFYHFRVRDITSHD
IEDWLFELSQTESRNSRKKVNGETLSKSYINRIRGHLKIVLDRAVKEGVIAKNPVEDVSS
LPSENKKVEFWEHSEFQKVMNELKDDKIQTHHRKIVYEMLFYTGIRIGELEALSWSNVDF
EKNTITIEKTLIYNTKDDWYFSTPKTKCAYRTIGLGKKLSLKLRQWYDLQKRIGNFEYVA
QLDGTFTPPYSFANWLKEAAKKAGVKPIKLHALRHSHVAFLIEQNIQPLSIQERLGHANI
QITLGTYGHLYAKSDQQVVSAIDNVQEGAILSKNDNLLPV
>FECAFAII_02681 hypothetical protein
METKCDFMVNRAILIEMGFKPSQAARMIKESKAYLARIEGIDFYNNRQVGVVPSRVIEHL
FHIQVAE
>FECAFAII_02682 hypothetical protein
MLDSLQEEVVPVNRVLIDYLTIHFFSNQHLKLIEEIIEMPIERFEELDYAPKGYIGQYVW
NQVITIRYSIDDAVKGTVMEFSGQGCKHLARWLKTRKTNWQQFFRKVLDYQGNFTRIDFT
LDDFVGSLSIPELKHKVILGHVWTTFQVSESHGGTDIINNESNGETLYLGSKKSQCRFCF
YQKDHEQRKRRGIPLEEAKVKNRFELRYRKEKAQSLAKIISKTHDLTKLFFELLNGAICF
YDRDPNDLGAKVDAKWAAFISNYGAITISLDTIPQSFEKTMSWLIHGVSPSLVFIAQVDQ
TFHSSLLPLIIEQGEMNPRQIKLLQNMKADPEYYQEEVEYYERKLQSISNEKTSY
>FECAFAII_02683 hypothetical protein
MNQVNQHDLGEAIRVSREERGWTQRYLAEKVGISR
>FECAFAII_02684 hypothetical protein
MEIDKQAVGNRIRQIRQELKLSMEKFGKLIGDLPRSTVNNWERGINLPKTETLHQIAEIG
HVTNEYLLYGDQENQYILEMLQKKAGKLDPKIEGLIVDEIKHADLVSEKEMDRMIEFFIT
NLIPPTEQDQFTFQCIDEKKQLYLGSTNFGKEAQLYLQHDNQNHILHMMPFTFSNFSVDR
ILVYLANQKSYSYFGKHLPKELGEKAILLYSINQLTSDVRIAPLVYSEETASYQYTEDNQ
YLLEQQYLYLPFVMEVEKERLLNAAYPSSK
>FECAFAII_02685 Putative fructokinase
MIYGAIEAGGTKFVCAVGTEELTILERVSFPTTTPVETMKQVIDFFKPFKEQLAGIGVGC
FGPIDIQCKSTSFGHITSTPKLAWQNFNFVGTLKQYFNIPIEWTTDVNAACYGEYVAGSG
KGLAGVAYFTVGTGIGGGALFNGTFVEGFSHPEMGHMLIKRHPKDNFSGNCPFHQDCLEG
MAAGPAIEKRLGVKGQNLLADDSFWQIEAFYLAQCAYNTTLMFSPDRIIFGGGVMKQEHM
KKKVQDKFVELINGYVEIPPIDSYIITPELGDNAGIIGGLALARKAVRNKQP
>FECAFAII_02686 hypothetical protein
MSILKNITQFKKIQSRAITPENPTGEKGKAAMLPSELGPSRKGRGAIPLTSGEETVIADI
TGTGIIRHMWMTIRDRTEFGSFVLRDLILRIYWDGSDSPAVESPLGDFFCNGFGERCEVN
SLPIVVNPTGGFNSYFEMPFQTSAKITIENLHPKDMSSFFYTINYALVDELEENSLYFHA
NWHRERITKLQEDYKLIDRLKGQGYYVGTYLALTCLERYWWGEGEFKFYIDGDSEYPTVT
STGSEDYFGGAWAFHEYDEFGRPHAKNYSTAFLGYPYQSNRDATRDRFETGKLNAVHAFG
DDAMPRHGLYRWHLQDPICFTEDLSVTLQQIGNDDVRLFERQDDVASVAYWYSTEASGNT
KRHFTDRERLPR
>FECAFAII_02687 hypothetical protein
MTINEVIYSPKHPFFNAELNDGNVTTSNEYSYYRNIPDVKGLTFDVSNQKTLANLDVCGT
IQTLTFYRENLLTEEKPGVWVNKQLSQTNSLSLKVEVNGIVYHLSESDHRIEVDVIQDCL
PRYIHHYSTFKVIVVSFAPILANKRLSMLVQQVYIVNETHESLQVSVKDVPSYQEKYSDQ
QNVLISQKGNKDTIAQQEVASFAIAFVDPNAFEEVMTFQESDIEKWLKETLNYFAQLFGQ
LSMPNDRVVHLYRRALYQSFSSFGMNRQGQVVGSNWGSYPATNRIWNKDMYYASLPFTMF
EPELCQKTVLWFDQYGVKFPGSKFTGGINHSLSNSLSSALLASLYFEHTGDTKFFERCPQ
VLLNASRIIEDILAQRRSGEPMLFPSVWLSDAFALGKYHTGSNLCLWKACIGLAEIFEAL
EQLSLSKRYKNIACKLKESICKQMTIDGPFGEQFLEGIGDEEKTTYSVKHYQKPILEQGL
IFLSDVIVDGKINLLMHDGEESDTTLMPFYQFLDNKDHLYQNTMAFSASSFNPTYSEEIK
GITWGLESGATFPGFITVLMSELHNPQAFVTRLEELICLADLDGSWWWWPYRLEAQQGEV
VRDFGCGKCGWASGLFVSLMISQYFGLKFKKGVLQIDPVDNLTFSWKNLKFGQAFISIEC
TQSELSISNLSEKPLKISDTKKILHVEKGKTIHIQRRKR
>FECAFAII_02688 PTS system mannose-specific EIID component
MKLADGISKDEKKLVRKMFWRSMTMYASVNPVTMGGGGFAYSMMPFINHFYKSEEDRAAA
LERHTQYFSTTIPCASFVMGIAASMEKENSEKAGFDVESINAIKTSLMGPLAGIGDSLFW
GVWRVVTAGLAINLANAGNILAPIIFLVMFNIPNYLMRYYGGVLGYSLGSKYIEKLYANG
LIEILTKAASILGLIMVGAMTISMVKFNTVLSFSMKGEELMNVQEILDSIFKGIVPLLVT
LSCFKLLDKKVGVIKIIFGMVVLGILLSLLGIA
>FECAFAII_02689 PTS system sorbose-specific EIIC component
MYDAFVVALAVFIGVAGHEMFGMSMLSRPIVVAPLAGALMGDLQTGLIVGASLEAIFMGV
VNIGISSTAEPSLAAGLATAFAIKMGGNVDAIIPIVFPLAVLGLQLMNMIFSFVCGPMAA
KFFKFAKSGDQKGIINLHFFMWFVHYALYALIPFFAVLFGADVVKSVLDNIPEVIMNGLT
VAGNLLPAVGMAMLLRMLWSKNIAVWFFFGAVVMAYLELPLIAIAAVGTIIAIVIAQRDL
QLKNISVHAVQSDAAVNATLDQEEEDFFQ
>FECAFAII_02690 putative phosphotransferase enzyme IIB component
MIKAVRIDERLIHGQVAMTWTKSLNLTGLVVASDEAATNDIQKMTLKMAAPSNVKVIIKT
VDDAIHLLKDPRAKDMRLMVLVPNVKDAVKVAKAFPTEIELMNVGNAGKMTPPSEDKKTL
SKEVMLTTSEIQDLKELVELYPDTVFQPTPAMEKRSAISILSDF
>FECAFAII_02691 hypothetical protein
MKKILIATHGHLASGFLSSIQLLTGKVQEITVINAYVDECDFEQELNVFVNQVNEQDQIF
VFTDLFGGSVNQKITKTFLEKEIAVTILSGFNLPILLEIVLATKELTKEDIQELVNKCQQ
ELKMTILDEVHVVNEEEDFF
>FECAFAII_02692 Transcriptional regulatory protein DagR
MKKSAKDRVFDELIRLTGNMSSVTAEKISKNLGISRQNASHYLTRLVEDKKVEKLPGKPV
LWKPLDEYAVVDNTEQINEAFHSVVGHDGSLREVIQKCIAAVKYPPNGLSVLINGATGVG
KSFLATKIFEYAIHEQIIEKDAPFAILNCADYADNPELLSATLFGYKKGAFTGAEKDTDG
LLATANNGYLFLDEVHRLSKENQEKLFLFIDTGNYRPVGENVNWHSAKVRFIFATTEKGE
NYLLDTFDRRIQISVMLPTFEDRPIRERLELIQLFFQNEADVLQKDIIVSREALSLMLSH
PFSGNIGKLKNIIKISCADVYSRTQEEPLTIGKNEILIQLNMLESEVESLPIASLLIKKN
QKIKTDRIKPFDYDSILEKITQLINEGNFNENFSSIKNEVQHLVHHIDKDSFLSMSRKLM
IQMFRKVWVSVLGKTYGLTTSGPVAEIISRSYVISPSYKTDLTGINRTLAANLPRTTYLC
NQFLEHLPPLSEKDENFLRLLIVVTLSDYVDESIELKGLLLAHGDSTASSIQAVVNQLCG
NYVFEALDMPVESNVSEIVESTRNFVKRQVNTDSLVLIVDMGSLNQIYTQIKNDLKGELL
LLNNLTTSIALDIGLKMTMNAPFKQIAEDAADKYSINVQYFEGFSQSSNIIISCMSGLGI
SDKLKDVFRHHLSDESIEVFTKDYRELRELIDQNDETYFDKTKLVITTSDLPRSFSIPNI
NVYDILDGDGAANLEHILSPEMKPAEFNRLIQELVKFFSLEGIADRLNFLNPTIVMSEVE
TVISKYENYYHFTLNGRVKLNLYMHTALMMERLFLARTEKSEEPNYDLKPDEDEFYYVSR
SIFQSMEMKYNFKVNAYELSLLYELLGPYIQK
>FECAFAII_02693 Spermidine/putrescine-binding periplasmic protein
MKKLQSLFLGILIIIAVLLLGVRQLEKTSGMSGAKVLTIYNWGDYIDPSLITKFEKEYGY
KVNYETFDSNEAMFTKIQQGGTNYDIAIPSEYMIQKMIKEKLVLPLDHSKIKGLNNIDPR
FLDLDFDPDNQYSIPYFWGTLGIVYNDKFFDANQIKHWDDLWKPELKDSLMLIDGAREVM
GLSLNSLGYSLNSKNMAQLTEAANKLNHLTPNVKAIVADEIKMYMINEEASVAVTFSGEA
ADMMWENEHLHYVIPPEGSNLWFDNIVMPKTVKNKEGAYDFINFMLEPENAAQNAEYIGY
STPNEEAKALLPKDISSDEQFYPSDDTISHLEVYKDLGSKYLGIYNDLFLEFKMYRR
>FECAFAII_02694 Inner membrane ABC transporter permease protein YdcV
MKKFKWSYLYLGIVFLFLYAPIFYLIFYSFNEGGTMNSFTGFTWENYEAVFEDTRLIIIV
LNTFMLAFLSALIATIIGTFGAMGIYYTKKRRARTALLSMNNILLVSPDVIIGASFLIFF
TLLGFGLGFQSVLLSHIAFSIPIVVLMVLPKLQEMNDSMVDAARDLGANNFQVVKNIILP
YLSPGIIAGYFMAFTYSLDDFAVTFFVTGNGFTTLSVEIYSRARQGISLEINALSALVFL
FSMILVIGYYFISKENRPKRLKKNRRVREGVARLR
>FECAFAII_02695 Spermidine/putrescine transport system permease protein PotB
MKTMRRIYSVPYILWLGLFVIAPVLMIIYQSFFDMNGQFTLNNYLSYFTSGTSLSMTINS
VWYAFLITFFTLIISYPTAYFLTKLKHKQLWLMLIILPTWVNLLLKAYAFIGIFSVHGSV
NHFFDFIGIGPKQILFTDFSFLFVATYIEIPFMIMPIFNALEEMNPSLISASRDLGANSF
ETFRRVIFPLSLNGVKSGVQAVFIPSLSLFMLTRLIGGNRVITLGTAIEQHFLVTQNWGM
GSTIGVILIIAMFIVMLLTGEKKKGGRS
>FECAFAII_02696 Spermidine/putrescine import ATP-binding protein PotA
MGKPIISFDQVVKRYDDETVLKKVSFEIEQGKFYTLLGPSGCGKTTILRIIAGFTEATEG
DIYFEGKRLNDLPANKRQVNTVFQDYALFPHMNVFDNVAFGLKIKKMSKSDIEKKVKDAL
RMVQLPGYEKREISEMSGGQRQRVAIARAIVNEPKVLLLDEPLSALDLKLRTDMQYELRD
LQQRLGITFIFVTHDQEEALAMSDEIFVMNKGKIVQSGTPVDIYDEPINHFVADFVGESN
IVDGVMIEDNLVEFVGKQFECVDGGMRLNEPVEVVLRPEDLTITTPDKGKLVVTVDTQLF
RGVHYEIICYDEQQNEWMVHSTKKAKEGSKVGLAFEPEDIHVMRFNESEEEFDARLDSYE
E
>FECAFAII_02697 HTH-type transcriptional regulator PuuR
MEIGEKLRNLRIQKNLTQEELGERTDLSKGYISQLERDLSSPSMETFFSILEVLGVTPEE
FFHQEAANLQVVYSKEDHTVYFDEENGYELEWLVADSNEKEMEPVLLTFEGAGEYKTFEP
SLSETFIFVLEGELELSLGETVYVAKAGQSIYYQATKQHQLRNHLKKRTKVLIVATQSYL
>FECAFAII_02698 putative acrylyl-CoA reductase AcuI
MNAFRSFQVIKEPVFHTAISDLPFTELAENEVLVKIAYSDVNYKDALAMSESGQVIRTYP
MTPGIDLSGTVVQSNNPRFSKEDLVLATGFGLGVTHPGGYSQYQKVPGDWLVPLPKNMTL
RQAMILGTAGFTAMLCVNALIRQGMTSDKKVVVTGASGGVGSTAIALLHKLGFQSIIAFS
RKEESVTWLKSLGALQVVRPDEFLPETTKALGKQQIDYVIDTVGGEQLSSLLPLISYNGA
VALCGNAGGIKLNATVLPFILRNIQLIGIDSVNVPIDQRLSLWQQMADLQIADELVVQEI
TLDQLPETASKLLAGTHQGRTLVNVGDHK
>FECAFAII_02699 Coenzyme A biosynthesis bifunctional protein CoaBC
MKILITAGGTTEKIDQVRAITNHSTGRLGQALADYLAANPDTTIDYVTTKQALKPKRHSN
ITIYTIESALDLFLQLEELTKKEHYDAIIHSMAVSDFTPAFSFSEEQLAKNLPTSSTQEE
LDNWFAENEQTDTTVSKISSNTEHLVLVLKKTPKIISYLREWQPKAKIIGFKLLVDVPKE
SLLAVAKNSLINNKTDFIFANDLTEIHGETHHGYLLSKDGTVEEAQSKSEIAALITEKIR
LEESK
>FECAFAII_02700 Coenzyme A biosynthesis bifunctional protein CoaBC
MKKILLGVTGSISAYKSADLTSQFVKLGAQVDVIMSKSSTHFITPLTLQSLSKRAVHTDV
MQESNPQVINHIELAKQADLFLIAPATANIIGKLANGIADDLLSTVAMALPVGTPKLIAP
AMNTNMYQNPITQRNLETLRSVGYQEIEPRESLLACGDFGKGALADIQTIIEQVMLTLNE
RNA
>FECAFAII_02701 Pantothenic acid transporter PanT
MKNTKNFTLTAMFLAILILLAVTPLGFIPIGPINATTMHIPVIIASIVLGPRLGAFLGGT
FGLISMIRSTVIQTPLSFVFSPFIPVIGTEHGSWKALLIAFIPRILIGVVPYFVYKGLRK
LMKQKADSVSLFLAGLSGSLTNTILVMNMIYFLFQQDYAKVIGTNLNAVYSAILAVIFTS
GIPEGIVAGLATAAVCNVLLRYFKHPSLTN
>FECAFAII_02702 putative sugar epimerase YhfK
MKIFVVGANGQIGRHLIKDLAPSSHEIFAGVRDVASQTLVKKENVSYVSFDLTWSVEKMT
EAFKGIDVLIFAAGSQGKNLLQVDLDGAIKTVIAAENAHVSRYLMVSAVYADEPAKWPES
MTDYYITKHYADEWLKRTNLDFVILQPVTLTNDEEVTSIQLTKPNEKASKTITRSTVAAV
LAALVEETDISRTTLVLSEGSKELNTAFQEWAKEE
>FECAFAII_02703 2-haloacrylate reductase
MRAISIKHPGSVDVLEQIEVPVPKPKQGELLIKVHTAAVNRTDIMKRESVSLKPPYPILG
VEVAGEVVENKSDISTFTPGTKVYGLVNLGGYAEYAVMPADRAILLPDTLDYVSAAGISE
VFLTAYQTLYWLGKLQEGETVLIHAGASGVGTAAIQLARQLSHAKIIVTAGSEEKLAFCK
ELGADELINYKKQDFQEEVRKITEGRGVDVILDFIGASYWEKNLASIAVDGRWVLIGMLG
GTIVPEIDLGVLIGKRVQLLGTLLTPRSDQYKAELAQTFMQKAGPFLENGKIRPIIDRTF
QFSAVKQAHEYMEANKNIGKIILKITE
>FECAFAII_02704 Fumarate reductase flavoprotein subunit
MKKLVAGLLTAVALLAMSACGADQKNTAQTSSSTKESAEVSSGASEQVYTDPKEMKESYD
VVIIGAGGAGMAAAIEAKDAGLNPVILEKMPVAGGNTSKSSSGMNASETKFQKEEGIKDS
NDAFYEETLKGGGGTNDKEMLRYFVDHSADAVDWLDQNGIKLDNLTITGGMSEKRTHRPS
DGSAIGGYLVEGLLNNVHEREIPIFVNADVTDIKKNGETVNEVTVHVQGEEPKEVTGKAI
VVTTGGFGASKEFIEKYRPDLADYITTNQEGSTGDGITMIEKLGGQTVDMDKIQIHPTVQ
QDEGVLIGEVVRGEGAILVDQEGKRFVNEMDTRDKVSAAITALPEKSAYLIFDQGVRDRA
TAIEFYDQKGYVTTGKTMEELAEKIDLPKETLAKTVDGWNTDVAEKKDAQFNRATAMEHD
LSSPNYYAIKIAPGIHYTMGGVKINTNTEVLDKENQPIRGLYAAGEVTGGLHGNNRIGGN
SVAEIIIFGRQAGIQAARFASENE
>FECAFAII_02705 hypothetical protein
MNHLKTFFTNSTKTAGRITNGIYILLRIIVVIMLVDQVWNQHWGNTMLLLLTLILFEIPY
FLEKILKIQIPNMLEIILLSFIFSSTVLGELSDFYGYFSMWDTFLHAFSGFLAGGVGFSL
VYLLNKNTKTMNLTPLLLAVVSFCFSMTVGVMWEFVEFSADKLLQFDMQKDTIIQQINSV
ELSKDGNTVYHVPDITRTIIESQNADGKTDKTIIQNGYLDVGIMDTMKDLFVNFIGAVVF
SVFGYLYSRNDYQKFTFIKNFIPKKIKR
>FECAFAII_02706 Mycothiol acetyltransferase
MLDKTLPYAEIWMTRPLQQNVPITPLAEGFEFRFYQKEDESAWAEIETSVGEFQTTDEAL
EYFQQNFAPYPEELERRMFFVETKKGEKVATCTAWRKKSREQVYPVFHWLAVKPDYQGKG
LAKALTARVLQEFPTLHTDGPIYLHTQTWSHQAIALYKKMGFTFIAENLDGTPNPDYEKV
MQVLSKLDK
>FECAFAII_02707 hypothetical protein
MCSKRRSKQLNKHACRLDKERSCSEKHYVKFMMRTMLISLSVGVYMHVPVQATTQTIKVV
RTSVSETTDSPITITHTFTDANGKQLLPALTSYNKVSYPPTINHYWLIPNKTLWTSETGS
SVPLSIFSDMTDPTKGDQLKQITDILNHALTDIKDGGSAQVSYVYEKDYSQFERKKIDVL
AGTKVSISDLVERLKNADGTQGDMSKVISNNGNIVDTTNTGTSTISLSYFDPIALKTMTA
SAVIHVRADQTAIKGKDLHLRTGESYAPKDLVEYVTKSDGTSGNKEEIKMNGTVDTTTPG
EYPVVLTYIDSKTSNVAETTAVVYVEASAASSTVITHFIDSQTNKELQAETHMSSVNRIP
DLRLPAEFSDRVPNIDLSTYEQNGKVTSISDWMQANGLDRKSHWSEILEVLHSELMNNRK
QSGGEITFTYVYIPDNRSLEGHDLIVHPNEKINKEELIQSATNSLGKPVPLKDVSVTINE
VPLEDGYLTKQTGDFTIMYSYHDPYSLQELHAQSLLHVLPLNKQIDQKEQKRQEESLSEK
KQQMAHAVSPTGKVKQTRSLELARISRKISESNKTIRQEAHLAPQVSGLENEILEPKIKQ
QSEKEFVAKQSEDQKESDDQKETKKKRLSTIDSTDEHLQPQVPLPSPGTPAPGGGIPSSA
LGDFMRGMAGTWVYANRNEFDADDWF
>FECAFAII_02708 hypothetical protein
MKLDYLIEEEDREKLLLARYLEFEKKNYVVLPKLYETLGLSKFKTRNYIIELNKEFTEFK
TKPEIQISEEAEIHVERLNLTDIKNLRRIYFQRSKIARLLTEIVDSKVTIEKFAENHFLS
ISRAYVKRRELVSFLEQHQIKLKKNILVGEEINIRNVLFGVYFGVFNGFSMPFRESVMNE
AKSIVQYFEYLFNLKLSATKRIKFNLLTTISLLRAYGNQPIGKRFFSDEYFKSSEGMKII
KDLSHISFLHIPKEQIIDEISYIMLFLITEEEFELDGAFGLAEAHFHDIHMISQKMSVEL
IDQLPFSIEISEEERLYIRKELRMGMMHVNRKNWIFDFEMTSFTSKKQLQFFFETYPIFS
TAIQKVIQENKRYFLGKDERFMIRLFYDYLFLLVGICPVSYFEAPIHVCIDFSQGSAYTD
YIISQVKGFKNYNIVIESRITSRTNIYLSDCLLEKFNKEQIIWKNPPTPDDWEYFGNTII
REKNRHLTEKIS
>FECAFAII_02709 UDP-N-acetylenolpyruvoylglucosamine reductase
MNKEEIVESLATITILFDEPLMNYTFTKTGGPADVLAFPKKQEEVKQIIDYCRIHDIPWM
VLGNASNLIVQDGGIRGVVIMLTEMKQIHVKGTMVIAEAGASLIDTTYAALAESLTGFEF
ACGIPGSVGGAVYMNAGAYGGEIKDVFAEVDLLLEDGTLKTLTKDEMVFSYRHSKVQELR
AIVLEARFSLQTGDYEAIKARMDELTELRQSKQPLEYPSCGSVFKRPVGHYTGQLIQQAG
LQGLKWGGAQVSEKHAGFIVNIDHATATDYIELIAHIQEVIKEKFDVSLETEVRIIGEKQ
AISETSRSLAN
>FECAFAII_02710 Putative oxidoreductase YceM
MKIGVIGVGNIAEKAYLPTYAKKQGTLDFYFATRNKETKERIQKEYGFQHLYETIDELLE
EKIEACMIHAATKVHYELAKKCLENGIHVYIDKPLSVHLNEVRELQELADKNQIILMIGF
NRRFAPMVEELKRIPDKRLIHLQKNRIAAKETTEFVLYDLFLHLIDTAVYLLDEPILRTK
YQIRETKEFLEYAILQLETQNQTAILTMDLASGANIEKYQVTSKNGTYEVNDLTQLVIQD
ADGKKVKEFGDWTNTLVKRGFEPMVEAFFSQIRLGKSETELLKQKEVVRSHELCEEVLKD
HYRHQL
>FECAFAII_02711 Exodeoxyribonuclease
MKFISWNVNGLRAIVNKNFLEVFHELDADFFCLQETKLQAGQIDLDLPGYYQYWNYAERK
GYSGTAIFAKKPALNATYGMGIDIHDTEGRLITLEYSDFFLVTCYTPNSQSELKRLDYRL
EWEEAFYNYLENLKKQKPVIVCGDLNVAHQKIDLKNWKTNQKNAGFTPEERAALSRLLDN
GFIDTFRYFYPTQEGVYSWWNYRFNSRKNNAGWRIDYFLTSKDLEPGLADAKIHTDIMGS
DHCPVELDLK
>FECAFAII_02712 DNA polymerase III PolC-type
MNFVAMDFETANHQPYSACSLALVMVKNSQIVDEFYTLIQPETPFFWRNVQIHGIHQEDV
RNAPKFPEVWQTIQPYFQKNRLVVAHNAAFDTKVLAGCLDYYHLEQPNYLSLCTVKSSRR
LFPEFPNHRLNTVCENLNIQLDHHHDALEDSRACAEILLYQEKKFGTDPLKKLVTIK
>FECAFAII_02713 Mycothiol acetyltransferase
MSEEVGIILREAVPGDAKDILLMMGQVNKETEFLVLDEAELLLPPETLEEELDYIYESNN
NLLLLAIYEGTIIGTASVKADSQFRLSHVGEVGISILQEYWGMGLGTLMLEEIISWAKEM
GVLFRLELDVQVRNERAVHLYRKMGFQIEAVMPRGARTDLGEFLDVYKMSYLIE
>FECAFAII_02714 tRNA threonylcarbamoyladenosine biosynthesis protein TsaE
MIELSGLTMTEQFAEAIGHSAMPGDNLILTGDLGAGKTTLTKGIAQGLGITQMIKSPTYT
IIREYSQGRIPLYHMDIYRVAASGADLGLDEYFEGDGLSVVEWGNLLEEALPEDYLELIL
EKSDTDLEKRYVKLISYGEQSETFKQRILEKWAENHE
>FECAFAII_02715 Phosphate acetyltransferase
MELFDSLRFKIVRRGIKIVFPEATDARILGAAARLKAEELVEPILVGNEEEIRNAAHARG
IKTSSFTIISPDNYDKWDEMVDTFVERRNGKASKEQAEKILKDVNYFGTMLTYMGIADGM
VSGAIHSTGDTVRPALQIIKTKPGISRTSGAMIMVRGRDQEKYVFSDCAINVNPTAQELA
EIAVDSAKTAELFDIEPKVAMMSFSTKGSAKSPEVDKVVEATKIAKKLAPQYMIDGELQF
DASYVPSVAQLKAPDSEVAGQATVFVFPELQSGNIGYKIAQRFGNFEAIGPILQGLNKPV
SDLSRGANEEDVYKLSIITAAQTLID
>FECAFAII_02716 Uracil-DNA glycosylase
MKEIIHNSWQEVLSSEFSKDYYLHLREFLKKEYASQKIHPDMYHIYEALELTPYEEVKVV
ILGQDPYHGENQAHGLSFSVQPGVKIPPSLRNIYKELYDDLGIAPVQHGNLVSWAKQGVL
LLNTVLTVREGQAYSHRGKGWERLTDTIIEKLNEREKPIVFILWGKPAQEKIKMIDKSRH
IIITSPHPSPLSASRGFFGSKPFSKTNDALLALGEEPIDWQLPETV
>FECAFAII_02717 Phosphatase YwpJ
MIKLIASDMDGTLLDAHMSVSPENAEAIRFANDAGVEFMVATGRNYQEARAALDEVGIDC
AMITLNGAQVFDKEGNSLFTVSIPNNQAISVLDILDANGIYYEVATNDGLYSENQAKRIE
SFASMVATHLPHLTYKMAIAMASAKLELLHITYVDSIRAILEEKNLEVLKIICFHTEGPA
VLGPVGKQISLLGDLAVTSSGQNNIEVNHKNAQKGIAVAHVAHERGISLEEVMTIGDNFN
DVSMLQVAGVSFAMGNAEIEVKDYAKYTTDTNLESGVGKAILRAIAEDL
>FECAFAII_02718 hypothetical protein
MSEFFIQEKQLGRATRTIVKNEKGHSLFLMVGRWGTKGDALSLYAMNGDLVAHIKQISLT
FGTRFELYKEFEKVGTMQKIFNWPGDFYYIRRLHWTVQGDIYNHQYQIHHFNQQIMKMDK
ATLFSGDYYVLDVSNDEDAPVCICIAAVLDYWLYRKDKSRDKPVSYRLNLS
>FECAFAII_02719 hypothetical protein
MIRFARKEDAPEIAPLILVILKDMELPFLKQTGEQKTLEILEEAITDPNYRYSYSRGIVE
EIDGKVAGVAYGYTDEEESIIDQPLVPILEKYQLDASTRLFIDKETFPNEWYLDSISVSE
DFRGQGIGSRLLEALPKLAKKANRSVIGLSVDEKNPKAKKLYERHDFKVVGQRMISGHLY
DHMQKNI
>FECAFAII_02720 hypothetical protein
MEKMKCPNCGKKFAYEEVNNVVEHNDKEMPVVCPYCRTEAARIVTHGYFITEKIEDFLK
>FECAFAII_02721 hypothetical protein
MKKMMFGVAALIVIGITGMTGLLNAAFHMDDISDQEYRISLKKAAAIVKNETKEHNISAI
HFAVEKDLENPTNATYEYQFFCEGQVIAVNPSTGKTTVRNDTEKAAEHLFDIEKTEEFKQ
PQAAMKEAVSYYGKKAKVKEWTLLVKDERPYYKVRLIDGEQDRQVWISA
>FECAFAII_02722 hypothetical protein
MNLTTIHHIAIIVSDYQKSRDFYVNKLGFEVIRENYRKERDDYKLDLKLGSAELEIFGIA
NAPQRPNYPEACGLRHLAFKVDDIEETIAELQSLGIESEPIREDTFTGKKMTFFFDPDGL
PLELHE
>FECAFAII_02723 Nicotinamide riboside transporter PnuC
MKSYFQFLAHQLKGWPQQNYYLFFFSLGCQVMTLVNSPITWLSVITFIGTTLGVLCILSI
NAAKSVNGILGILSAICFIIVGFSAKNYLSIGEQIAYMITLDIPVLLSKEWNHNMASKIR
KFTGKSWFIAIISTFLVYLVSGFLIGRYTDDPRPWVDAIAFSISLTAGIISFLRYNNQYY
WWLASGLAQMVLWYISFTHGSASLAMFVNSSVYLLNDVLAFTVSPWYNQKERERMQKMEE
EYYNAQQHA
>FECAFAII_02724 hypothetical protein
MEEWQSVFEEWFPKEISKSYPIKISKQYTSSQRWEIYAKLTKKQRELVDKHRRYLISSRF
MEEHYLAATDWVFSDFKINPFFRTKRSQQKLYCECGRELKVQYIVKSPKTGKILKLGINH
FADHLHVSPTVAASIHQGMTKVDLALDELLWLKQKNIDFPEGLWQKYCFVLYQNRRMKQP
YLPDIKLAQRLAEFRQVEMPIYIADYQALENEIKKISEHINGQSKKRQIKKELFDDFAEE
LVKDVEEFLINYRAFLRKDWQSIVYEEVPVHPNAYFETFISVLRKTKRQRTPEVTAQMEY
FAKNQRFIQPKIYLFIWKQYCRYGFTEGFFDSIPRIVRNGFLKVLRKEREAIQSADKKDR
TVSKEKWQLVVKDIQSGNVQETIDKWKGKHYRFTEAQKQALEYYQKLEESLRFNDEARKY
LKELL
>FECAFAII_02725 Pyrrolidone-carboxylate peptidase
MKVLVTGFDPFGGDKVNPAYEAVKKMPDEISGAEIIKVEVPTVFEKSSQVVKEAIQQHQP
DVVICVGQAGGRSAVSFERVAINLAEARIPDNEGNQPFDTALEENGPAAYFTSLPIKAMT
KNVQDHGLPAYISYTAGTFVCNDIMYRLLHLIETQFPAIRGGFIHVPFSPDQVIDRPVGT
PSMSLEDIASSLTYAVEAAVENKEDISGNAGTTH
>FECAFAII_02726 hypothetical protein
MDFFTNPDILLGDKLLEILYIVMGLVLIYTGVRNLTDKTNPHRYGSAFFWTVLGVVIAGG
RWLPAIVNGGLIFAMTIPAIAKKVSKGESRLPSKEYMEKMSDKLGMKIFIPALSIGVFAI
LFALFTNLGALVGVGVGVFAAMLILMFFSRDNRPSTFLDDAADMLGTVGPLSMLPMLLAS
LGAVFTSAGVGTVISNAVGTIVPEGNVNIGIIIYALGMVIFTVIMGNAFAAITVMTVGIG
APFVFSHGANPALIGMVALTCGFCGTLLTPMAANFNIVPVAMLEMKDKYGVIKNQLFIAL
FMLVFQIAYMILFK
>FECAFAII_02727 hypothetical protein
MENYLSLLGVLIVILGFAFKLDSILIVMVALVVTALTGGLGIQGMLELLGTSFVNNRGMA
IFIIIMLATGTLERNGLKESAASLIKRFKKVSAGMIVDIYGIFRMIFAAFNVSFGGVAGF
VRPIILPMALGTIESKGLEVHPKHEEELKGMASAMENVCWFFGQVLFIGGAGALLVQSTL
KDLGYDVTLGQLALVEVPVAITALVVASVYFYLKEKKLAKKYYPGKGQ
>FECAFAII_02728 Quaternary ammonium compound-resistance protein SugE
MAWMELIIAGILEVFWSTMMKWSDGFSKINYSFYTVIGMIASFYFLSKAIKSLPMSLSYP
IWTGIGAVGSVIIGVVLFHDKLNLSTWFFVGMLLISIIGIKITSGH
>FECAFAII_02729 ABC-type transporter ATP-binding protein EcsA
MKSLSVQELSKNFGHKQALSDVSFSLSPGKIVGLVGPNGAGKTTIMKAILGLIHYSDGTI
CIGENEISPSSHKGLEQVGALIEYPGIYPFLTGYDHLKLFSETNDVSAIDTIVNQLKMEK
YIHKKAKSYSLGMKQKLGIALALLNHPSIVILDEPMNGLDPQATRDVRKIITDLATQGTS
FLISSHLLSELEKMVDELILINQGKIIKQCTMAELNQTAQDFIVISTTNDLAARTILTEA
GYTLEDPDKIKLLKENEELLGTVIQLLSAQNIHVTDVQHLTNDLESSLLEILDSVKGEEE
K
>FECAFAII_02730 hypothetical protein
MTLLVKQELFKLIKKKSTAVLSVLLVVLLIGTALLAKKYTTIIDPVEMTAQLFSATSWIV
FIMIAAASTIISMEAQYGTLKNLLYRKYSRGEILVSKWITLVIYSVYLYLLAIIVTVLMK
LILFPSISFTEKVSTGQTLIQSLFTYTLGSYIGLWLILSLVLMIACFINSSGASISAGIV
FYFASSIISGILIALIQKWEWIKWNPISMLNLQNQIGNEEIMKQLTHLSTNQMLFGNLAY
IVLFLALGYLVFKRKNV
>FECAFAII_02731 Arginine/ornithine antiporter ArcD1
MDTEQQKKGIGLIPLAALVIGSAIGGGVFGIMTDISGSAGGPAIFSWVLVGTAMLMLSLS
INNINKKRPDLKGGIFSYAEEGFGRFAGFISGWGYWLTCWLGNVAFATLLMSALGYFFPV
FEGGQNLASIVMSTVFLWGYAWLVNRGVENASFVNAIVTFCKLVPLFLFIVVAISTFSIQ
QFIDNFSSDIILNANGQPIPFSSQVLSCIMVMLWVFVGIEGASVVGSRAKKQSDVGKATI
LGIFGLIIIYVLVSMLPYGTMTMNQLQTIKAQPAMGYVFEMMVGKWGAVVINGGLIISLV
GVWLSWTILPIETMGNMAEDGLLPKAWGKLNKNGAPTYAIVLTTLCTNVFLLSLLFTDSA
YNFAYTLGTAAIFFTWLFLGLYQMKLSYQRKEWVQFLVGLLASAFQVWAMLVVAFNEVML
VLVLFLPGIYFYLKARKEQNEPVQHIHLDKILLIGVTMVGVIAMVLFATGMLHV
>FECAFAII_02732 Putative NrdI-like protein
MNILYISISGNTRAFAKHLAEYAEKMHAEDPVNPEVTLKEIHENSDFTKETEPFFTFVPT
YLDGGNGLDNGDTEILTETMREYLEHEDNHKLCLGVVGSGNKNFNNQYCLTAKQYAQTFG
FPFLADYELRGTPSDVTRIYQILAENNK
>FECAFAII_02733 PTS system EIIBC component
MAKNELTLEELAKQIYKGAGGMGNVESIVHCMTRVRMKIINDDLVNVSELKAIPGVLGVV
EDEQLQVIIGPGKVNKVAQQMVDLAGVKLGEKLSSVSTATANSSASGKDRVNERAQEMKA
AQKSKQKPSKIKSVLKDISNIFVPMIPAFVGTGIVAGIAAVLANLVTAGTLDAATWQQYI
DVMNILKNGMFSYLVIYTGINAAQVFGATPTLGGVIGAVVMLTGMNPEAPLKNLFTGEAL
AAGQGGILGVIFAVWLLSIVEKKLHKVVPDAVDIIVTPTLSLIAIGLIEIFFIMPLAGFI
SDGMVGGINWVLGVGGAFAGFVLGTLFLPMVMFGLHQILTPIHVQMIDETGRTLLLPILA
MAGAGQVGAALALWIRCKKDKELTEMIKGALPVGILGIGEPLIYGVTLPLGRPFITACIG
GGIGGAVIGMIGNVGAIAIGPSGAALIPLISDGKWLGYILGLLAAYAGGFVATFFFGIPK
DRLEKEELATETATVNEVPEKVVPQTSAESVTILSSVADGTVVSLDKASDPVFAQKMMGE
GYFVEPENGHIYSPVTGVVSSVFPTKHAIGITTPNGLEILLHMGINTVDLGGTPFDVKVT
EGQQVTPDTLVAEADLEAIKAAGKETSMIVLVTNMDRVKNFVLEKTGKAKAKAPVMDVKA
>FECAFAII_02734 N-acetylmuramic acid 6-phosphate etherase
MSKINLENLTTERRNQETFGLDEMSISQAVQLMNKEDQKVAAAVEKELTSIEPVIANTIE
SFKKGGRLIYMGAGTSGRLGVLDAAECVPTFGVEPEMVIGLIAGGEEAMTVAVEGAEDSY
ELGQEDLIKLNLTKNDIVIGIAASGRTPYVIGGLDYAKSIGAVTGTISCNKQAEISKHAD
FPIEVDAGPEFLTGSTRLKSGTAQKLILNMISTISMIGIGKVFNNLMVDVKPTNEKLIER
SKRIIMQATEADYETAEKYFEEADQNVKLAIVMILTNSDKEEAQAKLAEANGFVKGTL
>FECAFAII_02735 hypothetical protein
MFGFSIFMNDSLSEEKKQYIRQMASNGFVGIFTSMHIPEDDVSAYQKRLIELGSEAKKNK
LELMVDISGEALERAGFSLEDLTPLKAIGVTGLRMDYHISNQQIADWSHQLKISLNASTI
TPKDIDELKEAEADFSQIEAWHNYYPRPETGLDKEWYQKKNQWLKIQGLLVQGFVPGDTE
LRGPLYQGLPTLEEHRGIHPLAGALDLLASNTDIVYIGDAGLSENVQEQFASFQKEQTVL
LHTEPVDEEFYEYILGKHTNRQDDARDVIRSVDARFREIPPIPARNTATRMKGSITLDNE
KYLRYMGEIQLTKYDLPADEKVNVVAKVIKEELPLINQIKAGMNYQFIRKEGR
>FECAFAII_02736 Putative phosphoserine phosphatase 2
MLYVTRHGETTWNAQGLVCGRADVPLTEKGQMQAQKLAEKVVDLPVPITKIIHSPLQRAR
DTAQAVADRLSLPLTVDERLVEMDFGDYDGLPSKDENFQKARLAFAVRFPNGESVLDVYA
RIVPLLKECIEDEENVYLLVCHNALIRVINAYFHPMPNEGFFTFMVDNTELVSYE
>FECAFAII_02737 putative ABC transporter ATP-binding protein YheS
MSKIEIKNLTFGYDSQGTLLFEQANLNFDTQWKLGLIGRNGRGKTTLLNILQNKLPYQGQ
VIHQQEFAYFPQQTKDKERLTYYVLNDITDFEIWEIERELQLMQTDPEILWREFSTLSGG
EKTKVLLALLFVDDTHFPLIDEPTNHLDISGRKQVAAYLKKKKQGFIVVSHDRGFIDEVV
DHVLAIEKSQLELYQGNFSIYEEQKKLRDEFEMAQNEKLKKEVSRLKKTAAEKAEWSRSR
EGDKTKKQVGFIDTESRRVNKGAVGADAARTMKRSKAIVNRMETQISEKEKLLKDIEYID
SLTMNSQASHHKRLLSVEDLQLGYENLLFEPIHFTIEPHQRVAISGPNGAGKSSIIHYLL
GAFNGKVIGEKYQPKHLSISYASQNYEDNRGTLAEFAEKNQVDYQAFLNNLRKLGMERDV
FHNKIEQMSMGQRKKVELAKSLSQPAELYTWDEPLNYLDVFNQEQLEQLILNVKPAMLLV
EHDQTFLDKVSTEIISLERI
>FECAFAII_02738 Glycerate 2-kinase
MDILAAIDSFKGSASSFELNQAVLNGWEDRKGRKINVPIADGGENTAEAIYYALRGTWRT
IDGMDLLFRQRKISYLLTTWQGKNTAVIESAQALGLDLLDKPTDQTIRLASSYALGELIK
DALLQEVEQIIVTLGGSGCSDGGLGLLQSLGASLEGYTEGNPLLSTKKLHFDRRNVLVSK
VKLIIAADVTNPYTGQQGAAWQFGRQKGGIDTTLAFLDKQAGKIAQQIKDFWEVDLDDIP
GSGAAGGIGGALFLLGAKMVSGFDLVSQITGLEKKIEQADVIITGEGRIDQQTIHGKVPY
GVAVLAKKYRKPIIAICGSRDQELEGLSDFLPIVLSIHLGPIGLEEAMEHRQTLEKTKIL
GQTLSRFFTILPK
>FECAFAII_02739 2-dehydropantoate 2-reductase
MKIAIAGAGAMGSRIGLMLHQSGNEVLLIDRWPAHIEAIRTNGLIADFNGKEVVAKLPIY
SPEEIIESNEHVDLIVALTKANQLDDMFCSIQSIITDNTYVLCLLNGLGHEDVLEKYVPK
KNILFGITMWTAGLAGPGKVTLLGDGEIELENLEPEGEAFTKKVVEVFQEANLNPIYSHN
VRYSIWRKACVNGTLNGLCTILDCNIAELGAQKAAESMVRTIVSEFASIAAKEGIILDQE
EVYQHIASTYDPDNIGLHYPSMYQDLIKNHRLTEIDYINGAIWRKGQKYDIATPYCAFLT
QLVHAKEGILGAE
>FECAFAII_02740 hypothetical protein
MNKNDVLLVAKNKSLYFLPSIRSLDVWSGKDLLQSEFIKSARQQLANYQLIVFLDYGFDM
EMARRVRPFTNAKIVLFFWNHFKAEHEAMLKQAQDEPAIDEIYHFDFLEAKELGLKHNSS
FYSKHMNFSSSEPKTDLFFGATNNGRKERAESYKQEFIKRDVTTNYFILPHRGNEQPGYL
TYEEYLKKTGESRGILELLREGQQGVTLRTFESMYFQKKLVTDNQAIAHYHFYRPENIFL
LRERDLDELPEFLHTPFKPILSELLEFYDAENWAKRFITNDSTIYEQYEYDLSSVENK
>FECAFAII_02741 putative amino acid permease YvbW
MEDKKLKKQLSSRHITMLALGGAIGAGLFKGSGEAIGIAGPSVLIAFLIGGLILYIVMKG
LGKIVLSGGDTHHGLSGLIRPYLGAHSADFTDWVYWSMWIINIIAEAVAAASFLQLWFPH
IPAWVFVFMLAVLTTIINLYSVRLFAETEYWLAFAKISVIILLIIFATYLVGQQMLGTGV
FPTLQQLTDHGGFTPHGMKGIISSLLVVIYSYGGSELIAITVSEADDPKRAIPKAIKGVM
GRIISFYIIPLFLLLILFPWNTLAGTNVSPFVMVFEKMNIPFAADIVNFVIVLALFSSIN
SGVYASSRILFFRLKDRKGSSRKLAVLNKHQVPQRAVLFCTSVLYLGVALSYFVGDKLFG
YLAGSLSYTVLLIWIIISAASFVLALRKGTLWDKGISFFALAVLGLIFLGILFTNSIGVT
VLTGLLYLFIYFSYQKKNDAFVLTNE
>FECAFAII_02742 hypothetical protein
MKKYWKFLLMIGVSTVVMFGMMYLNVYALDHIFFSRTRVFMALMMGAVMAVIMLLFMWKM
YENKKINVMILAASLLVFAGSLFMVRSQTTVNDTAWMKAMIPHHSIAILASKRADLKDPE
VKKLAEEIIQAQEEEIDKMKKMIKEME
>FECAFAII_02743 Na(+)/H(+) antiporter NhaC
MGKKGTPSFLEATLVLMVIVLGIAIGVVGLKVSPNITILAAIGMVMLYAVIKRYPTDWLH
EGIINGIKPGIIPIFIFILVGSLIAVWIQAGIIPTLMVIGFKLISVQWFVPSVFVVCAIV
GSAVGSAFTVMSTIGIAFFGIGTTLGLNPALVVGAIVSGAVFGDKMSPLSESTNLAAAIV
DADLFKHIKHMMWSTVPAFVVSFFLFMILGHTSKAASLSSIREVTDVLEANFTISIWSLI
PLFLMLLCAWKKVPAILTILLNIAVAVGMIFIQNPQTSLTKLAGVIESGFVSNTGNQQID
SLLSRGGIESMMPTVSLIILTLSLGGLLIEFGLISTVMERVSRKMTNTPNLIFTTLMTSI
GVNIFIGEQFLSVILPGNAFKETYEKAGFDPTVLGRTLEDGGTVINYLVPWGIAGSFVAS
TFGIPTLTYLPFVFFSLLSPVFSMVSAFTGWGISKKFVKPQEAVSKTAQLEQ
>FECAFAII_02744 p-aminobenzoyl-glutamate hydrolase subunit B
MTTTISTNQLKDLIQYRLPEYQALALDIHEHPEVSNYEFYSSAALIKQLEKERFWVEKEV
AGHRTAFDARYISNKPGPTIAFLAEFDALPGIGHACGHNLFGTYSVLAASIVKQFIDETG
GEIRVYGTPGEEGGENGSAKGSFVREGFFEDVDVALCVHPAFRYGKTTESLANDPVDIKF
YGVASHAAAAPEKGVNALEALIQVFNGINALRLQLPKDVNIHGIITDGGVAANVIPDYAA
GRFYLRAGNRQTLDKVYEKVENIVRGAAISTGTTFEFGLFQNAVDDVIVTPSFDDLFFQH
AKEAGVPDEEIETEQRTSLGSSDVGNVSQVIPTIQPTVAISETYIAGHTEEFKAAAKSDK
GLASIAIAAELLANTALDLLKEPKLLERIKQEHQEIVARKKQEGATF
>FECAFAII_02745 D-methionine-binding lipoprotein MetQ
MKKIIRFVVITFVAIIWLAGCSQGKADTTDKKETIVKLGIIGEDTDVWDNVKDRLKKENI
NLEYVKFTDYNQPNVALADGSIDLNSFQHQFFLDNYNKEHGTDLVSIGNTVNAPLGIYSN
TLKDVADIKDGAKVAIPNDVTNGGRALLLLQTAGLIKVDKAKGQAPTVSDITENRKNLDI
SELDASQTARALSDVDISVINSGVAVDAGFNPASDAIFLEPVDDHARPYVNIIVARKEDE
NNKTYQKIVDAYQTEDTVKVIEKTSKGSSVPAWETFGRK
>FECAFAII_02746 Methionine import system permease protein MetP
MTDFFKTYLPNVYLIPDEFVEATKQTLYMSFWTAFIGGMIGIILGVTLVVTRPNGLLANR
LLFEILDKLINIIRSIPFIILLSLLALTTRFLVGTTIGAKAALVPLIFGVVPFFARQIEN
ALLEVDPGVIEAAEAMGTSPIGIILRVYLLEGLPGIIRVSALTIINVIGLTTMAGAVGAG
GLGNLAISRGYNRFQTDVTIVATLLILILVFLSQFISNQLIKKITH
>FECAFAII_02747 Methionine import ATP-binding protein MetN
MIELRDVSVCFKQKEKEIQAVDSVDLTIEKGDVYGIVGYSGAGKSTLVRVMNLLQKPTAG
EVIVNQTNLSQLSPKELRKERKAIGMIFQHFNLMESRTIFDNVDFSLKYSGKSKQERRQK
VNELLELVGLEEKASAYPKQLSGGQKQRVAIARALANEPKVLLCDEATSALDPKTTLQIL
ALLKKLNRQLGLTIVLITHEMQVVKEICNKVAVMEDGRIVEKGSSIQIFSNPEEELTKDF
IRTATHLDQALETIIAHSAFADQIANKWLVELSYIGNQTNEPLIAHLYSKYQVTANILYG
NVELLQETPLGSLIVTLAGETKQRKKALDYLIKSGVKINILQKNDLDSRIKVIEGGR
>FECAFAII_02748 hypothetical protein
MRVTTSCSSCVHTQLLFKYDHTLARYRSQPSSPYIYARDELLDGHFPIVVPCFFSATEAL
CQRFFYRTYHFNANNIQKKSPFTNINYVSKRTTYRGTTFFRKFPSLKPNISKREIGVRFN
GRTVPNLPTYRQIILQGHFQLFLLDSSHQPEPLCKVSKLTFLFNEIDILLLGLIYMRKTE
KSSTKFKLFFLYLFFCFFI
>FECAFAII_02749 Phosphorylated carbohydrates phosphatase
MKGAIFDLDGLLVDTEKTYRDGWLWGFQQFDIHIPKEIVDAWGGKNWKQSFDILVKAAGS
PEKVQEVRAKREEYFYQQLTSGAIHLKPYAKEILADLKERHMKLGIATTTVTKRATDILD
HFKLADYLDTFTFGDEVSENKPSPIPYLTALERTGLEASSAFAVEDSLVGATAASRAGLG
VVLIPDSSFVRNYTVEEKEKLKLLAEGKDLRTVIEMLNKKTEK
>FECAFAII_02750 Magnesium-transporting ATPase, P-type 1
MSDHELAQVAEDHEVFVKLNPQQKARLTTALRKNGHTVGFLGDGINDAPAMKVADIGISV
DTAVDIAKESADVILLEKDLTILERGLLSGRETFGNIMKYIKATASSNFGNMFSVLIAST
FLPFLPMLPLQLLFLNLIYDVSCISLPWDRMDKEYLDEPKKWNASSIGEFMVYFGPTSSI
FDITTYLLMYFVICPAVVGGSFHTLDSSQRVIFIALFHAGWFVESLWTQTLVLHALRTPK
VPFIQSNATFAMFVITTLGIIVGSVLPFTSFGAELGLMPLPGNYWLWLFATVIAYLALVT
AVKKIYIRRFQELL
>FECAFAII_02751 hypothetical protein
MIPVGVVLSFAYRSKQLMNVGRGMVITSEEAILENEKKLTHWTPNTYRFGTYADDYRTVV
KGHSEKNLSQINTFVVDIDSKENHQGEIILACLDQVGYMPTLILESDHGYQVYFVLKTPG
YVTKKSNFKVIDVAKKISKTIRLQLAEKLSGVDLGCNHFGIARFPQENNIVFKEMNYQYS
FADWIQWSMKLESDQKTKEDRERKLIVFPEKKEIRQVDEPWFDMLLHKANIVGGEGRLGR
NNVIFTLSLAYYSSGYALDTCEYNMFTFNERLQEPLSEAELVKIVRSAYSGNYQAASREF
IIELCQQWVSPTLKNNDLFIQRRGWWKFKKPRDQRKYSHKNEWKEDLLAYLSEKSLASEP
YLNLSKKELASQLTMPKRTLDKILNELREENKVFYKVTRGRNGGMIIASVKTLFARVIQL
SKEKRLDYSTRITEVFGLNESLVEETFRQLSTP
>FECAFAII_02752 hypothetical protein
MSLKNYVYSHPVNVFIIGRLGLSVEVFCELYGFKQGTLSSWVTREKTVASLPIEFLHGLS
LASGETMDQVYDCLCVLEQEYIEYKIAVLLQSFKSTIK
>FECAFAII_02753 hypothetical protein
MNHFKGKQFQQDVIIVAVGYYLRYNLSYREVQEILYDRGINVSHTTIYRWVQEYGKLLYQ
IWKKKNKKSFYSWKMDETYIKIKGKWHYLYRAIDADGLTLDIWLRKKRDTQAAYAFLKRL
VKQFDEPKVVVTDKAPSITSAFKKLKEYGFYQGTEHRTIKYLNNLIEQDHRPVKRRNKFY
RSLRTASTTIKGMEAIRGLYKKTRKEGTLFGFSVCTEIKVLLGIPA
>FECAFAII_02754 Transcriptional regulatory protein WalR
MSDKILIVDDEHEIADLVELYLKNENYTVFKYYTAKEALECIDKSEIDLAILDIMLPGTS
GLTICQKIRDKHTYPIIMLTGKDTEVDKITGLTIGADDYITKPFRPLELIARVKAQLRRY
KKFSGVKEQNENVIVHSGLVINVNTHECYLNEKQLSLTPTEFSILRILCENKGNVVSSEL
LFHEIWGDEYFSKSNNTITVHIRHLREKMNDTIDNPKYIKTVWGVGYKIEK
>FECAFAII_02755 Sensor protein kinase WalK
MKNKKNDYSKLERKLYMYIVAIVVVAIVFVLYIRSMIRGKLGDWILSILENKYDLNHLDA
MKLYQYSIRNNIDIFIYVAIVISILILCRVMLSKFAKYFDEINTGIDVLIQNEDKQIELS
AEMDVMEQKLNTLKRTLEKREQDAKLAEQRKNDVVMYLAHDIKTPLTSIIGYLSLLDEAP
DMPVDQKAKYVHITLDKAYRLEQLIDEFFEITRYNLQTITLTKTHIDLYYMLVQMTDEFY
PQLSAHGKQAVIHAPEDLTVSGDPDKLARVFNNILKNAAAYSEDNSIIDITAGLSGDVVS
IEFKNTGSIPKDKLAAIFEKFYRLDNARSSDTGGAGLGLAIAKEIIVQHGGQIYAESNDN
YTTFRVELPAMPDLVDKRRS
>FECAFAII_02756 D-specific alpha-keto acid dehydrogenase
MNNIGITVYGCEQDEADAFHALSPRFGVMATIINANVSESNAKSAPFNQCISVGHKSEIS
ASILLALKRAGVKYISTRSIGCNHIDTTAAKRMGITVDNVAYSPDSVADYTMMLILMAVR
NVKSIVRSVEKHDFRLDSDRGKVLSDMTVGVVGTGQIGKAVIERLRGFGCKVLAYSRSRS
IEVNYVPFDELLQNSDIVTLHVPLNTDTHYIISHEQIQRMKQGAFLINTGRGPLVDTYEL
VKALENGKLGGAALDVLEGEEEFFYSDCTQKPIDNQFLLKLQRMPNVIITPHTAYYTEQA
LRDTVEKTIKNCLDFERRQEHE
>FECAFAII_02757 Vancomycin/teicoplanin A-type resistance protein VanA
MNRIKVAILFGGCSEEHDVSVKSAIEIAANINKEKYEPLYIGITKSGVWKMCEKPCAEWE
NDNCYSAVLSPDKKMHGLLVKKNHEYEINHVDVAFSALHGKSGEDGSIQGLFELSGIPFV
GCDIQSSAICMDKSLTYIVAKNAGIATPAFWVINKDDRPVAATFTYPVFVKPARSGSSFG
VKKVNSADELDYAIESARQYDSKILIEQAVSGCEVGCAVLGNSAALVVGEVDQIRLQYGI
FRIHQEVEPEKGSENAVITVPADLSAEERGRIQETAKKIYKALGCRGLARVDMFLQDNGR
IVLNEVNTLPGFTSYSRYPRMMAAAGIALPELIDRLIVLALKG
>FECAFAII_02758 D-alanyl-D-alanine dipeptidase
MEIGFTFLDEIVHGVRWDAKYATWDNFTGKPVDGYEVNRIVGTYELAESLLKAKELAATQ
GYGLLLWDGYRPKRAVNCFMQWAAQPENNLTKESYYPNIDRTEMISKGYVASKSSHSRGS
AIDLTLYRLDTGELVPMGSRFDFMDERSHHAANGISCNEAQNRRRLRSIMENSGFEAYSL
EWWHYVLRDEPYPNSYFDFPVK
>FECAFAII_02759 hypothetical protein
MNHFKGKQFQQDVIIVAVGYYLRYNLSYREVQEILYDRGINVSHTTIYRWVQEYGKLLYQ
IWKKKNKKSFYSWKMDETYIKIKGKWHYLYRAIDADGLTLDIWLRKKRDTQAAYAFLKRL
VKQFDEPKVVVTDKAPSITSAFKKLKEYGFYQGTEHRTIKYLNNLIEQDHRPVKRRNKFY
RSLRTASTTIKGMEAIRGLYKKTRKEGTLFGFSVCTEIKVLLGIPA
>FECAFAII_02760 hypothetical protein
MQQNHYHQRSLNLTPFTATGNFREMIDNVIIFIPFGLLLNVNFKEIGFLPKFAFVLVLSL
TFEIIQFIFAIGATDITDVITNTVGGFLGLKLYGLSNKHMNQKKLDRVIIFVGILLLVLL
LVYRTHLRINYV
>FECAFAII_02761 hypothetical protein
MELAFRESLKKMRGTKSKEKFSQELEMSRSNYSRIESGKSDPTIKTLEQIAKLTNSTLVV
DLIPNEPTEPEPETESEQVTLDLEMEEEKSNDFV
>FECAFAII_02762 hypothetical protein
MNHDECKTYIKNSLLEIRKLANIYTLETFKKELEKRNIYLETKSDKYFSSEGEDYIYKLI
ENNKIIYSISGKKLTYKGKKSFSKHAILKQLNEKANQVN
>FECAFAII_02763 hypothetical protein
MNIPFVVETVLHDGLLKYKFKNSKIRSITTKPGKSKGAIFAYRSKSSMIGGRGVVLTSEE
AIQENQDTFTHWTPNVYRYGTYADENRSYTKGHSENNLRQINTFFIDFDIHTAKETISAS
DILTTAIDLGFMPTMIIKSDKGYQAYFVLETPVYVTSKSEFKSVKAAKIISQNIREYFGK
SLPVDLTCNHFGIARIPRTDNVEFFDPNYRYSFKEWQDWSFKQTDNKGFTRSSLTVLSGT
EGKKQVDEPWFNLLLHETKFSGEKGLIGRNNVMFTLSLAYFSSGYSIETCEYNMFEFNNR
LDQPLEEKEVIKIVRSAYSENYQGANREYITILCKAWVSSDLTSKDLFVRQGWFKFKKKR
SERQRVHLSEWKEDLMAYISEKSDVYKPYLVTTKKEIREVLGIPERTLDKLLKVLKANQE
IFFKIKPGRNGGIQLASVKSLLLSIIKVKKEEKESYIKALTNSFDLEHTFIQETLNKLAE
RPKTDTQLDLFSYDTG
>FECAFAII_02764 hypothetical protein
MKKFIYRVLENDEVVAIFNEQQYAQDFIAYEKTISDKQFEIEKVDIADWLLQPREF
>FECAFAII_02765 Putative transposon Tn552 DNA-invertase bin3
MAKIGYARVSSKEQNLDRQLQALQGVSKVFSDKLSGQSVERPQLQAMLNYIREGDIVVVT
ELDRLGRNNKELTELMNAIQQKGATLEVLNLPSMNGIEDENLRRLINNLVIELYKYQAES
ERKRIKERQAQGIEIAKSKGKFKGRQHKFKENDPRLKHAFDLFLNGCSDKEVEEQTGINR
RTFRRYRKRYNVTVDQRKNKGKRDS
>FECAFAII_02766 hypothetical protein
MSTVILAEKPSQALAYAQAFNQRVLLQSFK
>FECAFAII_02767 hypothetical protein
MNHFKGKQFQQDVIIVAVGYYLRYNLSYREVQEILYDRDINVSHTTIYRWVQEYGKLLYQ
IWKKKNKKSFYSWKMDETYIKIKGKWHYLYRAIDADGLTLDIWLRKKRDTQAAYAFLKRL
VKQFDEPKVVVTDKAPSITSAFKKLKEYGFYQGTEHRTIKYLNNLIEQDHRPVKRRNKFY
RSLRTASTTIKGMEAIRGLYKKTRKEGTLFGFSVCTEIKVLLGIPA
>FECAFAII_02768 hypothetical protein
MKKTILSIFSVFTILIGGYFLLNLDSVNSNAQIKDQRVAEHNNKKMSLTKNIYSMSDEEL
YKEFGDLSGEQLEESIPGISDSDKIVVLSAGGQLMGDGKSELVSYKQNHRQFIDVNTDSN
AISIKDLKELLNSKRNELKQIKETNSVELE
>FECAFAII_02769 hypothetical protein
MKKIFGVSVGLLMMLTFGNAVYAAEKEVISDPEQYASRYFADFEEEDKVLALPEGGFLKG
EAKIVSMDNPDIIQGSYNSETDPASVSVTEAKKIVAEKFKNDIETTPIMPRGAFPPDVGT
SGHLLVLAGGGSYKSQPFSGAGWRFGGMGVKPADGTGNFLRWKSYIDDGRVGNVNQANAT
KSGSIQGMALYAREGFKYFAPNGPGWTMNIGIYYTYNPVAGTYYVVQNI
>FECAFAII_02770 hypothetical protein
MDEMVLSTQKWLNKKYSNVTGFDKVPENGRTGWPTIYGLIEGLQVELGITNLVANFGPTT
EKMYDNQVTPKWGKNLPKNIVFLIQGAFWCKGINPGGFDGVYTPYLDTAVKELQTDAGFN
GSAVTGVLDAKWAKALFDMSAFVLVPGGDSKIRKMQQWLNVNYLEYTGIMPCDGIYQRNS
NQALIFALQAELGYSPSEATGSYGNGTTSKTYPVSEGNSGNYVRIIQYGLYVNGYFEDGT
FDGIFTKYMGLEVLAFRKFMVLPEYTEIADVVVIKGLLSSAGDIRRSADGADTSTQLTRS
QIQTLVDNDIKIVGRYLTGTVGIGKDERNKYLTTEELNNIFSKNLSVFPIYQDGGAALAY
FTYDRGLSDGKKAIDAAKNLNIPLTTVIYFAVDLDMLGEEILAYAGEYFKGVSAVMSYSG
YQTGVYGTRNVCSQIINNGYASFAFVSDMSTGYSGNLGFPMPRQWSFDQFVEFTIGSGNG
AVGIDLIATSGRDSGFNELSNDTNNDNYIAKYNQKVINQMVRAYQYLSQAGLDNPWNPHL
TFYRYVNYSGLSWDIISSPVTEHDRKIYDEYRNKLTNSEGLYNYFIDPNTGSIIGLPHLI
VTLQSQMFLADTINDSVSDFAGWLGDLMTCWGEVKKLGIQMEQGVFALVGTAAGGTFSLE
DLYQDVDAVNVYTLAKRNSDSTALSALKTYYCDKGAIDRFNQFVKNRFGSSDKIASVTNS
LLENDETVDILGVGIISFFIDKIVNNSLGTDFTYLDFIGDEGKVANGFSEKIIQFQENRS
KLN
>FECAFAII_02771 hypothetical protein
MEEIEWNNLTQNNKNNSGCGIIFMFVIVLGIVVLLITVKIVDYFANTPEEQIQRKLPEFE
RVPPYDPRDNSFQVKKLKESPNEMWFEVTVESSDFKEKKKEYNYIVKAKVSKRFIFNPKL
EIYSVVIE
>FECAFAII_02772 Putative transposon Tn552 DNA-invertase bin3
MRKFFYIRVSSYDQSIERQLISAKELGIPEEYIFVEKASGKDFKRPEYQLMKRMFRKGDL
LYLQSLDRLGRNKQMILEEWRELTKEKQIDISVLDMPLLDTASYKQLDGLETLISDLILQ
LLSYMAEDERKRINSRQREGVEAAKQKGVKFGRKKIALPPEFPAIYSDWKAGKITAVYAM
DQLGMKRNTFYRRVKEYEHTLHHFS
>FECAFAII_02773 DNA ligase
MDLTNQRVVFTGTLQQMTRTQAIGLVHSLNGHCQSSVTSKTNFLVCGQYSKSLFDDSLYT
KKEQTARDLIALGHEITILSEVEFYALISQQLKEWQRYL
>FECAFAII_02774 hypothetical protein
MKRKSYDRWGIEITSFNRNIAFHVECDCGELAKSVYQKNYFYCPKCHRRYGVHGT
>FECAFAII_02775 Putative transposon Tn552 DNA-invertase bin3
MGKIGYIRVSSQDQNLDRQLAMMEGLNIDKLFQEKASGKDTERPEFQKLLNYIREGDCVI
VTSLDRLGRDYEDIKNTVAFMKQKKVALKILDAQFLDFNTGNELLDTAMFDMFLSLLSYI
AQNEREKIRERQRQGVLLAQKAGRYKGRPIEYSINSTDPQKRLVFKTVVDMLKQGIPVAE
IAKENGISRPTIYKIKKANDL
>FECAFAII_02776 hypothetical protein
MDEIKSNKKAFGIYLGEPSTEQLNQFFYLHEKDLELMETIRRPATRLGFALQLVSLRFLG
TFILDLTNIPQNVLSYVATQLNIDPGEIIYYSRRQTRYQHTKLIKSHYGYQDFNQPEIET
YLANWLLNRALYTTESSDMLFDMLLKKCLDEKIVLPGITTFSRFVASAIEKAEEHLYRQL
SLVPTEDERKRLLNHLELIGTPVYGAIIKMDILRTPLADDSHKEIARGFDRLKQFQAFST
EKWKMESIPEGKIKVLANYAFKAKAQLIQRMSEQKKLALLVAFIFIYKRKAMDEQILALS
NFFETVFRRAKNKESKERLRTIKDLDRAASTLSDIVDLVMSSHSDTNELSLRDRILEKYS
EENVTEAVSQVRLLVKNDREPIAISELLNTYRKFRKFIPDILTTLTFDSNDYGNNCKELW
TFINNRFPKPITYKMFGAIKHTLPKVLLQSFKSTIK
>FECAFAII_02777 hypothetical protein
MNHFKGKQFQQDVIIVAVGYYLRYNLSYREVQEILYDRGINVSHTTIYRWVQEYGKLLYQ
IWKKKNKKSFYSWKMDETYIKIKGKWHYLYRAIDADGLTLDIWLRKKRDTQAAYAFLKRL
VKQFDEPKVVVTDKAPSITSAFKKLKEYGFYQGTEHRTIKYLNNLIEQDHRPVKRRNKFY
RSLRTASTTIKGMEAIRGLYKKTRKEGTLFGFSVCTEIKVLLGIPA
>FECAFAII_02778 hypothetical protein
MQLRRGKATDWHAMVRESLDSFASPHYLPGDVKPVDRIMIKGLNQDHSEWAYISRNLKYR
LRKLLKEESQNDELTNHLRETFKESANDLKIELDTWLLGLDVTEK
>FECAFAII_02779 Replication initiation protein
MSKKGIIVNEWEKLNRISNRRLSVDDKVHPLKLSWSIDRITIVGKLNDTIAYWTQNGVVF
VDFEQLMRLNENQGYLKSVGTNGWQLFDQYGEDIAYIEMLKFHPDKGRIDFNPNKIGEFL
KGSMKQFIHDLFLDAHFSRADIACDILGVPDDFITQYRIVDPVSFKPIYGRSGKLETAYW
GSRASERQVRMGSVAKF
>FECAFAII_02780 hypothetical protein
MNHFKGKQFQQDVIIVAVGYYLRYNLSYREVQEILYDRGINVSHTTIYRWVQEYGKLLYQ
IWKKKNKKSFYSWKMDETYIKIKGKWHYLYRAIDADGLTLDIWLRKKRDTQAAYAFLKRL
VKQFDEPKVVVTDKAPSITSAFKKLKEYGFYQGTEHRTIKYLNNLIEQDHRPVKRRNKFY
RSLRTASTTIKGMEAIRGLYKKTRKEGTLFGFSVCTEIKVLLGIPA
>FECAFAII_02781 hypothetical protein
MSKKGTIINEWENLTALSNRRLNVKTFYTPLKIRWSIDRITIVGKLKENIYYHTQNDVLI
LDFEQLMRLNENNGYVKSVGLNGWQIVDKHDENIAYIEILKYQEGQGRIDFNPNKINQFL
ASSMKNFIHDLFLEPHFSRADIACDIIDVPDDFITQYRVVDPVSFKPIGSVAKF
>FECAFAII_02782 hypothetical protein
MGFSISFKKGTKNTSISHNNRELTDRQKTNDWHKHIDFTKSDENIYLEQTNLADKYEELF
GEVVEKYNAKQKRADRKIEDYLAKVRKDKKLEPQREFIVQIGILDDFQTNRADGSSTGIS
KQQAEQNRVIANKILVQYYKEFQERNPNLAVYNAVIHNDEISPHLHLNIVPVAEGYKRGV
QKQPSFNKALVQQGIHADKDNGRVLFNNFRNQEVDSIERLMNDYGWKRDIVGTNKIKDIH
EYKEIMSEISELRQTAVKERESVSAEMRYISKQREKNEREKALVASEKAKIEEEKKSIID
LEKELAVVFQKDPVPLTSFEKLPDGSYRLSSADFVDLYQKASNATNSKKYADMANESLGN
TLDKNIALFDKNMALEQENSFLKNQQKIDVSAVVAENKKLKEENRSLRQRLTQLKNAFQK
SITRLSIRFGLVEKDMGISEELKILDQEKTLASQQNAPERNIGRSENEMEW
>FECAFAII_02783 hypothetical protein
MGMTLADIKAQEEKLKKEQAKLRQQKKRLIEKENAEMGKALRKHFGFESFDDFERWLSSI
SDDQQHEKSVDNEWLADEKSAPSERDYPDESDGLFGVIPNKKSQMSESKFTSIFNDVNLR
>FECAFAII_02784 hypothetical protein
MDKIDLREETVDRIELMYERLADYLNLPDEDNYSEMLDRMMDVLNSTINVGLANSSLITD
KFVYGKIAETEDESEKEFWLNILTYVMQLNQIGVIYRNKSKGKEL
>FECAFAII_02785 hypothetical protein
MSNPVEKMTIKNLADELGISKNTVRNQLVNAGYDLARYKDNGVIMLDKELIGVVRSIYRS
KGGQLTGDLPVNDAGNDFPLEKENEFLREQLAEKDRHISELTEMIRDQQKLTLLQQQKND
QLLLENQELKNRKWWQFWK
>FECAFAII_02786 Replication initiation protein
MQQNQPIYGRSGKLETAYWGSRASERQIRMYNKKLEQERKRKIVPKEIETWWRLELQLRR
GKATDWHEMVHESLDSFASPHFLPIDTKHTDRIMIAGLMSDHSLWSGLTRPTKYKYRNLL
KQESQNDELTNHLRETFSESADDLKKELDTWLQGLDVTEVGAE
>FECAFAII_02787 hypothetical protein
MNHFKGKQFQQDVIIVAVGYYLRYNLSYREVQEILYDRGINVSHTTIYRWVQEYGKLLYQ
IWKKKNKKSFYSWKMDETYIKIKGKWHYLYRAIDADGLTLDIWLRKKRDTQAAYAFLKRL
VKQFDEPKVVVTDKAPSITSAFKKLKEYGFYQGTEHRTIKYLNNLIEQDHRPVKRRNKFY
RSLRTASTTIKGMEAIRGLYKKTRKEGTLFGFSVCTEIKVLLGIPA
>FECAFAII_02788 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIVAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFGSVAKF
>FECAFAII_02789 hypothetical protein
MALLPTNKDKKKIGAEDISIKDDINVELGERKYTAKERKPVQVDPPVLKTIRDLSYAKDI
PMYEIVKLAMDAYVDTLNDEERIIYNRRSKD
>FECAFAII_02790 Sporulation initiation inhibitor protein Soj
MENLRTAFKTSDKLGKVVMLTGRKGGIGKTTDNDLLAIVSSQLFEKDVLLIDYDQQRNTT
SNIGSTYQITSFDRSMSAAIKKGDWVSGITQVSPHLYIMAGSPGSEELNEYLSEKYPDRR
KRSLAFIKPLEELRKNFDYIFIDCPPSTDNVVRAFLTAADYIIAMQELKRYAMEGTEDFI
NKVLVPIVTNFEESHLQIIGILPVLFSVRRSSQHANYQKTIDKYGESNIFKSIVKGSDRL
EMYGENGIQLNDYVDRRWWAIFADIFTELEERIEYYEQHGDIEGFDYTPKYADSMANHIL
PLGKEIKLNGIITNEQR
>FECAFAII_02791 hypothetical protein
MLSEIYSAILKNGLRTYKYRNSTMKPAGHIDSSRSGAIFAYRSKQLMNVGRGMVITSEEA
ILENEKKLTHWTPNTYRFGTYADDYRTVVKGHSEKNLSQINTFVVDIDSKENHQGEIILA
CLDQVGYMPTLILESDHGYQVYFVLKTPGYVTKKSNFKVIDVAKKISKTIRLQLAEKLSG
VDLGCNHFGIARFPQENNIVFKEMNYQYSFADWIQWSMKLESDQKTKEDRERKLIVFPEK
KEIRQVDEPWFDMLLHKANIVGGEGRLGRNNVIFTLSLAYYSSGYALDTCEYNMFTFNER
LQEPLSEAELVKIVRSAYSGNYQAASREFIIELCQQWVSPTLKNNDLFIQRRGWWKFKKP
RDQRKYSHKNEWKEDLLAYLSEKSLASEPYLNLSKKELASQLTMPKRTLDKILNELREEN
KVFYKVTRGRNGGMIIASVKTLFARVIQLSKEKRLDYSTRITEVFGLNESLVEETFRQLS
TPLNPLKEVNLFEVDTG
>FECAFAII_02792 hypothetical protein
MSLKNYVYSHPVNVFIIGRLGLSVEVFCELYGFKQGTLSSWVTREKTVASLPIEFLHGLS
LASGETMDQVYDCLCVLEQEYIEYKIAVLLQSFKSTIK
>FECAFAII_02793 hypothetical protein
MNHFKGKQFQQDVIIVAVGYYLRYNLSYREVQEILYDRGINVSHTTIYRWVQEYGKLLYQ
IWKKKNKKSFYSWKMDETYIKIKGKWHYLYRAIDADGLTLDIWLRKKRDTQAAYAFLKRL
VKQFDEPKVVVTDKAPSITSAFKKLKEYGFYQGTEHRTIKYLNNLIEQDHRPVKRRNKFY
RSLRTASTTIKGMEAIRGLYKKTRKEGTLFGFSVCTEIKVLLGIPA
>FECAFAII_02794 Transcriptional regulatory protein WalR
MSDKILIVDDEHEIADLVELYLKNENYTVFKYYTAKEALECIDKSEIDLAILDIMLPGTS
GLTICQKIRDKHTYPIIMLTGKDTEVDKITGLTIGADDYITKPFRPLELIARVKAQLRRY
KKFSGVKEQNENVIVHSGLVINVNTHECYLNEKQLSLTPTEFSILRILCENKGNVVSSEL
LFHEIWGDEYFSKSNNTITVHIRHLREKMNDTIDNPKYIKTVWGLVIKLKNKKNDYSKLE
RKLYMYIVAIVVVAIVFVLYIRSMIRGKLGDWILSILENKYDLNHLDAMKLYQYSIRNNI
DIFIYVAIVISILILCRVMLSKFAKYFDEINTGIDVLIQNEDKQIELSAEMDVMEQKLNT
LKRTLEKREQDAKLAEQRKNDVVMYLAHDIKTPLTSIIGYLSLLDEAPDMPVDQKAKYVH
ITLDKAYRLEQLIDEFFEITRYNLQTITLTKTHIDLYYMLVQMTDEFYPQLSAHGKQAVI
HAPRI
>FECAFAII_02795 Sensor protein kinase WalK
MSGDPDKLARVFNNILKNAAAYSEDNSIIDITAGLSGDVVSIEFKNTGSIPKDKLAAIFE
KFYRLDNARSSDTGGAGLGLAIAKEIIVQHGGQIYAESNDNYTTFRVELPAMPDLVDKRR
S
>FECAFAII_02796 D-specific alpha-keto acid dehydrogenase
MNNIGITVYGCEQDEADAFHALSPRFGVMATIINANVSESNAKSAPFNQCISVGHKSEIS
ASILLALKRAGVKYISTRSIGCNHIDTTAAKRMGITVDNVAYSPDSVADYTMMLILMAVR
NVKSIVRSVEKHDFRLDSDRGKVLSDMTVGVVGTGQIGKAVIERLRGFGCKVLAYSRSRS
IEVNYVPFDELLQNSDIVTLHVPLNTDTHYIISHEQIQRMKQGAFLINTGRGPLVDTYEL
VKALENGKLGGAALDVLEGEEEFFYSDCTQKPIDNQFLLKLQRMPNVIITPHTAYYTEQA
LRDTVEKTIKNCLDFERRQEHE
>FECAFAII_02797 Vancomycin/teicoplanin A-type resistance protein VanA
MNRIKVAILFGGCSEEHDVSVKSAIEIAANINKEKYEPLYIGITKSGVWKMCEKPCAEWE
NDNCYSAVLSPDKKMHGLLVKKNHEYEINHVDVAFSALHGKSGEDGSIQGLFELSGIPFV
GCDIQSSAICMDKSLTYIVAKNAGIATPAFWVINKDDRPVAATFTYPVFVKPARSGSSFG
VKKVNSADELDYAIESARQYDSKILIEQAVSGCEVGCAVLGNSAALVVGEVDQIRLQYGI
FRIHQEVEPEKGSENAVITVPADLSAEERGRIQETAKKIYKALGCRGLARVDMFLQDNGR
IVLNEVNTLPGFTSYSRYPRMMAAAGIALPELIDRLIVLALKG
>FECAFAII_02798 D-alanyl-D-alanine dipeptidase
MEIGFTFLDEIVHGVRWDAKYATWDNFTGKPVDGYEVNRIVGTYELAESLLKAKELAATQ
GYGLLLWDGYRPKRAVNCFMQWAAQPENNLTKESYYPNIDRTEMISKGYVASKSSHSRGS
AIDLTLYRLDTGELVPMGSRFDFMDERSHHAANGISCNEAQNRRRLRSIMENSGFEAYSL
EWWHYVLRDEPYPNSYF
>FECAFAII_02799 hypothetical protein
MPQGGLNFDEEYVTYGNGYSRCVTVYHYTKNPTLFWLANLMNNPHTVATLDVSTDEKQKV
IDQINRALDELNDRSDNERKATDRNKSAEEYLELAEYARKLTSNGEISKQVKVRVHVYGN
TIQEVDERAQELIENLKGMDYRAVTYLHKTKRDWQSMFTMFDEQAEWFGNIKGQSLPSLN
IGGGFPFHHQTLKDPGGTQYGETMTGGPFVWNATYKNSVRLSTNTLLLGMMGAGKSTVLK
MIAEAHLAAGDFIWGFEKGKDFIPFLKEYNGIMVRLDGSDGMINPLEIFATRTYDEASSL
YDDGSVKDLKINEAASYQTHLDKVVYQVQLVILS
>FECAFAII_02800 hypothetical protein
MLEAIKTAFSPQNDQKVLDPLKQLGNREIEILKSKGYDLDF
>FECAFAII_02801 hypothetical protein
MKYPLIWLEKDVPKEETTRKFPHTLSLGKLGKGQSFHQVKNQTRRGDCTC
>FECAFAII_02802 hypothetical protein
MRVKGQNSVDKKSIFQFGKPEERSILDLFPYKSCTEEGVLVTKEDHFQRYYRVVSTDVEG
LNEQEKLERMNQLTTVMRTYVPTIKLVSLTTETDLTEQIVQKRQLLDKNRMEQSLGRNLQ
RLRKYEKKLVEEIQELKRAEQERPDLSFFFIIEGRTIKDLQTRNRQLMRSSGILGLKPLY
KKELIKILYRMNNMNDE
>FECAFAII_02803 hypothetical protein
MDKYINMKNPPRFSGEWKFFAFFFLDLLTLGGCFFWAKIVNNLVHLPLFFALLNYGLWIA
IALVIVWRPYNNPGQRQIFAIIESIFFTDKNHYHALDPNRNYHGTYKEDE
>FECAFAII_02804 hypothetical protein
MIIGGIFSGIADWWSGLFGEGDANPKTVTKVLQDYGNYLQYQDVFSWIWNTFLWGLIKGL
YNLNTLLEKTIYQSFDLKDLLNAAGVNALFQSLISKVLALFCVVTLIYLGLKFFMSKHPP
KVKNILVNLFMAMILIFGGSSLIDEGLNISKSFYGDVTAANKADKTGSPAFQIIQNNVID
VSTLLENDPNKVEHIPTDKRNALTAKNFKTANINGIITPDQAKKMSESSDISTVQKDRLK
ALQYRLELDDNGKEIPVQISDEGLAKYVYTSGYRRYISSPGIILAGESSLSVAYLFILFT
IVTCIIELVFKKFYLVIAASTDFETGQRMKSAIEDISQSFLLLAFTILELRIYTLMLSGI
GDLHAAGKINGFLYVVALIVLTIALFKGSQSVTKIFGVDTSLKNGSNSLLSMFALGNVAK
NVGSGAKNLASAGKSGLSNLNDIRKNGFGNRKDVTPDNGEEQSDDKATTVPNSKKTVSEM
FGKAKNGVSKAAEGLGYVNERGLKGTAEDLTEKAKDTLEEKLDGTRAKELAEAVKNPSET
LEKQKEKASEIKEGLKDAYGEGQVNAAVKANTTTEKENQEGAAIPSAKDHQDELHSNENS
EEGQNGQLPKTDPEQYRYKSNINSENEKRISDLPKRNQEVQTDDDSIDLPNDNGVEVGTE
KSTKIGLPKAQNLPMKDSRLNQFKENDQSFVHQSTAGNVQMKPSRLPENGNLTTVSYNLS
ESGETGNASVQNVVTREAAPEPIQRVHTGYKPANVAFTAPTKINVTRETKNRNNELKEQL
LRDIKQDIKP
>FECAFAII_02805 hypothetical protein
MDNMEGIMTVTAGRNMLWDLFIQSYQQLYAKYGEQNAAIIKENCQTHIYIMSTDDNTIEE
FSKKVGNKTVEQENSTINSLGMNTHINRNVDSDRILTPERISTFLEGETIVLAPLKRQDL
KGHKIRPYPIFNHGETNLPYAYQYIEDFNPSWDINDIDIHCTHADLDLKALQIDYDYFLP
DEYARNLYHGLHDQLEEKNEENMFYKIVQSLENETAKKLLIQFYEEQAADRLQEYVEKLI
KNKEISEMIGKRLLLESEKVVKE
>FECAFAII_02806 Group II intron-encoded protein LtrA
MTNTKGISLKNKQLRHAEYYDMTETFDELHAMSVAKSNFKNLMKFIIDDNNIFLAYRNIK
KNKGSATAGYDGVTIKDIEKLACGDFLTIIKRRFKDYRPRKVKRVEIPKPNGKLRPLGIP
SIWDRIVQQCILQILEPICEAKFNKHSYGFRPNCSTENAIADCLARINQSKMNYVVDIDI
KGFFDEVNHTKLMRQIWTMGIRDKQLLVIIRKMLKAPIVMRNGNVVFPTKGTPQGGILSP
LLANICLNEFDWWIANQWEERTVKELKHHYRKNGAWDKGNIYSKLRSHTSLKEMYLVRYA
DDFKIFCRTGEEAQRAFYATQKWLRERLKLPISMEKSKVTNLNKAESEFLGFSIRLHKKG
KKKVAFTYVCRKAEENIKNKLKQQIKKIQYAGAKKNRHRAIGDYNMMVIGIHNYYRIASH
CSVNFTEIYRSVRTVIEARLKARGMTKNGIYGQDHEGYRPYLKSKQMRYIEGFPILPIGY
IKKRTPLNKRRNLNKYTKEGRKLIHQEQQAIESWKIKYLVKGFSNNKKYTVEFSDNKISK
FISQKGKCAITGNELLMEEIECHHINPYHLSKDDSYKNLVIISREIHRLIHATSEETILK
LLRLLKLNHYQIRKLNTYRKKAANFPISIKMN
>FECAFAII_02807 hypothetical protein
MRVRETTKRKDKRFNLEKNRYLSHFYRYTPSGEELPEKHDKRISKKIFYSGLVYLPLEYL
VTRVPEVFNRLEIVKGSLQGINLFQLQEMPQVFHFDSAGFWNPFTPTTSLGTRLAISTVC
VVPAVLMGLKMDMWFRPLADGQKGDNRLMTLKEIQQIYPQIPETKTTFPGHGGIPITHYK
KYWYIQTDTVNTCIVGTSRSGKGQIEVLATIDNLSRAEKQSSMVVNDPKTELYVGSKDEL
EARGYDVYAFNITDPLQSMSDNPLALIVKYWKRGDIDTATQLTNTFTNTIYYDANASDNK
YFNENAQKAVNALIFALLEQADQTGDYSKLTPNNLVELLSEIGGFNYYPDPDNEFKQLNA
LDEFMNQLPPGNIAKKQYGATKIGSDKAKGNILSTAITGLNPFTLTKIAKMTSQSTIDYK
SVGFPKYLDLKLHESLLNQRVVVEFYHKGKKFHEERVKVGYKGFCEINFDCHLVAGDQVC
LKYDHQGKEYVAWYEFSQRVLKDEEGNIVYRKKRGETHLPELEKEAVLTLDEEKSNLLVE
SIRMHYTDKPMAIFMLTPDYDPSNHIIVSIFLSQLYKELSTQCVKTKGDKCHRRIHFILD
EFGNSVTCLA
>FECAFAII_02808 hypothetical protein
MFFTISGNAKLDKELIRKATKKVGKRTSFLPKTIKYSVIETEEQLHVLGQVLEQENQSSV
KLTLTLHDKEGKIEKAGTEYVFGPLDYQISEGFYPTLMDLIRLDVFKETDETMSVEESYR
NEKLLQVLEEELESDQRKVNQVSEVEVNEEVPWERPIFPKKESKEKETVYVDEQADIPTQ
KSIFEEENDVMGQLEVDPFEETMEDEETAEVEVDPVEANEESTWTEGDSQEYIEPLISEE
VEKNETEIQKATVFDYILDQYPPEHEWMKEKNKLFLNELYSKYQLPQTYQAFLESKEELI
SQGKGTLLEQLESVQSTNWHELAQEDLLATFEERQQETDQEINEYATEQSSNWEKVKEEL
NKEEQRVIEEEVQKIKERYEKKRDNAYSLCVEKINNFTKTNQEALSKEKENLLKERIKER
KEEFYRGLRTDKLKISKELNEQLNKLYQTTTEVLMEKHEQIQQELQVQIPKWKKEYEIQQ
QELKEQEEKQRQKEKEREQLEIRKREQDLAEQKMAIEKQRLEQEKEKEAAARKERQEQMD
TLRQAQLNYLAQPQPVAAVQTPVNNQANLTPSPQRSFNGWMVGCIASLSLLLGGGTVFAF
NHINQSSQADSVATTASIKEEAQEQARKEYEQQLEELLNRTNQSTTESSMENSKESDSSK
AKEGSSDSTVQSNSSESSESNEVK
>FECAFAII_02809 hypothetical protein
MFESITMNFLTQPKVVAAVDIFRALQTAATSLKNNLMIFAAVAAVASIALGGIFFFFGRR
GAENGKTHVGYVLLGVGVILAAASIVVSMFSMFGQTPQGL
>FECAFAII_02810 hypothetical protein
MIASLFICPEGGITVAKAKTPFEKAASKILERRGVSETQWKQEVLEKAQFDLLRGKDKDL
EGYIYQREREKLVFDEIIKH
>FECAFAII_02811 hypothetical protein
MKKKQLWFVSMFAIFFIILSGCSSNKKSEAKEDNSLLQPGTVWKEEVGGLVNNLKIIDDT
TWEYSESVWHPDPVQISVKRQKDYKGLERYKIVDSAGISDFINKPDSLFIVVPYEKDGVK
KMVFLGSSKDEKRTKEKLIHDGSQSNKYKLQKTSE
>FECAFAII_02812 hypothetical protein
MYADKNEIEWLLFESGISVKDIYKESGVARTTVIDLINKTSSIDKMRFDNAVKLTKMAKM
RKNLYENK
>FECAFAII_02813 Beta-L-arabinobiosidase
MKLLNQKTVIAGTFAVTLAATLALAGSVDAASTNVMYRLYNPNNHEHFYTSSTKERDHLV
KIKWGNYEGPAWEAPTSGGHLVYRLYNKGLRDHHYTASWDEVKWLTKNYGWTYEGPAWRS
AEKNNKPIYRLFLPGVKSGSHHYTASWKEVQWLTKDYGWKYEGIGWYGADTSKPKVNKSA
LEALYTSVKGTKKGDYTDNTWNAFQTALNNAKKVLNDSKATQKQVDSAKNKLDSAYKGLK
KKPAPTVNKAELQALYNRVKSTAKGDFTEESWNNFQTALSNAKKVLDDSKASQAQVNNAK
NSLDAAFKGLQHKPETPKEYMVTINHIDNQTGQVIATDQAKVTSGSTYTAKAKAFKYSEG
AKDNFSYKVIGNDTQSKTITGNTTITFNYNQVHQINLLCNNNYKNEGRVNILKEQIVNVT
HGDSVTLTAPSIQGYVLDDRVEPTNSVTLNNVTESQNYIFNYTRKFNVTVNHVNADTNAV
LSSESKTVYEGDSFSTPWKNMTDQNYFLCRNDDPTVTVDKNGQRSINNVDQNKTITFKYK
KISLNELRNFMRQKELAWLNDYRQQNGVAPMQFNDIVQQAADIRAKELQVSFSHYRPGGG
TFQDLLESLGCYGAKGENISQTGGYIDNLLSDDGAIDAMLGWKNSPAHNANLLYNNQSIL
GLGHNFKIYSDGSLGIDNVFISANPIFK
>FECAFAII_02814 hypothetical protein
MENKIHCTTGRVITLVLFLFLLLFARGTAVQALEKVDPSQIKENNNLVLYHDSDSLRNIE
VTGINGFKILDEYSTKKQKVLAWPKVKDLKSTSKIVAHYQKVGTYLGKEIDCDVTFSNFV
AHAGVNQDGLAKTINGKKYYNYLLFDKNIYRGFFMQSINVMNAKLEFKYAGTKTKVALSE
PQPEIQSKMRSMRAAGIDLNDTFLSIYSLNGQYQQRVSWYNDNNESVGERNIDMREFVGY
EKMGSLPYFVTTDTACAEYKAPALSTNNLTSKVVGGRAEKAYSSNDHFTDVVGADTYHRS
GVTYTLQGASPTFMIGANTNSMMFSFDTALLWTPQPSKPTKEVFNKANTEEAAHNIDKKV
IPQGSDVYYHIHQKFDALTVNTMNKYKSFKITDTFDNKNFDMVSDGKKYDGALWYVEANG
TWKKADTGGKLTVSGNTVTYTASDSFLANAANYGRDYILQLHMRAKNDAKGIAPNVATVT
FNNDPNKGTQKTNTVENYFSLKPNKKVEQDGKDVNGRNKGDNGPATEPLNAGSEVQYLVT
QKWHTKGVDIALDHYKQFSIQDPIEDRMTYQEGSAQVIDQSTGKDITSEGVLTYDSHSRT
LKWEASSDFLNNNFLDGREVQLIFTARTPLNKQVDIDNQANVSVENIEKETNVVTIGVEP
NLPQVIVPKTGSNHLVLTVIGSILFLTLASLGYVVLKLK
>FECAFAII_02815 hypothetical protein
MKIIRILVFNLSFLAATILCCGLIFSQLSIYPRYQRLFIHFLNIQCASMPLEVIKKLLIS
PIFMVSLVLLTGLVTWVLGKKE
>FECAFAII_02816 hypothetical protein
MNKRKWLFVCVAALFSTVAYSQLSFADSSDSSTTQTIDNSITAPSETDSSENTTEETADS
NISFTESTNPTSESSSETSEKPQDVEDTQVIKQAIHIQKIISSNQINNQGSQVAQQEGIN
GAKFIVYDITNILEEMTQDDNEKNQPVEIIESKLKDRAKKLSYDQLKKVAEGETKTIDDQ
EGVIEFSIEVPANKKQAYYIVNESSPENISNSEDIVLLTPVSNEKGEFLTDVWLYPKSEK
SEPKEEIKKVVSTGVKKNFFENCWEFFAQLFFDN
>FECAFAII_02817 hypothetical protein
MIIRKPPKRRVMHKLMIFFWLLSAVAVYLIPVVETNVAKFQQQQRILAIENLEKTDSSLD
VAKIELGDPVGVLTIPSISLKLPIYDGTSDKILENGVGITEGTGDITGGNGKNPLIAGHS
GLYKDNLFDDLPSVKKGQKFFIKVNEEQHAYQIYRIEEVKAEELKKNYLDYLMAEKDQDR
ITLMTCTPKGVNSHRFLVYGERVSFSKEDLKLQKKAKNRKSISLDWRLALLFAFFCVPII
FIYKKIRRRSE
>FECAFAII_02818 Trypsin-resistant surface T6 protein
MAINRYVKKAGMLVGMLGIIAGCFQGYQVHAEDVTQKTPPEKVNITVHKLMYDQGTQLNV
DIDGIKNDGYTHDQYPTGVTKYNKADYGDVEFTLGNITDQVLPREDSDLTNAKVDEIVQD
VEDKGSNSEYVKNATNKITSAVDENGEITFTDQPAYVNSKGNVYVVYESKSAAGLVTQKA
KPMVVIAPMTDKTGSGFLKNIHLYPKNIVSKLSFELTKFGDDGADQSKQTLLKGAKFELY
KGEPGKGTKLGDLVSDDQGKLTATDLTLGKYYFVEVPSEVVVGSDQEPTADQYLLGADAR
NDAHNKLTFEITNDGVTSDLKASYVNYKAPVIDKTVTNGTGQEHSFQIGDAVNYQGTIHI
PTDIAGGADGITVNGVKSETSPYSVFKWGDTAGQGLSYVAAKANIKVTNKDGSVVLKENT
DYKIQNSENGFVIDFIVNNGQVSDTVASLHGQDLQMTYNMYVNDSAAVANPLTNSVDFVY
NNNPFNQEEHHEKTKADVVTYGAKFLKVDSGLFGTGIKATPLEGAEFAVKNAEGKYYGGL
VDTDKDGVKEAVWVDNVANAAILKSDKEGHFEITGLTEGEYSLEETKAPENYQKLTEDIA
FKVNKNSFKEENRITVKNNQKAAIPLTGSNGFQTYVLISCLLLGAGGLSAVVYFKKKA
>FECAFAII_02819 hypothetical protein
MRKWLFGFLGVALIVFCSVFGYVSYQKHEGEVFKQNIEKKMPVDQINAHAKSYKEDATNV
NNDMSLGQMLSIQKEAIEMGVNKQVFAQIQIPALGLALPIFKGANQYTLSLGAATYFYED
AEMGKGNYVLAGHNMEMPGVLFSDIQKLSLGEVMDLVSNDGVYRYKVTRKFIVPGYFKLI
DGVPEENSFLSLPKKGEKPLLTLFTCVYTSQGKERYVVQGELQ
>FECAFAII_02820 hypothetical protein
MNYEEIENRKKVSKEMEEKLLKTMKQKHLKRLSVMQYINDMQITGKEKACLLGSMKNFEQ
LRRTYVKKSSNCQLLLEVS
>FECAFAII_02821 hypothetical protein
MARPVLEAMDMDTLTKGRYVQLLARGYSPKDVFKSLSKGTDMEKERLRKEFDYWRTHNGI
KDLKPARPVIKRKKKITQD
>FECAFAII_02822 hypothetical protein
MKNYDPNIRLGTHTIKVSFQRWDYKGFVTFRRGGNCKGLDVLALDEDDLYDQTLTDNPIG
FGLLPEDDEGNEWFKMTLMNDNGDELSVEDTWSYLSDYIVSVEIIEFVADKEE
>FECAFAII_02823 hypothetical protein
MIQKFAKMSKTAWIEKLENDLSVMRLAPKKFKREIAEKEAILSVLNAVDDKCPVKISFSD
IATIIEGIYYGEVDEEISSTKDLLDFLDKNKDTFIVLTDYEEVTTNEKL
>FECAFAII_02824 hypothetical protein
MSYTGILSLEDICHYGKRCTATEKITKKLSTGQSKAVVQCKKYIIQKDKVSEEMIYYTGK
RKQIILKDPIPLKELYPTIKHVYDQNGVLIGRRKNGVLRCTAKGMGRLIS
>FECAFAII_02825 hypothetical protein
MSTEFQSQKMIIKNWGYKATNVYIEKYYKFPSFLIQNSKYSKMKDSSKIAYMLFKNEFRR
ALHEKWIDADGLLYLEFTQADLMDKLNCYQGKVKTILNELETYNLISVVKGEFNPKTKKN
EKNKYYLLQPEISADDLFIQNSFDDDLSETIDKSTSSRNAEIARREETAKTLDNTGNAEI
ARREKTAETLDNTGNAEIAQDYYINKSLDTKRHLKDTETDQLQNQVLLDNFVEIMKEDSI
NTFVPEKVLSLIKTFSNTYEEAQQTVTTIHNAKHKAEELEKTVVVYEELESYGIDADKGL
YMTLLKAYQKQKTEKVNNLQNLIFVYVKNWFVEKAIAAKLANEQRETFNELPTVSTENWL
E
>FECAFAII_02826 hypothetical protein
MAERQSKLFPNKKARPRTNGMKDMEEFTKSLSISSADNSAPKVNTTEKHSDDNKNLKNPN
KSHKGKAGRKAEYKDPRLKKDLNTKISLSTKLRIQRLISRKFDNKSEGDVIDIALDYLVS
SFDRDDRDSLYKAYKEDMESMIPIIQEKNEKAKKQGKLTLDITDEINQQTLKEQKEKWVS
AKFE
>FECAFAII_02827 Sporulation initiation inhibitor protein Soj
MNANSIVVGNFKGGTGKSTSTQMLGFVNAFYKKRKTLLIDLDPQANASEVMSFTADNLGN
HFYQENGFPKTIWNVLYDGSLDGAVLPLIENLDLIAGNIAMSDYSDFMSAKFPNDKLAQF
EYFANILAPLKEEYDEIFIDVPPSLGTIVQSAMYFAEYVAIMLQTQPKSIRGAADYIDYM
EFFTERYNTQLGIAGIIPFMLDTKTSTESYMYNEAKKLYGDNLINTIVFRSARLIRYDET
GITLETKKNGELKKVDANPQNTFISILDELNEHISWFEEE
>FECAFAII_02828 hypothetical protein
MSINTFVYSHPINVYIIKNLGITVEQFCELYAYPQGTVASWITRQRRIKSLPASFIYDLS
LASSCNMSDVYEKLLILENEYDQFNSNQKKKKKKHID
>FECAFAII_02829 hypothetical protein
MNIIQQYELKYITFDQLSEEIWGYGQRLINLRIL
>FECAFAII_02830 hypothetical protein
MIDYNDRGRLKWAGFYLSDHTEEIDADNEQRANNNLAKEQMTTEEISEVLNAAVIKNRSV
CIQKEERNAEGYYPDDIVGKILGSDELGIYVGKYKIHYDEIRHIEFYQDNKWSRLE
>FECAFAII_02831 DNA polymerase IV
MMDYSKEPVNDYFLIDMKSFYASVECIERNLDPLTTELVVMSRADNTGSGLILASSPAAK
KKYGISNVSRPRDLPQPFPKTLHVVPPRMNLYIKRNMQVNNIFRRYVADEDLLIYSIDES
ILKVTRSLNLFTTEGTRSQRRQKLAQMIQEHIKEELGLIATVGVGDNPLLAKLALDNEAK
HNEGFVAEWTYENVPEKVWNIPEMTDFWGIGSRMKKRLNQMGILSIRDLANWNPYTIKNR
LGVIGLQLYFHANGIDRTDIAIPPEPTKEKSYGNSQVLPRDYTRRNEIELVVKEMAEQVA
IRIRQHNCKTGCVHLNIGTSILETRPGFSHQMKIPITDNTKELQNYCFFLFDKYYEGQEV
RHVGITYSKLIYTDSLQLDLFSDPQKQIDEENLDKIIDKIRQKYGFTAIVHASSMLEGAR
SITRSTLVGGHAGGNGGLKND
>FECAFAII_02832 Putative transposon Tn552 DNA-invertase bin3
MRVAYIRVSSIDQNEQRQIEEMKKFGAERIFIEKQSGATITHRPVFQEALDFVRDQDIFI
VEAIDRLGRNYDEIIASVNYLKKKNVQLIITSLPIMAEAIGNPLLDKFIKDLIIQILAMI
AEQERTESKRRQAQGIKIAKANGVYKGRPKLYSANAKDPQRRLVYKNIVEDLKKGVAIAK
IAKDYNVTRQTVYRIKKDSMVNHE
>FECAFAII_02833 Endoribonuclease PemK
MVRKPRQGDILLLNTAPRSGHEQTGKRPYIVLSHDIIADYSNVVTVAPISSTTRNYPLYV
NINSEYEMKTTGKVLLDQLTTIDYEARECIFLEKAHDSLVEELLMKVRTVFQKVSK
>FECAFAII_02834 Antitoxin MazE
MEMLPIKKWGNSNGLRLPKYIMEYLGIHTEDKVKIIQEEVNGQKRLIIEAANIENELTIE
QLFENYTDERNHVTIQNLGEAVGNEKW
>FECAFAII_02835 hypothetical protein
MFKKTKSLESGKKKIDLKIISSGYFKDFIVIDTKWNKKDIENILNSRNN
>FECAFAII_02836 hypothetical protein
MPIAIGNKRLPVTLDEKRQKELQQLKQKYGKSESKIMCIALDLLIAQEKAGFDIPALKK
>FECAFAII_02837 hypothetical protein
MNKIIPLLFVLFVGEILMRHAAAVHLNFVVFLGILVFCLIFWRFVLALVSLLFKMIAAIF
FIGLFR
>FECAFAII_02838 hypothetical protein
MNKVVYQLTTEDVSQFLTNKEHLNEVIRRIQKDFSCMEEMKYFIQRVEEQLYMESETSQT
KVTVSHNHLDVYKRRPETVKKGTELLRLETEKYIMNVYLERSELVENFVSYTICRKHYYS
ESEYYSIFESMELMEEEMEELNSKNATVDDYYLVFTRFLTCGTESIVLMGMDYELAVPEA
FLREYVEEVDNPGDDWYTTLTDFLDTYTYDDTEEIQNELDRKRMPYQRFERKKGK
>FECAFAII_02839 hypothetical protein
MAQNYYDEFVKLPLDKMAQKMEDMTFLYHETRVPKKHYKEKLSVAVEEMIESGVEMNLIA
TYYRTLEELKKQNGKWFFQALLCLEVGVKPSTIKPSEYQALELTYAKFAQIKKAKAMASD
WLDTFESIEKNGAFYTIESEEKDNE
>FECAFAII_02840 hypothetical protein
MKTQHKLLTVKEVVQILVDKEVISEKVAEALLIPRYWTIETPLVEDAPTMLFEDLVKIAG
YELHYQENMETYEIEYWLTKLEN
>FECAFAII_02841 hypothetical protein
MRKKFDYWGVPFSELFPNYHAPHTVECDCGERAKCIKSYRLYQCPTCGKKYTLSYGDYIL
IDEKVKKR
>FECAFAII_02842 hypothetical protein
MNKYVGLLDKIRVIKTQPLLVRFTLQTIHESINCVVADIEIIDKLLIMDDGKYNIAVTGH
FNKRNQLVIASMYVRNPDHFTRSMGI
>FECAFAII_02843 Single-stranded DNA-binding protein
MINNVTLVGRLTKDPDLRYTASGTAVATFSLAVNRNFTNQNGNREADFINCVIWRKPAET
MATLAKKGSLIGVVGRIQTRTYDNQQGQRVYVTEVVADNFQLLESKAATESRMHADQSSS
SPSPTTFEQRDTATPNNNGLNASQNPFGGQSIDISDDDLPF
>FECAFAII_02844 hypothetical protein
MTPTQFKEKTRNFAAEKHLNPQIVQRYYMMEKLLECIVESPYHDDFVLKGGFLIGSKYGL
ENRSTVDIDTTYRNSKLTKEKLETVFSELTANPTKDGIRFELKGLTETREADYYPGFQAK
FIAYLENARVPFKLDITSGDSIIPAALMYEHKLMFEDKTIHIPAYPTEQILAEKLHATFS
FGKDNSRMKDFYDLYMIPKLERIDEKNLYKSVQGTFKERNNQSVFKHLYDQEMPQLVKDE
GLREKWKRYQQENYFAKDISFESTLTSVDSLMQSIVEQEKAERKQNFKRSQQMNQEMER
>FECAFAII_02845 hypothetical protein
MKDKIQCIFDKHNGNLSLKDARSEGLSPMTLDRLAEKDKIEKVAPGFYTLKDAFVDELYL
AQSIYSRGIFSHETALDLFQVGTYIPKKINMMFPKGYNVSKEKLDQYAIQPHYTNKENFD
LGVTETESFYGNKILVYDLERTLCDMWNPRYKASVEVKQEALKEYMTSTSRNTNKLRRYM
DILKSPKEMTLYMLPLY
>FECAFAII_02846 hypothetical protein
MRNTTHKQQEIENQKAKIRSEQEKMRASKRRLQQLKNQQRIQKEIELDR
>FECAFAII_02847 DNA topoisomerase 3
MKTVILAEKPSQAKAYADSFSKATRKDGYFEIQDRLFSGETVITYGFGHLVELDSPDMYD
ENWKQWSLEHLPIFPTHYHYHVPKDKKKQFNVVKQQLQSADTIIIATDSDREGELIAWTI
IQQAGADQGKTFKRLWINSLEKEAIYQGFQQLRDAEETYPKFEEAQARQIADWLIGMNGS
PLYSLLLQQKGIPGSFSLGRVQTPTLYMIYQLQEKIRNFQKEPYFEGKAQVTAQNGIFDA
KLDPNETQATQEAFEAYLKEKGVQVGKQPGTILEVETEKKSAASPRLFSLSSLQSKMNQL
MKASAKDTLEAMQGLYEGKYLSYPRTDTPYITEGEYAYLLDHLDEYKHFLKAESIPTPIH
TPNSRYVNNKKVQEHYAIIPTKTVMTEATYESLTPLQQAIYEQVLKTTVAMFAEKYTYEE
TTILTQVQQLQLKAIGKVPIDLGWKKLFGKENDGKEKEEEPLLPKVTKGEMVTVDLQVLE
KETKPPQPYTEGTLITAMKTAGKTVDSEEAQSILKEVEGIGTEATRANIIETLKQKEYIK
VEKNKLVVTNKGILLCQAVEKEPLLTSAEMTAKWESYLLKIGERKGTQTTFLANIQKFVS
HLLEVVPGQIQSTDFGSTLQEVKAASEKQEAARHLGICPKCQEQEVILYQKVAACTSEAC
DFKLWTTIAKKKLTATQLKEIIQNGRTSQPVKGLKGQKGSFEATIVLKEDFTTGFEFSEK
KKTNFKKRTRRTTK
>FECAFAII_02848 hypothetical protein
MTEKKMSLIDRCKQIDIVDFARNNGMAVVNKGRDYRLEDHDSFVFDRRKQRFYWNSQNIS
GDIIELAKLFFIDKEIQDPKQQFKAATDFILKNEDKTERVENLHFETEKYKDHPVDYQPL
TEKGRNYLKEERKLPEWLIDYAEKEGLIAELKPKYERQNFLVRDDRLDHAVAFLWKDPQT
KETVGASYQGTFIDYERFGERGTYKHIDKNSTANHGFNLKIGDPKQLKFFESSIDLLSYA
ALNRDQLNDTWLVSMEGLKHHVISHYFGEAVSELRKKQAFPQSIEICVDNDRAGHIFYEK
EQLMGAVDPFTNQKVRCERGIANDWQVPREYKVIYEEVAKEEKVTPEAIMAIHKTENNLQ
LTNQLVSAHKVNASFGQQLSVNDSIEVISLKDICREVAKELKDCERSNGTYDFDRFYQGK
GDINSQILFSYKAEQYYKGYKNHEHEFVPEVKKDWNDQLKHEIHQQEIRKQKRAMLFQQG
RQQERE
>FECAFAII_02849 hypothetical protein
MKEKENDHFYRVEFNENDPEKGLKSYGGEIVTFELIDQLKTLDNQYAAEAGYYKFYFEEV
KNGEVVDQIRMDLGDGVNSNQPIYLELAKLCEQVPEKEQKQSVKNEPVSKEQMQSKETKT
KQKGYQKRTAEEIKQEVKSLSQQALDAVKKHTHSPEDVKELLNFMSRFPERSFRNQLLIE
EQFPGATACLGRAALKKEGIYIKKGEQGNKIFVRKTVKGFYEKGRGFVRETEATPEDKKR
IESGQIEVIKKPYYTIEKVFDITQTQLKPEDYPKIFPNRVFDFQLDKKGQSELQAGIQAV
ANNIGIQIRDMTESEVYQRELGQARGAYVRNEFTGEEEIVMNTRNTPTQHLATSIHELAH
ARMHKFSELDTATKELQAEMTSYIVCKHFGMDTSEKAIPYIAAWTKNGQTLDDKEAAERG
KIMNDVSRVANEFIQTISNEINQYREREPEIQPAEVKQEHKNTLETPENKNIVPVGSLWI
DKKDGKVMEEDTGRTLHLKDAAFIEDPQHNQVILKGKSYGKEIQTALPSEEFALGNPFRF
SLETVSEVAKRKNEIYYEQQLSQKERV
>FECAFAII_02850 hypothetical protein
MNDFNYYKSKEIYREKYYQMPKVFFTNEKYMDLSNDAKIAYMLLKDRFDYSVKNNWVDSD
DNIFFIFTVEELMKLLQCREGKVSKIKKELEKAGLLKQKRGRVNKRDGKIESMPNLLYLG
KPEVTNQDVFKIMERGRQY
>FECAFAII_02851 hypothetical protein
MAEDNRSQAAVSRLLGNKNKKNFKSKEVEEIELTKKNISKVIKDQGSSVRTADSIRINPI
LMSALKYWTTIAESDKSKPDVIEDALLKSIPEEYLIEGYKLAKKQNKI
>FECAFAII_02852 Sporulation initiation inhibitor protein Soj
MARILSVANQKGGVSKTTTSVNLAACLKFVYGKNVLLVDIDPQGNATDNVGFDIDGTNQP
TIYEVLKGEADITDAILDYKGIDVLPADIALSSAEREFTQVGSEHRLKRVLQPIKDNYDY
IIIDCPPSLGMLTVNAFTVSDEIIIPVEAAYFSLKGLIKLSETIETVKEYTNDKLEVRGV
LFTKYNKRYNISKEMTSAATEISRVIGAKIFKTYIRRTITVDEAQAAGSDLINFNKPSTA
EDDYKAFTEEYLKEVGDFDGRR
>FECAFAII_02853 hypothetical protein
MSINTFVYSHPINVYIIKNLGITVEQFCELYAYPQGTVASWITRQRRIKSLPASFVYDLS
LASSLNMSDVYEKLLSLEKEYDSFKIKHDKKIKKHI
>FECAFAII_02854 hypothetical protein
MNIIQQYELKYITFDQLSEEIWGYGQRLINEVGVERFSFYVEAAAGYHNFRFYIFPLYI
>FECAFAII_02855 hypothetical protein
MIDYNDRGRLKWAGFYLSDHTEEIDADNEQRTSQNLAKEQMTTEEIAEVLNAAVIKNRSV
SIQKEERNAEGYYPEDIIGKILGSDELGIYVGKDKIHYDEIRHIEFYQDNKWSRLE
>FECAFAII_02856 DNA polymerase IV
MMDYSKEPVNDYFLIDMKSFYASVECIERNLDPLTTELVVMSRADNTGSGLILASSPEAK
KRYGITNVSRPRDLPQPFPKTLHVVPPRMNLYIKRNMQVNNIFRRYVADEDLLIYSIDES
ILKVTRSLNLFTTEGTRSQRRKKLAQMIQENIKEELGLIATVGVGDNPLLAKLALDNEAK
HNEGFVAEWTYENVPEKVWNIPEMTDFWGIGSRMKKRLNQMGIMSIRDLANWNPYTIKNR
LGVIGLQLYFHANGIDRTDIAIPPEPTKEKSYGNSQVLPRDYTRRNEIELVVKEMAEQVA
IRIRQHNCKTGCVHLHIGTSILETRPGFSHQMKIPITDNTKELQNYCLFLFDKYYEGQEV
RHVGITYSKLVYTDSLQLDLFSDPQKQIDEENLDKIIDKIRQKYGFTSIVHASSMLEGAR
SITRSTLVGGHAGGNGGIKND
>FECAFAII_02857 Putative transposon Tn552 DNA-invertase bin3
MRVAYIRVSSIDQNEQRQIEEMKKFGAERIFIEKQSGATITHRPVFQEALDYVRDQDIFI
VEAIDRLGRNYDEIIASVNYLKKKNVKLIITSLPIMAEAIGNPLLDKFIKDLIIQILAMI
AEQERTESKRRQAQGIKIAKANGVYKGRPKLYSADAKDPQRRLVYKSIVEDLKNGVAIAK
IAKDYNVTRQTVYRIKKDSMVNDK
>FECAFAII_02858 hypothetical protein
MEYKFNLNLKEVLPTQGTININGQDNDDDIVIKKIEFIDSDINVFFYSKEKLADFSNIAE
MIERLKDFMISVWDVAMLADESNYTSSIYRLEDSNWIEISLELKTLPNSVNYIIRDITSE
AQQLVNYMHGHESIPFSLILLKRSKNISNTRDRFISIITACEIGVKEFYQQEKPDLTLIF
ENLQSPPVDKLLGSMFKGYFNIEFPKEIRKEIKNFIEKRNKLVHSPQGSKPTIEECFECY
MAVLKTFNFFYKINDSFMYRDFYEESIELTPTEPNKSQITLSKELERKVESQELAIGISI
TNVSTYKELYEAKSQDNKDFVENIDKEPTNTVGD
>FECAFAII_02859 Toxin YoeB
MIKAWSDDAWDDYLYWHEQGNKSNIKKINKLIKDIDRSPFAGLGKPEPLKHDLSGKWSRR
ITDEHRLIYRVENETIFIYSAKDHY
>FECAFAII_02860 hypothetical protein
MEAVAYSNFRQNLRSYMKQVNEDAETLIVTSKDVEDTVVVLSKRDYDSMQETLRTLSNNY
VMEKIRRGDEQFSKGAFKTHDLIEVESDD
>FECAFAII_02861 hypothetical protein
MPIAIGNKRLPVTLDEKRQKELQQLKQKYGKSESRIMCIALDLLIAQEKAGFEVPALKK
>FECAFAII_02862 hypothetical protein
MNKIIPLLLVLFVGEILMRHAAAVHLNFVVFLAILVFCLIFWRFVLALVSLLFKMIAAIF
FIGLFR
>FECAFAII_02863 hypothetical protein
MQQNPTEDVSHFLTNKEHLNEVIRRIQKDFSCMEEMKYFIQRVEEQLYLESETSQTKVTV
SHNRLDVYKRRPETVKKGTELLRLETEKYIMNVYLERSELVENFVSYTICRKHYYSESEY
YSIFESMELMEEEMEELNSKDATIDDYYLVFTRFLTCGTESIVLMGMDYELAVPEAFLRE
YVEEVDNPGDDWYTTLTDFLDTYTYDDTEEIQNELDRKRMPYQRFERKKRQ
>FECAFAII_02864 hypothetical protein
MNHFKGKQFQQDVIIVAVGYYLRYNLSYREVQEILYDRGINVSHTTIYRWVQEYGKLLYQ
IWKKKNKKSFYSWKMDETYIKIKGKWHYLYRAIDADGLTLDIWLRKKRDTQAAYAFLKRL
VKQFDEPKVVVTDKAPSITSAFKKLKEYGFYQGTEHRTIKYLNNLIEQDHRPVKRRNKFY
RSLRTASTTIKGMEAIRGLYKKTRKEGTLFGFSVCTEIKVLLGIPA
>FECAFAII_02865 hypothetical protein
MNDFNYYKSKEIYREKYYQMPKVFFTNEKYMDLSNDAKIAYMLLKDRFDYSVKNNWVDSD
DNIFFIFTVEELMKLLQCREGKVSKIKKELEKAGLLKQKRGRVNKRDGKIESMPNLLYLG
KPEVTNQDVFKIMEEEDNTDTTVIAKIANTAKPREINDTTVIAKIANTAKSSHIKDSTVI
AKIADNLFYSNSIDTNRHIIDTETDQLQNQVLLDNFVDIMKEDSINTFVPENVLNLIKTF
SSTYEDAQKTVQTIHNAKKKAEELEQTVVVYEELESYGIDADKGLYMTLLKAYQKQKTEK
VNNLQNLIFVYVKNWFVEKAIAAKLANEQRETFNELPTVSTENWLE
>FECAFAII_02866 hypothetical protein
MCNSIVTIQEKAEEELMRIEAEYKEKRKAIKRKKNAELKKYKEEQALKLGMMLCKYYDCY
DINEVLKKANLNQFCE
>FECAFAII_02867 hypothetical protein
MNKKYSIHNKKEPNKKNKAQIDKVYKKTKGVKLYLGAILGFLAIGMIIVFSPYVMGKSYD
FETVKMSSAQNVTSSLNMYVDDMEINREAGLFKLVLRYQDDTGTKSLSNIKSDYKLNFIT
NKNNEDVKTKVVKLSDEYTVIYYQNLPKDFGVISVTVNPRYIYPELEPSNDLKEKEIKFY
AVDKDIKSNAKLEVESTSDLQKDNFKYQIKAIENSIKDEKKSIEKMNLANKVVQKDIDKA
NQNLEFQTLDEQTDTKNEISSMQTTIENNKSSIEESENKIKQFEEKIKQLEKSASRFE
>FECAFAII_02868 Cell division protein FtsL
MIKRKNDNKWKYICGVLIIILVLGGLLSQLHTSNIQAKNKKLDQEVTQLEEQNSKLSKNI
SDLNANVEANLTNDDGSELNKQIAEVAKKFVELYPVYDIEKVEEKKADLEKIATPSVADS
IVPDDMITTSKKTLESKSTTQKGEAYSSDPTFKSKYKDSKLYTNYVNANTINYFAEVNYK
TESSSGDTENTVYMLFEVTNKDGQVLVDNYEIKYLK
>FECAFAII_02869 putative endopeptidase p60
MEQNKNNNVASTLARQGMKQVSKKIGLALKLKIGVVIGLITLVGLLVIGSLATLQGTQTA
TNTGGAEVIGGNKPLSPEVQKWQKTVEKYAEKYGIKELVPYALAIMQCESGGKLPDLMQS
SESAGLPVNTLQYEESIDQGLKHLSNVYNIAKSYGMESNYDGIVQAYNYGIAYMHYLGKN
KKTHTIETAEAYSKNVVAPSLGNTTGQTYSYVNEVSIKYGKTYLYLNGGNFYYAELVKQY
IGGGSGNPANPSEFWGKMKTEMEKYQGWPYVWGGKNPTTGFDCSGLTAYLYQFSAGITID
SYTVTQYEATEAVSIKEAKAGDLIFFRGTYGAPDFISHVGIYVNETTMYDSNSSGIGYHN
WQDSYWQSHSPEIRRVKK
>FECAFAII_02870 hypothetical protein
MLQDFYIHYGILPKEWREARDDNERNQLNTNICNLPNDSYPIYGEFLKFIENQQFKIKNA
TPERVRSIELIKLIVTDMCTTYPQIFNGVTTMPNFDTTKIVYYNIDSISKMSAPVFHCQL
FTALTTIWNSALQNGKIQKENFKKYGSDYYKYAQDFMVLIDECHNVINSNNKYACEYVLS
FEREMRKMRAGVYFATQTPEEIIPKDSGSEVADVIRNIFNLCTFKCFFNLDSALLEDIKK
VLGNTITDTEIMLLPELEVGQAVVQTSSEDTYMINFDPYPEQIERFDGGQ
>FECAFAII_02871 hypothetical protein
MAIPNTIATFDVCTADKEDLLHKINTSIGELDYRSTNENRTTDKTDALLDKYNLEDFAQE
ITKRGEVVKTVHARIFVYSDSLEELEKRISEIRKDLASVNHKAIVPQFRMKDEWMSLFQD
GMEQESKLFAKKGLTVPAKNIGGGIPFHHKSLKDPRGFYLGTTSTGGAFIFDPFYSTKQR
RSFNGFILGKMGFGKSTLIKQLQEGLQAKNCFIRGFDKSGEFEGMVKKAGGVYVDLGGGD
MVVNPLQIYATVMKKDQFGNDVVDESKSFKIISLSVVIKFAF
>FECAFAII_02872 hypothetical protein
MIVSKKLARNLVSEGYDLRLVESINRAVELNLMSVIFLLVMDM
>FECAFAII_02873 hypothetical protein
MLKHCRKGFCKVIKGKNAADLIFEWKESNLINVRGKNGSGKTERVMASIDNSRPRSRALV
IN
>FECAFAII_02874 hypothetical protein
MIVAESNENKLSGVFDKFLELVIPKDKDMCELLPYKKILKDGTLVTNDNKYQAFFKVKTT
DLTSISEDGFMRMVNKLTYLNRVYLEPYKIYSLTYPTETVNQAIYWKHRIQEAKRSLLSN
NDPNLETYLKWNLKLAYDNYERVDLVSTLPELMFVICVYGKTQKEVKNHADVMKQAGGRE
LDLQRITEGDLINVITKLMNPNTSL
>FECAFAII_02875 hypothetical protein
MPAFYEVKMMYRNPKNIKQEIKLFFFYLVDLGIVAGSVMASVYFAKLMPISPMMKFALYL
LAFVVGVWMCVRTPNHPKERNILMLYYLFKMDRNRYHEVEFKRNSRGKIEL
>FECAFAII_02876 hypothetical protein
MTESINWRKLNVQWLKYKWPIIVSLIIILFMAYPQRVFALPWITDNKEVLKFLTKYQDYL
QFTKGGFGSIVVQSLSWGLIRGAYFVCKSAENLVPQSLSLFSFVESSSLGAVYQSVLNTV
VVGLMILSLMFVGYKMITGKGTVDLKSVGMNVVMSIALILLMPTMISSGIQFAKTFYKDS
TTITKADGGVAWSLIEDGVTDLVYINKNDAYDRLGKDGVQKNALKEKNFFSYDFSEVITV
DTAKDLEDDNKKAEYLQSRLTPDGEGNMQAVKIDDGWMSMFSDSFKGGYYRFTKNTFALT
LGLLSLAVAYVFSIFIIVTAILELAFKRVLGVLVFATDIETGQRSKVVLSDILQCYLTVG
FQGFGLSMFAMFVSYLGTGGGSSVNPFIKAVAYVCAVFVLIKGSGTVMRYFGVDIGLKEG
YGQLASAFGMGAMLFRKGSNGFNRAKGSGNGNGSDSGEGEDRKPEKNFGETLSKKAGKTG
RALGYAHERGLSGLASDGATMASERATKPFKSMRDMANDTKNKFKEGLDDGTVSAINKNS
KPMLAKNKEDETGKYADSMPTRLSDRKDGAKVENADRIMSSSERMREAMKNNAESNNNPV
SAIQQKVQQDIEERKNAMHGQAKSAEELINQKRQEAKYTPEAMNREEMLRKRVEGRTGTN
TDEKEALTKERIQEAKNSNTGLEKLVKENLQNSTSSQGGRSVDVRENIQGSLNGHVGRNV
DVRENLQSSSNGQGTKTIGVRENLQSSSTSQPKTVDVRENVQNSTSSQGFKSVDVRENVQ
GSSASQPKTVDVRENVQSSTSSQGFKTVDVRENVQKDSGEMKEKTQKINIVEDRKSAKKF
DSNHETVIIDSEIRENDKGSKPRRRFTYEDNELFRDTLNDPNPLFDNLN
>FECAFAII_02877 hypothetical protein
MLFDLVIQSYSQLETRYDKAFKTIKENCQNHILIMSNDEETIEEISKKCGHKTTINRSAS
SKHLDTDSSVTSSAEQERVITVERASQLIEGEQIILRNLHRQDTKRNKIRPFPIFNTKET
NMPYRYQFLAEDFDTQRDINEIDIACEHINLSLQDNQIPYARFIKDLKTRLEYSIINNIP
ISEEDYQDYLNLSGSQQTINEEELLKLVNTEVKSQDMEGQVLSEQEMKINIYLKESQKEA
IELVKVINGRLADENSADMVIKTINSQILDTPFIQSLINDSIAIHNVQESKDQIMILEQQ
LANAYELAVFKTKNSILKNKIIKLKNAMTKLAKAI
>FECAFAII_02878 Group II intron-encoded protein LtrA
MTNTKGISLKNKQLRHAEYYDMTETFDELHAMSVAKSNFKNLMKFIIDDNNIFLAYRNIK
KNKGSATAGYDGVTIKDIEKLACGDFLTIIKRRFKDYRPRKVKRVEIPKPNGKLRPLGIP
SIWDRIVQQCILQILEPICEAKFNKHSYGFRPNCSTENAIADCLARINQSKMNYVVDIDI
KGFFDEVNHTKLMRQIWTMGIRDKQLLVIIRKMLKAPIVMRNGNVVFPTKGTPQGGILSP
LLANICLNEFDWWIANQWEERTVKELKHHYRKNGAWDKGNIYSKLRSHTSLKEMYLVRYA
DDFKIFCRTGEEAQRAFYATQKWLRERLKLPISMEKSKVTNLNKAESEFLGFSIRLHKKG
KKKVAFTYVCRKAEENIKNKLKQQIKKIQYAGAKKNRHRAIGDYNMMVIGIHNYYRIASH
CSVNFTEIYRSVRTVIEARLKARGMTKNGIYGQDHEGYRPYLKSKQMRYIEGFPILPIGY
IKKRTPLNKRRNLNKYTKEGRKLIHQEQQAIESWKIKYLVKGFSNNKKYTVEFSDNKISK
FISQKGKCAITGNELLMEEIECHHINPYHLSKDDSYKNLVIISREIHRLIHATSEETILK
LLRLLKLNHYQIRKLNTYRKKAANFPISIKMN
>FECAFAII_02879 hypothetical protein
MKLVQNNEVKEIKNGFVKNSNKILGKLKKVGSFKKNKYHTGKIEGEDLPKSLQDKLNVPL
VFIGVFLGSIVFLAITYLLNFLKALLVAIGQSESGLLGVEFDPKFSLAYLKPLGDTKQYF
MCAVVAVIGVAYLIYGKLNHESEKNLVYGQKGDSRLSTIKEIKRDYHEIPEKTEVYDGIG
GVPISHYQDKYYIDRDTVNTVVLGASRSGKGETFVVPLLDNLSRAKIQSNMVVNDPKGEL
FSASKETLEKRGYRVLVLNIDDPLESMSFNPLQLVIDSWANKDYHEASKRANTLTSMLFA
SGMGTDNEFFYKSAKSAVNAIILTIVEHCFNNDCIEKITMYNVAQMLNELGSLFYTDPKT
GKEKNALDEYFNTLPQGNQAKIQYGSTSFAGDKAKGSILSTASQGIEMFTSDLFGKLTSK
MSIDLKEIGFPKSIQFKVNTNLVGKRISISFLRKENDVIRLIKKYRVKVKALGLCVLNFN
EYLQDGDMLDIRYEEEKSRAWYRIEFPKKQANSHDTSLVTKKFKSGKNYSDLEISTLRLK
YTDQPTAVFMVIPDYDPSNHVLASIFISQLYTELASNCKQTPDKKCFRRVHFLLDEFGNS
VTCLA
>FECAFAII_02880 hypothetical protein
MSVFNNKVMLGNCYVNHIGFYDGGTYRVLFLRLSVFSYSKDGKGHYENINAQISCPLDRN
GETTTTSSHPKALMNKFIFEKLDRNLVEGMKISIHGNIRGTEQVLLNSGWKNFGQLSPLE
KEEYQKIPKNELVTRNQTYIYIEEVSMPEKEEFRKSQSKVTKEDVEVAEPNQADEILSDD
TDPVNDEGEVIEVFEAEIIEEEEEIKSFDKRMYREKPKGYVNFEDMYYDEYSNEPPIN
>FECAFAII_02881 hypothetical protein
MNQRFEYNFEDVEPKLLKKGKGLKKKNKYTLKQAEALVGWIQHNWSDKTTITLICSDTEE
GTKYAFDGIEITPFSIGGQEKLLFPDIEGQILQAPDSMISDPNKLILDINDQYKHEPDVA
EPTKESKSKLNLKLPSVVLPFAKKKNKLMNELIEPEETDIYEEELEEQEEIEELVVSSEE
TEEVEEIETVSENEEETEEIFDFEDEEEVENVQKGDLSTSSQNGLEAVNDPQVPPYISSQ
TPNYSPQYQAPNVLQPLRKHETVQLVTLKEYCDLGEEIETSISQMVEKLKPESLFKFIGI
PSTGLTNTRIDEYRSNHAMLRLAEVKFENLREHYSRQIISFKAEALDRLRTAVDIAWKKP
YDLDVKKNKAEELSKMEAEAEAKLNEFVKRQENNVNDKIKKFEIEQEIDLKNFIARQEAD
KAVFIATEKDRTQNLIDSKAESINADLLETKDKFIDEEMYKMKIEMNKNLFDGKQKIKSE
LATELAKANDNVWENALKFIQEIQDEIEAKTPIWAAEIKEFNSLEEQEHERMKQTKELQL
KEESIEIKRLEAEMNLKRMEELDHENKMLKIKLETALSKNELLAMEQDTKQVVNGSNRVG
ALNLFSKR
>FECAFAII_02882 hypothetical protein
MKNLVISKFAMLPRMDFFDNVSKFMSNMTSKLQGISLSVIIFCIVVTGLMFLFGEGPSRT
AKKWLTYIVIGAIIIFGASTIGQTIKSVGGF
>FECAFAII_02883 hypothetical protein
MEAIQENRKDNQETSEKNKKKRKKKVDKFTEMTDKIIEKKGLKPKDFDRQAIKEARQKLY
DDFVKENISQLLD
>FECAFAII_02884 hypothetical protein
MQENNVSRIIYLIGGLIILSLAIAGLVEHWPEIKLLIRNFYDNKMIKM
>FECAFAII_02885 hypothetical protein
MQEQSVMEIIKWFIGLMMIMAMVSIGLFCVQLQDINTFKQQVNYQIERKGGLTTEAVEAI
DKYSATNYDRRFTIESDKLNQKVSYGEEIDYTIKATIPIQILPLPDVTLSFNGNSVSQIR
>FECAFAII_02886 hypothetical protein
MKVKALKKKRKSSISPLKITKTEHKSFWIKLLGDVYYQKLREMNNSNIAIIKWQKQRLKK
SLIFILVGFLMYLFLGKEWYYLAGGIATSVGFYVWQAKSINGIYNQFRFERHLQFSKFTR
LLIPYLKQKKDGGNLYGVFAKIVKRLDYDTDKKLLMKLMQEMTDQPNDIRPFTEYAEQTS
GTDMSVLFMSTVYDIRQGSADLDVIEELDRLASEELMAGIDSIIDYKSRRFVFFPTKIAM
TSFILVVGFAVGVLFMNLKDINFGQ
>FECAFAII_02887 hypothetical protein
MKVQAMTKRKGLMDVSELNAYQVAYGKPLDYRDYLNYVGLPCLFMGGFSFALCYYWWIAL
ICGVIGGVYGFKVIMPKSIKRSYELKSLQERNKFINNMTQILTDDSKTVTRALSIAKQRT
KGELREDIQILESRLQGADKFQIAEAFREINNKYYSDVVFTQYFEQLETAIYEGRNNSDT
MKQIKSYHNDVKRKTEGFMKIKDGYLQDMKQMMFIVAVFIGAITFAFGFSTFYEGFARSP
IGWVFGSIYFLIMVSFMKSFFKHYFDDEIMSLGVSN
>FECAFAII_02888 Putative conjugal transfer protein
MRVVEEKKISPKIEETPKSKINIASIIKKNGIKENSEAIEGNLDFLTKLLEEDSGNYEPP
IEDAKLNMIRDDLTRNYSQEVLQALTDDEIRRKLVQVVLKEHGTFFKKDKEVAEYVVREC
IGTGIIERIMTNDEITDVGWNGSQLSIETNSNKWLFDGDKLNITQEYIERVISKYAVVND
RAFNSGNPIMDGMFKNVRISATHIDNSPDGSTFSMRVARPRLALNKENFEDFAPDYILEL
FEKMMKTKANICISGETGTGKTELQKLLLSFIDNHDRMIMIEDVQETHAKELFPDKDIFS
WITTPKKAISDLVKASLRNNPRWIIVSETRGSEAYEMLQAVLSGHYVVTTLHAVNARAIP
RRFVNMCASGFKINENAVEEDINRYFDFGVHIKKTVVDGKVIRYLNEIVEFSASEPTTVF
KQKFINGKFVIENGSLSEDFKEKMAEKFITFEFPEDQTNTEESLPEEEEVI
>FECAFAII_02889 hypothetical protein
MIYVAFFLDGSDVMLRDMPKMILLMFVGFFLILVIAYYSLNGYTQDSSVKGMQETLRTTA
IANRDDSIRVEKGRFALIKSDFEKDFKEKFGKSKNLNNETADYKFDYLTDGKDGIKAIKV
KVESGSKEYQATCILNVAND
>FECAFAII_02890 hypothetical protein
MLDQNTDRSWWMIGAVIVGAILIGTAKVAFPEVFNIVITFFKNMIPTNLG
>FECAFAII_02891 hypothetical protein
MRVQSYGNSVFDVKREFQDSRRKTKKLIAYFILSAIVFYIVKFVLELNSIVFTDMVHKML
NGEPINFNFDYMLEKAQSNQIVAFIVSIYYFIEKSIFSLKDFFFEMLTKLTTFYNKISKN
>FECAFAII_02892 hypothetical protein
MKNFDDIDYNDISSLQSALNDPKFPFLSEDELNEKLQKTKNTFESEALMKKTRGYFSQRI
LELSNNLNDVPKRAKVSRHALVSNRASQVSETRINPPNGYPWVIYLIRSNGYSYTENYAI
RRTIDGKEAFCLQAGVQATNTYTGSTSGYLSNSQREMISSILSAYKELGGWANNDAGKQR
WIATQMLVWENSNEKPKSITVTPNWKNGATKWKNDLVARANAIRVRTKWDSTSKTVDEGD
KATFKVTNTYGDHNLHVKSVSGGGKATISNGTLTVDTTGATGNKITVDMIKGSHPSDAHP
TTVWSNGSYQKLVTGSFYISTSVTVNVKRKGTVEVLKVDSETKKPLSGATFRFSYSGKTK
DVTTDSNGKAKLTERLKAGTVVKVKEIKAPNGYQLDSSEFSITVKENQNVTTTRTNKKST
GSVEIEKIGDLDGLGLPNVVFTIYNSDNKVVKDNLKTDSNGKIKVDELQFGKYYAVEKQG
VTGYDPDGKKYNFEISQDTPFTKPAKVKVTNIYEVSISEKVSDMNESQVLKNNWSADPND
YLQYDITTGNLKKSGERNVQSFIIEGFYDNKNVDVSKSEVYVGSTNVTNSFDINNDTNNG
KVIAKAKTSVLTNNDFYNKSYNLRITMKIKKSTLENTEKQKNLTIVKNSKVTVGSKISKS
ASSNDVETVLYSRKVTINHIDEKDKHLLKQDIDYKYDGETYEYKPRTDLFDKDGNNYKSD
VIHKGKIDGKDIVLNTPYHIPVLSVNVDRIQIDTARAVKNGYLPTKIELSKKEEYEKELE
KIVFKVKITDIDNNKVVYDENFKYKEFNSHMSLDLPTEYLTKNKKINYSVDILLVDNPDK
NKFETETKDLRTIGYTSSEKVLTNKDMTNNQVNYSAVVRTVKERENNNPVKEFNESINYK
FTDSTKTKTGYGISVDLEPTYRNEIGKQIDMKVYSYPMNELIDSKIDEIYQSGGKETEVK
MDRLKNDGKVESGISTQNLSFQFPHMNIERKTGNIYADSQRNDESIKYELIDGGRKLYVP
IWCDLGNYSIAIKSSNFGGNYISLDMNQNIDVYAYMYATIDSETKKDDELLLEPVYPEST
LPDGWSKNEIDWLNK
>FECAFAII_02893 ABC transporter ATP-binding protein YxdL
MILSVENFTLSINKKKIKQNWNFSISEKDFIIVTGKSGSGKTTLLNNLSLIDKQYTGNLF
YFEKKVSKHDIQRLRRNHISYLFQNYALLENQTVQYNFELAKKFNSNISNDHIYNLLTDF
SLPKDILKEKIFLLSGGEQQRIALIRNMLKPFDILFADEPTGNLDKENSTL
>FECAFAII_02894 hypothetical protein
MNFLKNLTEKEKKAVVLVTHDLNVLNYGTNIIEL
>FECAFAII_02895 hypothetical protein
MILLKKEYEKFYDRLIYSLQLPKKLNRQLQKTYETKSTEEWESYC
>FECAFAII_02896 hypothetical protein
MSEQNQNLASNSSKKYTYRSEPKQISFRVSESEFAKLKQSAEALQMSVPAFVKAKAQNAR
LVTPKVAPDIAQAIARDLAKAGGNINQIAKWCNTHQHDVASGDAQRLSENLKIMQKELQK
IWQQLR
>FECAFAII_02897 hypothetical protein
MATIKVSRTTSCSRAINYAEPRATIKTGINCDVDYAKSEMKQIRMLYGKDDRVQAHLLIQ
SFRPGEITAEKANQLGAEYAKKIAPDHQTAIYTHTDKDHIHNHIVINSVNLETGKKFQAH
GQAFLNKCYDLNDEICLAHNLPITERGKKPEKRTMSEIKLKEKNEPVWKDEIRIAIDQTM
KNKKTRTYDQFCNSLKTLGIHCFNRGKNFTYELIHKKKKVRSNRLGKDYEKETILHELDR
RERTYNQQRTNELRRARASIRETAEEVRREQRTLTPEQPEIRPARRNHEQHVERGTDHQQ
ELSL
>FECAFAII_02898 hypothetical protein
MAFYLPYLLIFVSISGSIWLIYKIFQTRYSLKGSKIRFKRFFFLGCIFSLIIVSSGLFGV
LEGNKRVSRSILLGNVTQKYESARDKKKKEQALAQKMEEFTTCYEEMNDIFVNQEKRLTD
KNMEKLTRLYQNLPEKQQKEVQDNYERTKKDVQYVKDTKIEEACSDLFGDTNPWFASEEE
KKEKQQSVTYERYEILLQQATNMQNPTKKETALNYLKSVKEWLDQQQQN
>FECAFAII_02899 hypothetical protein
MSNDIVRYNNGLNSVPLRKFTPIDMDLFWGICSKMKRKGTKEEIFTFKQIKELIDYNINA
RGDRFANDLIKMSKKIITLSFIYEDEKTYEQLNLFQKFKIDKVNETLLIKVSEEFEYILN
SIGTNFTRFELENMTNLKSSYVKELYRQLMAHKDRRSKKGHWFVKIEDFRALLAIPESYR
MRDIDKQIFAQAKKEFLNVNSTHPAIFKTFEIKKIKAYKGNKIGSLQIYFEENIPSITLD
NWLEK
>FECAFAII_02900 hypothetical protein
MQPKETFTIKELSELFEISRQAISKHVDKLDPSLLAKNERGYKVVLRSGVLQLASNLGNQ
RLLYRLHEYEQENDKNVYISSKNVIVNELLDKLREENEFLREQLSLKEQNNSNMQKLLDQ
QQQLTLQANQQIEKLQEQLQLAYTEETPEDESTTILSEETESIEKHTKKKKQKWWQLWK
>FECAFAII_02901 hypothetical protein
MTRKNLLFGSILLGILGFSPMLLSVINKGNKHGELKLNPNYYNSPNEELFVKETDK
>FECAFAII_02902 HTH-type transcriptional regulator ImmR
MEDLGSKLRELRVKKGYTQEYVARKFNVTRQTISKWENNKTTPDIETLKKICEFYSTNIN
SILNEDNSKNKKNNLLVLTAIIFNIFVTILGLFELIQMNFFSFTHGIFTWFALSGLIVID
ILNYFYIYYSYLKNEKFFYTMFFPLVILIILLS
>FECAFAII_02903 hypothetical protein
MKKFLCLSALMGVLLTSGGIASATEALNLDVPEDHTAIYGGGMEATEEGFSSSKLRYAAG
GGDFNCGVNGFKVYANYYHARAKHSATAKNGRGGQVRSVQKAGVRAYATCNATLTGNTGW
WNVY
>FECAFAII_02904 hypothetical protein
MLKKINAVLSLFVCITILFFSTNVINGIKTSEALYKNTAEIHMQYKDDMDFNSYINALYE
ISTQENINISQYSFTAVNQLTILATNPNANKHWKFSKKNILARNDSKVHYTNNKNSKYQL
KLPNNFLNINIYPFSHVENIGLSEILYVQGNSNKLIPVLKKYGTPTISNINQSDTFQINT
NIVLVICYLSIFIVITTIIFAFSKMKEITLKKMLGYNSFDTIKDSIKELNLLFCSLIITF
ILSIFLSIYYSNENFFLSFLLCSIFHFIISFLFIIVTLSIYHLSSIKNYLKNSRPLKLNL
CILNICLFLSMILLLIASTKVINTHNEAENNSLKYWERTTNLYKTNITNQLNRNNTVEEN
NYLKKASKFVYKIQKNYKTFIIAPYNYATIQENNKEFFIGQKVYPNFEDYVSQPAGAGIC
VDLNYLKYYNPISFEESTDLNLINSDPLTTYILVPKKYKEYAKMIEKNYLEDIQFRLEDS
PPQAPYKNPNLKNLKIKLIFVNNNQKYFSFNTLYGKAKDNYTITDPIVRVINPEITESLF
WGNILTSDGGLFFDQKHTSNQNFFNQINPYIKEFNLENIINFSYSVFQETGELLSQKKVN
KLNAYLQYLLILGLFIIINFQMIFVSFTINSKKIALKKIFGYSPISQVLDLCLLPFTIEL
FATMCFQLIFSKNTYLYFIIFMIFLINLITSIIIYKKNSFKYFKENIL
>FECAFAII_02905 Energy-coupling factor transporter ATP-binding protein EcfA2
MPKDILKEKIFLLSGGEQQRIALIRNMLKPFDILFADEPTGNLDKENSTFIMNFLKNLTE
KEKKAVVLVTHDLNVLNYGTNIIEL
>FECAFAII_02906 hypothetical protein
MILLKKEYEKFYDRLIYSLQLPKKLNRQLQKTYETKSTEEWESYC
>FECAFAII_02907 hypothetical protein
MSEQNQNLASNSSKKYTYRSEPKQISFRVSESEFAKLKQSAEALQMSVPAFVKAKAQNAR
LVTPKVAPDIAQAIARDLAKAGGNINQIAKWCNTHQHDVASGDAQRLSENLKIMQKELQK
IWQQLR
>FECAFAII_02908 hypothetical protein
MATIKVSRTTSCSRAINYAEPRATIKTGINCDVDYAKSEMKQIRMLYGKDDRVQAHLLIQ
SFRPGEITAEKANQLGAEYAKKIAPDHQTAIYTHTDKDHIHNHIVINSVNLETGKKFQAH
GQAFLNKCYDLNDEICLAHNLPITERGKKPEKRTMSEIKLKEKNEPVWKDEIRIAIDQTM
KNKKTRTYDQFCNSLKTLGIHCFNRGKNFTYELIHKKEKSTIQQTRKGLRKGDDFT
>FECAFAII_02909 hypothetical protein
MYRAIDADGLTLDIWLRKKRDTQAAYAFLKRLVKQFDEPKVVVTDKAPSITSAFKKLKEY
GFYQGTEHRTIKYLNNLIEQDHRPVKRRNKFYRSLRTASTTIKGMEAIRGLYKKTRKEGT
PLRVFGLY
>FECAFAII_02910 hypothetical protein
MITKTRKQGNSIMLTVPKDFNVPNGVEVEAKLVENGILYEFVEPQKEFYDFSEDILSDII
AEGYDKDEILVEFKNRKNKMHSSFRDIAEDTLTNSKVMTKEELATEIGL
>FECAFAII_02911 hypothetical protein
MAYEIVPSKHVIKYLKKLKEKTLKEKFLNLIYDEIAIDPYKGEQKTGDLSGIWSSGFKYA
GTTYRVAYEIIENKVIPVLLCGTHENFYEQLKKLI
>FECAFAII_02912 Sporulation initiation inhibitor protein Soj
MVAKKYVIGNFKGGVGKSTCAQMLGFESAVNEGKRTLIIDLDMQGNTSDVMNLTHMNFTN
EEGGGEGEPIVYENTVTDVLINNLPPKEAVYKVINNLYILPADMSFEMYDDWIKDQYNDS
LSQFKYMKEKLEPLFDEFDVIYLDVPPSISVYSKSAMYIADWAIVVLQTQVKSMRNAMQY
LEYMDFFVKEFDTNLYVAGVIPFMLESGDAVDQEMYKQAQEIYGEHLIKNVVLKNARLKR
YDGSGITMEKTKKGLLKQWDRKSHELFISILKELEEHENWYAEVE
>FECAFAII_02913 hypothetical protein
MADIKGLDIFGNNKGLAKIKKEAEAKKKQQAITPSENKQLEVHQVQEIKTSSNVERQSRG
RTKKVGAPIRKFDKVYSTKHPLKLSTLLNATSRVLVEKYETNMTRDELLRKALDEYIKQN
LTQEDKQDLFNDVVKELDLFREKYPIVPELDDRGEIIRTTSQIKQDTEDSLRKGWGMNNK
VR
>FECAFAII_02914 hypothetical protein
MMRKQSIEGRNQFAMLTIDDLVPKDHLVRKIDAAIQFDFIYPIVESTYSTHGRPSIDPVV
LIKLVFIQYLFGIRSMRQTIKDVETNVAYRWFLGYSFEDPIPHFSTFGKNYVRRFRETTL
FEDIFSHILEQAVKAGFVTEDNLYIDSTHIKANANKHKFTKEMTYGQAKAYQDELEDEIN
KERIAVGKRPFTWDTESELSLQKISHSDPESGYYVKGEREKQFAYSAHTSCEDNGFILST
LITPGNVHDSQVAIDLVKQSKRAFPNIKRVVADAGYKTPKFVHFLSHLKLYPILPYTVPH
GVKGMFRKKDFVYDAYFDCYLCPNNQPLLFSTITRDGYRTYKSNPKFCRSCPLLKNCTLS
TKHQKIVTRHVWADLMDELEHQRHTALNREIYKKRKQTIERIFADAKEKHGMRWTKYRGL
EKVATHTMLTFAAMNLKKLATWLWKAKKPMAFYLKFLQRLTKRSWQLSHSFLSTV
>FECAFAII_02915 hypothetical protein
MNHFKGKQFKKDVIIVAVGYYLRYNLSYREVQELLYDRGINVCHTTIYRWVQEYSKVLYY
LWKKKNRQSFYSWKMDETYIKIKGRWHYLYRAIDADGLTLDIWLRKKRDTQAAYAFLSG
>FECAFAII_02916 hypothetical protein
MKQFDEPKVVVTDKAPSITSAFKKLKEYGFYQGTEHRTIKYLNNLIEQDHRPVKRRNKFY
RSLRTASTTIKGMEAIRGLYKKTRKEGTLFGFSVCTEIKVLLGIPA
>FECAFAII_02917 Insertion sequence IS5376 putative ATP-binding protein
MDQAKSLETACKLLRLSHVLPTLVRKDLDYSFETKEDWLMYLLEKELACREELKTARLLK
QAKFPNKRTLEDYEWHDHICLPNATTKDELLSLSFIHQKENAVFVGTPGTGKTHLACGLG
QLAAKSGIDTRFWRVSDLVNELEHHWKNNTLEVFKHRFDKVKLIILDEMGYVPFTKEGAE
LLFQLISDWYERFCCKVLNKE
>FECAFAII_02918 hypothetical protein
MLTMTDINTIRNLRNNHDKSINHIAKELDVNWRTAKKYADDDLLPQPKARKKTGMMYTEK
WGGIVSLWLSEDAKLPKKKRRTAEAMTTALKADGFPGSYRTVCVFIQDWKATHYLETLED
QGFERLEHPPAEAQLDFGTMEVCHDGAFKDVKVLVMTFPFSNAGFAVVLPAENQECLLEG
MKELFSQSGGVPRKIRIDNMSTAVTQTKTKTEQAVLTDGFLRFSMHYGFETQVCNPRSGN
EKGSMENKVGYVRYNFFSSTPIMKDFASFNEALAVELSHDRERIHYEKHVIINDLWNTEK
TDLLALPDTDYPVFKEIEVKVNKYNEIKLDNERIHVPRVRNYSIIYGLLRFDSYQLISTD
GEIISEGLRPYMMKKRAIDWQAILPDWRRKSRAMHYSRYWKYLPERIKLFLSHPDWKEQE
KRLNQISGLLVTHDMLGIDTHFYDMFSASTTTDAYDIDWHQYDAFLSLTGEVID
>FECAFAII_02919 hypothetical protein
MELDTNNHSVFLLYYHLVLVTKYRRQVIDDEISDYAKTTFERISESYHITLVEWNHDKDH
VHIMFKAQPKTELTKFINAYKSASSRLIKRDFPRVKQFLWKEMFWSKSFCLLTTGGAPID
VIKKYIQNQGNNHK
>FECAFAII_02920 hypothetical protein
MEQLKAYKFRIYPTEEQEIFFAKSFGCVRKVYNLMLDDRKKAYEEVKNDSSKKMTFPTPA
KYKKEFPFLKEIDSLALANAQLNLDKAYKNFFRDKSVGFPRFKSKKNPVQSYTTNNQNGT
VALIDSKFIKVPKLKSLVRIKLHRQPKGIIKSATISRHSSGKYYISLLCKEEVRELPKSN
SAVGIDLGIIDFAILSTGQKFDNNKFTSKMEKKLKREQRKLSRRALLAKQKGINLFEARN
YQTQKRKVARLHEKVMNQRTDFLNKLSTEIIKNHDIICIEDLNTKGMLRNHKLAKSISDV
SWSSFVSKLQYKADWYGRKIIKVDKWFPSSQICSNCGHKDGKKSLEIREWTCPICHTHHD
RDINASINILTEGLRLHSMGLA
>FECAFAII_02921 Ribonuclease BN
MEIKVLFENSRINLNFKSGHGLSLLINYSGKKYLFDAGANKKLVYNATKMGETLNDLEAV
IISHGHSDHTGGLRYLKSGNAPIYTAEGVTLPHYLKILTTFLYVGIPKNEILKMHENLHT
IKTKTELAPSFHIIPLGKANSTTKNLYKKMDDKFVYDDFSDELLVVIEQEDGLIVFTGCS
HHGIIDMMEIALETFPTKPIKYLIGGFHMIGIPYINNLGLPEQEVMKIGNKLNDSRVEKI
LTCHCTGSKAFNILKTQLGNKLEAIKTGQHLEIS
>FECAFAII_02922 PTS system fructose-specific EIIA component
MATIILASHGEFAQGLKQTATMIIGDSVPIHALSAFRDEDESILVQIKKLLATIDIEETY
ILTDILGGSVNNDMLTIIKEYEGLQLITGMNLPLVISIATYNGKIGESELEKLIRESQQS
VIDCRKLLVEQLTGGDDL
>FECAFAII_02923 PTS system mannose-specific EIIAB component
MIKLVRIDHRLLHGQVVFSWSKSLNINRIIIANKEAANDEFKKMSLNLSKPTGIKLTIFS
VEQLLEKMPKIETLNENIMLIFGNTKEIRQFCEAYPKVQEINYGGIIKKEGSKQFSNAIF
LNESEQEDAKKLKALGIKQFIQQVPTSKKEDLNTML
>FECAFAII_02924 PTS system sorbose-specific EIIC component
MLVQSIGLGLIGVFCILDSRLLGRMNFERPLIVSTLVGLVLGDMEKGLIVGASLELMSLG
LVNIGAAAPPDMNMASIIATAFAILSNANAEAALTIAIPISVLGQILGILMRTILSNLTH
VADRFIEQGKFSQARRIHILYGSGLYALMYFIPIFLAIYFGTNLVSQIVDAIPEWLTNGL
TVASKILPAYGFALLLQTMLTKKMVPFLLLGFLITAYSGLGIIGIAAFACIVAFVMVQVQ
GKNSNGNQNEPDPLDDL
>FECAFAII_02925 PTS system mannose-specific EIID component
MKEKDQNAWKYRQFLWRSWAIQASWNYERQMNMGFMYGIAPILDNIYKNPEDEAMKKEAY
ERHMMYYNCTPQTSAFVLGLTASMEEQYYEDQENFNPESISAVKTSLMGPLSGVGDSFFQ
GTIRVLAFGLGINLAQQGSILGPILAMLISFVPSFLVTYYGGKIGYNMGNKYLSKLYQEG
LMDKVMYVCSIVGLMVIGSMIASMIGITTPIQMGKAFVLQDVLDSIMPQFLPLGLTFFMY
WLLQKKVKTGWMLAICLVGGIIFSLLGILQ
>FECAFAII_02926 Fructosamine deglycase FrlB
MNSKEIVKEIVAKKEVKSIVFVGCGASKADLYPAKYFLDQNAKQLRISHYTASEFNYATP
ASVDESTVVISASLGGTTPETVEANAVAKEKGATVISLTRSIDSPLTKDADYVIYHRFAE
NYAAKLEKTGYCLELAVELLHQVEGYDHYEAMQEGFATIYDLAQKSAESARKDAKKFAER
FKDEKVIYVMSSGATHEVAYSTSICLMMEMQWINSGTFHSGEFFHGPFEIVDKDVPFILL
MNDGKTRNIDARALTFLERFDTKTEVVDALDYGLSSHIAKEVLDYFNPFVITAVFRVYAE
ELSEAREHPLTKRRYMWKLTY
>FECAFAII_02927 Transcriptional regulatory protein DagR
MQRLNDYLYQLTLLLKSTPSDNYSARSISQALQLNRSTISSYLNEGVREGLFIKVKSYPV
LFLHRTALEELHITLNNSEIESIESLLTISQKPALDQVIGSKGSLKEAIDQIKTAVLYPG
KGLPLLLIGASGSGKTFLANKIYEYAVEEKVIHTSAPFIDYNCAQYVSNPELLSSALFGY
TKGAFTGASQEHTGLLEKADGGVLFLDEVHRLSGEGQEKLFTFMDTGEFSPMGDNSIRKK
ADVRLVFATTENIYTTFLPTFLRRLPVIVNLPRFQQRPSFERLSLIDEFFVSESKILAKE
LSVSDALIHFLMNSDFEGNVGNIKNIIKYACGNAYIHQKSQQTIQVKLLDMPLEYSYKFK
EQLNKPRKKRADRIYYPEETRQVQLERNNQLFVQFFDQLLTGFSEVIENNKDIKLFLEEM
VTKVTQVMDTLIFQEDYEKEQSLYAILNYHIRQSIDFMRESYGFEQDGNRVVALANYLYV
KDNQVIFENSLQEKKTKDQLNEFFANVLETPYWYAKKILSLLSECLDQPVYEEDIFFITL
YFYSLNVTNVKTGIKSIVLAHGYSTASSMANVANRMLNKNVFQAYDMPLDITLEKIEAKL
IQFLGDYRTDSGLILLVDMGSLNQLGGLLVNHLNGPLLIIDHINTPLLLEVGQQVLNNKS
ITEIGAEIETSLTFKKQLLLPKKKKKKAIITCCYTGIGSATQIQEILTKCLKDAVRELVI
IPYDYKKLLENKNFETPFQLYDVIMIVGTEDPKINQIPYIGLDRLINGEAIGEFVHYLEK
ELTIEVNDLQKELIFNFSISKIVENLTILDPDKVLSFVQKAIKELSKLLNFDFSNNQLFL
LYLHCSCMIERIVRKESVDEQEDIEEYMQANGEIMDKIHSAFFEIEREYTIEIPDLELRL
LSDIVQG
>FECAFAII_02928 2-deoxyglucose-6-phosphate phosphatase
MTMGVIFDMDGVLIDSETFYFERRMNFFQELEIDPGSNQIDDYVGKTEAAIWETLVPEDK
SLREELYPKYVDYRKTHPIDFAKDLRKEVKPLLDFLKKRDIPLALASSSPVVEIESMLIQ
CELTEYFSFVISGESLKQSKPHPEIYLKAKQQLDCDFFIAVEDSTIGIKSAKAANIYTVA
LKQPMQIDQSEADIQIESLQELEQIVLEKG
>FECAFAII_02929 Capsule synthesis positive regulator AcpA
MKNLQLKFIVDPSIVRWFRIINQFERNQLATKGELAKSNHVSERTIQTDVNKMKDYFSES
VQFVSTKSGYSFQKERPVLFLKQKEQLLENEILFELLGNVFYGELEDMTELIDRFHLSEA
TFRRYLKQIQPVLEEYGLELSLYPLDLKGEEANIRKFFKDFYYEGEMTPHTLVPPRDLHE
LVQATFYDKFEYFSIGTGTSPAEFYYSLYIAIERVRQGKTIAIPQGLIERVIASENFRLM
YSLKEAIQTNYQVALSEEEFCWLYLGFCCKVLNKE
>FECAFAII_02930 hypothetical protein
MDETYIKIKGKWHYLYRAIDADGLTLDIWLRKKRDTQAAYAFLKRLVKQFDEPKVVVTDK
APSITSAFKKLKEYGFYQGTEHRTIKYLNNLIEQDHRPVKRRNKFYRSLRTASTTIKGME
AIRGLYKKTRKEGTLFGFSVCTEIKVLLGIPA
>FECAFAII_02931 hypothetical protein
MSHFKGKQFQQDVIIVAVGYYLRYNLSYREVREILYDRGINVSHTTIYRWV
>FECAFAII_02932 HTH-type transcriptional repressor YvoA
MPKLINLLAYDLIDKIIAYIHEHHLTPGTKLPSERDLSEMFNVNRTTLRGALQKLVDNGT
LRAQTNSGYYLTAPKFEKNAHHFFTPIEDSLLSKQRLQLKATALSPKKAAALCPELNDFK
QQQPQAYLEYIDAEAISLMLLIPMETLKKSNFSDNPFQDFKSLAYTRSQEISLITDNDVA
ADLLGVDKEEVLLFVREEIRAGKELAAIALGYTISRRCNIQVNVATTLQSHS
>FECAFAII_02933 putative HTH-type transcriptional regulator YurK
MNTEELTNKLIQDIEQEKYKYAQAIPSERDFVQIYEMNRSAVKKAIQQLVNKEYLLKIHG
KGTFVKKNIHEHLQIKFHGLSELLEREGIQPSSLILASEIKPAGHIVGKALQLEPTEEVF
HLVRLRSGDGEPISIEDTYIPLNLIPDLQAFDFQIFSFYSTLAAYHYQIENIYQTISSSK
VRNKEARLLKTSLNRPVISLAITAVTTNEQAVEYTEVVVLPEFAAIYTKNVHQGKEMKIY
AQID
>FECAFAII_02934 Fructosamine deglycase FrlB
MLGFSEERFLSVLNGAVKNIETINQVADAISEKGFKNLYLVGSGGTYATISPLAYLLSTH
SELDYYHEIAAEVVCSQPKKINKDTVLITSSLTGTTQETVDVVKYANSQGATTIAFVGNA
ATPLGEIVDYAIENDADNDTLVEELQLQFFALGARLMKNNGEFPEYDEFIQTLQKMPEVL
LSVRQQNDQKALEFAEKHKNTEFHMFVGAGNTYGAAYEYAMCVLEEMQWIATKSIHAAEF
FHGTIEMTDKSMSFVLLKGEDQTRPLVDRVERFVNKYSDVVTVFDTADFELAGVPSAMRQ
YVAPMVMATALERVSAHFEKVRDHSLDIRRYYRTVEY
>FECAFAII_02935 PTS system fructose-specific EIIA component
MRKIVIATHSMMAKGLKDTLEFIIGPQKSLLAITAYIDSDYSINQEIEQLFSDLAPDDEL
IVTVDLLGGSVSNAFSEQIGKDNFYLISGVNLPLLLELCLSGEQDTKKLIQKAMNSGNEG
IVLVNELLEKTEEDDF
>FECAFAII_02936 putative phosphotransferase enzyme IIB component
MIKLLRVDERFVHGQVAFAWTNNLGANCIFVASNEIATNNLRKKTLKMAVPTGTKFVVKD
MTEAISVLNGEKIKKYQVFLIVGTVEDAYEITQHVPEIKEVNLGNLKKNENRKMITSSVY
LNEQELDLVKKMTENGITVQCQAVPTDKKINPLHD
>FECAFAII_02937 PTS system sorbose-specific EIIC component
MIQAILIALVAFLASIDEYTFGASMMGRPLFTAPFVGLILGDLESGIIIGATLESMFMGS
IMVGSATPPEVYASSVLGTAIAIQSGQGVGTAVALTLPLSIFLQMWRNFAYAMPITYFNN
KMDEALVNHDFKKAQKYHYVAQPLIVGVPSAILVFVATYFGVSTINAMIKLIPQVVLDSF
DVAAGVLSCVGLALLIKMMANKAMMPYLFLGFVGVMYLKMDVVGVAVVGLCLALLAVQKL
TFEEEEDL
>FECAFAII_02938 PTS system mannose-specific EIID component
MVKESVIGKKELRSIFWRSFFMQSSWSFDKMMAYGQMNGIERSLRKIYPNDDDYYTALQR
HTETFNITPHIAPFVMSLSVTMEEENAKNPEFDTDAINKIKTGLMGPLSGIGDSFFWGTF
RVIAAGIGISFAQQGNILGMILYFTLYTAIHFIFKWLATKYGYVLGTKFIDDTEDNHMID
KLSHGASILGLTVIGAMIGTMVTLNTSLKFTVGGAETSLQSIFDQIFPGLLPLGITFLCV
WLYSKGHKTITIILGIFVLCFLGTLGGIF
>FECAFAII_02939 hypothetical protein
MNHFKGKQFQQDVIIVAVGYYLRYNLSYREVQEILYDRGINVSHTTIYRWVQEYGKLLYQ
IWKKKNKKSFYSWKMDETYIKIKGKWPYLYRAIDADGLTLDIWLRKKRDTQAAYAFLKRL
VKQFDEPKVVVTDKAPSITSAFKKLKEYGFYQGTEHRTIKYLNNLIEQDHRPVKRRNKFY
RSLRTASTTIKGMEAIRGLYKKTRKEGTLFGFSVCTEIKVLLGIPA
>FECAFAII_02940 PTS system beta-glucoside-specific EIIBCA component
MNYKQTAEEVLQYIGGEENISHLEHCSTRLRFTLKDNSKVNMSQLEKVDGVMGVRQNVQC
QVIIGNDVVEVYDEVKALLGDNVSSTEEAPKQKQKLGSVLLDFIISIFQPLIPAIAGGGV
LKSLLLLASILGLISDQSQTYQILNLVGGAPLYFLPILVAMTTANKLKVNQLVAVSAVGA
LILPEMTAMLAEGATFLSFGLDNIAYASQVFPAILTVLFYAQLEKWFTKVSPKPIRIFFV
PMMSLLITVPIALLLLGPLGYNVGTAFSSIIVSLYNQFGWVATGVLAAVLPLMVVTGMHK
AMIPYAVSSMSELGAELLYLPASLAHNISEAGACFAVSIKTKDKKLKSTAVSAGISALFG
ITEPALYGVTILHKRVLYAVMFSSLIGGAFAGIVALQAFALVGPGIASITMFADKADPMN
LVWAFAVSGISFVVAFAAALVLYKDKEVVNEVETKMETAVVSDAVLSSPVNGKVISLSEV
KDTVFSSGMVGDGVAIIPEEGILVAPEDGEITMVFETKHAIGLKTANGAELLFHIGIDTV
QLEGKGFEAFVRSGEKVAKGQKLIAFDIDLIKEAGFDPTVICVVTNKDNYTIRSFNLEKL
VTNDSDLLAISPIA
>FECAFAII_02941 Aryl-phospho-beta-D-glucosidase BglH
MTNTTSFPKGFLWGGAIAANQVEGAWNVDGKGLSVADMATYKPNLDNKDFAAHMHVTLQS
IKEASEDKSDKWYPKRRGVDFYHHYKEDLALFAEMGFKTLRLSIAWTRLFPTGEELEPNE
KGVAFYENVFKEMQRLGIEPIVTLSHYEMPLALAVKYNGWVERRVIDDFVRFANVCFDRF
GKYVKYWLTFNEIDSIHRHPFTTAGIIQEKSAEGQEAQDIYQALHHQFVASALVTKDAHE
KIPGSQVGCMLTKLMTYPLTCAPEDVELTLKKNLENNFYADVQVKGEYPALIEKDLENRG
IQIKMEDEDREILKKHTVDFVSFSYYMSMAESADPNAERTPGNTVLGVKNPHLPSTDWGW
QIDPKGLKISLIELYDRYQVPLMIVENGMGAVDQVVDGKIHDPYRIDYFKAHFQQMKEAI
DEGVDLIAYTSWGPIDLVSAGTSQMSKRYGFIYVDADDEGNGTYNRLKKDSFNWYKEVIE
TNGASLFE
>FECAFAII_02942 Transcription antiterminator LicT
MISIKKVLNSSVVLVEENGKEMIALGKGIGFGQKAGDEISGDKVDKIFLPFEEKKSSQLL
ELVEEIPIEFFEITRTIVFEAEKGLDKKLNPGVYLTLTDHLHFAVERAQKGVNIANRLYW
EIKIYYPKEFQIGKYALTLLNEQYGIDLPKEEASNIAFHLINAQSEDPDSGAGFKYAKMI
GGIVNLVRYSLQKDIDTNSIHYARFITHVRFFVERYYSDALLDDGEEEFYNQMWILYPSA
MESAAKIKDYIEKVYHKTIPNDEVVYLGVHINRLMKHANG
>FECAFAII_02943 hypothetical protein
MSHTQLIKDTLNILDLNIYFEENCLTKEKYKGQICLIYKGTLLYKPEECSHCLCVVPSRI
IRWGTTTVRLLLNDVSEYRTYLELKKQRFKCKSCQRTFVADTSVAEKHCFISQKVRWSVI
ARLKENTSMTEIARQKNISTSSVYRVMKRFYRPLNPFKQTLPKVLCFDEFKSVRSVASAM
SFIMMDGQSHALLDIVENRRLPYLERYFSRFSLATREAVQLIVIDMYAPYVSLVKKLFPN
AQLIIDRFHIVQHIGRTFLNHRVKETTVRLKGNSHSQRGLGKKLKRYWKLLQKEEAKLNY
EKRVWRASFKDYLTESEIADRLLAACPNLRQGYQLYQDILYAVKKRDQSLFEDCLTRDIS
GLPETYTTTLRTFKKFLPQIQNALHYSYSNGPLECLNNHIKVLKRNVYGFRNFYNFKLRI
MIRHGKTFLTK
>FECAFAII_02944 PTS system beta-glucoside-specific EIIBCA component
MGYKELGKDILANVGGSENVSSLAHCATRLRFNLKDDSKADESAIRNLKGVVGVVNQGGQ
FQVIIGGDVKFVFAEIDKLGDFSASKESSSEANNKGIVSKVLDTIAGIFVPIVPALTGAG
MLKALLALLVMLEWMTPESQTYQFLNFIGDAAFYFLPVLLASSAAKKFGCNQYIAITLGA
ILLHPTFTAMIAGARETGESLALFGLPVTLANYGSSVIPIILAIWFMSYIEPIIDKLMPN
AVRIFMTPLLTLLIVAPITLIVIGPLGTFLGNGLGSLIEFVNTYASWLVPLLVGAFTPLL
VMTGMHYGLIPIGINMLATSGFDTVAGPGMMVSNIAQGGAALAVAFRTKQLSVKQLAVSS
GLSAFMGITEPALYGINMRFKKPLIASMVGGGAAGLFIGIMGVGRYAQVAPGILALPSFF
GEKGLSNFIYAAIGCAIAFVVGFIASFILGIDEETEEVKEDTSEIPVNIASDNRRL
>FECAFAII_02945 hypothetical protein
MTYTHLTSNKLAMIEAYYNNHQSVAKTAVLLNRSRQTIHKVYQFFKTGHNALDYFNQYKK
NKTRCGRRPIVLSDKQTEYIQKRVVQGWTPDVIVGRAEFSISCSMRTLYRMFKQGVFEVT
HLPMKGKRKANGHKETRGKQSFRRSLRDRGNDYSKFNQEFGHLEGDTIVGKKHKSAVITL
VERLSKVIITLQPEGRRAIDIENRLNQWMQSVPKHLFKSMTFR
>FECAFAII_02946 hypothetical protein
MTYKHLTIDELTMIESYYLQHNKPVEIANRMGRAIQTIYNVVNKFKQGKTALDYWHQYKE
NKKKCGRKVIQLPAHEVDYIKEKVTLGWTPDVIIGRKERLVSCGMITLYRLFSKGIFDID
TLPMKGKRKTNGHQEKRGKQQYQRSIHDRPDNYPDFNSEFGHLEGDTIVGIHHKSAVITL
VERLSKVIITIKPNGRKALDIETALNQWFSRFPKNFFKSITFDCGKEFSNWKAISNQHDI
DIYFADPGTPSQRPLNENSNGILRRNGLPKSMDFREVNQTFISSVSNQRNHIPRKSLNYR
TPIEIFLSYVQEAFYSSLI
>FECAFAII_02947 hypothetical protein
MTNHKRKNCVIPLAISMSLLIYTHVLSTFMSVIVIGFLFIGSLFSKRKEKKEMSDLILNM
IKAVGWTILLTAYVWYPMLQQVLHQKINRPFRTNLQERALNISDSLIGAVNNDLVTFTMG
TIGVVSLILPLFFLKKFTNKEKIIYFCAVTTWFLSTNLFPWEILQKTPIQIIQFPWRILG
FQVLFGSLILTIVFLKWKTSNKKSMWSLVGIVLIIFTVTAATEANYSHKIQSYKGRLVMT
KKDVTRYTSSRTGGLYDYAPLDALKYKDHLKKHEVKVGDRWRMHLIKHIIPK
>FECAFAII_02948 hypothetical protein
MENASHKAYNSKIVYTVEDADEQNITLPVFNYWGTVVKVNGKKSTIENDNGLVSIKGTGK
RTIVEVSSTYPTTMILSLLISSITFIFLFTRYLIRCCG
>FECAFAII_02949 hypothetical protein
MNDFTTEIVQTLVTKGDLNELFRSHLEKAINTLLRTELTAFLDYEKYDRTGFNSGNSRNG
SYFRSIKTEYGELTLEIPRDRNGEFKQQTLPAYKRTNDTLETTIIHLFEKGVTMSEIADL
IEKMYGHHYTPQTMSNMTKVLTEEVNAFKSRALNDKYVAIFMDATYIPLKRQTVSKEAIY
IAIGIREDGTKEVLSYAIAPTESTYVWNELLQDINSRGVQEVLLFITDGLKGMKDTIHQI
YPKAKYQHCCIHVSRNIAHKVRVKDRKEICDDFKAVYQANSKEEANTFLSGMIEKWKKNY
PKVTQSLIENQDLLTFYDFPPSIRRTIYSTNLIESFNKQIKRYSRRKEQFQNEESLERFL
VSIFDTYNQKFLNRSHKGFQQVTDTLVSMFTE
>FECAFAII_02950 hypothetical protein
MTYKHLTIDELTMIESYYLQHNKPVEIANRMGRAIQTIYNVVNKFKQGKTALDYWHQYKE
NKKKCGRKVIQLPAHEVDYIKEKVTLGWTPDVIIGRKERPVSCGMRTLYRLFSKGIFDID
TLPMKGKRKPNGHQEKRGKQQYQRSIHDRPDNYPDFNSEFGHLEGDTIVGIHHKSAVITL
VERLSKVIITIKPNGRKALDMRV
>FECAFAII_02951 hypothetical protein
MNDFTTEIVQTLVTKGDLNELFRSHLEKAINILLRTELTAFLDYEKYDRTGFNSGNSRNG
SYFRSIKTEYGELTLEIPRDRNGEFKQQTLPAYKRTNDTLETTIIHLFEKGVTMSEIADL
IEKMYGHHYTPQTMSNMTKVLTEEVNAFKSRALNDKYVAIFMDATYIPLKRQTVSKEAIY
IAIGIREDGTKEVLSYAIAPTESTYVWNELLQDINSRGVQEVLLFITDGLKGMKDTIHQI
YPKAKYQHCCIHVSRNIAHKVRVKDRKEICDDFKAVYQANSKEEANTFLSGMIEKWKKNY
PKVTQSLIENQDLLTFYDFPPSIRRTIYSTNLIESFNKQIKRYSRRKEQFQNEESLERFL
VSIFDTYNQKFLNRSHKGFQQVTDTLVSMFTE
>FECAFAII_02952 hypothetical protein
MHWLWVLIVGAIIGLIAGAITNKGGSMGWIANIVAGLVGSAIGQALLGSWGPQLAGMALI
PSIIGAIIVVAVVSFFLGRSRG
>FECAFAII_02953 Organic hydroperoxide resistance protein OhrB
MKKMYETAMINRGGRDGEVEAPNGSMHMKIDRPGIHSEGTNPEQLFAAGYASCFNGAVQH
MLEENNLESDSEVKARVSLFQLEDGGYQIGVVLEVSLPGLEKDQAEKIAEEAHAFCPYSK
ATRGNIDVEVTIVE
>FECAFAII_02954 hypothetical protein
MTQRVAIMILVLLVIGLLVYYVLKFKHWKQQRIHQDIEKKLKRYPIVQAAWEKAEAKQYN
IPGLTETRMVVPETGENEVCQWMTPQGLAFSQDFVFISAYCYDHQHHSIIHVLDRETGQP
IKLLILPKRPHVGGLVYDTKRELLWLTITGSATGRVAALRLIDILADTSEETGQPIAYWL
TTDLSEIPQASYLTQNNDQLVSGNFTLKGEGQLTFYLLPTIAEMKTAIRRKDKIQPTVTM
SRKTSDKIQGVAFYGHYLLASRSYGPYTSELLVSERDSPSRILKRIKFPPYLEQIVVVED
RLAVLFESGAAAYREKANPVLANVLLLDLATLLHANKRPKKIAATKK
>FECAFAII_02955 Type-1 restriction enzyme EcoKI specificity protein
MITVVHKERQEKSSSDVRLWVYLGSISTKIQYGYTDSAKKQGNVKFLRITDIQEGRVNWS
SVPYCDISNSKLIDLRLEENDILIARTGGTMGKSFLVKEISEESVFASYLIRIRLVEKLL
SEYVDCFLDSPLYWKLLEKISYGTGQPNVNGTNLSKLLIPLPPLEEQQRMTTKIEMIRRS
IRRINFE
>FECAFAII_02956 hypothetical protein
MNNNDRLLRLRYAIDLKDTDLIKAFELGGVPLTKEEAQAVLTKVQDKNKDNAENNVYEKT
INNQVFDAFLNGLILLARGPQKDKPIVDTPQKSKEIKYINNVLLKKLKIALSMTTDDILE
VFAEAEIYPSKGEIGAFLRKEGQRNFKPCGDKYMRNFLKGLGIYNRRKV
>FECAFAII_02957 hypothetical protein
MNDEYKNDEDKMLFEEIENRCRLNFELWGKMSLIQQKKYLANKSEFTLGHVEKLISDWIS
SRSEFTKIKQPIKFDMKKLLLNKSEIGNRDQYIRAKGQEIIDSLGEMRSYNYLYVTHRAD
GMVITVGKSSSNDIFLDGDLFYQLNTNHLSGTENIILRTEYGNEIFAKYDEILKNYLDWA
WIIPVESGDAKKLERLLGDELINKKVPILNYYSHRQ
>FECAFAII_02958 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIVAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYFAKRSTEGWTPDVIIGRAERTFSCSVSTLYRRFKTGEFNVL
HLPMQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEGDTIVGIHHKSAVITL
VERLSKAIIALKPEGRKAVDIENSINEWLQSVPKNLFKSITFDCGKEFSNWKSISNTNDI
DIYFADPGTPSQRGLNEHSNGLLRKDGLPKEMDFNQVNQGFISSVASKRNHIPRKSLNYQ
TPLEVFLSYVNGKFCLA
>FECAFAII_02959 hypothetical protein
MNGQTPQTPQTPVVEESTQQSQQTETTTEQVKLYGEVLTDPHEKAEMIRDLYEGNQGFNR
DILNSIPDQEIIDSFVGNATNAQLAQSTTNLLEKYPNLK
>FECAFAII_02960 Adenosine monophosphate-protein transferase NmFic
MVLENKLGITNQIALAKAEERISKQKAKHLYDSGKINEIEVGTFKGLATIHFYLFSDIYK
FAGEIRTVNLAKGNFRFAPLMYLETSLQYIDKMPQSTYKEIIEKYVEMNIAHPFREGNGR
SMRIWLDLMLKKELQKVIDWNLVDKEDYLSAMERSPINDLEISHLLSQALTEQIHDRQLF
MKGIDVSYFYEGYSEYTIDDL
>FECAFAII_02961 hypothetical protein
MRSSKYTEHYTDTFITFKEIMRTVSNIYHNCVPDKIKNRRNTDQLKQRDTVIIACVVWGI
INGYTSQRATYRAVCSVLFPNGDFPSRSRFTRLSSNLAYTIKIIRYFFIKKLTKGELVGI
IDSFPNPLCKPVRNRQAKLLNQIAKVGYNSTKKSYFYGLKIHMIVTKTGFPITYSITNPG
VHDVKVLETLSEEANLPNILGDKGYISHKIHEKLALKGITISVPPRKNMDKSEKLDHSLL
GKQRKTVETVFSSLEKLGCQNFNSRSVKGLESRFESILLAYSVLLSRAQRRFEGTLRYSL
GY
>FECAFAII_02962 Tyrosine recombinase XerD
MSYNVQPLRTNEEIQDFQFWLRRTSNPERDSFLFLFGINNGLRMSDIIGLKVGDIRGKSK
PIIVEHKTGKRKPIFIDNLREEILLYTEGKEENDWLFPSRQQGRHITRDRVYQIYADIAE
KLGRDDIGTHTLRKTFGYHYYKKTRDIATLMFIFNHSSQAITKRYIGITEDEIGASLRGF
KLGG
>FECAFAII_02963 hypothetical protein
MELDTNNHSVFLLYYHLVLVTKYRRQVIDDEISDYAKTTFERISESYHITLVEWNHDKDH
VHIMFKAQPKTELTKFINAYKSASSRLIKRDFPRVKQFLWKEMFWSKSFCLLTTGGAPID
VIKKYIQNQGNNHK
>FECAFAII_02964 hypothetical protein
MEQLKAYKFRIYPTEEQEIFFAKSFGCVRKVYNLMLDDRKKAYEEVKNDSSKKMTFPTPA
KYKKEFPFLKEIDSLALANAQLNLDKAYKNFFRDKSVGFPRFKSKKNPVQSYTTNNQNGT
VALIDSKFIKVPKLKSLVRIKLHRQPKGIIKSATISRHSSGKYYISLLCKEEVRELPKSN
SAVGIDLGIIDFAILSTGQKFDNNKFTSKMEKKLKREQRKLSRRALLAKQKGINLFEARN
YQTQKRKVARLHEKVMNQRTDFLNKLSTEIIKNHDIICIEDLNTKGMLRNHKLAKSISDV
SWSSFVSKLQYKADWYGRKIIKVDKWFPSSQICSNCGHKDGKKSLEIRKWTCPICHTHHD
RDINASINILTEGLRLHSMGLA
>FECAFAII_02965 hypothetical protein
MINSAYFHIKYLKKYEYEEVVLDYGLNRQSFLIYAINNGNLPSNKKNIIIETYAYLEGGS
KKLIKSCNIEYQLSVGEIKCVFEEDLELDLKKIFASIHDYIGLIYKIIEDDKQTELNMCY
FDREQDFFYYGGMGGGSIVPKINLVELDVNNYRELYVFNSLDFEIPMKQMKNIDIHILPS
ESCQIEYSIEYFYKVSFVKLS
>FECAFAII_02966 hypothetical protein
MTYTHLTPTELVMIEAYFNQSHSVSKVAHLVQRSRQTIYNVYRFLKSGGSAISYYEQYKK
NKRNCGRRPIVLPDGQQEYIQKKVAQGWTPDVLIGRAEFPIACSVRTLYRMFKDKTFDPH
DLPMKGKRKPNGHKEKRGKQAFRRSIQDRTTDYIQFNHEFGHLEGDTIVGGKHKSAVITL
VERLSKVIITLKPAGRQAIDIENRLNQWFQSVPKHLFKSITFDCGKEFSNWKKISNTNDI
SIYFADPGTPSQRGLNEHSNGLLRKDGLYKAMDFNKVSETFIQSVASKRNHIPRKSLHYR
TPLEVFLSYVGKDDLSSLI
>FECAFAII_02967 hypothetical protein
MNDCASAGENQIRGCSLSRAIGAITPQHSQHLIIFVKKSVAIPTNLIESFNKQIKRYSRR
KEQFQNEESLERFLVSIFDTYNQKFLNRSHKGFQQVTDTLVSMFTE
>FECAFAII_02968 hypothetical protein
MCKILNISRQTYYYQAKPIENESDLEEIVQEEFIRNRKAYGTRKLKKCLAKRGLQLSRRR
IGRIMKRRGLTSTYTIAHFKGQRTACNEAKTTNVLDRTFTQEQPLEAIVTDLTYVRVRKK
WHYICLILDLFNREIIGYSCGEKKDASLVKEAFGRIPYSLTDVKLFHTDRGKEFDSQTIH
EILNGFGITRSLSRKGCPYDNAVAESTHKSVKVEFVHQYQFETLAQLRLELFDYVHWWNY
LCLHGTLAYETPIQIRQQRLAKRILDNERGSDTSGEAA
>FECAFAII_02969 hypothetical protein
MSRRQRRTYSKEFKQQIVDLYLAGKPRAEIIREYELTPSSFDKWMKQAQSTGSFKERDNL
TPEQAELIALRKKNKQLEMENDILKQAALIFGRKDK
>FECAFAII_02970 hypothetical protein
MLLKVAIKCYCVKNKGGIIYEKIVPRGACLLLALCLSLSAVGCQKSNENNKIKEGQSISS
EEEGMSINANGKNETFKPSDYTLEAKKEYVYEYLGLKFKLSDKFRNYIADKKIAMLDDQS
PIDKELKYAILTFEKMTEEQKNAVIEKMGDGYKNWQNELERIGTIGIFEKNTSEEKNLKL
>FECAFAII_02971 Thiol-disulfide oxidoreductase ResA
MLSEKTDLENTEAFNKESVKDLRKLPTKDINGKDFTSKDFEKYDLTMVNVFATWCTACVK
EIPDLVEVQNEMKSKGVNIVGVVTDPVDDNGENKEAIEKSKLIHEKTKASYPFLMPDVEW
QHFF
>FECAFAII_02972 hypothetical protein
MCKILNISRQTYYYQAKPIENESDLEEIVQEEFIRNRKAYGTRKLKKCLAKRGLQLSRRR
IGRIMKRRGLTSTYTIAHFKGQRTACNEAKTANVLDRTFTQEQPLEAIVTDLTYVRVRKK
WHYICLILDLFNREIIGYSCGEKKDASLVKEAFGRIPYSLTDVKLFHTDRGKEFDNQTIH
EILNGFGITRSLSRKGCPYDNAVVESTYKSVKVEFVHQYQFETLAQLRLELFDYVHWWNY
LRLHGTLAYETPIQIRQQRLAKRILDNERGSDTSGEAA
>FECAFAII_02973 hypothetical protein
MPRRQRRTYSKEFKQQIVDLYLAGKPCAGIIREYELTPSSFDKWMKQAQSTGSFKERDNL
TPEQAELIALRKKNKQLEMENDILKQAALIFGRKDK
>FECAFAII_02974 Macrolide export ATP-binding/permease protein MacB
MIKNAIAYITRKKNRTLIIFIILTIVLSCLYSCLTIMKSSNEIEKALYESSNSSISITKK
DGKYFNVNQFKDIEKLKEIEEKIIQYDGLAKLKDAKVVSGEQRINREDLSDEFKNVVSLE
ATNNTKRNILFSSGVFTIKEGKNIEENDKNSIIVHEEFAKQNNLKLGDEVDLELLDIEKS
GKIKSHKFKIIGIFSGKKQETYTGLSSDFSENMVFVDYSTSQEILNNSENNEIANKILMY
SGSAESTDLALNKLKELKIDESKYFVEKDSNAFEESLESVSGIKYIIKVMTYSIMLGGMV
VLSLILILWLRERIYEIGIFLSIGTSKIQIIMQFIFELIFISIPSIISSLFLGNVLLKVI
VDGFINSEDSMISGGSLINNSSFMSNITTLGQSYLILISIIVLSVVFASSLMLIKKPKEI
LSKIS
>FECAFAII_02975 putative ABC transporter ATP-binding protein
MDILEIKNVAYSYANSKEKVLSGVNQKFELGKFYAIVGKSGTGKSTLLSLLAGLDKPQTG
KILFKNEDIQNKGYSNHRKNNISLVFQNYNLIDYLSPIENIRLVNKSADESILFELGLDK
KQIKRNVMKLSGGQQQRVAIARALVSDAPIILADEPTGNLDSVTAGEIINILKTLAKDRN
KCVIVVTHSKEVADSADIILELSGKKLKKVNKMNLEVE
>FECAFAII_02976 hypothetical protein
MIKNAFAYVTRKSLKSLIIILVILSMSTLSLISLSIKDATDRASKETFANITNSFSMEIN
RQVNPGTPRGGGNVKGEDIKKISQTDSIDSYVKRINSVADLVDYDIIETQETLANQSPER
AKNFKRTVMLTGVNDSTKETKFVSEAYKLVEGKHLENEDKNKILMHKDLAEKNNLKVGDK
IKIKSNLFDADNEKGADETVEVEIKGLFDGHNSGGVSAAQELYENTLITDIHTAAKVYGN
TEDTAVYQDATFFVKGDKNLDSVIKDLGKLDINWREYNLIKSSSNYPALQQSISGIYSIS
NKLFFGSLIFAGVVVSLLLFLWMNARKKEIAVLLSLGISKLEIFGQFLIEMVFISIPAFV
GSYFLAQYTADKLGNNILNKVTGDIAKQIAKQSASSQLGGGAEAEGFNKTLSSLDINVLP
KFMIYVVIFMSLVLLVSLIISSFNILRRNPKELLIDNN
>FECAFAII_02977 hypothetical protein
MARKKRNPDAEKLAESILNTYQPESVEDMQDVL
>FECAFAII_02978 hypothetical protein
MYKLNEIVPVQLGNEKSAPEKGKPAAAKLAMRIKRENGSEVLIYNGINNYILQAILKELL
SNAL
>FECAFAII_02979 hypothetical protein
METTDTLLQLLQEAHKTNQAQQQTIQNLTTEIQLLNEKVNYLTNKLFGRSKETLFEETNG
QLNLFSDEEISVSVPEAAATIIPVKGHQRVVGTKADKIKHLPITEKEHLLPLEEQFCEHC
GSQMKDIGRTKVREEIRFHQAMLDCLTHYQHTYCCKSCEKEGLSSFKKAIVPKPLISNSL
GSNSLVAETIRMKFGQKVPAYRQENYWKQTHGLDISRDNITNWHIKAVQNALDPLGERLR
VYLNQEEILHGDETSYRVIESAKTDTYYWQFCTGKDSQHPIVYYHHDESRAGDVPKTFLK
EFTGYLHCDGYSGYNAVESVRLVYCFAHVRRKFFEAIPKGKKNTDIPAAQAVKQLDKWFV
LEKKWKDFSPEKRLSCRQQELRPLFIAFYEWMATIDPVAKSKLDAAVQYACKLRSGFEPI
FEDGRLELTNNRAERNIKELVIGRKNWLHSTSLEGARTSGIILSVYKTAELNGLNPVKYL
EFLFDKIPNLPVLSAETLDQLLPWNKDVQQHFSRN
>FECAFAII_02980 hypothetical protein
MNDSIKKMLRLIEKDLMITEVSYETFQKKKTLIVDAVFSPAPHTCRNCGSTVVDGNGKVI
VVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKNCQVSLTTVIRTLKEFKSYLPKQSKRILPRVLMVDEFRSHASIED
KMSFICADGETGQLIDVLPTRKLPRLTSYFLGCTNPEEVKFLVTDMNAAYFQLTKRILPN
AKVVIDRFHIIKHMNQAFNELRIREMNELRKVGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLGFSTSLKEAYPYFHELVEAFRDKDPDLFFSLLAELP
ETLDDGFREKLQNLLTYEEGITNAMIYPYTNGKIEAKNTHIKTMKRVSYGFKSFENMRIR
IFLINQLIKVR
>FECAFAII_02981 hypothetical protein
MDEVEHLRLTDLNKSIYKKRKQTIERIFADAKEKHGMRWTKYRGLEKVATHTMLVFAAMN
LKKLATWLWKGKEPLFFCSKIRNEVDKKLFQARVTSLEQLLSTVCDVGDISFSIRNQLRF
KRSLPVSGNINVYFTKARFKRLIAITVSSIVMFLWLFRMGVIP
>FECAFAII_02982 hypothetical protein
MMSKNNTNGRNQFAMLTIDDLVPQDHLVRKIDAALDFEFIYPIVEATYSDLGRPSIDPVI
LIKLVFIQYLFGIRSMRQTIKEVDTNVAYRWFLGYSFEEKIPHFSTFGKNYVRRFRETTV
FEDIFAYILEQAVKAGFVTEDNLYLDSTHIKANANKHKFTKEMTHDEAKAYQDELEDEIN
RQRIEAGKRPFTLDLEKEVKLKERKISKADPESGYYVKGEREKQFAYSVHT
>FECAFAII_02983 4-hydroxyphenylacetate decarboxylase activating enzyme
MTAEEVMDEIEKDAVFYFHSDGGVTISGGEALVQADFAKEILQKSKYIGINTVLETSFCG
AYNEIQKVAPYVDTLFVDVKMFTSKLHKQWTGLDNQQILKNIRRFLIEYPNCEVRIRVPV
VPGINMNLTELLTIACFVADLDRFVPLELLPYHCYGMHGYQALGLEYPLADTPAPSPKEM
FALADQLARTVPHLLVTALTKTFIYLLNPSFILWINERHSLAAASSRIELLLKSVSVFLR
CFFEVNLSNEHWLNRYIFTVCRLSCDRCYDF
>FECAFAII_02984 Putative bifunctional phosphatase/peptidyl-prolyl cis-trans isomerase
MTTHLSARVIKEFVIQGGALDGSGDEAVSSYEGFFADEVHRGLYHFNGALALGDHGPHTN
GNQFFIVQNTKAQADLLM
>FECAFAII_02985 hypothetical protein
MLAAVPKQQLENFLVADSLQREKVQAYFAAFKDQPLEYLHAQFHLFYQVAAPDDYNDLRG
QLQLTFQADETAYTVLLGMARLGDQAKVEWRIFDI
>FECAFAII_02986 Histidinol-phosphatase
MQYYDQHLHTYFSFDSEEKFENYLAYQPEFFVSTDHFDLNNPSTGKDDIPDYPAYINKLD
SLKETYSTKFLRGIEIGVVPGQEERIVDYLAQHPYDLKLVSIHQNGRFDYMDDVVLTKDP
IQTTKEYFDQMLQVLTDFPEGDILTHFDYGLRRFTFTAEEFAEHFEAQLLTIFKKVVERE
LAMELNAKSFLKYGNEDLYRYAVPLYQSVGGKLFTLGSDAHVAEDYQLGFKKMSQLLADC
QVEKLLVIQGKERRLTPLPIL
>FECAFAII_02987 hypothetical protein
MKMNEKIRNMTIGLFCAATVSILLTGCGSGEATKQSAAADDSLDTIIEKAKEEGEIASLG
MPDTWANWVGTWNDLEKEYGLSHVDTDMSSAEELAKFESEGKNGTADIGDVGISFGPLAE
SKELTLPYKTNYWEEIPDWAKDDDGDWLLSYTGTISFITDKENVKQAPTSWKELQEGDYQ
VSVGDVTIANQAQFAVLAAAIANGGDEKDIQPGLNYYKKMAEKGRLSTVDASVANLEKGE
IDVAVVWDFNGLNYRDQIDSERFEVTVPTDGSIISGYTTLINKNAPHPNAAKLAREYILS
DEGQINLAKGYARPIRKVELPKEVAEKLLPEDAYEAAVPVEDNEAWNKTSVELPELWQAE
VLTYAK
>FECAFAII_02988 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MQSRLDKLIVVILDGCRYDTAVAQLGFMNHLVEHQQASLLKVKSELPSNSRPLYEVLMTG
VPAYENGIYSNYHAQRSKEWSLFELVKEAGGKTGAAAYHWYSELYNQAPYNRLVDRIQHQ
EERLIQHGIFYSEDTYPDSHLFADAHYLVNQYQPDFLVVHSMNIDDVGHKFTADSHEYAA
AVNQADRLLAIYLPEWLQKGYQVVVTADHGMDAHGLHGGSLAAHREVPFYLISNKRQKLK
EQTVPQLLAAPLFCWLLGIAPSEKMQDIQELMRG
>FECAFAII_02989 hypothetical protein
MKEMKKRLVLVPASFIFCAFLLLPLLFMVLCSLHSDLTNQWTLANYSDILSNKYYTQAFV
NSVLIAVSSSVIGLIGTFILCLCLMNLSTKLQEKITFVSNLAANFAGIPLAFSFIILLGN
VGVLKMILPFLADFNLYSWWGLTITYTYFQIPLGVLFLYPSMKEVKKEWLESAQLLGASS
AYAWFKVALPFLRPSIASTFVILFANGMGTYETAYALTSSNVNLLTIRIAALVSGDVFAK
PNLGSALAVALGVLLVTAMLIIQKKGKVVQT
>FECAFAII_02990 hypothetical protein
MKKLIKPILFCFVLYYLLPIIGTILYASSTKWSKSLLPSDFTLQWFQQLLTDREFIAAVG
RSLLLAGVVLVTILLLMIPTIIWIHLYFPRLNRWLEKLLLLPYALPGVILVTALLRTYAK
TGIPMFVVLVGALFITALPIVYLSLNNQMRLINLKELVDAAETLGAPMSTIIIQVLFPNI
RIGVTLVSLMIFSSVFGEYMLTNLLIGGRFQTVRIYMLRRMNENGHLASAVMVLYLLFMV
GIALTTFMLTYRQKQQLSLKQTREEKQSKKKPLKEL
>FECAFAII_02991 Spermidine/putrescine import ATP-binding protein PotA
MFLEIHDLNLFFDEKQILAIDEIQIEKGELVTLLGPSGCGKSTLLRCITGLEQPKSGEIV
LDNENIADKPTKDRNIGFVFQQYALFPTMTVFENVAFGLKVKKLSPEVIQEKVFEMLSLV
DMTEQADKNVQFLSGGQRQRVALARSLVTEPKVLLLDEPLSALDARIRKQLQRDLRAIQQ
SLGMTMIFVTHDQEEAMRISDRIFVMEAGRVAQVSTSKELYQNPQSRFVAEFIGNYNRFE
WYELNQYTHEFSAKGNRCIYYLRPELIQFEPVPQGVKIPVLWKESFILGNIQRYVFQTLE
GKEILVDRLNDREEKISDALYIQLKDILAIPVEIDTQHFAQQS
>FECAFAII_02992 hypothetical protein
MDNHTRKLLGLTDKHLFFDEEWLIEKEYKGVQAQFIKGKLDDSPSYCEHCRSVRIIRNGS
YTTRTQMLKVKEKLTILELKRTRFLCHDCGRTFSAKTDLVDEHHQLTKELKQAILMELYE
NQSRKLIAKKYFVSDGTVTRILREATKHYQSRMNFLPTVLCMDEFKSMKSVSGSMSFICV
DGTTNQLFTILEDRRLYKLTQYFLRFPRKARLKVKYLVMDMNASYCQLLKTVFPNAEIVT
DRFHIVQHINRSFNQLRVQIMNRFRTSHSENQKKYRRLKRYWKLLLKDSTTLEPLKRHYH
RLFKRPISQTEIVDELLSYNEELRTAYHFCQLLRYYFVKRGTEGFQETLKTISSTLPQSF
KKKFTIFHRYQSGISNAFKVSHSNGVTEGLNNKIKLIKRIAFGYRNFYNFRARIYLQQGL
IFEN
>FECAFAII_02993 putative response regulatory protein
MLRIAIVDDDCTIVEGIRHYLLKKVPDIIIDHCYTDGDEAFKNLQNQRFDLLITDITMGK
ISGLELIESLQQTSNRYFTSIVISAHQNFQYAKKGIDLSIKSYITKPIDFPYLVKLVQEE
KMRKSAANQNSLTDDSFNESIQQVIDYVQNNYSEKLTLKDVATQFHYHPAYLGRAFKKET
GYSFHDYLLDFRIKRASALLKDTFLSIDEISQKVGIDHVSYFSVLFKKTTGHSPSNYRKK
LL
>FECAFAII_02994 Sensor histidine kinase YpdA
MKNDLSKVIMRFTYILIFFITLLACFTLFFSYINVIEKEKNQNLQNIQQITHYMETYNRI
LSGIVTEIYQNYDFQENLNDYYLSSPAEYMEDILSKDRSPTYLVDNLKKLVQDDEVKNIS
ISLDYEKYLSAYAPTKNEKISFIRSLSFISEDMPDATLILDVSINALKKSLFPTHYNYSL
SNGIDSVNLSEDISPSKWKKTQQIAIGNHTLQVYENPNYSSQTLLGLAIMIFLLMSLFIL
AIHQLLNRSFRNYIQQYQEIITSLNHSSTGDYKSINIENKVGDLKEIAMHINQFYLDNAT
YQKTLYENNWLKQEAKYAALQYQIAPHFLFNNLEFIRMTAILNDDEEISDSIYLLSKLYR
NNTYQPDIIDLKEELINIDLSLQLHQRRYRHNFDYQLIDHIDQLMLPKLSLQPFVENYIK
HGFDSSKKENRLTVYATETTNHYVLKIVENGKGMDQDKLEHIQQKLNDDIPYSENIGISN
SFRRIKHLYPGDTRFVIESQLHVGTTITIKIQKGGNMHVENCNC
>FECAFAII_02995 putative multiple-sugar transport system permease YteP
MKLKKGLLGNLKKNRALFIMLLPGALWLFIFCYIPMFGVVIAFKDFRISSRGFFTSLFNS
PWVGWENFKYLFASQDAWIITRNTVVYNVVGILLSTFCTVSLAIILSQMANKRLLKKMQT
FMIFPNFLSWVVISYFVYAFLSTDKGLINILLSNFGVEPINWYSEPKYWPFIIVFTSLWK
GVGYGSIIYYASIMGIDTSYYEAALVDGASKWQQIRNVVLPHLRSIIVIMLILSVGSIFR
ADFGLFYQLPRNSGALYDVTNVLDTYVYRGLMNSGDIGMSTAAGLYQSSVGFVLILITNK
IVNKLDPSSALF
>FECAFAII_02996 L-arabinose transport system permease protein AraQ
MISKLKRQMYFSLPVERFFTILLILFTLSCIFPFIFVIVISLTDEKALQLNGYELLPAQW
STDAYQYLIQDGGQLLRSLGVTIMITVIGTLITVFMTGTYAYVLSRASFPYRKFFTFYLF
FTMLFAGGMVPSYLVMTKMLGLKNTIWALILPLAFSPYNVIILRTFFKKSIPESIIESAK
MDGCSEFRVFFQIVLPLAIPGVATIGLFSSLGYWNDWFNALLYIDTNKLIPLQYLLMKIQ
NSMEFLANNNDITLAQQQAIQNSLPQESTRMAMVVVATLPIAIVYPFFQKYFVQGLTIGG
VKE
>FECAFAII_02997 Lipoprotein LipO
MKKNMQKYLIGGVSVLTLGLLGACGSSNGEANNETGTTKVTWYQVGEEPKDFDEVMTKVN
EKLKEEINVELDMRLIPDGDYQQKLGVMINSGEEYDICFVNGTDYVNYGNKGAFISLNDH
LDKELKDYAAELNEGFIEGGAINGETYGLPVNNDIATTEYWTFNKDLVDQYQLDVENVEG
VETLAPVLEKFAEKNTDTNITPIGMTRTSVCIPYDNIIGGGVPLAVAFEGDTQTVVNTYE
TPEMMTYLKAMHEFYKKGYILKDAATVTTDPFRIDSKNWFLGRNSSGYQPLAQKKLEALA
GHGLILKPAGKAFKTTGFARVAMHAVSASSKHPEAALKLLNYVNTNQEVADLMVYGIEGK
HYDRNEDGSITLTNSDDYYQGAWALVNTYLVSKTSPITEESKKLEEESKKFQNEAPMSPI
LGFSFDASDFRTEIASVQNIVSQYEVLLSSGTVDPEQYVPELLEKLEKAGLDKIQASAQE
QYDEWRKSNK
>FECAFAII_02998 hypothetical protein
MNENKWTKGFNWVFQLLLLNFTYFILICLGFGILGFFPATIALIAGVVNRKKYGLQESVK
FMSKIYKKNFVRYNLYCWSATLLLAGNITTIWLCWQQSAPLFYLLSTLLSVITLFLVFAM
LNWVVIKSLGLWMMGDRLIDYLLFTATMLPTVVMQGLVLGIYFRILMILPVIFLFGGTAV
TVILISKLTERALAKLPCQIQSH
>FECAFAII_02999 hypothetical protein
MKLTDKQVANIAFIQQLEIPLTQKDEEQIDLIFTDTKANVRQIKITKNEQQRICLSYSHE
DLLYRGLFICLPRFLAQGGEMPYIEETSIIETSYSLDASRNGVMNKETLKKFISYLALMG
YNTLYIYTEDTYEVEDLPYFGYLRGAYTKEEVNEIVEFASGFGIEVVPSIQTLAHLTQFL
KWYAQQELMDDQNTLLIGEEKVYAAIEKMIIACKEMYQTERIHLGMDEAYQAGLGRYLSL
YGYCDRTTLMIQHMDRVLSIVDKYKMKPMIWSDFIYKLLDETGKDRYYNPDFKLKALAAK
GLPAGLTYVHWDYGSDEVSSYEKVIDNHLKFCDIDHYVLASGAHIWGRLAPNHGKTEAIV
SAAVKASKNKGVRSVMLTTWGDEGQETEHWHSLIGALKLADYVYSEEEWNDFEEIYDRLL
GTGSYQLMSELRYFDEVDTITNNNLQMASVSKLLLWQDPLVGIYDFHVAAHNKIATRTIG
TYYHELAQKLDMNKNWNPKQPILTTIRQRYILLAEILAQKAELGIYLQHCCLVEDLAGLM
ELANRCEALANRVNELASIHEIIWYQTYKTYGWEVLEQRYAALAHRLKTVARRIKNHLQG
QDALEELLEERLPFCQYQVPLEISGFNYRQSSVSGYN
>FECAFAII_03000 Evolved beta-galactosidase subunit alpha
MLSDYYQNLSVISVNTEPLRNYYIPYASKEEAKQELEREKTSQFIDLNGTWDFQYYPSVQ
QLPENFFQEAFTESYDRISVPGVWQTEGFDLPQYINVSYPIPFDPPYVPNDTPCGVYRRQ
FQIEQTDARFYLNLEGADSNCFVWINRNFVGYDQVSHSTSEFDVTKYLQVGVNEIQILVM
KWCDGTYFEDQDKWRMSGLFRPVYLLQRPTMHLTSYQLRTLTDPKKGSGTLMVSFQRFTP
IEVSLPISYELFHPDGRLIAKGECYSEQQINLDVEDCLFWTAETPKLYTLLLTCNGEYFK
EKVGFRALTIKNRKLLLNGTPIKLYGVNYHDVNQQGTPVMTREQLRADLLLMKKLNVNTV
RTAHYPKSPDFYELADEIGLYVINEADLECHGVVNLYDTEANYQLIANDPTFEKPIMDRV
IRSILPYQNRSSIIMWSMGNESGYGVNFEKAQALARKLDDSRLIHNERSIEPVIDQVNDF
SNLDVISQMYPPLEDVHRHCQRSDTEKPFFMCEYSHAMGNGPGDLKTYFDLIQQYDSFLG
GCVWEWTDHAINRGTLETPSYLYGGDFGEKYHDGNFCVDGLLTPDRQLTVGALEYRNIHS
PIQLIAVDEELQEVTLSNITAFTAGSAFNLSLEWYIDGKKTVYEVMNPFILEPGKSCSLP
ITVPTTIHGAHTVAVSLSVYKNDELYGQQQLFLKKEKMRLPRTAHHNDAPQISVKGTELI
IKGESFIYIYQLAKAAFTSVKINQKELLERPTQFSIWRAPTDNDRNLVNKWKAAGYAEMS
LEIRKKDWKFVDDHLLIETSYRGVIPGLQPIFTMHIQLKINGAGVINQKVSVEKNPIFPD
FPRFGMDWPLNDTFSKVSYCGYGPYESYPDKHYAAMFGIYEMEIEEFDQPYIKPQEYGNR
WQCDWVSIKNHQGSTMTVYGNSNFSALPYSQAQLTEKSHHYELIKENRTWFNLSYKQNGI
GSHSCGPYLEDRFRFMEDTFDWNIVITFKGENR
>FECAFAII_03001 O-GlcNAcase NagJ
MKETKINQVKKKLSRYQEVVYRNHCLKWSKNKLNVRFNGLFYRFEQLEEVWKPVTNFQSC
PVQLINDPKETYDLCITHLYNQHLKNDGFYLKVTNDNQLTIESANLRGFQYAMEALLESF
FSVGDQLLLPELILKHEPSVKIRGIIEGFYGIPWTHEMRLSLFSYMKDNQLNTFMYAPKD
DELLRKKWRELYDAQELDKFKELLSAAEASNIDFWYLISPGNDIDITCEEDIQVLLKKLE
QLIELGVFQFGLLMDDIDYQLKGAAKRRFREPAFAHAYLVNRVEEYLSTRLSNHELVICP
TEYDNRHGSRYLATLSQEIPEQLPFFWTGPSTLAASISTEELQEMASVYQRPMLIWDNIP
VNDYLEDKELLFMSPYENRTPNLSKERYQVTGVVSNPMAQLEASKFTINSMANYLWNCER
FDPLETWTSVVEKVVGSKLQPAYLTLTNAFPNHYTSSLLSDEELLLAKDPEWVTKEMAAL
VQAVKWIQQEQHTSRLRTELEPWLQAITESWTFWQEWQLKKDPKEAEEWLAKKKTHRIGR
DLVTAHLEQIIKS
>FECAFAII_03002 hypothetical protein
MVKRLISANYSDVKKMTSKELKQSIKASEGRVIVCETVANTLPQSGEITNAEVASAFGAD
LILLNGFDCYRPAVFGLPNVTIEKVFDLQQTIENPIPKLKELVGRPVGINLEPIAPKTNM
MSEKVEISQGRASSVETIQKAEELGVDFICFTGNPGTGVTNLEITKSVKMAKKYFSGLII
AGKMHSAGSEEPVVNKEAIISYAEAGADILLVPSVGSIPGFLEQDLIEAVRLAKKYDLLT
MSAIGTSQESARPETLRQLAIMNKSCGVDLQHIGDAGYGGLAPAENIFETSVAIRGMRHT
INCVSRSINR
>FECAFAII_03003 GMP synthase [glutamine-hydrolyzing]
MRRTERAAYRTKFYSNLSSPTRFDEEPKIIVLDYGSQYNQLITRRIREFGVFSELMSHRI
TAEEVKAMNPKGIILSGGPNSVYDEKAFGIDEKIFDLGIPVLGICYGMQLITYKLGGKVK
PAKNREYGKAELEITSAEAALFQNTPEKQTVWMSHGDLVTQAPTDFDVVATSKDCPIASI
QNAERKMYGIQFHAEVRHSEYGNDLLRHFTLDVCQCTGDWTMDNFIDMEIAKIREQVGDK
KVLLGLSGGVDSSVVGVLLQKAIGDQLTCIFVDHVLLRKGEAEQVMESLGGKFGLNIIKV
DAKERFLSKLAGVSDPEEKRKIIGNEFVYVFDDEATKLAGEEGVSFLAQGTLYTDVIESG
TETAQTIKSHHNVGGLPEDMQFKLIEPLNTLFKDEVRELGTQLGMPDSIVWRQPFPGPGL
GIRVLGELTEEKLEIVRESDAILREEIANAGLDRDIWQYFTVLPGIRSVGVMGDGRTYDY
TVGIRAVTSIDGMTADFARIPWEVLQKISVRIVNEVAHVNRIVYDITSKPPATVEWE
>FECAFAII_03004 hypothetical protein
MDNHTRKLLGLTDKHLFFDEEWLIEKEYKGVQAQFIKGRLDDSPSHCEHCGSIRIIRNGS
YTTRTQILKVKEKLTILELKRTRFLCYDCGQTFSAKTDLVDEHHQLTKELKQAILIELYE
NQSRKLIAKKYFVSDGTVTRILREATKHYQPRMNFLPTVLCMDEFKSMKSVSGSMSFICV
DGTTHQLFTILEDRRLYKLTQYFLHFPRKARLKVKYLVMDMNASYCQLLKTVFPNAEIVT
DRFHIVQHINRSFNQLRVQIMNRFRTSHSENQKKYRRLKRYWKLLLKDSTTWEPLKRHYH
RLFKRPISQTEIVDELLSYNEELRTAYHFCQLLRYYFVKRGTEGFQETLKTISSTLPQSF
KKKFTIFHRYQSGISNAFKVSHSNGVTEGLNNKIKLIKRIAFGYRNFYNFRARIYLQQGL
IFEN
>FECAFAII_03005 Transcriptional regulatory protein QseB
MKILTVEDDNMIREGISEYLSEFGYTVIQAKDGREALSKFNSDINLVILDIQIPFINGLE
VLKEIRKKSNLPILILTAFSDEEYKIDAFTNLVDGYVEKPFSLPVLKARIDSLIKKNYGH
LEKFEYKDLSVNFNSYTAKINGEEIDVNAKELEVLKCLLDNNGQVLTRMQIIDYVWKDSE
ETPYDRVIDVYIKELRKKLQLDCITTIRNVGYKLERK
>FECAFAII_03006 Heme sensor protein HssS
MKKLKIFPKMFIQIFSVLGIIIILVHSLIFFIFPKTYLETRKEKIHNMANEISSNMNGKE
IKYIEQTLEFYSKSSEIKVFIKEKNNKNEIQIKDNINVNLESDSNSLIIEEREIKLNDGK
KTNLQFVSTADMQKDAKDLSLKFLPYSLLISILFSAIISLIYAKSIKNNIQEIKIVTDKM
MKLDKKMSLKVSSNDEVGELKQQINDLYSTLLRTIDDLEFKNKEILKLEKLKYDFFKGAS
HELKTPLASLKIILENMKYNIGKYKERDIYINECIEIVDSLTKNISQILSVHSIENLNND
EEYLKINDTLEDILKKYEILANQKKITVNNYILDENVYIGKTALKIILSNLISNAVKYTD
VNGVINIGIVNDWLYIENSYGNNKISNMDKIFDVKFDLNKENSNGLGLYIVSNILNNYNI
EYKVLQDEEFFIFKIKIFS
>FECAFAII_03007 hypothetical protein
MNDFTTEIVQTLVTKGDLNELFRSHLEKAINTLLRTELTAFLDYEKYDRTGFNSGNSRNG
SYFRSIKTEYGELTLEIPRDRNGEFKQQTLPAYKRTNDTLETTIIHLFEKGVTMSEIADL
IEKMYGHHYTPQTMSNMTKVLTEEVNAFKSRALNDKYVAIFMDATYIPLKRQTVSKEAIY
IAIGIREDGTKEVLSYAIAPTESTYVWNELLQDINSRGVQEVLLFITDGLKGMKDTIHQI
YPKAKYQHCCIHVSRNIAHKVRVKDRKEICDDFKAVYQANSKEEANTFLSGMIEKWKKNY
PKVTQSLIENQDLLTFYDFPPSIRRTIYSTNLIESFNKQIKRYSRRKEQFQNEESLERFL
VSIFDTYNQKFLNRSHKGFQQVTDTLVSMFTE
>FECAFAII_03008 hypothetical protein
MKKIDLINMIGMLIGILVNIVIFTDWLGVLFSNLIPILIIGICGIILSILELFESRNTMN
RIFACIILIVNLLPMVYFTFLYFALG
>FECAFAII_03009 hypothetical protein
MEQLKAYKFRIYPTEEQEIFFAKSFGCVRKVYNLMLDDRKKAYEEVKNDSSKKMTFPTPA
KYKKEFPFLKEIDSLALANAQLNLDKAYKNFFRDKSVGFPRFKSKKNPVQSYTTNNQNGT
VALIDSKFIKVPKLKSLVRIKLHRQPKGIIKSATISRHSSGKYYISLLCKEEIIELPKTN
STIGIDLGIMDFAILSDGQKIDNNKFTSKMEKKLKREQRKLSRRALLAKNKGTNLFEAKN
YQKQKRKVARLHEKVMNQRTDFLNKLSTEMIKNHDIICIEDLNTKGMLRNHKLAKSISDV
SWSKFVTKLQYKADWYGRKIIKVDKWFPSSQICSECGHKDGKKSLEIREWTCPVCHTHHD
RDINASINILTEGLRLHSMGLA
>FECAFAII_03010 hypothetical protein
MELDTNNHSVFLLYYHLVLVTKYRRQVIDDEISDYAKTTFERISESYHITLVEWNHDKDH
VHIMFKAQPKTELTKFINAYKSASSRLIKRDFPRVKQFLWKEMFWSKSFCLLTTGGAPID
VIKKYIQNQGNNHK
>FECAFAII_03011 hypothetical protein
MNDSIKKMLRLIEKDLMITEVSYETFQKKKTLIVDAVFSPAPHTCRNCGSTVVDGNGKVI
VVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKNCQVSLTTVIRTLKEFKSYLPKQSKRILPRVLMVDEFRSHASIED
KMSFICADGETGQLIDVLPTRKLPRLTSYFLGCANPEEVKFLVTDMNAAYFQLTKRILPN
AKVVIDRFHIIKHMNQAFNELRIREMNELRKVGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLGFSTSLKEAYPYFHELVEAFRDKDPDLFFSLLAELP
ETLDDGFREKLQNLLTYEEGITNAMIYPYTNGKIEAKNTHIKTMKRVSYGFKSFENMRIR
IFLINQLIKVR
>FECAFAII_03012 hypothetical protein
MARKKRNPDAEKLAESILNAYQPESVDDMQDALKDVFGPLFEKMLQGELNNHLGYDAHSK
EPKEHDNRRNGYGTKTLKTSFGEVAIDVPRDREASFEPELIPKRKRDVSDIEGKVLSMYA
RGMSQ
>FECAFAII_03013 hypothetical protein
MISDITDAVLPELEEWQARPLAKCYAFLFVDCMYVTLRENYEAKEYAVHTILGYDLKGNK
EILGLWLNQTESKNRWMQVFDELKARGVEDVFFISMDGVSGLEEGAKAIFPSVIVQRCIV
HLVRNALRYIPSKDYKEVCRDMKKFYGASSLNAAHAAFDSFQNRWSHYSGAVDVWKRNFA
HVEQLFDYGSAIRKIMYTTNAVESVHSSFRKVTKKGAFSNENALLKLLYLRTKELHAKWS
GGRIQNWAMVLNQLMINETFSSRMKSMRFTFRNNGRFIQLCVRSKFI
>FECAFAII_03014 hypothetical protein
MNLLLSIAQLAKSTYYYWVKKLDKPDKYSKIKQEITAIVKESRNSYGYRRVTLALKMKGY
TINHKTVRKLMSQMGLTCQIRIKRYKSYKGTVGKIAKNVLKRNFSVDTPNKKWVTDVTEF
KIKGRKIYLSPILDLFNGEIISYSISTSPTYKLIEEMLQQAIKKKGTGGSLILHSDQGWQ
YQMPQYQKKLKENNIIQSMSRKGNCLDNSVIENFFGVLKSEFFYREKFRSIEIFQSKLNE
YIRWYNNKRIKLKLNGLSPVEYRKQSIK
>FECAFAII_03015 hypothetical protein
MRKYTFVFKKKVVSDYLNNEGGYKYLAHKYQINRTLVRHWVRIYNYHGWEGLVGGGKSYT
TKFKLDVIEYMETNGLSIQETAKKFNIGSNRTLSKWIEQYEEGGASSLESQKRGRKISMN
SKLNIPKKLKDESLEEEVIRLRAENAYLKKLETLIQEQDLSKKKSRLKQSFSSKKNLN
>FECAFAII_03016 hypothetical protein
MSKRTRRTFSQEFKQQIVNLYLAGKPRVEIIREYELTASAFDKWVKQSKTSGSFKEKDNL
TPEQKELLELRKRNQQLEMENDILKQAALIFGRRDK
>FECAFAII_03017 hypothetical protein
MCRILGLSRQSYYYQSKPKKDESELEEVVAEEFIRSRKAYGSRKIKKALSKRGIQISRRK
ISRIMKNRGLKSSYTVAYFKVHHSTCNEAKTTNVLNRKFLRDNPLEAIVTDLTYVRVGKK
WNYVCFILDLFNREILGYSCGEHKDVVLVKKAFSRIKQPLTEVEIFHTDRGKEFDNQAID
ELLTTFDINRSLSHKGCPFDNAVAESTYKSLKVEFVYQYTFETLQQLDLELFDYVNWWNH
LRLHGTLGYETPVGYRNQRLAQRILDNELGCANASEAV
>FECAFAII_03018 PTS system glucose-specific EIIA component
MFFNKKKEDIFAPVNGQIIKLENVNDPVFSSKAMGDGFGIEPEENHIYSPIIGKVISVFP
TKHAILLETKKGQSVLVHIGIDTVELNGQGIDVHVAEGQKVSEETLLATVDLPFILEQGK
QTTVIVAFEDIASIELINNNHVKVHEKLGDL
>FECAFAII_03019 Bifunctional alpha-galactosidase/sucrose kinase AgaSK
MRELIHYDSEKNTFTLSNNHVTYIMEIVENNYLVHRYWGKKVDSYHFSNRPILKKRSFAA
APTIEKPEISPEFLPLEISFPHQGDYRSAAVQIQQANGEEITRLCYKNYEIRNEAVELTD
LPHVRNTDEPAQTLIIFLYDQASKIELALYYTIFENSPMIVRSSSVKNDGIHSIKISKLL
SASIDTRYDQQFSTTFYGTHQKEFQLNRSEIQHGLFKIGSSRGASSPQYPPFIALSKDAN
EFQGEVHAMTVIYSGNHEITLERDQYNQIRMQIGINSETFSWRLEPGETFYSPQAILSYS
DEGFNGSSQNFHHFFSDHLIHPAWRNRERPILINSWEMTYYDVNDKLITDLIDAANDLGF
ETVVLDDGWYGKRNSSKTSLGDWQVDTDKFPNGIESLVDYAKQKNIGFGIWFEPEMISPN
SELIQKHPDWVMRSKKYEPLLSRSQYVLDLTKQEVQQFIIKTLSETITKLRVNYIKWDMN
RHISDPFSQDSTYEPSEYSHRYMLSLYNIINKLTNAFPDVLFENCSSGGGRLDPGMLYYF
PQTWISDNTDGLDRQQIQYGASHLFPVSSMTGHVSDVPNHQTNRSVSFETRAALASSTNM
GYEMDIIHLTEDEKESVRNHLKEYKRERTLIMEGEFYRLFSPFDGNICAWLFTNKEQILI
YVFRNTYKVFDLSLLVKIPTLDSNALYRDETTNQVYSGSELSNCGLALENTKGDFIVKRI
KLDKLETERV
>FECAFAII_03020 Arabinose operon regulatory protein
MYNKFMNNNLREYTDKFTDFSKKSISDFILYNSGIEYCEPNYSYGPKRRDYHFIHFVKEG
KGLLEIEDQKIEVHENQIFIVPANIVSTYTADKQSPWKYSWIGFTGIESVNFVQTLIQSS
PANFVMDCSDASFYEKRIEEIIELNQNTLASYFKINGIMYDIVGTLLGECEIKTVKNLET
SPSFQAMRYMELHYHDDIQISDIAYSVGIHPSYLSAMFKEEIGVSPKKYLTNLKINKAKK
LLTESDDPINLIAGSVGFADALSFSKFFRKELGLSPTEFRKDHN
>FECAFAII_03021 Sucrose-6-phosphate hydrolase
MENQHKNSFHIEPAKGLLNDPNGLIQFKGMYYFFHQWNRFETNHNYKEWGLFTSKDLVKW
ESQGSAILPDLEDDKGGIYSGSAIEKDGKMYLFYTGNSKKHGKRKSYQKIAYSEDGRTFI
KKDQVIETPIGYTEHHRDPKVWEKNGVWWMIVGAQTQANGGAITLFESSDLVNWQFNGEF
YSDEKLDQMCECPDVFSLSDDVDILMVCPQKRTSIEETDLSLSSYAGYLVGKIDYLQKKF
IEKEELRKLDHGFDFYAPQTFKDDKDRLIMTAWMSRMDDEEEANCPTLIDGYLHCLTMPR
ELKWKNNHLYQVPLEEYQVLRKDQQEFKNKSHLIKNQNSAYEMIIEFNESSSDFSLSLNS
EMNAINYSDGFLEISRINWVSGKSEAKRIELSSLFKLQIFNDTSAMEVFINDGEYVFSMR
TFSNNLKRDVYYQNLSHNGSVMFYNY
>FECAFAII_03022 PTS system trehalose-specific EIIBC component
MNNKDIAKKILELVGGNENVQSVTHCATRLRIITYDKDKIDIKAVEDIDKVKGSFFNSGQ
YQVILGTGLVNKVYEEFVPLIDGSGKDIAEEPAEKQKMTFQRAIRIFGDVFVPIIPVLVA
TGLFMGLRGLFTQEAVLGVVGLSPDDIPQQFLMITQILTDTAFAFLPALVAWSTFRIFGG
TPILGIVLGLMLVSSVLPNAYEVGQQAAEPLVFFGFIKVVGYQGSVLPAFVTGILGSKIE
IFLRKRIPDSLDLILTPFLTLLTGLILALFIIGPIFHEVEIGVLHAVEFLLNLPLGIGGL
IYGSFGQLLGIFGIHHILNFLEISMLAQDGWNYLNPIGTCGNIAQAGAVLAVAIKSVSPK
MKQIAYPSALSAALGITEPAVFGVTLRLIKPFIMSMIGGGVGGFLASLLHLRATGMALTG
IPGTLLYLNEQLPLYILVNLVAFAVSFGLTWMIGYKKDQEL
>FECAFAII_03023 hypothetical protein
MEQLKAYKFRIYPTEEQEIFFAKSFGCVRKVYNLMLDDRKKAYEEVKNDSSKKMTFPTPA
KYKKEFPFLKEIDSLALANAQLNLDKAYKNFFRDKSVGFPRFKSKKNPVQSYTTNNQNGT
VALIDSKFIKVPKLKSLVRIKLHRQPKGIIKSATISRHSSGKYYISLLCKEEVRELPKSN
SAVGIDLGIIDFAILSTGQKFDNNKFTSKMEKKLKREQRKLSRRALLAKQKGINLFEARN
YQTQKRKVARLHEKVMNQRTDFLNKLSTEIIKNHDIICIEDLNTKGMLRNHKLAKSISDV
SWSSFVSKLQYKADWYGRKIIKVDKWFPSSQICSNCGHKDGKKSLEIREWTCPICHTHHD
RDINASINILTEGLRLHSMGLA
>FECAFAII_03024 hypothetical protein
MELDTNNHSVFLLYYHLVLVTKYRRQVIDDEISDYAKTTFERISESYHITLVEWNHDKDH
VHIMFKAQPKTELTKFINAYKSASSRLIKRDFPRVKQFLWKEMFWSKSFCLLTTGGAPID
VIKKYIQNQGNNHK
>FECAFAII_03025 hypothetical protein
MMRKQSIEGRNQFAMLTIDDLVPKDHLVRKIDAAIQFDFIYPIVESTYSTHGRPSIDPVV
LIKLVFIQYLFGIRSMRQTIKDVETNVAYRWFLGYSFEDPIPHFSTFGKNYVRRFRETTL
FEDIFSHILEQAVKAGFVTEDNLYIDSTHIKANANKHKFTKEMTYGQAKAYQDELEDEIN
KERIAVGKRPFTWDTESELSLQKISHSDPESGYYVKGEREKQFAYSAHTSCEDNGFILST
LITPGNVHDSQVAIDLVKQSKRAFPNIKRVVADAGYKTPKFVHFLSHLKLYPILPYTVPH
GVKGMFRKKDFVYDAYFDCYLCPNNQPLLFSTITRDGYRTYKSNPKFCRSCPLLKNCTLS
TKHQKIVTRHVWADLMDELEHQRHTALNREIYKKRKQTIERIFADAKEKHGMRWTKYRGL
EKVATHTMLTFAAMNLKKLATWLWKAKKPMAFYLKFLQRLTKRSWQLSHSFLSTV
>FECAFAII_03026 hypothetical protein
MCRILGLSRQSYYYQSKPKKDESELEEVVAEEFIRSRKAYGSRKIKKALSKRGIQISRRK
ISRIMKNRGLKSSYTVAYFKVHHSTCNEAKTTNVLNRKFLRDNPLEAIVTDLTYVRVGKK
WNYVCFILDLFNREILGYSCGEHKDAVLVKKAFSRIKQPLTEVEIFHTDRGKEFDNQAID
ELLTTFDINRSLSHKGCPFDNAVAESTYKSLKVEFVYQYTFETLQQLDLELFDYVNWWNH
LRLHGTLGYETPVGYRNQKLAQRILDNELGCANASEAV
>FECAFAII_03027 HTH-type transcriptional repressor YvoA
MQNTFQSKSLYYQLVEILKQRIENSMVAHDKLPSERELTSFYGVSRTTVRLALQELEKMG
YIYRQHGKGTFVSELRTNATDLAGAYSFTEQMRAMGKHPETKILAFKKIEATKYLASHLN
VQLGEPLFQLDRLRLADDLPMMIEKSYLPVKLFMSLSQEILFLKPLYNLFSENFNQIVRL
ADEEFYASIVQKEDSELLNIPEGSPVLHLVRSTYNLENEVIEFTLSVARADKFHYKIRHL
RSTN
>FECAFAII_03028 Putative tagatose-6-phosphate ketose/aldose isomerase
MFMFSKEELRKLGAENTTREIRQQPELWHETFDRYQETVADLDRLFTDAKQHAGERPIRV
IFTGAGTSQYVGDTLIPFLTSQGNTNQFIFQSIGSTDIVATPKEYLIPDETTILVSFARS
GNSPESLAAVKMANQLVNKIYHIVITCAPDGLLATQMPTKKENLVLLMPNKANDAGFAMT
SSFSCMTLTALLIFDQASNQQKERYVHQLSRLGEEVIQRESEIQGYLASDFHRIIYLGSG
SLGGLTREAQLKVLELTAGKIATVFDTSLGFRHGPKSFVNEQTLVFLFVSNDSYTQKYDV
DMLEEIKNDGIAQRVVGIGQKGSLFSGDSFELVADSLLPDGYLALADIMVAQTIALLCSV
KVGNTPDTPSPSGTVNRVVKGVTIYPYEK
>FECAFAII_03029 Tagatose 1,6-diphosphate aldolase
MLEWSENKRQAMERLSTPEGIITALAIDQRGALKKMMSALGMEATKEKIEQFKTLISQEL
TPYASAILLDPEYGLPAAQKRAAASGLLLAYEKTGYDQTVPGRLPDLLSDCSVLRLKELG
ADAVKFLLYYDYEEAEEINRQKQVFVERIGSECMAEGLPFYLELLSYDAKNVDTKSLSYA
KAKPRKVIEMMKEFSKTQYKVDVLKVEVPVNMSFVEGNATGEIAYTRQEAAAYFKEQSDA
TDLPYIFLSAGVSAALFMETLRFAKHAGARFNGVLCGRATWKDAVAPFVEKGEAATLEWL
TEQGTQNIRQLNEVIRETAIPWYEKVSESTC
>FECAFAII_03030 hypothetical protein
MNKRLLDYSASDFLKAKPMELKQAILASEGRTIMAENVPSSCPYMGKSVTNAELERAAGA
DLILFNALDLFNPQISGVPLTLKENPIIWIKKALGRAIGVNLEPVDKEVLMSENRTEISS
GRIVSPETLKKANELGFNFICLTGNPGTGVSNRTIEKAITLSKSIFNGLIIAGKMHGAGV
DEPIMNLDIAKRFIKTGVDILLVPAPYTVPYFMESDLRGIVDYIKDFNRNKSIEEKVLVL
TANGTSQDSSDQETIKKIALASKACGADIQHIGDSLNGICLPENIFALGQAIRGYRHQII
MLGKSNYR
>FECAFAII_03031 Lichenan permease IIC component
MIDKVQKIAAKISNQRHLLALRDSMAAVMPLIIIGSFFMLLANFPIEGFTKWLSEIGVQS
FLNKASDSTFGIIGLAVTYSLGHNLAKTYGVDSLSAGLLSLSGYVLLTPLLDADGSIGFP
TKYFGTSGLFVGIIVALVSTEIFRWFVLKNITIKMPASVPPNVSRAFVAIIPGFFVVLLW
FIVVVICYKLGIENVHALIADTLAKPLSLLTKTLPGIILVILIQCFFWMFGIHGAQVTGP
IIEPLLLQNSDVNRIAYQAGKELPNIITYEFLYNFVFSGGAGCLFALAILTFFFSKSQEN
KTLGKLSIAPVSFQVAEPLLFGFPTILNIKMLIPFVTAPVVTTLITYFSMSMGLVAKPVG
ATIPWTTPPIIAGFLASGGRISGAVIQVITIAINVLIYYPFFKLDDNAKLKSEKND
>FECAFAII_03032 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIVAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYIEKRSTEGWTPDVIIGRAERTFSCSVSTLYRRFKTGEFNVL
HLPMQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEGDTIVGIHHKSAVITL
VERLSKAIIALKPEGRKAVDIENSINEWLQSVPKNLFKSITFDCGKEFSNWKSISNTNDI
DIYFADPGTPSQRGLNEHSNGLLRKDGLPKEMEFNQVNQGFISSVASKRNHIPRKSLNYQ
TPLEVFLSYVNGKFCLA
>FECAFAII_03033 Tyrosine recombinase XerS
MKNTEIYQKIDTIILHMPDYIKDFVQDREDKDQSPRTTLEYLKNYKLFYEWLLSESIVPD
TSITSIRQLTAYDLNLYKSHLKRRTKENVKKETTKTKLKDNNNLGLSTSTINRNITALKV
LFKYLSKSSNNPLGKPYLENNPMDQVATITDKTTLAARANAIEKKLFLDEDTQNYLDYIA
NEYKKTLSKRALIYYQRDVERDLAINALILGSGLRLSEVVNINLEDLSLEKNNVVVTRKG
NKRDAVNIAAFAMEYLANYLAIRKERYKVTENEKALFLAIYQGEAKRISGIAIERMVAKY
SKGFRVQVSPHKLRHTLATRLYQQTNSLVLTAQQLGHTSTNTTTLYTHIDNAATIDALNA
L
>FECAFAII_03034 hypothetical protein
MRTYKNKEELKKEINRTYTKYILEFETIPEELKDKRVEEVDRTPAENLAYQVGWTNLILK
WENDERNGLSVKTPSDQFKWNQLGELYKWFTNTYAHLPLKELEEILNRNIDDINMMIDSM
SDEDLFTAHKRKWADEATKTAVWEVYKFIHVNTVAPFGTFRTKIRKWKRLAL
>FECAFAII_03035 hypothetical protein
MCRILGLSRQSYYYQSKPKKDESELEEVVAEEFIRSRKAYGSRKIKKALSKRGIQISRRK
ISRIMKNRGLKSSYTVAYFKVHHSTCNEAKTTNVLNRKFLRDNPLEAIVTDLTYVRVGKK
WNYVCFILDLFNREILGYSCGEHKDAVLVKKAFSRIKQPLTEVEIFHTDRGKEFDNQAID
ELLTTFDINRSLSHKGCPFDNAVAESTYKSLKVEFVYQYTFETLQQLDLELFDYVNWWNH
LRLHGTLGYETPVGYRNQRLAQRILDNELGCANASEAV
>FECAFAII_03036 PTS system glucose-specific EIIA component
MFEIFKKKKQETFYAPCSGKIISITEVNDPVFSQKLLGDGFAVIPDGSKIYAPLAGRVTN
IFPTKHAINIKSNSGIDYLIHIGIDTVELQGEPFSICVQENDEVTPETSLVDVDFDKIIK
SGKDTSVIVVFPEKNQFNDLIIDNGRIAHGNSCGKITF
>FECAFAII_03037 hypothetical protein
MKLFVGIDVSSEKLDVCFLTDDNQLSILSEISVANDIEGASFIRETILEFNNSYHFDQIV
IGMESTSMYSFHPSMFFHEDEKLKKLNTLVTIENPFRVKQFSRMFDENKTDRNDALRIAD
FLRIQRFTTSPIKEEKYMALQRLTRTRYQLIKQLIRTKQHFLENLTYKCNTLAREMRDES
TSLFSATLISLMTEDFTLDELAELPLEAFCDLLQEKGKGRFKQPEKIAKAIQRAITMSYR
LGALAQESINVVLSVLVREIRALEKNIKELDKAIEQVIVVIPEYQCLTSIPGVGKVYAAG
LIAEIGQIERFEDQTKLAKYAGLSWKVNQSGNYQSQNTPLTKQGNRYFRYYLVEAANSVK
NYLPEYKAFYQSKYKEVPKHQHKRALVLTARKFTRLVDTLLRKHQLYTPPRSVIEK
>FECAFAII_03038 PTS system glucoside-specific EIICBA component
MFKKFSQLGRAFMLPIAILPVAGLLLGLGGALTNESAINAYPFLDQPWLHTILSIMSYAG
NAVFANLALIFAIGIAVGLANGDKGTAGLAGGVAYLVYTATISGFLELFSAKDATLDTGV
VGSIVVGGTVAFLHNRYRKIELPQFLGFFGGSRFIPIVSSLAAIIIGSFFYLIWPPIQNG
LVVAGEQIAQMGSLGTFLYGFLLRLTGAVGLHHTIYPLFWYTSLGGTETVAGSTIAGAQN
IFFAQLADPNHTGLFTYGTRFFAGRFATMMFGLPAACYAMYRAIPKKNRKKNGGLYFSGA
LTSFLTGITEPVEYMFLFVAPWLYVIHAFLDGLSFYFADILNIRVGNSFSGGLIDFLLFG
VLQGNDKTNWLKLIPFGIAWAFIYFFVFTFFIKKFKVAIPGMEEESEVHSEKVINKNTSL
HEESLIIIEALGGKENIESVEACATRLRVAVTNGEIIQKQTIKDTGATAVFEVKGGIQAV
FGGKADLLSQEINQILGKDN
>FECAFAII_03039 Putative N-acetylmannosamine-6-phosphate 2-epimerase
MDKKRFLDLISKGLIVSCQALPGEPFYKEEESLMPYFALAAQRAGAVGIRANSVRDIIEI
RKCVSLPMIGIIKRDYPPESPFITATMREVDELVETGVEVIALDCTLRNRHDGLSINSFI
TKIKEKYPHQLFMADISTFEEGKNAYKAGIDFVGTTLSGYTEESKKQDGPDIDLIKKLVE
EGICVIAEGRIHTPEQAKEIKKIGVAGIVVGGAITRPQEIASRFVKALS
>FECAFAII_03040 HTH-type transcriptional regulator RpiR
MSYIYLIKENYPFLTKSEKKVADFILNSGKTIIYSTMSDIKKNTKVGDATIIRFCQKIGF
SGFSDLKIEIAKEDFSQKKEHPTSVKYYDEIANSLTEALYSTIRLLDEEKLNEAIKMITQ
SKNIYIFGVGSSGNTSLDLENMFLRVGVQAKAVLDPHFQAQVASLLTVNDLVIIFSLSGK
TKDTYDSLKIAKKNGAKIIAITNYIHSPIGKSADLVLQTAIEEFLNGGSLAGKISQLYIC
DLLVHGYEQNNNIDSVELREKVLRSIIDKSIE
>FECAFAII_03041 Putative transposon Tn552 DNA-invertase bin3
MDHPLLNKFIKDLILQIFSMIDEQEPTESKRHRTQGIIKIAKRMFSIKGVLSYTVLIQKI
PNHLVYKNNVED
>FECAFAII_03042 hypothetical protein
MTSLHKNQVKFNSNITISHTGGQLSSDSGLVLVKELMNIFAFSELAKQHIHIEDERAYFT
HDNLSILEQFIMQLIAGYSADSAANLLRQDPVFKAVLDRKELASQSSLSRFLDRLSEENI
RELQALNQELIDKARLIRNDTELIIDLDSTHSDTFGHQEQTNYNTHYQTYGYHPLVAFDG
LTGDFLKAELRSGNQYTSKGVKEFLTPLLEHYNHSLPNTDILVRGDSGFATPGVYDSCES
KKSHYVIRLKNNRRLGQIAEKSVLYGDNQKWEEREVQYFSTTYQAQSWSQSRRVCIRSTR
EAGELLFRHEFIVTNLSENVSPDTIFSIYAKRGTMENFIKEAKAGFYFDKTDSPRFLENH
VRMMLSLIAYNLVNFLRTIGFEEVQKGMTIHSIRLKFLKVAGKLVQTGRRVYLKLSSYHV
YQNEFYRVFARLRRASQWI
>FECAFAII_03043 hypothetical protein
MSSWRSFKNPLLRGSECRPLLGGLKIHPSSRVYGLLIDLILTGVRNLCPERVMKFWQFTA
IQELAQATKITKHKFKH
>FECAFAII_03044 hypothetical protein
MSNDDKSLAYTRWNCKYHIIFTPKYQRKVIYGQLRKDLGKILRKLCEMKDVEIIEAHAML
DHIHMLVRVPPKICISSFMGYLKGRSAVLIHEQHANLKYKYGNKSFWSKRYYVSTVGLNQ
KTNEKYIREQEADDRIRYIISKREYVEPFKK
>FECAFAII_03045 hypothetical protein
MAKYTFELKLKIVHDYLDGKGGSDYLAKKYSIKAPSQVKRWINAYQEFGEEGLVRKRQKK
KYSVQFKLDAIELYLTSELSYREVANTLNMNNPNLIASWMRQFREGGIDGLSKTKGCPPI
LSKKNEPKNKKKSTTKATSKERERIEELEKRVRSLQIENAFLKELRKLRKQEAQQRRMKQ
SHESSQASEDRLN
>FECAFAII_03046 hypothetical protein
MYWQKRLDRKNPDQEIEAEMLKVREKHKDYGCLRMTNELRNRGFSINKKKVQRLIKKLGI
KVTTYTRKSRRYNSYRGQVGAVAKNRIHRRFYTSICHQKITTDTTEFKYHEVDAKGIIRQ
KKLYLDPFMDMFNSEILSYRISEKPNALAVMEGLEEAIQTTNDCPYRRTFHSDQGWAYQM
KAYRNKLKEYKIFQSMSRKGNCLDNSLMENFFGLLKQEIFHGKVYNCFEELKSAIDSYIY
YYNNERIKQKLNWQSPVQFRKTTVTVV
>FECAFAII_03047 HTH-type transcriptional regulator DegA
MVAKLTDVAELAGVSPTTVSRVINNKGYLSEKTKQKVHEAMKTLGYKPNNLARGLQGKSP
QLIGLIFPNISNIFYSELIEYLEIELFKHGYKTIICNSQNDPAKEREYIEMLEANQVDGI
ISSSHNLGIADYERVRAPIVAFDRNLAPNVSIVSSDNFEGGKLAAKTLQKNGCQNTIMIT
GNDNTDSPTELRALGFSFQNPNGKIFKIPNNLSTIRREMEIKSTIINHKPDGIFVSDDLT
AILTMKIAHQLKLNIPEDLKIIGYDGTSFIEKFFPQLTTIRQPIDEIASLIVDILLKKIK
GEKTNKDYILPISILSGGSI
>FECAFAII_03048 Sucrose-6-phosphate hydrolase
MNLPREIRYRAYSDWTKDEMDKIKDNVKRSPWRASYHIEPKTGLLNDPNGFSFFNGKYTL
FYQNWPFGAAHGLKEWVHNESDDLVHFHVTGAELLPDTKRDSHGAYSGSAYEIEGNLFLL
YTGNVRNENWERDTLQIGAWMDKDYNITKGENVLIHKPADVTDHFRDPQMFNYEGQLYAI
VGAQNLEKSGFIKLYKADDNNVETWEEVGNLDFGGTGSEYMIECPNLVFVDKKPVLIYCP
QGLDKSELNYGNIYPNTFKICQSLDIEKVKLVGASEIQNLDYGFEAYATQGFNTPDGRAL
IVSWIGLPDIDYPTDKYDYQGAMSLVKELSIKDGKLYQYPVEAITSLRASSEQFTAKAET
NNTYELELTFPPNQKSELLLFSDSKGNGLSLIVDTKEGKIILDRSKAGIQYATDFGTIRE
CSIDTKETTANIFVDNSIIEIFINKGEKVFTSRVFPENHQNGIQIKSGEPTGKYFELKY
>FECAFAII_03049 PTS system trehalose-specific EIIBC component
MNYSKVASDVIQAVGKDNLIAAAHCATRLRLVLKDDTKVNQKALDENPDVKGTFKIDGQY
QVIIGAGDVNFVYDELIKKTGLSEISTDDLKQIASKDKKFNPIMALIKLLSDIFVPIIPA
LVAGGLLMALQNFLTAAGLFGPKSIEEMYPAIEGISSMIQLMSAAPFMFLPILVGISAAK
RFGANQFLGAAIGMIMTTPDLGGSTEYWNIFGYHVSQTNYAYQVIPVLAAVWILSILEKF
FHKKLPSSIDFTFTPLLSVMITGFLTFTVIGPVMLLLSNGITDIIVWLYNTTGFIGMGIF
GGTYSLIVMTGLHQSFPAIETQLLSAWTNGIGHGDFIFVVASMANVAQGAATFAIWFLTK
NSKTKSLASSAGVSALLGITEPALFGVNLKYRFPFFCALIGSGIATAVAGLLKVVAVSLG
SAGFLGFLSINATSIPFYVLCELISFVVAFAITYFYGKTKAAGIFKAEEIAEQTPVNSSK
VATTDPISTDVESTQTKVSSETIVSPISGKVISLSSVNDPVFSSEAMGKGIAIKPNGNTV
HSPVDGTIQLTFETGHAYGIKSNNGAEVLIHIGIDTVSMGGKGFTQKVTTNQKVRKGDIL
GAFDRSMIEKEGLDDTTMIIVTNTSDYSEVNIVAENTVTEGTDLLEIK
>FECAFAII_03050 hypothetical protein
MTQVHFTLKSEEIQSIIEYSVKDDVSKNILTTVFNQLMENQRTEYIQAKEYERTENRQSQ
RNGYYERSFTTRVGTLELKVPRTRDGHFSPTVFERYQRNEKALMASMLEMYVSGVSTRKV
SKIVEELCGKSVSKSFVSSLTEQLEPMVNEWQNRLLSEKNYPYLMTDVLYIKVREENRVL
SKSCHIAIGITKDGDREIIGFMIQSGESEETWTTFFEYLKERGLQGTELVISDAHKGLVS
AIRKSFTNVSWQRCQVHFLRNIFTTIPKKNSKSFREAVKGIFKFTDINLAREAKNRLIHD
YIDQPKYSKACASLDDGFEDAFQYTVQGNSHNRLKSTNLIERLNQEVRRREKIIRIFPNQ
TSANRLIGAVLMDLHDEWIYSSRKYINFDK
>FECAFAII_03051 Putative fructokinase
MLYGAIEAGGTKFVCAIGDEEMTIKERVSFPTTTPEETMPLVIDFFKQYQADLAGIGIGS
FGPIDIHRDSATYGYITSTPKLAWQNFDFIGTMKKEFPIPISWTTDVNAAAYGEYVFGSG
KGLSSVVYYTIGTGVGGGALQEGRFIEGFSHPEMGHMLVVPHPKDDFAGSCPFHGNCLEG
MAAGPAIEKRLGKKGQEVAEDDPYWEIEASYIAQCAYNTTLMFSPDVIIFGGGVMKQRHM
LQNVHDAFAKLVNGYVETPELSKYIVTPALEDNAGTLGCLALAREAVLHS
>FECAFAII_03052 hypothetical protein
MNHFKGKQFQQDVIIVAVGYYLRYNLSYREVQEILYDRGINVSHTTIYRWVQEYGKLLYQ
IWKKKNKKSFYSWKMALFVSSHRCRWFNLGYLVT
>FECAFAII_03053 hypothetical protein
MYRAIDADGLTLDIWLRKKRETQAAYAFLKRLVKQFDEPKVVVTDKAPSITSAFKKLKEY
GGFYQGTEHRTIKYLNNLIEQDHRPVKRRNKFYRSLRTASTTIKGMEAIRGLYKKTRKEG
TLFGFSVCTEIKVLLGIPA
>FECAFAII_03054 hypothetical protein
MSTLYIIGNGFDLSHGLKTRYTDFSKWVEKSHSEIFDKIDTMINENNEVRSTADDKIGWF
NFESSLHELIQSPVFEDYVEESKDYLIGYGHEDWSDSAHHDFQNMVYDYVVSLEELQQLF
KEWIRKEIQPTIEHKIPKYQFSSDVLFFTFNYTDVLEILYKQPKENIYHIHGSYDDIIIG
HSENFDNFIGDPVLLQSFK
>FECAFAII_03055 Tyrosine recombinase XerD
MKTVEPIRDKKKIDAMKAILASGKYGQRNLVLFSIGINTAYRISDLRQLKLADVLEISRG
RVVVKDRLAMKEQKTAKHNSVYISNKLRKTILEYVQQEFPDQLLQQDFDGYLFPSRKGTN
EPLNRQSLWRIIHDAGTAIGLKDIGPHSMRKTFGYFLYKQGTKTEIIQSLLNHSSQRETL
RYIGITQEDKDTAVKSLDL
>FECAFAII_03056 hypothetical protein
MNKKDIVPVQFSSAAQKSQIDTKPKLACRIKSEDKEIFIYNGMDKYLLYTLLKELNANAH
>FECAFAII_03057 hypothetical protein
MLIDATALKHIFIVCGKTDLRKGIDGLAAFVIEEYDLDVYDQALFLFCGTKKDRFKALY
>FECAFAII_03058 hypothetical protein
MTKMESELLVQIKQLTQLLEIQQQENTLLREQIAEMNRRLFGRKKETPPVDGQIDLLDDS
TFNEPEHTGQESQEPITVSSFKRRKRKGLKALSLEGLPEVPIHYELKGADCLCEDCGHTL
HDIGATRLREEPLYVPAHIEKQVIYQHAYHCRECEALGETKIKKAPVPKPLINNSLGSSS
IVTQSIWEKFVKKVPAYRQEKEWHALGFPLDRKKITNWHIKVSEMVLEPIYNCLHQELSN
QEVLHADETSYRVLNTHKEKTFYWLYASGKSEEKQVVLYEHANSRSVDEPKSFLESFSGF
LHTDGYAAYGKLPVNNVYCWAHVRRKFFEALGKQPSPKSHAKIGLDFCDKMFRIERTFNK
LSAEERFVARKETLQPVMTEFFHWCESFAYLPKSQLGKAVQYAVNHKDGLQIVLLDGRLE
LSNNRAERAIKELVIGRKNWLFSKSLKGARSNGIILSIIQTAVANGLNIRKYLNHLFTEI
PNLSSMTPEALRAYLPWNQQIQEICK
>FECAFAII_03059 3-hexulose-6-phosphate isomerase
MTNKDQNKNYLEAIILELQNNSKRINSVELEQFSEKIVQAKHIFLAGAGRSGIAMQAFTN
RLMHLGFSVSLVGEISSPHSQPGDLLIICSGSGETGSLKNLAAKANQSGVSIALVTMKKD
SSIGQLADSVLVLPGITKDENQREEDTFSQPMGSSFEQLAFLTFDSLVLSLMDKTGESSE
TMFARHADFE
>FECAFAII_03060 Ribulose-phosphate 3-epimerase
MTIAPSLLNAPIAEVKELFEILKEKNVDYLHIDVMDGCFVPDMAFGPSVIKDIRPLTDVV
FDVHLMIDTPEKIVTRFVEAGADIVTFHIEATKHAMKVIQLVKEAGAKVGITFNPATPVS
FIEPVLSLVDQVLVMTINPGTENKHFIQETVVKIEQLDVIRKQNDYTYDIEVDGKIDNQT
IKVCSKAGADIFVSGGFIFNGKNTPQEQIDKLNQSLEEVK
>FECAFAII_03061 hypothetical protein
MRFHHDTLTIETVSGRPSYHDIRKELLDTVDTAGIENGMLVISSPHTTCSLFFEETMHDT
NFFGDDYLHVDINNVMETIIPKMTSENQYNSPGPKHIDFGTRLSDPNYPAEKWVMLNTDA
HLRSSIYGTNSMTLIVQEGKLLLGEMGRVYFVDWDQLRERTRTINLMIMGE
>FECAFAII_03062 hypothetical protein
MKKLLVICGAGHATSTIAVAKLSKWLEEEGLTDQVKIYQSKIADELNKIDEYDAVVSTTI
VPDVIKAKVTNGLGLLTGIGTDAIYADVKERLGV
>FECAFAII_03063 PTS system galactitol-specific EIIC component
MDIVLNAFEWFIGLGSNVFLPLIIFVIGILFGLKPGKAFVSGVTVGIGSIGLGLVLSLLS
DGLGTAIQQMGEQYGGGLNILDIGVGVGGPLAYSTSLGILMIPISLILNFIFVVLGWTKT
LNVDIWNFWFAIFLGMITQSVTGNFWFGLIGAIVAVILQWFLADRTQKTVSEFFGYPGIS
ITHMMGLSGVLFAKPVNWVFDRIPGFNKIDADAETLTKRFGVLGDTVVIGLIIGIVVGIM
AGYDVAGIGNLGIMTAAVMKIMPKMVAMFMEGLMPIAEAAKEFTNKKLNGRQVNIGMDAA
LTVGHPTIMSTSLLLVPISLLLALILPGNKVLPFGDLAFFAFAICLMIPYFKGNIVRSLV
GCSLYVVTTLYMATWLAPIITDVFTLASFDVGTAGLVTMLLCGLWPVGLFVLLASYFGVI
GIGGLGVVLVGASIYMNKVKKA
>FECAFAII_03064 PTS system galactitol-specific EIIA component
MYLDKELCLFQLEVKDQKELFQVMSEQLKNAGCVKDSFLEGITNREQEFPTGLEVNQIGF
AIPHTDSAHVNSSQICFASLKEPLVFSDMTDKSHEIPVRLVFMLAMSQPHEQIDTLQNLV
SLFQNEEKVNELLACTTKEAFIELVHSAGVY
>FECAFAII_03065 Transcriptional regulator ManR
MIERHVNLLKLLSRQEDFKPASFFSDKLAVSTKTIYQDIELLEDYVVNYQVTIERLPSLG
IKLIGDRKNVEHLISSVENYLEKDIYSPEKRRVEIIKEVLFGDKPVSLTHLSQSFMVSKT
SLYNDLRIINKIIGSGEVKLQSSAEGISFTGNEQAIQRAIKQLVFYYANDMESKTFFQVL
NMLFDSKVISVIHDLLFNDYSELTEKVSDYYVRSLISTLVIQCNRLLKGHHLTVEEEFLF
NSIRYMETYIVANGLIEELKAKLNLPFYDADKEYLCRQLFAHRVTNNLKTSNEEYAMSVH
KLIERMSEIEKIDLTQNDRLYQSLLYHVPAMVLRLKKGIKIQNPLLENIKSQYSELFSIV
WYAMSILEEEFDVTLTDDEVSLILIHFQIAIEDQSKANNIIIICQYGISSAQLIYNKVRR
FLPAKDNVEISTLDKFHLAEIGEVDLIISSLSFDAGGIPLVRVSPLVSKTDYMNIMEAYT
KYLIEEPSRFIQNELIPKAVKVPTISKFVQSSLVKTGVQVESKEECLDLMISELEANSLV
TEEFRASIFSREKMGNTNLESGVALPHANPSMVIESNIFIVALKNAINWGDRKVKLVIMV
SLAEEDVSEIRGVYEELYQFIGQKEMVDRLLQVHDSEKLLRIFQQKGE
>FECAFAII_03066 hypothetical protein
MNDFTTEIVQTLVTKGDLNELFRSHLEKAINTLLRTELTAFLDYEKYDRTGFNSGNSRNG
SYFRSIKTEYGELTLEIPRDRNGEFKQQTLPAYKRTNDTLETTIIHLFEKGVTMSEIADL
IEKMYGHHYTPQTMSNMTKVLTEEVNAFKSRALNDKYVAIFMDATYIPLKRQTVSKEAIY
IAIGIREDGTKEVLSYAIAPTESTYVWNELLQDINSRGVQEVLLFITDGLKGMKDTIHQI
YPKAKYQHCCIHVSRNIAHKVRVKDRKEICDDFKAVYQANSKEEANTFLSGMIEKWKKNY
PKVTQSLIENQDLLTFYDFPPSIRRTIYSTNLIESFNKQIKRYSRRKEQFQNEESLERFL
VSIFDTYNQKFLNRSHKGFQQVTDTLVSMFTE
>FECAFAII_03067 hypothetical protein
MQQLGKKGLKATLQSPLTFPKKVLFEKYRKQINWSCSTKSLFFVASIVSLISALVLGFFD
SIFSNVLFSFSVFILFLNYNLPLISDVFNMKKFRRV
>FECAFAII_03068 hypothetical protein
MKKNLLLVLPILGFAGFFVGVPMLSANIGISSYAAKKVIDIINTGSTVATIISIVAAVVG
GGLITAGIVATAKSLIKKYGAKYAAAW
>FECAFAII_03069 hypothetical protein
MTYTHLTPNELVMIEAYFHQETPVAIVAKQLKRGRQTIYNVYNFLKCGGTALEYFEQYKE
NKRRCGRTEIIFPAEEKEYIEKRSTEGWTPDVIIGRAERTFSCSVSTLYRRFKTGEFNVL
HLPMQGKRKPNGYKEKRGKQAFKRNISERKKDYVVFEEEFGHLEGDTIVGIHHKSAVITL
VERLSKAIIALKPEGRKAVDIENSINEWLQSVPKNLFKSITFDCGKEFSNWKSISNTNDI
DIYFADPGTPSQRGLNEHSNGLLRKDGLPKEMEFNQVNQGFISSVASKRNHIPRKSLNYQ
TPLEVFLSYVNGKFCLA
>FECAFAII_03070 hypothetical protein
MMEYKDKVTNITIITSLICYGLLSISILSIDYGVTILQALVLAMPMYLSLFIMHEIYKLF
VLSKNVEIRVNILVNSYQKELKERRRWRYLLKG
>FECAFAII_03071 hypothetical protein
MLKTKKNSYKLKLSILSIICLLGMIISGHLYRVAYTQFIEYKVHSLGLAGDRYVEYVHYS
LKCSSYILLWLIFSLFELLNLIAISSYHLDKLNTKSSRYNEVFKENVKLESDLNKLKK
>FECAFAII_03072 hypothetical protein
MPIAIGNKRLPVTLDEKRQKELQQLKQKYGKSESKIMCIALDLLIAQEKAGFDVPALKK
>FECAFAII_03073 hypothetical protein
MNLIATYYRTLEELKKQNAKWFFQALLCLEVGVKPSTIKPSEYQALELTYAKFIETKKAK
TVSSEWLDYFENINKYGAYYTMKKEDNENE
>FECAFAII_03074 hypothetical protein
MAQNYYDEFVKLPLDKMAQKMEDMTFLYNETRVPKKHYKEKLSVAVEEMIE
>FECAFAII_03075 hypothetical protein
MKTQHKLLTVKEVVQILVDKEVISEKVAEVLLIPRYWTIETPLVEDAPTMLFEDLVKIAG
YELHYQENLETYENEYWLTKLEN
>FECAFAII_03076 hypothetical protein
MRKKFDYWGVPFSELFPNYHAPHTVECDCGERAKCIKSYCLYQCPTCGKKYTLSYGDYIL
IDEKGKKR
>FECAFAII_03077 hypothetical protein
MAKKISLTMDLLIPVIAFIDGISLGVTENPLVNRIAKGSLFLVFVYLVCSYLLKRAGKDN
SFWRLTKVTVAATAVILTAILPLYM
>FECAFAII_03078 Single-stranded DNA-binding protein
MATLAKKGSLIGVVGRIQTRTYDNQQGQRVYVTEVVADNFQLLESKAATESRAHADQSST
SPSTATFEQRNTATPNNNGLNASQNPFGGQSIDISDDDLPF
>FECAFAII_03079 Single-stranded DNA-binding protein A
MINNVTLVGRLTKDPDLRYTASGTAVATFTLAVNRNFTNQNGN
>FECAFAII_03080 hypothetical protein
MTPTQLKAKVKNISREKEVDPQLVLRHFMMEKFLEKISESPYRENFVLKGGFLIGSKYGI
ENRTTKDIDTTLREMKVTKETLTTVLNEIFSTPTKEGIQFEIQGMKETREADYYPGFSLR
VLAHLENMRPDFKVDVTTGDSIYPATITHSHKLMFEDRTIPLESYPTEQIIAEKLSATFD
FLTDNSRGKDFYDLYTIPKMEKIDEKTLKDSVRNTFTRRGKTDPLKIYYEKDMDVLKNSH
ELKDTWKKYQKSNPYAASITYDETMDSISNLMEKVIHVEEKERKLAYQRHQQMNREMER
>FECAFAII_03081 hypothetical protein
MTKAMVYKLLEEFNGTLALKDAKKAGISPVTIKRMVDRGELDREYPGFFTLPGQFPDELF
MAQKKYERGIISHITALDLYDLTDMIPRQIDLTVPYGYHVSEKGLKEFAVELHYTKAEWY
ELGKIEIKSRYGNPIIAYDPERTLCDIWNPWYTVEDEIKVKAIKNYMESDRKNLRKLNEY
RRILPTDKTMRSYIMALN
>FECAFAII_03082 hypothetical protein
MRNTTHKQQEIENQKAKIRSEQEKMRASKRRLQQLKNQQRIQKEIELDR
>FECAFAII_03083 DNA topoisomerase 3
MKTVILAEKPSQAKAYADSFSKATRKDGYFEIQDRLFTGETVITYGFGHLVELDSPDMYD
EKWKQWALEHLPIFPNQYHYHVPKDKKKQFSVVKRQLQSADTIVIATDSDREGELIAWSI
IQQAGANQGKTFKRLWINSLEKEAIYQGFQQLRDAEETYPKFEEVQARQIADWLIGMNGS
PLYSLLLQQKGIPGSFSLGRVQTPTLYMIYQLQEKIRNFQKEPYFEGKAQVIAQNGAFDA
KLDPNETQATQEAFEAYLKEKGVQLGKQPGTILQVETEKKSAASPRLFSLSSLQSKMNQL
MKASAKDTLEAMQGLYEGKYLSYPRTDTPYITEGEYAYLLDHLDEYKHFLKAEAIPTPIH
TPNSRYVNNKKVQEHYAIIPTKTVMTAAAFEQLSPLQQAIYEQVLKTTVAMFAEKYTYEE
TTILTQVQQLQLKAIEKVPLDLGWKKLFGKESDGKEKEEEPLLPKVTKGEMVTVDLQVLE
KETKPPQPYTEGTLITAMKTAGKTVDSEEAQSILKEVEGIGTEATRANIIETLKQKEYIK
VEKNKLVVTNKGILLCQAVEKEPLLTSAEMTAKWESYLLKIGERKGTQTTFLANIQKFVS
HLLEVVPGQIQSTDFGSTLQEVKAASEKQEAARHLGICPKCQEQEVLLYQKVAACTSEAC
DFKRSEGFI
>FECAFAII_03084 hypothetical protein
MTEKKMSLIDRCKQIDIVDFARNNGMAVVNKGRDYRLEDHDSFVFDRRKQRFYWNSQNIS
GDIIELAKLFFIDKEIQDPKQQFKAATDFILKNEDKTERVENLHFETEKYKDHPVDYQPL
TEKGRNYLKEERKLPEWLIDYAEKEGLIAELKPKHERQNFLVGDDRLDHAVAFLWKDPQT
GETVGASYQGTIVDFNRFGKRGTYKHIDKNPTPNHGFNLKIGDPKHLKFFESSIDLLSYA
ALNREKLQDAWLVSMDGLKHHVISHYVEESISELRRKQTFPQSIEICVDNDRAGHIFYEK
EQMKGIVDPFTNKKIRCERGIPNDWQVPKEYKATYEAVAKEMSVEPEAIMAIHKTETNLQ
LTNQLVSAHDVQSTFGKMLAKGEPVETIDLKEACTTVAKELKVCERADGTYNFDRFYSRK
ANIKDVNAGILLSYKAEQYYKGYKKHEHEFVPEVKKDWNDQLKHEIQQQEIRKQKRAMLF
QQGRQQERE
>FECAFAII_03085 hypothetical protein
MAEEKEPLDNSRLGKSKRKLVRLQNELNEQIEKMFEHQRKTNGQPMNDKRNGHSWFRQQE
RIENKVHSLREEIKQQEKQVEKLERQEEIKEMGYNKYGGLDMTIENIPRIKEEIERFEKG
ESAFSAATIRKYQRKLETLEQLKEKSEKGKENILPEVQAIIDSGRVTQWKKNPTIYFLKG
YRKVALELNENGGFEESKKYQATSEEEKAAVRELLEEARPTDSMKEKENDHFYRVEFNEN
DPEKGLKSYGGEIVTFELIDQLKTLDNQYAAEAGYYKFYFEEVKNGEVVDQIRMDLGDGV
NSNQPIYLELAKLCEQVPEKEQKQSVKNEPVSKEQMQSKETKTKQKGYQKRTAEEIKQEV
KSLSQQALDAVKKHTHSPEDVKELLNFMSRFPERSFRNQLLIEEQFPGATACLGRAALKK
EGIYIKKGEQGNKIFVRKTVKGFYEKGRGFVREIEATPEDKKRIESGQIEVIKKTYYTIE
KVFDITQTQLKPEDYPKIFPNRVFDFQLDKKGQSELQAGIQAVANNIGIQIRDMTESEVY
QRELGQARGAYVRNEFTGEEEIVMNTRNTPTQHLATSIHELAHARMHKFSELDTATKELQ
AEMTSYIVCKHFGMDTLEKAIPYIAAWTKNGQTLDDKEAAERGKIMNDVSRVANEFIQTI
SNEINQYREREPEIQPAEVKQEHKNTVETAEQKNIVPVGSLWIDKKDGKVMEEDTGRTLH
LKDAAFIEDPQHNQVILKGKSYGKEIQTALPSEEFALGNSFRFSLETVSEVAKRKNEIYY
EQQLSQKERV
>FECAFAII_03086 hypothetical protein
MKLFVGIDVSSEKLDVCFLTDDNQLSILSEISVANDIEGASFIRETILEFNNSYHFDQIV
IGMESTSMYSFHPSMFFHEDEKLKKLNTLVTIENPFRVKQFSRMFDENKTDRNDALRIAD
FLRIQRFTTSPIKEEKYMALQRLTRTRYQLIKQLIRTKQHFLENLTYKCNTLAREMRDES
TSLFSATLISLMTEDFTLDELAELPLEAFCDLLQEKGKGRFKQPEKIAKAIQRAITMSYR
LGALAQESINVVLSVLVREIRALEKNIKELDKAIEQVIVVIPEYQCLTSIPGVGKVYAAG
LIAEIGQIERFEDQTKLAKYAGLSWKVNQSGNYQSQNTPLTKQGNRYFRYYLVEAANSVK
NYLPEYKAFYQSKYKEVPKHQHKRALVLTARKFTRLVDTLLRKHQLYTPPRNVIEK
>FECAFAII_03087 hypothetical protein
MVHSTIGVVVEKSRDNLVFVTEIQTGRSFVVTDKAAKAYQSSDILTLNLTTKTFVDATED
YPFV
>FECAFAII_03088 hypothetical protein
MKQYLDQWKVIEGSLREERIEQLPDCLEKEHLFQIREMLRNEQFDPNQFLVVEYPATGVY
CCNHVNGEKYFIIQEYEGKLAPYYTTWEMNEEGINNFPCKSIEESISLTEC
>FECAFAII_03089 hypothetical protein
MTQSPSVILTCQFTLPNKKSFSTYIDYITREQALEEKERRTPEEEQELQRIKNALEEFYI
PEGETFSESKTGKEFSETSNEAQSLMEHGINFDKLEEQDFTNYLSYMTRHYALEQKKELT
QSEQKEYQRLNQAMKKYQTEPHKKASGNLPGVFSIASDEVKGSDLKEIKQIFQRGQQKGS
IIYQDVVSHDHSYLEKIGLYDPKTDTLDEEGLKAAGRKMMETLFEKEQLNETGYWMATIH
RNTKHIHIHFAVVEKKNTRKPYTEIENGVSYIVPKGKRRQATLDEMKTNYVHELERFSYE
KNRMGMEKRNLLTRKSDLRNTLTKVVKEPVRYDRHAMSLLTEVYKNLPKKRSEWHYGDEN
RTKLSPYTREKLDELTKYVLTKEPEYQEYIQISKALKEEAKSLYGESKRESKDAEKNALF
DLKKRTGNAILTELKKQDSQIKPLIERMDQMQSIYNERSFRTLKQLPTNEYKYSYEEFMK
RRKQFQQRVVTQRSLRQLNRTINAHEEKYHASKAYEEQQRRIQMEQERQ
>FECAFAII_03090 hypothetical protein
MAKVIDKHIYFHQTHIDVLDEIISTHAEVKNYSEAVRFLCMNYDPEVEKKVNSNQAKLNG
MSKEISILTEMVSEFADLHLKDTGILIGKNSTVYQEAKERVEGKIKSNQTKKYSPQLKKP
VNESVHARVDPFDPTKILKR
>FECAFAII_03091 hypothetical protein
MNVKIRDLDPKFISEIDRRCVELSNRTGNKWSRNDYLKLLVENDFDRPLMEYKQEKFDQL
LEKFSEIQSYNTKILEEYVSQNNRIIEILIEQNRGSEL
>FECAFAII_03092 hypothetical protein
MILLYRIVLIVGTELKILKKEQLFKVKEHHNQLLCIKTGTMNIQYRTEYLELTNQTDFLS
IREQHKQEKLMATYSQLIDEWEQFKESKT
>FECAFAII_03093 hypothetical protein
MKKTYQKFLWISYIVLFIVGFLVSVSVIVGTLFLLFSDEDLVLKGLMSTLSCVMLLYLCI
QINEIMPPHWQEKKKEFKEEIEIKSNDWIEYTWLPLKRNSKRKEFWALQLWPIGKLFIYM
ASLMVTLIGYLVVVYGVAYYLLSEPKQIAASNIFTAVMTLMCVMCFSIFSYLLVQFIRQN
LTMSKLFKSLLDLLILGSMLTTLTDRFEQSEKTVEGIKNFLTTIDQFINGYMYLFEVGFI
LTLFGCVFIKLIKRSIEKEMVIDLIPTLSGYEYYVDFGKYEELIHTDIVHTSIHEVTVKG
IRSTLKDGQETKTIDRRKEVYNFYKVEASLRYGIGKLRLDGSNIQQNKPYVLGKVVI
>FECAFAII_03094 hypothetical protein
MKRANLVGKDTFAEQKVLIKAYLKVVKAKEICQEVNYLTQQYLS
>FECAFAII_03095 hypothetical protein
MSKKKGERQRFKKRKSYLRWLGIFMIIGFLILASPIYTHKKVDIPDEVSTNAFLNTKELT
MVSKEKGANQQLVFEFAIDDEDQSLLKELANLNYRVEVKTAKGDYQAIKAKVIKVSDDYF
AVKLSHVPEEYIAMRLTIIPEKIDPKVDMQEPQDLIFYIHEDKVKDHVKDEDYEQHAINY
KVKGYKKEQKAAQKQIESFQATIDLNEELVKKLKDQLPYQVAEDQENTENKINSYQQEIE
TSKTQMKDQEESIQKLQEKIDRMTKENI
>FECAFAII_03096 hypothetical protein
MENKTLKIVLTAAISVSLIGNIALFWQLKEEQATNTYKIEEVAKNASEKLKKNSSSAQAK
IDKLNQTINEKNQEIDQLKQQDGTKAKEEVNEAQSKTAEEFGKLAIDKSLSRNELTEKLK
DVATQEVIDKLSPADDDHQHDDYGSYSFTLGDVQTYAQTSSVKEEQNFVVFVDYTIGNPQ
FKDVKPQKIKGGLTVTEKQVDGQWKVTDFSYFTR
>FECAFAII_03097 hypothetical protein
MENQNESLIKQYVKRRAKRRLFLWVFGTSAGLITILITVFVTLFLILAAGSIDNSDSDSS
SGGEAFTGEYSEGLPIYKEIKGRGPFSDEIAQYAVGAAVKYKLLPSVILSQYGYESAFGT
SASARNDLNYFGITWFDGCLFPKGTARGIGGIEGGWYMKFPNSKAAFSYYGFMVATQSNF
NACVGNKSPGASLLILGRGGYAAAGITEDSPYYTGCMSIITSNKLTEYDEFAIKHWGEGG
NNNGTITGEWTNPFPGSSLDKSTFSGGQLFGTNPGSEFRPNGFHDGLDFGSVDHPGSEIH
AVHGGKVVYVGNPGISGLGACVIVINYDGLNMVYQEFANSTGNSRVKVGDQVKVGQVIGI
RDTAHLHLGFTRMDWRQAQGHAFTDDGTWIDPLPFLNSSKK
>FECAFAII_03098 hypothetical protein
MLEAIKTAFSPQNDQKVLDPLKQLGNREIEILKSKGYDLDFLKQVMPQGGLNFDEEYVTY
GNGYSRCVTVYHYTKNPTLFWLANLMNNPHTVATLDVSTDEKQKVIDQINRALDELNDRS
DNERKATDRNKSAEEYLELAEYARKLTSNGEISKQVKVRVHVYGNTIQEVDERAQELIEN
LKGMDYRAVTYLHKTKRDWQSMFTMFDEQAEWFGNIKGQSLPSLNIGGGFPFHHQTLKDP
GGTQYGETMTGGPFVWNATYKNSVRLSTNTLLLGMMGAGKSTVLKMIAEAHLAAGDFIWG
FEKGKDFIPFLKEYNGIMVRLDGSDGMINPLEIFATRTYDEASSLYDDGSVKDLKINEAA
SYQTHLDKVVYQVQLVSPQLKGTMKAEFKTYLNRFYEEYGTVPRGFTSSNSRSNTETQVT
GKDPEAYPTFKEFLDFLGQLELPGASQEKKNRKEEMESIVESLCETYGMIFDGHSTIRHL
DQQQLVFFDIDSITGLDRGVQQCQMYMAMTLIWNQALIQGRRQRRLIKEKQMEEQDFKRF
LAMIDECHNAINPDFIETVNYVTNFQREMRKVEAMTVLATQSPQEMVPENMSSDNFSKLK
KVFEFSSTKIFMRMDESILRHIEGLVGKSMTNSELESIPQQNQGDAVINFGSKETIRVHF
SPNKRQLKLFDGGK
>FECAFAII_03099 hypothetical protein
MKYPLIWLEKDVPKEETTRKFPHTLSLGKLGKGQSFHQVKNQTRRGDCTC
>FECAFAII_03100 hypothetical protein
MRVKGQNSVDKKSIFQFGKPEERSILDLFPYKSCTEEGVLVTKEDHFQRYYRVVSTDVEG
LNEQEKLERMNQLTTVMRTYVPTIKLVSLTTETDLTEQIVQKRQLLDKNRMEQSLGRNLQ
RLRKYEKKLVEEIQELKRAEQERPDLSFFFIIEGRTIKDLQTRNRQLMRSSGILGLKPLY
KKELIKILYRMNNMNDE
>FECAFAII_03101 hypothetical protein
MDKYINMKNPPRFSGEWKFFAFFFLDLLTLGGCFFWAKIVNNLVHLPLFFALLNYGLWIA
IALVIVWRPYNNPGQRQIFAIIESIFFTDKNHYHALDPNRNYHGTYKEDE
>FECAFAII_03102 hypothetical protein
MIIGGIFSGIADWWSGLFGDGDADPKTVTKVLQDYGNYLQYQDVFSWICNTFLWGLIKGL
YNLNTLLEKTIYQSFDLKDLLNAAGVNELFQSLISKVLALFCVVTLIYLGLKFFMSKHPP
KIKNILVNLFMAMILIFGGSSLIDEGLNISKNFYGDVTAANKADKTGSPAFQIIQNNVID
VSTLLENDPNKVEHIPTDKRNALTAKNFKTANINGIITPDQAKKMSESSDISTVQKDRLK
ALQYRLELDDNGKEIPVQISDEGLAKYVYTSGYRRYISSPGIILAGESSLSVAYLFILFT
IVTCIIELVFKKFYLVIAASTDFETGQRMKSAIEDISQSFLLLAFTILELRIYTLMLSGI
GDLHAAGKINGFLYVVALIVLTIALFKGSQSVTKIFGVDTSLKNGSNSLLSMFALGNVAK
NVGSGAKNLASAGKSGLSNLNDIRKNGFGNRKDVTPDNGEEQSDDKATTVPNSKKTVSEM
FGKAKNGVSKAAEGLGYVNERGLKGTAEDLTEKAKDTLEEKLDGTRAKELAEAVKNPSET
LEKQKEKASEIKEGLKDAYGEGQVNAAVKANTTTEKENQEGAAIPSAKDHQDELHSNENS
EEGQNGQLPKTDPEQYRYKSNINSENEKRISDLPKRNQEVQTDDDSIDLPNDNGVEVGTE
KSTKIGLPKAQNLPMKDSRLNQFKENDQSFVHQSTAGNVQMKPSRLPENGNLTTVSYNLS
ESGETGNASVQNVVTREAAPEPIQRVHTGYKPANVAFTAPTKINVTRETKNRNNELKEQL
LRDIKQDIKP
>FECAFAII_03103 hypothetical protein
MDNMEGIMTVTAGRNMLWDLFIQSYQQLYAKYGEQNAAIIKENCQTHIYIMSTDDNTIEE
FSKKVGNKTVEQENSTINSLGMNTHINRNVDSDRILTPERISTFLEGETIVLAPLKRQDL
KGHKIRPYPIFNHGETNLPYAYQYIEDFNPSWDINDIDIHCTHADLDLKALQIDYDYFLP
DIYARRLYHNMHDQIEEEAKENIFIKIVQSLDNSTAQKLLIQFYEEKQIDRLQEYLEKLR
QNEEITEVIRKRLLLEAEKAVKE
>FECAFAII_03104 Group II intron-encoded protein LtrA
MTNTKGISLKNKQLRHAEYYDMTETFDELHAMSVAKSNFKNLMKFIIDDNNIFLAYRNIK
KNKGSATAGYDGVTIKDIEKLACGDFLTIIKRRFKDYRPRKVKRVEIPKPNGKLRPLGIP
SIWDRIVQQCILQILEPICEAKFNKHSYGFRPNCSTENAIADCLARINQSKMNYVVDIDI
KGFFDEVNHTKLMRQIWTMGIRDKQLLVIIRKMLKAPIVMRNGNVVFPTKGTPQGGILSP
LLANICLNEFDWWIANQWEERTVKELKHHYRKNGAWDKGNIYSKLRSHTSLKEMYLVRYA
DDFKIFCRTGEEAQRAFYATQKWLRERLKLPISMEKSKVTNLNKAESEFLGFSIRLHKKG
KKKVAFTYVCRKAEENIKNKLKQQIKKIQYAGAKKNRHRAIGDYNMMVIGIHNYYRIASH
CSVNFTEIYRSVRTVIEARLKARGMTKNGIYGQDHEGYRPYLKSKQMRYIEGFPILPIGY
IKKRTPLNKRRNLNKYTKEGRKLIHQEQQAIESWKIKYLVKGFSNNKKYTVEFSDNKISK
FISQKGKCAITGNELLMEEIECHHINPYHLSKDDSYKNLVIISREIHRLIHATSEETILK
LLRLLKLNHYQIRKLNTYRKKAANFPISIKMN
>FECAFAII_03105 hypothetical protein
MRVRETTRRKDKRFNLEKNRYLSHFYRYTPSGEELPEKHDKRISQKIFYSGLAYLPLNYV
VTRIPEAFHRFEIIPGSLQGVNIFQLQEMPQLFHFDSTGFWNPLTPTTSLGTRLVVSTIC
VVPAVLMGLKMDMWFRPLADGQKGDNRLKTLKEIQQIYPQIPESKGGFPGYGGIPITHYK
KYWYIQTDTVNTCIVGTSRSGKGQIEVLATIDNLSRAERQSSMVVNDPKTELYVASKDEL
EARGYDVYAFNITDPLQSMSDNPLALIVKYWKRGDIDTATQLTNTFTNTIYYDANASDNK
YFNENAQKAVNALIFALLEQADQTGDYSKLTPNNLVELLSEIGGFNYQDPDNEFKQLNAL
DEFMNQLPPGNIAKKQYGATKIGSDKAKGNILSTAITGLNPFTLTKIAKMTSQSTIDYKS
IGFPKYLDLKLHESLLNQRIVVEFYHQGKKFHEERVKVGYRGFCEINFDCHLEQGDHVCL
KYDHRGKEYVAWYEFSQRVLKDEEGNIVYRKKRGETHLPELEKEAVLTLDEDKSNLLVES
IRMHYTDKPMAIFMLTPDYDPSNHIIVSIFLSQLYKELSTQCVKTKGDKCHRRIHFILDE
FGNSVTCLA
>FECAFAII_03106 hypothetical protein
MYFTIAGNTKTDKELIKKATKEVGKRTSFLPKTIKYSVIETEEQLHVLGKVLEHESRSSV
KLTLTLHDTEGKIEKAGTEYVFGPLDYQISEGFYPTLMDLIRLDVFKETDETMSVEESYR
NEKLLQVLEEELESDQRKVNQGSEVEVNEEVPWERPIFPKKESKEKETVYVDEQADIPTQ
KSIFEEENDVMGQLEVDPFEETMEDEETAEVEVDPVEANEESTWTEGDSQEYIEPLISEE
VEKNEIEIQKATVFDYILDQYPPEHEWMKEKNKLFLNELYSKYQLPQTYQAFLESKEELI
SQGKGTLLEQLESVQSTNWHELAQEDLLATFEERQQETDQEINEYATEQSSNWEKAKEEL
NKEEQRVIEEEVQKIKERYEKKRDNAYSLCVAKINNFTQTNQEALSKEKENLLKERIKER
KEEFYRGLRTDKLKISKELNEQLNKLYQTTTEVLMEKYEKIQQELQVQIPKWKKEYEIQQ
QELKEQEEKQRQKEKEREQLELKKREQDLAEQQMAIEKQRLNQEKEKEAAARKERQEQMD
TLRQAQLNYLAQPQPTPSVAAVQTPMNNQTNLTPSPQRSFNGWMVGCIASLSLLLGGGTV
FAFNHINQSSQADSVATTTSIKEEAQEQARKEYEQQLEELLNRTNQSTTESSMENSKESD
PSKAKEGSSDSTVQSNTSESSESNEVK
>FECAFAII_03107 hypothetical protein
MFESITMNFLTQPKVVAAVDIFRALQTAATSLKNNLMIFAAAAAVASIVIGGLFFLFGRR
GAENGKMHVGYVLMGVGVILAAASIVVSLFGLFGQTPQGL
>FECAFAII_03108 hypothetical protein
MIASLFICPEGGITVAKAKTPFEKAASKILERRGVSETQWKQEVLEKAQFDLLRGKDKDL
EGYIYQREREKLVFDEIIKH
>FECAFAII_03109 hypothetical protein
MIAMIVILVGCSNEKNKQTNQDNGVLKSGTMWKEEVGGLVYNLKIIDETTWEYSESVWHP
DPVQITVKRQKDYKGLERYKIVDSAGVREFINKSDSLFIVVPYEKNGVKKIIFLGSSKDE
KRTKEKLIHDGSQSNKYKLQKTSE
>FECAFAII_03110 hypothetical protein
MNFKHSWTRRLKYVFPIMMMLGTLFGLKTANVFAEKVIVDPSNPIQNVKNNFIIPKDVPN
AKTNITVNGASKVYKYHVDANKGGFTDDYVGLVEGNKNIRYPSFQKEYGETNLVLEGVTT
NTKVNIDYGKIGTYNGKKVNIKLVLSNIHLYSDTLPWNLLDNNYTKTHFRDDGYKNTNGA
MSKSKKRTVLWISDNLFSGIVYHSTQMNVQLVATYEDGSPVQFSGDTFISFNSLNPAGGK
STDLKGEYAHYDKMNTTDWYVRKDTVLSEFKSFYNNLNVVGGHPGGSSKLTQADNDFNNL
HDKLGDPKFGQGTVSFKISEANPTFVIGSSNVQTWFTLSSATIFSVVPDQPEKTGVDKNG
NNVNDKMLQVGDTIQYRIKQKVNRLGVDLLAVYDRFELIDNLPKEVNYVDAHVESGTNKK
FDVSGEVTYDKTKHQVKYAAKADTLKNRMKYNGETYELVINVKVNELANQNSVAKNQGTS
IINKVEKDTNIITVYFPKIPVKEVQQNGKDVNGRNDGKKGTPTAPLNAGSEVQYLVTQKW
HTKGVDAASDHYKQFSIQDPIEARLTYKEGSAQVIDKSKGKDITSEGTLTYDSNSRTLKW
EASADFLSNNLLDGREIQLIFTAKTPLQSEKNIDNQAVVAVDNVSNKTNVVTIGVDPNLP
QVIVPKTGSTHLVTISAVSLLLLVLATFSYAVLRYI
>FECAFAII_03111 hypothetical protein
MKLIKLLLFNFSCLTAVFLYCGLLFSKLSILPSYQLYLMRILNIPAASMPLDIMEKLIRN
PLFTTINLIVIVGISLVIYKKEGMKG
>FECAFAII_03112 hypothetical protein
MRNRKWLFVCAAALFSFTAYTQLTFADRQESTDSTEQTIQTSDSSTIQSSDETVDSSTVD
SSEEPKIAEDDQIVKQTIHVQKIISSEQLDNQGHEKQEGVNGAKFSVYDVSDILQKMDVK
DLTTDQIESQLKNRVKKLSSDQLKLVSNEETKTIDQQTGVFEFSVEVQANQKQAYYIVNE
SSPENISNSEDILLLTPVSDKNGEFLKDVWIYPKSEASQPKEEVKKIVSTGVKKNFFENC
WDFVTHLFSRD
>FECAFAII_03113 hypothetical protein
MIIRKPKKKRIMGKWIIAFWLLSAVGVLLLMPAEASVAKYQQNQQIAAIDRTGTAAETDS
SLDVAKIELGDPVGILTILSISLKLPIYDGTSDKILENGVGITEGTGDITGGNGKNPLIA
GHSGLYKDNLFDDLPSVKKGEKFYIKVDGEQHAYQIDRIEEVQKDELQRNFVTYLESNPN
EDRVTLMTCTPKGINTHRFLVYGKRVTFTKSELKDEENKKQKLSWKWLLGSTVFLSVMII
GSLFVYKKKK
>FECAFAII_03114 hypothetical protein
MAINRYVKKAGMLVGMLGIIASCFQGYQAYAEDVTQKTPPEKVNITVHKLMYDQGTQLNV
DIDGIKNDGYTHDQYPTGVTKYNKADYGDVEFTLGNITDQVLPTEDSDLTNAKVDEIVKD
VEDKGSNSEYVKNATNKITSAVDENGEITFADQPAYVNSKGNVYVVYESKSAAGLVTQKA
KPMVVIAPMTDNTGSGFLKDIHLYPKNIVSKLSFELTKFGDDGTAQSKQTPLKGAKFELY
KGEPGKGTKLGDLVSDDQGKLTATDLTLGKYYFVEVPSEVVVGSDKEPTADQYLLGADAR
NDAHNKLTFEITNDGVTSDLKASYVNYKAPVIDKTVTNGTGQEHSFQIGDAVNYQGTIHI
PTDIAGGAGGITVNGVKSETSPYSVFKWGDIAGQGLSYVAAKANIKVTNKDGSVVLKENT
DYKIQNSENGFVIDFIVNNGQVSDTVASLHGQDLQMTYNMYVNDSAAVANPLTNSVDFVY
NNNPFNQEEHHEKTKADVVTYGAKFLKVDSGLFGIGIKATPLEGAEFAAKNAEGKYYGGL
VDTDKNGVKEAVWVDDVANAAILKSDKEGHFEITGLTEGEYSLEETKAPENYQKLTKEIS
FKVDKDSYKEENRITIKNNQKASVPMTGSNGFQTYVLISCLLLGAGALSAVVYFKKKA
>FECAFAII_03115 hypothetical protein
MDEKMVIFFLGVALIVFCSVFGYVSYQKHEGEVFKQNIEKKIPVDQINAHAKSYKEDATN
VNNDMSLGQMLSIQKEAIEMGVNKQVFAQIQIPALGLALPIFKGTNQYTLSLGAATYFYE
DGEMGKGNYVLAGHNMEMPGVLFSDIQKLSLGEVMDLVSNDGVYRYKVTRKFIVPEYFKL
IDGVPEENSFLSLPKKGEKPLLTLFTCVYTSQGKERYVVQGELQ
>FECAFAII_03116 hypothetical protein
MDGGVKSSYDIIYDNAAQLVTFFVGCLFLLNLYKVKRNDLFFIAAGILFYLFFSFFRSYR
VDTFYGDLIVPTIIAIILIVKWTEFTVFDRSLYLVVFYVFLLVTVYRVFTEIPVPEGQSI
WNPSNKLSDIWINTNTIGSSLMTLALLITGFASSFVKWYMRLLSLPALILAGATIWVCQS
KAALYALVIFVILEILPKKIFRNTHLSFWMYAAVSVLALPISYFAAMSDKVHLFTGREEI
WRKFYETLGEKTGQIFVGMKPFFFHIGNQILGNHNTYHALVNHYGLIGFALSIIPLLSFL
WLLVRKCELTNGQLTFLWAFLAIMCQSFMEETLTTISWVPIVFLMLAMATHQYKTTR
>FECAFAII_03117 hypothetical protein
MNKNNKTLFNPYVGVIIVFLLFSYFAYQGHQKDKIAEKVDGVTKTIHIQEQDKTYQDNLT
SLTDISKRQLITNQKQALEKDLKGEIAGKLVFSSTGFILPVFQGANSDTLSLGVASTYYP
DAEMGNGNYILAGYNVDTPSVLLSDMIDLSEGEEIDLIDAHYKYQYEVSKRGKIYDYSQV
VQSKENNSFLSLPKAGKKPLLTLLDFEANNMKKCDVIQCELVNVEKINK
>FECAFAII_03118 hypothetical protein
MARPVLDAMDMDTLTKGRYVQLLARSYSPKDVFKALSKGTDMEKERLRKEFDYWRIYNGI
KDLKPARPVVKRKKKITQE
>FECAFAII_03119 hypothetical protein
MKFFEVKSPCYYALIAENNEEECAEITTNNKKLVLSLDIE
>FECAFAII_03120 hypothetical protein
MKNYDPNIRLGTHTIKVSFQRWDYKGFVTFRRGGNCKGLDVLALDEDDLYD
>FECAFAII_03121 hypothetical protein
MSYTGILSLKDICHYGKRCTATEKITKKLSTGQSKTVVQCKKYIIQKDKVSEEMIYYIGK
QKQIILKDPIPLKELYPTIKHVYDQNGVLIGRRKNGVLRCTAKGMGRLIS
>FECAFAII_03122 hypothetical protein
MTDFNFFKADRVYNELFYQFPKVFIVSDEYKKMKDSTKIAYMLLKARLEIAISKRQIDEE
GNVYFTYTTNELCSVLNCQKQKAIAIKKELESFGLLLQKQMGFNKQLGKNNPNRLYLAEL
KVSENDIYLLEKFDRENRENVDKSEGMKIIPTLDEKSDAESLGAQEGMKIIPCQNVDKSE
GMKIIPELNNNILDTNRHNIDTEKDRLQDQLLLDNFETIMTNDSIATFVPERVLNLIKTF
SSSYSEAQKTVQTIHNAKKKAEIESGISIVFEELDSYYVNAEQELYTTLLKAYQKLKTEK
VENIQNLIFVYVKNWFIEKPIAAKVSSEKRLNYESSPSTITKDWLE
>FECAFAII_03123 hypothetical protein
MNDSIKKMLRLIEKDLMITEVSYETFQKKKTLIVDAVFSPAPHTCRNCGSTVVDGNGKVI
VVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKNCQVSLTTVIRTLKEFKSYLPKQSKRILPRVLMVDEFRSHASIED
KMSFICADGETGQLIDVLPTRKLPRLTSYFLGCTNPEEVKFLVTDMNAAYFQLTKRILPN
AKVVIDRFHIIKHMNQAFNELRIREMNELRKVGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLGFSTSLKEAYPYFHELVEAFRDKDPDLFFSLLAELP
ETLDDGFREKLQNLLTYEEGITNAMIYPYTNGKIEAKNTHIKTMKRVSYGFKSFENMRIR
IFLINQLIKVR
>FECAFAII_03124 hypothetical protein
MPTRKLPRLTSYFLGCTNPEEVKFLVTDMNAAYFQLTKRILPNAKVVIDRFHIIKHMNQA
FNELRIREMNELRKVGQKSQAEKLKKNWRFLLKNRANINHYEYKTWKSFRAPKYPFLTEA
MMIDRLLGFSTSLKEAYPYFHELVEAFRDKDPDLFFSLLAELPETLDDGFREKLQNLLTY
EEGITNAMIYPYTNGKIEAKNTHIKTMKRVSYGFKSFENMRIRIFLINQLIKVR
>FECAFAII_03125 hypothetical protein
MSYTGILSLKDICHYGKRCTATEKITKKLSTGQSKTVVQCKKYIIQKDKVSEEMIYYIGK
QKQIILKDPIPLKELYPTIKHVYDQNGVLIGRRKNGVLRCTAKGMGRLIS
>FECAFAII_03126 hypothetical protein
MGFNKQLGKNNPNRLYLAELKVSENDIYLLEKFDRENRENVDKSEGMKIIPTLDEKSDAE
SLGAQEGMKIIPCQNVDKSEGMKIIPELNNNILDTNRHNIDTEKDRLQDQLLLDNFETIM
TNDSIATFVPERVLNLIKTFSSSYSEAQKTVQTIHNAKKKAEIESGISIVFEELDSYYVN
AEQELYTTLLKAYQKLKTEKVENIQNLIFVYVKNWFIEKPIAAKVSSEKRLNYESSPSTI
TKDWLE
>FECAFAII_03127 hypothetical protein
MTDFNFFKADRVYNELFYQFPKVFIVSDEYKKMKDSTKIAYMLLKARLEIAISKRQIDEE
GNVYFTYTTNELCSVLNCQNKKR
>FECAFAII_03128 hypothetical protein
MIDRLLGFSTSLKEAYPYFHELVEAFRDKDPDLFFSLLAELPETLDDGFREKLQNLLTYE
EGITNAMIYPYTNGKIEAKNTHIKTMKRVSYGFKSFENMRIRIFLINQLIKVR
>FECAFAII_03129 hypothetical protein
MNDSIKKMLRLIEKDLMITEVSYETFQKKKTLIVDAVFSPAPHTCRNCGSTVVDGNGKVI
VVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKNCQVSLTTVIRTLKEFKSYLPKQSKRILPRVLMVDEFRSHASIED
KMSFICADGETGQLIDVLPTRKLPRLTSYFLGCTNPEEVKFLVTDMNAAYFQLTKRILPN
AKVVIDRFHIIKHMNQAFNELRIREMNELRKVGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKVPISYGSDDD
>FECAFAII_03130 hypothetical protein
MNDSIKKMLRLIEKDLMITEVSYETFQKKKTLIVDAVFSPAPHTCRNCGSTVVDGNGKVI
VVKNGKKETIVRFEQYNHMPLVMRLKKQRYTCKNCRTHWTAQSYFVQPRHSIANHVRYKI
ASLLTEKVSLSFIAKNCQVSLTTVIRTLKEFKSYLPKQSKRILPRVLMVDEFRSHASIED
KMSFICADGETGQLIDVLPTRKLPRLTSYFLGCTNPEEVKFLVTDMNAAYFQLTKRILPN
AKVVIDRFHIIKHMNQAFNELRIREMNELRKVGQKSQAEKLKKNWRFLLKNRANINHYEY
KTWKSFRAPKYPFLTEAMMIDRLLGFSTSLKEAYPYFHELVEAFRDKDPDFFSPYWQNFP
KR
>FECAFAII_03131 hypothetical protein
MKRYWKLLQKEEAKLNYEKRVWRASFKDYLTESEIADRLLAACPNLRQGYQLYQDILYAV
KKRDQSLFEDCLTRDISGLPETYTTTLRTFKKFLPQIQNALHYSYSNGPLECLNNHIKVL
KRNAYGFRNFYNFKLRIMIRHGKTFWLYNLWD
>FECAFAII_03132 hypothetical protein
MLKNTVSLVKKVRWSVIARLKENTSMTEIARQKNISTSSVYRVMKRFYRPLNPFKQTLPK
VLCFDEFKSVRSVASAMSFIMMDGQSHALLDIVENRRLPYLERYFSRFSLATREAVQLIV
IDMYAPYVSLVKKLFPNAQLIIDRFHIVQHIGRTFLNHRVKETTYDLKEIPTLNEG
>FECAFAII_03133 hypothetical protein
MSHTQLIKDTLNILDLNIYFEENCLTKEKYKGQICLIYKGTLLYKPEECSHCLCVVPSRI
IRWGTTTVRLLLNDVSEYRTYLELKKQ
